PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Pink, RC; Eskiw, CH; Caley, DP; Carter, DRF				Pink, Ryan C.; Eskiw, Christopher H.; Caley, Daniel P.; Carter, David R. F.			Analysis of beta-globin Chromatin Micro-Environment Using a Novel 3C Variant, 4Cv	PLOS ONE			English	Article							TRANSCRIPTION FACTORIES; CHROMOSOME TERRITORIES; ACTIVE GENES; NUCLEAR; ORGANIZATION; DOMAINS; COMPLEX; SITES; LOCALIZATION; ARCHITECTURE	Higher order chromatin folding is critical to a number of developmental processes, including the regulation of gene expression. Recently developed biochemical techniques such as RNA TRAP and chromosome conformation capture (3C) have provided us with the tools to probe chromosomal structures. These techniques have been applied to the beta-globin locus, revealing a complex pattern of interactions with regions along the chromosome that the gene resides on. However, biochemical and microscopy data on the nature of beta-globin interactions with other chromosomes is contradictory. Therefore we developed a novel 4C variant, Complete-genome 3C by vectorette amplification (4Cv), which allows an unbiased and quantitative method to examine chromosomal structure. We have used 4Cv to study the microenvironment of the beta-globin locus in mice and show that a significant proportion of the interactions of beta-globin are inter-chromosomal. Furthermore, our data show that in the liver, where the gene is active, beta-globin is more likely to interact with other chromosomes, compared to the brain where the gene is silent and is more likely to interact with other regions along the same chromosome. Our data suggest that transcriptional activation of the beta-globin locus leads to a change in nuclear position relative to the chromosome territory.	[Pink, Ryan C.; Eskiw, Christopher H.; Caley, Daniel P.; Carter, David R. F.] Oxford Brookes Univ, Sch Life Sci, Oxford OX3 0BP, England	Oxford Brookes University	Pink, RC (corresponding author), Oxford Brookes Univ, Sch Life Sci, Oxford OX3 0BP, England.	dcarter@brookes.ac.uk		Pink, Ryan Charles/0000-0001-7501-558X	Action Medical Research; Dunhill Medical Trust; British Society for Haematology	Action Medical Research; Dunhill Medical Trust(Dunhill Medical Trust); British Society for Haematology	Ryan Pink is supported by a grant from Action Medical Research; Daniel Caley is supported by a grant from The Dunhill Medical Trust; David Carter is supported by a grant from the British Society for Haematology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett O, 2006, BIOCHEM SOC SYMP, V73, P67, DOI 10.1042/bss0730067; Blanton J, 2003, GENE DEV, V17, P664, DOI 10.1101/gad.1052003; Branco MR, 2007, TRENDS CELL BIOL, V17, P127, DOI 10.1016/j.tcb.2006.12.006; Branco MR, 2006, PLOS BIOL, V4, P780, DOI 10.1371/journal.pbio.0040138; Brown JM, 2008, J CELL BIOL, V182, P1083, DOI 10.1083/jcb.200803174; Brown JM, 2006, J CELL BIOL, V172, P177, DOI 10.1083/jcb.200507073; Brown KE, 2001, NAT CELL BIOL, V3, P602, DOI 10.1038/35078577; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Carter DRF, 2008, BIOCHEM SOC T, V36, P585, DOI 10.1042/BST0360585; Chakalova L, 2005, PROG MOLEC, V38, P183; Chakalova L, 2004, METHOD ENZYMOL, V375, P479; Chambeyron S, 2005, DEVELOPMENT, V132, P2215, DOI 10.1242/dev.01813; COOK PR, 1995, J CELL SCI, V108, P2927; Cremer T, 2006, CURR OPIN CELL BIOL, V18, P307, DOI 10.1016/j.ceb.2006.04.007; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; de Wit E, 2009, CHROMOSOMA, V118, P25, DOI 10.1007/s00412-008-0186-0; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; ESKIW C, 2008, RNA POLYM 2 AC UNPUB; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gribnau J, 2000, MOL CELL, V5, P377, DOI 10.1016/S1097-2765(00)80432-3; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Kumar P, 2007, NAT CELL BIOL, V9, P45, DOI 10.1038/ncb1516; Kurz A, 1996, J CELL BIOL, V135, P1195, DOI 10.1083/jcb.135.5.1195; LICHTER P, 1988, HUM GENET, V80, P224, DOI 10.1007/BF01790090; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Mahy NL, 2002, J CELL BIOL, V159, P753, DOI 10.1083/jcb.200207115; Marenduzzo D, 2007, TRENDS GENET, V23, P126, DOI 10.1016/j.tig.2007.01.007; Marenduzzo D, 2006, J CELL BIOL, V175, P681, DOI 10.1083/jcb.200609066; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Mitchell JA, 2008, GENE DEV, V22, P20, DOI 10.1101/gad.454008; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; Osborne CS, 2007, PLOS BIOL, V5, P1763, DOI 10.1371/journal.pbio.0050192; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Palstra RJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001661; Ragoczy T, 2003, CHROMOSOME RES, V11, P513, DOI 10.1023/A:1024939130361; Ragoczy T, 2006, GENE DEV, V20, P1447, DOI 10.1101/gad.1419506; SAITOH Y, 1993, COLD SPRING HARB SYM, V58, P755, DOI 10.1101/SQB.1993.058.01.083; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Sexton T, 2007, SEMIN CELL DEV BIOL, V18, P691, DOI 10.1016/j.semcdb.2007.08.008; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Verschure PJ, 1999, J CELL BIOL, V147, P13, DOI 10.1083/jcb.147.1.13; Volpi EV, 2000, J CELL SCI, V113, P1565; WEINTRAUB H, 1976, SCIENCE, V193, P848, DOI 10.1126/science.948749; Williams RRE, 2002, EXP CELL RES, V272, P163, DOI 10.1006/excr.2001.5400; Wurtele H, 2006, CHROMOSOME RES, V14, P477, DOI 10.1007/s10577-006-1075-0; Xu M, 2008, BBA-MOL CELL RES, V1783, P2155, DOI 10.1016/j.bbamcr.2008.07.013; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891; Zirbel RM, 1993, CHROMOSOME RES, V1, P93, DOI 10.1007/BF00710032	55	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e13045	10.1371/journal.pone.0013045	http://dx.doi.org/10.1371/journal.pone.0013045			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20927371	Green Published, gold, Green Submitted			2022-12-27	WOS:000282269400013
J	Stroeymeyt, N; Giurfa, M; Franks, NR				Stroeymeyt, Nathalie; Giurfa, Martin; Franks, Nigel R.			Improving Decision Speed, Accuracy and Group Cohesion through Early Information Gathering in House-Hunting Ants	PLOS ONE			English	Article							NEST-SITE SELECTION; HABITAT SELECTION; PUBLIC INFORMATION; COLONIES; EXPERIENCE; CHOICE; SIZE; PERFORMANCE; EMIGRATION; STRATEGIES	Background: Successful collective decision-making depends on groups of animals being able to make accurate choices while maintaining group cohesion. However, increasing accuracy and/or cohesion usually decreases decision speed and vice-versa. Such trade-offs are widespread in animal decision-making and result in various decision-making strategies that emphasize either speed or accuracy, depending on the context. Speed-accuracy trade-offs have been the object of many theoretical investigations, but these studies did not consider the possible effects of previous experience and/or knowledge of individuals on such trade-offs. In this study, we investigated how previous knowledge of their environment may affect emigration speed, nest choice and colony cohesion in emigrations of the house-hunting ant Temnothorax albipennis, a collective decision-making process subject to a classical speed-accuracy trade-off. Methodology/Principal Findings: Colonies allowed to explore a high quality nest site for one week before they were forced to emigrate found that nest and accepted it faster than emigrating naive colonies. This resulted in increased speed in single choice emigrations and higher colony cohesion in binary choice emigrations. Additionally, colonies allowed to explore both high and low quality nest sites for one week prior to emigration remained more cohesive, made more accurate decisions and emigrated faster than emigrating naive colonies. Conclusions/Significance: These results show that colonies gather and store information about available nest sites while their nest is still intact, and later retrieve and use this information when they need to emigrate. This improves colony performance. Early gathering of information for later use is therefore an effective strategy allowing T. albipennis colonies to improve simultaneously all aspects of the decision-making process - i.e. speed, accuracy and cohesion - and partly circumvent the speed-accuracy trade-off classically observed during emigrations. These findings should be taken into account in future studies on speed-accuracy trade-offs.	[Stroeymeyt, Nathalie; Franks, Nigel R.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Stroeymeyt, Nathalie; Giurfa, Martin] Univ Toulouse, UPS, Ctr Rech Cognit Anim, Toulouse, France; [Stroeymeyt, Nathalie; Giurfa, Martin] CNRS, Ctr Rech Cognit Anim, Toulouse, France	University of Bristol; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Stroeymeyt, N (corresponding author), Univ Bristol, Sch Biol Sci, Bristol, Avon, England.	Nathalie.Stroeymeyt@bristol.ac.uk	Giurfa, Martin MG/A-7322-2008; Franks, Nigel/AAG-8207-2019; Stroeymeyt, Nathalie/H-2371-2013; Giurfa, Martin/AAS-4945-2020; Giurfa, Martin/H-5140-2016	Franks, Nigel/0000-0001-8139-9604; Stroeymeyt, Nathalie/0000-0001-8047-449X; Giurfa, Martin/0000-0001-7173-769X; Giurfa, Martin/0000-0001-7173-769X	Pole de Recherche et d'Enseignement Superieur (PRES) "Universite de Toulouse"; "programme Lavoisier 'Cotutelle de these' du Ministere des Affaires Etrangeres et Europeennes"; Centre National de la Recherche Scientifique (CNRS); University Paul Sabatier; Engineering and Physical Sciences Research Council (EPSRC) [EP/D076226/1]; EPSRC [EP/D076226/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/D076226/1] Funding Source: researchfish	Pole de Recherche et d'Enseignement Superieur (PRES) "Universite de Toulouse"; "programme Lavoisier 'Cotutelle de these' du Ministere des Affaires Etrangeres et Europeennes"; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); University Paul Sabatier; Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	NS acknowledges Pole de Recherche et d'Enseignement Superieur (PRES) "Universite de Toulouse" and the "programme Lavoisier 'Cotutelle de these' du Ministere des Affaires Etrangeres et Europeennes" for funding. MG acknowledges the support of the Centre National de la Recherche Scientifique (CNRS) and of the University Paul Sabatier. NRF acknowledges Engineering and Physical Sciences Research Council (EPSRC) grant EP/D076226/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, INT J COMP PSYCHOL; Blanchard GB, 2000, ANIM BEHAV, V59, P723, DOI 10.1006/anbe.1999.1374; Burns JG, 2008, CURR BIOL, V18, pR953, DOI 10.1016/j.cub.2008.08.028; Burns JG, 2008, ANIM BEHAV, V76, P911, DOI 10.1016/j.anbehav.2008.02.017; Chittka L, 2003, NATURE, V424, P388, DOI 10.1038/424388a; Chittka L, 2009, TRENDS ECOL EVOL, V24, P400, DOI 10.1016/j.tree.2009.02.010; Collett TS, 2008, CURR BIOL, V18, pR131, DOI 10.1016/j.cub.2007.11.052; Conradt L, 2005, TRENDS ECOL EVOL, V20, P449, DOI 10.1016/j.tree.2005.05.008; Danchin Etienne, 2001, P243; Doligez B, 2004, ANIM BEHAV, V67, P457, DOI 10.1016/j.anbehav.2003.03.010; Dornhaus A, 2006, BEHAV ECOL SOCIOBIOL, V61, P151, DOI 10.1007/s00265-006-0246-5; Dornhaus A, 2009, BEHAV ECOL, V20, P922, DOI 10.1093/beheco/arp070; Franks Nigel R., 2007, Swarm Intelligence, V1, P81, DOI 10.1007/s11721-007-0007-8; Franks NR, 2007, ANIM BEHAV, V73, P525, DOI 10.1016/j.anbehav.2006.05.020; Franks NR, 2006, ANIM BEHAV, V72, P611, DOI 10.1016/j.anbehav.2005.11.019; Franks NR, 2008, ANIM BEHAV, V76, P323, DOI 10.1016/j.anbehav.2008.02.009; Franks NR, 2007, P R SOC B, V274, P1505, DOI 10.1098/rspb.2007.0138; Franks NR, 2009, PHILOS T R SOC B, V364, P845, DOI 10.1098/rstb.2008.0224; Franks NR, 2006, P ROY SOC B-BIOL SCI, V273, P165, DOI 10.1098/rspb.2005.3312; Franks NR, 2003, ANIM BEHAV, V65, P215, DOI 10.1006/anbe.2002.2032; Franks NR, 2000, BEHAV ECOL, V11, P315, DOI 10.1093/beheco/11.3.315; Franks NR, 2005, BIOL LETTERS, V1, P190, DOI 10.1098/rsbl.2005.0302; Franks NR, 2006, NATURE, V439, P153, DOI 10.1038/439153a; Franks NR, 2003, P ROY SOC B-BIOL SCI, V270, P2457, DOI 10.1098/rspb.2003.2527; Healey CIM, 2008, ANIM BEHAV, V76, P893, DOI 10.1016/j.anbehav.2008.02.016; Holldobler B., 1990, pi; Langridge EA, 2004, BEHAV ECOL SOCIOBIOL, V56, P523, DOI 10.1007/s00265-004-0824-3; Mallon EB, 2001, BEHAV ECOL SOCIOBIOL, V50, P352, DOI 10.1007/s002650100377; Marshall JAR, 2006, J R SOC INTERFACE, V3, P243, DOI 10.1098/rsif.2005.0075; Marshall JAR, 2009, J R SOC INTERFACE, V6, P1065, DOI 10.1098/rsif.2008.0511; MOGLICH M, 1978, INSECT SOC, V25, P205, DOI 10.1007/BF02224742; Muller H, 2008, CURR BIOL, V18, pR961, DOI 10.1016/j.cub.2008.09.001; Part T, 2003, P ROY SOC B-BIOL SCI, V270, P1809, DOI 10.1098/rspb.2003.2419; Passino KM, 2006, BEHAV ECOL SOCIOBIOL, V59, P427, DOI 10.1007/s00265-005-0067-y; Planque R, 2007, BEHAV ECOL SOCIOBIOL, V61, P347, DOI 10.1007/s00265-006-0263-4; Pratt SC, 2005, ANIM BEHAV, V70, P1023, DOI 10.1016/j.anbehav.2005.01.022; Pratt SC, 2006, P NATL ACAD SCI USA, V103, P15906, DOI 10.1073/pnas.0604801103; Reddi BAJ, 2000, NAT NEUROSCI, V3, P827, DOI 10.1038/77739; Robinson EJH, 2009, P ROY SOC B-BIOL SCI, V276, P2635, DOI 10.1098/rspb.2009.0350; Robinson EJH, 2009, BEHAV ECOL SOCIOBIOL, V63, P627, DOI 10.1007/s00265-008-0696-z; Scholes DR, 2009, INSECT SOC, V56, P413, DOI 10.1007/s00040-009-0039-8; Skorupski P, 2010, J NEUROSCI, V30, P3896, DOI 10.1523/JNEUROSCI.5700-09.2010; Spaethe J, 2001, P NATL ACAD SCI USA, V98, P3898, DOI 10.1073/pnas.071053098; Stamps JA, 2005, ECOLOGY, V86, P510, DOI 10.1890/04-0516; STROEYMEYT N, ROLES PRIVATE UNPUB; SULLIVAN MS, 1994, ANIM BEHAV, V47, P141, DOI 10.1006/anbe.1994.1016; Sumpter DJT, 2009, PHILOS T R SOC B, V364, P743, DOI 10.1098/rstb.2008.0204; Trimmer PC, 2008, P ROY SOC B-BIOL SCI, V275, P2353, DOI 10.1098/rspb.2008.0417; Visscher PK, 2007, ANNU REV ENTOMOL, V52, P255, DOI 10.1146/annurev.ento.51.110104.151025; Ward MP, 2005, OECOLOGIA, V145, P650, DOI 10.1007/s00442-005-0179-0	50	37	37	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e13059	10.1371/journal.pone.0013059	http://dx.doi.org/10.1371/journal.pone.0013059			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20927374	Green Published, gold, Green Submitted			2022-12-27	WOS:000282269400014
J	Sandfort, V; Eke, I; Cordes, N				Sandfort, Veit; Eke, Iris; Cordes, Nils			The Role of the Focal Adhesion Protein PINCH1 for the Radiosensitivity of Adhesion and Suspension Cell Cultures	PLOS ONE			English	Article							INTEGRIN-LINKED KINASE; MEDIATED DRUG-RESISTANCE; IN-VITRO; EXTRACELLULAR-MATRIX; IONIZING-RADIATION; ADAPTER PROTEIN; CANCER-CELLS; TYROSINE PHOSPHORYLATION; CARCINOMA-CELLS; TUMOR-CELLS	Focal adhesion (FA) signaling mediated by adhesion to extracellular matrix and growth factor receptors contributes to the regulation of the cellular stress response to external stimuli. Critical to focal adhesion assembly and signaling is the adapter protein PINCH1. To evaluate whether the prosurvival function of PINCH1 in radiation cell survival depends on cell adhesion, we examined PINCH1(fl/fl) and PINCH1(-/-) mouse embryonic fibroblasts and human cancer cell lines. Here, we found that the enhanced cellular radiosensitivity mediated by PINCH1 depletion observed under adhesion conditions is conserved when cells are irradiated under suspension conditions. This unsuspected finding could not be explained by the observed modification of adhesion and growth factor associated signaling involving FAK, Paxillin, p130(CAS), Src, AKT, GSK3 beta and ERK1/2 under suspension and serum withdrawal relative to adhesion conditions with serum. Our data suggest that the adapter protein PINCH1 critically participates in the regulation of the cellular radiosensitivity of normal and malignant cells similarly under adhesion and suspension conditions.	[Sandfort, Veit; Eke, Iris; Cordes, Nils] Tech Univ Dresden, OncoRay Ctr Radiat Res Oncol, Med Fac Carl Gustav Carus, D-8027 Dresden, Germany; [Eke, Iris; Cordes, Nils] Tech Univ Dresden, Univ Hosp, Dept Radiat Oncol, D-8027 Dresden, Germany; [Sandfort, Veit] Tech Univ Dresden, Dept Med & Cardiol, Heart Ctr Dresden Univ Hosp, D-8027 Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden	Sandfort, V (corresponding author), Tech Univ Dresden, OncoRay Ctr Radiat Res Oncol, Med Fac Carl Gustav Carus, D-8027 Dresden, Germany.	Nils.Cordes@Oncoray.de	Eke, Iris/B-9251-2016	Eke, Iris/0000-0002-3591-019X; Cordes, Nils/0000-0001-5684-629X	Bundesministerium Bildung und Forschung [BMBF-03ZIK041]; Bundesministerium Verteidigung	Bundesministerium Bildung und Forschung; Bundesministerium Verteidigung	This work was supported in part by the Bundesministerium Bildung und Forschung (BMBF-03ZIK041 to N.C.) and the Bundesministerium Verteidigung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Aronsohn MS, 2003, LARYNGOSCOPE, V113, P1944, DOI 10.1097/00005537-200311000-00017; Beinke C, 2003, INT J RADIAT BIOL, V79, P721, DOI 10.1080/09553000310001610231; Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Cance WG, 2000, CLIN CANCER RES, V6, P2417; Chen H, 2005, LAB INVEST, V85, P1342, DOI 10.1038/labinvest.3700345; Chen K, 2008, J BIOL CHEM, V283, P2508, DOI 10.1074/jbc.M707307200; Cordes N, 2007, ONCOGENE, V26, P6851, DOI 10.1038/sj.onc.1210498; Cordes N, 2006, ONCOGENE, V25, P1378, DOI 10.1038/sj.onc.1209164; Cordes N, 2004, STRAHLENTHER ONKOL, V180, P157, DOI 10.1007/s00066-004-1144-2; Cordes N, 2003, STRAHLENTHER ONKOL, V179, P337, DOI 10.1007/s00066-003-1074-4; Damiano JS, 2002, CURR CANCER DRUG TAR, V2, P37, DOI 10.2174/1568009023334033; Damiano JS, 1999, BLOOD, V93, P1658, DOI 10.1182/blood.V93.5.1658; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Dougherty GW, 2008, EUR J CELL BIOL, V87, P721, DOI 10.1016/j.ejcb.2008.02.011; Dougherty GW, 2005, EXP CELL RES, V306, P168, DOI 10.1016/j.yexcr.2005.01.025; EKE I, 2010, J CLIN INVEST    JUN; Eke I, 2007, INT J RADIAT BIOL, V83, P793, DOI 10.1080/09553000701727549; Eke I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006434; Estrugo D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000269; FUKS Z, 1992, EUR J CANCER, V28A, P725, DOI 10.1016/0959-8049(92)90104-A; Golding SE, 2009, CANCER BIOL THER, V8, P730, DOI 10.4161/cbt.8.8.7927; Hehlgans S, 2007, BBA-REV CANCER, V1775, P163, DOI 10.1016/j.bbcan.2006.09.001; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jeggo P, 2007, ONCOGENE, V26, P7717, DOI 10.1038/sj.onc.1210868; Kasahara T, 2002, ANTIOXID REDOX SIGN, V4, P491, DOI 10.1089/15230860260196290; Kim IA, 2005, CANCER RES, V65, P7902, DOI 10.1158/0008-5472.CAN-05-0513; Klein S, 2009, CURR OPIN CELL BIOL, V21, P185, DOI 10.1016/j.ceb.2008.12.006; KORNBERG L, 1992, J BIOL CHEM, V267, P23439; Kornberg LJ, 1998, HEAD NECK-J SCI SPEC, V20, P745, DOI 10.1002/(SICI)1097-0347(199812)20:8<745::AID-HED14>3.0.CO;2-Z; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Li SH, 2005, J CELL SCI, V118, P2913, DOI 10.1242/jcs.02422; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; MacPhail SH, 2003, INT J RADIAT BIOL, V79, P351, DOI 10.1080/0955300032000093128; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Martinsen BJ, 2006, DEV DYNAM, V235, P152, DOI 10.1002/dvdy.20616; Meads MB, 2009, NAT REV CANCER, V9, P665, DOI 10.1038/nrc2714; MEREDITH JE, 1993, MOL BIOL CELL, V4, P953, DOI 10.1091/mbc.4.9.953; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Park CC, 2006, CANCER RES, V66, P1526, DOI 10.1158/0008-5472.CAN-05-3071; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Sandfort V, 2007, INT J RADIAT BIOL, V83, P727, DOI 10.1080/09553000701694335; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Stanchi F, 2005, J CELL SCI, V118, P5899, DOI 10.1242/jcs.02686; Stanchi F, 2009, J CELL SCI, V122, P1800, DOI 10.1242/jcs.044602; Storch K, 2010, CANCER RES, V70, P3925, DOI 10.1158/0008-5472.CAN-09-3848; Tu YZ, 1998, MOL BIOL CELL, V9, P3367, DOI 10.1091/mbc.9.12.3367; Tu YZ, 1999, MOL CELL BIOL, V19, P2425; Wang-Rodriguez J, 2002, CANCER-AM CANCER SOC, V95, P1387, DOI 10.1002/cncr.10878; Wickstrom SA, 2010, EMBO J, V29, P281, DOI 10.1038/emboj.2009.376; Zhang YJ, 2002, J BIOL CHEM, V277, P318, DOI 10.1074/jbc.M108257200	51	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2010	5	9							e13056	10.1371/journal.pone.0013056	http://dx.doi.org/10.1371/journal.pone.0013056			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654ZQ	20927395	Green Submitted, Green Published, gold			2022-12-27	WOS:000282210700023
J	Levin, A; Fang, A; Hansen, PM; Pyle, D; Dia, O; Schwalbe, N				Levin, Ann; Fang, Arnold; Hansen, Peter M.; Pyle, David; Dia, Ousmane; Schwalbe, Nina			A Global Health Partnership's Use of Time-Limited Support to Catalyze Health Practice Change: The Case of GAVI's Injection Safety Support	PLOS ONE			English	Article							COST	This paper presents the findings of a study to assess the effectiveness and sustainability of a GAVI (Global Alliance of Vaccines and Immunization) sponsored, time-limited Injection Safety (INS) support. The support came in two forms: 1) in-kind, in the form of AD syringes and safety boxes, and 2) in cash, for those countries that already had a secure, multi-year source of AD syringes and safety boxes, but proposed to use INS support to strengthen their injection safety activities. In total, GAVI gave INS support for a three-year period to 58 countries: 46 with commodities and 12 with cash support. To identify variables that might be associated with financial sustainability, frequencies and cross-tabulations were run against various programmatic and socio-economic variables in the 58 countries. All but two of the 46 commodity-recipient countries were able to replace and sustain the use of AD syringes and safety boxes after the end of their GAVI INS support despite the fact that standard disposable syringes are less costly than ADs (10-15 percent differential). In addition, all 12 cash-recipient countries continued to use AD syringes and safety boxes in their immunization programs in the years following GAVI INS assistance. At the same time, countries were often not prepared for the increased waste management requirements associated with the use of the syringes, suggesting the importance of anticipating challenges with the introduction of new technologies. The sustained use of AD syringes in countries receiving injection safety support from GAVI, in a majority of cases through government financing, following the completion of three years of time-limited support, represents an early indication of how GHPs can contribute to improved health outcomes in immunization safety in the world's poorest countries in a sustainable way.	[Fang, Arnold; Hansen, Peter M.; Schwalbe, Nina] GAVI Alliance, Geneva, Switzerland; [Pyle, David; Dia, Ousmane] John Snow Int, Arlington, VA USA			annlevin@verizon.net						AHMEDOV M, 2008, HLTH SYSTEMS TRANSIT; Battersby A, 1999, B WORLD HEALTH ORGAN, V77, P812; Battersby A, 1999, B WORLD HEALTH ORGAN, V77, P996; CAINES K, 2004, 4 DFID STUD GLOB HLT; DZIEKAN G, 2003, B WHO, V81; Miller MA, 1999, B WORLD HEALTH ORGAN, V77, P808; PEARSON M, 2004, 2 DFID STUD GLOB HLT; Ravishankar N, 2009, LANCET, V373, P2113, DOI 10.1016/S0140-6736(09)60881-3; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3; *WHO, WHO INJ SAF FACT SHE	10	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e12986	10.1371/journal.pone.0012986	http://dx.doi.org/10.1371/journal.pone.0012986			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20885995	Green Published, gold, Green Submitted			2022-12-27	WOS:000282167100004
J	Lowe, EL; Crother, TR; Rabizadeh, S; Hu, B; Wang, HL; Chen, SA; Shimada, K; Wong, MH; Michelsen, KS; Arditi, M				Lowe, Emily L.; Crother, Timothy R.; Rabizadeh, Shervin; Hu, Bing; Wang, Hanlin; Chen, Shuang; Shimada, Kenichi; Wong, Michelle H.; Michelsen, Kathrin S.; Arditi, Moshe			Toll-Like Receptor 2 Signaling Protects Mice from Tumor Development in a Mouse Model of Colitis-Induced Cancer	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; NITRIC-OXIDE SYNTHASE; REGULATORY T-CELLS; SPONTANEOUS INTESTINAL TUMORIGENESIS; DENDRITIC CELLS; TGF-BETA; COLORECTAL-CANCER; EPITHELIAL-CELLS; CUTTING EDGE; IN-VIVO	Inflammatory bowel disease (IBD) is a disorder of chronic inflammation with increased susceptibility to colorectal cancer. The etiology of IBD is unclear but thought to result from a dysregulated adaptive and innate immune response to microbial products in a genetically susceptible host. Toll-like receptor (TLR) signaling induced by intestinal commensal bacteria plays a crucial role in maintaining intestinal homeostasis, innate immunity and the enhancement of intestinal epithelial cell (IEC) integrity. However, the role of TLR2 in the development of colorectal cancer has not been studied. We utilized the AOM-DSS model for colitis-associated colorectal cancer (CAC) in wild type (WT) and TLR2(-/-) mice. Colons harvested from WT and TLR2(-/-) mice were used for histopathology, immunohistochemistry, immunofluorescence and cytokine analysis. Mice deficient in TLR2 developed significantly more and larger colorectal tumors than their WT controls. We provide evidence that colonic epithelium of TLR2(-/-) mice have altered immune responses and dysregulated proliferation under steady-state conditions and during colitis, which lead to inflammatory growth signals and predisposition to accelerated neoplastic growth. At the earliest time-points assessed, TLR2(-/-) colons exhibited a significant increase in aberrant crypt foci (ACF), resulting in tumors that developed earlier and grew larger. In addition, the intestinal microenvironment revealed significantly higher levels of IL-6 and IL-17A concomitant with increased phospho-STAT3 within ACF. These observations indicate that in colitis, TLR2 plays a protective role against the development of CAC.	[Lowe, Emily L.; Crother, Timothy R.; Chen, Shuang; Shimada, Kenichi; Arditi, Moshe] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Div Pediat Infect Dis & Immunol, Los Angeles, CA 90048 USA; [Lowe, Emily L.; Crother, Timothy R.; Rabizadeh, Shervin; Hu, Bing; Wang, Hanlin; Chen, Shuang; Shimada, Kenichi; Wong, Michelle H.; Michelsen, Kathrin S.; Arditi, Moshe] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Rabizadeh, Shervin] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Div Pediat Gastroenterol, Los Angeles, CA 90048 USA; [Hu, Bing; Wang, Hanlin] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Dept Pathol, Los Angeles, CA 90048 USA; [Wong, Michelle H.; Michelsen, Kathrin S.] Univ Calif Los Angeles, Ctr Inflammatory Bowel Dis, Los Angeles, CA USA; [Wong, Michelle H.; Michelsen, Kathrin S.] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Burns & Allen Res Inst, Immunobiol Res Inst, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Cedars Sinai Medical Center; University of California System; University of California Los Angeles	Lowe, EL (corresponding author), Univ Calif Los Angeles, Cedars Sinai Med Ctr, Div Pediat Infect Dis & Immunol, Los Angeles, CA 90048 USA.	kathrin.michelsen@cshs.org; moshe.arditi@cshs.org	Lowe, Emily/G-1690-2010; Wang, Han/GPW-9809-2022; Crother, Timothy R/E-2879-2010	Crother, Timothy R/0000-0001-8465-6127	National Institutes of Health [AI-058128]; Donna and Jesse Garber Endowment; Crohns and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK089076] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Donna and Jesse Garber Endowment; Crohns and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grants from the National Institutes of Health (AI-058128 supplement to M.A.) and Donna and Jesse Garber Endowment (to K.S.M. and M.A.). In addition, K.S.M. is currently supported by the Crohns and Colitis Foundation of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Becker C, 2005, CELL CYCLE, V4, P217; Beckman JS, 1996, CHEM RES TOXICOL, V9, P836, DOI 10.1021/tx9501445; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Boulard O, 2010, EUR J IMMUNOL, V40, P516, DOI 10.1002/eji.200939669; Cario E, 2004, GASTROENTEROLOGY, V127, P224, DOI 10.1053/j.gastro.2004.04.015; Cario E, 2007, GASTROENTEROLOGY, V132, P1359, DOI 10.1053/j.gastro.2007.02.056; Chae WJ, 2010, P NATL ACAD SCI USA, V107, P5540, DOI 10.1073/pnas.0912675107; Chen Q, 2009, J IMMUNOL, V183, P4458, DOI 10.4049/jimmunol.0901465; Chung YC, 2003, J SURG ONCOL, V83, P222, DOI 10.1002/jso.10269; Clevers H, 2004, CELL, V118, P671, DOI 10.1016/j.cell.2004.09.005; Cooper HS, 2000, CARCINOGENESIS, V21, P757, DOI 10.1093/carcin/21.4.757; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Dillon S, 2004, J IMMUNOL, V172, P4733, DOI 10.4049/jimmunol.172.8.4733; DiNapoli MR, 1996, J EXP MED, V183, P1323, DOI 10.1084/jem.183.4.1323; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Ey B, 2009, J BIOL CHEM, V284, P22332, DOI 10.1074/jbc.M901619200; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Fukata M, 2005, AM J PHYSIOL-GASTR L, V288, pG1055, DOI 10.1152/ajpgi.00328.2004; Fukata M, 2007, GASTROENTEROLOGY, V133, P1869, DOI 10.1053/j.gastro.2007.09.008; Fukata M, 2006, GASTROENTEROLOGY, V131, P862, DOI 10.1053/j.gastro.2006.06.017; Fukata M, 2009, INFLAMM BOWEL DIS, V15, P997, DOI 10.1002/ibd.20880; Galizia G, 2002, CLIN IMMUNOL, V102, P169, DOI 10.1006/clim.2001.5163; Gounaris E, 2009, CANCER RES, V69, P5490, DOI 10.1158/0008-5472.CAN-09-0304; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Guruvayoorappan C, 2008, INTEGR CANCER THER, V7, P90, DOI 10.1177/1534735408319060; Halliwell B, 1997, FEBS LETT, V411, P157, DOI 10.1016/S0014-5793(97)00469-9; Khare Sharad, 2009, V472, P373, DOI 10.1007/978-1-60327-492-0_17; Klimp AH, 2001, CANCER RES, V61, P7305; Lee J, 2006, NAT CELL BIOL, V8, P1327, DOI 10.1038/ncb1500; Liu HY, 2006, P NATL ACAD SCI USA, V103, P7048, DOI 10.1073/pnas.0601554103; Manicassamy S, 2009, NAT MED, V15, P401, DOI 10.1038/nm.1925; Maynard CL, 2009, IMMUNITY, V31, P389, DOI 10.1016/j.immuni.2009.08.012; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Ortega-Cava CF, 2003, J IMMUNOL, V170, P3977, DOI 10.4049/jimmunol.170.8.3977; Piconese S, 2009, BLOOD, V114, P2639, DOI 10.1182/blood-2009-05-220004; Popivanova BK, 2008, J CLIN INVEST, V118, P560, DOI [10.1172/JC132453, 10.1172/JCI32453]; Rachmilewitz D, 2004, GASTROENTEROLOGY, V126, P520, DOI 10.1053/j.gastro.2003.11.019; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rakoff-Nahoum S, 2006, IMMUNITY, V25, P319, DOI 10.1016/j.immuni.2006.06.010; Rakoff-Nahoum S, 2007, SCIENCE, V317, P124, DOI 10.1126/science.1140488; Re F, 2001, J BIOL CHEM, V276, P37692, DOI 10.1074/jbc.M105927200; Redecke V, 2004, J IMMUNOL, V172, P2739, DOI 10.4049/jimmunol.172.5.2739; Sellon RK, 1998, INFECT IMMUN, V66, P5224, DOI 10.1128/IAI.66.11.5224-5231.1998; Singer II, 1996, GASTROENTEROLOGY, V111, P871, DOI 10.1016/S0016-5085(96)70055-0; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; Tanaka T, 2003, CANCER SCI, V94, P965, DOI 10.1111/j.1349-7006.2003.tb01386.x; Taupin D, 2003, NAT REV MOL CELL BIO, V4, P721, DOI 10.1038/nrm1203; Taylor KD, 2008, INFLAMM BOWEL DIS, V14, P1185, DOI 10.1002/ibd.20478; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Vijay-Kumar M, 2006, AM J PATHOL, V169, P1686, DOI 10.2353/ajpath.2006.060345; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Xiao H, 2007, IMMUNITY, V26, P461, DOI 10.1016/j.immuni.2007.02.012; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zaph C, 2007, NATURE, V446, P552, DOI 10.1038/nature05590; Zhang R, 2007, BIOCHEM SOC T, V35, P1375, DOI 10.1042/BST0351375; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	62	117	121	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e13027	10.1371/journal.pone.0013027	http://dx.doi.org/10.1371/journal.pone.0013027			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20885960	Green Published, gold, Green Submitted			2022-12-27	WOS:000282167100025
J	Sasaki, K; Ishii, N				Sasaki, Kazushige; Ishii, Naokata			Unloaded Shortening Velocity of Voluntarily and Electrically Activated Human Dorsiflexor Muscles In Vivo	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; MOTOR UNITS; RECRUITMENT ORDER; ISOMETRIC CONTRACTIONS; FIBER COMPOSITION; MYOSIN ISOFORMS; BODY-SIZE; FORCE; STIMULATION; LENGTH	We have previously shown that unloaded shortening velocity (V-0) of human plantar flexors can be determined in vivo, by applying the "slack test'' to submaximal voluntary contractions (J Physiol 567: 1047-1056, 2005). In the present study, to investigate the effect of motor unit recruitment pattern on V-0 of human muscle, we modified the slack test and applied this method to both voluntary and electrically elicited contractions of dorsiflexors. A series of quick releases (i.e., rapid ankle joint rotation driven by an electrical dynamometer) was applied to voluntarily activated dorsiflexor muscles at three different contraction intensities (15, 50, and 85% of maximal voluntary contraction; MVC). The quick-release trials were also performed on electrically activated dorsiflexor muscles, in which three stimulus conditions were used: submaximal (equal to 15% MVC) 50-Hz stimulation, supramaximal 50-Hz stimulation, and supramaximal 20-Hz stimulation. Modification of the slack test in vivo resulted in good reproducibility of V-0, with an intraclass correlation coefficient of 0.87 (95% confidence interval: 0.68-0.95). Regression analysis showed that V-0 of voluntarily activated dorsiflexor muscles significantly increased with increasing contraction intensity (R-2 = 0.52, P<0.001). By contrast, V-0 of electrically activated dorsiflexor muscles remained unchanged (R-2<0.001, P = 0.98) among three different stimulus conditions showing a large variation of tetanic torque. These results suggest that the recruitment pattern of motor units, which is quite different between voluntary and electrically elicited contractions, plays an important role in determining shortening velocity of human skeletal muscle in vivo.	[Sasaki, Kazushige; Ishii, Naokata] Univ Tokyo, Dept Life Sci, Grad Sch Arts & Sci, Tokyo, Japan	University of Tokyo	Sasaki, K (corresponding author), Univ Tokyo, Dept Life Sci, Grad Sch Arts & Sci, Tokyo, Japan.	sasaki@idaten.c.u-tokyo.ac.jp		Sasaki, Kazushige/0000-0001-6709-8581	Ministry of Education, Culture, Sports, Science and Technology, Japan [18300217]; Japan Society for the Promotion of Science [19800010]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by the Grant-in-Aid for Scientific Research (KAKENHI) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (No. 18300217 to NI) and from Japan Society for the Promotion of Science (No. 19800010 to KS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam A, 2005, J APPL PHYSIOL, V99, P268, DOI 10.1152/japplphysiol.01344.2004; ANGEL RW, 1965, J PHYSIOL-LONDON, V180, P864, DOI 10.1113/jphysiol.1965.sp007736; Arampatzis A, 2005, J BIOMECH, V38, P885, DOI 10.1016/j.jbiomech.2004.04.027; Bottinelli R, 1996, J PHYSIOL-LONDON, V495, P573, DOI 10.1113/jphysiol.1996.sp021617; Bottinelli R, 2001, PFLUG ARCH EUR J PHY, V443, P6, DOI 10.1007/s004240100700; Bottinelli R, 1999, J ELECTROMYOGR KINES, V9, P87, DOI 10.1016/S1050-6411(98)00040-6; CABRIC M, 1987, INT J SPORTS MED, V8, P323, DOI 10.1055/s-2008-1025677; Camilleri MJ, 2005, J BIOMECH, V38, P2172, DOI 10.1016/j.jbiomech.2004.09.037; Chow JW, 1999, J APPL PHYSIOL, V86, P1025, DOI 10.1152/jappl.1999.86.3.1025; CLAFLIN DR, 1985, J PHYSIOL-LONDON, V359, P357, DOI 10.1113/jphysiol.1985.sp015589; Curran-Everett D, 2000, AM J PHYSIOL-REG I, V279, pR1, DOI 10.1152/ajpregu.2000.279.1.R1; De Zee M, 2002, J APPL PHYSIOL, V93, P324, DOI 10.1152/japplphysiol.00696.2001; EDMAN KAP, 1979, J PHYSIOL-LONDON, V291, P143, DOI 10.1113/jphysiol.1979.sp012804; Elliott GF, 2001, INT J BIOL MACROMOL, V29, P211, DOI 10.1016/S0141-8130(01)00162-3; Enoka RM, 2002, MUSCLE NERVE, V25, P763, DOI 10.1002/mus.10117; Erim Z, 1996, MUSCLE NERVE, V19, P563, DOI 10.1002/(SICI)1097-4598(199605)19:5<563::AID-MUS3>3.0.CO;2-9; Feiereisen P, 1997, EXP BRAIN RES, V114, P117, DOI 10.1007/PL00005610; Fenn WO, 1935, J PHYSIOL-LONDON, V85, P277, DOI 10.1113/jphysiol.1935.sp003318; Fukunaga T, 1996, J APPL PHYSIOL, V80, P158, DOI 10.1152/jappl.1996.80.1.158; Gregory CM, 2005, PHYS THER, V85, P358, DOI 10.1093/ptj/85.4.358; GULATI J, 1985, J GEN PHYSIOL, V86, P479, DOI 10.1085/jgp.86.4.479; Hamada T, 2004, J ELECTROMYOGR KINES, V14, P531, DOI 10.1016/j.jelekin.2004.03.008; HENNEMAN E, 1965, J NEUROPHYSIOL, V28, P560, DOI 10.1152/jn.1965.28.3.560; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; HOLLAND PW, 1977, COMMUN STAT A-THEOR, V6, P813, DOI 10.1080/03610927708827533; Holmback AM, 2003, J APPL PHYSIOL, V95, P2416, DOI 10.1152/japplphysiol.00517.2002; Ishii N, 1997, BBA-BIOENERGETICS, V1319, P155, DOI 10.1016/S0005-2728(96)00156-9; JOHNSON MA, 1973, J NEUROL SCI, V18, P111, DOI 10.1016/0022-510X(73)90023-3; JOSEPHSON RK, 1988, ACTA PHYSIOL SCAND, V132, P341, DOI 10.1111/j.1748-1716.1988.tb08338.x; Jubeau M, 2007, INT J SPORTS MED, V28, P901, DOI 10.1055/s-2007-965075; Karatzaferi C, 2008, AM J PHYSIOL-REG I, V294, pR948, DOI 10.1152/ajpregu.00541.2007; Maffiuletti NA, 2010, EUR J APPL PHYSIOL, V110, P223, DOI 10.1007/s00421-010-1502-y; Maganaris CN, 2001, ACTA PHYSIOL SCAND, V172, P279, DOI 10.1046/j.1365-201x.2001.00799.x; Magnusson SP, 2001, J PHYSIOL-LONDON, V531, P277, DOI 10.1111/j.1469-7793.2001.0277j.x; MARTYN DA, 1994, BIOPHYS J, V67, P1984, DOI 10.1016/S0006-3495(94)80681-2; Marx JO, 2006, PFLUG ARCH EUR J PHY, V452, P222, DOI 10.1007/s00424-005-0017-6; Muraoka T, 2002, CELLS TISSUES ORGANS, V171, P260, DOI 10.1159/000063128; Ochala J, 2004, EXP GERONTOL, V39, P349, DOI 10.1016/j.exger.2003.11.004; Pellegrino MA, 2003, J PHYSIOL-LONDON, V546, P677, DOI 10.1113/jphysiol.2002.027375; PETROFSKY JS, 1980, MED BIOL ENG COMPUT, V18, P381, DOI 10.1007/BF02443305; PHILLIPS CA, 1980, J BIOMECH, V13, P549, DOI 10.1016/0021-9290(80)90055-X; RANATUNGA KW, 1984, J PHYSIOL-LONDON, V351, P517, DOI 10.1113/jphysiol.1984.sp015260; RUGG SG, 1990, J BIOMECH, V23, P495, DOI 10.1016/0021-9290(90)90305-M; RUTHERFORD OM, 1986, EUR J APPL PHYSIOL O, V55, P100, DOI 10.1007/BF00422902; Sanchez BR, 2005, J STRENGTH COND RES, V19, P438, DOI 10.1519/00124278-200505000-00033; Sasaki K, 2005, J PHYSIOL-LONDON, V567, P1047, DOI 10.1113/jphysiol.2005.091124; SINACORE DR, 1990, PHYS THER, V70, P416, DOI 10.1093/ptj/70.7.416; Trappe S, 2003, J PHYSIOL-LONDON, V552, P47, DOI 10.1113/jphysiol.2003.044966; WICKIEWICZ TL, 1984, J APPL PHYSIOL, V57, P435, DOI 10.1152/jappl.1984.57.2.435; ZAJAC FE, 1985, J NEUROPHYSIOL, V53, P1303, DOI 10.1152/jn.1985.53.5.1303	50	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e13043	10.1371/journal.pone.0013043	http://dx.doi.org/10.1371/journal.pone.0013043			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20885951	Green Submitted, gold, Green Published			2022-12-27	WOS:000282167100029
J	Peyre, M; Commo, F; Dantas-Barbosa, C; Andreiuolo, F; Puget, S; Lacroix, L; Drusch, F; Scott, V; Varlet, P; Mauguen, A; Dessen, P; Lazar, V; Vassal, G; Grill, J				Peyre, Matthieu; Commo, Frederic; Dantas-Barbosa, Carmela; Andreiuolo, Felipe; Puget, Stephanie; Lacroix, Ludovic; Drusch, Francoise; Scott, Veronique; Varlet, Pascale; Mauguen, Audrey; Dessen, Philippe; Lazar, Vladimir; Vassal, Gilles; Grill, Jacques			Portrait of Ependymoma Recurrence in Children: Biomarkers of Tumor Progression Identified by Dual-Color Microarray-Based Gene Expression Analysis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; PEDIATRIC INTRACRANIAL EPENDYMOMA; METALLOTHIONEIN MESSENGER-RNA; SQUAMOUS-CELL CARCINOMA; PROGNOSTIC-FACTORS; POSTOPERATIVE CHEMOTHERAPY; MOLECULAR SIGNATURES; TRANSCRIPTION FACTOR; DNA METHYLATION; CANDIDATE GENES	Background: Children with ependymoma may experience a relapse in up to 50% of cases depending on the extent of resection. Key biological events associated with recurrence are unknown. Methodology/Principal Findings: To discover the biology behind the recurrence of ependymomas, we performed CGHarray and a dual-color gene expression microarray analysis of 17 tumors at diagnosis co-hybridized with the corresponding 27 first or subsequent relapses from the same patient. As treatment and location had only limited influence on specific gene expression changes at relapse, we established a common signature for relapse. Eighty-seven genes showed an absolute fold change >= 2 in at least 50% of relapses and were defined as the gene expression signature of ependymoma recurrence. The most frequently upregulated genes are involved in the kinetochore (ASPM, KIF11) or in neural development (CD133, Wnt and Notch pathways). Metallothionein (MT) genes were downregulated in up to 80% of the recurrences. Quantitative PCR for ASPM, KIF11 and MT3 plus immunohistochemistry for ASPM and MT3 confirmed the microarray results. Immunohistochemistry on an independent series of 24 tumor pairs at diagnosis and at relapse confirmed the decrease of MT3 expression at recurrence in 17/24 tumor pairs (p = 0.002). Conversely, ASPM expression was more frequently positive at relapse (87.5% vs 37.5%, p = 0.03). Loss or deletion of the MT genes cluster was never observed at relapse. Promoter sequencing after bisulfite treatment of DNA from primary tumors and recurrences as well as treatment of short-term ependymoma cells cultures with a demethylating agent showed that methylation was not involved in MT3 downregulation. However, in vitro treatment with a histone deacetylase inhibitor or zinc restored MT3 expression. Conclusions/Significance: The most frequent molecular events associated with ependymoma recurrence were overexpression of kinetochore proteins and down-regulation of metallothioneins. Metallothionein-3 expression is epigenetically controlled and can be restored in vitro by histone deacetylase inhibitors.	[Peyre, Matthieu; Dantas-Barbosa, Carmela; Andreiuolo, Felipe; Puget, Stephanie; Scott, Veronique; Vassal, Gilles; Grill, Jacques] Univ Paris 11, CNRS, UMR Vectorol & Anticanc Treatments 8203, Inst Gustave Roussy, Villejuif, France; [Commo, Frederic; Dessen, Philippe] Inst Gustave Roussy, CNRS FRE 2939, Bioinformat Grp, Villejuif, France; [Puget, Stephanie] Univ Paris 05, Necker Sick Childrens Hosp, Dept Neurosurg, Paris, France; [Andreiuolo, Felipe; Lacroix, Ludovic; Drusch, Francoise] Inst Gustave Roussy, Translat Res Lab, Villejuif, France; [Varlet, Pascale] St Anne Hosp, Dept Neuropathol, Paris, France; [Mauguen, Audrey] Inst Gustave Roussy, Dept Biostat, Villejuif, France; [Lazar, Vladimir] Inst Gustave Roussy, Funct Genom Unit, Villejuif, France; [Vassal, Gilles; Grill, Jacques] Inst Gustave Roussy, Dept Pediat & Adolescent Oncol, Villejuif, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Gustave Roussy; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy	Peyre, M (corresponding author), Univ Paris 11, CNRS, UMR Vectorol & Anticanc Treatments 8203, Inst Gustave Roussy, Villejuif, France.	grill@igr.fr	Dantas-Barbosa, Carmela/D-3179-2013; Lazar, Vladimir/AAQ-2086-2020; Grill, Jacques/R-8093-2019; Lazar, Vladimir/AAV-2087-2020	Dantas-Barbosa, Carmela/0000-0001-6100-2585; Andreiuolo, Felipe/0000-0002-2568-6155; VARLET, pascale/0000-0002-8164-1517; Peyre, Matthieu/0000-0001-8470-9516; Mauguen, Audrey/0000-0003-3236-6093	Societe de Neurochirurgie de Langue Francaise; Institut National du Cancer; Region Ile de France; Societe Francaise des Cancers de l'Enfant/Enfants et Sante; charity "l'Etoile de Martin"	Societe de Neurochirurgie de Langue Francaise; Institut National du Cancer(Institut National du Cancer (INCA) France); Region Ile de France(Region Ile-de-France); Societe Francaise des Cancers de l'Enfant/Enfants et Sante; charity "l'Etoile de Martin"	The authors thank the Societe de Neurochirurgie de Langue Francaise for the fellowship of MP and the Institut National du Cancer and the Region Ile de France for the Fellowship of CDB and FA, as well as the grant support from the Societe Francaise des Cancers de l'Enfant/Enfants et Sante 2006 (http://www.enfants-sante.asso.fr/) and from the charity "l'Etoile de Martin" (http://www.letoiledemartin.org/) for FA and CDB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso ME, 2002, CANCER GENET CYTOGEN, V134, P1, DOI 10.1016/S0165-4608(01)00591-X; Bizzoca A, 2009, CELL ADHES MIGR, V3, P53, DOI 10.4161/cam.3.1.7462; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Bortolotto S, 2001, J NEURO-ONCOL, V54, P9, DOI 10.1023/A:1012537105775; Bouffet E, 1998, MED PEDIATR ONCOL, V30, P319, DOI 10.1002/(SICI)1096-911X(199806)30:6<319::AID-MPO1>3.0.CO;2-H; Cherian MG, 2003, MUTAT RES-FUND MOL M, V533, P201, DOI 10.1016/j.mrfmmm.2003.07.013; Chin GM, 2006, MOL CANCER THER, V5, P2580, DOI 10.1158/1535-7163.MCT-06-0201; Colin C, 2007, NEUROPATH APPL NEURO, V33, P431, DOI 10.1111/j.1365-2990.2007.00829.x; Corson TW, 2007, CLIN CANCER RES, V13, P3229, DOI 10.1158/1078-0432.CCR-07-0393; Corson TW, 2006, INT J CANCER, V119, P1088, DOI 10.1002/ijc.21954; Corson TW, 2005, ONCOGENE, V24, P4741, DOI 10.1038/sj.onc.1208641; Dalgin GS, 2008, J UROLOGY, V180, P1126, DOI 10.1016/j.juro.2008.04.137; Deng DJ, 2003, CARCINOGENESIS, V24, P25, DOI 10.1093/carcin/24.1.25; Donson AM, 2009, J IMMUNOL, V183, P7428, DOI 10.4049/jimmunol.0902811; EBADI M, 1995, NEUROCHEM INT, V27, P1, DOI 10.1016/0197-0186(94)00164-P; Ferrario C, 2008, LAB INVEST, V88, P474, DOI 10.1038/labinvest.2008.17; Figarella-Branger D, 2000, J NEUROSURG, V93, P605, DOI 10.3171/jns.2000.93.4.0605; Garrett SH, 1999, TOXICOL LETT, V105, P207, DOI 10.1016/S0378-4274(99)00003-X; Ghoshal K, 2002, MOL CELL BIOL, V22, P8302, DOI 10.1128/MCB.22.23.8302-8319.2002; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Grill J, 2002, CANCER GENET CYTOGEN, V136, P121, DOI 10.1016/S0165-4608(02)00516-2; Grill J, 2001, J CLIN ONCOL, V19, P1288, DOI 10.1200/JCO.2001.19.5.1288; Grundy RG, 2007, LANCET ONCOL, V8, P696, DOI 10.1016/S1470-2045(07)70208-5; Hamilton RL, 1997, BRAIN PATHOL, V7, P807, DOI 10.1111/j.1750-3639.1997.tb01066.x; Haq F, 2003, MUTAT RES-FUND MOL M, V533, P211, DOI 10.1016/j.mrfmmm.2003.07.014; Hayama S, 2006, CANCER RES, V66, P10339, DOI 10.1158/0008-5472.CAN-06-2137; Henrique R, 2005, CANCER EPIDEM BIOMAR, V14, P1274, DOI 10.1158/1055-9965.EPI-04-0659; Hidalgo J, 2001, BRAIN RES BULL, V55, P133, DOI 10.1016/S0361-9230(01)00452-X; Hirose Y, 2001, AM J PATHOL, V158, P1137, DOI 10.1016/S0002-9440(10)64061-8; Ki DH, 2007, INT J CANCER, V121, P2005, DOI 10.1002/ijc.22975; Kilday JP, 2009, MOL CANCER RES, V7, P765, DOI 10.1158/1541-7786.MCR-08-0584; Korshunov A, 1999, J NEURO-ONCOL, V45, P219, DOI 10.1023/A:1006369829576; Korshunov A, 2010, J CLIN ONCOL, V28, P3182, DOI 10.1200/JCO.2009.27.3359; Kramer KK, 1996, TOXICOL APPL PHARM, V141, P1; Kramer KK, 1996, TOXICOL APPL PHARM, V136, P94, DOI 10.1006/taap.1996.0011; L'Esperance S, 2006, INT J ONCOL, V29, P5; Liu CJ, 2008, J PATHOL, V214, P489, DOI 10.1002/path.2306; Lu RX, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-314; von Zangen IL, 2007, ACTA NEUROPATHOL, V113, P325, DOI 10.1007/s00401-006-0190-5; Martin-Magniette ML, 2005, BIOINFORMATICS, V21, P1995, DOI 10.1093/bioinformatics/bti302; Mc Lendon RE, 2007, WHO CLASSIFICATION T, P74; Mendrzyk F, 2006, CLIN CANCER RES, V12, P2070, DOI 10.1158/1078-0432.CCR-05-2363; Merchant TE, 2009, LANCET ONCOL, V10, P258, DOI 10.1016/S1470-2045(08)70342-5; Michiels S, 2007, BRIT J CANCER, V96, P1155, DOI 10.1038/sj.bjc.6603673; Modena P, 2006, J CLIN ONCOL, V24, P5223, DOI 10.1200/JCO.2006.06.3701; Muller C, 2007, CANCER CHEMOTH PHARM, V59, P157, DOI 10.1007/s00280-006-0254-1; Palm T, 2009, CANCER-AM CANCER SOC, V115, P3955, DOI 10.1002/cncr.24476; Perilongo G, 1997, MED PEDIATR ONCOL, V29, P79; Peris-Bonet R, 2006, EUR J CANCER, V42, P2064, DOI 10.1016/j.ejca.2006.05.009; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Puget S, 2009, J CLIN ONCOL, V27, P1884, DOI 10.1200/JCO.2007.15.4195; Qi YC, 2001, DEVELOPMENT, V128, P2723; QUAIFE CJ, 1994, BIOCHEMISTRY-US, V33, P7250, DOI 10.1021/bi00189a029; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Ridley L, 2008, NEURO-ONCOLOGY, V10, P675, DOI 10.1215/15228517-2008-036; Rome C, 2006, MOL CARCINOGEN, V45, P774, DOI 10.1002/mc.20244; SATO M, 1993, FREE RADICAL BIO MED, V14, P325, DOI 10.1016/0891-5849(93)90029-T; SATOH M, 1994, CANCER RES, V54, P5255; Schneider D, 2009, CANCER GENET CYTOGEN, V191, P90, DOI 10.1016/j.cancergencyto.2009.02.010; Sharma MK, 2007, CANCER RES, V67, P890, DOI 10.1158/0008-5472.CAN-06-0973; Smith E, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-42; Snuderl M, 2008, J NEUROPATH EXP NEUR, V67, P911, DOI 10.1097/NEN.0b013e318184f413; Sousa JF, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-19; Sowar K, 2006, J NEURO-ONCOL, V78, P41, DOI 10.1007/s11060-005-9072-2; Suarez-Merino B, 2005, NEURO-ONCOLOGY, V7, P20; 't Hoen PAC, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh038; Tabori U, 2006, J CLIN ONCOL, V24, P1522, DOI 10.1200/JCO.2005.04.2127; Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001; Thirumoorthy N, 2007, WORLD J GASTROENTERO, V13, P993, DOI 10.3748/wjg.v13.i7.993; UCHIDA Y, 1991, NEURON, V7, P337, DOI 10.1016/0896-6273(91)90272-2; Valensin S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-196; van Veelen-Vincent MLC, 2002, J NEUROSURG, V97, P827, DOI 10.3171/jns.2002.97.4.0827; Voulgari A, 2009, BBA-REV CANCER, V1796, P75, DOI 10.1016/j.bbcan.2009.03.002; Wei H, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-7; WETJEN N, 2006, NEUROONCOLOGY CNS TU, P453; Yap XL, 2009, J PATHOL, V217, P563, DOI 10.1002/path.2489; Zhong S, 2007, ONCOGENE, V26, P2621, DOI 10.1038/sj.onc.1210041	77	31	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2010	5	9							e12932	10.1371/journal.pone.0012932	http://dx.doi.org/10.1371/journal.pone.0012932			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653UN	20885975	Green Submitted, gold, Green Published			2022-12-27	WOS:000282122600002
J	Choi, JW; Kim, S; Kim, TM; Kim, YM; Seo, HW; Park, TS; Jeong, JW; Song, G; Han, JY				Choi, Jin Won; Kim, Sujung; Kim, Tae Min; Kim, Young Min; Seo, Hee Won; Park, Tae Sub; Jeong, Jae-Wook; Song, Gwonhwa; Han, Jae Yong			Basic Fibroblast Growth Factor Activates MEK/ERK Cell Signaling Pathway and Stimulates the Proliferation of Chicken Primordial Germ Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; P38 MAP KINASE; SELF-RENEWAL; MOUSE; MIGRATION; TRANSMISSION; DERIVATION; EXPRESSION; CULTURE; PROTEIN	Background: Long-term maintenance of avian primordial germ cells (PGCs) in vitro has tremendous potential because it can be used to deepen our understanding of the biology of PGCs. A transgenic bioreactor based on the unique migration of PGCs toward the recipients' sex cord via the bloodstream and thereby creating a germline chimeric bird has many potential applications. However, the growth factors and the signaling pathway essential for inducing proliferation of chicken PGCs are unknown. Methodology/Principal Findings: Therefore, we conducted this study to investigate the effects of various combinations of growth factors on the survival and proliferation of PGCs under feeder-free conditions. We observed proliferation of PGCs in media containing bFGF. Subsequent characterization confirmed that the cultured PGCs maintained expression of PGC-specific markers, telomerase activity, normal migrational activity, and germline transmission. We also found that bFGF activates the mitogen-activated protein kinase kinase/extracellular-signal regulated kinase (MEK/ERK) signaling. Also, the expression of 133 transcripts was reversibly altered by bFGF withdrawal. Conclusions/Significance: Our results demonstrate that chicken PGCs can be maintained in vitro without any differentiation or dedifferentiation in feeder free culture conditions, and subsequent analysis revealed that bFGF is one of the key factors that enable proliferation of chicken PGCs via MEK/ERK signaling regulating downstream genes that may be important for PGC proliferation and survival.	[Choi, Jin Won; Kim, Sujung; Kim, Tae Min; Kim, Young Min; Seo, Hee Won; Song, Gwonhwa; Han, Jae Yong] Seoul Natl Univ, Dept Agr Biotechnol, WCU Biomodulat Major, Seoul, South Korea; [Park, Tae Sub] Optifarm Solut Inc, Avicore Biotechnol Inst, Gyeonggi Do, South Korea; [Jeong, Jae-Wook] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Seoul National University (SNU); Baylor College of Medicine	Choi, JW (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, WCU Biomodulat Major, Seoul, South Korea.	jaehan@snu.ac.kr	Lim, Whasun/F-2060-2013; Song, Gwonhwa/H-3647-2015; gwonhwa, song/H-3208-2015		Ministry of Education, Science and Technology [KRF-2006-311-F00087, R31-10056]	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Korea Research Foundation program (KRF-2006-311-F00087) and also supported by World Class University (WCU) program (R31-10056) through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HJ, 2009, FEBS LETT, V583, P2922, DOI 10.1016/j.febslet.2009.07.056; Ali N, 2007, J BIOL CHEM, V282, P37378, DOI 10.1074/jbc.M702170200; ANDO Y, 1983, DEV GROWTH DIFFER, V25, P345; Anneren C, 2004, J BIOL CHEM, V279, P31590, DOI 10.1074/jbc.M403547200; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; Delaune E, 2005, DEVELOPMENT, V132, P299, DOI 10.1242/dev.01582; Durcova-Hills G, 2006, STEM CELLS, V24, P1441, DOI 10.1634/stemcells.2005-0424; Durcova-Hills G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003531; ENGLAND MA, 1993, J ANAT, V183, P67; Extavour CG, 2003, DEVELOPMENT, V130, P5869, DOI 10.1242/dev.00804; EYALGILADI H, 1981, J EMBRYOL EXP MORPH, V65, P139; Fan LC, 2008, STEM CELLS DEV, V17, P585, DOI 10.1089/scd.2007.0178; FELDMAN B, 1995, SCIENCE, V267, P246, DOI 10.1126/science.7809630; FRITTSWI.ML, 1972, EXP CELL RES, V75, P512, DOI 10.1016/0014-4827(72)90459-4; Ginsburg M, 1997, POULTRY SCI, V76, P91, DOI 10.1093/ps/76.1.91; GOMPERTS M, 1994, DEVELOPMENT, V120, P135; Guay J, 1997, J CELL SCI, V110, P357; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Han JY, 2009, COMP IMMUNOL MICROB, V32, P61, DOI 10.1016/j.cimid.2007.11.010; Hayashi K, 2007, SCIENCE, V316, P394, DOI 10.1126/science.1137545; He ZP, 2008, STEM CELLS, V26, P266, DOI 10.1634/stemcells.2007-0436; Jirmanova L, 2002, ONCOGENE, V21, P5515, DOI 10.1038/sj.onc.1205728; Jung JS, 2005, STEM CELLS, V23, P689, DOI 10.1634/stemcells.2004-0208; Kim JN, 2004, MOL REPROD DEV, V68, P81, DOI 10.1002/mrd.20051; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; KUWANA T, 1987, ANAT RECORD, V219, P164, DOI 10.1002/ar.1092190209; Lavial F, 2007, DEVELOPMENT, V134, P3549, DOI 10.1242/dev.006569; Lee J, 2007, DEVELOPMENT, V134, P1853, DOI 10.1242/dev.003004; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li J, 2007, DIFFERENTIATION, V75, P299, DOI 10.1111/j.1432-0436.2006.00143.x; Loffing J, 2006, ANNU REV PHYSIOL, V68, P461, DOI 10.1146/annurev.physiol.68.040104.131654; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; MEYER DB, 1964, DEV BIOL, V10, P154, DOI 10.1016/0012-1606(64)90009-0; Motono M, 2008, CYTOTECHNOLOGY, V57, P199, DOI 10.1007/s10616-008-9156-x; NAITO M, 1994, MOL REPROD DEV, V39, P153, DOI 10.1002/mrd.1080390206; NIEUWKOOP PD, 1979, PRIMORDIAL GERM CELL, pR11; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; Park HJ, 2006, MOL REPROD DEV, V73, P452, DOI 10.1002/mrd.20441; Park TS, 2003, BIOL REPROD, V68, P1657, DOI 10.1095/biolreprod.102.006825; Park TS, 2000, MOL REPROD DEV, V56, P475, DOI 10.1002/1098-2795(200008)56:4&lt;475::AID-MRD5&gt;3.0.CO;2-M; Reifers F, 1998, DEVELOPMENT, V125, P2381; Robinson LLL, 2001, MOL HUM REPROD, V7, P845, DOI 10.1093/molehr/7.9.845; Rubinfeld H, 2005, MOL BIOTECHNOL, V31, P151, DOI 10.1385/MB:31:2:151; Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726; Strome S, 2007, SCIENCE, V316, P392, DOI 10.1126/science.1140846; TAJIMA A, 1993, THERIOGENOLOGY, V40, P509, DOI 10.1016/0093-691X(93)90404-S; Takeuchi Y, 2005, DEVELOPMENT, V132, P5399, DOI 10.1242/dev.02080; Tan Y, 1996, EMBO J, V15, P4629, DOI 10.1002/j.1460-2075.1996.tb00840.x; Torii S, 2004, DEV CELL, V7, P33, DOI 10.1016/j.devcel.2004.05.019; Tsunekawa N, 2000, DEVELOPMENT, V127, P2741; UKESHIMA A, 1991, J ELECTRON MICROSC, V40, P124; van de Lavoir MC, 2006, NATURE, V441, P766, DOI 10.1038/nature04831; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; ZACCANTI F, 1990, DIFFERENTIATION, V43, P71, DOI 10.1111/j.1432-0436.1990.tb00432.x; Zhao YT, 2007, J BIOL CHEM, V282, P14165, DOI 10.1074/jbc.M701279200	59	87	100	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12968	10.1371/journal.pone.0012968	http://dx.doi.org/10.1371/journal.pone.0012968			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886037	Green Published, gold			2022-12-27	WOS:000282091100057
J	Hrabovska, A; Bernard, V; Krejci, E				Hrabovska, Anna; Bernard, Veronique; Krejci, Eric			A Novel System for the Efficient Generation of Antibodies Following Immunization of Unique Knockout Mouse Strains	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; HUMAN BUTYRYLCHOLINESTERASE; HUMAN ACETYLCHOLINESTERASE; GENE; MICE; PURIFICATION; EXPRESSION	Background: We wished to develop alternate production strategies to generate antibodies against traditionally problematic antigens. As a model we chose butyrylcholinesterase (BChE), involved in termination of cholinergic signaling, and widely considered as a poor immunogen. Methodology/Principal Findings: Jettisoning traditional laborious in silico searching methods to define putative epitopes, we simply immunized available BChE knock-out mice with full-length recombinant BChE protein (having been produced for crystallographic analysis). Immunization with BChE, in practically any form (recombinant human or mouse BChE, BChE purified from human serum, native or denatured), resulted in strong immune responses. Native BChE produced antibodies that favored ELISA and immunostaining detection. Denatured and reduced BChE were more selective for antibodies specific in Western blots. Two especially sensitive monoclonal antibodies were found capable of detecting 0.25 ng of BChE within one min by ELISA. One is specific for human BChE; the other cross-reacts with mouse and rat BChE. Immunization of wildtype mice served as negative controls. Conclusions/Significance: We examined a simple, fast, and highly efficient strategy to produce antibodies by mining two expanding databases: namely those of knock-out mice and 3D crystallographic protein-structure analysis. We conclude that the immunization of knock-out mice should be a strategy of choice for antibody production.	[Hrabovska, Anna; Bernard, Veronique; Krejci, Eric] Univ Paris 05, CNRS, UMR8194, CESeM, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Hrabovska, A (corresponding author), Comenius Univ, Fac Pharm, Dept Pharmacol & Toxicol, Bratislava, Slovakia.	anna.hrabovska@gmail.com	Bernard, Veronique/A-9691-2012; Hrabovska, Anna/ABE-8931-2020	Bernard, Veronique/0000-0003-4748-5167; 	Association Francaise contre les Myopathies (AFM); Ministere de la recherche (ANR Neuroscience); Centre national de la recherche scientifique; AFM, ANR Neuroscience; APW [SK-FR-0031-09/Stefanik 23101PC]	Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Ministere de la recherche (ANR Neuroscience)(French National Research Agency (ANR)Ministry of Research, France); Centre national de la recherche scientifique(Centre National de la Recherche Scientifique (CNRS)); AFM, ANR Neuroscience(Association Francaise contre les MyopathiesFrench National Research Agency (ANR)); APW	Work was supported by Association Francaise contre les Myopathies (AFM) and Ministere de la recherche (ANR Neuroscience). E. K. was supported by Centre national de la recherche scientifique and A. H. was supported by AFM, ANR Neuroscience. Exchange visits were supported by APW grant SK-FR-0031-09/Stefanik 23101PC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRIMIJOIN S, 1983, MOL PHARMACOL, V24, P513; CHECLER F, 1990, J NEUROCHEM, V55, P750, DOI 10.1111/j.1471-4159.1990.tb04555.x; Chilukuri N, 2008, CHEM-BIOL INTERACT, V175, P327, DOI 10.1016/j.cbi.2008.04.009; Darvesh S, 2003, NAT REV NEUROSCI, V4, P131, DOI 10.1038/nrn1035; DECLERCK PJ, 1995, J BIOL CHEM, V270, P8397, DOI 10.1074/jbc.270.15.8397; Hrabovska A, 2005, CHEM-BIOL INTERACT, V157, P71, DOI 10.1016/j.cbi.2005.10.014; Krejci E, 1997, J BIOL CHEM, V272, P22840, DOI 10.1074/jbc.272.36.22840; Li B, 2006, J MOL NEUROSCI, V30, P193, DOI 10.1385/JMN:30:1:193; Moser N, 2007, J NEUROCHEM, V102, P479, DOI 10.1111/j.1471-4159.2007.04498.x; Nachon F, 2002, EUR J BIOCHEM, V269, P630, DOI 10.1046/j.0014-2956.2001.02692.x; Nguyen AT, 2006, BBA-MOL CELL BIOL L, V1761, P182, DOI 10.1016/j.bbalip.2006.02.004; Perrier AL, 2002, NEURON, V33, P275, DOI 10.1016/S0896-6273(01)00584-0; Pradidarcheep W, 2009, N-S ARCH PHARMACOL, V379, P397, DOI 10.1007/s00210-009-0393-0; PRUSINER SB, 1993, P NATL ACAD SCI USA, V90, P10608, DOI 10.1073/pnas.90.22.10608; Saxena A, 2008, PROTEIN EXPRES PURIF, V61, P191, DOI 10.1016/j.pep.2008.05.021; Shichkin VP, 2006, IMMUNOL LETT, V102, P148, DOI 10.1016/j.imlet.2005.08.005	16	18	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12892	10.1371/journal.pone.0012892	http://dx.doi.org/10.1371/journal.pone.0012892			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886120	Green Published, gold			2022-12-27	WOS:000282091100008
J	Pattenden, SG; Gogol, MM; Workman, JL				Pattenden, Samantha G.; Gogol, Madelaine M.; Workman, Jerry L.			Features of Cryptic Promoters and Their Varied Reliance on Bromodomain-Containing Factors	PLOS ONE			English	Article							CHROMATIN-REMODELING COMPLEX; RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; HISTONE ACETYLATION; RSC; GENOME; YEAST; TRANSCRIPTION; SET2	The Set2-Rpd3S pathway is important for the control of transcription memory. Mutation of components of this pathway results in cryptic transcription initiation within the coding region of approximately 30% of yeast genes. Specifically, deletion of the Set2 histone methyltransferase or Rco1, a component of the Rpd3S histone deacetylase complex leads to hyperacetylation of certain open reading frames (ORFs). We used this mutant as a system to study the role of histone modifications and co-activator recruitment in preinitiation complex (PIC) formation. Specifically, we looked at the dependence of promoters on the bromodomain-containing RSC complex and the Bdf1 protein. We found that the dependence of cryptic promoters for these proteins varied. Overall, our data indicate that cryptic promoters are independently regulated, and their activation is dependent on factors that govern gene activation at canonical promoters.	[Pattenden, Samantha G.; Gogol, Madelaine M.; Workman, Jerry L.] Stowers Inst Med Res, Kansas City, MO USA	Stowers Institute for Medical Research	Pattenden, SG (corresponding author), Stowers Inst Med Res, Kansas City, MO USA.	jlw@stowers.org		Gogol, Madelaine/0000-0002-8738-0995	Natural Sciences and Engineering Research Council; National Institute of General Medical Sciences [R37 GM47867]; Stowers Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM047867] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Stowers Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the Natural Sciences and Engineering Research Council Postdoctoral Fellowship (SGP), National Institute of General Medical Sciences (R37 GM47867) and the Stowers Institute (www.stowers.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus-Hill ML, 2001, MOL CELL, V7, P741, DOI 10.1016/S1097-2765(01)00219-2; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Bungard D, 2004, EUKARYOT CELL, V3, P910, DOI 10.1128/EC.3.4.910-918.2004; Cairns BR, 1999, MOL CELL, V4, P715, DOI 10.1016/S1097-2765(00)80382-2; Cairns BR, 1996, CELL, V87, P1249, DOI 10.1016/S0092-8674(00)81820-6; Campsteijn C, 2007, PLOS GENET, V3, P947, DOI 10.1371/journal.pgen.0030092; Cao YX, 1997, MOL CELL BIOL, V17, P3323, DOI 10.1128/MCB.17.6.3323; Carey M, 2006, MOL CELL, V24, P481, DOI 10.1016/j.molcel.2006.09.012; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chai B, 2005, GENE DEV, V19, P1656, DOI 10.1101/gad.1273105; Cheung V, 2008, PLOS BIOL, V6, P2550, DOI 10.1371/journal.pbio.0060277; Choi JK, 2009, BIOCHEM CELL BIOL, V87, P139, DOI 10.1139/O08-112; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Du J, 1998, GENETICS, V150, P987; Durant M, 2006, MOL CELL BIOL, V26, P2791, DOI 10.1128/MCB.26.7.2791-2802.2006; Durant M, 2007, MOL CELL BIOL, V27, P5327, DOI 10.1128/MCB.00468-07; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Goodacre SL, 2001, P ROY SOC B-BIOL SCI, V268, P1, DOI 10.1098/rspb.2000.1322; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Hartley PD, 2009, CELL, V137, P445, DOI 10.1016/j.cell.2009.02.043; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Hsu JM, 2003, MOL CELL BIOL, V23, P3202, DOI 10.1128/MCB.23.9.3202-3215.2003; Huang J, 2004, MOL CELL, V13, P739, DOI 10.1016/S1097-2765(04)00103-0; Huebert DJ, 2006, METHODS, V40, P365, DOI 10.1016/j.ymeth.2006.07.032; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Kanemaki M, 2003, NATURE, V423, P720, DOI 10.1038/nature01692; Kasten M, 2004, EMBO J, V23, P1348, DOI 10.1038/sj.emboj.7600143; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Ladurner AG, 2003, MOL CELL, V11, P365, DOI 10.1016/S1097-2765(03)00035-2; LAURENT BC, 1992, MOL CELL BIOL, V12, P1893, DOI 10.1128/MCB.12.4.1893; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Li B, 2003, J BIOL CHEM, V278, P8897, DOI 10.1074/jbc.M212134200; Li B, 2007, GENE DEV, V21, P1422, DOI 10.1101/gad.1539307; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Li JX, 2002, J BIOL CHEM, V277, P49383, DOI 10.1074/jbc.M209294200; Liu CL, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-19; Martinez-Campa C, 2004, MOL CELL, V15, P69, DOI 10.1016/j.molcel.2004.05.022; Matangkasombut O, 2000, GENE DEV, V14, P951; Matangkasombut O, 2003, MOL CELL, V11, P353, DOI 10.1016/S1097-2765(03)00033-9; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Ng HH, 2002, GENE DEV, V16, P806, DOI 10.1101/gad.978902; Parnell TJ, 2008, EMBO J, V27, P100, DOI 10.1038/sj.emboj.7601946; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sanders SL, 2002, MOL CELL BIOL, V22, P4723, DOI 10.1128/MCB.22.13.4723-4738.2002; Schaft D, 2003, NUCLEIC ACIDS RES, V31, P2475, DOI 10.1093/nar/gkg372; Shim EY, 2007, MOL CELL BIOL, V27, P1602, DOI 10.1128/MCB.01956-06; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Soukas A, 2000, GENE DEV, V14, P963; Soutourina J, 2006, MOL CELL BIOL, V26, P4920, DOI 10.1128/MCB.00415-06; van Bakel H, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1144; Yukawa M, 2002, FEMS YEAST RES, V2, P87, DOI 10.1111/j.1567-1364.2002.tb00073.x; Zanton SJ, 2004, P NATL ACAD SCI USA, V101, P16843, DOI 10.1073/pnas.0404988101	58	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12927	10.1371/journal.pone.0012927	http://dx.doi.org/10.1371/journal.pone.0012927			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886085	Green Published, Green Submitted, gold			2022-12-27	WOS:000282091100031
J	Silveira, JM; Barlow, J; Louzada, J; Moutinho, P				Silveira, Juliana M.; Barlow, Jos; Louzada, Julio; Moutinho, Paulo			Factors Affecting the Abundance of Leaf-Litter Arthropods in Unburned and Thrice-Burned Seasonally-Dry Amazonian Forests	PLOS ONE			English	Article							SURFACE-ACTIVE ARTHROPODS; EXPERIMENTAL FIRE REGIMES; LONG-TERM; CONSERVATION BIOLOGY; PRESCRIBED FIRES; RESPONSES; SOIL; DECOMPOSITION; AUTUMN; MICROARTHROPODS	Fire is frequently used as a land management tool for cattle ranching and annual crops in the Amazon. However, these maintenance fires often escape into surrounding forests, with potentially severe impacts for forest biodiversity. We examined the effect of experimental fires on leaf-litter arthropod abundance in a seasonally-dry forest in the Brazilian Amazon. The study plots (50 ha each) included a thrice-burned forest and an unburned control forest. Pitfall-trap samples were collected at 160 randomly selected points in both plots, with sampling stratified across four intra-annual replicates across the dry and wet seasons, corresponding to 6, 8, 10 and 12 months after the most recent fire. Arthropods were identified to the level of order (separating Formicidae). In order to better understand the processes that determine arthropod abundance in thrice-burned forests, we measured canopy openness, understory density and litter depth. All arthropod taxa were significantly affected by fire and season. In addition, the interactions between burn treatment and season were highly significant for all taxa but Isoptera. The burned plot was characterized by a more open canopy, lower understory density and shallower litter depth. Hierarchical partitioning revealed that canopy openness was the most important factor explaining arthropod order abundances in the thrice-burned plot, whereas all three environmental variables were significant in the unburned control plot. These results reveal the marked impact of recurrent wildfires and seasonality on litter arthropods in this transitional forest, and demonstrate the overwhelming importance of canopy-openness in driving post-fire arthropod abundance.	[Silveira, Juliana M.; Louzada, Julio] Univ Fed Lavras UFLA, Dept Ecol, Lavras, MG, Brazil; [Silveira, Juliana M.] Museu Paraense Emilio Goeldi MPEG, Dept Zool, Belem, Para, Brazil; [Barlow, Jos] Univ Lancaster, Lancaster Environm Ctr, Lancaster, England; [Moutinho, Paulo] Inst Pesquisa Ambiental Amazonia IPAM, Brasilia, DF, Brazil	Universidade Federal de Lavras; Museu Paraense Emilio Goeldi; Lancaster University	Silveira, JM (corresponding author), Univ Fed Lavras UFLA, Dept Ecol, Lavras, MG, Brazil.	silveira.juli@gmail.com	Louzada, Julio/F-1265-2010; Barlow, Jos/HGE-9486-2022; Barlow, Jos/E-7861-2014	Louzada, Julio/0000-0002-1481-3112; Moutinho, Paulo/0000-0003-0596-1823	David and Lucile Packard Foundation; NASA; NSF; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais- FAPEMIG; Engineering and Physical Sciences Research Council [EP/E500811/1] Funding Source: researchfish; Natural Environment Research Council [ceh010010] Funding Source: researchfish	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais- FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	J. M. Silveira gratefully acknowledges the Conselho Nacional de Pesquisa Cientifica (CNPq), which supported the data collection of her Ph.D. research. Funding for the experimental fires was provided by the David and Lucile Packard Foundation, NASA LBA-ECO program, and NSF Biocomplexity in the Environment and Ecosystems programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; J. M. Silveira gratefully the Instituto de Pesquisa Ambiental da Amazonia ( IPAM) field staff who helped collect the data. Grupo Amaggi provided logistical support. Secretaria de Agricultura de Querencia-MT provided the rainfall data. Mark Cochrane provided comments that improved the manuscript. Special thanks to Fundacao de Amparo a Pesquisa do Estado de Minas Gerais- FAPEMIG which provided a post-doctoral fellowship to the first author while she was writing the manuscript.	Alencar A, 2006, EARTH INTERACT, V10; Andersen AN, 2000, AUSTRAL ECOL, V25, P199, DOI 10.1046/j.1442-9993.2000.01038.x; Apigian KO, 2006, FOREST ECOL MANAG, V221, P110, DOI 10.1016/j.foreco.2005.09.009; Aragao LEOC, 2008, PHILOS T R SOC B, V363, P1779, DOI 10.1098/rstb.2007.0026; Balch JK, 2008, GLOBAL CHANGE BIOL, V14, P2276, DOI 10.1111/j.1365-2486.2008.01655.x; Barlow J, 2004, ECOL APPL, V14, P1358, DOI 10.1890/03-5077; Barlow J, 2004, PHILOS T R SOC B, V359, P367, DOI 10.1098/rstb.2003.1423; BARLOW J, 2008, PHILOS T ROYALTY SOC, V363, P1767; Barlow J, 2007, J APPL ECOL, V44, P1001, DOI 10.1111/j.1365-2664.2007.01347.x; Barlow Jos, 2009, P543, DOI 10.1007/978-3-540-77381-8_19; Barratt BIP, 2006, RANGELAND ECOL MANAG, V59, P383, DOI 10.2111/05-190R1.1; Basset Y, 2008, INSECT CONSERV DIVER, V1, P55, DOI 10.1111/j.1752-4598.2007.00011.x; Bignell D. E., 2000, ABOVE GROUND BIODIVE, P91; CAMARGO JLC, 1995, J TROP ECOL, V11, P205, DOI 10.1017/S026646740000866X; CHEVAN A, 1991, AM STAT, V45, P90, DOI 10.2307/2684366; COCHRANE M, 2009, GLOBAL CHANGE BIOL; Cochrane MA, 1999, SCIENCE, V284, P1832, DOI 10.1126/science.284.5421.1832; Coleman TW, 2006, FOREST ECOL MANAG, V233, P52, DOI 10.1016/j.foreco.2006.06.001; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; Collett N, 2003, FOREST ECOL MANAG, V182, P117, DOI 10.1016/S0378-1127(03)00009-4; Collett NG, 1998, FOREST ECOL MANAG, V107, P253, DOI 10.1016/S0378-1127(97)00332-0; Crawley M. J, 2002, STAT COMPUTING INTRO; Dawes-Gromadzki TZ, 2007, AUSTRAL ECOL, V32, P663, DOI 10.1111/j.1442-9993.2007.01752.x; DENSLOW JS, 1994, LA SELVA ECOLOGY NAT, P120; Frazer GW, 1999, GAP LIGHT ANAL GLA V; Fredericksen NJ, 2002, BIODIVERS CONSERV, V11, P27, DOI 10.1023/A:1014065510554; Hanula JL, 2003, FOREST ECOL MANAG, V175, P163, DOI 10.1016/S0378-1127(02)00130-5; Haugaasen T, 2003, ANIM CONSERV, V6, P299, DOI 10.1017/S1367943003003366; Hellmann JJ, 2003, ECOL ENTOMOL, V28, P74, DOI 10.1046/j.1365-2311.2003.00484.x; Holdsworth AR, 1997, ECOL APPL, V7, P713, DOI 10.1890/1051-0761(1997)007[0713:FIASLR]2.0.CO;2; Holldobler B., 1990, pi; LAVELLE P, 1993, BIOTROPICA, V25, P130, DOI 10.2307/2389178; Mac Nally R, 2000, BIODIVERS CONSERV, V9, P655, DOI 10.1023/A:1008985925162; Mac Nally R, 2002, BIODIVERS CONSERV, V11, P1397, DOI 10.1023/A:1016250716679; MAJER JD, 1984, PEDOBIOLOGIA, V26, P229; Malhi Y., 2009, P NATL ACAD SCI; Nadeau L, 2006, J KANSAS ENTOMOL SOC, V79, P2, DOI 10.2317/0406.02.1; Nepstad DC, 1999, NATURE, V398, P505, DOI 10.1038/19066; Nichols E, 2008, BIOL CONSERV, V141, P1461, DOI 10.1016/j.biocon.2008.04.011; Orgeas J, 2001, J APPL ECOL, V38, P49, DOI 10.1046/j.1365-2664.2001.00575.x; R Core Team, 2018, R LANG ENV STAT COMP; Ray D, 2005, ECOL APPL, V15, P1664, DOI 10.1890/05-0404; Richards LA, 2007, J TROP ECOL, V23, P169, DOI 10.1017/S0266467406003907; SANTILLI M, 2005, TROPICAL DEFORESTATI, P47; Schlesinger WH., 1997, BIOGEOCHEMISTRY; SEASTEDT TR, 1984, ANNU REV ENTOMOL, V29, P25, DOI 10.1146/annurev.en.29.010184.000325; Silveira JM, 2009, J TROP ECOL, V25, P657, DOI 10.1017/S0266467409990150; UHL C, 1985, BIOTROPICA, V17, P265, DOI 10.2307/2388588; UHL C, 1990, ECOLOGY, V71, P437, DOI 10.2307/1940299; VASCONCELOS HL, 2010, PLOSONE; York A, 1999, J INSECT CONSERV, V3, P191, DOI 10.1023/A:1009643627781	51	29	30	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2010	5	9							e12877	10.1371/journal.pone.0012877	http://dx.doi.org/10.1371/journal.pone.0012877			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652JO	20877720	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000282002900016
J	Glasser, J; Taneri, D; Feng, ZL; Chuang, JH; Tull, P; Thompson, W; McCauley, MM; Alexander, J				Glasser, John; Taneri, Denis; Feng, Zhilan; Chuang, Jen-Hsiang; Tull, Peet; Thompson, William; McCauley, Mary Mason; Alexander, James			Evaluation of Targeted Influenza Vaccination Strategies via Population Modeling	PLOS ONE			English	Article							PANDEMIC INFLUENZA; RATES; INTERVENTIONS; TRANSMISSION; MORTALITY; EVOLUTION; DISEASE; SPREAD	Background: Because they can generate comparable predictions, mathematical models are ideal tools for evaluating alternative drug or vaccine allocation strategies. To remain credible, however, results must be consistent. Authors of a recent assessment of possible influenza vaccination strategies conclude that older children, adolescents, and young adults are the optimal targets, no matter the objective, and argue for vaccinating them. Authors of two earlier studies concluded, respectively, that optimal targets depend on objectives and cautioned against changing policy. Which should we believe? Methods and Findings: In matrices whose elements are contacts between persons by age, the main diagonal always predominates, reflecting contacts between contemporaries. Indirect effects (e. g., impacts of vaccinating one group on morbidity or mortality in others) result from off-diagonal elements. Mixing matrices based on periods in proximity with others have greater sub-and super-diagonals, reflecting contacts between parents and children, and other off-diagonal elements (reflecting, e. g., age-independent contacts among co-workers), than those based on face-to-face conversations. To assess the impact of targeted vaccination, we used a time-usage study's mixing matrix and allowed vaccine efficacy to vary with age. And we derived mortality rates either by dividing observed deaths attributed to pneumonia and influenza by average annual cases from a demographically-realistic SEIRS model or by multiplying those rates by ratios of (versus adding to them differences between) pandemic and pre-pandemic mortalities. Conclusions: In our simulations, vaccinating older children, adolescents, and young adults averts the most cases, but vaccinating either younger children and older adults or young adults averts the most deaths, depending on the age distribution of mortality. These results are consistent with those of the earlier studies.	[Glasser, John; Taneri, Denis; Thompson, William; McCauley, Mary Mason; Alexander, James] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Feng, Zhilan] Purdue Univ, Dept Math, W Lafayette, IN 47907 USA; [Chuang, Jen-Hsiang] Ctr Dis Control, Epidem Intelligence Ctr, Taipei, Taiwan; [Tull, Peet] European Ctr Dis Prevent & Control, Sci Advice Unit, Stockholm, Sweden	Centers for Disease Control & Prevention - USA; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Centers For Disease Control - Taiwan; European Centre for Disease Prevention & Control	Glasser, J (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.	jglasser@cdc.gov	Chuang, Jen-Hsiang/G-4356-2010; Feng, Zhilan/L-4027-2018	Chuang, Jen-Hsiang/0000-0002-7114-3418; 				*ACIP, 2009, H1N1 VACC REC; ANDERSON R M, 1991; Arino J, 2006, J R SOC INTERFACE, V3, P453, DOI 10.1098/rsif.2006.0112; Bailey NTJ, 1975, MATH THEORY INFECT D; Bansal S, 2006, PLOS MED, V3, P1816, DOI 10.1371/journal.pmed.0030387; Belongia E., 2008, Morbidity and Mortality Weekly Report, V57, P393; CDC, 2005, NAT VIT STAT SYST; *CDC NAT CTR HLTH, 2008, NCHS HLTH E STAT VAC; *CDCP, 2010, SEAS INFL VACC SUPPL; CHIN TDY, 1960, PUBLIC HEALTH REP, V75, P149, DOI 10.2307/4590751; Del Valle SY, 2007, SOC NETWORKS, V29, P539, DOI 10.1016/j.socnet.2007.04.005; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Dushoff J, 2007, PLOS MED, V4, P921, DOI 10.1371/journal.pmed.0040174; Earn DJD, 2002, TRENDS ECOL EVOL, V17, P334, DOI 10.1016/S0169-5347(02)02502-8; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Glass RJ, 2006, EMERG INFECT DIS, V12, P1671, DOI 10.3201/eid1211.060255; Glezen WP, 1996, EPIDEMIOL REV, V18, P64, DOI 10.1093/oxfordjournals.epirev.a017917; GOVAERT TME, 1994, JAMA-J AM MED ASSOC, V272, P1661, DOI 10.1001/jama.272.21.1661; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Haber MJ, 2007, EMERG INFECT DIS, V13, P581, DOI 10.3201/eid1304.060828; *HHS, 2010, PAND INFL PLAN; Hurford A, 2010, J R SOC INTERFACE, V7, P561, DOI 10.1098/rsif.2009.0448; Izurieta HS, 2000, NEW ENGL J MED, V342, P232, DOI 10.1056/NEJM200001273420402; JACQUEZ JA, 1988, MATH BIOSCI, V92, P119, DOI 10.1016/0025-5564(88)90031-4; King JC, 2006, NEW ENGL J MED, V355, P2523, DOI 10.1056/NEJMoa055414; King JC, 2005, PEDIATRICS, V116, pE868, DOI 10.1542/peds.2005-1301; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; Lipsitch M, 2007, PLOS MED, V4, P111, DOI 10.1371/journal.pmed.0040015; Loeb M, 2010, JAMA-J AM MED ASSOC, V303, P943, DOI 10.1001/jama.2010.250; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Luk J, 2001, CLIN INFECT DIS, V33, P1375, DOI 10.1086/322662; May RM, 2004, SCIENCE, V303, P790, DOI 10.1126/science.1094442; Medlock J, 2009, SCIENCE, V325, P1705, DOI 10.1126/science.1175570; MONTO AS, 1970, J INFECT DIS, V122, P16, DOI 10.1093/infdis/122.1-2.16; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Nichol KL, 2007, NEW ENGL J MED, V357, P1373, DOI 10.1056/NEJMoa070844; NOLD A, 1980, MATH BIOSCI, V124, P59; Reichert TA, 2001, NEW ENGL J MED, V344, P889, DOI 10.1056/NEJM200103223441204; Renshaw E., 1991, MODELING BIOL POPULA; Vynnycky E, 2008, EPIDEMIOL INFECT, V136, P166, DOI 10.1017/S0950268807008369; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; Wallinga J, 2010, P NATL ACAD SCI USA, V107, P923, DOI 10.1073/pnas.0908491107; Zagheni E, 2008, AM J EPIDEMIOL, V168, P1082, DOI 10.1093/aje/kwn220	46	23	23	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2010	5	9							e12777	10.1371/journal.pone.0012777	http://dx.doi.org/10.1371/journal.pone.0012777			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651XL	20862297	gold, Green Published, Green Submitted			2022-12-27	WOS:000281960800010
J	Renshaw, D; Montero-Melendez, T; Dalli, J; Kamal, A; Brancaleone, V; D'Acquisto, F; Cirino, G; Perretti, M				Renshaw, Derek; Montero-Melendez, Trinidad; Dalli, Jesmond; Kamal, Ahmad; Brancaleone, Vincenzo; D'Acquisto, Fulvio; Cirino, Giuseppe; Perretti, Mauro			Downstream Gene Activation of the Receptor ALX by the Agonist Annexin A1	PLOS ONE			English	Article							FORMYL PEPTIDE RECEPTOR; ADHESION MOLECULE-C; SPHINGOSINE 1-PHOSPHATE; SYNOVIAL INFLAMMATION; APOPTOTIC NEUTROPHILS; LEUKOCYTE ADHESION; CONNECTIVITY MAP; HDAC INHIBITOR; EXPRESSION; PHAGOCYTOSIS	Background: Our understanding of pro-resolution factors in determining the outcome of inflammation has recently gained ground, yet not many studies have investigated whether specific genes or patterns of genes, are modified by these mediators. Here, we have focussed on the glucocorticoid modulated pro-resolution factor annexin A1 (AnxA1), studying if its interaction with the ALX receptor would affect downstream genomic targets. Methodology/Principal Findings: Using microarray technology in ALX transfected HEK293 cells, we discovered an overlapping, yet distinct gene activation profile for AnxA1 compared to its N-terminal mimetic peptide Ac2-26, which may be suggestive of unique downstream inflammatory outcomes for each substance. When the up-regulated genes were explored, consistently induced was the sphingosine phosphate phosphatase-2 gene (SGPP2), involved in regulation of the sphingosine 1 phosphate chemotactic system. Up-regulation of this gene, as well as JAG1 (and down-regulation of JAM3), was confirmed using real time PCR both with transfected HEK293 cells and human peripheral blood leukocytes. Furthermore, lymph nodes taken from AnxA1(null) mice displayed lower SGPP2 gene activity. Finally, connectivity map analysis for AnxA1 and peptide Ac2-26 indicated striking similarities with known anti-inflammatory therapeutics, glucocorticoids and aspirin-like compounds, as well as with histone deacetylase inhibitors. Conclusion/Significance: We believe these new data raise the profile of AnxA1 from being solely a short-term antiinflammatory factor, to being a 'trigger' of the endogenous pro-resolution arsenal.	[Renshaw, Derek; Montero-Melendez, Trinidad; Dalli, Jesmond; Kamal, Ahmad; Brancaleone, Vincenzo; D'Acquisto, Fulvio; Perretti, Mauro] Queen Mary Univ London, Barts & London Sch Med, William Harvey Res Inst, London, England; [Brancaleone, Vincenzo; Cirino, Giuseppe] Univ Naples Federico II, Sch Pharm, Dept Expt Pharmacol, Naples, Italy	University of London; Queen Mary University London; University of Naples Federico II	Renshaw, D (corresponding author), Queen Mary Univ London, Barts & London Sch Med, William Harvey Res Inst, London, England.	m.perretti@qmul.ac.uk	D'Acquisto, Fulvio/E-7204-2018; Montero-Melendez, Trinidad/AAF-6345-2020	D'Acquisto, Fulvio/0000-0002-4513-1608; brancaleone, vincenzo/0000-0002-0063-659X; Montero-Melendez, Trinidad/0000-0002-3563-376X; Dalli, Jesmond/0000-0001-6328-3640; Cirino, Giuseppe/0000-0003-3954-4083; Renshaw, Derek/0000-0002-2759-0229	William Harvey Research Foundation; Special Trustees of St Bartholomew's Hospital; Wellcome Trust [086867/Z/08, 069234/Z/02]; Arthritis Research Campaign UK [15755]; National Institute of Health Research	William Harvey Research Foundation; Special Trustees of St Bartholomew's Hospital; Wellcome Trust(Wellcome TrustEuropean Commission); Arthritis Research Campaign UK(Versus Arthritis); National Institute of Health Research(National Institute for Health Research (NIHR))	This work was supported by the William Harvey Research Foundation, the Special Trustees of St Bartholomew's Hospital, the Wellcome Trust (086867/Z/08 and 069234/Z/02) and the Arthritis Research Campaign UK (grant 15755). This work forms part of the research themes contributing to the translational research portfolio of Barts and the London Cardiovascular Biomedical Research Unit which is supported and funded by the National Institute of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Catania A, 2006, THESCIENTIFICWORLDJO, V6, P1241, DOI 10.1100/tsw.2006.227; Charnley M, 2008, PEPTIDES, V29, P1004, DOI 10.1016/j.peptides.2008.02.004; Chatterjee BE, 2005, J LEUKOCYTE BIOL, V78, P639, DOI 10.1189/jlb.0405206; Chiang N, 2006, PHARMACOL REV, V58, P463, DOI 10.1124/pr.58.3.4; D'Acquisto F, 2008, BRIT J PHARMACOL, V155, P152, DOI 10.1038/bjp.2008.252; D'Acquisto F, 2007, BLOOD, V109, P1095, DOI 10.1182/blood-2006-05-022798; DACQUISTO F, 2009, CURR OPIN PHARM; Damazo AS, 2005, AM J PATHOL, V166, P1607, DOI 10.1016/S0002-9440(10)62471-6; Elyaman W, 2007, J IMMUNOL, V179, P5990, DOI 10.4049/jimmunol.179.9.5990; Ernst S, 2004, J IMMUNOL, V172, P7669, DOI 10.4049/jimmunol.172.12.7669; Fu HM, 2006, J LEUKOCYTE BIOL, V79, P247, DOI 10.1189/jlb.0905498; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gilroy DW, 2004, NAT REV DRUG DISCOV, V3, P401, DOI 10.1038/nrd1383; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; Glauben R, 2006, J IMMUNOL, V176, P5015, DOI 10.4049/jimmunol.176.8.5015; Hannon R, 2002, FASEB J, V16, P253, DOI 10.1096/fj.02-0239fje; Hayhoe RPG, 2006, BLOOD, V107, P2123, DOI 10.1182/blood-2005-08-3099; Hieronymus H, 2006, CANCER CELL, V10, P321, DOI 10.1016/j.ccr.2006.09.005; Lamb J, 2007, NAT REV CANCER, V7, P54, DOI 10.1038/nrc2044; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Maderna P, 2005, J IMMUNOL, V174, P3727, DOI 10.4049/jimmunol.174.6.3727; Massberg S, 2006, NEW ENGL J MED, V355, P1088, DOI 10.1056/NEJMp068159; Mechtcheriakova D, 2007, CELL SIGNAL, V19, P748, DOI 10.1016/j.cellsig.2006.09.004; Meng JH, 2005, OSTEOARTHR CARTILAGE, V13, P1115, DOI 10.1016/j.joca.2005.03.010; Nasu Y, 2008, OSTEOARTHR CARTILAGE, V16, P723, DOI 10.1016/j.joca.2007.10.014; Palmer G, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2223; Perretti M, 2002, NAT MED, V8, P1296, DOI 10.1038/nm786; PERRETTI M, 1993, J IMMUNOL, V151, P4306; Perretti M, 1997, TRENDS PHARMACOL SCI, V18, P418; Perretti M, 2004, BIOCHEM SOC T, V32, P507, DOI 10.1042/BST0320507; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Petrella A, 2008, EUR J CANCER, V44, P740, DOI 10.1016/j.ejca.2008.01.023; Rabquer BJ, 2008, ARTHRITIS RHEUM, V58, P3020, DOI 10.1002/art.23867; Rempe S., 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P232, DOI 10.2174/187153007782794344; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Scannell M, 2007, J IMMUNOL, V178, P4595, DOI 10.4049/jimmunol.178.7.4595; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Tabe Y, 2007, CELL DEATH DIFFER, V14, P1443, DOI 10.1038/sj.cdd.4402139; Walther A, 2000, MOL CELL, V5, P831, DOI 10.1016/S1097-2765(00)80323-8; Wei G, 2006, CANCER CELL, V10, P331, DOI 10.1016/j.ccr.2006.09.006; Yang YH, 1999, ARTHRITIS RHEUM, V42, P1538, DOI 10.1002/1529-0131(199907)42:7<1538::AID-ANR29>3.0.CO;2-3; Yang YH, 2004, ARTHRITIS RHEUM-US, V50, P976, DOI 10.1002/art.20201; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578; Zhang B, 2008, BRAIN RES, V1226, P181, DOI 10.1016/j.brainres.2008.05.085	45	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2010	5	9							e12771	10.1371/journal.pone.0012771	http://dx.doi.org/10.1371/journal.pone.0012771			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651XL	20862244	gold, Green Published, Green Submitted			2022-12-27	WOS:000281960800009
J	Bartlett, JD; Dobeck, JM; Tye, CE; Perez-Moreno, M; Stokes, N; Reynolds, AB; Fuchs, E; Skobe, Z				Bartlett, John D.; Dobeck, Justine M.; Tye, Coralee E.; Perez-Moreno, Mirna; Stokes, Nicole; Reynolds, Albert B.; Fuchs, Elaine; Skobe, Ziedonis			Targeted p120-Catenin Ablation Disrupts Dental Enamel Development	PLOS ONE			English	Article							RAT INCISOR AMELOGENESIS; RHO-FAMILY GTPASES; E-CADHERIN; P120 CATENIN; SECRETORY AMELOBLASTS; TOOTH DEVELOPMENT; TRANSCRIPTION FACTOR; ACTIN CYTOSKELETON; P-CADHERIN; EXPRESSION	Dental enamel development occurs in stages. The ameloblast cell layer is adjacent to, and is responsible for, enamel formation. When rodent pre-ameloblasts become tall columnar secretory-stage ameloblasts, they secrete enamel matrix proteins, and the ameloblasts start moving in rows that slide by one another. This movement is necessary to form the characteristic decussating enamel prism pattern. Thus, a dynamic system of intercellular interactions is required for proper enamel development. Cadherins are components of the adherens junction (AJ), and they span the cell membrane to mediate attachment to adjacent cells. p120 stabilizes cadherins by preventing their internalization and degradation. So, we asked if p120-mediated cadherin stability is important for dental enamel formation. Targeted p120 ablation in the mouse enamel organ had a striking effect. Secretory stage ameloblasts detached from surrounding tissues, lost polarity, flattened, and ameloblast E-and N-cadherin expression became undetectable by immunostaining. The enamel itself was poorly mineralized and appeared to be composed of a thin layer of merged spheres that abraded from the tooth. Significantly, p120 mosaic mouse teeth were capable of forming normal enamel demonstrating that the enamel defects were not a secondary effect of p120 ablation. Surprisingly, blood-filled sinusoids developed in random locations around the developing teeth. This has not been observed in other p120-ablated tissues and may be due to altered p120-mediated cell signaling. These data reveal a critical role for p120 in tooth and dental enamel development and are consistent with p120 directing the attachment and detachment of the secretory stage ameloblasts as they move in rows.	[Bartlett, John D.; Dobeck, Justine M.; Tye, Coralee E.; Skobe, Ziedonis] Forsyth Inst, Dept Cytokine Biol, Boston, MA USA; [Bartlett, John D.; Tye, Coralee E.] Harvard Univ, Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA; [Perez-Moreno, Mirna] Ctr Nacl Invest Oncol, Madrid, Spain; [Stokes, Nicole; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; [Reynolds, Albert B.] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA	Harvard University; Forsyth Institute; Harvard University; Harvard School of Dental Medicine; Howard Hughes Medical Institute; Rockefeller University; Vanderbilt University	Bartlett, JD (corresponding author), Forsyth Inst, Dept Cytokine Biol, Boston, MA USA.	jbartlett@forsyth.org	Fuchs, Elaine/G-1565-2016; Perez-Moreno, Mirna/I-3687-2015; Bartlett, John/L-9832-2017	Perez-Moreno, Mirna/0000-0002-0170-6406; Tye, Coralee/0000-0002-3349-1833; Bartlett, John/0000-0003-2052-6299	National Institutes of Health (NIH) [AR27833, R01CA55724]; Forsyth Institute; NATIONAL CANCER INSTITUTE [R01CA055724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016276] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Forsyth Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health (NIH) grants AR27833 (E.F.) and R01CA55724 (A.B.R.) and by the Forsyth Institute (www.forsyth.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasiadis PZ, 2000, NAT CELL BIOL, V2, P637, DOI 10.1038/35023588; Bartlett JD, 1999, CRIT REV ORAL BIOL M, V10, P425, DOI 10.1177/10454411990100040101; Daniel JM, 1999, MOL CELL BIOL, V19, P3614; Daniel JM, 2007, BBA-MOL CELL RES, V1773, P59, DOI 10.1016/j.bbamcr.2006.08.052; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Davis MA, 2006, DEV CELL, V10, P21, DOI 10.1016/j.devcel.2005.12.004; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Elia LP, 2006, NEURON, V51, P43, DOI 10.1016/j.neuron.2006.05.018; Fausser JL, 1998, DIFFERENTIATION, V63, P1, DOI 10.1046/j.1432-0436.1998.6310001.x; Ferber A, 2002, EXP CELL RES, V274, P35, DOI 10.1006/excr.2001.5436; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Heymann R, 2002, AM J PATHOL, V160, P2123, DOI 10.1016/S0002-9440(10)61161-3; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Ito Y, 2001, DEV BIOL, V236, P181, DOI 10.1006/dbio.2001.0332; KALLENBA.E, 1970, J ULTRA MOL STRUCT R, V30, P38, DOI 10.1016/S0022-5320(70)90063-8; Kim SW, 2004, NAT CELL BIOL, V6, P1212, DOI 10.1038/ncb1191; LEBLOND CP, 1979, J DENT RES, V58, P950, DOI 10.1177/00220345790580024901; Maas R, 1997, CRIT REV ORAL BIOL M, V8, P4, DOI 10.1177/10454411970080010101; Maeda M, 2006, ONCOGENE, V25, P4595, DOI 10.1038/sj.onc.1209396; MINA M, 1987, ARCH ORAL BIOL, V32, P123, DOI 10.1016/0003-9969(87)90055-0; NISHIKAWA S, 1990, CELL STRUCT FUNCT, V15, P245, DOI 10.1247/csf.15.245; NISHIKAWA S, 1988, EUR J CELL BIOL, V47, P222; Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567; Oas RG, 2010, CIRC RES, V106, P941, DOI 10.1161/CIRCRESAHA.109.207753; Obara N, 1998, ANAT EMBRYOL, V197, P469, DOI 10.1007/s004290050157; PALACIOS J, 1995, INT J DEV BIOL, V39, P663; Park JI, 2005, DEV CELL, V8, P843, DOI 10.1016/j.devcel.2005.04.010; Perez-Moreno M, 2006, CELL, V124, P631, DOI 10.1016/j.cell.2005.11.043; Perez-Moreno M, 2008, P NATL ACAD SCI USA, V105, P15399, DOI 10.1073/pnas.0807301105; REITH EJ, 1973, ARCH ORAL BIOL, V18, P445, DOI 10.1016/0003-9969(73)90170-2; RISNES S, 1979, ARCH ORAL BIOL, V24, P299, DOI 10.1016/0003-9969(79)90092-X; Smith CE, 1998, CRIT REV ORAL BIOL M, V9, P128, DOI 10.1177/10454411980090020101; Sorkin BC, 2000, J HISTOCHEM CYTOCHEM, V48, P397, DOI 10.1177/002215540004800309; Spandidos A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-633; Terling C, 1998, EUR J ORAL SCI, V106, P137, DOI 10.1111/j.1600-0722.1998.tb02166.x; Thesleff I, 1995, CONNECT TISSUE RES, V32, P9, DOI 10.3109/03008209509013700; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Tucker A, 2004, NAT REV GENET, V5, P499, DOI 10.1038/nrg1380; Tung K, 2006, ARCH ORAL BIOL, V51, P464, DOI 10.1016/j.archoralbio.2005.12.001; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; WARSHAWSKY H, 1971, ANAT RECORD, V169, P585, DOI 10.1002/ar.1091690308; Wildenberg GA, 2006, CELL, V127, P1027, DOI 10.1016/j.cell.2006.09.046; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001	44	34	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2010	5	9							e12703	10.1371/journal.pone.0012703	http://dx.doi.org/10.1371/journal.pone.0012703			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650QH	20862276	gold, Green Published, Green Submitted			2022-12-27	WOS:000281864100005
J	Jamali, S; Salzmann, A; Perroud, N; Ponsole-Lenfant, M; Cillario, J; Roll, P; Roeckel-Trevisiol, N; Crespel, A; Balzar, J; Schlachter, K; Gruber-Sedlmayr, U; Pataraia, E; Baumgartner, C; Zimprich, A; Zimprich, F; Malafosse, A; Szepetowski, P				Jamali, Sarah; Salzmann, Annick; Perroud, Nader; Ponsole-Lenfant, Magali; Cillario, Jennifer; Roll, Patrice; Roeckel-Trevisiol, Nathalie; Crespel, Ariel; Balzar, Jorg; Schlachter, Kurt; Gruber-Sedlmayr, Ursula; Pataraia, Ekaterina; Baumgartner, Christoph; Zimprich, Alexander; Zimprich, Fritz; Malafosse, Alain; Szepetowski, Pierre			Functional Variant in Complement C3 Gene Promoter and Genetic Susceptibility to Temporal Lobe Epilepsy and Febrile Seizures	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ALZHEIMERS-DISEASE; IDENTIFIES VARIANTS; HUMAN C3-GENE; TRANSCRIPTION; ACTIVATION; EXPRESSION; SEQUENCES; CORTEX; NEURODEGENERATION	Background: Human mesial temporal lobe epilepsies (MTLE) represent the most frequent form of partial epilepsies and are frequently preceded by febrile seizures (FS) in infancy and early childhood. Genetic associations of several complement genes including its central component C3 with disorders of the central nervous system, and the existence of C3 dysregulation in the epilepsies and in the MTLE particularly, make it the C3 gene a good candidate for human MTLE. Methodology/Principal Findings: A case-control association study of the C3 gene was performed in a first series of 122 patients with MTLE and 196 controls. Four haplotypes (HAP1 to 4) comprising GF100472, a newly discovered dinucleotide repeat polymorphism [(CA) 8 to (CA) 15] in the C3 promoter region showed significant association after Bonferroni correction, in the subgroup of MTLE patients having a personal history of FS (MTLE-FS+). Replication analysis in independent patients and controls confirmed that the rare HAP4 haplotype comprising the minimal length allele of GF100472 [(CA) 8], protected against MTLE-FS+. A fifth haplotype (HAP5) with medium-size (CA) 11 allele of GF100472 displayed four times higher frequency in controls than in the first cohort of MTLE-FS+ and showed a protective effect against FS through a high statistical significance in an independent population of 97 pure FS. Consistently, (CA) 11 allele by its own protected against pure FS in a second group of 148 FS patients. Reporter gene assays showed that GF100472 significantly influenced C3 promoter activity (the higher the number of repeats, the lower the transcriptional activity). Taken together, the consistent genetic data and the functional analysis presented here indicate that a newly-identified and functional polymorphism in the promoter of the complement C3 gene might participate in the genetic susceptibility to human MTLE with a history of FS, and to pure FS. Conclusions/Significance: The present study provides important data suggesting for the first time the involvement of the complement system in the genetic susceptibility to epileptic seizures and to epilepsy.	[Salzmann, Annick; Malafosse, Alain] Univ Hosp Geneva, Dept Med Genet & Dev, Geneva, Switzerland; [Perroud, Nader; Malafosse, Alain] Univ Hosp Geneva, Dept Psychiat, Geneva, Switzerland; [Ponsole-Lenfant, Magali; Cillario, Jennifer; Szepetowski, Pierre] Univ Aix Marseille 2, INSERM, Mediterranean Inst Neurobiol INMED, UMR901, Marseille, France; [Crespel, Ariel] Univ Hosp Montpellier, Epilepsy Unit, Montpellier, France; [Balzar, Jorg; Pataraia, Ekaterina; Zimprich, Alexander; Zimprich, Fritz] Med Univ Vienna, Dept Clin Neurol, Vienna, Austria; [Schlachter, Kurt] LKH Bregenz, Dept Pediat, Bregenz, Austria; [Gruber-Sedlmayr, Ursula] Med Univ Graz, Dept Pediat, Graz, Austria; [Baumgartner, Christoph] Gen Hosp Hietzing, Neurol Ctr Rosenhuegel, Dept Neurol 2, Vienna, Austria; [Jamali, Sarah; Roll, Patrice; Roeckel-Trevisiol, Nathalie; Szepetowski, Pierre] Univ Aix Marseille 2, INSERM, UMR 910, Marseille, France	University of Geneva; University of Geneva; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; CHU de Montpellier; Medical University of Vienna; Medical University of Graz; Hietzing Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Jamali, S (corresponding author), CINaM CNRS, Campus Luminy, Marseille, France.	alain.malafosse@hcuge.ch; szepetowski@inmed.univ-mrs.fr	Zimprich, Alexander/A-5232-2017; ROLL, Patrice/GLS-4467-2022; Zimprich, Fritz/W-1738-2017; ROLL, Patrice/I-4355-2016; Zimprich, Fritz/O-1406-2019	Zimprich, Alexander/0000-0002-1668-5177; ROLL, Patrice/0000-0002-0045-5641; Zimprich, Fritz/0000-0002-6998-5480; ROLL, Patrice/0000-0002-0045-5641; Zimprich, Fritz/0000-0002-6998-5480; Pataraia, Ekaterina/0000-0002-1454-7600; Salzmann, Annick/0000-0003-0571-251X	Institut National de la Sante et de la Recherche Medicale (INSERM); Association pour la Recherche sur la Genetique des Epilepsies (ARGE); Agence Nationale de la Recherche (ANR MRAR/EPICOGN); Ligue Francaise contre l'Epilepsie (LFCE); French Ministere de la Recherche et de la Technologie (MRT); Swiss National; Geneva Neurocenter	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association pour la Recherche sur la Genetique des Epilepsies (ARGE); Agence Nationale de la Recherche (ANR MRAR/EPICOGN)(French National Research Agency (ANR)); Ligue Francaise contre l'Epilepsie (LFCE); French Ministere de la Recherche et de la Technologie (MRT); Swiss National; Geneva Neurocenter	This study was supported by Institut National de la Sante et de la Recherche Medicale (INSERM), by the Association pour la Recherche sur la Genetique des Epilepsies (ARGE) and by the Agence Nationale de la Recherche (ANR MRAR/EPICOGN). SJ has been a recipient of a Ligue Francaise contre l'Epilepsie (LFCE) PhD fellowship, JC is a recipient of a French Ministere de la Recherche et de la Technologie (MRT) PhD fellowship and AS has been a recipient of the Swiss National Fund PhD fellowship and is a recipient of the Geneva Neurocenter Post-Doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronica E, 2007, NEUROBIOL DIS, V26, P497, DOI 10.1016/j.nbd.2007.01.015; Baulac S, 2001, ANN NEUROL, V49, P786, DOI 10.1002/ana.1014; Berkovic SF, 1996, ANN NEUROL, V40, P227, DOI 10.1002/ana.410400214; Bruder C, 2004, MOL IMMUNOL, V40, P949, DOI 10.1016/j.molimm.2003.10.016; Cavalleri GL, 2007, LANCET NEUROL, V6, P970, DOI 10.1016/S1474-4422(07)70247-8; Cendes F, 1998, NEUROLOGY, V50, P554, DOI 10.1212/WNL.50.2.554; Claes L, 2004, J MED GENET, V41, P710, DOI 10.1136/jmg.2004.019257; DELIC J, 1991, BIOCHEM BIOPH RES CO, V181, P818, DOI 10.1016/0006-291X(91)91263-C; Depondt C, 2002, NEUROLOGY, V58, P1429, DOI 10.1212/WNL.58.9.1429; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Gambardella A, 2009, EPILEPSIA, V50, P55, DOI 10.1111/j.1528-1167.2009.02123.x; Gasque P, 2000, IMMUNOPHARMACOLOGY, V49, P171, DOI 10.1016/S0162-3109(00)80302-1; Gebhardt F, 1999, J BIOL CHEM, V274, P13176, DOI 10.1074/jbc.274.19.13176; Gendrel M, 2009, NATURE, V461, P992, DOI 10.1038/nature08430; Gorter JA, 2006, J NEUROSCI, V26, P11083, DOI 10.1523/JNEUROSCI.2766-06.2006; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hedera P, 2007, NEUROLOGY, V68, P2107, DOI 10.1212/01.wnl.0000261246.75977.89; Helbig I, 2009, NAT GENET, V41, P160, DOI 10.1038/ng.292; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Ingram G, 2009, CLIN EXP IMMUNOL, V155, P128, DOI 10.1111/j.1365-2249.2008.03830.x; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Jamali S, 2006, BRAIN, V129, P625, DOI 10.1093/brain/awl001; Johnson EW, 1998, HUM MOL GENET, V7, P63, DOI 10.1093/hmg/7.1.63; JUAN TSC, 1993, P NATL ACAD SCI USA, V90, P2584, DOI 10.1073/pnas.90.7.2584; Kauffman MA, 2008, GENET MED, V10, P83, DOI 10.1097/GIM.0b013e318161317c; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Li JL, 2005, J BIOL CHEM, V280, P7427, DOI 10.1074/jbc.M411473200; Loscher W, 2002, TRENDS PHARMACOL SCI, V23, P113, DOI 10.1016/S0165-6147(00)01974-X; NAYLOR LH, 1990, NUCLEIC ACIDS RES, V18, P1595, DOI 10.1093/nar/18.6.1595; Norris JD, 1996, MOL ENDOCRINOL, V10, P1605, DOI 10.1210/mend.10.12.8961270; Pitkanen A, 2002, LANCET NEUROL, V1, P173, DOI 10.1016/S1474-4422(02)00073-X; Rahpeymai Y, 2006, EMBO J, V25, P1364, DOI 10.1038/sj.emboj.7601004; Rice TK, 2008, ADV GENET, V60, P293, DOI 10.1016/S0065-2660(07)00412-9; Ricklin D, 2007, NAT BIOTECHNOL, V25, P1265, DOI 10.1038/nbt1342; Roll P, 2006, HUM MOL GENET, V15, P1195, DOI 10.1093/hmg/ddl035; Shen Y, 2003, PROG NEUROBIOL, V70, P463, DOI 10.1016/j.pneurobio.2003.08.001; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; TAE HJ, 1994, J BIOL CHEM, V269, P10475; Tan NCK, 2004, EPILEPSIA, V45, P1429, DOI 10.1111/j.0013-9580.2004.22904.x; Van Beek J, 2003, ANN NY ACAD SCI, V992, P56; VIK DP, 1991, BIOCHEMISTRY-US, V30, P1080, DOI 10.1021/bi00218a029; WALLACE SJ, 2004, EPILEPSY CHILDREN, P122; Whitney KD, 2000, J NEUROSCI, V20, P7307; WILSON DR, 1990, MOL CELL BIOL, V10, P6181, DOI 10.1128/MCB.10.12.6181; Xiong ZQ, 2003, J NEUROSCI, V23, P955; Yamada N, 2000, AM J HUM GENET, V66, P187, DOI 10.1086/302729	46	24	24	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2010	5	9							e12740	10.1371/journal.pone.0012740	http://dx.doi.org/10.1371/journal.pone.0012740			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650QH	20862287	gold, Green Published, Green Submitted			2022-12-27	WOS:000281864100008
J	Yen, K; Le, TT; Bansal, A; Narasimhan, D; Cheng, JX; Tissenbaum, HA				Yen, Kelvin; Le, Thuc T.; Bansal, Ankita; Narasimhan, Devi; Cheng, Ji-Xin; Tissenbaum, Heidi A.			A Comparative Study of Fat Storage Quantitation in Nematode Caenorhabditis elegans Using Label and Label-Free Methods	PLOS ONE			English	Article							RAMAN-SCATTERING MICROSCOPY; LIPID DROPLETS; C. ELEGANS; LIFE-SPAN; CARS MICROSCOPY; NILE RED; METABOLISM; LIPOFUSCIN; LOCALIZATION; ACCUMULATION	The nematode Caenorhabditis elegans has been employed as a model organism to study human obesity due to the conservation of the pathways that regulate energy metabolism. To assay for fat storage in C. elegans, a number of fat-soluble dyes have been employed including BODIPY, Nile Red, Oil Red O, and Sudan Black. However, dye-labeled assays produce results that often do not correlate with fat stores in C. elegans. An alternative label-free approach to analyze fat storage in C. elegans has recently been described with coherent anti-Stokes Raman scattering (CARS) microscopy. Here, we compare the performance of CARS microscopy with standard dye-labeled techniques and biochemical quantification to analyze fat storage in wild type C. elegans and with genetic mutations in the insulin/IGF-1 signaling pathway including the genes daf-2 (insulin/IGF-1 receptor), rict-1 (rictor) and sgk-1 (serum glucocorticoid kinase). CARS imaging provides a direct measure of fat storage with unprecedented details including total fat stores as well as the size, number, and lipid-chain unsaturation of individual lipid droplets. In addition, CARS/TPEF imaging reveals a neutral lipid species that resides in both the hypodermis and the intestinal cells and an autofluorescent organelle that resides exclusively in the intestinal cells. Importantly, coherent addition of the CARS fields from the C-H abundant neutral lipid permits selective CARS imaging of the fat store, and further coupling of spontaneous Raman analysis provides unprecedented details including lipid-chain unsaturation of individual lipid droplets. We observe that although daf-2, rict-1, and sgk-1 mutants affect insulin/IGF-1 signaling, they exhibit vastly different phenotypes in terms of neutral lipid and autofluorescent species. We find that CARS imaging gives quantification similar to standard biochemical triglyceride quantification. Further, we independently confirm that feeding worms with vital dyes does not lead to the staining of fat stores, but rather the sequestration of dyes in lysosome-related organelles. In contrast, fixative staining methods provide reproducible data but are prone to errors due to the interference of autofluorescent species and the non-specific staining of cellular structures other than fat stores. Importantly, both growth conditions and developmental stage should be considered when comparing methods of C. elegans lipid storage. Taken together, we confirm that CARS microscopy provides a direct, non-invasive, and label-free means to quantitatively analyze fat storage in living C. elegans.	[Yen, Kelvin; Bansal, Ankita; Narasimhan, Devi; Tissenbaum, Heidi A.] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; [Le, Thuc T.; Cheng, Ji-Xin] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Cheng, Ji-Xin] Purdue Univ, Purdue Canc Ctr, W Lafayette, IN 47907 USA; [Cheng, Ji-Xin] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Tissenbaum, Heidi A.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Massachusetts System; University of Massachusetts Worcester	Yen, K (corresponding author), Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA.	jcheng@purdue.edu; Heidi.Tissenbaum@umassmed.edu	Yen, Kelvin/J-5378-2019	Yen, Kelvin/0000-0003-4595-971X; Bansal, Ankita/0000-0002-6668-1676	Ellison Medical Foundation; Glenn Foundation; William Randolph Hearst Foundation; National Institutes of Health [F32HL089074, AG025891, R01EB7243]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL089074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007243] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025891] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); Glenn Foundation; William Randolph Hearst Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The following funders were used for this grant: Ellison Medical Foundation, Glenn Foundation, William Randolph Hearst Foundation, and grants F32HL089074, AG025891, and R01EB7243 from the National Institutes of Health.	Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Bancroft J., 2007, THEORY PRACTICE HIST, V6 ed; Brock TJ, 2007, GENETICS, V176, P865, DOI 10.1534/genetics.107.071860; Brooks KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007545; Brunk UT, 2002, FREE RADICAL BIO MED, V33, P611, DOI 10.1016/S0891-5849(02)00959-0; Cheng JX, 2004, J PHYS CHEM B, V108, P827, DOI 10.1021/jp035693v; Chronis N, 2007, NAT METHODS, V4, P727, DOI 10.1038/NMETH1075; Chung KH, 2008, NAT METHODS, V5, P637, DOI 10.1038/nmeth.1227; CLOKEY GV, 1986, MECH AGEING DEV, V35, P79, DOI 10.1016/0047-6374(86)90068-0; Evans CL, 2008, ANNU REV ANAL CHEM, V1, P883, DOI 10.1146/annurev.anchem.1.031207.112754; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Freudiger CW, 2008, SCIENCE, V322, P1857, DOI 10.1126/science.1165758; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Guo Y, 2009, J CELL SCI, V122, P749, DOI 10.1242/jcs.037630; Hellerer T, 2007, P NATL ACAD SCI USA, V104, P14658, DOI 10.1073/pnas.0703594104; Hertweck M, 2004, DEV CELL, V6, P577, DOI 10.1016/S1534-5807(04)00095-4; HOSOKAWA H, 1994, MECH AGEING DEV, V74, P161, DOI 10.1016/0047-6374(94)90087-6; Hulme SE, 2010, LAB CHIP, V10, P589, DOI 10.1039/b919265d; Ivnitski-Steele I, 2009, ANAL BIOCHEM, V394, P87, DOI 10.1016/j.ab.2009.07.001; Jones KT, 2009, PLOS BIOL, V7, P604, DOI 10.1371/journal.pbio.1000060; JUNG T, 2010, LIPOFUSCIN DETECTION, P173; Jung T, 2007, ANN NY ACAD SCI, V1119, P97, DOI 10.1196/annals.1404.008; Kaletta T, 2006, NAT REV DRUG DISCOV, V5, P387, DOI 10.1038/nrd2031; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Le TT, 2010, J LIPID RES, V51, P672, DOI 10.1194/jlr.D000638; Le TT, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-42; Le TT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005189; Mak HY, 2006, NAT GENET, V38, P363, DOI 10.1038/ng1739; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Mukherjee S, 2007, BBA-BIOMEMBRANES, V1768, P59, DOI 10.1016/j.bbamem.2006.07.010; Narasimhan SD, 2009, CURR BIOL, V19, pR657, DOI 10.1016/j.cub.2009.06.013; O'Rourke EJ, 2009, CELL METAB, V10, P430, DOI 10.1016/j.cmet.2009.10.002; Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723; Padmanabhan S, 2009, CELL, V136, P939, DOI 10.1016/j.cell.2009.01.025; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; Rinia HA, 2008, BIOPHYS J, V95, P4908, DOI 10.1529/biophysj.108.137737; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Slipchenko MN, 2009, J PHYS CHEM B, V113, P7681, DOI 10.1021/jp902231y; Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409; Srinivasan S, 2008, CELL METAB, V7, P533, DOI 10.1016/j.cmet.2008.04.012; Thumser AE, 2007, MOL CELL BIOCHEM, V299, P67, DOI 10.1007/s11010-005-9041-2; Viegas MS, 2007, EUR J HISTOCHEM, V51, P59; Walther TC, 2009, BBA-MOL CELL BIOL L, V1791, P459, DOI 10.1016/j.bbalip.2008.10.009; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942	48	171	178	6	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2010	5	9							e12810	10.1371/journal.pone.0012810	http://dx.doi.org/10.1371/journal.pone.0012810			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650QH	20862331	Green Published, gold			2022-12-27	WOS:000281864100025
J	Wodarczyk, C; Distefano, G; Rowe, I; Gaetani, M; Bricoli, B; Muorah, M; Spitaleri, A; Mannella, V; Ricchiuto, P; Pema, M; Castelli, M; Casanova, AE; Mollica, L; Banzi, M; Boca, M; Antignac, C; Saunier, S; Musco, G; Boletta, A				Wodarczyk, Claas; Distefano, Gianfranco; Rowe, Isaline; Gaetani, Massimiliano; Bricoli, Barbara; Muorah, Mordi; Spitaleri, Andrea; Mannella, Valeria; Ricchiuto, Piero; Pema, Monika; Castelli, Maddalena; Casanova, Ariel E.; Mollica, Luca; Banzi, Manuela; Boca, Manila; Antignac, Corinne; Saunier, Sophie; Musco, Giovanna; Boletta, Alessandra			Nephrocystin-1 Forms a Complex with Polycystin-1 via a Polyproline Motif/SH3 Domain Interaction and Regulates the Apoptotic Response in Mammals	PLOS ONE			English	Article							KIDNEY-DISEASE; AUTOSOMAL-DOMINANT; NEPHRONOPHTHISIS; PROTEINS; CILIA; GENE; ENCODES; PKD1	Mutations in PKD1, the gene encoding for the receptor Polycystin-1 (PC-1), cause autosomal dominant polycystic kidney disease (ADPKD). The cytoplasmic C-terminus of PC-1 contains a coiled-coil domain that mediates an interaction with the PKD2 gene product, Polycystin-2 (PC-2). Here we identify a novel domain in the PC-1 C-terminal tail, a polyproline motif mediating an interaction with Src homology domain 3 (SH3). A screen for interactions using the PC-1 C-terminal tail identified the SH3 domain of nephrocystin-1 (NPHP1) as a potential binding partner of PC-1. NPHP1 is the product of a gene that is mutated in a different form of renal cystic disease, nephronophthisis (NPHP). We show that in vitro pull-down assays and NMR structural studies confirmed the interaction between the PC-1 polyproline motif and the NPHP1 SH3 domain. Furthermore, the two full-length proteins interact through these domains; using a recently generated model system allowing us to track endogenous PC-1, we confirm the interaction between the endogenous proteins. Finally, we show that NPHP1 trafficking to cilia does not require PC-1 and that PC-1 may require NPHP1 to regulate resistance to apoptosis, but not to regulate cell cycle progression. In line with this, we find high levels of apoptosis in renal specimens of NPHP patients. Our data uncover a link between two different ciliopathies, ADPKD and NPHP, supporting the notion that common pathogenetic defects, possibly involving de-regulated apoptosis, underlie renal cyst formation.	[Wodarczyk, Claas; Distefano, Gianfranco; Rowe, Isaline; Pema, Monika; Castelli, Maddalena; Casanova, Ariel E.; Banzi, Manuela; Boca, Manila; Boletta, Alessandra] Ist Sci San Raffaele, Dulbecco Telethon Inst Dibit, Div Genet & Cell Biol, I-20132 Milan, Italy; [Gaetani, Massimiliano; Bricoli, Barbara; Spitaleri, Andrea; Mannella, Valeria; Ricchiuto, Piero; Mollica, Luca; Musco, Giovanna] Ist Sci San Raffaele, Dulbecco Telethon Inst Dibit, Biomol NMR Lab, I-20132 Milan, Italy; [Muorah, Mordi; Antignac, Corinne; Saunier, Sophie] Hop Necker Enfants Malad, INSERM, U574, Paris, France; [Muorah, Mordi; Antignac, Corinne; Saunier, Sophie] Univ Paris 05, Paris, France; [Antignac, Corinne] Hop Necker Enfants Malad, Dept Genet, AP HP, Paris, France	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Wodarczyk, C (corresponding author), Ist Sci San Raffaele, Dulbecco Telethon Inst Dibit, Div Genet & Cell Biol, I-20132 Milan, Italy.	musco.giovanna@hsr.it; boletta.alessandra@hsr.it	Mannella, Valeria/AAN-1946-2020; Gaetani, Massimiliano/Z-1252-2019; Spitaleri, Andrea/S-9368-2019; Saunier, Sophie/G-6044-2015; Musco, Giovanna/Q-2756-2019; Ricchiuto, Piero/G-1820-2011; distefano, gianfranco/AAN-7169-2020; musco, giovanna/I-7122-2012; rowe, isaline/AAN-1985-2020; ANTIGNAC, Corinne/H-8945-2017	Gaetani, Massimiliano/0000-0001-5610-0797; Spitaleri, Andrea/0000-0003-3012-3557; Saunier, Sophie/0000-0002-1069-0047; distefano, gianfranco/0000-0002-4956-0629; musco, giovanna/0000-0002-0469-2994; rowe, isaline/0000-0002-5398-1776; MOLLICA, LUCA/0000-0001-8164-7663; ANTIGNAC, Corinne/0000-0002-9934-4940	Italian Telethon Foundation [TCR 07005, S99035]; Cariplo Foundation; Italian Ministry for Research Fondo per gli Investimenti della Ricerca di Base [RBIP06FYF7]; European Community [MC-EXT002785]	Italian Telethon Foundation(Fondazione Telethon); Cariplo Foundation(Fondazione Cariplo); Italian Ministry for Research Fondo per gli Investimenti della Ricerca di Base; European Community(European Commission)	This work was supported by the Italian Telethon Foundation to AB (TCR 07005) and to GM (S99035); by the Cariplo Foundation to AB and GM (2004/2005), by the Italian Ministry for Research Fondo per gli Investimenti della Ricerca di Base (FIRB, N. RBIP06FYF7 to GM) and by the European Community 6th Framework Programme (MC-EXT002785 to AB). Both AB and GM are Associate Telethon Scientists. SS is laureat of the Equipe FRM (grant # DEQ20071210558), and the Agence National de la Recherche (ANR) grant # R07089KS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benzing T, 2001, P NATL ACAD SCI USA, V98, P9784, DOI 10.1073/pnas.171269898; Boletta A, 2003, TRENDS CELL BIOL, V13, P484, DOI 10.1016/S0962-8924(03)00169-7; Boletta A, 2000, MOL CELL, V6, P1267, DOI 10.1016/S1097-2765(00)00123-4; Boletta Alessandra, 2009, Pathogenetics, V2, P6, DOI 10.1186/1755-8417-2-6; DE VRIES SJ, 2007, PROTEINS, V69, P726; Delous M, 2009, HUM MOL GENET, V18, P4711, DOI 10.1093/hmg/ddp434; Distefano G, 2009, MOL CELL BIOL, V29, P2359, DOI 10.1128/MCB.01259-08; Donaldson JC, 2000, EXP CELL RES, V256, P168, DOI 10.1006/excr.2000.4822; Fliegauf M, 2006, J AM SOC NEPHROL, V17, P2424, DOI 10.1681/ASN.2005121351; Garcia-Gonzalez MA, 2007, HUM MOL GENET, V16, P1940, DOI 10.1093/hmg/ddm141; Hildebrandt F, 2007, J AM SOC NEPHROL, V18, P1855, DOI 10.1681/ASN.2006121344; Jiang ST, 2009, HUM MOL GENET, V18, P1566, DOI 10.1093/hmg/ddp068; Joly D, 2006, J BIOL CHEM, V281, P26329, DOI 10.1074/jbc.M601373200; Kaneko T, 2008, FRONT BIOSCI-LANDMRK, V13, P4938, DOI 10.2741/3053; LE MAIRE A, 2005, PROTEINS, V59, P347; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Mollet G, 2002, NAT GENET, V32, P300, DOI 10.1038/ng996; Ohlson S, 2008, DRUG DISCOV TODAY, V13, P433, DOI 10.1016/j.drudis.2008.02.001; Parnell SC, 1998, BIOCHEM BIOPH RES CO, V251, P625, DOI 10.1006/bbrc.1998.9514; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; Roitbak T, 2004, MOL BIOL CELL, V15, P1334, DOI 10.1091/mbc.E03-05-0296; Saunier S, 2005, CURR OPIN GENET DEV, V15, P324, DOI 10.1016/j.gde.2005.04.012; Saunier S, 1997, HUM MOL GENET, V6, P2317, DOI 10.1093/hmg/6.13.2317; Shao XL, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000016444.90348.50; Shibazaki S, 2008, HUM MOL GENET, V17, P1505, DOI 10.1093/hmg/ddn039; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Tory K, 2007, J AM SOC NEPHROL, V18, P1566, DOI 10.1681/ASN.2006101164; Wodarczyk C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007137; Wolf MTF, 2005, J AM SOC NEPHROL, V16, P676, DOI 10.1681/ASN.2003121025; WOO D, 1995, NEW ENGL J MED, V333, P18, DOI 10.1056/NEJM199507063330104; Wu YL, 2006, HUM MOL GENET, V15, P3280, DOI 10.1093/hmg/ddl404; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; Yoder BK, 2007, J AM SOC NEPHROL, V18, P1381, DOI 10.1681/ASN.2006111215	33	20	25	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2010	5	9							e12719	10.1371/journal.pone.0012719	http://dx.doi.org/10.1371/journal.pone.0012719			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZO	20856870	gold, Green Submitted, Green Published			2022-12-27	WOS:000281815700009
J	Wu, YG; Zhou, P; Lan, GC; Gao, D; Li, Q; Wei, DL; Wang, HL; Tan, JH				Wu, Yan-Guang; Zhou, Ping; Lan, Guo-Cheng; Gao, Da; Li, Qing; Wei, De-Li; Wang, Hui-Li; Tan, Jing-He			MPF Governs the Assembly and Contraction of Actomyosin Rings by Activating RhoA and MAPK during Chemical-Induced Cytokinesis of Goat Oocytes	PLOS ONE			English	Article							MYOSIN LIGHT-CHAIN; DEMECOLCINE-ASSISTED ENUCLEATION; POLAR BODY EXTRUSION; PROTEIN-KINASE; MOUSE OOCYTES; XENOPUS-OOCYTE; SMOOTH-MUSCLE; RAT OOCYTES; SIGNALING PATHWAYS; CORTICAL GRANULES	The interplay between maturation-promoting factor (MPF), mitogen-activated protein kinase (MAPK) and Rho GTPase during actin-myosin interactions has yet to be determined. The mechanism by which microtubule disrupters induce the formation of ooplasmic protrusion during chemical-assisted enucleation of mammalian oocytes is unknown. Moreover, a suitable model is urgently needed for the study of cytokinesis. We have established a model of chemical-induced cytokinesis and have studied the signaling events leading to cytokinesis using this model. The results suggested that microtubule inhibitors activated MPF, which induced actomyosin assembly (formation of ooplasmic protrusion) by activating RhoA and thus MAPK. While MAPK controlled actin recruitment on its own, MPF promoted myosin enrichment by activating RhoA and MAPK. A further chemical treatment of oocytes with protrusions induced constriction of the actomyosin ring by inactivating MPF while activating RhoA. In conclusion, the present data suggested that the assembly and contraction of the actomyosin ring were two separable steps: while an increase in MPF activity promoted the assembly through RhoA-mediated activation of MAPK, a decrease in MPF activity triggered contraction of the ring by activating RhoA.	[Wu, Yan-Guang; Zhou, Ping; Lan, Guo-Cheng; Gao, Da; Li, Qing; Wei, De-Li; Wang, Hui-Li; Tan, Jing-He] Shandong Agr Univ, Coll Anim Sci & Vet Med, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Wu, YG (corresponding author), Shandong Agr Univ, Coll Anim Sci & Vet Med, Tai An, Shandong, Peoples R China.	tanjh@sdau.edu.cn	yu, qing/HGC-4611-2022; wang, hui/GRS-4730-2022		China Ministry of Science and Technology [2006CB944003, 2007CB947403, 2008AA10Z160, 2008AA101003]; China National Natural Science Foundation [30771556, 30972096]	China Ministry of Science and Technology(Ministry of Science and Technology, China); China National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Basic Research Project of the China Ministry of Science and Technology (Nos. 2006CB944003 and 2007CB947403), the China National Natural Science Foundation (Nos. 30771556 and 30972096) and the National "863" Project of the China Ministry of Science and Technology (Nos. 2008AA10Z160 and 2008AA101003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki K, 1996, BIOL REPROD, V55, P1315, DOI 10.1095/biolreprod55.6.1315; Balasubramanian MK, 2004, CURR BIOL, V14, pR806, DOI 10.1016/j.cub.2004.09.022; Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; Bielak-Zmijewska A, 2008, DEV BIOL, V322, P21, DOI 10.1016/j.ydbio.2008.06.039; Birkenfeld J, 2007, DEV CELL, V12, P699, DOI 10.1016/j.devcel.2007.03.014; Brunet S, 2005, REPRODUCTION, V130, P801, DOI 10.1530/rep.1.00364; Chen RH, 1996, SCIENCE, V274, P242, DOI 10.1126/science.274.5285.242; Cheresh DA, 1999, J CELL BIOL, V146, P1107, DOI 10.1083/jcb.146.5.1107; Chu CL, 2000, INVEST OPHTH VIS SCI, V41, P3374; Connors SA, 1998, DEV BIOL, V200, P103, DOI 10.1006/dbio.1998.8945; D'Angiolella V, 2003, GENE DEV, V17, P2520, DOI 10.1101/gad.267603; Dedieu T, 1996, MOL REPROD DEV, V45, P351; Deng MQ, 2007, DEV CELL, V12, P301, DOI 10.1016/j.devcel.2006.11.008; Deng MQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007171; Deng MQ, 2005, DEV BIOL, V278, P358, DOI 10.1016/j.ydbio.2004.11.013; Deng MQ, 2003, DEV BIOL, V257, P166, DOI 10.1016/S0012-1606(03)00045-9; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; Elbaz J., 2009, BIOL REPROD, V81; Ge L, 2008, FERTIL STERIL, V90, P2376, DOI 10.1016/j.fertnstert.2007.10.054; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; GORIS J, 1989, FEBS LETT, V245, P91, DOI 10.1016/0014-5793(89)80198-X; GOTOH Y, 1991, EMBO J, V10, P2661, DOI 10.1002/j.1460-2075.1991.tb07809.x; Guertin DA, 2002, MICROBIOL MOL BIOL R, V66, P155, DOI 10.1128/MMBR.66.2.155-178.2002; HACCARD O, 1993, MOL REPROD DEV, V36, P96, DOI 10.1002/mrd.1080360114; Hai CM, 2006, EUR J CELL BIOL, V85, P305, DOI 10.1016/j.ejcb.2005.08.008; Han MY, 2007, MOL CELL BIOL, V27, P8190, DOI 10.1128/MCB.00661-07; Hayne C, 2000, J BIOL CHEM, V275, P31876, DOI 10.1074/jbc.M002766200; Hirano K, 2003, MOL CELL BIOCHEM, V248, P105, DOI 10.1023/A:1024180101032; Homer HA, 2005, GENE DEV, V19, P202, DOI 10.1101/gad.328105; Huang TS, 2000, APOPTOSIS, V5, P235, DOI 10.1023/A:1009652412399; Josefsberg LBY, 2000, BIOL REPROD, V62, P1270, DOI 10.1095/biolreprod62.5.1270; Josefsberg LBY, 2003, BIOL REPROD, V68, P1282, DOI 10.1095/biolreprod.102.006882; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; Khatiwala CB, 2009, J BONE MINER RES, V24, P886, DOI [10.1359/jbmr.081240, 10.1359/JBMR.081240]; Khurana A, 2003, DIFFERENTIATION, V71, P42, DOI 10.1046/j.1432-0436.2003.700604.x; Kikuchi K, 2000, BIOL REPROD, V63, P715, DOI 10.1095/biolreprod63.3.715; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Komatsu S, 2000, J BIOL CHEM, V275, P34512, DOI 10.1074/jbc.M003019200; KOSAKO H, 1994, EMBO J, V13, P2131, DOI 10.1002/j.1460-2075.1994.tb06489.x; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Lan GC, 2008, CLONING STEM CELLS, V10, P189, DOI 10.1089/clo.2007.0088; Lazar S, 2004, J MOL ENDOCRINOL, V33, P73, DOI 10.1677/jme.0.0330073; Leader B, 2002, NAT CELL BIOL, V4, P921, DOI 10.1038/ncb880; Li Y, 1996, SCIENCE, V274, P246, DOI 10.1126/science.274.5285.246; Li Y, 1997, P NATL ACAD SCI USA, V94, P12431, DOI 10.1073/pnas.94.23.12431; Lim GE, 2009, ENDOCRINOLOGY, V150, P5249, DOI 10.1210/en.2009-0508; Ling YH, 1998, INT J CANCER, V75, P925, DOI 10.1002/(SICI)1097-0215(19980316)75:6<925::AID-IJC16>3.0.CO;2-1; Liu D, 2000, DEV BIOL, V224, P388, DOI 10.1006/dbio.2000.9776; Liu XY, 2005, HUM REPROD, V20, P3402, DOI 10.1093/humrep/dei265; LONGO FJ, 1985, DEV BIOL, V107, P382, DOI 10.1016/0012-1606(85)90320-3; Ma CQ, 2006, CURR BIOL, V16, P214, DOI 10.1016/j.cub.2005.11.067; MARO B, 1986, J EMBRYOL EXP MORPH, V92, P11; MATSUDA S, 1992, EMBO J, V11, P973, DOI 10.1002/j.1460-2075.1992.tb05136.x; Mishima M, 1996, J BIOCHEM-TOKYO, V119, P906; Mishima M, 2004, ENCY BIOL CHEM, V1, P556; Nguyen DHD, 1999, J CELL BIOL, V146, P149, DOI 10.1083/jcb.146.1.149; Niiya F, 2006, ONCOGENE, V25, P827, DOI 10.1038/sj.onc.1209124; Nwariaku FE, 2003, J APPL PHYSIOL, V95, P1889, DOI 10.1152/japplphysiol.00225.2003; O'Malley D, 2007, EUR J NEUROSCI, V25, P673, DOI 10.1111/j.1460-9568.2007.05347.x; Ohan N, 1999, J CELL SCI, V112, P2177; Palmer A, 1998, EMBO J, V17, P5037, DOI 10.1093/emboj/17.17.5037; Peter M, 2002, DEVELOPMENT, V129, P2129; RIME H, 1990, CELL DIFFER DEV, V29, P47, DOI 10.1016/0922-3371(90)90023-P; SAGATA N, 1989, SCIENCE, V245, P643, DOI 10.1126/science.2474853; Samaj J, 2004, J EXP BOT, V55, P189, DOI 10.1093/jxb/erh012; SATTERWHITE LL, 1992, J CELL BIOL, V118, P595, DOI 10.1083/jcb.118.3.595; Shulman JM, 1999, TRENDS BIOCHEM SCI, V24, pM60, DOI 10.1016/S0968-0004(99)01490-5; SMYTHE C, 1992, CELL, V68, P787, DOI 10.1016/0092-8674(92)90153-4; SOEWARTO D, 1995, HUM REPROD, V10, P2350; Somlyo AP, 2000, J PHYSIOL-LONDON, V522, P177, DOI 10.1111/j.1469-7793.2000.t01-2-00177.x; Stone AA, 2000, EXP CELL RES, V254, P110, DOI 10.1006/excr.1999.4731; Tani T, 2006, CLONING STEM CELLS, V8, P61, DOI 10.1089/clo.2006.8.61; Tani T, 2007, FRONT BIOSCI, V12, P2693, DOI 10.2741/2265; VANBLERKOM J, 1986, J EMBRYOL EXP MORPH, V93, P213; Wang Y, 2009, CURR OPIN MICROBIOL, V12, P644, DOI 10.1016/j.mib.2009.09.002; Wu JQ, 2003, DEV CELL, V5, P723, DOI 10.1016/S1534-5807(03)00324-1; YAMASHIRO S, 1991, NATURE, V349, P169, DOI 10.1038/349169a0; YAMASHIRO S, 1991, BIOESSAYS, V13, P563, DOI 10.1002/bies.950131103; Yamashiro S, 2008, DEV CELL, V14, P787, DOI 10.1016/j.devcel.2008.02.013; Yin XJ, 2002, BIOL REPROD, V67, P442, DOI 10.1095/biolreprod67.2.442; Yujiri T, 1999, J BIOL CHEM, V274, P12605, DOI 10.1074/jbc.274.18.12605; ZernickaGoetz M, 1997, EUR J CELL BIOL, V72, P30; Zhang X, 2008, DEV CELL, V15, P386, DOI 10.1016/j.devcel.2008.07.005; Zheng XD, 2007, EMBO J, V26, P3760, DOI 10.1038/sj.emboj.7601814; Zohrabian VM, 2009, ANTICANCER RES, V29, P119	85	11	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2010	5	9							e12706	10.1371/journal.pone.0012706	http://dx.doi.org/10.1371/journal.pone.0012706			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648ZZ	20856880	Green Published, Green Submitted, gold			2022-12-27	WOS:000281735700021
J	Pershing, AJ; Christensen, LB; Record, NR; Sherwood, GD; Stetson, PB				Pershing, Andrew J.; Christensen, Line B.; Record, Nicholas R.; Sherwood, Graham D.; Stetson, Peter B.			The Impact of Whaling on the Ocean Carbon Cycle: Why Bigger Was Better	PLOS ONE			English	Article							IRON FERTILIZATION; HUMPBACK WHALES; KILLER WHALES; NORTH; GROWTH; FISH; AGE; DEPLETION; COLLAPSE; ATLANTIC	Background: Humans have reduced the abundance of many large marine vertebrates, including whales, large fish, and sharks, to only a small percentage of their pre-exploitation levels. Industrial fishing and whaling also tended to preferentially harvest the largest species and largest individuals within a population. We consider the consequences of removing these animals on the ocean's ability to store carbon. Methodology/Principal Findings: Because body size is critical to our arguments, our analysis focuses on populations of baleen whales. Using reconstructions of pre-whaling and modern abundances, we consider the impact of whaling on the amount of carbon stored in living whales and on the amount of carbon exported to the deep sea by sinking whale carcasses. Populations of large baleen whales now store 9.1 x 10(6) tons less carbon than before whaling. Some of the lost storage has been offset by increases in smaller competitors; however, due to the relative metabolic efficiency of larger organisms, a shift toward smaller animals could decrease the total community biomass by 30% or more. Because of their large size and few predators, whales and other large marine vertebrates can efficiently export carbon from the surface waters to the deep sea. We estimate that rebuilding whale populations would remove 1.6 x 10(5) tons of carbon each year through sinking whale carcasses. Conclusions/Significance: Even though fish and whales are only a small portion of the ocean's overall biomass, fishing and whaling have altered the ocean's ability to store and sequester carbon. Although these changes are small relative to the total ocean carbon sink, rebuilding populations of fish and whales would be comparable to other carbon management schemes, including ocean iron fertilization.	[Pershing, Andrew J.; Record, Nicholas R.; Stetson, Peter B.] Univ Maine, Sch Marine Sci, Orono, ME 04469 USA; [Pershing, Andrew J.; Record, Nicholas R.; Sherwood, Graham D.; Stetson, Peter B.] Gulf Maine Res Inst, Portland, ME USA; [Christensen, Line B.] Univ British Columbia, Fisheries Ctr, Vancouver, BC V5Z 1M9, Canada	University of Maine System; University of Maine Orono; Gulf of Maine Research Institute; University of British Columbia	Pershing, AJ (corresponding author), Univ Maine, Sch Marine Sci, Orono, ME 04469 USA.	andrew.pershing@maine.edu			NASA [NNA07CN69A]; NSF [OCE0709518]	NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF))	This work was supported by NASA's Applied Sciences Program (NNA07CN69A) and NSF's Coupled Natural and Human Systems Program (OCE0709518). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainley D, 2007, ANTARCT SCI, V19, P283, DOI 10.1017/S095410200700051X; Barlow J, 1997, ECOLOGY, V78, P535; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Branch TA, 2004, MAR MAMMAL SCI, V20, P726, DOI 10.1111/j.1748-7692.2004.tb01190.x; Brown JH, 2003, P NATL ACAD SCI USA, V100, P1467, DOI 10.1073/pnas.0630310100; Buesseler KO, 2008, SCIENCE, V319, P162, DOI 10.1126/science.1154305; Buesseler KO, 2004, SCIENCE, V304, P414, DOI 10.1126/science.1086895; BUTMAN CA, 1995, CONSERV BIOL, V9, P462, DOI 10.1046/j.1523-1739.1995.9020462.x; Chowdhury J. A., 2006, BETTER FOREST MANAGE; Christensen LB, 2006, MARINE MAMMAL POPULA; Doney Scott C., 2001, Oceanography, V14, P93; Ducklow Hugh W., 2001, Oceanography, V14, P50; Essington TE, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P38; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; Gabriele CM, 2007, MAR MAMMAL SCI, V23, P226, DOI 10.1111/j.1748-7692.2006.00100.x; Gabriele CM, 2001, CAN J ZOOL, V79, P589, DOI 10.1139/cjz-79-4-589; George JC, 1999, CAN J ZOOL, V77, P571, DOI 10.1139/cjz-77-4-571; Greene C. H., 2003, OCEANOGRAPHY, V16, P98, DOI DOI 10.5670/OCEANOG.2003.16; Greene CH, 2007, SCIENCE, V315, P1084, DOI 10.1126/science.1136495; Hofmann E, 2008, OCEANOGRAPHY, V21, P86, DOI 10.5670/oceanog.2008.70; Hutchings JA, 2005, CAN J FISH AQUAT SCI, V62, P824, DOI 10.1139/F05-081; IPCC, 2007, CLIM CHANG 2007 PHYS; *IWC, 2001, RIGHT WHAL WORLD STA, P1; Jelmert A, 1996, CONSERV BIOL, V10, P653, DOI 10.1046/j.1523-1739.1996.10020653.x; Jennings S, 2004, J ANIM ECOL, V73, P632, DOI 10.1111/j.0021-8790.2004.00839.x; Kerr S. R., 2001, COM ECO SYS; KLEIBER MAX, 1932, HILGARDIA, V6, P315; Kraus Scott D., 2001, Journal of Cetacean Research and Management Special Issue, V2, P231; Laist DW, 2001, MAR MAMMAL SCI, V17, P35, DOI 10.1111/j.1748-7692.2001.tb00980.x; LAMBERTSEN RH, 1992, INT OFFICE EPIZOOTIC, V11, P1131; LOCKYER C, 1976, J CONSEIL, V36, P259, DOI 10.1093/icesjms/36.3.259; MARTIN JH, 1988, NATURE, V331, P341, DOI 10.1038/331341a0; Mazzochi Maria Grazia, 2009, GLOBEC International Newsletter, V15, P3; Mizroch SA, 2004, J MAMMAL, V85, P963, DOI 10.1644/BOS-123; Mizroch SA, 2006, MAR ECOL PROG SER, V310, P235, DOI 10.3354/meps310235; Moore JK, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002220; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Nicol S, 2008, MAR FRESHWATER RES, V59, P361, DOI 10.1071/MF07161; Nicol S, 2007, ANTARCT SCI, V19, P291, DOI 10.1017/S0954102007000491; Nicol S, 2010, FISH FISH, V11, P203, DOI 10.1111/j.1467-2979.2010.00356.x; Reeves R. R., 2002, NATL AUDUBON SOC GUI; Roman J, 2003, SCIENCE, V301, P508, DOI 10.1126/science.1084524; Sarmiento JL, 2002, PHYS TODAY, V55, P30, DOI 10.1063/1.1510279; SHELDON RW, 1972, LIMNOL OCEANOGR, V17, P327, DOI 10.4319/lo.1972.17.3.0327; Sherwood GD, 2007, DEEP-SEA RES PT II, V54, P2794, DOI 10.1016/j.dsr2.2007.08.007; Smetacek V, 2008, PHILOS T R SOC A, V366, P3947, DOI 10.1098/rsta.2008.0144; SMITH CR, 2003, OCEANOGRAPHY MARINE, V311, P354; Springer AM, 2003, P NATL ACAD SCI USA, V100, P12223, DOI 10.1073/pnas.1635156100; Stevick PT, 1999, MAR MAMMAL SCI, V15, P725, DOI 10.1111/j.1748-7692.1999.tb00839.x; Trick CG, 2010, P NATL ACAD SCI USA, V107, P5887, DOI 10.1073/pnas.0910579107; TYNAN CT, 2004, MARINE ECOLOGY PROGR, V300, P272; Walsh MR, 2006, ECOL LETT, V9, P142, DOI 10.1111/j.1461-0248.2005.00858.x; Whitehead H, 2005, BIOL LETTERS, V1, P415, DOI 10.1098/rsbl.2005.0348; Wilson RW, 2009, SCIENCE, V323, P359, DOI 10.1126/science.1157972	55	81	84	10	126	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12444	10.1371/journal.pone.0012444	http://dx.doi.org/10.1371/journal.pone.0012444			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865156	gold, Green Published			2022-12-27	WOS:000281292100032
J	Kanzaki, S; Yamaguchi, A; Yamaguchi, K; Kojima, Y; Suzuki, K; Koumitsu, N; Nagashima, Y; Nagahama, K; Ehara, M; Hirayasu, Y; Ryo, A; Aoki, I; Yamanaka, S				Kanzaki, Seiichi; Yamaguchi, Akira; Yamaguchi, Kayoko; Kojima, Yoshitsugu; Suzuki, Kyoko; Koumitsu, Noriko; Nagashima, Yoji; Nagahama, Kiyotaka; Ehara, Michiko; Hirayasu, Yoshio; Ryo, Akihide; Aoki, Ichiro; Yamanaka, Shoji			Thymic Alterations in GM2 Gangliosidoses Model Mice	PLOS ONE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; MACROPHAGE-INFLAMMATORY PROTEIN-1-ALPHA; MURINE LYMPHOCYTE SUBPOPULATIONS; HUMAN TAY-SACHS; MOUSE MODELS; NALP3 INFLAMMASOME; SANDHOFF-DISEASE; T-CELLS; ACTIVATION; EXPRESSION	Background: Sandhoff disease is a lysosomal storage disorder characterized by the absence of beta-hexosaminidase and storage of GM2 ganglioside and related glycolipids. We have previously found that the progressive neurologic disease induced in Hexb(-/-) mice, an animal model for Sandhoff disease, is associated with the production of pathogenic anti-glycolipid autoantibodies. Methodology/Principal Findings: In our current study, we report on the alterations in the thymus during the development of mild to severe progressive neurologic disease. The thymus from Hexb(-/-) mice of greater than 15 weeks of age showed a marked decrease in the percentage of immature CD4(+)/CD8(+) T cells and a significantly increased number of CD4(+)/CD8(-) T cells. During involution, the levels of both apoptotic thymic cells and IgG deposits to T cells were found to have increased, whilst swollen macrophages were prominently observed, particularly in the cortex. We employed cDNA microarray analysis to monitor gene expression during the involution process and found that genes associated with the immune responses were upregulated, particularly those expressed in macrophages. CXCL13 was one of these upregulated genes and is expressed specifically in the thymus. B1 cells were also found to have increased in the thy mus. It is significant that these alterations in the thymus were reduced in FcR gamma additionally disrupted Hexb(-/-) mice. Conclusions/Significance: These results suggest that the FcR gamma chain may render the usually poorly immunogenic thymus into an organ prone to autoimmune responses, including the chemotaxis of B1 cells toward CXCL13.	[Kanzaki, Seiichi; Yamaguchi, Akira; Yamaguchi, Kayoko; Koumitsu, Noriko; Nagashima, Yoji; Nagahama, Kiyotaka; Ehara, Michiko; Aoki, Ichiro; Yamanaka, Shoji] Yokohama City Univ, Sch Med, Dept Pathol, Yokohama, Kanagawa 232, Japan; [Kojima, Yoshitsugu; Ryo, Akihide] Yokohama City Univ, Sch Med, Dept Microbiol, Yokohama, Kanagawa 232, Japan; [Suzuki, Kyoko; Hirayasu, Yoshio] Yokohama City Univ, Sch Med, Dept Psychiat, Yokohama, Kanagawa 232, Japan	Yokohama City University; Yokohama City University; Yokohama City University	Kanzaki, S (corresponding author), Yokohama City Univ, Sch Med, Dept Pathol, Yokohama, Kanagawa 232, Japan.	yamaguchiakira@mac.com	Nagashima, Yoji/AAA-2591-2021		Japan Society for the Promotion of Science [17590355, 20590407, 19790734]; Yokohama City University, Yokohama, Japan [K200003]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Yokohama City University, Yokohama, Japan	This work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (to SY, #17590355, 20590407 and AY, 19790734; http://www.jsps.go.jp/j-grantsinaid/) and from the Yokohama City University, Yokohama, Japan (to YN, #K200003; http://www.yokohama-cu.ac.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balreira A, 2005, BRIT J HAEMATOL, V129, P667, DOI 10.1111/j.1365-2141.2005.05503.x; Castaneda JA, 2008, ACTA NEUROPATHOL, V115, P159, DOI 10.1007/s00401-007-0296-4; Cavallotti D, 2005, NEUROL RES, V27, P41, DOI 10.1179/016164105X18197; Chattopadhyay S, 2002, HUM MOL GENET, V11, P1421, DOI 10.1093/hmg/11.12.1421; Cox NR, 1998, VET IMMUNOL IMMUNOP, V63, P335, DOI 10.1016/S0165-2427(98)00113-5; DiRosario J, 2009, J NEUROSCI RES, V87, P978, DOI 10.1002/jnr.21912; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Ferri C, 2006, RHEUMATOLOGY, V45, P72, DOI 10.1093/rheumatology/kei101; Gadola SD, 2006, J EXP MED, V203, P2293, DOI 10.1084/jem.20060921; Galbiati F, 2007, J NEUROSCI, V27, P13730, DOI 10.1523/JNEUROSCI.3379-07.2007; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Gravel R. A., 2001, METABOLIC MOL BASES, V3, P3827; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; HAYAKAWA K, 1983, J EXP MED, V157, P202, DOI 10.1084/jem.157.1.202; Herzenberg LA, 2000, IMMUNOL REV, V175, P9, DOI 10.1111/j.1600-065X.2000.imr017520.x; HERZENBERG LA, 1986, IMMUNOL REV, V93, P81, DOI 10.1111/j.1600-065X.1986.tb01503.x; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Huang JQ, 1997, HUM MOL GENET, V6, P1879, DOI 10.1093/hmg/6.11.1879; Ishikawa S, 2001, J EXP MED, V193, P1393, DOI 10.1084/jem.193.12.1393; Ishikawa S, 2007, FRONT BIOSCI-LANDMRK, V12, P1790, DOI 10.2741/2188; ITOH H, 1984, BRAIN DEV-JPN, V6, P467, DOI 10.1016/S0387-7604(84)80029-7; Jeyakumar M, 2003, BRAIN, V126, P974, DOI 10.1093/brain/awg089; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; Lim MJ, 2007, NEUROBIOL DIS, V25, P239, DOI 10.1016/j.nbd.2006.09.005; Meraouna A, 2006, BLOOD, V108, P432, DOI 10.1182/blood-2005-06-2383; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; NEUFELD EF, 1991, ANNU REV BIOCHEM, V60, P257, DOI 10.1146/annurev.biochem.60.1.257; Norflus F, 1998, J CLIN INVEST, V101, P1881, DOI 10.1172/JCI2127; Pearce DA, 2004, NEUROLOGY, V63, P2001, DOI 10.1212/01.WNL.0000145836.72059.3B; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Phaneuf D, 1996, HUM MOL GENET, V5, P1, DOI 10.1093/hmg/5.1.1; Ramirez-Montealegre D, 2005, NEUROLOGY, V64, P743, DOI 10.1212/01.WNL.0000151973.08426.7E; SANGO K, 1995, NAT GENET, V11, P170, DOI 10.1038/ng1095-170; Sato T, 2004, EUR J IMMUNOL, V34, P3346, DOI 10.1002/eji.200425373; SCHWARTING GA, 1983, J BIOL CHEM, V258, P5893; SCHWARTING GA, 1981, J IMMUNOL, V126, P2403; SHOENFELD Y, 1995, J CLIN IMMUNOL, V15, P363, DOI 10.1007/BF01541326; TAKAHASHI A, 1974, BEITR PATHOL, V152, P418; TATEMATSU M, 1981, ACTA PATHOL JAPON, V31, P503; Tsuji D, 2005, J NEUROCHEM, V92, P1497, DOI 10.1111/j.1471-4159.2005.02986.x; Wada R, 2000, P NATL ACAD SCI USA, V97, P10954, DOI 10.1073/pnas.97.20.10954; Wu YP, 2004, P NATL ACAD SCI USA, V101, P8425, DOI 10.1073/pnas.0400625101; Yamaguchi A, 2004, J CLIN INVEST, V113, P200, DOI 10.1172/JCI200419639; YAMANAKA S, 1994, GENOMICS, V21, P588, DOI 10.1006/geno.1994.1318; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440; Zhou J, 1998, VET IMMUNOL IMMUNOP, V66, P25, DOI 10.1016/S0165-2427(98)00180-9; Zhou J, 1998, CELL IMMUNOL, V183, P90, DOI 10.1006/cimm.1998.1247	47	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12105	10.1371/journal.pone.0012105	http://dx.doi.org/10.1371/journal.pone.0012105			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20856892	Green Published, gold, Green Submitted			2022-12-27	WOS:000280811900038
J	Jettestuen, E; Nermoen, A; Hestmark, G; Timdal, E; Mathiesen, J				Jettestuen, Espen; Nermoen, Anders; Hestmark, Geir; Timdal, Einar; Mathiesen, Joachim			Competition on the Rocks: Community Growth and Tessellation	PLOS ONE			English	Article							DYNAMICS	Crustose lichen communities on rocks exhibit fascinating spatial mosaics resembling political maps of nations or municipalities. Although the establishment and development of biological populations are important themes in ecology, our understanding of the formation of such patterns on the rocks is still in its infancy. Here, we present a novel model of the concurrent growth, establishment and interaction of lichens. We introduce an inverse technique based on Monte Carlo simulations to test our model on field samples of lichen communities. We derive an expression for the time needed for a community to cover a surface and predict the historical spatial dynamics of field samples. Lichens are frequently used for dating the time of exposure of rocks in glacial deposits, lake retreats or rock falls. We suggest our method as a way to improve the dating.	[Jettestuen, Espen; Hestmark, Geir] Univ Oslo, Dept Biol, Oslo, Norway; [Jettestuen, Espen] Int Res Inst Stavanger, Stavanger, Norway; [Timdal, Einar] Univ Oslo, Nat Hist Museum, Oslo, Norway; [Mathiesen, Joachim] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark	University of Oslo; University of Oslo; University of Copenhagen; Niels Bohr Institute	Jettestuen, E (corresponding author), Univ Oslo, Dept Biol, Oslo, Norway.	mathies@nbi.dk		Mathiesen, Joachim/0000-0002-5621-5487	Center of Excellence grant; Danish National Research Foundation through the Center for Models of Life	Center of Excellence grant; Danish National Research Foundation through the Center for Models of Life	This study was supported by a Center of Excellence grant to the Physics of Geological Processes Center at the University of Oslo and by the Danish National Research Foundation through the Center for Models of Life. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong R, 2010, GEOGR ANN A, V92A, P3, DOI 10.1111/j.1468-0459.2010.00374.x; Benedict JB, 2008, ARCT ANTARCT ALP RES, V40, P15, DOI 10.1657/1523-0430(06-030)[BENEDICT]2.0.CO;2; BOWLER PA, 1975, BOT J LINN SOC, V70, P325, DOI 10.1111/j.1095-8339.1975.tb01653.x; Bradwell T, 2009, GEOGR ANN A, V91A, P61, DOI 10.1111/j.1468-0459.2009.00354.x; Ferkinghoff-Borg J, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.266103; FLYVBJERG H, 1994, PHYS REV LETT, V73, P2372, DOI 10.1103/PhysRevLett.73.2372; Grube M, 2009, ISME J, V3, P1105, DOI 10.1038/ismej.2009.63; Jomelli V, 2007, GEOMORPHOLOGY, V86, P131, DOI 10.1016/j.geomorph.2006.08.010; KUENNEN E, 2008, J STAT MECH-THEORY E, V5, P5014; Mathiesen J, 2004, J GLACIOL, V50, P325, DOI 10.3189/172756504781829873; Munoz J, 2004, SCIENCE, V304, P1144, DOI 10.1126/science.1095210; Nash TH, 2008, LICHEN BIOLOGY, 2ND EDITION, P1, DOI 10.1017/CBO9780511790478; Ramstad S, 2000, MYCOL RES, V104, P198, DOI 10.1017/S0953756299001975; Sletvold N, 1999, CAN J BOT, V77, P1655; van Saarloos W, 2003, PHYS REP, V386, P29, DOI 10.1016/j.physrep.2003.08.001; Yuan XL, 2005, SCIENCE, V308, P1017, DOI 10.1126/science.1111347	16	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e12820	10.1371/journal.pone.0012820	http://dx.doi.org/10.1371/journal.pone.0012820			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20941362	Green Published, gold			2022-12-27	WOS:000282312600005
J	Ignacio, BL; Julio, LM; Junqueira, AOR; Ferreira-Silva, MAG				Ignacio, Barbara L.; Julio, Luciana M.; Junqueira, Andrea O. R.; Ferreira-Silva, Maria A. G.			Bioinvasion in a Brazilian Bay: Filling Gaps in the Knowledge of Southwestern Atlantic Biota	PLOS ONE			English	Article							BIOLOGICAL INVASIONS; ARTIFICIAL SUBSTRATA; SUBTIDAL EPIBIOTA; URBAN STRUCTURES; MYTILUS-GALLOPROVINCIALIS; INTERTIDAL ASSEMBLAGES; SPECIES-DIVERSITY; NATURAL HABITATS; PARANAGUA BAY; NORTH-AMERICA	Background: Biological invasions are a major cause of global species change. Nevertheless, knowledge about the distribution and ecology of introduced species is regionally biased, and many gaps in knowledge exist for most developing countries. Methodology/Principal Findings: To study the zoobenthos on the hard substratum of the Ilha Grande Bay, a survey was conducted on both natural and artificial substrata at three depths and seven sites. The species recorded were classified as native, cryptogenic or introduced. Multivariate analyses were conducted to assess the prevalence of introduced species in these communities and to compare the distribution of species on natural and artificial substrata of this bay to identify possible discrepancies in habitat use. Of the 61 species, 25 were cryptogenic, 10 were introduced and 26 were native. Similar numbers of introduced species were found on both natural and artificial substrata, though the community composition was significantly different between them. We also compared the species composition of the Ilha Grande Bay survey to other inventories taken around the world. The highest similarities were found between the Ilha Grande Bay inventory and the Atlantic coastal region (Tampa Bay, USA and the Gulf of Mexico), American Samoa and Pearl Harbor (USA) inventories. Conclusions/Significance: This study presents the first published comprehensive list of hard substratum sessile marine invertebrate species in a Brazilian bay. The high percentage of cryptogenic species reveals gaps in both zoological records and information on introduced species for the Brazilian coast. The introduced species successfully colonized different sites in the Ilha Grande Bay, including both natural and artificial substrata. In addition, we find that artificial structures may not be good surrogates for natural rocky shores and may represent an ecological threat. Comparisons with other inventories suggest a history of broad-scale invasion, though more evidence is needed to support this conclusion.	[Ignacio, Barbara L.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil; [Julio, Luciana M.; Junqueira, Andrea O. R.; Ferreira-Silva, Maria A. G.] Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Ignacio, BL (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil.	lagebarbara@yahoo.com.br	JUNQUEIRA, ANDREA/G-4705-2014; Ignacio, Barbara Lage/I-5204-2012	OLIVEIRA RIBEIRO JUNQUEIRA, ANDREA/0000-0002-3386-2454; Ignacio, Barbara/0000-0001-6943-7348	CNPq (Conselho Nacional de Desenvolvimento Cienti-fico e Tecnologico - Brazil); Ignacio's PhD scholarship	CNPq (Conselho Nacional de Desenvolvimento Cienti-fico e Tecnologico - Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ignacio's PhD scholarship	Financial support came from CNPq (Conselho Nacional de Desenvolvimento Cienti-fico e Tecnologico - Brazil) and Ignacio's PhD scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AQ PTY LTD, 2001, EX MAR PESTS SURV PO; Ashton Gail, 2006, Aquatic Invasions, V1, P214, DOI 10.3391/ai.2006.1.4.4; Audzijonyte A, 2008, DIVERS DISTRIB, V14, P179, DOI 10.1111/j.1472-4642.2007.00434.x; Bacchiocchi F, 2003, ESTUAR COAST SHELF S, V56, P1157, DOI 10.1016/S0272-7714(02)00322-0; BAKER P, 2004, NONINDIGENOUS MARINE; Breves-Ramos A, 2010, J MAR BIOL ASSOC UK, V90, P453, DOI 10.1017/S0025315409990919; Bulleri F, 2005, AUSTRAL ECOL, V30, P655, DOI 10.1111/j.1442-9993.2005.01507.x; Bulleri F, 2004, MAR BIOL, V145, P381, DOI 10.1007/s00227-004-1316-8; Bulleri F, 2010, J APPL ECOL, V47, P26, DOI 10.1111/j.1365-2664.2009.01751.x; Butler AJ, 1996, BIOFOULING, V9, P187, DOI 10.1080/08927019609378303; Cardigos F, 2006, HELGOLAND MAR RES, V60, P160, DOI 10.1007/s10152-006-0034-7; Carlton JT, 1996, ECOLOGY, V77, P1653, DOI 10.2307/2265767; CARLTON JT, 1989, CONSERV BIOL, V3, P265, DOI 10.1111/j.1523-1739.1989.tb00086.x; Castilla JC, 2005, BIOL INVASIONS, V7, P213, DOI 10.1007/s10530-004-0198-5; CHAPMAN JW, 1991, J CRUSTACEAN BIOL, V11, P386, DOI 10.2307/1548465; Clark GF, 2005, MAR ECOL PROG SER, V298, P9, DOI 10.3354/meps298009; Cohen AN, 2005, BIOL INVASIONS, V7, P995, DOI 10.1007/s10530-004-3121-1; Coles SL, 1999, MAR BIOL, V135, P147, DOI 10.1007/s002270050612; COLES SL, 2006, LANAI NONINDIGENOUS; COLES SL, 2003, PACIFIC BIOL SURVEY; Connell SD, 2001, MAR ENVIRON RES, V52, P115, DOI 10.1016/S0141-1136(00)00266-X; Connell SD, 1999, MAR ENVIRON RES, V47, P373, DOI 10.1016/S0141-1136(98)00126-3; CREED J.C., 2007, BIODIVERSIDADE MARIN, P19; Creed JC, 2007, MAR ECOL PROG SER, V330, P101, DOI 10.3354/meps330101; CRISP DJ, 1960, NATURE, V185, P119, DOI 10.1038/185119a0; Elton C. S., 1958, ECOLOGY INVASIONS AN; Farrapeira Cristiane Maria Rocha, 2008, Biota Neotropica, V8, P31; Fletcher RL, 1998, HELGOLANDER MEERESUN, V52, P259, DOI 10.1007/BF02908901; Floerl O, 2005, BIOL INVASIONS, V7, P459, DOI 10.1007/s10530-004-4863-5; Floerl O, 2003, AUSTRAL ECOL, V28, P116, DOI 10.1046/j.1442-9993.2003.01254.x; Floerl O, 2004, ECOL APPL, V14, P1724, DOI 10.1890/03-5399; Galil BS, 2007, MAR POLLUT BULL, V55, P314, DOI 10.1016/j.marpolbul.2006.11.008; Galil BS, 2009, BIOL INVASIONS, V11, P359, DOI 10.1007/s10530-008-9253-y; Galil Bella S., 2007, Aquatic Invasions, V2, P281, DOI 10.3391/ai.2007.2.4.2; Geller JB, 2010, ANNU REV MAR SCI, V2, P367, DOI 10.1146/annurev.marine.010908.163745; Glasby TM, 2007, MAR BIOL, V151, P887, DOI 10.1007/s00227-006-0552-5; Glasby TM, 1999, AMBIO, V28, P595; Glasby TM, 1999, ESTUAR COAST SHELF S, V48, P281, DOI 10.1006/ecss.1998.0417; Godwin LS, 2003, BIOFOULING, V19, P123, DOI 10.1080/0892701031000061750; Hanekom N, 2008, BIOL INVASIONS, V10, P233, DOI 10.1007/s10530-007-9125-x; Hewitt CL, 2004, MAR BIOL, V144, P183, DOI 10.1007/s00227-003-1173-x; Hufbauer RA, 2008, DIVERS DISTRIB, V14, P252, DOI 10.1111/j.1472-4642.2007.00424.x; Hutchings P. A., 2002, Pacific Science, V56, P223, DOI 10.1353/psc.2002.0017; *INV SPEC FOC TEAM, 2000, INV NON AQ SPEC OCC; Karpinsky MG, 2005, HANDB ENVIRON CHEM, V5, P175, DOI 10.1007/698_5_009; Klautau M, 1999, EVOLUTION, V53, P1414, DOI 10.1111/j.1558-5646.1999.tb05406.x; Kremer LP, 2010, BIOL INVASIONS, V12, P1581, DOI 10.1007/s10530-009-9571-8; Lacombe D., 1977, Publicacoes Inst Pesq Mar Rio de J, VNo. 109, P1; Lambert CC, 1998, MAR BIOL, V130, P675, DOI 10.1007/s002270050289; Leite Ferreira Carlos Eduardo, 2009, V204, P459; Mayer-Pinto M, 2003, MAR POLLUT BULL, V46, P1495, DOI 10.1016/S0025-326X(03)00249-2; MCGUINNESS KA, 1989, MAR ECOL PROG SER, V52, P201, DOI 10.3354/meps052201; Neves CS, 2008, BRAZ ARCH BIOL TECHN, V51, P623, DOI 10.1590/S1516-89132008000300025; Neves CS, 2007, BIOFOULING, V23, P319, DOI 10.1080/08927010701399174; Nicastro KR, 2007, MAR ECOL PROG SER, V336, P169, DOI 10.3354/meps336169; Nunez MA, 2010, BIOL INVASIONS, V12, P707, DOI 10.1007/s10530-009-9517-1; Orensanz Jose Maria (Lobo), 2002, Biological Invasions, V4, P115; Provan J, 2008, DIVERS DISTRIB, V14, P343, DOI 10.1111/j.1472-4642.2007.00420.x; Pysek P, 2008, TRENDS ECOL EVOL, V23, P237, DOI 10.1016/j.tree.2008.02.002; RAMALHO LV, 2006, TAXONOMIA DISTRIBUIC; Ricciardi A, 2007, CONSERV BIOL, V21, P329, DOI 10.1111/j.1523-1739.2006.00615.x; Richardson DM, 2008, DIVERS DISTRIB, V14, P161, DOI 10.1111/j.1472-4642.2007.00464.x; Ruiz GM, 2000, ANNU REV ECOL SYST, V31, P481, DOI 10.1146/annurev.ecolsys.31.1.481; Ruiz GM, 1997, AM ZOOL, V37, P621; RUSS GR, 1982, OECOLOGIA, V53, P12, DOI 10.1007/BF00377130; RUSSELL B. C., 2000, BASELINE SURVEY PORT; Simberloff Daniel, 1997, P3; Simone Luiz Ricardo L., 2006, Pap. Avulsos Zool. (São Paulo), V46, P57, DOI 10.1590/S0031-10492006000600001; Smith SDA, 2002, J EXP MAR BIOL ECOL, V277, P25, DOI 10.1016/S0022-0981(02)00242-3; Stachowicz JJ, 1999, SCIENCE, V286, P1577, DOI 10.1126/science.286.5444.1577; Stachowicz JJ, 2002, ECOLOGY, V83, P2575; Stachowicz JJ, 2006, MAR ECOL PROG SER, V311, P251, DOI 10.3354/meps311251; Streftaris N, 2005, OCEANOGR MAR BIOL, V43, P419; SUTHERLAND JP, 1977, ECOL MONOGR, V47, P425, DOI 10.2307/1942176; Tyrrell MC, 2007, J EXP MAR BIOL ECOL, V342, P54, DOI 10.1016/j.jembe.2006.10.014; Vaselli S, 2008, MAR ENVIRON RES, V66, P395, DOI 10.1016/j.marenvres.2008.06.002; Vieira LM, 2008, ZOOTAXA, P1; Walters LJ, 1996, MAR ECOL PROG SER, V137, P161, DOI 10.3354/meps137161; Wasson K, 2001, BIOL CONSERV, V102, P143, DOI 10.1016/S0006-3207(01)00098-2; WOLDA H, 1981, OECOLOGIA, V50, P296, DOI 10.1007/BF00344966; Wyatt ASJ, 2005, DIVERS DISTRIB, V11, P33, DOI 10.1111/j.1366-9516.2005.00109.x; Zardi GI, 2008, MAR BIOL, V153, P853, DOI 10.1007/s00227-007-0857-z	82	33	35	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e13065	10.1371/journal.pone.0013065	http://dx.doi.org/10.1371/journal.pone.0013065			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20927375	Green Submitted, Green Published, gold			2022-12-27	WOS:000282269400017
J	Rajala, AZ; Reininger, KR; Lancaster, KM; Populin, LC				Rajala, Abigail Z.; Reininger, Katharine R.; Lancaster, Kimberly M.; Populin, Luis C.			Rhesus Monkeys (Macaca mulatta) Do Recognize Themselves in the Mirror: Implications for the Evolution of Self-Recognition	PLOS ONE			English	Article							CHIMPANZEES PAN-TROGLODYTES; PRIMATES; AWARENESS; EMERGENCE; RESPONSES; MIND	Self-recognition in front of a mirror is used as an indicator of self-awareness. Along with humans, some chimpanzees and orangutans have been shown to be self-aware using the mark test. Monkeys are conspicuously absent from this list because they fail the mark test and show persistent signs of social responses to mirrors despite prolonged exposure, which has been interpreted as evidence of a cognitive divide between hominoids and other species. In stark contrast with those reports, the rhesus monkeys in this study, who had been prepared for electrophysiological recordings with a head implant, showed consistent self-directed behaviors in front of the mirror and showed social responses that subsided quickly during the first experimental session. The self-directed behaviors, which were performed in front of the mirror and did not take place in its absence, included extensive observation of the implant and genital areas that cannot be observed directly without a mirror. We hypothesize that the head implant, a most salient mark, prompted the monkeys to overcome gaze aversion inhibition or lack of interest in order to look and examine themselves in front of the mirror. The results of this study demonstrate that rhesus monkeys do recognize themselves in the mirror and, therefore, have some form of self-awareness. Accordingly, instead of a cognitive divide, they support the notion of an evolutionary continuity of mental functions.	[Rajala, Abigail Z.; Populin, Luis C.] Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA; [Reininger, Katharine R.; Lancaster, Kimberly M.; Populin, Luis C.] Univ Wisconsin, Dept Anat, Madison, WI 53706 USA; [Populin, Luis C.] Univ Wisconsin, Eye Res Inst, Madison, WI 53706 USA; [Populin, Luis C.] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Rajala, AZ (corresponding author), Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA.	Lpopulin@wisc.edu		Lauwereyns, Jan/0000-0003-0551-2550	National Science Foundation (NSF) [IOB-0517458]; National Institutes of Health (NIH) [DC003693]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003693] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from the National Science Foundation (NSF) (IOB-0517458) and National Institutes of Health (NIH) (DC003693). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSTERDAM B, 1972, DEV PSYCHOBIOL, V5, P297, DOI 10.1002/dev.420050403; Anderson James R., 1994, P315, DOI 10.1017/CBO9780511565526.023; ANDERSON JR, 1983, Q J EXP PSYCHOL-B, V35, P201, DOI 10.1080/14640748308400905; Bard KA, 2006, INFANCY, V9, P191, DOI 10.1207/s15327078in0902_6; Boccia M.L., 1994, SELF AWARENESS ANIMA, P350, DOI [10.1017/CBO9780511565526.025, DOI 10.1017/CBO9780511565526.025]; EGLASH AR, 1983, AM J PRIMATOL, V5, P211, DOI 10.1002/ajp.1350050305; FRYREAR JL, 1981, J PSYCHOL, V104, P123; GALLUP GG, 1970, SCIENCE, V167, P86, DOI 10.1126/science.167.3914.86; GALLUP GG, 1977, DEV PSYCHOBIOL, V10, P281, DOI 10.1002/dev.420100312; GALLUP GG, 1982, AM J PRIMATOL, V2, P237, DOI 10.1002/ajp.1350020302; GALLUP GG, 1979, AM SCI, V67, P417; GALLUP GG, 1977, AM PSYCHOL, V32, P329, DOI 10.1037/0003-066X.32.5.329; GALLUP GG, 1987, COMP PRIMATE BIOL B, V2, P3; Griffin Donald R., 1976, QUESTION ANIMAL AWAR; HAUSER MD, 1995, P NATL ACAD SCI USA, V92, P10811, DOI 10.1073/pnas.92.23.10811; Hauser MD, 2001, AM J PRIMATOL, V53, P131; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; KELLER H, 2004, DEV CONSEQUENCES EAR; LETHMATE J, 1973, Zeitschrift fuer Tierpsychologie, V33, P248; MACPHAIL E, 1987, MINDWAVES THOUGHTS I, P177; MACPHAIL EM, 1987, BEHAV BRAIN SCI, V10, P645, DOI 10.1017/S0140525X00054984; MITCHELL RW, 1993, NEW IDEAS PSYCHOL, V11, P295, DOI 10.1016/0732-118X(93)90002-U; PATTERSON FGP, 1994, SELF AWARENESS ANIMA, P373; Plotnik JM, 2006, P NATL ACAD SCI USA, V103, P17053, DOI 10.1073/pnas.0608062103; Populin LC, 2006, J NEUROSCI, V26, P9820, DOI 10.1523/JNEUROSCI.3061-06.2006; POVINELLI DJ, 1993, J COMP PSYCHOL, V107, P347, DOI 10.1037/0735-7036.107.4.347; POVINELLI DJ, 1993, AM PSYCHOL, V48, P493, DOI 10.1037/0003-066X.48.5.493; Prior H, 2008, PLOS BIOL, V6, P1642, DOI 10.1371/journal.pbio.0060202; Reiss D, 2001, P NATL ACAD SCI USA, V98, P5937, DOI 10.1073/pnas.101086398; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; SUAREZ SD, 1981, J HUM EVOL, V10, P175, DOI 10.1016/S0047-2484(81)80016-4; Swartz Karyl B., 1994, P189, DOI 10.1017/CBO9780511565526.013; SWARTZ KB, 1991, PRIMATES, V32, P483, DOI 10.1007/BF02381939	33	50	52	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e12865	10.1371/journal.pone.0012865	http://dx.doi.org/10.1371/journal.pone.0012865			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20927365	Green Submitted, Green Published, gold			2022-12-27	WOS:000282269400004
J	DeQuach, JA; Mezzano, V; Miglani, A; Lange, S; Keller, GM; Sheikh, F; Christman, KL				DeQuach, Jessica A.; Mezzano, Valeria; Miglani, Amar; Lange, Stephan; Keller, Gordon M.; Sheikh, Farah; Christman, Karen L.			Simple and High Yielding Method for Preparing Tissue Specific Extracellular Matrix Coatings for Cell Culture	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; MESENCHYMAL STEM-CELLS; GROWTH-FACTORS; DIFFERENTIATION; FIBROBLASTS; MIGRATION; DECORIN; MICROENVIRONMENTS; CARDIOMYOCYTES; PROLIFERATION	Background: The native extracellular matrix (ECM) consists of a highly complex, tissue-specific network of proteins and polysaccharides, which help regulate many cellular functions. Despite the complex nature of the ECM, in vitro cell-based studies traditionally assess cell behavior on single ECM component substrates, which do not adequately mimic the in vivo extracellular milieu. Methodology/Principal Findings: We present a simple approach for developing naturally derived ECM coatings for cell culture that provide important tissue-specific cues unlike traditional cell culture coatings, thereby enabling the maturation of committed C2C12 skeletal myoblast progenitors and human embryonic stem cells differentiated into cardiomyocytes. Here we show that natural muscle-specific coatings can (i) be derived from decellularized, solubilized adult porcine muscle, (ii) contain a complex mixture of ECM components including polysaccharides, (iii) adsorb onto tissue culture plastic and (iv) promote cell maturation of committed muscle progenitor and stem cells. Conclusions: This versatile method can create tissue-specific ECM coatings, which offer a promising platform for cell culture to more closely mimic the mature in vivo ECM microenvironment.	[DeQuach, Jessica A.; Miglani, Amar; Christman, Karen L.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Mezzano, Valeria; Lange, Stephan; Sheikh, Farah] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Keller, Gordon M.] Univ Hlth Network, McEwen Ctr Regenerat Med, Toronto, ON, Canada	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Toronto; University Toronto Affiliates; University Health Network Toronto	DeQuach, JA (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	christman@bioeng.ucsd.edu	Mezzano, Valeria/A-7758-2015; Lange, Stephan/A-1422-2010	Mezzano, Valeria/0000-0003-4675-9146; Lange, Stephan/0000-0001-9361-6602; Keller, Gordon/0000-0001-9309-9297	National Institutes of Health (NIH) [DP2OD004309]; National Heart Lung and Blood Institute [R21HL104493]; American Heart Association; California Institute for Regenerative Medicine (CIRM); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095780, R21HL104493] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004309] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research is funded in part by the National Institutes of Health (NIH) Director's New Innovator Award Program (K. L. C., DP2OD004309), which is part of the NIH Roadmap for Medical Research, and the National Heart Lung and Blood Institute (K.L.C. and F. S., R21HL104493). F.S. is also a recipient of the National Scientist Development grant from the American Heart Association. J.A.D. would like to acknowledge the California Institute for Regenerative Medicine (CIRM) under the UCSD Interdisciplinary Stem Cell Research and Training Program for a pre-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach AD, 2004, J CELL MOL MED, V8, P413, DOI 10.1111/j.1582-4934.2004.tb00466.x; Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013; Binah O, 2007, J ELECTROCARDIOL, V40, pS192, DOI 10.1016/j.jelectrocard.2007.05.035; Bosnakovski D, 2006, BIOTECHNOL BIOENG, V93, P1152, DOI 10.1002/bit.20828; BRAFMAN DA, 2009, STEM CELLS DEV; Brandan E, 2008, MATRIX BIOL, V27, P700, DOI 10.1016/j.matbio.2008.07.004; Brown BN, 2010, BIOMATERIALS, V31, P428, DOI 10.1016/j.biomaterials.2009.09.061; Cabello-Verrugio C, 2007, J BIOL CHEM, V282, P18842, DOI 10.1074/jbc.M700243200; Canavan HE, 2007, LANGMUIR, V23, P50, DOI 10.1021/la062330o; Cao F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003474; Casar JC, 2004, J CELL SCI, V117, P73, DOI 10.1242/jcs.00828; Chastain SR, 2006, J BIOMED MATER RES A, V78A, P73, DOI 10.1002/jbm.a.30686; Cooper ST, 2004, CELL MOTIL CYTOSKEL, V58, P200, DOI 10.1002/cm.20010; Droguett R, 2006, MATRIX BIOL, V25, P332, DOI 10.1016/j.matbio.2006.04.004; Everitt EA, 1996, J LEUKOCYTE BIOL, V60, P199, DOI 10.1002/jlb.60.2.199; Flaim CJ, 2008, STEM CELLS DEV, V17, P29, DOI 10.1089/scd.2007.0085; Freytes DO, 2008, BIOMATERIALS, V29, P1630, DOI 10.1016/j.biomaterials.2007.12.014; GAI H, 2009, CELL BIOL INT; Gerull B, 2004, NAT GENET, V36, P1162, DOI 10.1038/ng1461; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Hirschy A, 2006, DEV BIOL, V289, P430, DOI 10.1016/j.ydbio.2005.10.046; Huber O, 2003, CELL MOL LIFE SCI, V60, P1872, DOI 10.1007/s00018-003-3050-7; Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004; KOOCHEKPOUR S, 1995, EUR J CANCER, V31A, P375, DOI 10.1016/0959-8049(94)00476-L; Kottke MD, 2006, J CELL SCI, V119, P797, DOI 10.1242/jcs.02888; Laflamme MA, 2005, AM J PATHOL, V167, P663, DOI 10.1016/S0002-9440(10)62041-X; Leschik J, 2008, NAT PROTOC, V3, P1381, DOI 10.1038/nprot.2008.116; LHOEST J, 2001, J BIOMEDICAL; Lin XH, 1999, DEVELOPMENT, V126, P3715; Liu J, 2007, STEM CELLS, V25, P3038, DOI 10.1634/stemcells.2007-0549; Luo Y, 2006, TISSUE ENG, V12, P3365, DOI 10.1089/ten.2006.12.3365; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Macfelda K, 2007, ARTIF ORGANS, V31, P4, DOI 10.1111/j.1525-1594.2007.00334.x; MAKOVITZKY J, 2009, ACTA HISTOCHEM, P273; Okamoto O, 1999, BIOCHEM J, V337, P537, DOI 10.1042/0264-6021:3370537; Olguin HC, 2003, DEV BIOL, V259, P209, DOI 10.1016/S0012-1606(03)00180-5; PETERS NS, 1994, CIRCULATION, V90, P713, DOI 10.1161/01.CIR.90.2.713; Prydz K, 2000, J CELL SCI, V113, P193; Radisic M, 2008, J BIOMED MATER RES A, V86A, P713, DOI 10.1002/jbm.a.31578; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Rios R, 2001, BIOCHEM BIOPH RES CO, V280, P561, DOI 10.1006/bbrc.2000.4159; Schuldiner M, 2000, P NATL ACAD SCI USA, V97, P11307, DOI 10.1073/pnas.97.21.11307; SIMONASSMANN P, 1995, EXPERIENTIA, V51, P883, DOI 10.1007/BF01921739; Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045; Stern MM, 2009, BIOMATERIALS, V30, P2393, DOI 10.1016/j.biomaterials.2008.12.069; Suzuki A, 2003, DEVELOPMENT, V130, P2513, DOI 10.1242/dev.00459; Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361; Ueno H, 2001, BIOMATERIALS, V22, P2125, DOI 10.1016/S0142-9612(00)00401-4; Uriel S, 2009, TISSUE ENG PART C-ME, V15, P309, DOI 10.1089/ten.tec.2008.0309; Uygun BE, 2009, TISSUE ENG PT A, V15, P3499, DOI [10.1089/ten.tea.2008.0405, 10.1089/ten.TEA.2008.0405]; VanWinkle WB, 1996, IN VITRO CELL DEV-AN, V32, P478; Vlodavsky I, 1996, CANCER METAST REV, V15, P177, DOI 10.1007/BF00437470; Williams CM, 2008, CANCER RES, V68, P3185, DOI 10.1158/0008-5472.CAN-07-2673; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Zhang YY, 2009, BIOMATERIALS, V30, P4021, DOI 10.1016/j.biomaterials.2009.04.005	56	185	189	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e13039	10.1371/journal.pone.0013039	http://dx.doi.org/10.1371/journal.pone.0013039			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20885963	gold, Green Published, Green Submitted			2022-12-27	WOS:000282167100027
J	Ferrer, NL; Gomez, AB; Neyrolles, O; Gicquel, B; Martin, C				Ferrer, Nadia L.; Gomez, Ana B.; Neyrolles, Olivier; Gicquel, Brigitte; Martin, Carlos			Interactions of Attenuated Mycobacterium tuberculosis phoP Mutant with Human Macrophages	PLOS ONE			English	Article							HUMAN ALVEOLAR MACROPHAGES; NITRIC-OXIDE; PHAGOSOME MATURATION; PROTECTIVE IMMUNITY; GUINEA-PIGS; CELLS; BCG; VIRULENCE; SUSCEPTIBILITY; STRAINS	Background: Mycobacterium tuberculosis phoP mutant SO2 derived from a clinical isolate was shown to be attenuated in mouse bone marrow-derived macrophages and in vivo mouse infection model and has demonstrated a high potential as attenuated vaccine candidate against tuberculosis. Methodology/Principal Findings: In this study, we analyze the adhesion and the intracellular growth and trafficking of SO2 in human macrophages. Our results indicate an enhanced adhesion to phagocitic cells and impaired intracellular replication of SO2 in both monocyte-derived macrophages and human cell line THP-1 in comparison with the wild type strain, consistent with murine model. Intracellular trafficking analysis in human THP-1 cells suggest that attenuation of SO2 within macrophages could be due to an impaired ability to block phagosome-lysosome fusion compared with the parental M. tuberculosis strain. No differences were found between SO2 and the wild-type strains in the release and mycobacterial susceptibility to nitric oxide (NO) produced by infected macrophages. Conclusions/Significance: SO2 has enhanced ability to bind human macrophages and differs in intracellular trafficking as to wild-type M. tuberculosis. The altered lipid profile expression of the phoP mutant SO2 and its inability to secrete ESAT-6 is discussed.	[Ferrer, Nadia L.; Gomez, Ana B.; Martin, Carlos] Univ Zaragoza, Dept Microbiol Med Prevent & Salud Publ, Grp Genet Micobacterias, Zaragoza, Spain; [Neyrolles, Olivier; Gicquel, Brigitte; Martin, Carlos] Inst Pasteur, Unit Mycobacterial Genet, Paris, France; [Ferrer, Nadia L.; Gomez, Ana B.; Martin, Carlos] Inst Salud Carlos III, Ctr Invest Biomed Red CIBER Enfermedades Resp, Madrid, Spain	University of Zaragoza; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III	Ferrer, NL (corresponding author), Univ Complutense Madrid, Fac Farm, Dept Microbiol 2, Madrid, Spain.	carlos@unizar.es	Neyrolles, Olivier B/A-3184-2011; Neyrolles, Olivier/AAG-3692-2019; Martin, Carlos/A-7283-2008	Neyrolles, Olivier/0000-0003-0047-5885; Martin, Carlos/0000-0003-2993-5478; Gomez Aguirre, Ana Belen/0000-0002-9713-2127	Spanish Ministerio de Educacion y Ciencia [BES-2003-1088]; Ministerio de Ciencia e Innovacion [BIO2005-07949-C02-01, BIO2008-01561]; European TBVAC Project [FP6-503367]; European NEWTBVAC Project [FP7 241745]	Spanish Ministerio de Educacion y Ciencia(Spanish Government); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); European TBVAC Project; European NEWTBVAC Project	This work was supported by the Spanish Ministerio de Educacion y Ciencia (BES-2003-1088), Ministerio de Ciencia e Innovacion (BIO2005-07949-C02-01, BIO2008-01561) and by the European TBVAC FP6-503367 and NEWTBVAC FP7 241745 Projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar D, 2007, CLIN EXP IMMUNOL, V147, P330, DOI 10.1111/j.1365-2249.2006.03284.x; Asensio JG, 2006, J BIOL CHEM, V281, P1313, DOI 10.1074/jbc.C500388200; Aston C, 1998, AM J RESP CRIT CARE, V157, P1943, DOI 10.1164/ajrccm.157.6.9705028; Behr MA, 2002, LANCET INFECT DIS, V2, P86, DOI 10.1016/S1473-3099(02)00182-2; BLOOM BR, 1992, SCIENCE, V257, P1055, DOI 10.1126/science.257.5073.1055; Brosch R, 2007, P NATL ACAD SCI USA, V104, P5596, DOI 10.1073/pnas.0700869104; Chan ED, 2001, AM J RESP CELL MOL, V25, P606, DOI 10.1165/ajrcmb.25.5.4487; Chen F, 1996, APMIS, V104, P176, DOI 10.1111/j.1699-0463.1996.tb00705.x; Chesne-Seck ML, 2008, J BACTERIOL, V190, P1329, DOI 10.1128/JB.01465-07; FIELDS PI, 1989, SCIENCE, V243, P1059, DOI 10.1126/science.2646710; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Frigui W, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040033; Gonzalo-Asensio J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003496; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Jackson M, 2007, TUBERCULOSIS, V87, P78, DOI 10.1016/j.tube.2006.05.003; Jagannath C, 1998, NITRIC OXIDE-BIOL CH, V2, P174, DOI 10.1006/niox.1998.9999; Jo EK, 2008, CURR OPIN INFECT DIS, V21, P279, DOI 10.1097/QCO.0b013e3282f88b5d; Jordao L, 2008, CELL MICROBIOL, V10, P529, DOI 10.1111/j.1462-5822.2007.01067.x; Katti MK, 2008, CELL MICROBIOL, V10, P1286, DOI 10.1111/j.1462-5822.2008.01126.x; Kaufmann SHE, 2006, NAT REV IMMUNOL, V6, P699, DOI 10.1038/nri1920; Lee Ji-Sook, 2009, Immune Netw, V9, P192, DOI 10.4110/in.2009.9.5.192; Lee JS, 2008, CELL HOST MICROBE, V3, P97, DOI 10.1016/j.chom.2008.01.002; Li AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011066; Long R, 1999, ANTIMICROB AGENTS CH, V43, P403, DOI 10.1128/AAC.43.2.403; Ludwiczak P, 2002, MICROBIOL-SGM, V148, P3029, DOI 10.1099/00221287-148-10-3029; MacGurn JA, 2007, INFECT IMMUN, V75, P2668, DOI 10.1128/IAI.01872-06; Martin C, 2006, VACCINE, V24, P3408, DOI 10.1016/j.vaccine.2006.03.017; OBRIEN L, 1994, INFECT IMMUN, V62, P5187, DOI 10.1128/IAI.62.11.5187-5190.1994; PANDOLFI F, 1978, CLIN EXP IMMUNOL, V32, P504; Perez E, 2001, MOL MICROBIOL, V41, P179, DOI 10.1046/j.1365-2958.2001.02500.x; Rhoades ER, 1997, INFECT IMMUN, V65, P1189, DOI 10.1128/IAI.65.4.1189-1195.1997; Rich EA, 1997, TUBERCLE LUNG DIS, V78, P247, DOI 10.1016/S0962-8479(97)90005-8; Rousseau C, 2003, INFECT IMMUN, V71, P4684, DOI 10.1128/IAI.71.8.4684-4690.2003; Rousseau C, 2003, CELL MICROBIOL, V5, P405, DOI 10.1046/j.1462-5822.2003.00289.x; Saavedra R, 2006, MICROBES INFECT, V8, P533, DOI 10.1016/j.micinf.2005.08.005; Shiloh MU, 2000, CURR OPIN MICROBIOL, V3, P35, DOI 10.1016/S1369-5274(99)00048-X; Torrelles JB, 2010, TUBERCULOSIS, V90, P84, DOI 10.1016/j.tube.2010.02.003; van Faassen H, 2004, J IMMUNOL, V172, P3491, DOI 10.4049/jimmunol.172.6.3491; Vergne I, 2004, ANNU REV CELL DEV BI, V20, P367, DOI 10.1146/annurev.cellbio.20.010403.114015; Verreck FAW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005264; Walters SB, 2006, MOL MICROBIOL, V60, P312, DOI 10.1111/j.1365-2958.2006.05102.x; Wang CH, 1998, EUR RESPIR J, V11, P809, DOI 10.1183/09031936.98.11040809; *WHO, 2006, GLOB TUB CONTR SURV; *WHO IUATLD, 2004, 3 WHOIUATLD; Young D, 2006, CELL, V124, P683, DOI 10.1016/j.cell.2006.02.013; Young DB, 2003, NAT MED, V9, P503, DOI 10.1038/nm868	48	38	40	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2010	5	9							e12978	10.1371/journal.pone.0012978	http://dx.doi.org/10.1371/journal.pone.0012978			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653UN	20885976	Green Published, gold, Green Submitted			2022-12-27	WOS:000282122600014
J	Belloni, V; Faivre, B; Guerreiro, R; Arnoux, E; Bellenger, J; Sorci, G				Belloni, Virginia; Faivre, Bruno; Guerreiro, Romain; Arnoux, Emilie; Bellenger, Jerome; Sorci, Gabriele			Suppressing an Anti-Inflammatory Cytokine Reveals a Strong Age-Dependent Survival Cost in Mice	PLOS ONE			English	Article							IMMUNE-RESPONSE; INFLAMMATION; STRESS	Background: The central paradigm of ecological immunology postulates that selection acts on immunity as to minimize its cost/benefit ratio. Costs of immunity may arise because the energetic requirements of the immune response divert resources that are no longer available for other vital functions. In addition to these resource-based costs, mis-directed or over-reacting immune responses can be particularly harmful for the host. In spite of the potential importance of immunopathology, most studies dealing with the evolution of the immune response have neglected such non resource-based costs. To keep the immune response under control, hosts have evolved regulatory pathways that should be considered when studying the target of the selection pressures acting on immunity. Indeed, variation in regulation may strongly modulate the negative outcome of immune activation, with potentially important fitness consequences. Methodology/Principal Findings: Here, we experimentally assessed the survival costs of reduced immune regulation by inhibiting an anti-inflammatory cytokine (IL-10) with anti-IL-10 receptor antibodies (anti-IL-10R) in mice that were either exposed to a mild inflammation or kept as control. The experiment was performed on young (3 months) and old (15 months) individuals, as to further assess the age-dependent cost of suppressing immune regulation. IL-10 inhibition induced high mortality in old mice exposed to the mild inflammatory insult, whereas no mortality was observed in young mice. However, young mice experienced a transitory lost in body mass when injected with the anti-IL-10R antibodies, showing that the treatment was to a lesser extent also costly for young individuals. Conclusions: These results suggest a major role of immune regulation that deserves attention when investigating the evolution of immunity, and indicate that the capacity to down-regulate the inflammatory response is crucial for late survival and longevity.	[Belloni, Virginia; Faivre, Bruno; Guerreiro, Romain; Arnoux, Emilie; Sorci, Gabriele] Univ Bourgogne, CNRS, UMR 5561, Dijon, France; [Bellenger, Jerome] Univ Bourgogne, INSERM, UMR U866, Dijon, France	Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne	Belloni, V (corresponding author), Univ Bourgogne, CNRS, UMR 5561, Dijon, France.	virginia.belloni@u-bourgogne.fr	BELLENGER, Jerome/AAC-9423-2022	BELLENGER, Jerome/0000-0001-8643-6195; Sorci, Gabriele/0000-0002-0799-3995; Belloni, Virginia/0000-0001-9807-1912; Mead, Simon/0000-0002-4326-1468	Region Bourgogne	Region Bourgogne(Region Bourgogne-Franche-Comte)	Financial support was provided by the Region Bourgogne to VB, BF, and GS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annane D, 2005, LANCET, V365, P63, DOI 10.1016/S0140-6736(04)17667-8; Bai FW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000610; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Eraud C, 2005, FUNCT ECOL, V19, P110, DOI 10.1111/j.0269-8463.2005.00934.x; Eraud C, 2009, EVOLUTION, V63, P1036, DOI 10.1111/j.1558-5646.2008.00540.x; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Frasca D, 2005, SEMIN IMMUNOL, V17, P378, DOI 10.1016/j.smim.2005.05.005; Graham AL, 2005, ANNU REV ECOL EVOL S, V36, P373, DOI 10.1146/annurev.ecolsys.36.102003.152622; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Kolla VK, 2009, CYTOKINE, V47, P173, DOI 10.1016/j.cyto.2009.06.007; Long GH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-128; Martin LB, 2003, P ROY SOC B-BIOL SCI, V270, P153, DOI 10.1098/rspb.2002.2185; Miteva L, 2008, HUM IMMUNOL, V69, P562, DOI 10.1016/j.humimm.2008.07.008; PAWALEC G, 2002, TRENDS IMMUNOL, V23, P330; Pawelec G, 2010, J COMP PATHOL, V141, pS39, DOI 10.1016/j.jcpa.2009.09.005; Pawelec G, 2006, EXP GERONTOL, V41, P1239, DOI 10.1016/j.exger.2006.09.005; Raberg L, 1998, P ROY SOC B-BIOL SCI, V265, P1637, DOI 10.1098/rspb.1998.0482; Raberg L, 2002, P ROY SOC B-BIOL SCI, V269, P817, DOI 10.1098/rspb.2001.1953; Sansoni P, 2008, EXP GERONTOL, V43, P61, DOI 10.1016/j.exger.2007.06.008; *SAS I, 2001, SAS STAT SOFTW VERS; Sell S., 2001, IMMUNOLOGY IMMUNOPAT; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Sorci G, 2009, PHILOS T R SOC B, V364, P71, DOI 10.1098/rstb.2008.0151; Swindle EJ, 2007, IMMUNOL REV, V217, P186, DOI 10.1111/j.1600-065X.2007.00513.x; Tateda K, 1996, INFECT IMMUN, V64, P769, DOI 10.1128/IAI.64.3.769-774.1996; Viney ME, 2005, TRENDS ECOL EVOL, V20, P665, DOI 10.1016/j.tree.2005.10.003; Wikby A, 2006, MECH AGEING DEV, V127, P695, DOI 10.1016/j.mad.2006.04.003; Zampieri CA, 2007, NAT IMMUNOL, V8, P1159, DOI 10.1038/ni1519; Zuk M, 2002, AM NAT, V160, pS9, DOI 10.1086/342131	33	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12940	10.1371/journal.pone.0012940	http://dx.doi.org/10.1371/journal.pone.0012940			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886083	gold, Green Published, Green Submitted			2022-12-27	WOS:000282091100039
J	Crowley, TJ; Dalwani, MS; Mikulich-Gilbertson, SK; Du, YPP; Lejuez, CW; Raymond, KM; Banich, MT				Crowley, Thomas J.; Dalwani, Manish S.; Mikulich-Gilbertson, Susan K.; Du, Yiping P.; Lejuez, Carl W.; Raymond, Kristen M.; Banich, Marie T.			Risky Decisions and Their Consequences: Neural Processing by Boys with Antisocial Substance Disorder	PLOS ONE			English	Article							VENTROMEDIAL PREFRONTAL CORTEX; CONDUCT DISORDER; DRUG-ABUSE; NEUROANATOMICAL CORRELATE; DIAGNOSTIC INTERVIEW; ORBITOFRONTAL CORTEX; PSYCHOPATHIC TRAITS; ALCOHOL DEPENDENCE; ANTERIOR CINGULATE; NUCLEUS-ACCUMBENS	Background: Adolescents with conduct and substance problems ("Antisocial Substance Disorder'' (ASD)) repeatedly engage in risky antisocial and drug-using behaviors. We hypothesized that, during processing of risky decisions and resulting rewards and punishments, brain activation would differ between abstinent ASD boys and comparison boys. Methodology/Principal Findings: We compared 20 abstinent adolescent male patients in treatment for ASD with 20 community controls, examining rapid event-related blood-oxygen-level-dependent (BOLD) responses during functional magnetic resonance imaging. In 90 decision trials participants chose to make either a cautious response that earned one cent, or a risky response that would either gain 5 cents or lose 10 cents; odds of losing increased as the game progressed. We also examined those times when subjects experienced wins, or separately losses, from their risky choices. We contrasted decision trials against very similar comparison trials requiring no decisions, using whole-brain BOLD-response analyses of group differences, corrected for multiple comparisons. During decision-making ASD boys showed hypoactivation in numerous brain regions robustly activated by controls, including orbitofrontal and dorsolateral prefrontal cortices, anterior cingulate, basal ganglia, insula, amygdala, hippocampus, and cerebellum. While experiencing wins, ASD boys had significantly less activity than controls in anterior cingulate, temporal regions, and cerebellum, with more activity nowhere. During losses ASD boys had significantly more activity than controls in orbitofrontal cortex, dorsolateral prefrontal cortex, brain stem, and cerebellum, with less activity nowhere. Conclusions/Significance: Adolescent boys with ASD had extensive neural hypoactivity during risky decision-making, coupled with decreased activity during reward and increased activity during loss. These neural patterns may underlie the dangerous, excessive, sustained risk-taking of such boys. The findings suggest that the dysphoria, reward insensitivity, and suppressed neural activity observed among older addicted persons also characterize youths early in the development of substance use disorders.	[Crowley, Thomas J.; Dalwani, Manish S.; Mikulich-Gilbertson, Susan K.; Raymond, Kristen M.] Univ Colorado, Dept Psychiat, Subst Dependence Div, Denver, CO 80202 USA; [Du, Yiping P.; Banich, Marie T.] Univ Colorado, Brain Imaging Ctr, Denver, CO USA; [Lejuez, Carl W.] Univ Maryland, Dept Psychol, College Pk, MD 20742 USA; [Banich, Marie T.] Univ Colorado, Inst Cognit Sci, Dept Psychol, Boulder, CO 80309 USA; [Banich, Marie T.] Univ Colorado, Dept Neurosci, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Denver; University System of Maryland; University of Maryland College Park; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Crowley, TJ (corresponding author), Univ Colorado, Dept Psychiat, Subst Dependence Div, Denver, CO 80202 USA.	thomas.crowley@ucdenver.edu		BANICH, MARIE/0000-0001-9373-9194; Lejuez, Carl/0000-0003-2772-7835; Du, Yiping/0000-0002-8326-7901	National Institute on Drug Abuse [DA 009842, 011015]; Kane Family Foundation; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA009842, R37DA009842, P60DA011015] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Kane Family Foundation; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	National Institute on Drug Abuse (www.nida.nih.gov) Grants DA 009842, 011015; Kane Family Foundation (kanefamilyfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHENBACH TM, 1991, MONOGR SOC RES CHILD, V56, pR5; ALESSI NE, 1984, J AFFECT DISORDERS, V6, P9, DOI 10.1016/0165-0327(84)90003-X; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], DRUG ALCOHOL SERVICE; ASHBURNER J, SPM5 MANUAL; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Baillieux H, 2008, CLIN NEUROL NEUROSUR, V110, P763, DOI 10.1016/j.clineuro.2008.05.013; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Bamford NS, 2008, NEURON, V58, P89, DOI 10.1016/j.neuron.2008.01.033; Banich MT, 2007, DRUG ALCOHOL DEPEN, V90, P175, DOI 10.1016/j.drugalcdep.2007.03.009; Beeli G, 2008, BEHAV BRAIN FUNCT, V4, DOI [10.1186/1744-9081-4-34, 10.1186/1744-9081-4-55]; Belin D, 2009, BEHAV BRAIN RES, V199, P89, DOI 10.1016/j.bbr.2008.09.027; Benegal V, 2007, ADDICT BIOL, V12, P122, DOI 10.1111/j.1369-1600.2006.00043.x; Bennett CM, 2009, SOC COGN AFFECT NEUR, V4, P417, DOI 10.1093/scan/nsp053; Bjork JM, 2008, DRUG ALCOHOL DEPEN, V95, P115, DOI 10.1016/j.drugalcdep.2007.12.014; Blair RJR, 2008, PHILOS T R SOC B, V363, P2557, DOI 10.1098/rstb.2008.0027; Boes AD, 2008, BEHAV NEUROSCI, V122, P677, DOI 10.1037/0735-7044.122.3.677; Boes AD, 2009, SOC COGN AFFECT NEUR, V4, P1, DOI 10.1093/scan/nsn035; Buckholtz JW, 2010, NAT NEUROSCI, V13, P419, DOI 10.1038/nn.2510; Button TMM, 2007, DRUG ALCOHOL DEPEN, V87, P46, DOI 10.1016/j.drugalcdep.2006.07.012; Cadoret RJ, 1996, COMPR PSYCHIAT, V37, P88, DOI 10.1016/S0010-440X(96)90567-2; CARROLL BJ, 1981, BRIT J PSYCHIAT, V138, P194, DOI 10.1192/bjp.138.3.194; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Childress A. R., 2006, RETHINKING SUBSTANCE, P46; Compton WM, 1996, DRUG ALCOHOL DEPEN, V41, P179, DOI 10.1016/0376-8716(96)01249-5; Costello EJ, 2003, ARCH GEN PSYCHIAT, V60, P837, DOI 10.1001/archpsyc.60.8.837; COTTLER LB, 1995, DRUG ALCOHOL DEPEN, V38, P59, DOI 10.1016/0376-8716(94)01091-X; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; CRISTIANA CP, 2007, PLOS ONE, V2, pE424, DOI DOI 10.1371/JOURNAL.PONE.0000424; Crowley TJ, 2006, J AM ACAD CHILD PSY, V45, P175, DOI 10.1097/01.chi.0000188893.60551.31; CROWLEY TJ, 1972, COMPR PSYCHIAT, V13, P51, DOI 10.1016/0010-440X(72)90034-X; Crowley TJ, 1998, DRUG ALCOHOL DEPEN, V49, P225, DOI 10.1016/S0376-8716(98)00016-7; Crowley TJ, 2001, J AM ACAD CHILD PSY, V40, P265, DOI 10.1097/00004583-200103000-00005; CROWLEY TJ, 2010, ENCY BEHAV NEUROSCIE; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; David SP, 2005, BIOL PSYCHIAT, V58, P488, DOI 10.1016/j.biopsych.2005.04.028; Depue BE, 2007, SCIENCE, V317, P215, DOI 10.1126/science.1139560; Disney ER, 1999, AM J PSYCHIAT, V156, P1515, DOI 10.1176/ajp.156.10.1515; Du YPP, 2007, MAGN RESON MED, V57, P396, DOI 10.1002/mrm.21150; Elliott R, 2005, INT REV NEUROBIOL, V65, P89, DOI 10.1016/S0074-7742(04)65004-5; Ernst M, 2004, NEUROPSYCHOLOGIA, V42, P1585, DOI 10.1016/j.neuropsychologia.2004.05.011; Eshel N, 2007, NEUROPSYCHOLOGIA, V45, P1270, DOI 10.1016/j.neuropsychologia.2006.10.004; EYSENCK SBG, 1980, PERS INDIV DIFFER, V1, P73, DOI 10.1016/0191-8869(80)90006-9; Finger EC, 2008, ARCH GEN PSYCHIAT, V65, P586, DOI 10.1001/archpsyc.65.5.586; Galvan A, 2005, J NEUROSCI, V25, P8650, DOI 10.1523/JNEUROSCI.2431-05.2005; Galvan A, 2007, DEVELOPMENTAL SCI, V10, pF8, DOI 10.1111/j.1467-7687.2006.00579.x; Hansen HH, 2008, ANN NEUROL, V64, P42, DOI 10.1002/ana.21287; Hicks BM, 2004, ARCH GEN PSYCHIAT, V61, P922, DOI 10.1001/archpsyc.61.9.922; Hollingshead August B., 1958, SOCIAL CLASS MENTAL; Huebner T, 2008, J AM ACAD CHILD PSY, V47, P540, DOI 10.1097/CHI.0b013e3181676545; Killgore WDS, 2005, DEV PSYCHOBIOL, V47, P377, DOI 10.1002/dev.20099; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Krain AL, 2006, NEUROIMAGE, V32, P477, DOI 10.1016/j.neuroimage.2006.02.047; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Lane SD, 2001, EXP CLIN PSYCHOPHARM, V9, P74, DOI 10.1037//1064-1297.9.1.74; Larm P, 2008, DRUG ALCOHOL DEPEN, V96, P79, DOI 10.1016/j.drugalcdep.2008.01.026; Lauritzen M, 2003, J NEUROSCI, V23, P3972; Mai JK., 2008, ATLAS HUMAN BRAIN, V3rd ed; Matthews SC, 2004, NEUROREPORT, V15, P2123, DOI 10.1097/00001756-200409150-00025; McNamee RL, 2008, ALCOHOL CLIN EXP RES, V32, P405, DOI 10.1111/j.1530-0277.2007.00604.x; Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103; Morgan VL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006660; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Neto LL, 2008, NEUROMODULATION, V11, P13, DOI 10.1111/j.1525-1403.2007.00138.x; NEWMAN JP, 1987, J ABNORM PSYCHOL, V96, P145, DOI 10.1037/0021-843X.96.2.145; *NRW RES GROUP HEM, 2003, MUNST T2T CONV; Parvizi J, 2006, P NATL ACAD SCI USA, V103, P1563, DOI 10.1073/pnas.0507729103; Paulus MP, 2003, NEUROIMAGE, V19, P1439, DOI 10.1016/S1053-8119(03)00251-9; Petrides M, 2005, PHILOS T ROY SOC B, V360, P781, DOI 10.1098/rstb.2005.1631; Poldrack RA, 2008, NEUROIMAGE, V40, P409, DOI 10.1016/j.neuroimage.2007.11.048; Preuschoff K, 2008, J NEUROSCI, V28, P2745, DOI 10.1523/JNEUROSCI.4286-07.2008; Raine A, 2006, SOC COGN AFFECT NEUR, V1, P203, DOI 10.1093/scan/nsl033; RANSON SW, 1959, ANATOMY NERVOUS SYST, P356; Reitan RM, 1985, HALSTEAD REITAN NEUR; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Robbins TW, 2008, ANN NY ACAD SCI, V1141, P1, DOI 10.1196/annals.1441.020; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; Sanfey AG, 2007, SCIENCE, V318, P598, DOI 10.1126/science.1142996; Savage LM, 2009, BEHAV BRAIN RES, V198, P1, DOI 10.1016/j.bbr.2008.10.028; Shaffer D, 2000, J AM ACAD CHILD PSY, V39, P28, DOI 10.1097/00004583-200001000-00014; Slutske WS, 1998, J ABNORM PSYCHOL, V107, P363, DOI 10.1037/0021-843X.107.3.363; Sterzer P, 2007, NEUROIMAGE, V37, P335, DOI 10.1016/j.neuroimage.2007.04.043; Sullivan EV, 2005, PSYCHOPHARMACOLOGY, V180, P583, DOI 10.1007/s00213-005-2267-6; Tapert SF, 2007, PSYCHOPHARMACOLOGY, V194, P173, DOI 10.1007/s00213-007-0823-y; Tomlinson KL, 2004, PSYCHOL ADDICT BEHAV, V18, P160, DOI 10.1037/0893-164X.18.2.160; Volkow ND, 2009, NEUROPHARMACOLOGY, V56, P3, DOI 10.1016/j.neuropharm.2008.05.022; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Ward B. D., 2000, SIMULTANEOUS INFEREN, DOI https://afni.nimh.nih.gov/pub/dist/doc/manuals/AlphaSim.pdf; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Yan CG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005743	90	97	101	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12835	10.1371/journal.pone.0012835	http://dx.doi.org/10.1371/journal.pone.0012835			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	653AC	20877644	Green Published, gold, Green Submitted			2022-12-27	WOS:000282053100015
J	Liu, D; Meckel, T; Long, EO				Liu, Dongfang; Meckel, Tobias; Long, Eric O.			Distinct Role of Rab27a in Granule Movement at the Plasma Membrane and in the Cytosol of NK Cells	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; SINGLE SECRETORY GRANULES; LYTIC GRANULES; IMMUNOLOGICAL SYNAPSE; MELANOSOME TRANSPORT; ACTIN POLYMERIZATION; T-CELLS; F-ACTIN; EXOCYTOSIS; POLARIZATION	Protocols were developed to automate image analysis and to track the movement of thousands of vesicular compartments in live cells. Algorithms were used to discriminate among different types of movement (e. g. random, caged, and directed). We applied these tools to investigate the steady-state distribution and movement of lytic granules (LG) in live natural killer (NK) cells by high-speed 3-dimensional (3D) spinning disc confocal and 2-dimensional total internal reflection fluorescence microscopy. Both mouse NK cells and a human NK cell line deficient in the small GTPase Rab27a were examined. The unbiased analysis of large datasets led to the following observations and conclusions. The majority of LG in the cytosol and at the plasma membrane of unstimulated NK cells are mobile. The use of inhibitors indicated that movement in the cytosol required microtubules but not actin, whereas movement at the plasma membrane required both. Rab27a deficiency resulted in fewer LG, and in a reduced fraction of mobile LG, at the plasma membrane. In contrast, loss of Rab27a increased the fraction of mobile LG and the extent of their movement in the cytosol. Therefore, in addition to its documented role in LG delivery to the plasma membrane, Rab27a may restrict LG movement in the cytosol.	[Liu, Dongfang; Meckel, Tobias; Long, Eric O.] NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Liu, D (corresponding author), NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA.	eLong@nih.gov	Meckel, Tobias/F-4372-2010; Long, Eric O/G-5475-2011	Meckel, Tobias/0000-0003-0759-2072; Long, Eric O/0000-0002-7793-3728; Liu, Dongfang/0000-0002-7295-8088	National Institutes of Health, National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000525] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura N, 2009, DEV CELL, V16, P675, DOI 10.1016/j.devcel.2009.03.005; Axelrod D, 2001, TRAFFIC, V2, P764, DOI 10.1034/j.1600-0854.2001.21104.x; Bahadoran P, 2001, J CELL BIOL, V152, P843, DOI 10.1083/jcb.152.4.843; Bossi G, 1999, NAT MED, V5, P90, DOI 10.1038/4779; Bossi G, 2005, SEMIN IMMUNOL, V17, P87, DOI 10.1016/j.smim.2004.09.007; Bryceson YT, 2005, J EXP MED, V202, P1001, DOI 10.1084/jem.20051143; Brzezinska AA, 2008, TRAFFIC, V9, P2151, DOI 10.1111/j.1600-0854.2008.00838.x; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; BUBB MR, 1994, J BIOL CHEM, V269, P14869; BURKHARDT JK, 1990, J CELL BIOL, V111, P2327, DOI 10.1083/jcb.111.6.2327; CARPEN O, 1983, J IMMUNOL, V131, P2695; Chen Y, 2008, FEBS J, V275, P705, DOI 10.1111/j.1742-4658.2007.06232.x; Clark RH, 2003, NAT IMMUNOL, V4, P1111, DOI 10.1038/ni1000; Fukuda M, 2006, BIOCHEM SOC T, V34, P691, DOI 10.1042/BST0340691; Goode BL, 2000, CURR OPIN CELL BIOL, V12, P63, DOI 10.1016/S0955-0674(99)00058-7; GRISCELLI C, 1978, AM J MED, V65, P691, DOI 10.1016/0002-9343(78)90858-6; Haddad EK, 2001, J CELL BIOL, V152, P835, DOI 10.1083/jcb.152.4.835; Holt O, 2008, TRAFFIC, V9, P446, DOI 10.1111/j.1600-0854.2008.00714.x; Hong WJ, 2005, TRENDS CELL BIOL, V15, P644, DOI 10.1016/j.tcb.2005.10.003; Hume AN, 2007, J CELL SCI, V120, P3111, DOI 10.1242/jcs.010207; Johnson JL, 2009, TRAFFIC; Jung SR, 2009, TRAFFIC, V10, P392, DOI 10.1111/j.1600-0854.2009.00884.x; Kasai K, 2005, J CLIN INVEST, V115, P388, DOI 10.1172/JCI200522955; KATZ P, 1982, J IMMUNOL, V129, P2816; Kim HS, 2010, IMMUNITY, V32, P175, DOI 10.1016/j.immuni.2010.02.004; KUPFER A, 1983, P NATL ACAD SCI-BIOL, V80, P7224, DOI 10.1073/pnas.80.23.7224; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Lang T, 2000, BIOPHYS J, V78, P2863, DOI 10.1016/S0006-3495(00)76828-7; Li DD, 2004, BIOPHYS J, V87, P1991, DOI 10.1529/biophysj.104.043281; Liu DF, 2005, P NATL ACAD SCI USA, V102, P123, DOI 10.1073/pnas.0405737102; Liu DF, 2009, IMMUNITY, V31, P99, DOI 10.1016/j.immuni.2009.05.009; Lodoen MB, 2006, CURR OPIN IMMUNOL, V18, P391, DOI 10.1016/j.coi.2006.05.002; Lopes VS, 2007, TRAFFIC, V8, P486, DOI 10.1111/j.1600-0854.2007.00548.x; Lyubchenko TA, 2003, J PHYSIOL-LONDON, V547, P835, DOI 10.1113/jphysiol.2002.033522; Menager MM, 2007, NAT IMMUNOL, V8, P257, DOI 10.1038/ni1431; Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024; Menasche G, 2008, BLOOD, V112, P5052, DOI 10.1182/blood-2008-02-141069; Mentlik AN, 2010, MOL BIOL CELL, V21, P2241, DOI 10.1091/mbc.E09-11-0930; O'Keefe JP, 2005, J IMMUNOL, V175, P5581, DOI 10.4049/jimmunol.175.9.5581; Ohara-Imaizumi M, 2002, J BIOL CHEM, V277, P3805, DOI 10.1074/jbc.C100712200; OHBAYASHI N, 2010, PIGMENT CELL MELANOM; Orange JS, 2003, P NATL ACAD SCI USA, V100, P14151, DOI 10.1073/pnas.1835830100; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; PETERS PJ, 1991, J EXP MED, V173, P1099, DOI 10.1084/jem.173.5.1099; Rogers SL, 2000, CURR OPIN CELL BIOL, V12, P57, DOI 10.1016/S0955-0674(99)00057-5; Sanal O, 2002, J CLIN IMMUNOL, V22, P237, DOI 10.1023/A:1016045026204; Sanborn KB, 2009, J IMMUNOL, V182, P6969, DOI 10.4049/jimmunol.0804337; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Schmoranzer J, 2000, J CELL BIOL, V149, P23, DOI 10.1083/jcb.149.1.23; Schutz GJ, 1997, BIOPHYS J, V73, P1073, DOI 10.1016/S0006-3495(97)78139-6; Steyer JA, 1999, BIOPHYS J, V76, P2262, DOI 10.1016/S0006-3495(99)77382-0; Stinchcombe J, 2004, SCIENCE, V305, P55, DOI 10.1126/science.1095291; Stinchcombe JC, 2007, ANNU REV CELL DEV BI, V23, P495, DOI 10.1146/annurev.cellbio.23.090506.123521; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Stinchcombe JC, 2001, J CELL BIOL, V152, P825, DOI 10.1083/jcb.152.4.825; Trapani JA, 2002, NAT REV IMMUNOL, V2, P735, DOI 10.1038/nri911; Wehrle-Haller B, 2003, INT J BIOCHEM CELL B, V35, P39, DOI 10.1016/S1357-2725(02)00071-7; Wilson SM, 2000, P NATL ACAD SCI USA, V97, P7933, DOI 10.1073/pnas.140212797; WOOD SM, 2009, BLOOD; Wu XF, 2000, CURR OPIN CELL BIOL, V12, P42, DOI 10.1016/S0955-0674(99)00055-1; Wulfing C, 2003, P NATL ACAD SCI USA, V100, P7767, DOI 10.1073/pnas.1336920100	62	26	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2010	5	9							e12870	10.1371/journal.pone.0012870	http://dx.doi.org/10.1371/journal.pone.0012870			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652JO	20877725	Green Published, Green Submitted, gold			2022-12-27	WOS:000282002900013
J	Sysoeva, OV; Tonevitsky, AG; Wackermann, J				Sysoeva, Olga V.; Tonevitsky, Alexander G.; Wackermann, Jiri			Genetic Determinants of Time Perception Mediated by the Serotonergic System	PLOS ONE			English	Article							DOPAMINE TRANSPORTER GENE; CATECHOL-O-METHYLTRANSFERASE; 5-HT2A RECEPTOR GENE; POSITRON-EMISSION; MONOAMINE-OXIDASE; VARIABLE NUMBER; HUMAN STRIATUM; POLYMORPHISM; HUMANS; BEHAVIOR	Background: The present study investigates neurobiological underpinnings of individual differences in time perception. Methodology: Forty-four right-handed Russian Caucasian males (18-35 years old) participated in the experiment. The polymorphism of the genes related to the activity of serotonin (5-HT) and dopamine (DA)-systems (such as 5-HTT, 5HT2a, MAOA, DAT, DRD2, COMT) was determined upon the basis of DNA analysis according to a standard procedure. Time perception in the supra-second range (mean duration 4.8 s) was studied, using the duration discrimination task and parametric fitting of psychometric functions, resulting in individual determination of the point of subjective equality (PSE). Assuming the 'dual klepsydra model' of internal duration representation, the PSE values were transformed into equivalent values of the parameter kappa (kappa), which is a measure of the 'loss rate' of the duration representation. An association between time representation parameters (PSE and k, respectively) and 5-HT-related genes was found, but not with DA-related genes. Higher 'loss rate' (k) of the cumulative duration representation were found for the carriers of genotypes characterized by higher 5-HT transmission, i.e., 1) lower 5-HT reuptake, known for the 5-HTTLPR SS polymorphism compared with LL, 2) lower 5-HT degradation, described for the 'low expression' variant of MAOA VNTR gene compared with 'high expression' variant, and 3) higher 5-HT2a receptor density, proposed for the TT polymorphism of 5-HT2a T102C gene compared with CC. Conclusion: Convergent findings of the present study and previous sychopharmacological studies suggest an action path from 5-HT-activity-related genes, via activity of 5-HT in the brain, to time perception. An involvement of the DA-system in the encoding of durations in the supra-second range is questioned.	[Sysoeva, Olga V.] Russian Acad Sci, Inst Higher Nervous Act & Neurophysiol, Moscow, Russia; [Tonevitsky, Alexander G.] Russian Res Inst Sport & Phys Educ, Moscow, Russia; [Wackermann, Jiri] Inst Frontier Areas Psychol & Mental Hlth, Freiburg, Germany	Institute of Higher Nervous Activity & Neurophysiology of RAS; Russian Academy of Sciences; Federal Science Center of Physical Culture & Sport (VNIIFK); Russian State University of Physical Education, Sport, Youth & Tourism	Sysoeva, OV (corresponding author), Russian Acad Sci, Inst Higher Nervous Act & Neurophysiol, Moscow, Russia.	olga.v.sysoeva@gmail.com	Sysoeva, Olga V/D-3540-2011; Sysoeva, Olga V/F-9301-2019; Tonevitsky, Alexander/R-5596-2019; Tonevitsky, Alexander G/F-8640-2014	Sysoeva, Olga V/0000-0002-4005-9512; Tonevitsky, Alexander/0000-0002-7079-7145; Wackermann, Jiri/0000-0001-5149-4248	RFH [10-06-00331a]	RFH	The work was supported by the RFH grant 10-06-00331a and Russian Science contract 02.740.11.0300. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRATT ES, 1983, PERS INDIV DIFFER, V4, P387, DOI 10.1016/0191-8869(83)90004-1; Block RA, 2000, MEM COGNITION, V28, P1333, DOI 10.3758/BF03211834; Brown SW, 1998, PERCEPTION, V27, P609, DOI 10.1068/p270609; BUCHWALD C, 1974, J CONSULT CLIN PSYCH, V42, P639, DOI 10.1037/h0036939; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Eisler AD, 2003, NATO SCI SER II-MATH, V95, P5; Frankle WG, 2005, AM J PSYCHIAT, V162, P915, DOI 10.1176/appi.ajp.162.5.915; Fuke S., 2001, Pharmacogenomics Journal, V1, P152; Gil S, 2009, BEHAV PROCESS, V80, P169, DOI 10.1016/j.beproc.2008.11.012; Gorwood P, 2000, BIOL PSYCHIAT, V48, P259, DOI 10.1016/S0006-3223(00)00840-4; Heils A, 1996, J NEUROCHEM, V66, P2621; Heinz A, 2000, NEUROPSYCHOPHARMACOL, V22, P133, DOI 10.1016/S0893-133X(99)00099-8; Herken H, 2003, NEUROPSYCHOBIOLOGY, V47, P27, DOI 10.1159/000068872; Ho MY, 2002, PHARMACOL BIOCHEM BE, V71, P773, DOI 10.1016/S0091-3057(01)00672-4; Hong CC, 2003, CANCER EPIDEM BIOMAR, V12, P838; Jech R, 2005, NEUROREPORT, V16, P1467, DOI 10.1097/01.wnr.0000175616.00936.1c; Kang AM, 1999, BIOL PSYCHIAT, V46, P151, DOI 10.1016/S0006-3223(99)00101-8; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lesch KP, 2000, BEHAV SCI LAW, V18, P581, DOI 10.1002/1099-0798(200010)18:5<581::AID-BSL411>3.0.CO;2-L; Lewis PA, 2006, BEHAV PROCESS, V71, P226, DOI 10.1016/j.beproc.2005.12.009; Lewis PA, 2003, NEUROPSYCHOLOGIA, V41, P1583, DOI 10.1016/S0028-3932(03)00118-0; LOTTA T, 1995, BIOCHEMISTRY-US, V34, P4202, DOI 10.1021/bi00013a008; Martinez D, 2001, NEUROPSYCHOPHARMACOL, V24, P553, DOI 10.1016/S0893-133X(00)00216-5; Meck WH, 1996, COGNITIVE BRAIN RES, V3, P227, DOI 10.1016/0926-6410(96)00009-2; Mill J, 2002, AM J MED GENET, V114, P975, DOI 10.1002/ajmg.b.10948; Miro E, 2003, HUM FACTORS, V45, P148, DOI 10.1518/hfes.45.1.148.27227; MITRANI L, 1977, ACTIV NERV SUPER, V19, P103; Nichols DE, 2004, PHARMACOL THERAPEUT, V101, P131, DOI 10.1016/j.pharmthera.2003.11.002; Noble E P, 1994, Alcohol Alcohol Suppl, V2, P35; Onoe H, 2001, NEUROIMAGE, V13, P37, DOI 10.1006/nimg.2000.0670; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Poppel E, 1997, TRENDS COGN SCI, V1, P56, DOI 10.1016/S1364-6613(97)01008-5; Polesskaya OO, 2002, J NEUROSCI RES, V67, P812, DOI 10.1002/jnr.10173; Portnova GV, 2007, ZH VYSSH NERV DEYAT+, V57, P450; RAMMSAYER T, 1990, INT J NEUROSCI, V53, P111, DOI 10.3109/00207459008986593; RAMMSAYER TH, 1993, BIOL PSYCHOL, V36, P209, DOI 10.1016/0301-0511(93)90018-4; Rammsayer TH, 1997, NEUROPSYCHOBIOLOGY, V35, P36, DOI 10.1159/000119328; Rammsayer TH, 1999, Q J EXP PSYCHOL-B, V52, P273; Rammsayer TH, 2002, PERS INDIV DIFFER, V32, P827, DOI 10.1016/S0191-8869(01)00089-7; RAMMSAYER TH, 1994, INT J NEUROSCI, V77, P61, DOI 10.3109/00207459408986019; Rammsayer TH, 1997, BIOL PSYCHOL, V46, P169, DOI 10.1016/S0301-0511(97)05251-4; Sabol SZ, 1998, HUM GENET, V103, P273, DOI 10.1007/s004390050816; SANO A, 1993, HUM GENET, V91, P405; Sevigny MC, 2003, BRAIN COGNITION, V53, P351, DOI 10.1016/S0278-2626(03)00141-6; Shih JC, 1999, ANNU REV NEUROSCI, V22, P197, DOI 10.1146/annurev.neuro.22.1.197; SPATI JP, 2005, THESIS A LUDWIG U; Sysoeva OV, 2009, INT J PSYCHOPHYSIOL, V72, P173, DOI 10.1016/j.ijpsycho.2008.12.005; Thompson J, 1997, PHARMACOGENETICS, V7, P479, DOI 10.1097/00008571-199712000-00006; TSYKANOV BI, 1988, VOP PSIKHOL+, V4, P129; van Dyck CH, 2005, J NUCL MED, V46, P745; VANDENBERGH DJ, 1992, GENOMICS, V14, P1104, DOI 10.1016/S0888-7543(05)80138-7; VanNess SH, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-55; Wackermann J, 2006, J THEOR BIOL, V239, P482, DOI 10.1016/j.jtbi.2005.08.024; WACKERMANN J, 2005, ENDOPHYSICS TIME QUA, P189; Wackermann J, 2008, NEUROSCI LETT, V435, P51, DOI 10.1016/j.neulet.2008.02.006; Wackermann J, 2006, ACTA NEUROBIOL EXP, V66, P245; WARREN JT, 1993, HUM MOL GENET, V2, P338, DOI 10.1093/hmg/2.3.338; WEARDEN JH, 1993, Q J EXP PSYCHOL-B, V46, P163; Wittmann M, 2008, TRENDS COGN SCI, V12, P7, DOI 10.1016/j.tics.2007.10.004; Wittmann M, 2007, DRUG ALCOHOL DEPEN, V90, P183, DOI 10.1016/j.drugalcdep.2007.03.005; Wittmann M, 2007, J PSYCHOPHARMACOL, V21, P50, DOI 10.1177/0269881106065859; Wittmann Marc, 2006, Palliat Support Care, V4, P357	64	34	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2010	5	9							e12650	10.1371/journal.pone.0012650	http://dx.doi.org/10.1371/journal.pone.0012650			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651XL	20862259	Green Published, gold, Green Submitted			2022-12-27	WOS:000281960800003
J	Caballero, OL; Zhao, Q; Rimoldi, D; Stevenson, BJ; Svobodova, S; Devalle, S; Rohrig, UF; Pagotto, A; Michielin, O; Speiser, D; Wolchok, JD; Liu, CL; Pejovic, T; Odunsi, K; Brasseur, F; Van den Eynde, BJ; Old, LJ; Lu, X; Cebon, J; Strausberg, RL; Simpson, AJ				Caballero, Otavia L.; Zhao, Qi; Rimoldi, Donata; Stevenson, Brian J.; Svobodova, Suzanne; Devalle, Sylvie; Roehrig, Ute F.; Pagotto, Anna; Michielin, Olivier; Speiser, Daniel; Wolchok, Jedd D.; Liu, Cailian; Pejovic, Tanja; Odunsi, Kunle; Brasseur, Francis; Van den Eynde, Benoit J.; Old, Lloyd J.; Lu, Xin; Cebon, Jonathan; Strausberg, Robert L.; Simpson, Andrew J.			Frequent MAGE Mutations in Human Melanoma	PLOS ONE			English	Article							CANCER-TESTIS ANTIGENS; EXPRESSION; GENES; COMPLEXES; APOPTOSIS; PROTEINS; SURVIVAL; TUMORS	Background: Cancer/testis (CT) genes are expressed only in the germ line and certain tumors and are most frequently located on the X-chromosome (the CT-X genes). Amongst the best studied CT-X genes are those encoding several MAGE protein families. The function of MAGE proteins is not well understood, but several have been shown to potentially influence the tumorigenic phenotype. Methodology/Principal Findings: We undertook a mutational analysis of coding regions of four CT-X MAGE genes, MAGEA1, MAGEA4, MAGEC1, MAGEC2 and the ubiquitously expressed MAGEE1 in human melanoma samples. We first examined cell lines established from tumors and matching blood samples from 27 melanoma patients. We found that melanoma cell lines from 37% of patients contained at least one mutated MAGE gene. The frequency of mutations in the coding regions of individual MAGE genes varied from 3.7% for MAGEA1 and MAGEA4 to 14.8% for MAGEC2. We also examined 111 fresh melanoma samples collected from 86 patients. In this case, samples from 32% of the patients exhibited mutations in one or more MAGE genes with the frequency of mutations in individual MAGE genes ranging from 6% in MAGEA1 to 16% in MAGEC1. Significance: These results demonstrate for the first time that the MAGE gene family is frequently mutated in melanoma.	[Caballero, Otavia L.; Devalle, Sylvie; Wolchok, Jedd D.; Old, Lloyd J.] Ludwig Inst Canc Res Ltd, New York Branch, Mem Sloan Kettering Canc Ctr, New York, NY USA; [Zhao, Qi] J Craig Venter Inst, Rockville, MD USA; [Rimoldi, Donata; Stevenson, Brian J.; Roehrig, Ute F.; Michielin, Olivier; Speiser, Daniel] Ludwig Inst Canc Res Ltd, Lausanne Branch, Lausanne, Switzerland; [Svobodova, Suzanne; Cebon, Jonathan] Ludwig Inst Canc Res Ltd, Melbourne Ctr Clin Sci, Austin Hlth, Heidelberg, Vic, Australia; [Pagotto, Anna] Univ Oxford, Nuffield Dept Clin Med, Ludwig Inst Canc Res Ltd, Oxford Branch, Oxford, England; [Wolchok, Jedd D.; Liu, Cailian] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Wolchok, Jedd D.; Liu, Cailian] Mem Sloan Kettering Canc Ctr, Ludwig Ctr Canc Immunotherapy, New York, NY 10021 USA; [Pejovic, Tanja] Oregon Hlth & Sci Univ, Div Gynecol Oncol, Portland, OR 97201 USA; [Pejovic, Tanja] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Odunsi, Kunle] Roswell Pk Canc Inst, Dept Gynecol Oncol, Buffalo, NY 14263 USA; [Odunsi, Kunle] Roswell Pk Canc Inst, Ctr Immunotherapy, Buffalo, NY 14263 USA; [Brasseur, Francis; Van den Eynde, Benoit J.] Catholic Univ Louvain, Ludwig Inst Canc Res Ltd, Brussels Branch, B-1200 Brussels, Belgium	Ludwig Institute for Cancer Research; Memorial Sloan Kettering Cancer Center; J. Craig Venter Institute; Ludwig Institute for Cancer Research; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Ludwig Institute for Cancer Research; Ludwig Institute for Cancer Research; University of Oxford; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Oregon Health & Science University; Oregon Health & Science University; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Ludwig Institute for Cancer Research; Universite Catholique Louvain	Caballero, OL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA.	ocaball1@jhmi.edu	Speiser, Daniel E./F-2173-2013; Cebon, Jonathan S/H-1643-2013; Michielin, Olivier/ABE-7924-2020	Roehrig, Ute/0000-0002-4676-4087; Lu, Xin/0000-0002-6587-1152; Cebon, Jonathan/0000-0002-3898-950X; Devalle, Sylvie/0000-0002-9533-2571	Conrad N. Hilton Foundation; Ludwig Institute for Cancer Research; Medical Research Council [G9900991B] Funding Source: researchfish	Conrad N. Hilton Foundation; Ludwig Institute for Cancer Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was conducted as part of the Hilton-Ludwig Cancer Metastasis Initiative, funded by the Conrad N. Hilton Foundation and the Ludwig Institute for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], COSMIC CATALOGUE SOM; Atanackovic D, 2010, HAEMATOL-HEMATOL J, V95, P785, DOI 10.3324/haematol.2009.014464; Atanackovic D, 2009, CLIN CANCER RES, V15, P1343, DOI 10.1158/1078-0432.CCR-08-0989; Bergeron A, 2009, INT J CANCER, V125, P1365, DOI 10.1002/ijc.24503; Brichard VG, 2008, EXPERT OPIN BIOL TH, V8, P951, DOI [10.1517/14712598.8.7.951, 10.1517/14712598.8.7.951 ]; Caballero OL, 2009, CANCER SCI, V100, P2014, DOI 10.1111/j.1349-7006.2009.01303.x; DEPLAEN E, 1994, IMMUNOGENETICS, V40, P360, DOI 10.1007/BF01246677; Grau E, 2009, J CANCER RES CLIN, V135, P523, DOI 10.1007/s00432-008-0484-1; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Gure AO, 2005, CLIN CANCER RES, V11, P8055, DOI 10.1158/1078-0432.CCR-05-1203; JEON CH, 2010, J CLIN GASTROENTEROL; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Liu W, 2008, CANCER RES, V68, P8104, DOI 10.1158/0008-5472.CAN-08-2132; Monte M, 2006, P NATL ACAD SCI USA, V103, P11160, DOI 10.1073/pnas.0510834103; Nagao T, 2003, J BIOL CHEM, V278, P10668, DOI 10.1074/jbc.M206104200; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Peikert T, 2006, CANCER RES, V66, P4693, DOI 10.1158/0008-5472.CAN-05-3327; Pejovic T, 2009, TRANSL ONCOL, V2, P341, DOI 10.1593/tlo.09199; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Sharma P, 2006, CLIN CANCER RES, V12, P5442, DOI 10.1158/1078-0432.CCR-06-0527; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Singer G, 2005, AM J SURG PATHOL, V29, P218, DOI 10.1097/01.pas.0000146025.91953.8d; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yang B, 2007, CANCER RES, V67, P9954, DOI 10.1158/0008-5472.CAN-07-1478	25	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2010	5	9							e12773	10.1371/journal.pone.0012773	http://dx.doi.org/10.1371/journal.pone.0012773			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650QH	20862285	Green Published, gold			2022-12-27	WOS:000281864100016
J	Tang, YA; Wen, WL; Chang, JW; Wei, TT; Tan, YHC; Salunke, S; Chen, CT; Chen, CS; Wang, YC				Tang, Yen-An; Wen, Wei-Ling; Chang, Jer-Wei; Wei, Tzi-Tang; Tan, Yi-Hung Carol; Salunke, Santosh; Chen, Chien-Tien; Chen, Ching-Shih; Wang, Yi-Ching			A Novel Histone Deacetylase Inhibitor Exhibits Antitumor Activity via Apoptosis Induction, F-Actin Disruption and Gene Acetylation in Lung Cancer	PLOS ONE			English	Article							T-CELL LYMPHOMA; IN-VIVO; EXPRESSION; SENSITIVITY; P21(WAF1); PROTEINS; BCL-2	Background: Lung cancer is the leading cause of cancer mortality worldwide, yet the therapeutic strategy for advanced non-small cell lung cancer (NSCLC) is limitedly effective. In addition, validated histone deacetylase (HDAC) inhibitors for the treatment of solid tumors remain to be developed. Here, we propose a novel HDAC inhibitor, OSU-HDAC-44, as a chemotherapeutic drug for NSCLC. Methodology/Principal Findings: The cytotoxicity effect of OSU-HDAC-44 was examined in three human NSCLC cell lines including A549 (p53 wild-type), H1299 (p53 null), and CL1-1 (p53 mutant). The antiproliferatative mechanisms of OSU-HDAC-44 were investigated by flow cytometric cell cycle analysis, apoptosis assays and genome-wide chromatin-immunoprecipitation-on-chip (ChIP-on-chip) analysis. Mice with established A549 tumor xenograft were treated with OSU-HDAC-44 or vehicle control and were used to evaluate effects on tumor growth, cytokinesis inhibition and apoptosis. OSU-HDAC-44 was a pan-HDAC inhibitor and exhibits 3-4 times more effectiveness than suberoylanilide hydroxamic acid (SAHA) in suppressing cell viability in various NSCLC cell lines. Upon OSU-HDAC-44 treatment, cytokinesis was inhibited and subsequently led to mitochondria-mediated apoptosis. The cytokinesis inhibition resulted from OSU-HDAC-44-mediated degradation of mitosis and cytokinesis regulators Auroroa B and survivin. The deregulation of F-actin dynamics induced by OSU-HDAC-44 was associated with reduction in RhoA activity resulting from srGAP1 induction. ChIP-on-chip analysis revealed that OSU-HDAC-44 induced chromatin loosening and facilitated transcription of genes involved in crucial signaling pathways such as apoptosis, axon guidance and protein ubiquitination. Finally, OSU-HDAC-44 efficiently inhibited A549 xenograft tumor growth and induced acetylation of histone and non-histone proteins and apoptosis in vivo. Conclusions/Significance: OSU-HDAC-44 significantly suppresses tumor growth via induction of cytokinesis defect and intrinsic apoptosis in preclinical models of NSCLC. Our data provide compelling evidence that OSU-HDAC-44 is a potent HDAC targeted inhibitor and can be tested for NSCLC chemotherapy.	[Tang, Yen-An; Wang, Yi-Ching] Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 70101, Taiwan; [Wen, Wei-Ling; Tan, Yi-Hung Carol] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Chang, Jer-Wei; Wei, Tzi-Tang; Wang, Yi-Ching] Natl Cheng Kung Univ, Dept Pharmacol, Tainan 70101, Taiwan; [Salunke, Santosh] Natl Taiwan Normal Univ, Dept Chem, Taipei, Taiwan; [Chen, Chien-Tien] Natl Tsing Hua Univ, Dept Chem, Hsinchu, Taiwan; [Chen, Ching-Shih] Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, Columbus, OH 43210 USA	National Cheng Kung University; National Taiwan Normal University; National Cheng Kung University; National Taiwan Normal University; National Tsing Hua University; University System of Ohio; Ohio State University	Tang, YA (corresponding author), Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 70101, Taiwan.	ycw5798@mail.ncku.edu.tw	Wang, Yi-Ching/J-8702-2019	Wang, Yi-Ching/0000-0002-7694-2067; Tan, Yi-Hung Carol/0000-0001-7541-007X	National Science Council [NSC97-2627-M-006-005, NSC99-2628-B-006-004-MY3]; Department of Health (The Executive Yuan, Republic of China) [DOH98-TD-G-111-024]	National Science Council(Ministry of Science and Technology, Taiwan); Department of Health (The Executive Yuan, Republic of China)	This work was supported in part by grants NSC97-2627-M-006-005 and NSC99-2628-B-006-004-MY3 from the National Science Council and grant DOH98-TD-G-111-024 from the Department of Health (The Executive Yuan, Republic of China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlesi F, 2007, J CLIN ONCOL, V25, P4358, DOI 10.1200/JCO.2007.11.2599; Bhalla KN, 2005, J CLIN ONCOL, V23, P3971, DOI 10.1200/JCO.2005.16.600; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Canes D, 2005, INT J CANCER, V113, P841, DOI 10.1002/ijc.20634; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Chen JG, 2009, BLOOD, V113, P4038, DOI 10.1182/blood-2008-08-176024; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; Danesi R, 2003, PHARMACOL REV, V55, P57, DOI 10.1124/pr.55.1.4; Glaser KB, 2003, MOL CANCER THER, V2, P151; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Gui CY, 2004, P NATL ACAD SCI USA, V101, P1241, DOI 10.1073/pnas.0307708100; Lens SMA, 2006, CURR OPIN CELL BIOL, V18, P616, DOI 10.1016/j.ceb.2006.08.016; Li H, 2000, SCIENCE, V289, P1159, DOI 10.1126/science.289.5482.1159; Li JW, 2002, GENE DEV, V16, P687, DOI 10.1101/gad.962502; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Lu Q, 2004, J MED CHEM, V47, P467, DOI 10.1021/jm0303655; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; Marsoni S, 2008, EPIGENETICS-US, V3, P164, DOI 10.4161/epi.3.3.6253; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Mitsiades CS, 2004, P NATL ACAD SCI USA, V101, P540, DOI 10.1073/pnas.2536759100; Noh EJ, 2005, CANCER RES, V65, P11400, DOI 10.1158/0008-5472.CAN-05-1092; Peart MJ, 2005, P NATL ACAD SCI USA, V102, P3697, DOI 10.1073/pnas.0500369102; Pfister DG, 2004, J CLIN ONCOL, V22, P330, DOI 10.1200/JCO.2004.09.053; Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Stinchcombe Thomas E, 2009, Proc Am Thorac Soc, V6, P233, DOI 10.1513/pats.200809-110LC; Tang TTL, 2002, J BIOL CHEM, V277, P14255, DOI 10.1074/jbc.M110901200; Vigushin DM, 2001, CLIN CANCER RES, V7, P971; Vischioni B, 2006, MOL CANCER THER, V5, P2905, DOI 10.1158/1535-7163.MCT-06-0301; Wilson AJ, 2010, CANCER RES, V70, P609, DOI 10.1158/0008-5472.CAN-09-2327; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yang P, 2005, CHEST, V128, P452, DOI 10.1378/chest.128.1.452	34	40	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2010	5	9							e12417	10.1371/journal.pone.0012417	http://dx.doi.org/10.1371/journal.pone.0012417			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZO	20856855	Green Submitted, Green Published, gold			2022-12-27	WOS:000281815700003
J	Bagwell, CE; Hixson, KK; Milliken, CE; Lopez-Ferrer, D; Weitz, KK				Bagwell, Christopher E.; Hixson, Kim K.; Milliken, Charles E.; Lopez-Ferrer, Daniel; Weitz, Karl K.			Proteomic and Physiological Responses of Kineococcus radiotolerans to Copper	PLOS ONE			English	Article							TANDEM MASS-SPECTRA; ESCHERICHIA-COLI; SUPEROXIDE-DISMUTASE; ENTEROCOCCUS-HIRAE; SP NOV.; DISULFIDE OXIDOREDUCTASE; SACCHAROMYCES-CEREVISIAE; LIQUID-CHROMATOGRAPHY; RADIATION-RESISTANCE; INTRACELLULAR COPPER	Copper is a highly reactive, toxic metal; consequently, transport of this metal within the cell is tightly regulated. Intriguingly, the actinobacterium Kineococcus radiotolerans has been shown to not only accumulate soluble copper to high levels within the cytoplasm, but the phenotype also correlated with enhanced cell growth during chronic exposure to ionizing radiation. This study offers a first glimpse into the physiological and proteomic responses of K. radiotolerans to copper at increasing concentration and distinct growth phases. Aerobic growth rates and biomass yields were similar over a range of Cu(II) concentrations (0-1.5 mM) in complex medium. Copper uptake coincided with active cell growth and intracellular accumulation was positively correlated with Cu(II) concentration in the growth medium (R-2 = 0.7). Approximately 40% of protein coding ORFs on the K. radiotolerans genome were differentially expressed in response to the copper treatments imposed. Copper accumulation coincided with increased abundance of proteins involved in oxidative stress and defense, DNA stabilization and repair, and protein turnover. Interestingly, the specific activity of superoxide dismutase was repressed by low to moderate concentrations of copper during exponential growth, and activity was unresponsive to perturbation with paraquot. The biochemical response pathways invoked by sub-lethal copper concentrations are exceptionally complex; though integral cellular functions are preserved, in part, through the coordination of defense enzymes, chaperones, antioxidants and protective osmolytes that likely help maintain cellular redox. This study extends our understanding of the ecology and physiology of this unique actinobacterium that could potentially inspire new biotechnologies in metal recovery and sequestration, and environmental restoration.	[Bagwell, Christopher E.; Milliken, Charles E.] Savannah River Natl Lab, Dept Environm Sci & Biotechnol, Aiken, SC USA; [Hixson, Kim K.] Environm Mol Sci Lab, Richland, WA USA; [Lopez-Ferrer, Daniel; Weitz, Karl K.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA	United States Department of Energy (DOE); Savannah River National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Bagwell, CE (corresponding author), Savannah River Natl Lab, Dept Environm Sci & Biotechnol, Aiken, SC USA.	Christopher.bagwell@srnl.doe.gov	Hixson, Kim/AAJ-7714-2020; Hixson, Kim/AAW-2332-2020	Hixson, Kim/0000-0003-3716-0326; Hixson, Kim/0000-0003-3915-7040	U.S. Department of Energy, Office of Environmental Management; U.S. Department of Energy's Office of Biological and Environmental Research located at Pacific Northwest National Laboratory, Richland WA, USA	U.S. Department of Energy, Office of Environmental Management(United States Department of Energy (DOE)); U.S. Department of Energy's Office of Biological and Environmental Research located at Pacific Northwest National Laboratory, Richland WA, USA	This investigation was supported by the U.S. Department of Energy, Office of Environmental Management as administered through the SRNL Laboratory Directed Research and Development Program. A portion of this research was performed at the Environmental Molecular Sciences Laboratory (EMSL), a national scientific user facility sponsored by the U.S. Department of Energy's Office of Biological and Environmental Research located at Pacific Northwest National Laboratory, Richland WA, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard-Joris M, 2007, BIOCHIMIE, V89, P1474, DOI 10.1016/j.biochi.2007.06.005; Albarracin VH, 2005, CHEM ERDE-GEOCHEM, V65, P145, DOI 10.1016/j.chemer.2005.06.004; Ansaldi M, 2007, MOL MICROBIOL, V66, P484, DOI 10.1111/j.1365-2958.2007.05936.x; ATTFIELD PV, 1987, FEBS LETT, V225, P259, DOI 10.1016/0014-5793(87)81170-5; Bagwell CE, 2008, APPL ENVIRON MICROB, V74, P1376, DOI 10.1128/AEM.02175-07; Bagwell CE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003878; BAIKUN L, 2004, WATER RES, V38, P1248; Bringer MA, 2007, J BACTERIOL, V189, P4860, DOI 10.1128/JB.00233-07; CHA JS, 1991, P NATL ACAD SCI USA, V88, P8915, DOI 10.1073/pnas.88.20.8915; COOKSEY DA, 1993, MOL MICROBIOL, V7, P1, DOI 10.1111/j.1365-2958.1993.tb01091.x; COOKSEY DA, 1992, APPL ENVIRON MICROB, V58, P274, DOI 10.1128/AEM.58.1.274-278.1992; Coombs JT, 2003, APPL ENVIRON MICROB, V69, P5603, DOI 10.1128/AEM.69.9.5603-5608.2003; CULOTTA VC, 1995, J BIOL CHEM, V270, P29991; Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185; Dameron CT, 1998, AM J CLIN NUTR, V67, p1091S, DOI 10.1093/ajcn/67.5.1091S; de la Torre JR, 2003, APPL ENVIRON MICROB, V69, P3858, DOI 10.1128/AEM.69.7.3858-3867.2003; De Mot R, 1999, TRENDS MICROBIOL, V7, P88, DOI 10.1016/S0966-842X(98)01432-2; De Smet KAL, 2000, MICROBIOL-UK, V146, P199, DOI 10.1099/00221287-146-1-199; Deaconescu AM, 2007, CURR OPIN STRUC BIOL, V17, P96, DOI 10.1016/j.sbi.2007.01.005; DENISOV ET, 2005, OXIDATION ANTIOXIDAN, P819; Ellington MJK, 2003, MICROBIOL-SGM, V149, P1533, DOI 10.1099/mic.0.26277-0; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; ERARDI FX, 1987, APPL ENVIRON MICROB, V53, P1951, DOI 10.1128/AEM.53.8.1951-1954.1987; Fabisiak JP, 1999, ARCH BIOCHEM BIOPHYS, V363, P171, DOI 10.1006/abbi.1998.1077; Fredrickson JK, 2004, APPL ENVIRON MICROB, V70, P4230, DOI 10.1128/AEM.70.7.4230-4241.2004; FRIDOVICH I, 1983, ANNU REV PHARMACOL, V23, P239, DOI 10.1146/annurev.pa.23.040183.001323; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; GARRITY GM, 1996, IND MICROBIOL BIOTEC, V17, P268; Geslin C, 2001, RES MICROBIOL, V152, P901, DOI 10.1016/S0923-2508(01)01273-6; Gomez-Silva Benito, 2008, V13, P117; Grassmann J, 2002, PLANT PHYSIOL BIOCH, V40, P471, DOI 10.1016/S0981-9428(02)01395-5; Gremion F, 2003, ENVIRON MICROBIOL, V5, P896, DOI 10.1046/j.1462-2920.2003.00484.x; Gupta D, 2009, EXPERT OPIN DRUG SAF, V8, P81, DOI [10.1517/14740330802655538, 10.1517/14740330802655538 ]; Haferburg G, 2007, J BASIC MICROB, V47, P474, DOI 10.1002/jobm.200700256; Han WD, 1998, GENE, V217, P31, DOI 10.1016/S0378-1119(98)00378-3; HASSAN HM, 1977, J BIOL CHEM, V252, P7667; HASSAN HM, 1979, ARCH BIOCHEM BIOPHYS, V196, P385, DOI 10.1016/0003-9861(79)90289-3; Imperi F, 2007, ENVIRON MICROBIOL, V9, P2894, DOI 10.1111/j.1462-2920.2007.01393.x; ISHIGURO EE, 1970, J BACTERIOL, V104, P566, DOI 10.1128/JB.104.1.566-580.1970; JOHNSTON DW, 1976, FRESHWATER BIOL, V6, P465, DOI 10.1111/j.1365-2427.1976.tb01636.x; KELNER MJ, 1990, J BIOL CHEM, V265, P10872; Keyer K, 1996, P NATL ACAD SCI USA, V93, P13635, DOI 10.1073/pnas.93.24.13635; Kim S, 2008, J PROTEOME RES, V7, P3354, DOI 10.1021/pr8001244; Kim TK, 2005, ENVIRON MICROBIOL, V7, P509, DOI 10.1111/j.1462-2920.2005.00716.x; Kodali Vidya Prabhakar, 2008, Biotechnol J, V3, P245, DOI 10.1002/biot.200700208; Konstantinidis KT, 2003, MICROB ECOL, V45, P191, DOI 10.1007/s00248-002-1035-y; Kuhlman KR, 2006, APPL ENVIRON MICROB, V72, P1708, DOI 10.1128/AEM.72.2.1708-1715.2006; Lee SD, 2006, INT J SYST EVOL MICR, V56, P1279, DOI 10.1099/ijs.0.64128-0; Liu M, 2009, INT J SYST EVOL MICR, V59, P1090, DOI 10.1099/ijs.0.004168-0; LOEWEN PC, 1984, J BACTERIOL, V157, P622, DOI 10.1128/JB.157.2.622-626.1984; Lopez-Ferrer D, 2004, ANAL CHEM, V76, P6853, DOI 10.1021/ac049305c; Lu ZH, 2003, BIOMETALS, V16, P137; Lu ZH, 2001, J BIOL CHEM, V276, P47822, DOI 10.1074/jbc.M106218200; LUEDEMANN GM, 1968, J BACTERIOL, V96, P1848, DOI 10.1128/JB.96.5.1848-1858.1968; Macomber L, 2007, J BACTERIOL, V189, P1616, DOI 10.1128/JB.01357-06; Makarova KS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000955; Masselon C, 2005, ANAL CHEM, V77, P400, DOI 10.1021/ac049043e; MAYFIELD C I, 1972, Soil Biology and Biochemistry, V4, P79, DOI 10.1016/0038-0717(72)90045-4; Milagres AMF, 1999, J MICROBIOL METH, V37, P1, DOI 10.1016/S0167-7012(99)00028-7; Mincer TJ, 2002, APPL ENVIRON MICROB, V68, P5005, DOI 10.1128/AEM.68.10.5005-5011.2002; Monobe M, 2005, J RADIAT RES, V46, P117, DOI 10.1269/jrr.46.117; O'Halloran TV, 2000, J BIOL CHEM, V275, P25057, DOI 10.1074/jbc.R000006200; ODERMATT A, 1994, BIOCHEM BIOPH RES CO, V202, P44, DOI 10.1006/bbrc.1994.1891; PEEK JA, 1992, P NATL ACAD SCI USA, V89, P6210, DOI 10.1073/pnas.89.13.6210; Phillips RW, 2002, INT J SYST EVOL MICR, V52, P933, DOI 10.1099/00207713-52-3-933; Polpitiya AD, 2008, BIOINFORMATICS, V24, P1556, DOI 10.1093/bioinformatics/btn217; Qian WJ, 2005, J PROTEOME RES, V4, P53, DOI 10.1021/pr0498638; QING Z, 2006, CHINESE SCI BULL, V51, P2993; Radajewski S, 2001, MICROB ECOL, V41, P233, DOI 10.1007/s002480000112; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Rosadini CV, 2008, INFECT IMMUN, V76, P1498, DOI 10.1128/IAI.01378-07; Schabereiter-Gurtner C, 2001, ARCH MICROBIOL, V176, P347, DOI 10.1007/s002030100333; Schmidt J, 2005, J ENVIRON HEALTH, V67, P44; SCHWARTZ CE, 1983, J BIOL CHEM, V258, P6277; SCOTT MD, 1987, J BIOL CHEM, V262, P3640; Shen YF, 2001, ANAL CHEM, V73, P3011, DOI 10.1021/ac001393n; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Silver S, 1996, ANNU REV MICROBIOL, V50, P753, DOI 10.1146/annurev.micro.50.1.753; Smith RD, 2002, PROTEOMICS, V2, P513, DOI 10.1002/1615-9861(200205)2:5<513::AID-PROT513>3.0.CO;2-W; Song YH, 1996, J BACTERIOL, V178, P5045, DOI 10.1128/jb.178.16.5045-5048.1996; Su MH, 2005, BIOCHEMISTRY-US, V44, P5572, DOI 10.1021/bi0472705; Swaving J, 1996, J BACTERIOL, V178, P6644, DOI 10.1128/jb.178.22.6644-6646.1996; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Urzi C, 2001, ENVIRON MICROBIOL, V3, P471, DOI 10.1046/j.1462-2920.2001.00217.x; Urzl C, 2000, INT J SYST EVOL MICR, V50, P529, DOI 10.1099/00207713-50-2-529; Van Nostrand JD, 2007, MICROB ECOL, V53, P670, DOI 10.1007/s00248-006-9160-7; WEST TS, 1981, T ROYAL SOC LONDON B, V294, P19; Williams S. T., 1989, BERGEYS MANUAL SYSTE, V4; Wohl DL, 1998, FEMS MICROBIOL ECOL, V26, P135, DOI 10.1111/j.1574-6941.1998.tb00499.x; YOKOTA A, 1993, INT J SYST BACTERIOL, V43, P52, DOI 10.1099/00207713-43-1-52; Zimmer JSD, 2006, MASS SPECTROM REV, V25, P450, DOI 10.1002/mas.20071	91	15	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12427	10.1371/journal.pone.0012427	http://dx.doi.org/10.1371/journal.pone.0012427			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865147	gold, Green Published, Green Submitted			2022-12-27	WOS:000281292100022
J	Motta, MCM; Catta-Preta, CMC; Schenkman, S; Martins, ACD; Miranda, K; de Souza, W; Elias, MC				Machado Motta, Maria Cristina; Costa Catta-Preta, Carolina Moura; Schenkman, Sergio; de Azevedo Martins, Allan Cezar; Miranda, Kildare; de Souza, Wanderley; Elias, Maria Carolina			The Bacterium Endosymbiont of Crithidia deanei Undergoes Coordinated Division with the Host Cell Nucleus	PLOS ONE			English	Article							TRYPANOSOMA-BRUCEI; MORPHOLOGICAL EVENTS; TOXOPLASMA-GONDII; PARAFLAGELLAR ROD; CYCLE; PROTOZOA; KINETOPLAST; CYTOSKELETON; CYTOKINESIS; ORGANELLES	In trypanosomatids, cell division involves morphological changes and requires coordinated replication and segregation of the nucleus, kinetoplast and flagellum. In endosymbiont-containing trypanosomatids, like Crithidia deanei, this process is more complex, as each daughter cell contains only a single symbiotic bacterium, indicating that the prokaryote must replicate synchronically with the host protozoan. In this study, we used light and electron microscopy combined with three-dimensional reconstruction approaches to observe the endosymbiont shape and division during C. deanei cell cycle. We found that the bacterium replicates before the basal body and kinetoplast segregations and that the nucleus is the last organelle to divide, before cytokinesis. In addition, the endosymbiont is usually found close to the host cell nucleus, presenting different shapes during the protozoan cell cycle. Considering that the endosymbiosis in trypanosomatids is a mutualistic relationship, which resembles organelle acquisition during evolution, these findings establish an excellent model for the understanding of mechanisms related with the establishment of organelles in eukaryotic cells.	[Machado Motta, Maria Cristina; Costa Catta-Preta, Carolina Moura; de Azevedo Martins, Allan Cezar; Miranda, Kildare; de Souza, Wanderley] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Ultraestrutura Celular Hertha Meyer, BR-21941 Rio De Janeiro, Brazil; [Machado Motta, Maria Cristina; Costa Catta-Preta, Carolina Moura; de Azevedo Martins, Allan Cezar; Miranda, Kildare; de Souza, Wanderley] Inst Nacl Ciencia & Tecnol Biol Estrut & Bioimage, Rio De Janeiro, Brazil; [Schenkman, Sergio] Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil; [Miranda, Kildare; de Souza, Wanderley] Inst Nacl Metrol Normalizacao & Qualidade Ind In, Rio De Janeiro, Brazil; [Elias, Maria Carolina] Inst Butantan, Parasitol Lab, Sao Paulo, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal de Sao Paulo (UNIFESP); Instituto Butantan	Motta, MCM (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Ultraestrutura Celular Hertha Meyer, BR-21941 Rio De Janeiro, Brazil.	motta@biof.ufrj.br; carol@butantan.gov.br	Elias, Maria Carolina/E-9197-2015; Elias, Maria QB/AAW-9284-2021; Catta Preta, Carolina/J-2505-2014; Azevedo-Martins, Allan Cézar de/AAC-6883-2022; Motta, Maria Cristina M/I-3140-2014; Azevedo-Martins, Allan Cézar de/M-9298-2015; Schenkman, Sergio/A-9227-2013	Elias, Maria Carolina/0000-0002-0501-8280; Azevedo-Martins, Allan Cézar de/0000-0002-9798-0636; Azevedo-Martins, Allan Cézar de/0000-0002-9798-0636; Schenkman, Sergio/0000-0001-9353-8480; Motta, Maria Cristina/0000-0002-0947-4830; Catta-Preta, Carolina/0000-0001-8983-3487	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro; Conselho Nacional de Pesquisa (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, and Conselho Nacional de Pesquisa (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHN TI, 1979, J CELL PHYSIOL, V98, P49, DOI 10.1002/jcp.1040980107; BHATTACHARYA A, 1985, INDIAN J EXP BIOL, V23, P629; Brown WJ, 2000, INFECT IMMUN, V68, P708, DOI 10.1128/IAI.68.2.708-715.2000; CAMARGO EP, 1977, NATURE, V270, P52, DOI 10.1038/270052a0; Cavalcanti DP, 2008, HISTOCHEM CELL BIOL, V130, P1177, DOI 10.1007/s00418-008-0450-7; CAVALIERSMITH T, 1985, J PROTOZOOL, V32, P376, DOI 10.1111/j.1550-7408.1985.tb04031.x; COSGROVE WB, 1970, J PROTOZOOL, V17, P172, DOI 10.1111/j.1550-7408.1970.tb02350.x; De Souza W, 2002, CURR PHARM DESIGN, V8, P269, DOI 10.2174/1381612023396276; de Souza W, 1999, FEMS MICROBIOL LETT, V173, P1, DOI 10.1111/j.1574-6968.1999.tb13477.x; DU YB, 1994, J BACTERIOL, V176, P3081, DOI 10.1128/JB.176.10.3081-3084.1994; Elias MC, 2007, PROTIST, V158, P147, DOI 10.1016/j.protis.2006.10.002; Gadelha C, 2005, EUKARYOT CELL, V4, P516, DOI 10.1128/EC.4.3.516-525.2005; GALINARI S, 1978, EXP PARASITOL, V46, P277, DOI 10.1016/0014-4894(78)90141-8; Gull K, 1999, ANNU REV MICROBIOL, V53, P629, DOI 10.1146/annurev.micro.53.1.629; Hammarton TC, 2007, CURR OPIN MICROBIOL, V10, P520, DOI 10.1016/j.mib.2007.10.005; He CY, 2004, J CELL BIOL, V165, P313, DOI 10.1083/jcb.200311076; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lacomble S, 2009, J CELL SCI, V122, P1081, DOI 10.1242/jcs.045740; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; MATTHIJSDEWINTE.DA, 2009, J MICROSC-OXFORD, V233, P372; McKean PG, 2003, CURR OPIN MICROBIOL, V6, P600, DOI 10.1016/j.mib.2003.10.010; Moreira-Leite FF, 2001, SCIENCE, V294, P610, DOI 10.1126/science.1063775; Motta Maria Cristina Machado, 1991, Microscopia Electronica y Biologia Celular, V15, P131; Motta MCM, 1997, J EUKARYOT MICROBIOL, V44, P492, DOI 10.1111/j.1550-7408.1997.tb05729.x; Motta MCM, 2004, J EUKARYOT MICROBIOL, V51, P394, DOI 10.1111/j.1550-7408.2004.tb00386.x; Motta MCM, 1997, EUR J CELL BIOL, V72, P370; Ogbadoyi E, 2000, CHROMOSOMA, V108, P501, DOI 10.1007/s004120050402; Osteryoung KW, 2003, SCIENCE, V302, P1698, DOI 10.1126/science.1082192; Ploubidou A, 1999, J CELL SCI, V112, P4641; Portman N, 2010, INT J PARASITOL, V40, P135, DOI 10.1016/j.ijpara.2009.10.005; Rios RM, 2004, CELL, V118, P323; ROBINSON DR, 1991, NATURE, V352, P731, DOI 10.1038/352731a0; SALZMAN TA, 1985, INT J BIOCHEM, V17, P1343, DOI 10.1016/0020-711X(85)90058-8; SILVA PMF, 1996, PARASITOL RES, V82, P125; Striepen B, 2000, J CELL BIOL, V151, P1423, DOI 10.1083/jcb.151.7.1423; Vaishnava S, 2006, MOL MICROBIOL, V61, P1380, DOI 10.1111/j.1365-2958.2006.05343.x; van Dooren GG, 2009, CURR BIOL, V19, P267, DOI 10.1016/j.cub.2008.12.048; Vaughan S, 2008, BIOCHEM SOC T, V36, P421, DOI 10.1042/BST0360421; WARREN LG, 1960, J PARASITOL, V46, P529, DOI 10.2307/3274932; WEIS D, 1969, SPECIALIA, V15, P664; Williams A. F, 1971, SYSTEM ANAL SIMULATI, P247; WOODS A, 1989, J CELL SCI, V93, P491; WOODWARD R, 1990, J CELL SCI, V95, P49; YI QM, 1985, J MOL BIOL, V184, P399, DOI 10.1016/0022-2836(85)90290-6	44	31	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12415	10.1371/journal.pone.0012415	http://dx.doi.org/10.1371/journal.pone.0012415			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865129	gold, Green Published, Green Submitted			2022-12-27	WOS:000281292100015
J	Chisholm, RH; Hughes, BD; Landman, KA				Chisholm, Rebecca H.; Hughes, Barry D.; Landman, Kerry A.			Building a Morphogen Gradient without Diffusion in a Growing Tissue	PLOS ONE			English	Article							DEVELOPMENTAL BIOLOGY; PATTERN-FORMATION; DOMAIN GROWTH; CHICK-EMBRYO; SEGMENTATION; LIMB; FGF8; MECHANISM; MESODERM; DPP	In many developmental systems, spatial pattern arises from morphogen gradients, which provide positional information for cells to determine their fate. Typically, diffusion is thought to be the mechanism responsible for building a morphogen gradient. An alternative mechanism is investigated here. Using mathematical modeling, we demonstrate how a non-diffusive morphogen concentration gradient can develop in axially growing tissue systems, where growth is due to cell proliferation only. Two distinct cases are considered: in the first, all cell proliferation occurs in a localized zone where active transcription of a morphogen-producing gene occurs, and in the second, cell proliferation is uniformly distributed throughout the tissue, occurring in both the active transcription zone and beyond. A cell containing morphogen mRNA produces the morphogen protein, hence any gradient in mRNA transcripts translates into a corresponding morphogen protein gradient. Proliferation-driven growth gives rise to both advection (the transport term) and dilution (a reaction term). These two key mechanisms determine the resultant mRNA transcript distribution. Using the full range of uniform initial conditions, we show that advection and dilution due to cell proliferation are, in general, sufficient for morphogen gradient formation for both types of axially growing systems. In particular, mRNA transcript degradation is not necessary for gradient formation; it is only necessary with localized proliferation for one special value of the initial concentration. Furthermore, the morphogen concentration decreases with distance away from the transcription zone, except in the case of localized proliferation with the initial concentration sufficiently large, when the concentration can either increase with distance from the transcription zone or sustain a local minimum. In both localized and uniformly distributed proliferation, in order for a concentration gradient to form across the whole domain, transcription must occur in a zone equal to the initial domain size; otherwise, it will only form across part of the tissue.	[Chisholm, Rebecca H.; Hughes, Barry D.; Landman, Kerry A.] Univ Melbourne, Dept Math & Stat, Melbourne, Vic 3010, Australia	University of Melbourne	Chisholm, RH (corresponding author), Univ Melbourne, Dept Math & Stat, Melbourne, Vic 3010, Australia.	kerryl@unimelb.edu.au	Hughes, Barry Douglas/AAB-9382-2020	Hughes, Barry Douglas/0000-0003-3594-4303; Chisholm, Rebecca/0000-0002-7830-793X	Australian Research Council [DP 0878200]	Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council (DP 0878200), http://www.arc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Baker RE, 2007, J MATH BIOL, V54, P597, DOI 10.1007/s00285-006-0060-8; Baker RE, 2007, MATH BIOSCI, V209, P30, DOI 10.1016/j.mbs.2007.01.006; Bolognesi R, 2008, CURR BIOL, V18, P1624, DOI 10.1016/j.cub.2008.09.057; CHISHOLM RH, 2010, ARE CELLULAR O UNPUB; Crampin EJ, 2002, B MATH BIOL, V64, P747, DOI 10.1006/bulm.2002.0295; Crossley PH, 1996, NATURE, V380, P66, DOI 10.1038/380066a0; Delfini MC, 2005, P NATL ACAD SCI USA, V102, P11343, DOI 10.1073/pnas.0502933102; Dillon R, 2003, P NATL ACAD SCI USA, V100, P10152, DOI 10.1073/pnas.1830500100; Dubrulle J, 2004, DEVELOPMENT, V131, P5783, DOI 10.1242/dev.01519; Dubrulle J, 2004, NATURE, V427, P419, DOI 10.1038/nature02216; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Gomez C, 2008, NATURE, V454, P335, DOI 10.1038/nature07020; Gregor T, 2005, P NATL ACAD SCI USA, V102, P18403, DOI 10.1073/pnas.0509483102; Kerszberg M, 1998, J THEOR BIOL, V191, P103, DOI 10.1006/jtbi.1997.0575; Lander AD, 2002, DEV CELL, V2, P785, DOI 10.1016/S1534-5807(02)00179-X; Lewis J, 2008, SCIENCE, V322, P399, DOI 10.1126/science.1166154; MAYER G, 2010, LACK LOCALISE UNPUB; McDowell N, 1999, SEMIN CELL DEV BIOL, V10, P311, DOI 10.1006/scdb.1999.0307; Meinhardt H., 1982, MODELS BIOL PATTERN; Oates AC, 2009, NAT REV GENET, V10, P517, DOI 10.1038/nrg2548; Pfeiffer S, 2000, CURR BIOL, V10, P321, DOI 10.1016/S0960-9822(00)00381-X; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; Seaver EC, 2005, EVOL DEV, V7, P312, DOI 10.1111/j.1525-142X.2005.05037.x; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; TAM PPL, 1986, NATO ASI SER, V118, P17; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Teleman AA, 2001, CELL, V105, P559, DOI 10.1016/S0092-8674(01)00377-4; Tiedemann HB, 2007, J THEOR BIOL, V248, P120, DOI 10.1016/j.jtbi.2007.05.014; Vogel A, 1996, DEVELOPMENT, V122, P1737; VOGEL A, 1993, DEVELOPMENT, V119, P199; Whitham G.B., 1974, LINEAR NONLINEAR WAV; Yu SR, 2009, NATURE, V461, P533, DOI 10.1038/nature08391	33	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e12857	10.1371/journal.pone.0012857	http://dx.doi.org/10.1371/journal.pone.0012857			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20927336	Green Published, Green Submitted, gold			2022-12-27	WOS:000282312600006
J	Ang, SF; Zhao, ZS; Lim, L; Manser, E				Ang, Su-Fen; Zhao, Zhuo-shen; Lim, Louis; Manser, Ed			DAAM1 Is a Formin Required for Centrosome Re-Orientation during Cell Migration	PLOS ONE			English	Article							GOLGI-APPARATUS; MYOSIN IIB; ACTIN CYTOSKELETON; VERTEBRATE GASTRULATION; PROTEIN DAAM1; RHO; POLARITY; CDC42; MICROTUBULES; ACTIVATION	Background: Disheveled-associated activator of morphogenesis 1 (DAAM1) is a formin acting downstream of Wnt signaling that is important for planar cell polarity. It has been shown to promote proper cell polarization during embryonic development in both Xenopus and Drosophila. Importantly, DAAM1 binds to Disheveled (Dvl) and thus functions downstream of the Frizzled receptors. Little is known of how DAAM1 is localized and functions in mammalian cells. We investigate here how DAAM1 affects migration and polarization of cultured cells and conclude that it plays a key role in centrosome polarity. Methodology/Principal Findings: Using a specific antibody to DAAM1, we find that the protein localizes to the acto-myosin system and co-localizes with ventral myosin IIB-containing actin stress fibers. These fibers are particularly evident in the sub-nuclear region. An N-terminal region of DAAM1 is responsible for this targeting and the DAAM1(1-440) protein can interact with myosin IIB fibers independently of either F-actin or RhoA binding. We also demonstrate that DAAM1 depletion inhibits Golgi reorientation in wound healing assays. Wound-edge cells exhibit multiple protrusions characteristic of unpolarized cell migration. Finally, in U2OS cells lines stably expressing DAAM1, we observe an enhanced myosin IIB stress fiber network which opposes cell migration. Conclusions/Significance: This work highlights the importance of DAAM1 in processes underlying cell polarity and suggests that it acts in part by affecting the function of acto-myosin IIB system. It also emphasizes the importance of the N-terminal half of DAAM1. DAAM1 depletion strongly blocks centrosomal re-polarization, supporting the concept that DAAM1 signaling cooperates with the established Cdc42 associated polarity complex. These findings are also consistent with the observation that ablation of myosin IIB but not myosin IIA results in polarity defects downstream of Wnt signaling. The structure-function analysis of DAAM1 in cultured cells parallels more complex morphological events in the developing embryo.	[Zhao, Zhuo-shen; Manser, Ed] ASTAR, sGSK NRP Grp, Singapore, Singapore; [Ang, Su-Fen; Manser, Ed] ASTAR, Rho GTPases Stem Cells RGS Grp, Inst Med Biol, Singapore, Singapore; [Lim, Louis] UCL, Inst Neurol, London, England	Agency for Science Technology & Research (A*STAR); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); University of London; University College London	Ang, SF (corresponding author), ASTAR, Rho GTPases Stem Cells RGS Grp, Inst Med Biol, Singapore, Singapore.	ed.manser@imb.a-star.edu.sg	Manser, Edward/ABD-2301-2020	Ang, Su Fen/0000-0003-4055-3374	Agency for Science, Technology and Research (A*STAR), Singapore	Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR))	Agency for Science, Technology and Research (A*STAR), Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Aspenstrom P, 2006, EXP CELL RES, V312, P2180, DOI 10.1016/j.yexcr.2006.03.013; BERSHADSKY AD, 1994, P NATL ACAD SCI USA, V91, P5686, DOI 10.1073/pnas.91.12.5686; Desai RA, 2009, J CELL SCI, V122, P905, DOI 10.1242/jcs.028183; Eng CH, 2006, MOL BIOL CELL, V17, P5004, DOI 10.1091/mbc.E05-10-0914; Erickson JW, 1996, J BIOL CHEM, V271, P26850, DOI 10.1074/jbc.271.43.26850; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Evangelista M, 2003, J CELL SCI, V116, P2603, DOI 10.1242/jcs.00611; Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; Ishizaki T, 2001, NAT CELL BIOL, V3, P8; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Ju R, 2010, P NATL ACAD SCI USA, V107, P6906, DOI 10.1073/pnas.1001075107; Kolega J, 2003, MOL BIOL CELL, V14, P4745, DOI 10.1091/mbc.E03-04-0205; KUPFER A, 1982, P NATL ACAD SCI-BIOL, V79, P2603, DOI 10.1073/pnas.79.8.2603; Lammers M, 2005, EMBO J, V24, P4176, DOI 10.1038/sj.emboj.7600879; Liu W, 2008, P NATL ACAD SCI USA, V105, P210, DOI 10.1073/pnas.0707277105; Lo CM, 2004, MOL BIOL CELL, V15, P982, DOI 10.1091/mbc.E03-06-0359; Lu J, 2007, J MOL BIOL, V369, P1258, DOI 10.1016/j.jmb.2007.04.002; Matusek T, 2006, DEVELOPMENT, V133, P957, DOI 10.1242/dev.02266; Mellor H, 2004, CURR BIOL, V14, pR434, DOI 10.1016/j.cub.2004.05.038; Nezami AG, 2006, STRUCTURE, V14, P257, DOI 10.1016/j.str.2005.12.003; Otomo T, 2005, MOL CELL, V18, P273, DOI 10.1016/j.molcel.2005.04.002; Petersen J, 1998, J CELL BIOL, V141, P1217, DOI 10.1083/jcb.141.5.1217; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Pring M, 2003, BIOCHEMISTRY-US, V42, P486, DOI 10.1021/bi026520j; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Rolo A, 2009, DEV BIOL, V327, P327, DOI 10.1016/j.ydbio.2008.12.009; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604; Sagot I, 2002, NAT CELL BIOL, V4, P42, DOI 10.1038/ncb719; SANDOVAL IV, 1984, J CELL BIOL, V99, pS113, DOI 10.1083/jcb.99.1.113s; Sato A, 2006, DEVELOPMENT, V133, P4219, DOI 10.1242/dev.02590; Schlessinger K, 2007, J CELL BIOL, V178, P355, DOI 10.1083/jcb.200701083; Schmoranzer J, 2009, CURR BIOL, V19, P1065, DOI 10.1016/j.cub.2009.05.065; Seth A, 2006, J CELL BIOL, V174, P701, DOI 10.1083/jcb.200605006; Skoglund P, 2008, DEVELOPMENT, V135, P2435, DOI 10.1242/dev.014704; SKOUFIAS DA, 1990, J CELL BIOL, V111, P1929, DOI 10.1083/jcb.111.5.1929; Tan I, 2008, CELL, V135, P123, DOI 10.1016/j.cell.2008.09.018; Taniguchi K, 2009, J BIOL CHEM, V284, P29873, DOI 10.1074/jbc.M109.059303; Thyberg J, 1999, EXP CELL RES, V246, P263, DOI 10.1006/excr.1998.4326; Vicente-Manzanares M, 2008, J CELL BIOL, V183, P543, DOI 10.1083/jcb.200806030; Vicente-Manzanares M, 2007, J CELL BIOL, V176, P573, DOI 10.1083/jcb.200612043; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Watanabe T, 2005, TRENDS CELL BIOL, V15, P76, DOI 10.1016/j.tcb.2004.12.006; Wen Y, 2004, NAT CELL BIOL, V6, P820, DOI 10.1038/ncb1160; Yamashita M, 2007, GENES CELLS, V12, P1255, DOI 10.1111/j.1365-2443.2007.01132.x	50	45	46	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e13064	10.1371/journal.pone.0013064	http://dx.doi.org/10.1371/journal.pone.0013064			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20927366	Green Published, Green Submitted, gold			2022-12-27	WOS:000282269400016
J	Wiltgen, BJ; Royle, GA; Gray, EE; Abdipranoto, A; Thangthaeng, N; Jacobs, N; Saab, F; Tonegawa, S; Heinemann, SF; O'Dell, TJ; Fanselow, MS; Vissel, B				Wiltgen, Brian J.; Royle, Gordon A.; Gray, Erin E.; Abdipranoto, Andrea; Thangthaeng, Nopporn; Jacobs, Nate; Saab, Faysal; Tonegawa, Susumu; Heinemann, Stephen F.; O'Dell, Thomas J.; Fanselow, Michael S.; Vissel, Bryce			A Role for Calcium-Permeable AMPA Receptors in Synaptic Plasticity and Learning	PLOS ONE			English	Article							LONG-TERM POTENTIATION; ANTERIOR CINGULATE CORTEX; REMOTE SPATIAL MEMORY; IN-VIVO EXPERIENCE; NMDA RECEPTOR; CONTEXTUAL FEAR; MUTANT MICE; DORSAL HIPPOCAMPUS; DIFFERENTIAL CONTRIBUTION; POSTSYNAPTIC DENSITY-95	A central concept in the field of learning and memory is that NMDARs are essential for synaptic plasticity and memory formation. Surprisingly then, multiple studies have found that behavioral experience can reduce or eliminate the contribution of these receptors to learning. The cellular mechanisms that mediate learning in the absence of NMDAR activation are currently unknown. To address this issue, we examined the contribution of Ca(2+)-permeable AMPARs to learning and plasticity in the hippocampus. Mutant mice were engineered with a conditional genetic deletion of GluR2 in the CA1 region of the hippocampus (GluR2-cKO mice). Electrophysiology experiments in these animals revealed a novel form of long-term potentiation (LTP) that was independent of NMDARs and mediated by GluR2-lacking Ca(2+)-permeable AMPARs. Behavioral analyses found that GluR2-cKO mice were impaired on multiple hippocampus-dependent learning tasks that required NMDAR activation. This suggests that AMPAR-mediated LTP interferes with NMDAR-dependent plasticity. In contrast, NMDAR-independent learning was normal in knockout mice and required the activation of Ca(2+)-permeable AMPARs. These results suggest that GluR2-lacking AMPARs play a functional and previously unidentified role in learning; they appear to mediate changes in synaptic strength that occur after plasticity has been established by NMDARs.	[Wiltgen, Brian J.] Univ Virginia, Dept Psychol, Charlottesville, VA 22903 USA; [Wiltgen, Brian J.; Jacobs, Nate; Saab, Faysal; Fanselow, Michael S.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Wiltgen, Brian J.; Jacobs, Nate; Saab, Faysal; Fanselow, Michael S.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA; [Royle, Gordon A.; Abdipranoto, Andrea; Thangthaeng, Nopporn; Vissel, Bryce] Garvan Inst Med Res, Neural Plast & Regenerat Res Grp, Neurosci Res Program, Sydney, NSW, Australia; [Gray, Erin E.] Univ Calif Los Angeles, Interdept Phd Program Neurosci, Los Angeles, CA 90024 USA; [Tonegawa, Susumu] MIT, Picower Inst Learning & Memory, Boston, MA USA; [O'Dell, Thomas J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90024 USA; [Heinemann, Stephen F.] Salk Inst Biol Studies, Dept Mol Neurobiol, La Jolla, CA USA	University of Virginia; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Garvan Institute of Medical Research; University of California System; University of California Los Angeles; Massachusetts Institute of Technology (MIT); Northwell Health; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Salk Institute	Wiltgen, BJ (corresponding author), Univ Virginia, Dept Psychol, Gilmer Hall, Charlottesville, VA 22903 USA.	brycevissel@gmail.com	Saab, Faysal/AAT-8312-2020; Wiltgen, Brian/D-2947-2013	Saab, Faysal/0000-0002-4568-3613; Jacobs, Nathan S/0000-0003-2175-6627; Vissel, Bryce/0000-0001-8860-8050	National Health and Medical Research Council Australia [188819]; NSW State Government Office of Science and Medical Research; Amadeus Energy Ltd. Western Australia; Bill and Laura Gruy; Walter and Edith Sheldon; Tony and Vivian Howland-Rose; Silvio O. Conte Center; National Institute of Mental Health [P50-MH58880, MH609197, MH62122]; National Science Foundation [0543651]; Jeffress Memorial Trust; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062122, P50MH058880] Funding Source: NIH RePORTER	National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); NSW State Government Office of Science and Medical Research; Amadeus Energy Ltd. Western Australia; Bill and Laura Gruy; Walter and Edith Sheldon; Tony and Vivian Howland-Rose; Silvio O. Conte Center; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Science Foundation(National Science Foundation (NSF)); Jeffress Memorial Trust; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The work was supported by National Health and Medical Research Council Australia Grant number 188819 to B. V., NSW State Government's BioFirst Award and a NSW Spinal Cord Injury and Related Neurological Conditions Research Grant to B. V. (from the NSW State Government Office of Science and Medical Research), Amadeus Energy Ltd. Western Australia, Bill and Laura Gruy, Walter and Edith Sheldon, Tony and Vivian Howland-Rose, the Silvio O. Conte Center, National Institute of Mental Health Grant P50-MH58880 to S. T. and S. H., the National Science Foundation grant number 0543651 to T.J.O., National Institute of Mental Health grant number MH609197 to T.J.O., National Institute of Mental Health grant number MH62122 to M. S. F., the Jeffress Memorial Trust to B.J.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdipranoto-Cowley A, 2009, STEM CELLS, V27, P1330, DOI 10.1002/stem.80; Adesnik H, 2007, J NEUROSCI, V27, P4598, DOI 10.1523/JNEUROSCI.0325-07.2007; Anagnostaras SG, 2003, NAT NEUROSCI, V6, P51, DOI 10.1038/nn992; Anagnostaras SG, 1999, J NEUROSCI, V19, P1106; Anagnostaras SG, 2000, LEARN MEMORY, V7, P58, DOI 10.1101/lm.7.1.58; Asrar S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004339; BANNERMAN DM, 1995, NATURE, V378, P182, DOI 10.1038/378182a0; BILLA SK, 2010, MOL PHARM; Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; Buldakova SL, 2007, NEUROSCIENCE, V144, P88, DOI 10.1016/j.neuroscience.2006.09.005; Cho YH, 1999, BEHAV BRAIN RES, V98, P77; Clem RL, 2006, NEURON, V49, P663, DOI 10.1016/j.neuron.2006.01.019; Clem RL, 2008, SCIENCE, V319, P101, DOI 10.1126/science.1143808; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; Cuthbert PC, 2007, J NEUROSCI, V27, P2673, DOI 10.1523/JNEUROSCI.4457-06.2007; FANSELOW MS, 1980, PAVLOVIAN J BIOL SCI, V15, P177; FANSELOW MS, 1984, BEHAV NEUROSCI, V98, P269, DOI 10.1037/0735-7044.98.2.269; FANSELOW MS, 1986, LEARN MOTIV, V17, P16, DOI 10.1016/0023-9690(86)90018-4; FANSELOW MS, 1990, ANIM LEARN BEHAV, V18, P264, DOI 10.3758/BF03205285; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; Gerlai R, 1998, BEHAV BRAIN RES, V95, P37, DOI 10.1016/S0166-4328(98)00002-3; Gray EE, 2007, J NEUROPHYSIOL, V98, P2488, DOI 10.1152/jn.00473.2007; Guire ES, 2008, J NEUROSCI, V28, P6000, DOI 10.1523/JNEUROSCI.0384-08.2008; Hardt O, 2009, LEARN MEMORY, V16, P224, DOI 10.1101/lm.1267409; Iihara K, 2001, J NEUROSCI, V21, P2224, DOI 10.1523/JNEUROSCI.21-07-02224.2001; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; JARRARD LE, 1983, BEHAV NEUROSCI, V97, P873, DOI 10.1037/0735-7044.97.6.873; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; Kaczmarek Leszek, 1993, Acta Neurobiologiae Experimentalis (Warsaw), V53, P187; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Komiyama NH, 2002, J NEUROSCI, V22, P9721; Kullmann DM, 2008, J PHYSIOL-LONDON, V586, P1481, DOI 10.1113/jphysiol.2007.148064; Lamsa KP, 2007, SCIENCE, V315, P1262, DOI 10.1126/science.1137450; Lee H, 1998, J NEUROSCI, V18, P8444; Lee I, 2002, NAT NEUROSCI, V5, P162, DOI 10.1038/nn790; Lu Y, 2007, EMBO J, V26, P4879, DOI 10.1038/sj.emboj.7601884; Magazanik LG, 1997, J PHYSIOL-LONDON, V505, P655, DOI 10.1111/j.1469-7793.1997.655ba.x; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Maren S, 1997, BEHAV BRAIN RES, V88, P261, DOI 10.1016/S0166-4328(97)00088-0; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; MCDONALD RJ, 1993, BEHAV NEUROSCI, V107, P3, DOI 10.1037/0735-7044.107.1.3; Meng YH, 2003, NEURON, V39, P163, DOI 10.1016/S0896-6273(03)00368-4; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Murphy GG, 2006, AM J GERIAT PSYCHIAT, V14, P1004, DOI 10.1097/01.JGP.0000209405.27548.7b; NADEL L, 1980, BEHAV NEURAL BIOL, V29, P405, DOI 10.1016/S0163-1047(80)90430-6; OLTON DS, 1979, BEHAV BRAIN SCI, V2, P313, DOI 10.1017/S0140525X00062713; OLTON DS, 1979, NEUROPSYCHOLOGIA, V17, P669, DOI 10.1016/0028-3932(79)90042-3; Panicker S, 2008, P NATL ACAD SCI USA, V105, P1032, DOI 10.1073/pnas.0711313105; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Rudy JW, 2004, NEUROSCI BIOBEHAV R, V28, P675, DOI 10.1016/j.neubiorev.2004.09.004; Sage JR, 2000, BEHAV NEUROSCI, V114, P295, DOI 10.1037/0735-7044.114.2.295; Samoilova MV, 1999, NEUROSCIENCE, V94, P261, DOI 10.1016/S0306-4522(99)00326-7; Sanders MJ, 2003, NEUROBIOL LEARN MEM, V80, P123, DOI 10.1016/S1074-7427(03)00040-6; SAUCIER D, 1995, NATURE, V378, P186, DOI 10.1038/378186a0; Schauwecker PE, 1997, P NATL ACAD SCI USA, V94, P4103, DOI 10.1073/pnas.94.8.4103; Sepehrizadeh Z, 2008, CLIN EXP PHARMACOL P, V35, P1321, DOI 10.1111/j.1440-1681.2008.05004.x; Shimshek DR, 2006, J NEUROSCI, V26, P8428, DOI 10.1523/JNEUROSCI.5410-05.2006; Stote DL, 2004, BEHAV NEUROSCI, V118, P253, DOI 10.1037/0735-7044.118.1.253; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Teixeira CM, 2006, J NEUROSCI, V26, P7555, DOI 10.1523/JNEUROSCI.1068-06.2006; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Vissel B, 2001, NEURON, V29, P217, DOI 10.1016/S0896-6273(01)00192-1; Wiltgen BJ, 2001, BEHAV NEUROSCI, V115, P26, DOI 10.1037/0735-7044.115.1.26; Yan J, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-03-j0002.2002; YOUNG SL, 1994, BEHAV NEUROSCI, V108, P19, DOI 10.1037/0735-7044.108.1.19	72	78	80	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e12818	10.1371/journal.pone.0012818	http://dx.doi.org/10.1371/journal.pone.0012818			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20927382	Green Published, Green Submitted, gold			2022-12-27	WOS:000282269400003
J	Rhodes, CJ; Demetrius, L				Rhodes, Christopher J.; Demetrius, Lloyd			Evolutionary Entropy Determines Invasion Success in Emergent Epidemics	PLOS ONE			English	Article							TRANSMISSION DYNAMICS; INFECTIOUS-DISEASES; INFLUENZA; STRAIN; PERSISTENCE; IMPACT	Background: Standard epidemiological theory claims that in structured populations competition between multiple pathogen strains is a deterministic process which is mediated by the basic reproduction number (R-0) of the individual strains. A new theory based on analysis, simulation and empirical study challenges this predictor of success. Principal Findings: We show that the quantity R-0 is a valid predictor in structured populations only when size is infinite. In this article we show that when population size is finite the dynamics of infection by multi-strain pathogens is a stochastic process whose outcome can be predicted by evolutionary entropy, S, an information theoretic measure which describes the uncertainty in the infectious age of an infected parent of a randomly chosen new infective. Evolutionary entropy characterises the demographic stability or robustness of the population of infectives. This statistical parameter determines the duration of infection and thus provides a quantitative index of the pathogenicity of a strain. Standard epidemiological theory based on R-0 as a measure of selective advantage is the limit as the population size tends to infinity of the entropic selection theory. The standard model is an approximation to the entropic selection theory whose validity increases with population size. Conclusion: An epidemiological analysis based on entropy is shown to explain empirical observations regarding the emergence of less pathogenic strains of human influenza during the antigenic drift phase. Furthermore, we exploit the entropy perspective to discuss certain epidemiological patterns of the current H1N1 swine 'flu outbreak.	[Rhodes, Christopher J.] Univ London Imperial Coll Sci Technol & Med, Inst Math Sci, London, England; [Demetrius, Lloyd] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Demetrius, Lloyd] Max Planck Inst Mol Genet, Berlin, Germany	Imperial College London; Harvard University; Max Planck Society	Rhodes, CJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Inst Math Sci, London, England.	c.rhodes@imperial.ac.uk			Research Councils of the United Kingdom; Medical Research Council [G0600719B] Funding Source: researchfish	Research Councils of the United Kingdom; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Research Councils of the United Kingdom (www.rcuk.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ANDERSON R M, 1991; ANDERSON RM, 1986, PHILOS T ROY SOC B, V314, P533, DOI 10.1098/rstb.1986.0072; Antia R, 2003, NATURE, V426, P658, DOI 10.1038/nature02104; Austin DJ, 1999, P NATL ACAD SCI USA, V96, P6908, DOI 10.1073/pnas.96.12.6908; Buckee CO, 2004, P NATL ACAD SCI USA, V101, P10839, DOI 10.1073/pnas.0402000101; Chan PKS, 2002, CLIN INFECT DIS, V34, pS58, DOI 10.1086/338820; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Creanza N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008544; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; DEMETRIUS L, 1983, J STAT PHYS, V30, P709, DOI 10.1007/BF01009685; DEMETRIUS L, 1974, P NATL ACAD SCI USA, V71, P4645, DOI 10.1073/pnas.71.12.4645; Demetrius L, 1997, P NATL ACAD SCI USA, V94, P3491, DOI 10.1073/pnas.94.8.3491; Demetrius L, 1999, STOCHASTIC DYNAMICS, P371, DOI 10.1007/0-387-22655-9_16; Demetrius L, 2007, THEOR POPUL BIOL, V72, P323, DOI 10.1016/j.tpb.2007.05.004; Demetrius L, 2009, PHYSICA A, V388, P651, DOI 10.1016/j.physa.2008.10.048; Demetrius L, 2009, B MATH BIOL, V71, P800, DOI 10.1007/s11538-008-9382-6; Earn DJD, 2002, TRENDS ECOL EVOL, V17, P334, DOI 10.1016/S0169-5347(02)02502-8; Enserink M, 2003, SCIENCE, V300, P1351; Fisher RA, 1930, GENETICAL THEORY NAT; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Gog JR, 2002, P NATL ACAD SCI USA, V99, P17209, DOI 10.1073/pnas.252512799; Gomes MGM, 2002, P ROY SOC B-BIOL SCI, V269, P227, DOI 10.1098/rspb.2001.1869; Grassly NC, 2008, NAT REV MICROBIOL, V6, P477, DOI 10.1038/nrmicro1845; Gupta S, 1998, SCIENCE, V280, P912, DOI 10.1126/science.280.5365.912; Heymann DL, 1998, BRIT MED BULL, V54, P693, DOI 10.1093/oxfordjournals.bmb.a011720; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Keeling, 2008, MODELLING INFECT DIS; Kowald A, 2005, P ROY SOC B-BIOL SCI, V272, P741, DOI 10.1098/rspb.2004.3012; Levine A., 1992, VIRUSES; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; May RM, 2001, PHILOS T R SOC B, V356, P901, DOI 10.1098/rstb.2001.0866; Meyers LA, 2007, B AM MATH SOC, V44, P63; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Smith DJ, 2006, SCIENCE, V312, P392, DOI 10.1126/science.1122665; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Viboud C, 2006, VACCINE, V24, P6701, DOI 10.1016/j.vaccine.2006.05.067; [No title captured]	42	17	17	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12951	10.1371/journal.pone.0012951	http://dx.doi.org/10.1371/journal.pone.0012951			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886082	gold, Green Published, Green Submitted			2022-12-27	WOS:000282091100046
J	Gul, N; Smith, LA; Ahmed, SA				Gul, Nizamettin; Smith, Leonard A.; Ahmed, S. Ashraf			Light Chain Separated from the Rest of the Type A Botulinum Neurotoxin Molecule Is the Most Catalytically Active Form	PLOS ONE			English	Article							RECEPTOR-BINDING-SITE; HEAVY-CHAIN; SEROTYPE-A; SUBSTRATE RECOGNITION; STRUCTURAL-ANALYSIS; IDENTIFICATION; TRANSLOCATION; PROTEINS; CLEAVAGE; PROTEASE	Botulinum neurotoxins (BoNT) are the most potent of all toxins. The 50 kDa N-terminal endopeptidase catalytic light chain (LC) of BoNT is located next to its central, putative translocation domain. After binding to the peripheral neurons, the central domain of BoNT helps the LC translocate into cytosol where its proteolytic action on SNARE (soluble NSF attachment protein receptor) proteins blocks exocytosis of acetyl choline leading to muscle paralysis and eventual death. The translocation domain also contains 105 angstrom -long stretch of similar to 100 residues, known as "belt,'' that crosses over and wraps around the LC to shield the active site from solvent. It is not known if the LC gets dissociated from the rest of the molecule in the cytosol before catalysis. To investigate the structural identity of the protease, we prepared four variants of type A BoNT (BoNT/A) LC, and compared their catalytic parameters with those of BoNT/A whole toxin. The four variants were LC + translocation domain, a trypsin-nicked LC + translocation domain, LC + belt, and a free LC. Our results showed that K(m) for a 17-residue SNAP-25 (synaptosomal associated protein of 25 kDa) peptide for these constructs was not very different, but the turnover number (k(cat)) for the free LC was 6-100-fold higher than those of its four variants. Moreover, none of the four variants of the LC was prone to autocatalysis. Our results clearly demonstrated that in vitro, the LC minus the rest of the molecule is the most catalytically active form. The results may have implication as to the identity of the active, toxic moiety of BoNT/A in vivo.	[Gul, Nizamettin; Smith, Leonard A.; Ahmed, S. Ashraf] USA, Med Res Inst Infect Dis, Dept Cell Biol & Biochem, Integrated Toxicol Div, Ft Detrick, MD 21702 USA; [Smith, Leonard A.] USA, Med Res & Mat Command, Ft Detrick, MD USA		Gul, N (corresponding author), CBMS, MITS, Ft Detrick, MD USA.	syed.ahmed@amedd.army.mil			Joint Science and Technology Office - Chemical and Biological Defense [CBS.MEDBIO.01.10.RD.002]	Joint Science and Technology Office - Chemical and Biological Defense	The research described herein was supported by Joint Science and Technology Office - Chemical and Biological Defense project number CBS.MEDBIO.01.10.RD.002 to SAA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2008, J BIOL CHEM, V283, P25944, DOI 10.1074/jbc.M803756200; Ahmed SA, 2008, PROTEIN J, V27, P151, DOI 10.1007/s10930-007-9118-8; Ahmed SA, 2004, PROTEIN J, V23, P445; Ahmed SA, 2003, BIOCHEMISTRY-US, V42, P12539, DOI 10.1021/bi030062c; Ahmed SA, 2001, J PROTEIN CHEM, V20, P221, DOI 10.1023/A:1010952025677; Ahmed SA, 2000, J PROTEIN CHEM, V19, P475, DOI 10.1023/A:1026549431380; Alderton JM, 2000, CELL CALCIUM, V28, P161, DOI 10.1054/ceca.2000.0144; Baldwin MR, 2007, BIOCHEMISTRY-US, V46, P3200, DOI 10.1021/bi602396x; Baldwin MR, 2004, PROTEIN EXPRES PURIF, V37, P187, DOI 10.1016/j.pep.2004.05.009; Beecher DJ, 1997, J PROTEIN CHEM, V16, P701, DOI 10.1023/A:1026358504860; Binz T, 2002, BIOCHEMISTRY-US, V41, P1717, DOI 10.1021/bi0157969; Brown DR, 1997, HYBRIDOMA, V16, P447, DOI 10.1089/hyb.1997.16.447; Brunger AT, 2007, PLOS PATHOG, V3, P1191, DOI 10.1371/journal.ppat.0030113; Cai SW, 2001, BIOCHEMISTRY-US, V40, P15327, DOI 10.1021/bi011350g; CANTOR CH, 1982, PROTEINS, P145; Chai Q, 2006, NATURE, V444, P1096, DOI 10.1038/nature05411; Chen S, 2006, J BIOL CHEM, V281, P10906, DOI 10.1074/jbc.M513032200; DanielsHolgate PU, 1996, J NEUROSCI RES, V44, P263, DOI 10.1002/(SICI)1097-4547(19960501)44:3<263::AID-JNR7>3.0.CO;2-E; DasGupta BR, 2005, PROTEIN J, V24, P337, DOI 10.1007/s10930-005-7589-z; Eswaramoorthy S, 2001, ACTA CRYSTALLOGR D, V57, P1743, DOI 10.1107/S0907444901013531; Fischer A, 2007, J BIOL CHEM, V282, P29604, DOI 10.1074/jbc.M703619200; Fischer A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000245; Jayaraman S, 2005, BIOCHEM BIOPH RES CO, V330, P97, DOI 10.1016/j.bbrc.2005.02.123; Jensen MJ, 2003, TOXICON, V41, P691, DOI 10.1016/S0041-0101(03)00042-4; Koriazova LK, 2003, NAT STRUCT BIOL, V10, P13, DOI 10.1038/nsb879; Kumaran D, 2008, J BIOL CHEM, V283, P18883, DOI 10.1074/jbc.M801240200; Kumaran D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000165; Lacy DB, 1999, J MOL BIOL, V291, P1091, DOI 10.1006/jmbi.1999.2945; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li L, 2000, BIOCHEMISTRY-US, V39, P2399, DOI 10.1021/bi992321x; Maurel MC, 2006, PHYS LIFE REV, V3, P56, DOI 10.1016/j.plrev.2005.12.001; Montal M, 2009, TOXICON, V54, P565, DOI 10.1016/j.toxicon.2008.11.018; Montecucco C, 1995, Q REV BIOPHYS, V28, P423, DOI 10.1017/S0033583500003292; Ringe D, 2008, NAT CHEM BIOL, V4, P325, DOI 10.1038/nchembio0608-325; Rummel A, 2007, P NATL ACAD SCI USA, V104, P359, DOI 10.1073/pnas.0609713104; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schmidt JJ, 1995, J PROTEIN CHEM, V14, P703, DOI 10.1007/BF01886909; Schmidt JJ, 1997, J PROTEIN CHEM, V16, P19, DOI 10.1023/A:1026386710428; Simpson LL, 2004, ANNU REV PHARMACOL, V44, P167, DOI 10.1146/annurev.pharmtox.44.101802.121554; Stenmark P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000129; Swaminathan S, 2000, NAT STRUCT BIOL, V7, P693, DOI 10.1038/78005; Vivian JT, 2001, BIOPHYS J, V80, P2093, DOI 10.1016/S0006-3495(01)76183-8; Xu JA, 1999, SCIENCE, V286, P2345, DOI 10.1126/science.286.5448.2345	44	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12872	10.1371/journal.pone.0012872	http://dx.doi.org/10.1371/journal.pone.0012872			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877571	gold, Green Submitted, Green Published			2022-12-27	WOS:000282053100024
J	Wang, YC; Huang, CC; Hsu, KS				Wang, Yu-Chen; Huang, Chiung-Chun; Hsu, Kuei-Sen			The Role of Growth Retardation in Lasting Effects of Neonatal Dexamethasone Treatment on Hippocampal Synaptic Function	PLOS ONE			English	Article							MATERNAL-CARE; TOTAL NUMBER; OUTCOMES; NEURONS; LTD; RAT; ACTIVATION; PLASTICITY; SYNAPSES; BEHAVIOR	Background: Dexamethasone (DEX), a synthetic glucocorticoid, is commonly used to prevent or lessen the morbidity of chronic lung disease in preterm infants. However, evidence is now increasing that this clinical practice negatively affects somatic growth and may result in long-lasting neurodevelopmental deficits. We therefore hypothesized that supporting normal somatic growth may overcome the lasting adverse effects of neonatal DEX treatment on hippocampal function. Methodology/Principal Findings: To test this hypothesis, we developed a rat model using a schedule of tapering doses of DEX similar to that used in premature infants and examined whether the lasting influence of neonatal DEX treatment on hippocampal synaptic plasticity and memory performance are correlated with the deficits in somatic growth. We confirmed that neonatal DEX treatment switched the direction of synaptic plasticity in hippocampal CA1 region, favoring low-frequency stimulation-and group I metabotropic glutamate receptor agonist (S)-3,5,-dihydroxyphenylglycine-induced long-term depression (LTD), and opposing the induction of long-term potentiation (LTP) by high-frequency stimulation in the adolescent period. The effects of DEX on LTP and LTD were correlated with an increase in the autophosphorylation of Ca2+/ calmodulin-dependent protein kinase II at threonine-286 and a decrease in the protein phosphatase 1 expression. Neonatal DEX treatment resulted in a disruption of memory retention subjected to object recognition task and passive avoidance learning. The adverse effects of neonatal DEX treatment on hippocampal synaptic plasticity and memory performance of the animals from litters culled to 4 pups were significantly less than those for the 8-pup litters. However, there was no significant difference in maternal care between groups. Conclusion/Significance: Our results demonstrate that growth retardation plays a crucial role in DEX-induced long-lasting influence of hippocampal function. Our findings suggest that therapeutic strategies designed to support normal development and somatic growth may exert beneficial effects to reduce lasting adverse effects following neonatal DEX treatment.	[Wang, Yu-Chen; Huang, Chiung-Chun; Hsu, Kuei-Sen] Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 70101, Taiwan; [Hsu, Kuei-Sen] Natl Cheng Kung Univ, Ctr Gene Regulat & Signal Transduct Res, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University	Wang, YC (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 70101, Taiwan.	richard@mail.ncku.edu.tw	Hsu, Kuei-Sen/AAV-8386-2021		National Science Council, Taiwan [NSC98-2321-B-006-008, NSC98-2320-B-006-005-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by research grants (NSC98-2321-B-006-008; NSC98-2320-B-006-005-MY3) from the National Science Council, Taiwan (http://web1.nsc.gov.tw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnish ND, 1997, FUND APPL TOXICOL, V38, P2, DOI 10.1006/faat.1997.2318; Barrington K J, 2001, BMC Pediatr, V1, P1, DOI 10.1186/1471-2431-1-1; Bashir ZI, 2003, NEUROSCI RES, V45, P363, DOI 10.1016/S0168-0102(03)00002-6; Berry MA, 1997, PEDIATRICS, V100, P640; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; Broadbent NJ, 2010, LEARN MEMORY, V17, P794, DOI 10.1101/lm.1650110; Champagne DL, 2008, J NEUROSCI, V28, P6037, DOI 10.1523/JNEUROSCI.0526-08.2008; Champagne FA, 2003, PHYSIOL BEHAV, V79, P359, DOI 10.1016/S0031-9384(03)00149-5; Chaouloff F, 2007, J NEUROSCI, V27, P7130, DOI 10.1523/JNEUROSCI.1150-07.2007; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Ferguson SA, 1999, NEUROTOXICOL TERATOL, V21, P71, DOI 10.1016/S0892-0362(98)00029-4; Flagel SB, 2002, AM J PHYSIOL-REG I, V282, pR55, DOI 10.1152/ajpregu.2002.282.1.R55; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; HANSON PI, 1994, NEURON, V12, P943, DOI 10.1016/0896-6273(94)90306-9; Huang CC, 2004, J BIOL CHEM, V279, P12286, DOI 10.1074/jbc.M312868200; Huang CC, 2007, PEDIATR RES, V62, P267, DOI 10.1203/PDR.0b013e318123f744; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Kamphuis PJGH, 2004, NEUROPHARMACOLOGY, V47, P461, DOI 10.1016/j.neuropharm.2004.04.008; Kamphuis PJGH, 2003, FASEB J, V17, P911, DOI 10.1096/fj.02-0333fje; Kreckmann K. H., 1994, Teratology, V49, P402; Kreider ML, 2006, NEUROPSYCHOPHARMACOL, V31, P12, DOI 10.1038/sj.npp.1300783; KUMARESAN P, 1967, P SOC EXP BIOL MED, V126, P41, DOI 10.3181/00379727-126-32363; Lee SK, 2000, PEDIATRICS, V106, P1070, DOI 10.1542/peds.106.5.1070; Leitch CA, 1999, PEDIATR RES, V46, P109, DOI 10.1203/00006450-199907000-00018; Lemons JA, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.1.e1; Lin HJ, 2006, ANN NEUROL, V59, P939, DOI 10.1002/ana.20885; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; MAYFORD M, 1995, CELL, V81, P891, DOI 10.1016/0092-8674(95)90009-8; MINGS JJ, 1989, NEW ENGL J MED, V320, P1505; Morrow BA, 2005, J COMP NEUROL, V488, P215, DOI 10.1002/cne.20599; MYERS MM, 1989, DEV PSYCHOBIOL, V22, P29, DOI 10.1002/dev.420220104; Neal CR, 2004, AM J PHYSIOL-REG I, V287, pR375, DOI 10.1152/ajpregu.00012.2004; Palmer AK, 1997, FUND APPL TOXICOL, V38, P7, DOI 10.1006/faat.1997.2319; Palmer MJ, 1997, NEUROPHARMACOLOGY, V36, P1517, DOI 10.1016/S0028-3908(97)00181-0; Shiroma S, 2005, NEUROPHARMACOLOGY, V49, P97, DOI 10.1016/j.neuropharm.2005.02.002; Shrivastava A, 2000, EUR J PEDIATR, V159, P380, DOI 10.1007/s004310051291; Squire LR, 2007, NAT REV NEUROSCI, V8, P872, DOI 10.1038/nrn2154; Wells DG, 2001, J NEUROSCI, V21, P9541, DOI 10.1523/JNEUROSCI.21-24-09541.2001; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; West MJ, 1999, TRENDS NEUROSCI, V22, P51, DOI 10.1016/S0166-2236(98)01362-9; Whitelaw A, 2000, ARCH DIS CHILD-FETAL, V83, pF154, DOI 10.1136/fn.83.2.F154; Yeh TF, 2004, NEW ENGL J MED, V350, P1304, DOI 10.1056/NEJMoa032089; Yu S, 2010, ANN NEUROL, V67, P21, DOI 10.1002/ana.21812; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	44	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2010	5	9							e12806	10.1371/journal.pone.0012806	http://dx.doi.org/10.1371/journal.pone.0012806			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652JO	20877626	gold, Green Submitted, Green Published			2022-12-27	WOS:000282002900006
J	Yang, M; Zhang, XW; Liu, GM; Yin, YX; Chen, KF; Yun, QZ; Zhao, DJ; Al-Mssallem, IS; Yu, J				Yang, Meng; Zhang, Xiaowei; Liu, Guiming; Yin, Yuxin; Chen, Kaifu; Yun, Quanzheng; Zhao, Duojun; Al-Mssallem, Ibrahim S.; Yu, Jun			The Complete Chloroplast Genome Sequence of Date Palm (Phoenix dactylifera L.)	PLOS ONE			English	Article							TRANSFER-RNA GENES; PHYLOGENETIC-RELATIONSHIPS; STRUCTURAL ORGANIZATION; PLASTID DNA; EVOLUTION; ANGIOSPERMS; INVERSIONS	Background: Date palm (Phoenix dactylifera L.), a member of Arecaceae family, is one of the three major economically important woody palms-the two other palms being oil palm and coconut tree-and its fruit is a staple food among Middle East and North African nations, as well as many other tropical and subtropical regions. Here we report a complete sequence of the data palm chloroplast (cp) genome based on pyrosequencing. Methodology/Principal Findings: After extracting 369,022 cp sequencing reads from our whole-genome-shotgun data, we put together an assembly and validated it with intensive PCR-based verification, coupled with PCR product sequencing. The date palm cp genome is 158,462 bp in length and has a typical quadripartite structure of the large (LSC, 86,198 bp) and small single-copy (SSC, 17,712 bp) regions separated by a pair of inverted repeats (IRs, 27,276 bp). Similar to what has been found among most angiosperms, the date palm cp genome harbors 112 unique genes and 19 duplicated fragments in the IR regions. The junctions between LSC/IRs and SSC/IRs show different features of sequence expansion in evolution. We identified 78 SNPs as major intravarietal polymorphisms within the population of a specific cp genome, most of which were located in genes with vital functions. Based on RNA-sequencing data, we also found 18 polycistronic transcription units and three highly expression-biased genes-atpF, trnA-UGC, and rrn23. Conclusions: Unlike most monocots, date palm has a typical cp genome similar to that of tobacco-with little rearrangement and gene loss or gain. High-throughput sequencing technology facilitates the identification of intravarietal variations in cp genomes among different cultivars. Moreover, transcriptomic analysis of cp genes provides clues for uncovering regulatory mechanisms of transcription and translation in chloroplasts.	[Yang, Meng; Zhang, Xiaowei; Liu, Guiming; Yin, Yuxin; Chen, Kaifu; Yun, Quanzheng; Zhao, Duojun; Al-Mssallem, Ibrahim S.; Yu, Jun] KACST, DPGP, Riyadh, Saudi Arabia; [Yang, Meng; Zhang, Xiaowei; Liu, Guiming; Yin, Yuxin; Chen, Kaifu; Yun, Quanzheng; Zhao, Duojun; Yu, Jun] Chinese Acad Sci, Beijing Inst Genom, Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Al-Mssallem, Ibrahim S.] King Faisal Univ, Coll Agr & Food Sci, Dept Biotechnol, Al Hssa, Hofuf, Saudi Arabia	King Abdulaziz City for Science & Technology; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; King Faisal University	Yang, M (corresponding author), KACST, DPGP, Riyadh, Saudi Arabia.	imssallem@kacst.edu.sa; junyu@big.ac.cn	郑, 征/C-8514-2011; Yin, Yuxin/G-2694-2014	Yin, Yuxin/0000-0002-1639-285X; , Meng/0000-0002-2672-3069	King Abdulaziz city for science and technology, Riyadh, Saudi Arabia [KACST 428-29]	King Abdulaziz city for science and technology, Riyadh, Saudi Arabia	The project is supported by a project grant from KACST 428-29, King Abdulaziz city for science and technology, Riyadh, Saudi Arabia. The funder had no role in study design and analysis.	Al-Mssallem IS, 1996, ARABIAN GLOBAL ENCY, V7, P182; Catalano SA, 2009, CLADISTICS, V25, P93, DOI 10.1111/j.1096-0031.2008.00236.x; Bain JF, 2006, CAN J BOT, V84, P862, DOI 10.1139/B06-057; Bausher MG, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-21; CAROEBTER JB, 1976, 56 DAT GROW I; CHABANE AAD, 2007, CR BIOL, P330; Chang CC, 2006, MOL BIOL EVOL, V23, P279, DOI 10.1093/molbev/msj029; Chumley TW, 2006, MOL BIOL EVOL, V23, P2175, DOI 10.1093/molbev/msl089; CORRIVEAU JL, 1988, AM J BOT, V75, P1443, DOI 10.2307/2444695; Cronn R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn502; Diekmann K, 2009, DNA RES, V16, P165, DOI 10.1093/dnares/dsp008; DOYLE JJ, 1992, P NATL ACAD SCI USA, V89, P7722, DOI 10.1073/pnas.89.16.7722; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fray R, 2003, PHILOS T ROY SOC B, V358, P106; Gao L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-130; Gawel N.J., 1991, PLANT MOL BIOL REP, V9, P262, DOI [10.1007/BF02672076, DOI 10.1007/BF02672076]; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Goremykin VV, 2005, MOL BIOL EVOL, V22, P1813, DOI 10.1093/molbev/msi173; Hansen DR, 2007, MOL PHYLOGENET EVOL, V45, P547, DOI 10.1016/j.ympev.2007.06.004; HIRATSUKA J, 1989, MOL GEN GENET, V217, P185, DOI 10.1007/BF02464880; Howe CJ, 2003, PHILOS T ROY SOC B, V358, P99, DOI 10.1098/rstb.2002.1176; Jansen RK, 2005, METHOD ENZYMOL, V395, P348, DOI 10.1016/S0076-6879(05)95020-9; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Kim KJ, 2005, MOL CELLS, V19, P104; Kim KJ, 2004, DNA RES, V11, P247, DOI 10.1093/dnares/11.4.247; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Lee B, 2006, INT J AUTO TECH-KOR, V7, P61; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MAIER RM, 1995, J MOL BIOL, V251, P614, DOI 10.1006/jmbi.1995.0460; Mardanov AV, 2008, J MOL EVOL, V66, P555, DOI 10.1007/s00239-008-9091-7; MARY M, 2010, J MOL EVOL, V70, P149; Moore MJ, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-17; Pyke KA, 1999, PLANT CELL, V11, P549, DOI 10.1105/tpc.11.4.549; Raubeson LA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-174; SASAKI Y, 1993, FEBS LETT, V316, P93, DOI 10.1016/0014-5793(93)81743-J; Saski C, 2005, PLANT MOL BIOL, V59, P309, DOI 10.1007/s11103-005-8882-0; Saski C, 2007, THEOR APPL GENET, V115, P571, DOI 10.1007/s00122-007-0595-0; Sghaier-Hammami B, 2009, PROTEOMICS, V9, P2543, DOI 10.1002/pmic.200800523; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; Sugita M, 1996, PLANT MOL BIOL, V32, P315, DOI 10.1007/BF00039388; Tang JB, 2004, PLANT PHYSIOL, V135, P412, DOI 10.1104/pp.103.031245; TANGPHATSORNRUA S, 2009, DNA RES, P1; Tangphatsornruang S, 2010, DNA RES, V17, P11, DOI 10.1093/dnares/dsp025; Tian XJ, 2006, PLANT PHYSIOL, V140, P401, DOI 10.1104/pp.105.070060; Wu FH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-68; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	48	196	209	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12762	10.1371/journal.pone.0012762	http://dx.doi.org/10.1371/journal.pone.0012762			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856810	Green Submitted, Green Published, gold			2022-12-27	WOS:000281815800024
J	Larsen, MV; Lelic, A; Parsons, R; Nielsen, M; Hoof, I; Lamberth, K; Loeb, MB; Buus, S; Bramson, J; Lund, O				Larsen, Mette Voldby; Lelic, Alina; Parsons, Robin; Nielsen, Morten; Hoof, Ilka; Lamberth, Kasper; Loeb, Mark B.; Buus, Soren; Bramson, Jonathan; Lund, Ole			Identification of CD8(+) T Cell Epitopes in the West Nile Virus Polyprotein by Reverse-Immunology Using NetCTL	PLOS ONE			English	Article							CLASS-I BINDING; INFLUENZA-A; PEPTIDE BINDING; HLA MOLECULES; CTL EPITOPES; GENOME-WIDE; RESPONSES; RECOGNITION; PREDICTION; SPECIFICITY	Background: West Nile virus (WNV) is a growing threat to public health and a greater understanding of the immune response raised against WNV is important for the development of prophylactic and therapeutic strategies. Methodology/Principal Findings: In a reverse-immunology approach, we used bioinformatics methods to predict WNV-specific CD8(+) T cell epitopes and selected a set of peptides that constitutes maximum coverage of 20 fully-sequenced WNV strains. We then tested these putative epitopes for cellular reactivity in a cohort of WNV-infected patients. We identified 26 new CD8(+) T cell epitopes, which we propose are restricted by 11 different HLA class I alleles. Aiming for optimal coverage of human populations, we suggest that 11 of these new WNV epitopes would be sufficient to cover from 48% to 93% of ethnic populations in various areas of the World. Conclusions/Significance: The 26 identified CD8(+) T cell epitopes contribute to our knowledge of the immune response against WNV infection and greatly extend the list of known WNV CD8(+) T cell epitopes. A polytope incorporating these and other epitopes could possibly serve as the basis for a WNV vaccine.	[Larsen, Mette Voldby; Nielsen, Morten; Hoof, Ilka; Lund, Ole] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Lelic, Alina; Parsons, Robin; Loeb, Mark B.; Bramson, Jonathan] McMaster Univ, Inst Mol Med & Hlth, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Lamberth, Kasper; Buus, Soren] Univ Copenhagen, Panum Inst, Inst Med Microbiol & Immunol, Div Expt Immunol, DK-2200 Copenhagen, Denmark	Technical University of Denmark; McMaster University; University of Copenhagen	Larsen, MV (corresponding author), Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark.	metteb@cbs.dtu.dk	Nielsen, Morten/AAL-8700-2020; Lund, Ole/F-4437-2014; Buus, Soren/F-5446-2010; Nielsen, Morten/E-7754-2011	Nielsen, Morten/0000-0001-7885-4311; Lund, Ole/0000-0003-1108-0491; Nielsen, Morten/0000-0001-7885-4311; Bramson, Jonathan/0000-0003-2874-6886; Buus, Soren/0000-0001-8363-1999; Hoof, Ilka/0000-0003-3827-7227	National Institutes of Health (NIH) [HHSN266200400025C, HHSN266200400083C]; Danish Research Council for Technology and Production Sciences;  [N01-AI-40066]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI040066] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Research Council for Technology and Production Sciences; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (NIH) (contracts HHSN266200400025C and HHSN266200400083C) and N01-AI-40066 to J.L.B. and M. B. L. as well as by a grant from the Danish Research Council for Technology and Production Sciences (project title "Disease Gene Finding, Somatic Mutations, and Vaccine Design'', principal funding recipient is Soeren Brunak). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Assarsson E, 2007, J IMMUNOL, V178, P7890, DOI 10.4049/jimmunol.178.12.7890; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Betts MR, 2000, J VIROL, V74, P9144, DOI 10.1128/JVI.74.19.9144-9151.2000; Brien JD, 2007, EUR J IMMUNOL, V37, P1855, DOI 10.1002/eji.200737196; DE GROOT AS, 2001, EMERG INFECT DIS, V7, P706; Frahm N, 2007, EUR J IMMUNOL, V37, P2419, DOI 10.1002/eji.200737365; Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a; Hayes EB, 2006, ANNU REV MED, V57, P181, DOI 10.1146/annurev.med.57.121304.131418; Hillen N, 2008, EUR J IMMUNOL, V38, P2993, DOI 10.1002/eji.200838632; HOOF I, 2008, IMMUNOGENETICS; Hoof I, 2010, J IMMUNOL, V184, P5383, DOI 10.4049/jimmunol.0903516; Jameson J, 1998, J VIROL, V72, P8682, DOI 10.1128/JVI.72.11.8682-8689.1998; Klein RS, 2008, TRENDS MOL MED, V14, P286, DOI 10.1016/j.molmed.2008.05.004; Koo QY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005352; Lanteri MC, 2008, J INFECT DIS, V197, P1296, DOI 10.1086/586898; Larsen MV, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-424; Larsen MV, 2005, EUR J IMMUNOL, V35, P2295, DOI 10.1002/eji.200425811; LEHNER PJ, 1995, J EXP MED, V181, P79, DOI 10.1084/jem.181.1.79; Lin HH, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-8; Loeb M, 2005, EMERG INFECT DIS, V11, P1433; Lund O, 2004, IMMUNOGENETICS, V55, P797, DOI 10.1007/s00251-004-0647-4; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; McMurtrey CP, 2008, P NATL ACAD SCI USA, V105, P2981, DOI 10.1073/pnas.0711874105; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Nielsen M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000796; Parsons R, 2008, J IMMUNOL, V181, P1563, DOI 10.4049/jimmunol.181.2.1563; Pasquetto V, 2005, J IMMUNOL, V175, P5504, DOI 10.4049/jimmunol.175.8.5504; Perez CL, 2008, J IMMUNOL, V180, P5092, DOI 10.4049/jimmunol.180.7.5092; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Purtha WE, 2007, EUR J IMMUNOL, V37, P1845, DOI 10.1002/eji.200737192; Rao XY, 2009, J IMMUNOL, V182, P1526, DOI 10.4049/jimmunol.182.3.1526; SETTE A, 1994, J IMMUNOL, V153, P5586; Shrestha B, 2004, J VIROL, V78, P8312, DOI [10.1128/JVI.78.15.8312-8321.2004, 10.1128/jvi.78.15.8312-8321.2004]; Stranzl T, 2010, IMMUNOGENETICS, V62, P357, DOI 10.1007/s00251-010-0441-4; Suhoski MM, 2007, MOL THER, V15, P981, DOI 10.1038/mt.sj.6300134; Sylvester-Hvid C, 2004, TISSUE ANTIGENS, V63, P395, DOI 10.1111/j.0001-2815.2004.00221.x; Sylvester-Hvid C, 2002, TISSUE ANTIGENS, V59, P251, DOI 10.1034/j.1399-0039.2002.590402.x; Tang ST, 2008, ARCH VIROL, V153, P1833, DOI 10.1007/s00705-008-0194-7; Wang MJ, 2007, VACCINE, V25, P2823, DOI 10.1016/j.vaccine.2006.12.038; Wang MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010533	41	28	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2010	5	9							e12697	10.1371/journal.pone.0012697	http://dx.doi.org/10.1371/journal.pone.0012697			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZO	20856867	Green Submitted, gold, Green Published			2022-12-27	WOS:000281815700007
J	Hatakeyama, H; Cheng, HX; Wirth, P; Counsell, A; Marcrom, SR; Wood, CB; Pohlmann, PR; Gilbert, J; Murphy, B; Yarbrough, WG; Wheeler, DL; Harari, PM; Guo, Y; Shyr, Y; Slebos, RJ; Chung, CH				Hatakeyama, Hiromitsu; Cheng, Haixia; Wirth, Pamela; Counsell, Ashley; Marcrom, Samuel R.; Wood, Carey Burton; Pohlmann, Paula R.; Gilbert, Jill; Murphy, Barbara; Yarbrough, Wendell G.; Wheeler, Deric L.; Harari, Paul M.; Guo, Yan; Shyr, Yu; Slebos, Robbert J.; Chung, Christine H.			Regulation of Heparin-Binding EGF-Like Growth Factor by miR-212 and Acquired Cetuximab-Resistance in Head and Neck Squamous Cell Carcinoma	PLOS ONE			English	Article							TO-MESENCHYMAL TRANSITION; LUNG-CANCER; GEFITINIB RESISTANCE; EXPRESSION PROFILES; PLUS CETUXIMAB; DISTINCT ROLES; NUCLEAR EXPORT; TGF-ALPHA; PHASE-II; GENE	Background: We hypothesized that chronic inhibition of epidermal growth factor receptor (EGFR) by cetuximab, a monoclonal anti-EGFR antibody, induces up-regulation of its ligands resulting in resistance and that microRNAs (miRs) play an important role in the ligand regulation in head and neck squamous cell carcinoma (HNSCC). Methodology/Principal Findings: Genome-wide changes in gene and miR expression were determined in cetuximab-sensitive cell line, SCC1, and its resistant derivative 1Cc8 using DNA microarrays and RT-PCR. The effects of differentially expressed EGFR ligands and miRs were examined by MTS, colony formation, ELISA, and western blot assays. Heparin-binding EGF-like growth factor (HB-EGF) and its regulator, miR-212, were differentially expressed with statistical significance when SCC1 and 1Cc8 were compared for gene and miR expression. Stimulation with HB-EGF induced cetuximab resistance in sensitive cell lines. Inhibition of HB-EGF and the addition of miR-212 mimic induced cetuximab sensitivity in resistant cell lines. MicroRNA-212 and HB-EGF expression were inversely correlated in an additional 33 HNSCC and keratinocyte cell lines. Six tumors and 46 plasma samples from HNSCC patients were examined for HB-EGF levels. HB-EGF plasma levels were lower in newly diagnosed HNSCC patients when compared to patients with recurrent disease. Conclusions/Significance: Increased expression of HB-EGF due to down-regulation of miR-212 is a possible mechanism of cetuximab resistance. The combination of EGFR ligand inhibitors or miR modulators with cetuximab may improve the clinical outcome of cetuximab therapy in HNSCC.	[Hatakeyama, Hiromitsu; Wirth, Pamela; Counsell, Ashley; Marcrom, Samuel R.; Wood, Carey Burton; Pohlmann, Paula R.; Gilbert, Jill; Murphy, Barbara; Guo, Yan] Vanderbilt Univ, Sch Med, Div Hematol Oncol, Dept Med, Nashville, TN 37212 USA; [Cheng, Haixia; Chung, Christine H.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Yarbrough, Wendell G.] Vanderbilt Univ, Sch Med, Dept Otolaryngol, Nashville, TN 37212 USA; [Yarbrough, Wendell G.; Slebos, Robbert J.] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA; [Wheeler, Deric L.; Harari, Paul M.] Univ Wisconsin, Dept Human Oncol, Sch Med & Publ Hlth, Madison, WI USA; [Guo, Yan; Shyr, Yu] Vanderbilt Univ, Sch Med, Dept Biostat, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA	Vanderbilt University; Johns Hopkins University; Vanderbilt University; Vanderbilt University; University of Wisconsin System; University of Wisconsin Madison; Vanderbilt University	Hatakeyama, H (corresponding author), Vanderbilt Univ, Sch Med, Div Hematol Oncol, Dept Med, Nashville, TN 37212 USA.	cchung11@jhmi.edu	Marcrom, Samuel/K-5034-2019; Cheng, Haixia/F-5736-2015	Pohlmann, Paula/0000-0001-7914-5162	Damon Runyon Clinical Investigator Award [CL-28-05]; National Institutes of Health [R01-DE-017982, R01-CA-113448]; Vanderbilt-Ingram Cancer Center; Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation; NATIONAL CANCER INSTITUTE [R01CA113448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017982] Funding Source: NIH RePORTER	Damon Runyon Clinical Investigator Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt-Ingram Cancer Center; Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The project was funded in part by Damon Runyon Clinical Investigator Award (CL-28-05) and National Institutes of Health (R01-DE-017982) to CHC, and by Vanderbilt-Ingram Cancer Center and the Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation. The Vanderbilt-Ingram Cancer Center and an endowment from Barry and Amy Baker to The Barry Baker Laboratory for Head and Neck Cancer provided funds for collection and storage of biospecimens. The PMH laboratory is supported in part by the National Institutes of Health (R01-CA-113448). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arteaga C, 2003, SEMIN ONCOL, V30, P3, DOI 10.1016/S0093-7754(03)00185-4; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BISSADA E, 2008, J CLIN ONCOL, V26; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Cappuzzo F, 2005, JNCI-J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; CHAN E, 2010, AM J CLIN O IN PRESS; Chung CH, 2006, CANCER RES, V66, P8210, DOI 10.1158/0008-5472.CAN-06-1213; Cohen EEW, 2003, J CLIN ONCOL, V21, P1980, DOI 10.1200/JCO.2003.10.051; Cohen EEW, 2005, CLIN CANCER RES, V11, P8105, DOI 10.1158/1078-0432.CCR-05-0926; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Frederick BA, 2007, MOL CANCER THER, V6, P1683, DOI 10.1158/1535-7163.MCT-07-0138; GILL GN, 1984, J BIOL CHEM, V259, P7755; GOISHI K, 1995, MOL BIOL CELL, V6, P967, DOI 10.1091/mbc.6.8.967; Grandis JR, 1998, JNCI-J NATL CANCER I, V90, P824, DOI 10.1093/jnci/90.11.824; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Harris RC, 2003, EXP CELL RES, V284, P2, DOI 10.1016/S0014-4827(02)00105-2; *IMCLONE SYST INC, 2007, ERB CET PRESCR INF; Iwamoto R, 1999, J BIOL CHEM, V274, P25906, DOI 10.1074/jbc.274.36.25906; Iwamoto R, 2003, P NATL ACAD SCI USA, V100, P3221, DOI 10.1073/pnas.0537588100; Iwamoto R, 2006, CELL STRUCT FUNCT, V31, P1, DOI 10.1247/csf.31.1; Khambata-Ford S, 2007, J CLIN ONCOL, V25, P3230, DOI 10.1200/JCO.2006.10.5437; LICITRA L, 2009, J CLIN ONCOL, V27; Luetteke NC, 1999, DEVELOPMENT, V126, P2739; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Mutsaers AJ, 2009, CLIN CANCER RES, V15, P2397, DOI 10.1158/1078-0432.CCR-08-1627; Nanba D, 2004, CYTOKINE GROWTH F R, V15, P13, DOI 10.1016/j.cytogfr.2003.10.002; Nanba D, 2003, J CELL BIOL, V163, P489, DOI 10.1083/jcb.200303017; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Raab G, 1997, BBA-REV CANCER, V1333, pF179, DOI 10.1016/S0304-419X(97)00024-3; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Shirakata Y, 2005, J CELL SCI, V118, P2363, DOI 10.1242/jcs.02346; Smith JP, 2009, AM J PHYSIOL-RENAL, V296, pF957, DOI 10.1152/ajprenal.90490.2008; Soulieres D, 2004, J CLIN ONCOL, V22, P77, DOI 10.1200/JCO.2004.06.075; Thomson S, 2005, CANCER RES, V65, P9455, DOI 10.1158/0008-5472.CAN-05-1058; Tran N, 2007, BIOCHEM BIOPH RES CO, V358, P12, DOI 10.1016/j.bbrc.2007.03.201; Troyer KL, 2001, GASTROENTEROLOGY, V121, P68, DOI 10.1053/gast.2001.25478; Vermorken JB, 2008, NEW ENGL J MED, V359, P1116, DOI 10.1056/NEJMoa0802656; Wang F, 2007, ONCOGENE, V26, P2006, DOI 10.1038/sj.onc.1209999; Wang F, 2007, CANCER RES, V67, P8486, DOI 10.1158/0008-5472.CAN-07-0498; WHEELER DL, 2008, ONCOGENE; Yagi H, 2008, MOL CANCER THER, V7, P3441, DOI 10.1158/1535-7163.MCT-08-0417; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yauch RL, 2005, CLIN CANCER RES, V11, P8686, DOI 10.1158/1078-0432.CCR-05-1492	47	110	119	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2010	5	9							e12702	10.1371/journal.pone.0012702	http://dx.doi.org/10.1371/journal.pone.0012702			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648ZZ	20856931	Green Published, Green Submitted, gold			2022-12-27	WOS:000281735700019
J	Lienard, A; Merckaert, I; Libert, Y; Bragard, I; Delvaux, N; Etienne, AM; Marchal, S; Meunier, J; Reynaert, C; Slachmuylder, JL; Razavi, D				Lienard, Aurore; Merckaert, Isabelle; Libert, Yves; Bragard, Isabelle; Delvaux, Nicole; Etienne, Anne-Marie; Marchal, Serge; Meunier, Julie; Reynaert, Christine; Slachmuylder, Jean-Louis; Razavi, Darius			Transfer of Communication Skills to the Workplace during Clinical Rounds: Impact of a Program for Residents	PLOS ONE			English	Article							BAD-NEWS; PHYSICIANS COMMUNICATION; CONSOLIDATION WORKSHOPS; PATIENTS PERCEPTIONS; INTERNAL-MEDICINE; TRAINING-PROGRAM; CONTROLLED-TRIAL; CANCER; CARE; EFFICACY	Background and Purpose: Communication with patients is a core clinical skill in medicine that can be acquired through communication skills training. Meanwhile, the importance of transfer of communication skills to the workplace has not been sufficiently studied. This study aims to assess the efficacy of a 40-hour training program designed to improve patients' satisfaction and residents' communication skills during their daily clinical rounds. Methods: Residents were randomly assigned to the training program or to a waiting list. Patients' satisfaction was assessed with a visual analog scale after each visit. Transfer of residents' communication skills was assessed in audiotaped actual inpatient visits during a half-day clinical round. Transcripted audiotapes were analyzed using content analysis software (LaComm). Training effects were tested with Mann-Whitney tests and generalized linear Poisson regression models. Results: Eighty-eight residents were included. First, patients interacting with trained residents reported a higher satisfaction with residents' communication (Median = 92) compared to patients interacting with untrained residents (Median = 88) (p = .046). Second, trained residents used more assessment utterances (Relative Risk (RR) = 1.17; 95% Confidence intervals (95%CI) = 1.02-1.34; p = .023). Third, transfer was also observed when residents' training attendance was considered: residents' use of assessment utterances (RR = 1.01; 95%CI = 1.01-1.02; p = .018) and supportive utterances (RR = 0.99; 95% CI = 0.98-1.00; p = .042) (respectively 1.15 (RR), 1.08-1.23 (95% CI), p<.001 for empathy and 0.95 (RR), 0.92-0.99 (95% CI), p = .012 for reassurance) was proportional to the number of hours of training attendance. Conclusion: The training program improved patients' satisfaction and allowed the transfer of residents' communication skills learning to the workplace. Transfer was directly related to training attendance but remained limited. Future studies should therefore focus on the improvement of the efficacy of communication skills training in order to ensure a more important training effect size on transfer.	[Lienard, Aurore; Merckaert, Isabelle; Libert, Yves; Razavi, Darius] Inst Jules Bordet, B-1000 Brussels, Belgium; [Lienard, Aurore; Merckaert, Isabelle; Libert, Yves; Delvaux, Nicole; Meunier, Julie; Razavi, Darius] Univ Libre Bruxelles, Fac Sci Psychol & Educ, Brussels, Belgium; [Bragard, Isabelle; Delvaux, Nicole; Etienne, Anne-Marie; Meunier, Julie] Univ Liege, Fac Psychol, Liege, Belgium; [Delvaux, Nicole; Meunier, Julie] Free Univ Brussels, Hop Erasme, B-1070 Brussels, Belgium; [Marchal, Serge; Meunier, Julie; Slachmuylder, Jean-Louis] Ctr Psychooncol, Brussels, Belgium; [Reynaert, Christine] Catholic Univ Louvain, Fac Psychol & Sci Educ, B-1348 Louvain, Belgium	Institut Jules Bordet; Universite Libre de Bruxelles; University of Liege; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Catholique Louvain	Lienard, A (corresponding author), Inst Jules Bordet, B-1000 Brussels, Belgium.	drazavi@ulb.ac.be			"Fonds National de la Recherche Scientifique - Section Televie" of Belgium	"Fonds National de la Recherche Scientifique - Section Televie" of Belgium(Fonds de la Recherche Scientifique - FNRS)	This research program was supported by the "Fonds National de la Recherche Scientifique - Section Televie" of Belgium (a national funding source) (www.fnrs.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander SC, 2006, ACAD MED, V81, P1008, DOI 10.1097/01.ACM.0000242580.83851.ad; Back AL, 2007, ARCH INTERN MED, V167, P453, DOI 10.1001/archinte.167.5.453; BALDWIN TT, 1988, PERS PSYCHOL, V41, P63, DOI 10.1111/j.1744-6570.1988.tb00632.x; BOOTH C, 1991, DEV RATING SYSTEM AS; BRAGARD I, 2006, TEACHING COMMUNICATI, P1; Bredart A, 2005, EUR J CANCER, V41, P2120, DOI 10.1016/j.ejca.2005.04.041; Butow PN, 1996, CANCER-AM CANCER SOC, V77, P2630, DOI 10.1002/(SICI)1097-0142(19960615)77:12<2630::AID-CNCR29>3.3.CO;2-K; Cohen-Cole SA, 1991, MED INTERVIEW 3 FUNC; Delvaux N, 2005, CANCER-AM CANCER SOC, V103, P2397, DOI 10.1002/cncr.21093; Delvaux N, 2004, BRIT J CANCER, V90, P106, DOI 10.1038/sj.bjc.6601459; Fallowfield L, 2002, LANCET, V359, P650, DOI 10.1016/S0140-6736(02)07810-8; Gibon A-S, 2010, PSYCHO-ONCOLOGY, V19, P133; Hogenraad R, 1995, THEORIE METHOD UNPUB; Jenkins V, 2002, J CLIN ONCOL, V20, P765, DOI 10.1200/JCO.20.3.765; Kramer AWM, 2004, MED EDUC, V38, P158, DOI 10.1111/j.1365-2923.2004.01747.x; Langewitz WA, 1998, PSYCHOSOM MED, V60, P268, DOI 10.1097/00006842-199805000-00009; LEVINSON W, 1993, J GEN INTERN MED, V8, P318, DOI 10.1007/BF02600146; Lienard A, 2010, BRIT J CANCER, V103, P171, DOI 10.1038/sj.bjc.6605749; Losh DP, 2005, ACAD MED, V80, P118, DOI 10.1097/00001888-200502000-00002; Maguire P, 1996, EUR J CANCER, V32A, P78, DOI 10.1016/0959-8049(95)00527-7; OBERST MT, 1984, CANCER, V53, P2366; Oh J, 2001, ACAD MED, V76, P647, DOI 10.1097/00001888-200106000-00019; Pennebacker JW, 2007, LINGUISTIC INQUIRY W; Ptacek JT, 2001, J CLIN ONCOL, V19, P4160, DOI 10.1200/JCO.2001.19.21.4160; Razavi D, 2003, J CLIN ONCOL, V21, P3141, DOI 10.1200/JCO.2003.08.031; ROBBINS AS, 1979, J MED EDUC, V54, P885; Sitzia J, 1999, INT J QUAL HEALTH C, V11, P319, DOI 10.1093/intqhc/11.4.319; Smith RC, 1998, ANN INTERN MED, V128, P118, DOI 10.7326/0003-4819-128-2-199801150-00008; Stone P.J., 1966, GEN INQUIRER COMPUTE	29	36	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12426	10.1371/journal.pone.0012426	http://dx.doi.org/10.1371/journal.pone.0012426			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	643JL	20865055	Green Published, Green Submitted, gold			2022-12-27	WOS:000281292100021
J	Monzon-Casanova, E; Steiniger, B; Schweigle, S; Clemen, H; Zdzieblo, D; Starick, L; Muller, I; Wang, CR; Rhost, S; Cardell, S; Pyz, E; Herrmann, T				Monzon-Casanova, Elisa; Steiniger, Birte; Schweigle, Stefanie; Clemen, Holger; Zdzieblo, Daniela; Starick, Lisa; Mueller, Ingrid; Wang, Chyung-Ru; Rhost, Sara; Cardell, Susanna; Pyz, Elwira; Herrmann, Thomas			CD1d Expression in Paneth Cells and Rat Exocrine Pancreas Revealed by Novel Monoclonal Antibodies Which Differentially Affect NKT Cell Activation	PLOS ONE			English	Article							CD1D-RESTRICTED T-CELLS; MOUSE CD1; ANTIGEN PRESENTATION; MARGINAL ZONE; MURINE CD1; B-CELLS; MICE; LOCALIZATION; RECOGNITION; MOLECULES	Background: CD1d is a nonpolymorphic MHC class I-like molecule which presents nonpeptide ligands, e.g. glycolipids, to NKT cells. These cells are known to have multiple effects on innate and adaptive immune responses and on the development of pathological conditions. In order to analyze CD1d expression and function in the rat, the first rat CD1d-specific monoclonal antibodies (mAbs) were generated. Methodology/Principal Findings: Two mAbs, WTH-1 and WTH-2, were generated which bound equally well to cell surface-expressed rat and mouse CD1d. Their non-overlapping epitopes were mapped to the CD1d heavy chain. Flow cytometry and immunohistological analyses revealed a nearly identical degree and pattern of CD1d expression for hematopoieitic cells of both species. Notable is also the detection of CD1d protein in mouse and rat Paneth cells as well as the extremely high CD1d expression in acinar exocrine cells of the rat pancreas and the expression of CD4 on rat marginal zone B cells. Both mAbs blocked alpha-galactosylceramide recognition by primary rat and mouse NKT cells. Interestingly, the two mAbs differed in their impact on the activation of various autoreactive T cell hybridomas, including the XV19.2 hybridoma whose activation was enhanced by the WTH-1 mAb. Conclusions/Significance: The two novel monoclonal antibodies described in this study, allowed the analysis of CD1d expression and CD1d-restricted T cell responses in the rat for the first time. Moreover, they provided new insights into mechanisms of CD1d-restricted antigen recognition. While CD1d expression by hematopoietic cells of mice and rats was extremely similar, CD1d protein was detected at not yet described sites of non-lymphatic tissues such as the rat exocrine pancreas and Paneth cells. The latter is of special relevance given the recently reported defects of Paneth cells in CD1d(-/-) mice, which resulted in an altered composition of the gut flora.	[Monzon-Casanova, Elisa; Schweigle, Stefanie; Clemen, Holger; Zdzieblo, Daniela; Starick, Lisa; Mueller, Ingrid; Pyz, Elwira; Herrmann, Thomas] Univ Wurzburg, Inst Virol & Immunobiol, D-8700 Wurzburg, Germany; [Steiniger, Birte] Univ Marburg, Dept Anat & Cell Biol, D-3550 Marburg, Germany; [Wang, Chyung-Ru] Northwestern Univ, Feinberg Sch Med, Dept Microbiol & Immunol, Chicago, IL 60611 USA; [Rhost, Sara; Cardell, Susanna] Univ Gothenburg, Inst Biomed, Dept Microbiol & Immunol, Gothenburg, Sweden	University of Wurzburg; Philipps University Marburg; Northwestern University; Feinberg School of Medicine; University of Gothenburg	Monzon-Casanova, E (corresponding author), Univ Wurzburg, Inst Virol & Immunobiol, Versbacher Str 7, D-8700 Wurzburg, Germany.	herrmann-t@vim.uni-wuerzburg.de	Cardell, Susanna/ABC-4944-2021; Herrmann, Thomas/J-4943-2012	Herrmann, Thomas/0000-0002-1093-0194; Monzon-Casanova, Elisa/0000-0001-6617-6138; Steiniger, Birte/0000-0002-3602-7331	Deutsche Forschungsgemeinschaft Graduate College; Deutsche Akademische Auslandsdienst; Swedish Research Council [K2010-57X14063-10-3]; Swedish Cancer Foundation [09 0532]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043407] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft Graduate College(German Research Foundation (DFG)); Deutsche Akademische Auslandsdienst(Deutscher Akademischer Austausch Dienst (DAAD)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Deutsche Forschungsgemeinschaft Graduate College 520 Immunomodulation (http://www.dfg.de/), and E.M.C. was also supported by a STIBET Doktoranden grant of the Deutsche Akademische Auslandsdienst (http://www.daad.de/hochschulen/betreuung/stibet/05096.de.html). S.C. was supported by the Swedish Research Council K2010-57X14063-10-3 and the Swedish Cancer Foundation 09 0532. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angenieux C, 2000, J BIOL CHEM, V275, P37757, DOI 10.1074/jbc.M007082200; Behar SM, 2000, SEMIN IMMUNOL, V12, P551, DOI 10.1006/smim.2000.0273; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; BLEICHER PA, 1990, SCIENCE, V250, P679, DOI 10.1126/science.1700477; Blomqvist M, 2009, EUR J IMMUNOL, V39, P1726, DOI 10.1002/eji.200839001; Bonish B, 2000, J IMMUNOL, V165, P4076, DOI 10.4049/jimmunol.165.7.4076; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; BRADBURY A, 1988, EMBO J, V7, P3081, DOI 10.1002/j.1460-2075.1988.tb03173.x; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; BROEREN CPM, 1995, IMMUNOLOGY, V84, P193; Brossay L, 1997, J IMMUNOL, V159, P1216; Burdin N, 2000, P NATL ACAD SCI USA, V97, P10156, DOI 10.1073/pnas.97.18.10156; BURKE S, 1994, GASTROENTEROLOGY, V106, P1143, DOI 10.1016/0016-5085(94)90003-5; CALABI F, 1989, EUR J IMMUNOL, V19, P285, DOI 10.1002/eji.1830190211; CARDELL S, 1995, J EXP MED, V182, P993, DOI 10.1084/jem.182.4.993; Chen XQ, 2006, MOL CELL PROTEOMICS, V5, P306, DOI 10.1074/mcp.M500172-MCP200; Chen YH, 1999, J IMMUNOL, V162, P4560; CROCKER PR, 1987, J EXP MED, V166, P613, DOI 10.1084/jem.166.2.613; de la Salle H, 2005, SCIENCE, V310, P1321, DOI 10.1126/science.1115301; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Higuchi R., 1990, PCR PROTOCOLS GUIDE; ICHIMIYA S, 1994, J IMMUNOL, V153, P1112; Jahng A, 2004, J EXP MED, V199, P947, DOI 10.1084/jem.20031389; Kasai K, 1997, CLIN EXP IMMUNOL, V109, P317, DOI 10.1046/j.1365-2249.1997.3661267.x; Kasmar A, 2009, CURR OPIN IMMUNOL, V21, P397, DOI 10.1016/j.coi.2009.05.022; Katabami S, 1998, IMMUNOGENETICS, V48, P22, DOI 10.1007/s002510050396; Kenny E, 2004, EUR J IMMUNOL, V34, P1262, DOI 10.1002/eji.200324363; Knodel M, 1999, EUR J IMMUNOL, V29, P2988; KROESE FGM, 1990, EUR J IMMUNOL, V20, P1527, DOI 10.1002/eji.1830200718; KUMARARATNE DS, 1981, EUR J IMMUNOL, V11, P858, DOI 10.1002/eji.1830111103; LACASSE J, 1992, J HISTOCHEM CYTOCHEM, V40, P1527, DOI 10.1177/40.10.1382091; Makowska A, 1999, EUR J IMMUNOL, V29, P3285, DOI 10.1002/(SICI)1521-4141(199910)29:10<3285::AID-IMMU3285>3.3.CO;2-G; Mandal M, 1998, MOL IMMUNOL, V35, P525, DOI 10.1016/S0161-5890(98)00055-8; Matsuura A, 2000, J IMMUNOL, V164, P3140, DOI 10.4049/jimmunol.164.6.3140; Mendiratta SK, 1997, IMMUNITY, V6, P469, DOI 10.1016/S1074-7613(00)80290-3; MOSSER DD, 1991, IMMUNOLOGY, V73, P298; Nieuwenhuis EES, 2009, J CLIN INVEST, V119, P1241, DOI 10.1172/JCI36509; Park SH, 1998, J IMMUNOL, V160, P3128; Pyz E, 2006, J IMMUNOL, V176, P7447, DOI 10.4049/jimmunol.176.12.7447; Rindler MJ, 2007, J PROTEOME RES, V6, P2978, DOI 10.1021/pr0607029; Roark JH, 1998, J IMMUNOL, V160, P3121; SCHNEIDER C, 1982, J BIOL CHEM, V257, P766; Silk JD, 2008, ANNU REV CELL DEV BI, V24, P369, DOI 10.1146/annurev.cellbio.24.110707.175359; SONEOKA Y, 1995, NUCLEIC ACIDS RES, V23, P628, DOI 10.1093/nar/23.4.628; Steiniger B, 2006, HISTOCHEM CELL BIOL, V126, P641, DOI 10.1007/s00418-006-0210-5; Tupin E, 2007, NAT REV MICROBIOL, V5, P405, DOI 10.1038/nrmicro1657; van den Berg TK, 2001, IMMUNOL REV, V184, P109, DOI 10.1034/j.1600-065x.2001.1840110.x; Wang ZD, 2000, J IMMUNOL METHODS, V233, P167, DOI 10.1016/S0022-1759(99)00184-2; Wei DG, 2005, J EXP MED, V202, P239, DOI 10.1084/jem.20050413; Zimmer MI, 2006, J IMMUNOL, V176, P1421, DOI 10.4049/jimmunol.176.3.1421; Zimmer MI, 2009, P NATL ACAD SCI USA, V106, P1909, DOI 10.1073/pnas.0808476106	52	16	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e13089	10.1371/journal.pone.0013089	http://dx.doi.org/10.1371/journal.pone.0013089			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20927351	Green Submitted, Green Published, gold			2022-12-27	WOS:000282312600022
J	Bi, JM; Deng, GC; Dong, J; Kong, FL; Li, XZ; Xu, QA; Zhang, MJ; Zhao, LH; Qiao, JA				Bi, Jianmin; Deng, Guangcun; Dong, Jun; Kong, Fuli; Li, Xuezhu; Xu, Qiang; Zhang, Miaojie; Zhao, Lihong; Qiao, Jian			Phylogenetic and Molecular Characterization of H9N2 Influenza Isolates from Chickens in Northern China from 2007-2009	PLOS ONE			English	Article							A H5N1 VIRUS; AVIAN INFLUENZA; HUMAN INFECTION; HONG-KONG; EVOLUTION; PATHOGENICITY; HEMAGGLUTININ; POULTRY; GENES; DUCKS	The repeated transmission to pigs and humans, and the long-term endemicity in terrestrial poultry of H9N2 viruses in China lend urgency to the study of their ecology and pathogenicity. In the present paper, we reported an H9N2 virus sublineage isolated from chickens in northern China from 2007 to 2009 has high lethality for mice. Phylogenetic analysis of the full genome indicated that six representative H9N2 isolates shared high homology to each other, and they clustered in the same sublineage with other H9N2 viruses isolated recently in northern China. The isolates were double-reassortant viruses containing M genes similar to A/Quail/Hong Kong/G1/97 (H9N2) and the other seven gene segments from A/Chicken/Shanghai/F/98 (H9N2). These six isolates were capable of replicating in the lungs of infected chickens without producing observable clinical signs of disease or death. However, they were highly lethal to mice with mortality rates as high as 100% (14/14) without prior adaptation. The affected mice exhibited severe respiratory syndromes and diffuse lung injury. The H9N2 viruses could be detected in multiple organs of the infected mice, including hearts, livers, spleens, lungs and kidneys. Our findings demonstrated that H9N2 viruses isolated from the chickens in northern China have established a stable sublineage with enhanced pathogenicity to mice, suggesting that urgent attention will need to be paid to the transmission of H9N2 viruses from chickens to mammals.	[Bi, Jianmin; Deng, Guangcun; Dong, Jun; Kong, Fuli; Li, Xuezhu; Xu, Qiang; Zhang, Miaojie; Zhao, Lihong; Qiao, Jian] China Agr Univ, Dept Pathophysiol, Coll Vet Med, Beijing 100094, Peoples R China	China Agricultural University	Bi, JM (corresponding author), China Agr Univ, Dept Pathophysiol, Coll Vet Med, Beijing 100094, Peoples R China.	zhlhong@cau.edu.cn; qiaojian@cau.edu.cn		Deng, Guangcun/0000-0002-9079-9084	National Natural Science Foundation of China [30972163, 30571398]; Program for Cheung Kong Scholars and Innovative Research Team in University of China [IRT0866]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Cheung Kong Scholars and Innovative Research Team in University of China(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the National Natural Science Foundation of China (Grant number: 30972163 and 30571398) and by the Program for Cheung Kong Scholars and Innovative Research Team in University of China (No. IRT0866). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; Banks J, 2001, ARCH VIROL, V146, P963, DOI 10.1007/s007050170128; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Chen B, 1994, CHIN J VET MED, V22, P3; Chen H, 2004, P NATL ACAD SCI USA, V101, P10452, DOI 10.1073/pnas.0403212101; Choi YK, 2004, J VIROL, V78, P8609, DOI 10.1128/JVI.78.16.8609-8614.2004; Cong YL, 2008, VIRUS GENES, V36, P461, DOI 10.1007/s11262-008-0227-z; Deng GC, 2010, ARCH VIROL, V155, P187, DOI 10.1007/s00705-009-0560-0; Guan Y, 1999, P NATL ACAD SCI USA, V96, P9363, DOI 10.1073/pnas.96.16.9363; Guan Y, 2001, INT CONGR SER, V1219, P187, DOI 10.1016/S0531-5131(01)00660-4; Guo Y, 1999, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V13, P105; Guo YJ, 2000, VIROLOGY, V267, P279, DOI 10.1006/viro.1999.0115; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; HOMME P J, 1970, Avian Diseases, V14, P66, DOI 10.2307/1588557; Hossain MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003170; Huang YY, 2009, VIRUS GENES, V38, P398, DOI 10.1007/s11262-009-0339-0; Hulse DJ, 2004, J VIROL, V78, P9954, DOI 10.1128/JVI.78.18.9954-9964.2004; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; KAWAOKA Y, 1988, VIROLOGY, V163, P247, DOI 10.1016/0042-6822(88)90260-7; KAWAOKA Y, 1988, P NATL ACAD SCI USA, V85, P324, DOI 10.1073/pnas.85.2.324; Kendal AP, 1982, CONCEPTS PROCEDURES; Li CJ, 2005, VIROLOGY, V340, P70, DOI 10.1016/j.virol.2005.06.025; Liu JH, 2003, VIRUS GENES, V27, P197, DOI 10.1023/A:1025736829103; Lu JH, 2005, VIRUS GENES, V31, P163, DOI 10.1007/s11262-005-1790-1; Lu XH, 1999, J VIROL, V73, P5903, DOI 10.1128/JVI.73.7.5903-5911.1999; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Matrosovich M, 1999, J VIROL, V73, P1146, DOI 10.1128/JVI.73.2.1146-1155.1999; Matrosovich MN, 2001, VIROLOGY, V281, P156, DOI 10.1006/viro.2000.0799; Nishimura H, 2000, J GEN VIROL, V81, P2503, DOI 10.1099/0022-1317-81-10-2503; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Peiris M, 1999, J CLIN MICROBIOL, V37, P3426, DOI 10.1128/JCM.37.10.3426-3427.1999; Perez DR, 2003, AVIAN DIS, V47, P1114, DOI 10.1637/0005-2086-47.s3.1114; Perez DR, 2003, J VIROL, V77, P3148, DOI 10.1128/JVI.77.5.3148-3156.2003; REED L. J., 1938, AMER JOUR HYG, V27, P493; Saito T, 2001, VACCINE, V20, P125, DOI 10.1016/S0264-410X(01)00279-1; SCHOLTISSEK C, 1985, VIROLOGY, V147, P287, DOI 10.1016/0042-6822(85)90131-X; SHARP GB, 1993, EPIDEMIOL INFECT, V110, P161, DOI 10.1017/S0950268800050780; Shortridge K F, 1992, Semin Respir Infect, V7, P11; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; Steinhauer DA, 1999, VIROLOGY, V258, P1, DOI 10.1006/viro.1999.9716; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Wan H, 2007, J VIROL, V81, P5181, DOI 10.1128/JVI.02827-06; Wan HQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002923; Wan HQ, 2006, VIROLOGY, V346, P278, DOI 10.1016/j.virol.2005.10.035; WEBSTER RG, 1987, CELL, V50, P665, DOI 10.1016/0092-8674(87)90321-7; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wu R, 2009, VET MICROBIOL, V138, P85, DOI 10.1016/j.vetmic.2009.03.010; Xu CT, 2004, MICROBES INFECT, V6, P919, DOI 10.1016/j.micinf.2004.04.015; Xu KM, 2007, J VIROL, V81, P10389, DOI 10.1128/JVI.00979-07; Xu T, 2006, AM J RESP CRIT CARE, V174, P1011, DOI 10.1164/rccm.200511-1751OC; Zhang PH, 2008, J GEN VIROL, V89, P3102, DOI 10.1099/vir.0.2008/005652-0	51	47	52	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e13063	10.1371/journal.pone.0013063	http://dx.doi.org/10.1371/journal.pone.0013063			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20927364	gold, Green Published, Green Submitted			2022-12-27	WOS:000282269400015
J	Salinthone, S; Yadav, V; Schillace, RV; Bourdette, DN; Carr, DW				Salinthone, Sonemany; Yadav, Vijayshree; Schillace, Robynn V.; Bourdette, Dennis N.; Carr, Daniel W.			Lipoic Acid Attenuates Inflammation via cAMP and Protein Kinase A Signaling	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; T-CELL MIGRATION; CENTRAL-NERVOUS-SYSTEM; NECROSIS-FACTOR-ALPHA; MULTIPLE-SCLEROSIS; CYCLIC-AMP; DIABETIC POLYNEUROPATHY; CERAMIDE-1-PHOSPHATE ANALOG; INHIBITS EXPRESSION; DIAGNOSTIC-CRITERIA	Background: Abnormal regulation of the inflammatory response is an important component of diseases such as diabetes, Alzheimer's disease and multiple sclerosis (MS). Lipoic acid (LA) has been shown to have antioxidant and anti-inflammatory properties and is being pursued as a therapy for these diseases. We first reported that LA stimulates cAMP production via activation of G-protein coupled receptors and adenylyl cyclases. LA also suppressed NK cell activation and cytotoxicity. In this study we present evidence supporting the hypothesis that the anti-inflammatory properties of LA are mediated by the cAMP/PKA signaling cascade. Additionally, we show that LA oral administration elevates cAMP levels in MS subjects. Methodology/Principal Findings: We determined the effects of LA on IL-6, IL-17 and IL-10 secretion using ELISAs. Treatment with 50 mg/ml and 100 mg/ml LA significantly reduced IL-6 levels by 19 and 34%, respectively, in T cell enriched PBMCs. IL-17 levels were also reduced by 35 and 50%, respectively. Though not significant, LA appeared to have a biphasic effect on IL-10 production. Thymidine incorporation studies showed LA inhibited T cell proliferation by 90%. T-cell activation was reduced by 50% as measured by IL-2 secretion. Western blot analysis showed that LA treatment increased phosphorylation of Lck, a downstream effector of protein kinase A. Pretreatment with a peptide inhibitor of PKA, PKI, blocked LA inhibition of IL-2 and IFN gamma production, indicating that PKA mediates these responses. Oral administration of 1200 mg LA to MS subjects resulted in increased cAMP levels in PBMCs four hours after ingestion. Average cAMP levels in 20 subjects were 43% higher than baseline. Conclusions/Significance: Oral administration of LA in vivo resulted in significant increases in cAMP concentration. The anti-inflammatory effects of LA are mediated in part by the cAMP/PKA signaling cascade. These novel findings enhance our understanding of the mechanisms of action of LA.	[Salinthone, Sonemany; Yadav, Vijayshree; Schillace, Robynn V.; Bourdette, Dennis N.; Carr, Daniel W.] Portland VA Med Ctr, Portland, OR USA; [Salinthone, Sonemany; Yadav, Vijayshree; Schillace, Robynn V.; Bourdette, Dennis N.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Carr, Daniel W.] Oregon Hlth & Sci Univ, Dept Endocrinol, Portland, OR 97201 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Oregon Health & Science University; Oregon Health & Science University	Salinthone, S (corresponding author), Portland VA Med Ctr, Portland, OR USA.	carrd@ohsu.edu	Yadav, Vijayshree/Y-9772-2019	Yadav, Vijayshree/0000-0001-8476-403X	Department of Veterans Affairs Biomedical Laboratory Research & Development Service; Collins Medical Trust; National Multiple Sclerosis Society [CA1055A]; Laura Fund for Innovation in Multiple Sclerosis Research and Nancy Davis Center Without Walls; National Center of Complementary and Alternative Medicine [K23 AT003258]; Oregon Clinical and Translational Research Institute (OCTRI); National Center for Research Resources, National Institutes of Health (NIH), NIH Roadmap for Medical Research [UL1RR024140]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [K23AT003258] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024140] Funding Source: NIH RePORTER	Department of Veterans Affairs Biomedical Laboratory Research & Development Service(US Department of Veterans Affairs); Collins Medical Trust; National Multiple Sclerosis Society(National Multiple Sclerosis Society); Laura Fund for Innovation in Multiple Sclerosis Research and Nancy Davis Center Without Walls; National Center of Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Oregon Clinical and Translational Research Institute (OCTRI); National Center for Research Resources, National Institutes of Health (NIH), NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by the Department of Veterans Affairs Biomedical Laboratory Research & Development Service (D.B and D.C), the Collins Medical Trust (S.S), National Multiple Sclerosis Society (CA1055A, D.B), the Laura Fund for Innovation in Multiple Sclerosis Research and Nancy Davis Center Without Walls (D.B), the National Center of Complementary and Alternative Medicine (K23 AT003258, D.B), Oregon Clinical and Translational Research Institute (OCTRI, V.Y)), National Center for Research Resources (UL1RR024140, V.Y.), components of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research (V.Y). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal SM, 2007, INT REV NEUROBIOL, V79, P99, DOI 10.1016/S0074-7742(07)79005-0; Aihara M, 1999, BIOL CELL, V91, P525, DOI 10.1016/S0248-4900(00)88209-X; Ametov AS, 2003, DIABETES CARE, V26, P770, DOI 10.2337/diacare.26.3.770; Bettini M, 2009, CURR OPIN IMMUNOL, V21, P612, DOI 10.1016/j.coi.2009.09.011; BETZ M, 1991, J IMMUNOL, V146, P108; Bhat R, 2009, NEURON, V64, P123, DOI 10.1016/j.neuron.2009.09.015; Borger P, 2000, CLIN EXP ALLERGY, V30, P920; Bryce PJ, 1999, IMMUNOPHARMACOLOGY, V41, P139, DOI 10.1016/S0162-3109(98)00060-5; Chaudhary P, 2006, J NEUROIMMUNOL, V175, P87, DOI 10.1016/j.jneuroim.2006.03.007; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Eigler A, 1998, J LEUKOCYTE BIOL, V63, P101, DOI 10.1002/jlb.63.1.101; Feng WG, 2002, CELL RES, V12, P331, DOI 10.1038/sj.cr.7290135; Franchimont D, 1999, J CLIN ENDOCR METAB, V84, P2834, DOI 10.1210/jc.84.8.2834; Furukawa Y, 1996, CLIN IMMUNOL IMMUNOP, V79, P25, DOI 10.1006/clin.1996.0047; Goldsmith M, 2009, MOL IMMUNOL, V46, P1979, DOI 10.1016/j.molimm.2009.03.009; Goldsmith M, 2009, IMMUNOLOGY, V127, P103, DOI 10.1111/j.1365-2567.2008.02928.x; Holm AM, 2003, J IMMUNOL, V170, P5772, DOI 10.4049/jimmunol.170.11.5772; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jennings DL, 2009, ANN PHARMACOTHER, V43, P1872, DOI 10.1345/aph.1M357; Kamenetsky M, 2006, J MOL BIOL, V362, P623, DOI 10.1016/j.jmb.2006.07.045; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kunt T, 1999, CLIN SCI, V96, P75, DOI 10.1042/CS19980224; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; LACOUR M, 1994, INT IMMUNOL, V6, P1333, DOI 10.1093/intimm/6.9.1333; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lavasani S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009009; Liopeta K, 2009, MOL IMMUNOL, V46, P345, DOI 10.1016/j.molimm.2008.10.025; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Marracci GH, 2006, BIOCHEM BIOPH RES CO, V344, P963, DOI 10.1016/j.bbrc.2006.03.172; Marracci GH, 2004, J NEUROSCI RES, V78, P362, DOI 10.1002/jnr.20255; Marracci GH, 2002, J NEUROIMMUNOL, V131, P104, DOI 10.1016/S0165-5728(02)00269-2; Matusevicius D, 1999, MULT SCLER J, V5, P101, DOI 10.1177/135245859900500206; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Mendel I, 1998, EUR J IMMUNOL, V28, P1727, DOI 10.1002/(SICI)1521-4141(199805)28:05<1727::AID-IMMU1727>3.0.CO;2-#; Moini H, 2002, TOXICOL APPL PHARM, V182, P84, DOI 10.1006/taap.2002.9437; Morini M, 2004, J NEUROIMMUNOL, V148, P146, DOI 10.1016/j.jneuroim.2003.11.021; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; NOVAK TJ, 1990, P NATL ACAD SCI USA, V87, P9353, DOI 10.1073/pnas.87.23.9353; O'Neill EJ, 2006, J NEUROIMMUNOL, V178, P1, DOI 10.1016/j.jneuroim.2006.05.030; OFLYNN K, 1985, NATURE, V313, P686, DOI 10.1038/313686a0; Parry GCN, 1997, J IMMUNOL, V159, P5450; PARRY RJ, 1983, TETRAHEDRON, V39, P1215, DOI 10.1016/S0040-4020(01)91887-3; Pavan B, 2009, DRUG DISCOV TODAY, V14, P982, DOI 10.1016/j.drudis.2009.07.007; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Reiffel JA, 2000, AM J CARDIOL, V85, p46D; Rentzos M, 2008, CLIN NEUROL NEUROSUR, V110, P992, DOI 10.1016/j.clineuro.2008.06.005; ROTT O, 1993, EUR J IMMUNOL, V23, P1745, DOI 10.1002/eji.1830230802; Salinthone S, 2008, J NEUROIMMUNOL, V199, P46, DOI 10.1016/j.jneuroim.2008.05.003; Salinthone Sonemany, 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P132, DOI 10.2174/187153008784534303; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Schillace RV, 2007, BIOCHEM BIOPH RES CO, V354, P259, DOI 10.1016/j.bbrc.2006.12.195; Schillace RV, 2006, CRIT REV IMMUNOL, V26, P113, DOI 10.1615/CritRevImmunol.v26.i2.20; Schreibelt G, 2006, J IMMUNOL, V177, P2630, DOI 10.4049/jimmunol.177.4.2630; Serada S, 2008, P NATL ACAD SCI USA, V105, P9041, DOI 10.1073/pnas.0802218105; SNIJDEWINT FGM, 1995, IMMUNOPHARMACOLOGY, V29, P93, DOI 10.1016/0162-3109(94)00048-K; Tasken K, 2006, BIOCHEM SOC T, V34, P476, DOI 10.1042/BST0340476; TSURUTA L, 1995, J IMMUNOL, V154, P5255; VALENTINE MA, 1985, EUR J IMMUNOL, V15, P851, DOI 10.1002/eji.1830150821; Wall EA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000202; Yadav V, 2005, MULT SCLER J, V11, P159, DOI 10.1191/1352458505ms1143oa; YADAV V, MULT SCLER, V16, P387; Yates MA, 2010, J NEUROIMMUNOL, V220, P136, DOI 10.1016/j.jneuroim.2010.01.013; Zhang B, 2002, NEUROPHARMACOLOGY, V42, P262, DOI 10.1016/S0028-3908(01)00174-5; Zhang WJ, 2007, P NATL ACAD SCI USA, V104, P4077, DOI 10.1073/pnas.0700305104; Ziegler D, 1999, DIABETES CARE, V22, P1296, DOI 10.2337/diacare.22.8.1296; Ziegler D, 1999, EXP CLIN ENDOCR DIAB, V107, P421, DOI 10.1055/s-0029-1212132; Zippin JH, 2004, J CELL BIOL, V164, P527, DOI 10.1083/jcb.200311119	68	69	76	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2010	5	9							e13058	10.1371/journal.pone.0013058	http://dx.doi.org/10.1371/journal.pone.0013058			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654ZQ	20927401	gold, Green Published, Green Submitted			2022-12-27	WOS:000282210700025
J	Anderson, RV; McGill, J; Legge, KL				Anderson, Rebecca VanOosten; McGill, Jodi; Legge, Kevin L.			Quantification of the Frequency and Multiplicity of Infection of Respiratory- and Lymph Node-Resident Dendritic Cells During Influenza Virus Infection	PLOS ONE			English	Article							CD8(+) T-CELLS; ANTIGEN PRESENTATION; RESPONSES; PROLIFERATION; ACTIVATION; SUBSETS; LUNG; MICE; MIGRATION; HYBRIDS	Background: Previous studies have demonstrated that DC differentially regulate influenza A virus (IAV)-specific CD8 T cell responses in vivo during high and low dose IAV infections. Furthermore, in vitro infection of DC with IAV at low versus high multiplicities of infection (MOI) results in altered cytokine production and a reduced ability to prime naive CD8 T cell responses. Flow cytometric detection of IAV proteins within DC, a commonly used method for detection of cellular IAV infection, does not distinguish between the direct infection of these cells or their uptake of viral proteins from dying epithelial cells. Methods/Principal Findings: We have developed a novel, sensitive, single-cell RT-PCR-based approach to assess the infection of respiratory DC (rDC) and lymph node (LN)-resident DC (LNDC) following high and low dose IAV infections. Our results show that, while a fraction of both rDC and LNDC contain viral mRNA following IAV infection, there is little correlation between the percentage of rDC containing viral mRNA and the initial IAV inoculum dose. Instead, increasing IAV inoculums correlate with augmented rDC MOI. Conclusion/Significance: Together, our results demonstrate a novel and sensitive method for the detection of direct IAV infection at the single-cell level and suggest that the previously described ability of DC to differentially regulate IAV-specific T cell responses during high and low dose IAV infections could relate to the MOI of rDC within the LN rather than the percentage of rDC infected.	[Anderson, Rebecca VanOosten; McGill, Jodi; Legge, Kevin L.] Univ Iowa, Dept Pathol, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA	University of Iowa	Anderson, RV (corresponding author), NIAID, Rocky Mt Labs, Intracellular Parasites Lab, NIH, Hamilton, MT 59840 USA.	kevin-legge@uiowa.edu		Legge, Kevin/0000-0001-9800-6854	National Institutes of Health (NIH) [AI-071085]; Department of Pathology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071085] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Pathology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grant AI-071085 and Department of Pathology Start-Up Funds to KLL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhardwaj N, 1995, ADV EXP MED BIOL, V378, P375; BHARDWAJ N, 1994, J CLIN INVEST, V94, P797, DOI 10.1172/JCI117399; EICHELBERGER MC, 1991, J GEN VIROL, V72, P1695, DOI 10.1099/0022-1317-72-7-1695; GeurtsvanKessel CH, 2008, J EXP MED, V205, P1621, DOI 10.1084/jem.20071365; HAMILTONEASTON A, 1995, J VIROL, V69, P6359, DOI 10.1128/JVI.69.10.6359-6366.1995; Hao XL, 2008, J VIROL, V82, P4908, DOI 10.1128/JVI.02367-07; Jenkins MR, 2008, J IMMUNOL, V181, P3818, DOI 10.4049/jimmunol.181.6.3818; Kelso A, 2002, INT IMMUNOL, V14, P605, DOI 10.1093/intimm/dxf028; Kim TS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004204; Kusuhara M, 2002, EUR J IMMUNOL, V32, P1035, DOI 10.1002/1521-4141(200204)32:4<1035::AID-IMMU1035>3.0.CO;2-7; Lamb R.A., 2001, FIELDS VIROLOGY; Legge KL, 2005, IMMUNITY, V23, P649, DOI 10.1016/j.immuni.2005.11.006; Legge KL, 2003, IMMUNITY, V18, P265, DOI 10.1016/S1074-7613(03)00023-2; Matsue H, 2001, BLOOD, V98, P3465, DOI 10.1182/blood.V98.12.3465; Mizumoto N, 2005, J INVEST DERMATOL, V124, P718, DOI 10.1111/j.0022-202X.2005.23616.x; Oh S, 2000, J VIROL, V74, P5460, DOI 10.1128/JVI.74.12.5460-5469.2000; Oh S, 2001, VIROLOGY, V286, P403, DOI 10.1006/viro.2001.0992; Oh S, 1999, VIROLOGY, V264, P427, DOI 10.1006/viro.1999.0019; Oh S, 2000, J VIROL, V74, P7738, DOI 10.1128/JVI.74.17.7738-7744.2000; Valenzuela JO, 2005, J IMMUNOL, V174, P600, DOI 10.4049/jimmunol.174.2.600; Zammit DJ, 2006, IMMUNITY, V24, P439, DOI 10.1016/j.immuni.2006.01.015	21	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12902	10.1371/journal.pone.0012902	http://dx.doi.org/10.1371/journal.pone.0012902			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886117	gold, Green Published, Green Submitted			2022-12-27	WOS:000282091100012
J	Bru, A; Cardona, PJ				Bru, Antonio; Cardona, Pere-Joan			Mathematical Modeling of Tuberculosis Bacillary Counts and Cellular Populations in the Organs of Infected Mice	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; PROTECTIVE IMMUNITY; GRANULOMA-FORMATION; MURINE MACROPHAGES; TUBERCLE-BACILLI; SERUM THERAPY; BCG INFECTION; IN-VITRO	Background: Mycobacterium tuberculosis is a particularly aggressive microorganism and the host's defense is based on the induction of cellular immunity, in which the creation of a granulomatous structure has an important role. Methodology: We present here a new 2D cellular automata model based on the concept of a multifunctional process that includes key factors such as the chemokine attraction of the cells; the role of innate immunity triggered by natural killers; the presence of neutrophils; apoptosis and necrosis of infected macrophages; the removal of dead cells by macrophages, which induces the production of foamy macrophages (FMs); the life cycle of the bacilli as a determinant for the evolution of infected macrophages; and the immune response. Results: The results obtained after the inclusion of two degrees of tolerance to the inflammatory response triggered by the infection shows that the model can cover a wide spectrum, ranging from highly-tolerant (i.e. mice) to poorly-tolerant hosts (i.e. mini-pigs or humans). Conclusions: This model suggest that stopping bacillary growth at the onset of the infection might be difficult and the important role played by FMs in bacillary drainage in poorly-tolerant hosts together with apoptosis and innate lymphocytes. It also shows the poor ability of the cellular immunity to control the infection, provides a clear protective character to the granuloma, due its ability to attract a sufficient number of cells, and explains why an already infected host can be constantly reinfected.	[Bru, Antonio] Univ Complutense Madrid, Dept Matemat Aplicada, Fac Matemat, Madrid, Spain; [Cardona, Pere-Joan] Univ Autonoma Barcelona, Unitat TB Expt, Fundacio Inst Invest Ciencies Salut Germans Trias, Badalona, Spain; [Cardona, Pere-Joan] Inst Salud Carlos III, Ctr Invest Biomed Red CIBER Enfermedades Resp, Palma de Mallorca, Spain	Complutense University of Madrid; Autonomous University of Barcelona; Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III	Bru, A (corresponding author), Univ Complutense Madrid, Dept Matemat Aplicada, Fac Matemat, Madrid, Spain.	pjcardona.igtp.germanstrias@gencat.cat	Mas, Maria Teresa/AAC-2082-2020; Cardona, Pere-Joan/A-5258-2011	Mas, Maria Teresa/0000-0001-6914-5329; Cardona, Pere-Joan/0000-0001-5623-7873	Universidad Complutense de Madrid; Institut Germans Trias i Pujol (IGTP)	Universidad Complutense de Madrid; Institut Germans Trias i Pujol (IGTP)	The authors have been funded by the Universidad Complutense de Madrid and the Institut Germans Trias i Pujol (IGTP). The funders had no role in the decision to publish or preparation of the manuscript.	Algood HMS, 2005, CLIN INFECT DIS, V41, pS189, DOI 10.1086/429994; Andersen P, 1997, SCAND J IMMUNOL, V45, P115, DOI 10.1046/j.1365-3083.1997.d01-380.x; Ayres JS, 2008, PLOS BIOL, V6, P2764, DOI 10.1371/journal.pbio.0060305; BARER M, 2003, DORMANCY LOW GROWTH; Brinkmann V, 2007, NAT REV MICROBIOL, V5, P577, DOI 10.1038/nrmicro1710; Buchanan RE, 1918, J INFECT DIS, V23, P109, DOI 10.1086/infdis/23.2.109; Buddle BM, 2005, TUBERCULOSIS, V85, P19, DOI 10.1016/j.tube.2004.09.003; Bui TD, 1998, J APPL PHYSIOL, V84, P2070, DOI 10.1152/jappl.1998.84.6.2070; Caceres N, 2009, TUBERCULOSIS, V89, P175, DOI 10.1016/j.tube.2008.11.001; Canetti G., 1955, TUBERCLE BACILLUS PU; Capuano SV, 2003, INFECT IMMUN, V71, P5831, DOI 10.1128/IAI.71.10.5831-5844.2003; Cardona PJ, 2009, INFECTION, V37, P80, DOI 10.1007/s15010-008-8087-y; Cardona Pere-Joan, 2007, Inflammation & Allergy Drug Targets, V6, P27; Cardona PJ, 2006, TUBERCULOSIS, V86, P273, DOI 10.1016/j.tube.2006.01.024; Cardona PJ, 2000, SCAND J IMMUNOL, V52, P156, DOI 10.1046/j.1365-3083.2000.00763.x; Cardona PJ, 2004, EUR RESPIR J, V24, P1044, DOI 10.1183/09031936.04.00072604; Cardona PJ, 2003, INFECT IMMUN, V71, P5845, DOI 10.1128/IAI.71.10.5845-5854.2003; Chackerian AA, 2002, INFECT IMMUN, V70, P4501, DOI 10.1128/IAI.70.8.4501-4509.2002; Converse PJ, 1996, INFECT IMMUN, V64, P4776, DOI 10.1128/IAI.64.11.4776-4787.1996; Cox RA, 2004, MICROBIOL-SGM, V150, P1413, DOI 10.1099/mic.0.26560-0; D'Avila H, 2008, CELL MICROBIOL, V10, P2589, DOI 10.1111/j.1462-5822.2008.01233.x; Dannenberg AM, 2006, PATHOGENESIS OF HUMAN PULMONARY TUBERCULOSIS: INSIGHTS FROM THE RABBIT MODEL, P1; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; DesJardin LE, 2002, MICROBIOL-SGM, V148, P3161, DOI 10.1099/00221287-148-10-3161; Egen JG, 2008, IMMUNITY, V28, P271, DOI 10.1016/j.immuni.2007.12.010; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Gil O, 2006, MICROBES INFECT, V8, P628, DOI 10.1016/j.micinf.2005.08.014; Gil O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010030; Gill WP, 2009, NAT MED, V15, P211, DOI 10.1038/nm.1915; Glatman-Freedman A, 1998, CLIN MICROBIOL REV, V11, P514, DOI 10.1128/CMR.11.3.514; Gomes MS, 1999, INFECT IMMUN, V67, P3199, DOI 10.1128/IAI.67.7.3199-3206.1999; Gordillo S, 2006, SCAND J IMMUNOL, V64, P30, DOI 10.1111/j.1365-3083.2006.01765.x; Grosset J, 2003, ANTIMICROB AGENTS CH, V47, P833, DOI 10.1128/AAC.47.3.833-836.2003; Guillier L, 2005, APPL ENVIRON MICROB, V71, P2940, DOI 10.1128/AEM.71.6.2940-2948.2005; Guirado E, 2006, MICROBES INFECT, V8, P1252, DOI 10.1016/j.micinf.2005.12.004; HEMSWORTH GR, 1978, INFECT IMMUN, V19, P170, DOI 10.1128/IAI.19.1.170-177.1978; Herzog Erica L, 2008, Proc Am Thorac Soc, V5, P778, DOI 10.1513/pats.200803-028HR; Holt PG, 2000, J AEROSOL MED, V13, P361, DOI 10.1089/jam.2000.13.361; Holt PG, 2000, AM J RESP CRIT CARE, V162, pS151, DOI 10.1164/ajrccm.162.supplement_3.15tac2; Jung YJ, 2005, J EXP MED, V201, P1915, DOI 10.1084/jem.20050265; Khader SA, 2009, J IMMUNOL, V183, P8004, DOI 10.4049/jimmunol.0901937; KINDLER V, 1989, CELL, V56, P731, DOI 10.1016/0092-8674(89)90676-4; Kipnis A, 2003, J LEUKOCYTE BIOL, V74, P992, DOI 10.1189/jlb.0603301; Lee J, 2006, J IMMUNOL, V176, P4267, DOI 10.4049/jimmunol.176.7.4267; Leemans JC, 2005, J INFECT DIS, V191, P65, DOI 10.1086/426395; Lenaerts AJ, 2007, ANTIMICROB AGENTS CH, V51, P3338, DOI 10.1128/AAC.00276-07; Lenzi HL, 2006, MEM I OSWALDO CRUZ, V101, P219, DOI 10.1590/S0074-02762006000900034; Martinez D, 2007, J IMMUNOL, V179, P1950, DOI 10.4049/jimmunol.179.3.1950; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Mollenkopf HJ, 2004, J INFECT DIS, V190, P588, DOI 10.1086/422394; Morita RY, 1993, STARVATION BACTERIA, P1, DOI [10.1007/978-1-4899-2439-1_1, DOI 10.1007/978-1-4899-2439-1_1]; Munoz-Elias EJ, 2005, INFECT IMMUN, V73, P546, DOI 10.1128/IAI.73.1.546-551.2005; Murray JF, 2010, INT J TUBERC LUNG D, V14, P391; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; Otto SP, 2007, BIOL GUIDE MATH MODE; Park JS, 2006, J LEUKOCYTE BIOL, V79, P80, DOI 10.1189/jlb.0505250; Parrish NM, 1998, TRENDS MICROBIOL, V6, P107, DOI 10.1016/S0966-842X(98)01216-5; Paul S, 1996, J INFECT DIS, V174, P105, DOI 10.1093/infdis/174.1.105; Persson YAZ, 2008, MICROBES INFECT, V10, P233, DOI 10.1016/j.micinf.2007.11.007; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Prats C, 2008, J THEOR BIOL, V252, P56, DOI 10.1016/j.jtbi.2008.01.019; RHOADES ER, 1995, INFECT IMMUN, V63, P3871, DOI 10.1128/IAI.63.10.3871-3877.1995; Rhoades ER, 1997, TUBERCLE LUNG DIS, V78, P57, DOI 10.1016/S0962-8479(97)90016-2; Roach DR, 2002, J IMMUNOL, V168, P4620, DOI 10.4049/jimmunol.168.9.4620; Roberts Esteban A., 2008, V445, P439, DOI 10.1007/978-1-59745-157-4_28; Rodrigues MF, 2009, IMMUNOLOGY, V128, pe691, DOI 10.1111/j.1365-2567.2009.03062.x; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Sada-Ovalle I, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000239; Sapoval B, 2002, P NATL ACAD SCI USA, V99, P10411, DOI 10.1073/pnas.122352499; Saunders BM, 2007, IMMUNOL CELL BIOL, V85, P103, DOI 10.1038/sj.icb.7100027; Segovia-Juarez JL, 2004, J THEOR BIOL, V231, P357, DOI 10.1016/j.jtbi.2004.06.031; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Shleeva MO, 2002, MICROBIOL-SGM, V148, P1581, DOI 10.1099/00221287-148-5-1581; Silver RF, 1998, INFECT IMMUN, V66, P1190, DOI 10.1128/IAI.66.3.1190-1199.1998; Tan BH, 2006, J IMMUNOL, V177, P1864, DOI 10.4049/jimmunol.177.3.1864; Ulrichs T, 2006, J PATHOL, V208, P261, DOI 10.1002/path.1906; Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102; WALLACE JG, 1961, AM REV RESPIR DIS, V83, P866; WAYNE LG, 1976, AM REV RESPIR DIS, V114, P807; Wolf AJ, 2008, J EXP MED, V205, P105, DOI 10.1084/jem.20071367; World Health Organization, 2009, GLOB TUB CONTR EP ST; Zhang X, 2009, IMMUNITY, V31, P761, DOI 10.1016/j.immuni.2009.09.016	82	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12985	10.1371/journal.pone.0012985	http://dx.doi.org/10.1371/journal.pone.0012985			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886087	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000282091100062
J	Devi, L; Ohno, M				Devi, Latha; Ohno, Masuo			Phospho-eIF2 alpha Level Is Important for Determining Abilities of BACE1 Reduction to Rescue Cholinergic Neurodegeneration and Memory Defects in 5XFAD Mice	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; CARBOXYL-TERMINAL FRAGMENT; BETA-SECRETASE ACTIVITY; CLEAVING ENZYME 1; ALZHEIMERS-DISEASE; TRANSGENIC MICE; IN-VIVO; MOUSE MODELS; A-BETA; SYNAPTIC PLASTICITY	beta-Site APP-cleaving enzyme 1 (BACE1) initiates amyloid-beta (A beta) generation and thus represents a prime therapeutic target in treating Alzheimer's disease (AD). Notably, increasing evidence indicates that BACE1 levels become elevated in AD brains as disease progresses; however, it remains unclear how the BACE1 upregulation may affect efficacies of therapeutic interventions including BACE1-inhibiting approaches. Here, we crossed heterozygous BACE1 knockout mice with AD transgenic mice (5XFAD model) and compared the abilities of partial BACE1 reduction to rescue AD-like phenotypes at earlier (6-month-old) and advanced (15-18-month-old) stages of disease, which expressed normal (similar to 100%) and elevated (similar to 200%) levels of BACE1, respectively. BACE1(+/-) deletion rescued memory deficits as tested by the spontaneous alternation Y-maze task in 5XFAD mice at the earlier stage and prevented their septohippocampal cholinergic deficits associated with significant neuronal loss. Importantly, BACE1(+/-) deletion was no longer able to rescue memory deficits or cholinergic neurodegeneration in 5XFAD mice at the advanced stage. Moreover, BACE1(+/-) deletion significantly reduced levels of A beta 42 and the beta-secretase-cleaved C-terminal fragment (C99) in 6-month-old 5XFAD mouse brains, while these neurotoxic beta-cleavage products dramatically elevated with age and were not affected by BACE1(+/-) deletion in 15-18-month-old 5XFAD brains. Interestingly, although BACE1(+/-) deletion lowered BACE1 expression by similar to 50% in 5XFAD mice irrespective of age in concordance with the reduction in gene copy number, BACE1 equivalent to wild-type controls remained in BACE1(+/-) . 5XFAD mice at the advanced age. In accord, phosphorylation of the translation initiation factor eIF2 alpha, an important mediator of BACE1 elevation, was dramatically increased (similar to 9-fold) in 15-18-month-old 5XFAD mice and remained highly upregulated (similar to 6-fold) in age-matched BACE1(+/-) . 5XFAD mice. Together, our results indicate that partial reduction of BACE1 is not sufficient to block the phospho-eIF2 alpha-dependent BACE1 elevation during the progression of AD, thus limiting its abilities to reduce cerebral A beta/C99 levels and rescue memory deficits and cholinergic neurodegeneration.	[Devi, Latha; Ohno, Masuo] NYU, Sch Med, Ctr Dementia Res, Nathan Kline Inst, Orangeburg, NY USA	Nathan Kline Institute for Psychiatric Research; New York University	Devi, L (corresponding author), NYU, Sch Med, Ctr Dementia Res, Nathan Kline Inst, Orangeburg, NY USA.	mohno@nki.rfmh.org			National Institutes of Health [R01 MH067251]; Alzheimer's Association [IIRG-08-91231]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067251] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health grant R01 MH067251 (M.O.) and Alzheimer's Association grant IIRG-08-91231 (M.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed RR, 2010, J NEUROCHEM, V112, P1045, DOI 10.1111/j.1471-4159.2009.06528.x; Bellucci A, 2006, NEUROBIOL DIS, V23, P260, DOI 10.1016/j.nbd.2006.03.012; Berger-Sweeney J, 1999, MOL BRAIN RES, V66, P150, DOI 10.1016/S0169-328X(99)00014-5; Boncristiano S, 2002, J NEUROSCI, V22, P3234, DOI 10.1523/JNEUROSCI.22-08-03234.2002; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Chang Q, 2004, HIPPOCAMPUS, V14, P170, DOI 10.1002/hipo.10160; Chang RCC, 2002, NEUROREPORT, V13, P2429, DOI 10.1097/00001756-200212200-00011; Chang WP, 2007, FASEB J, V21, P3184, DOI 10.1096/fj.06-7993com; Choi SH, 2001, FASEB J, V15, P1816, DOI 10.1096/fj.00-0859fje; Christensen DZ, 2010, NEUROBIOL AGING, V31, P1153, DOI 10.1016/j.neurobiolaging.2008.07.022; Citron M, 2004, TRENDS PHARMACOL SCI, V25, P92, DOI 10.1016/j.tips.2003.12.004; Cole SL, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-22; Contestabile A, 2008, NEUROCHEM RES, V33, P318, DOI 10.1007/s11064-007-9497-4; Cruz JC, 2006, J NEUROSCI, V26, P10536, DOI 10.1523/JNEUROSCI.3133-06.2006; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; Devi L, 2010, EUR J NEUROSCI, V31, P110, DOI 10.1111/j.1460-9568.2009.07031.x; FEASEYTRUGER KJ, 1992, BRAIN RES, V591, P296, DOI 10.1016/0006-8993(92)91711-M; de Sevilla DF, 2008, J NEUROSCI, V28, P1469, DOI 10.1523/JNEUROSCI.2723-07.2008; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Frisardi V, 2010, CURR ALZHEIMER RES, V7, P40, DOI 10.2174/156720510790274400; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Ghosh AK, 2008, NEUROTHERAPEUTICS, V5, P399, DOI 10.1016/j.nurt.2008.05.007; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hunt CE, 2009, FEBS J, V276, P1845, DOI 10.1111/j.1742-4658.2009.06929.x; Hussain I, 2007, J NEUROCHEM, V100, P802, DOI 10.1111/j.1471-4159.2006.04260.x; JAWHAR S, 2010, NEUROBIOL A IN PRESS; John V, 2006, CURR TOP MED CHEM, V6, P569, DOI 10.2174/156802606776743084; Kimura R, 2010, J NEUROCHEM, V113, P248, DOI 10.1111/j.1471-4159.2010.06608.x; Kimura R, 2009, NEUROBIOL DIS, V33, P229, DOI 10.1016/j.nbd.2008.10.006; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0; Lee KW, 2006, NEUROBIOL DIS, V22, P10, DOI 10.1016/j.nbd.2005.09.011; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; McConlogue L, 2007, J BIOL CHEM, V282, P26326, DOI 10.1074/jbc.M611687200; Nalbantoglu J, 1997, NATURE, V387, P500, DOI 10.1038/387500a0; O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Ohno M, 2006, EUR J NEUROSCI, V23, P251, DOI 10.1111/j.1460-9568.2005.04551.x; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; OHNO M, 1992, J PHARMACOL EXP THER, V263, P943; Ohno M, 2008, RECENT ADV BIOL SECR, P1; Ohno M, 2007, NEUROBIOL DIS, V26, P134, DOI 10.1016/j.nbd.2006.12.008; Ohno M, 2006, REV NEUROSCIENCE, V17, P429; Ohno M, 2009, NEUROBIOL LEARN MEM, V92, P455, DOI 10.1016/j.nlm.2009.05.001; Ovsepian SV, 2004, EUR J NEUROSCI, V20, P1267, DOI 10.1111/j.1460-9568.2004.03582.x; Perez SE, 2007, NEUROBIOL DIS, V28, P3, DOI 10.1016/j.nbd.2007.06.015; Sanchez G, 2009, J NEUROSCI RES, V87, P691, DOI 10.1002/jnr.21876; Sankaranarayanan S, 2009, J PHARMACOL EXP THER, V328, P131, DOI 10.1124/jpet.108.143628; Sarajarvi T, 2009, J BIOL CHEM, V284, P34433, DOI 10.1074/jbc.M109.036202; Shinoe T, 2005, J NEUROSCI, V25, P11194, DOI 10.1523/JNEUROSCI.2338-05.2005; Singer O, 2005, NAT NEUROSCI, V8, P1343, DOI 10.1038/nn1531; Song DK, 1998, J NEUROCHEM, V71, P875; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Wen Y, 2008, NEURON, V57, P680, DOI 10.1016/j.neuron.2008.02.024; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Zhang XM, 2009, EUR J NEUROSCI, V30, P2271, DOI 10.1111/j.1460-9568.2009.07017.x; Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007	60	82	86	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12974	10.1371/journal.pone.0012974	http://dx.doi.org/10.1371/journal.pone.0012974			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886088	Green Published, Green Submitted, gold			2022-12-27	WOS:000282091100058
J	Nufio, CR; McGuire, CR; Bowers, MD; Guralnick, RP				Nufio, Cesar R.; McGuire, Chris R.; Bowers, M. Deane; Guralnick, Robert P.			Grasshopper Community Response to Climatic Change: Variation Along an Elevational Gradient	PLOS ONE			English	Article							PHENOLOGICAL RESPONSE; ALTITUDINAL VARIATION; ORTHOPTERA-ACRIDIDAE; NORTHERN COLORADO; ROCKY MOUNTAINS; THERMAL TIME; BUTTERFLIES; ABUNDANCE; IMPACTS; MODEL	Background: The impacts of climate change on phenological responses of species and communities are well-documented; however, many such studies are correlational and so less effective at assessing the causal links between changes in climate and changes in phenology. Using grasshopper communities found along an elevational gradient, we present an ideal system along the Front Range of Colorado USA that provides a mechanistic link between climate and phenology. Methodology/Principal Findings: This study utilizes past (1959-1960) and present (2006-2008) surveys of grasshopper communities and daily temperature records to quantify the relationship between amount and timing of warming across years and elevations, and grasshopper timing to adulthood. Grasshopper communities were surveyed at four sites, Chautauqua Mesa (1752 m), A1 (2195 m), B1 (2591 m), and C1 (3048 m), located in prairie, lower montane, upper montane, and subalpine life zones, respectively. Changes to earlier first appearance of adults depended on the degree to which a site warmed. The lowest site showed little warming and little phenological advancement. The next highest site (A1) warmed a small, but significant, amount and grasshopper species there showed inconsistent phenological advancements. The two highest sites warmed the most, and at these sites grasshoppers showed significant phenological advancements. At these sites, late-developing species showed the greatest advancements, a pattern that correlated with an increase in rate of late-season warming. The number of growing degree days (GDDs) associated with the time to adulthood for a species was unchanged across the past and present surveys, suggesting that phenological advancement depended on when a set number of GDDs is reached during a season. Conclusions: Our analyses provide clear evidence that variation in amount and timing of warming over the growing season explains the vast majority of phenological variation in this system. Our results move past simple correlation and provide a stronger process-oriented and predictive framework for understanding community level phenological responses to climate change.	[Nufio, Cesar R.; Bowers, M. Deane; Guralnick, Robert P.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Nufio, Cesar R.; McGuire, Chris R.; Bowers, M. Deane; Guralnick, Robert P.] Univ Colorado, Nat Hist Museum, Boulder, CO 80309 USA; [McGuire, Chris R.] Univ Colorado, Environm Studies Program, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Nufio, CR (corresponding author), Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA.	nufio@colorado.edu		BOWERS, M/0000-0002-5697-888X	National Science Foundation [1543813]; University of Colorado Museum of Natural History; Chancellor's Office of the University of Colorado, Boulder	National Science Foundation(National Science Foundation (NSF)); University of Colorado Museum of Natural History; Chancellor's Office of the University of Colorado, Boulder	This research was supported by the National Science Foundation (Grant #1543813), the University of Colorado Museum of Natural History's Walker Van Riper research grant and a post-doctoral diversity fellowship from the Chancellor's Office of the University of Colorado, Boulder. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian R, 2006, GLOBAL CHANGE BIOL, V12, P652, DOI 10.1111/j.1365-2486.2006.01125.x; ALEXANDE.G, 1969, ECOL MONOGR, V39, P385, DOI 10.2307/1942354; ALEXANDER G, 1964, ECOLOGY, V45, P77, DOI 10.2307/1937109; Altermatt F, 2010, P ROY SOC B-BIOL SCI, V277, P1281, DOI 10.1098/rspb.2009.1910; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; BASKERVILLE GL, 1969, ECOLOGY, V50, P514, DOI 10.2307/1933912; Berner D, 2006, J ANIM ECOL, V75, P130, DOI 10.1111/j.1365-2656.2005.01028.x; Bertin RI, 2008, J TORREY BOT SOC, V135, P126, DOI 10.3159/07-RP-035R.1; Brust ML, 2009, ENVIRON ENTOMOL, V38, P1521, DOI 10.1603/022.038.0521; CANNELL MGR, 1983, J APPL ECOL, V20, P951, DOI 10.2307/2403139; Chappell M.A., 1990, P143; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; COXWELL CC, 1995, OECOLOGIA, V104, P433, DOI 10.1007/BF00341340; DALY C, 2009, INT J CLIMATOLOGY, DOI DOI 10.1002/JOC.2007; DEARN JM, 1977, OECOLOGIA, V28, P67, DOI 10.1007/BF00346837; DINGLE H, 1990, OECOLOGIA, V84, P199, DOI 10.1007/BF00318272; Fielding DJ, 2007, PHYSIOL BIOCHEM ZOOL, V80, P607, DOI 10.1086/521801; Fielding DJ, 2004, ENVIRON ENTOMOL, V33, P1513, DOI 10.1603/0046-225X-33.6.1513; Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; GAGE SH, 1976, CAN ENTOMOL, V108, P245, DOI 10.4039/Ent108245-3; GAGE SH, 1977, ENVIRON ENTOMOL, V6, P469, DOI 10.1093/ee/6.3.469; Gerten D, 2002, FRESHWATER BIOL, V47, P2163, DOI 10.1046/j.1365-2427.2002.00970.x; Gienapp P, 2005, GLOBAL CHANGE BIOL, V11, P600, DOI 10.1111/j.1365-2486.2005.00925.x; Grenier M, 2009, BOTANY, V87, P492, DOI 10.1139/B09-018; Guo K, 2009, GLOBAL CHANGE BIOL, V15, P2539, DOI 10.1111/j.1365-2486.2009.01861.x; Hassall C, 2007, GLOBAL CHANGE BIOL, V13, P933, DOI 10.1111/j.1365-2486.2007.01318.x; Hassall M, 2006, J EVOLUTION BIOL, V19, P267, DOI 10.1111/j.1420-9101.2005.00967.x; Inouye DW, 2000, P NATL ACAD SCI USA, V97, P1630, DOI 10.1073/pnas.97.4.1630; INOUYE DW, 1991, AM J BOT, V78, P997, DOI 10.2307/2445179; Jentsch A, 2009, GLOBAL CHANGE BIOL, V15, P837, DOI 10.1111/j.1365-2486.2008.01690.x; Joern A., 1990, P415; Laws AN, 2010, ENVIRON ENTOMOL, V39, P312, DOI 10.1603/EN09294; MARR JW, 1967, U COLORADO STUDIES S; Menzel A, 2003, INT J CLIMATOL, V23, P793, DOI 10.1002/joc.915; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Morin X, 2009, GLOBAL CHANGE BIOL, V15, P961, DOI 10.1111/j.1365-2486.2008.01735.x; Olfert Owen, 2006, Journal of Orthoptera Research, V15, P65, DOI 10.1665/1082-6467(2006)15[65:BMOMSF]2.0.CO;2; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2007, GLOBAL CHANGE BIOL, V13, P1860, DOI 10.1111/j.1365-2486.2007.01404.x; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Parry M. L., 2007, CLIMATE CHANGE 2007; Pepin N, 2000, ARCT ANTARCT ALP RES, V32, P135, DOI 10.2307/1552445; Pitt WC, 1999, EVOL ECOL, V13, P499, DOI 10.1023/A:1006792726166; Primack RB, 2009, BIOL CONSERV, V142, P2569, DOI 10.1016/j.biocon.2009.06.003; Primack RB, 2009, BIOL CONSERV, V142, P1943, DOI 10.1016/j.biocon.2009.03.016; Richter O, 2008, FRESHWATER BIOL, V53, P1868, DOI 10.1111/j.1365-2427.2008.02012.x; Roltsch WJ, 1999, INT J BIOMETEOROL, V42, P169, DOI 10.1007/s004840050101; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Roy DB, 2000, GLOB CHANGE BIOL, V6, P407, DOI 10.1046/j.1365-2486.2000.00322.x; SALSER MA, 2003, THESIS U CALIFORNIA; Samietz J, 2005, J EVOLUTION BIOL, V18, P1087, DOI 10.1111/j.1420-9101.2005.00893.x; Schwartz MD, 2006, GLOBAL CHANGE BIOL, V12, P343, DOI 10.1111/j.1365-2486.2005.01097.x; Stefanescu C, 2003, GLOBAL CHANGE BIOL, V9, P1494, DOI 10.1046/j.1365-2486.2003.00682.x; Telfer MG, 1999, OECOLOGIA, V121, P245, DOI 10.1007/s004420050926; Thackeray SJ, 2008, J ECOL, V96, P523, DOI 10.1111/j.1365-2745.2008.01355.x; Trudgill DL, 2005, ANN APPL BIOL, V146, P1, DOI 10.1111/j.1744-7348.2005.04088.x; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997; Visser ME, 2001, P ROY SOC B-BIOL SCI, V268, P289, DOI 10.1098/rspb.2000.1363; Willis CG, 2008, P NATL ACAD SCI USA, V105, P17029, DOI 10.1073/pnas.0806446105; Wilson L. T., 1983, California Agriculture, V37, P4	61	49	53	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12977	10.1371/journal.pone.0012977	http://dx.doi.org/10.1371/journal.pone.0012977			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886093	gold, Green Published, Green Submitted			2022-12-27	WOS:000282091100060
J	Wang, YL; Lacroix, G; Haines, J; Doukhanine, E; Almazan, G; Richard, S				Wang, Yunling; Lacroix, Genevieve; Haines, Jeffery; Doukhanine, Evgueni; Almazan, Guillermina; Richard, Stephane			The QKI-6 RNA Binding Protein Localizes with the MBP mRNAs in Stress Granules of Glial Cells	PLOS ONE			English	Article							NUCLEAR-LOCALIZATION; QUAKING; MYELIN; REVEALS; DYSMYELINATION; TRANSLATION; SPECIFICITY; MUTATION; SIGNAL; QK1	Background: The quaking viable (qk(v)) mouse has several developmental defects that result in rapid tremors in the hind limbs. The qkl gene expresses three major alternatively spliced mRNAs (5, 6 and 7 kb) that encode the QKI-5, QKI-6 and QKI-7 RNA binding proteins that differ in their C-terminal 30 amino acids. The QKI isoforms are known to regulate RNA metabolism within oligodendrocytes, however, little is known about their roles during cellular stress. Methodology/Principal Findings: In this study, we report an interaction between the QKI-6 isoform and a component of the RNA induced silencing complex (RISC), argonaute 2 (Ago2). We show in glial cells that QKI-6 co-localizes with Ago2 and the myelin basic protein mRNA in cytoplasmic stress granules. Conclusions: Our findings define the QKI isoforms as Ago2-interacting proteins. We also identify the QKI-6 isoform as a new component of stress granules in glial cells.	[Wang, Yunling; Lacroix, Genevieve; Doukhanine, Evgueni; Richard, Stephane] McGill Univ, Terry Fox Mol Oncol Grp, Lady Davis Inst Med Res, Montreal, PQ, Canada; [Wang, Yunling; Lacroix, Genevieve; Doukhanine, Evgueni; Richard, Stephane] McGill Univ, Dept Oncol, Bloomfield Ctr Res Aging, Montreal, PQ, Canada; [Wang, Yunling; Lacroix, Genevieve; Doukhanine, Evgueni] McGill Univ, Dept Med, Bloomfield Ctr Res Aging, Montreal, PQ, Canada; [Haines, Jeffery; Almazan, Guillermina] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada	Lady Davis Institute; McGill University; McGill University; McGill University; McGill University	Wang, YL (corresponding author), McGill Univ, Terry Fox Mol Oncol Grp, Lady Davis Inst Med Res, Montreal, PQ, Canada.	stephane.richard@mcgill.ca			Multiple Sclerosis Society of Canada (MSSOC); le Fonds Quebecois de la recherche sur la Nature et les Technolgies; MSSOC	Multiple Sclerosis Society of Canada (MSSOC); le Fonds Quebecois de la recherche sur la Nature et les Technolgies; MSSOC	This work was supported by grants from the Multiple Sclerosis Society of Canada (MSSOC) to G. A. and S. R. Y.W. was a recipient of a postdoctoral fellowship from le Fonds Quebecois de la recherche sur la Nature et les Technolgies and is supported by a fellowship from the MSSOC. E. V. and G. L. were recipients of MSSOC studentships. S. R. is a Chercheur National des Fonds en Recherche en Sante du Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMAZAN G, 1993, J NEUROSCI RES, V36, P163, DOI 10.1002/jnr.490360206; Anderson P, 2009, CURR BIOL, V19, pR397, DOI 10.1016/j.cub.2009.03.013; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; [Anonymous], MYELIN; Bockbrader K, 2008, FUTUR NEUROL, V3, P655, DOI 10.2217/14796708.3.6.655; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Chen TP, 1998, MOL CELL BIOL, V18, P4863, DOI 10.1128/MCB.18.8.4863; Chenard CA, 2008, J NEUROSCI RES, V86, P233, DOI 10.1002/jnr.21485; COLMAN DR, 1982, J CELL BIOL, V95, P598, DOI 10.1083/jcb.95.2.598; Dapper JD, 2005, MOVEMENT DISORD, V20, P1369, DOI 10.1002/mds.20595; Ebersole TA, 1996, NAT GENET, V12, P260, DOI 10.1038/ng0396-260; Galarneau A, 2005, NAT STRUCT MOL BIOL, V12, P691, DOI 10.1038/nsmb963; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hardy RJ, 1996, J NEUROSCI RES, V46, P246, DOI 10.1002/(SICI)1097-4547(19961015)46:2<246::AID-JNR13>3.0.CO;2-0; Jiao XF, 2009, J NEUROSCI, V29, P12419, DOI 10.1523/JNEUROSCI.5954-08.2009; Jin P, 2004, NAT NEUROSCI, V7, P113, DOI 10.1038/nn1174; Keene JD, 2003, NAT GENET, V33, P111, DOI 10.1038/ng0203-111; Larocque D, 2005, NAT NEUROSCI, V8, P27, DOI 10.1038/nn1359; Larocque D, 2002, NEURON, V36, P815, DOI 10.1016/S0896-6273(02)01055-3; Larocque D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005867; Lee Min-Ho, 2006, WormBook, P1; Leung AKL, 2006, P NATL ACAD SCI USA, V103, P18125, DOI 10.1073/pnas.0608845103; Li ZZ, 2000, J NEUROSCI, V20, P4944; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Lukong KE, 2003, BBA-REV CANCER, V1653, P73, DOI 10.1016/j.bbcan.2003.09.001; Lukong KE, 2008, TRENDS GENET, V24, P416, DOI 10.1016/j.tig.2008.05.004; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Pilotte J, 2001, GENE DEV, V15, P845, DOI 10.1101/gad.860301; Ryder SP, 2004, RNA, V10, P1449, DOI 10.1261/rna.7780504; Ryder SP, 2004, NAT STRUCT MOL BIOL, V11, P20, DOI 10.1038/nsmb706; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Thomas MG, 2005, MOL BIOL CELL, V16, P405, DOI 10.1091/mbc.E04-06-0516; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Volk T, 2008, TRENDS GENET, V24, P94, DOI 10.1016/j.tig.2007.11.009; Wu J, 1999, J BIOL CHEM, V274, P29202, DOI 10.1074/jbc.274.41.29202; Wu JI, 2002, P NATL ACAD SCI USA, V99, P4233, DOI 10.1073/pnas.072090399; Zhao LX, 2006, J NEUROSCI, V26, P11278, DOI 10.1523/JNEUROSCI.2677-06.2006	38	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2010	5	9							e12824	10.1371/journal.pone.0012824	http://dx.doi.org/10.1371/journal.pone.0012824			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651XL	20862255	Green Published, gold, Green Submitted			2022-12-27	WOS:000281960800019
J	Lovatt, M; Bijlmakers, MJ				Lovatt, Matthew; Bijlmakers, Marie-Jose			Stabilisation of beta-Catenin Downstream of T Cell Receptor Signalling	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; WNT; EXPRESSION; ACTIVATION; TRANSCRIPTION; SELECTION; LITHIUM; MEMORY; LOCALIZATION; SURVIVAL	Background: The role of TCF/beta-catenin signalling in T cell development is well established, but important roles in mature T cells have only recently come to light. Methodology/Principal Findings: Here we have investigated the signalling pathways that are involved in the regulation of beta-catenin in primary human T cells. We demonstrate that beta-catenin expression is upregulated rapidly after T cell receptor (TCR) stimulation and that this involves protein stabilisation rather than an increase in mRNA levels. Similar to events in Wnt signalling, the increase in beta-catenin coincides with an inhibition of GSK3, the kinase that is required for beta-catenin degradation. beta-catenin stabilisation in T cells can also be induced by the activation of PKC with phorbol esters and is blocked by inhibitors of phosphatidylinositol 3-kinase (PI3K) and phospholipase C (PKC). Upon TCR signalling, b-catenin accumulates in the nucleus and, parallel to this, the ratio of TCF1 isoforms is shifted in favour of the longer beta-catenin binding isoforms. However, phosphorylated beta-catenin, which is believed to be inactive, can also be detected and the expression of Wnt target genes Axin2 and dickkopf is down regulated. Conclusions/Significance: These data show that in mature human T cells, TCR signalling via PI3K and PKC can result in the stabilisation of beta-catenin, allowing beta-catenin to migrate to the nucleus. They further highlight important differences between beta-catenin activities in TCR and Wnt signalling.	Kings Coll London, Peter Gorer Dept Immunobiol, Sch Med, Kings Coll Hosp,Guys Hosp, London WC2R 2LS, England; Kings Coll London, Peter Gorer Dept Immunobiol, Sch Med, St Thomas Hosp,Guys Hosp, London WC2R 2LS, England	Guy's & St Thomas' NHS Foundation Trust; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Lovatt, M (corresponding author), ASTAR, Inst Med Biol, Singapore, Singapore.	matthew.lovatt@imb.a-star.edu.sg	bijlmakers, marie-jose/N-5369-2014	bijlmakers, marie-jose/0000-0001-6762-1168	The Wellcome Trust [078170]	The Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a project grant (078170) from The Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arce L, 2006, ONCOGENE, V25, P7492, DOI 10.1038/sj.onc.1210056; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; BRAGA VMM, 1995, CELL ADHES COMMUN, V3, P201, DOI 10.3109/15419069509081287; Christian SL, 2002, J IMMUNOL, V169, P758, DOI 10.4049/jimmunol.169.2.758; Chung EJ, 2002, BLOOD, V100, P982, DOI 10.1182/blood.V100.3.982; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Diehn M, 2002, P NATL ACAD SCI USA, V99, P11796, DOI 10.1073/pnas.092284399; Ding Y, 2008, NAT MED, V14, P162, DOI 10.1038/nm1707; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Huang P, 2007, ONCOGENE, V26, P4357, DOI 10.1038/sj.onc.1210217; Jeannet G, 2010, P NATL ACAD SCI USA, V107, P9777, DOI 10.1073/pnas.0914127107; Jope RS, 2003, TRENDS PHARMACOL SCI, V24, P441, DOI 10.1016/S0165-6147(03)00206-2; Kovalovsky D, 2009, J IMMUNOL, V183, P3873, DOI 10.4049/jimmunol.0901369; Lafont V, 2000, FEBS LETT, V486, P38, DOI 10.1016/S0014-5793(00)02235-3; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Ng SS, 2009, J BIOL CHEM, V284, P35308, DOI 10.1074/jbc.M109.078261; PAGES F, 1994, NATURE, V369, P327, DOI 10.1038/369327a0; Prieve MG, 1999, MOL CELL BIOL, V19, P4503; Ryves WJ, 2001, BIOCHEM BIOPH RES CO, V280, P720, DOI 10.1006/bbrc.2000.4169; Sadot E, 2002, J CELL SCI, V115, P2771; Staal FJT, 1999, INT IMMUNOL, V11, P317, DOI 10.1093/intimm/11.3.317; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Staal FJT, 2008, EUR J IMMUNOL, V38, P1788, DOI 10.1002/eji.200738118; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Verheyen EM, 2010, DEV DYNAM, V239, P34, DOI 10.1002/dvdy.22019; Welsh GI, 1996, J BIOL CHEM, V271, P11410, DOI 10.1074/jbc.271.19.11410; Willinger T, 2006, J IMMUNOL, V176, P1439, DOI 10.4049/jimmunol.176.3.1439; Wu BB, 2007, IMMUNITY, V26, P227, DOI 10.1016/j.immuni.2006.12.007; Xu M, 2009, J IMMUNOL, V182, P759, DOI 10.4049/jimmunol.182.2.759; Xu M, 2009, J IMMUNOL, V182, P751, DOI 10.4049/jimmunol.182.2.751; Xu YY, 2003, NAT IMMUNOL, V4, P1177, DOI 10.1038/ni1008; Yu Q, 2009, NAT IMMUNOL, V10, P992, DOI 10.1038/ni.1762; Zhao DM, 2010, J IMMUNOL, V184, P1191, DOI 10.4049/jimmunol.0901199	36	38	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2010	5	9							e12794	10.1371/journal.pone.0012794	http://dx.doi.org/10.1371/journal.pone.0012794			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650QH	20862283	Green Published, gold, Green Submitted			2022-12-27	WOS:000281864100024
J	Mann, AP; Somasunderam, A; Nieves-Alicea, R; Li, X; Hu, A; Sood, AK; Ferrari, M; Gorenstein, DG; Tanaka, T				Mann, Aman P.; Somasunderam, Anoma; Nieves-Alicea, Rene; Li, Xin; Hu, Austin; Sood, Anil K.; Ferrari, Mauro; Gorenstein, David G.; Tanaka, Takemi			Identification of Thioaptamer Ligand against E-Selectin: Potential Application for Inflamed Vasculature Targeting	PLOS ONE			English	Article							COLON-CANCER CELLS; RADIOLABELED MONOCLONAL-ANTIBODY; LEUKOCYTE ADHESION MOLECULE; COMBINATORIAL SELECTION; IN-VIVO; RHEUMATOID-ARTHRITIS; THERAPEUTIC AGENTS; BREAST-CANCER; NUCLEIC-ACIDS; APTAMERS	Active targeting of a drug carrier to a specific target site is crucial to provide a safe and efficient delivery of therapeutics and imaging contrast agents. E-selectin expression is induced on the endothelial cell surface of vessels in response to inflammatory stimuli but is absent in the normal vessels. Thus, E-selectin is an attractive molecular target, and high affinity ligands for E-selectin could be powerful tools for the delivery of therapeutics and/or imaging agents to inflamed vessels. In this study, we identified a thiophosphate modified aptamer (thioaptamer, TA) against E-selectin (ESTA-1) by employing a two-step selection strategy: a recombinant protein-based TA binding selection from a combinatorial library followed by a cell-based TA binding selection using E-selectin expressing human microvascular endothelial cells. ESTA-1 selectively bound to E-selectin with nanomolar binding affinity (K(D) = 47 nM) while exhibiting minimal cross reactivity to P- and L-selectin. Furthermore, ESTA-1 binding to E-selectin on the endothelial cells markedly antagonized the adhesion (over 75% inhibition) of sLe(x) positive HL-60 cells at nanomolar concentration. ESTA-1 also bound specifically to the inflamed tumor-associated vasculature of human carcinomas derived from breast, ovarian, and skin but not to normal organs, and this binding was highly associated with the E-selectin expression level. Similarly, intravenously injected ESTA-1 demonstrated distinct binding to the tumor vasculature in a breast cancer xenograft model. Together, our data substantiates the discovery of a thioaptamer (ESTA-1) that binds to E-selectin with high affinity and specificity, thereby highlighting the potential application of ESTA-1 for E-selectin targeted delivery.	[Mann, Aman P.; Somasunderam, Anoma; Nieves-Alicea, Rene; Ferrari, Mauro; Tanaka, Takemi] Univ Texas Hlth Sci Ctr Houston, Dept Nanomed & Biomed Engn, Houston, TX USA; [Li, Xin; Gorenstein, David G.] Univ Texas Hlth Sci Ctr Houston, Inst Mol Med, Houston, TX USA; [Hu, Austin; Ferrari, Mauro; Tanaka, Takemi] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Ferrari, Mauro] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Ferrari, Mauro] Rice Univ, Dept Bioengn, Houston, TX USA; [Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA; [Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Tanaka, Takemi] Thomas Jefferson Univ, Dept Pharmaceut Sci, Philadelphia, PA 19107 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Austin; University of Texas System; UTMD Anderson Cancer Center; Rice University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Jefferson University	Mann, AP (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Nanomed & Biomed Engn, Houston, TX USA.	Takemi.Tanaka@jefferson.edu			Department of Defense [BC096250, W81XWH-07-2-0101, W81XWH-09-1-0212]; National Institutes of Health [U54CA151668, R01CA128797, N01-HV-28184]; Welch Foundation [H-1296]; NASA [NNX08AW91G]; USAMRMC [10117004]; AM Biotechnologies; AptaMed Inc.; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028184] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA128797, U54CA151668] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NASA(National Aeronautics & Space Administration (NASA)); USAMRMC(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); AM Biotechnologies; AptaMed Inc.; DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Department of Defense (BC096250 to T.T., W81XWH-07-2-0101 to M.F., W81XWH-09-1-0212 to M.F.); the National Institutes of Health (U54CA151668, R01CA128797 to M.F., N01-HV-28184 to D.G.); the Welch Foundation (H-1296 to D. G.); and Alliance for NanoHealth supported by NASA (NNX08AW91G to A.M.) and USAMRMC (10117004 to A.S., D.G., T.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; D.G. has financial interest in AM Biotechnologies and AptaMed Inc. A.M, A.S., D.G, and T.T are inventors on a patent on ESTA-1 in preparation. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Barthel SR, 2007, EXPERT OPIN THER TAR, V11, P1473, DOI 10.1517/14728222.11.11.1473; BECKERANDRE M, 1992, EUR J BIOCHEM, V206, P401, DOI 10.1111/j.1432-1033.1992.tb16940.x; BERG EL, 1991, J BIOL CHEM, V266, P14869; BEVILACQUA MP, 1993, ANNU REV IMMUNOL, V11, P767, DOI 10.1146/annurev.iy.11.040193.004003; BEVILACQUA MP, 1987, P NATL ACAD SCI USA, V84, P9238, DOI 10.1073/pnas.84.24.9238; Bhushan M, 2002, BRIT J DERMATOL, V146, P824, DOI 10.1046/j.1365-2133.2002.04743.x; Chapman PT, 1996, ARTHRITIS RHEUM, V39, P1371, DOI 10.1002/art.1780390815; Dong ZM, 1998, J CLIN INVEST, V102, P145, DOI 10.1172/JCI3001; Ehrhardt C, 2004, ADV DRUG DELIVER REV, V56, P527, DOI 10.1016/j.addr.2003.10.029; Eichbaum MHR, 2004, ONCOL RES, V14, P603, DOI 10.3727/0965040042707916; ELLINGTON AD, 1992, NATURE, V355, P850, DOI 10.1038/355850a0; Ernst B, 2009, NAT REV DRUG DISCOV, V8, P661, DOI 10.1038/nrd2852; Farokhzad OC, 2006, P NATL ACAD SCI USA, V103, P6315, DOI 10.1073/pnas.0601755103; Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566; Funovics M, 2005, NEOPLASIA, V7, P904, DOI 10.1593/neo.05352; GOLD L, 1995, J BIOL CHEM, V270, P13581, DOI 10.1074/jbc.270.23.13581; Gout S, 2008, CLIN EXP METASTAS, V25, P335, DOI 10.1007/s10585-007-9096-4; Gryaznov SM, 1999, BBA-GENE STRUCT EXPR, V1489, P131, DOI 10.1016/S0167-4781(99)00151-7; Guo KT, 2008, INT J MOL SCI, V9, P668, DOI 10.3390/ijms9040668; Hicke BJ, 1996, J CLIN INVEST, V98, P2688, DOI 10.1172/JCI119092; Jamar F, 1997, BRIT J RADIOL, V70, P473, DOI 10.1259/bjr.70.833.9227228; JAMAR F, 1995, RADIOLOGY, V194, P843, DOI 10.1148/radiology.194.3.7532314; Jenison RD, 1998, ANTISENSE NUCLEIC A, V8, P265, DOI 10.1089/oli.1.1998.8.265; Jhaveri S, 1998, BIOORG MED CHEM LETT, V8, P2285, DOI 10.1016/S0960-894X(98)00414-4; JOYCE GF, 1994, CURR OPIN STRUC BIOL, V4, P331, DOI 10.1016/S0959-440X(94)90100-7; KEELAN ETM, 1994, AM J PHYSIOL, V266, pH279, DOI 10.1152/ajpheart.1994.266.1.H279; King DJ, 1998, BIOCHEMISTRY-US, V37, P16489, DOI 10.1021/bi981780f; King DJ, 2002, BIOCHEMISTRY-US, V41, P9696, DOI 10.1021/bi020220k; Kneuer C, 2006, DRUG DISCOV TODAY, V11, P1034, DOI 10.1016/j.drudis.2006.09.004; KUIJPERS TW, 1994, J IMMUNOL, V152, P5060; Magnani John L, 2009, Discov Med, V8, P247; Marcucci F, 2004, DRUG DISCOV TODAY, V9, P219, DOI 10.1016/S1359-6446(03)02988-X; MARTENS CL, 1995, J BIOL CHEM, V270, P21129, DOI 10.1074/jbc.270.36.21129; Micklefield J, 2001, CURR MED CHEM, V8, P1157, DOI 10.2174/0929867013372391; Monteith DK, 1998, TOXICOL SCI, V46, P365, DOI 10.1093/toxsci/46.2.365; Monteith DK, 1997, ANTI-CANCER DRUG DES, V12, P421; Nawrot B, 1998, NUCLEIC ACIDS RES, V26, P2650, DOI 10.1093/nar/26.11.2650; Neri D, 2005, NAT REV CANCER, V5, P436, DOI 10.1038/nrc1627; Osborne SE, 1997, CURR OPIN CHEM BIOL, V1, P5, DOI 10.1016/S1367-5931(97)80102-0; Shao R, 2004, BIOCHEM BIOPH RES CO, V321, P788, DOI 10.1016/j.bbrc.2004.07.033; Somasunderam A, 2005, BIOCHEMISTRY-US, V44, P10388, DOI 10.1021/bi0507074; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; TOZEREN A, 1995, INT J CANCER, V60, P426; Tremblay PL, 2006, ONCOGENE, V25, P6563, DOI 10.1038/sj.onc.1209664; Tremblay PL, 2008, CANCER RES, V68, P5167, DOI 10.1158/0008-5472.CAN-08-1229; Volk DE, 2002, TETRAHEDRON LETT, V43, P4443, DOI 10.1016/S0040-4039(02)00850-X; WELPLY JK, 1994, BBA-REV BIOMEMBRANES, V1197, P215, DOI 10.1016/0304-4157(94)90006-X; Yang XB, 2004, CURR DRUG TARGETS, V5, P705, DOI 10.2174/1389450043345074; Yang XB, 2006, ANN NY ACAD SCI, V1082, P116, DOI 10.1196/annals.1348.065; Zen K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001826; ZETTER BR, 1993, SEMIN CANCER BIOL, V4, P219	51	67	73	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e13050	10.1371/journal.pone.0013050	http://dx.doi.org/10.1371/journal.pone.0013050			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20927342	gold, Green Published, Green Submitted			2022-12-27	WOS:000282312600014
J	Honarmand, M; Goymann, W; Naguib, M				Honarmand, Mariam; Goymann, Wolfgang; Naguib, Marc			Stressful Dieting: Nutritional Conditions but Not Compensatory Growth Elevate Corticosterone Levels in Zebra Finch Nestlings and Fledglings	PLOS ONE			English	Article							CATCH-UP GROWTH; TAENIOPYGIA-GUTTATA; BROOD SIZE; DEVELOPMENTAL STRESS; REARING ENVIRONMENT; NEONATAL NUTRITION; AMERICAN KESTRELS; POEPHILA-GUTTATA; METABOLIC-RATE; CLIMATE-CHANGE	Unfavourable conditions throughout the period of parental care can severely affect growth, reproductive performance, and survival. Yet, individuals may be affected differently, depending on the developmental period during which constraints are experienced. Here we tested whether the nestling phase compared to the fledgling phase is more susceptible to nutritional stress by considering biometry, physiology, sexually selected male ornaments and survival using zebra finches (Taeniopygia guttata) as a model species. As nestlings (day 0-17) or fledglings (day 17-35), subjects were raised either on low or high quality food. A low quality diet resulted in significantly elevated baseline corticosterone titres in both nestlings and fledglings. Subjects showed substantial compensatory growth after they had experienced low quality food as nestlings but catch-up growth did neither lead to elevated baseline corticosterone titres nor did we detect long term effects on biometry, male cheek patch, or survival. The compensation for temporally unfavourable environmental conditions reflects substantial phenotypic plasticity and the results show that costs of catch-up growth were not mediated via corticosterone as a physiological correlate of allostatic load. These findings provide new insights into the mechanisms and plasticity with which animals respond to periods of constraints during development as they may occur in a mistiming of breeding.	[Honarmand, Mariam; Naguib, Marc] Univ Bielefeld, Dept Anim Behav, Bielefeld, Germany; [Honarmand, Mariam] Free Univ Berlin, Dept Anim Behav, D-1000 Berlin, Germany; [Goymann, Wolfgang] Max Planck Inst Ornithol, Abt Verhaltensneurobiol, Evolutionary & Environm Physiol Lab, Seewiesen, Germany; [Naguib, Marc] Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, Heteren, Netherlands	University of Bielefeld; Free University of Berlin; Max Planck Society; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Honarmand, M (corresponding author), Univ Bielefeld, Dept Anim Behav, Bielefeld, Germany.	m.honarmand@fu-berlin.de	Naguib, Marc/C-2650-2009; Goymann, Wolfgang/E-4854-2010	Goymann, Wolfgang/0000-0002-7553-5910; Naguib, Marc/0000-0003-0494-4888	German Research Foundation (DFG) [Na335/6]	German Research Foundation (DFG)(German Research Foundation (DFG))	The research and MH were funded by a grant of the German Research Foundation (DFG) to MN (Na335/6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apanius V., 1998, AVIAN GROWTH DEV EVO; Arnold KE, 2007, J AVIAN BIOL, V38, P356, DOI 10.1111/j.2007.0908-8857.03818.x; Barber I, 2001, P ROY SOC B-BIOL SCI, V268, P71, DOI 10.1098/rspb.2000.1331; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Birkhead TR, 1999, P ROY SOC B-BIOL SCI, V266, P385, DOI 10.1098/rspb.1999.0649; Blas J, 2006, GEN COMP ENDOCR, V148, P172, DOI 10.1016/j.ygcen.2006.02.011; Blount JD, 2003, P ROY SOC B-BIOL SCI, V270, P1691, DOI 10.1098/rspb.2003.2411; BOAG PT, 1987, AUK, V104, P155, DOI 10.1093/auk/104.2.155; Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; Bradbury RR, 1998, P ROY SOC B-BIOL SCI, V265, P895, DOI 10.1098/rspb.1998.0375; Brinkhof MWG, 1999, P ROY SOC B-BIOL SCI, V266, P2315, DOI 10.1098/rspb.1999.0925; Criscuolo F, 2008, P ROY SOC B-BIOL SCI, V275, P1565, DOI 10.1098/rspb.2008.0148; DeKogel CH, 1997, J ANIM ECOL, V66, P167; Forstmeier W, 2007, MOL ECOL, V16, P4039, DOI 10.1111/j.1365-294X.2007.03444.x; Gil D, 2008, HORM BEHAV, V54, P238, DOI 10.1016/j.yhbeh.2007.11.013; Glennemeier KA, 2002, GEN COMP ENDOCR, V127, P16, DOI 10.1016/S0016-6480(02)00015-1; Goymann W, 2004, ANIM BEHAV, V67, P591, DOI 10.1016/j.anbehav.2003.08.007; Goymann W, 2006, HORM BEHAV, V49, P644, DOI 10.1016/j.yhbeh.2005.12.006; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; GUSTAFSSON L, 1988, NATURE, V335, P813, DOI 10.1038/335813a0; Haase E., 1980, Avian endocrinology., P549; Hales CN, 2003, J PHYSIOL-LONDON, V547, P5, DOI 10.1113/jphysiol.2002.024406; Harper E J, 1998, J Nutr, V128, p2684S, DOI 10.1093/jn/128.12.2684S; Harper EJ, 1998, SEMIN AVIAN EXOT PET, V7, P116, DOI 10.1016/S1055-937X(98)80002-9; Hayward LS, 2004, GEN COMP ENDOCR, V135, P365, DOI 10.1016/j.ygcen.2003.11.002; HAYWOOD S, 1992, P ROY SOC B-BIOL SCI, V249, P195, DOI 10.1098/rspb.1992.0103; Holveck MJ, 2010, P ROY SOC B-BIOL SCI, V277, P153, DOI 10.1098/rspb.2009.1222; Jawor JM, 2003, AUK, V120, P249, DOI 10.1642/0004-8038(2003)120[0249:MOHASS]2.0.CO;2; Kilner R, 1998, ANIM BEHAV, V56, P155, DOI 10.1006/anbe.1998.0775; Kitaysky AS, 1999, J COMP PHYSIOL B, V169, P303, DOI 10.1007/s003600050225; Krause ET, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005015; Leader N, 2006, ANIM BEHAV, V72, P113, DOI 10.1016/j.anbehav.2005.09.013; Love OP, 2003, PHYSIOL BIOCHEM ZOOL, V76, P753, DOI 10.1086/376431; MARTIN JT, 1978, AM ZOOL, V18, P489; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; McGraw KJ, 2007, BEHAV ECOL, V18, P137, DOI 10.1093/beheco/arl059; Mcgraw KJ, 2004, CONDOR, V106, P686, DOI 10.1650/7418.1; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Morici LA, 1997, J EXP ZOOL, V279, P156, DOI 10.1002/(SICI)1097-010X(19971001)279:2&lt;156::AID-JEZ6&gt;3.0.CO;2-N; Naguib M, 2004, P ROY SOC B-BIOL SCI, V271, P833, DOI 10.1098/rspb.2003.2673; Naguib M, 2005, BIOL LETT-UK, V1, P95, DOI 10.1098/rsbl.2004.0277; Naguib M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000901; Pinheiro JC, 2006, NLME LINEAR NONLINEA, P31; Pravosudov VV, 2006, GEN COMP ENDOCR, V145, P25, DOI 10.1016/j.ygcen.2005.06.011; Pravosudov VV, 2001, P ROY SOC B-BIOL SCI, V268, P363, DOI 10.1098/rspb.2000.1401; Quillfeldt P, 2007, NATURWISSENSCHAFTEN, V94, P919, DOI 10.1007/s00114-007-0275-6; Riebel K, 2009, ANIM BEHAV, V78, P1397, DOI 10.1016/j.anbehav.2009.09.011; Romero LM, 2009, HORM BEHAV, V55, P375, DOI 10.1016/j.yhbeh.2008.12.009; SAPOLSKY R M, 1992, P287; Sims CG, 2000, GEN COMP ENDOCR, V119, P193, DOI 10.1006/gcen.2000.7506; Sockman KW, 2001, GEN COMP ENDOCR, V122, P205, DOI 10.1006/gcen.2001.7626; Spencer KA, 2003, HORM BEHAV, V44, P132, DOI 10.1016/S0018-506X(03)00124-7; Verhulst S, 1997, FUNCT ECOL, V11, P714, DOI 10.1046/j.1365-2435.1997.00145.x; Verhulst S, 2006, BIOL LETTERS, V2, P478, DOI 10.1098/rsbl.2006.0496; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997; Visser ME, 2006, OECOLOGIA, V147, P164, DOI 10.1007/s00442-005-0299-6; Wada H, 2008, J EXP BIOL, V211, P1696, DOI 10.1242/jeb.009191; Wada H, 2008, GEN COMP ENDOCR, V156, P441, DOI 10.1016/j.ygcen.2008.02.004; WILSON PN, 1960, BIOL REV, V35, P324, DOI 10.1111/j.1469-185X.1960.tb01327.x; Zann RA., 1996, ZEBRA FINCH SYNTHESI	60	48	48	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2010	5	9							e12930	10.1371/journal.pone.0012930	http://dx.doi.org/10.1371/journal.pone.0012930			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654ZQ	20927394	Green Published, gold, Green Submitted			2022-12-27	WOS:000282210700005
J	Qin, J; Li, WQ; Zhang, L; Chen, F; Liang, WH; Mao, FF; Zhang, XM; Lahn, BT; Yu, WH; Xiang, AP				Qin, Jie; Li, Wei-Qiang; Zhang, Li; Chen, Fei; Liang, Wen-Hua; Mao, Frank Fuxiang; Zhang, Xiu-Ming; Lahn, Bruce T.; Yu, Wei-Hua; Xiang, Andy Peng			A Stem Cell-Based Tool for Small Molecule Screening in Adipogenesis	PLOS ONE			English	Article							DIFFERENTIATION; IDENTIFICATION; INHIBITION; EXPRESSION; DRUGS; ASSAY	Techniques for small molecule screening are widely used in biological mechanism study and drug discovery. Here, we reported a novel adipocyte differentiation assay for small molecule selection, based on human mesenchymal stem cells (hMSCs) transduced with fluorescence reporter gene driven by adipogenic specific promoter - adipocyte Protein 2 (aP2; also namely Fatty Acid Binding Protein 4, FABP4). During normal adipogenic induction as well as adipogenic inhibition by Ly294002, we confirmed that the intensity of green fluorescence protein corresponded well to the expression level of aP2 gene. Furthermore, this variation of green fluorescence protein intensity can be read simply through fluorescence spectrophotometer. By testing another two small molecules in adipogenesis - Troglitazone and CHIR99021, we proved that this is a simple and sensitive method, which could be applied in adipocyte biology, drug discovery and toxicological study in the future.	[Qin, Jie; Li, Wei-Qiang; Chen, Fei; Zhang, Xiu-Ming; Lahn, Bruce T.; Yu, Wei-Hua; Xiang, Andy Peng] Sun Yat Sen Univ, Ctr Stem Cell Biol & Tissue Engn, Guangzhou 510275, Guangdong, Peoples R China; [Qin, Jie; Li, Wei-Qiang; Chen, Fei; Zhang, Xiu-Ming; Lahn, Bruce T.; Yu, Wei-Hua; Xiang, Andy Peng] Minist Educ, Key Lab Stem Cells & Tissue Engn, Guangzhou, Guangdong, Peoples R China; [Zhang, Li; Mao, Frank Fuxiang; Lahn, Bruce T.] Univ Chicago, Howard Hughes Med Inst, Dept Human Genet, Chicago, IL 60637 USA; [Liang, Wen-Hua] Sun Yat Sen Univ, Zhongshan Med Sch, Guangzhou 510275, Guangdong, Peoples R China; [Xiang, Andy Peng] Sun Yat Sen Univ, Affiliated Hosp 3, Cell Therapy Ctr, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Howard Hughes Medical Institute; University of Chicago; Sun Yat Sen University; Sun Yat Sen University	Qin, J (corresponding author), Sun Yat Sen Univ, Ctr Stem Cell Biol & Tissue Engn, Guangzhou 510275, Guangdong, Peoples R China.	ywh7811@126.com; xiangp@mail.sysu.edu.cn	Yu, Wei/GZL-3831-2022	Wenhua, Liang/0000-0002-1391-8238	National Basic Research Program of China [2009CB522100, 2010CB945400]; National Natural Science Foundation of China [30928015, 81000150, 81000362]; Key Scientific and Technological Projects of Guangdong Province [2007A032100003]; China Postdoctoral Science Foundation [4109005]; Program for New Century Excellent Talents in University; Fundamental Research Funds for the Central Universities	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Scientific and Technological Projects of Guangdong Province; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	All grant information: Supported by the National Basic Research Program of China (2009CB522100 and 2010CB945400, http://www.most.gov.cn), National Natural Science Foundation of China (30928015, 81000150 and 81000362, http://www.nsfc.gov.cn), the Key Scientific and Technological Projects of Guangdong Province (2007A032100003, http://www.stw.gd.cn/), China Postdoctoral Science Foundation (4109005, http://www.chinapostdoctor.org.cn), Program for New Century Excellent Talents in University and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F; Cardno TS, 2009, RNA, V15, P1614, DOI 10.1261/rna.1586709; Chen S, 2009, NAT CHEM BIOL, V5, P258, DOI 10.1038/nchembio.154; Ding S, 2003, P NATL ACAD SCI USA, V100, P7632, DOI 10.1073/pnas.0732087100; Haffner SM, 2007, AM J MED, V120, P10, DOI 10.1016/j.amjmed.2007.06.006; Hojo H, 2008, BIOCHEM BIOPH RES CO, V376, P375, DOI 10.1016/j.bbrc.2008.08.167; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kan A, 2009, ARTHRITIS RHEUM-US, V60, P3314, DOI 10.1002/art.24878; Ke H, 2009, DIFFERENTIATION, V77, P256, DOI 10.1016/j.diff.2008.09.021; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Li W, 2008, BIOL CHEM, V389, P169, DOI 10.1515/BC.2008.015; Park KW, 2008, MOL ENDOCRINOL, V22, P2038, DOI 10.1210/me.2007-0454; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Podechard N, 2009, TOXICOL IN VITRO, V23, P1139, DOI 10.1016/j.tiv.2009.05.011; Rival Y, 2004, J PHARMACOL EXP THER, V311, P467, DOI 10.1124/jpet.104.068254; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rubin LL, 2008, CELL, V132, P549, DOI 10.1016/j.cell.2008.02.010; Ryden M, 2003, BIOCHEM BIOPH RES CO, V311, P391, DOI 10.1016/j.bbrc.2003.10.010; Suter DM, 2006, STEM CELLS, V24, P615, DOI 10.1634/stemcells.2005-0226; TONTONOZ P, 1995, MOL CELL BIOL, V15, P351, DOI 10.1128/MCB.15.1.351; Trayhurn P, 2005, ACTA PHYSIOL SCAND, V184, P285, DOI 10.1111/j.1365-201X.2005.01468.x; Waki H, 2007, CELL METAB, V5, P357, DOI 10.1016/j.cmet.2007.03.010; Willson TM, 2000, J MED CHEM, V43, P527, DOI 10.1021/jm990554g; Wu X, 2004, J AM CHEM SOC, V126, P1590, DOI 10.1021/ja038950i; Wu X, 2002, J AM CHEM SOC, V124, P14520, DOI 10.1021/ja0283908; Xia XM, 1999, J CELL PHYSIOL, V178, P9, DOI 10.1002/(SICI)1097-4652(199901)178:1<9::AID-JCP2>3.0.CO;2-#; Yin DZ, 2009, MOL THER, V17, P1967, DOI 10.1038/mt.2009.151; Yu WH, 2008, MOL CELL BIOCHEM, V310, P11, DOI 10.1007/s11010-007-9661-9	29	11	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e13014	10.1371/journal.pone.0013014	http://dx.doi.org/10.1371/journal.pone.0013014			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20885962	Green Published, gold			2022-12-27	WOS:000282167100016
J	Too, WCS; Wong, MT; Few, LL; Konrad, M				Too, Wei Cun See; Wong, Mun Teng; Few, Ling Ling; Konrad, Manfred			Highly Specific Antibodies for Co-Detection of Human Choline Kinase alpha 1 and alpha 2 Isoforms	PLOS ONE			English	Article							BREAST-CANCER CELLS; PHOSPHATIDYLCHOLINE BIOSYNTHESIS; ETHANOLAMINE KINASE; ESCHERICHIA-COLI; GROWTH-FACTORS; GENE; RAT; OVEREXPRESSION; PHOSPHOCHOLINE; EXPRESSION	Background: Choline kinase is the first enzyme in the CDP-choline pathway that synthesizes phosphatidylcholine, the major phospholipid in eukaryotic cell membranes. In humans, choline kinase exists as three isoforms (CK alpha 1, alpha 2, and beta). Specific inhibition of CK alpha has been reported to selectively kill tumoral cells. Monoclonal and polyclonal antibodies against CKa used in previous studies to detect the level of this isozyme in different cellular or biochemical contexts were able to detect either the alpha 1 or the alpha 2 isoform. Methodology/Principal Findings: In this study, an antiserum against CK alpha was produced by immunizing rabbits with denatured, purified recombinant CK alpha 2 full-length protein. This antiserum was highly specific for CK alpha when tested with extracts from different cell lines, and there was no cross reactivity with purified CK beta and other related proteins like human ethanolamine kinases (EK) and yeast choline or ethanolamine kinases. The antiserum simultaneously detected both CK alpha 1 and alpha 2 isoforms in MCF-7 and HepG2 cell extracts, but not in HeLa, HCT-116, and mouse embryonic stem cell extracts. Subsequent protein dot blot assay of total CK alpha in a human normal/tumor protein array of 30 tissue samples by using the antiserum showed that CK alpha was not overexpressed in all tumor tissues when compared to their normal counterparts. Most striking differences between tumor and normal CK alpha expression levels were observed in kidney (11-fold higher in tumor) and liver (15-fold lower in tumor) samples. Conclusion/Significance: Apart from its high sensitivity and specificity, the antiserum produced in this work, which does not require further purification, has the advantage of co-detecting both alpha 1 and alpha 2 isoforms in cell extracts for direct comparison of their expression levels.	[Too, Wei Cun See; Wong, Mun Teng; Few, Ling Ling] Univ Sains Malaysia, Sch Hlth Sci, Kubang Kerian, Kelantan, Malaysia; [Too, Wei Cun See; Konrad, Manfred] Max Planck Inst Biophys Chem, Gottingen, Germany	Universiti Sains Malaysia; Max Planck Society	Too, WCS (corresponding author), Univ Sains Malaysia, Sch Hlth Sci, Kubang Kerian, Kelantan, Malaysia.	stweicun@kb.usm.my	Few, Ling Ling/E-1964-2012; See Too, Wei Cun/C-9382-2016	Few, Ling Ling/0000-0001-8296-8135; See Too, Wei Cun/0000-0003-1933-3107	Ministry of Higher Education [203/PPSK/6170023]; Universiti Sains Malaysia Research University [1001/PPSK/813008]	Ministry of Higher Education(Science and Technology Development Fund (STDF)Ministry of Higher Education & Scientific Research (MHESR)); Universiti Sains Malaysia Research University(Universiti Sains Malaysia)	This work was partly supported by the Fundamental Research Grant Scheme, Ministry of Higher Education (203/PPSK/6170023) and Universiti Sains Malaysia Research University Grant (1001/PPSK/813008). MTW is supported by a Universiti Sains Malaysia Research University Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama C, 2004, PROG LIPID RES, V43, P266, DOI 10.1016/j.plipres.2003.12.001; Aoyama C, 2000, J LIPID RES, V41, P452; Aoyama C, 2002, BIOCHEM J, V363, P777, DOI 10.1042/0264-6021:3630777; Banez-Coronel M, 2008, CURR CANCER DRUG TAR, V8, P709, DOI 10.2174/156800908786733432; BILLAH MM, 1990, BIOCHEM J, V269, P281, DOI 10.1042/bj2690281; Blake JA, 2002, NUCLEIC ACIDS RES, V30, P113, DOI 10.1093/nar/30.1.113; Brundiers R, 1999, J BIOL CHEM, V274, P35289, DOI 10.1074/jbc.274.50.35289; CUADRADO A, 1993, ONCOGENE, V8, P2959; de Molina AR, 2002, ONCOGENE, V21, P4317, DOI 10.1038/sj.onc.1205556; Eliyahu G, 2007, INT J CANCER, V120, P1721, DOI 10.1002/ijc.22293; Gallego-Ortega D, 2006, INT J ONCOL, V29, P335; Gallego-Ortega D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007819; Glunde K, 2005, CANCER RES, V65, P11034, DOI 10.1158/0008-5472.CAN-05-1807; Glunde K, 2007, LANCET ONCOL, V8, P855, DOI 10.1016/S1470-2045(07)70289-9; HOSAKA K, 1989, J BIOL CHEM, V264, P2053; Huang H, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r47; Kim KS, 1999, J BIOL CHEM, V274, P14857, DOI 10.1074/jbc.274.21.14857; Kiss Z, 1999, CELL SIGNAL, V11, P149, DOI 10.1016/S0898-6568(98)00057-6; Krishnamachary B, 2009, CANCER RES, V69, P3464, DOI 10.1158/0008-5472.CAN-08-4120; Lykidis A, 2001, J BIOL CHEM, V276, P2174, DOI 10.1074/jbc.M008794200; MacBeath G, 2002, NAT GENET, V32, P526, DOI 10.1038/ng1037; Malito E, 2006, J MOL BIOL, V364, P136, DOI 10.1016/j.jmb.2006.08.084; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Nakagami K, 1999, JPN J CANCER RES, V90, P1212, DOI 10.1111/j.1349-7006.1999.tb00698.x; Nakagami K, 1999, JPN J CANCER RES, V90, P419, DOI 10.1111/j.1349-7006.1999.tb00764.x; PORTER TJ, 1990, J BIOL CHEM, V265, P414; Ramirez de Molina A, 2002, BIOCHEM BIOPH RES CO, V296, P580, DOI 10.1016/S0006-291X(02)00920-8; Ramirez de Molina A, 2002, ONCOGENE, V21, P937, DOI 10.1038/sj.onc.1205144; Ramirez de Molina A, 2007, LANCET ONCOL, V8, P889, DOI 10.1016/S1470-2045(07)70279-6; Shah T, 2010, NMR BIOMED, V23, P633, DOI 10.1002/nbm.1510; Sydor Jens R, 2003, Proteome Sci, V1, P3, DOI 10.1186/1477-5956-1-3; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; UCHIDA T, 1990, BIOCHIM BIOPHYS ACTA, V1043, P281, DOI 10.1016/0005-2760(90)90028-V; WARDEN CH, 1985, J BIOL CHEM, V260, P6006; Wu GS, 2008, J BIOL CHEM, V283, P1456, DOI 10.1074/jbc.M708766200; Wu GS, 2010, BIOCHEM CELL BIOL, V88, P559, DOI 10.1139/O09-160	36	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e12999	10.1371/journal.pone.0012999	http://dx.doi.org/10.1371/journal.pone.0012999			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20886003	Green Published, Green Submitted, gold			2022-12-27	WOS:000282167100008
J	Menzel, S; Qin, JA; Vasavda, N; Thein, SL; Ramakrishnan, R				Menzel, Stephan; Qin, Jian; Vasavda, Nisha; Thein, Swee Lay; Ramakrishnan, Ramesh			Experimental Generation of SNP Haplotype Signatures in Patients with Sickle Cell Anaemia	PLOS ONE			English	Article							COPY NUMBER VARIATION; SINGLE DNA-MOLECULES; NANOFLUIDIC PLATFORM; FETAL-HEMOGLOBIN; HIGH-THROUGHPUT; GENOME; PCR; GENE	Background: Sickle cell anemia is caused by a single type of mutation, a homozygous A -> T substitution in the beta globin gene. Clinical severity is diverse, partially due to additional, disease-modifying genetic factors. We are studying one such modifier locus, HMIP (HBS1L-MYB intergenic polymorphism, chromosome 6q23.3). Working with a genetically admixed patient population, we have encountered the necessity to generate haplotype signatures of genetic markers to label genomic fragments with distinct genealogical origin at this locus. With the goal to generate haplotype signatures from patients experimentally, we have investigated the suitability of an existing nanofluidic assay platform to perform phase alignment with single-nucleotide polymorphism alleles. Methodology/Principal Findings: Patient DNA samples were loaded onto Fluidigm Digital Arrays and individual DNA molecules were assayed with allele-specific probes for SNP markers. Here we present data showing the utility of the nanofluidic approach, yielding haplotype data identical to those obtained with a family-based method. We then determined haplotype composition in a group of patients with sickle cell disease, including in those where a mathematical inference approach gave ambiguous or misleading results. Experimental phasing of genotypes across 3.8 kb for rs9399137, rs9402685, and rs11759553 created unequivocal haplotype signatures for each of the patients. In 68 patients, we found 8 copies of a haplotype signature ('C-C-T'), which is known to be prevalent in Europeans but to be absent in West African populations. We have confirmed the identity of our phased allele pairs by single-molecule sequencing and have demonstrated, in principle, that three-allele phasing (using three colors) is a potential extension to this method. Conclusions/Significance: Phased haplotypes yield more information than the individual marker genotypes. Procedures such as the one described here would therefore benefit genetic mapping and functional studies as well as diagnostic procedures where the identity or parental origin of short genetic fragments is of importance.	[Menzel, Stephan; Vasavda, Nisha; Thein, Swee Lay] Kings Coll London, Sch Med, Div Gene & Cell Based Therapy, London, England; [Qin, Jian; Ramakrishnan, Ramesh] Fluidigm Corp, San Francisco, CA USA; [Thein, Swee Lay] Kings Coll Hosp, Dept Haematol Med, London, England	University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital	Menzel, S (corresponding author), Kings Coll London, Sch Med, Div Gene & Cell Based Therapy, London, England.	stephan.menzel@kcl.ac.uk	Menzel, Stephan/U-6906-2019	Menzel, Stephan/0000-0002-1590-9108	Fluidigm Corporation; Medical Research Council [G0000111] Funding Source: researchfish; MRC [G0000111] Funding Source: UKRI	Fluidigm Corporation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Specific funding for this study was provided by Fluidigm Corporation. With the exception of the two authors RR and JQ, Fluidigm had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhat S, 2009, ANAL BIOANAL CHEM, V394, P457, DOI 10.1007/s00216-009-2729-5; Burgtorf C, 2003, GENOME RES, V13, P2717, DOI 10.1101/gr.1442303; Creary LE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004218; Daly AK, 2010, NAT REV GENET, V11, P241, DOI 10.1038/nrg2751; Ding CM, 2003, P NATL ACAD SCI USA, V100, P7449, DOI 10.1073/pnas.1232475100; Diskin SJ, 2009, NATURE, V459, P987, DOI 10.1038/nature08035; Dressman D, 2003, P NATL ACAD SCI USA, V100, P8817, DOI 10.1073/pnas.1133470100; Dube S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002876; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Fan JB, 2006, NAT REV GENET, V7, P632, DOI 10.1038/nrg1901; Hall A, 2010, PUBLIC HEALTH GENOM, V13, P246, DOI 10.1159/000279626; Harris TD, 2008, SCIENCE, V320, P106, DOI 10.1126/science.1150427; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Mitra RD, 2003, P NATL ACAD SCI USA, V100, P5926, DOI 10.1073/pnas.0936399100; Oehler VG, 2009, LEUKEMIA, V23, P396, DOI 10.1038/leu.2008.183; Pastinen T, 2010, NAT REV GENET, V11, P533, DOI 10.1038/nrg2815; Qin J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn518; RUANO G, 1989, NUCLEIC ACIDS RES, V17, P8392, DOI 10.1093/nar/17.20.8392; Spurgeon SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001662; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; THEIN SL, 1994, AM J HUM GENET, V54, P214; Thein SL, 2007, P NATL ACAD SCI USA, V104, P11346, DOI 10.1073/pnas.0611393104; Tost J, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf095; Wetmur JG, 2005, NUCLEIC ACIDS RES, V33, P2615, DOI 10.1093/nar/gki556; Xiao M, 2009, NAT METHODS, V6, P199, DOI [10.1038/nmeth.1301, 10.1038/NMETH.1301]	26	8	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2010	5	9							e13004	10.1371/journal.pone.0013004	http://dx.doi.org/10.1371/journal.pone.0013004			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653UN	20886046	Green Published, Green Submitted, gold			2022-12-27	WOS:000282122600022
J	Honma, M; Soshi, T; Kim, Y; Kuriyama, K				Honma, Motoyasu; Soshi, Takahiro; Kim, Yoshiharu; Kuriyama, Kenichi			Right Prefrontal Activity Reflects the Ability to Overcome Sleepiness during Working Memory Tasks: A Functional Near-Infrared Spectroscopy Study	PLOS ONE			English	Article							BRAIN ACTIVATION; OLDER-ADULTS; CHEWING GUM; REM-SLEEP; ATTENTION; DEPRIVATION; PERFORMANCE; TIME; DYNAMICS; CORTEX	It has been speculated that humans have an inherent ability to overcome sleepiness that counteracts homeostatic sleep pressure. However, it remains unclear which cortical substrate activities are involved in the ability to overcome sleepiness during the execution of cognitive tasks. Here we sought to confirm that this ability to overcome sleepiness in task execution improves performance on cognitive tasks, showing activation of neural substrates in the frontal cortex, by using a modified n-back (2- and 0-back) working memory task and functional near-infrared spectroscopy. The change in alertness was just correlated with performances on the 2- back task. Activity in the right prefrontal cortex changed depending on alertness changes on the 2- and 0-back tasks independently, which indicates that activity in this region clearly reflects the ability to overcome sleepiness; it may contribute to the function of providing sufficient activity to meet the task load demands. This study reveals characteristics of the ability to overcome sleepiness during the n-back working memory task which goes beyond the attention-control function traditionally proposed.	[Honma, Motoyasu; Soshi, Takahiro; Kim, Yoshiharu; Kuriyama, Kenichi] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Adult Mental Hlth, Tokyo, Japan	National Center for Neurology & Psychiatry - Japan	Honma, M (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Adult Mental Hlth, Tokyo, Japan.	kenichik@ncnp.go.jp	Honma, Motoyasu/M-7124-2018	Honma, Motoyasu/0000-0003-4612-0115; Soshi, Takahiro/0000-0003-1924-936X	Ministry of Education, Sports, Science, and Culture of Japan [21790235]; Ministry of Health, Labour and Welfare, Japan [20300701-009]; Grants-in-Aid for Scientific Research [21790235] Funding Source: KAKEN	Ministry of Education, Sports, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research (grant number 21790235) from the Ministry of Education, Sports, Science, and Culture of Japan, and a research grant for Nervous and Mental Disorders, 20300701-009, Health Science Grant from the Ministry of Health, Labour and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAN A, 1992, INT J PSYCHOPHYSIOL, V12, P95, DOI 10.1016/0167-8760(92)90001-R; Altena E, 2008, J SLEEP RES, V17, P335, DOI 10.1111/j.1365-2869.2008.00671.x; BADDELEY A, 1981, COGNITION, V10, P17, DOI 10.1016/0010-0277(81)90020-2; Bennett CL, 2008, AM J PSYCHOL, V121, P349, DOI 10.2307/20445471; Cannestra AF, 2003, NEUROREPORT, V14, P1961, DOI 10.1097/00001756-200310270-00016; Chang C, 2007, NEUROIMAGE, V34, P1253, DOI 10.1016/j.neuroimage.2006.08.056; Chee MWL, 2004, J NEUROSCI, V24, P4560, DOI 10.1523/JNEUROSCI.0007-04.2004; CORRIGALL WA, 1992, PSYCHOPHARMACOLOGY, V107, P285, DOI 10.1007/BF02245149; Deiber MP, 2007, J COGNITIVE NEUROSCI, V19, P158, DOI 10.1162/jocn.2007.19.1.158; Drummond SPA, 2001, NEUROPSYCHOPHARMACOL, V25, pS68, DOI 10.1016/S0893-133X(01)00325-6; Engstrom M, 2009, SLEEP, V32, P681, DOI 10.1093/sleep/32.5.681; GEVINS A, 1993, ELECTROEN CLIN NEURO, V87, P128, DOI 10.1016/0013-4694(93)90119-G; Giam G. C. K., 1997, Annals Academy of Medicine Singapore, V26, P88; GROSVENOR A, 1984, SLEEP, V7, P155, DOI 10.1093/sleep/7.2.155; Hamilton LS, 2009, HUM BRAIN MAPP, V30, P3958, DOI 10.1002/hbm.20820; Harmening D, 1996, LAB MED, V27, P25, DOI 10.1093/labmed/27.1.25; Herrmann MJ, 2008, PSYCHOPHYSIOLOGY, V45, P480, DOI 10.1111/j.1469-8986.2007.00633.x; Hidalgo MPL, 2004, PSYCHOL REP, V95, P75, DOI 10.2466/PR0.95.5.75-85; Hirano Y, 2008, NEUROSCI LETT, V436, P189, DOI 10.1016/j.neulet.2008.03.033; Hock C, 1997, BRAIN RES, V755, P293, DOI 10.1016/S0006-8993(97)00122-4; HODDES E, 1972, PSYCHOPHYSIOLOGY, V9, P150; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; IDZIKOWSKI C, 1984, BRIT J PSYCHOL, V75, P439, DOI 10.1111/j.2044-8295.1984.tb01914.x; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Marklund P, 2007, CORTEX, V43, P22, DOI 10.1016/S0010-9452(08)70443-X; McEvoy LK, 1998, CEREB CORTEX, V8, P563, DOI 10.1093/cercor/8.7.563; Mcnab F, 2008, NAT NEUROSCI, V11, P103, DOI 10.1038/nn2024; Moorcroft WH, 1997, SLEEP, V20, P40, DOI 10.1093/sleep/20.1.40; Mu QW, 2005, SLEEP, V28, P433, DOI 10.1093/sleep/28.4.433; O'Grada C, 2009, SCHIZOPHR RES, V107, P319, DOI 10.1016/j.schres.2008.07.013; Obrig H, 2003, J CEREBR BLOOD F MET, V23, P1, DOI 10.1097/01.WCB.0000043472.45775.29; Ohayon MM, 2005, SLEEP, V28, P981; Okamoto M, 2004, NEUROIMAGE, V21, P1275, DOI 10.1016/j.neuroimage.2003.12.003; Osaka M, 2007, COGN AFFECT BEHAV NE, V7, P130, DOI 10.3758/CABN.7.2.130; Sadeh A, 2003, CHILD DEV, V74, P444, DOI 10.1111/1467-8624.7402008; Sandrini M, 2008, NEUROPSYCHOLOGIA, V46, P2056, DOI 10.1016/j.neuropsychologia.2008.02.003; Scheer FAJL, 2008, J BIOL RHYTHM, V23, P353, DOI 10.1177/0748730408318081; Schmidt C, 2009, SCIENCE, V324, P516, DOI 10.1126/science.1167337; Shechter-Amir D, 2000, SLEEP MED, V1, P101, DOI 10.1016/S1389-9457(99)00016-7; Short M, 2010, SLEEP, V33, P123, DOI 10.1093/sleep/33.1.123; Silva EJ, 2008, BEHAV NEUROSCI, V122, P928, DOI 10.1037/0735-7044.122.4.928; Smith A, 2009, HUM PSYCHOPHARM CLIN, V24, P239, DOI 10.1002/hup.1020; Smith ME, 2002, SLEEP, V25, P784; Soshi T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008395; Swann CE, 2006, J SLEEP RES, V15, P23, DOI 10.1111/j.1365-2869.2006.00495.x; TILLEY AJ, 1978, BIOL PSYCHOL, V6, P293, DOI 10.1016/0301-0511(78)90031-5; Toronov V, 2001, MED PHYS, V28, P521, DOI 10.1118/1.1354627; Tucha O, 2004, APPETITE, V42, P327, DOI 10.1016/j.appet.2004.01.003; Van Den Berg J, 2006, PERCEPT MOTOR SKILL, V102, P589, DOI 10.2466/PMS.102.2.589-599; Xu JS, 2006, PSYCHIAT RES-NEUROIM, V148, P103, DOI 10.1016/j.pscychresns.2006.09.005	51	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12923	10.1371/journal.pone.0012923	http://dx.doi.org/10.1371/journal.pone.0012923			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	653KV	20886073	Green Submitted, Green Published, gold			2022-12-27	WOS:000282091100027
J	Lo Presti, M; Ferro, A; Contino, F; Mazzarella, C; Sbacchi, S; Roz, E; Lupo, C; Perconti, G; Giallongo, A; Migliorini, P; Marrazzo, A; Feo, S				Lo Presti, Mariavera; Ferro, Arianna; Contino, Flavia; Mazzarella, Claudia; Sbacchi, Silvia; Roz, Elena; Lupo, Carmelo; Perconti, Giovanni; Giallongo, Agata; Migliorini, Paola; Marrazzo, Antonio; Feo, Salvatore			Myc Promoter-Binding Protein-1 (MBP-1) Is a Novel Potential Prognostic Marker in Invasive Ductal Breast Carcinoma	PLOS ONE			English	Article							CELL LUNG-CANCER; ALPHA-ENOLASE; PROTEOMIC ANALYSIS; GLYCOLYTIC ENZYME; NUDE-MICE; GENE; IDENTIFICATION; PROGRESSION; EXPRESSION; METASTASES	Background Alpha-enolase is a glycolytic enzyme that catalyses the formation of phosphoenolpyruvate in the cell cytoplasm. alpha-Enolase and the predominantly nuclear Myc promoter-binding protein-1 (MBP-1) originate from a single gene through the alternative use of translational starting sites. MBP-1 binds to the P2 c-myc promoter and competes with TATA-box binding protein (TBP) to suppress gene transcription. Although several studies have shown an antiproliferative effect of MBP-1 overexpression on several human cancer cells, to date detailed observations of alpha-enolase and MBP-1 relative expression in primary tumors versus normal tissues and their correlation with clinicopathological features have not been undertaken. Methodology and Findings: We analyzed alpha-enolase and MBP-1 expression in normal breast epithelium and primary invasive ductal breast carcinoma (IDC) from 177 patients by Western blot and immunohistochemical analyses, using highly specific anti-alpha-enolase monoclonal antibodies. A significant increase in the expression of cytoplasmic alpha-enolase was observed in 98% of the tumors analysed, compared to normal tissues. Nuclear MBP-1 was found in almost all the normal tissues while its expression was retained in only 35% of the tumors. Statistically significant associations were observed among the nuclear expression of MBP-1 and ErbB2 status, Ki-67 expression, node status and tumor grade. Furthermore MBP-1 expression was associated with good survival of patients with IDC. Conclusions: MBP-1 functions in repressing c-myc gene expression and the results presented indicate that the loss of nuclear MBP-1 expression in a large number of IDC may be a critical step in the development and progression of breast cancer and a predictor of adverse outcome. Nuclear MBP-1 appears to be a novel and valuable histochemical marker with potential prognostic value in breast cancer.	[Lo Presti, Mariavera; Ferro, Arianna; Contino, Flavia; Mazzarella, Claudia; Sbacchi, Silvia; Perconti, Giovanni; Marrazzo, Antonio; Feo, Salvatore] Univ Palermo, Dipartimento Oncol Sperimentale & Applicaz Clin, Palermo, Italy; [Perconti, Giovanni; Giallongo, Agata; Feo, Salvatore] CNR, Ist Biomed & Immunol Mol, Palermo, Italy; [Migliorini, Paola] Univ Pisa, Dipartimento Med Interna, Pisa, Italy; [Roz, Elena; Lupo, Carmelo] Dipartimento Oncol III Iivello La Maddalena, Palermo, Italy	University of Palermo; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomedicina e di Immunologia Molecolare "Alberto Monroy" (IBIM-CNR); University of Pisa	Lo Presti, M (corresponding author), Univ Palermo, Dipartimento Oncol Sperimentale & Applicaz Clin, Palermo, Italy.	feo@unipa.it	Feo, Salvatore/C-1333-2012; Migliorini, Paola/P-6176-2015; Giallongo, Agata/ABD-1103-2020; antonio, marrazzo/E-9598-2013; Perconti, Giovanni/ABG-9327-2021	Feo, Salvatore/0000-0003-3877-2906; Migliorini, Paola/0000-0001-6433-4964; Giallongo, Agata/0000-0001-9998-4481; antonio, marrazzo/0000-0002-6341-3094; Lupo, Carmelo/0000-0003-3287-7299	Italian Space Agency (ASI) [I/014/06/0]; Italian "Ministero dell'Istruzione, dell'Universita e della Ricerca - MIUR'' [RBNE08YYBM]; Regione Sicilia	Italian Space Agency (ASI)(Agenzia Spaziale Italiana (ASI)); Italian "Ministero dell'Istruzione, dell'Universita e della Ricerca - MIUR''(Ministry of Education, Universities and Research (MIUR)); Regione Sicilia(Regione Sicilia)	G. P. was partially supported by Italian Space Agency (ASI), project contract no. I/014/06/0. This work was supported in part by grants from Italian "Ministero dell'Istruzione, dell'Universita e della Ricerca - MIUR'' (FIRB-MERIT: n RBNE08YYBM), and from Regione Sicilia (POR misura 3.14 DiaMol) to S. F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; BORG A, 1992, GENE CHROMOSOME CANC, V5, P311, DOI 10.1002/gcc.2870050406; Carramusa L, 2007, J CELL PHYSIOL, V213, P511, DOI 10.1002/jcp.21133; Chang YS, 2003, CLIN CANCER RES, V9, P3641; CHAUDHARY D, 1995, BIOCHEMISTRY-US, V34, P3438, DOI 10.1021/bi00010a036; Demir AY, 2005, CELL TISSUE RES, V322, P299, DOI 10.1007/s00441-005-0002-6; Ejeskar K, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-161; Feo S, 2000, FEBS LETT, V473, P47, DOI 10.1016/S0014-5793(00)01494-0; Ghosh AK, 1999, BIOCHEM BIOPH RES CO, V260, P405, DOI 10.1006/bbrc.1999.0921; Ghosh AK, 2005, CANCER RES, V65, P718; Ghosh AK, 2001, MOL CELL BIOL, V21, P655, DOI 10.1128/MCB.21.2.655-662.2001; Ghosh AK, 2005, J BIOL CHEM, V280, P14325, DOI 10.1074/jbc.M413313200; Ghosh AK, 2006, J BIOL CHEM, V281, P23652, DOI 10.1074/jbc.M602930200; Ghosh AK, 2006, CANCER RES, V66, P11907, DOI 10.1158/0008-5472.CAN-06-2754; Ghosh AK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003384; Giovanni P, 2007, BBA-MOL CELL RES, V1773, P1774, DOI 10.1016/j.bbamcr.2007.09.002; HENNIPMAN A, 1988, TUMOR BIOL, V9, P241, DOI 10.1159/000217568; Hsu KW, 2008, MOL CELL BIOL, V28, P4829, DOI 10.1128/MCB.00175-08; Hsu KW, 2009, MOL BIOL CELL, V20, P5127, DOI 10.1091/mbc.E09-05-0386; Ito S, 2007, CANCER SCI, V98, P499, DOI 10.1111/j.1349-7006.2007.00411.x; Jeyabalan J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010646; Kanda T, 2009, CANCER RES, V69, P9354, DOI 10.1158/0008-5472.CAN-09-2974; Kim JW, 2005, TRENDS BIOCHEM SCI, V30, P142, DOI 10.1016/j.tibs.2005.01.005; LIU KJ, 2007, J CANC MOL, V2, P45; Moscato S, 2000, EUR J IMMUNOL, V30, P3575, DOI 10.1002/1521-4141(200012)30:12<3575::AID-IMMU3575>3.0.CO;2-#; Pancholi V, 2001, CELL MOL LIFE SCI, V58, P902, DOI 10.1007/PL00000910; Peebles KA, 2003, CARCINOGENESIS, V24, P651, DOI 10.1093/carcin/bgg008; RAY R, 1991, MOL CELL BIOL, V11, P2154, DOI 10.1128/MCB.11.4.2154; RAY RB, 1995, CANCER RES, V55, P3747; Sedoris KC, 2007, BIOCHEMISTRY-US, V46, P8659, DOI 10.1021/bi7003558; Sedoris KC, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-157; Subramanian A, 2000, J BIOL CHEM, V275, P5958, DOI 10.1074/jbc.275.8.5958; Takashima M, 2005, PROTEOMICS, V5, P1686, DOI 10.1002/pmic.200401022; TOMAINO B, 2010, J PROTEOME RES; Wang WY, 2005, J ENDOCRINOL, V184, P85, DOI 10.1677/joe.1.05909; White RA, 1997, GENOMICS, V39, P406, DOI 10.1006/geno.1996.4499; Wu WG, 2002, CLIN EXP METASTAS, V19, P319, DOI 10.1023/A:1015515119300; Zhang L, 2000, J SURG RES, V93, P108, DOI 10.1006/jsre.2000.5957	38	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12961	10.1371/journal.pone.0012961	http://dx.doi.org/10.1371/journal.pone.0012961			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886042	Green Published, gold			2022-12-27	WOS:000282091100054
J	Ochanuna, Z; Geiger-Maor, A; Dembinsky-Vaknin, A; Karussis, D; Tykocinski, ML; Rachmilewitz, J				Ochanuna, Zohar; Geiger-Maor, Anat; Dembinsky-Vaknin, Adi; Karussis, Dimitrios; Tykocinski, Mark L.; Rachmilewitz, Jacob			Inhibition of Effector Function but Not T Cell Activation and Increase in FoxP3 Expression in T Cells Differentiated in the Presence of PP14	PLOS ONE			English	Article							PLACENTAL PROTEIN-14; MULTIPLE-SCLEROSIS; RETINOIC-ACID; ENDOMETRIAL PROTEIN; REGULATORY ACTIVITY; BETA RECEPTOR; GLYCODELIN-A; IN-VITRO; PREGNANCY; LINEAGE	Background: T-helper polarization of naive T cells is determined by a complex mechanism that involves many factors, eventually leading to activation of Th1, Th2, or Th17 responses or alternatively the generation of regulatory T cells. Placental Protein 14 (PP14) is a 28 kDa glycoprotein highly secreted in early pregnancy that is able to desensitize T cell receptor (TCR) signaling and modulate T cell activation. Methodology/Principal Findings: Prolonged antigen-specific stimulation of T cells in the presence of PP14 resulted in an impaired secretion of IFN-gamma, IL-5 and IL-17 upon restimulation, although the cells proliferated and expressed activation markers. Furthermore, the generation of regulatory CD4(+)CD25(high)Foxp3(+) T cells was induced in the presence of PP14, in both antigen-specific as well as polyclonal stimulation. In accordance with previous reports, we found that the induction of FoxP3 expression by PP14 is accompanied by down regulation of the PI3K-mTOR signaling pathway. Conclusions/Significance: These data suggest that PP14 arrests T cells in a unique activated state that is not accompanied with the acquisition of effector function, together with promoting the generation of regulatory T cells. Taken together, our results may elucidate the role of PP14 in supporting immune tolerance in pregnancy by reducing T cell effector functions along with augmenting Treg differentiation.	[Ochanuna, Zohar; Geiger-Maor, Anat; Rachmilewitz, Jacob] Hadassah Hebrew Univ Med Ctr, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel; [Dembinsky-Vaknin, Adi; Karussis, Dimitrios] Hadassah Hebrew Univ Med Ctr, Dept Neurol, Jerusalem, Israel; [Tykocinski, Mark L.] Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Jefferson University	Ochanuna, Z (corresponding author), Hadassah Hebrew Univ Med Ctr, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel.	rjacob@cc.huji.ac.il			Horowitz foundation; National Multiple Sclerosis Society	Horowitz foundation; National Multiple Sclerosis Society(National Multiple Sclerosis Society)	This work was supported by grants from the Horowitz foundation and the National Multiple Sclerosis Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achiron A, 2004, CLIN IMMUNOL, V113, P155, DOI 10.1016/j.clim.2004.06.004; Agnello D, 2003, J CLIN IMMUNOL, V23, P147, DOI 10.1023/A:1023381027062; Amsalem H, 2008, INT IMMUNOL, V20, P1147, DOI 10.1093/intimm/dxn072; BELL SC, 1989, BAILLIERE CLIN OB GY, V3, P271, DOI 10.1016/S0950-3552(89)80022-7; Borovsky Z, 2002, J BIOL CHEM, V277, P21529, DOI 10.1074/jbc.M201613200; Buyon JP, 1996, CLIN IMMUNOL IMMUNOP, V78, P99, DOI 10.1006/clin.1996.0018; Cho TH, 2000, MOL CELLS, V10, P695; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; CULOUSCOU JM, 1986, J REPROD IMMUNOL, V9, P33, DOI 10.1016/0165-0378(86)90023-9; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091; Gambineri E, 2003, CURR OPIN RHEUMATOL, V15, P430, DOI 10.1097/00002281-200307000-00010; Hamalainen H, 2001, GENOME BIOL, V2; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Ish-Shalom E, 2006, GLYCOBIOLOGY, V16, P173, DOI 10.1093/glycob/cwj053; Jayachandran R, 2006, GLYCOBIOLOGY, V16, P1052, DOI 10.1093/glycob/cwl024; JULKUNEN M, 1986, HUM REPROD, V1, P7, DOI 10.1093/oxfordjournals.humrep.a136349; Karande Anjali A., 2005, Indian Journal of Physiology and Pharmacology, V49, P271; Koistinen H, 1996, MOL HUM REPROD, V2, P759, DOI 10.1093/molehr/2.10.759; Kontopidis G, 2004, J DAIRY SCI, V87, P785, DOI 10.3168/jds.S0022-0302(04)73222-1; Lapid K, 2006, GLYCOBIOLOGY, V16, p39R, DOI 10.1093/glycob/cwj059; Marie JC, 2006, IMMUNITY, V25, P441, DOI 10.1016/j.immuni.2006.07.012; McClain MA, 2007, J IMMUNOL, V179, P8146, DOI 10.4049/jimmunol.179.12.8146; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; MINCHEVANILSSON L, 1992, J IMMUNOL, V149, P2203; Mishan-Eisenberg G, 2004, J IMMUNOL, V173, P5524, DOI 10.4049/jimmunol.173.9.5524; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Mukhopadhyay D, 2004, J BIOL CHEM, V279, P8577, DOI 10.1074/jbc.M306673200; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; NEWCOMER ME, 1995, FASEB J, V9, P229, DOI 10.1096/fasebj.9.2.7781925; Nguyen JT, 2001, J IMMUNOL, V167, P5697, DOI 10.4049/jimmunol.167.10.5697; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; POCKLEY AG, 1989, CLIN EXP IMMUNOL, V77, P252; POCKLEY AG, 1989, BIOLOGY, V69, P277; Rachmilewitz J, 2003, J BIOL CHEM, V278, P14059, DOI 10.1074/jbc.M211716200; Rachmilewitz J, 2002, TRENDS IMMUNOL, V23, P592, DOI 10.1016/S1471-4906(02)02342-6; Rachmilewitz J, 2002, J IMMUNOL, V168, P2745, DOI 10.4049/jimmunol.168.6.2745; Rachmilewitz J, 2001, BLOOD, V98, P3727, DOI 10.1182/blood.V98.13.3727; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; SEPPALA M, 1990, EUR J OBSTET GYN R B, V36, P250, DOI 10.1016/0028-2243(90)90206-G; Seppala M, 2002, ENDOCR REV, V23, P401, DOI 10.1210/er.2001-0026; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Song MQ, 2001, P NATL ACAD SCI USA, V98, P9265, DOI 10.1073/pnas.151151198; SWAIN SL, 1990, J IMMUNOL, V144, P1788; Takano T, 2001, MOL CELL BIOL, V21, P5050, DOI 10.1128/MCB.21.15.5050-5062.2001; Tejada-Simon MV, 2001, EUR J IMMUNOL, V31, P907, DOI 10.1002/1521-4141(200103)31:3<907::AID-IMMU907>3.0.CO;2-1; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Van den Nieuwenhof IM, 2000, EUR J BIOCHEM, V267, P4753, DOI 10.1046/j.1432-1327.2000.01528.x; Walker MR, 2003, J CLIN INVEST, V112, P1437, DOI 10.1172/JCI200319441; Weetman AP, 1999, THYROID, V9, P643, DOI 10.1089/thy.1999.9.643; Wohlfert EA, 2006, J IMMUNOL, V176, P1316, DOI 10.4049/jimmunol.176.3.1316; Xiao S, 2008, J IMMUNOL, V181, P2277, DOI 10.4049/jimmunol.181.4.2277; ZHANG JW, 1992, CELL IMMUNOL, V139, P118	57	16	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12868	10.1371/journal.pone.0012868	http://dx.doi.org/10.1371/journal.pone.0012868			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886106	Green Submitted, Green Published, gold			2022-12-27	WOS:000282091100003
J	Placencio, VR; Li, XH; Sherrill, TP; Fritz, G; Bhowmick, NA				Placencio, Veronica R.; Li, Xiaohong; Sherrill, Taylor P.; Fritz, Gloria; Bhowmick, Neil A.			Bone Marrow Derived Mesenchymal Stem Cells Incorporate into the Prostate during Regrowth	PLOS ONE			English	Article							CANCER METASTASIS; BETA-CATENIN; DIFFERENTIATION; ANDROGEN; FUSION; GROWTH; MODEL; TUMOR; LIVER; TRANSPLANTATION	Background: Prostate cancer recurrence involves increased growth of cancer epithelial cells, as androgen dependent prostate cancer progresses to castrate resistant prostate cancer (CRPC) following initial therapy. Understanding CRPC prostate regrowth will provide opportunities for new cancer therapies to treat advanced disease. Methodology/Principal Findings: Elevated chemokine expression in the prostate stroma of a castrate resistant mouse model, Tgfbr2(fspKO), prompted us to look at the involvement of bone marrow derived cells (BMDCs) in prostate regrowth. We identified bone marrow cells recruited to the prostate in GFP-chimeric mice. A dramatic increase in BMDC recruitment for prostate regrowth occurred three days after exogenous testosterone implantation. Recruitment led to incorporation of BMDCs within the prostate epithelia. Immunofluorescence staining suggested BMDCs in the prostate coexpressed androgen receptor; p63, a basal epithelial marker; and cytokeratin 8, a luminal epithelial marker. A subset of the BMDC population, mesenchymal stem cells (MSCs), were specifically found to be incorporated in the prostate at its greatest time of remodeling. Rosa26 expressing MSCs injected into GFP mice supported MSC fusion with resident prostate epithelial cells through co-localization of beta-galactosidase and GFP during regrowth. In a human C4-2B xenograft model of CRPC, MSCs were specifically recruited. Injection of GFP-labeled MSCs supported C4-2B tumor progression by potentiating canonical Wnt signaling. The use of MSCs as a targeted delivery vector for the exogenously expressed Wnt antagonist, secreted frizzled related protein-2 (SFRP2), reduced tumor growth, increased apoptosis and potentiated tumor necrosis. Conclusions/Significance: Mesenchymal stem cells fuse with prostate epithelia during the process of prostate regrowth. MSCs recruited to the regrowing prostate can be used as a vehicle for transporting genetic information with potential therapeutic effects on castrate resistant prostate cancer, for instance by antagonizing Wnt signaling through SFRP2.	[Placencio, Veronica R.; Li, Xiaohong; Bhowmick, Neil A.] Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37232 USA; [Li, Xiaohong; Fritz, Gloria; Bhowmick, Neil A.] Vanderbilt Univ, Dept Urol Surg, Nashville, TN USA; [Sherrill, Taylor P.] Vanderbilt Univ, Dept Pulm & Crit Care Med, Nashville, TN USA; [Bhowmick, Neil A.] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Cedars Sinai Medical Center	Placencio, VR (corresponding author), Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37232 USA.	bhowmickn@cshs.org	Bhowmick, Neil/AAA-7302-2019	Bhowmick, Neil/0000-0001-8747-5989; , Xiaohong/0000-0001-5074-193X	National Institute of Health/National Cancer Institute [CA108646, CA126505]; Department of Defense Prostate Cancer Research [PC081246]; National Institute of Health/NRSA [GM079879]; NIH [CA68485, DK20593, DK58404, HD15052, DK59637, EY08126]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009592, P30CA068485, R01CA108646, U54CA126505] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020593, P60DK020593, P30DK058404, U24DK059637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM079879] Funding Source: NIH RePORTER	National Institute of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense Prostate Cancer Research(United States Department of Defense); National Institute of Health/NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by the National Institute of Health/National Cancer Institute (CA108646 and CA126505 to NAB), the Department of Defense Prostate Cancer Research Program (PC081246 to NAB), and National Institute of Health/NRSA (GM079879 to VRP). Immunofluorescence and confocal images were taken in part through the VUMC Cell Imaging Shared Resource (supported by NIH grants CA68485, DK20593, DK58404, HD15052, DK59637, and EY08126). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro MP, 2008, P NATL ACAD SCI USA, V105, P18366, DOI 10.1073/pnas.0803437105; Alison MR, 2009, CURR OPIN ONCOL, V21, P77, DOI 10.1097/CCO.0b013e32831de4cf; Ammirante M, 2010, NATURE, V464, P302, DOI 10.1038/nature08782; Anumanthan G, 2008, J UROLOGY, V180, P1778, DOI 10.1016/j.juro.2008.04.076; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Bisson I, 2009, CELL RES, V19, P683, DOI 10.1038/cr.2009.43; Boomershine CS, 2009, GUT, V58, P1267, DOI 10.1136/gut.2008.170779; Chytil A, 2002, GENESIS, V32, P73, DOI 10.1002/gene.10046; Dan YY, 2008, J GASTROEN HEPATOL, V23, P687, DOI 10.1111/j.1440-1746.2008.05383.x; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Davies PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006530; Dittmar T, 2009, MED HYPOTHESES, V73, P542, DOI 10.1016/j.mehy.2009.05.044; Everhart MB, 2005, J LEUKOCYTE BIOL, V77, P173, DOI 10.1189/jlb.1203647; Fritz V, 2008, CURR STEM CELL RES T, V3, P32, DOI 10.2174/157488808783489462; Fritz V, 2008, STEM CELLS, V26, P2981, DOI 10.1634/stemcells.2008-0139; Li HC, 2006, WORLD J GASTROENTERO, V12, P363, DOI 10.3748/wjg.v12.i3.363; Houghton J, 2004, SCIENCE, V306, P1568, DOI 10.1126/science.1099513; Houghton J, 2007, SEMIN CANCER BIOL, V17, P191, DOI 10.1016/j.semcancer.2006.04.003; Ichim TE, 2010, CELL IMMUNOL, V260, P75, DOI 10.1016/j.cellimm.2009.10.006; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kasper S, 1998, LAB INVEST, V78, P319; Kawada H, 2004, BLOOD, V104, P3581, DOI 10.1182/blood-2004-04-1488; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469; LI X, 2008, PROSTATE TUMOR PROGR; Liu CF, 2006, NEOPLASIA, V8, P716, DOI 10.1593/neo.06253; Luo JL, 2007, NATURE, V446, P690, DOI 10.1038/nature05656; Palapattu GS, 2006, J UROLOGY, V176, P813, DOI 10.1016/j.juro.2006.03.077; Phinney DG, 1999, J CELL BIOCHEM, V72, P570; Placencio VR, 2008, CANCER RES, V68, P4709, DOI 10.1158/0008-5472.CAN-07-6289; Reinders MEJ, 2010, NEPHROL DIAL TRANSPL, V25, P17, DOI 10.1093/ndt/gfp552; Rizvi AZ, 2006, P NATL ACAD SCI USA, V103, P6321, DOI 10.1073/pnas.0508593103; Song H, 2010, EXPERT OPIN BIOL TH, V10, P309, DOI 10.1517/14712590903455997; Spagnoli A, 2005, ENDOCRIN DEV, V9, P17, DOI 10.1159/000085719; Terry S, 2006, J CELL BIOCHEM, V99, P402, DOI 10.1002/jcb.20983; THALMANN GN, 1994, CANCER RES, V54, P2577; Tsujimura A, 2002, J CELL BIOL, V157, P1257, DOI 10.1083/jcb.200202067; Vaday GG, 2006, PROSTATE, V66, P124, DOI 10.1002/pros.20306; Vassilopoulos G, 2003, NATURE, V422, P901, DOI 10.1038/nature01539; Verras M, 2006, CANCER LETT, V237, P22, DOI 10.1016/j.canlet.2005.06.004; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Xu WT, 2009, CANCER LETT, V281, P32, DOI 10.1016/j.canlet.2009.02.022; Yu XP, 2009, PROSTATE, V69, P249, DOI 10.1002/pros.20877	46	42	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12920	10.1371/journal.pone.0012920	http://dx.doi.org/10.1371/journal.pone.0012920			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886110	Green Submitted, gold, Green Published			2022-12-27	WOS:000282091100024
J	Wen, L; Wang, HX; Tanimoto, S; Egawa, R; Matsuzaka, Y; Mushiake, H; Ishizuka, T; Yawo, H				Wen, Lei; Wang, Hongxia; Tanimoto, Saki; Egawa, Ryo; Matsuzaka, Yoshiya; Mushiake, Hajime; Ishizuka, Toru; Yawo, Hiromu			Opto-Current-Clamp Actuation of Cortical Neurons Using a Strategically Designed Channelrhodopsin	PLOS ONE			English	Article							IMMEDIATE-EARLY GENES; MILLISECOND-TIMESCALE; OPTICAL CONTROL; C-FOS; LIGHT; NETWORK; ACTIVATION; CELLS; CHLAMYDOMONAS; HIPPOCAMPUS	Background: Optogenetic manipulation of a neuronal network enables one to reveal how high-order functions emerge in the central nervous system. One of the Chlamydomonas rhodopsins, channelrhodopsin-1 (ChR1), has several advantages over channelrhodopsin-2 (ChR2) in terms of the photocurrent kinetics. Improved temporal resolution would be expected by the optogenetics using the ChR1 variants with enhanced photocurrents. Methodology/Principal Findings: The photocurrent retardation of ChR1 was overcome by exchanging the sixth helix domain with its counterpart in ChR2 producing Channelrhodopsin-green receiver (ChRGR) with further reform of the molecule. When the ChRGR photocurrent was measured from the expressing HEK293 cells under whole-cell patch clamp, it was preferentially activated by green light and has fast kinetics with minimal desensitization. With its kinetic advantages the use of ChRGR would enable one to inject a current into a neuron by the time course as predicted by the intensity of the shedding light (opto-current clamp). The ChRGR was also expressed in the motor cortical neurons of a mouse using Sindbis pseudovirion vectors. When an oscillatory LED light signal was applied sweeping through frequencies, it robustly evoked action potentials synchronized to the oscillatory light at 5-10 Hz in layer 5 pyramidal cells in the cortical slice. The ChRGR-expressing neurons were also driven in vivo with monitoring local field potentials (LFPs) and the time-frequency energy distribution of the light-evoked response was investigated using wavelet analysis. The oscillatory light enhanced both the in-phase and out-phase responses of LFP at the preferential frequencies of 5-10 Hz. The spread of activity was evidenced by the fact that there were many c-Fos-immunoreactive neurons that were negative for ChRGR in a region of the motor cortex. Conclusions/Significance: The opto-current-clamp study suggests that the depolarization of a small number of neurons wakes up the motor cortical network over some critical point to the activated state.	[Wen, Lei; Wang, Hongxia; Tanimoto, Saki; Egawa, Ryo; Ishizuka, Toru; Yawo, Hiromu] Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Sendai, Miyagi 980, Japan; [Wen, Lei; Wang, Hongxia; Tanimoto, Saki; Egawa, Ryo; Matsuzaka, Yoshiya; Mushiake, Hajime; Ishizuka, Toru; Yawo, Hiromu] Japan Sci & Technol Agcy, CREST, Tokyo, Japan; [Wen, Lei; Wang, Hongxia; Tanimoto, Saki; Egawa, Ryo; Mushiake, Hajime; Yawo, Hiromu] Tohoku Univ, Basic & Translat Res Ctr Global Brain Sci, Sendai, Miyagi 980, Japan; [Matsuzaka, Yoshiya; Mushiake, Hajime] Tohoku Univ, Dept Physiol, Grad Sch Med, Sendai, Miyagi 980, Japan; [Mushiake, Hajime; Yawo, Hiromu] Tohoku Univ, Grad Sch Med, Ctr Neurosci, Sendai, Miyagi 980, Japan	Tohoku University; Japan Science & Technology Agency (JST); Tohoku University; Tohoku University; Tohoku University	Wen, L (corresponding author), Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Sendai, Miyagi 980, Japan.	yawo-hiromu@m.tohoku.ac.jp	Ishizuka, Toru/L-8191-2017; Yawo, Hiromu/I-4871-2015	Ishizuka, Toru/0000-0003-4405-8792; Yawo, Hiromu/0000-0002-4299-3288; Mushiake, Hajime/0000-0002-5130-4720	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [21026002]; MEXT [08030013]	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST): http://www.jst.go.jp/kisoken/crest/en/index.html. Grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, #21026002: http://www.nips.ac.jp/cellsensor/index.html. Global COE Program (Basic & Translational Research Centre for Global Brain Science), MEXT: http://sendaibrain.org/. Strategic Research Program for Brain Sciences (SRPBS), MEXT, #08030013: http://brainprogram.mext.go.jp/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Callaway EM, 2005, TRENDS NEUROSCI, V28, P196, DOI 10.1016/j.tins.2005.01.007; Callaway EM, 2002, CURR OPIN NEUROBIOL, V12, P587, DOI 10.1016/S0959-4388(02)00364-1; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Destexhe A, 2006, SCIENCE, V314, P85, DOI 10.1126/science.1127241; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Douglass AD, 2008, CURR BIOL, V18, P1133, DOI 10.1016/j.cub.2008.06.077; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; GUTFREUND Y, 1995, J PHYSIOL-LONDON, V483, P621, DOI 10.1113/jphysiol.1995.sp020611; Guzowski JF, 2001, J NEUROSCI, V21, P5089, DOI 10.1523/JNEUROSCI.21-14-05089.2001; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; Han X, 2009, NEURON, V62, P191, DOI 10.1016/j.neuron.2009.03.011; Hasselmo ME, 2006, J MOL NEUROSCI, V30, P133, DOI 10.1385/JMN:30:1:133; Hegemann P, 2005, BIOPHYS J, V89, P3911, DOI 10.1529/biophysj.105.069716; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Hutcheon B, 2000, TRENDS NEUROSCI, V23, P216, DOI 10.1016/S0166-2236(00)01547-2; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; KALIL K, 1984, TRENDS NEUROSCI, V7, P394, DOI 10.1016/S0166-2236(84)80064-8; Kramer RH, 2009, CURR OPIN NEUROBIOL, V19, P544, DOI 10.1016/j.conb.2009.09.004; Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Miesenbock G, 2004, CURR OPIN NEUROBIOL, V14, P395, DOI 10.1016/j.conb.2004.05.004; Miesenbock G, 2009, SCIENCE, V326, P395, DOI 10.1126/science.1174520; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2005, BIOCHEM SOC T, V33, P863, DOI 10.1042/BST0330863; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; PUIL E, 1986, J NEUROPHYSIOL, V55, P995, DOI 10.1152/jn.1986.55.5.995; Rolls ET, 2008, EUR J NEUROSCI, V28, P782, DOI 10.1111/j.1460-9568.2008.06379.x; Schoenenberger P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008185; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Steriade M, 2000, NEUROSCIENCE, V101, P243, DOI 10.1016/S0306-4522(00)00353-5; Sugiyama Y, 2009, PHOTOCH PHOTOBIO SCI, V8, P328, DOI 10.1039/b815762f; Sutoh T, 2000, CLIN NEUROPHYSIOL, V111, P858, DOI 10.1016/S1388-2457(99)00321-1; Suzuki T, 2003, BIOCHEM BIOPH RES CO, V301, P711, DOI 10.1016/S0006-291X(02)03079-6; TERASHIMA T, 1995, NEUROSCI RES, V22, P139, DOI 10.1016/0168-0102(95)00895-9; Tohidi V, 2009, J NEUROSCI, V29, P6427, DOI 10.1523/JNEUROSCI.0545-09.2009; Tomita H, 2007, INVEST OPHTH VIS SCI, V48, P3821, DOI 10.1167/iovs.06-1501; Tomita H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007679; Van der Zee EA, 1999, PROG NEUROBIOL, V58, P409, DOI 10.1016/S0301-0082(98)00092-6; Wang HX, 2009, J BIOL CHEM, V284, P5685, DOI 10.1074/jbc.M807632200; Weiler N, 2008, NAT NEUROSCI, V11, P360, DOI 10.1038/nn2049; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120; Zhang YP, 2007, NAT METHODS, V4, P139, DOI 10.1038/nmeth988	49	56	63	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12893	10.1371/journal.pone.0012893	http://dx.doi.org/10.1371/journal.pone.0012893			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886118	Green Published, Green Submitted, gold			2022-12-27	WOS:000282091100009
J	Bishai, JD; Bishai, WR; Bishai, DM				Bishai, Jason D.; Bishai, William R.; Bishai, David M.			Heightened Vulnerability to MDR-TB Epidemics after Controlling Drug-Susceptible TB	PLOS ONE			English	Article							RESISTANT MYCOBACTERIUM-TUBERCULOSIS; EXOGENOUS REINFECTION; EMERGENCE; DYNAMICS; RUSSIA; PATTERNS; MODEL; COST	Background: Prior infection with one strain TB has been linked with diminished likelihood of re-infection by a new strain. This paper attempts to determine the role of declining prevalence of drug-susceptible TB in enabling future epidemics of MDR-TB. Methods: A computer simulation of MDR-TB epidemics was developed using an agent-based model platform programmed in NetLogo (See http://mdr.tbtools.org/). Eighty-one scenarios were created, varying levels of treatment quality, diagnostic accuracy, microbial fitness cost, and the degree of immunogenicity elicited by drug-susceptible TB. Outcome measures were the number of independent MDR-TB cases per trial and the proportion of trials resulting in MDR-TB epidemics for a 500 year period after drug therapy for TB is introduced. Results: MDR-TB epidemics propagated more extensively after TB prevalence had fallen. At a case detection rate of 75%, improving therapeutic compliance from 50% to 75% can reduce the probability of an epidemic from 45% to 15%. Paradoxically, improving the case-detection rate from 50% to 75% when compliance with DOT is constant at 75% increases the probability of MDR-TB epidemics from 3% to 45%. Conclusions: The ability of MDR-TB to spread depends on the prevalence of drug-susceptible TB. Immunologic protection conferred by exposure to drug-susceptible TB can be a crucial factor that prevents MDR-TB epidemics when TB treatment is poor. Any single population that successfully reduces its burden of drug-susceptible TB will have reduced herd immunity to externally or internally introduced strains of MDR-TB and can experience heightened vulnerability to an epidemic. Since countries with good TB control may be more vulnerable, their self interest dictates greater promotion of case detection and DOTS implementation in countries with poor control to control their risk of MDR-TB.	[Bishai, Jason D.] Stanford Univ, Sch Humanities & Sci, Stanford, CA 94305 USA; [Bishai, William R.] Johns Hopkins Sch Med, Dept Med, Div Infect Dis, Baltimore, MD USA; [Bishai, David M.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	Stanford University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Bishai, JD (corresponding author), Stanford Univ, Sch Humanities & Sci, Stanford, CA 94305 USA.	dbishai@jhsph.edu	, David Bishai/GRO-4211-2022	Bishai, David/0000-0003-0714-9062	Consortium to Respond Effectively to the AIDS/TB Epidemic (CREATE); National Institutes of Health [5R01AI036973-15, 5R01AI037856-10]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037856, R01AI036973] Funding Source: NIH RePORTER	Consortium to Respond Effectively to the AIDS/TB Epidemic (CREATE); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported in part by the Consortium to Respond Effectively to the AIDS/TB Epidemic (CREATE) and National Institutes of Health grants 5R01AI036973-15 and NIH 5R01AI037856-10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Balabanova Y, 2004, J ANTIMICROB CHEMOTH, V54, P673, DOI 10.1093/jac/dkh383; BLOOM BR, 1992, SCIENCE, V257, P1055, DOI 10.1126/science.257.5073.1055; BLOWER SM, 1995, NAT MED, V1, P815, DOI 10.1038/nm0895-815; Blower SM, 1998, J MOL MED, V76, P624, DOI 10.1007/s001090050260; Blower SM, 2004, NAT MED, V10, P1111, DOI 10.1038/nm1102; Burgos M, 2003, J INFECT DIS, V188, P1878, DOI 10.1086/379895; Burzynski J, 2008, SEMIN RESP CRIT CARE, V29, P492, DOI 10.1055/s-0028-1085701; Cohen T, 2004, NAT MED, V10, P1117, DOI 10.1038/nm1110; Cohen T, 2003, LANCET INFECT DIS, V3, P13, DOI 10.1016/S1473-3099(03)00483-3; Cohen T, 2007, J R SOC INTERFACE, V4, P523, DOI 10.1098/rsif.2006.0193; Dye C, 2001, P ROY SOC B-BIOL SCI, V268, P45, DOI 10.1098/rspb.2000.1328; Dye C, 2000, INT J EPIDEMIOL, V29, P558, DOI 10.1093/ije/29.3.558; Fine PEM, 1999, NEW ENGL J MED, V341, P1226, DOI 10.1056/NEJM199910143411609; Gagneux S, 2006, SCIENCE, V312, P1944, DOI 10.1126/science.1124410; Ginsberg AM, 2008, SEMIN RESP CRIT CARE, V29, P552, DOI 10.1055/s-0028-1085706; GLAZIOU P, 2006, MATH MODELING TB EPI; Grange JM, 2001, INT J TUBERC LUNG D, V5, P208; GRZYBOWSKI S, 1976, TUBERCLE, V57, pS1, DOI 10.1016/0041-3879(76)90059-3; JOESOEF MR, 1989, INT J EPIDEMIOL, V18, P174, DOI 10.1093/ije/18.1.174; Matsumoto M, 2006, PLOS MED, V3, P2131, DOI 10.1371/journal.pmed.0030466; Mitnick CD, 2008, SEMIN RESP CRIT CARE, V29, P499, DOI 10.1055/s-0028-1085702; Murray C J, 1990, Bull Int Union Tuberc Lung Dis, V65, P6; Richardson M, 2002, J CLIN MICROBIOL, V40, P2750, DOI 10.1128/JCM.40.8.2750-2754.2002; Roberts C. A., 2003, BIOARCHEOLOGY TUBERC; Sawert H, 1997, SOC SCI MED, V44, P1805, DOI 10.1016/S0277-9536(96)00289-4; Schneider E, 2005, CLIN CHEST MED, V26, P183, DOI 10.1016/j.ccm.2005.02.007; SHAFER RW, 1995, J INFECT DIS, V171, P170, DOI 10.1093/infdis/171.1.170; Shilova MV, 2001, ANN NY ACAD SCI, V953, P124, DOI 10.1111/j.1749-6632.2001.tb11369.x; SMALL PM, 1993, NEW ENGL J MED, V328, P1137, DOI 10.1056/NEJM199304223281601; Stott H, 1973, Tubercle, V54, P1; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; Styblo K, 1991, EPIDEMIOLOGY TUBERCU; Van Rie A, 1999, NEW ENGL J MED, V341, P1174, DOI 10.1056/NEJM199910143411602; *WHO, 2008, ANT DRUG RES WORLD; Wilensky U., 1999, NETLOGO; Yerokhin VV, 2001, ANN NY ACAD SCI, V953, P133, DOI 10.1111/j.1749-6632.2001.tb11370.x	37	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12843	10.1371/journal.pone.0012843	http://dx.doi.org/10.1371/journal.pone.0012843			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877639	Green Published, gold, Green Submitted			2022-12-27	WOS:000282053100016
J	Hoving, S; Heeneman, S; Gijbels, MJJ; Poele, JAMT; Bolla, M; Pol, JFC; Simons, MY; Russell, NS; Daemen, MJ; Stewart, FA				Hoving, Saske; Heeneman, Sylvia; Gijbels, Marion J. J.; Poele, Johannes A. M. Te; Bolla, Manlio; Pol, Jeffrey F. C.; Simons, Michelle Y.; Russell, Nicola S.; Daemen, Mat J.; Stewart, Fiona A.			NO-Donating Aspirin and Aspirin Partially Inhibit Age-Related Atherosclerosis but Not Radiation-Induced Atherosclerosis in ApoE Null Mice	PLOS ONE			English	Article							OXIDE-RELEASING ASPIRIN; INFLAMMATORY PLAQUE PHENOTYPE; PROGRESSION; THROMBOEMBOLISM; INITIATION; PLATELET; ADHESION; NECK; THROMBOMODULIN; ATHEROGENESIS	Background: We previously showed that irradiation to the carotid arteries of ApoE(-/-) mice accelerated the development of macrophage-rich, inflammatory atherosclerotic lesions, prone to intra-plaque hemorrhage. In this study we investigated the potential of anti-inflammatory and anti-coagulant intervention strategies to inhibit age-related and radiation-induced atherosclerosis. Methodology/Principal Findings: ApoE(-/-) mice were given 0 or 14 Gy to the neck and the carotid arteries and aortic arches were harvested at 4 or 30 weeks after irradiation. Nitric oxide releasing aspirin (NCX 4016, 60 mg/kg/day) or aspirin (ASA, 30 or 300 mg/kg/day) were given continuously in the chow. High dose ASA effectively blocked platelet aggregation, while the low dose ASA or NCX 4016 had no significant effect on platelet aggregation. High dose ASA, but not NCX 4016, inhibited endothelial cell expression of VCAM-1 and thrombomodulin in the carotid arteries at 4 weeks after irradiation; eNOS and ICAM-1 levels were unchanged. After 30 weeks of follow-up, NCX 4016 significantly reduced the total number of lesions and the number of initial macrophage-rich lesions in the carotid arteries of unirradiated mice, but these effects were not seen in the brachiocephalic artery of the aortic arch (BCA). In contrast, high dose ASA lead to a decrease in the number of initial lesions in the BCA, but not in the carotid artery. Both high dose ASA and NCX 4016 reduced the collagen content of advanced lesions and increased the total plaque burden in the BCA of unirradiated mice. At 30 weeks after irradiation, neither NCX 4016 nor ASA significantly influenced the number or distribution of lesions, but high dose ASA lead to formation of collagen-rich "stable" advanced lesions in carotid arteries. The total plaque area of the irradiated BCA was increased after ASA, but the plaque burden was very low compared with the carotid artery. Conclusions/Significance: The development and characteristics of radiation-induced atherosclerosis varied between different arteries but could not be circumvented by anti-inflammatory and anti-coagulant therapies. This implicates other underlying mechanistic pathways compared to age-related atherosclerosis.	[Hoving, Saske; Poele, Johannes A. M. Te; Stewart, Fiona A.] Netherlands Canc Inst, Div Expt Therapy, NL-1066 CX Amsterdam, Netherlands; [Russell, Nicola S.] Netherlands Canc Inst, Div Radiotherapy, NL-1066 CX Amsterdam, Netherlands; [Heeneman, Sylvia; Pol, Jeffrey F. C.; Simons, Michelle Y.; Daemen, Mat J.] Univ Maastricht, Dept Pathol, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [Gijbels, Marion J. J.] Univ Maastricht, Dept Mol Genet, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [Bolla, Manlio] NicOx SA, Sophia Antipolis, France	Netherlands Cancer Institute; Netherlands Cancer Institute; Maastricht University; Maastricht University	Hoving, S (corresponding author), Netherlands Canc Inst, Div Expt Therapy, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	f.stewart@nki.nl		Daemen, Mat/0000-0003-1076-199X	Dutch Cancer Society [NKI 2055-3373]	Dutch Cancer Society(KWF Kankerbestrijding)	This work was supported by the Dutch Cancer Society (project number NKI 2055-3373). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman BMP, 2003, J CLIN ONCOL, V21, P3431, DOI 10.1200/JCO.2003.07.131; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Baluna RG, 2006, RADIAT RES, V166, P819, DOI 10.1667/RR0380.1; Berger JS, 2006, JAMA-J AM MED ASSOC, V295, P306, DOI 10.1001/jama.295.3.306; Bolla M, 2006, EUR J CLIN PHARMACOL, V62, P145, DOI 10.1007/s00228-005-0026-6; Cheng SWK, 2004, J VASC SURG, V39, P409, DOI 10.1016/j.jvs.2003.08.031; Cottin Y, 2001, Cardiovasc Radiat Med, V2, P231, DOI 10.1016/S1522-1865(02)00129-4; Cyrus T, 2002, CIRCULATION, V106, P1282, DOI 10.1161/01.CIR.0000027816.54430.96; Darby S, 2003, BRIT MED J, V326, P256, DOI 10.1136/bmj.326.7383.256; Dorresteijn LDA, 2002, J CLIN ONCOL, V20, P282, DOI 10.1200/JCO.20.1.282; Gresele P, 2006, CARDIOVASC DRUG REV, V24, P148, DOI 10.1111/j.1527-3466.2006.00148.x; Hallahan DE, 1999, RADIAT RES, V152, P6, DOI 10.2307/3580044; Hoving S, 2008, INT J RADIAT ONCOL, V71, P848, DOI 10.1016/j.ijrobp.2008.02.031; Ignarro LJ, 2001, P NATL ACAD SCI USA, V98, P4202, DOI 10.1073/pnas.071054698; Li M, 2007, ATHEROSCLEROSIS, V194, P348, DOI 10.1016/j.atherosclerosis.2006.11.006; Lutgens E, 2002, ARTERIOSCL THROM VAS, V22, P975, DOI 10.1161/01.ATV.0000019729.39500.2F; Mackay J, 2006, CANC ATLAS; Martin JD, 2005, INT J RADIAT ONCOL, V63, P1197, DOI 10.1016/j.ijrobp.2005.04.017; Massberg S, 2002, J EXP MED, V196, P887, DOI 10.1084/jem.20012044; Momi S, 2005, THROMB HAEMOSTASIS, V93, P535, DOI 10.1160/TH04-07-0464; Momi S, 2001, HAEMATOLOGICA, V86, P297; Momi S, 2000, EUR J PHARMACOL, V397, P177, DOI 10.1016/S0014-2999(00)00223-5; Napoli C, 2002, P NATL ACAD SCI USA, V99, P12467, DOI 10.1073/pnas.192244499; Napoli C, 2001, P NATL ACAD SCI USA, V98, P2860, DOI 10.1073/pnas.041602898; Richter KK, 1997, RADIOTHER ONCOL, V44, P65, DOI 10.1016/S0167-8140(97)00063-7; Schiller NK, 2001, ARTERIOSCL THROM VAS, V21, P1674, DOI 10.1161/hq1001.096724; Stewart FA, 2006, AM J PATHOL, V168, P649, DOI 10.2353/ajpath.2006.050409; Tailor A, 2007, AM J PHYSIOL-HEART C, V293, pH3636, DOI 10.1152/ajpheart.01105.2006; Tous M, 2004, BASIC CLIN PHARMACOL, V95, P15, DOI 10.1111/j.1742-7843.2004.pto950104.x; Tribble DL, 1999, ARTERIOSCL THROM VAS, V19, P1387, DOI 10.1161/01.ATV.19.6.1387; Van Assche T, 2011, J VASC RES, V48, P31, DOI 10.1159/000317398; Van Kleef EM, 2000, INT J RADIAT BIOL, V76, P1565; VanderLaan PA, 2004, ARTERIOSCL THROM VAS, V24, P12, DOI 10.1161/01.ATV.0000105054.43931.f0; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Wang JR, 2002, AM J PATHOL, V160, P2063, DOI 10.1016/S0002-9440(10)61156-X; WEBER C, 1995, CIRCULATION, V91, P1914, DOI 10.1161/01.CIR.91.7.1914; Wolfe MM, 1999, NEW ENGL J MED, V340, P1888, DOI 10.1056/NEJM199906173402407; Yu J, 2002, LAB INVEST, V82, P825, DOI 10.1097/01.LAB.0000018828.61722.BD; Zhao W, 2007, BRIT J RADIOL, V80, pS23, DOI 10.1259/bjr/18237646	39	28	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2010	5	9							e12874	10.1371/journal.pone.0012874	http://dx.doi.org/10.1371/journal.pone.0012874			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652JO	20877628	Green Submitted, Green Published, gold			2022-12-27	WOS:000282002900015
J	Harscoet, E; Dubreucq, B; Palauqui, JC; Lepiniec, L				Harscoet, Erwana; Dubreucq, Bertrand; Palauqui, Jean-Christophe; Lepiniec, Loic			NOF1 Encodes an Arabidopsis Protein Involved in the Control of rRNA Expression	PLOS ONE			English	Article							DNA METHYLATION; NUCLEOLAR PROTEIN; GENE ENCODES; JMJC DOMAIN; AUXIN; SACCHAROMYCES; TRANSCRIPTION; EMBRYO; YEAST; EMBRYOGENESIS	The control of ribosomal RNA biogenesis is essential for the regulation of protein synthesis in eukaryotic cells. Here, we report the characterization of NOF1 that encodes a putative nucleolar protein involved in the control of rRNA expression in Arabidopsis. The gene has been isolated by T-DNA tagging and its function verified by the characterization of a second allele and genetic complementation of the mutants. The nof1 mutants are affected in female gametogenesis and embryo development. This result is consistent with the detection of NOF1 mRNA in all tissues throughout plant life's cycle, and preferentially in differentiating cells. Interestingly, the closely related proteins from zebra fish and yeast are also necessary for cell division and differentiation. We showed that the nof1-1 mutant displays higher rRNA expression and hypomethylation of rRNA promoter. Taken together, the results presented here demonstrated that NOF1 is an Arabidopsis gene involved in the control of rRNA expression, and suggested that it encodes a putative nucleolar protein, the function of which may be conserved in eukaryotes.	[Harscoet, Erwana; Dubreucq, Bertrand; Palauqui, Jean-Christophe; Lepiniec, Loic] INRA AgroParisTech, INRA, IJPB, UMR 1318, Versailles, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Harscoet, E (corresponding author), INRA AgroParisTech, INRA, IJPB, UMR 1318, Versailles, France.	lepiniec@versailles.inra.fr	Lepiniec, Loic/G-5808-2012; DUBREUCQ, Bertrand/AAY-9948-2020	Lepiniec, Loic/0000-0002-5845-3323; DUBREUCQ, Bertrand/0000-0003-2661-5479	French Genoplante Program	French Genoplante Program	This work was supported by the French Genoplante Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Balzergue S, 2001, BIOTECHNIQUES, V30, P496, DOI 10.2144/01303bm06; Baserga S J, 1997, Nucleic Acids Symp Ser, P64; Baud S, 2002, PLANT PHYSIOL BIOCH, V40, P151, DOI 10.1016/S0981-9428(01)01350-X; Baudry A, 2006, PLANT J, V46, P768, DOI 10.1111/j.1365-313X.2006.02733.x; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; BECKER D, 1990, NUCLEIC ACIDS RES, V18, P203, DOI 10.1093/nar/18.1.203; Bernstein KA, 2004, EUKARYOT CELL, V3, P1619, DOI 10.1128/EC.3.6.1619-1626.2004; Boisson M, 2001, EMBO J, V20, P1010, DOI 10.1093/emboj/20.5.1010; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Brady SM, 2009, PLANT CELL, V21, P1034, DOI 10.1105/tpc.109.066050; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Brown JWS, 2005, NUCLEIC ACIDS RES, V33, pD633, DOI 10.1093/nar/gki052; Browne SE, 1998, EUR J NEUROSCI, V10, P649, DOI 10.1046/j.1460-9568.1998.00084.x; Byrne ME, 2009, TRENDS PLANT SCI, V14, P512, DOI 10.1016/j.tplants.2009.06.009; Caperta AD, 2007, PROTOPLASMA, V232, P55, DOI 10.1007/s00709-007-0277-4; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Chelysheva L, 2005, J CELL SCI, V118, P4621, DOI 10.1242/jcs.02583; Chen J, 2005, GENE DEV, V19, P2900, DOI 10.1101/gad.1366405; Chen ZJ, 1997, GENE DEV, V11, P2124, DOI 10.1101/gad.11.16.2124; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; DOELLING JH, 1995, PLANT J, V8, P683, DOI 10.1046/j.1365-313X.1995.08050683.x; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Dubreucq B, 2000, PLANT J, V23, P643, DOI 10.1046/j.1365-313x.2000.00829.x; Dunbar DA, 1997, MOL CELL BIOL, V17, P5803, DOI 10.1128/MCB.17.10.5803; Fleurdepine S, 2007, NUCLEIC ACIDS RES, V35, P3306, DOI 10.1093/nar/gkm200; Frescas D, 2007, NATURE, V450, P309, DOI 10.1038/nature06255; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Geisler-Lee J, 2007, PLANT PHYSIOL, V145, P317, DOI 10.1104/pp.107.103465; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Geldner N, 2000, PLANT GROWTH REGUL, V32, P187, DOI 10.1023/A:1010765914644; Germann S, 2006, PLANT J, V48, P153, DOI 10.1111/j.1365-313X.2006.02859.x; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Griffith ME, 2007, PLANT CELL, V19, P2246, DOI 10.1105/tpc.106.042697; Hamann T, 2002, GENE DEV, V16, P1610, DOI 10.1101/gad.229402; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Jiang L, 2007, PLANT J, V50, P1020, DOI 10.1111/j.1365-313X.2007.03106.x; JURGENS G, 1995, PHILOS T R SOC B, V350, P19, DOI 10.1098/rstb.1995.0132; Kamakaka RT, 1998, GENETICS, V149, P903; Keener J, 1997, P NATL ACAD SCI USA, V94, P13458, DOI 10.1073/pnas.94.25.13458; KONCZ C, 1984, EMBO J, V3, P1029, DOI 10.1002/j.1460-2075.1984.tb01923.x; Kressler D, 1999, MOL CELL BIOL, V19, P7897; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lahmy S, 2004, PLANT J, V39, P809, DOI 10.1111/j.1365-313X.2004.02166.x; Lawrence RJ, 2004, CELL CYCLE, V3, P880; Lawrence RJ, 2004, MOL CELL, V13, P599, DOI 10.1016/S1097-2765(04)00064-4; LEPINIEC L, 2005, GENETIC MOL CONTROL, P511; Lewis MS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000815; Liang G, 2007, NAT STRUCT MOL BIOL, V14, P243, DOI 10.1038/nsmb1204; Libault M, 2005, PLANTA, V222, P910, DOI 10.1007/s00425-005-0129-4; MEINKE DW, 1995, ANNU REV PLANT PHYS, V46, P369, DOI 10.1146/annurev.pp.46.060195.002101; Meinke DW, 2003, PLANT PHYSIOL, V131, P409, DOI 10.1104/pp.014134; Miura K, 2007, CURR OPIN PLANT BIOL, V10, P495, DOI 10.1016/j.pbi.2007.07.002; Olson MOJ, 2000, TRENDS CELL BIOL, V10, P189, DOI 10.1016/S0962-8924(00)01738-4; Pendle AF, 2005, MOL BIOL CELL, V16, P260, DOI 10.1091/mbc.E04-09-0791; Petricka JJ, 2007, PLANT PHYSIOL, V144, P173, DOI 10.1104/pp.106.093575; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Rowland RRR, 2003, VIRUS RES, V95, P23, DOI 10.1016/S0168-1702(03)00161-8; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Samson F, 2002, NUCLEIC ACIDS RES, V30, P94, DOI 10.1093/nar/30.1.94; Santoro R, 2001, MOL CELL, V8, P719, DOI 10.1016/S1097-2765(01)00317-3; Saze H, 2008, SCIENCE, V319, P462, DOI 10.1126/science.1150987; Shaw PJ, 1995, ANNU REV CELL DEV BI, V11, P93, DOI 10.1146/annurev.cb.11.110195.000521; Shi DQ, 2005, PLANT CELL, V17, P2340, DOI 10.1105/tpc.105.033563; Sirri V, 2002, J CELL BIOL, V156, P969, DOI 10.1083/jcb.200201024; TRUERNIT E, 2008, PLANT CELL; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; VASQUEZ JS, 2008, ADV BOT RES, V47, P2; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Wehner KA, 2002, MOL CELL BIOL, V22, P7258, DOI 10.1128/MCB.22.20.7258-7267.2002; Weijers D, 2006, DEV CELL, V10, P265, DOI 10.1016/j.devcel.2005.12.001; Weijers D, 2005, CURR OPIN PLANT BIOL, V8, P32, DOI 10.1016/j.pbi.2004.11.001; Xue Y, 2006, NUCLEIC ACIDS RES, V34, pW254, DOI 10.1093/nar/gkl207; Zilberman D, 2007, DEVELOPMENT, V134, P3959, DOI 10.1242/dev.001131	75	31	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2010	5	9							e12829	10.1371/journal.pone.0012829	http://dx.doi.org/10.1371/journal.pone.0012829			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651YH	20877469	Green Published, gold, Green Submitted			2022-12-27	WOS:000281963200011
J	Henry, KA; Blank, HM; Hoose, SA; Polymenis, M				Henry, Kelsey A.; Blank, Heidi M.; Hoose, Scott A.; Polymenis, Michael			The Unfolded Protein Response Is Not Necessary for the G1/S Transition, but It Is Required for Chromosome Maintenance in Saccharomyces cerevisiae	PLOS ONE			English	Article							CONTINUOUS CULTURES; DNA-REPLICATION; ENDOPLASMIC-RETICULUM; METABOLIC CYCLE; CELL-DIVISION; YEAST; STRESS; GROWTH; DIFFERENTIATION; COORDINATION	Background: The unfolded protein response (UPR) is a eukaryotic signaling pathway, from the endoplasmic reticulum (ER) to the nucleus. Protein misfolding in the ER triggers the UPR. Accumulating evidence links the UPR in diverse aspects of cellular homeostasis. The UPR responds to the overall protein synthesis capacity and metabolic fluxes of the cell. Because the coupling of metabolism with cell division governs when cells start dividing, here we examined the role of UPR signaling in the timing of initiation of cell division and cell cycle progression, in the yeast Saccharomyces cerevisiae. Methodology/Principal Findings: We report that cells lacking the ER-resident stress sensor Ire1p, which cannot trigger the UPR, nonetheless completed the G1/S transition on time. Furthermore, loss of UPR signaling neither affected the nutrient and growth rate dependence of the G1/S transition, nor the metabolic oscillations that yeast cells display in defined steady-state conditions. Remarkably, however, loss of UPR signaling led to hypersensitivity to genotoxic stress and a ten-fold increase in chromosome loss. Conclusions/Significance: Taken together, our results strongly suggest that UPR signaling is not necessary for the normal coupling of metabolism with cell division, but it has a role in genome maintenance. These results add to previous work that linked the UPR with cytokinesis in yeast. UPR signaling is conserved in all eukaryotes, and it malfunctions in a variety of diseases, including cancer. Therefore, our findings may be relevant to other systems, including humans.	[Henry, Kelsey A.; Blank, Heidi M.; Hoose, Scott A.; Polymenis, Michael] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Henry, KA (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	polymenis@tamu.edu	Polymenis, Michael/AAJ-3389-2021		National Science Foundation [MCB-0818248]; Div Of Molecular and Cellular Bioscience [0818248] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by a grant from the National Science Foundation (MCB-0818248) to M. P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Baganz F, 1997, YEAST, V13, P1563, DOI 10.1002/(SICI)1097-0061(199712)13:16<1563::AID-YEA240>3.3.CO;2-Y; Baganz F, 1998, YEAST, V14, P1417, DOI 10.1002/(SICI)1097-0061(199811)14:15<1417::AID-YEA334>3.0.CO;2-N; Bicknell AA, 2007, J CELL BIOL, V177, P1017, DOI 10.1083/jcb.200702101; Blank HM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008018; Blank HM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000047; Brauer MJ, 2008, MOL BIOL CELL, V19, P352, DOI 10.1091/mbc.E07-08-0779; Castellano C, 2007, REV CONSTR, V6, P4; Chen Z, 2007, SCIENCE, V316, P1916, DOI 10.1126/science.1140958; CREANOR J, 1979, J GEN MICROBIOL, V112, P385, DOI 10.1099/00221287-112-2-385; Delneri D, 2008, NAT GENET, V40, P113, DOI 10.1038/ng.2007.49; Guo JB, 2004, ARCH MICROBIOL, V182, P326, DOI 10.1007/s00203-004-0704-2; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Kaiser C., 1994, METHODS YEAST GENETI; Kaufman RJ, 2002, NAT REV MOL CELL BIO, V3, P411, DOI 10.1038/nrm829; Klevecz RR, 2004, P NATL ACAD SCI USA, V101, P1200, DOI 10.1073/pnas.0306490101; Koc A, 2004, J BIOL CHEM, V279, P223, DOI 10.1074/jbc.M303952200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Murray DB, 2003, EXP CELL RES, V287, P10, DOI 10.1016/S0014-4827(03)00068-5; Murray DB, 2007, P NATL ACAD SCI USA, V104, P2241, DOI 10.1073/pnas.0606677104; Niwa M, 2005, GENOME BIOL, V6; NOVICK P, 1979, P NATL ACAD SCI USA, V76, P1858, DOI 10.1073/pnas.76.4.1858; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Patil CK, 2004, PLOS BIOL, V2, P1208, DOI 10.1371/journal.pbio.0020246; PORRO D, 1988, BIOTECHNOL BIOENG, V32, P411, DOI 10.1002/bit.260320402; PRINGLE JR, 1981, MOL BIOL YEAST SACCH, P97; Rutkowski DT, 2010, J CELL BIOL, V189, P783, DOI 10.1083/jcb.201003138; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Saldanha AJ, 2004, MOL BIOL CELL, V15, P4089, DOI 10.1091/mbc.e04-04-0306; Schroder M, 2000, GENE DEV, V14, P2962, DOI 10.1101/gad.852300; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; Silverman SJ, 2010, P NATL ACAD SCI USA, V107, P6946, DOI 10.1073/pnas.1002422107; SPENCER F, 1990, GENETICS, V124, P237; Strome ED, 2008, GENETICS, V178, P1193, DOI 10.1534/genetics.107.084103; Tu BP, 2007, P NATL ACAD SCI USA, V104, P16886, DOI 10.1073/pnas.0708365104; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; Wiseman RL, 2010, CELL, V140, P590, DOI 10.1016/j.cell.2010.02.006; Zhao LH, 2006, CURR OPIN CELL BIOL, V18, P444, DOI 10.1016/j.ceb.2006.06.005	41	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2010	5	9							e12732	10.1371/journal.pone.0012732	http://dx.doi.org/10.1371/journal.pone.0012732			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZO	20856872	Green Published, Green Submitted, gold			2022-12-27	WOS:000281815700018
J	Roosild, TP; Castronovo, S				Roosild, Tarmo P.; Castronovo, Samantha			Active Site Conformational Dynamics in Human Uridine Phosphorylase 1	PLOS ONE			English	Article							DEPRIVATION-INDUCED DEATH; ESCHERICHIA-COLI; IDENTIFICATION; EXPRESSION; INHIBITORS; BENZYLACYCLOURIDINE; METABOLISM; ENZYME; LIVER; MODEL	Uridine phosphorylase (UPP) is a central enzyme in the pyrimidine salvage pathway, catalyzing the reversible phosphorolysis of uridine to uracil and ribose-1-phosphate. Human UPP activity has been a focus of cancer research due to its role in activating fluoropyrimidine nucleoside chemotherapeutic agents such as 5-fluorouracil (5-FU) and capecitabine. Additionally, specific molecular inhibitors of this enzyme have been found to raise endogenous uridine concentrations, which can produce a cytoprotective effect on normal tissues exposed to these drugs. Here we report the structure of hUPP1 bound to 5-FU at 2.3 A resolution. Analysis of this structure reveals new insights as to the conformational motions the enzyme undergoes in the course of substrate binding and catalysis. The dimeric enzyme is capable of a large hinge motion between its two domains, facilitating ligand exchange and explaining observed cooperativity between the two active sites in binding phosphate-bearing substrates. Further, a loop toward the back end of the uracil binding pocket is shown to flexibly adjust to the varying chemistry of different compounds through an "induced-fit'' association mechanism that was not observed in earlier hUPP1 structures. The details surrounding these dynamic aspects of hUPP1 structure and function provide unexplored avenues to develop novel inhibitors of this protein with improved specificity and increased affinity. Given the recent emergence of new roles for uridine as a neuron protective compound in ischemia and degenerative diseases, such as Alzheimer's and Parkinson's, inhibitors of hUPP1 with greater efficacy, which are able to boost cellular uridine levels without adverse side-effects, may have a wide range of therapeutic applications.	[Roosild, Tarmo P.; Castronovo, Samantha] Nevada Canc Inst, Dept Drug Dev, Las Vegas, NV USA	University of California System; University of California San Diego	Roosild, TP (corresponding author), Nevada Canc Inst, Dept Drug Dev, Las Vegas, NV USA.	troosild@nvcancer.org			National Institutes of Health (NIH) [P20 RR-016464]; National Center for Research Resources; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by funds to TPR from National Institutes of Health (NIH) Grant Number P20 RR-016464 from the INBRE Program of the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AL SAFARJALANI ON, 2006, CANCER CHEMOTH PHARM, V58, P692; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bu WM, 2005, ACTA CRYSTALLOGR D, V61, P863, DOI 10.1107/S0907444905007882; Burling FT, 2003, ACTA CRYSTALLOGR D, V59, P73, DOI [10.1107/S0907444902018929, 10.1107/s0907444902018929]; Cansev M, 2008, NEUROSCI RES, V62, P206, DOI 10.1016/j.neures.2008.07.005; Cao DL, 2004, DRUG TODAY, V40, P431, DOI 10.1358/dot.2004.40.5.850491; Cao DL, 2002, CANCER RES, V62, P2313; Cappiello M, 1998, BBA-GEN SUBJECTS, V1425, P273, DOI 10.1016/S0304-4165(98)00071-3; Caradoc-Davies TT, 2004, J MOL BIOL, V337, P337, DOI 10.1016/j.jmb.2004.01.039; Choi JW, 2008, J NEUROTRAUM, V25, P695, DOI 10.1089/neu.2007.0409; Choi JW, 2006, NEUROSCI RES, V56, P111, DOI 10.1016/j.neures.2006.06.004; CHU MYW, 1984, CANCER RES, V44, P1852; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dontsova MV, 2005, ACTA CRYSTALLOGR F, V61, P337, DOI 10.1107/S1744309105007463; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Holguin S, 2008, FASEB J, V22, P3938, DOI 10.1096/fj.08-112425; Johansson M, 2003, BIOCHEM BIOPH RES CO, V307, P41, DOI 10.1016/S0006-291X(03)01062-3; Kawamura K, 2006, ANTICANCER RES, V26, P4647; Klecker RW, 2006, BIOORGAN MED CHEM, V14, P62, DOI 10.1016/j.bmc.2005.07.053; Kong XX, 2009, MOL PHARMACOL, V76, P854, DOI 10.1124/mol.109.056424; Larson ET, 2010, J MOL BIOL, V396, P1244, DOI 10.1016/j.jmb.2010.01.013; Lashkov AA, 2009, ACTA CRYSTALLOGR F, V65, P601, DOI 10.1107/S1744309109016133; Lashkov AA, 2010, ACTA CRYSTALLOGR D, V66, P51, DOI 10.1107/S0907444909044175; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Liu MP, 1998, CANCER RES, V58, P5418; MORGUNOVA EY, 1995, FEBS LETT, V367, P183, DOI 10.1016/0014-5793(95)00489-V; NIEDZWICKI JG, 1982, BIOCHEM PHARMACOL, V31, P1857, DOI 10.1016/0006-2952(82)90488-9; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paul D, 2010, BIOCHEMISTRY-US, V49, P3499, DOI 10.1021/bi902073b; Pizzorno G, 1998, CLIN CANCER RES, V4, P1165; Renck D, 2010, ARCH BIOCHEM BIOPHYS, V497, P35, DOI 10.1016/j.abb.2010.03.004; Roosild TP, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-14; Russell RL, 2001, J BIOL CHEM, V276, P13302, DOI 10.1074/jbc.M008512200; Tozzi MG, 2006, FEBS J, V273, P1089, DOI 10.1111/j.1742-4658.2006.05155.x; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; WATANABE SI, 1995, BIOCHEM BIOPH RES CO, V216, P265, DOI 10.1006/bbrc.1995.2619; Zhang Y, 2004, MOL ENDOCRINOL, V18, P851, DOI 10.1210/me.2003-0285	37	13	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2010	5	9							e12741	10.1371/journal.pone.0012741	http://dx.doi.org/10.1371/journal.pone.0012741			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZO	20856879	Green Published, Green Submitted, gold			2022-12-27	WOS:000281815700022
J	Thomson, D; Hartling, L; Cohen, E; Vandermeer, B; Tjosvold, L; Klassen, TP				Thomson, Denise; Hartling, Lisa; Cohen, Eyal; Vandermeer, Ben; Tjosvold, Lisa; Klassen, Terry P.			Controlled Trials in Children: Quantity, Methodological Quality and Descriptive Characteristics of Pediatric Controlled Trials Published 1948-2006	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; CLINICAL-TRIALS; SURVIVAL; HUMIDITY; OUTCOMES	Background: The objective of this study was to describe randomized controlled trials (RCTs) and controlled clinical trials (CCTs) in child health published between 1948 and 2006, in terms of quantity, methodological quality, and publication and trial characteristics. We used the Trials Register of the Cochrane Child Health Field for overall trends and a sample from this to explore trial characteristics in more detail. Methodology/Principal Findings: We extracted descriptive data on a random sample of 578 trials. Ninety-six percent of the trials were published in English; the percentage of child-only trials was 90.5%. The most frequent diagnostic categories were infectious diseases (13.2%), behavioural and psychiatric disorders (11.6%), neonatal critical care (11.4%), respiratory disorders (8.9%), non-critical neonatology (7.9%), and anaesthesia (6.5%). There were significantly fewer child-only studies (i.e., more mixed child and adult studies) over time (P = 0.0460). The proportion of RCTs to CCTs increased significantly over time (P < 0.0001), as did the proportion of multicentre trials (P = 0.002). Significant increases over time were found in methodological quality (Jadad score) (P < 0.0001), the proportion of double-blind studies (P < 0.0001), and studies with adequate allocation concealment (P < 0.0001). Additionally, we found an improvement in reporting over time: adequate description of withdrawals and losses to follow-up (P < 0.0001), sample size calculations (P < 0.0001), and intention-to-treat analysis (P < 0.0001). However, many trials still do not describe their level of blinding, and allocation concealment was inadequately reported in the majority of studies across the entire time period. The proportion of studies with industry funding decreased slightly over time (P = 0.003), and these studies were more likely to report positive conclusions (P = 0.028). Conclusions/Significance: The quantity and quality of pediatric controlled trials has increased over time; however, much work remains to be done, particularly in improving methodological issues around conduct and reporting of trials.	[Thomson, Denise; Tjosvold, Lisa; Klassen, Terry P.] Univ Alberta, Dept Pediat, Cochrane Child Hlth Field, Edmonton, AB, Canada; [Hartling, Lisa; Vandermeer, Ben; Tjosvold, Lisa; Klassen, Terry P.] Univ Alberta, Dept Pediat, Alberta Res Ctr Hlth Evidence, Edmonton, AB, Canada; [Cohen, Eyal] Univ Toronto, Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada	University of Alberta; University of Alberta; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Thomson, D (corresponding author), Univ Alberta, Dept Pediat, Cochrane Child Hlth Field, Edmonton, AB, Canada.	dthomson@ualberta.ca		Thomson, Denise/0000-0002-4972-5331; Klassen, Terry/0000-0002-5309-7091; Tjosvold, Lisa/0000-0002-5667-6312	Canadian Institutes of Health Research [13278]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research (13278). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker-Smith CM, 2008, AM HEART J, V156, P682, DOI 10.1016/j.ahj.2008.05.001; Benjamin DK, 2006, JAMA-J AM MED ASSOC, V296, P1266, DOI 10.1001/jama.296.10.1266; Caldwell PHY, 2004, LANCET, V364, P803, DOI 10.1016/S0140-6736(04)16942-0; Christensen ML, 1999, PEDIATRICS, V104, P593; Cramer Kristie, 2005, BMC Pediatr, V5, P38, DOI 10.1186/1471-2431-5-38; Dickersin K, 2002, EVAL HEALTH PROF, V25, P38, DOI 10.1177/0163278702025001004; Falagas ME, 2009, J CLIN EPIDEMIOL, V62, P227, DOI 10.1016/j.jclinepi.2008.07.012; FRANCIS T, 1957, EVALUATION 1954 FIEL, P1; Gidding SS, 2007, JAMA-J AM MED ASSOC, V298, P1214, DOI 10.1001/jama.298.10.1214; Hammick M, 2009, MED TEACH, V31, P1, DOI 10.1080/01421590802585561; Hartling L, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4012; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Karlberg JPE, 2006, TXB CLIN TRIALS, P701; Klassen TP, 2008, PLOS MED, V5, P1180, DOI 10.1371/journal.pmed.0050172; Li JS, 2007, JAMA-J AM MED ASSOC, V297, P480, DOI 10.1001/jama.297.5.480; Martinez-Castaldi C, 2008, PEDIATRICS, V122, P52, DOI 10.1542/peds.2007-2849; MURPHY S, 2006, TXB CLIN TRIALS, P63; Nkansah N, 2009, PUBLIC HEALTH NUTR, V12, P1931, DOI 10.1017/S136898000900487X; Pandolfini C, 2009, EUR J CLIN PHARMACOL, V65, P873, DOI 10.1007/s00228-009-0687-7; *POL VACC COMM, 1957, BMJ-BRIT MED J, V1, P1271; Royle P, 2003, INT J TECHNOL ASSESS, V19, P591, DOI 10.1017/S0266462303000552; Shaddy RE, 2007, JAMA-J AM MED ASSOC, V298, P1171, DOI 10.1001/jama.298.10.1171; SILVERMAN WA, 1958, PEDIATRICS, V22, P876; SILVERMAN WA, 1956, PEDIATRICS, V17, P1; SILVERMAN WA, 1957, PEDIATRICS, V20, P477; SILVERMAN WA, 1963, PEDIATRICS, V31, P719; Sinha I, 2008, PLOS MED, V5, P569, DOI 10.1371/journal.pmed.0050096; Sismondo S, 2008, CONTEMP CLIN TRIALS, V29, P109, DOI 10.1016/j.cct.2007.08.001; TJOSVOLD L, 2008, DEV CHILD HLTH TRIAL; *US FDA, 2009, FDA JOINS CHILDR HLT, V100, P1997	30	47	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e13106	10.1371/journal.pone.0013106	http://dx.doi.org/10.1371/journal.pone.0013106			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20927344	gold, Green Published, Green Submitted			2022-12-27	WOS:000282312600028
J	Jiang, L; Saetre, P; Radomska, KJ; Jazin, E; Carlstrom, EL				Jiang, Lin; Saetre, Peter; Radomska, Katarzyna J.; Jazin, Elena; Carlstrom, Eva Lindholm			QKI-7 Regulates Expression of Interferon-Related Genes in Human Astrocyte Glioma Cells	PLOS ONE			English	Article							GUANYLATE BINDING PROTEIN-1; MYELINATION-RELATED GENES; MESSENGER-RNA EXPRESSION; CENTRAL-NERVOUS-SYSTEM; INNATE IMMUNITY; SCHIZOPHRENIA; QUAKING; INFECTION; DYSMYELINATION; PATHOGENESIS	Background: The human QKI gene, called quaking homolog, KH domain RNA binding (mouse), is a candidate gene for schizophrenia encoding an RNA-binding protein. This gene was shown to be essential for myelination in oligodendrocytes. QKI is also highly expressed in astrocytes, but its function in these cells is not known. Methods/Principal Findings: We studied the effect of small interference RNA (siRNA)-mediated QKI depletion on global gene expression in human astrocyte glioma cells. Microarray measurements were confirmed with real-time quantitative polymerase chain reaction (qPCR). The presence of QKI binding sites (QRE) was assessed by a bioinformatic approach. Viability and cell morphology were also studied. The most significant alteration after QKI silencing was the decreased expression of genes involved in interferon (IFN) induction (P = 6.3E-10), including IFIT1, IFIT2, MX1, MX2, G1P2, G1P3, GBP1 and IFIH1. All eight genes were down-regulated after silencing of the splice variant QKI-7, but were not affected by QKI-5 silencing. Interestingly, four of them were up-regulated after treatment with the antipsychotic agent haloperidol that also resulted in increased QKI-7 mRNA levels. Conclusions/Significance: The coordinated expression of QKI-7 splice variant and IFN-related genes supports the idea that this particular splice variant has specific functions in astrocytes. Furthermore, a role of QKI-7 as a regulator of an inflammatory gene pathway in astrocytes is suggested. This hypothesis is well in line with growing experimental evidence on the role of inflammatory components in schizophrenia.	[Jiang, Lin; Saetre, Peter; Radomska, Katarzyna J.; Jazin, Elena; Carlstrom, Eva Lindholm] Uppsala Univ, Dept Genet & Dev, Uppsala, Sweden; [Saetre, Peter] Karolinska Hosp & Inst, HUBIN Project, Dept Clin Neurosci, Stockholm, Sweden	Uppsala University; Karolinska Institutet; Karolinska University Hospital	Jiang, L (corresponding author), Uppsala Univ, Dept Genet & Dev, Uppsala, Sweden.	eva.lindholm@ebc.uu.se		Radomska, Katarzyna/0000-0001-8243-0669; Jiang, Lin/0000-0001-9123-5988; Jazin, Elena/0000-0002-0363-3466	Brain Foundation in Sweden; Marcus Borgstrom's Foundation, Uppsala University, Sweden	Brain Foundation in Sweden; Marcus Borgstrom's Foundation, Uppsala University, Sweden	The research was supported by a grant from the Brain Foundation in Sweden and Eva Lindholm Carlstrom is funded by Marcus Borgstrom's Foundation, Uppsala University, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg K, 2006, P NATL ACAD SCI USA, V103, P7482, DOI 10.1073/pnas.0601213103; Barley K, 2009, SCHIZOPHR RES, V112, P54, DOI 10.1016/j.schres.2009.04.019; Bernstein HG, 2009, EXPERT REV NEUROTHER, V9, P1059, DOI [10.1586/ern.09.59, 10.1586/ERN.09.59]; Bilbo SD, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.014.2009; Buka SL, 2008, BIOL PSYCHIAT, V63, P809, DOI 10.1016/j.biopsych.2007.09.022; Chen TP, 1997, MOL CELL BIOL, V17, P5707, DOI 10.1128/MCB.17.10.5707; Chen YT, 2007, J BIOL CHEM, V282, P23553, DOI 10.1074/jbc.M702045200; De Keyser J, 2008, J NEUROL SCI, V267, P3, DOI 10.1016/j.jns.2007.08.044; Delhaye S, 2006, P NATL ACAD SCI USA, V103, P7835, DOI 10.1073/pnas.0602460103; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; Ebersole TA, 1996, NAT GENET, V12, P260, DOI 10.1038/ng0396-260; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Foster R, 2006, EUR J NEUROSCI, V24, P3561, DOI 10.1111/j.1460-9568.2006.05219.x; Galarneau A, 2005, NAT STRUCT MOL BIOL, V12, P691, DOI 10.1038/nsmb963; Guenzi E, 2003, EMBO J, V22, P3772, DOI 10.1093/emboj/cdg382; Hakak Y, 2001, P NATL ACAD SCI USA, V98, P4746, DOI 10.1073/pnas.081071198; Haller O, 2007, BIOCHIMIE, V89, P812, DOI 10.1016/j.biochi.2007.04.015; Hanson DR, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-7; Hardy RJ, 1996, J NEUROSCI, V16, P7941; Haroutunian V, 2006, AM J PSYCHIAT, V163, P1834, DOI 10.1176/appi.ajp.163.10.1834; Herberts CA, 2003, HUM IMMUNOL, V64, P44, DOI 10.1016/S0198-8859(02)00707-3; Jiang Lin, 2009, BMC Pharmacology, V9, P6, DOI 10.1186/1471-2210-9-6; Karoutzou G, 2008, MOL PSYCHIATR, V13, P245, DOI 10.1038/sj.mp.4002096; KOLOMEETS NS, 2009, WORLD J BIOL PSYCHIA, P1; Larocque Daniel, 2005, RNA Biol, V2, P37, DOI 10.4161/rna.2.2.1603; Lenhard B, 2002, BIOINFORMATICS, V18, P1135, DOI 10.1093/bioinformatics/18.8.1135; Lindholm E, 2001, AM J HUM GENET, V69, P96, DOI 10.1086/321288; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; McCullumsmith RE, 2007, SCHIZOPHR RES, V90, P15, DOI 10.1016/j.schres.2006.11.017; McInnes LA, 2006, NEUROSCI BIOBEHAV R, V30, P551, DOI 10.1016/j.neubiorev.2005.10.003; Monji A, 2009, PSYCHIAT CLIN NEUROS, V63, P257, DOI 10.1111/j.1440-1819.2009.01945.x; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Muller Norbert, 2009, Dialogues Clin Neurosci, V11, P319; Naschberger E, 2006, AM J PATHOL, V169, P1088, DOI 10.2353/ajpath.2006.060244; POST GR, 1992, MOL CHEM NEUROPATHOL, V16, P303, DOI 10.1007/BF03159976; Potvin S, 2008, BIOL PSYCHIAT, V63, P801, DOI 10.1016/j.biopsych.2007.09.024; Ritchie KJ, 2004, NAT MED, V10, P1374, DOI 10.1038/nm1133; Saetre P, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-46; Segal D, 2007, INT J NEUROPSYCHOPH, V10, P503, DOI 10.1017/S146114570600722X; Sugai T, 2004, ANN NY ACAD SCI, V1025, P84, DOI 10.1196/annals.1316.011; Wacher C, 2007, J VIROL, V81, P860, DOI 10.1128/JVI.01167-06; Walterfang M, 2006, NEUROSCI BIOBEHAV R, V30, P918, DOI 10.1016/j.neubiorev.2006.02.001; WESTERMARK B, 1973, ACTA PATH MICRO IM A, VA 81, P791; Wolf F, 2008, SCIENCE, V320, P1597, DOI 10.1126/science.1160122; Wu JI, 2002, P NATL ACAD SCI USA, V99, P4233, DOI 10.1073/pnas.072090399	46	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e13079	10.1371/journal.pone.0013079	http://dx.doi.org/10.1371/journal.pone.0013079			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20927331	Green Submitted, Green Published, gold			2022-12-27	WOS:000282269400026
J	Mallau, S; Vaugoyeau, M; Assaiante, C				Mallau, Sophie; Vaugoyeau, Marianne; Assaiante, Christine			Postural Strategies and Sensory Integration: No Turning Point between Childhood and Adolescence	PLOS ONE			English	Article							VOLUNTARY HEAD STABILIZATION; OSCILLATORY TRUNK MOVEMENTS; DEVELOPMENTAL PERSPECTIVE; STANDING BALANCE; EYE-MOVEMENTS; YOUNG-ADULTS; VISUAL CUES; CHILDREN; SWAY; ORIENTATION	In this study, we investigated the sensory integration to postural control in children and adolescents from 5 to 15 years of age. We adopted the working hypothesis that considerable body changes occurring during these periods may lead subjects to under-use the information provided by the proprioceptive pathway and over-use other sensory systems such as vision to control their orientation and stabilize their body. It was proposed to determine which maturational differences may exist between the sensory integration used by children and adolescents in order to test the hypothesis that adolescence may constitute a specific phase in the development of postural control. This hypothesis was tested by applying an original protocol of slow oscillations below the detection threshold of the vestibular canal system, which mainly serves to mediate proprioceptive information, to the platform on which the subjects were standing. We highlighted the process of acquiring an accurate sensory and anatomical reference frame for functional movement. We asked children and adolescents to maintain a vertical stance while slow sinusoidal oscillations in the frontal plane were applied to the support at 0.01 Hz (below the detection threshold of the semicircular canal system) and at 0.06 Hz (above the detection threshold of the semicircular canal system) with their eyes either open or closed. This developmental study provided evidence that there are mild differences in the quality of sensory integration relative to postural control in children and adolescents. The results reported here confirmed the predominance of vision and the gradual mastery of somatosensory integration in postural control during a large period of ontogenesis including childhood and adolescence. The youngest as well as the oldest subjects adopted similar qualitative damping and segmental stabilization strategies that gradually improved with age without reaching an adult's level. Lastly, sensory reweighting for postural strategies as assessed by very slow support oscillations presents a linear development without any qualitative turning point between childhood and adolescence.	[Mallau, Sophie] Univ Aix Marseille 1, Grp DPA, UMR 6149, Marseille, France; CNRS, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS)	Mallau, S (corresponding author), Univ Aix Marseille 1, Grp DPA, UMR 6149, Pole 3C, Marseille, France.	marianne.vaugoyeau@univ-provence.fr						Amblard B, 1997, EXP BRAIN RES, V114, P214, DOI 10.1007/PL00005630; Amblard B, 2001, EXP BRAIN RES, V137, P170, DOI 10.1007/s002210000621; Anoh-Tanon MJ, 2000, PEDIATR NEUROL, V23, P49, DOI 10.1016/S0887-8994(00)00140-5; ASSAIANTE C, 1993, NEUROREPORT, V4, P875, DOI 10.1097/00001756-199307000-00009; ASSAIANTE C, 1995, HUM MOVEMENT SCI, V14, P13, DOI 10.1016/0167-9457(94)00048-J; ASSAIANTE C, 1992, HUM MOVEMENT SCI, V11, P533, DOI 10.1016/0167-9457(92)90014-3; ASSAIANTE C, 1993, EXP BRAIN RES, V93, P499; Assaiante C, 2005, NEURAL PLAST, V12, P33; Bacsi AM, 2005, EXP BRAIN RES, V160, P22, DOI 10.1007/s00221-004-1982-2; Bair WN, 2007, EXP BRAIN RES, V183, P435, DOI 10.1007/s00221-007-1057-2; Borel L, 2002, BRAIN, V125, P880, DOI 10.1093/brain/awf085; Bringoux L, 2000, J VESTIBUL RES-EQUIL, V10, P251; BUTTERWORTH G, 1977, PERCEPTION, V6, P255, DOI 10.1068/p060255; Cherng RJ, 2001, PERCEPT MOTOR SKILL, V92, P1167, DOI 10.2466/pms.2001.92.3c.1167; Diamond A, 2008, CURR DIR PSYCHOL SCI, V17, P136, DOI 10.1111/j.1467-8721.2008.00563.x; Ferber-Viart C, 2007, INT J PEDIATR OTORHI, V71, P1041, DOI 10.1016/j.ijporl.2007.03.012; FITZPATRICK R, 1994, J PHYSIOL-LONDON, V478, P173, DOI 10.1113/jphysiol.1994.sp020240; FORSSBERG H, 1982, J NEUROSCI, V2, P545; Franchignoni F P, 1985, Minerva Med, V76, P835; HENN V, 1980, NEUROSCI RES PROG B, V18, P459; HIRABAYASHI S, 1995, BRAIN DEV-JPN, V17, P111, DOI 10.1016/0387-7604(95)00009-Z; HYTONEN M, 1993, ACTA OTO-LARYNGOL, V113, P119, DOI 10.3109/00016489309135778; Isableu B, 1997, EXP BRAIN RES, V114, P584, DOI 10.1007/PL00005667; Isableu B, 2003, EXP BRAIN RES, V150, P208, DOI 10.1007/s00221-003-1446-0; Jahn K, 2002, BRAIN, V125, P2005, DOI 10.1093/brain/awf204; JOUEN F, 1985, BEHAV BRAIN RES, V15, P241, DOI 10.1016/0166-4328(85)90178-0; KIKUKAWA M, 1985, 7 INT S INT SOC POST; LEE DN, 1974, PERCEPT PSYCHOPHYS, V15, P529, DOI 10.3758/BF03199297; Mallau S, 2007, SPINE, V32, pE14, DOI 10.1097/01.brs.0000251069.58498.eb; Nadeau S, 2003, GAIT POSTURE, V18, P134, DOI 10.1016/S0966-6362(02)00070-X; OBLACK B, 1985, 7 INT S INT SOC POST; ODENRICK P, 1984, HUM NEUROBIOL, V3, P241; Olivier I, 2007, NEUROREPORT, V18, P817, DOI 10.1097/WNR.0b013e3280e129e1; Peterka R J, 1990, J Vestib Res, V1, P73; RIACH CL, 1987, DEV MED CHILD NEUROL, V29, P650; Rival C, 2005, NEUROSCI LETT, V376, P133, DOI 10.1016/j.neulet.2004.11.042; SAKAGUCHI M, 1994, INT J PEDIATR OTORHI, V29, P101, DOI 10.1016/0165-5876(94)90089-2; Schmitz C, 2002, EXP BRAIN RES, V142, P354, DOI 10.1007/s00221-001-0910-y; SHUMWAYCOOK A, 1985, J MOTOR BEHAV, V17, P131; Sparto PJ, 2006, EXP BRAIN RES, V168, P505, DOI 10.1007/s00221-005-0109-8; STOFFREGEN TA, 1987, PERCEPTION, V16, P113, DOI 10.1068/p160113; Strupp M, 2003, ANN NY ACAD SCI, V1004, P352, DOI 10.1196/annals.1303.033; Sveistrup H, 2008, EXP BRAIN RES, V188, P237, DOI 10.1007/s00221-008-1357-1; UCHIDA T, 1979, NEUROSCI LETT, V13, P253, DOI 10.1016/0304-3940(79)91503-9; Vacherot F, 2007, CLIN NEUROPHYSIOL, V118, P1019, DOI 10.1016/j.clinph.2007.01.013; VAUGHT GM, 1975, B PSYCHONOMIC SOC, V5, P151; Vaugoyeau M, 2008, GAIT POSTURE, V27, P294, DOI 10.1016/j.gaitpost.2007.04.003; Vaugoyeau M, 2007, NEUROSCIENCE, V146, P852, DOI 10.1016/j.neuroscience.2007.01.052; VAUGOYEAU M, 2005, GAIT POSTURE, V21, pS31; WITKIN HA, 1967, J PERS SOC PSYCHOL, V7, P291, DOI 10.1037/h0025070; Wolff DR, 1998, J ORTHOPAED RES, V16, P271, DOI 10.1002/jor.1100160215	51	42	42	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e13078	10.1371/journal.pone.0013078	http://dx.doi.org/10.1371/journal.pone.0013078			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20927328	Green Submitted, Green Published, gold			2022-12-27	WOS:000282269400025
J	Liu, K; Liu, JL; Huang, Y; Liu, Y; Lou, YQ; Wang, ZG; Zhang, H; Yan, S; Li, ZZ; Wen, SJ				Liu, Kuo; Liu, Jielin; Huang, Yan; Liu, Ya; Lou, Yuqing; Wang, Zuoguang; Zhang, Hong; Yan, Shan; Li, Zhizhong; Wen, Shaojun			Alpha-Adducin Gly460Trp Polymorphism and Hypertension Risk: A Meta-Analysis of 22 Studies Including 14303 Cases and 15961 Controls	PLOS ONE			English	Article							LOW-RENIN HYPERTENSION; BLOOD-PRESSURE; JAPANESE POPULATION; GENE POLYMORPHISMS; SALT SENSITIVITY; G460W POLYMORPHISM; CANDIDATE GENES; ASSOCIATION; SODIUM; VARIANT	Background: No clear consensus has been reached on the alpha-adducin polymorphism (Gly460Trp) and essential hypertension risk. We performed a meta-analysis in an effort to systematically summarize the possible association. Methodology/Principal Findings: Studies were identified by searching MEDLINE and EMBASE databases complemented with perusal of bibliographies of retrieved articles and correspondence with original authors. The fixed-effects model and the random-effects model were applied for dichotomous outcomes to combine the results of the individual studies. We selected 22 studies that met the inclusion criteria including a total of 14303 hypertensive patients and 15961 normotensive controls. Overall, the 460Trp allele showed no statistically significant association with hypertension risk compared to Gly460 allele (P=0.69, OR=1.02, 95% CI 0.94-1.10, P(heterogeneity)<0.0001) in all subjects. Meta-analysis under other genetic contrasts still did not reveal any significant association in all subjects, Caucasians, East Asians and others. The results were similar but heterogeneity did not persist when sensitivity analyses were limited to these studies. Conclusions/Significance: Our meta-analysis failed to provide evidence for the genetic association of a-adducin gene Gly460Trp polymorphism with hypertension. Further studies investigating the effect of genetic networks, environmental factors, individual biological characteristics and their mutual interactions are needed to elucidate the possible mechanism for hypertension in humans.	[Liu, Kuo; Liu, Jielin; Liu, Ya; Lou, Yuqing; Wang, Zuoguang; Yan, Shan; Wen, Shaojun] Capital Med Univ, Dept Hypertens Res, Beijing Anzhen Hosp, Beijing, Peoples R China; [Liu, Kuo; Liu, Jielin; Liu, Ya; Lou, Yuqing; Wang, Zuoguang; Yan, Shan; Wen, Shaojun] Beijing Inst Heart Lung & Blood Vessel Dis, Beijing, Peoples R China; [Huang, Yan] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Inst Genet, Shanghai 200433, Peoples R China; [Zhang, Hong] Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiac Surg, Beijing, Peoples R China; [Li, Zhizhong] Capital Med Univ, Beijing Anzhen Hosp, Emergency Ctr Heart Lung & Blood Vessel Dis, Beijing, Peoples R China	Capital Medical University; Fudan University; Capital Medical University; Capital Medical University	Liu, K (corresponding author), Capital Med Univ, Dept Hypertens Res, Beijing Anzhen Hosp, Beijing, Peoples R China.	dr_lizhizhong@yahoo.com.cn; wenshaojun@yahoo.com.cn		Wang, Zuoguang/0000-0002-0230-1611; Liu, Ya/0000-0002-7816-684X	Ministry of Science and Technology in People's Republic of China [2008AA02Z441, 2008BAI52B03]	Ministry of Science and Technology in People's Republic of China	This work was financially supported by the National High Technology Research and Development Program (2008AA02Z441) (http://program.most.gov.cn/page/pds/mian1_ AA.htm?planId=AA), and the National Eleventh Five-year Plan Program (2008BAI52B03) (http://program.most.gov.cn/page/pds/mian1_ BA.htm?planId=BA) from the Ministry of Science and Technology in People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam S, 2000, J HUM HYPERTENS, V14, P199, DOI 10.1038/sj.jhh.1000944; Barlassina C, 2000, AM J HYPERTENS, V13, P719, DOI 10.1016/S0895-7061(00)01187-0; Barlassina C, 2000, KIDNEY INT, V57, P1083, DOI 10.1046/j.1523-1755.2000.00935.x; Bianchi G, 2005, HYPERTENSION, V45, P331, DOI 10.1161/01.HYP.0000156497.39375.37; Bianchi Giuseppe, 1995, Clinical and Experimental Pharmacology and Physiology, V22, pS7, DOI 10.1111/j.1440-1681.1995.tb02974.x; CASARI G, 1995, HYPERTENSION, V25, P320, DOI 10.1161/01.HYP.25.3.320; Ciechanowicz A, 2001, KIDNEY BLOOD PRESS R, V24, P201, DOI 10.1159/000054228; CITTERIO L, 2010, BIOCHIM BIO IN PRESS; Clark CJ, 2000, HYPERTENSION, V36, P990, DOI 10.1161/01.HYP.36.6.990; Cusi D, 1997, LANCET, V349, P1353, DOI 10.1016/S0140-6736(97)01029-5; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Falkner B, 1996, PEDIATRICS, V98, P649; Fava C, 2007, AM J HYPERTENS, V20, P981, DOI 10.1016/j.amjhyper.2007.04.007; Frankel WN, 1996, NAT GENET, V14, P371, DOI 10.1038/ng1296-371; Glorioso N, 1999, HYPERTENSION, V34, P649, DOI 10.1161/01.HYP.34.4.649; Grant FD, 2002, HYPERTENSION, V39, P191, DOI 10.1161/hy0202.104273; He X, 2001, CLIN EXP HYPERTENS, V23, P579, DOI 10.1081/CEH-100106828; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ishikawa K, 1998, AM J HYPERTENS, V11, P502, DOI 10.1016/S0895-7061(97)00486-X; Iwai N, 1997, LANCET, V350, P369, DOI 10.1016/S0140-6736(05)63430-7; Ju ZY, 2003, J HYPERTENS, V21, P1861, DOI 10.1097/00004872-200310000-00013; Kato N, 1998, HYPERTENSION, V31, P730, DOI 10.1161/01.HYP.31.3.730; KURTZ TW, 1993, AM J MED, V94, P77, DOI 10.1016/0002-9343(93)90124-8; Lanzani C, 2005, J HYPERTENS, V23, P543, DOI 10.1097/01.hjh.0000160210.48479.78; Larson N, 2000, HYPERTENSION, V35, P1297, DOI 10.1161/01.HYP.35.6.1297; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; LIN BY, 1995, GENOMICS, V25, P93, DOI 10.1016/0888-7543(95)80113-Z; Manunta P, 1998, FEBS LETT, V430, P41, DOI 10.1016/S0014-5793(98)00457-8; Manunta P, 1998, KIDNEY INT, V53, P1471, DOI 10.1046/j.1523-1755.1998.00931.x; Matsuoka Y, 2000, CELL MOL LIFE SCI, V57, P884, DOI 10.1007/PL00000731; Mead PA, 2005, CLIN SCI, V108, P231, DOI 10.1042/CS20040267; Melander O, 2000, J HUM HYPERTENS, V14, P43, DOI 10.1038/sj.jhh.1000942; Nakamura Y, 2007, J HUM HYPERTENS, V21, P253, DOI 10.1038/sj.jhh.1002135; Niu WQ, 2010, J HUM HYPERTENS, V24, P467, DOI 10.1038/jhh.2009.88; O'Shaughnessy KM, 2001, BRIT J CLIN PHARMACO, V51, P5, DOI 10.1046/j.1365-2125.2001.01254.x; Petitti D, 1994, METAANALYSIS DECISIO, P15; Province MA, 2000, AM J HYPERTENS, V13, P710, DOI 10.1016/S0895-7061(99)00282-4; Psaty BM, 2000, J HUM HYPERTENS, V14, P95, DOI 10.1038/sj.jhh.1000943; Ramachandran V, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-11; Sciarrone MT, 2003, HYPERTENSION, V41, P398, DOI 10.1161/01.HYP.0000057010.27011.2C; Shin MH, 2004, J KOREAN MED SCI, V19, P812, DOI 10.3346/jkms.2004.19.6.812; Shioji K, 2004, HYPERTENS RES, V27, P31, DOI 10.1291/hypres.27.31; Staessen JA, 2003, LANCET, V361, P1629, DOI 10.1016/S0140-6736(03)13302-8; Staessen JA, 2001, J HYPERTENS, V19, P1349, DOI 10.1097/00004872-200108000-00002; Sugimoto K, 2002, J HYPERTENS, V20, P1779, DOI 10.1097/00004872-200209000-00022; Sunder-Plassmann G, 2002, CRIT CARE MED, V30, P2236, DOI 10.1097/00003246-200210000-00010; Suonsyrja T, 2009, AM J HYPERTENS, V22, P169, DOI 10.1038/ajh.2008.343; Tamaki S, 1998, HYPERTENS RES-CLIN E, V21, P29, DOI 10.1291/hypres.21.29; Tripodi G, 1996, J CLIN INVEST, V97, P2815, DOI 10.1172/JCI118737; Turner ST, 2003, AM J HYPERTENS, V16, P834, DOI 10.1016/S0895-7061(03)01011-2; van Rijn MJE, 2007, J HYPERTENS, V25, P565, DOI 10.1097/HJH.0b013e32801449fb; van Rijn MJE, 2006, STROKE, V37, P2930, DOI 10.1161/01.STR.0000248760.67039.2b; Varda NM, 2006, ACTA PAEDIATR, V95, P353, DOI 10.1080/08035250500434777; Wang R, 2010, J APPL GENET, V51, P87, DOI 10.1007/BF03195715; Wang WYS, 1999, AM J HYPERTENS, V12, P632, DOI 10.1016/S0895-7061(99)00004-7; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; Yamagishi K, 2004, AM J HYPERTENS, V17, P385, DOI 10.1016/j.amjhyper.2003.12.018; Yazdanpanah M, 2006, DIABETES, V55, P2922, DOI 10.2337/db06-0302; Zafarmand MH, 2008, HYPERTENSION, V51, P1665, DOI 10.1161/HYPERTENSIONAHA.108.112458	59	30	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2010	5	9							e13057	10.1371/journal.pone.0013057	http://dx.doi.org/10.1371/journal.pone.0013057			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654ZQ	20927398	Green Published, Green Submitted, gold			2022-12-27	WOS:000282210700024
J	Alvarez-Tabares, I; Perez-Martin, J				Alvarez-Tabares, Isabel; Perez-Martin, Jose			Septins from the Phytopathogenic Fungus Ustilago maydis Are Required for Proper Morphogenesis but Dispensable for Virulence	PLOS ONE			English	Article							CEREVISIAE CELL-CYCLE; CORN SMUT FUNGUS; SACCHAROMYCES-CEREVISIAE; CANDIDA-ALBICANS; HYPHAL GROWTH; PATHOGENIC DEVELOPMENT; GENE-PRODUCT; FILAMENTOUS GROWTH; ASHBYA-GOSSYPII; PROTEIN-KINASE	Background: Septins are a highly conserved family of GTP-binding proteins involved in multiple cellular functions, including division and morphogenesis. Studies of septins in fungal cells underpin a clear correlation between septin-based structures and fungal morphology, providing clues to understand the molecular frame behind the varied morphologies found in fungal world. Methodology/Principal Findings: Ustilago maydis genome has the ability to encode four septins. Here, using loss-of-function as well as GFP-tagged alleles of these septin genes, we investigated the roles of septins in the morphogenesis of this basidiomycete fungus. We described that septins in U. maydis could assemble into at least three different structures coexisting in the same cell: bud neck collars, band-like structures at the growing tip, and long septin fibers that run from pole to pole near the cell cortex. We also found that in the absence of septins, U. maydis cells lost their elongated shape, became wider at the central region and ended up losing their polarity, pointing to an important role of septins in the morphogenesis of this fungus. These morphological defects were alleviated in the presence of an osmotic stabilizer suggesting that absence of septins affected the proper formation of the cell wall, which was coherent with a higher sensitivity of septin defective cells to drugs that affect cell wall construction as well as exocytosis. As U. maydis is a phytopathogen, we analyzed the role of septins in virulence and found that in spite of the described morphological defects, septin mutants were virulent in corn plants. Conclusions/Significance: Our results indicated a major role of septins in morphogenesis in U. maydis. However, in contrast to studies in other fungal pathogens, in which septins were reported to be necessary during the infection process, we found a minor role of septins during corn infection by U. maydis.	[Alvarez-Tabares, Isabel; Perez-Martin, Jose] Ctr Nacl Biotecnol CSIC, Dept Biotecnol Microbiana, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Alvarez-Tabares, I (corresponding author), Ctr Nacl Biotecnol CSIC, Dept Biotecnol Microbiana, Madrid, Spain.	jperez@cnb.csic.es	Perez-Martin, Jose/K-5117-2014	Perez-Martin, Jose/0000-0001-9849-7382	Spanish Government [BIO2008-04054]	Spanish Government(Spanish GovernmentEuropean Commission)	This work was supported by a Spanish Government grant (BIO2008-04054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS AEM, 1984, J CELL BIOL, V98, P934, DOI 10.1083/jcb.98.3.934; Amin ND, 2008, J NEUROSCI, V28, P3631, DOI 10.1523/JNEUROSCI.0453-08.2008; An HB, 2004, MOL BIOL CELL, V15, P5551, DOI 10.1091/mbc.E04-07-0640; Banuett F, 1996, DEVELOPMENT, V122, P2965; BANUETT F, 1989, P NATL ACAD SCI USA, V86, P5878, DOI 10.1073/pnas.86.15.5878; Becht P, 2005, EUKARYOT CELL, V4, P121, DOI 10.1128/EC.4.1.121-133.2005; Becht P, 2006, J CELL SCI, V119, P4964, DOI 10.1242/jcs.03287; Beites CL, 2001, METHOD ENZYMOL, V329, P499; BLACKETER MJ, 1993, MOL CELL BIOL, V13, P5567, DOI 10.1128/MCB.13.9.5567; Bohmer C, 2009, MOL MICROBIOL, V74, P1484, DOI 10.1111/j.1365-2958.2009.06948.x; Bouquin N, 2000, J CELL SCI, V113, P1435; Boyce KJ, 2005, EUKARYOT CELL, V4, P2044, DOI 10.1128/EC.4.12.2044-2056.2005; Brachmann A, 2001, MOL MICROBIOL, V42, P1047, DOI 10.1046/j.1365-2958.2001.02699.x; Brachmann A, 2004, MOL GENET GENOMICS, V272, P216, DOI 10.1007/s00438-004-1047-z; Brefort T, 2009, ANNU REV PHYTOPATHOL, V47, P423, DOI 10.1146/annurev-phyto-080508-081923; BYERS B, 1976, J CELL BIOL, V69, P717, DOI 10.1083/jcb.69.3.717; Canovas D, 2009, FUNGAL GENET BIOL, V46, P190, DOI 10.1016/j.fgb.2008.11.003; Carbo N, 2008, FUNGAL GENET BIOL, V45, P1315, DOI 10.1016/j.fgb.2008.06.010; Carbo N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001009; Castillo-Lluva S, 2007, J CELL SCI, V120, P1584, DOI 10.1242/jcs.005314; Caudron F, 2009, DEV CELL, V16, P493, DOI 10.1016/j.devcel.2009.04.003; Caviston JP, 2003, MOL BIOL CELL, V14, P4051, DOI 10.1091/mbc.E03-04-0247; DEMAY BS, 2009, MOL BIOL CELL; Douglas LM, 2005, EUKARYOT CELL, V4, P1503, DOI 10.1128/EC.4.9.1503-1512.2005; Pablo-Hernando ME, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-55; Faty M, 2002, CURR GENET, V41, P123, DOI 10.1007/s00294-002-0304-0; Feldbrugge M, 2004, CURR OPIN MICROBIOL, V7, P666, DOI 10.1016/j.mib.2004.10.006; Flor-Parra I, 2007, PLANT CELL, V19, P3280, DOI 10.1105/tpc.107.052738; FORD SK, 1991, DEV GENET, V12, P281, DOI 10.1002/dvg.1020120405; Fuchs U, 2005, MOL BIOL CELL, V16, P2746, DOI 10.1091/mbc.E05-03-0176; Gladfelter AS, 2005, J CELL SCI, V118, P1617, DOI 10.1242/jcs.02286; Gladfelter AS, 2004, EUKARYOT CELL, V3, P847, DOI 10.1128/EC.3.4.847-854.2004; Gladfelter AS, 2002, J CELL BIOL, V156, P315, DOI 10.1083/jcb.200109062; Gladfelter AS, 2006, NAT REV MICROBIOL, V4, P223, DOI 10.1038/nrmicro1345; Gow NAR, 2002, CURR OPIN MICROBIOL, V5, P366, DOI 10.1016/S1369-5274(02)00338-7; HAARER BK, 1987, MOL CELL BIOL, V7, P3678, DOI 10.1128/MCB.7.10.3678; HARTWELL LH, 1971, EXP CELL RES, V69, P265, DOI 10.1016/0014-4827(71)90223-0; Helfer H, 2006, MOL BIOL CELL, V17, P4494, DOI 10.1091/mbc.E06-03-0215; HOLLIDAY R, 1974, HDB GENETICS, P575; Hsu SC, 1998, NEURON, V20, P1111, DOI 10.1016/S0896-6273(00)80493-6; Kaufmann A, 2009, MOL CELL BIOL, V29, P771, DOI 10.1128/MCB.01150-08; KIM HB, 1991, J CELL BIOL, V112, P535, DOI 10.1083/jcb.112.4.535; Kinoshita M, 2006, CURR OPIN CELL BIOL, V18, P54, DOI 10.1016/j.ceb.2005.12.005; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; KOZUBOWSKI L, 2009, MOL MICROBIOL; Lenz JH, 2006, EMBO J, V25, P2275, DOI 10.1038/sj.emboj.7601119; Lindsey R, 2006, CURR OPIN MICROBIOL, V9, P559, DOI 10.1016/j.mib.2006.10.009; Lindsey R, 2010, EUKARYOT CELL, V9, P155, DOI 10.1128/EC.00269-09; Mahlert M, 2006, MOL MICROBIOL, V59, P567, DOI 10.1111/j.1365-2958.2005.04952.x; Martin SW, 2005, EUKARYOT CELL, V4, P1191, DOI 10.1128/EC.4.7.1191-1202.2005; Martin SW, 2004, J BIOL CHEM, V279, P40861, DOI 10.1074/jbc.M406422200; Pan FF, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-103; Schmidt K, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-43; SHAH N, 1993, J BIOL CHEM, V268, P5345; Steinberg G, 2001, J CELL SCI, V114, P609; Steinberg G, 1998, J CELL SCI, V111, P2235; Steinberg G, 2008, TRENDS CELL BIOL, V18, P61, DOI 10.1016/j.tcb.2007.11.008; Straube A, 2005, EMBO J, V24, P1674, DOI 10.1038/sj.emboj.7600644; Straube A, 2001, EMBO J, V20, P5091, DOI 10.1093/emboj/20.18.5091; Sudbery PE, 2001, MOL MICROBIOL, V41, P19, DOI 10.1046/j.1365-2958.2001.02459.x; Surka MC, 2002, MOL BIOL CELL, V13, P3532, DOI 10.1091/mbc.E02-01-0042; Thomas CL, 2003, YEAST, V20, P813, DOI 10.1002/yea.1003; TSUKUDA T, 1988, MOL CELL BIOL, V8, P3703, DOI 10.1128/MCB.8.9.3703; VOGEL JP, 1993, J BIOL CHEM, V268, P3040; Warenda AJ, 2003, INFECT IMMUN, V71, P4045, DOI 10.1128/IAI.71.7.4045-4051.2003; Warenda AJ, 2002, MOL BIOL CELL, V13, P2732, DOI 10.1091/mbc.E02-01-0013; Weber I, 2003, PLANT CELL, V15, P2826, DOI 10.1105/tpc.016246; Wedlich-Soldner R, 2002, MOL BIOL CELL, V13, P965, DOI 10.1091/mbc.01-10-0475; Weirich CS, 2008, NAT REV MOL CELL BIO, V9, P478, DOI 10.1038/nrm2407	69	43	45	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e12933	10.1371/journal.pone.0012933	http://dx.doi.org/10.1371/journal.pone.0012933			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20885997	Green Submitted, gold, Green Published			2022-12-27	WOS:000282167100002
J	Meng, JR; Fang, BL; Liao, Y; Chresta, CM; Smith, PD; Roth, JA				Meng, Jieru; Fang, Bingliang; Liao, Yong; Chresta, Christine M.; Smith, Paul D.; Roth, Jack A.			Apoptosis Induction by MEK Inhibition in Human Lung Cancer Cells Is Mediated by Bim	PLOS ONE			English	Article							PATHWAY PROMOTES PHOSPHORYLATION; FORKHEAD TRANSCRIPTION FACTORS; BH3-ONLY PROTEIN; AKT ACTIVITY; AZD6244; FOXO3A; DEATH; ACTIVATION; EXPRESSION; DEGRADATION	AZD6244 (ARRY-142886) is an inhibitor of MEK1/2 and can inhibit cell proliferation or induce apoptosis in a cell-type dependent manner. The precise molecular mechanism of AZD6244-induced apoptosis is not clear. To investigate mechanisms of AZD6244 induced apoptosis in human lung cancer, we determined the molecular changes of two subgroups of human lung cancer cell lines that are either sensitive or resistant to AZD6244 treatment. We found that AZD6244 elicited a large increase of Bim proteins and a smaller increase of PUMA and NOXA proteins, and induced cell death in sensitive lung cancer cell lines, but had no effect on other Bcl-2 related proteins in those cell lines. Knockdown of Bim by siRNA greatly increased the IC50 and reduced apoptosis for AZD6244 treated cells. We also found that levels of endogenous p-Thr32-FOXO3a and p-Ser253-FOXO3a were lower in AZD6244-sensitive cells than in AZD6244-resistant cells. In the sensitive cells, AZD6244 induced FOXO3a nuclear translocation required for Bim activation. Moreover, the silencing of FOXO3a by siRNA abrogated AZD6244-induced cell apoptosis. In addition, we found that transfection of constitutively active AKT up-regulated p-Thr32-FOXO3a and p-Ser253-FOXO3a expression and inhibited AZD6244-induced Bim expression in sensitive cells. These results show that Bim plays an important role in AZD6244-induced apoptosis in lung cancer cells and that the PI3K/AKT/FOXO3a pathway is involved in Bim regulation and susceptibility of lung cancer cells to AZD6244. These results have implications in the development of strategies to overcome resistance to MEK inhibitors.	[Meng, Jieru; Fang, Bingliang; Roth, Jack A.] Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA; [Liao, Yong] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Chresta, Christine M.; Smith, Paul D.] Astrazeneca, Canc & Infect Res, Macclesfield, Cheshire, England	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; AstraZeneca	Meng, JR (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA.	jmeng@mdanderson.org			National Cancer Institute Specialized Program of Research Excellence (SPORE) [CA-70907, CA-092487]; Cancer Center [CA-16672]; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA070907, R01CA092487] Funding Source: NIH RePORTER	National Cancer Institute Specialized Program of Research Excellence (SPORE)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute Specialized Program of Research Excellence (SPORE) Grant CA-70907 (J. Minna and J. Roth), R01 Grant CA-092487 (B. Fang), and Cancer Center Support Grant CA-16672. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was also supported by a Sponsored Research Grant from AstraZeneca Pharmaceutics who did have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Bursch W, 2001, CELL DEATH DIFFER, V8, P569, DOI 10.1038/sj.cdd.4400852; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Chen XF, 2001, ONCOGENE, V20, P6073, DOI 10.1038/sj.onc.1204736; Clark AS, 2002, MOL CANCER THER, V1, P707; Cragg MS, 2007, PLOS MED, V4, P1681, DOI 10.1371/journal.pmed.0040316; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Davies BR, 2007, MOL CANCER THER, V6, P2209, DOI 10.1158/1535-7163.MCT-07-0231; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; de Mattos SF, 2008, MOL CANCER THER, V7, P3237, DOI 10.1158/1535-7163.MCT-08-0398; Finnberg N, 2004, CANCER BIOL THER, V3, P614, DOI 10.4161/cbt.3.7.1057; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Haass NK, 2008, CLIN CANCER RES, V14, P230, DOI 10.1158/1078-0432.CCR-07-1440; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Huynh H, 2007, MOL CANCER THER, V6, P2468, DOI 10.1158/1535-7163.MCT-07-0162; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Kelekar A, 1998, TRENDS CELL BIOL, V8, P324, DOI 10.1016/S0962-8924(98)01321-X; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Leung KT, 2008, CARCINOGENESIS, V29, P544, DOI 10.1093/carcin/bgm294; Ley R, 2003, J BIOL CHEM, V278, P18811, DOI 10.1074/jbc.M301010200; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Meng JR, 2009, CANCER BIOL THER, V8, P2073, DOI 10.4161/cbt.8.21.9844; Nordigarden A, 2009, BLOOD, V113, P2302, DOI 10.1182/blood-2008-07-167023; Pei XY, 2007, BLOOD, V110, P2092, DOI 10.1182/blood-2007-04-083204; Puthalakath H, 2002, CELL DEATH DIFFER, V9, P505, DOI 10.1038/sj.cdd.4400998; Schmidt M, 2002, MOL CELL BIOL, V22, P7842, DOI 10.1128/MCB.22.22.7842-7852.2002; Sunters A, 2003, J BIOL CHEM, V278, P49795, DOI 10.1074/jbc.M309523200; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Yang JY, 2006, INT J ONCOL, V29, P643; Yang JY, 2010, CANCER RES, V70, P4709, DOI 10.1158/0008-5472.CAN-09-4524; Yeh TC, 2007, CLIN CANCER RES, V13, P1576, DOI 10.1158/1078-0432.CCR-06-1150; Yuan ZQ, 2003, J BIOL CHEM, V278, P23432, DOI 10.1074/jbc.M302674200; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	37	49	50	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e13026	10.1371/journal.pone.0013026	http://dx.doi.org/10.1371/journal.pone.0013026			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20885957	Green Submitted, gold, Green Published			2022-12-27	WOS:000282167100024
J	Oxnard, C; Obendorf, PJ; Kefford, BJ				Oxnard, Charles; Obendorf, Peter J.; Kefford, Ben J.			Post-Cranial Skeletons of Hypothyroid Cretins Show a Similar Anatomical Mosaic as Homo floresiensis	PLOS ONE			English	Article							LATE PLEISTOCENE; HOMININ	Human remains, some as recent as 15 thousand years, from Liang Bua (LB) on the Indonesian island of Flores have been attributed to a new species, Homo floresiensis. The definition includes a mosaic of features, some like modern humans (hence derived: genus Homo), some like modern apes and australopithecines (hence primitive: not species sapiens), and some unique (hence new species: floresiensis). Conversely, because only modern humans (H. sapiens) are known in this region in the last 40 thousand years, these individuals have also been suggested to be genetic human dwarfs. Such dwarfs resemble small humans and do not show the mosaic combination of the most complete individuals, LB1 and LB6, so this idea has been largely dismissed. We have previously shown that some features of the cranium of hypothyroid cretins are like those of LB1. Here we examine cretin postcrania to see if they show anatomical mosaics like H. floresiensis. We find that hypothyroid cretins share at least 10 postcranial features with Homo floresiensis and unaffected humans not found in apes (or australopithecines when materials permit). They share with H. floresiensis, modern apes and australopithecines at least 11 postcranial features not found in unaffected humans. They share with H. floresiensis, at least 8 features not found in apes, australopithecines or unaffected humans. Sixteen features can be rendered metrically and multivariate analyses demonstrate that H. floresiensis co-locates with cretins, both being markedly separate from humans and chimpanzees (P<0.001: from analysis of similarity (ANOSIM) over all variables, ANOSIM, global R>0.999). We therefore conclude that LB1 and LB6, at least, are, most likely, endemic cretins from a population of unaffected Homo sapiens. This is consistent with recent hypothyroid endemic cretinism throughout Indonesia, including the nearby island of Bali.	[Oxnard, Charles] Univ Western Australia, Sch Anat & Human Biol, Crawley, WA, Australia; [Oxnard, Charles] Univ Western Australia, Forens Sci Ctr, Crawley, WA, Australia; [Obendorf, Peter J.] RMIT Univ, Sch Appl Sci, Melbourne, Vic, Australia; [Kefford, Ben J.] Univ Technol Sydney, Ctr Environm Sustainabil, Dept Environm Sci, Broadway, NSW, Australia	University of Western Australia; University of Western Australia; Royal Melbourne Institute of Technology (RMIT); University of Technology Sydney	Oxnard, C (corresponding author), Univ Western Australia, Sch Anat & Human Biol, Crawley, WA, Australia.	charles.oxnard@uwa.edu.au		Kefford, Ben/0000-0001-6789-4254	Australian Research Council [DP0557157, 0772742, 0984372]	Australian Research Council(Australian Research Council)	Australian Research Council Discovery Grants DP0557157, 0772742 and 0984372 to Charles Oxnard. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello LC, 2010, AM J PHYS ANTHROPOL, V142, P167, DOI 10.1002/ajpa.21255; Argue D, 2006, J HUM EVOL, V51, P360, DOI 10.1016/j.jhevol.2006.04.013; Berger LR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001780; BOYAGES SC, 1988, J CLIN ENDOCR METAB, V67, P1262, DOI 10.1210/jcem-67-6-1262; Broom R, 1950, TRANSVAAL MUSEUM MEM, V4; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; Brumm A, 2010, NATURE, V464, P748, DOI 10.1038/nature08844; Chen ZP, 2010, BEST PRACT RES CL EN, V24, P39, DOI 10.1016/j.beem.2009.08.014; DEQUERVAIN F, 1936, ENDEMISCHE KRETINISM; EERLAND LD, 1932, GENEESK TIJDSCHR NED, V72, P1299; Falk D, 2009, J HUM EVOL, V57, P597, DOI 10.1016/j.jhevol.2008.10.008; Falk D, 2009, AM J PHYS ANTHROPOL, V140, P52, DOI 10.1002/ajpa.21035; Fuge R., 2005, ESSENTIALS MED GEOLO, P417; Gorley C.K., 2006, GETTING STARTED PRIM; He T Y, 1984, Zhonghua Fang She Xue Za Zhi, V18, P279; Hershkovitz I, 2007, AM J PHYS ANTHROPOL, V134, P198, DOI 10.1002/ajpa.20655; HILL WCO, 1936, CEYLON J SCI, V4, P71; Jacob T, 2006, P NATL ACAD SCI USA, V103, P13421, DOI 10.1073/pnas.0605563103; Jungers WL, 2009, J HUM EVOL, V57, P538, DOI 10.1016/j.jhevol.2008.08.014; Jungers WL, 2009, NATURE, V459, P81, DOI 10.1038/nature07989; JUNGERS WL, 2009, SIGNIFICANCE, V6, P159, DOI DOI 10.1111/J.1740-9713.2009.00389.X; Larson SG, 2009, J HUM EVOL, V57, P555, DOI 10.1016/j.jhevol.2008.06.007; Larson SG, 2007, J HUM EVOL, V53, P718, DOI 10.1016/j.jhevol.2007.06.003; LOVEJOY CO, 2009, SCIENCE, V326; Lyras GA, 2009, ANTHROPOL SCI, V117, P33, DOI 10.1537/ase.080411; Martin RD, 2006, ANAT REC PART A, V288A, P1123, DOI 10.1002/ar.a.20389; Morwood MJ, 2005, NATURE, V437, P1012, DOI 10.1038/nature04022; NOOSTEN D, 1935, GENEESK TIJDSCHR NED, V75, P1420; O'Connor S, 2007, ANTIQUITY, V81, P523, DOI 10.1017/S0003598X00095569; Obendorf PJ, 2008, P ROY SOC B-BIOL SCI, V275, P1287, DOI 10.1098/rspb.2007.1488; ORTNER DJ, 1993, BONE GROWTH; OXNARD C, 2008, GHOSTLY MUSCLES WRIN; OXNARD CE, 1968, AM J PHYS ANTHROPOL, V29, P429, DOI 10.1002/ajpa.1330290317; OXNARD CE, 1968, AM J PHYS ANTHROPOL, V28, P213, DOI 10.1002/ajpa.1330280218; Oxnard CE, 1983, ORDER MAN BIOMATHEMA; Preedy VR, 2009, COMPREHENSIVE HANDBOOK OF IODINE: NUTRITIONAL, BIOCHEMICAL, PATHOLOGICAL AND THERAPEUTIC ASPECTS, P1; Rencher AC, 2002, METHODS MULTIVARIATE; Tocheri MW, 2008, J ANAT, V212, P544, DOI 10.1111/j.1469-7580.2008.00865.x; Tocheri MW, 2007, SCIENCE, V317, P1743, DOI 10.1126/science.1147143; WILKINS L., 1941, AMER JOUR DIS CHILDREN, V61, P13	40	18	20	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e13018	10.1371/journal.pone.0013018	http://dx.doi.org/10.1371/journal.pone.0013018			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20885948	gold, Green Published, Green Submitted			2022-12-27	WOS:000282167100019
J	Parra, P; Serra, F; Palou, A				Parra, Pilar; Serra, Francisca; Palou, Andreu			Expression of Adipose MicroRNAs Is Sensitive to Dietary Conjugated Linoleic Acid Treatment in Mice	PLOS ONE			English	Article							LIPID-METABOLISM; SUBCUTANEOUS ADIPOSE; PANTOTHENATE KINASE; GENES; EFFICACY; OBESITY; MIRNAS	Background: Investigation of microRNAs (miRNAs) in obesity, their genetic targets and influence by dietary modulators is of great interest because it may potentially identify novel pathways involved in this complex metabolic disorder and influence future therapeutic approaches. This study aimed to determine whether miRNAs expression may be influenced by conjugated linoleic acid (CLA), currently used to induce fat loss. Methodology/Principal Findings: We determined retroperitoneal adipose tissue (rWAT) expression of five miRNAs related to adipocyte differentiation (miRNA-143) and lipid metabolism (miRNA-103 and -107) and altered in obesity (miRNA-221 and -222), using the TaqMan (R) MicroRNA Assay (Applied-Biosystems). In the first experiment, mice were fed with a standard fat diet and orally treated with sunflower oil (control group) and 3 or 10 mg CLA/day for 37 days. In the second experiment, mice were fed with a high fat diet for 65 days. For the first 30 days, mice received the same doses of CLA described above and, from that time onwards, animals received a double dose. Results showed that expression of selected miRNAs was modified in response to CLA treatment and metabolic status. Interestingly, a strong correlation was observed between miR-103 and -107 expression, as well as miR-221 and -222 in both experiments. Moreover, changes in miRNAs expression correlated with several adipocyte gene expressions: miR-103 and -107 correlated with genes involved in fatty acid metabolism whereas miR-221 and miR-222 correlated with the expression of adipocytokines. Regarding the minor changes observed in miR-143 expression, no differences in expression of adipogenic markers were observed. Conclusions/Significance: Although elucidating the functional implications of miRNAs is beyond the scope of this study, these findings provide the first evidence that miRNAs expression may be influenced by dietary manipulation, reflecting or even contributing to the new metabolic state originated by CLA treatment.	[Parra, Pilar] Univ Balearic Isl, Dept Fundamental Biol & Hlth Sci, Palma de Mallorca, Baleares, Spain; CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Palma de Mallorca, Baleares, Spain	Universitat de les Illes Balears; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN	Parra, P (corresponding author), Univ Balearic Isl, Dept Fundamental Biol & Hlth Sci, Palma de Mallorca, Baleares, Spain.	francisca.serra@uib.es	Palou, Andreu/K-9881-2014; Serra, Francisca/B-8641-2008; Xie, Huangming/B-2260-2012	Palou, Andreu/0000-0002-0295-4452; Serra, Francisca/0000-0002-8307-9732; 	Spanish Government [AGL2009-11277]; European Union [FP6-506360]	Spanish Government(Spanish GovernmentEuropean Commission); European Union(European Commission)	This work was supported by Spanish Government (grant AGL2009-11277). The authors' Laboratory is a member of the European Research Network of Excellence NuGO (The European Nutrigenomics Organization, European Union Contract No. FP6-506360). CIBER de Fisiopatologi-a de la Obesidad y Nutricion is an initiative from ISCIII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Cawthorn WP, 2008, FEBS LETT, V582, P117, DOI 10.1016/j.febslet.2007.11.051; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; He AB, 2007, MOL ENDOCRINOL, V21, P2785, DOI 10.1210/me.2007-0167; Heneghan HM, 2010, OBES REV, V11, P354, DOI 10.1111/j.1467-789X.2009.00659.x; House RL, 2005, OBES REV, V6, P247, DOI 10.1111/j.1467-789X.2005.00198.x; Kajimoto K, 2006, RNA, V12, P1626, DOI 10.1261/rna.7228806; Kloting N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004699; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2006, CELL METAB, V4, P9, DOI 10.1016/j.cmet.2006.05.009; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lin Q, 2009, FEBS J, V276, P2348, DOI 10.1111/j.1742-4658.2009.06967.x; Lin SL, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/26818; Nakanishi N, 2009, BIOCHEM BIOPH RES CO, V385, P492, DOI 10.1016/j.bbrc.2009.05.058; Ortega FJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009022; Parra Pilar, 2010, Nutr Metab (Lond), V7, P5, DOI 10.1186/1743-7075-7-5; Parra P, 2010, J NUTR BIOCHEM, V21, P107, DOI 10.1016/j.jnutbio.2008.10.010; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rock CO, 2000, J BIOL CHEM, V275, P1377, DOI 10.1074/jbc.275.2.1377; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; Sun TW, 2009, MOL ENDOCRINOL, V23, P925, DOI 10.1210/me.2008-0298; Takanabe R, 2008, BIOCHEM BIOPH RES CO, V376, P728, DOI 10.1016/j.bbrc.2008.09.050; VALLARI DS, 1987, J BIOL CHEM, V262, P2468; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Wang YW, 2004, INT J OBESITY, V28, P941, DOI 10.1038/sj.ijo.0802641; Whigham LD, 2007, AM J CLIN NUTR, V85, P1203; Wilfred BR, 2007, MOL GENET METAB, V91, P209, DOI 10.1016/j.ymgme.2007.03.011; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Ying SY, 2006, J BIOMED SCI, V13, P5, DOI 10.1007/s11373-005-9036-8	34	81	95	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e13005	10.1371/journal.pone.0013005	http://dx.doi.org/10.1371/journal.pone.0013005			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20886002	Green Published, gold, Green Submitted			2022-12-27	WOS:000282167100012
J	Bento, CF; Marques, F; Fernandes, R; Pereira, P				Bento, Carla Figueira; Marques, Filipa; Fernandes, Rosa; Pereira, Paulo			Methylglyoxal Alters the Function and Stability of Critical Components of the Protein Quality Control	PLOS ONE			English	Article							DNA-BINDING ACTIVITY; HEAT-SHOCK PROTEINS; UBIQUITIN-PROTEASOME PATHWAY; RETINAL-PIGMENT EPITHELIUM; GLYCATION END-PRODUCTS; BOVINE SERUM-ALBUMIN; MOLECULAR CHAPERONES; TRANSCRIPTION FACTOR; ALPHA-CRYSTALLIN; REDOX REGULATION	Background: Increased production and accumulation of methylglyoxal (MGO), as well as increased modification of proteins by glycoxidation, are hallmarks of aging and diabetes. MGO was shown to modify proteins and to contribute to the accumulation of damaged proteins that can be toxic to cells. However, the effect of MGO on the cell systems responsible for repairing or degrading damaged proteins is still unclear. In this study, the effect of MGO on the function of the ubiquitin-proteasome system (UPS) and on molecular chaperones, two cooperative mechanisms associated with protein quality control, was investigated. Principal Findings: In this work it is shown that treatment of cells with MGO leads to accumulation of ubiquitin conjugates and depletion of free ubiquitin. Moreover, MGO significantly decreases the proteolytic activity of the 20S proteasome. Data further shows that MGO decreases the levels of the molecular chaperones Hsc70 and Hsp90 and leads to accumulation of CHIP-, Hsp40- and ubiquitin-containing aggregates. The formation of large aggregates containing CHIP is a consequence of its binding to misfolded proteins and to molecular chaperones. Moreover, dysfunction of the chaperones/CHIP/UPS axis is associated with accumulation of oxidized and argpyrimidine-modified proteins, which is likely to be associated with decreased cell viability. Interestingly, data further shows that MGO-induced stress induces the activation of heat shock factor-1 (Hsf-1), the main transcription factor involved in the regulation of the expression of heat shock proteins (HSPs) and cell response to stress. Conclusions: The data obtained in this work suggests that MGO impairs both the UPS and the protein quality control dependent on CHIP and molecular chaperones, leading to accumulation of toxic aggregates and increased cell death. However, these MGO-induced changes appear to elicit a response from the Hsf-1 system, which is crucial to help cells to cope with cellular stress and to re-establish homeostasis.	[Bento, Carla Figueira; Marques, Filipa; Fernandes, Rosa; Pereira, Paulo] Univ Coimbra, Fac Med, Inst Biomed Res Light & Image IBILI, Ctr Ophthalmol & Vis Sci, Coimbra, Portugal; [Bento, Carla Figueira] Univ Coimbra, Ctr Neurosci & Cell Biol CNC, PhD Programme Expt Biol & Biomed, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra	Bento, CF (corresponding author), Univ Coimbra, Fac Med, Inst Biomed Res Light & Image IBILI, Ctr Ophthalmol & Vis Sci, Coimbra, Portugal.	ppereira@ibili.uc.pt	Pereira, Paulo/AAD-8375-2022; Fernandes, Rosa/P-1102-2014	Pereira, Paulo/0000-0002-9908-2290; Fernandes, Rosa/0000-0001-7828-2296; Bento, Carla F./0000-0001-8377-4543	FCT - Fundacao para a Ciencia e a Tecnologia, Portugal [SFRH/BD/15229/2004, POCI/SAU-OBS/57772/2004, PDTC/SAU-OBS/67498/2006]	FCT - Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This work was supported by the PhD fellowship SFRH/BD/15229/2004 (Carla F. Bento) and the grants POCI/SAU-OBS/57772/2004 and PDTC/SAU-OBS/67498/2006 (FCT - Fundacao para a Ciencia e a Tecnologia, Portugal). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682; Ahn SG, 2003, GENE DEV, V17, P516, DOI 10.1101/gad.1044503; Aslund F, 1999, CELL, V96, P751, DOI 10.1016/S0092-8674(00)80584-X; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Biswas A, 2008, BIOCHEM J, V409, P771, DOI 10.1042/BJ20071006; BROWNLEE M, 1995, ANNU REV MED, V46, P223, DOI 10.1146/annurev.med.46.1.223; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Bulteau AL, 2001, J BIOL CHEM, V276, P45662, DOI 10.1074/jbc.M105374200; Caron C, 2005, BIOESSAYS, V27, P408, DOI 10.1002/bies.20210; Casas S, 2007, DIABETES, V56, P2284, DOI 10.2337/db07-0178; Chen K, 2006, J NEUROCHEM, V99, P1413, DOI 10.1111/j.1471-4159.2006.04181.x; Coffe V, 2006, NEUROCHEM RES, V31, P103, DOI 10.1007/s11064-005-9236-7; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Denis U, 2002, FREE RADICAL BIO MED, V33, P236, DOI 10.1016/S0891-5849(02)00879-1; Du J, 2006, INT J BIOCHEM CELL B, V38, P1084, DOI 10.1016/j.biocel.2005.10.019; Ferrington DA, 2001, J BIOL CHEM, V276, P937, DOI 10.1074/jbc.M005356200; FRIGUET B, 1994, ARCH BIOCHEM BIOPHYS, V311, P168, DOI 10.1006/abbi.1994.1222; Friguet B, 2000, ANN NY ACAD SCI, V908, P143; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Grune T, 1997, FASEB J, V11, P526, DOI 10.1096/fasebj.11.7.9212076; Hammes HP, 2003, J DIABETES COMPLICAT, V17, P16, DOI 10.1016/S1056-8727(02)00275-1; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Holmberg CI, 2001, EMBO J, V20, P3800, DOI 10.1093/emboj/20.14.3800; Hooper Philip L., 2007, Metabolic Syndrome and Related Disorders, V5, P220, DOI 10.1089/met.2007.0005; JacquierSarlin MR, 1996, BIOCHEM J, V318, P187, DOI 10.1042/bj3180187; Jan CR, 2005, CELL SIGNAL, V17, P847, DOI 10.1016/j.cellsig.2004.11.007; Kang JH, 2006, J BIOCHEM MOL BIOL, V39, P335; Kumar MS, 2004, EXP EYE RES, V79, P577, DOI 10.1016/j.exer.2004.07.003; Kumar PA, 2007, BIOCHEM J, V408, P251, DOI 10.1042/BJ20070989; KUMAR S, 1992, MOL CELL BIOL, V12, P3094, DOI 10.1128/MCB.12.7.3094; Lasch P, 2001, J BIOL CHEM, V276, P9492, DOI 10.1074/jbc.M008528200; Lee C, 1998, J BIOL CHEM, V273, P25272, DOI 10.1074/jbc.273.39.25272; Lee SJ, 2009, CELL METAB, V10, P379, DOI 10.1016/j.cmet.2009.10.003; LO TWC, 1994, J BIOL CHEM, V269, P32299; Ma H, 2009, J CELL MOL MED, V13, P1751, DOI 10.1111/j.1582-4934.2008.00547.x; Marques C, 2006, FASEB J, V20, P741, DOI 10.1096/fj.05-5080fje; Merforth S, 2003, INT J BIOCHEM CELL B, V35, P740, DOI 10.1016/S1357-2725(02)00381-3; Miller AG, 2006, J BIOL CHEM, V281, P11864, DOI 10.1074/jbc.M513813200; Monnier VM, 1996, NEPHROL DIAL TRANSPL, V11, P20; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Murata S, 2003, INT J BIOCHEM CELL B, V35, P572, DOI 10.1016/S1357-2725(02)00394-1; Nagaraj RH, 2003, BIOCHEMISTRY-US, V42, P10746, DOI 10.1021/bi034541n; OBIN M, 1994, BIOCHEM BIOPH RES CO, V200, P1169, DOI 10.1006/bbrc.1994.1574; Okouchi M, 2005, CURR NEUROVASC RES, V2, P13, DOI 10.2174/1567202052773535; Oya-Ito T, 2006, J CELL BIOCHEM, V99, P279, DOI 10.1002/jcb.20781; Park SH, 2007, MOL BIOL CELL, V18, P153, DOI 10.1091/mbc.E06-04-0338; Petropoulos I, 2000, J GERONTOL A-BIOL, V55, pB220, DOI 10.1093/gerona/55.5.B220; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; Portero-Otin M, 1999, DIABETES, V48, P2215, DOI 10.2337/diabetes.48.11.2215; Queisser MA, 2010, DIABETES, V59, P670, DOI 10.2337/db08-1565; Ramasamy R, 2006, CELL, V124, P258, DOI 10.1016/j.cell.2006.01.002; RAY S, 1994, BIOCHEM J, V303, P69, DOI 10.1042/bj3030069; Reinke H, 2008, GENE DEV, V22, P331, DOI 10.1101/gad.453808; Rondeau P, 2008, FREE RADICAL BIO MED, V45, P799, DOI 10.1016/j.freeradbiomed.2008.06.004; Rosca MG, 2005, AM J PHYSIOL-RENAL, V289, pF420, DOI 10.1152/ajprenal.00415.2004; Rosca MG, 2002, AM J PHYSIOL-RENAL, V283, pF52, DOI 10.1152/ajprenal.00302.2001; Sakamoto H, 2002, J BIOL CHEM, V277, P45770, DOI 10.1074/jbc.M207485200; SASAKI T, 1984, J BIOL CHEM, V259, P2489; Schalkwijk CG, 1999, PERITON DIALYSIS INT, V19, P325; Schalkwijk CG, 2006, FEBS LETT, V580, P1565, DOI 10.1016/j.febslet.2006.01.086; Shang F, 2005, J BIOL CHEM, V280, P20365, DOI 10.1074/jbc.M414356200; Thornalley Paul J., 2008, Drug Metabolism and Drug Interactions, V23, P125; Tian J, 2005, P NATL ACAD SCI USA, V102, P11846, DOI 10.1073/pnas.0504759102; Vernace VA, 2007, AGING CELL, V6, P599, DOI 10.1111/j.1474-9726.2007.00329.x; Voellmy R, 2004, CELL STRESS CHAPERON, V9, P122, DOI 10.1379/CSC-14R.1; Voellmy R, 2007, ADV EXP MED BIOL, V594, P89; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Zeng JM, 2006, CHEM RES TOXICOL, V19, P1668, DOI 10.1021/tx0602158	69	32	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2010	5	9							e13007	10.1371/journal.pone.0013007	http://dx.doi.org/10.1371/journal.pone.0013007			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653UN	20885985	Green Published, gold, Green Submitted			2022-12-27	WOS:000282122600024
J	Benedetti-Cecchi, L; Iken, K; Konar, B; Cruz-Motta, J; Knowlton, A; Pohle, G; Castelli, A; Tamburello, L; Mead, A; Trott, T; Miloslavich, P; Wong, M; Shirayama, Y; Lardicci, C; Palomo, G; Maggi, E				Benedetti-Cecchi, Lisandro; Iken, Katrin; Konar, Brenda; Cruz-Motta, Juan; Knowlton, Ann; Pohle, Gerhard; Castelli, Alberto; Tamburello, Laura; Mead, Angela; Trott, Tom; Miloslavich, Patricia; Wong, Melisa; Shirayama, Yoshihisa; Lardicci, Claudio; Palomo, Gabriela; Maggi, Elena			Spatial Relationships between Polychaete Assemblages and Environmental Variables over Broad Geographical Scales	PLOS ONE			English	Article							TAXONOMIC SUFFICIENCY; BETA DIVERSITY; RUN-OFF; CLIMATE; IMPACTS; BIODIVERSITY; RESOLUTION; COMMUNITY; FRAMEWORK; PATTERNS	This study examined spatial relationships between rocky shore polychaete assemblages and environmental variables over broad geographical scales, using a database compiled within the Census of Marine Life NaGISA (Natural Geography In Shore Areas) research program. The database consisted of abundance measures of polychaetes classified at the genus and family levels for 74 and 93 sites, respectively, from nine geographic regions. We tested the general hypothesis that the set of environmental variables emerging as potentially important drivers of variation in polychaete assemblages depend on the spatial scale considered. Through Moran's eigenvector maps we indentified three submodels reflecting spatial relationships among sampling sites at intercontinental (>10000 km), continental (1000-5000 km) and regional (20-500 km) scales. Using redundancy analysis we found that most environmental variables contributed to explain a large and significant proportion of variation of the intercontinental submodel both for genera and families (54% and 53%, respectively). A subset of these variables, organic pollution, inorganic pollution, primary productivity and nutrient contamination was also significantly related to spatial variation at the continental scale, explaining 25% and 32% of the variance at the genus and family levels, respectively. These variables should therefore be preferably considered when forecasting large-scale spatial patterns of polychaete assemblages in relation to ongoing or predicted changes in environmental conditions. None of the variables considered in this study were significantly related to the regional submodel.	[Benedetti-Cecchi, Lisandro; Castelli, Alberto; Tamburello, Laura; Lardicci, Claudio; Maggi, Elena] Univ Pisa, Dept Biol, CoNISMa Natl Interuniv Consortium Marine Sci, Pisa, Italy; [Iken, Katrin; Konar, Brenda; Knowlton, Ann] Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Fairbanks, AK USA; [Cruz-Motta, Juan; Miloslavich, Patricia] Univ Simon Bolivar, Dept Estudios Ambient, Ctr Biodiversidad Marina, Caracas, Venezuela; [Pohle, Gerhard] Huntsman Marine Sci Ctr, Atlantic Reference Ctr, St Andrews, NB, Canada; [Mead, Angela] Univ Cape Town, Dept Zool, ZA-7925 Cape Town, South Africa; [Trott, Tom] Suffolk Univ, Dept Biol, Boston, MA 02114 USA; [Wong, Melisa] Bedford Inst Oceanog, Dartmouth, NS, Canada; [Shirayama, Yoshihisa] Kyoto Univ, Seto Marine Biol Lab, Shirahama, Japan; [Palomo, Gabriela] Museo Argentino Ciencias Nat Bernardino Rivadavia, Lab Ecosistemas Costeros, Buenos Aires, DF, Argentina	University of Pisa; University of Alaska System; University of Alaska Fairbanks; Simon Bolivar University; University of Cape Town; Suffolk University; Bedford Institute of Oceanography; Kyoto University; Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN)	Benedetti-Cecchi, L (corresponding author), Univ Pisa, Dept Biol, CoNISMa Natl Interuniv Consortium Marine Sci, Pisa, Italy.	lbenedetti@biologia.unipi.it	lardicci, claudio/K-8698-2018; Maggi, Elena/AAR-9910-2021; Benedetti-Cecchi, Lisandro/J-8225-2019; Trott, Thomas J/N-4660-2018	Benedetti-Cecchi, Lisandro/0000-0001-5244-5202; Trott, Thomas J/0000-0002-1851-5243; Palomo, Maria Gabriela/0000-0002-9102-1282; CASTELLI, ALBERTO/0000-0002-0762-1403; Cruz Motta, Juan Jose/0000-0001-6117-9014; TAMBURELLO, LAURA/0000-0003-1305-8802; Miloslavich, Patricia/0000-0001-5409-1401; MAGGI, Elena/0000-0001-6934-9380; LARDICCI, CLAUDIO/0000-0001-5356-7914	Alfred P. Sloan Foundation; Nippon Foundation; History of Near Shore (HNS)	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Nippon Foundation(Nippon Foundation); History of Near Shore (HNS)	This work is part of the Census of Marine Life program and the authors would like to express their sincerest gratitude to the Alfred P. Sloan Foundation for funding. Additional support was provided by a PRIN Project from the Italian Ministry of University and Research and by the University of Pisa to LBC. Nippon Foundation provided financial support to YS for carrying out sampling in the western Pacific. Suffolk University provided generous financial support for sampling in Maine and data processing. The Gulf Ecosystem Monitoring program provided funds for sampling in Alaska to BK and KI. The History of Near Shore (HNS) initiative provided financial support for field collections in South Africa, and Maine, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], [No title captured]; Balmford A, 1996, P ROY SOC B-BIOL SCI, V263, P1267, DOI 10.1098/rspb.1996.0186; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Bellier E, 2007, ECOGRAPHY, V30, P385, DOI [10.1111/j.2007.0906-7590.04911.x, 10.1111/j.0906-7590.2007.04911.x]; Bertrand Y, 2006, SYST BIODIVERS, V4, P149, DOI 10.1017/S1477200005001908; Blanchette CA, 2009, PROG OCEANOGR, V83, P107, DOI 10.1016/j.pocean.2009.07.038; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; Broitman BR, 2006, MAR ECOL PROG SER, V327, P15, DOI 10.3354/meps327015; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Corfield J, 2000, ICES J MAR SCI, V57, P1517, DOI 10.1006/jmsc.2000.0901; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Darling ES, 2008, ECOL LETT, V11, P1278, DOI 10.1111/j.1461-0248.2008.01243.x; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; ELLIS D, 1985, MAR POLLUT BULL, V16, P459, DOI 10.1016/0025-326X(85)90362-5; Firth LB, 2009, GLOBAL CHANGE BIOL, V15, P1413, DOI 10.1111/j.1365-2486.2009.01863.x; Fraschetti S, 2005, MAR ECOL PROG SER, V296, P13, DOI 10.3354/meps296013; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Harrison S, 2008, ECOL LETT, V11, P969, DOI 10.1111/j.1461-0248.2008.01210.x; Hendriks IE, 2010, ESTUAR COAST SHELF S, V86, P157, DOI 10.1016/j.ecss.2009.11.022; Hewitt JE, 2009, GLOBAL CHANGE BIOL, V15, P1911, DOI 10.1111/j.1365-2486.2008.01825.x; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Josefson AB, 1997, MAR ECOL PROG SER, V147, P49, DOI 10.3354/meps147049; Kilpatrick KA, 2001, J GEOPHYS RES-OCEANS, V106, P9179, DOI 10.1029/1999JC000065; Lee HW, 2006, MAR ECOL PROG SER, V307, P175, DOI 10.3354/meps307175; Legendre P., 2012, NUMERICAL ECOLOGY; Legendre P, 2009, ECOLOGY, V90, P663, DOI 10.1890/07-1880.1; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; McClain CR, 2004, DEEP-SEA RES PT II, V51, P5, DOI 10.1016/j.dsr2.2003.11.001; Musco L, 2009, MAR ECOL PROG SER, V383, P199, DOI 10.3354/meps07989; Olsgard F, 2003, BIODIVERS CONSERV, V12, P1033, DOI 10.1023/A:1022800405253; Parmesan C, 1996, NATURE, V382, P765, DOI 10.1038/382765a0; Pascual M, 2005, TRENDS ECOL EVOL, V20, P88, DOI 10.1016/j.tree.2004.11.012; Pearson T.H., 1978, Oceanography and Marine Biology an Annual Review, V16, P229; Peters DPC, 2008, FRONT ECOL ENVIRON, V6, P229, DOI 10.1890/070098; Ramette A, 2007, P NATL ACAD SCI USA, V104, P2761, DOI 10.1073/pnas.0610671104; Rohani P, 1997, TRENDS ECOL EVOL, V12, P70, DOI 10.1016/S0169-5347(96)20103-X; Salen-Picard C, 2002, OECOLOGIA, V133, P380, DOI 10.1007/s00442-002-1032-3; Selman P, 2009, LAND USE POLICY, V26, pS142, DOI 10.1016/j.landusepol.2009.08.005; Terlizzi A, 2009, DIVERS DISTRIB, V15, P450, DOI 10.1111/j.1472-4642.2008.00551.x; THRUSH SF, 1994, ECOL APPL, V4, P31, DOI 10.2307/1942112; Widdicombe S, 2009, MAR ECOL PROG SER, V379, P59, DOI 10.3354/meps07894; Wilmers CC, 2007, AM NAT, V169, P673, DOI 10.1086/513484; Witman J.D., 2009, MARINE MACROECOLOGY, DOI 10.7208/chicago/9780226904146.001.0001; Wootton JT, 2008, P NATL ACAD SCI USA, V105, P18848, DOI 10.1073/pnas.0810079105; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Wu J., 2000, ANN GIS, V6, P6, DOI DOI 10.1080/10824000009480529; [No title captured]	50	18	18	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12946	10.1371/journal.pone.0012946	http://dx.doi.org/10.1371/journal.pone.0012946			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886075	Green Published, gold			2022-12-27	WOS:000282091100043
J	Hamad, OA; Nilsson, PH; Lasaosa, M; Ricklin, D; Lambris, JD; Nilsson, B; Ekdahl, KN				Hamad, Osama A.; Nilsson, Per H.; Lasaosa, Maria; Ricklin, Daniel; Lambris, John D.; Nilsson, Bo; Ekdahl, Kristina Nilsson			Contribution of Chondroitin Sulfate A to the Binding of Complement Proteins to Activated Platelets	PLOS ONE			English	Article							GLOBULAR HEAD REGION; FACTOR-H BINDS; HUMAN SERUM; DERMATAN SULFATE; IMMUNE-COMPLEXES; B-CHAIN; C1Q; BLOOD; THROMBIN; GLYCOSAMINOGLYCANS	Background: Exposure of chondroitin sulfate A (CS-A) on the surface of activated platelets is well established. The aim of the present study was to investigate to what extent CS-A contributes to the binding of the complement recognition molecule C1q and the complement regulators C1 inhibitor (C1INH), C4b-binding protein (C4BP), and factor H to platelets. Principal Findings: Human blood serum was passed over Sepharose conjugated with CS-A, and CS-A-specific binding proteins were identified by Western blotting and mass spectrometric analysis. C1q was shown to be the main protein that specifically bound to CS-A, but C4BP and factor H were also shown to interact. Binding of C1INH was dependent of the presence of C1q and then not bound to CS-A from C1q-depleted serum. The specific interactions observed of these proteins with CS-A were subsequently confirmed by surface plasmon resonance analysis using purified proteins. Importantly, C1q, C4BP, and factor H were also shown to bind to activated platelets and this interaction was inhibited by a CS-A-specific monoclonal antibody, thereby linking the binding of C1q, C4BP, and factor H to exposure of CS-A on activated platelets. CS-A-bound C1q was also shown to amplify the binding of model immune complexes to both microtiter plate-bound CS-A and to activated platelets. Conclusions: This study supports the concept that CS-A contributes to the binding of C1q, C4BP, and factor H to platelets, thereby adding CS-A to the previously reported binding sites for these proteins on the platelet surface. CS-A-bound C1q also seems to amplify the binding of immune complexes to activated platelets, suggesting a role for this molecule in immune complex diseases.	[Hamad, Osama A.; Nilsson, Bo; Ekdahl, Kristina Nilsson] Uppsala Univ, Div Clin Immunol, Rudbeck Lab C5, Uppsala, Sweden; [Nilsson, Per H.; Ekdahl, Kristina Nilsson] Linnaeus Univ, Sch Nat Sci, Kalmar, Sweden; [Lasaosa, Maria; Ricklin, Daniel; Lambris, John D.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	Uppsala University; Linnaeus University; University of Pennsylvania	Hamad, OA (corresponding author), Uppsala Univ, Div Clin Immunol, Rudbeck Lab C5, Uppsala, Sweden.	bo.nilsson@klinimm.uu.se	Nilsson, Bo/B-3102-2012; Ekdahl, Kristina Nilsson/B-5301-2012; Lambris, John/Q-5633-2018; Ricklin, Daniel/F-5104-2011	Nilsson, Bo/0000-0003-0057-2730; Lambris, John/0000-0002-9370-5776; Ricklin, Daniel/0000-0001-6140-0233; Nilsson, Per/0000-0002-7192-5794	National Institutes of Health [AI068730, EB003968, GM62134, GM069736]; Swedish Research Council [2009-4462, 2009-4675, 15244]; Natural Sciences Faculty, Linneaus University, Kalmar and Vaxjo, Sweden; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI068730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003968] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062134, R24GM069736] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Natural Sciences Faculty, Linneaus University, Kalmar and Vaxjo, Sweden; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants AI068730, EB003968, GM62134, and GM069736, Swedish Research Council grants 2009-4462, 2009-4675 and 15244, and grants from the Natural Sciences Faculty, Linneaus University, Kalmar and Vaxjo, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderluh M, 2002, CURR MED CHEM, V9, P1229, DOI 10.2174/0929867023369934; DAHLBACK B, 1990, J BIOL CHEM, V265, P16082; Deepa SS, 2007, GLYCOBIOLOGY, V17, P631, DOI 10.1093/glycob/cwm021; DEVINE DV, 1987, P NATL ACAD SCI USA, V84, P5873, DOI 10.1073/pnas.84.16.5873; DONATO JL, 1994, BRAZ J MED BIOL RES, V27, P2163; Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x; Hamad OA, 2008, J THROMB HAEMOST, V6, P1413, DOI 10.1111/j.1538-7836.2008.03034.x; HAMAD OA, J IMMUNOL, V184, P2686; HAMMER CH, 1981, J BIOL CHEM, V256, P3995; Henningsson AJ, 2007, J NEUROIMMUNOL, V183, P200, DOI 10.1016/j.jneuroim.2006.10.022; Kishimoto TK, 2008, NEW ENGL J MED, V358, P2457, DOI 10.1056/NEJMoa0803200; Kishore U, 1998, BIOCHEM J, V333, P27, DOI 10.1042/bj3330027; Lamari FN, 2006, ADV PHARMACOL, V53, P33, DOI 10.1016/S1054-3589(05)53003-5; Lamari FN, 2006, BIOMED CHROMATOGR, V20, P539, DOI 10.1002/bmc.669; LINDAHL TL, 1993, PLATELETS, V4, P73, DOI 10.3109/09537109309013199; MACPHERSON GG, 1972, J CELL SCI, V10, P705; MALMSTROM A, 1982, BIOCHEM J, V201, P489, DOI 10.1042/bj2010489; McGrath FDG, 2006, J IMMUNOL, V176, P2950, DOI 10.4049/jimmunol.176.5.2950; Mnjoyan Z, 2008, PLATELETS, V19, P512, DOI 10.1080/09537100802238494; MORTON TA, 1995, ANAL BIOCHEM, V227, P176, DOI 10.1006/abio.1995.1268; Myszka DG, 1998, TRENDS BIOCHEM SCI, V23, P149, DOI 10.1016/S0968-0004(98)01183-9; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; NILSSON UR, 1965, J EXP MED, V122, P277, DOI 10.1084/jem.122.2.277; Notkins AL, 2004, TRENDS IMMUNOL, V25, P174, DOI 10.1016/j.it.2004.02.004; OKAYAMA M, 1986, BIOCHEM J, V233, P73, DOI 10.1042/bj2330073; PEERSCHKE EIB, 1994, SEMIN HEMATOL, V31, P320; PEERSCHKE EIB, 1988, J IMMUNOL, V141, P3505; Peerschke EIB, 1997, J IMMUNOL, V159, P5594; PEERSCHKE EIB, 1987, J IMMUNOL, V138, P1537; PEERSCHKE EIB, 1992, CLIN IMMUNOL IMMUNOP, V63, P45, DOI 10.1016/0090-1229(92)90092-3; Sherman LS, 2008, TRENDS NEUROSCI, V31, P44, DOI 10.1016/j.tins.2007.11.001; SJOHOLM AG, 1991, APMIS, V99, P1120; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; SUZUKI H, 1995, EXP MOL PATHOL, V62, P63, DOI 10.1006/exmp.1995.1007; Taylor KR, 2006, FASEB J, V20, P9, DOI 10.1096/fj.05-4682rev; TENNER AJ, 1981, J IMMUNOL, V127, P648; Tissot B, 2005, BIOCHEMISTRY-US, V44, P2602, DOI 10.1021/bi047802h; Vaziri-Sani F, 2005, J THROMB HAEMOST, V3, P154, DOI 10.1111/j.1538-7836.2004.01010.x; WARD JV, 1979, BIOCHIM BIOPHYS ACTA, V583, P196, DOI 10.1016/0304-4165(79)90427-6; Woulfe DS, 2008, BLOOD, V111, P3458, DOI 10.1182/blood-2007-07-104703	40	37	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12889	10.1371/journal.pone.0012889	http://dx.doi.org/10.1371/journal.pone.0012889			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886107	Green Published, gold			2022-12-27	WOS:000282091100006
J	Hayes, KR; Beatty, M; Meng, X; Simmons, CR; Habben, JE; Danilevskaya, ON				Hayes, Kevin R.; Beatty, Mary; Meng, Xin; Simmons, Carl R.; Habben, Jeffrey E.; Danilevskaya, Olga N.			Maize Global Transcriptomics Reveals Pervasive Leaf Diurnal Rhythms but Rhythms in Developing Ears Are Largely Limited to the Core Oscillator	PLOS ONE			English	Article							PSEUDO-RESPONSE REGULATORS; CIRCADIAN CLOCK; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; KEY PATHWAYS; GROWTH; TIME; PHOTOSYNTHESIS; NETWORK; BIOLOGY	Background: Plant diurnal rhythms are vital environmental adaptations to coordinate internal physiological responses to alternating day-night cycles. A comprehensive view of diurnal biology has been lacking for maize (Zea mays), a major world crop. Methodology: A photosynthetic tissue, the leaf, and a non-photosynthetic tissue, the developing ear, were sampled under natural field conditions. Genome-wide transcript profiling was conducted on a high-density 105 K Agilent microarray to investigate diurnal rhythms. Conclusions: In both leaves and ears, the core oscillators were intact and diurnally cycling. Maize core oscillator genes are found to be largely conserved with their Arabidopsis counterparts. Diurnal gene regulation occurs in leaves, with some 23% of expressed transcripts exhibiting a diurnal cycling pattern. These transcripts can be assigned to over 1700 gene ontology functional terms, underscoring the pervasive impact of diurnal rhythms on plant biology. Considering the peak expression time for each diurnally regulated gene, and its corresponding functional assignment, most gene functions display temporal enrichment in the day, often with distinct patterns, such as dawn or midday preferred, indicating that there is a staged procession of biological events undulating with the diurnal cycle. Notably, many gene functions display a bimodal enrichment flanking the midday photosynthetic maximum, with an initial peak in mid-morning followed by another peak during the afternoon/evening. In contrast to leaves, in developing ears as few as 47 gene transcripts are diurnally regulated, and this set of transcripts includes primarily the core oscillators. In developing ears, which are largely shielded from light, the core oscillator therefore is intact with little outward effect on transcription.	[Hayes, Kevin R.; Beatty, Mary; Meng, Xin; Simmons, Carl R.; Habben, Jeffrey E.; Danilevskaya, Olga N.] Pioneer HiBred Int Inc, Johnston, IA 50131 USA	DuPont	Hayes, KR (corresponding author), Pioneer HiBred Int Inc, Johnston, IA 50131 USA.	olga.danilevskaya@pioneer.com			Pioneer Hi-Bred International, Inc., a DuPont Company	Pioneer Hi-Bred International, Inc., a DuPont Company	This work was supported by Pioneer Hi-Bred International, Inc., a DuPont Company. Investigators from Pioneer were involved in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Barak S, 2000, TRENDS PLANT SCI, V5, P517, DOI 10.1016/S1360-1385(00)01785-4; Bieniawska Z, 2008, PLANT PHYSIOL, V147, P263, DOI 10.1104/pp.108.118059; Blasing OE, 2005, PLANT CELL, V17, P3257, DOI 10.1105/tpc.105.035261; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bruggmann R, 2006, GENOME RES, V16, P1241, DOI 10.1101/gr.5338906; Ciceri P, 1999, PLANT PHYSIOL, V121, P1321, DOI 10.1104/pp.121.4.1321; Covington MF, 2007, PLOS BIOL, V5, P1773, DOI 10.1371/journal.pbio.0050222; Covington MF, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r130; de Montaigu A, 2010, TRENDS GENET, V26, P296, DOI 10.1016/j.tig.2010.04.003; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Facella P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002798; Fukushima A, 2009, P NATL ACAD SCI USA, V106, P7251, DOI 10.1073/pnas.0900952106; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Graf A, 2010, P NATL ACAD SCI USA, V107, P9458, DOI 10.1073/pnas.0914299107; Gutierez RA, 2008, P NATL ACAD SCI USA, V105, P4939, DOI 10.1073/pnas.0800211105; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Harmer SL, 2009, ANNU REV PLANT BIOL, V60, P357, DOI 10.1146/annurev.arplant.043008.092054; Hazen SP, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r17; Hudson KA, 2010, PLANT GENOME-US, V3, P3, DOI 10.3835/plantgenome2009.08.0025; Hughes M, 2007, COLD SPRING HARB SYM, V72, P381, DOI 10.1101/sqb.2007.72.011; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; JAHN D, 1992, TRENDS BIOCHEM SCI, V17, P215, DOI 10.1016/0968-0004(92)90380-R; James AB, 2008, SCIENCE, V322, P1832, DOI 10.1126/science.1161403; KALTTORRES W, 1987, PLANT PHYSIOL, V83, P283, DOI 10.1104/pp.83.2.283; KALTTORRES W, 1987, PLANT PHYSIOL, V83, P294, DOI 10.1104/pp.83.2.294; Kaufmann K, 2010, SCIENCE, V328, P85, DOI 10.1126/science.1185244; Lagercrantz U, 2009, J EXP BOT, V60, P2501, DOI 10.1093/jxb/erp139; Legnaioli T, 2009, EMBO J, V28, P3745, DOI 10.1038/emboj.2009.297; Mas P, 2003, NATURE, V426, P567, DOI 10.1038/nature02163; Mas P, 2008, TRENDS CELL BIOL, V18, P273, DOI 10.1016/j.tcb.2008.03.005; Michael TP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040014; Michael TP, 2008, PLOS BIOL, V6, P1887, DOI 10.1371/journal.pbio.0060225; Michaels SD, 2009, CURR OPIN PLANT BIOL, V12, P75, DOI 10.1016/j.pbi.2008.09.005; Miller TA, 2008, PLANTA, V227, P1377, DOI 10.1007/s00425-008-0709-1; Mockler TC, 2007, COLD SPRING HARB SYM, V72, P353, DOI 10.1101/sqb.2007.72.006; Murakami M, 2003, PLANT CELL PHYSIOL, V44, P1229, DOI 10.1093/pcp/pcg135; Murakami M, 2007, PLANT CELL PHYSIOL, V48, P110, DOI 10.1093/pcp/pcl043; Murakami M, 2007, BIOSCI BIOTECH BIOCH, V71, P1107, DOI 10.1271/bbb.70048; Nakamichi N, 2010, PLANT CELL, V22, P594, DOI 10.1105/tpc.109.072892; Nelson DC, 2000, CELL, V101, P331, DOI 10.1016/S0092-8674(00)80842-9; Nernhauser JL, 2008, CURR OPIN PLANT BIOL, V11, P4, DOI 10.1016/j.pbi.2007.10.005; Ni ZF, 2009, NATURE, V457, P327, DOI 10.1038/nature07523; Nozue K, 2006, PLANT CELL ENVIRON, V29, P396, DOI 10.1111/j.1365-3040.2005.01489.x; Nozue K, 2007, NATURE, V448, P358, DOI 10.1038/nature05946; Pruneda-Paz JL, 2009, SCIENCE, V323, P1481, DOI 10.1126/science.1167206; Ptitsyn A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S9-S18; Rawat R, 2009, P NATL ACAD SCI USA, V106, P16883, DOI 10.1073/pnas.0813035106; REDINBAUGH MG, 1990, P NATL ACAD SCI USA, V87, P6853, DOI 10.1073/pnas.87.17.6853; Ritchie SW, 1997, CORN PLANT DEV; Schaffer R, 2001, PLANT CELL, V13, P113, DOI 10.1105/tpc.13.1.113; Schultz TF, 2001, PLANT CELL, V13, P2659, DOI 10.1105/tpc.13.12.2659; Somers DE, 2000, CELL, V101, P319, DOI 10.1016/S0092-8674(00)80841-7; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sun N, 2003, PLANT MOL BIOL, V53, P467, DOI 10.1023/B:PLAN.0000019071.12878.9e; Tsuji H, 2008, RICE, V1, P25, DOI 10.1007/s12284-008-9005-8; Ueda HR, 2006, MOL SYST BIOL, V2, DOI 10.1038/mbs4100105; Velde AAT, 2007, INFLAMM BOWEL DIS, V13, P325, DOI 10.1002/ibd.20079; Wichert S, 2004, BIOINFORMATICS, V20, P5, DOI 10.1093/bioinformatics/btg364	58	52	54	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12887	10.1371/journal.pone.0012887	http://dx.doi.org/10.1371/journal.pone.0012887			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886102	gold, Green Published, Green Submitted			2022-12-27	WOS:000282091100005
J	Liu, J; Hu, B; Yang, Y; Ma, ZY; Yu, YA; Liu, SP; Wang, BJ; Zhao, XP; Lu, MJ; Yang, DL				Liu, Jia; Hu, Bin; Yang, Yan; Ma, Zhiyong; Yu, Yuan; Liu, Shenpei; Wang, Baoju; Zhao, Xiping; Lu, Mengji; Yang, Dongliang			A New Splice Variant of the Major Subunit of Human Asialoglycoprotein Receptor Encodes a Secreted Form in Hepatocytes	PLOS ONE			English	Article							INTERNAL SIGNAL SEQUENCE; HEPATITIS-C VIRUS; LIGAND-BINDING; LIVER; CELLS; AUTOANTIBODIES; PROTEINS; DOMAIN; GENES; H2	Background: The human asialoglycoprotein receptor (ASGPR) is composed of two polypeptides, designated H1 and H2. While variants of H2 have been known for decades, the existence of H1 variants has never been reported. Principal Findings: We identified two splice variants of ASGPR H1 transcripts, designated H1a and H1b, in human liver tissues and hepatoma cells. Molecular cloning of ASGPR H1 variants revealed that they differ by a 117 nucleotide segment corresponding to exon 2 in the ASGPR genomic sequence. Thus, ASGPR variant H1b transcript encodes a protein lacking the transmembrane domain. Using an H1b-specific antibody, H1b protein and a functional soluble ASGPR (sASGPR) composed of H1b and H2 in human sera and in hepatoma cell culture supernatant were identified. The expression of ASGPR H1a and H1b in Hela cells demonstrated the different cellular loctions of H1a and H1b proteins at cellular membranes and in intracellular compartments, respectively. In vitro binding assays using flourescence-labeled sASGPR or the substract ASOR revealed that the presence of sASGPR reduced the binding of ASOR to cells. However, ASOR itself was able to enhance the binding of sASGPR to cells expressing membrane-bound ASGPR. Further, H1b expression is reduced in liver tissues from patients with viral hepatitis. Conclusions: We conclude that two naturally occurring ASGPR H1 splice variants are produced in human hepatocytes. A hetero-oligomeric complex sASGPR consists of the secreted form of H1 and H2 and may bind to free substrates in circulation and carry them to liver tissue for uptake by ASGPR-expressing hepatocytes.	[Liu, Jia; Hu, Bin; Ma, Zhiyong; Wang, Baoju; Zhao, Xiping; Yang, Dongliang] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Div Clin Immunol, Wuhan 430074, Hubei Province, Peoples R China; [Yang, Yan; Yu, Yuan; Liu, Shenpei; Yang, Dongliang] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Ctr Med Expt, Wuhan 430074, Hubei Province, Peoples R China; [Lu, Mengji] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Microbiol, Wuhan 430074, Hubei Province, Peoples R China; [Lu, Mengji] Duisburg Essen Univ, Sch Med, Inst Virol, Essen, Germany	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; University of Duisburg Essen	Liu, J (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Div Clin Immunol, Wuhan 430074, Hubei Province, Peoples R China.	mengji.lu@uni-due.de; dlyang@tjh.tjmu.edu.cn	Lu, Mengji/ABF-9410-2020		National Natural Science Foundation of China [30571646]; National High Technology Research and Development Program of China [2006AA02Z128]; Major State Basic Research Development Program of China [2005CB522901, 2007CB512804, 2009CB522500]; National Major Science and Technology Special Project for Infectious Diseases of China [2008ZX10002-011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Major State Basic Research Development Program of China(National Basic Research Program of China); National Major Science and Technology Special Project for Infectious Diseases of China	This work was supported by grants from the National Natural Science Foundation of China (30571646), the National High Technology Research and Development Program of China (863 program) (No. 2006AA02Z128), the Major State Basic Research Development Program of China (973 Program) (No. 2005CB522901, 2007CB512804, 2009CB522500), and the National Major Science and Technology Special Project for Infectious Diseases of China (No. 2008ZX10002-011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMOVICH C, 1994, FEBS LETT, V338, P295, DOI 10.1016/0014-5793(94)80287-4; ACS G, 1987, P NATL ACAD SCI USA, V84, P4641, DOI 10.1073/pnas.84.13.4641; ASHWELL G, 1982, ANNU REV BIOCHEM, V51, P531, DOI 10.1146/annurev.bi.51.070182.002531; BECKER S, 1995, J GEN VIROL, V76, P393, DOI 10.1099/0022-1317-76-2-393; BIDER MD, 1995, EUR J BIOCHEM, V230, P207, DOI 10.1111/j.1432-1033.1995.0207i.x; Bider MD, 1996, J BIOL CHEM, V271, P31996, DOI 10.1074/jbc.271.50.31996; BISCHOFF J, 1987, J BIOL CHEM, V262, P11825; BRAITERMAN LT, 1989, J BIOL CHEM, V264, P1682; BREITBART RE, 1987, ANNU REV BIOCHEM, V56, P467, DOI 10.1146/annurev.bi.56.070187.002343; CHIACCHIA KB, 1984, J BIOL CHEM, V259, P5440; CROWE PD, 1993, J IMMUNOL, V151, P6882; Dotzauer A, 2000, J VIROL, V74, P10950, DOI 10.1128/JVI.74.23.10950-10957.2000; EHLERS MRW, 1991, BIOCHEMISTRY-US, V30, P10065, DOI 10.1021/bi00106a001; Grewal PK, 2008, NAT MED, V14, P648, DOI 10.1038/nm1760; HALBERG DF, 1987, J BIOL CHEM, V262, P9828; HARDY MR, 1985, BIOCHEMISTRY-US, V24, P22, DOI 10.1021/bi00322a004; Hilgard P, 2004, HEPATOLOGY, V39, P1398, DOI 10.1002/hep.20172; MCFARLANE BM, 1986, J HEPATOL, V3, P196, DOI 10.1016/S0168-8278(86)80026-5; OKA JA, 1990, BIOCHEM BIOPH RES CO, V170, P1308, DOI 10.1016/0006-291X(90)90536-V; PAIETTA E, 1992, HEPATOLOGY, V15, P395, DOI 10.1002/hep.1840150307; Ruiz NI, 1996, GLYCOBIOLOGY, V6, P551, DOI 10.1093/glycob/6.5.551; Saunier B, 2003, J VIROL, V77, P546, DOI 10.1128/JVI.77.1.546-559.2003; SAWAMURA T, 1984, GASTROENTEROLOGY, V87, P1217; Saxena A, 2002, J BIOL CHEM, V277, P35297, DOI 10.1074/jbc.M205653200; SHARP PA, 1994, CELL, V77, P805, DOI 10.1016/0092-8674(94)90130-9; SPIESS M, 1987, EMBO J, V6, P2683, DOI 10.1002/j.1460-2075.1987.tb02560.x; SPIESS M, 1985, P NATL ACAD SCI USA, V82, P6465, DOI 10.1073/pnas.82.19.6465; SPIESS M, 1985, J BIOL CHEM, V260, P1979; SPIESS M, 1986, CELL, V44, P177, DOI 10.1016/0092-8674(86)90496-4; STOCKERT RJ, 1983, HEPATOLOGY, V3, P750; STOORVOGEL W, 1987, J CELL BIOL, V104, P1261, DOI 10.1083/jcb.104.5.1261; Tian YJ, 2007, J CLIN MICROBIOL, V45, P2971, DOI 10.1128/JCM.00508-07; Tolchinsky S, 1996, J BIOL CHEM, V271, P14496, DOI 10.1074/jbc.271.24.14496; TREICHEL U, 1995, PROTEIN EXPRES PURIF, V6, P251, DOI 10.1006/prep.1995.1032; TREICHEL U, 1993, J HEPATOL, V19, P55, DOI 10.1016/S0168-8278(05)80176-X; TREICHEL U, 1990, HEPATOLOGY, V11, P606, DOI 10.1002/hep.1840110413; Treichel U, 1997, ARCH VIROL, V142, P493, DOI 10.1007/s007050050095; TYCKO B, 1983, J CELL BIOL, V97, P1762, DOI 10.1083/jcb.97.6.1762; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; WEIGEL PH, 1994, BIOESSAYS, V16, P519, DOI 10.1002/bies.950160713; Weigel PH, 2002, BBA-GEN SUBJECTS, V1572, P341, DOI 10.1016/S0304-4165(02)00318-5; YAGO H, 1995, HEPATOLOGY, V21, P383, DOI 10.1016/0270-9139(95)90096-9	42	11	13	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12934	10.1371/journal.pone.0012934	http://dx.doi.org/10.1371/journal.pone.0012934			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886072	Green Published, Green Submitted, gold			2022-12-27	WOS:000282091100033
J	Tapia, M; Wandosell, F; Garrido, JJ				Tapia, Monica; Wandosell, Francisco; Jose Garrido, Juan			Impaired Function of HDAC6 Slows Down Axonal Growth and Interferes with Axon Initial Segment Development	PLOS ONE			English	Article							KINESIN-1 MOTOR DOMAIN; HISTONE DEACETYLASE-6; MICROTUBULE STABILIZATION; TUBULIN; PROTEIN; ACETYLATION; SIRT2; TRANSPORT; DYNAMICS; BINDING	The development of morphological neuronal polarity starts by the formation and elongation of an axon. At the same time the axon initial segment (AIS) is generated and creates a diffusion barrier which differentiate axon and somatodendritic compartment. Different structural and functional proteins that contribute to the generation of neuronal action potential are concentrated at the axon initial segment. While axonal elongation is controlled by signalling pathways that regulate cytoskeleton through microtubule associated proteins and tubulin modifications, the microtubule cytoskeleton under the AIS is mostly unknown. Thus, understanding which proteins modify tubulin, where in the neuron and at which developmental stage is crucial to understanding how morphological and functional neuronal polarity is achieved. In this study performed in mice and using a well established model of murine cultured hippocampal neurons, we report that the tubulin deacetylase HDAC6 is localized at the distal region of the axon, and its inhibition with TSA or tubacin slows down axonal growth. Suppression of HDAC6 expression with HDAC6 shRNAs or expression of a non-active mutant of HDAC6 also reduces axonal length. Furthermore, HDAC6 inhibition or suppression avoids the concentration of ankyrinG and sodium channels at the axon initial segment (AIS). Moreover, treatment of mouse cultured hippocampal neurons with detergents to eliminate the soluble pool of microtubules identified a pool of detergent resistant acetylated microtubules at the AIS, not present at the rest of the axon. Inhibition or suppression of HDAC6 increases acetylation all along the axon and disrupts the specificity of AIS cytoskeleton, modifying the axonal distal gradient localization of KIF5C to a somatodendritic and axonal localization. In conclusion, our results reveal a new role of HDAC6 tubulin deacetylase as a regulator of microtubule characteristics in the axon distal region where axonal elongation takes place, and allowing the development of acetylated microtubules microdomains where HDAC6 is not concentrated, such as the axon initial segment.	[Tapia, Monica; Jose Garrido, Juan] CSIC, Inst Cajal, Dept Mol Cellular & Dev Neurobiol, E-28002 Madrid, Spain; [Tapia, Monica; Wandosell, Francisco; Jose Garrido, Juan] CSIC UAM, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Tapia, Monica; Wandosell, Francisco; Jose Garrido, Juan] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBERNED	Tapia, M (corresponding author), CSIC, Inst Cajal, Dept Mol Cellular & Dev Neurobiol, E-28002 Madrid, Spain.	jjgarrido@cajal.csic.es	Wandosell, Francisco/AAV-6391-2020; Garrido, Juan Jose/E-6782-2012; Tapia, Monica/J-3664-2018; Wandosell, Francisco/G-6105-2015	Garrido, Juan Jose/0000-0002-4499-4487; Wandosell, Francisco/0000-0001-6537-2321	Ministerio de Educacion y Ciencia e Innovacion [SAF2006-00906, SAF2009-12249-C02-02, SAF2006-12782-C03-C01, SAF2009-12249-C02-01, EU-FP7-2009-CT222887]; Centro de Investigacion Biomedica en Red de Enfermedades Neurodegenerativas (CIBERNED); CSIC	Ministerio de Educacion y Ciencia e Innovacion(Spanish Government); Centro de Investigacion Biomedica en Red de Enfermedades Neurodegenerativas (CIBERNED); CSIC	This work was supported by grants from the Ministerio de Educacion y Ciencia e Innovacion (SAF2006-00906, SAF2009-12249-C02-02 to J.J.G. and SAF2006-12782-C03-C01 and SAF2009-12249-C02-01 to F. W.) and EU-FP7-2009-CT222887; and by the Centro de Investigacion Biomedica en Red de Enfermedades Neurodegenerativas (CIBERNED). M. T. is supported by a JAE fellowship from CSIC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD FJ, 1993, J NEUROSCI, V13, P856; BAAS PW, 1990, J CELL BIOL, V111, P495, DOI 10.1083/jcb.111.2.495; BAAS PW, 1993, J NEUROSCI, V13, P2177; BROWN A, 1993, J CELL SCI, V104, P339; Brush MH, 2004, J BIOL CHEM, V279, P7685, DOI 10.1074/jbc.M310997200; Cabrero JR, 2006, MOL BIOL CELL, V17, P3435, DOI 10.1091/mbc.E06-01-0008; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Creppe C, 2009, CELL, V136, P551, DOI 10.1016/j.cell.2008.11.043; Destaing O, 2005, J CELL SCI, V118, P2901, DOI 10.1242/jcs.02425; Ding HP, 2008, J NEUROCHEM, V106, P2119, DOI 10.1111/j.1471-4159.2008.05564.x; Dunn S, 2008, J CELL SCI, V121, P1085, DOI 10.1242/jcs.026492; Gao YS, 2007, MOL CELL BIOL, V27, P8637, DOI 10.1128/MCB.00393-07; Garrido JJ, 2003, SCIENCE, V300, P2091, DOI 10.1126/science.1085167; GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Hammond JW, 2010, MOL BIOL CELL, V21, P572, DOI 10.1091/mbc.E09-01-0044; Hedstrom KL, 2008, J CELL BIOL, V183, P635, DOI 10.1083/jcb.200806112; HOBARA T, 2009, J PSYCHIAT RES; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Jacobson C, 2006, NEURON, V49, P797, DOI 10.1016/j.neuron.2006.02.005; Jiang Q, 2008, J NEUROSCI, V28, P12993, DOI 10.1523/JNEUROSCI.2860-08.2008; Garrido JJ, 2007, FEBS LETT, V581, P1579, DOI 10.1016/j.febslet.2007.03.018; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kim AH, 2009, CELL, V136, P322, DOI 10.1016/j.cell.2008.11.050; Konishi Y, 2009, NAT NEUROSCI, V12, P559, DOI 10.1038/nn.2314; Liao H, 1998, J BIOL CHEM, V273, P21901, DOI 10.1074/jbc.273.34.21901; Magnani E, 2007, EMBO J, V26, P4546, DOI 10.1038/sj.emboj.7601878; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Nakata T, 2003, J CELL BIOL, V162, P1045, DOI 10.1083/jcb.200302175; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Pandithage R, 2008, J CELL BIOL, V180, P915, DOI 10.1083/jcb.200707126; PEREZ M, 2009, J NEUROCHEM; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Rivieccio MA, 2009, P NATL ACAD SCI USA, V106, P19599, DOI 10.1073/pnas.0907935106; Sanchez-Ponce D, 2008, MOL CELL NEUROSCI, V37, P832, DOI 10.1016/j.mcn.2008.01.010; Shea TB, 1999, BRAIN RES BULL, V48, P255, DOI 10.1016/S0361-9230(98)00019-7; Song AH, 2009, CELL, V136, P1148, DOI 10.1016/j.cell.2009.01.016; Southwood CM, 2007, NEUROCHEM RES, V32, P187, DOI 10.1007/s11064-006-9127-6; Stiess M, 2010, SCIENCE, V327, P704, DOI 10.1126/science.1182179; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Winckler B, 1999, NATURE, V397, P698, DOI 10.1038/17789; Witte H, 2008, J CELL BIOL, V180, P619, DOI 10.1083/jcb.200707042; Yan JZ, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000047; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zilberman Y, 2009, J CELL SCI, V122, P3531, DOI 10.1242/jcs.046813	49	79	84	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12908	10.1371/journal.pone.0012908	http://dx.doi.org/10.1371/journal.pone.0012908			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886111	Green Published, Green Submitted, gold			2022-12-27	WOS:000282091100016
J	Vandegehuchte, ML; de la Pena, E; Bonte, D				Vandegehuchte, Martijn L.; de la Pena, Eduardo; Bonte, Dries			Relative Importance of Biotic and Abiotic Soil Components to Plant Growth and Insect Herbivore Population Dynamics	PLOS ONE			English	Article							BELOW-GROUND INTERACTIONS; GRASS AMMOPHILA-ARENARIA; ROOT-FEEDING NEMATODES; MYCORRHIZAL FUNGI; COASTAL DUNES; ENDOPARASITIC NEMATODES; PARASITIC NEMATODES; MARRAM GRASS; L LINK; COMMUNITY	Background: Plants are affected by several aspects of the soil, which have the potential to exert cascading effects on the performance of herbivorous insects. The effects of biotic and abiotic soil characteristics have however mostly been investigated in isolation, leaving their relative importance largely unexplored. Such is the case for the dune grass Ammophila, whose decline under decreasing sand accretion is argued to be caused by either biotic or abiotic soil properties. Methodology/Principal Findings: By manipulating dune soils from three different regions, we decoupled the contributions of region, the abiotic and biotic soil component to the variation in characteristics of Ammophila arenaria seedlings and Schizaphis rufula aphid populations. Root mass fraction and total dry biomass of plants were affected by soil biota, although the latter effect was not consistent across regions. None of the measured plant properties were significantly affected by the abiotic soil component. Aphid population characteristics all differed between regions, irrespective of whether soil biota were present or absent. Hence these effects were due to differences in abiotic soil properties between regions. Although several chemical properties of the soil mixtures were measured, none of these were consistent with results for plant or aphid traits. Conclusions/Significance: Plants were affected more strongly by soil biota than by abiotic soil properties, whereas the opposite was true for aphids. Our results thus demonstrate that the relative importance of the abiotic and biotic component of soils can differ for plants and their herbivores. The fact that not all effects of soil properties could be detected across regions moreover emphasizes the need for spatial replication in order to make sound conclusions about the generality of aboveground-belowground interactions.	[Vandegehuchte, Martijn L.; de la Pena, Eduardo; Bonte, Dries] Univ Ghent, Dept Biol, B-9000 Ghent, Belgium	Ghent University	Vandegehuchte, ML (corresponding author), Univ Ghent, Dept Biol, B-9000 Ghent, Belgium.	martijn.vandegehuchte@ugent.be	de la Pena, Eduardo/B-8037-2015; Bonte, Dries/AAH-3913-2021	de la Pena, Eduardo/0000-0002-6057-6664; Bonte, Dries/0000-0002-3320-7505; Vandegehuchte, Martijn L./0000-0003-1283-4654	FWO [G.0057.09N]	FWO(FWO)	The first author is a Ph.D. candidate and Eduardo de la Pena is a postdoctoral fellow of the Research Foundation - Flanders (FWO). The project is partially funded by FWO research project G.0057.09N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Bardgett RD, 1999, PLANT SOIL, V212, P23, DOI 10.1023/A:1004642218792; Bezemer TM, 2005, TRENDS ECOL EVOL, V20, P617, DOI 10.1016/j.tree.2005.08.006; Bezemer TM, 2005, ECOL LETT, V8, P652, DOI 10.1111/j.1461-0248.2005.00762.x; Blossey B, 2003, ANNU REV ENTOMOL, V48, P521, DOI 10.1146/annurev.ento.48.091801.112700; Borowicz VA, 1997, OECOLOGIA, V112, P534, DOI 10.1007/s004420050342; Boudreau S, 2001, ECOSCIENCE, V8, P392, DOI 10.1080/11956860.2001.11682667; Brinkman EP, 2005, SOIL BIOL BIOCHEM, V37, P2077, DOI 10.1016/j.soilbio.2005.03.011; Brinkman EP, 2005, NEMATOLOGY, V7, P169, DOI 10.1163/1568541054879647; Brinkman EP, 2005, OIKOS, V110, P417, DOI 10.1111/j.0030-1299.2005.13659.x; Brinkman EP, 2004, APPL SOIL ECOL, V27, P65, DOI 10.1016/j.apsoil.2004.02.004; de la Pena E, 2006, NEW PHYTOL, V169, P829, DOI 10.1111/j.1469-8137.2005.01602.x; de la Pena E, 2008, PLANT SOIL, V310, P113, DOI 10.1007/s11104-008-9636-y; de la Pena E, 2007, NEMATOLOGY, V9, P881, DOI 10.1163/156854107782331289; DEROOIJVANDERGOES PCEM, 1995, NEW PHYTOL, V129, P661, DOI 10.1111/j.1469-8137.1995.tb03035.x; ELDRED RA, 1982, CAN J BOT, V60, P1371, DOI 10.1139/b82-174; Gange AC, 1999, OECOLOGIA, V120, P123, DOI 10.1007/s004420050840; Gange AC, 1997, NEW PHYTOL, V137, P335, DOI 10.1046/j.1469-8137.1997.00813.x; Haase J, 2008, ECOLOGY, V89, P3072, DOI 10.1890/07-1983.1; Hartley SE, 2009, ANNU REV ENTOMOL, V54, P323, DOI 10.1146/annurev.ento.54.110807.090614; Hol WHG, 2007, BASIC APPL ECOL, V8, P500, DOI 10.1016/j.baae.2006.09.013; Huberty AF, 2006, OECOLOGIA, V149, P444, DOI 10.1007/s00442-006-0462-8; HUISKES AHL, 1979, J ECOL, V67, P363, DOI 10.2307/2259356; Joosten L, 2009, PLANT SOIL, V325, P133, DOI 10.1007/s11104-009-9963-7; Kaplan I, 2008, ECOL LETT, V11, P841, DOI 10.1111/j.1461-0248.2008.01200.x; Kooijman AM, 2002, J ECOL, V90, P394, DOI 10.1046/j.1365-2745.2001.00661.x; Koricheva J, 2009, ECOLOGY, V90, P2088, DOI 10.1890/08-1555.1; Kowalchuk GA, 2002, MOL ECOL, V11, P571, DOI 10.1046/j.0962-1083.2001.01457.x; Little LR, 1996, J ECOL, V84, P1, DOI 10.2307/2261694; MARSHALL JK, 1965, J ECOL, V53, P447, DOI 10.2307/2257988; MASTERS GJ, 1995, ACTA OECOL, V16, P135; McGuinness KA, 2002, AUSTRAL ECOL, V27, P681, DOI 10.1046/j.1442-9993.2002.01233.x; Neter J., 1996, APPL LINEAR STAT MOD; Newton EL, 2009, OECOLOGIA, V160, P63, DOI 10.1007/s00442-009-1281-5; Piskiewicz AM, 2008, SOIL BIOL BIOCHEM, V40, P2729, DOI 10.1016/j.soilbio.2008.07.006; Piskiewicz AM, 2009, FUNCT ECOL, V23, P621, DOI 10.1111/j.1365-2435.2008.01510.x; Poll J, 2007, FEMS MICROBIOL ECOL, V62, P268, DOI 10.1111/j.1574-6941.2007.00383.x; ROWNTREE JK, 2010, OECOLOGIA IN PRESS; Staley JT, 2008, BASIC APPL ECOL, V9, P673, DOI 10.1016/j.baae.2007.10.006; Staley JT, 2007, GLOBAL CHANGE BIOL, V13, P866, DOI 10.1111/j.1365-2486.2007.01338.x; Van der Putten WH, 1998, APPL SOIL ECOL, V10, P253, DOI 10.1016/S0929-1393(98)00124-3; Van der Putten WH, 2001, TRENDS ECOL EVOL, V16, P547, DOI 10.1016/S0169-5347(01)02265-0; van der Stoel CD, 2002, J ECOL, V90, P978, DOI 10.1046/j.1365-2745.2002.00727.x; Vandegehuchte ML, 2010, OIKOS, V119, P1011, DOI 10.1111/j.1600-0706.2009.18360.x; VANDERPUTTEN WH, 1988, OECOLOGIA, V76, P313, DOI 10.1007/BF00379970; VANDERPUTTEN WH, 1993, NATURE, V362, P53; Wall JW, 2002, BIOL FERT SOILS, V35, P293, DOI 10.1007/s00374-002-0478-0; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; WHITE TCR, 1984, OECOLOGIA, V63, P90, DOI 10.1007/BF00379790; WHITE TCR, 1978, OECOLOGIA, V33, P71, DOI 10.1007/BF00376997; WILLIS AJ, 1965, J ECOL, V53, P735, DOI 10.2307/2257632	51	23	23	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12937	10.1371/journal.pone.0012937	http://dx.doi.org/10.1371/journal.pone.0012937			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886078	gold, Green Published			2022-12-27	WOS:000282091100036
J	Degl'Innocenti, D; Alberti, C; Castellano, G; Greco, A; Miranda, C; Pierotti, MA; Seregni, E; Borrello, MG; Canevari, S; Tomassetti, A				Degl'Innocenti, Debora; Alberti, Chiara; Castellano, Giancarlo; Greco, Angela; Miranda, Claudia; Pierotti, Marco A.; Seregni, Ettore; Borrello, Maria Grazia; Canevari, Silvana; Tomassetti, Antonella			Integrated Ligand-Receptor Bioinformatic and In Vitro Functional Analysis Identifies Active TGFA/EGFR Signaling Loop in Papillary Thyroid Carcinomas	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; OVARIAN-CARCINOMA; MONOCLONAL-ANTIBODY; HUMAN THYROCYTES; EGF-RECEPTOR; CELL-LINES; CANCER; GROWTH; MECHANISMS; REVEALS	Background: Papillary thyroid carcinoma (PTCs), the most frequent thyroid cancer, is usually not life threatening, but may recur or progress to aggressive forms resistant to conventional therapies. A more detailed understanding of the signaling pathways activated in PTCs may help to identify novel therapeutic approaches against these tumors. The aim of this study is to identify signaling pathways activated in PTCs. Methodology/Principal Findings: We examined coordinated gene expression patterns of ligand/receptor (L/R) pairs using the L/R database DRLP-rev1 and five publicly available thyroid cancer datasets of gene expression on a total of 41 paired PTC/normal thyroid tissues. We identified 26 (up) and 13 (down) L/R pairs coordinately and differentially expressed. The relevance of these L/R pairs was confirmed by performing the same analysis on REarranged during Transfection (RET)/PTC1-infected thyrocytes with respect to normal thyrocytes. TGFA/EGFR emerged as one of the most tightly regulated L/R pair. Furthermore, PTC clinical samples analyzed by real-time RT-PCR expressed EGFR transcript levels similar to those of 5 normal thyroid tissues from patients with pathologies other than thyroid cancer, whereas significantly elevated levels of TGFA transcripts were only present in PTCs. Biochemical analysis of PTC cell lines demonstrated the presence of EGFR on the cell membrane and TGFA in conditioned media. Moreover, conditioned medium of the PTC cell line NIM-1 activated EGFR expressed on HeLa cells, culminating in both ERK and AKT phosphorylation. In NIM-1 cells harboring BRAF mutation, TGFA stimulated proliferation, contributing to P13K/AKT activation independent of MEK/ERK signaling. Conclusions/Significance: We compiled a reliable list of L/R pairs associated with PTC and validated the biological role of one of the emerged L/R pair, the TGFA/EGFR, in this cancer, in vitro. These data provide a better understanding of the factors involved in the biology of PTCs and would be useful in developing combination therapeutic approaches against these cancers.	[Degl'Innocenti, Debora; Alberti, Chiara; Castellano, Giancarlo; Greco, Angela; Miranda, Claudia; Pierotti, Marco A.; Seregni, Ettore; Borrello, Maria Grazia; Canevari, Silvana; Tomassetti, Antonella] Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Milan, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan	Degl'Innocenti, D (corresponding author), Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Milan, Italy.	mariagrazia.borrello@istitutotumori.mi.it; silvana.canevari@istitutotumori.mi.it	Borrello, Maria Grazia/C-3161-2017; Seregni, Ettore/C-2597-2017; Tomassetti, Antonella/G-7906-2015; Pierotti, Marco Alessandro/AAC-4728-2022; Greco, Angela/C-1953-2017	Borrello, Maria Grazia/0000-0002-6854-2848; Seregni, Ettore/0000-0002-5097-049X; Tomassetti, Antonella/0000-0001-6772-9937; Pierotti, Marco Alessandro/0000-0002-7431-8332; Greco, Angela/0000-0003-2994-0349; Castellano, Giancarlo/0000-0002-5715-7733	Ministry of Health, Grant Alleanza contro il Cancro (ACC); Fondo per gli Investimenti della Ricerca di Base (FIRB) [RBIPO6LCA9]; Programma Integrato in Oncologia (PIO) [RFPS-2006-2-3491988.4]; Associazione Italiana per la Ricerca sul Cancro (AIRC)	Ministry of Health, Grant Alleanza contro il Cancro (ACC); Fondo per gli Investimenti della Ricerca di Base (FIRB)(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Programma Integrato in Oncologia (PIO); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by grants from Ministry of Health, Grant Alleanza contro il Cancro (ACC) to S. C., Fondo per gli Investimenti della Ricerca di Base (FIRB) n. RBIPO6LCA9 to M. A. P. and Programma Integrato in Oncologia (PIO) n. RFPS-2006-2-3491988.4 to A. T., and from Associazione Italiana per la Ricerca sul Cancro (AIRC) to A. G. and S. C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldred MA, 2004, J CLIN ONCOL, V22, P3531, DOI 10.1200/JCO.2004.08.127; Bernard DJ, 2001, RECENT PROG HORM RES, V56, P417, DOI 10.1210/rp.56.1.417; Borrello MG, 2005, P NATL ACAD SCI USA, V102, P14825, DOI 10.1073/pnas.0503039102; Cassinelli G, 2009, NEOPLASIA, V11, P10, DOI 10.1593/neo.08916; Castellano G, 2006, CANCER RES, V66, P10709, DOI 10.1158/0008-5472.CAN-06-1327; Castellone MD, 2008, BEST PRACT RES CL EN, V22, P1023, DOI 10.1016/j.beem.2008.09.012; Castellone MD, 2004, ONCOGENE, V23, P5958, DOI 10.1038/sj.onc.1207790; Croyle M, 2008, CANCER RES, V68, P4183, DOI 10.1158/0008-5472.CAN-08-0413; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; De Santis G, 2009, ONCOGENE, V28, P1206, DOI 10.1038/onc.2008.470; Delys L, 2007, ONCOGENE, V26, P7894, DOI 10.1038/sj.onc.1210588; Frattini M, 2004, ONCOGENE, V23, P7436, DOI 10.1038/sj.onc.1207980; Giordano TJ, 2005, ONCOGENE, V24, P6646, DOI 10.1038/sj.onc.1208822; GORGOULIS V, 1992, In Vivo (Attiki), V6, P291; Graeber TG, 2001, NAT GENET, V29, P295, DOI 10.1038/ng755; Greco A, 2009, Q J NUCL MED MOL IM, V53, P440; Griffith OL, 2006, J CLIN ONCOL, V24, P5043, DOI 10.1200/JCO.2006.06.7330; Guarino V, 2005, J CLIN ENDOCR METAB, V90, P5270, DOI 10.1210/jc.2005-0271; Hancox RA, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2251; Handkiewicz-Junak D, 2010, MOL CELL ENDOCRINOL, V322, P8, DOI 10.1016/j.mce.2010.01.007; Harding J, 2005, DRUG TODAY, V41, P107, DOI 10.1358/dot.2005.41.2.882662; HAUGEN DRF, 1993, INT J CANCER, V55, P37, DOI 10.1002/ijc.2910550108; Huang Y, 2001, P NATL ACAD SCI USA, V98, P15044, DOI 10.1073/pnas.251547398; Hundahl SA, 1998, CANCER-AM CANCER SOC, V83, P2638, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1; Jarzab B, 2005, CANCER RES, V65, P1587, DOI 10.1158/0008-5472.CAN-04-3078; LEMOINE NR, 1989, BRIT J CANCER, V60, P897, DOI 10.1038/bjc.1989.387; Madshus IH, 2009, J CELL SCI, V122, P3433, DOI 10.1242/jcs.050260; Middendorp M, 2010, SEMIN NUCL MED, V40, P145, DOI 10.1053/j.semnuclmed.2009.10.006; Nikiforova MN, 2008, EXPERT REV MOL DIAGN, V8, P83, DOI 10.1586/14737159.8.1.83; Pennell NA, 2008, THYROID, V18, P317, DOI 10.1089/thy.2007.0120; Sanna E, 2007, EXP CELL RES, V313, P1307, DOI 10.1016/j.yexcr.2007.02.005; Schneider MR, 2009, J CELL PHYSIOL, V218, P460, DOI 10.1002/jcp.21635; Schweppe RE, 2008, J CLIN ENDOCR METAB, V93, P4331, DOI 10.1210/jc.2008-1102; Smalley KSM, 2009, CANCER RES, V69, P3241, DOI 10.1158/0008-5472.CAN-08-4305; TOHYAMA K, 1992, JPN J CANCER RES, V83, P153, DOI 10.1111/j.1349-7006.1992.tb00080.x; Tomassetti A, 2003, CANCER RES, V63, P696; TOSI E, 1995, INT J CANCER, V62, P643, DOI 10.1002/ijc.2910620525; Ulisse S, 2006, EUR J CANCER, V42, P2631, DOI 10.1016/j.ejca.2006.04.017; Vasko V, 2007, P NATL ACAD SCI USA, V104, P2803, DOI 10.1073/pnas.0610733104; Westermark K, 1996, HISTOPATHOLOGY, V28, P221, DOI 10.1046/j.1365-2559.1996.d01-427.x	40	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12701	10.1371/journal.pone.0012701	http://dx.doi.org/10.1371/journal.pone.0012701			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877637	gold, Green Submitted, Green Published			2022-12-27	WOS:000282053100005
J	Ranjith-Kumar, CT; Lai, Y; Sarisky, RT; Kao, CC				Ranjith-Kumar, C. T.; Lai, Yvonne; Sarisky, Robert T.; Kao, C. Cheng			Green Tea Catechin, Epigallocatechin Gallate, Suppresses Signaling by the dsRNA Innate Immune Receptor RIG-I	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; B KINASE-ACTIVITY; T-CELL-RECEPTOR; KAPPA-B; ANTIVIRAL RESPONSES; STRANDED-RNA; POLYPHENOL; (-)-EPIGALLOCATECHIN-3-GALLATE; LIPOPOLYSACCHARIDE; ACTIVATION	Background: The Innate immune system constitutes the first line of defense against pathogen infections. The Retinoic acid-inducible gene I (RIG-I) receptor recognizes triphosphorylated ssRNAs and dsRNA to initiate downstream signaling of interferon response. However, unregulated activity of these receptors could lead to autoimmune diseases. We seek to identify small molecules that can specifically regulate RIG-I signaling. Methodology/Principal Findings: Epigallocatechin gallate (EGCG), a polyphenolic catechin present in green tea, was identified in a small molecule screen. It was found to bind RIG-I and inhibits its signaling at low micromolar concentrations in HEK293T cells. Furthermore, EGCG dose-dependently inhibited the ATPase activity of recombinant RIG-I but did not compete with RIG-I interaction with RNA or with ATP. EGCG did not inhibit signaling by Toll-like receptors 3, 4, 9 or constitutive signaling by the adapter protein IPS-1. Structure activity relationship analysis showed that EGCG, its epimer GCG and a digallate-containing compound, theaflavin 3,3' digallate (TFDG) were potent RIG-I inhibitors. EGCG also inhibited IL6 secretion and IFN- beta mRNA synthesis in BEAS-2B cells, which harbors intact endogenous RIG-I signaling pathway. Conclusions/Significance: EGCG and its derivatives could have potential therapeutic use as a modulator of RIG-I mediated immune responses.	[Ranjith-Kumar, C. T.; Lai, Yvonne; Kao, C. Cheng] Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA; [Sarisky, Robert T.] Johnson & Johnson, Pharmaceut Res & Dev, Raritan, NJ USA	Indiana University System; Indiana University Bloomington; Johnson & Johnson; Johnson & Johnson USA	Ranjith-Kumar, CT (corresponding author), Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA.	ctrkumar@indiana.edu	Kumar CT, Ranjith/J-5701-2016; Mackie, Ken/E-3384-2013		NIH [RAI075015A]; Johnson and Johnson Pharmaceuticals; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI075015] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johnson and Johnson Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	CK acknowledges NIH grant RAI075015A that partially supported members of the laboratory and a gift from Johnson & Johnson Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded in part by an unrestricted research grant from Johnson and Johnson Pharmaceuticals, where J&J does not have any restriction for the research direction, the use of reagents, the interpretation of the results, or any claim for intellectual property.	Chyu KY, 2004, CIRCULATION, V109, P2448, DOI 10.1161/01.CIR.0000128034.70732.C2; Crespy V, 2004, J NUTR, V134, p3431S, DOI 10.1093/jn/134.12.3431S; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Ermakova S, 2005, J BIOL CHEM, V280, P16882, DOI 10.1074/jbc.M414185200; Ermakova SP, 2006, CANCER RES, V66, P9260, DOI 10.1158/0008-5472.CAN-06-1586; Hayakawa S, 2001, BIOCHEM BIOPH RES CO, V285, P1102, DOI 10.1006/bbrc.2001.5293; Hirao K, 2010, LIFE SCI, V86, P654, DOI 10.1016/j.lfs.2010.02.017; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Le Goffic R, 2007, J IMMUNOL, V178, P3368, DOI 10.4049/jimmunol.178.6.3368; Lee KM, 2004, HELICOBACTER, V9, P632, DOI 10.1111/j.1083-4389.2004.00281.x; Li XJ, 2009, J BIOL CHEM, V284, P13881, DOI 10.1074/jbc.M900818200; Lu C, 2010, STRUCTURE, V18, P1032, DOI 10.1016/j.str.2010.05.007; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Pan MH, 2000, BIOCHEM PHARMACOL, V59, P357, DOI 10.1016/S0006-2952(99)00335-4; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Ranjith-Kumar CT, 2008, MOL CELL BIOL, V28, P4507, DOI 10.1128/MCB.00308-08; Ranjith-Kumar CT, 2009, J BIOL CHEM, V284, P1155, DOI 10.1074/jbc.M806219200; Ronnblom L, 2008, LUPUS, V17, P394, DOI 10.1177/0961203308090020; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Samanta M, 2006, EMBO J, V25, P4207, DOI 10.1038/sj.emboj.7601314; Schlee M, 2009, IMMUNOL REV, V227, P66, DOI 10.1111/j.1600-065X.2008.00724.x; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shim JH, 2008, J BIOL CHEM, V283, P28370, DOI 10.1074/jbc.M802200200; Suzuki Y, 2001, CANCER LETT, V173, P15, DOI 10.1016/S0304-3835(01)00685-1; Tachibana H, 2004, NAT STRUCT MOL BIOL, V11, P380, DOI 10.1038/nsmb743; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Uzri D, 2009, J VIROL, V83, P4174, DOI 10.1128/JVI.02449-08; Veranth JM, 2004, TOXICOL SCI, V82, P88, DOI 10.1093/toxsci/kfh248; Williamson MP, 2006, J ALLERGY CLIN IMMUN, V118, P1369, DOI 10.1016/j.jaci.2006.08.016; Yang CS, 2002, ANNU REV PHARMACOL, V42, P25, DOI 10.1146/annurev.pharmtox.42.082101.154309; Yang FJ, 2001, MOL PHARMACOL, V60, P528; Yang FJ, 1998, J NUTR, V128, P2334, DOI 10.1093/jn/128.12.2334; Yoneyama M, 2007, J BIOL CHEM, V282, P15315, DOI 10.1074/jbc.R700007200; Youn HS, 2006, BIOCHEM PHARMACOL, V72, P850, DOI 10.1016/j.bcp.2006.06.021	39	25	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12878	10.1371/journal.pone.0012878	http://dx.doi.org/10.1371/journal.pone.0012878			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877565	Green Published, Green Submitted, gold			2022-12-27	WOS:000282053100026
J	Eduati, F; Corradin, A; Di Camillo, B; Toffolo, G				Eduati, Federica; Corradin, Alberto; Di Camillo, Barbara; Toffolo, Gianna			A Boolean Approach to Linear Prediction for Signaling Network Modeling	PLOS ONE			English	Article								The task of the DREAM4 (Dialogue for Reverse Engineering Assessments and Methods) "Predictive signaling network modeling" challenge was to develop a method that, from single-stimulus/inhibitor data, reconstructs a cause-effect network to be used to predict the protein activity level in multi-stimulus/inhibitor experimental conditions. The method presented in this paper, one of the best performing in this challenge, consists of 3 steps: 1. Boolean tables are inferred from singlestimulus/inhibitor data to classify whether a particular combination of stimulus and inhibitor is affecting the protein. 2. A cause-effect network is reconstructed starting from these tables. 3. Training data are linearly combined according to rules inferred from the reconstructed network. This method, although simple, permits one to achieve a good performance providing reasonable predictions based on a reconstructed network compatible with knowledge from the literature. It can be potentially used to predict how signaling pathways are affected by different ligands and how this response is altered by diseases.	[Eduati, Federica; Corradin, Alberto; Di Camillo, Barbara; Toffolo, Gianna] Univ Padua, Dept Informat Engn, Padua, Italy	University of Padua	Eduati, F (corresponding author), Univ Padua, Dept Informat Engn, Padua, Italy.	toffolo@dei.unipd.it	Di Camillo, Barbara/L-3202-2013; Eduati, Federica/AAH-6526-2021	Di Camillo, Barbara/0000-0001-8415-4688; Eduati, Federica/0000-0002-7822-3867	Cariparo [2008/2010]	Cariparo(Fondazione Cariparo)	Funding was provided by Cariparo project 2008/2010 Systems Biology approaches to infer gene regulation from gene and protein time series data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos LG, 2010, MOL CELL PROTEOMICS, V9, P1849, DOI 10.1074/mcp.M110.000406; COBELLI C, 2000, TRACER KINETICS BIOM; Di Camillo B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S4-S11; Di Camillo B, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S1-S10; Jones D, 2008, NAT REV DRUG DISCOV, V7, P874, DOI 10.1038/nrd2748; Li F, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000292; Mitsos A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000591; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Saez-Rodriguez J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.87; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102	10	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2010	5	9							e12789	10.1371/journal.pone.0012789	http://dx.doi.org/10.1371/journal.pone.0012789			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650QH	20862273	gold, Green Submitted, Green Published			2022-12-27	WOS:000281864100022
J	Gessmann, R; Kourtis, N; Petratos, K; Tavernarakis, N				Gessmann, Renate; Kourtis, Nikos; Petratos, Kyriacos; Tavernarakis, Nektarios			Molecular Modeling of Mechanosensory Ion Channel Structural and Functional Features	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; HYDROPHOBIC MOMENT; PROTEIN STRUCTURES; DEG/ENAC CHANNEL; C-ELEGANS; MEC-4; TRANSMEMBRANE; SUBUNIT; FAMILY; MECHANOTRANSDUCTION	The DEG/ENaC (Degenerin/Epithelial Sodium Channel) protein family comprises related ion channel subunits from all metazoans, including humans. Members of this protein family play roles in several important biological processes such as transduction of mechanical stimuli, sodium re-absorption and blood pressure regulation. Several blocks of amino acid sequence are conserved in DEG/ENaC proteins, but structure/function relations in this channel class are poorly understood. Given the considerable experimental limitations associated with the crystallization of integral membrane proteins, knowledge-based modeling is often the only route towards obtaining reliable structural information. To gain insight into the structural characteristics of DEG/ENaC ion channels, we derived three-dimensional models of MEC-4 and UNC-8, based on the available crystal structures of ASIC1 (Acid Sensing Ion Channel 1). MEC-4 and UNC-8 are two DEG/ENaC family members involved in mechanosensation and proprioception respectively, in the nematode Caenorhabditis elegans. We used these models to examine the structural effects of specific mutations that alter channel function in vivo. The trimeric MEC-4 model provides insight into the mechanism by which gain-of-function mutations cause structural alterations that result in increased channel permeability, which trigger cell degeneration. Our analysis provides an introductory framework to further investigate the multimeric organization of the DEG/ENaC ion channel complex.	[Gessmann, Renate; Kourtis, Nikos; Petratos, Kyriacos; Tavernarakis, Nektarios] Fdn Res & Technol, Inst Mol Biol & Biotechnol, Iraklion, Crete, Greece		Gessmann, R (corresponding author), Fdn Res & Technol, Inst Mol Biol & Biotechnol, Iraklion, Crete, Greece.	tavernarakis@imbb.forth.gr	Tavernarakis, Nektarios/B-9684-2013; Petratos, Kyriacos/AAV-9957-2021	Tavernarakis, Nektarios/0000-0002-5253-1466; Petratos, Kyriacos/0000-0003-0876-1835	European Commission [LSHM-CT-2005-19063]; Manasaki scholarship	European Commission(European CommissionEuropean Commission Joint Research Centre); Manasaki scholarship	This work was supported by the European Commission Coordination Action ENINET (contract number LSHM-CT-2005-19063). N.K. is a recipient of a Manasaki scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baud F, 1999, P NATL ACAD SCI USA, V96, P12494, DOI 10.1073/pnas.96.22.12494; Benos DJ, 1999, J PHYSIOL-LONDON, V520, P631, DOI 10.1111/j.1469-7793.1999.00631.x; Brown AL, 2007, J GEN PHYSIOL, V129, P161, DOI 10.1085/jgp.200609672; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; EISENBERG D, 1982, NATURE, V299, P371, DOI 10.1038/299371a0; EISENBERG D, 1984, P NATL ACAD SCI-BIOL, V81, P140, DOI 10.1073/pnas.81.1.140; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hong K, 2000, J NEUROSCI, V20, P2575; HONG KS, 1994, NATURE, V367, P470, DOI 10.1038/367470a0; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Liu W, 2004, J MOL BIOL, V337, P713, DOI 10.1016/j.jmb.2004.02.001; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Royal DC, 2005, J BIOL CHEM, V280, P41976, DOI 10.1074/jbc.M510732200; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Senes A, 2007, J MOL BIOL, V366, P436, DOI 10.1016/j.jmb.2006.09.020; Syntichaki P, 2004, PHYSIOL REV, V84, P1097, DOI 10.1152/physrev.00043.2003; Tavernarakis N, 1997, NEURON, V18, P107, DOI 10.1016/S0896-6273(01)80050-7; Tavernarakis N, 2001, ANN NY ACAD SCI, V940, P28; Tavernarakis N, 2001, CURR BIOL, V11, pR205, DOI 10.1016/S0960-9822(01)00106-3; Tavernarakis N, 2000, J NEUROGENET, V13, P257, DOI 10.3109/01677060009084497; Waldmann R, 1999, ANN NY ACAD SCI, V868, P67, DOI 10.1111/j.1749-6632.1999.tb11274.x; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014	29	8	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2010	5	9							e12814	10.1371/journal.pone.0012814	http://dx.doi.org/10.1371/journal.pone.0012814			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650QH	20877470	Green Submitted, gold, Green Published			2022-12-27	WOS:000281864100027
J	Gossens, K; Naus, S; Hollander, GA; Ziltener, HJ				Gossens, Klaus; Naus, Silvia; Hollaender, Georg A.; Ziltener, Hermann J.			Deficiency of the Metalloproteinase-Disintegrin ADAM8 Is Associated with Thymic Hyper-Cellularity	PLOS ONE			English	Article							CELL-MIGRATION; THYMOCYTE DEVELOPMENT; EPITHELIAL-CELLS; T-CELL; EXPRESSION; MICE; MICROENVIRONMENTS; PROGENITORS; ADHESION; DIFFERENTIATION	Background: Thymopoiesis requires thymocyte-stroma interactions and proteases that promote cell migration by degrading extracellular matrix and releasing essential cytokines and chemokines. A role for several members of the A Disintegrin and Metalloprotease (ADAM) family in T cell development has been reported in the past. Methodology/Principal Findings: Here, we present data indicating that the family member ADAM8 plays a role in thymic T cell development. We used qrtPCR on FACS sorted thymic subsets together with immunofluorescene to analyze thymic ADAM8 expression. We found that ADAM8 was expressed in murine thymic stromal cells and at lower levels in thymocytes where its expression increased as cell matured, suggesting involvement of ADAM8 in thymopoiesis. Further flow cytometry analysis revealed that ADAM8 deficient mice showed normal development and expansion of immature thymocyte subsets. There was however an intrathymic accumulation of single positive CD4 and CD8 T cells which was most noticeable in the late mature T cell subsets. Accumulation of single positive T cells coincided with changes in the thymic architecture manifest in a decreased cortex/medulla ratio and an increase in medullary epithelial cells as determined by histology and flow cytometry. The increase in single positive T cells was thymus-intrinsic, independent of progenitor homing to the thymus or thymic exit rate of mature T cells. Chemotaxis assays revealed that ADAM8 deficiency was associated with reduced migration of single positive thymocytes towards CCL21. Conclusions/Significance: Our results show that ADAM8 is involved in T cell maturation in the medulla and suggest a role for this protease in fine-tuning maturation of thymocytes in the medulla. In contrast to ADAM10 and ADAM17 lack of ADAM8 appears to have a relatively minor impact on T cell development, which was unexpected given that maturation of thymocytes is dependent on proper localization and timing of migration.	[Gossens, Klaus; Naus, Silvia; Ziltener, Hermann J.] Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada; [Ziltener, Hermann J.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Gossens, Klaus; Naus, Silvia; Hollaender, Georg A.] Univ Basel, Dept Biomed, Lab Pediat Immunol, Basel, Switzerland; [Gossens, Klaus; Naus, Silvia; Hollaender, Georg A.] Univ Childrens Hosp UKBB, Basel, Switzerland	University of British Columbia; University of British Columbia; University of Basel	Gossens, K (corresponding author), Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada.	hermann@brc.ubc.ca		Hollander, Georg/0000-0002-8790-0874	Canadian Institutes of Health Research [MOP-64267, MOP-77552]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Supported by Grants MOP-64267 and MOP-77552 (to H.J.Z.) from the Canadian Institutes of Health Research. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfandari D, 2001, CURR BIOL, V11, P918, DOI 10.1016/S0960-9822(01)00263-9; Diestel S, 2005, J NEUROCHEM, V95, P1777, DOI 10.1111/j.1471-4159.2005.03475.x; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Ehrlich LIR, 2009, IMMUNITY, V31, P986, DOI 10.1016/j.immuni.2009.09.020; Foss DL, 2001, J EXP MED, V193, P365, DOI 10.1084/jem.193.3.365; Gomez-Gaviro M, 2007, J IMMUNOL, V178, P8053, DOI 10.4049/jimmunol.178.12.8053; Gossens K, 2009, J EXP MED, V206, P761, DOI 10.1084/jem.20082502; Gray DHD, 2008, J IMMUNOL METHODS, V329, P56, DOI 10.1016/j.jim.2007.09.010; Griffith AV, 2009, IMMUNITY, V31, P999, DOI 10.1016/j.immuni.2009.09.024; Haidl ID, 2006, SCAND J IMMUNOL, V64, P280, DOI 10.1111/j.1365-3083.2006.01820.x; Haidl ID, 2002, GENE, V283, P163, DOI 10.1016/S0378-1119(01)00871-X; Hikosaka Y, 2008, IMMUNITY, V29, P438, DOI 10.1016/j.immuni.2008.06.018; Irla M, 2008, IMMUNITY, V29, P451, DOI 10.1016/j.immuni.2008.08.007; Ishikawa N, 2004, CLIN CANCER RES, V10, P8363, DOI 10.1158/1078-0432.CCR-04-1436; Johansson MW, 2004, AM J RESP CELL MOL, V31, P413, DOI 10.1165/rcmb.2004-0099OC; Kelly K, 2005, DEV DYNAM, V232, P221, DOI 10.1002/dvdy.20221; KUBBUTAT MHG, 1994, J CLIN PATHOL, V47, P524, DOI 10.1136/jcp.47.6.524; Li NY, 2007, J IMMUNOL, V178, P4214, DOI 10.4049/jimmunol.178.7.4214; Lind EF, 2001, J EXP MED, V194, P127, DOI 10.1084/jem.194.2.127; Manilay JO, 2005, J IMMUNOL, V174, P6732, DOI 10.4049/jimmunol.174.11.6732; McCaughtry TM, 2008, J EXP MED, V205, P2575, DOI 10.1084/jem.20080866; McCusker C, 2009, MOL BIOL CELL, V20, P78, DOI 10.1091/mbc.E08-05-0535; Mechtersheimer S, 2001, J CELL BIOL, V155, P661, DOI 10.1083/jcb.200101099; Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010; Naus S, 2004, J BIOL CHEM, V279, P16083, DOI 10.1074/jbc.M400560200; Nous S, 2010, AM J RESP CRIT CARE, V181, P1318, DOI 10.1164/rccm.200909-1396OC; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Porritt HE, 2004, IMMUNITY, V20, P735, DOI 10.1016/j.immuni.2004.05.004; Prockop SE, 2004, J IMMUNOL, V173, P1604, DOI 10.4049/jimmunol.173.3.1604; Rao HW, 2006, J BONE MINER RES, V21, P1657, DOI 10.1359/JBMR.060718; Richens J, 2007, IMMUNOBIOLOGY, V212, P29, DOI 10.1016/j.imbio.2006.06.012; Rossi FMV, 2005, NAT IMMUNOL, V6, P626, DOI 10.1038/ni1203; Schlomann U, 2002, J BIOL CHEM, V277, P48210, DOI 10.1074/jbc.M203355200; SCOLLAY RG, 1980, EUR J IMMUNOL, V10, P210, DOI 10.1002/eji.1830100310; Tian L, 2008, INT IMMUNOL, V20, P1181, DOI 10.1093/intimm/dxn076; Valkovskaya N, 2007, J CELL MOL MED, V11, P1162, DOI 10.1111/j.1582-4934.2007.00082.x; Wildeboer D, 2006, J NEUROPATH EXP NEUR, V65, P516, DOI 10.1097/01.jnen.0000229240.51490.d3; YOSHIDA S, 1990, INT IMMUNOL, V2, P585, DOI 10.1093/intimm/2.6.585; Yoshiyama K, 1997, GENOMICS, V41, P56, DOI 10.1006/geno.1997.4607; Zack MD, 2009, ARTHRITIS RHEUM-US, V60, P2704, DOI 10.1002/art.24753	43	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12766	10.1371/journal.pone.0012766	http://dx.doi.org/10.1371/journal.pone.0012766			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856819	Green Published, Green Submitted, gold			2022-12-27	WOS:000281815800028
J	Khan, E; Kisat, M; Khan, N; Nasir, A; Ayub, S; Hasan, R				Khan, Erum; Kisat, Mehreen; Khan, Nabil; Nasir, Amna; Ayub, Salma; Hasan, Rumina			Demographic and Clinical Features of Dengue Fever in Pakistan from 2003-2007: A Retrospective Cross-Sectional Study	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; KARACHI; EPIDEMIOLOGY; DEFINITION; OUTBREAK; VIRUS	Background: Demographic features of dengue fever have changed tremendously in Pakistan over the past two decades. Small scale studies from all over the country have reported different aspects of individual outbreaks during this time. However, there is scarcity of data looking at the overall trend of dengue virus infection in the country. In this study, we examined annual trends, seasonality, and clinical features of dengue fever in the Pakistani population. Methods: Demographic information and dengue IgM status of all patients tested for dengue IgM antibody at Aga Khan University Hospital from January 2003 to December 2007 were analyzed to look for trends of IgM-positive cases in Pakistan. In addition, clinical and biochemical parameters were abstracted retrospectively from medical records of all patients hospitalized with IgM-proven dengue fever between January 2006 and December 2007. These patients were categorized into dengue fever and dengue hemorrhagic fever according to the WHO severity grading scale. Results: Out of a total of 15040 patients (63.2% male and 36.8% female), 3952 (26.3%) tested positive for dengue IgM antibody. 209 IgM proven dengue patients were hospitalized during the study period. During 2003, IgM positive cases were seen only during the months of July-December. In contrast, such cases were detected throughout the year from the 2004-2007. The median age of IgM positive patients decreased every year from 32.0 years in 2003 to 24.0 years in 2007 (p<0.001). Among hospitalized patients, nausea was the most common presenting feature found in 124/209 (59.3%) patients. Children presented with a higher median body temperature than adults (p=0.010). In addition, neutropenia was seen more commonly in children while raised serum ALT levels were seen more commonly in adults (both p=0.006). While a low total white cell count was more common in patients with dengue fever as compared to Dengue Hemorrhagic Fever (p=0.020), neutropenia (p=0.019), monocytosis (p=0.001) and raised serum ALT level (p=0.005) were observed more commonly in the latter group. Conclusions: Dengue virus is now endemic in Pakistan, circulating throughout the year with a peak incidence in the post monsoon period. Median age of dengue patients has decreased and younger patients may be more susceptible. Total and differential leukocyte counts may help identify patients at risk of hemorrhage.	[Khan, Erum; Khan, Nabil; Nasir, Amna; Ayub, Salma; Hasan, Rumina] Aga Khan Univ Hosp, Dept Pathol & Microbiol, Karachi, Pakistan; [Kisat, Mehreen] Aga Khan Univ Hosp, Coll Med, Karachi, Pakistan	Aga Khan University; Aga Khan University	Khan, E (corresponding author), Aga Khan Univ Hosp, Dept Pathol & Microbiol, Karachi, Pakistan.	erum.khan@aku.edu	Hasan, Rumina/F-4420-2015		Higher Education Commission/Ministry of Science and Technology, Islamabad, Pakistan; United States Agency for International Development (USAID) Islamabad, Pakistan; University Research Council, Aga Khan University Hospital, Pakistan	Higher Education Commission/Ministry of Science and Technology, Islamabad, Pakistan; United States Agency for International Development (USAID) Islamabad, Pakistan(United States Agency for International Development (USAID)); University Research Council, Aga Khan University Hospital, Pakistan	This work was supported in part through a grant from the Joint Pakistan-United States Academic and Research Program, Higher Education Commission/Ministry of Science and Technology, Islamabad, Pakistan; United States Agency for International Development (USAID) Islamabad, Pakistan; and University Research Council, Aga Khan University Hospital, Pakistan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akram Dure Samin, 1998, Indian Journal of Pediatrics, V65, P735, DOI 10.1007/BF02731055; Chan YC, 1995, T ROY SOC TROP MED H, V89, P619, DOI 10.1016/0035-9203(95)90412-3; Chuang Vivien W. M., 2008, Hong Kong Medical Journal, V14, P170; DE SOUZA LJ, 2007, BRAZ J INFECT DIS, V11, P407; DIETZ VJ, 1992, B WORLD HEALTH ORGAN, V70, P745; Gibbons RV, 2002, BMJ-BRIT MED J, V324, P1563, DOI 10.1136/bmj.324.7353.1563; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Gupta E, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-92; Guzman MG, 2003, J CLIN VIROL, V27, P1, DOI 10.1016/S1386-6532(03)00010-6; Jamil B, 2007, EMERG INFECT DIS, V13, P182, DOI 10.3201/eid1301.060376; Keating J, 2001, SOC SCI MED, V53, P1587, DOI 10.1016/S0277-9536(00)00443-3; Khan E, 2008, J CLIN VIROL, V43, P176, DOI 10.1016/j.jcv.2008.06.003; Khan E, 2007, T ROY SOC TROP MED H, V101, P1114, DOI 10.1016/j.trstmh.2007.06.016; Murgue B, 1999, TROP MED INT HEALTH, V4, P765, DOI 10.1046/j.1365-3156.1999.00478.x; Paul R E, 1998, Int J Infect Dis, V2, P197, DOI 10.1016/S1201-9712(98)90052-2; Petersen LR, 2005, J TRAVEL MED, V12, pS3; POTTS JA, 2008, TROP MED INT HLTH; PREMARATNA R, 2008, T R SOC TROP MED HYG; Srikiatkhachorn A, 2010, CLIN INFECT DIS, V50, P1135, DOI 10.1086/651268; Strobel M, 2001, REV MED INTERNE, V22, P638, DOI 10.1016/S0248-8663(01)00401-5; SUMARMO, 1987, Southeast Asian Journal of Tropical Medicine and Public Health, V18, P269; Thomas Stephen J, 2003, Adv Virus Res, V61, P235, DOI 10.1016/S0065-3527(03)61006-7; Tripathi P, 2008, INDIAN PEDIATR, V45, P315; World Health Organization, 1997, DENG HEM FEV DIAGN T, V2nd; Ying Ruo-su, 2007, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V21, P123	25	78	81	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2010	5	9							e12505	10.1371/journal.pone.0012505	http://dx.doi.org/10.1371/journal.pone.0012505			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648ZZ	20856935	gold, Green Published, Green Submitted			2022-12-27	WOS:000281735700003
J	Yu, YL; Zeng, PY; Xiong, JB; Liu, ZY; Berger, SL; Merlino, G				Yu, Yanlin; Zeng, Pingyao; Xiong, Jingbo; Liu, Ziyang; Berger, Shelley L.; Merlino, Glenn			Epigenetic Drugs Can Stimulate Metastasis through Enhanced Expression of the Pro-Metastatic Ezrin Gene	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENES; ERM PROTEINS; PROSTATE-CANCER; DNA METHYLATION; CARCINOMA CELLS; MELANOMA-CELLS; LINKER EZRIN; THERAPY; MIGRATION; MECHANISM	Ezrin has been reported to be upregulated in many tumors and to participate in metastatic progression. No study has addressed epigenetic modification in the regulation of Ezrin gene expression, the importance of which is unknown. Here, we report that highly metastatic rhabdomyosarcoma (RMS) cells with high levels of Ezrin have elevated acetyl-H3-K9 and tri-methyl-H3-K4 as well as reduced DNA methylation at the Ezrin gene promoter. Conversely, poorly metastatic RMS cells with low levels of Ezrin have reduced acetyl-H3-K9 and elevated methylation. Thus epigenetic covalent modifications to histones within nucleosomes of the Ezrin gene promoter are linked to Ezrin expression, which in fact can be regulated by epigenetic mechanisms. Notably, treatment with histone deacetylase (HDAC) inhibitors or DNA demethylating agents could restore Ezrin expression and stimulate the metastatic potential of poorly metastatic RMS cells characterized by low Ezrin levels. However, the ability of epigenetic drugs to stimulate metastasis in RMS cells was inhibited by expression of an Ezrin-specific shRNA. Our data demonstrate the potential risk associated with clinical application of broadly acting covalent epigenetic modifiers, and highlight the value of combination therapies that include agents specifically targeting potent pro-metastatic genes.	[Yu, Yanlin; Liu, Ziyang; Merlino, Glenn] NCI, Lab Canc Biol & Genet, NIH, Bethesda, MD 20892 USA; [Zeng, Pingyao; Berger, Shelley L.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Xiong, Jingbo] So Med Univ, Dept Cell Biol, Guangzhou, Guangdong, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Pennsylvania; Southern Medical University - China	Yu, YL (corresponding author), NCI, Lab Canc Biol & Genet, NIH, Bethesda, MD 20892 USA.	YuY@mail.nih.gov		Berger, Shelley/0000-0001-5398-4400	National Cancer Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA078831, ZIABC010871, ZIABC008756] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Cancer Institute, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akisawa N, 1999, BIOCHEM BIOPH RES CO, V258, P395, DOI 10.1006/bbrc.1999.0653; Baylin SB, 1998, ADV CANCER RES, V72, P141; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Blagosklonny MV, 2004, CANCER CELL, V5, P13, DOI 10.1016/S1535-6108(03)00336-2; Blagosklonny MV, 2005, CELL DEATH DIFFER, V12, P592, DOI 10.1038/sj.cdd.4401610; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chuan YC, 2006, J BIOL CHEM, V281, P29938, DOI 10.1074/jbc.M602237200; Crepaldi T, 1997, J CELL BIOL, V138, P423, DOI 10.1083/jcb.138.2.423; Curto M, 2004, CANCER CELL, V5, P113, DOI 10.1016/S1535-6108(04)00031-5; Elliott BE, 2005, BREAST CANCER RES, V7, pR365, DOI 10.1186/bcr1006; Fahrner JA, 2002, CANCER RES, V62, P7213; Fahrner JA, 2003, GENE DEV, V17, P1805, DOI 10.1101/gad.1123303; Feinberg AP, 2004, SEMIN CANCER BIOL, V14, P427, DOI 10.1016/j.semcancer.2004.06.005; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; FELSENFELD G, 1992, NATURE, V355, P219, DOI 10.1038/355219a0; Gao SY, 2009, J BIOL CHEM, V284, P7995, DOI 10.1074/jbc.M809734200; Gautreau A, 2002, CURR OPIN CELL BIOL, V14, P104, DOI 10.1016/S0955-0674(01)00300-3; Geiger KD, 2000, AM J PATHOL, V157, P1785, DOI 10.1016/S0002-9440(10)64816-X; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hirao M, 1996, J CELL BIOL, V135, P37, DOI 10.1083/jcb.135.1.37; Ilmonen S, 2005, MODERN PATHOL, V18, DOI 10.1038/modpathol.3800429; Ilmonen S, 2005, MODERN PATHOL, V18, P503, DOI 10.1038/modpathol.3800300; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jun HJ, 2009, CANCER RES, V69, P2180, DOI 10.1158/0008-5472.CAN-08-3351; Karpf AR, 2002, ONCOGENE, V21, P5496, DOI 10.1038/sj.onc.1205602; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; Khanna C, 2001, CANCER RES, V61, P3750; Kim MS, 2001, NAT MED, V7, P437, DOI 10.1038/86507; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Louvet-Vallee S, 2000, BIOL CELL, V92, P305, DOI 10.1016/S0248-4900(00)01078-9; Lugini L, 2006, CANCER RES, V66, P3629, DOI 10.1158/0008-5472.CAN-05-3204; Majid S, 2008, CANCER RES, V68, P2736, DOI 10.1158/0008-5472.CAN-07-2290; Mangeat P, 1999, TRENDS CELL BIOL, V9, P187, DOI 10.1016/S0962-8924(99)01544-5; Martin TA, 2003, CRIT REV ONCOL HEMAT, V46, P165, DOI 10.1016/S1040-8428(02)00172-5; McClatchey AI, 2003, NAT REV CANCER, V3, P877, DOI 10.1038/nrc1213; Mellor J, 2006, TRENDS GENET, V22, P320, DOI 10.1016/j.tig.2006.03.008; Mirmohammadsadegh A, 2006, CANCER RES, V66, P6546, DOI 10.1158/0008-5472.CAN-06-0384; Momparler RL, 2005, SEMIN ONCOL, V32, P443, DOI 10.1053/j.seminoncol.2005.07.008; Mori T, 2005, CANCER RES, V65, P1800, DOI 10.1158/0008-5472.CAN-04-3531; Nestl A, 2001, CANCER RES, V61, P1569; Orian-Rousseau V, 2002, GENE DEV, V16, P3074, DOI 10.1101/gad.242602; Pulukuri SMK, 2007, CANCER RES, V67, P930, DOI 10.1158/0008-5472.CAN-06-2892; Rabbani SA, 2008, NEOPLASIA, V10, P266, DOI 10.1593/neo.07947; Schmitz AAP, 2000, EXP CELL RES, V261, P1, DOI 10.1006/excr.2000.5049; Shiue H, 2005, J BIOL CHEM, V280, P1688, DOI 10.1074/jbc.M409471200; Srivastava J, 2005, MOL BIOL CELL, V16, P1481, DOI 10.1091/mbc.e04-08-0721; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Yu YL, 2006, CANCER RES, V66, P1982, DOI 10.1158/0008-5472.CAN-05-2360; Yu YL, 2004, NAT MED, V10, P175, DOI 10.1038/nm966; Yu YL, 2002, CANCER RES, V62, P2951	58	35	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2010	5	9							e12710	10.1371/journal.pone.0012710	http://dx.doi.org/10.1371/journal.pone.0012710			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648ZZ	20856924	Green Published, gold, Green Submitted			2022-12-27	WOS:000281735700022
J	Emmert-Streib, F				Emmert-Streib, Frank			Statistic Complexity: Combining Kolmogorov Complexity with an Ensemble Approach	PLOS ONE			English	Article								Background: The evaluation of the complexity of an observed object is an old but outstanding problem. In this paper we are tying on this problem introducing a measure called statistic complexity. Methodology/Principal Findings: This complexity measure is different to all other measures in the following senses. First, it is a bivariate measure that compares two objects, corresponding to pattern generating processes, on the basis of the normalized compression distance with each other. Second, it provides the quantification of an error that could have been encountered by comparing samples of finite size from the underlying processes. Hence, the statistic complexity provides a statistical quantification of the statement 'X is similarly complex as Y'. Conclusions: The presented approach, ultimately, transforms the classic problem of assessing the complexity of an object into the realm of statistics. This may open a wider applicability of this complexity measure to diverse application areas.	Queens Univ, Ctr Canc Res & Cell Biol, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland	Queens University Belfast	Emmert-Streib, F (corresponding author), Queens Univ, Ctr Canc Res & Cell Biol, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland.	v@bio-complexity.com	Emmert-Streib, Frank/G-8099-2011; Emmert-Streib, Frank/AAF-2878-2020	Emmert-Streib, Frank/0000-0003-0745-5641; Emmert-Streib, Frank/0000-0003-0745-5641				[Anonymous], 1988, UNIVERSAL TURING MAC; Badii R, 1997, COMPLEXITY HIERARCHI; Bar-yam Y., 2019, DYNAMICS COMPLEX SYS; Bialek W, 2001, NEURAL COMPUT, V13, P2409, DOI 10.1162/089976601753195969; Casella G., 2002, STAT INFERENCE, V2nd; Cebrian M, 2005, COMMUN INF SYST, V5, P367; CHAITIN GJ, 1966, J ACM, V13, P547, DOI 10.1145/321356.321363; Cilibrasi R, 2005, IEEE T INFORM THEORY, V51, P1523, DOI 10.1109/TIT.2005.844059; Conover WJ., 1999, PRACTICAL NONPARAMET, V3rd; CRUTCHFIELD JP, 1983, PHYSICA D, V7, P201, DOI 10.1016/0167-2789(83)90127-6; CRUTCHFIELD JP, 1989, PHYS REV LETT, V63, P105, DOI 10.1103/PhysRevLett.63.105; Crutchfield JP, 1997, PHYS REV E, V55, pR1239, DOI 10.1103/PhysRevE.55.R1239; Dehmer M, 2008, CYBERNET SYST, V39, P825, DOI 10.1080/01969720802435925; Dehmer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008057; Emmert-Streib F, 2007, J COMPUT BIOL, V14, P961, DOI 10.1089/cmb.2007.0041; Emmert-Streib F, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.026103; Feldman DP, 1998, PHYS LETT A, V238, P244, DOI 10.1016/S0375-9601(97)00855-4; Gell-Mann M., 1996, Complexity, V2, P44, DOI 10.1002/(SICI)1099-0526(199609/10)2:1<44::AID-CPLX10>3.0.CO;2-X; GRASSBERGER P, 1986, INT J THEOR PHYS, V25, P907, DOI 10.1007/BF00668821; GRASSBERGER P, 1989, HELV PHYS ACTA, V62, P489; Kolmogorov A. N., 1968, International Journal of Computer Mathematics, V2, P157, DOI 10.1080/00207166808803030; Lehman E. L., 2005, TESTING STAT HYPOTHE, V3rd; Li M, 2004, IEEE T INFORM THEORY, V50, P3250, DOI 10.1109/TIT.2004.838101; LI M, 1997, INTRO KOLMOGOROV COM; LLOYD S, 1988, ANN PHYS-NEW YORK, V188, P186, DOI 10.1016/0003-4916(88)90094-2; LopezRuiz R, 1995, PHYS LETT A, V209, P321, DOI 10.1016/0375-9601(95)00867-5; Mattos TG, 2004, BRAZ J PHYS, V34, P448, DOI 10.1590/S0103-97332004000300024; MILBRODT H, 1990, J STAT PLAN INFER, V26, P1, DOI 10.1016/0378-3758(90)90091-8; Mood A., 1973, INTRO THEORY STAT; Nicolis G., 1989, EXPLORING COMPLEXITY; Prokopenko M, 2009, COMPLEXITY, V15, P11, DOI 10.1002/cplx.20249; R Core Team, 2018, R LANG ENV STAT COMP; Schuster H, 2002, COMPLEX ADAPTIVE SYS; Smirnov N., 1939, B MOSCOW U, V2, P3; Solomonoff R., 1960, V131 ZAT CO; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WOLFRAM S, 1983, REV MOD PHYS, V55, P601, DOI 10.1103/RevModPhys.55.601; Zurek W., 1990, COMPLEXITY ENTROPY P	38	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12256	10.1371/journal.pone.0012256	http://dx.doi.org/10.1371/journal.pone.0012256			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865047	Green Published, Green Submitted, gold			2022-12-27	WOS:000281292100002
J	Guantes, R; Estrada, J; Poyatos, JF				Guantes, Raul; Estrada, Javier; Poyatos, Juan F.			Trade-offs and Noise Tolerance in Signal Detection by Genetic Circuits	PLOS ONE			English	Article							FEEDFORWARD LOOP; INPUT FUNCTIONS; NETWORK; PROPAGATION	Genetic circuits can implement elaborated tasks of amplitude or frequency signal detection. What type of constraints could circuits experience in the performance of these tasks, and how are they affected by molecular noise? Here, we consider a simple detection process-a signal acting on a two-component module-to analyze these issues. We show that the presence of a feedback interaction in the detection module imposes a trade-off on amplitude and frequency detection, whose intensity depends on feedback strength. A direct interaction between the signal and the output species, in a type of feed-forward loop architecture, greatly modifies these trade-offs. Indeed, we observe that coherent feed-forward loops can act simultaneously as good frequency and amplitude noise-tolerant detectors. Alternatively, incoherent feed-forward loop structures can work as high-pass filters improving high frequency detection, and reaching noise tolerance by means of noise filtering. Analysis of experimental data from several specific coherent and incoherent feed-forward loops shows that these properties can be realized in a natural context. Overall, our results emphasize the limits imposed by circuit structure on its characteristic stimulus response, the functional plasticity of coherent feed-forward loops, and the seemingly paradoxical advantage of improving signal detection with noisy circuit components.	[Guantes, Raul; Estrada, Javier] Univ Autonoma Madrid, Fac Sci, Dept Condensed Matter Phys, Madrid, Spain; [Guantes, Raul; Estrada, Javier] Univ Autonoma Madrid, Fac Sci, Inst Mat Sci Nicolas Cabrera, Madrid, Spain; [Poyatos, Juan F.] CSIC, Spanish Natl Biotechnol Ctr, Log Genom Syst Lab, Madrid, Spain	Autonomous University of Madrid; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC)	Guantes, R (corresponding author), Univ Autonoma Madrid, Fac Sci, Dept Condensed Matter Phys, Madrid, Spain.	raul.guantes@uam.es	Guantes, Raul/B-7271-2014	Guantes, Raul/0000-0003-1916-944X; Estrada Diez, Francisco Javier/0000-0001-8918-2573; Estrada, Javier/0000-0003-3646-204X	Ministerio de Ciencia, Tecnologia e Innovacion (Spain) [BFU2008-03632/BMC]; Comunidad Autonoma de Madrid (Spain) [CCG08-CSIC/SAL-3651]; UAM-FPI	Ministerio de Ciencia, Tecnologia e Innovacion (Spain); Comunidad Autonoma de Madrid (Spain)(Comunidad de Madrid); UAM-FPI	This work was supported by the Ministerio de Ciencia, Tecnologia e Innovacion (Spain), grant BFU2008-03632/BMC, (JFP and RG) and Comunidad Autonoma de Madrid (Spain), grant CCG08-CSIC/SAL-3651, (JFP). JE acknowledges a UAM-FPI postgraduate grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Austin DW, 2006, NATURE, V439, P608, DOI 10.1038/nature04194; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Behar M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000197; Bennett MR, 2008, NATURE, V454, P1119, DOI 10.1038/nature07211; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Bruggeman FJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000506; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Cournac A, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-29; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Cox CD, 2008, P NATL ACAD SCI USA, V105, P10809, DOI 10.1073/pnas.0804829105; Dunlop MJ, 2008, NAT GENET, V40, P1493, DOI 10.1038/ng.281; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Guantes R, 2006, PLOS COMPUT BIOL, V2, P188, DOI 10.1371/journal.pcbi.0020030; Hersen P, 2008, P NATL ACAD SCI USA, V105, P7165, DOI 10.1073/pnas.0710770105; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Hornung G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040008; Ishihara S, 2005, GENES CELLS, V10, P1025, DOI 10.1111/j.1365-2443.2005.00897.x; Kaplan S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.43; Kaplan S, 2008, MOL CELL, V29, P786, DOI 10.1016/j.molcel.2008.01.021; Keizer J, 1987, STAT THERMODYNAMICS; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lipan O, 2005, P NATL ACAD SCI USA, V102, P7063, DOI 10.1073/pnas.0403790102; Ljung L., 1999, SYSTEM IDENTIFICATIO; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; Maheshri N, 2007, ANNU REV BIOPH BIOM, V36, P413, DOI 10.1146/annurev.biophys.36.040306.132705; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Mettetal JT, 2008, SCIENCE, V319, P482, DOI 10.1126/science.1151582; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Paulsson J, 2005, PHYS LIFE REV, V2, P157, DOI 10.1016/j.plrev.2005.03.003; Richet E, 2000, EMBO J, V19, P5222, DOI 10.1093/emboj/19.19.5222; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Shimizu TS, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.37; Simpson ML, 2003, P NATL ACAD SCI USA, V100, P4551, DOI 10.1073/pnas.0736140100; Sohka T, 2009, P NATL ACAD SCI USA, V106, P10135, DOI 10.1073/pnas.0901246106; Tan CM, 2007, BIOPHYS J, V93, P3753, DOI 10.1529/biophysj.107.110403; Weinberger LS, 2008, NAT GENET, V40, P466, DOI 10.1038/ng.116	38	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12314	10.1371/journal.pone.0012314	http://dx.doi.org/10.1371/journal.pone.0012314			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865033	gold, Green Published, Green Submitted			2022-12-27	WOS:000281292100007
J	De Arcangelis, V; Serra, F; Cogoni, C; Vivarelli, E; Monaco, L; Naro, F				De Arcangelis, Valeria; Serra, Filippo; Cogoni, Carlo; Vivarelli, Elisabetta; Monaco, Lucia; Naro, Fabio			beta 1-Syntrophin Modulation by miR-222 in mdx Mice	PLOS ONE			English	Article							DYSTROPHIN-ASSOCIATED PROTEINS; MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; EXPRESSION; DUCHENNE; DYSTROGLYCAN; SYNTROPHINS; MICRORNAS; COMPLEX; DIFFERENTIATION	Background: In mdx mice, the absence of dystrophin leads to the deficiency of other components of the dystrophin-glycoprotein complex (DAPC), making skeletal muscle fibers more susceptible to necrosis. The mechanisms involved in the disappearance of the DAPC are not completely understood. The muscles of mdx mice express normal amounts of mRNA for the DAPC components, thus suggesting post-transcriptional regulation. Methodology/Principal Findings: We investigated the hypothesis that DAPC reduction could be associated with the microRNA system. Among the possible microRNAs (miRs) found to be upregulated in the skeletal muscle tissue of mdx compared to wt mice, we demonstrated that miR-222 specifically binds to the 3'-UTR of beta 1-syntrophin and participates in the downregulation of b1-syntrophin. In addition, we documented an altered regulation of the 3'-UTR of beta 1-syntrophin in muscle tissue from dystrophic mice. Conclusion/Significance: These results show the importance of the microRNA system in the regulation of DAPC components in dystrophic muscle, and suggest a potential role of miRs in the pathophysiology of dystrophy.	[De Arcangelis, Valeria; Serra, Filippo; Vivarelli, Elisabetta; Naro, Fabio] Univ Roma La Sapienza, Dept Histol & Med Embryol, Rome, Italy; [Monaco, Lucia] Univ Roma La Sapienza, Dept Physiol & Pharmacol, Rome, Italy; [Cogoni, Carlo] Univ Roma La Sapienza, Dept Cellular Biotechnol & Ematol, Rome, Italy; [Naro, Fabio] IIM, Pavia, Italy	Sapienza University Rome; Sapienza University Rome; Sapienza University Rome	De Arcangelis, V (corresponding author), Univ Roma La Sapienza, Dept Histol & Med Embryol, Rome, Italy.	lucia.monaco@uniroma1.it			Italian Ministry of University; AFM	Italian Ministry of University(Ministry of Education, Universities and Research (MIUR)); AFM(Association Francaise contre les Myopathies)	Grants from the Italian Ministry of University (FIRB to FN; PRIN to FN, LDA), Faculty (to FN and LM) and AFM (to LM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn AH, 1996, J BIOL CHEM, V271, P2724, DOI 10.1074/jbc.271.5.2724; Allikian MJ, 2007, TRAFFIC, V8, P177, DOI 10.1111/j.1600-0854.2006.00519.x; Araishi K, 1999, HUM MOL GENET, V8, P1589, DOI 10.1093/hmg/8.9.1589; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Biggar WD, 2006, PEDIATR REV, V27, P83, DOI 10.1542/pir.27-3-83; Bonuccelli G, 2003, AM J PATHOL, V163, P1663, DOI 10.1016/S0002-9440(10)63523-7; Bonuccelli G, 2007, CELL CYCLE, V6, P1242, DOI 10.4161/cc.6.10.4182; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Callis TE, 2007, DNA CELL BIOL, V26, P219, DOI 10.1089/dna.2006.0556; Cardinali B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007607; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen JF, 2009, J CELL SCI, V122, P13, DOI 10.1242/jcs.041723; Chen ZJ, 2006, J BIOL CHEM, V281, P12414, DOI 10.1074/jbc.M508651200; Davies KE, 2006, NAT REV MOL CELL BIO, V7, P762, DOI 10.1038/nrm2024; De Luca A, 2003, J PHARMACOL EXP THER, V304, P453, DOI 10.1124/jpet.102.041343; Dona M, 2003, BIOCHEM BIOPH RES CO, V312, P1132, DOI 10.1016/j.bbrc.2003.11.032; Duclos F, 1998, J CELL BIOL, V142, P1461, DOI 10.1083/jcb.142.6.1461; Durbeej M, 2000, MOL CELL, V5, P141, DOI 10.1016/S1097-2765(00)80410-4; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; Eisenberg I, 2009, J CELL MOL MED, V13, P2, DOI 10.1111/j.1582-4934.2008.00524.x; Ervasti JM, 2007, BBA-MOL BASIS DIS, V1772, P108, DOI 10.1016/j.bbadis.2006.05.010; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fornari F, 2008, ONCOGENE, V27, P5651, DOI 10.1038/onc.2008.178; Gavillet B, 2006, CIRC RES, V99, P407, DOI 10.1161/01.RES.0000237466.13252.5e; Gazzerro E, 2010, AM J PATHOL, V176, P1863, DOI 10.2353/ajpath.2010.090468; Gee SH, 1998, J NEUROSCI, V18, P128; Greco S, 2009, FASEB J, V23, P3335, DOI 10.1096/fj.08-128579; Grounds MD, 2008, NEUROBIOL DIS, V31, P1, DOI 10.1016/j.nbd.2008.03.008; Hack AA, 2000, J CELL SCI, V113, P2535; Hack AA, 1998, J CELL BIOL, V142, P1279, DOI 10.1083/jcb.142.5.1279; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Holt KH, 2000, FEBS LETT, V468, P79, DOI 10.1016/S0014-5793(00)01195-9; Jones KJ, 2003, NEUROMUSCULAR DISORD, V13, P456, DOI 10.1016/S0960-8966(03)00066-X; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Komati H, 2004, FEBS LETT, V577, P409, DOI 10.1016/j.febslet.2004.10.036; Lapidos KA, 2004, CIRC RES, V94, P1023, DOI 10.1161/01.RES.0000126574.61061.25; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; Leonoudakis D, 2004, J BIOL CHEM, V279, P22331, DOI 10.1074/jbc.M400285200; Mattei E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000774; MATTHEW L, 2001, CURRENT PROTOCOLS HU; McCarthy JJ, 2008, BBA-GENE REGUL MECH, V1779, P682, DOI 10.1016/j.bbagrm.2008.03.001; Monaco L, 2005, P NATL ACAD SCI USA, V102, P14244, DOI 10.1073/pnas.0506252102; OHLENDIECK K, 1991, J CELL BIOL, V115, P1685, DOI 10.1083/jcb.115.6.1685; Okuhira K, 2005, J BIOL CHEM, V280, P39653, DOI 10.1074/jbc.M510187200; Ozawa E, 2005, MUSCLE NERVE, V32, P563, DOI 10.1002/mus.20349; Peters MF, 1997, J CELL BIOL, V138, P81, DOI 10.1083/jcb.138.1.81; Sandona D, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001203; Sciandra F, 2007, TRENDS BIOTECHNOL, V25, P262, DOI 10.1016/j.tibtech.2007.04.002; Tomczak KK, 2003, FASEB J, V17, P403, DOI 10.1096/f.03-0568fje; Williams AH, 2009, CURR OPIN CELL BIOL, V21, P461, DOI 10.1016/j.ceb.2009.01.029	51	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12098	10.1371/journal.pone.0012098	http://dx.doi.org/10.1371/journal.pone.0012098			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20856896	Green Published, gold, Green Submitted			2022-12-27	WOS:000280811900035
J	Otomo, T; Tomchick, DR; Otomo, C; Machius, M; Rosen, MK				Otomo, Takanori; Tomchick, Diana R.; Otomo, Chinatsu; Machius, Mischa; Rosen, Michael K.			Crystal Structure of the Formin mDia1 in Autoinhibited Conformation	PLOS ONE			English	Article							DIAPHANOUS-RELATED FORMINS; ACTIN-FILAMENT ELONGATION; ARP2/3 COMPLEX; AUTOREGULATORY DOMAIN; HOMOLOGY-2 DOMAIN; FH2 DOMAIN; PROTEIN; RHO; ACTIVATION; NUCLEATION	Background: Formin proteins utilize a conserved formin homology 2 (FH2) domain to nucleate new actin filaments. In mammalian diaphanous-related formins (DRFs) the FH2 domain is inhibited through an unknown mechanism by intramolecular binding of the diaphanous autoinhibitory domain (DAD) and the diaphanous inhibitory domain (DID). Methodology/Principal Findings: Here we report the crystal structure of a complex between DID and FH2-DAD fragments of the mammalian DRF, mDia1 (mammalian diaphanous 1 also called Drf1 or p140mDia). The structure shows a tetrameric configuration (4 FH2 + 4 DID) in which the actin-binding sites on the FH2 domain are sterically occluded. However biochemical data suggest the full-length mDia1 is a dimer in solution (2 FH2 + 2 DID). Based on the crystal structure, we have generated possible dimer models and found that architectures of all of these models are incompatible with binding to actin filament but not to actin monomer. Furthermore, we show that the minimal functional monomeric unit in the FH2 domain, termed the bridge element, can be inhibited by isolated monomeric DID. NMR data on the bridge-DID system revealed that at least one of the two actin-binding sites on the bridge element is accessible to actin monomer in the inhibited state. Conclusions/Significance: Our findings suggest that autoinhibition in the native DRF dimer involves steric hindrance with the actin filament. Although the structure of a full-length DRF would be required for clarification of the presented models, our work here provides the first structural insights into the mechanism of the DRF autoinhibition.	[Otomo, Takanori; Tomchick, Diana R.; Otomo, Chinatsu; Machius, Mischa; Rosen, Michael K.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Rosen, Michael K.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Otomo, T (corresponding author), Scripps Res Inst, Dept Mol Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	Michael.Rosen@UTSouthwestern.edu	Tomchick, Diana/HGV-2018-2022; , PEP-MX Core/AGV-4051-2022	Tomchick, Diana/0000-0002-7529-4643; Otomo, Takanori/0000-0003-3589-238X	National Institutes of Health (NIH) [R01 GM056322]; Howard Hughes Medical Institute; Human Frontier Science Program; U.S. Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056322] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Human Frontier Science Program(Human Frontier Science Program); U.S. Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) Grant R01 GM056322 and the Howard Hughes Medical Institute. T.O. was supported by the Human Frontier Science Program fellowship. The structure shown in this report is derived from work performed on beamline 19-ID at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne is operated by UChicago Argonne, LLC, for the U.S. Department of Energy, Office of Biological and Environmental Research under contract DE-AC02-06CH11357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Carlier MF, 2003, CR BIOL, V326, P161, DOI 10.1016/S1631-0691(03)00067-2; Chang F, 2003, CURR BIOL, V13, pR692, DOI 10.1016/j.cub.2003.08.038; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Evangelista M, 2002, NAT CELL BIOL, V4, P32, DOI 10.1038/ncb718; Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118; Gardner KH, 1997, J AM CHEM SOC, V119, P7599, DOI 10.1021/ja9706514; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Higashida C, 2004, SCIENCE, V303, P2007, DOI 10.1126/science.1093923; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Kovar DR, 2005, MOL BIOL CELL, V16, P2313, DOI 10.1091/mbc.E04-09-0781; Kovar DR, 2004, P NATL ACAD SCI USA, V101, P14725, DOI 10.1073/pnas.0405902101; Lammers M, 2005, EMBO J, V24, P4176, DOI 10.1038/sj.emboj.7600879; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Li F, 2005, J BIOL CHEM, V280, P6986, DOI 10.1074/jbc.M411605200; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Lu J, 2007, J MOL BIOL, V369, P1258, DOI 10.1016/j.jmb.2007.04.002; Marchand JB, 2001, NAT CELL BIOL, V3, P76, DOI 10.1038/35050590; Matusek T, 2006, DEVELOPMENT, V133, P957, DOI 10.1242/dev.02266; Narumiya S, 1997, FEBS LETT, V410, P68, DOI 10.1016/S0014-5793(97)00317-7; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nezami AG, 2006, STRUCTURE, V14, P257, DOI 10.1016/j.str.2005.12.003; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Otomo T, 2005, MOL CELL, V18, P273, DOI 10.1016/j.molcel.2005.04.002; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Otwinowski Z, 1991, P CCP4 STUD WEEK IS, P80; Paul AS, 2009, CELL MOTIL CYTOSKEL, V66, P606, DOI 10.1002/cm.20379; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Pufall MA, 2002, ANNU REV CELL DEV BI, V18, P421, DOI 10.1146/annurev.cellbio.18.031502.133614; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Seth A, 2006, J CELL BIOL, V174, P701, DOI 10.1083/jcb.200605006; Shemesh T, 2005, J CELL BIOL, V170, P889, DOI 10.1083/jcb.200504156; Shimada A, 2004, MOL CELL, V13, P511, DOI 10.1016/S1097-2765(04)00059-0; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Vavylonis D, 2006, MOL CELL, V21, P455, DOI 10.1016/j.molcel.2006.01.016; Wallar BJ, 2006, J BIOL CHEM, V281, P4300, DOI 10.1074/jbc.M510277200; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Weaver AM, 2003, CURR OPIN CELL BIOL, V15, P23, DOI 10.1016/S0955-0674(02)00015-7; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Zigmond S, 2004, NAT CELL BIOL, V6, P12, DOI 10.1038/ncb0104-12	57	33	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e12896	10.1371/journal.pone.0012896	http://dx.doi.org/10.1371/journal.pone.0012896			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20927343	gold, Green Published, Green Submitted			2022-12-27	WOS:000282312600008
J	Benaglio, P; Rivolta, C				Benaglio, Paola; Rivolta, Carlo			Ultra High Throughput Sequencing in Human DNA Variation Detection: A Comparative Study on the NDUFA3-PRPF31 Region	PLOS ONE			English	Article							HUMAN GENOME; COPY NUMBER; VARIANTS; TECHNOLOGY; PRIMER	Background: Ultra high throughput sequencing (UHTS) technologies find an important application in targeted resequencing of candidate genes or of genomic intervals from genetic association studies. Despite the extraordinary power of these new methods, they are still rarely used in routine analysis of human genomic variants, in part because of the absence of specific standard procedures. The aim of this work is to provide human molecular geneticists with a tool to evaluate the best UHTS methodology for efficiently detecting DNA changes, from common SNPs to rare mutations. Methodology/Principal Findings: We tested the three most widespread UHTS platforms (Roche/454 GS FLX Titanium, Illumina/Solexa Genome Analyzer II and Applied Biosystems/SOLiD System 3) on a well-studied region of the human genome containing many polymorphisms and a very rare heterozygous mutation located within an intronic repetitive DNA element. We identify the qualities and the limitations of each platform and describe some peculiarities of UHTS in resequencing projects. Conclusions/Significance: When appropriate filtering and mapping procedures are applied UHTS technology can be safely and efficiently used as a tool for targeted human DNA variations detection. Unless particular and platform-dependent characteristics are needed for specific projects, the most relevant parameter to consider in mainstream human genome resequencing procedures is the cost per sequenced base-pair associated to each machine.	[Benaglio, Paola; Rivolta, Carlo] Univ Lausanne, Dept Med Genet, Lausanne, Switzerland	University of Lausanne	Benaglio, P (corresponding author), Univ Lausanne, Dept Med Genet, Lausanne, Switzerland.	carlo.rivolta@unil.ch		Rivolta, Carlo/0000-0002-0733-9950	Swiss National Science Foundation [320030-121929]; European Union [HEALTH-2007-201550]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union(European Commission)	This work was supported by the Swiss National Science Foundation (grant # 320030-121929) and the European Union (grant HEALTH-2007-201550). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Craig DW, 2008, NAT METHODS, V5, P887, DOI 10.1038/NMETH.1251; Frio TR, 2009, HUM MUTAT, V30, P1340, DOI 10.1002/humu.21071; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Harismendy O, 2009, BIOTECHNIQUES, V46, P229, DOI 10.2144/000113082; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Ikegawa S, 2002, HUM GENET, V110, P606, DOI 10.1007/s00439-002-0735-1; Ingman M, 2009, EUR J HUM GENET, V17, P383, DOI 10.1038/ejhg.2008.182; Lennon NJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r15; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Massouras A, 2010, NAT METHODS, V7, P485, DOI [10.1038/nmeth.f.308, 10.1038/NMETH.f.308]; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Meyer M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm566; Out AA, 2009, HUM MUTAT, V30, P1703, DOI 10.1002/humu.21122; Parameswaran P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm760; Park H, 2010, NAT GENET, V42, P400, DOI 10.1038/ng.555; Pop M, 2008, TRENDS GENET, V24, P142, DOI 10.1016/j.tig.2007.12.006; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Richard GF, 2008, MICROBIOL MOL BIOL R, V72, P686, DOI 10.1128/MMBR.00011-08; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Smith DR, 2008, GENOME RES, V18, P1638, DOI 10.1101/gr.077776.108; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884	23	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e13071	10.1371/journal.pone.0013071	http://dx.doi.org/10.1371/journal.pone.0013071			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20927379	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000282269400021
J	Okabayashi, T; Nakanishi, K; Tsuchihara, T; Arino, H; Yoshihara, Y; Tominaga, S; Uenoyama, M; Suzuki, S; Asagiri, M; Nemoto, K				Okabayashi, Toshitaka; Nakanishi, Kuniaki; Tsuchihara, Toyokazu; Arino, Hiroshi; Yoshihara, Yasuo; Tominaga, Susumu; Uenoyama, Maki; Suzuki, Shinya; Asagiri, Masataka; Nemoto, Koichi			Axonal-Transport-Mediated Gene Transduction in the Interior of Rat Bone	PLOS ONE			English	Article							HEMAGGLUTINATING VIRUS; SENSORY NEURONS; FRACTURE REPAIR; THERAPY; DELIVERY; EXPRESSION; CELLS; OSTEOGENESIS; INFLAMMATION; OSTEOPENIA	Gene transduction has been considered advantageous for the sustained delivery of proteins to specific target tissues. However, in the case of hard tissues, such as bone, local gene delivery remains problematic owing to anatomical accessibility limitations of the target sites. Methodology/Principal Findings: Here, we evaluated the feasibility of exogenous gene transduction in the interior of bone via axonal transport following intramuscular administration of a nonviral vector. A high expression level of the transduced gene was achieved in the tibia ipsilateral to the injected tibialis anterior muscle, as well as in the ipsilateral sciatic nerve and dorsal root ganglia. In sciatic transection rats, the gene expression level was significantly lowered in bone. Conclusions/Significance: These results suggest that axonal transport is critical for gene transduction. Our study may provide a basis for developing therapeutic methods for efficient gene delivery into hard tissues.	[Okabayashi, Toshitaka; Tsuchihara, Toyokazu; Arino, Hiroshi; Yoshihara, Yasuo; Nemoto, Koichi] Natl Def Med Coll, Dept Orthopaed Surg, Saitama, Japan; [Nakanishi, Kuniaki] Natl Def Med Coll, Dept Lab Med, Saitama, Japan; [Tominaga, Susumu] Natl Def Med Coll, Dept Pathol & Lab Med, Saitama, Japan; [Uenoyama, Maki; Suzuki, Shinya] Natl Def Med Coll Res Inst, Div Environm Med, Saitama, Japan; [Asagiri, Masataka] Univ Calif San Diego, Dept Chem & Biochem, San Diego, CA 92103 USA	National Defense Medical College - Japan; National Defense Medical College - Japan; National Defense Medical College - Japan; National Defense Medical College - Japan; University of California System; University of California San Diego	Okabayashi, T (corresponding author), Natl Def Med Coll, Dept Orthopaed Surg, Saitama, Japan.	t-okabayashi@umin.ac.jp			National Defense Medical College	National Defense Medical College	This study was supported by the special research program of the National Defense Medical College. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alden TD, 2000, J CRANIOFAC SURG, V11, P24, DOI 10.1097/00001665-200011010-00005; Ashinoff RL, 2004, ANN PLAS SURG, V52, P585, DOI 10.1097/01.sap.0000123023.28874.1e; Baltzer AWA, 2000, GENE THER, V7, P734, DOI 10.1038/sj.gt.3301166; Baltzer AWA, 2000, CLIN ORTHOP RELAT R, pS120; Bert AG, 2000, PLASMID, V44, P173, DOI 10.1006/plas.2000.1474; Bolon B, 2001, MOL THER, V3, P197, DOI 10.1006/mthe.2001.0245; Brown A, 2003, J CELL BIOL, V160, P817, DOI 10.1083/jcb.200212017; Carpintero P, 1998, Acta Leprol, V11, P21; CUNDY TF, 1985, DIABETIC MED, V2, P461, DOI 10.1111/j.1464-5491.1985.tb00683.x; EVANS CH, 1995, J BONE JOINT SURG AM, V77A, P1103, DOI 10.2106/00004623-199507000-00021; Evans CH, 2009, MOL THER, V17, P231, DOI 10.1038/mt.2008.265; Gouze E, 2003, MOL THER, V7, P460, DOI 10.1016/S1525-0016(03)00024-8; Helm GA, 2000, J NEUROSURG, V92, P191, DOI 10.3171/spi.2000.92.2.0191; HUNT CC, 1954, J GEN PHYSIOL, V38, P117, DOI 10.1085/jgp.38.1.117; Kaneda Y, 2002, MOL THER, V6, P219, DOI 10.1006/mthe.2002.0647; Kato N, 2003, J NEUROCHEM, V85, P810, DOI 10.1046/j.1471-4159.2003.01730.x; Kostenuik PJ, 2004, BONE, V34, P656, DOI 10.1016/j.bone.2003.12.006; Krebsbach PH, 2000, HUM GENE THER, V11, P1201, DOI 10.1089/10430340050015248; Lieberman JR, 1999, J BONE JOINT SURG AM, V81A, P905, DOI 10.2106/00004623-199907000-00002; LUNDBORG G, 2002, NERVE INJURY REPAIR, P6; MARIEB EN, 1997, HUMAN ANATOMY, P117; Mason JM, 1998, GENE THER, V5, P1098, DOI 10.1038/sj.gt.3300703; MENDELSON L, 1975, SCAND J REHABIL MED, V7, P141; Newman KD, 1995, J CLIN INVEST, V96, P2955, DOI 10.1172/JCI118367; Ohtori S, 2003, EUR SPINE J, V12, P576, DOI 10.1007/s00586-003-0573-4; Partridge KA, 2004, TISSUE ENG, V10, P295, DOI 10.1089/107632704322791934; Sameda H, 2001, SPINE, V26, P1105, DOI 10.1097/00007632-200105150-00003; Sherrington CS, 1894, J PHYSL, V17, P212; Sherrington CS., 1894, J PHYSL, V17, P210; Thakor D, 2007, MOL THER, V15, P2124, DOI 10.1038/sj.mt.6300256; Tomishima MJ, 2001, TRAFFIC, V2, P429, DOI 10.1034/j.1600-0854.2001.020701.x; Verma IM, 2005, ANNU REV BIOCHEM, V74, P711, DOI 10.1146/annurev.biochem.74.050304.091637; Wang S, 2001, MOL THER, V3, P658, DOI 10.1006/mthe.2001.0324; Wazen RM, 2006, GENE THER, V13, P1595, DOI 10.1038/sj.gt.3302824; WITTENBERG RH, 1992, J BONE JOINT SURG BR, V74, P215, DOI 10.1302/0301-620X.74B2.1544955	35	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2010	5	9							e13034	10.1371/journal.pone.0013034	http://dx.doi.org/10.1371/journal.pone.0013034			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654ZQ	20927397	Green Submitted, gold, Green Published			2022-12-27	WOS:000282210700014
J	Hamada, T; Kurachi, S; Kurachi, K				Hamada, Toshiyuki; Kurachi, Sumiko; Kurachi, Kotoku			Heterogeneous Nuclear Ribonucleoprotein A3 Is the Liver Nuclear Protein Binding to Age Related Increase Element RNA of the Factor IX Gene	PLOS ONE			English	Article							MESSENGER-RNA; ARGININE METHYLATION; PROTEOMIC ANALYSIS; BLOOD-COAGULATION; HNRNP PROTEINS; HEMOPHILIA-B; IN-VITRO; PHOSPHORYLATION; MECHANISMS; CELLS	Background: In the ASE/AIE-mediated genetic mechanism for age-related gene regulation, a recently identified age-related homeostasis mechanism, two genetic elements, ASE (age-related stability element) and AIE (age-related increase element as a stem-loop forming RNA), play critical roles in producing specific age-related expression patterns of genes. Principal Finding: We successfully identified heterogeneous nuclear ribonucleoprotein A3 (hnRNP A3) as a major mouse liver nuclear protein binding to the AIE-derived RNAs of human factor IX (hFIX) as well as mouse factor IX (mFIX) genes. HnRNP A3 bound to the AIE RNA was not phosphorylated at its Ser(359), while hnRNP A3 in the mouse liver nuclear extracts was a mixture of phosphorylated and unphosphorylated Ser(359). HepG2 cells engineered to express recombinant hFIX transduced with adenoviral vectors harboring an effective siRNA against hnRNP A3 resulted in a substantial reduction in hFIX expression only in the cells carrying a hFIX expression vector with AIE, but not in the cells carrying a hFIX expression vector without AIE. The nuclear hnRNP A3 protein level in the mouse liver gradually increased with age, while its mRNA level stayed age-stable. Conclusions: We identified hnRNP A3 as a major liver nuclear protein binding to FIX-AIE RNA. This protein plays a critical role in age-related gene expression, likely through an as yet unidentified epigenetic mechanism. The present study assigned a novel functional role to hnRNP A3 in age-related regulation of gene expression, opening up a new avenue for studying age-related homeostasis and underlying molecular mechanisms.	[Hamada, Toshiyuki; Kurachi, Sumiko; Kurachi, Kotoku] Natl Inst Adv Ind Sci & Technol, Age Dimens Res Ctr, Tsukuba, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Hamada, T (corresponding author), Hokkaido Univ, Grad Sch Med, Adv Photon Bioimaging Ctr, Sapporo, Hokkaido, Japan.	fuku-kurachi@hq.kyushu-u.ac.jp	Hamada, Toshiyuki/AAZ-2258-2020; Hamada, Toshiyuki/G-6482-2012	Hamada, Toshiyuki/0000-0002-3998-2916; Hamada, Toshiyuki/0000-0002-1901-933X	National Institute of Advanced Industrial Science and Technology (AIST)	National Institute of Advanced Industrial Science and Technology (AIST)	This study was supported by the internal funding of the National Institute of Advanced Industrial Science and Technology (AIST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Buxade M, 2005, IMMUNITY, V23, P177, DOI 10.1016/j.immuni.2005.06.009; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cok SJ, 2004, J BIOL CHEM, V279, P8196, DOI 10.1074/jbc.M308475200; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; GORLACH M, 1992, EMBO J, V11, P3289, DOI 10.1002/j.1460-2075.1992.tb05407.x; He YW, 2009, CELL MOL LIFE SCI, V66, P1239, DOI 10.1007/s00018-008-8532-1; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; Kurachi K, 2005, J THROMB HAEMOST, V3, P909, DOI 10.1111/j.1538-7836.2005.01123.x; Kurachi S, 1999, SCIENCE, V285, P739, DOI 10.1126/science.285.5428.739; KURACHI S, 1995, J BIOL CHEM, V270, P5276, DOI 10.1074/jbc.270.10.5276; Kurachi S, 2009, P NATL ACAD SCI USA, V106, P7921, DOI 10.1073/pnas.0902191106; Li TW, 2004, P NATL ACAD SCI USA, V101, P8551, DOI 10.1073/pnas.0402889101; LIU Q, 1995, MOL CELL BIOL, V15, P2800; Ma ASW, 2002, J BIOL CHEM, V277, P18010, DOI 10.1074/jbc.M200050200; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; Makeyev AV, 2005, J EXP ZOOL PART A, V303A, P259, DOI 10.1002/jez.a.164; MERRILL BM, 1988, J BIOL CHEM, V263, P3307; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; Ostareck-Lederer A, 2002, MOL CELL BIOL, V22, P4535, DOI 10.1128/MCB.22.13.4535-4543.2002; Plomaritoglou A, 2000, BBA-GENE STRUCT EXPR, V1490, P54, DOI 10.1016/S0167-4781(99)00054-8; Rousseau S, 2002, EMBO J, V21, P6505, DOI 10.1093/emboj/cdf639; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Tanaka E, 2007, BIOCHEM BIOPH RES CO, V358, P608, DOI 10.1016/j.bbrc.2007.04.177; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; WEIGHARDT F, 1995, J CELL SCI, V108, P545; Yamaoka K, 2006, BIOCHEM BIOPH RES CO, V345, P1240, DOI 10.1016/j.bbrc.2006.04.183; YAO SN, 1991, P NATL ACAD SCI USA, V88, P8101, DOI 10.1073/pnas.88.18.8101; YOSHITAKE S, 1985, BIOCHEMISTRY-US, V24, P3736, DOI 10.1021/bi00335a049; Zhang KZ, 2002, J BIOL CHEM, V277, P4532, DOI 10.1074/jbc.M109524200	30	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2010	5	9							e12971	10.1371/journal.pone.0012971	http://dx.doi.org/10.1371/journal.pone.0012971			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653UN	20885981	Green Published, Green Submitted, gold			2022-12-27	WOS:000282122600010
J	Kane, NM; Jones, M; Brosens, JJ; Kelly, RW; Saunders, PTK; Critchley, HOD				Kane, Nicole M.; Jones, Marius; Brosens, Jan J.; Kelly, Rodney W.; Saunders, Philippa T. K.; Critchley, Hilary O. D.			TGF beta 1 Attenuates Expression of Prolactin and IGFBP-1 in Decidualized Endometrial Stromal Cells by Both SMAD-Dependent and SMAD-Independent Pathways	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; IN-VITRO; PROGESTERONE-RECEPTOR; OVARIAN-STEROIDS; EARLY-PREGNANCY; HUMAN PLACENTA; RELAXIN; PROLIFERATION; MECHANISMS; RELEASE	Background: Decidualization (differentiation) of the endometrial stromal cells during the secretory phase of the menstrual cycle is essential for successful implantation. Transforming Growth Factor beta 1 (TGF beta 1) canonically propagates its actions via SMAD signalling. A role for TGF beta 1 in decidualization remains to be established and published data concerning effects of TGF beta 1 on markers of endometrial decidualization are inconsistent. Methodology/Principal Findings: Non-pregnant endometrial stromal cells (ESC) and first trimester decidual stromal cells (DSC) were cultured in the presence or absence of a decidualizing stimulus. Incubation of ESCs with TGF beta 1 (10 ng/ml) down-regulated the expression of transcripts encoding the decidual marker proteins prolactin (PRL), insulin-like growth factor binding protein-1 (IGFBP-1) and tissue factor (TF). TGF beta 1 also inhibited secretion of PRL and IGFBP-1 proteins by ESCs and surprisingly this response preceded down-regulation of their mRNAs. In contrast, DSCs were more refractory to the actions of TGF beta 1, characterized by blunted and delayed down-regulation of PRL, IGFBP-1, and TF transcripts, which was not associated with a significant reduction in secretion of PRL or IGFBP-1 proteins. Addition of an antibody directed against TGF beta 1 increased expression of IGFBP-1 mRNA in decidualised cells. Knockdown of SMAD 4 using siRNAs abrogated the effect of TGF beta 1 on expression of PRL in ESCs but did not fully restore expression of IGFBP-1 mRNA and protein. Conclusions/Significance: TGF beta 1 inhibits the expression and secretion of decidual marker proteins. The impact of TGF beta 1 on PRL is SMAD-dependent but the impact on IGFBP1 is via an alternative mechanism. In early pregnancy, resistance of DSC to the impact of TGF beta 1 may be important to ensure tissue homeostasis.	[Kane, Nicole M.; Kelly, Rodney W.; Saunders, Philippa T. K.] Queens Med Res Inst, Ctr Reprod Biol, Med Res Council Human Reprod Sci Unit, Edinburgh, Midlothian, Scotland; [Jones, Marius; Brosens, Jan J.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sch Med, Inst Reprod & Dev Biol, London, England; [Critchley, Hilary O. D.] Univ Edinburgh, Queens Med Res Inst, Ctr Reprod Biol, Div Reprod & Dev Sci, Edinburgh, Midlothian, Scotland	University of Edinburgh; Imperial College London; University of Edinburgh	Kane, NM (corresponding author), Univ Glasgow, British Heart Fdn Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland.	hilary.critchley@ed.ac.uk	Saunders, Philippa TK/C-7489-2013	Saunders, Philippa TK/0000-0001-9051-9380; CRITCHLEY, HILARY/0000-0003-1913-4044; Brosens, Jan/0000-0003-0116-9329	Medical Research Council [G0500047]; Medical Research Council Reproductive Sciences Unit [U1276.00.002.00005.01]; MRC [G0500047, MC_U127685844] Funding Source: UKRI; Medical Research Council [MC_U127685844, G9900991B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council Reproductive Sciences Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	NMK was the recipient of a Medical Research Council PhD studentship to the Medical Research Council Human Reproductive Sciences Unit. RK and PTKS were funded by the core grant to the Medical Research Council Reproductive Sciences Unit (U1276.00.002.00005.01). Support to HODC came from Medical Research Council Programme Grant G0500047. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELL SC, 1990, BRIT MED BULL, V46, P720, DOI 10.1093/oxfordjournals.bmb.a072427; Brosens JJ, 1999, ENDOCRINOLOGY, V140, P4809, DOI 10.1210/en.140.10.4809; Chang HJ, 2008, FERTIL STERIL, V90, P1357, DOI 10.1016/j.fertnstert.2007.09.010; Chevronnay HPG, 2008, ENDOCRINOLOGY, V149, P1015, DOI 10.1210/en.2007-0849; Coya R, 1999, J NEUROENDOCRINOL, V11, P351; CRABTREE JS, 2008, MOL CELL ENDOCRINOL; Critchley HOD, 2009, REPROD SCI, V16, P191, DOI 10.1177/1933719108331121; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dimitriadis E, 2005, J CLIN ENDOCR METAB, V90, P3458, DOI 10.1210/jc.2004-1014; Dunn Carolyn L, 2003, Reprod Biomed Online, V7, P151; Finn CA, 1996, EUR J OBSTET GYN R B, V70, P3, DOI 10.1016/S0301-2115(96)02565-1; Gellersen B, 2003, J ENDOCRINOL, V178, P357, DOI 10.1677/joe.0.1780357; Gellersen B, 2007, SEMIN REPROD MED, V25, P445, DOI 10.1055/s-2007-991042; Hanson EK, 2009, ANAL BIOCHEM, V387, P303, DOI 10.1016/j.ab.2009.01.037; Hendy GN, 2005, HORM METAB RES, V37, P375, DOI 10.1055/s-2005-870152; Jokhi PP, 1997, CYTOKINE, V9, P126, DOI 10.1006/cyto.1996.0146; Kane N, 2008, MOL ENDOCRINOL, V22, P716, DOI 10.1210/me.2007-0316; Kane N, 2009, ENDOCRINOLOGY, V150, P2882, DOI 10.1210/en.2008-1309; Kim MR, 2005, MOL HUM REPROD, V11, P801, DOI 10.1093/molehr/gah240; Kimatrai M, 2003, J CLIN ENDOCR METAB, V88, P844, DOI 10.1210/jc.2002-021224; King A, 2000, HUM REPROD UPDATE, V6, P28, DOI 10.1093/humupd/6.1.28; Krikun G, 2009, THROMB RES, V124, P393, DOI 10.1016/j.thromres.2009.06.013; Kubota T, 1997, EUR J ENDOCRINOL, V137, P200, DOI 10.1530/eje.0.1370200; LANE B, 1994, HUM REPROD, V9, P259, DOI 10.1093/oxfordjournals.humrep.a138492; Lessey BA, 2000, BEST PRACT RES CL OB, V14, P775, DOI 10.1053/beog.2000.0118; Lockwood CJ, 1999, SEMIN REPROD ENDOCR, V17, P45, DOI 10.1055/s-2007-1016211; LYSIAK JJ, 1995, PLACENTA, V16, P221, DOI 10.1016/0143-4004(95)90110-8; Mazella J, 2004, HUM REPROD, V19, P1513, DOI 10.1093/humrep/deh274; Milne SA, 1999, J CLIN ENDOCR METAB, V84, P2563, DOI 10.1210/jc.84.7.2563; Nasu K, 2005, FERTIL STERIL, V84, P1114, DOI 10.1016/j.fertnstert.2005.02.055; NOYES RW, 1950, FERTIL STERIL, V1, P3, DOI 10.1016/s0015-0282(16)30062-0; OMWANDHO CO, 2009, HUM REPROD; Pan Q, 2008, SEMIN REPROD MED, V26, P479, DOI 10.1055/s-0028-1096128; Pan Q, 2008, J CELL MOL MED, V12, P227, DOI 10.1111/j.1582-4934.2007.00207.x; Popovici RM, 2000, ENDOCRINOLOGY, V141, P3510, DOI 10.1210/en.141.9.3510; RAMSEY EM, 1976, AM J OBSTET GYNECOL, V124, P647, DOI 10.1016/0002-9378(76)90068-5; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Simpson H, 2002, PLACENTA, V23, P44, DOI 10.1053/plac.2001.0746; Singer CF, 1997, P NATL ACAD SCI USA, V94, P10341, DOI 10.1073/pnas.94.19.10341; Stoikos CJ, 2008, HUM REPROD, V23, P1447, DOI 10.1093/humrep/den110; Tulac S, 2003, J CLIN ENDOCR METAB, V88, P3860, DOI 10.1210/jc.2003-030494; VICOVAC LM, 1994, J CLIN ENDOCR METAB, V79, P1877, DOI 10.1210/jc.79.6.1877; Zhang Y, 1997, CURR BIOL, V7, P270, DOI 10.1016/S0960-9822(06)00123-0	43	16	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2010	5	9							e12970	10.1371/journal.pone.0012970	http://dx.doi.org/10.1371/journal.pone.0012970			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653UN	20885978	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000282122600009
J	Kot, CY; Fujioka, E; Hazen, LJ; Best, BD; Read, AJ; Halpin, PN				Kot, Connie Y.; Fujioka, Ei; Hazen, Lucie J.; Best, Benjamin D.; Read, Andrew J.; Halpin, Patrick N.			Spatio-Temporal Gap Analysis of OBIS-SEAMAP Project Data: Assessment and Way Forward	PLOS ONE			English	Article							AERIAL SURVEYS; MARINE; CONSERVATION; CETACEANS; BEHAVIOR; WATERS; SHIP; TOOL	The OBIS-SEAMAP project has acquired and served high-quality marine mammal, seabird, and sea turtle data to the public since its inception in 2002. As data accumulated, spatial and temporal biases resulted and a comprehensive gap analysis was needed in order to assess coverage to direct data acquisition for the OBIS-SEAMAP project and for taxa researchers should true gaps in knowledge exist. All datasets published on OBIS-SEAMAP up to February 2009 were summarized spatially and temporally. Seabirds comprised the greatest number of records, compared to the other two taxa, and most records were from shipboard surveys, compared to the other three platforms. Many of the point observations and polyline tracklines were located in northern and central Atlantic and the northeastern and central-eastern Pacific. The Southern Hemisphere generally had the lowest representation of data, with the least number of records in the southern Atlantic and western Pacific regions. Temporally, records of observations for all taxa were the lowest in fall although the number of animals sighted was lowest in the winter. Oceanographic coverage of observations varied by platform for each taxa, which showed that using two or more platforms represented habitat ranges better than using only one alone. Accessible and published datasets not already incorporated do exist within spatial and temporal gaps identified. Other related open-source data portals also contain data that fill gaps, emphasizing the importance of dedicated data exchange. Temporal and spatial gaps were mostly a result of data acquisition effort, development of regional partnerships and collaborations, and ease of field data collection. Future directions should include fostering partnerships with researchers in the Southern Hemisphere while targeting datasets containing species with limited representation. These results can facilitate prioritizing datasets needed to be represented and for planning research for true gaps in space and time.	[Kot, Connie Y.; Fujioka, Ei; Hazen, Lucie J.; Best, Benjamin D.; Halpin, Patrick N.] Duke Univ, Nicholas Sch Environm, Marine Geospatial Ecol Lab, Beaufort, NC USA	Duke University	Kot, CY (corresponding author), Duke Univ, Nicholas Sch Environm, Marine Geospatial Ecol Lab, Beaufort, NC USA.	connie.kot@duke.edu	Read, Andrew/AAE-8386-2019	Kot, Connie/0000-0002-4900-5289	National Science Foundation; National Oceanic Partnership Program [NSF-OCE-07-39199]	National Science Foundation(National Science Foundation (NSF)); National Oceanic Partnership Program	Current funding for OBIS-SEAMAP comes from the National Science Foundation (http://www.nsf.gov) and the National Oceanic Partnership Program (http://www.nopp.org) 3-year award number NSF-OCE-07-39199. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Best BD, 2007, ECOL INFORM, V2, P210, DOI 10.1016/j.ecoinf.2007.07.007; Bodkin JL, 1999, MARINE MAMMAL SURVEY AND ASSESSMENT METHODS, P13; Bowman AW, 2003, COMPUT STAT DATA AN, V42, P545, DOI 10.1016/S0167-9473(02)00118-4; Bowman AW, 1997, APPL SMOOTHING TECHN; BRIGGS KT, 1985, J WILDLIFE MANAGE, V49, P405, DOI 10.2307/3801542; Carlton JT, 1999, ANNU REV ECOL SYST, V30, P515, DOI 10.1146/annurev.ecolsys.30.1.515; Certain G, 2008, ICES J MAR SCI, V65, P656, DOI 10.1093/icesjms/fsn046; Clapham Phillip J., 2004, Journal of Cetacean Research and Management, V6, P1; Coyne MS, 2005, MAR ECOL PROG SER, V301, P1, DOI 10.3354/meps301001; Decker CJ, 2002, OCEANOL ACTA, V25, P179, DOI 10.1016/S0399-1784(02)01208-2; DiSciara GN, 1997, MAR FRESHW BEHAV PHY, V30, P125; ESRI, 2009, ARCGIS 9 3 1; GOODMAN LA, 1961, ANN MATH STAT, V32, P148, DOI 10.1214/aoms/1177705148; Halpin PN, 2006, MAR ECOL PROG SER, V316, P239, DOI 10.3354/meps316239; Halpin PN, 2009, OCEANOGRAPHY, V22, P104, DOI 10.5670/oceanog.2009.42; Hart Kristen M., 2010, Endangered Species Research, V10, P9, DOI 10.3354/esr00238; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; HARTIGAN PM, 1985, J R STAT SOC C-APPL, V34, P320; Hooker, 1992, NASA TECHNICAL MEMOR; Hopkins ME, 2007, DIVERS DISTRIB, V13, P561, DOI 10.1111/j.1472-4642.2007.00364.x; IOC IHO and BODC, 2003, CENT ED GEBCO DIG AT; Jennings S., 2001, MARINE FISHERIES ECO; Kaschner K, 2006, MAR ECOL PROG SER, V316, P285, DOI 10.3354/meps316285; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; LILLIEFO.HW, 1969, J AM STAT ASSOC, V64, P387, DOI 10.2307/2283748; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; Luschi P, 2006, S AFR J SCI, V102, P51; Lydersen C, 2008, ARCTIC, V61, P119; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Matthiopoulos J, 2004, J APPL ECOL, V41, P476, DOI 10.1111/j.0021-8901.2004.00911.x; McManus RJ, 1998, BMJ-BRIT MED J, V317, P1562, DOI 10.1136/bmj.317.7172.1562; O'Brien J, 2009, BIOL ENVIRON, V109B, P63, DOI 10.3318/BIOE.2009.109.2.63; OCorry-Crowe G.M., 2002, ENCY MARINE MAM MALS, P94; Peters J.L., 1934, CHECK LIST BIRDS WOR; Potter JR, 2007, IEEE J OCEANIC ENG, V32, P469, DOI 10.1109/JOE.2006.880427; Pullin AS, 2001, CONSERV BIOL, V15, P50, DOI 10.1046/j.1523-1739.2001.99499.x; Reddy S, 2003, J BIOGEOGR, V30, P1719, DOI 10.1046/j.1365-2699.2003.00946.x; Rice D. W., 1998, SOC MARINE MAMMALOGY, V4, P1; Schreiber EA, 2001, BIOL MARINE BIRDS; SCOTT JM, 1993, WILDLIFE MONOGR, P1; Shaffer SA, 2006, IEEE J OCEANIC ENG, V31, P82, DOI 10.1109/JOE.2006.872210; Siebert U, 2006, J SEA RES, V56, P65, DOI 10.1016/j.seares.2006.01.003; Smith WHF, 1997, SCIENCE, V277, P1956, DOI 10.1126/science.277.5334.1956; Stevinson C, 2004, COMPLEMENT THER MED, V12, P228, DOI 10.1016/j.ctim.2004.09.003; Sutherland WJ, 2004, TRENDS ECOL EVOL, V19, P305, DOI 10.1016/j.tree.2004.03.018; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	55	17	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2010	5	9							e12990	10.1371/journal.pone.0012990	http://dx.doi.org/10.1371/journal.pone.0012990			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653UN	20886047	Green Published, Green Submitted, gold			2022-12-27	WOS:000282122600019
J	Zhao, YH; Ayoub, NA; Hayashi, CY				Zhao, Yonghui; Ayoub, Nadia A.; Hayashi, Cheryl Y.			Chromosome Mapping of Dragline Silk Genes in the Genomes of Widow Spiders (Araneae, Theridiidae)	PLOS ONE			English	Article							MAJOR AMPULLATE SILK; MECHANICAL-PROPERTIES; SEX-CHROMOSOMES; EVOLUTION; FIBROIN; LATRODECTUS; SEQUENCE; PROTEIN; FISH; KARYOTYPES	With its incredible strength and toughness, spider dragline silk is widely lauded for its impressive material properties. Dragline silk is composed of two structural proteins, MaSp1 and MaSp2, which are encoded by members of the spidroin gene family. While previous studies have characterized the genes that encode the constituent proteins of spider silks, nothing is known about the physical location of these genes. We determined karyotypes and sex chromosome organization for the widow spiders, Latrodectus hesperus and L. geometricus (Araneae, Theridiidae). We then used fluorescence in situ hybridization to map the genomic locations of the genes for the silk proteins that compose the remarkable spider dragline. These genes included three loci for the MaSp1 protein and the single locus for the MaSp2 protein. In addition, we mapped a MaSp1 pseudogene. All the MaSp1 gene copies and pseudogene localized to a single chromosomal region while MaSp2 was located on a different chromosome of L. hesperus. Using probes derived from L. hesperus, we comparatively mapped all three MaSp1 loci to a single region of a L. geometricus chromosome. As with L. hesperus, MaSp2 was found on a separate L. geometricus chromosome, thus again unlinked to the MaSp1 loci. These results indicate orthology of the corresponding chromosomal regions in the two widow genomes. Moreover, the occurrence of multiple MaSp1 loci in a conserved gene cluster across species suggests that MaSp1 proliferated by tandem duplication in a common ancestor of L. geometricus and L. hesperus. Unequal crossover events during recombination could have given rise to the gene copies and could also maintain sequence similarity among gene copies over time. Further comparative mapping with taxa of increasing divergence from Latrodectus will pinpoint when the MaSp1 duplication events occurred and the phylogenetic distribution of silk gene linkage patterns.	[Zhao, Yonghui; Ayoub, Nadia A.; Hayashi, Cheryl Y.] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA	University of California System; University of California Riverside	Zhao, YH (corresponding author), Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA.	yonghuiz@ucr.edu		Ayoub, Nadia/0000-0003-4404-1472	Army Research Office [W911NF-06-1-0455]; National Science Foundation [IOS-0951086, IOS-0951061]; Division Of Integrative Organismal Systems [0951086] Funding Source: National Science Foundation	Army Research Office; National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The research was funded by the Army Research Office (W911NF-06-1-0455 to CH) and National Science Foundation (IOS-0951086 to NA, IOS-0951061 to CH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo D, 2010, MICRON, V41, P165, DOI 10.1016/j.micron.2009.10.002; Araújo F. G, 2005, Braz. J. Biol., V65, P1, DOI 10.1590/S1519-69842005000100002; Arnedo MA, 2004, MOL PHYLOGENET EVOL, V31, P225, DOI 10.1016/S1055-7903(03)00261-6; Ayoub NA, 2008, MOL BIOL EVOL, V25, P277, DOI 10.1093/molbev/msm246; Ayoub NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000514; Ayoub Nadia A., 2009, P255; Blackledge TA, 2005, ZOOLOGY, V108, P41, DOI 10.1016/j.zool.2004.11.001; Blasingame E, 2009, J BIOL CHEM, V284, P29097, DOI 10.1074/jbc.M109.021378; Cabrero J, 2009, CHROMOSOME RES, V17, P397, DOI 10.1007/s10577-009-9030-5; Camacho JPM, 2000, PHILOS T R SOC B, V355, P163, DOI 10.1098/rstb.2000.0556; Chen SH, 1999, ZOOL STUD, V38, P423; Chinali A, 2010, J MOL EVOL, V70, P325, DOI 10.1007/s00239-010-9326-2; COPPIETERS W, 1994, MAMM GENOME, V5, P591, DOI 10.1007/BF00354938; Datta SN, 1983, CHROMOSOME INF SERV, V35, P6; Dimitri P, 2009, CHROMOSOMA, V118, P419, DOI 10.1007/s00412-009-0211-y; Foelix R., 2011, BIOL SPIDERS, V3; Gaines WA, 2008, INSECT MOL BIOL, V17, P465, DOI 10.1111/j.1365-2583.2008.00828.x; GANAL MW, 1991, MOL GEN GENET, V225, P501, DOI 10.1007/BF00261693; Ganley ARD, 2007, GENOME RES, V17, P184, DOI 10.1101/gr.5457707; Garb JE, 2005, P NATL ACAD SCI USA, V102, P11379, DOI 10.1073/pnas.0502473102; Garb JE, 2004, MOL PHYLOGENET EVOL, V31, P1127, DOI 10.1016/j.ympev.2003.10.012; Garb JE, 2007, MOL BIOL EVOL, V24, P2454, DOI 10.1093/molbev/msm179; Garb JE, 2006, SCIENCE, V312, P1762, DOI 10.1126/science.1127946; Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561; GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9; Gregory TR, 2003, J HERED, V94, P285, DOI 10.1093/jhered/esg070; GREGORY TR, 2006, ANIMAL GENOME SIZE D; Guerrero B, 2010, COMP BIOCHEM PHYS C, V151, P113, DOI 10.1016/j.cbpc.2009.09.005; Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0; Hayashi CY, 2004, MOL BIOL EVOL, V21, P1950, DOI 10.1093/molbev/msh204; Hayashi CY, 2000, SCIENCE, V287, P1477, DOI 10.1126/science.287.5457.1477; HINMAN MB, 1992, J BIOL CHEM, V267, P19320; Hurles M, 2004, PLOS BIOL, V2, P900, DOI 10.1371/journal.pbio.0020206; Kral J, 2007, CHROMOSOME RES, V15, P863, DOI 10.1007/s10577-007-1169-3; Kral J, 2006, CHROMOSOME RES, V14, P859, DOI 10.1007/s10577-006-1095-9; Kukekova AV, 2009, J HERED, V100, pS42, DOI 10.1093/jhered/esp037; LAAN M, 1995, GENOME RES, V5, P13, DOI 10.1101/gr.5.1.13; Lawrence BA, 2004, BIOMACROMOLECULES, V5, P689, DOI 10.1021/bm0342640; MADDISON WP, 1982, CHROMOSOMA, V85, P23, DOI 10.1007/BF00344592; MARTINDALE C, 1980, P ENT C ENT SOC SO A, V3, P45; MITA K, 1994, J MOL EVOL, V38, P583; Motriuk-Smith D, 2005, BIOMACROMOLECULES, V6, P3152, DOI 10.1021/bm050472b; Peng Yu, 1998, Acta Arachnologica Sinica, V7, P142; PLATNICK NI, 2010, WORLD SPIDER CATALOG; Repping S, 2003, MOL HUM REPROD, V9, P183, DOI 10.1093/molehr/gag032; Rezac M, 2006, HEREDITAS, V143, P123; Rising A, 2007, INSECT MOL BIOL, V16, P551, DOI 10.1111/j.1365-2583.2007.00749.x; ROWELL DM, 1985, CHROMOSOMA, V93, P169, DOI 10.1007/BF00293165; Swanson BO, 2006, EVOLUTION, V60, P2539; TUGMON CR, 1990, J ARACHNOL, V18, P41; XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120; Yasukochi Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007465; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8	53	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2010	5	9							e12804	10.1371/journal.pone.0012804	http://dx.doi.org/10.1371/journal.pone.0012804			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652JO	20877726	gold, Green Published, Green Submitted			2022-12-27	WOS:000282002900004
J	Fu, LP; Van Doorslaer, K; Chen, ZG; Ristriani, T; Masson, M; Trave, G; Burk, RD				Fu, Leiping; Van Doorslaer, Koenraad; Chen, Zigui; Ristriani, Tutik; Masson, Murielle; Trave, Gilles; Burk, Robert D.			Degradation of p53 by Human Alphapapillomavirus E6 Proteins Shows a Stronger Correlation with Phylogeny than Oncogenicity	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; DNA; IMMORTALIZATION; CLASSIFICATION; PATHOGENESIS; ONCOPROTEIN; INFECTION; BINDING; LESIONS; CANCER	Background: Human Papillomavirus (HPV) E6 induced p53 degradation is thought to be an essential activity by which high-risk human Alphapapillomaviruses (alpha-HPVs) contribute to cervical cancer development. However, most of our understanding is derived from the comparison of HPV16 and HPV11. These two viruses are relatively distinct viruses, making the extrapolation of these results difficult. In the present study, we expand the tested strains (types) to include members of all known HPV species groups within the Alphapapillomavirus genus. Principal Findings: We report the biochemical activity of E6 proteins from 27 HPV types representing all alpha-HPV species groups to degrade p53 in human cells. Expression of E6 from all HPV types epidemiologically classified as group 1 carcinogens significantly reduced p53 levels. However, several types not associated with cancer (e. g., HPV53, HPV70 and HPV71) were equally active in degrading p53. HPV types within species groups alpha 5, 6, 7, 9 and 11 share a most recent common ancestor (MRCA) and all contain E6 ORFs that degrade p53. A unique exception, HPV71 E6 ORF that degraded p53 was outside this clade and is one of the most prevalent HPV types infecting the cervix in a population-based study of 10,000 women. Alignment of E6 ORFs identified an amino acid site that was highly correlated with the biochemical ability to degrade p53. Alteration of this amino acid in HPV71 E6 abrogated its ability to degrade p53, while alteration of this site in HPV71-related HPV90 and HPV106 E6s enhanced their capacity to degrade p53. Conclusions: These data suggest that the alpha-HPV E6 proteins' ability to degrade p53 is an evolved phenotype inherited from a most recent common ancestor of the high-risk species that does not always segregate with carcinogenicity. In addition, we identified an amino-acid residue strongly correlated with viral p53 degrading potential.	[Fu, Leiping; Van Doorslaer, Koenraad; Chen, Zigui; Burk, Robert D.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Ristriani, Tutik; Masson, Murielle; Trave, Gilles] Ecole Super Biotechnol Strasbourg, Equipe Oncoprot, CNRS, UMR 7100, Illkirch Graffenstaden, France; [Burk, Robert D.] Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10467 USA; [Burk, Robert D.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth & Obstet, Bronx, NY 10467 USA; [Burk, Robert D.] Albert Einstein Coll Med, Dept Gynecol & Womens Hlth, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Centre National de la Recherche Scientifique (CNRS); Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Fu, LP (corresponding author), Cornell Univ, Dept Pharmacol, Joan & Sanford I Weill Med Sch, New York, NY 10021 USA.	Robert.Burk@einstein.yu.edu	Chen, Zigui/E-8490-2017; TRAVE, Gilles/P-8577-2016	Chen, Zigui/0000-0002-8577-1298; Van Doorslaer, Koenraad/0000-0002-2985-0733	National Cancer Institute [CA78527]; Einstein Cancer Research Center; Center for AIDS Research (CFAR); NATIONAL CANCER INSTITUTE [U01CA078527, R01CA078527] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Einstein Cancer Research Center; Center for AIDS Research (CFAR); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by Public Health Service awards CA78527 from the National Cancer Institute (RDB) and center grants to the Einstein Cancer Research Center and the Center for AIDS Research (CFAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUERSPERG N, 1964, J NATL CANCER I, V32, P135; Berkhout RJM, 2000, J CLIN MICROBIOL, V38, P2087; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Chen Z, 2007, INT J CANCER, V121, P2947; Chen ZG, 2005, J VIROL, V79, P7014, DOI 10.1128/JVI.79.11.7014-7023.2005; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Glaunsinger BA, 2000, ONCOGENE, V19, P5270, DOI 10.1038/sj.onc.1203906; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Harwood CA, 2000, J MED VIROL, V61, P289, DOI 10.1002/1096-9071(200007)61:3&lt;289::AID-JMV2&gt;3.0.CO;2-Z; Hebner CM, 2006, REV MED VIROL, V16, P83, DOI 10.1002/rmv.488; Herrero R, 2005, J INFECT DIS, V191, P1796, DOI 10.1086/428850; Hiller T, 2006, CANCER EPIDEM BIOMAR, V15, P1262, DOI 10.1158/1055-9965.EPI-05-0778; Howie HL, 2009, VIROLOGY, V384, P324, DOI 10.1016/j.virol.2008.11.017; LECHNER MS, 1994, J VIROL, V68, P4262, DOI 10.1128/JVI.68.7.4262-4273.1994; Li N, 2010, INT J CANC; Liu Y, 1999, J VIROL, V73, P7297, DOI 10.1128/JVI.73.9.7297-7307.1999; Mantovani F, 2001, ONCOGENE, V20, P7874, DOI 10.1038/sj.onc.1204869; McLaughlin-Drubin ME, 2009, VIRUS RES, V143, P195, DOI 10.1016/j.virusres.2009.06.008; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; MUNGER K, 1989, J VIROL, V63, P4417; Narechania A, 2005, J VIROL, V79, P15503, DOI 10.1128/JVI.79.24.15503-15510.2005; Nomine Y, 2006, MOL CELL, V21, P665, DOI 10.1016/j.molcel.2006.01.024; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Pfister Herbert, 2003, J Natl Cancer Inst Monogr, P52; Pim D, 1999, ONCOGENE, V18, P7403, DOI 10.1038/sj.onc.1203134; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Schiffman M, 2005, VIROLOGY, V337, P76, DOI 10.1016/j.virol.2005.04.002; Schironi F, 2009, SOZOMENA-STUD RECOV, V4, P8; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; YEE C, 1985, AM J PATHOL, V119, P361; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	35	39	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2010	5	9							e12816	10.1371/journal.pone.0012816	http://dx.doi.org/10.1371/journal.pone.0012816			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651XL	20862247	gold, Green Published, Green Submitted			2022-12-27	WOS:000281960800017
J	Bui, T; Stevenson, J; Hoekman, J; Zhang, SR; Maravilla, K; Ho, RJY				Bui, Tot; Stevenson, Jeff; Hoekman, John; Zhang, Shanrong; Maravilla, Kenneth; Ho, Rodney J. Y.			Novel Gd Nanoparticles Enhance Vascular Contrast for High-Resolution Magnetic Resonance Imaging	PLOS ONE			English	Article							MR-ANGIOGRAPHY; IN-VIVO; LIPOSOMES; ALBUMIN; AGENT	Background: Gadolinium (Gd), with its 7 unpaired electrons in 4f orbitals that provide a very large magnetic moment, is proven to be among the best agents for contrast enhanced MRI. Unfortunately, the most potent MR contrast agent based on Gd requires relatively high doses of Gd. The Gd-chelated to diethylene-triamine-penta-acetic acid (DTPA), or other derivatives (at 0.1 mmole/kg recommended dose), distribute broadly into tissues and clear through the kidney. These contrast agents carry the risk of Nephrogenic Systemic Fibrosis (NSF), particularly in kidney impaired subjects. Thus, Gd contrast agents that produce higher resolution images using a much lower Gd dose could address both imaging sensitivity and Gd safety. Methodology/Principal Findings: To determine whether a biocompatible lipid nanoparticle with surface bound Gd can improve MRI contrast sensitivity, we constructed Gd-lipid nanoparticles (Gd-LNP) containing lipid bound DTPA and Gd. The Gd-LNP were intravenously administered to rats and MR images collected. We found that Gd in Gd-LNP produced a greater than 33-fold higher longitudinal (T(1)) relaxivity, r(1), constant than the current FDA approved Gd-chelated contrast agents. Intravenous administration of these Gd-LNP at only 3% of the recommended clinical Gd dose produced MRI signal-to-noise ratios of greater than 300 in all vasculatures. Unlike current Gd contrast agents, these Gd-LNP stably retained Gd in normal vasculature, and are eliminated predominately through the biliary, instead of the renal system. Gd-LNP did not appear to accumulate in the liver or kidney, and was eliminated completely within 24 hrs. Conclusions/Significance: The novel Gd-nanoparticles provide high quality contrast enhanced vascular MRI at 97% reduced dose of Gd and do not rely on renal clearance. This new agent is likely to be suitable for patients exhibiting varying degrees of renal impairment. The simple and adaptive nanoparticle design could accommodate ligand or receptor coating for drug delivery optimization and in vivo drug-target definition in system biology profiling, increasing the margin of safety in treatment of cancers and other diseases.	[Bui, Tot; Hoekman, John; Ho, Rodney J. Y.] Univ Washington, Dept Pharmaceut, Seattle, WA 98195 USA; [Stevenson, Jeff; Zhang, Shanrong; Maravilla, Kenneth] Univ Washington, Dept Radiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Bui, T (corresponding author), Univ Washington, Dept Pharmaceut, Seattle, WA 98195 USA.	rodneyho@uw.edu			National Institutes of Health (NIH) [AI 077390, NS 39178]; University of Washington; Milo Gibaldi Endowment fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039178] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington(University of Washington); Milo Gibaldi Endowment fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported in part by National Institutes of Health (NIH) grants AI 077390, NS 39178 and the University of Washington Technology Gap Innovation Fund (TGIF) program. RJYH is also supported by Milo Gibaldi Endowment fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballmer PE, 2001, CLIN NUTR, V20, P271, DOI 10.1054/clnu.2001.0439; FDA, 2007, INF HEALTHC PROF GAD; HAK S, 2008, EUR J PHARM BIOPHARM; HUANG SK, 1992, CANCER RES, V52, P5135; Lauffer RB, 1998, RADIOLOGY, V207, P529, DOI 10.1148/radiology.207.2.9577506; Meaney JFM, 2007, EUR RADIOL, V17, pB1, DOI 10.1007/s10406-007-0199-4; Neubauer AM, 2008, MAGN RESON MED, V60, P1353, DOI 10.1002/mrm.21795; PETERS T, 1972, J BIOL CHEM, V247, P3858; Rofsky NM, 2008, RADIOLOGY, V247, P608, DOI 10.1148/radiol.2473071975; Sitharaman B, 2005, CHEM COMMUN, P3915, DOI 10.1039/b504435a; SOLOMON I, 1956, J CHEM PHYS, V25, P261, DOI 10.1063/1.1742867; TRUBETSKOY VS, 1995, MAGN RESON IMAGING, V13, P31, DOI 10.1016/0730-725X(94)00083-F; Woods Mark, 2004, Current Medicinal Chemistry - Immunology Endocrine & Metabolic Agents, V4, P349, DOI 10.2174/1568013043357338	13	40	42	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e13082	10.1371/journal.pone.0013082	http://dx.doi.org/10.1371/journal.pone.0013082			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20927340	gold, Green Published, Green Submitted			2022-12-27	WOS:000282312600017
J	Li, S; Ou, XH; Wang, ZB; Xiong, B; Tong, JS; Wei, LA; Li, M; Yuan, J; Ouyang, YC; Hou, Y; Schatten, H; Sun, QY				Li, Sen; Ou, Xiang-Hong; Wang, Zhen-Bo; Xiong, Bo; Tong, Jing-Shan; Wei, Liang; Li, Mo; Yuan, Ju; Ouyang, Ying-Chun; Hou, Yi; Schatten, Heide; Sun, Qing-Yuan			ERK3 Is Required for Metaphase-Anaphase Transition in Mouse Oocyte Meiosis	PLOS ONE			English	Article							KINETOCHORE-MICROTUBULE INTERFACE; SPINDLE-ASSEMBLY CHECKPOINT; ACTIVATED PROTEIN-KINASE; MAP KINASE; DYNAMIC INSTABILITY; MEIOTIC RESUMPTION; FEMALE MEIOSIS; MATURATION; CELLS; CDC20	ERK3 (extracellular signal-regulated kinase 3) is an atypical member of the mitogen-activated protein (MAP) kinase family of serine/threonine kinases. Little is known about its function in mitosis, and even less about its roles in mammalian oocyte meiosis. In the present study, we examined the localization, expression and functions of ERK3 during mouse oocyte meiotic maturation. Immunofluorescent analysis showed that ERK3 localized to the spindles from the pre-MI stage to the MII stage. ERK3 co-localized with alpha-tubulin on the spindle fibers and asters in oocytes after taxol treatment. Deletion of ERK3 by microinjection of ERK3 morpholino (ERK3 MO) resulted in oocyte arrest at the MI stage with severely impaired spindles and misaligned chromosomes. Most importantly, the spindle assembly checkpoint protein BubR1 could be detected on kinetochores even in oocytes cultured for 10 h. Low temperature treatment experiments indicated that ERK3 deletion disrupted kinetochore-microtubule (K-MT) attachments. Chromosome spreading experiments showed that knock-down of ERK3 prevented the segregation of homologous chromosomes. Our data suggest that ERK3 is crucial for spindle stability and required for the metaphase-anaphase transition in mouse oocyte maturation.	[Li, Sen; Ou, Xiang-Hong; Wang, Zhen-Bo; Xiong, Bo; Tong, Jing-Shan; Wei, Liang; Li, Mo; Yuan, Ju; Ouyang, Ying-Chun; Hou, Yi; Sun, Qing-Yuan] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Li, Sen; Wang, Zhen-Bo; Wei, Liang; Li, Mo; Yuan, Ju] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Schatten, Heide] Univ Missouri, Dept Vet Pathobiol, Columbia, MO USA	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Missouri System; University of Missouri Columbia	Li, S (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China.	sunqy@ioz.ac.cn	Wei, Liang/U-4349-2017	Tong, Jingshan/0000-0003-1640-5769	National Natural Science Foundation of China [30930065]; National Basic Research Program of China [2006CB504004, 2006CB944001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (30930065) and National Basic Research Program of China (2006CB504004, 2006CB944001) to QYS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Coulombe P, 2007, BBA-MOL CELL RES, V1773, P1376, DOI 10.1016/j.bbamcr.2006.11.001; Doubilet S, 2007, CHROMOSOME RES, V15, P681, DOI 10.1007/s10577-007-1148-8; Fan HY, 2009, SCIENCE, V324, P938, DOI 10.1126/science.1171396; Fan HY, 2004, BIOL REPROD, V70, P535, DOI 10.1095/biolreprod.103.022830; Fukagawa T, 2008, FRONT BIOSCI-LANDMRK, V13, P2705, DOI 10.2741/2877; Gerton JL, 2007, GENE DEV, V21, P238, DOI 10.1101/gad.1523107; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; HAYDEN JH, 1990, J CELL BIOL, V111, P1039, DOI 10.1083/jcb.111.3.1039; HILL TL, 1985, P NATL ACAD SCI USA, V82, P4404, DOI 10.1073/pnas.82.13.4404; Hoeflich KP, 2006, INT J ONCOL, V29, P839; HOLY TE, 1994, P NATL ACAD SCI USA, V91, P5682, DOI 10.1073/pnas.91.12.5682; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; JONES KT, CELL CYCLE, V9; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; Klinger S, 2009, P NATL ACAD SCI USA, V106, P16710, DOI 10.1073/pnas.0900919106; Li M, 2008, BIOL REPROD, V79, P897, DOI 10.1095/biolreprod.108.069245; Li M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007701; Liang CG, 2007, MOL ENDOCRINOL, V21, P2037, DOI 10.1210/me.2006-0408; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; Mehlmann LM, 2005, REPRODUCTION, V130, P791, DOI 10.1530/rep.1.00793; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Schindler K, 2009, CELL CYCLE, V8, P1090, DOI 10.4161/cc.8.7.8144; Schumacher S, 2004, EMBO J, V23, P4770, DOI 10.1038/sj.emboj.7600467; Seternes OM, 2004, EMBO J, V23, P4780, DOI 10.1038/sj.emboj.7600489; Sirard MA, 2001, THERIOGENOLOGY, V55, P1241, DOI 10.1016/S0093-691X(01)00480-0; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Swan A, 2005, CELL CYCLE, V4, P1332, DOI 10.4161/cc.4.10.2088; TANGUAY PL, BIOCH J, V428, P103; Turgeon B, 2000, BIOCHEM J, V346, P169, DOI 10.1042/0264-6021:3460169; VERLHAC MH, 1993, DEV BIOL, V158, P330, DOI 10.1006/dbio.1993.1192; VERLHAC MH, 1994, DEVELOPMENT, V120, P1017; Wassmann K, 2003, CURR BIOL, V13, P1596, DOI 10.1016/j.cub.2003.08.052; WEI L, CELL CYCLE, V9; Westermann S, 2007, ANNU REV BIOCHEM, V76, P563, DOI 10.1146/annurev.biochem.76.052705.160607; Yin S, 2008, CELL CYCLE, V7, P2997, DOI 10.4161/cc.7.19.6809; Yin S, 2007, CELL CYCLE, V6, P2990, DOI 10.4161/cc.6.23.4993	40	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e13074	10.1371/journal.pone.0013074	http://dx.doi.org/10.1371/journal.pone.0013074			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20927325	Green Published, Green Submitted, gold			2022-12-27	WOS:000282269400023
J	Suptawiwat, O; Tantilipikorn, P; Boonarkart, C; Lumyongsatien, J; Uiprasertkul, M; Puthavathana, P; Auewarakul, P				Suptawiwat, Ornpreya; Tantilipikorn, Pongsakorn; Boonarkart, Chompunuch; Lumyongsatien, Jate; Uiprasertkul, Mongkol; Puthavathana, Pilaipan; Auewarakul, Prasert			Enhanced Susceptibility of Nasal Polyp Tissues to Avian and Human Influenza Viruses	PLOS ONE			English	Article							NF-KAPPA-B; A H5N1; ORGAN-CULTURES; EXPRESSION; SIALYLTRANSFERASES; TRANSMISSION; REPLICATION	Background: Influenza viruses bind and infect respiratory epithelial cells through sialic acid on cell surface. Differential preference to sialic acid types contributes to host-and tissue-tropism of avian and seasonal influenza viruses. Although the highly pathogenic avian influenza virus H5N1 can infect and cause severe diseases in humans, it is not efficient in infecting human upper respiratory tract. This is because of the scarcity of its receptor, alpha 2,3-linked sialic acid, in human upper airway. Expression of sialic acid can be influenced by various factors including inflammatory process. Allergic rhinitis and nasal polyp are common inflammatory conditions of nasal mucosa and may affect expression of the sialic acid and susceptibility to influenza infection. Methodology/Principal Finding: To test this hypothesis, we detected alpha 2,3- and alpha 2,6-linked sialic acid in human nasal polyp and normal nasal mucosal tissues by lectin staining and infected explants of those tissues with avian influenza viruses H5N1 and seasonal influenza viruses. We show here that mucosal surface of nasal polyp expressed higher level of alpha 2,3- and alpha 2,6-linked sialic acid than normal nasal mucosa. Accordingly, both H5N1 avian influenza viruses and seasonal influenza viruses replicated more efficiently in nasal polyp tissues explants. Conclusions/Significance: Our data suggest a role of nasal inflammatory conditions in susceptibility to influenza infection, especially by avian influenza viruses, which is generally inefficient in infecting human upper airway. The increased receptor expression may contribute to increased susceptibility in some individuals. This may contribute to the gradual adaptation of the virus to human population.	[Suptawiwat, Ornpreya; Boonarkart, Chompunuch; Puthavathana, Pilaipan; Auewarakul, Prasert] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok 10700, Thailand; [Tantilipikorn, Pongsakorn; Lumyongsatien, Jate] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Otorhinolaryngol, Bangkok 10700, Thailand; [Uiprasertkul, Mongkol] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Pathol, Bangkok 10700, Thailand	Mahidol University; Mahidol University; Mahidol University	Suptawiwat, O (corresponding author), Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok 10700, Thailand.	sipaw@mahidol.ac.th	Tantilipikorn, Pongsakorn/D-2797-2019; Auewarakul, Prasert/D-6015-2011	Tantilipikorn, Pongsakorn/0000-0003-1995-4798; Auewarakul, Prasert/0000-0002-4745-4291	Thailand Research Fund; Faculty of Medicine Siriraj Hospital	Thailand Research Fund(Thailand Research Fund (TRF)); Faculty of Medicine Siriraj Hospital	This study was supported by Thailand Research Fund. O.S. and C. B. were supported by post-doctoral and research assistant grants of Faculty of Medicine Siriraj Hospital. The sponsors of the study had no role in study design, collection, analysis, or interpretation of data, or in the writing of the report.	Dall'Olio F, 2001, GLYCOCONJUGATE J, V18, P841, DOI 10.1023/A:1022288022969; FASANO MB, CURR OPIN OTOLARYNGO, V18, P15; Fireman P, 1996, ALLERGY ASTHMA PROC, V17, P175, DOI 10.2500/108854196778996886; GINZBURG VP, 1985, ACTA VIROL, V29, P424; GINZBURG VP, 1982, ARCH VIROL, V74, P293, DOI 10.1007/BF01314162; JENSEN C, 1987, AGENTS ACTIONS, V20, P161, DOI 10.1007/BF02074657; KITAGAWA H, 1994, J BIOL CHEM, V269, P17872; Kumar N, 2008, J VIROL, V82, P9880, DOI 10.1128/JVI.00909-08; Lopez Perez G, 2009, REV ALERG MEX, V56, P86; Miller EK, 2008, PEDIATRICS, V121, P1, DOI 10.1542/peds.2007-1053; Nicholls JM, 2007, NAT MED, V13, P147, DOI 10.1038/nm1529; Nishimori H, 1997, ONCOGENE, V15, P2145, DOI 10.1038/sj.onc.1201542; Olsen SJ, 2005, EMERG INFECT DIS, V11, P1799; Ortiz JR, 2007, J INFECT DIS, V196, P1685, DOI 10.1086/522158; Petretti T, 2000, GUT, V46, P359, DOI 10.1136/gut.46.3.359; ROGERS GN, 1983, VIROLOGY, V127, P361, DOI 10.1016/0042-6822(83)90150-2; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; Shimizu T, 2001, AM J RESP CRIT CARE, V164, P1077, DOI 10.1164/ajrccm.164.6.2012058; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Suzuki Y, 2005, BIOL PHARM BULL, V28, P399, DOI 10.1248/bpb.28.399; Uiprasertkul M, 2005, EMERG INFECT DIS, V11, P1036, DOI 10.3201/eid1107.041313; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; Valera FCP, 2008, CLIN EXP ALLERGY, V38, P579, DOI 10.1111/j.1365-2222.2007.02929.x; Wang PH, 2005, GYNECOL ONCOL, V99, P631, DOI 10.1016/j.ygyno.2005.07.016	24	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2010	5	9							e12973	10.1371/journal.pone.0012973	http://dx.doi.org/10.1371/journal.pone.0012973			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653UN	20885984	Green Published, Green Submitted, gold			2022-12-27	WOS:000282122600012
J	Chang, JH; Cha, HR; Lee, DS; Seo, KY; Kweon, MN				Chang, Jae-Hoon; Cha, Hye-Ran; Lee, Dong-Sup; Seo, Kyoung Yul; Kweon, Mi-Na			1,25-Dihydroxyvitamin D-3 Inhibits the Differentiation and Migration of T(H)17 Cells to Protect against Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							REGULATORY T-CELLS; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; VITAMIN-D; DENDRITIC CELLS; TH17 CELLS; IN-VITRO; TGF-BETA; TRANSCRIPTIONAL REPRESSION; PREFERENTIAL RECRUITMENT	Background: Vitamin D-3, the most physiologically relevant form of vitamin D, is an essential organic compound that has been shown to have a crucial effect on the immune responses. Vitamin D-3 ameliorates the onset of the experimental autoimmune encephalomyelitis (EAE); however, the direct effect of vitamin D-3 on T cells is largely unknown. Methodology/ Principal Findings: In an in vitro system using cells from mice, the active form of vitamin D-3 (1,25dihydroxyvitamin D-3) suppresses both interleukin (IL)-17-producing T cells (T(H)17) and regulatory T cells (Treg) differentiation via a vitamin D receptor signal. The ability of 1,25-dihydroxyvitamin D-3 (1,25(OH)(2)D-3) to reduce the amount of IL-2 regulates the generation of Treg cells, but not T(H)17 cells. Under T(H)17-polarizing conditions, 1,25(OH)(2)D-3 helps to increase the numbers of IL-10-producing T cells, but 1,25(OH)(2)D-3' s negative regulation of T(H)17 development is still defined in the IL-10 2/ 2 T cells. Although the STAT1 signal reciprocally affects the secretion of IL-10 and IL-17, 1,25(OH)(2)D-3 inhibits IL-17 production in STAT1 2/ 2 T cells. Most interestingly, 1,25(OH)(2)D-3 negatively regulates CCR6 expression which might be essential for T(H)17 cells to enter the central nervous system and initiate EAE. Conclusions/ Significance: Our present results in an experimental murine model suggest that 1,25(OH)(2)D-3 can directly regulate T cell differentiation and could be applied in preventive and therapeutic strategies for T(H)17-mediated autoimmune diseases.	[Chang, Jae-Hoon; Cha, Hye-Ran; Seo, Kyoung Yul; Kweon, Mi-Na] Int Vaccine Inst, Mucosal Immunol Sect, Div Sci Lab, Seoul, South Korea; [Lee, Dong-Sup] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Seo, Kyoung Yul] Yonsei Univ, Coll Med, Dept Ophthalmol, Inst Vis Res, Seoul, South Korea	International Vaccine Institute; Seoul National University (SNU); Yonsei University; Yonsei University Health System	Chang, JH (corresponding author), Int Vaccine Inst, Mucosal Immunol Sect, Div Sci Lab, Seoul, South Korea.	mnkweon@ivi.int	Lee, Dong-Sup/J-2777-2012; Seo, Kyoung Yul/I-5484-2019	Cha, Hye-Ran/0000-0001-7112-7525; Seo, Kyoung Yul/0000-0002-9855-1980	MEST [2007-04213]	MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Mid-Career Researcher Program through a NRF grant funded by the MEST (No. 2007-04213) http://www.nrf.go.kr/html/kr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALROY I, 1995, MOL CELL BIOL, V15, P5789; Amadi-Obi A, 2007, NAT MED, V13, P711, DOI 10.1038/nm1585; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Barrat FJ, 2002, J EXP MED, V195, P603, DOI 10.1084/jem.20011629; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; BHALLA AK, 1986, CELL IMMUNOL, V98, P311, DOI 10.1016/0008-8749(86)90291-1; BRENNAN A, 1987, IMMUNOLOGY, V61, P457; Brucklacher-Waldert V, 2009, BRAIN, V132, P3329, DOI 10.1093/brain/awp289; Cantorna MT, 1996, P NATL ACAD SCI USA, V93, P7861, DOI 10.1073/pnas.93.15.7861; Cippitelli M, 1998, EUR J IMMUNOL, V28, P3017, DOI 10.1002/(SICI)1521-4141(199810)28:10<3017::AID-IMMU3017>3.3.CO;2-Y; Correale J, 2009, BRAIN, V132, P1146, DOI 10.1093/brain/awp033; D'Ambrosio D, 1998, J CLIN INVEST, V101, P252, DOI 10.1172/JCI1050; Daniel C, 2008, J PHARMACOL EXP THER, V324, P23, DOI 10.1124/jpet.107.127209; Diveu C, 2009, J IMMUNOL, V182, P5748, DOI 10.4049/jimmunol.0801162; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Ebers GC, 2008, LANCET NEUROL, V7, P268, DOI 10.1016/S1474-4422(08)70042-5; Fitzgerald DC, 2007, NAT IMMUNOL, V8, P1372, DOI 10.1038/ni1540; Fritsche J, 2003, BLOOD, V102, P3314, DOI 10.1182/blood-2002-11-3521; Gaffen SL, 2008, CYTOKINE, V43, P402, DOI 10.1016/j.cyto.2008.07.017; Ghoreishi M, 2009, J IMMUNOL, V182, P6071, DOI 10.4049/jimmunol.0804064; Gorman S, 2007, J IMMUNOL, V179, P6273, DOI 10.4049/jimmunol.179.9.6273; Griffin MD, 2001, P NATL ACAD SCI USA, V98, P6800, DOI 10.1073/pnas.121172198; Hayes CE, 1997, P SOC EXP BIOL MED, V216, P21, DOI 10.3181/00379727-216-44153A; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Issa LL, 1998, INFLAMM RES, V47, P451, DOI 10.1007/s000110050360; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kebir H, 2009, ANN NEUROL, V66, P390, DOI 10.1002/ana.21748; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; LEMIRE JM, 1985, J IMMUNOL, V134, P3032; Li JF, 2005, J NEUROL SCI, V232, P3, DOI 10.1016/j.jns.2004.12.013; MEEHAN MA, 1992, CELL IMMUNOL, V140, P400, DOI 10.1016/0008-8749(92)90206-5; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; Munger KL, 2006, JAMA-J AM MED ASSOC, V296, P2832, DOI 10.1001/jama.296.23.2832; Munger KL, 2004, NEUROLOGY, V62, P60, DOI 10.1212/01.WNL.0000101723.79681.38; Neufert C, 2007, EUR J IMMUNOL, V37, P1809, DOI 10.1002/eji.200636896; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Penna G, 2005, BLOOD, V106, P3490, DOI 10.1182/blood-2005-05-2044; Penna G, 2000, J IMMUNOL, V164, P2405, DOI 10.4049/jimmunol.164.5.2405; Penna G, 2006, J IMMUNOL, V177, P8504, DOI 10.4049/jimmunol.177.12.8504; PROVVEDINI DM, 1983, SCIENCE, V221, P1181, DOI 10.1126/science.6310748; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; RIGBY WFC, 1984, J CLIN INVEST, V74, P1451, DOI 10.1172/JCI111557; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Sigmundsdottir H, 2007, NAT IMMUNOL, V8, P285, DOI 10.1038/ni1433; Spach KM, 2006, J IMMUNOL, V177, P6030, DOI 10.4049/jimmunol.177.9.6030; Staeva-Vieira TP, 2002, J IMMUNOL, V168, P1181, DOI 10.4049/jimmunol.168.3.1181; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; Veldman CM, 2000, ARCH BIOCHEM BIOPHYS, V374, P334, DOI 10.1006/abbi.1999.1605; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Xiao S, 2008, J IMMUNOL, V181, P2277, DOI 10.4049/jimmunol.181.4.2277; Yanagisawa J, 1999, SCIENCE, V283, P1317, DOI 10.1126/science.283.5406.1317; Zheng SG, 2007, J IMMUNOL, V178, P2018, DOI 10.4049/jimmunol.178.4.2018	57	139	148	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12925	10.1371/journal.pone.0012925	http://dx.doi.org/10.1371/journal.pone.0012925			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886077	gold, Green Published, Green Submitted			2022-12-27	WOS:000282091100029
J	Szereszewski, JM; Pampillo, M; Ahow, MR; Offermanns, S; Bhattacharya, M; Babwah, AV				Szereszewski, Jacob M.; Pampillo, Macarena; Ahow, Maryse R.; Offermanns, Stefan; Bhattacharya, Moshmi; Babwah, Andy V.			GPR54 Regulates ERK1/2 Activity and Hypothalamic Gene Expression in a G alpha(q/11) and beta-Arrestin-Dependent Manner	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; KINASE ACTIVATION; BETA-ARRESTIN-1; PATHWAYS; MUTATION; LIGANDS; ROLES	G protein-coupled receptor 54 (GPR54) is a G(q/11)-coupled 7 transmembrane-spanning receptor (7TMR). Activation of GPR54 by kisspeptin (Kp) stimulates PIP2 hydrolysis, Ca2+ mobilization and ERK1/2 MAPK phosphorylation. Kp and GPR54 are established regulators of the hypothalamic-pituitary-gonadal (HPG) axis and loss-of-function mutations in GPR54 are associated with an absence of puberty and hypogonadotropic hypogonadism, thus defining an important role of the Kp/GPR54 signaling system in reproductive function. Given the tremendous physiological and clinical importance of the Kp/GPR54 signaling system, we explored the contributions of the GPR54-coupled G(q/11) and beta-arrestin pathways on the activation of a major downstream signaling molecule, ERK, using G(q/11) and beta-arrestin knockout mouse embryonic fibroblasts. Our study revealed that GPR54 employs the G(q/11) and beta-arrestin-2 pathways in a co-dependent and temporally overlapping manner to positively regulate ERK activity and pERK nuclear localization. We also show that while beta-arrestin-2 potentiates GPR54 signaling to ERK, beta-arrestin-1 inhibits it. Our data also revealed that diminished beta-arrestin-1 and -2 expression in the GT1-7 GnRH hypothalamic neuronal cell line triggered distinct patterns of gene expression following Kp10 treatment. Thus, beta-arrestin-1 and -2 also regulate distinct downstream responses in gene expression. Finally, we showed that GPR54, when uncoupled from the G(q/11) pathway, as is the case for several naturally occurring GPR54 mutants associated with hypogonadotropic hypogonadism, continues to regulate gene expression in a G protein-independent manner. These new and exciting findings add significantly to our mechanistic understanding of how this important receptor signals intracellularly in response to kisspeptin stimulation.	[Szereszewski, Jacob M.; Pampillo, Macarena; Ahow, Maryse R.; Babwah, Andy V.] Childrens Hlth Res Inst, London, ON, Canada; [Szereszewski, Jacob M.; Pampillo, Macarena; Ahow, Maryse R.; Babwah, Andy V.] Lawson Hlth Res Inst, London, ON, Canada; [Szereszewski, Jacob M.; Pampillo, Macarena; Ahow, Maryse R.; Babwah, Andy V.] Univ Western Ontario, Dept Obstet & Gynaecol, London, ON, Canada; [Szereszewski, Jacob M.; Ahow, Maryse R.; Bhattacharya, Moshmi; Babwah, Andy V.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada; [Offermanns, Stefan] Max Planck Inst Heart & Lung Res, Dept Pharmacol, Bad Nauheim, Germany	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Max Planck Society	Szereszewski, JM (corresponding author), Childrens Hlth Res Inst, London, ON, Canada.	ababwah@uwo.ca	Offermanns, Stefan/L-3313-2017	Offermanns, Stefan/0000-0001-8676-6805	Natural Sciences and Engineering Research Council of Canada (NSERC) [327334-2006]; Canadian Institute of Health Research (CIHR) [81383]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Research reported in this study was supported by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC, http://www.nserc-crsng.gc.ca) 327334-2006 (AVB) and the Canadian Institute of Health Research (CIHR, http://www.cihr-irsc.gc.ca) MOP#81383 (AVB). The following are recipients of a salary award and studentships: Andy Babwah: CIHR/CIHR's Institute of Gender and Health/Ontario Women's Health Council New Investigator Award, Moshmi Bhattacharya: NSERC University Faculty Award and Jacob Szereszewski: Department of Obstetrics and Gynaecology, University of Western Ontario, Studentship and Frederick Banting and Charles Best Canada Graduate Scholarship-Master's Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjobo-Hermans MJW, 2008, J CELL SCI, V121, P3770, DOI 10.1242/jcs.029785; Ahn S, 2004, J BIOL CHEM, V279, P7807, DOI 10.1074/jbc.C300443200; Barnes WG, 2005, J BIOL CHEM, V280, P8041, DOI 10.1074/jbc.M412924200; Blaukat A, 2000, MOL CELL BIOL, V20, P6837, DOI 10.1128/MCB.20.18.6837-6848.2000; Cerrato F, 2007, REV ENDOCR METAB DIS, V8, P47, DOI 10.1007/s11154-007-9027-3; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; Defea K, 2008, BRIT J PHARMACOL, V153, pS298, DOI 10.1038/sj.bjp.0707508; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Drake MT, 2008, J BIOL CHEM, V283, P5669, DOI 10.1074/jbc.M708118200; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Horie-Inoue K, 2006, SEMIN CANCER BIOL, V16, P235, DOI 10.1016/j.semcancer.2006.03.006; Hunton DL, 2005, MOL PHARMACOL, V67, P1229, DOI 10.1124/mol.104.006270; Kim J, 2009, J BIOL CHEM, V284, P11953, DOI 10.1074/jbc.M808176200; Kobayashi H, 2005, CELL SIGNAL, V17, P1248, DOI 10.1016/j.cellsig.2004.12.014; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Kohout TA, 2004, J BIOL CHEM, V279, P23214, DOI 10.1074/jbc.M402125200; Kotani M, 2001, J BIOL CHEM, V276, P34631, DOI 10.1074/jbc.M104847200; Kovacs JJ, 2009, DEV CELL, V17, P443, DOI 10.1016/j.devcel.2009.09.011; Kumar P, 2007, AM J PHYSIOL-CELL PH, V293, pC346, DOI 10.1152/ajpcell.00010.2007; Kuo FT, 2006, CELL SIGNAL, V18, P1914, DOI 10.1016/j.cellsig.2006.02.009; Lee DK, 1999, FEBS LETT, V446, P103, DOI 10.1016/S0014-5793(99)00009-5; Lelouvier B, 2008, J NEUROSCI, V28, P4336, DOI 10.1523/JNEUROSCI.4379-07.2008; Luttrell DK, 2003, ASSAY DRUG DEV TECHN, V1, P327, DOI 10.1089/15406580360545143; Luttrell LM, 2002, J CELL SCI, V115, P455; Mayer CM, 2009, FRONT NEUROENDOCRIN, V30, P405, DOI 10.1016/j.yfrne.2009.03.005; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Novaira HJ, 2009, MOL CELL ENDOCRINOL, V311, P126, DOI 10.1016/j.mce.2009.06.011; Pampillo M, 2009, MOL ENDOCRINOL, V23, P2060, DOI 10.1210/me.2009-0013; Quan WY, 2008, BIOCHEM BIOPH RES CO, V377, P705, DOI 10.1016/j.bbrc.2008.10.044; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Ren XR, 2005, P NATL ACAD SCI USA, V102, P1448, DOI 10.1073/pnas.0409534102; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Sneddon WB, 2007, ENDOCRINOLOGY, V148, P4073, DOI 10.1210/en.2007-0343; Sun JY, 2008, P NATL ACAD SCI USA, V105, P17085, DOI 10.1073/pnas.0802701105; Sun Y, 2002, J BIOL CHEM, V277, P49212, DOI 10.1074/jbc.M207294200; Teles MG, 2008, NEW ENGL J MED, V358, P709, DOI 10.1056/NEJMoa073443; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; Wacker JL, 2008, J BIOL CHEM, V283, P31068, DOI 10.1074/jbc.M805251200; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104; Zywietz A, 2001, J BIOL CHEM, V276, P3840, DOI 10.1074/jbc.M007819200	43	43	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12964	10.1371/journal.pone.0012964	http://dx.doi.org/10.1371/journal.pone.0012964			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886089	Green Published, gold, Green Submitted			2022-12-27	WOS:000282091100055
J	Nalca, A; Livingston, VA; Garza, NL; Zumbrun, EE; Frick, OM; Chapman, JL; Hartings, JM				Nalca, Aysegul; Livingston, Virginia A.; Garza, Nicole L.; Zumbrun, Elizabeth E.; Frick, Ondraya M.; Chapman, Jennifer L.; Hartings, Justin M.			Experimental Infection of Cynomolgus Macaques (Macaca fascicularis) with Aerosolized Monkeypox Virus	PLOS ONE			English	Article							VACCINIA VIRUS; SMALLPOX VACCINE; MODEL; PROTECTION; CHALLENGE; DISEASE; ST-246; CONGO	Monkeypox virus (MPXV) infection in humans results in clinical symptoms very similar to ordinary smallpox. Aerosol is a route of secondary transmission for monkeypox, and a primary route of smallpox transmission in humans. Therefore, an animal model for aerosol exposure to MPXV is needed to test medical countermeasures. To characterize the pathogenesis in cynomolgus macaques (Macaca fascicularis), groups of macaques were exposed to four different doses of aerosolized MPXV. Blood was collected the day before, and every other day after exposure and assessed for complete blood count (CBC), clinical chemistry analysis, and quantitative PCR. Macaques showed mild anorexia, depression, and fever on day 6 post-exposure. Lymphadenopathy, which differentiates monkeypox from smallpox, was observed in exposed macaques around day 6 post-exposure. CBC and clinical chemistries showed abnormalities similar to human monkeypox cases. Whole blood and throat swab viral loads peaked around day 10, and in survivors, gradually decreased until day 28 post-exposure. Survival was not dose dependent. As such, doses of 4 x 10(4) PFU, 1 x 10(5) PFU, or 1 x 10(6) PFU resulted in lethality for 70% of the animals, whereas a dose of 4 x 10(5) PFU resulted in 85% lethality. Overall, cynomolgus macaques exposed to aerosolized MPXV develop a clinical disease that resembles that of human monkeypox. These findings provide a strong foundation for the use of aerosolized MPXV exposure of cynomolgus macaques as an animal model to test medical countermeasures against orthopoxviruses.	[Nalca, Aysegul; Livingston, Virginia A.; Garza, Nicole L.; Zumbrun, Elizabeth E.; Frick, Ondraya M.; Hartings, Justin M.] USA, Med Res Inst Infect Dis, Ctr Aerobiol Sci, Ft Detrick, MD 21702 USA; [Chapman, Jennifer L.] USA, Med Res Inst Infect Dis, Div Pathol, Ft Detrick, MD 21702 USA		Nalca, A (corresponding author), USA, Med Res Inst Infect Dis, Ctr Aerobiol Sci, Ft Detrick, MD 21702 USA.	aysegul.nalca@us.army.mil	Nalca, Aysegul/L-8149-2019	Nalca, Aysegul/0000-0001-8581-7535; Zumbrun, Elizabeth/0000-0002-9897-7201	Office of Biodefense Research Affairs (OBRA)/National Institute of Allergy and Infectious Diseases (NIAID) [A120-B11]; USAMRIID	Office of Biodefense Research Affairs (OBRA)/National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); USAMRIID	This study was supported by an interagency agreement (IAA: A120-B11) between The Office of Biodefense Research Affairs (OBRA)/National Institute of Allergy and Infectious Diseases (NIAID) and USAMRIID. The sponsors had input in study design and review of the manuscript, but had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MM, 2007, J VIROL, V81, P11084, DOI 10.1128/JVI.00423-07; Bauer KD, 2000, CLIN CANCER RES, V6, P3552; Besch TK, 1996, LAB ANIM SCI, V46, P539; Earl PL, 2008, P NATL ACAD SCI USA, V105, P10889, DOI 10.1073/pnas.0804985105; Earl PL, 2004, NATURE, V428, P182, DOI 10.1038/nature02331; Edghill-Smith Y, 2005, NAT MED, V11, P740, DOI 10.1038/nm1261; FINE PEM, 1988, INT J EPIDEMIOL, V17, P643, DOI 10.1093/ije/17.3.643; Garza NL, 2009, VACCINE, V27, P5496, DOI 10.1016/j.vaccine.2009.06.105; HAHON N, 1961, BACTERIOL REV, V25, P459, DOI 10.1128/MMBR.25.4.459-476.1961; HAHON N, 1961, J INFECT DIS, V109, P294, DOI 10.1093/infdis/109.3.294; Handley L, 2009, EXPERT REV VACCINES, V8, P841, DOI 10.1586/ERV.09.55; Hartings Justin M., 2004, Journal of Pharmacological and Toxicological Methods, V49, P39, DOI 10.1016/j.vascn.2003.07.001; Huggins J, 2009, ANTIMICROB AGENTS CH, V53, P2620, DOI 10.1128/AAC.00021-09; Huhn GD, 2005, CLIN INFECT DIS, V41, P1742, DOI 10.1086/498115; Hutin YJF, 2001, EMERG INFECT DIS, V7, P434; Hutson C. L., PLOS ONE, V5, pe8912; Hutson CL, 2009, J GEN VIROL, V90, P323, DOI 10.1099/vir.0.005108-0; Jahrling PB, 2004, P NATL ACAD SCI USA, V101, P15196, DOI 10.1073/pnas.0405954101; Jezek Z., 1988, MONOGRAPHS VIROLOGY; Jordan R, 2009, ANTIMICROB AGENTS CH, V53, P1817, DOI 10.1128/AAC.01596-08; KRAMSKI M, PLOS ONE, V5; Marriott KA, 2008, VACCINE, V26, P581, DOI 10.1016/j.vaccine.2007.10.063; Nalca A, 2005, CLIN INFECT DIS, V41, P1765, DOI 10.1086/498155; Nalca A, 2008, ANTIVIR RES, V79, P121, DOI 10.1016/j.antiviral.2008.03.005; Nigam P, 2007, VIROLOGY, V366, P73, DOI 10.1016/j.virol.2007.04.010; Parker S, 2007, FUTURE MICROBIOL, V2, P17, DOI 10.2217/17460913.2.1.17; Prophet E. B., 1992, LAB METHODS HISTOTEC; Reynolds MG, 2006, J INFECT DIS, V194, P773, DOI 10.1086/505880; Rimoin AW, 2007, EMERG INFECT DIS, V13, P934, DOI 10.3201/eid1306.061540; Schriewer Jill, 2004, Methods Mol Biol, V269, P289; Shchelkunov SN, 2001, FEBS LETT, V509, P66, DOI 10.1016/S0014-5793(01)03144-1; Smee Donald F., 2008, Antiviral Chemistry & Chemotherapy, V19, P115; Stittelaar KJ, 2006, NATURE, V439, P745, DOI 10.1038/nature04295; Stittelaar KJ, 2005, J VIROL, V79, P7845, DOI 10.1128/JVI.79.12.7845-7851.2005; SWEARENGEN JR, 2006, BIODEFENSE RES METHO; Tesh RB, 2004, EMERG INFECT DIS, V10, P1563, DOI 10.3201/eid1009.040310; Zaucha GM, 2001, LAB INVEST, V81, P1581, DOI 10.1038/labinvest.3780373	38	42	42	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2010	5	9							e12880	10.1371/journal.pone.0012880	http://dx.doi.org/10.1371/journal.pone.0012880			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651YH	20862223	Green Submitted, Green Published, gold			2022-12-27	WOS:000281963200023
J	Hedborg, F; Fischer-Colbrie, R; Ostlin, N; Sandstedt, B; Tran, MGB; Maxwell, PH				Hedborg, Fredrik; Fischer-Colbrie, Reiner; Ostlin, Nurtena; Sandstedt, Bengt; Tran, Maxine G. B.; Maxwell, Patrick H.			Differentiation in Neuroblastoma: Diffusion-Limited Hypoxia Induces Neuro-Endocrine Secretory Protein 55 and Other Markers of a Chromaffin Phenotype	PLOS ONE			English	Article							IGF2 EXPRESSION; GENE-EXPRESSION; ADRENAL-MEDULLA; NERVOUS-SYSTEM; CELLS; HIF-2-ALPHA; HIF-1-ALPHA; NESP55; GROWTH; TUMORS	Background: Neuroblastoma is a childhood malignancy of sympathetic embryonal origin. A high potential for differentiation is a hallmark of neuroblastoma cells. We have previously presented data to suggest that in situ differentiation in tumors frequently proceeds along the chromaffin lineage and that decreased oxygen ( hypoxia) plays a role in this. Here we explore the utility of Neuro-Endocrine Secretory Protein 55 ( NESP55), a novel member of the chromogranin family, as a marker for this process. Methodology/Principal Findings: Immunohistochemical analyses and in situ hybridizations were performed on human fetal tissues, mouse xenografts of human neuroblastoma cell lines, and on specimens of human neuroblastoma/ganglioneuroma. Effects of anaerobic exposure on gene expression by cultured neuroblastoma cells was analyzed with quantitative real-time PCR. Fetal sympathetic nervous system expression of NESP55 was shown to be specific for chromaffin cell types. In experimental and clinical neuroblastoma NESP55 immunoreactivity was specific for regions of chronic hypoxia. NESP55 expression also correlated strikingly with morphological evidence of differentiation and with other chromaffin-specific patterns of gene expression, including IGF2 and HIF2 alpha. Anaerobic culture of five neuroblastoma cell lines resulted in an 18.9-fold mean up-regulation of NESP55. Conclusions/Significance: The data confirms that chronic tumor hypoxia is a key microenvironmental factor for neuroblastoma cell differentiation, causing induction of chromaffin features and NESP55 provides a reliable marker for this neuronal to neuroendocrine transition. The hypoxia-induced phenotype is the predominant form of differentiation in stroma-poor tumors, while in stroma-rich tumors the chromaffin phenotype coexists with ganglion cell-like differentiation. The findings provide new insights into the biological diversity which is a striking feature of this group of tumors.	[Hedborg, Fredrik; Ostlin, Nurtena] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, Uppsala, Sweden; [Hedborg, Fredrik] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Fischer-Colbrie, Reiner] Innsbruck Med Univ, Dept Pharmacol, Innsbruck, Austria; [Sandstedt, Bengt] Karolinska Inst, Childhood Canc Res Unit, Stockholm, Sweden; [Tran, Maxine G. B.] Univ Cambridge, Li Ka Shing Ctr, Canc Res Inst, Canc Res UK, Cambridge, England; [Maxwell, Patrick H.] UCL, Div Med, London, England	Uppsala University; Uppsala University; Medical University of Innsbruck; Karolinska Institutet; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of London; University College London	Hedborg, F (corresponding author), Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, Uppsala, Sweden.	fredrik.hedborg@genpat.uu.se	Tran, Maxine/ABF-4197-2021; Maxwell, Patrick H/C-5557-2008	Maxwell, Patrick H/0000-0002-0338-2679; Tran, Maxine Gia Binh/0000-0002-6034-4433	Lion's Cancer Fund of the Uppsala-Orebro Region; governmental and local funding via the regional health care organisation of Uppsala County; National Institute for Health Research [NF-SI-0507-10315] Funding Source: researchfish	Lion's Cancer Fund of the Uppsala-Orebro Region; governmental and local funding via the regional health care organisation of Uppsala County; National Institute for Health Research(National Institute for Health Research (NIHR))	The project was supported by grants from Lion's Cancer Fund of the Uppsala-Orebro Region (http://www.lcff.se/), and by governmental and local funding via the regional health care organisation of Uppsala County (http://www.medfarm.uu.se/intranet/ALF/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrae J, 2002, BIOCHEM BIOPH RES CO, V296, P604, DOI 10.1016/S0006-291X(02)00917-8; Axelson H, 2004, CANCER LETT, V204, P171, DOI 10.1016/S0304-3835(03)00453-1; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Bristow RG, 2008, NAT REV CANCER, V8, P180, DOI 10.1038/nrc2344; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466, DOI 10.1200/JCO.1993.11.8.1466; BRODEUR GM, 2000, NEUROBLASTOMA; Coupland RE., 1965, NATURAL HIST CHROMAF; Edsjo A, 2007, SEMIN CANCER BIOL, V17, P248, DOI 10.1016/j.semcancer.2006.04.005; Feldman SA, 2003, ENDOCR PATHOL, V14, P3, DOI 10.1385/EP:14:1:3; Fischer-Colbrie R, 2002, ANN NY ACAD SCI, V971, P317, DOI 10.1111/j.1749-6632.2002.tb04486.x; Fredlund E, 2008, BIOCHEM BIOPH RES CO, V366, P1054, DOI 10.1016/j.bbrc.2007.12.074; Gestblom C, 1997, AM J PATHOL, V150, P107; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; HEDBORG F, 1995, AM J PATHOL, V146, P833; HEDBORG F, 1994, AM J PATHOL, V145, P802; Hedborg F, 2003, FASEB J, V17, P598, DOI 10.1096/fj.02-0390com; Hedborg F, 2001, MED PEDIATR ONCOL, V36, P149, DOI 10.1002/1096-911X(20010101)36:1<149::AID-MPO1036>3.0.CO;2-M; HERVONEN A, 1972, ACTA OBSTET GYN SCAN, V51, P17, DOI 10.3109/00016347209154963; Hoehner JC, 1998, LAB INVEST, V78, P29; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Jakobsen AM, 2003, BRIT J CANCER, V88, P1746, DOI 10.1038/sj.bjc.6600924; Jogi A, 2002, P NATL ACAD SCI USA, V99, P7021, DOI 10.1073/pnas.102660199; Jurgensen JS, 2004, FASEB J, V18, P1415, DOI 10.1096/fj.04-1605fje; Li JY, 2002, NEUROSCIENCE, V110, P731, DOI 10.1016/S0306-4522(01)00465-1; Liu SQ, 2005, CANCER LETT, V228, P125, DOI 10.1016/j.canlet.2005.01.056; LUNT SJ, 2008, TUMOR MICROENVIRONME; Maxwell PH, 2001, CURR OPIN GENET DEV, V11, P293, DOI 10.1016/S0959-437X(00)00193-3; Maxwell PH, 2005, EXP PHYSIOL, V90, P791, DOI 10.1113/expphysiol.2005.030924; OHLSSON R, 1989, EMBO J, V8, P1993, DOI 10.1002/j.1460-2075.1989.tb03606.x; Overgaard J, 2007, J CLIN ONCOL, V25, P4066, DOI 10.1200/JCO.2007.12.7878; Pahlman S, 2000, NEUROBLASTOMA, P9; Pahlman S, 2004, SEMIN CANCER BIOL, V14, P365, DOI 10.1016/j.semcancer.2004.04.016; PAHLMAN S, 1990, ACTA PHYSIOL SCAND, V140, P25; Reynolds CP, 2003, CANCER LETT, V197, P185, DOI 10.1016/S0304-3835(03)00108-3; Schramm A, 2005, CANCER LETT, V228, P143, DOI 10.1016/j.canlet.2005.02.051; Shimada H, 1999, CANCER, V86, P349, DOI 10.1002/(SICI)1097-0142(19990715)86:2<349::AID-CNCR20>3.3.CO;2-P; Siemann DW, 1998, INT J RADIAT ONCOL, V42, P697, DOI 10.1016/S0360-3016(98)00336-8; Sullivan R, 2007, CANCER METAST REV, V26, P319, DOI 10.1007/s10555-007-9062-2; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; Tian H, 1998, GENE DEV, V12, P3320, DOI 10.1101/gad.12.21.3320; Valentiner U, 2008, TUMOR BIOL, V29, P152, DOI 10.1159/000143401; Vaupel P, 2004, SEMIN RADIAT ONCOL, V14, P198, DOI 10.1016/j.semradonc.2004.04.008; Weiss U, 2000, NEUROENDOCRINOLOGY, V71, P177, DOI 10.1159/000054535; Wiesener MS, 1998, BLOOD, V92, P2260, DOI 10.1182/blood.V92.7.2260.2260_2260_2268; WINKLER H, 1992, NEUROSCIENCE, V49, P497, DOI 10.1016/0306-4522(92)90222-N	46	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2010	5	9							e12825	10.1371/journal.pone.0012825	http://dx.doi.org/10.1371/journal.pone.0012825			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651XL	20862257	Green Submitted, Green Published, gold			2022-12-27	WOS:000281960800020
J	Lewis, TB; Glasgow, JN; Glandon, AM; Curiel, DT; Standaert, DG				Lewis, Travis B.; Glasgow, Joel N.; Glandon, Anya M.; Curiel, David T.; Standaert, David G.			Transduction of Brain Dopamine Neurons by Adenoviral Vectors Is Modulated by CAR Expression: Rationale for Tropism Modified Vectors in PD Gene Therapy	PLOS ONE			English	Article							IDIOPATHIC PARKINSONS-DISEASE; NEUROTROPHIC FACTOR; CHIMERIC FIBER; EXPANDED TROPISM; OPEN-LABEL; RECEPTOR; COXSACKIEVIRUS; CANCER; SAFETY; VIRUS	Background: Gene-based therapy is a new paradigm for the treatment of Parkinson disease (PD) and offers considerable promise for precise targeting and flexibility to impact multiple pathobiological processes for which small molecule agents are not available. Some success has been achieved utilizing adeno-associated virus for this approach, but it is likely that the characteristics of this vector system will ultimately create barriers to progress in clinical therapy. Adenovirus (Ad) vector overcomes limitations in payload size and targeting. The cellular tropism of Ad serotype 5 (Ad5)-based vectors is regulated by the Ad attachment protein binding to its primary cellular receptor, the coxsackie and adenovirus receptor (CAR). Many clinically relevant tissues are refractory to Ad5 infection due to negligible CAR levels but can be targeted by tropism-modified, CAR-independent forms of Ad. Our objective was to evaluate the role of CAR protein in transduction of dopamine (DA) neurons in vivo. Methodology/Principal Findings: Ad5 was delivered to the substantia nigra (SN) in wild type (wt) and CAR transgenic animals. Cellular tropism was assessed by immunohistochemistry (IHC) in the SN and striatal terminals. CAR expression was assessed by western blot and IHC. We found in wt animals, Ad5 results in robust transgene expression in astrocytes and other non-neuronal cells but poor infection of DA neurons. In contrast, in transgenic animals, Ad5 infects SNc neurons resulting in expression of transduced protein in their striatal terminals. Western blot showed low CAR expression in the ventral midbrain of wt animals compared to transgenic animals. Interestingly, hCAR protein localizes with markers of postsynaptic structures, suggesting synapses are the point of entry into dopaminergic neurons in transgenic animals. Conclusions/Significance: These findings demonstrate that CAR deficiency limits infection of wild type DA neurons by Ad5 and provide a rationale for the development of tropism-modified, CAR-independent Ad-vectors for use in gene therapy of human PD.	[Lewis, Travis B.] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA; [Lewis, Travis B.; Glasgow, Joel N.; Curiel, David T.] Univ Alabama Birmingham, Dept Med, Div Human Gene Therapy, Birmingham, AL 35294 USA; [Lewis, Travis B.; Glasgow, Joel N.; Curiel, David T.] Univ Alabama Birmingham, Dept Obstet & Gynecol, Div Human Gene Therapy, Birmingham, AL 35294 USA; [Lewis, Travis B.; Glasgow, Joel N.; Curiel, David T.] Univ Alabama Birmingham, Dept Pathol, Div Human Gene Therapy, Birmingham, AL 35294 USA; [Lewis, Travis B.; Glasgow, Joel N.; Curiel, David T.] Univ Alabama Birmingham, Dept Surg, Div Human Gene Therapy, Birmingham, AL 35294 USA; [Lewis, Travis B.; Glasgow, Joel N.; Glandon, Anya M.; Standaert, David G.] Univ Alabama Birmingham, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL 35294 USA; [Glasgow, Joel N.; Curiel, David T.] Univ Alabama Birmingham, Gene Therapy Ctr, Birmingham, AL 35294 USA; [Glasgow, Joel N.] Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Lewis, TB (corresponding author), Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA.	dstandaert@uab.edu		Glasgow, Joel/0000-0002-2842-7917; Standaert, David/0000-0003-2921-8348	American Parkinson Disease Association (APDA) Advanced Center for Parkinson Research at The University of Alabama at Birmingham (UAB); National Institutes of Health (NIH) [F30NS065661, R01CA122930]; NATIONAL CANCER INSTITUTE [R01CA122930] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS065661] Funding Source: NIH RePORTER	American Parkinson Disease Association (APDA) Advanced Center for Parkinson Research at The University of Alabama at Birmingham (UAB); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors wish to acknowledge support by the American Parkinson Disease Association (APDA) Advanced Center for Parkinson Research at The University of Alabama at Birmingham (UAB) and National Institutes of Health (NIH) grants F30NS065661 and R01CA122930. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKLI S, 1993, NAT GENET, V3, P224, DOI 10.1038/ng0393-224; *AM SOC GEN THER, 2009, MOL THER S1, V17, pS1; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Bjorklund T, 2010, MOVEMENT DISORD, V25, pS161, DOI 10.1002/mds.22785; *CER, 2010, DOUBL BLIND MULT SHA; *CER, 2010, SAF CERE 120 AAV2 NT; *CER, 2010, SAF EFF CERE 120 SUB; Christine CW, 2009, NEUROLOGY, V73, P1662, DOI 10.1212/WNL.0b013e3181c29356; Cripe TP, 2001, CANCER RES, V61, P2953; Dmitriev I, 1998, J VIROL, V72, P9706, DOI 10.1128/JVI.72.12.9706-9713.1998; Eberling JL, 2008, NEUROLOGY, V70, P1980, DOI 10.1212/01.wnl.0000312381.29287.ff; FIELDS BN, 1996, FIELDS VIROLOGY, P1146; *GENZ, 2010, STUD AAV HAADC 2 SUB; Glasgow JN, 2006, CANCER GENE THER, V13, P830, DOI 10.1038/sj.cgt.7700928; Glasgow JN, 2004, VIROLOGY, V324, P103, DOI 10.1016/j.virol.2004.03.028; GRAYBIEL AM, 1990, ADV NEUROL, V53, P17; Guse K, 2009, GENE THER, V16, P1009, DOI 10.1038/gt.2009.56; Hammond R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007007; Hedley SJ, 2006, GENE THER, V13, P88, DOI 10.1038/sj.gt.3302603; Honda T, 2000, MOL BRAIN RES, V77, P19, DOI 10.1016/S0169-328X(00)00036-X; Hotta Y, 2003, DEV BRAIN RES, V143, P1, DOI 10.1016/S0165-3806(03)00035-X; JIMENEZCASTELLANOS J, 1987, NEUROSCIENCE, V23, P223, DOI 10.1016/0306-4522(87)90285-5; Kanerva A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002917; Kaplitt MG, 2007, LANCET, V369, P2097, DOI 10.1016/S0140-6736(07)60982-9; Kordower JH, 2003, ANN NEUROL, V53, pS120, DOI 10.1002/ana.10485; Lewis TB, 2008, EXP NEUROL, V209, P41, DOI 10.1016/j.expneurol.2007.08.012; Li HJ, 2007, CANCER RES, V67, P5354, DOI 10.1158/0008-5472.CAN-06-4679; Manfredsson FP, 2009, MOL THER, V17, P980, DOI 10.1038/mt.2009.45; Marks WJ, 2008, LANCET NEUROL, V7, P400, DOI 10.1016/S1474-4422(08)70065-6; *NEUR INC, 2010, STUD AAV GAD GEN TRA; *NEUR INC WEILL ME, 2010, SAF STUD SUBTHAL NUC; Nutt JG, 2003, NEUROLOGY, V60, P69, DOI 10.1212/WNL.60.1.69; *OXF BIOMEDICA, 2010, PHAS 1 2 STUD SAF EF; Paul CPL, 2008, CANCER BIOL THER, V7, P786, DOI 10.4161/cbt.7.5.5421; Pesonen S, 2010, GENE THER, V17, P892, DOI 10.1038/gt.2010.17; Reynolds PN, 2001, NAT BIOTECHNOL, V19, P838, DOI 10.1038/nbt0901-838; Slevin JT, 2007, J NEUROSURG, V106, P614, DOI 10.3171/jns.2007.106.4.614; Smith-Arica JR, 2000, MOL THER, V2, P579, DOI 10.1006/mthe.2000.0215; Soudais C, 2001, FASEB J, V15, P2283, DOI 10.1096/fj.01-0321fje; Stoff-Khalili MA, 2005, GENE THER, V12, P1696, DOI 10.1038/sj.gt.3302588; Su XM, 2009, HUM GENE THER, V20, P1627, DOI 10.1089/hum.2009.103; Tallone T, 2001, P NATL ACAD SCI USA, V98, P7910, DOI 10.1073/pnas.141223398; Tatarewicz SM, 2007, J CLIN IMMUNOL, V27, P620, DOI 10.1007/s10875-007-9117-8; Tomko RP, 1997, P NATL ACAD SCI USA, V94, P3352, DOI 10.1073/pnas.94.7.3352; *U AL BIRM NAT CAN, 2010, STUD INF ENH SUIC GE; Ulasov IV, 2007, J NEUROSURG, V107, P617, DOI 10.3171/JNS-07/09/0617; Wu HJ, 2002, HUM GENE THER, V13, P1647, DOI 10.1089/10430340260201734	47	14	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2010	5	9							e12672	10.1371/journal.pone.0012672	http://dx.doi.org/10.1371/journal.pone.0012672			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651XL	20862245	Green Published, Green Submitted, gold			2022-12-27	WOS:000281960800005
J	Deans, MR; Peterson, JM; Wong, GW				Deans, Michael R.; Peterson, Jonathan M.; Wong, G. William			Mammalian Otolin: A Multimeric Glycoprotein Specific to the Inner Ear that Interacts with Otoconial Matrix Protein Otoconin-90 and Cerebellin-1	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ACELLULAR MEMBRANES; STRUCTURAL PROTEIN; HUMAN ADIPONECTIN; SEVERE IMBALANCE; ADIPOSE-TISSUE; MAJOR PROTEIN; MUTANT MICE; FAMILY; GENE	Background: The mammalian otoconial membrane is a dense extracellular matrix containing bio-mineralized otoconia. This structure provides the mechanical stimulus necessary for hair cells of the vestibular maculae to respond to linear accelerations and gravity. In teleosts, Otolin is required for the proper anchoring of otolith crystals to the sensory maculae. Otoconia detachment and subsequent entrapment in the semicircular canals can result in benign paroxysmal positional vertigo (BPPV), a common form of vertigo for which the molecular basis is unknown. Several cDNAs encoding protein components of the mammalian otoconia and otoconial membrane have recently been identified, and mutations in these genes result in abnormal otoconia formation and balance deficits. Principal Findings: Here we describe the cloning and characterization of mammalian Otolin, a protein constituent of otoconia and the otoconial membrane. Otolin is a secreted glycoprotein of,70 kDa, with a C-terminal globular domain that is homologous to the immune complement C1q, and contains extensive posttranslational modifications including hydroxylated prolines and glycosylated lysines. Like all C1q/TNF family members, Otolin multimerizes into higher order oligomeric complexes. The expression of otolin mRNA is restricted to the inner ear, and immunohistochemical analysis identified Otolin protein in support cells of the vestibular maculae and semi-circular canal cristae. Additionally, Otolin forms protein complexes with Cerebellin-1 and Otoconin-90, two protein constituents of the otoconia, when expressed in vitro. Otolin was also found in subsets of support cells and non-sensory cells of the cochlea, suggesting that Otolin is also a component of the tectorial membrane. Conclusion: Given the importance of Otolin in lower organisms, the molecular cloning and biochemical characterization of the mammalian Otolin protein may lead to a better understanding of otoconial development and vestibular dysfunction.	[Deans, Michael R.] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Deans, Michael R.] Johns Hopkins Univ, Sch Med, Ctr Hearing & Balance, Baltimore, MD USA; [Deans, Michael R.] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Baltimore, MD USA; [Peterson, Jonathan M.; Wong, G. William] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Deans, MR (corresponding author), Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA.	gwwong@jhmi.edu	Peterson, Jonathan M./H-3122-2019	Peterson, Jonathan M./0000-0002-9873-3880; Wong, G. William/0000-0002-5286-6506	National Institute on Deafness and Other Communication Disorders (NIDCD) [R03 DC009490]; National Organization for Hearing Research (NOHR); American Heart Association [SDG2260721]; Baltimore Diabetes Research and Training Center (DRTC) [P60DK079637]; National Institutes of Health [DK084171]; National Institute of Diabetes and Digestive and Kidney Diseases [F32DK084607]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK084607, P60DK079637, R01DK084171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC009490] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Organization for Hearing Research (NOHR); American Heart Association(American Heart Association); Baltimore Diabetes Research and Training Center (DRTC); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	MRD is supported by National Institute on Deafness and Other Communication Disorders (NIDCD) R03 DC009490 and a research grant from National Organization for Hearing Research (NOHR). GWW is supported by research grants from the American Heart Association (SDG2260721), the Baltimore Diabetes Research and Training Center (DRTC; P60DK079637), and the National Institutes of Health (DK084171). JMP is supported by a National Research Service Award postdoctoral fellowship (F32DK084607) from the National Institute of Diabetes and Digestive and Kidney Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Moreno-Pelayo MA, 2008, JARO-J ASSOC RES OTO, V9, P202, DOI 10.1007/s10162-008-0116-0; ANNIKO M, 1988, ACTA OTO-LARYNGOL, V106, P208, DOI 10.3109/00016488809106427; Bao DS, 2006, MOL CELL BIOL, V26, P9327, DOI 10.1128/MCB.01161-06; Cohen-Salmon M, 1997, P NATL ACAD SCI USA, V94, P14450, DOI 10.1073/pnas.94.26.14450; DAVIS JG, 1995, SCIENCE, V267, P1031, DOI 10.1126/science.7863331; El-Amraoui A, 2001, HEARING RES, V158, P151, DOI 10.1016/S0378-5955(01)00312-4; ERWAY LC, 1986, SCANNING MICROSCOPY, V1986, P1681; GERSHONI JM, 1985, ANAL BIOCHEM, V146, P59, DOI 10.1016/0003-2697(85)90395-1; Ghai R, 2007, IMMUNOBIOLOGY, V212, P253, DOI 10.1016/j.imbio.2006.11.001; Hirai H, 2005, NAT NEUROSCI, V8, P1534, DOI 10.1038/nn1576; Hudspeth AJ, 2008, NEURON, V59, P530, DOI 10.1016/j.neuron.2008.07.012; Hughes I, 2006, BRAIN RES, V1091, P58, DOI 10.1016/j.brainres.2006.01.074; Hurle B, 2003, HUM MOL GENET, V12, P777, DOI 10.1093/hmg/ddg087; Jones SM, 2004, HEARING RES, V191, P34, DOI 10.1016/j.heares.2004.01.008; Jones SM, 1999, HEARING RES, V135, P56, DOI 10.1016/S0378-5955(99)00090-8; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; KANG YJ, 2008, J ASS RES OTOLARYNGO; Kishore U, 2004, TRENDS IMMUNOL, V25, P551, DOI 10.1016/j.it.2004.08.006; Kiss PJ, 2006, CURR BIOL, V16, P208, DOI 10.1016/j.cub.2005.12.025; Kozel PJ, 1998, J BIOL CHEM, V273, P18693, DOI 10.1074/jbc.273.30.18693; Legan PK, 2005, NAT NEUROSCI, V8, P1035, DOI 10.1038/nn1496; Legan PK, 1997, J BIOL CHEM, V272, P8791, DOI 10.1074/jbc.272.13.8791; Lim D J, 1973, Ann Otol Rhinol Laryngol, V82, P23; Lundberg YXW, 2006, BRAIN RES, V1091, P47, DOI 10.1016/j.brainres.2006.02.083; MELTON LJ, 1996, BONE S3, V18, P121; Murayama E, 2005, MECH DEVELOP, V122, P791, DOI 10.1016/j.mod.2005.03.002; Murayama E, 2004, HISTOCHEM CELL BIOL, V121, P155, DOI 10.1007/s00418-003-0605-5; Murayama E, 2002, EUR J BIOCHEM, V269, P688, DOI 10.1046/j.0014-2956.2001.02701.x; Mustapha M, 1999, HUM MOL GENET, V8, P409, DOI 10.1093/hmg/8.3.409; Oghalai JS, 2000, OTOLARYNG HEAD NECK, V122, P630, DOI 10.1016/S0194-5998(00)70187-2; Ornitz DM, 1998, HEARING RES, V122, P60, DOI 10.1016/S0378-5955(98)00080-X; Paffenholz R, 2004, GENE DEV, V18, P486, DOI 10.1101/gad.1172504; Pajvani UB, 2003, J BIOL CHEM, V278, P9073, DOI 10.1074/jbc.M207198200; Peake PW, 2007, J MOL ENDOCRINOL, V39, P45, DOI 10.1677/JME-07-0030; Petko JA, 2008, DEV NEUROBIOL, V68, P209, DOI 10.1002/dneu.20587; POTE KG, 1993, BIOCHEMISTRY-US, V32, P5017, DOI 10.1021/bi00070a007; POTE KG, 1991, COMP BIOCHEM PHYS B, V98, P287, DOI 10.1016/0305-0491(91)90181-C; Rau A, 1999, J COMP NEUROL, V405, P271; ROSS MD, 1984, PHILOS T ROY SOC B, V304, P445, DOI 10.1098/rstb.1984.0038; Salvinelli F, 2004, Clin Ter, V155, P395; Shapiro L, 1998, CURR BIOL, V8, P335, DOI 10.1016/S0960-9822(98)70133-2; SHINKAI H, 1979, BIOCHEM J, V177, P847, DOI 10.1042/bj1770847; Simmler MC, 2000, MAMM GENOME, V11, P961, DOI 10.1007/s003350010197; Simmler MC, 2000, NAT GENET, V24, P139, DOI 10.1038/72793; Sollner C, 2004, DEV GENES EVOL, V214, P582, DOI 10.1007/s00427-004-0440-2; Sollner C, 2003, SCIENCE, V302, P282, DOI 10.1126/science.1088443; Squires TM, 2004, J BIOMECH, V37, P1137, DOI 10.1016/j.jbiomech.2003.12.014; Sreenath T, 2003, J BIOL CHEM, V278, P24874, DOI 10.1074/jbc.M303908200; Thalmann I, 2001, DIS MARKERS, V17, P259, DOI 10.1155/2001/476738; Thalmann R, 2001, ANN NY ACAD SCI, V942, P162; Tohse H, 2008, FEBS J, V275, P2512, DOI 10.1111/j.1742-4658.2008.06400.x; Torres M, 1998, MECH DEVELOP, V71, P5, DOI 10.1016/S0925-4773(97)00155-X; Trune DR, 1983, J NEUROGENET, V1, P53, DOI 10.3109/01677068309107072; Tsao TS, 2003, J BIOL CHEM, V278, P50810, DOI 10.1074/jbc.M309469200; Verpy E, 1999, P NATL ACAD SCI USA, V96, P529, DOI 10.1073/pnas.96.2.529; Vitagliano L, 2001, BIOPOLYMERS, V58, P459, DOI 10.1002/1097-0282(20010415)58:5<459::AID-BIP1021>3.0.CO;2-V; Waki H, 2003, J BIOL CHEM, V278, P40352, DOI 10.1074/jbc.M300365200; Wang Y, 2002, J BIOL CHEM, V277, P19521, DOI 10.1074/jbc.M200601200; Wang Y, 2008, BIOCHEM J, V409, P623, DOI 10.1042/BJ20071492; Wang YX, 1998, P NATL ACAD SCI USA, V95, P15345, DOI 10.1073/pnas.95.26.15345; Whitfield TT, 2002, DEV DYNAM, V223, P427, DOI 10.1002/dvdy.10073; Wong GW, 2009, FASEB J, V23, P241, DOI 10.1096/fj.08-114991; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Yuzaki M, 2008, CELL MOL LIFE SCI, V65, P1698, DOI 10.1007/s00018-008-7550-3; Zhao X, 2008, NEUROSCIENCE, V153, P289, DOI 10.1016/j.neuroscience.2008.01.055; Zhao X, 2007, DEV BIOL, V304, P508, DOI 10.1016/j.ydbio.2007.01.013; Zwaenepoel I, 2002, P NATL ACAD SCI USA, V99, P6240, DOI 10.1073/pnas.082515999	68	71	76	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12765	10.1371/journal.pone.0012765	http://dx.doi.org/10.1371/journal.pone.0012765			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856818	Green Published, Green Submitted, gold			2022-12-27	WOS:000281815800027
J	Bailey, AL; Brewer, MS; Hendrixson, BE; Bond, JE				Bailey, Ashley L.; Brewer, Michael S.; Hendrixson, Brent E.; Bond, Jason E.			Phylogeny and Classification of the Trapdoor Spider Genus Myrmekiaphila: An Integrative Approach to Evaluating Taxonomic Hypotheses	PLOS ONE			English	Article							SPECIES DELIMITATION; CRYPTIC SPECIATION; MOLECULAR TAXONOMY; MITOCHONDRIAL-DNA; MALE GENITALIA; ARANEAE; MYGALOMORPHAE; POPULATION; COMPLEX; CYRTAUCHENIIDAE	Background: Revised by Bond and Platnick in 2007, the trapdoor spider genus Myrmekiaphila comprises 11 species. Species delimitation and placement within one of three species groups was based on modifications of the male copulatory device. Because a phylogeny of the group was not available these species groups might not represent monophyletic lineages; species definitions likewise were untested hypotheses. The purpose of this study is to reconstruct the phylogeny of Myrmekiaphila species using molecular data to formally test the delimitation of species and species-groups. We seek to refine a set of established systematic hypotheses by integrating across molecular and morphological data sets. Methods and Findings: Phylogenetic analyses comprising Bayesian searches were conducted for a mtDNA matrix composed of contiguous 12S rRNA, tRNA-val, and 16S rRNA genes and a nuclear DNA matrix comprising the glutamyl and prolyl tRNA synthetase gene each consisting of 1348 and 481 bp, respectively. Separate analyses of the mitochondrial and nuclear genome data and a concatenated data set yield M. torreya and M. millerae paraphyletic with respect to M. coreyi and M. howelli and polyphyletic fluviatilis and foliata species groups. Conclusions: Despite the perception that molecular data present a solution to a crisis in taxonomy, studies like this demonstrate the efficacy of an approach that considers data from multiple sources. A DNA barcoding approach during the species discovery process would fail to recognize at least two species M. coreyi and M. howelli) whereas a combined approach more accurately assesses species diversity and illuminates speciation pattern and process. Concomitantly these data also demonstrate that morphological characters likewise fail in their ability to recover monophyletic species groups and result in an unnatural classification. Optimizations of these characters demonstrate a pattern of "Dollo evolution'' wherein a complex character evolves only once but is lost multiple times throughout the group's history.	[Bailey, Ashley L.; Brewer, Michael S.; Bond, Jason E.] E Carolina Univ, N Carolina Ctr Biodivers, Greenville, NC 27858 USA; [Bailey, Ashley L.; Brewer, Michael S.; Bond, Jason E.] E Carolina Univ, Dept Biol, Greenville, NC USA; [Hendrixson, Brent E.] Millsaps Coll, Dept Biol, Jackson, MS 39210 USA	University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; Millsaps College	Bailey, AL (corresponding author), E Carolina Univ, N Carolina Ctr Biodivers, Greenville, NC 27858 USA.	bondja@ecu.edu	Bond, Jason E./P-1501-2017	Bond, Jason E./0000-0001-6373-3875	National Science Foundation [DEB 0315160]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation (http://www.nsf.gov) grant DEB 0315160 to J. Bond. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarsson I, 2007, SYST BIOL, V56, P531, DOI 10.1080/10635150701424546; Albert EM, 2009, ZOOTAXA, P56, DOI 10.11646/zootaxa.2234.1.4; Astrin JJ, 2006, ZOOL SCR, V35, P441, DOI 10.1111/j.1463-6409.2006.00239.x; Atkinson GF, 1886, ENTOMOLOGICA AM, V2, P109, DOI DOI 10.1371/JOURNAL.PONE.0012744; Ballard JWO, 2005, ANNU REV ECOL EVOL S, V36, P621, DOI 10.1146/annurev.ecolsys.36.091704.175513; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bond JE, 2006, MOL PHYLOGENET EVOL, V41, P70, DOI 10.1016/j.ympev.2006.04.026; Bond JE, 2008, SYST BIOL, V57, P628, DOI 10.1080/10635150802302443; Bond JE, 2002, EVOLUTION, V56, P1123; Bond JE, 2006, ANIM CONSERV, V9, P145, DOI 10.1111/j.1469-1795.2006.00024.x; Bond JE, 2001, MOL ECOL, V10, P899, DOI 10.1046/j.1365-294X.2001.01233.x; Bond JE, 2004, INVERTEBR SYST, V18, P361, DOI 10.1071/IS04008; Bond JE, 2003, INVERTEBR SYST, V17, P711, DOI 10.1071/IS03026; Bond JE, 2002, ZOOL J LINN SOC-LOND, V136, P487, DOI 10.1046/j.1096-3642.2002.00035.x; BOND JE, 2007, TAXONOMIC REV TRAPDO, P1; BUTLIN RK, 1987, AM NAT, V130, P461, DOI 10.1086/284723; BUTLIN RK, 1995, TRENDS ECOL EVOL, V10, P432, DOI 10.1016/S0169-5347(00)89173-9; Collin R, 2008, TRENDS ECOL EVOL, V23, P602, DOI 10.1016/j.tree.2008.06.013; de Queiroz K, 1999, SPECIES, P49; de Queiroz K, 1998, ENDLESS FORMS, P57; Dobzhansky T, 1940, AM NAT, V74, P312, DOI 10.1086/280899; Eberhard W.G., 1985, SEXUAL SELECTION ANI; EBERHARD WG, 1987, NAT HIST, V96, P4; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Goldberg EE, 2008, EVOLUTION, V62, P2727, DOI 10.1111/j.1558-5646.2008.00505.x; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hedin M, 2006, MOL PHYLOGENET EVOL, V41, P454, DOI 10.1016/j.ympev.2006.05.017; Hedin M, 2010, MOL PHYLOGENET EVOL, V54, P107, DOI 10.1016/j.ympev.2009.08.020; Hendrixson BE, 2005, MOL PHYLOGENET EVOL, V36, P405, DOI 10.1016/j.ympev.2005.01.021; Hendrixson BE, 2007, MOL PHYLOGENET EVOL, V42, P738, DOI 10.1016/j.ympev.2006.09.010; Huang DW, 2009, MOL PHYLOGENET EVOL, V50, P102, DOI 10.1016/j.ympev.2008.10.012; Huber B, 2004, BIOSEMIOTIK PRAKTISC, P89; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Kameda Y, 2009, AM NAT, V173, P689, DOI 10.1086/597607; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Korf RP, 2005, MYCOTAXON, V93, P407; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Lou M, 2007, MOL ECOL NOTES, V7, P908, DOI 10.1111/j.1471-8286.2007.01904.x; Maddison D. R., 2000, MACCLADE 4 ANAL PHYL; Maddison WP, 2009, MESQUITE MODULAR SYS; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meier R, 2008, SYST ASSOC SPEC VOL, V76, P95; Metzger GA, 2010, MOL PHYLOGENET EVOL, V54, P405, DOI 10.1016/j.ympev.2009.07.027; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; O'Meara BC, 2010, SYST BIOL, V59, P59, DOI 10.1093/sysbio/syp077; Paquin P, 2004, MOL ECOL, V13, P3239, DOI 10.1111/j.1365-294X.2004.02296.x; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Rambaut A., 2009, TRACER MCMC TRACE AN; Regier JC, 2008, SYST BIOL, V57, P920, DOI 10.1080/10635150802570791; RICE WR, 1993, EVOLUTION, V47, P1637, DOI [10.2307/2410209, 10.1111/j.1558-5646.1993.tb01257.x]; ROBINSON EA, 2009, PROSPECTS USING DNA, P27; Rodman JE, 2003, SYST BIOL, V52, P428, DOI 10.1080/10635150390197055; Ross KG, 2010, SYST BIOL, V59, P162, DOI 10.1093/sysbio/syp089; Rundle HD, 1998, EVOLUTION, V52, P200, DOI 10.1111/j.1558-5646.1998.tb05153.x; Servedio MR, 2003, ANNU REV ECOL EVOL S, V34, P339, DOI 10.1146/annurev.ecolsys.34.011802.132412; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Song HJ, 2010, CLADISTICS, V26, P23, DOI 10.1111/j.1096-0031.2009.00273.x; Starrett J, 2007, MOL ECOL, V16, P583, DOI 10.1111/j.1365-294X.2006.03164.x; Stockman AK, 2008, ZOOTAXA, P25, DOI 10.11646/zootaxa.1823.1.2; Stockman AK, 2007, MOL ECOL, V16, P3374, DOI 10.1111/j.1365-294X.2007.03389.x; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Tan DSH, 2010, ZOOL SCR, V39, P51, DOI 10.1111/j.1463-6409.2009.00408.x; Tanabe AS, 2007, MOL ECOL NOTES, V7, P962, DOI 10.1111/j.1471-8286.2007.01807.x; Tanabe T, 2008, AM NAT, V171, P692, DOI 10.1086/587075; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Wares JP, 2010, EVOLUTION, V64, P1136, DOI 10.1111/j.1558-5646.2009.00870.x; Wheeler QD, 2004, PHILOS T R SOC B, V359, P571, DOI 10.1098/rstb.2003.1452; Wiens JJ, 2002, SYST BIOL, V51, P69, DOI 10.1080/106351502753475880; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878; Will KW, 2004, CLADISTICS, V20, P47, DOI 10.1111/j.1096-0031.2003.00008.x	74	14	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2010	5	9							e12744	10.1371/journal.pone.0012744	http://dx.doi.org/10.1371/journal.pone.0012744			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZO	20856873	Green Published, Green Submitted, gold			2022-12-27	WOS:000281815700024
J	Piekarski, DJ; Place, NJ; Zucker, I				Piekarski, David J.; Place, Ned J.; Zucker, Irving			Facilitation of Male Sexual Behavior in Syrian Hamsters by the Combined Action of Dihydrotestosterone and Testosterone	PLOS ONE			English	Article							RECEPTOR MESSENGER-RNA; ANDROGEN-RECEPTOR; HORMONAL-REGULATION; BRAIN; RAT; 5-ALPHA-DIHYDROTESTOSTERONE; METABOLITES; EXPRESSION; INDUCTION; ESTRADIOL	Background: Testosterone (T) controls male Syrian hamster sexual behavior, however, neither of T's primary metabolites, dihydrotestosterone (DHT) and estradiol (E-2), even in highly supraphysiological doses, fully restores sexual behavior in castrated hamsters. DHT and T apparently interact with androgen receptors differentially to control male sexual behavior (MSB), but whether these two hormones act synergistically or antagonistically to control MSB has received scant experimental attention and is addressed in the present study. Methodology/Principal Findings: Sexually experienced male Syrian hamsters were gonadectomized and monitored 5 weeks later to confirm elimination of the ejaculatory reflex (week 0), at which time they received subcutaneous DHT-filled or empty capsules that remained in situ for the duration of the experiment. Daily injections of a physiological dose of 25 mu g T or vehicle commenced two weeks after capsule implantation. MSB was tested 2, 4 and 5 weeks after T treatment began. DHT capsules were no more effective than control treatment for long-term restoration of ejaculation. Combined DHT + T treatment, however, restored the ejaculatory reflex more effectively than T alone, as evidenced by more rapid recovery of ejaculatory behavior, shorter ejaculation latencies, and a greater number of ejaculations in 30 minute tests. Conclusions/Significance: DHT and T administered together restored sexual behavior to pre-castration levels more rapidly than did T alone, whereas DHT and vehicle were largely ineffective. The additive actions of DHT and T on MSB are discussed in relation to different effects of these androgens on androgen receptors in the male hamster brain mating circuit.	[Piekarski, David J.; Zucker, Irving] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; [Zucker, Irving] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Place, Ned J.] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Cornell University	Piekarski, DJ (corresponding author), Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA.	piekarski@berkeley.edu		Piekarski, David/0000-0002-6055-2849	National Institute of Child Health and Human Development [HD 043098]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD043098] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by grant HD 043098 from the National Institute of Child Health and Human Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arteaga-Silva M, 2008, PHYSIOL BEHAV, V94, P412, DOI 10.1016/j.physbeh.2008.02.007; Arteaga-Silva M, 2005, PHYSIOL BEHAV, V85, P571, DOI 10.1016/j.physbeh.2005.06.004; Askew EB, 2007, J BIOL CHEM, V282, P25801, DOI 10.1074/jbc.M703268200; Ball GF, 2006, HORM BEHAV, V49, P1, DOI 10.1016/j.yhbeh.2005.07.008; Baum MJ, 2003, SCAND J PSYCHOL, V44, P213, DOI 10.1111/1467-9450.00338; BURGESS LH, 1993, MOL BRAIN RES, V19, P31, DOI 10.1016/0169-328X(93)90145-F; Cooper TT, 2000, HORM BEHAV, V37, P237, DOI 10.1006/hbeh.2000.1579; Crescioli C, 2004, EUR J ENDOCRINOL, V150, P591, DOI 10.1530/eje.0.1500591; DOHERTY PC, 1981, BRAIN RES, V219, P327, DOI 10.1016/0006-8993(81)90295-X; DOMINGUEZ P, 1994, MOL CELL ENDOCRINOL, V106, P81, DOI 10.1016/0303-7207(94)90189-9; Faruzzi AN, 2005, HORM BEHAV, V47, P569, DOI 10.1016/j.yhbeh.2004.11.023; Gutzler SJ, 2009, HORM BEHAV, V56, P481, DOI 10.1016/j.yhbeh.2009.08.007; Handa RJ, 1996, MOL BRAIN RES, V39, P57, DOI 10.1016/0169-328X(95)00353-T; Hsiao PW, 2000, MOL CELL BIOCHEM, V206, P169, DOI 10.1023/A:1007024726889; Hull E. M., 2002, HORMONES BRAIN BEHAV; Larsson K., 1979, Endocrine control of sexual behavior., P77; Lu SF, 1999, J NEUROBIOL, V41, P505, DOI 10.1002/(SICI)1097-4695(199912)41:4<505::AID-NEU6>3.0.CO;2-N; LUTTGE WG, 1973, HORM BEHAV, V4, P31, DOI 10.1016/0018-506X(73)90014-7; Lynch CS, 2000, PHYSIOL BEHAV, V69, P445, DOI 10.1016/S0031-9384(99)00257-7; MCGINNIS MY, 1989, ENDOCRINOLOGY, V124, P618, DOI 10.1210/endo-124-2-618; Meek LR, 1997, HORM BEHAV, V31, P75, DOI 10.1006/hbeh.1997.1371; MORALI G, 1994, BIOL REPROD, V51, P562, DOI 10.1095/biolreprod51.3.562; Oliveira AG, 2007, STEROIDS, V72, P914, DOI 10.1016/j.steroids.2007.08.001; Park JH, 2007, HORM BEHAV, V52, P169, DOI 10.1016/j.yhbeh.2007.03.008; Piekarski DJ, 2009, HORM BEHAV, V55, P182, DOI 10.1016/j.yhbeh.2008.10.003; Pieper DR, 2000, P SOC EXP BIOL MED, V224, P278, DOI 10.1046/j.1525-1373.2000.22432.x; POWERS JB, 1985, PHYSIOL BEHAV, V35, P607, DOI 10.1016/0031-9384(85)90149-0; Putnam SK, 2005, HORM BEHAV, V47, P513, DOI 10.1016/j.yhbeh.2005.01.007; Putnam SK, 2003, HORM BEHAV, V44, P419, DOI 10.1016/j.yhbeh.2003.06.006; ROSELLI CE, 1987, BIOL REPROD, V37, P628, DOI 10.1095/biolreprod37.3.628; Sachs B.D., 1988, P1393; SCHLEICHER G, 1989, J STEROID BIOCHEM, V33, P581, DOI 10.1016/0022-4731(89)90044-7; SHERIDAN PJ, 1991, MOL CELL ENDOCRINOL, V76, pC39, DOI 10.1016/0303-7207(91)90279-2; SHOLL SA, 1981, PSYCHONEUROENDOCRINO, V6, P105, DOI 10.1016/0306-4530(81)90002-0; Wood RI, 1999, J NEUROBIOL, V39, P359, DOI 10.1002/(SICI)1097-4695(19990605)39:3<359::AID-NEU3>3.0.CO;2-W; WOOD RI, 1992, BRAIN RES, V596, P89, DOI 10.1016/0006-8993(92)91536-N; Wood RI, 1997, HORM BEHAV, V32, P40, DOI 10.1006/hbeh.1997.1403; YOUNG WC, 1961, SEX INTERNAL SECRETI, V2, P1173; ZAKAR T, 1980, J STEROID BIOCHEM, V13, P743, DOI 10.1016/0022-4731(80)90226-5; [No title captured]	40	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2010	5	9							e12749	10.1371/journal.pone.0012749	http://dx.doi.org/10.1371/journal.pone.0012749			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZO	20856876	Green Published, gold, Green Submitted			2022-12-27	WOS:000281815700025
J	Simba, DO; Warsame, M; Kakoko, D; Mrango, Z; Tomson, G; Premji, Z; Petzold, M				Simba, Daudi O.; Warsame, Marian; Kakoko, Deodatus; Mrango, Zakayo; Tomson, Goran; Premji, Zul; Petzold, Max			Who Gets Prompt Access to Artemisinin-Based Combination Therapy? A Prospective Community-Based Study in Children from Rural Kilosa, Tanzania	PLOS ONE			English	Article							FEBRILE CHILDREN; DRUG POLICY; MALARIA; MANAGEMENT; DETERMINANTS; SERVICES; SEEKING; DELAY	Background: Effective and timely case management remains one of the fundamental pillars for control of malaria. Tanzania introduced artemisinin-combination therapy [ACT] for uncomplicated malaria; however, the policy change is challenged by limited availability of ACTs due to high cost. This study aimed to determine factors influencing prompt access to ACTs among febrile children in rural Kilosa, Tanzania. Methods and Findings: In a community-based study, 1,235 randomly selected children under five were followed up weekly for six months, in 2008. Using a structured questionnaire, children's caretakers were asked about the child's febrile history in the last seven days, and treatment actions including timing, medicines used and source of care. Caretakers' knowledge about malaria and socioeconomic and demographic data were also obtained. About half of followed-up children had at least one episode of fever. Less than half (44.8%) of febrile children were taken to government facilities. Almost one-third (37.6%; 95% CI 33.1-42.1) of febrile children had prompt access to ACT. Care-seeking from a government facility was the overriding factor, increasing the likelihood of prompt access to an ACT 18 times (OR 17.7; 95% CI 10.55-29.54; adjusted OR 16.9; 95% CI 10.06-28.28). Caretakers from the better-off household (3rd-5th quintiles) were more likely to seek care from government facilities (OR 3.66; 95% CI 2.56-5.24; adjusted OR 1.80; 95% CI 1.18-2.76). The majority of antimalarials accessed by the poor were ineffective [86.0%; 295/343], however, they paid more for them (median Tsh 500) compared to the better-offs (median Tsh 0). Conclusions: Prompt access to ACT among febrile children was unacceptably low, due mainly to limited availability of subsidised ACT at the location where most caretakers sought care. There is urgent need to accelerate implementation of strategies that will ensure availability of ACT at an affordable price in remote rural areas, where the burden of malaria is	[Simba, Daudi O.] Muhimbili Univ Hlth & Allied Sci, Dept Community Hlth, Dar Es Salaam, Tanzania; [Simba, Daudi O.; Warsame, Marian; Tomson, Goran; Petzold, Max] Karolinska Inst, Dept Publ Hlth Sci, Div Int Hlth IHCAR, Stockholm, Sweden; [Kakoko, Deodatus] Muhimbili Univ Hlth & Allied Sci, Dept Behav Sci, Dar Es Salaam, Tanzania; [Tomson, Goran] Karolinska Inst, Med Management Ctr, Stockholm, Sweden; [Premji, Zul] Muhimbili Univ Hlth & Allied Sci, Dept Parasitol & Med Entomol, Dar Es Salaam, Tanzania; [Petzold, Max] Nord Sch Publ Hlth, Gothenburg, Sweden	Muhimbili University of Health & Allied Sciences; Karolinska Institutet; Muhimbili University of Health & Allied Sciences; Karolinska Institutet; Muhimbili University of Health & Allied Sciences	Simba, DO (corresponding author), Muhimbili Univ Hlth & Allied Sci, Dept Community Hlth, Dar Es Salaam, Tanzania.	dsimba@muhas.ac.tz		Tomson, Goran/0000-0001-9222-3604	Sida/SAREC Tanzania; Sweden research cooperation through the Muhimbili University of Health and Allied Sciences/Karolinska Institutet Malaria research project	Sida/SAREC Tanzania; Sweden research cooperation through the Muhimbili University of Health and Allied Sciences/Karolinska Institutet Malaria research project	This study was funded by the Sida/SAREC Tanzania and Sweden research cooperation through the Muhimbili University of Health and Allied Sciences/Karolinska Institutet Malaria research project [URL link http://www.sida.se.]. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahorlu CK, 2006, TROP MED INT HEALTH, V11, P1022, DOI 10.1111/j.1365-3156.2006.01660.x; Amin AA, 2003, TROP MED INT HEALTH, V8, P1143, DOI 10.1046/j.1360-2276.2003.01140.x; CHUMA J, 2009, MALARIA J, V8, DOI DOI 10.1186/1475-2875-1188-1243; DODOO A, 2009, MALARIA J, V8, DOI DOI 10.1186/1475-2875-1188-1182; Eriksen J, 2005, TROP MED INT HEALTH, V10, P1038, DOI 10.1111/j.1365-3156.2005.01486.x; Gitonga CW, 2008, TROP MED INT HEALTH, V13, P487, DOI 10.1111/j.1365-3156.2008.02026.x; GOODMAN C, 2007, HLTH POLICY PLANNING, V1, DOI DOI 10.1093/HEAPOL/CZM1033; Hart J.T., 1971, LANCET; HETZEL M, 2008, BMC PUBLIC HEALTH, V8, DOI DOI 10.1186/1471-2458-1188-1317; Hetzel MW, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-7; Kalter HD, 2003, ACTA PAEDIATR, V92, P103; Malenga G, 2005, BMJ-BRIT MED J, V331, P706, DOI 10.1136/bmj.331.7519.706; Moon S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000106; Munguti KJ, 1998, E AFR MED J, V75, P687; *NBS TANZ MACR, 2005, TANZ DEM HLTH SURV 2; NJAU J, 2006, TROP MED INT HEALTH, V11, DOI DOI 10.1111/J.1365-3156..01569.X; Njogu J, 2008, East Afr Med J, V85, P213; Noor AM, 2003, TROP MED INT HEALTH, V8, P917, DOI 10.1046/j.1365-3156.2003.01112.x; Nsungwa-Sabiiti J, 2007, T ROY SOC TROP MED H, V101, P1199, DOI 10.1016/j.trstmh.2007.08.005; *RBM PARTN, 2008, GLOB MAL ACT PLAN; Rutebemberwa E, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-45; Rutebemberwa E, 2009, TROP MED INT HEALTH, V14, P472, DOI 10.1111/j.1365-3156.2009.02237.x; Sabot O, 2009, DISTRIBUTION ARTEMIS; TIPKE M, 2009, MALARIA J, V8, DOI DOI 10.1186/1475-2875-1188-1266; *WHO, 2009, WORLD MAL REP; Williams HA, 2004, HEALTH POLICY PLANN, V19, P356, DOI 10.1093/heapol/czh051; WINCH PJ, 1994, SOC SCI MED, V39, P63, DOI 10.1016/0277-9536(94)90166-X; Yeung S, 2005, TROP MED INT HEALTH, V10, P121, DOI 10.1111/j.1365-3156.2004.01364.x; ZUROVAC D, 2005, BRIT MED J	29	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12104	10.1371/journal.pone.0012104	http://dx.doi.org/10.1371/journal.pone.0012104			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20856897	gold, Green Published			2022-12-27	WOS:000280811900037
J	Qiu, XN; Hother, C; Ralfkiaer, UM; Sogaard, A; Lu, QJ; Workman, CT; Liang, GN; Jones, PA; Gronbaek, K				Qiu, Xiangning; Hother, Christoffer; Ralfkiaer, Ulrik M.; Sogaard, Alexandra; Lu, Qianjin; Workman, Christopher T.; Liang, Gangning; Jones, Peter A.; Gronbaek, Kirsten			Equitoxic Doses of 5-Azacytidine and 5-Aza-2 ' Deoxycytidine Induce Diverse Immediate and Overlapping Heritable Changes in the Transcriptome	PLOS ONE			English	Article							CONVENTIONAL CARE REGIMENS; CANCER-TESTIS GENE; MYELODYSPLASTIC SYNDROME; DNA METHYLATION; EPIGENETIC CHANGES; PHASE-II; AZACITIDINE; DECITABINE; EXPRESSION; CTCF	Background: The hypomethylating agent 5-Azacytidine (5-Aza-CR) is the first drug to prolong overall survival in patients with myelodysplastic syndrome (MDS). Surprisingly, the deoxyribonucleoside analog 5-Aza-2'deoxycytidine (5-Aza-CdR) did not have a similar effect on survival in a large clinical trial. Both drugs are thought to exert their effects after incorporation into DNA by covalent binding of DNA methyltransferase (DNMT). While 5-Aza-CdR is incorporated into only DNA, 5-Aza-CR is also incorporated into RNA. Here, we have analyzed whether this difference in nucleic acid incorporation may influence the capacities of these drugs to regulate the expression of mRNA and microRNAs (miRNA), which may potentially affect the activities of the drugs in patients. Methodology/Principal Findings: A hematopoietic (HL-60; acute myeloid leukemia) and a solid (T24; transitional cell carcinoma) cancer cell line were treated with equitoxic doses of 5-Aza-CR and 5-Aza-CdR for 24 hrs, and the immediate (day 2) and lasting (day 8) effects on RNA expression examined. There was considerable overlap between the RNAs heritably upregulated by both drugs on day 8 but more RNAs were stably induced by the deoxy analog. Both drugs strongly induced expression of cancer testis antigens. On day 2 more RNAs were downregulated by 5-Aza-CR, particularly at higher doses. A remarkable downregulation of miRNAs and a significant upregulation of tRNA synthetases and other genes involved in amino acid metabolism was observed in T24 cells. Conclusions/Significance: Overall, this suggests that significant differences exist in the immediate action of the two drugs, however the dominant pattern of the lasting, and possible heritable changes, is overlapping.	[Qiu, Xiangning; Liang, Gangning; Jones, Peter A.] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Hother, Christoffer; Ralfkiaer, Ulrik M.; Sogaard, Alexandra; Gronbaek, Kirsten] Rigshosp, Dept Hematol, DK-2100 Copenhagen, Denmark; [Workman, Christopher T.] Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Qiu, Xiangning; Lu, Qianjin] Cent S Univ, Xiangya Hosp 2, Dept Dermatol, Changsha, Hunan, Peoples R China	University of Southern California; Rigshospitalet; University of Copenhagen; Technical University of Denmark; Central South University	Qiu, XN (corresponding author), Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA.	kirsten.groenbaek@rh.regionh.dk	Ralfkiaer, Ulrik/N-2836-2016; Workman, Christopher T/K-1066-2015	Ralfkiaer, Ulrik/0000-0003-2647-2148; Workman, Christopher T/0000-0002-2210-3743; Liang, Gangning/0000-0001-8664-922X; Gronbaek, Kirsten/0000-0002-1535-9601	Rigshospitalets Research Foundation; Danish Cancer Society; Novo Nordisk Foundation; Lundbeck Foundation; NIH [R37 CA82422, R01 CA1378794]; China Scholarship Council; NATIONAL CANCER INSTITUTE [R01CA138794, R37CA082422] Funding Source: NIH RePORTER	Rigshospitalets Research Foundation; Danish Cancer Society(Danish Cancer Society); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by grants from Rigshospitalets Research Foundation (CH, KG), The Danish Cancer Society (CH, KG), The Novo Nordisk Foundation (KG), The Lundbeck Foundation (KG), NIH (R37 CA82422, PAJ), (R01 CA1378794, GL). Xiangning Qiu is supported by the China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa-Morais NL, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp942; Borthakur G, 2008, LEUKEMIA LYMPHOMA, V49, P690, DOI 10.1080/10428190701882146; Caballero OL, 2009, CANCER SCI, V100, P2014, DOI 10.1111/j.1349-7006.2009.01303.x; Cashen AF, 2010, J CLIN ONCOL, V28, P556, DOI 10.1200/JCO.2009.23.9178; CONSTANTINIDES PG, 1978, DEV BIOL, V66, P57, DOI 10.1016/0012-1606(78)90273-7; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; DALTON WT, 1988, BLOOD, V71, P242; De Smet C, 1999, MOL CELL BIOL, V19, P7327; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Fandy TE, 2009, BLOOD, V114, P2764, DOI 10.1182/blood-2009-02-203547; Fenaux P, 2010, J CLIN ONCOL, V28, P562, DOI 10.1200/JCO.2009.23.8329; Fenaux P, 2009, LANCET ONCOL, V10, P223, DOI 10.1016/S1470-2045(09)70003-8; Flotho C, 2009, LEUKEMIA, V23, P1019, DOI 10.1038/leu.2008.397; Gonzalgo ML, 1997, NUCLEIC ACIDS RES, V25, P2529, DOI 10.1093/nar/25.12.2529; Gronbaek K, 2007, APMIS, V115, P1039, DOI 10.1111/j.1600-0463.2007.apm_636.xml.x; Guldberg P, 2002, METHODS, V27, P121, DOI 10.1016/S1046-2023(02)00063-4; Hollenbach PW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009001; Hong JA, 2005, CANCER RES, V65, P7763, DOI 10.1158/0008-5472.CAN-05-0823; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; Kantarjian H, 2006, CANCER-AM CANCER SOC, V106, P1794, DOI 10.1002/cncr.21792; Kantarjian H, 2007, BLOOD, V109, P52, DOI 10.1182/blood-2006-05-021162; Khan R, 2006, EXP HEMATOL, V34, P35, DOI 10.1016/j.exphem.2005.09.007; Kim WJ, 2005, CANCER RES, V65, P9347, DOI 10.1158/0008-5472.CAN-05-1647; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; MOMPARLER RL, 1976, BIOCHEM PHARMACOL, V25, P389, DOI 10.1016/0006-2952(76)90338-5; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Qin TC, 2009, BLOOD, V113, P659, DOI 10.1182/blood-2008-02-140038; Renaud S, 2007, NUCLEIC ACIDS RES, V35, P7372, DOI 10.1093/nar/gkm896; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Saito Y, 2009, BIOCHEM BIOPH RES CO, V379, P726, DOI 10.1016/j.bbrc.2008.12.098; Schaefer M, 2009, CANCER RES, V69, P8127, DOI 10.1158/0008-5472.CAN-09-0458; Silverman LR, 2002, J CLIN ONCOL, V20, P2429, DOI 10.1200/JCO.2002.04.117; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki H, 2002, NAT GENET, V31, P141, DOI 10.1038/ng892; Vatolin S, 2005, CANCER RES, V65, P7751, DOI 10.1158/0008-5472.CAN-05-0858; WEBER J, 1994, CANCER RES, V54, P1766; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Wijermans P, 2000, J CLIN ONCOL, V18, P956, DOI 10.1200/JCO.2000.18.5.956; WIJERMANS P, 2008, BLOOD, V112; WORKMAN C, 2002, GENOME BIOL, V0003; Zlatanova J, 2009, CELL MOL LIFE SCI, V66, P1647, DOI 10.1007/s00018-009-8647-z	43	52	53	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e12994	10.1371/journal.pone.0012994	http://dx.doi.org/10.1371/journal.pone.0012994			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20927380	gold, Green Published, Green Submitted			2022-12-27	WOS:000282269400008
J	van der Werf-Eldering, MJ; Burger, H; Holthausen, EAE; Aleman, A; Nolen, WA				van der Werf-Eldering, Marieke J.; Burger, Huibert; Holthausen, Esther A. E.; Aleman, Andre; Nolen, Willem A.			Cognitive Functioning in Patients with Bipolar Disorder: Association with Depressive Symptoms and Alcohol Use	PLOS ONE			English	Article							REPORT QIDS-SR; NEUROCOGNITIVE IMPAIRMENT; EUTHYMIC PATIENTS; NEUROPSYCHOLOGICAL DEFICITS; CLINICAL PREDICTORS; NATURAL-HISTORY; QUICK INVENTORY; SYMPTOMATOLOGY; ILLNESS; METAANALYSIS	Background: Cognitive dysfunction is clearly recognized in bipolar patients, but the degree of impairment varies due to methodological factors as well as heterogeneity in patient populations. The goal of this study was to evaluate cognitive functioning in bipolar patients and to assess its association with depressive symptoms. Post hoc the relationship with lifetime alcohol use disorder was explored. Methodology/Principal Findings: The study included 110 bipolar patients and 75 healthy controls. Patients with severe depressive symptoms, (hypo) manic symptoms and current severe alcohol use disorder were excluded. Diagnoses were evaluated via the Mini-International Neuropsychiatric Interview. Cognitive functioning was measured in domains of psychomotor speed, speed of information processing, attentional switching, verbal memory, visual memory, executive functioning and an overall mean score. Severity of depression was assessed by the Inventory of Depressive Symptomatology-self rating. Patients were euthymic (n=46) or with current mild (n=38) or moderate (n=26) depressive symptoms. Cognitive impairment was found in 26% (z-score 2 or more above reference control group for at least one domain) of patients, most prominent in executive functioning (effect size; ES 0.49) and speed of information processing (ES 0.47). Depressive symptoms were associated with dysfunction in psychomotor speed (adjusted beta 0.43; R-2 7%), speed of information processing (adjusted beta 0.36; R-2 20%), attentional switching (adjusted beta 0.24; R-2 16%) and the mean score (adjusted beta 0.23; R-2 24%), but not with verbal and visual memory and executive functioning. Depressive symptoms explained 24% of the variance in the mean z-score of all 6 cognitive domains. Comorbid lifetime alcohol use (n=21) was not associated with cognitive dysfunction. Conclusions/Significance: Cognitive dysfunction in bipolar disorder is more severe in patients with depressive symptoms, especially regarding speed and attention. Therefore, interpretation of cognitive functioning in patients with depressive symptoms should be cautious. No association was found between cognitive functioning and lifetime comorbid alcohol use disorder.	[van der Werf-Eldering, Marieke J.; Burger, Huibert; Holthausen, Esther A. E.; Nolen, Willem A.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands; [Burger, Huibert] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Aleman, Andre] Univ Groningen, BCN Neuroimaging Ctr, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	van der Werf-Eldering, MJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands.	m.j.van.der.werf@psy.umcg.nl	Aleman, Andre/E-1341-2012; Nolen, Willem A/E-9006-2014	Eldering, Marieke/0000-0002-7715-5946	AstraZeneca, The Netherlands; The Netherlands Organisation for Health Research and Development; European Union; Stanley Medical Research Institute; Astra Zeneca; Eli Lilly; GlaxoSmithKline; Wyeth; Pfizer; Servier	AstraZeneca, The Netherlands(Netherlands GovernmentAstraZeneca); The Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); European Union(European Commission); Stanley Medical Research Institute; Astra Zeneca(AstraZeneca); Eli Lilly(Eli Lilly); GlaxoSmithKline(GlaxoSmithKline); Wyeth(Wyeth); Pfizer(Pfizer); Servier(Servier)	M.J. van der Werf-Eldering received an unrestricted Young Investigators award from AstraZeneca, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; M.J. van der Werf-Eldering received an unrestricted Young Investigator's award from AstraZeneca, The Netherlands. W. A. Nolen has received grants from The Netherlands Organisation for Health Research and Development, the European Union, the Stanley Medical Research Institute, Astra Zeneca, Eli Lilly, GlaxoSmithKline and Wyeth; has received honoraria/speaker's fees from Astra Zeneca, Eli Lilly, Pfizer, Servier and Wyeth; and has served in advisory boards for Astra Zeneca, Cyberonics, Pfizer and Servier. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. All other authors deny any conflicts of interest or commercial associations in connection with the submitted manuscript.	Arts B, 2008, PSYCHOL MED, V38, P771, DOI 10.1017/S0033291707001675; Balanza-Martinez V, 2010, EUR J PHARMACOL, V626, P87, DOI 10.1016/j.ejphar.2009.10.018; Bonnin CM, 2010, J AFFECT DISORDERS, V121, P156, DOI 10.1016/j.jad.2009.05.014; Bora E, 2009, J AFFECT DISORDERS, V113, P1, DOI 10.1016/j.jad.2008.06.009; BRANDT J, 1983, ARCH GEN PSYCHIAT, V40, P435; Carey KB, 2003, J NERV MENT DIS, V191, P300; Castaneda AE, 2010, PSYCHOL MED, V40, P29, DOI 10.1017/S0033291709005959; DALES LG, 1978, INT J EPIDEMIOL, V7, P373, DOI 10.1093/ije/7.4.373; Dean BB, 2004, CURR MED RES OPIN, V20, P139, DOI 10.1185/030079903125002801; Delis DC., 2000, CALIFORNIA VERBAL LE; Dickerson F, 2010, BIPOLAR DISORD, V12, P10, DOI 10.1111/j.1399-5618.2009.00784.x; Ferrier IN, 2002, BRIT J PSYCHIAT, V180, P293, DOI 10.1192/bjp.180.4.293; Frangou S, 2002, BIPOLAR DISORD, V4, P41, DOI 10.1034/j.1399-5618.4.s1.13.x; Frasch K, 2009, PSYCHOPATHOLOGY, V42, P59, DOI 10.1159/000187635; Frye MA, 2006, BIPOLAR DISORD, V8, P677, DOI 10.1111/j.1399-5618.2006.00370.x; Goldberg JF, 2008, COGNITIVE DYSFUNCTION IN BIPOLAR DISORDER: A GUIDE FOR CLINICIANS, P1; Goldberg JF, 2009, BIPOLAR DISORD, V11, P123, DOI 10.1111/j.1399-5618.2009.00716.x; Golden, 1978, STROOP COLOUR WORD T; GOODWIN FK, 2007, MANICDEPRESSIVE ILLN, P273; Gualtieri CT, 2008, J CLIN PSYCHIAT, V69, P1122, DOI 10.4088/JCP.v69n0712; Hedges L. V., 1985, STAT METHODS META AN, DOI [DOI 10.1016/B978-0-08-057065-5.50005-1, 10.2307/1164953, DOI 10.2307/1164953]; Huxley N, 2007, BIPOLAR DISORD, V9, P183, DOI 10.1111/j.1399-5618.2007.00430.x; Iverson GL, 2009, APPL NEUROPSYCHOL, V16, P207, DOI 10.1080/09084280903098778; Judd LL, 2002, ARCH GEN PSYCHIAT, V59, P530, DOI 10.1001/archpsyc.59.6.530; Judd LL, 2003, ARCH GEN PSYCHIAT, V60, P261, DOI 10.1001/archpsyc.60.3.261; KEEFE RSE, 1995, AM J PSYCHIAT, V152, P6; Kennedy N, 2007, BIPOLAR DISORD, V9, P25, DOI 10.1111/j.1399-5618.2007.00326.x; Kupka RW, 2007, BIPOLAR DISORD, V9, P531, DOI 10.1111/j.1399-5618.2007.00467.x; Kurtz MM, 2009, NEUROPSYCHOLOGY, V23, P551, DOI 10.1037/a0016277; Leverich GS, 2001, J AFFECT DISORDERS, V67, P33, DOI 10.1016/S0165-0327(01)00430-X; Levin FR, 2004, BIOL PSYCHIAT, V56, P738, DOI 10.1016/j.biopsych.2004.05.008; Levy B, 2008, PSYCHIAT RES, V161, P28, DOI 10.1016/j.psychres.2007.09.009; Levy B, 2009, HARVARD REV PSYCHIAT, V17, P226, DOI 10.1080/10673220902979870; Lezak MD, 2004, NEUROPSYCHOLOGICAL A, V4th, P1016; Malhi GS, 2007, BIPOLAR DISORD, V9, P114, DOI 10.1111/j.1399-5618.2007.00324.x; Martinez-Aran A, 2004, AM J PSYCHIAT, V161, P262, DOI 10.1176/appi.ajp.161.2.262; Martino DJ, 2008, J AFFECT DISORDERS, V109, P149, DOI 10.1016/j.jad.2007.12.232; McDermott LM, 2009, J AFFECT DISORDERS, V119, P1, DOI 10.1016/j.jad.2009.04.022; Mur M, 2009, PSYCHOPATHOLOGY, V42, P148, DOI 10.1159/000207456; Nelson HE., 1982, NATL ADULT READING T; Olley A, 2005, J NERV MENT DIS, V193, P323, DOI 10.1097/01.nmd.0000161684.35904.f4; Parsons OA, 1998, ALCOHOL CLIN EXP RES, V22, P954, DOI 10.1097/00000374-199806000-00029; Pavuluri MN, 2006, AM J PSYCHIAT, V163, P286, DOI 10.1176/appi.ajp.163.2.286; ROBBINS TW, 1994, DEMENTIA, V5, P266, DOI 10.1159/000106735; Robinson LJ, 2006, BIPOLAR DISORD, V8, P103, DOI 10.1111/j.1399-5618.2006.00277.x; Robinson LJ, 2006, J AFFECT DISORDERS, V93, P105, DOI 10.1016/j.jad.2006.02.016; Rosa AR, 2009, BIPOLAR DISORD, V11, P401, DOI 10.1111/j.1399-5618.2009.00698.x; Royall DR, 2007, J NEUROPSYCH CLIN N, V19, P249, DOI 10.1176/appi.neuropsych.19.3.249; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; Rush AJ, 1996, PSYCHOL MED, V26, P477, DOI 10.1017/S0033291700035558; Sanchez-Moreno J, 2009, J CLIN PSYCHIAT, V70, P1120, DOI 10.4088/JCP.08m04302; Savitz J, 2005, BIPOLAR DISORD, V7, P216, DOI 10.1111/j.1399-5618.2005.00203.x; Savitz JB, 2005, NEUROMOL MED, V7, P275, DOI 10.1385/NMM:7:4:275; Savitz JB, 2008, BIPOLAR DISORD, V10, P479, DOI 10.1111/j.1399-5618.2008.00591.x; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Smid HGOM, 2006, J CLIN EXP NEUROPSYC, V28, P859, DOI 10.1080/13803390591001025; SPSS Inc, 2008, STAT PACK SOC SCI SP; Suppes T, 2001, J AFFECT DISORDERS, V67, P45, DOI 10.1016/S0165-0327(01)00432-3; Tabares-Seisdedos R, 2008, J AFFECT DISORDERS, V109, P286, DOI 10.1016/j.jad.2007.12.234; Tamam L, 2008, EUR ARCH PSY CLIN N, V258, P385, DOI 10.1007/s00406-008-0807-x; Thompson JM, 2005, BRIT J PSYCHIAT, V186, P32, DOI 10.1192/bjp.186.1.32; Torres IJ, 2007, ACTA PSYCHIAT SCAND, V116, P17, DOI 10.1111/j.1600-0447.2007.01055.x; Trivedi MH, 2004, PSYCHOL MED, V34, P73, DOI 10.1017/S0033291703001107; van Gorp WG, 1998, ARCH GEN PSYCHIAT, V55, P41, DOI 10.1001/archpsyc.55.1.41; Wilson B.A., 1996, BEHAV ASSESSMENT DYS; Wingo AP, 2009, J CLIN PSYCHIAT, V70, P1588, DOI 10.4088/JCP.08r04972; Wingo AP, 2009, BIPOLAR DISORD, V11, P113, DOI 10.1111/j.1399-5618.2009.00665.x; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429	68	27	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2010	5	9							e13032	10.1371/journal.pone.0013032	http://dx.doi.org/10.1371/journal.pone.0013032			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	654ZQ	20927392	Green Submitted, Green Published, gold			2022-12-27	WOS:000282210700013
J	Wei, JW; Heeley, EL; Jan, S; Huang, YN; Huang, QF; Wang, JG; Cheng, Y; Xu, E; Yang, QD; Anderson, CS				Wei, Jade W.; Heeley, Emma L.; Jan, Stephen; Huang, Yining; Huang, Qifang; Wang, Ji-Guang; Cheng, Yan; Xu, En; Yang, Qidong; Anderson, Craig S.		ChinaQUEST Investigators	Variations and Determinants of Hospital Costs for Acute Stroke in China	PLOS ONE			English	Article							HEALTH-INSURANCE REFORM; LONG-TERM COST; ISCHEMIC-STROKE; CARE; REHABILITATION; CHARGES; LENGTH; STAY; SERVICES; SUBTYPES	Background: The burden of stroke is high and increasing in China. We modelled variations in, and predictors of, the costs of hospital care for patients with acute stroke in China. Methods and Findings: Baseline characteristics and hospital costs for 5,255 patients were collected using the prospective register-based ChinaQUEST study, conducted in 48 Level 3 and 14 Level 2 hospitals in China during 2006-2007. Ordinary least squares estimation was used to determine factors associated with hospital costs. Overall mean cost of hospitalisation was 11,216 Chinese Yuan Renminbi (CNY) (approximate to US$1,602) per patient, which equates to more than half the average annual wage in China. Variations in cost were largely attributable to stroke severity and length of hospital stay (LOS). Model forecasts showed that reducing LOS from the mean of 20 days for Level 3 and 18 days for Level 2 hospitals to a duration of 1 week, which is common among Western countries, afforded cost reductions of 49% and 19%, respectively. Other lesser determinants varied by hospital level: in Level 3 hospitals, health insurance and the occurrence of in-hospital complications were each associated with 10% and 18% increases in cost, respectively, whilst treatment in a teaching hospital was associated with approximately 39% decrease in cost on average. For Level 2 hospitals, stroke due to intracerebral haemorrhage was associated with a 19% greater cost than for ischaemic stroke. Conclusions: Changes to hospital policies to standardise resource use and reduce the variation in LOS could attenuate costs and improve efficiencies for acute stroke management in China. The success of these strategies will be enhanced by broader policy initiatives currently underway to reform hospital reimbursement systems.	[Wei, Jade W.; Heeley, Emma L.; Jan, Stephen; Anderson, Craig S.] Royal Prince Alfred Hosp, George Inst Global Hlth, Sydney, NSW, Australia; [Wei, Jade W.; Heeley, Emma L.; Jan, Stephen; Anderson, Craig S.] Univ Sydney, Sydney, NSW 2006, Australia; [Huang, Yining] Peking Univ First Hosp, Dept Neurol, Beijing, Peoples R China; [Huang, Qifang; Wang, Ji-Guang] Shanghai Jiao Tong Univ, Sch Med, Ctr Epidemiol Studies & Clin Trials, Ruijin Hosp, Shanghai 200030, Peoples R China; [Cheng, Yan] Tianjin Med Univ, Gen Hosp, Dept Neurol, Tianjin, Peoples R China; [Xu, En] Guangzhou Med Univ, Affiliated Hosp 2, Dept Neurol, Guangzhou, Guangdong, Peoples R China; [Yang, Qidong] Ctr S Univ, Xiangya Hosp, Dept Neurol, Changsha, Hunan, Peoples R China	George Institute for Global Health; University of Sydney; University of Sydney; Peking University; Shanghai Jiao Tong University; Tianjin Medical University; Guangzhou Medical University; Central South University	Wei, JW (corresponding author), Royal Prince Alfred Hosp, George Inst Global Hlth, Sydney, NSW, Australia.	jwei@george.org.au	Wang, Ji Guang/AAP-4045-2021; Jan, Stephen/AAG-3333-2021; Demchuk, Andrew M/E-1103-2012	Wang, Ji Guang/0000-0001-8511-1524; Demchuk, Andrew M/0000-0002-4930-7789; Jan, Stephen/0000-0003-2839-1405; Heeley, Emma/0000-0001-9190-2832; Anderson, Craig/0000-0002-7248-4863	Macquarie Bank Foundation; The George Foundation; AstraZeneca Pharmaceutical China; The George Institute for International Health; National Health and Medical Research Council of Australia (NHMRC); Australian Postgraduate Award	Macquarie Bank Foundation; The George Foundation; AstraZeneca Pharmaceutical China(AstraZeneca); The George Institute for International Health; National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government)	The ChinaQUEST study was supported by grants from the Macquarie Bank Foundation, The George Foundation, and AstraZeneca Pharmaceutical China. CSA received salary support from The George Institute for International Health and as a Senior Principal Research Fellow of the National Health and Medical Research Council of Australia (NHMRC). JWW was a recipient of an Australian Postgraduate Award. SJ is a recipient of a Career Development Award from the NHMRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The ChinaQUEST study was an academic initiated and conducted study. Commercial sources of funding including AstraZeneca Pharmaceutical China had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors exercise complete right to make freely available any materials and information described in their publication that are reasonably requested by others for the purpose of academic, non-commercial research.	Bowling A, 2005, J PUBLIC HEALTH-UK, V27, P281, DOI 10.1093/pubmed/fdi031; BURNS LR, 1991, MED CARE, V29, P251, DOI 10.1097/00005650-199103000-00007; Chang KC, 2002, STROKE, V33, P2670, DOI 10.1161/01.STR.0000034396.68980.39; *CHIN CDC CHIN MED, 2007, CHIN GUID CER DIS PR; Dewey HM, 2003, STROKE, V34, P2502, DOI 10.1161/01.STR.0000091395.85357.09; DOBKIN B, 1995, NEUROLOGY, V45, pS6; DUAN N, 1983, J AM STAT ASSOC, V78, P605, DOI 10.2307/2288126; Evers S, 2002, HEALTH POLICY, V61, P21, DOI 10.1016/S0168-8510(01)00219-6; Fjaertoft Hild, 2007, Tidsskr Nor Laegeforen, V127, P744; Galán Iñaki, 2004, Gac Sanit, V18, P440, DOI 10.1157/13069762; Gao WM, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-110; Gioldasis G, 2008, ACTA NEUROL SCAND, V118, P268, DOI 10.1111/j.1600-0404.2008.01014.x; Harvey RL, 1998, ARCH PHYS MED REHAB, V79, P1349, DOI 10.1016/S0003-9993(98)90226-X; HAUSMAN JA, 1978, ECONOMETRICA, V46, P1251, DOI 10.2307/1913827; Heeley E, 2009, STROKE, V40, P2149, DOI 10.1161/STROKEAHA.108.540054; Jorgensen HS, 1997, STROKE, V28, P1138, DOI 10.1161/01.STR.28.6.1138; Joshi R, 2008, J AM COLL CARDIOL, V52, P1817, DOI 10.1016/j.jacc.2008.08.049; Khealani B. A., 2003, JPMA Journal of the Pakistan Medical Association, V53, P552; Kwan J, 2007, J CLIN NEUROSCI, V14, P189, DOI 10.1016/j.jocn.2006.01.026; Langhorne P, 2005, LANCET, V365, P501; Lee WC, 2007, CEREBROVASC DIS, V23, P57, DOI 10.1159/000096542; LI L, 2008, CHINESE J HLTH EC, V27; Lim Seung-Ji, 2009, J Prev Med Public Health, V42, P251, DOI 10.3961/jpmph.2009.42.4.251; Liu GG, 2002, SOC SCI MED, V55, P1779, DOI 10.1016/S0277-9536(01)00306-9; Liu M, 2007, LANCET NEUROL, V6, P456, DOI 10.1016/S1474-4422(07)70004-2; Liu YL, 2002, HEALTH POLICY, V60, P133, DOI 10.1016/S0168-8510(01)00207-X; Manning WG, 2001, J HEALTH ECON, V20, P461, DOI 10.1016/S0167-6296(01)00086-8; McGowan B, 2003, Ir Med J, V96, P234; MENG Q, 2008, HLTH PROVIDER PAYMEN; Meng QY, 2004, HEALTH POLICY, V68, P197, DOI 10.1016/j.healthpol.2003.09.010; *MIN HLTH PEOPL RE, 2007, CHIN HLTH STAT YB; Payne KA, 2002, PHARMACOECONOMICS, V20, P813, DOI 10.2165/00019053-200220120-00002; Petersen MA, 2009, REV FINANC STUD, V22, P435, DOI 10.1093/rfs/hhn053; Qureshi AI, 2007, STROKE, V38, P2180, DOI 10.1161/STROKEAHA.106.467506; SHI LY, 2006, CHINESE J PUBLIC HLT, V22, P1022; Tu F, 2003, HEALTH POLICY, V66, P239, DOI 10.1016/S0168-8510(03)00080-0; Tu F, 2002, HEALTH POLICY, V59, P243, DOI 10.1016/S0168-8510(01)00182-8; Tukey JW, 1977, EXPLORATORY DATA ANA; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; WADE DT, 1985, J EPIDEMIOL COMMUN H, V39, P347, DOI 10.1136/jech.39.4.347; Wang H, 2009, HEALTH ECON, V18, pS65, DOI 10.1002/hec.1465; Xu L, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-37; Yip W, 2008, HEALTH AFFAIR, V27, P460, DOI 10.1377/hlthaff.27.2.460; Yip WCM, 2010, LANCET, V375, P1120, DOI 10.1016/S0140-6736(10)60063-3; Yoneda Y, 2005, HEALTH POLICY, V73, P202, DOI 10.1016/j.healthpol.2004.11.016; Zizza C, 2004, AM J PUBLIC HEALTH, V94, P1587, DOI 10.2105/AJPH.94.9.1587	46	77	82	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2010	5	9							e13041	10.1371/journal.pone.0013041	http://dx.doi.org/10.1371/journal.pone.0013041			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	654ZQ	20927384	Green Published, gold, Green Submitted			2022-12-27	WOS:000282210700017
J	Dubey, S; Shine, R				Dubey, Sylvain; Shine, Richard			Evolutionary Diversification of the Lizard Genus Bassiana (Scincidae) across Southern Australia	PLOS ONE			English	Article							SOUTHEASTERN AUSTRALIA; PHYLOGENETIC-RELATIONSHIPS; COMPARATIVE PHYLOGEOGRAPHY; ENVIRONMENTAL EVOLUTION; MITOCHONDRIAL-DNA; DIVERGENCE; CLIMATE; COLONIZATION; BIOGEOGRAPHY; POPULATIONS	Background: Relatively recent (Plio-Pleistocene) climatic variations had strong impacts on the fauna and flora of temperate-zone North America and Europe; genetic analyses suggest that many lineages were restricted to unglaciated refuges during this time, and have expanded their ranges since then. Temperate-zone Australia experienced less severe glaciation, suggesting that patterns of genetic structure among species may reflect older (aridity-driven) divergence events rather than Plio-Pleistocene (thermally-mediated) divergences. The lizard genus Bassiana (Squamata, Scincidae) contains three species that occur across a wide area of southern Australia (including Tasmania), rendering them ideally-suited to studies on the impact of past climatic fluctuations. Methodology/Principal Findings: We performed molecular phylogenetic and dating analyses using two partial mitochondrial genes (ND2 and ND4) of 97 samples of Bassiana spp. Our results reveal a pattern of diversification beginning in the Middle Miocene, with intraspecific diversification arising from 5.7 to 1.7 million years ago in the Upper Miocene-Lower Pleistocene. Conclusions/Significance: In contrast to the temperate-zone Northern Hemisphere biota, patterns of evolutionary diversification within southern Australian taxa appear to reflect geologically ancient events, mostly relating to east-west discontinuities imposed by aridity rather than (as is the case in Europe and North America) relatively recent recolonisation of northern regions from unglaciated refugia to the south.	[Dubey, Sylvain; Shine, Richard] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	University of Sydney	Dubey, S (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	sylvain.dubey@bio.usyd.edu.au	Dubey, Sylvain/B-3662-2013		Australian Research Council	Australian Research Council(Australian Research Council)	The work was funded by the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert EM, 2009, GENE, V441, P12, DOI 10.1016/j.gene.2008.05.014; Alley N. F., 1995, GEOLOGICAL SURVEY S, V2, P151; [Anonymous], 2014, TRACER V1 6; AREVALO E, 1994, SYST BIOL, V43, P387, DOI 10.2307/2413675; Bowler Jim M., 2006, Proceedings of the Royal Society of Victoria, V118, P161; BOWLER JM, 1982, EVOLUTION FLORA FAUN, P35; Brown RP, 2008, MOL PHYLOGENET EVOL, V48, P350, DOI 10.1016/j.ympev.2008.04.013; Byrne M, 2008, MOL ECOL, V17, P4398, DOI 10.1111/j.1365-294X.2008.03899.x; Chapple DG, 2005, MOL ECOL, V14, P1279, DOI 10.1111/j.1365-294X.2005.02463.x; Cogger H, 2000, REPTILES AMPHIBIANS; Cogger H. G., 1983, REPTILES AMPHIBIANS; Colgan DJ, 2009, AUST J ZOOL, V57, P317, DOI 10.1071/ZO08088; Commonwealth of Australia, 2005, INT BIOG REG AUSTR V; Donnellan SC, 1999, AUST J ZOOL, V47, P275, DOI 10.1071/ZO99013; DRUMMOND AJ, 2006, BEAST V1 4; Drummond AJ, 2007, ROUGH GUIDE BEAST 1; Dubey S, 2011, BIOL LETTERS, V7, P96, DOI 10.1098/rsbl.2010.0557; Dubey S, 2010, J BIOGEOGR, V37, P902, DOI 10.1111/j.1365-2699.2009.02266.x; Emerson BC, 2005, CURR BIOL, V15, pR367, DOI 10.1016/j.cub.2005.05.016; Fairbairn J, 1998, MOL PHYLOGENET EVOL, V10, P95, DOI 10.1006/mpev.1997.0468; Frakes LA, 1987, FAUNA AUSTR A, P1; Gallagher SJ, 2003, PALAEOGEOGR PALAEOCL, V193, P349, DOI 10.1016/S0031-0182(03)00231-1; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HARRIS PT, 2005, 200330 GEOSC AUSTR; Hewitt G.M., 2001, INTEGRATING ECOLOGY, P271; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt Godfrey M., 2004, Frontiers in Zoology, V1, P1, DOI 10.1186/1742-9994-1-4; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Huey RB, 2009, P NATL ACAD SCI USA, V106, P3647, DOI 10.1073/pnas.0900934106; Kearney M, 2009, P NATL ACAD SCI USA, V106, P3835, DOI 10.1073/pnas.0808913106; Keogh JS, 2005, EVOLUTION, V59, P226; Kershaw A.P., 1994, AUSTR VEGETATION HIS; Macey JR, 1999, MOL PHYLOGENET EVOL, V12, P250, DOI 10.1006/mpev.1999.0615; MARKGRAF V, 1995, TRENDS ECOL EVOL, V10, P143, DOI 10.1016/S0169-5347(00)89023-0; Martin HA, 2006, J ARID ENVIRON, V66, P533, DOI 10.1016/j.jaridenv.2006.01.009; Martin JE, 2004, J HERPETOL, V38, P180, DOI 10.1670/25-03A; McGowran B, 2004, AUST J EARTH SCI, V51, P459, DOI 10.1111/j.1400-0952.2004.01078.x; Melville J, 2007, CONSERV GENET, V8, P185, DOI 10.1007/s10592-006-9161-6; Oliver P, 2007, MOL PHYLOGENET EVOL, V44, P77, DOI 10.1016/j.ympev.2007.02.002; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Read K, 2001, MOL PHYLOGENET EVOL, V21, P294, DOI 10.1006/mpev.2001.1014; Schauble CS, 2001, BIOL J LINN SOC, V74, P157, DOI 10.1006/bijl.2001.0562; Schultz MB, 2008, MOL ECOL, V17, P5291, DOI 10.1111/j.1365-294X.2008.03996.x; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SMITH MA, 1937, REC INDIAN MUS, V39, P213; Sniderman JMK, 2007, GEOLOGY, V35, P41, DOI 10.1130/G23247A.1; Swofford DL., 2001, PAUP PHYLOGENETIC AN; Symula R, 2008, MOL PHYLOGENET EVOL, V47, P569, DOI 10.1016/j.ympev.2008.01.011; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Torres-Carvajal O, 2009, MOL PHYLOGENET EVOL, V50, P31, DOI 10.1016/j.ympev.2008.10.002; Veevers J.J, 2000, BILLION YEAR EARTH H, P45; Wells R.W., 1983, Australian Journal of Herpetology, V1, P73; Williams MAJ, 1998, QUATERNARY ENV; Zamudio KR, 1997, BIOL J LINN SOC, V62, P421, DOI 10.1111/j.1095-8312.1997.tb01634.x	56	29	32	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2010	5	9							e12982	10.1371/journal.pone.0012982	http://dx.doi.org/10.1371/journal.pone.0012982			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653UN	20886050	Green Published, gold, Green Submitted			2022-12-27	WOS:000282122600017
J	Worbe, Y; Mallet, L; Golmard, JL; Behar, C; Durif, F; Jalenques, I; Damier, P; Derkinderen, P; Pollak, P; Anheim, M; Broussolle, E; Xie, J; Mesnage, V; Mondon, K; Viallet, F; Jedynak, P; Ben Djebara, M; Schupbach, M; Pelissolo, A; Vidailhet, M; Agid, Y; Houeto, JL; Hartmann, A				Worbe, Yulia; Mallet, Luc; Golmard, Jean-Louis; Behar, Cecile; Durif, Franck; Jalenques, Isabelle; Damier, Philippe; Derkinderen, Pascal; Pollak, Pierre; Anheim, Mathieu; Broussolle, Emannuel; Xie, Jing; Mesnage, Valerie; Mondon, Karl; Viallet, Francois; Jedynak, Pierre; Ben Djebara, Mouna; Schuepbach, Michael; Pelissolo, Antoine; Vidailhet, Marie; Agid, Yves; Houeto, Jean-Luc; Hartmann, Andreas			Repetitive Behaviours in Patients with Gilles de la Tourette Syndrome: Tics, Compulsions, or Both?	PLOS ONE			English	Article							SELF-INJURIOUS-BEHAVIOR; DISORDER; SYMPTOMS; OCD; DIMENSIONS; IMPULSIVITY; SEVERITY; CHILDREN; VOLUMES; PLACEBO	Background: Repetitive behaviours (RB) in patients with Gilles de la Tourette syndrome (GTS) are frequent. However, a controversy persists whether they are manifestations of obssessive-compulsive disorder (OCD) or correspond to complex tics. Methods: 166 consecutive patients with GTS aged 15-68 years were recruited and submitted to extensive neurological, psychiatric and psychological evaluations. RB were evaluated by the YBOCS symptom checklist and Mini International Neuropsychiatric Interview (M.I.N.I), and classified on the basis of a semi-directive psychiatric interview as compulsions or tics. Results: RB were present in 64.4% of patients with GTS (107/166) and categorised into 3 major groups: a 'tic-like' group (24.3%-40/166) characterised by RB such as touching, counting, 'just right' and symmetry searching; an 'OCD-like' group (20.5%-34/166) with washing and checking rituals; and a 'mixed' group (13.2%-22/166) with both 'tics-like' and 'OCD-like' types of RB present in the same patient. In 6.3% of patients, RB could not be classified into any of these groups and were thus considered 'undetermined'. Conclusions: The results confirm the phenomenological heterogeneity of RB in GTS patients and allows to distinguish two types: tic-like behaviours which are very likely an integral part of GTS; and OCD-like behaviours, which can be considered as a comorbid condition of GTS and were correlated with higher score of complex tics, neuroleptic and SSRIs treatment frequency and less successful socio-professional adaptation. We suggest that a meticulous semiological analysis of RB in GTS patients will help to tailor treatment and allow to better classify patients for future pathophysiologic studies.	[Worbe, Yulia; Mallet, Luc; Behar, Cecile; Jedynak, Pierre; Ben Djebara, Mouna; Schuepbach, Michael; Vidailhet, Marie; Agid, Yves; Hartmann, Andreas] Univ Paris 06, Grp Hosp Pitie Salpetriere, AP HP, Ctr Invest Clin INSERM CIC 9503, Paris, France; [Golmard, Jean-Louis] Grp Hosp Pitie Salpetriere, AP HP, Dept Biostat, F-75634 Paris, France; [Durif, Franck] Ctr Hosp Univ Clermont Ferrand, Dept Neurol, Clermont Ferrand, France; [Jalenques, Isabelle] CHU Clermont Ferrand, Serv Psychiat Adulte & Psychol Med A, Clermont Ferrand, France; [Jalenques, Isabelle] Univ Auvergne Clermont 1, Clermont Univ, UFR Med, Equipe Accueil 3845, Clermont Ferrand, France; [Damier, Philippe; Derkinderen, Pascal] CHU Nantes, Dept Neurol, F-44035 Nantes 01, France; [Pollak, Pierre; Anheim, Mathieu] CHU Grenoble, Dept Neurol, F-38043 Grenoble, France; [Broussolle, Emannuel; Xie, Jing] Univ Lyon 1, Fac Med Lyon Sud Charles Merieux, Hosp Civils Lyon,Dept Neurol C,CNRS UMR 5229, Hop Neurol Pierre Wertheimer,Ctr Neurosci Cognit, F-69365 Lyon, France; [Mesnage, Valerie; Houeto, Jean-Luc] Ctr Hosp Univ Poitiers, Dept Neurol, Poitiers, France; [Mondon, Karl] CHU Tours, Dept Neurol, Tours, France; [Viallet, Francois] Ctr Hosp Aix En Provence, Dept Neurol, Aix En Provence, France; [Pelissolo, Antoine] Grp Hosp Pitie Salpetriere, AP HP, Dept Psychiat, F-75634 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Clermont Ferrand; CHU Clermont Ferrand; Universite Clermont Auvergne (UCA); Nantes Universite; CHU de Nantes; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Poitiers; Universite de Poitiers; CHU Tours; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Worbe, Y (corresponding author), Univ Paris 06, Grp Hosp Pitie Salpetriere, AP HP, Ctr Invest Clin INSERM CIC 9503, Paris, France.	andreas.hartmann@psl.aphp.fr	Broussolle, Emmanuel/H-1592-2017; Worbe, Yulia/GYV-3751-2022; Derkinderen, Pascal/K-2393-2015; Damier, Philippe/T-7829-2019; Mallet, Luc/F-7156-2013; Durif, Franck/CAA-1077-2022	Broussolle, Emmanuel/0000-0002-0410-9519; Mallet, Luc/0000-0001-8061-1167; BEN DJEBARA, Mouna/0000-0002-5647-2598; Anheim, Mathieu/0000-0001-8121-0605; Worbe, Yulia/0000-0001-5903-9370; PELISSOLO, Antoine/0000-0003-0465-5648	GIS-Institut des Maladie Rares (France) [RB 04-18]; Association Francaise du Syndrome Gilles de la Tourette (AFSGT)	GIS-Institut des Maladie Rares (France); Association Francaise du Syndrome Gilles de la Tourette (AFSGT)	This work was supported by a grant from GIS-Institut des Maladie Rares, grant RB 04-18 (France; www.institutmaladiesrares.net). Y.W. was supported by the Association Francaise du Syndrome Gilles de la Tourette (AFSGT; www.france-tourette.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Anholt GE, 2006, BEHAV RES THER, V44, P1537, DOI 10.1016/j.brat.2005.11.007; Barrett PM, 2008, J CLIN CHILD ADOLESC, V37, P131, DOI 10.1080/15374410701817956; Bloch MH, 2006, MOL PSYCHIATR, V11, P622, DOI 10.1038/sj.mp.4001823; Bloch MH, 2005, NEUROLOGY, V65, P1253, DOI 10.1212/01.wnl.0000180957.98702.69; Bloch MH, 2008, AM J PSYCHIAT, V165, P1532, DOI 10.1176/appi.ajp.2008.08020320; Cath DC, 2001, PSYCHIAT RES, V101, P171, DOI 10.1016/S0165-1781(01)00219-0; Chamberlain SR, 2008, SCIENCE, V321, P421, DOI 10.1126/science.1154433; Coffey BJ, 1998, J NERV MENT DIS, V186, P201, DOI 10.1097/00005053-199804000-00001; Diniz JB, 2006, J PSYCHIATR RES, V40, P487, DOI 10.1016/j.jpsychires.2005.09.002; do Rosario-Campos MC, 2001, AM J PSYCHIAT, V158, P1899, DOI 10.1176/appi.ajp.158.11.1899; Fontenelle LF, 2007, EXPERT OPIN PHARMACO, V8, P563, DOI 10.1517/14656566.8.5.563; Gilbert AR, 2008, J AFFECT DISORDERS, V109, P117, DOI 10.1016/j.jad.2007.12.223; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; Grados MA, 2008, BIOL PSYCHIAT, V64, P219, DOI 10.1016/j.biopsych.2008.01.019; Hanna GL, 2002, AM J MED GENET, V114, P541, DOI 10.1002/ajmg.10519; Hasler G, 2007, BIOL PSYCHIAT, V61, P617, DOI 10.1016/j.biopsych.2006.05.040; Herpertz S, 1997, J PSYCHIAT RES, V31, P451, DOI 10.1016/S0022-3956(97)00004-6; HOLZER JC, 1994, BRIT J PSYCHIAT, V164, P469, DOI 10.1192/bjp.164.4.469; Langlois F, 2000, BEHAV RES THER, V38, P157, DOI 10.1016/S0005-7967(99)00027-3; LECKMAN JF, 1994, AM J PSYCHIAT, V151, P675; Leckman JF, 2000, LEA SER PER CLIN PSY, P43; Leckman JF, 1997, AM J PSYCHIAT, V154, P911; LECKMAN JF, 1989, J AM ACAD CHILD PSY, V28, P566, DOI 10.1097/00004583-198907000-00015; Mataix-Cols D, 1999, AM J PSYCHIAT, V156, P1409; Mataix-Cols D, 2002, PSYCHOTHER PSYCHOSOM, V71, P255, DOI 10.1159/000064812; Mathews CA, 2004, J NEUROL NEUROSUR PS, V75, P1149, DOI 10.1136/jnnp.2003.020693; Mathews CA, 2007, BIOL PSYCHIAT, V61, P292, DOI 10.1016/j.biopsych.2006.02.009; MCDOUGLE CJ, 1994, ARCH GEN PSYCHIAT, V51, P302; Menzies L, 2007, BRAIN, V130, P3223, DOI 10.1093/brain/awm205; Miguel EC, 1997, BRIT J PSYCHIAT, V170, P140, DOI 10.1192/bjp.170.2.140; Miguel EC, 2003, J PSYCHOSOM RES, V55, P49, DOI 10.1016/S0022-3999(02)00583-4; Mink Jonathan W, 2006, Adv Neurol, V99, P89; Muller N, 1997, PSYCHIAT RES, V70, P105, DOI 10.1016/S0165-1781(97)02658-9; MULLERVAHL KR, 2009, BMC NEUROSCI, V12, P10; Orth M, 2009, J NEUROL NEUROSUR PS, V80, P29, DOI 10.1136/jnnp.2008.149484; PAULS DL, 1991, AM J HUM GENET, V48, P154; Peterson BS, 2003, ARCH GEN PSYCHIAT, V60, P415, DOI 10.1001/archpsyc.60.4.415; Prado HD, 2008, CNS SPECTRUMS, V13, P425, DOI 10.1017/S1092852900016606; Robertson MM, 2008, BRIT J PSYCHIAT, V193, P31, DOI 10.1192/bjp.bp.107.039909; Robertson MM, 2000, BRAIN, V123, P425, DOI 10.1093/brain/123.3.425; ROBERTSON MM, 1989, PSYCHOL MED, V19, P611, DOI 10.1017/S0033291700024211; Roth RM, 2007, BIOL PSYCHIAT, V62, P901, DOI 10.1016/j.biopsych.2006.12.007; Salkovskis PM, 1998, BRIT J PSYCHIAT, V173, P53, DOI 10.1192/S0007125000297900; SHAPIRO AK, 1992, COMPR PSYCHIAT, V33, P152, DOI 10.1016/0010-440X(92)90024-K; SHAPIRO AK, 1988, G DELATOURETTES SYND; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sowell ER, 2008, NAT NEUROSCI, V11, P637, DOI 10.1038/nn.2121; STEINGARD R, 1992, PSYCHIAT CLIN N AM, V15, P849; Stewart SE, 2008, J AM ACAD CHILD PSY, V47, P763, DOI 10.1097/CHI.0b013e318172ef1e; Stewart SE, 2006, J AM ACAD CHILD PSY, V45, P1354, DOI 10.1097/01.chi.0000251211.36868.fe; Swain JE, 2007, J AM ACAD CHILD PSY, V46, P947, DOI 10.1097/chi.0b013e318068fbcc; van den Heuvel OA, 2009, BRAIN, V132, P853, DOI 10.1093/brain/awn267	53	77	77	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2010	5	9							e12959	10.1371/journal.pone.0012959	http://dx.doi.org/10.1371/journal.pone.0012959			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	653UN	20885982	Green Published, gold			2022-12-27	WOS:000282122600003
J	Ichii, M; Oritani, K; Yokota, T; Zhang, QZ; Garrett, KP; Kanakura, Y; Kincade, PW				Ichii, Michiko; Oritani, Kenji; Yokota, Takafumi; Zhang, Qingzhao; Garrett, Karla P.; Kanakura, Yuzuru; Kincade, Paul W.			The Density of CD10 Corresponds to Commitment and Progression in the Human B Lymphoid Lineage	PLOS ONE			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; BONE-MARROW; CORD BLOOD; STEM-CELL; DENDRITIC CELLS; PROGENITOR; IL-7; LYMPHOPOIESIS; GROWTH; IDENTIFICATION	Background: Requirements for human B lymphopoiesis are still poorly understood, and that has hampered investigation of differentiation events. For example, there are few cell surface antigens that can be used as milestones of lineage progression. The CD10 ectoenzyme is one such marker and has been used to define CLP, but we found substantial tissue specific variations in CD10 levels, and there was no information about how that corresponded to differentiation options. Methodology/Principal Findings: The aim of the present study was to use recently developed culture methods to assess the nature and differentiation potential of progenitors sorted according to CD10 density from umbilical cord blood (CB), adult bone marrow (BM) or G-CSF mobilized peripheral blood (PB). Many CD34(+) cells in BM express high levels of CD10, while low or low/negative CD10 densities were found on CD34(+) cells in CB or G-CSF mobilized PB, respectively. The relative abundance of CD10(Lo) versus CD10 Hi cells only accounts for some CB versus BM differences. Almost all of the CD34(+) CD10(Hi) cells expressed CD19 and lymphocyte transcription factors and corresponded to loss of myeloid potential. A high degree of immunoglobulin DH-JH gene rearrangements was characteristic only of the CD10(Hi) subset. In contrast, the CD34(+) CD10(Lo) progenitors efficiently produced plasmacytoid and conventional dendritic cells as well as myeloid cells. These findings suggest a positive correlation between CD10 density and degree of differentiation. Although freshly isolated CD34(+) CD10(Hi) cells were in cycle, those from CB or BM expanded poorly in culture, suggesting regulators of populations remain to be discovered. Conclusions/Significance: Steps in human B lymphopoiesis have not been sufficiently studied, and we now show that increased CD10 expression corresponds to differentiation potential and stage. CD34(+) CD10(Hi) progenitors are obviously in the B lineage but may have progressed beyond the point where they can be expanded in culture.	[Ichii, Michiko; Zhang, Qingzhao; Garrett, Karla P.; Kincade, Paul W.] Oklahoma Med Res Fdn, Immunobiol & Canc Program, Oklahoma City, OK 73104 USA; [Oritani, Kenji; Yokota, Takafumi; Kanakura, Yuzuru] Osaka Univ, Grad Sch Med, Dept Hematol & Oncol, Osaka, Japan	Oklahoma Medical Research Foundation; Osaka University	Ichii, M (corresponding author), Oklahoma Med Res Fdn, Immunobiol & Canc Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	kincade@omrf.ouhsc.edu			National Institutes of Health [AI020069]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI020069, R01AI020069] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grant AI020069 (P.W.K.) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. P. W. K. holds the William H. and Rita Bell Endowed Chair in Biomedical Research.	Balciunaite G, 2005, EUR J IMMUNOL, V35, P2019, DOI 10.1002/eji.200526318; Buckley RH, 2010, J ALLERGY CLIN IMMUN, V125, P790, DOI 10.1016/j.jaci.2010.02.012; Buckley RH, 2004, ANNU REV IMMUNOL, V22, P625, DOI 10.1146/annurev.immunol.22.012703.104614; CROOKS GM, 2004, HDB STEM CELLS, P347; DITTEL BN, 1995, J IMMUNOL, V154, P58; GALY A, 1995, IMMUNITY, V3, P459, DOI 10.1016/1074-7613(95)90175-2; Haddad R, 2004, BLOOD, V104, P3918, DOI 10.1182/blood-2004-05-1845; Hao QL, 2001, BLOOD, V97, P3683, DOI 10.1182/blood.V97.12.3683; Harman BC, 2008, J IMMUNOL, V181, P7514, DOI 10.4049/jimmunol.181.11.7514; Hoebeke I, 2007, LEUKEMIA, V21, P311, DOI 10.1038/sj.leu.2404488; Hou YH, 2005, BLOOD, V105, P3488, DOI 10.1182/blood-2004-07-2839; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Hystad ME, 2007, J IMMUNOL, V179, P3662, DOI 10.4049/jimmunol.179.6.3662; Ichii M, 2008, EXP HEMATOL, V36, P587, DOI 10.1016/j.exphem.2007.12.013; Ichii M, 2010, J IMMUNOL METHODS, V359, P47, DOI 10.1016/j.jim.2010.06.002; Inlay MA, 2009, GENE DEV, V23, P2376, DOI 10.1101/gad.1836009; Iwata M, 2002, BLOOD, V100, P1318, DOI 10.1182/blood-2002-01-0062; Johnson SE, 2005, J IMMUNOL, V175, P7325, DOI 10.4049/jimmunol.175.11.7325; Johnson SE, 2008, J IMMUNOL, V180, P8109, DOI 10.4049/jimmunol.180.12.8109; Karsunky H, 2008, BLOOD, V111, P5562, DOI 10.1182/blood-2007-11-126219; Kawamoto H, 2009, TRENDS IMMUNOL, V30, P193, DOI 10.1016/j.it.2009.03.001; KEE BL, 1992, INT IMMUNOL, V4, P1041, DOI 10.1093/intimm/4.9.1041; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kouro T, 2001, BLOOD, V97, P2708, DOI 10.1182/blood.V97.9.2708; Laughlin MJ, 2004, NEW ENGL J MED, V351, P2265, DOI 10.1056/NEJMoa041276; Lefranc Marie-Paule, 2005, In Silico Biology, V5, P45; Michonneau D, 2009, BRIT J HAEMATOL, V145, P107, DOI 10.1111/j.1365-2141.2008.07574.x; Ng YY, 2004, J LEUKOCYTE BIOL, V75, P314, DOI 10.1189/jlb.0603287; Nishihara M, 1998, EUR J IMMUNOL, V28, P855, DOI 10.1002/(SICI)1521-4141(199803)28:03<855::AID-IMMU855>3.0.CO;2-X; Parrish YK, 2009, J IMMUNOL, V182, P4255, DOI 10.4049/jimmunol.0800489; Pribyl JAR, 1996, P NATL ACAD SCI USA, V93, P10348, DOI 10.1073/pnas.93.19.10348; Rossi MID, 2003, BLOOD, V101, P576, DOI 10.1182/blood-2002-03-0896; Rumfelt LL, 2006, J EXP MED, V203, P675, DOI 10.1084/jem.20052444; Sanz E, 2003, BLOOD, V101, P3424, DOI 10.1182/blood-2002-07-2244; Sanz E, 2010, P NATL ACAD SCI USA, V107, P5925, DOI 10.1073/pnas.0907942107; Schmitz N, 2002, SEMIN HEMATOL, V39, P3, DOI 10.1053/shem.2002.29245; Six EM, 2007, J EXP MED, V204, P3085, DOI 10.1084/jem.20071003; Tomblyn MB, 2009, J CLIN ONCOL, V27, P3634, DOI 10.1200/JCO.2008.20.2960; van Zelm MC, 2005, J IMMUNOL, V175, P5912, DOI 10.4049/jimmunol.175.9.5912; Wang JCY, 1997, BLOOD, V89, P3919, DOI 10.1182/blood.V89.11.3919; Welner RS, 2008, BLOOD, V112, P3753, DOI 10.1182/blood-2008-04-151506; WOLF ML, 1991, J IMMUNOL, V147, P3324	42	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12954	10.1371/journal.pone.0012954	http://dx.doi.org/10.1371/journal.pone.0012954			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886092	Green Published, Green Submitted, gold			2022-12-27	WOS:000282091100049
J	Ramon, HE; Cejas, PJ; LaRosa, D; Rahman, A; Harris, JE; Zhang, JD; Hunter, C; Choi, Y; Turka, LA				Ramon, Hilda E.; Cejas, Pedro J.; LaRosa, David; Rahman, Adeeb; Harris, John E.; Zhang, Jidong; Hunter, Christopher; Choi, Yongwon; Turka, Laurence A.			EGR-2 Is Not Required for In Vivo CD4 T Cell Mediated Immune Responses	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; FAS LIGAND; GROWTH; PROTEINS	Background: The zinc finger transcription factor EGR-2 has been shown to play an important role in the induction of T cell anergy and the regulation of peripheral T cell tolerance. In vitro, a prior study has show that T cells deficient in EGR-2 are hyperproliferative to IL-2 and produce elevated levels of the effector cytokine IFN-gamma. EGR-2 deficient mice have increased levels of CD44(high) T cells in peripheral lymphoid organs, and with age, develop autoimmune-like features. Principal Findings: Here we show that despite increased numbers of cells bearing an activated CD44(high) CD62L(low) phenotype, T cells from young healthy EGR-2 deficient mice have normal proliferative and cytokine responses, and the mice themselves mount normal immune responses against minor histocompatibility antigens, and the pathogens Toxoplasma gondii and lymphocytic choriomeningitis virus. Conclusions: Our results indicate that EGR-2 is not required to mount normal acute in vivo immune responses against foreign antigens, and suggest instead that it may serve to regulate the response to chronic antigenic exposure, such as that which occurs to autoantigens.	[Ramon, Hilda E.; LaRosa, David; Rahman, Adeeb; Zhang, Jidong; Turka, Laurence A.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Cejas, Pedro J.; Choi, Yongwon] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Harris, John E.] Univ Penn, Sch Med, Dept Dermatol, Philadelphia, PA 19104 USA; [Hunter, Christopher] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Ramon, HE (corresponding author), Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA.	lturka@bidmc.harvard.edu	Hunter, Christopher/H-1970-2011	Rahman, Adeeb/0000-0002-8620-3161	National Institutes of Health [AI-43620]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI043620] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant AI-43620 to Christopher Hunter, Yongwon Choi and Laurence A. Turka. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Collins S, 2008, EUR J IMMUNOL, V38, P528, DOI 10.1002/eji.200737157; Cron RQ, 2006, J IMMUNOL, V176, P811, DOI 10.4049/jimmunol.176.2.811; Decker EL, 2003, NUCLEIC ACIDS RES, V31, P911, DOI 10.1093/nar/gkg186; Denkers EY, 1998, CLIN MICROBIOL REV, V11, P569, DOI 10.1128/CMR.11.4.569; Dzierszinski FS, 2008, PARASITE IMMUNOL, V30, P235, DOI 10.1111/j.1365-3024.2007.01016.x; GAMPER CJ, 2010, IMMUNOL RES; Gelman AE, 2004, J IMMUNOL, V172, P6065, DOI 10.4049/jimmunol.172.10.6065; Gomez-Martin D, 2009, AUTOIMMUN REV, V9, P34, DOI 10.1016/j.autrev.2009.02.035; Harris JE, 2004, J IMMUNOL, V173, P7331, DOI 10.4049/jimmunol.173.12.7331; Khanolkar A, 2002, IMMUNOL RES, V26, P309, DOI 10.1385/IR:26:1-3:309; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Mittelstadt PR, 1998, MOL CELL BIOL, V18, P3744, DOI 10.1128/MCB.18.7.3744; Mittelstadt PR, 1999, J BIOL CHEM, V274, P3222, DOI 10.1074/jbc.274.5.3222; O'Donovan KJ, 1999, TRENDS NEUROSCI, V22, P167, DOI 10.1016/S0166-2236(98)01343-5; Safford M, 2005, NAT IMMUNOL, V6, P472, DOI 10.1038/ni1193; Skerka C, 1997, IMMUNOBIOLOGY, V198, P179, DOI 10.1016/S0171-2985(97)80039-3; Taillebourg E, 2002, GENESIS, V32, P112, DOI 10.1002/gene.10062; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Yang SZ, 2006, J CELL BIOCHEM, V97, P1292, DOI 10.1002/jcb.20736; Zhu B, 2008, J EXP MED, V205, P2295, DOI 10.1084/jem.20080187	20	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12904	10.1371/journal.pone.0012904	http://dx.doi.org/10.1371/journal.pone.0012904			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886122	gold, Green Submitted, Green Published			2022-12-27	WOS:000282091100013
J	Marre, ML; Petnicki-Ocwieja, T; DeFrancesco, AS; Darcy, CT; Hu, LT				Marre, Meghan L.; Petnicki-Ocwieja, Tanja; DeFrancesco, Alicia S.; Darcy, Courtney T.; Hu, Linden T.			Human Integrin alpha(3)beta(1) Regulates TLR2 Recognition of Lipopeptides from Endosomal Compartments	PLOS ONE			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; FIBRONECTIN-BINDING PROTEIN; INNATE IMMUNE-SYSTEM; TOLL-LIKE RECEPTOR-2; BORRELIA-BURGDORFERI; I INTERFERON; DENDRITIC CELLS; MATRIX METALLOPROTEINASES; INFLAMMATORY MEDIATORS; STAPHYLOCOCCUS-AUREUS	Background: Toll-like receptor (TLR)-2/TLR1 heterodimers recognize bacterial lipopeptides and initiate the production of inflammatory mediators. Adaptors and co-receptors that mediate this process, as well as the mechanisms by which these adaptors and co-receptors function, are still being discovered. Methodology/Principal Findings: Using shRNA, blocking antibodies, and fluorescent microscopy, we show that U937 macrophage responses to the TLR2/1 ligand, Pam(3)CSK(4), are dependent upon an integrin, alpha(3)beta(1). The mechanism for integrin alpha(3)beta(1) involvement in TLR2/1 signaling is through its role in endocytosis of lipopeptides. Using inhibitors of endosomal acidification/maturation and physical tethering of the ligand, we show that the endocytosis of Pam(3)CSK(4) is necessary for the complete TLR2/1-mediated pro-inflammatory cytokine response. We also show that TLR2/1 signaling from the endosome results in the induction of different inflammatory mediators than TLR2/1 signaling from the plasma membrane. Conclusion/Significance: Here we identify integrin alpha(3)beta(1) as a novel regulator for the recognition of bacterial lipopeptides. We demonstrate that induction of a specific subset of cytokines is dependent upon integrin alpha(3)beta(1)-mediated endocytosis of the ligand. In addition, we address an ongoing controversy regarding endosomal recognition of bacterial lipopeptides by demonstrating that TLR2/1 signals from within endosomal compartments as well as the plasma membrane, and that downstream responses may differ depending upon receptor localization. We propose that the regulation of endosomal TLR2/1 signaling by integrin alpha(3)beta(1) serves as a mechanism for modulating inflammatory responses.	[Marre, Meghan L.; Hu, Linden T.] Tufts Univ, Sackler Sch Grad Biomed Sci, Grad Program Immunol, Boston, MA 02111 USA; [Petnicki-Ocwieja, Tanja; DeFrancesco, Alicia S.; Darcy, Courtney T.; Hu, Linden T.] Tufts Med Ctr, Div Geog Med & Infect Dis, Boston, MA USA	Tufts University; Tufts Medical Center	Marre, ML (corresponding author), Tufts Univ, Sackler Sch Grad Biomed Sci, Grad Program Immunol, Boston, MA 02111 USA.	lhu@tuftsmedicalcenter.org	Hu, Linden/L-6314-2016	Hu, Linden/0000-0003-1659-5558	U.S. National Institutes of Health [R56AI80846, R01-AI-50043, T32AI07077, T32AI007329]; National Institutes of Health [P30 NS047243]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050043, R56AI080646, T32AI007077, T32AI007329] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047243] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by the U.S. National Institutes of Health (R56AI80846, R01-AI-50043 to L.T.H., T32AI07077 to M.L.M, and T32AI007329 to T.P.O.). The Tufts Center for Neuroscience Research microscopy core is funded by the National Institutes of Health (P30 NS047243 to F.Rob Jackson). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akula SM, 2002, CELL, V108, P407, DOI 10.1016/S0092-8674(02)00628-1; Barbalat R, 2009, NAT IMMUNOL, V10, P1200, DOI 10.1038/ni.1792; BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Behera AK, 2005, INFECT IMMUN, V73, P126, DOI 10.1128/IAI.73.1.126-134.2005; Behera AK, 2008, CELL MICROBIOL, V10, P320, DOI 10.1111/j.1462-5822.2007.01043.x; Behera AK, 2006, J IMMUNOL, V177, P657, DOI 10.4049/jimmunol.177.1.657; Bowdish DME, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000474; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; COBURN J, 1993, P NATL ACAD SCI USA, V90, P7059, DOI 10.1073/pnas.90.15.7059; Coburn J, 1998, INFECT IMMUN, V66, P1946, DOI 10.1128/IAI.66.5.1946-1952.1998; COBURN J, 1994, INFECT IMMUN, V62, P5559, DOI 10.1128/IAI.62.12.5559-5567.1994; Coburn Jenifer, 2001, Current Drug Targets - Infectious Disorders, V1, P171, DOI 10.2174/1568005014606062; Cole LE, 2010, J LEUKOCYTE BIOL, V87, P275, DOI 10.1189/jlb.0909619; Dietrich N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010250; Dupuy AG, 2008, J CELL SCI, V121, P1773, DOI 10.1242/jcs.018036; Dziewanowska K, 1999, INFECT IMMUN, V67, P4673, DOI 10.1128/IAI.67.9.4673-4678.1999; Ferwerda G, 2008, CELL MICROBIOL, V10, P2058, DOI 10.1111/j.1462-5822.2008.01188.x; Fleetwood AJ, 2009, J LEUKOCYTE BIOL, V86, P411, DOI 10.1189/jlb.1108702; Galdiero M, 2006, CYTOKINE, V36, P218, DOI 10.1016/j.cyto.2006.12.003; Garrigues HJ, 2008, J VIROL, V82, P1570, DOI 10.1128/JVI.01673-07; Gautier G, 2005, J EXP MED, V201, P1435, DOI 10.1084/jem.20041964; Gerold G, 2008, NAT IMMUNOL, V9, P761, DOI 10.1038/ni.1618; Herskovits AA, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030051; Hirschfeld M, 1999, J IMMUNOL, V163, P2382; Hoffmann PR, 2001, J CELL BIOL, V155, P649, DOI 10.1083/jcb.200108080; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Ingalls RR, 1998, PROG CLIN BIOL RES, V397, P107; ISBERG RR, 1990, CELL, V60, P861, DOI 10.1016/0092-8674(90)90099-Z; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Katsumi A, 2005, J BIOL CHEM, V280, P16546, DOI 10.1074/jbc.C400455200; Kenny EF, 2009, J IMMUNOL, V183, P3642, DOI 10.4049/jimmunol.0901140; Khan S, 2007, J BIOL CHEM, V282, P21145, DOI 10.1074/jbc.M701705200; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Malinin NL, 2009, NAT MED, V15, P313, DOI 10.1038/nm.1917; Marina-Garcia N, 2009, J IMMUNOL, V182, P4321, DOI 10.4049/jimmunol.0802197; McGettrick AF, 2010, CURR OPIN IMMUNOL, V22, P20, DOI 10.1016/j.coi.2009.12.002; McKenna K, 2005, J VIROL, V79, P17, DOI 10.1128/JVI.79.1.17-27.2005; Mitani Y, 2001, GENES CELLS, V6, P631, DOI 10.1046/j.1365-2443.2001.00448.x; Nilsen NJ, 2008, J LEUKOCYTE BIOL, V84, P280, DOI 10.1189/jlb.0907656; Perera PY, 2001, J IMMUNOL, V166, P574, DOI 10.4049/jimmunol.166.1.574; Petzke MM, 2009, J IMMUNOL, V183, P5279, DOI 10.4049/jimmunol.0901390; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Scott MJ, 2008, J BIOL CHEM, V283, P29433, DOI 10.1074/jbc.M803905200; Shin OS, 2008, INFECT IMMUN, V76, P2341, DOI 10.1128/IAI.01600-07; Shin OS, 2009, J IMMUNOL, V183, P491, DOI 10.4049/jimmunol.0900724; Sinha B, 1999, CELL MICROBIOL, V1, P101, DOI 10.1046/j.1462-5822.1999.00011.x; Somersan S, 2001, J CELL BIOL, V155, P501, DOI 10.1083/jcb.200110066; Spandidos A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-633; TAKADA Y, 1988, J CELL BIOCHEM, V37, P385, DOI 10.1002/jcb.240370406; TAKEMURA H, 1992, BIOCHEM PHARMACOL, V44, P1395, DOI 10.1016/0006-2952(92)90541-P; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Thomas KE, 2006, J BIOL CHEM, V281, P31119, DOI 10.1074/jbc.M604958200; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Wang X, 2005, NAT MED, V11, P515, DOI 10.1038/nm1236; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; WAYNER EA, 1987, J CELL BIOL, V105, P1873, DOI 10.1083/jcb.105.4.1873; Wooten RM, 2002, VECTOR-BORNE ZOONOT, V2, P275, DOI 10.1089/153036602321653860; Wooten RM, 2002, J IMMUNOL, V168, P348, DOI 10.4049/jimmunol.168.1.348; Yamane I, 2005, INT J PHARMACEUT, V305, P145, DOI 10.1016/j.ijpharm.2005.08.020; Yoshimura A, 1999, J IMMUNOL, V163, P1; Zeng H, 2007, J VIROL, V81, P12439, DOI 10.1128/JVI.01134-07; Zullig S, 2004, SCIENCE, V304, P1123	65	50	50	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12871	10.1371/journal.pone.0012871	http://dx.doi.org/10.1371/journal.pone.0012871			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877569	gold, Green Published, Green Submitted			2022-12-27	WOS:000282053100023
J	Tatarenkov, A; Ring, BC; Elder, JF; Bechler, DL; Avise, JC				Tatarenkov, Andrey; Ring, Brian C.; Elder, John F.; Bechler, David L.; Avise, John C.			Genetic Composition of Laboratory Stocks of the Self-Fertilizing Fish Kryptolebias marmoratus: A Valuable Resource for Experimental Research	PLOS ONE			English	Article							RIVULUS-OCELLATUS-MARMORATUS; HERMAPHRODITIC FISH; MANGROVE KILLIFISH; ONCOGENE EXPRESSION; SEQUENCE ALIGNMENT; MITOCHONDRIAL-DNA; HEPATIC NEOPLASMS; ACUTE TOXICITY; AIR-EXPOSURE; DIETHYLNITROSAMINE	The hermaphroditic Mangrove Killifish, Kryptolebias marmoratus, is the world's only vertebrate that routinely self-fertilizes. As such, highly inbred and presumably isogenic "clonal'' lineages of this androdioecious species have long been maintained in several laboratories and used in a wide variety of experiments that require genetically uniform vertebrate specimens. Here we conduct a genetic inventory of essentially all laboratory stocks of the Mangrove Killifish held worldwide. At 32 microsatellite loci, these stocks proved to show extensive interline differentiation as well as some intraline variation, much of which can be attributed to post-origin de novo mutations and/or to the segregation of polymorphisms from wild progenitors. Our genetic findings also document that many of the surveyed laboratory strains are not what they have been labeled, apparently due to the rather frequent mishandling or unintended mixing of various laboratory stocks over the years. Our genetic inventory should help to clarify much of this confusion about the clonal identities and genetic relationships of laboratory lines, and thereby help to rejuvenate interest in K. marmoratus as a reliable vertebrate model for experimental research that requires or can capitalize upon "clonal'' replicate specimens.	[Tatarenkov, Andrey; Avise, John C.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA; [Ring, Brian C.; Elder, John F.; Bechler, David L.] Valdosta State Univ, Dept Biol, Valdosta, GA USA	University of California System; University of California Irvine; University System of Georgia; Valdosta State University	Tatarenkov, A (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA.	tatarenk@uci.edu; bcring@valdosta.edu	Tatarenkov, Andrey/D-5228-2009	Tatarenkov, Andrey/0000-0002-0516-5862	Valdosta State University College of Arts & Science Center for Applied Research [2008-09]; Eunice Kennedy Shriver National Institute of Child Health & Human Development [R15HD060017]; University of California-Irvine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R15HD060017] Funding Source: NIH RePORTER	Valdosta State University College of Arts & Science Center for Applied Research; Eunice Kennedy Shriver National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); University of California-Irvine(University of California System); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was fully supported by a Valdosta State University College of Arts & Science Center for Applied Research Grant Number 2008-09 to BCR, DLB, and JFE (URL: http://www.valdosta.edu/cas/car/), partially funded by Eunice Kennedy Shriver National Institute of Child Health & Human Development Award Number R15HD060017 to BCR (URL: http://www.nichd.nih.gov/), and fully supported by University of California-Irvine funds to JCA (URL: http://www.uci.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL DC, 1987, ENVIRON BIOL FISH, V18, P67, DOI 10.1007/BF00002329; ABEL DC, 1984, B ENVIRON CONTAM TOX, V33, P33, DOI 10.1007/BF01625508; ABEL DC, 1981, THESIS COLL CHARLEST; Atz J. W., 1964, INTERSEXUALITY VERTE, P145; Avise J., 2008, CLONALITY GENETICS E; AVISE JC, 2011, HERMAPHRODI IN PRESS; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; Bongers ABJ, 1998, LAB ANIM-UK, V32, P349, DOI 10.1258/002367798780599749; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; BROCKMANN F W, 1975, Florida Scientist, V38, P35; CARTER TC, 1952, CANCER RES, V12, P602; Cole KS, 1997, COPEIA, P596; Costa WJEM, 2010, BIOL J LINN SOC, V99, P344, DOI 10.1111/j.1095-8312.2009.01359.x; COUCH JA, 1995, CANCER RES, V55, P2438; COURTNEY LA, 1988, J FISH DIS, V14, P111; Darvasi A, 1998, NAT GENET, V18, P19, DOI 10.1038/ng0198-19; DAVE G, 1993, SETAC SP P, P129; Davis W.P., 1990, Ichthyological Exploration of Freshwaters, V1, P123; DAVIS WP, 1988, ENVIRON BIOL FISH, V21, P81, DOI 10.1007/BF00004844; DAVIS WP, 1995, B MAR SCI, V57, P208; DAVIS WP, 1984, MAR ENVIRON RES, V14, P502, DOI 10.1016/0141-1136(84)90135-1; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Earley RL, 2000, ETHOLOGY, V106, P743, DOI 10.1046/j.1439-0310.2000.00586.x; Earley RL, 2008, HORM BEHAV, V53, P442, DOI 10.1016/j.yhbeh.2007.11.017; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Frick NT, 2002, J EXP BIOL, V205, P91; Goldstein D, 1999, MICROSATELLITES EVOL; GOODWIN AE, 1994, CARCINOGENESIS, V15, P1993, DOI 10.1093/carcin/15.9.1993; GOODWIN AE, 1994, CARCINOGENESIS, V15, P1985, DOI 10.1093/carcin/15.9.1985; GOODWIN AE, 1994, J HISTOCHEM CYTOCHEM, V42, P109, DOI 10.1177/42.1.7505299; Grageda MVC, 2004, ICHTHYOL RES, V51, P309, DOI 10.1007/s10228-004-0235-5; GRIZZLE JM, 1988, DIS AQUAT ORGAN, V5, P39, DOI 10.3354/dao005039; GRIZZLE JM, 1987, COPEIA, P237, DOI 10.2307/1446065; HARRINGTON R, 1961, SCIENCE, V134, P1749, DOI 10.1126/science.134.3492.1749; Harrington R.W. Jr., 1975, P249; HARRINGTON RW, 1968, AM NAT, V102, P337, DOI 10.1086/282547; HARRINGTON RW, 1971, COPEIA, P389; HEATH AG, 1993, HYDROBIOLOGIA, V259, P47, DOI 10.1007/BF00005964; Hsu YY, 1999, ANIM BEHAV, V57, P903, DOI 10.1006/anbe.1998.1049; Hsu YY, 2001, ANIM BEHAV, V61, P777, DOI 10.1006/anbe.2000.1650; HUBER JH, 1986, J AM KILLIFISH ASS, V19, P81; HUEHNER M K, 1985, Florida Scientist, V48, P1; KALLMAN KD, 1964, BIOL BULL, V126, P101, DOI 10.2307/1539420; Koenig C C, 1984, Natl Cancer Inst Monogr, V65, P15; Koenig C. C., 1980, WATER CHLORINATION E, P827; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; LAUGHLIN TF, 1995, J HERED, V86, P399, DOI 10.1093/oxfordjournals.jhered.a111610; Lee JS, 2008, J FISH BIOL, V72, P1871, DOI 10.1111/j.1095-8649.2008.01818.x; LEE JS, 1995, BIOCHEM MOL BIOL INT, V35, P57; LEE JS, 2005, NIPPON GYORUI GAKKAI, V38, P27; LEE JS, 1995, BIOCHEM MOL BIOL INT, V35, P921; LEE JS, 1994, THESIS HANYANG U SEO; LIN HC, 1993, ARCH ENVIRON CON TOX, V25, P41; Litwiller SL, 2006, J EXP BIOL, V209, P1737, DOI 10.1242/jeb.02197; Lubinski BA, 1995, J HERED, V86, P469, DOI 10.1093/oxfordjournals.jhered.a111623; Luke KN, 2010, CURR ZOOL, V56, P6, DOI 10.1093/czoolo/56.1.6; MACKIEWICZ M, 2006, P ROY SOC LOND B BIO, V273, P2249; Mackiewicz M, 2006, J HERED, V97, P508, DOI 10.1093/jhered/esl017; Mackiewicz M, 2006, P NATL ACAD SCI USA, V103, P9924, DOI 10.1073/pnas.0603847103; Martin SB, 2007, J FISH BIOL, V71, P1383, DOI 10.1111/j.1095-8649.2007.01603.x; MCMILLAN CM, 1979, THESIS COLL CHARLEST; Murphy WJ, 1999, MOL PHYLOGENET EVOL, V13, P289, DOI 10.1006/mpev.1999.0656; Nakamura Y, 2008, CAN J ZOOL, V86, P976, DOI 10.1139/Z08-075; Ong KJ, 2007, J EXP BIOL, V210, P1109, DOI 10.1242/jeb.002238; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Park E. H., 1992, JPN J ICTHYOL, V34, P476; PARK EH, 1984, J NATL CANCER I, V73, P871; PARK EH, 1993, JPN J CANCER RES, V84, P608, DOI 10.1111/j.1349-7006.1993.tb02020.x; PARK EH, 1994, CAN J FISH AQUAT SCI, V51, P280, DOI 10.1139/f94-029; PARK EH, 1992, TERATOGEN CARCIN MUT, V12, P129, DOI 10.1002/tcm.1770120304; PARK EH, 1990, JPN J CANCER RES, V81, P738, DOI 10.1111/j.1349-7006.1990.tb02638.x; Sato A, 2002, GENETICS, V162, P1791; Silver L.M., 1995, MOUSE GENETICS CONCE; SOTO CG, 1992, CAN J ZOOL, V70, P2338, DOI 10.1139/z92-314; SOTO CG, 1988, THESIS U GUELPH GUEL; STAATS JOAN, 1966, P1; Taphorn D.C., 1980, Zoologische Mededelingen (Leiden), V55, P127; Tatarenkov A, 2007, MOL ECOL, V16, P2701, DOI 10.1111/j.1365-294X.2007.03349.x; Tatarenkov A, 2007, P R SOC B, V274, P1795, DOI 10.1098/rspb.2007.0169; Tatarenkov A, 2009, P NATL ACAD SCI USA, V106, P14456, DOI 10.1073/pnas.0907852106; TAYLON D S, 1988, Northeast Gulf Science, V10, P63; Taylor DS, 2008, AM NAT, V171, P263, DOI 10.1086/524960; Taylor D. Scott, 2000, Florida Scientist, V63, P242; TAYLOR DS, 1995, B MAR SCI, V57, P202; THIYAGARAJAH A, 1995, MAR ENVIRON RES, V39, P279, DOI 10.1016/0141-1136(94)00073-X; THIYAGARAJAH A, 1986, J NATL CANCER I, V77, P141; THOMERSON JAIMtE E., 1966, J AMER KILUFISH ASS, V3, P48; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turner B. J., 2003, P 9 S NAT HIST BAH, P91; TURNER BJ, 1990, P NATL ACAD SCI USA, V87, P5653, DOI 10.1073/pnas.87.15.5653; TURNER BJ, 1992, P NATL ACAD SCI USA, V89, P10643, DOI 10.1073/pnas.89.22.10643; TURNER BJ, 1992, J FISH BIOL, V40, P307, DOI 10.1111/j.1095-8649.1992.tb02576.x; Turner BJ, 2006, EVOL ECOL RES, V8, P1475; VOGELBEIN WK, 1987, J FISH BIOL, V31, P145, DOI 10.1111/j.1095-8649.1987.tb05306.x; VRIJENHOEK RC, 1985, J HERED, V76, P82, DOI 10.1093/oxfordjournals.jhered.a110050; Weibel AC, 1999, EVOLUTION, V53, P1217, DOI 10.1111/j.1558-5646.1999.tb04534.x	96	66	66	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12863	10.1371/journal.pone.0012863	http://dx.doi.org/10.1371/journal.pone.0012863			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877576	gold, Green Published			2022-12-27	WOS:000282053100019
J	Fatti, G; Grimwood, A; Bock, P				Fatti, Geoffrey; Grimwood, Ashraf; Bock, Peter			Better Antiretroviral Therapy Outcomes at Primary Healthcare Facilities: An Evaluation of Three Tiers of ART Services in Four South African Provinces	PLOS ONE			English	Article							TREATMENT PROGRAM; FOLLOW-UP; MORTALITY; BARRIERS; CHILDREN; ACCESS; INCOME; ADULTS	Background: There are conflicting reports of antiretroviral therapy (ART) effectiveness comparisons between primary healthcare (PHC) facilities and hospitals in low-income settings. This comparison has not been evaluated on a broad scale in South Africa. Methodology/Principal Findings: A retrospective cohort study was conducted including ART-naive adults from 59 facilities in four provinces in South Africa, enrolled between 2004 and 2007. Kaplan-Meier estimates, competing-risks Cox regression, generalised estimating equation population-averaged models and logistic regression were used to compare death, loss to follow-up (LTFU) and virological suppression (VS) between PHC, district and regional hospitals. 29 203 adults from 47 PHC facilities, nine district hospitals and three regional hospitals were included. Patients at PHC facilities had more advanced WHO stage disease when starting ART. Retention in care was 80.1% (95% CI: 79.3%-80.8%), 71.5% (95% CI: 69.1%-73.8%) and 68.7% (95% CI: 67.0%-69.7%) at PHC, district and regional hospitals respectively, after 24 months of treatment (P<0.0001). In adjusted regression analyses, LTFU was independently increased at regional hospitals (aHR 2.19; 95% CI: 1.94-2.47) and mortality was independently elevated at district hospitals (aHR 1.60; 95% CI: 1.30-1.99) compared to PHC facilities after 12 months of ART. District and regional hospital patients had independently reduced probabilities of VS, aOR 0.76 (95% CI: 0.59-0.97) and 0.64 (95% CI: 0.56-0.75) respectively compared to PHC facilities over 24 months of treatment. Conclusions/Significance: ART outcomes were superior at PHC facilities, despite PHC patients having more advanced clinical stage disease when starting ART, suggesting that ART can be adequately provided at this level and supporting the South African government's call for rapid up-scaling of ART at the primary level of care. Further prospective research is required to determine the degree to which outcome differences are attributable to either facility level characteristics or patient co-morbidity at hospital level.	[Fatti, Geoffrey; Grimwood, Ashraf; Bock, Peter] Kheth Impilo, Cape Town, South Africa; [Fatti, Geoffrey] Univ Cape Town, Lung Inst, Lung Clin Res Unit, ZA-7925 Cape Town, South Africa; [Bock, Peter] Univ Cape Town, Primary Healthcare Directorate, ZA-7925 Cape Town, South Africa	University of Cape Town; University of Cape Town	Fatti, G (corresponding author), Kheth Impilo, Cape Town, South Africa.	geoffrey.fatti@khethimpilo.org	Fatti, Geoffrey/AAA-9217-2019	Fatti, Geoffrey/0000-0002-6467-662X; Bock, Peter/0000-0003-3211-6078				*ACT SOC S AFR, 2005, ASSA2003 AIDS DEM MO; Adam MA, 2009, SAMJ S AFR MED J, V99, P661; [Anonymous], UNAIDS WHO AIDS EPID; Bedelu M, 2007, J INFECT DIS, V196, pS464, DOI 10.1086/521114; Bekker LG, 2006, SAMJ S AFR MED J, V96, P315; Bock P, 2008, T ROY SOC TROP MED H, V102, P905, DOI 10.1016/j.trstmh.2008.06.010; Boulle A, 2008, B WORLD HEALTH ORGAN, V86, P678, DOI 10.2471/BLT.07.045294; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Charles M, 2008, B WORLD HEALTH ORGAN, V86, P970, DOI 10.2471/BLT.07.050120; Cohen R, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-23; Collinson MA, 2007, SCAND J PUBLIC HEALT, V35, P77, DOI 10.1080/14034950701356401; Colvin CJ, 2010, SAMJ S AFR MED J, V100, P210, DOI 10.7196/SAMJ.4124; Cornell M, 2009, SAMJ S AFR MED J, V99, P653; Forster M, 2008, B WORLD HEALTH ORGAN, V86, P939, DOI 10.2471/BLT.07.049908; Fox MP, 2010, TROP MED INT HEALTH, V15, P405, DOI 10.1111/j.1365-3156.2010.02473.x; Keiser O, 2008, TROP MED INT HEALTH, V13, P870, DOI 10.1111/j.1365-3156.2008.02078.x; Keiser O, 2008, PLOS MED, V5, P1409, DOI 10.1371/journal.pmed.0050195; Lampe FC, 2006, ARCH INTERN MED, V166, P521, DOI 10.1001/archinte.166.5.521; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; LUNN M, 1995, BIOMETRICS, V51, P524, DOI 10.2307/2532940; Massaquoi M, 2009, T ROY SOC TROP MED H, V103, P594, DOI 10.1016/j.trstmh.2009.02.012; NACHEGA J, 2009, J ACQ IMMUN DEF SYND, V51, P61; Posse M, 2008, TROP MED INT HEALTH, V13, P904, DOI 10.1111/j.1365-3156.2008.02091.x; *S AFR DEP HLTH, 2008, DEP REP; *S AFR NAT TREAS, 2008, 2008 NAT BUDG REV; Sanne I, 2010, LANCET, V376, P33, DOI 10.1016/S0140-6736(10)60894-X; Schaay N, 2008, S AFRICAN HLTH REV 2; South Sudan Ministry of Health, 2007, STRAT PLAN HUM RES H; van Dijk JH, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-169; Walensky RP, 2008, J INFECT DIS, V197, P1324, DOI 10.1086/587184; UNAIDS WHO EPIDEMIOL	33	88	91	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2010	5	9							e12888	10.1371/journal.pone.0012888	http://dx.doi.org/10.1371/journal.pone.0012888			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652JO	20877631	Green Published, gold, Green Submitted			2022-12-27	WOS:000282002900019
J	Benn, AR; Weaver, PP; Billet, DSM; van den Hove, S; Murdock, AP; Doneghan, GB; Le Bas, T				Benn, Angela R.; Weaver, Philip P.; Billet, David S. M.; van den Hove, Sybille; Murdock, Andrew P.; Doneghan, Gemma B.; Le Bas, Tim			Human Activities on the Deep Seafloor in the North East Atlantic: An Assessment of Spatial Extent	PLOS ONE			English	Article								Background: Environmental impacts of human activities on the deep seafloor are of increasing concern. While activities within waters shallower than 200 m have been the focus of previous assessments of anthropogenic impacts, no study has quantified the extent of individual activities or determined the relative severity of each type of impact in the deep sea. Methodology: The OSPAR maritime area of the North East Atlantic was chosen for the study because it is considered to be one of the most heavily impacted by human activities. In addition, it was assumed data would be accessible and comprehensive. Using the available data we map and estimate the spatial extent of five major human activities in the North East Atlantic that impact the deep seafloor: submarine communication cables, marine scientific research, oil and gas industry, bottom trawling and the historical dumping of radioactive waste, munitions and chemical weapons. It was not possible to map military activities. The extent of each activity has been quantified for a single year, 2005. Principal Findings: Human activities on the deep seafloor of the OSPAR area of the North Atlantic are significant but their footprints vary. Some activities have an immediate impact after which seafloor communities could re-establish, while others can continue to make an impact for many years and the impact could extend far beyond the physical disturbance. The spatial extent of waste disposal, telecommunication cables, the hydrocarbon industry and marine research activities is relatively small. The extent of bottom trawling is very significant and, even on the lowest possible estimates, is an order of magnitude greater than the total extent of all the other activities. Conclusions/Significance: To meet future ecosystem-based management and governance objectives for the deep sea significant improvements are required in data collection and availability as well as a greater awareness of the relative impact of each human activity.	[Benn, Angela R.; Billet, David S. M.] Natl Oceanog Ctr Southampton, Ocean Biogeochem & Ecosyst Grp, Southampton, Hants, England; [Weaver, Philip P.; Le Bas, Tim] Natl Oceanog Ctr Southampton, Geol & Geophys Grp, Southampton, Hants, England; [van den Hove, Sybille] Median, Valldoreix, Spain; [van den Hove, Sybille] Univ Autonoma Barcelona, Inst Ciencia & Tecnol Ambientals, E-08193 Barcelona, Spain; [Murdock, Andrew P.; Doneghan, Gemma B.] Univ Southampton, GeoData Inst, Southampton, Hants, England	NERC National Oceanography Centre; University of Southampton; NERC National Oceanography Centre; University of Southampton; Autonomous University of Barcelona; University of Southampton	Benn, AR (corresponding author), Natl Oceanog Ctr Southampton, Ocean Biogeochem & Ecosyst Grp, Southampton, Hants, England.	arb103@noc.soton.ac.uk	Le+Bas, Tim/AAP-9805-2020	Weaver, Philip/0000-0002-9541-3830; Gubbins, Gemma/0000-0002-0554-1856	Census of Marine Life; EC [GOCE-CT-2005-511234]; EU [226354]; Natural Environment Research Council [noc010004, noc010009, noc010011] Funding Source: researchfish; NERC [noc010004, noc010009, noc010011] Funding Source: UKRI	Census of Marine Life; EC(European CommissionEuropean Commission Joint Research Centre); EU(European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	AB was supported by the Continental Margin Ecosystems (COMARGE) project of the Census of Marine Life initiated by the Alfred P. Sloan Foundation. This research was also supported by the HERMES project, EC contract no GOCE-CT-2005-511234, funded by the European Commission's Sixth Framework Programme under the priority "Sustainable Development, Global Change and Ecosystems"; the HERMIONE project (EU contract 226354 funded by the European Commission's Seventh Framework Programme under the priority 'Deep-Sea Ecosystems'). The publication reflects only the views of the authors and the EC is not liable for any use that may be made of the information contained therein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFONSODIAS M, 2004, DEDICATED GIS ESTIMA, P323; BEDDINGTON J, MUNITIONS DUMPED SEA; Bensch A., 2008, WORLDWIDE REV BOTTOM; Breuer E, 2004, MAR POLLUT BULL, V48, P12, DOI 10.1016/j.marpolbul.2003.08.009; CALMET C, 1989, INT ATOMIC ENERGY AG, V4; Carter L., 2009, SUBMARINE CABLES OCE; Charmasson S., 1998, CYCLE COMBUSTIBLE NU; Davies AJ, 2007, BIOL CONSERV, V138, P299, DOI 10.1016/j.biocon.2007.05.011; deGroot SJ, 1996, ICES J MAR SCI, V53, P1045, DOI 10.1006/jmsc.1996.0130; Eastwood PD, 2007, ICES J MAR SCI, V64, P453, DOI 10.1093/icesjms/fsm001; *EC, 2003, OFFICIAL J EUROPEAN, P26; European Commission, 2008, OFFICIAL J EUROPEAN, VL164, P19, DOI DOI 10.1016/J.MARENVRES.2012.03.003; European Union, 2003, OFFICIAL J EUROPEA L, V71, P17; Gage J. D., 1991, DEEP SEA BIOL NATURA; Gianni M., 2004, HIGH SEAS BOTTOM TRA; Glover AG, 2003, ENVIRON CONSERV, V30, P219, DOI 10.1017/S0376892903000225; Hall-Spencer J, 2002, P ROY SOC B-BIOL SCI, V269, P507, DOI 10.1098/rspb.2001.1910; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; *ICES, 2007, ICES ADV 2007 BOOK 9; IMO (International Maritime Organization), 1996, PROT CONV PREV MAR P; International Maritime Organisation IMO, 1972, CONV PREV MAR POLL D; IOC IHO and BODC, 2003, CENT ED GEBCO DIG AT; LUMB CM, 2004, IRISH SEA PILOT REPO; *NEA, 1985, REV CONT SUIT DUMP S; *NEAFC, 2010, SCHEM CONTR ENF; *NPD, 2005, FACTS 2005 NORW PETR; *NPD, 2009, NPDS FACT PAG; *OLF, 2009, ANN ENV REP 2009; *OLF, 2006, ANN ENV REP 2006 NOR; *OSPAR, 2008, M OSPAR COMM BREST F; *OSPAR, 1995, 9581E OSPAR; *OSPAR, 2000, OSPAR QUAL STAT REP, pCH3; *OSPAR, 2005, OV PAST DUMP SEA CHE; *OSPAR, 2008, COD COND RESP MAR RE; *OSPAR, 2003, BIOD EC STRAT 2003 S; OSPAR, 2009, ASS IMP DUMP CONV CH; Thiel H, 2003, ECOSY WORLD, V28, P427; United Nations, 1992, CONV BIOL DIV; United Nations General Assembly, 2006, AGR IMPL PROV UN CON, V71, P1; Van den Hove S, 2007, ECOSYSTEMS BIODIVERS	40	99	99	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2010	5	9							e12730	10.1371/journal.pone.0012730	http://dx.doi.org/10.1371/journal.pone.0012730			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648ZZ	20856885	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000281735700025
J	Olcott, MH; Henkels, MD; Rosen, KL; Walker, FL; Sneh, B; Loper, JE; Taylor, BJ				Olcott, Marika H.; Henkels, Marcella D.; Rosen, Kise L.; Walker, Francesca L.; Sneh, Baruch; Loper, Joyce E.; Taylor, Barbara J.			Lethality and Developmental Delay in Drosophila melanogaster Larvae after Ingestion of Selected Pseudomonas fluorescens Strains	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; III SECRETION; HOST-DEFENSE; INFECTION; PATHWAY; GROWTH; GENE; REGULATOR; VIRULENCE; IMMUNITY	Background: The fruit fly, Drosophila melanogaster, is a well-established model organism for probing the molecular and cellular basis of physiological and immune system responses of adults or late stage larvae to bacterial challenge. However, very little is known about the consequences of bacterial infections that occur in earlier stages of development. We have infected mid-second instar larvae with strains of Pseudomonas fluorescens to determine how infection alters the ability of larvae to survive and complete development. Methodology/Principal Findings: We mimicked natural routes of infection using a non-invasive feeding procedure to study the toxicity of the three sequenced P. fluorescens strains (Pf0-1, SBW25, and Pf-5) to Drosophila melanogaster. Larvae fed with the three strains of P. fluorescens showed distinct differences in developmental trajectory and survival. Treatment with SBW25 caused a subset of insects to die concomitant with a systemic melanization reaction at larval, pupal or adult stages. Larvae fed with Pf-5 died in a dose-dependent manner with adult survivors showing eye and wing morphological defects. In addition, larvae in the Pf-5 treatment groups showed a dose-dependent delay in the onset of metamorphosis relative to control-, Pf0-1-, and SBW25-treated larvae. A functional gacA gene is required for the toxic properties of wild-type Pf-5 bacteria. Conclusions/Significance: These experiments are the first to demonstrate that ingestion of P. fluorescens bacteria by D. melanogaster larvae causes both lethal and non-lethal phenotypes, including delay in the onset of metamorphosis and morphological defects in surviving adult flies, which can be decoupled.	[Olcott, Marika H.; Rosen, Kise L.; Walker, Francesca L.; Taylor, Barbara J.] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; [Henkels, Marcella D.; Loper, Joyce E.] USDA ARS, Hort Crops Res Lab, Corvallis, OR USA; [Loper, Joyce E.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Sneh, Baruch] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Biol & Ecol Plants, IL-69978 Tel Aviv, Israel	Oregon State University; United States Department of Agriculture (USDA); Oregon State University; Tel Aviv University	Olcott, MH (corresponding author), Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA.	taylorb@science.oregonstate.edu		Loper, Joyce/0000-0003-3501-5969	United States Department of Agriculture Cooperative State Research, Education, and Extension Service [2006-35319-17427, 2008-35600-18770]; National Institutes of Health [9RO1 GM085818-14A2]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085818] Funding Source: NIH RePORTER	United States Department of Agriculture Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by National Research Initiative Competitive Grants 2006-35319-17427 and 2008-35600-18770 from the United States Department of Agriculture Cooperative State Research, Education, and Extension Service to JEL and by National Institutes of Health Grant 9RO1 GM085818-14A2 to BJT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey MJ, 1995, MOL ECOL, V4, P755, DOI 10.1111/j.1365-294X.1995.tb00276.x; BAINBRIDGE SP, 1981, J EMBRYOL EXP MORPH, V66, P57; Bischoff V, 2006, PLOS PATHOG, V2, P139, DOI 10.1371/journal.ppat.0020014; Brennan CA, 1998, DEVELOPMENT, V125, P2653; Britton JS, 1998, DEVELOPMENT, V125, P2149; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Broderick KE, 2008, J INFECT DIS, V197, P457, DOI 10.1086/525282; Coburn B, 2007, CLIN MICROBIOL REV, V20, P535, DOI 10.1128/CMR.00013-07; COMPEAU G, 1988, APPL ENVIRON MICROB, V54, P2432, DOI 10.1128/AEM.54.10.2432-2438.1988; CORBELL N, 1995, J BACTERIOL, V177, P6230, DOI 10.1128/jb.177.21.6230-6236.1995; Daborn PJ, 2002, P NATL ACAD SCI USA, V99, P10742, DOI 10.1073/pnas.102068099; Dionne MS, 2008, DIS MODEL MECH, V1, P43, DOI 10.1242/dmm.000307; Dionne MS, 2003, INFECT IMMUN, V71, P3540, DOI 10.1128/IAI.71.6.3540-3550.2003; Fauvarque MO, 2002, MICROB PATHOGENESIS, V32, P287, DOI 10.1006/mpat.2002.0504; ffrench-Constant RH, 2007, TOXICON, V49, P436, DOI 10.1016/j.toxicon.2006.11.019; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Govind S, 2008, INSECT SCI, V15, P29, DOI 10.1111/j.1744-7917.2008.00185.x; Grant SR, 2006, ANNU REV MICROBIOL, V60, P425, DOI 10.1146/annurev.micro.60.080805.142251; Gross H, 2009, NAT PROD REP, V26, P1408, DOI 10.1039/b817075b; Hassan KA, 2010, ENVIRON MICROBIOL, V12, P899, DOI 10.1111/j.1462-2920.2009.02134.x; HOWELL CR, 1979, PHYTOPATHOLOGY, V69, P480, DOI 10.1094/Phyto-69-480; Kim SH, 2008, INFECT IMMUN, V76, P4152, DOI 10.1128/IAI.01637-07; KING EO, 1954, J LAB CLIN MED, V44, P301; Lapouge K, 2008, MOL MICROBIOL, V67, P241, DOI 10.1111/j.1365-2958.2007.06042.x; Lee DG, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r90; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Leulier F, 2009, NAT IMMUNOL, V10, P936, DOI 10.1038/ni0909-936; Liehl P, 2006, PLOS PATHOG, V2, P551, DOI 10.1371/journal.ppat.0020056; Lutter EI, 2008, INFECT IMMUN, V76, P1877, DOI 10.1128/IAI.01165-07; Mathee K, 2008, P NATL ACAD SCI USA, V105, P3100, DOI 10.1073/pnas.0711982105; Mirth CK, 2009, DEVELOPMENT, V136, P2345, DOI 10.1242/dev.032672; Mirth CK, 2007, BIOESSAYS, V29, P344, DOI 10.1002/bies.20552; Nehme NT, 2007, PLOS PATHOG, V3, P1694, DOI 10.1371/journal.ppat.0030173; Nijhout HF, 2003, DEVELOPMENT, V130, P5863, DOI 10.1242/dev.00902; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; Paulsen IT, 2005, NAT BIOTECHNOL, V23, P873, DOI 10.1038/nbt1110; Pechy-Tarr M, 2008, ENVIRON MICROBIOL, V10, P2368, DOI 10.1111/j.1462-2920.2008.01662.x; Pielage JF, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000031; Preston GM, 2001, MOL MICROBIOL, V41, P999, DOI 10.1046/j.1365-2958.2001.02560.x; Rutschmann S, 2000, IMMUNITY, V12, P569, DOI 10.1016/S1074-7613(00)80208-3; Sibley CD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000184; Silby MW, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r51; Stein D, 1998, DEVELOPMENT, V125, P2159; Stieper BC, 2008, DEV BIOL, V321, P18, DOI 10.1016/j.ydbio.2008.05.556; Stockwell VO, 2005, MICROBIOL-SGM, V151, P3001, DOI 10.1099/mic.0.28077-0; Vallet-Gely I, 2008, NAT REV MICROBIOL, V6, P302, DOI 10.1038/nrmicro1870; Vodovar N, 2005, P NATL ACAD SCI USA, V102, P11414, DOI 10.1073/pnas.0502240102; Vodovar N, 2006, NAT BIOTECHNOL, V24, P673, DOI 10.1038/nbt1212; Whistler CA, 1998, J BACTERIOL, V180, P6635, DOI 10.1128/JB.180.24.6635-6641.1998; Ye YXH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000385; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000	52	36	36	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2010	5	9							e12504	10.1371/journal.pone.0012504	http://dx.doi.org/10.1371/journal.pone.0012504			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648ZZ	20856932	Green Published, Green Submitted, gold			2022-12-27	WOS:000281735700002
J	Dasgupta, S; Sirisha, PVS; Neelaveni, K; Anuradha, K; Reddy, AG; Thangaraj, K; Reddy, BM				Dasgupta, Shilpi; Sirisha, Pisapati V. S.; Neelaveni, Kudugunti; Anuradha, Kathragadda; Reddy, Alla G.; Thangaraj, Kumarasamy; Reddy, B. Mohan			Androgen Receptor CAG Repeat Polymorphism and Epigenetic Influence among the South Indian Women with Polycystic Ovary Syndrome	PLOS ONE			English	Article							X-CHROMOSOME INACTIVATION; TRINUCLEOTIDE REPEATS; GENE; INFERTILITY; CRITERIA; LENGTH	The present study was carried out to assess the role of androgen receptor CAG repeat polymorphism and X chromosome inactivation (XCI) pattern among Indian PCOS women and controls which has not been hitherto explored and also to test the hypothesis that shorter CAG alleles would be preferentially activated in PCOS. CAG repeat polymorphism and X chromosome methylation patterns were compared between PCOS and non-PCOS women. 250 PCOS women and 299 controls were included for this study. Androgen receptor CAG repeat sizes, XCI percentages, and clinical and biochemical parameters were measured. The mean CAG repeat number is similar between the cases (18.74 +/- 0.13) and controls (18.73 +/- 0.12). The obese PCOS women were significantly more frequent in the 18 and 20 CAG repeat category than the lean PCOS women, yielding a highly significant odds (p = 0.001). Among the women with non-random X-inactivation, alleles with,19 repeats were more frequently activated among cases than controls (p = 0.33). CAG repeat polymorphism by itself cannot be considered as a useful marker for discriminating PCOS. We observed a trend of preferential activation of the shorter allele among the PCOS cases with non random XCI pattern. In the obese PCOS women, this microsatellite variation may account for the hyperandrogenicity to a larger extent than the lean PCOS women.	[Dasgupta, Shilpi; Sirisha, Pisapati V. S.; Reddy, B. Mohan] Indian Stat Inst, Biol Anthropol Unit, Mol Anthropol Grp, Hyderabad, Andhra Pradesh, India; [Neelaveni, Kudugunti] Osmania Gen Hosp, Dept Endocrinol, Hyderabad, Andhra Pradesh, India; [Anuradha, Kathragadda] Anu Test Tube Baby Ctr, Hyderabad, Andhra Pradesh, India; [Reddy, Alla G.; Thangaraj, Kumarasamy] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India	Indian Statistical Institute; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Dasgupta, S (corresponding author), Indian Stat Inst, Biol Anthropol Unit, Mol Anthropol Grp, Hyderabad, Andhra Pradesh, India.	bmr@isical.ac.in	Thangaraj, Kumarasamy/G-5596-2010	Thangaraj, Kumarasamy/0000-0002-0075-0106	Indian Statistical Institute, Kolkata	Indian Statistical Institute, Kolkata	The study was funded by the Indian Statistical Institute, Kolkata. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azziz R, 2006, J CLIN ENDOCR METAB, V91, P4237, DOI 10.1210/jc.2006-0178; Calvo RM, 2000, J CLIN ENDOCR METAB, V85, P1735, DOI 10.1210/jc.85.4.1735; CHAMBERLAIN NL, 1994, NUCLEIC ACIDS RES, V22, P3181, DOI 10.1093/nar/22.15.3181; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Cram DS, 2000, MOL HUM REPROD, V6, P861, DOI 10.1093/molehr/6.9.861; EDWARDS A, 1992, GENOMICS, V12, P241, DOI 10.1016/0888-7543(92)90371-X; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Ferk P, 2008, FERTIL STERIL, V90, P860, DOI 10.1016/j.fertnstert.2007.07.1291; Hickey T, 2002, J CLIN ENDOCR METAB, V87, P161, DOI 10.1210/jc.87.1.161; Ibanez L, 2003, J CLIN ENDOCR METAB, V88, P3333, DOI 10.1210/jc.2002-021791; Jaaskelainen J, 2005, FERTIL STERIL, V83, P1724, DOI 10.1016/j.fertnstert.2004.11.080; Kim JJ, 2008, FERTIL STERIL, V90, P2318, DOI 10.1016/j.fertnstert.2007.10.030; Liu QR, 2008, ENDOCRINE, V33, P165, DOI 10.1007/s12020-008-9069-7; Mifsud A, 2000, J CLIN ENDOCR METAB, V85, P3484, DOI 10.1210/jc.85.9.3484; Mohlig M, 2006, EUR J ENDOCRINOL, V155, P127, DOI 10.1530/eje.1.02195; Pasquali R, 2006, FERTIL STERIL, V85, P1319, DOI 10.1016/j.fertnstert.2005.10.054; Reddy BM, 2005, HUM BIOL, V77, P803, DOI 10.1353/hub.2006.0018; Sambrook J, 1989, MOL CLONING LABORATO; Shah NA, 2008, J CLIN ENDOCR METAB, V93, P1939, DOI 10.1210/jc.2008-0038; Van Nieuwerburgh F, 2008, GYNECOL ENDOCRINOL, V24, P669, DOI 10.1080/09513590802342841; Xita N, 2008, HUM REPROD, V23, P693, DOI 10.1093/humrep/dem382	21	33	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12401	10.1371/journal.pone.0012401	http://dx.doi.org/10.1371/journal.pone.0012401			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865044	Green Published, Green Submitted, gold			2022-12-27	WOS:000281292100011
J	Del Debbio, CB; Balasubramanian, S; Parameswaran, S; Chaudhuri, A; Qiu, F; Ahmad, I				Del Debbio, Carolina Beltrame; Balasubramanian, Sudha; Parameswaran, Sowmya; Chaudhuri, Anathbandhu; Qiu, Fang; Ahmad, Iqbal			Notch and Wnt Signaling Mediated Rod Photoreceptor Regeneration by Muller Cells in Adult Mammalian Retina	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; DIFFERENTIAL REGULATION; PROGENITOR CELLS; SIDE POPULATION; GANGLION-CELLS; GROWTH-FACTORS; RAT RETINA; DYE EFFLUX; NEURONS; GLIA	Background: Evidence emerging from a variety of approaches used in different species suggests that Muller cell function may extend beyond its role of maintaining retinal homeostasis to that of progenitors in the adult retina. Enriched Muller cells in vitro or those that re-enter cell cycle in response to neurotoxin-damage to retina in vivo display multipotential and self-renewing capacities, the cardinal features of stem cells. Methodology/Principal Findings: We demonstrate that Notch and Wnt signaling activate Muller cells through their canonical pathways and that a rare subset of activated Muller cells differentiates along rod photoreceptor lineage in the outer nuclear layer. The differentiation of activated Muller cells along photoreceptor lineage is confirmed by multiple approaches that included Hoechst dye efflux analysis, genetic analysis using retina from Nrl-GFP mice, and lineage tracing using GS-GFP lentivirus in wild type and rd mice in vitro and S334ter rats in vivo. Examination of S334ter rats for head-neck tracking of visual stimuli, a behavioral measure of light perception, demonstrates a significant improvement in light perception in animals treated to activate Muller cells. The number of activated Muller cells with rod photoreceptor phenotype in treated animals correlates with the improvement in their light perception. Conclusion/Significance: In summary, our results provide a proof of principle for non-neurotoxin-mediated activation of Muller cells through Notch and Wnt signaling toward the regeneration of rod photoreceptors.	[Del Debbio, Carolina Beltrame; Balasubramanian, Sudha; Parameswaran, Sowmya; Chaudhuri, Anathbandhu; Ahmad, Iqbal] Univ Nebraska, Med Ctr, Coll Publ Hlth, Dept Ophthalmol & Visual Sci, Omaha, NE 68198 USA; [Qiu, Fang] Univ Nebraska, Med Ctr, Coll Publ Hlth, Dept Biostat, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Del Debbio, CB (corresponding author), Univ Nebraska, Med Ctr, Coll Publ Hlth, Dept Ophthalmol & Visual Sci, Omaha, NE 68198 USA.	iahmad@unmc.edu	Chaudhuri, Anathbandhu/F-2501-2017; Sowmya, Parameswaran/GZK-8635-2022	Chaudhuri, Anathbandhu/0000-0003-4833-3077; 	Lincy Foundation; Pearson Foundation; Nebraska Department of Health and Human Services; Research to Prevent Blindness	Lincy Foundation; Pearson Foundation; Nebraska Department of Health and Human Services; Research to Prevent Blindness(Research to Prevent Blindness (RPB))	This work was supported by Lincy Foundation, Pearson Foundation, Nebraska Department of Health and Human Services, and Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad I, 2004, SEMIN CELL DEV BIOL, V15, P53, DOI 10.1016/j.semcdb.2003.09.003; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Bernardos RL, 2007, J NEUROSCI, V27, P7028, DOI 10.1523/JNEUROSCI.1624-07.2007; Bhattacharya S, 2003, INVEST OPHTH VIS SCI, V44, P2764, DOI 10.1167/iovs.02-0899; Bhattacharya S, 2008, STEM CELLS, V26, P2611, DOI 10.1634/stemcells.2008-0222; Bhattacharya S, 2007, J CELL SCI, V120, P2652, DOI 10.1242/jcs.008417; Burke ZD, 2006, J CELL PHYSIOL, V206, P147, DOI 10.1002/jcp.20438; Castelo-Branco GA, 2003, P NATL ACAD SCI USA, V100, P12747, DOI 10.1073/pnas.1534900100; CEPKO CL, 1993, METHOD ENZYMOL, V225, P933; Challen GA, 2006, STEM CELLS, V24, P3, DOI 10.1634/stemcells.2005-0116; Das AV, 2006, DEV BIOL, V299, P283, DOI 10.1016/j.ydbio.2006.07.029; Das AV, 2008, DEV NEUROSCI-BASEL, V30, P389, DOI 10.1159/000178017; Dyer MA, 2000, NAT NEUROSCI, V3, P873, DOI 10.1038/78774; Fausett BV, 2008, J NEUROSCI, V28, P1109, DOI 10.1523/JNEUROSCI.4853-07.2008; Fausett BV, 2006, J NEUROSCI, V26, P6303, DOI 10.1523/JNEUROSCI.0332-06.2006; Faux CH, 2001, J NEUROSCI, V21, P5587, DOI 10.1523/JNEUROSCI.21-15-05587.2001; Fischer AJ, 2002, DEVELOPMENT, V129, P2283; Fujimura N, 2009, DEV BIOL, V334, P31, DOI 10.1016/j.ydbio.2009.07.002; Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X; Ge WH, 2002, J NEUROSCI RES, V69, P848, DOI 10.1002/jnr.10364; Geller SF, 2008, MOL VIS, V14, P691; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Hitchcock P, 2004, PROG RETIN EYE RES, V23, P183, DOI 10.1016/j.preteyeres.2004.01.001; Hojo M, 2000, DEVELOPMENT, V127, P2515; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Hulspas R, 2000, CYTOMETRY, V40, P245, DOI 10.1002/1097-0320(20000701)40:3<245::AID-CYTO10>3.3.CO;2-X; Jadhav AR, 2006, DEVELOPMENT, V133, P913, DOI 10.1242/dev.02245; James J, 2004, J NEUROBIOL, V61, P359, DOI 10.1002/neu.20064; Kamakura S, 2004, NAT CELL BIOL, V6, P547, DOI 10.1038/ncb1138; Kohwi M, 2005, J NEUROSCI, V25, P6997, DOI 10.1523/JNEUROSCI.1435-05.2005; Kubo F, 2003, DEVELOPMENT, V130, P587, DOI 10.1242/dev.00244; Lamba DA, 2008, DEV DYNAM, V237, P3016, DOI 10.1002/dvdy.21697; Lamba DA, 2009, PROG BRAIN RES, V175, P23, DOI 10.1016/S0079-6123(09)17502-7; Liao YF, 2004, J BIOL CHEM, V279, P49523, DOI 10.1074/jbc.M402034200; Liu CD, 1999, J NEUROSCI, V19, P4778; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Mouthon MA, 2006, J NEUROCHEM, V99, P807, DOI 10.1111/j.1471-4159.2006.04118.x; Murata K, 2005, MOL CELL BIOL, V25, P4262, DOI 10.1128/MCB.25.10.4262-4271.2005; Ooto S, 2004, P NATL ACAD SCI USA, V101, P13654, DOI 10.1073/pnas.0402129101; Osakada F, 2007, J NEUROSCI, V27, P4210, DOI 10.1523/JNEUROSCI.4193-06.2007; Parameswaran S, 2010, STEM CELLS, V28, P695, DOI 10.1002/stem.320; Poche RA, 2008, J COMP NEUROL, V510, P237, DOI 10.1002/cne.21746; Rapaport DH, 2004, J COMP NEUROL, V474, P304, DOI 10.1002/cne.20134; Sarmento LM, 2005, J EXP MED, V202, P157, DOI 10.1084/jem.20050559; Shen CN, 2000, NAT CELL BIOL, V2, P879, DOI 10.1038/35046522; Takeda M, 2008, INVEST OPHTH VIS SCI, V49, P1142, DOI 10.1167/iovs.07-0434; Tomita K, 1996, NEURON, V16, P723, DOI 10.1016/S0896-6273(00)80093-8; Viti J, 2003, J NEUROSCI, V23, P5919; WATANABE T, 1992, DEVELOPMENT, V114, P899; Weijzen S, 2002, J IMMUNOL, V169, P4273, DOI 10.4049/jimmunol.169.8.4273; Weksberg DC, 2008, BLOOD, V111, P2444, DOI 10.1182/blood-2007-09-115006; Zhao X, 2005, DEV DYNAM, V232, P349, DOI 10.1002/dvdy.20290; Zhao X, 2002, BIOCHEM BIOPH RES CO, V297, P177, DOI 10.1016/S0006-291X(02)02126-5; Zhao X, 2008, STEM CELLS, V26, P939, DOI 10.1634/stemcells.2007-0727; Zhou CJ, 2004, J NEUROSCI, V24, P121, DOI 10.1523/JNEUROSCI.4071-03.2004	58	69	70	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12425	10.1371/journal.pone.0012425	http://dx.doi.org/10.1371/journal.pone.0012425			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865053	Green Published, gold, Green Submitted			2022-12-27	WOS:000281292100020
J	Gollner, S; Riemer, B; Arbizu, PM; Le Bris, N; Bright, M				Gollner, Sabine; Riemer, Barbara; Arbizu, Pedro Martinez; Le Bris, Nadine; Bright, Monika			Diversity of Meiofauna from the 9 degrees 50 ' N East Pacific Rise across a Gradient of Hydrothermal Fluid Emissions	PLOS ONE			English	Article							VENT MUSSEL BEDS; DE-FUCA RIDGE; COMMUNITY STRUCTURE; ENVIRONMENTAL-STRESS; RIFTIA-PACHYPTILA; SEA; AGGREGATIONS; TUBEWORM; COPEPODA; SYMBIOSIS	Background: We studied the meiofauna community at deep-sea hydrothermal vents along a gradient of vent fluid emissions in the axial summit trought (AST) of the East Pacific Rise 9 degrees 50'N region. The gradient ranged from extreme high temperatures, high sulfide concentrations, and low pH at sulfide chimneys to ambient deep-sea water conditions on bare basalt. We explore meiofauna diversity and abundance, and discuss its possible underlying ecological and evolutionary processes. Methodology/Principal Findings: After sampling in five physico-chemically different habitats, the meiofauna was sorted, counted and classified. Abundances were low at all sites. A total of 52 species were identified at vent habitats. The vent community was dominated by hard substrate generalists that also lived on bare basalt at ambient deep-sea temperature in the axial summit trough (AST generalists). Some vent species were restricted to a specific vent habitat (vent specialists), but others occurred over a wide range of physico-chemical conditions (vent generalists). Additionally, 35 species were only found on cold bare basalt (basalt specialists). At vent sites, species richness and diversity clearly increased with decreasing influence of vent fluid emissions from extreme flow sulfide chimney (no fauna), high flow pompei worm (S: 4-7, H-loge': 0.11-0.45), vigorous flow tubeworm (S: 8-23; H-loge': 0.44-2.00) to low flow mussel habitats (S: 28-31; H-loge': 2.34-2.60). Conclusions/Significance: Our data suggest that with increasing temperature and toxic hydrogen sulfide concentrations and increasing amplitude of variation of these factors, fewer species are able to cope with these extreme conditions. This results in less diverse communities in more extreme habitats. The finding of many species being present at sites with and without vent fluid emissions points to a non endemic deep-sea hydrothermal vent meiofaunal community. This is in contrast to a mostly endemic macrofauna but similar to what is known for meiofauna from shallow-water vents.	[Gollner, Sabine; Riemer, Barbara; Bright, Monika] Univ Vienna, Dept Marine Biol, Vienna, Austria; [Gollner, Sabine; Arbizu, Pedro Martinez] Forschungsinst Senckenberg, Deutsch Zentrum Marine Biodiversitatsforsch, Wilhelmshaven, Germany; [Le Bris, Nadine] IFREMER, Dept Environm Profond, Brest, France	University of Vienna; Senckenberg Gesellschaft fur Naturforschung (SGN); Ifremer	Gollner, S (corresponding author), Univ Vienna, Dept Marine Biol, Vienna, Austria.	sabine.gollner@senckenberg.de	Bright, Monika/AAA-7015-2021; Bright, Monika/I-5542-2012; Le Bris, Nadine/E-1381-2014	Bright, Monika/0000-0001-7066-1363; Le Bris, Nadine/0000-0002-0142-4847; Martinez-Arbizu, Pedro/0000-0002-0891-1154	Austrian Science Foundation [P16774-B03, P20190-B17]; National Science Foundation, USA [OCE-0002729]; ChEss	Austrian Science Foundation(Austrian Science Fund (FWF)); National Science Foundation, USA(National Science Foundation (NSF)); ChEss	This work was supported by the Austrian Science Foundation grant FWF (P16774-B03, P20190-B17 to MB), the National Science Foundation, USA (OCE-0002729 to CR Fisher), and ChEss. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begon M., 1996, ECOLOGY; Bertness M.D., 2001, MARINE COMMUNITY ECO; Bright M, 2005, SYMBIOSIS, V38, P1; Bright M, 2010, DEEP-SEA RES PT II, V57, P1982, DOI 10.1016/j.dsr2.2010.05.003; BRIGHT M, 2006, HDB HYDROTHERMAL VEN, P27; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Bruno JF, 2001, MARINE COMMUNITY ECOLOGY, P201; Carbotte SM, 1994, J GEOPHYS RES, V97, P6959; CHILDRESS JJ, 1992, OCEANOGR MAR BIOL, V30, P337; Clarke K., 2001, PRIMER V5 USER MANUA; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; Copley JTP, 2007, J MAR BIOL ASSOC UK, V87, P1141, DOI 10.1017/S0025315407055956; Danovaro R, 2002, MAR ECOL PROG SER, V230, P159, DOI 10.3354/meps230159; Desbruyeres D., 2006, HDB DEEP SEA HYDROTH; Di Meo-Savoie CA, 2004, GEOCHIM COSMOCHIM AC, V68, P2055, DOI 10.1016/j.gca.2003.10.039; Dinet A, 1988, OCEANOL ACTA, V85, P7; Dubilier N, 2008, NAT REV MICROBIOL, V6, P725, DOI 10.1038/nrmicro1992; Etter RJ, 2001, MARINE COMMUNITY ECOLOGY, P367; Fisher CR, 2007, OCEANOGRAPHY, V20, P14, DOI 10.5670/oceanog.2007.75; Flint HC, 2006, CAH BIOL MAR, V47, P365; Fornari DJ, 1998, J GEOPHYS RES-SOL EA, V103, P9827, DOI 10.1029/98JB00028; Galkin SV, 2008, OCEANOLOGY+, V48, P509, DOI 10.1134/S0001437008040061; Gheerardyn H, 2009, SCI MAR, V73, P747, DOI 10.3989/scimar.2009.73n4747; Giere O, 2009, MEIOBENTHOLOGY MICRO, DOI 10.1007/978-3-540-68661-3; GOLLNER S, PLOS ONE IN PRESS; Gollner S, 2008, ZOOTAXA, P323, DOI 10.11646/zootaxa.1866.1.16; Gollner S, 2006, CAH BIOL MAR, V47, P397; Gollner S, 2007, MAR ECOL PROG SER, V337, P39, DOI 10.3354/meps337039; Govenar B, 2005, MAR ECOL PROG SER, V305, P67, DOI 10.3354/meps305067; Govenar B, 2007, MAR ECOL-EVOL PERSP, V28, P3, DOI 10.1111/j.1439-0485.2007.00148.x; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; HAYMON RM, 1991, EARTH PLANET SC LETT, V104, P513, DOI 10.1016/0012-821X(91)90226-8; Heptner M. V., 2002, Arthropoda Selecta, V11, P117; Hessler R., 1985, B BIOL SOC WASH, V6, P411; Hourdez S, 2000, BIOL BULL-US, V199, P95, DOI 10.2307/1542868; HUMES A G, 1989, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V11, P829; HUMES A G, 1990, Scientia Marina, V54, P145; HUMES AG, 1987, B MAR SCI, V41, P645; HUMES AG, 1989, ZOOL SCR, V18, P103, DOI 10.1111/j.1463-6409.1989.tb00125.x; HUMES AG, 1994, J CRUSTACEAN BIOL, V14, P337, DOI 10.2307/1548913; HUSTON M, 1979, AM NAT, V113, P81, DOI 10.1086/283366; Huston M. A., 1994, BIOL DIVERSITY; Ivanenko VN, 2006, HDB HYDROTHERMAL VEN, P316; JOHNSON KS, 1988, DEEP-SEA RES, V35, P1711, DOI 10.1016/0198-0149(88)90045-3; JOHNSON KS, 1988, DEEP-SEA RES, V35, P1723, DOI 10.1016/0198-0149(88)90046-5; KAMENEV GM, 1993, NEW ZEAL J MAR FRESH, V27, P407, DOI 10.1080/00288330.1993.9516582; Karl DM, 1995, MICR EXTREM UNUSUAL, P35; Katz S, 2006, MAR ECOL PROG SER, V320, P89, DOI 10.3354/meps320089; KIENEKE A, 2007, DESMODASYS ABYSSALIS, P1; Kornicker L. S., 1991, SMITHSONIAN CONTRIBU, V516, P1, DOI DOI 10.5479/SI.00810282.516; Kouris A, 2007, MAR ECOL-EVOL PERSP, V28, P63, DOI 10.1111/j.1439-0485.2006.00118.x; Le Bris N, 2006, MAR CHEM, V98, P167, DOI 10.1016/j.marchem.2005.08.008; Le Bris N, 2005, DEEP-SEA RES PT I, V52, P1071, DOI 10.1016/j.dsr.2005.01.003; Le Bris N, 2003, DEEP-SEA RES PT I, V50, P737, DOI 10.1016/S0967-0637(03)00051-7; Le Bris N, 2007, REV ENVIRON SCI BIO, V6, P167; Lee RW, 2003, BIOL BULL-US, V205, P98, DOI 10.2307/1543230; Limen H, 2007, MAR BIOL, V153, P129, DOI 10.1007/s00227-007-0790-1; Luther GW, 2001, NATURE, V410, P813, DOI 10.1038/35071069; Matabos M, 2008, J MAR BIOL ASSOC UK, V88, P995, DOI 10.1017/S002531540800163X; MENGE BA, 1987, AM NAT, V130, P730, DOI 10.1086/284741; Micheli F, 2002, ECOL MONOGR, V72, P365, DOI 10.1890/0012-9615(2002)072[0365:PSCADS]2.0.CO;2; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; Mullineaux LS, 2003, ECOL MONOGR, V73, P523, DOI 10.1890/02-0674; Nees HA, 2008, J SHELLFISH RES, V27, P169, DOI 10.2983/0730-8000(2008)27[169:HVMHCP]2.0.CO;2; Nemeschkal HL, 1999, EVOLUTION, V53, P899, DOI 10.1111/j.1558-5646.1999.tb05384.x; Olafsson E, 2003, VIE MILIEU, V53, P249; Ott J, 2004, SYMBIOSIS, V36, P103; Ott J, 2004, OCEANOGR MAR BIOL, V42, P95; Panieri G, 2005, MAR GEOL, V218, P207, DOI 10.1016/j.margeo.2005.04.002; Rapoport E. H., 1982, AREOGRAPHY GEOGRAPHI, P269; Scrosati R, 2007, MAR ECOL PROG SER, V342, P1, DOI 10.3354/meps342001; Sell AF, 2000, P ROY SOC B-BIOL SCI, V267, P2323, DOI 10.1098/rspb.2000.1286; Shank TM, 1998, DEEP-SEA RES PT II, V45, P465, DOI 10.1016/S0967-0645(97)00089-1; SHIRAYAMA Y, 1990, Journal of the Oceanographical Society of Japan, V46, P118, DOI 10.1007/BF02123438; Soltwedel T, 2005, J MARINE SYST, V55, P271, DOI 10.1016/j.jmarsys.2004.09.001; Soltwedel T, 2000, PROG OCEANOGR, V46, P59, DOI 10.1016/S0079-6611(00)00030-6; Sousa WP, 2001, MARINE COMMUNITY ECOLOGY, P85; Tarasov VG, 1999, CONT SHELF RES, V19, P79, DOI 10.1016/S0278-4343(98)00073-9; Tarasov VG, 2005, CHEM GEOL, V224, P5, DOI 10.1016/j.chemgeo.2005.07.021; Thiermann F, 1997, MAR BIOL, V128, P149, DOI 10.1007/s002270050078; Thiermann F., 1994, Vie et Milieu, V44, P215; Tolstoy M, 2006, SCIENCE, V314, P1920, DOI 10.1126/science.1133950; Tsurumi M, 2003, DEEP-SEA RES PT I, V50, P611, DOI 10.1016/S0967-0637(03)00039-6; Tsurumi M, 2003, J MAR BIOL ASSOC UK, V83, P469, DOI 10.1017/S0025315403007367h; Tunnicliffe V, 1998, ADV MAR BIOL, V34, P353, DOI 10.1016/S0065-2881(08)60213-8; TUNNICLIFFE V, 1992, Palaios, V7, P338, DOI 10.2307/3514820; Van Dover CL, 2003, MAR ECOL PROG SER, V253, P55, DOI 10.3354/meps253055; Van Dover CL, 2002, MAR ECOL PROG SER, V230, P137, DOI 10.3354/meps230137; Van Dover CL, 2000, ECOLOGY HYDROTHERMAL; Van Gaever S, 2009, DEEP-SEA RES PT I, V56, P772, DOI 10.1016/j.dsr.2008.12.015; Vanreusel A, 1997, MAR ECOL PROG SER, V157, P207, DOI 10.3354/meps157207; VANREUSEL A, PLOS ONE IN PRESS; Vanreusel A, 2010, MAR ECOL-EVOL PERSP, V31, P6, DOI 10.1111/j.1439-0485.2009.00352.x; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Zekely J, 2006, DEEP-SEA RES PT I, V53, P1363, DOI 10.1016/j.dsr.2006.05.010; Zekely J, 2006, CAH BIOL MAR, V47, P477; Zeppilli D, 2009, AQUAT BIOL, V5, P75, DOI 10.3354/ab00140	97	52	52	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12321	10.1371/journal.pone.0012321	http://dx.doi.org/10.1371/journal.pone.0012321			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20856898	Green Published, gold, Green Submitted			2022-12-27	WOS:000280811900039
J	Nezami, A; Poy, F; Toms, A; Zheng, W; Eck, MJ				Nezami, Azin; Poy, Florence; Toms, Angela; Zheng, Wei; Eck, Michael J.			Crystal Structure of a Complex between Amino and Carboxy Terminal Fragments of mDia1: Insights into Autoinhibition of Diaphanous-Related Formins	PLOS ONE			English	Article							ACTIN-FILAMENT ELONGATION; HOMOLOGY-2 DOMAIN; FH2 DOMAIN; AUTOREGULATORY DOMAIN; BINDING PROTEIN; ARP2/3 COMPLEX; RHO; NUCLEATION; PROFILIN; MECHANISM	Formin proteins direct the nucleation and assembly of linear actin filaments in a variety of cellular processes using their conserved formin homology 2 (FH2) domain. Diaphanous-related formins (DRFs) are effectors of Rho-family GTPases, and in the absence of Rho activation they are maintained in an inactive state by intramolecular interactions between their regulatory N-terminal region and a C-terminal segment referred to as the DAD domain. Although structures are available for the isolated DAD segment in complex with the interacting region in the N-terminus, it remains unclear how this leads to inhibition of actin assembly by the FH2 domain. Here we describe the crystal structure of the N-terminal regulatory region of formin mDia1 in complex with a C-terminal fragment containing both the FH2 and DAD domains. In the crystal structure and in solution, these fragments form a tetrameric complex composed of two interlocking N+C dimers. Formation of the tetramer is likely a consequence of the particular N-terminal construct employed, as we show that a nearly full-length mDia1 protein is dimeric, as are other autoinhibited N+C complexes containing longer N-terminal fragments. The structure provides the first view of the intact C-terminus of a DRF, revealing the relationship of the DAD to the FH2 domain. Delineation of alternative dimeric N+C interactions within the tetramer provides two general models for autoinhibition in intact formins. In both models, engagement of the DAD by the N-terminus is incompatible with actin filament formation on the FH2, and in one model the actin binding surfaces of the FH2 domain are directly blocked by the N-terminus.	[Nezami, Azin; Poy, Florence; Toms, Angela; Zheng, Wei; Eck, Michael J.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Nezami, Azin; Toms, Angela; Zheng, Wei; Eck, Michael J.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Nezami, A (corresponding author), Vertex Pharmaceut, Cambridge, MA USA.	eck@red.dfci.harvard.edu			National Institutes of Health (NIH) [R01GM071834]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071834] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grant R01GM071834 (MJE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Copeland JW, 2004, J BIOL CHEM, V279, P50250, DOI 10.1074/jbc.M404429200; Copeland SJ, 2007, J BIOL CHEM, V282, P30120, DOI 10.1074/jbc.M703834200; Eisenmann KM, 2007, J BIOL CHEM, V282, P25152, DOI 10.1074/jbc.M703243200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evangelista M, 2002, NAT CELL BIOL, V4, P32, DOI 10.1038/ncb718; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Higgs HN, 2005, MOL BIOL CELL, V16, P1, DOI 10.1091/mbc.E04-07-0565; Humphries CL, 2002, J CELL BIOL, V159, P993, DOI 10.1083/jcb.200206113; Ishizaki T, 2001, NAT CELL BIOL, V3, P8; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P829, DOI 10.1107/S0907444996001783; Kursula P, 2008, J MOL BIOL, V375, P270, DOI 10.1016/j.jmb.2007.10.050; Lammers M, 2005, EMBO J, V24, P4176, DOI 10.1038/sj.emboj.7600879; Lammers M, 2008, J BIOL CHEM, V283, P35236, DOI 10.1074/jbc.M805634200; Li F, 2005, J BIOL CHEM, V280, P6986, DOI 10.1074/jbc.M411605200; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Lu J, 2007, J MOL BIOL, V369, P1258, DOI 10.1016/j.jmb.2007.04.002; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Moseley JB, 2004, MOL BIOL CELL, V15, P896, DOI 10.1091/mbc.E03-08-0621; Nezami AG, 2006, STRUCTURE, V14, P257, DOI 10.1016/j.str.2005.12.003; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Otomo T, 2005, MOL CELL, V18, P273, DOI 10.1016/j.molcel.2005.04.002; Paul A, 2008, CURR BIOL, V18, P9, DOI 10.1016/j.cub.2007.11.062; Peng J, 2007, CANCER RES, V67, P7565, DOI 10.1158/0008-5472.CAN-07-1467; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Sakata D, 2007, J EXP MED, V204, P2031, DOI 10.1084/jem.20062647; Shimada A, 2004, MOL CELL, V13, P511, DOI 10.1016/S1097-2765(04)00059-0; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Vavylonis D, 2006, MOL CELL, V21, P455, DOI 10.1016/j.molcel.2006.01.016; Wallar BJ, 2006, J BIOL CHEM, V281, P4300, DOI 10.1074/jbc.M510277200; Wasilko DJ, 2009, PROTEIN EXPRES PURIF, V65, P122, DOI 10.1016/j.pep.2009.01.002; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Winn MD, 2003, J SYNCHROTRON RADIAT, V10, P23, DOI 10.1107/S0909049502017235; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Yamashita M, 2007, GENES CELLS, V12, P1255, DOI 10.1111/j.1365-2443.2007.01132.x	42	34	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e12992	10.1371/journal.pone.0012992	http://dx.doi.org/10.1371/journal.pone.0012992			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20927338	gold, Green Published, Green Submitted			2022-12-27	WOS:000282312600010
J	Ge, F; Xiao, CL; Bi, LJ; Tao, SC; Xiong, S; Yin, XF; Li, LP; Lu, CH; Jia, HT; He, QY				Ge, Feng; Xiao, Chuan-Le; Bi, Li-Jun; Tao, Sheng-Ce; Xiong, Sheng; Yin, Xin-Feng; Li, Li-Ping; Lu, Chun-Hua; Jia, Hai-Tao; He, Qing-Yu			Quantitative Phosphoproteomics of Proteasome Inhibition in Multiple Myeloma Cells	PLOS ONE			English	Article							AMINO-ACIDS; PROTEIN; PHOSPHORYLATION; AUTOPHAGY; PS-341; APOPTOSIS; STATHMIN; SURVIVAL; CULTURE; DEATH	Background: The proteasome inhibitor bortezomib represents an important advance in the treatment of multiple myeloma (MM). Bortezomib inhibits the activity of the 26S proteasome and induces cell death in a variety of tumor cells; however, the mechanism of cytotoxicity is not well understood. Methodology/Principal Findings: We investigated the differential phosphoproteome upon proteasome inhibition by using stable isotope labeling by amino acids in cell culture (SILAC) in combination with phosphoprotein enrichment and LC-MS/MS analysis. In total 233 phosphoproteins were identified and 72 phosphoproteins showed a 1.5-fold or greater change upon bortezomib treatment. The phosphoproteins with expression alterations encompass all major protein classes, including a large number of nucleic acid binding proteins. Site-specific phosphopeptide quantitation revealed that Ser38 phosphorylation on stathmin increased upon bortezomib treatment, suggesting new mechanisms associated to bortezomib-induced apoptosis in MM cells. Further studies demonstrated that stathmin phosphorylation profile was modified in response to bortezomib treatment and the regulation of stathmin by phosphorylation at specific Ser/Thr residues participated in the cellular response induced by bortezomib. Conclusions/Significance: Our systematic profiling of phosphorylation changes in response to bortezomib treatment not only advanced the global mechanistic understanding of the action of bortezomib on myeloma cells but also identified previously uncharacterized signaling proteins in myeloma cells.	[Ge, Feng; Xiao, Chuan-Le; Xiong, Sheng; Yin, Xin-Feng; Li, Li-Ping; Lu, Chun-Hua; Jia, Hai-Tao; He, Qing-Yu] Jinan Univ, Inst Life & Hlth Engn, Guangzhou, Guangdong, Peoples R China; [Ge, Feng; Xiao, Chuan-Le; Xiong, Sheng; Yin, Xin-Feng; Li, Li-Ping; Lu, Chun-Hua; Jia, Hai-Tao; He, Qing-Yu] Jinan Univ, Natl Engn Res Ctr Genet Med, Guangzhou, Guangdong, Peoples R China; [Ge, Feng] Chinese Acad Sci, Inst Hydrobiol, Wuhan, Peoples R China; [Bi, Li-Jun] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Tao, Sheng-Ce] Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Shanghai 200030, Peoples R China	Jinan University; Jinan University; Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Shanghai Jiao Tong University	Ge, F (corresponding author), Jinan Univ, Inst Life & Hlth Engn, Guangzhou, Guangdong, Peoples R China.	tqyhe@jnu.edu.cn	He, Qing-Yu/H-7078-2014; ge, feng/AGA-6334-2022; Tao, Sheng-ce/A-5833-2012; ge, feng/E-9158-2011	He, Qing-Yu/0000-0003-0503-9492; ge, feng/0000-0002-1032-280X; Tao, Sheng-ce/0000-0002-9210-1823; ge, feng/0000-0002-1032-280X	Chang-Jiang Scholars Program; "211'' Projects; Chinese Academy of Sciences; National Protein Research Fund [2009CB825400, 2006CB910902]; Ministry of Health of China [2008ZX10003-005]; State Key Development Program for Basic Research of China [2010CB529205]; Fundamental Research Funds for the Central Universities	Chang-Jiang Scholars Program(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); "211'' Projects; Chinese Academy of Sciences(Chinese Academy of Sciences); National Protein Research Fund; Ministry of Health of China; State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was partially supported by the 2007 Chang-Jiang Scholars Program, "211'' Projects, the Hundred Talents Program of The Chinese Academy of Sciences, the National Protein Research Fund (Grant No: 2009CB825400 and 2006CB910902) and the Major Special Program on Infectious Diseases from Ministry of Health of China (2008ZX10003-005), the State Key Development Program for Basic Research of China (Grant No. 2010CB529205) and the Fundamental Research Funds for the Central Universities (to Q.-Y.H). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; Carra S, 2008, J BIOL CHEM, V283, P1437, DOI 10.1074/jbc.M706304200; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Chauhan D, 2005, MOL CANCER THER, V4, P686, DOI 10.1158/1535-7163.MCT-04-0338; Chauhan D, 2003, CANCER RES, V63, P6174; Chauhan D, 2003, J BIOL CHEM, V278, P17593, DOI 10.1074/jbc.C300076200; Chauhan D, 2003, APOPTOSIS, V8, P337, DOI 10.1023/A:1024164700094; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; DiPaolo G, 1997, FEBS LETT, V416, P149, DOI 10.1016/S0014-5793(97)01188-5; Doong H, 2003, J BIOL CHEM, V278, P28490, DOI 10.1074/jbc.M209682200; Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29; Ge F, 2009, J PROTEOME RES, V8, P3006, DOI 10.1021/pr9001004; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; Haas W, 2006, MOL CELL PROTEOMICS, V5, P1326, DOI 10.1074/mcp.M500339-MCP200; Hamilton AL, 2005, J CLIN ONCOL, V23, P6107, DOI 10.1200/JCO.2005.01.136; Hideshima T, 2001, CANCER RES, V61, P3071; Hideshima T, 2003, BLOOD, V101, P1530, DOI 10.1182/blood-2002-08-2543; Holmfeldt P, 2001, MOL BIOL CELL, V12, P73, DOI 10.1091/mbc.12.1.73; Kabbage M, 2008, CELL MOL LIFE SCI, V65, P1390, DOI 10.1007/s00018-008-7535-2; Kassis JN, 2006, EXP CELL RES, V312, P2962, DOI 10.1016/j.yexcr.2006.05.023; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Lawler S, 1998, CURR BIOL, V8, pR212, DOI 10.1016/S0960-9822(98)70128-9; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Marklund U, 1996, EMBO J, V15, P5290, DOI 10.1002/j.1460-2075.1996.tb00914.x; Mi HY, 2007, NUCLEIC ACIDS RES, V35, pD247, DOI 10.1093/nar/gkl869; Mitsiades N, 2002, P NATL ACAD SCI USA, V99, P14374, DOI 10.1073/pnas.202445099; Mitsiades N, 2003, BLOOD, V101, P2377, DOI 10.1182/blood-2002-06-1768; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Moreno FJ, 1998, MOL CELL BIOCHEM, V183, P201, DOI 10.1023/A:1006807814580; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsten MEK, 2004, BIOCHEM CELL BIOL, V82, P681, DOI 10.1139/O04-116; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Pan C, 2008, PROTEOMICS, V8, P4534, DOI 10.1002/pmic.200800105; Piazza FA, 2006, BLOOD, V108, P1698, DOI 10.1182/blood-2005-11-013672; Poruchynsky MS, 2008, CELL CYCLE, V7, P940, DOI 10.4161/cc.7.7.5625; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Romano MF, 2003, CELL DEATH DIFFER, V10, P383, DOI 10.1038/sj.cdd.4401167; Santamaria E, 2009, PROTEOMICS, V9, P4495, DOI 10.1002/pmic.200900110; Schewe DM, 2009, CANCER RES, V69, P1545, DOI 10.1158/0008-5472.CAN-08-3858; Sui SH, 2008, PROTEOMICS, V8, P2024, DOI 10.1002/pmic.200700896; SUN X, 2009, J PROTEOME RES; Sunwoo JB, 2001, CLIN CANCER RES, V7, P1419; Tedford NC, 2009, PROTEOMICS, V9, P1469, DOI 10.1002/pmic.200800468; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Zada AAP, 2006, PROTEOMICS, V6, P5705, DOI 10.1002/pmic.200600307; Zhang GA, 2006, J PROTEOME RES, V5, P581, DOI 10.1021/pr050362b; Zhang L, 2010, J VIROL, V84, P6050, DOI 10.1128/JVI.00213-10; Zhu K, 2010, ONCOGENE, V29, P451, DOI 10.1038/onc.2009.343	54	27	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e13095	10.1371/journal.pone.0013095	http://dx.doi.org/10.1371/journal.pone.0013095			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20927383	Green Published, gold, Green Submitted			2022-12-27	WOS:000282269400031
J	Suyemoto, MM; Spears, PA; Hamrick, TS; Barnes, JA; Havell, EA; Orndorff, PE				Suyemoto, M. Mitsu; Spears, Patricia A.; Hamrick, Terri S.; Barnes, Jill A.; Havell, Edward A.; Orndorff, Paul E.			Factors Associated with the Acquisition and Severity of Gestational Listeriosis	PLOS ONE			English	Article							FETOPLACENTAL LISTERIOSIS; MONOCYTOGENES INFECTION; GUINEA-PIG; PREGNANCY; MICE; PATHOGENESIS; HOST	Gravid mammals are more prone to listeriosis than their nongravid counterparts. However, many features of the disease in gravid animals are not well defined. We determined, in mice, that increased susceptibility to lethal infection following oral inoculation begins surprisingly early in pregnancy and extends through embryonic development. Pregnancy did not demonstrably increase the spread of listeriae from the intestine to the liver and spleen in the initial 96 h period post inoculation. Consequently, it appeared that gravid animals were competent to contain an enteric infection, but in those instances where escape did occur, a lethal outcome was more likely. Interestingly, colonic colonization level and prevalence, measured 96 h post inoculation, was significantly higher in gravid individuals. In terms of human risk factors for listeriosis, our results suggest that the window of listeriosis susceptibility afforded by pregnancy may be open longer than previously appreciated. Our results also suggest that while gravid animals are competent to contain an enteric infection, enteric carriage rate may be more of a factor in defining disease incidence than previously considered.	[Suyemoto, M. Mitsu; Spears, Patricia A.; Havell, Edward A.; Orndorff, Paul E.] N Carolina State Univ, Coll Vet Med, Dept Populat Hlth & Pathobiol, Raleigh, NC 27695 USA; [Hamrick, Terri S.] Campbell Univ, Sch Pharm, Dept Pharmaceut Sci, Buies Creek, NC 27506 USA; [Barnes, Jill A.] N Carolina State Univ, Coll Vet Med, Dept Biomed Sci, Raleigh, NC USA	University of North Carolina; North Carolina State University; Campbell University; University of North Carolina; North Carolina State University	Suyemoto, MM (corresponding author), N Carolina State Univ, Coll Vet Med, Dept Populat Hlth & Pathobiol, Raleigh, NC 27695 USA.	paul_orndorff@ncsu.edu		Hamrick, Terri/0000-0003-0388-1256	National Institutes of Health [R03AI064217, R21AI064333, 1R21AI083838]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083838, R03AI064217, R21AI064333] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants R03AI064217, R21AI064333 and 1R21AI083838 from the National Institutes of Health. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram M, 1997, FOLIA MICROBIOL, V42, P65, DOI 10.1007/BF02898648; ARMSTRONG D, 1995, PRINCIPLES PRACTICE; Bakardjiev AI, 2005, J INFECT DIS, V191, P1889, DOI 10.1086/430090; Bakardjiev AI, 2004, INFECT IMMUN, V72, P489, DOI 10.1128/IAI.72.1.489-497.2004; Bakardjiev AI, 2006, PLOS PATHOG, V2, P623, DOI 10.1371/journal.ppat.0020066; BORTOLUSSI R, 1984, SURV SYN PATHOL RES, V3, P311; Carson DD, 2000, DEV BIOL, V223, P217, DOI 10.1006/dbio.2000.9767; CIESIELSKI CA, 1988, ARCH INTERN MED, V148, P1416, DOI 10.1001/archinte.148.6.1416; Disson O, 2008, NATURE, V455, P1114, DOI 10.1038/nature07303; GELLIN BG, 1991, AM J EPIDEMIOL, V133, P392, DOI 10.1093/oxfordjournals.aje.a115893; Hamrick TS, 2003, INFECT IMMUN, V71, P5202, DOI 10.1128/IAI.71.9.5202-5209.2003; Low JC, 1997, VET J, V153, P9, DOI 10.1016/S1090-0233(97)80005-6; NAKANE A, 1985, INFECT IMMUN, V50, P877, DOI 10.1128/IAI.50.3.877-880.1985; NODEN DM, 1985, EMBRYOLOGY DOMESTIC, P47; Orndorff PE, 2006, VET MICROBIOL, V114, P1, DOI 10.1016/j.vetmic.2005.12.003; PEZESHKIAN R, 1984, BRIT J OBSTET GYNAEC, V91, P85, DOI 10.1111/j.1471-0528.1984.tb05284.x; REDLINE RW, 1987, J CLIN INVEST, V79, P1234, DOI 10.1172/JCI112942; REED LJ, 1938, AM J HYG, V27, P293; Robbins JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000732; WEINBERG ED, 1984, REV INFECT DIS, V6, P814	20	2	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e13000	10.1371/journal.pone.0013000	http://dx.doi.org/10.1371/journal.pone.0013000			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20885996	Green Published, gold, Green Submitted			2022-12-27	WOS:000282167100009
J	Hackl, H; Rommer, A; Konrad, TA; Nassimbeni, C; Wieser, R				Hackl, Hubert; Rommer, Anna; Konrad, Torsten A.; Nassimbeni, Christine; Wieser, Rotraud			Tetracycline Regulator Expression Alters the Transcriptional Program of Mammalian Cells	PLOS ONE			English	Article							GENE-EXPRESSION; GROWTH ARREST; DIFFERENTIATION; CYCLE	Background: Tetracycline regulated ectopic gene expression is a widely used tool to study gene function. However, the tetracycline regulator (tetR) itself has been reported to cause certain phenotypic changes in mammalian cells. We, therefore, asked whether human myeloid U937 cells expressing the tetR in an autoregulated manner would exhibit alterations in gene expression upon removal of tetracycline. Methodology/Principal Findings: Microarray analyses revealed that 172 and 774 unique genes were significantly differentially expressed by at least 2- or 1.5-fold, respectively, when tetR expressing U937 cells were maintained in media with or without the antibiotic. Conclusions/Significance: These alterations in gene expression are likely to contribute to the phenotypic consequences of tetR expression. In addition, they need to be taken into consideration when using the tetR system for the identification of target genes of transcription factors or other genes of interest.	[Hackl, Hubert] Innsbruck Med Univ, Sect Bioinformat, Bioctr, Innsbruck, Austria; [Rommer, Anna; Nassimbeni, Christine; Wieser, Rotraud] Med Univ Vienna, Med Clin 1, Vienna, Austria; [Rommer, Anna; Konrad, Torsten A.; Wieser, Rotraud] Med Univ Vienna, Inst Human Genet, Vienna, Austria	Medical University of Innsbruck; Medical University of Vienna; Medical University of Vienna	Hackl, H (corresponding author), Innsbruck Med Univ, Sect Bioinformat, Bioctr, Innsbruck, Austria.	rotraud.wieser@meduniwien.ac.at	Hackl, Hubert/B-3168-2018	Hackl, Hubert/0000-0003-4055-3841; Wieser, Rotraud/0000-0003-4384-6658	Austrian Science Foundation (FWF) [P20920]; Austrian Science Fund (FWF) [P 20920] Funding Source: researchfish	Austrian Science Foundation (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Foundation (FWF), http://www.fwf.ac.at/, grant no P20920 to RW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Boer J, 1998, MOL CELL BIOL, V18, P1236, DOI 10.1128/MCB.18.3.1236; Bromleigh VC, 2000, GENE DEV, V14, P2581, DOI 10.1101/gad.817100; Caslini C, 2000, P NATL ACAD SCI USA, V97, P2797, DOI 10.1073/pnas.040574897; Caslini C, 2004, LEUKEMIA, V18, P1064, DOI 10.1038/sj.leu.2403321; FORNEROD M, 1995, ONCOGENE, V10, P1739; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Hakansson P, 2004, EXP HEMATOL, V32, P476, DOI 10.1016/j.exphem.2004.02.012; Hakansson P, 2004, LEUKEMIA, V18, P538, DOI 10.1038/sj.leu.2403255; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hultquist A, 2004, MOL CANCER RES, V2, P464; Konrad TA, 2009, J LEUKOCYTE BIOL, V86, P813, DOI 10.1189/jlb.0109042; Liang H, 2005, ONCOGENE, V24, P2625, DOI 10.1038/sj.onc.1208167; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McConnell MJ, 2003, MOL CELL BIOL, V23, P9375, DOI 10.1128/MCB.23.24.9375-9388.2003; Meester-Smoor MA, 2008, CARCINOGENESIS, V29, P2025, DOI 10.1093/carcin/bgn168; Morimoto M, 2009, DEV BIOL, V325, P171, DOI 10.1016/j.ydbio.2008.10.013; Rice KL, 2009, BLOOD, V114, P5499, DOI 10.1182/blood-2009-03-206524; SHOCKETT P, 1995, P NATL ACAD SCI USA, V92, P6522, DOI 10.1073/pnas.92.14.6522; Vignali DAA, 1996, J EXP MED, V183, P2097, DOI 10.1084/jem.183.5.2097	22	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2010	5	9							e13013	10.1371/journal.pone.0013013	http://dx.doi.org/10.1371/journal.pone.0013013			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653UN	20886048	Green Published, gold			2022-12-27	WOS:000282122600025
J	Nalla, AK; Asuthkar, S; Bhoopathi, P; Gujrati, M; Dinh, DH; Rao, JS				Nalla, Arun Kumar; Asuthkar, Swapna; Bhoopathi, Praveen; Gujrati, Meena; Dinh, Dzung H.; Rao, Jasti S.			Suppression of uPAR Retards Radiation-Induced Invasion and Migration Mediated by Integrin beta 1/FAK Signaling in Medulloblastoma	PLOS ONE			English	Article							FOCAL ADHESION KINASE; EPITHELIAL-MESENCHYMAL TRANSITIONS; UROKINASE RECEPTOR; CELL-MIGRATION; PLASMINOGEN-ACTIVATOR; CANCER-CELLS; TUMOR-GROWTH; PROGNOSTIC-FACTORS; ADULT MEDULLOBLASTOMA; VINCULIN RECRUITMENT	Background: Despite effective radiotherapy for the initial stages of cancer, several studies have reported the recurrence of various cancers, including medulloblastoma. Here, we attempt to capitalize on the radiation-induced aggressive behavior of medulloblastoma cells by comparing the extracellular protease activity and the expression pattern of molecules, known to be involved in cell adhesion, migration and invasion, between non-irradiated and irradiated cells. Methodology/Principal Findings: We identified an increase in invasion and migration of irradiated compared to non-irradiated medulloblastoma cells. RT-PCR analysis confirmed increased expression of uPA, uPAR, focal adhesion kinase (FAK), N-Cadherin and integrin subunits (e. g., alpha 3, alpha 5 and beta 1) in irradiated cells. Furthermore, we noticed a similar to 2-fold increase in tyrosine phosphorylation of FAK in irradiated cells. Immunoprecipitation studies confirmed increased interaction of integrin beta 1 and FAK in irradiated cells. In addition, our results show that overexpression of uPAR in cancer cells can mimic radiation-induced activation of FAK signaling. Moreover, by inhibiting FAK phosphorylation, we were able to reduce the radiation-induced invasiveness of the cancer cells. In this vein, we studied the effect of siRNA-mediated knockdown of uPAR on cell migration and adhesion in irradiated and non-irradiated medulloblastoma cells. Downregulation of uPAR reduced the radiation-induced adhesion, migration and invasion of the irradiated cells, primarily by inhibiting phosphorylation of FAK, Paxillin and Rac-1/Cdc42. As observed from the immunoprecipitation studies, uPAR knockdown reduced interaction among the focal adhesion molecules, such as FAK, Paxillin and p130Cas, which are known to play key roles in cancer metastasis. Pretreatment with uPAR shRNA expressing construct reduced uPAR and phospho FAK expression levels in pre-established medulloblastoma in nude mice. Conclusion/Significance: Taken together, our results show that radiation enhances uPAR-mediated FAK signaling and by targeting uPAR we can inhibit radiation-activated cell adhesion and migration both in vitro and in vivo.	[Nalla, Arun Kumar; Asuthkar, Swapna; Bhoopathi, Praveen; Rao, Jasti S.] Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Peoria, IL 61656 USA; [Gujrati, Meena] Univ Illinois, Coll Med Peoria, Dept Pathol, Peoria, IL USA; [Dinh, Dzung H.; Rao, Jasti S.] Univ Illinois, Coll Med Peoria, Dept Neurosurg, Peoria, IL USA	University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria	Nalla, AK (corresponding author), Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Peoria, IL 61656 USA.	jsrao@uic.edu	Nalla, Arun Kumar/D-1457-2012		National Institutes of Health [CA138409]; NATIONAL CANCER INSTITUTE [R01CA138409] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by a grant from National Institutes of Health, CA138409 (to J.S.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bass R, 2005, J BIOL CHEM, V280, P14811, DOI 10.1074/jbc.M414189200; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Biswas S, 2007, J CLIN INVEST, V117, P1305, DOI 10.1172/JCI30740; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Blasi F, 1999, APMIS, V107, P96, DOI 10.1111/j.1699-0463.1999.tb01531.x; Bouton AH, 2001, ONCOGENE, V20, P6448, DOI 10.1038/sj.onc.1204785; Brooks SA, 2010, ACTA HISTOCHEM, V112, P3, DOI 10.1016/j.acthis.2008.11.022; Camphausen K, 2001, CANCER RES, V61, P2207; Cary LA, 1998, J CELL BIOL, V140, P211, DOI 10.1083/jcb.140.1.211; Casadei R, 2010, PANCREATOLOGY, V10, P33, DOI 10.1159/000217604; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chan AW, 2000, NEUROSURGERY, V47, P623, DOI 10.1097/00006123-200009000-00018; Chan MY, 2007, ANN ACAD MED SINGAP, V36, P314; Chaurasia P, 2006, J BIOL CHEM, V281, P14852, DOI 10.1074/jbc.M512311200; Chen JS, 2010, CLIN EXP METASTAS, V27, P71, DOI 10.1007/s10585-010-9306-3; Cheng JCH, 2006, ONCOGENE, V25, P7009, DOI 10.1038/sj.onc.1209706; Crawford JR, 2007, LANCET NEUROL, V6, P1073, DOI 10.1016/S1474-4422(07)70289-2; Dumbauld DW, 2010, BIOL CELL, V102, P203, DOI 10.1042/BC20090104; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Feltbower R, 2004, PEDIATR HEMAT ONCOL, V21, P647, DOI 10.1080/08880010490501079; Friedl P, 2009, CANCER METAST REV, V28, P129, DOI 10.1007/s10555-008-9174-3; FU KK, 1991, HEMATOL ONCOL CLIN N, V5, P737, DOI 10.1016/S0889-8588(18)30413-1; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Ghiso JAA, 2002, ONCOGENE, V21, P2513, DOI 10.1038/sj/onc/1205342; Gondi CS, 2004, NEURON GLIA BIOL, V1, P165, DOI 10.1017/S1740925X04000237; Grose R, 2002, DEVELOPMENT, V129, P2303; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Hegedus B, 2004, J NEURO-ONCOL, V67, P147, DOI 10.1023/B:NEON.0000021826.73020.f3; Hehlgans S, 2007, INT J RADIAT BIOL, V83, P769, DOI 10.1080/09553000701694327; Howes TL, 2006, J NEURO-ONCOL, V80, P191, DOI 10.1007/s11060-006-9175-4; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Janik ME, 2010, BBA-GEN SUBJECTS, V1800, P545, DOI 10.1016/j.bbagen.2010.03.013; Jo M, 2009, AM J PATHOL, V175, P190, DOI 10.2353/ajpath.2009.081053; Jung JW, 2007, EUR J CANCER, V43, P1214, DOI 10.1016/j.ejca.2007.01.034; Kargiotis O, 2008, INT J ONCOL, V33, P937, DOI 10.3892/ijo_00000081; Kim J, 1998, CELL, V94, P353, DOI 10.1016/S0092-8674(00)81478-6; Kopac S, 2004, PEDIATR HEMAT ONCOL, V21, P17, DOI 10.1080/08880010490263344; Kuban DA, 2003, INT J RADIAT ONCOL, V57, P915, DOI 10.1016/S0360-3016(03)00632-1; Lakka SS, 2005, J BIOL CHEM, V280, P21882, DOI 10.1074/jbc.M408520200; Leo E, 1997, J NEURO-ONCOL, V32, P149, DOI 10.1023/A:1005721510659; LIOTTA LA, 1986, EUR J CANCER CLIN ON, V22, P345, DOI 10.1016/0277-5379(86)90403-7; LOWENFELS AB, 1989, GASTROENTEROLOGY, V96, P551, DOI 10.1016/S0016-5085(89)91616-8; Lozano E, 2003, BIOESSAYS, V25, P452, DOI 10.1002/bies.10262; Madani I, 2008, B CANCER, V95, P292, DOI 10.1684/bdc.2008.0598; Mazloom A, 2010, INT J RADIAT ONCOL, V78, P72, DOI 10.1016/j.ijrobp.2009.07.1729; Mitra SK, 2006, ONCOGENE, V25, P4429, DOI 10.1038/sj.onc.1209482; Nguyen DHD, 1998, J BIOL CHEM, V273, P8502, DOI 10.1074/jbc.273.14.8502; Ogata K, 2009, HEPATO-GASTROENTEROL, V56, P1760; Ossowski L, 2000, CURR OPIN CELL BIOL, V12, P613, DOI 10.1016/S0955-0674(00)00140-X; Painter KJ, 2010, J THEOR BIOL, V264, P1057, DOI 10.1016/j.jtbi.2010.03.033; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; POLTE TR, 1995, P NATL ACAD SCI USA, V92, P10678, DOI 10.1073/pnas.92.23.10678; Qian LW, 2002, CLIN CANCER RES, V8, P1223; Ranger A, 2009, CAN J NEUROL SCI, V36, P631, DOI 10.1017/S0317167100008155; Rao JS, 2007, CANCER RES, V67, P4956, DOI 10.1158/0008-5472.CAN-07-0380; Rao JS, 2003, NAT REV CANCER, V3, P489, DOI 10.1038/nrc1121; Rathinam R, 2010, CANCER METAST REV, V29, P223, DOI 10.1007/s10555-010-9211-x; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rutkauskiene Giedre, 2006, Medicina (Kaunas), V42, P22; Schwartz MA, 2008, CURR OPIN CELL BIOL, V20, P551, DOI 10.1016/j.ceb.2008.05.005; Shi Q, 2003, MOL BIOL CELL, V14, P4306, DOI 10.1091/mbc.E03-01-0046; Shibue T, 2009, P NATL ACAD SCI USA, V106, P10290, DOI 10.1073/pnas.0904227106; Shook D, 2003, MECH DEVELOP, V120, P1351, DOI 10.1016/j.mod.2003.06.005; Smith HW, 2008, J CELL BIOL, V182, P777, DOI 10.1083/jcb.200712050; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Sun LM, 2002, J NEURO-ONCOL, V58, P77, DOI 10.1023/A:1015865614640; Tang CH, 2008, J CELL SCI, V121, P3747, DOI 10.1242/jcs.029769; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tsutsumi K, 2009, CELL STRUCT FUNCT, V34, P89, DOI 10.1247/csf.09006; Uings IJ, 2000, J CLIN PATHOL-MOL PA, V53, P295; Wei Y, 2001, MOL BIOL CELL, V12, P2975, DOI 10.1091/mbc.12.10.2975; Wei Y, 1999, J CELL BIOL, V144, P1285, DOI 10.1083/jcb.144.6.1285; Wild-Bode C, 2001, CANCER RES, V61, P2744; Yebra M, 1996, J BIOL CHEM, V271, P29393, DOI 10.1074/jbc.271.46.29393; Zhang F, 2003, J CELL BIOL, V163, P177, DOI 10.1083/jcb.200304065; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4	78	44	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2010	5	9							e13006	10.1371/journal.pone.0013006	http://dx.doi.org/10.1371/journal.pone.0013006			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653UN	20886051	gold, Green Published, Green Submitted			2022-12-27	WOS:000282122600023
J	Bastianetto, S; Dumont, Y; Duranton, A; Vercauteren, F; Breton, L; Quirion, R				Bastianetto, Stephane; Dumont, Yvan; Duranton, Albert; Vercauteren, Freya; Breton, Lionel; Quirion, Remi			Protective Action of Resveratrol in Human Skin: Possible Involvement of Specific Receptor Binding Sites	PLOS ONE			English	Article							NITRIC-OXIDE; RED WINE; TRANS-RESVERATROL; POTENTIAL ROLE; APOPTOSIS; KERATINOCYTES; PEROXYNITRITE; AGGREGATION; POLYPHENOLS; CONSUMPTION	Background: Resveratrol is a plant-derived polyphenol with purported protecting action on various disorders associated with aging. It has been suggested that resveratrol could exert its protective action by acting on specific plasma membrane polyphenol binding sites (Han Y. S., et al. (2006) J Pharmacol Exp Ther 318: 238-245). The purpose of this study was to investigate, in human skin, the possible existence of specific binding sites that mediate the protective action of resveratrol. Methods and Findings: Using human skin tissue, we report here the presence of specific [H-3]-resveratrol binding sites (K-D = 180 nM) that are mainly located in the epidermis. Exposure of HaCaT cells to the nitric oxide free radical donor sodium nitroprusside (SNP; 0.3-3 mM) resulted in cell death which was reduced by resveratrol (EC50 = 14.7 mu M), and to a much lesser extent by the resveratrol analogue piceatannol (EC50 = 95 mu M) and epigallocatechin gallate (EC50 = 200 mu M), a green-tea derived polyphenol. The protective action of resveratrol likely relates to its anti-apoptotic effect since at the same range of concentration it was able to reduce both the number of apoptotic cells as well as mitochondrial apoptotic events triggered by SNP. Conclusion: Taken together, these findings suggest that resveratrol, by acting on specific polyphenol binding sites in epidermis, may be useful to prevent skin disorders associated with aging.	[Bastianetto, Stephane; Dumont, Yvan; Vercauteren, Freya; Quirion, Remi] McGill Univ, Douglas Mental Hlth Univ Inst, Dept Psychiat, Montreal, PQ, Canada; [Duranton, Albert; Breton, Lionel] LOreal Rech, Clichy, France	McGill University; L'Oreal Group	Bastianetto, S (corresponding author), McGill Univ, Douglas Mental Hlth Univ Inst, Dept Psychiat, Montreal, PQ, Canada.	remi.quirion@douglas.mcgill.ca		Duranton, Albert/0000-0002-4057-7176	L'Oreal Research & Development, France	L'Oreal Research & Development, France	This work was supported by a research grant from L'Oreal Research & Development, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2004, ANTICANCER RES, V24, P2783; Anekonda TS, 2006, BRAIN RES REV, V52, P316, DOI 10.1016/j.brainresrev.2006.04.004; Bastianetto S, 2008, MINI-REV MED CHEM, V8, P429, DOI 10.2174/138955708784223512; Bastianetto S, 2000, BRIT J PHARMACOL, V131, P711, DOI 10.1038/sj.bjp.0703626; Bastianetto S, 2004, FRONT BIOSCI-LANDMRK, V9, P3447, DOI 10.2741/1493; Bastianetto S, 2002, NUTRITION, V18, P432, DOI 10.1016/S0899-9007(01)00745-6; Baumann L, 2007, J PATHOL, V211, P241, DOI 10.1002/path.2098; Baxter Richard A, 2008, J Cosmet Dermatol, V7, P2, DOI 10.1111/j.1473-2165.2008.00354.x; Bikle DD, 2001, MOL CELL ENDOCRINOL, V177, P161, DOI 10.1016/S0303-7207(01)00452-X; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Bournival J, 2009, CELL MOL NEUROBIOL, V29, P1169, DOI 10.1007/s10571-009-9411-5; BOZYCZKOCOYNE D, 1993, J NEUROSCI METH, V50, P205, DOI 10.1016/0165-0270(93)90009-G; Chan MMY, 2002, BIOCHEM PHARMACOL, V63, P99, DOI 10.1016/S0006-2952(01)00886-3; Chen M, 2009, NEUROSIGNALS, V17, P162, DOI 10.1159/000205525; Corder R, 2001, NATURE, V414, P863, DOI 10.1038/414863a; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; DELICONSTANTINOS G, 1995, BRIT J PHARMACOL, V114, P1257, DOI 10.1111/j.1476-5381.1995.tb13341.x; Feart C, 2009, JAMA-J AM MED ASSOC, V302, P638, DOI 10.1001/jama.2009.1146; FRANKEL EN, 1993, LANCET, V341, P454, DOI 10.1016/0140-6736(93)90206-V; Gan LX, 2005, BIOCHEM BIOPH RES CO, V337, P1092, DOI 10.1016/j.bbrc.2005.09.169; GOLDBERG DM, 1995, CLIN CHIM ACTA, V237, P155, DOI 10.1016/0009-8981(95)06069-P; Han YS, 2006, J PHARMACOL EXP THER, V318, P238, DOI 10.1124/jpet.106.102319; Han YS, 2004, BRIT J PHARMACOL, V141, P997, DOI 10.1038/sj.bjp.0705688; Jung JY, 2007, NEUROSCI LETT, V411, P222, DOI 10.1016/j.neulet.2006.09.089; Karuppagounder SS, 2009, NEUROCHEM INT, V54, P111, DOI 10.1016/j.neuint.2008.10.008; La Vecchia C, 2009, NUTR REV, V67, pS126, DOI 10.1111/j.1753-4887.2009.00174.x; Lee ER, 2005, J BIOL CHEM, V280, P31498, DOI 10.1074/jbc.M505537200; Lee SK, 2007, CANCER LETT, V249, P283, DOI 10.1016/j.canlet.2006.09.012; Liu RH, 2003, AM J CLIN NUTR, V78, p517S, DOI 10.1093/ajcn/78.3.517S; Marambaud P, 2005, J BIOL CHEM, V280, P37377, DOI 10.1074/jbc.M508246200; Marques FZ, 2009, INT J BIOCHEM CELL B, V41, P2125, DOI 10.1016/j.biocel.2009.06.003; Orallo F, 2008, CURR MED CHEM, V15, P1887, DOI 10.2174/092986708785132951; PACEASCIAK CR, 1995, CLIN CHIM ACTA, V235, P207, DOI 10.1016/0009-8981(95)06045-1; Renaud SC, 2004, AM J CLIN NUTR, V80, P621; Salvolini E, 2010, ARCH DERMATOL RES, V302, P367, DOI 10.1007/s00403-009-1018-7; SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671; Sparrow RL, 2005, J IMMUNOL METHODS, V305, P173, DOI 10.1016/j.jim.2005.07.017; VILLIOTOU V, 1995, ANTICANCER RES, V15, P931; Weller R, 2003, CLIN EXP DERMATOL, V28, P511, DOI 10.1046/j.1365-2230.2003.01365.x; Xia Y, 1996, P NATL ACAD SCI USA, V93, P6770, DOI 10.1073/pnas.93.13.6770; Yu W, 2009, J CELL BIOCHEM, V107, P741, DOI 10.1002/jcb.22169	41	42	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12935	10.1371/journal.pone.0012935	http://dx.doi.org/10.1371/journal.pone.0012935			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886076	gold, Green Submitted, Green Published			2022-12-27	WOS:000282091100034
J	Engel, LA; Jing, Z; O'Brien, DE; Sun, MY; Kotzbauer, PT				Engel, Laura A.; Jing, Zheng; O'Brien, Daniel E.; Sun, Mengyang; Kotzbauer, Paul T.			Catalytic Function of PLA2G6 Is Impaired by Mutations Associated with Infantile Neuroaxonal Dystrophy but Not Dystonia-Parkinsonism	PLOS ONE			English	Article							PHOSPHOLIPASE A(2); ALPHA-SYNUCLEIN; SEITELBERGERS-DISEASE; FATTY-ACIDS; GENE; HOMEOSTASIS; MODEL; MICE	Background: Mutations in the PLA2G6 gene have been identified in autosomal recessive neurodegenerative diseases classified as infantile neuroaxonal dystrophy (INAD), neurodegeneration with brain iron accumulation (NBIA), and dystonia-parkinsonism. These clinical syndromes display two significantly different disease phenotypes. NBIA and INAD are very similar, involving widespread neurodegeneration that begins within the first 1-2 years of life. In contrast, patients with dystonia-parkinsonism present with a parkinsonian movement disorder beginning at 15 to 30 years of age. The PLA2G6 gene encodes the PLA2G6 enzyme, also known as group VIA calcium-independent phospholipase A(2), which has previously been shown to hydrolyze the sn-2 acyl chain of phospholipids, generating free fatty acids and lysophospholipids. Methodology/Principal Findings: We produced purified recombinant wildtype (WT) and mutant human PLA2G6 proteins and examined their catalytic function using in vitro assays with radiolabeled lipid substrates. We find that human PLA2G6 enzyme hydrolyzes both phospholipids and lysophospholipids, releasing free fatty acids. Mutations associated with different disease phenotypes have different effects on catalytic activity. Mutations associated with INAD/NBIA cause loss of enzyme activity, with mutant proteins exhibiting less than 20% of the specific activity of WT protein in both lysophospholipase and phospholipase assays. In contrast, mutations associated with dystonia-parkinsonism do not impair catalytic activity, and two mutations produce a significant increase in specific activity for phospholipid but not lysophospholipid substrates. Conclusions/Significance: These results indicate that different alterations in PLA2G6 function produce the different disease phenotypes of NBIA/INAD and dystonia-parkinsonism. INAD/NBIA is caused by loss of the ability of PLA2G6 to catalyze fatty acid release from phospholipids, which predicts accumulation of PLA2G6 phospholipid substrates and provides a mechanistic explanation for the accumulation of membranes in neuroaxonal spheroids previously observed in histopathological studies of INAD/NBIA. In contrast, dystonia-parkinsonism mutations do not appear to directly impair catalytic function, but may modify substrate preferences or regulatory mechanisms for PLA2G6.	[Engel, Laura A.] Washington Univ, Sch Med, Dept Neurol, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Dev Biol, Hope Ctr Neurol Disorders, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL)	Engel, LA (corresponding author), Washington Univ, Sch Med, Dept Neurol, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA.	kotzbauerp@neuro.wustl.edu	Sun, Mengyang/AAP-5033-2020	Sun, Mengyang/0000-0002-3998-8744	NINDS [NS48924-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS048924] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NINDS grant NS48924-01 (PTK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AICARDI J, 1979, BRAIN, V102, P727, DOI 10.1093/brain/102.4.727; Baburina I, 1999, J BIOL CHEM, V274, P9400, DOI 10.1074/jbc.274.14.9400; Barbour SE, 1999, BBA-MOL CELL BIOL L, V1439, P77, DOI 10.1016/S1388-1981(99)00078-5; Broersen K, 2006, BIOCHEMISTRY-US, V45, P15610, DOI 10.1021/bi061743l; DELEON GA, 1985, ACTA NEUROPATHOL, V66, P89, DOI 10.1007/BF00688682; Ellis CE, 2005, MOL CELL BIOL, V25, P10190, DOI 10.1128/MCB.25.22.10190-10201.2005; Golovko MY, 2007, J NEUROCHEM, V101, P201, DOI 10.1111/j.1471-4159.2006.04357.x; Golovko MY, 2006, BIOCHEMISTRY-US, V45, P6956, DOI 10.1021/bi0600289; Gregory A, 2008, NEUROLOGY, V71, P1402, DOI 10.1212/01.wnl.0000327094.67726.28; Jenkins CM, 2006, J BIOL CHEM, V281, P15615, DOI 10.1074/jbc.M511623200; Jenkins CM, 2001, J BIOL CHEM, V276, P7129, DOI 10.1074/jbc.M010439200; KIMURA S, 1991, PEDIATR NEUROL, V7, P116, DOI 10.1016/0887-8994(91)90007-8; Kurian MA, 2008, NEUROLOGY, V70, P1623, DOI 10.1212/01.wnl.0000310986.48286.8e; Lio YC, 1998, BBA-LIPID LIPID MET, V1392, P320, DOI 10.1016/S0005-2760(98)00049-6; LIU HM, 1974, ACTA NEUROPATHOL, V27, P201; Ma ZM, 1999, J BIOL CHEM, V274, P9607, DOI 10.1074/jbc.274.14.9607; Malik I, 2008, AM J PATHOL, V172, P406, DOI 10.2353/ajpath.2008.070823; Morgan NV, 2006, NAT GENET, V38, P752, DOI 10.1038/ng1826; Paisan-Ruiz C, 2008, ANN NEUROL, V64, pS36; RAMAEKERS VT, 1987, NEUROPEDIATRICS, V18, P170, DOI 10.1055/s-2008-1052474; Sharon R, 2001, P NATL ACAD SCI USA, V98, P9110, DOI 10.1073/pnas.171300598; Sharon R, 2003, J BIOL CHEM, V278, P49874, DOI 10.1074/jbc.M309127200; Shinzawa K, 2008, J NEUROSCI, V28, P2212, DOI 10.1523/JNEUROSCI.4354-07.2008; Sina F, 2009, EUR J NEUROL, V16, P101, DOI 10.1111/j.1468-1331.2008.02356.x; Tang J, 1997, J BIOL CHEM, V272, P8567, DOI 10.1074/jbc.272.13.8567; Wada H, 2009, AM J PATHOL, V175, P2257, DOI 10.2353/ajpath.2009.090343; Wang ZP, 2005, J BIOL CHEM, V280, P6840, DOI 10.1074/jbc.M405287200; Wolf MJ, 1996, J BIOL CHEM, V271, P30879, DOI 10.1074/jbc.271.48.30879; Wu Y, 2009, EUR J NEUROL, V16, P240, DOI 10.1111/j.1468-1331.2008.02397.x; YAGISHITA S, 1974, ACTA NEUROPATHOL, V29, P115, DOI 10.1007/BF00684770; YAGISHITA S, 1975, ACTA NEUROPATHOL, V31, P191, DOI 10.1007/BF00684558	31	73	82	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12897	10.1371/journal.pone.0012897	http://dx.doi.org/10.1371/journal.pone.0012897			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886109	Green Published, gold, Green Submitted			2022-12-27	WOS:000282091100010
J	Moritoh, S; Tanaka, KF; Jouhou, H; Ikenaka, K; Koizumi, A				Moritoh, Satoru; Tanaka, Kenji F.; Jouhou, Hiroshi; Ikenaka, Kazuhiro; Koizumi, Amane			Organotypic Tissue Culture of Adult Rodent Retina Followed by Particle-Mediated Acute Gene Transfer In Vitro	PLOS ONE			English	Article							GANGLION-CELLS; MOUSE RETINA; IDENTIFICATION; DENDRITES; ALLOWS	Background: Organotypic tissue culture of adult rodent retina with an acute gene transfer that enables the efficient introduction of variable transgenes would greatly facilitate studies into retinas of adult rodents as animal models. However, it has been a difficult challenge to culture adult rodent retina. The purpose of this present study was to develop organotypic tissue culture of adult rodent retina followed by particle-mediated acute gene transfer in vitro. Methodology/Principal Findings: We established an interphase organotypic tissue culture for adult rat retinas (>P35 of age) which was optimized from that used for adult rabbit retinas. We implemented three optimizations: a greater volume of Ames' medium (>26 mL) per retina, a higher speed (constant 55 rpm) of agitation by rotary shaker, and a greater concentration (10%) of horse serum in the medium. We also successfully applied this method to adult mouse retina (>P35 of age). The organotypic tissue culture allowed us to keep adult rodent retina morphologically and structurally intact for at least 4 days. However, mouse retinas showed less viability after 4-day culture. Electrophysiologically, ganglion cells in cultured rat retina were able to generate action potentials, but exhibited less reliable light responses. After transfection of EGFP plasmids by particle-mediated acute gene transfer, we observed EGFP-expressing retinal ganglion cells as early as 1 day of culture. We also introduced polarized-targeting fusion proteins such as PSD95-GFP and melanopsin-EYFP (hOPN4-EYFP) into rat retinal ganglion cells. These fusion proteins were successfully transferred into appropriate locations on individual retinal neurons. Conclusions/Significance: This organotypic culture method is largely applicable to rat retinas, but it can be also applied to mouse retinas with a caveat regarding cell viability. This method is quite flexible for use in acute gene transfection in adult rodent retina, replacing molecular biological bioassays that used to be conducted in isolated cultured cells.	[Moritoh, Satoru; Koizumi, Amane] Natl Inst Physiol Sci, Div Correlat Physiol, Okazaki, Aichi 444, Japan; [Tanaka, Kenji F.; Ikenaka, Kazuhiro] Natl Inst Physiol Sci, Div Neurobiol & Bioinformat, Okazaki, Aichi 444, Japan; [Koizumi, Amane] Natl Inst Physiol Sci, Sect Commun & Publ Liaison, Okazaki, Aichi 444, Japan; [Tanaka, Kenji F.; Ikenaka, Kazuhiro; Koizumi, Amane] Grad Univ Adv Studies SOKENDAI, Sch Life Sci, Dept Physiol Sci, Okazaki, Aichi, Japan; [Jouhou, Hiroshi] Astellas Pharma Inc, Drug Safety Res Labs, Osaka, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan; Astellas Pharmaceuticals	Moritoh, S (corresponding author), Natl Inst Physiol Sci, Div Correlat Physiol, Okazaki, Aichi 444, Japan.	amane@nips.ac.jp	Koizumi, Amane/E-7771-2011	Koizumi, Amane/0000-0003-1177-0185; Tanaka, Kenji/0000-0003-2511-0057	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [21026030, 22700421]; Naito Foundation	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation)	This study was financially supported by a Grant-in-Aid for Scientific Research on Priority Areas No. 21026030 (AK, KFT), and Grant-in-Aid for Young Scientists (B) No. 22700421 (AK) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. This study was also supported by the Naito Foundation (AK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	El-Hussein AE, 2000, SCIENCE, V290, P1364; Fried SI, 2009, J NEUROPHYSIOL, V101, P1972, DOI 10.1152/jn.91081.2008; Fuerst PG, 2008, NATURE, V451, P470, DOI 10.1038/nature06514; Fukata Y, 2005, J CELL BIOL, V169, P399, DOI 10.1083/jcb.200501121; Garcia-Frigola C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-103; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Green DG, 1999, VISION RES, V39, P2165, DOI 10.1016/S0042-6989(98)00318-6; Gustmann S, 2010, JOVE-J VIS EXP, DOI [10.3791/1634, DOI 10.3791/1634]; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Huberman AD, 2009, NEURON, V62, P327, DOI 10.1016/j.neuron.2009.04.014; Jakobs TC, 2008, J COMP NEUROL, V510, P221, DOI 10.1002/cne.21795; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Keeley PW, 2007, J COMP NEUROL, V505, P539, DOI 10.1002/cne.21518; Kim IJ, 2008, NATURE, V452, P478, DOI 10.1038/nature06739; Koilkonda RD, 2009, MOL VIS, V15; Koizumi A, 2004, MOL VIS, V10, P328; Koizumi A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000221; Kong JH, 2005, J COMP NEUROL, V489, P293, DOI 10.1002/cne.20631; Kretz A, 2004, J NEUROSCI METH, V136, P207, DOI 10.1016/j.jneumeth.2004.01.012; Lin B, 2008, P NATL ACAD SCI USA, V105, P16009, DOI 10.1073/pnas.0806114105; Lohmann C, 2002, NATURE, V418, P177, DOI 10.1038/nature00850; Lye Ming H, 2007, J Vis Exp, P190, DOI 10.3791/190; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; Petros Timothy J, 2009, J Vis Exp, DOI 10.3791/1333; RODIECK RW, 1991, VISUAL NEUROSCI, V6, P95, DOI 10.1017/S095252380001049X; Ruan GX, 2008, PLOS BIOL, V6, P2248, DOI 10.1371/journal.pbio.0060249; Siegert S, 2009, NAT NEUROSCI, V12, P1197, DOI 10.1038/nn.2370; Sun WZ, 2002, VISUAL NEUROSCI, V19, P483, DOI 10.1017/S0952523802194107; Van Wyk M, 2009, VISUAL NEUROSCI, V26, P297, DOI 10.1017/S0952523809990137; Volgyi B, 2009, J COMP NEUROL, V512, P664, DOI 10.1002/cne.21912; Weng SJ, 2005, J PHYSIOL-LONDON, V562, P915, DOI 10.1113/jphysiol.2004.076695; Xin H, 2007, J NEUROSCI METH, V159, P35, DOI 10.1016/j.jneumeth.2006.06.013; YANG G, 1994, J NEUROSCI, V14, P5267; ZHANG HR, 1994, PROG RETIN EYE RES, V13, P243, DOI 10.1016/1350-9462(94)90012-4	35	26	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12917	10.1371/journal.pone.0012917	http://dx.doi.org/10.1371/journal.pone.0012917			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886064	Green Submitted, Green Published, gold			2022-12-27	WOS:000282091100022
J	Pereira, MJB; Behera, V; Walter, NG				Pereira, Miguel J. B.; Behera, Vivek; Walter, Nils G.			Nondenaturing Purification of Co-Transcriptionally Folded RNA Avoids Common Folding Heterogeneity	PLOS ONE			English	Article							DELTA VIRUS RIBOZYME; NATIVE AFFINITY PURIFICATION; CONFORMATIONAL SWITCH; NONCODING RNAS; SELF-CLEAVAGE; CRYSTALLIZATION; NEUROSPORA; CATALYSIS; SINGLE; CHROMATOGRAPHY	Due to the energetic frustration of RNA folding, tertiary structured RNA is typically characterized by a rugged folding free energy landscape where deep kinetic barriers separate numerous misfolded states from one or more native states. While most in vitro studies of RNA rely on (re) folding chemically and/or enzymatically synthesized RNA in its entirety, which frequently leads into kinetic traps, nature reduces the complexity of the RNA folding problem by segmental, co-transcriptional folding starting from the 59 end. We here have developed a simplified, general, nondenaturing purification protocol for RNA to ask whether avoiding denaturation of a co-transcriptionally folded RNA can reduce commonly observed in vitro folding heterogeneity. Our protocol bypasses the need for large-scale auxiliary protein purification and expensive chromatographic equipment and involves rapid affinity capture with magnetic beads and removal of chemical heterogeneity by cleavage of the target RNA from the beads using the ligand-induced glmS ribozyme. For two disparate model systems, the Varkud satellite (VS) and hepatitis delta virus (HDV) ribozymes, we achieve > 95% conformational purity within one hour of enzymatic transcription, without the need for any folding chaperones. We further demonstrate that in vitro refolding introduces severe conformational heterogeneity into the natively-purified VS ribozyme but not into the compact, double-nested pseudoknot fold of the HDV ribozyme. We conclude that conformational heterogeneity in complex RNAs can be avoided by co-transcriptional folding followed by nondenaturing purification, providing rapid access to chemically and conformationally pure RNA for biologically relevant biochemical and biophysical studies.	[Pereira, Miguel J. B.; Behera, Vivek; Walter, Nils G.] Univ Michigan, Dept Chem, Single Mol Anal Grp, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Pereira, MJB (corresponding author), NYU, Dept Chem, New York, NY 10003 USA.	nwalter@umich.edu	Walter, Nils G/G-7504-2016; Walter, Nils/P-3163-2019	Walter, Nils G/0000-0002-7301-1275; Walter, Nils/0000-0002-7301-1275; Behera, Vivek/0000-0001-6013-5706	American Chemical Society PRF [43875-AC4]; National Institutes of Health [GM062357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062357] Funding Source: NIH RePORTER	American Chemical Society PRF(American Chemical Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was funded by American Chemical Society PRF Grant 43875-AC4 and National Institutes of Health grant GM062357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hashimi HM, 2008, CURR OPIN STRUC BIOL, V18, P321, DOI 10.1016/j.sbi.2008.04.004; Batey RT, 2007, RNA, V13, P1384, DOI 10.1261/rna.528007; Bernacchi S, 2005, J BIOL CHEM, V280, P40112, DOI 10.1074/jbc.M503230200; Bhaskaran H, 2007, NATURE, V449, P1014, DOI 10.1038/nature06235; Cheong HK, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh081; COLLINS RA, 1990, NATURE, V345, P177, DOI 10.1038/345177a0; Ditzler MA, 2008, NUCLEIC ACIDS RES, V36, P7088, DOI 10.1093/nar/gkn871; Doudna Jennifer A., 1997, V74, P365; Ferre-D'Amare AR, 2000, J MOL BIOL, V295, P541, DOI 10.1006/jmbi.1999.3398; Ferre-D'Amare AR, 1998, NATURE, V395, P567, DOI 10.1038/26912; GUO HCT, 1993, J MOL BIOL, V232, P351, DOI 10.1006/jmbi.1993.1395; Harris DA, 2004, J MOL BIOL, V341, P389, DOI 10.1016/j.jmb.2004.05.074; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hodak JH, 2005, P NATL ACAD SCI USA, V102, P10505, DOI 10.1073/pnas.0408645102; Holmberg A, 2005, ELECTROPHORESIS, V26, P501, DOI 10.1002/elps.200410070; Jacquier A, 2009, NAT REV GENET, V10, P833, DOI 10.1038/nrg2683; Ke A, 2007, STRUCTURE, V15, P281, DOI 10.1016/j.str.2007.01.017; Ke AL, 2004, NATURE, V429, P201, DOI 10.1038/nature02522; Kieft JS, 2004, RNA, V10, P988, DOI 10.1261/rna.7040604; Kim I, 2007, RNA, V13, P289, DOI 10.1261/rna.342607; Korennykh AV, 2007, BIOCHEMISTRY-US, V46, P12744, DOI 10.1021/bi700931y; Lipfert J, 2008, STRUCTURE, V16, P1357, DOI 10.1016/j.str.2008.07.007; Lukavsky PJ, 2004, RNA, V10, P889, DOI 10.1261/rna.5264804; Mahen EM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000307; McKenna SA, 2007, NAT PROTOC, V2, P3270, DOI 10.1038/nprot.2007.480; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; OUBRIDGE C, 1995, J MOL BIOL, V249, P409, DOI 10.1006/jmbi.1995.0306; Pereira MJB, 2008, J MOL BIOL, V382, P496, DOI 10.1016/j.jmb.2008.07.020; Russell R, 2008, FRONT BIOSCI-LANDMRK, V13, P1, DOI 10.2741/2557; SAVILLE BJ, 1990, CELL, V61, P685, DOI 10.1016/0092-8674(90)90480-3; Solomatin SV, 2010, NATURE, V463, P681, DOI 10.1038/nature08717; Tinsley RA, 2007, RNA, V13, P468, DOI 10.1261/rna.341807; UHLENBECK OC, 1995, RNA, V1, P4; Uhlenbeck OC, 2009, BIOPOLYMERS, V91, P811, DOI 10.1002/bip.21269; Vicens Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006740; WALTER NG, 2009, NONPROTEIN CODING RN; Winkler WC, 2004, NATURE, V428, P281, DOI 10.1038/nature02362; Wong TN, 2007, P NATL ACAD SCI USA, V104, P17995, DOI 10.1073/pnas.0705038104; Zhuang XW, 2002, SCIENCE, V296, P1473, DOI 10.1126/science.1069013	40	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12953	10.1371/journal.pone.0012953	http://dx.doi.org/10.1371/journal.pone.0012953			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886091	Green Published, gold			2022-12-27	WOS:000282091100048
J	Schroder, J; Bailey, J; Conway, T; Zobel, J				Schroeder, Jan; Bailey, James; Conway, Thomas; Zobel, Justin			Reference-Free Validation of Short Read Data	PLOS ONE			English	Article							GENOME	Background: High-throughput DNA sequencing techniques offer the ability to rapidly and cheaply sequence material such as whole genomes. However, the short-read data produced by these techniques can be biased or compromised at several stages in the sequencing process; the sources and properties of some of these biases are not always known. Accurate assessment of bias is required for experimental quality control, genome assembly, and interpretation of coverage results. An additional challenge is that, for new genomes or material from an unidentified source, there may be no reference available against which the reads can be checked. Results: We propose analytical methods for identifying biases in a collection of short reads, without recourse to a reference. These, in conjunction with existing approaches, comprise a methodology that can be used to quantify the quality of a set of reads. Our methods involve use of three different measures: analysis of base calls; analysis of k-mers; and analysis of distributions of k-mers. We apply our methodology to wide range of short read data and show that, surprisingly, strong biases appear to be present. These include gross overrepresentation of some poly-base sequences, per-position biases towards some bases, and apparent preferences for some starting positions over others. Conclusions: The existence of biases in short read data is known, but they appear to be greater and more diverse than identified in previous literature. Statistical analysis of a set of short reads can help identify issues prior to assembly or resequencing, and should help guide chemical or statistical methods for bias rectification.	[Schroeder, Jan; Bailey, James; Zobel, Justin] Univ Melbourne, Dept Comp Sci & Software Engn, Parkville, Vic 3052, Australia; [Schroeder, Jan; Bailey, James; Conway, Thomas; Zobel, Justin] NICTA Victoria Res Lab, Parkville, Vic, Australia	University of Melbourne	Schroder, J (corresponding author), Univ Melbourne, Dept Comp Sci & Software Engn, Parkville, Vic 3052, Australia.	schroder@csse.unimelb.edu.au		SCHROEDER, JAN/0000-0001-5270-0605	Australian Research Council; NICTA Victorian Research Laboratory; Australian Government, Department of Broadband, Communications and the Digital Economy	Australian Research Council(Australian Research Council); NICTA Victorian Research Laboratory(NICTA); Australian Government, Department of Broadband, Communications and the Digital Economy(Australian Government)	This work was supported by the Australian Research Council, and by the NICTA Victorian Research Laboratory. NICTA is funded by the Australian Government as represented by the Department of Broadband, Communications and the Digital Economy and the Australian Research Council through the ICT Centre of Excellence program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chaisson MJ, 2009, GENOME RES, V19, P336, DOI 10.1101/gr.079053.108; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Erlich Y, 2008, NAT METHODS, V5, P679, DOI 10.1038/nmeth.1230; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Hernandez D, 2008, GENOME RES, V18, P802, DOI 10.1101/gr.072033.107; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kircher M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r83; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Qu W, 2009, GENOME RES, V19, P1309, DOI 10.1101/gr.089151.108; Rougemont J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-431; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHRODER J, 2009, BIOINFORMATICS OXFOR; von Bubnoff A, 2008, CELL, V132, P721, DOI 10.1016/j.cell.2008.02.028; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	17	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12681	10.1371/journal.pone.0012681	http://dx.doi.org/10.1371/journal.pone.0012681			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877643	Green Published, Green Submitted, gold			2022-12-27	WOS:000282053100003
J	Silk, JB; Strum, SC				Silk, Joan B.; Strum, Shirley C.			Maternal Condition Does Not Influence Birth Sex Ratios in Anubis Baboons (Papio anubis)	PLOS ONE			English	Article							REPRODUCTION; HYPOTHESIS; PREGNANCY; DOMINANCE; SELECTION; SUCCESS; RANK	Trivers and Willard predicted that when parental condition has differential effects on the fitness of male and female offspring, parents who are in good condition will bias investment toward the sex that benefits most from additional investment. Efforts to test predictions derived from Trivers and Willard's model have had mixed results, perhaps because most studies have relied on proxy measures of parental condition, such as dominance rank. Here, we examine the effects of female baboons condition on birth sex ratios and post-natal investment, based on visual assessments of maternal body condition. We find that local environmental conditions have significant effects on female condition, but maternal condition at conception has no consistent relationship with birth sex ratios. Mothers who are in poorer condition at the time of conception resume cycling significantly later than females who are in better condition, but the sex of their infants has no effect on the time to resumption of cycling. Thus, our findings provide strong evidence that maternal condition influences females' ability to reproduce, but females do not facultatively adjust the sex ratio of their offspring in relation to their dominance rank or current condition.	[Silk, Joan B.] Univ Calif Los Angeles, Dept Anthropol, Los Angeles, CA 90024 USA; [Silk, Joan B.] Univ Calif Los Angeles, Ctr Soc & Genet, Los Angeles, CA 90024 USA; [Strum, Shirley C.] Univ Calif San Diego, Dept Anthropol, San Diego, CA 92103 USA; [Strum, Shirley C.] Uaso Ngiro Baboon Project, Nairobi, Kenya	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California San Diego	Silk, JB (corresponding author), Univ Calif Los Angeles, Dept Anthropol, Los Angeles, CA 90024 USA.	jsilk@anthro.ucla.edu			National Geographic Society; Wildlife Conservation Society; Conservation International; African Conservation Fund (ACF); Dutch Government (DGIS)	National Geographic Society(National Geographic Society); Wildlife Conservation Society; Conservation International; African Conservation Fund (ACF); Dutch Government (DGIS)	National Geographic Society, Wildlife Conservation Society, Conservation International, African Conservation Fund (ACF), and a grant from the Dutch Government (DGIS) provided funding for the research from 1984 to 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts SC, 2006, ANIM BEHAV, V72, P1177, DOI 10.1016/j.anbehav.2006.05.001; Altmann J, 2003, OFFSPRING, P140; Andersen R, 2000, J ANIM ECOL, V69, P672, DOI 10.1046/j.1365-2656.2000.00425.x; BARTON RA, 1992, ANIM BEHAV, V43, P831, DOI 10.1016/S0003-3472(05)80206-4; BARTON RA, 1993, ANIM BEHAV, V46, P791, DOI 10.1006/anbe.1993.1256; BARTON RA, 1992, FOLIA PRIMATOL, V58, P56, DOI 10.1159/000156608; Beehner JC, 2006, BEHAV ECOL, V17, P741, DOI 10.1093/beheco/arl006; Beehner JC, 2006, HORM BEHAV, V49, P688, DOI 10.1016/j.yhbeh.2005.12.016; BERMAN CM, 1988, AM NAT, V131, P307, DOI 10.1086/284792; Brown GR, 2002, P NATL ACAD SCI USA, V99, P11252, DOI 10.1073/pnas.162360599; Cameron EZ, 2004, P ROY SOC B-BIOL SCI, V271, P1723, DOI 10.1098/rspb.2004.2773; Cheney DL, 2004, INT J PRIMATOL, V25, P401, DOI 10.1023/B:IJOP.0000019159.75573.13; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; CLUTTONBROCK TH, 1986, ANIM BEHAV, V34, P460, DOI 10.1016/S0003-3472(86)80115-4; Dittus WPJ, 1998, BEHAV ECOL SOCIOBIOL, V44, P149, DOI 10.1007/s002650050527; KRACKOW S, 1995, BIOL REV, V70, P225, DOI 10.1111/j.1469-185X.1995.tb01066.x; McNaughton SJ., 1979, SERENGETI DYNAMICS E, P46; Plavcan JM, 2001, YEARB PHYS ANTHROPOL, V44, P25, DOI 10.1002/ajpa.10011; Schino G, 2004, BEHAV ECOL, V15, P850, DOI 10.1093/beheco/arh094; Sheldon BC, 2004, AM NAT, V163, P40, DOI 10.1086/381003; SMUTS B, 1989, AM J PRIMATOL, V19, P229, DOI 10.1002/ajp.1350190405; Stearns S.C., 1992, pi; Strum S.C., 1982, International Journal of Primatology, V3, P175, DOI 10.1007/BF02693494; Strum SC, 2005, AM J PRIMATOL, V65, P117, DOI 10.1002/ajp.20103; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; WESTNEY P, 1984, IRAL-INT REV APPL LI, V22, P229; [No title captured], DOI DOI 10.1371/JOURNAL.PONE.0012750	27	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12750	10.1371/journal.pone.0012750	http://dx.doi.org/10.1371/journal.pone.0012750			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877648	Green Published, gold, Green Submitted			2022-12-27	WOS:000282053100006
J	Sun, QX; Jackson, RA; Ng, C; Guy, GR; Sivaraman, J				Sun, Qingxiang; Jackson, Rebecca A.; Ng, Cherlyn; Guy, Graeme R.; Sivaraman, J.			Additional Serine/Threonine Phosphorylation Reduces Binding Affinity but Preserves Interface Topography of Substrate Proteins to the c-Cbl TKB Domain	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; TYROSINE KINASE INHIBITORS; CELL LUNG-CANCER; EGF RECEPTOR; TERMINAL DOMAIN; DOWN-REGULATION; SERINE; ACTIVATION; MUTATIONS; SPROUTY	The E3-ubiquitin ligase, c-Cbl, is a multi-functional scaffolding protein that plays a pivotal role in controlling cell phenotype. As part of the ubiquitination and downregulation process, c-Cbl recognizes targets, such as tyrosine kinases and the Sprouty proteins, by binding to a conserved (NX/R)pY(S/T) XXP motif via its uniquely embedded SH2 domain (TKB domain). We previously outlined the mode of binding between the TKB domain and various substrate peptide motifs, including epidermal growth factor receptor (EGFR) and Sprouty2 (Spry2), and demonstrated that an intrapetidyl hydrogen bond forms between the (pY-1) arginine or (pY-2) asparagine and the phosphorylated tyrosine, which is crucial for binding. Recent reports demonstrated that, under certain types of stimulation, the serine/threonine residues at the pY+1 and/or pY+2 positions within this recognition motif of EGFR and Sprouty2 may be endogenously phosphorylated. Using structural and binding studies, we sought to determine whether this additional phosphorylation could affect the binding of the TKB domain to these peptides and consequently, whether the type of stimulation can dictate the degree to which substrates bind to c-Cbl. Here, we show that additional phosphorylation significantly reduces the binding affinity between the TKB domain and its target proteins, EGFR and Sprouty2, as compared to peptides bearing a single tyrosine phosphorylation. The crystal structure indicates that this is accomplished with minimal changes to the essential intrapeptidyl bond and that the reduced strength of the interaction is due to the charge repulsion between c-Cbl and the additional phosphate group. This obvious reduction in binding affinity, however, indicates that Cbl's interactions with its TKB-centered binding partners may be more favorable in the absence of Ser/Thr phosphorylation, which is stimulation and context specific in vivo. These results demonstrate the importance of understanding the environment in which certain residues are phosphorylated, and the necessity of including this in structural investigations.	[Sun, Qingxiang; Sivaraman, J.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Jackson, Rebecca A.; Ng, Cherlyn; Guy, Graeme R.] Biopolis, Inst Mol & Cell Biol, Singapore, Singapore	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Sun, QX (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	mcbgg@imcb.a-star.edu.sg; dbsjayar@nus.edu.sg	Ng, Cherlyn/AAW-8058-2021; Sivaraman, J/H-8028-2012	Ng, Cherlyn/0000-0001-5816-8744; J, Sivaraman/0000-0001-9781-5326	Biomedical Research Council (BMRC) [BMRC 05/1/21/19/385]; Singapore Millennium Foundation (SMF)	Biomedical Research Council (BMRC)(Agency for Science Technology & Research (A*STAR)); Singapore Millennium Foundation (SMF)(Singapore Millennium Foundation)	This work was supported by the Biomedical Research Council (BMRC) grant (BMRC 05/1/21/19/385). Sun Qingxiang is a graduate student of the National University of Singapore, receiving a Singapore Millennium Foundation (SMF) scholarship (http://www.smf-scholar.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi S, 2009, CARCINOGENESIS, V30, P1544, DOI 10.1093/carcin/bgp166; Bell DW, 2005, J CLIN ONCOL, V23, P8081, DOI 10.1200/JCO.2005.02.7078; Chiang SH, 2001, NATURE, V410, P944, DOI 10.1038/35073608; COUNTAWAY JL, 1992, J BIOL CHEM, V267, P1129; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dikic I, 2003, BIOCHEM SOC T, V31, P1178; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feinmesser RL, 1999, J BIOL CHEM, V274, P16168, DOI 10.1074/jbc.274.23.16168; Fong CW, 2003, J BIOL CHEM, V278, P33456, DOI 10.1074/jbc.M301317200; GAMOU S, 1994, J CELL PHYSIOL, V158, P151, DOI 10.1002/jcp.1041580119; GAMOU S, 1995, FEBS LETT, V357, P161, DOI 10.1016/0014-5793(94)01335-X; Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.198; Guy GR, 2009, J ENDOCRINOL, V203, P191, DOI 10.1677/JOE-09-0110; HEISERMANN GJ, 1988, J BIOL CHEM, V263, P13152; Hu JJ, 2005, J BIOL CHEM, V280, P18943, DOI 10.1074/jbc.M414157200; KASHLES O, 1988, P NATL ACAD SCI USA, V85, P9567, DOI 10.1073/pnas.85.24.9567; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lupher ML, 1997, J BIOL CHEM, V272, P33140, DOI 10.1074/jbc.272.52.33140; Meng WY, 1999, NATURE, V398, P84, DOI 10.1038/18050; Miin Wong Esther Sook, 2006, V327, P61; Mitsudomi T, 2007, CANCER SCI, V98, P1817, DOI 10.1111/j.1349-7006.2007.00607.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ng C, 2008, EMBO J, V27, P804, DOI 10.1038/emboj.2008.18; Nishimura M, 2009, MOL CELL BIOL, V29, P5529, DOI 10.1128/MCB.00375-09; Oksvold MP, 2003, ONCOGENE, V22, P8509, DOI 10.1038/sj.onc.1207117; Oksvold MP, 2004, RADIAT RES, V161, P685, DOI 10.1667/RR3185; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peschard P, 2004, J BIOL CHEM, V279, P29565, DOI 10.1074/jbc.M403954200; Rubin C, 2003, CURR BIOL, V13, P297, DOI 10.1016/S0960-9822(03)00053-8; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Sweet SMM, 2008, ANAL CHEM, V80, P6650, DOI 10.1021/ac800963a; THEROUX SJ, 1992, MOL ENDOCRINOL, V6, P1849, DOI 10.1210/me.6.11.1849; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Wong ESM, 2002, EMBO J, V21, P4796, DOI 10.1093/emboj/cdf493; Wong ESM, 2001, J BIOL CHEM, V276, P5866, DOI 10.1074/jbc.M006945200; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1443, DOI 10.1021/bi00379a035; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1434, DOI 10.1021/bi00379a034	40	16	17	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12819	10.1371/journal.pone.0012819	http://dx.doi.org/10.1371/journal.pone.0012819			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877636	Green Published, Green Submitted, gold			2022-12-27	WOS:000282053100012
J	Booker, KS; Schwarz, J; Garrett, MB; Jones, AM				Booker, Katherine S.; Schwarz, John; Garrett, Michelle B.; Jones, Alan M.			Glucose Attenuation of Auxin-Mediated Bimodality in Lateral Root Formation Is Partly Coupled by the Heterotrimeric G Protein Complex	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; CELL ELONGATION; TRANSPORT; REGULATOR; SUGAR; ORGANOGENESIS; ORGANIZATION; INITIATION; INDUCTION; EMERGENCE	Background: Auxin and glucose are both essential elements in normal root development. The heterotrimeric G protein complex in Arabidopsis thaliana, defined as containing alpha (AtGPA1), beta (AGB1), and gamma (AGG) subunits and a GTPase accelerating protein called Regulator of G Signaling 1 protein (AtRGS1), are involved in glucose signaling and regulate auxin transport. Methodology/Principal Findings: A systems approach was used to show that formation of lateral roots, a process requiring coordinated cell division followed by targeted cell expansion, involves a signaling interaction between glucose and auxin. We dissected the relationship between auxin and glucose action using lateral root formation as the biological context. We found that auxin and glucose act synergistically to yield a complex output involving both stimulatory and antagonist glucose effects on auxin responsiveness. Auxin-induced, lateral-root formation becomes bimodal with regard to auxin dose in the presence of glucose. This bimodality is mediated, in part, by the G protein complex defined above. Conclusion/Significance: Auxin and glucose are essential signals controlling the rate of cell proliferation and expansion in roots. Auxin promotes the formation of lateral roots and is consequently essential for proper root architecture. Glucose affects the activation state of the heterotrimeric G protein complex which regulates auxin distribution in the root. The bimodality of auxin-induced, lateral-root formation becomes prominent in the presence of glucose and in roots lacking the G protein complex. Bimodality is apparent without added glucose in all loss-of-function mutants for these G protein components, suggesting that the heterotrimeric G protein complex attenuates the bimodality and that glucose inhibits this attenuation through the complex. The bimodality can be further resolved into the processes of lateral root primordia formation and lateral root emergence, from which a model integrating these signals is proposed.	[Booker, Katherine S.; Garrett, Michelle B.; Jones, Alan M.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA; [Schwarz, John] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Jones, Alan M.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Booker, KS (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA.	alan_jones@unc.edu			NIGMS [R01GM065989]; DOE [DE-FG02-05er15671]; NSF [MCB-0723515, MCB-0718202]; UNC; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065989] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); UNC(Secretaria de Ciencia y Tecnologia (SECYT)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the NIGMS (R01GM065989), DOE (DE-FG02-05er15671) and NSF (MCB-0723515 and MCB-0718202) to A.M.J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Michael Friedman and the entire 2010 Biology 447 class for technical assistance and the UNC GRC program for support to J.S.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; Bhalerao RP, 2002, PLANT J, V29, P325, DOI 10.1046/j.0960-7412.2001.01217.x; BLATT MR, 1994, PLANT J, V5, P55, DOI 10.1046/j.1365-313X.1994.5010055.x; Casimiro I, 2001, PLANT CELL, V13, P843, DOI 10.1105/tpc.13.4.843; Casimiro I, 2003, TRENDS PLANT SCI, V8, P165, DOI 10.1016/S1360-1385(03)00051-7; Chen JG, 2004, METHOD ENZYMOL, V389, P338; Chen JG, 2003, SCIENCE, V301, P1728, DOI 10.1126/science.1087790; Chen JG, 2001, PLANT J, V28, P607, DOI 10.1046/j.1365-313x.2001.01152.x; Chen JG, 2001, GENE DEV, V15, P902, DOI 10.1101/gad.866201; Chen Y, 2006, PLANT PHYSIOL, V140, P302, DOI 10.1104/pp.105.069872; De Smet I, 2010, P NATL ACAD SCI USA, V107, P2705, DOI 10.1073/pnas.0915001107; Ditengou FA, 2008, P NATL ACAD SCI USA, V105, P18818, DOI 10.1073/pnas.0807814105; DOLAN L, 1993, DEVELOPMENT, V119, P71; Enstone DE, 2001, TREES-STRUCT FUNCT, V15, P98, DOI 10.1007/s004680000079; Forde B, 2001, PLANT SOIL, V232, P51, DOI 10.1023/A:1010329902165; Galvez-Valdivieso G, 2009, PLANT CELL, V21, P2143, DOI 10.1105/tpc.108.061507; Gancedo JM, 2008, FEMS MICROBIOL REV, V32, P673, DOI 10.1111/j.1574-6976.2008.00117.x; Grigston JC, 2008, FEBS LETT, V582, P3577, DOI 10.1016/j.febslet.2008.08.038; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Johnston CA, 2007, P NATL ACAD SCI USA, V104, P17317, DOI 10.1073/pnas.0704751104; Jones AM, 2003, PLANT PHYSIOL, V131, P1623, DOI 10.1104/pp.102.017624; Jones AM, 1998, SCIENCE, V282, P2201, DOI 10.1126/science.282.5397.2201; JONES AM, 1990, PLANT PHYSIOL, V93, P1154, DOI 10.1104/pp.93.3.1154; Malamy JE, 1997, DEVELOPMENT, V124, P33; Mishra BS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004502; MUDAY GK, 1994, PLANT PHYSIOL BIOCH, V32, P193; Mudgil Y, 2009, PLANT CELL, V21, P3591, DOI 10.1105/tpc.109.065557; Okushima Y, 2007, PLANT CELL, V19, P118, DOI 10.1105/tpc.106.047761; Peret B, 2009, J EXP BOT, V60, P3637, DOI 10.1093/jxb/erp232; Peret B, 2009, TRENDS PLANT SCI, V14, P399, DOI 10.1016/j.tplants.2009.05.002; R Core Team, 2020, R LANG ENV STAT COMP; RAYLE DL, 1970, P NATL ACAD SCI USA, V65, P184, DOI 10.1073/pnas.65.1.184; Richter GL, 2009, PLANT PHYSIOL, V151, P1855, DOI 10.1104/pp.109.142448; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Sabina J, 2009, EUKARYOT CELL, V8, P1314, DOI 10.1128/EC.00138-09; Thevelein JM, 2009, MOL BIOL EVOL, V26, P2407, DOI 10.1093/molbev/msp168; Tian QY, 2009, NEW PHYTOL, V184, P918, DOI 10.1111/j.1469-8137.2009.03004.x; Ullah H, 2003, PLANT CELL, V15, P393, DOI 10.1105/tpc.006148; WILSON JW, 1978, PROC R SOC SER B-BIO, V203, P153, DOI 10.1098/rspb.1978.0098; Wu G, 2007, PLANT CELL, V19, P1826, DOI 10.1105/tpc.106.048777; Zolla G, 2010, J EXP BOT, V61, P211, DOI 10.1093/jxb/erp290	41	39	43	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2010	5	9							e12833	10.1371/journal.pone.0012833	http://dx.doi.org/10.1371/journal.pone.0012833			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651XL	20862254	Green Published, gold, Green Submitted			2022-12-27	WOS:000281960800023
J	Becker, M; Siems, WE; Kluge, R; Gembardt, F; Schultheiss, HP; Schirner, M; Walther, T				Becker, Matthias; Siems, Wolf-Eberhard; Kluge, Reinhart; Gembardt, Florian; Schultheiss, Heinz-Peter; Schirner, Michael; Walther, Thomas			New Function for an Old Enzyme: NEP Deficient Mice Develop Late-Onset Obesity	PLOS ONE			English	Article							NEUTRAL ENDOPEPTIDASE INHIBITOR; NATRIURETIC PEPTIDE; FOOD-INTAKE; METABOLIC SYNDROME; PREVENTS OBESITY; CANDOXATRIL; KNOCKOUT; LEPTIN; ENERGY; MOUSE	Background: According to the World Health Organization (WHO) there is a pandemic of obesity with approximately 300 million people being obese. Typically, human obesity has a polygenetic causation. Neutral endopeptidase (NEP), also known as neprilysin, is considered to be one of the key enzymes in the metabolism of many active peptide hormones. Methodology/Principal Findings: An incidental observation in NEP-deficient mice was a late-onset excessive gain in body weight exclusively from a ubiquitous accumulation of fat tissue. In accord with polygenetic human obesity, mice were characterized by deregulation of lipid metabolism, higher blood glucose levels, with impaired glucose tolerance. The key role of NEP in determining body mass was confirmed by the use of the NEP inhibitor candoxatril in wild-type mice that increased body weight due to increased food intake. This is a peripheral and not a central NEP action on the switch for appetite control, since candoxatril cannot cross the blood-brain barrier. Furthermore, we demonstrated that inhibition of NEP in mice with cachexia delayed rapid body weight loss. Thus, lack in NEP activity, genetically or pharmacologically, leads to a gain in body fat. Conclusions/Significance: In the present study, we have identified NEP to be a crucial player in the development of obesity. NEP-deficient mice start to become obese under a normocaloric diet in an age of 6-7 months and thus are an ideal model for the typical human late-onset obesity. Therefore, the described obesity model is an ideal tool for research on development, molecular mechanisms, diagnosis, and therapy of the pandemic obesity.	[Becker, Matthias; Siems, Wolf-Eberhard] Leibniz Inst Mol Pharmacol, Dept Biochem Neurobiol, Berlin, Germany; [Kluge, Reinhart] Deutsch Inst Ernahrungsforsch, Max Rubner Lab, Potsdam, Germany; [Gembardt, Florian] Univ Hull, Ctr Biomed Res, Hull York Med Sch, Kingston Upon Hull HU6 7RX, N Humberside, England; [Gembardt, Florian] Univ Giessen, Dept Expt Cardiol, Giessen, Germany; [Schultheiss, Heinz-Peter] Charite, Dept Cardiol, D-13353 Berlin, Germany; [Schirner, Michael] Mivenion GmbH, Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); University of Hull; University of York - UK; Justus Liebig University Giessen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Becker, M (corresponding author), Leibniz Inst Mol Pharmacol, Dept Biochem Neurobiol, Berlin, Germany.	thomas.walther@hyms.ac.uk	Gembardt, Florian/H-2360-2011	Gembardt, Florian/0000-0003-2739-345X; Becker, Matthias/0000-0001-9965-6648	Deutsche Forschungsgemeinschaft (DFG) [SI-483/8/1-2, SI-483/8/1-3, WA1441/18/1-2, WA1441/18/1-3]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) grant (SI-483/8/1-2 and -3, as well as WA1441/18/1-2 and -3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiels M, 2008, ARTERIOSCL THROM VAS, V28, P1225, DOI 10.1161/ATVBAHA.107.160192; Aust L, 2001, EUR J NUTR, V40, P23, DOI 10.1007/PL00007382; Bell CG, 2005, NAT REV GENET, V6, P221, DOI 10.1038/nrg1556; BEVAN EG, 1992, J HYPERTENS, V10, P607; Chan Dick C, 2004, Am J Cardiovasc Drugs, V4, P227, DOI 10.2165/00129784-200404040-00004; Cummings DE, 2007, J CLIN INVEST, V117, P13, DOI 10.1172/JCI30227; Davidson E, 2009, EXP DIABETES RES, DOI 10.1155/2009/431980; Finer N, 2003, CLIN MED, V3, P23, DOI 10.7861/clinmedicine.3-1-23; Fischer HS, 2002, J MOL NEUROSCI, V18, P129, DOI 10.1385/JMN:18:1-2:129; Freemantle N, 2008, INT J CLIN PRACT, V62, P1391, DOI 10.1111/j.1742-1241.2008.01805.x; Gross V, 2000, J HYPERTENS, V18, P955, DOI 10.1097/00004872-200018070-00018; Harris RBS, 2002, AM J PHYSIOL-REG I, V283, pR1094, DOI 10.1152/ajpregu.00339.2002; Inuzuka M, 2010, ENDOCRINOLOGY, V151, P3633, DOI 10.1210/en.2010-0141; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Jaworski K, 2009, NAT MED, V15, P159, DOI 10.1038/nm.1904; Kaye B, 1997, XENOBIOTICA, V27, P1091, DOI 10.1080/004982597240046; Kuo LE, 2007, NAT MED, V13, P803, DOI 10.1038/nm1611; LU B, 1995, J EXP MED, V181, P2271, DOI 10.1084/jem.181.6.2271; McDowell G, 2000, CARDIOVASC DRUG REV, V18, P259; Miyawaki K, 2002, NAT MED, V8, P738, DOI 10.1038/nm727; *NHS INF CTR, 2008, STAT OB PHYS ACT DIE; Pankow K, 2007, CIRC RES, V101, P875, DOI 10.1161/CIRCRESAHA.107.153585; Pankow K, 2009, J MOL BIOL, V393, P496, DOI 10.1016/j.jmb.2009.08.025; Poritsanos NJ, 2009, INT J OBESITY, V33, P1381, DOI 10.1038/ijo.2009.187; Powell DR, 2006, OBES REV, V7, P89, DOI 10.1111/j.1467-789X.2006.00220.x; RIVIERE PJM, 1987, LIFE SCI, V41, P333, DOI 10.1016/0024-3205(87)90157-3; Roth J, 2004, OBES RES, V12, p88S, DOI 10.1038/oby.2004.273; Scholzen TE, 2004, EXP DERMATOL, V13, P22, DOI 10.1111/j.1600-0625.2004.00260.x; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Shirakami A, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740309; Siems WE, 2000, EUR J PHARMACOL, V397, P327, DOI 10.1016/S0014-2999(00)00222-3; Sturiale S, 1999, P NATL ACAD SCI USA, V96, P11653, DOI 10.1073/pnas.96.20.11653; Turner AJ, 2007, INT REV NEUROBIOL, V82, P113, DOI 10.1016/S0074-7742(07)82006-X; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Walther T, 2004, BIOL CHEM, V385, P179, DOI 10.1515/BC.2004.036; Walther T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004590; Winkler A, 1998, BBA-MOL BASIS DIS, V1406, P219, DOI 10.1016/S0925-4439(97)00041-0; Zemel MB, 2000, NUTR REV, V58, P177, DOI 10.1111/j.1753-4887.2000.tb01857.x	38	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2010	5	9							e12793	10.1371/journal.pone.0012793	http://dx.doi.org/10.1371/journal.pone.0012793			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650QH	20862277	gold, Green Submitted, Green Published			2022-12-27	WOS:000281864100023
J	Lingappa, JR; Hughes, JP; Wang, RS; Baeten, JM; Celum, C; Gray, GE; Stevens, WS; Donnell, D; Campbell, MS; Farquhar, C; Essex, M; Mullins, JI; Coombs, RW; Rees, H; Corey, L; Wald, A				Lingappa, Jairam R.; Hughes, James P.; Wang, Richard S.; Baeten, Jared M.; Celum, Connie; Gray, Glenda E.; Stevens, Wendy S.; Donnell, Deborah; Campbell, Mary S.; Farquhar, Carey; Essex, M.; Mullins, James I.; Coombs, Robert W.; Rees, Helen; Corey, Lawrence; Wald, Anna		Partners Prevention HSV HIV Transm	Estimating the Impact of Plasma HIV-1 RNA Reductions on Heterosexual HIV-1 Transmission Risk	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; PLACEBO-CONTROLLED TRIAL; VIRAL LOAD; DISEASE PROGRESSION; SOUTH-AFRICA; DOUBLE-BLIND; INFECTION; THERAPY; ACYCLOVIR; WOMEN	Background: The risk of sexual transmission of HIV-1 is strongly associated with the level of HIV-1 RNA in plasma making reduction in HIV-1 plasma levels an important target for HIV-1 prevention interventions. A quantitative understanding of the relationship of plasma HIV-1 RNA and HIV-1 transmission risk could help predict the impact of candidate HIV-1 prevention interventions that operate by reducing plasma HIV-1 levels, such as antiretroviral therapy (ART), therapeutic vaccines, and other non-ART interventions. Methodology/Principal Findings: We use prospective data collected from 2004 to 2008 in East and Southern African HIV-1 serodiscordant couples to model the relationship of plasma HIV-1 RNA levels and heterosexual transmission risk with confirmation of HIV-1 transmission events by HIV-1 sequencing. The model is based on follow-up of 3381 HIV-1 serodiscordant couples over 5017 person-years encompassing 108 genetically-linked HIV-1 transmission events. HIV-1 transmission risk was 2.27 per 100 person-years with a log-linear relationship to log(10) plasma HIV-1 RNA. The model predicts that a decrease in average plasma HIV-1 RNA of 0.74 log(10) copies/mL (95% CI 0.60 to 0.97) reduces heterosexual transmission risk by 50%, regardless of the average starting plasma HIV-1 level in the population and independent of other HIV-1-related population characteristics. In a simulated population with a similar plasma HIV-1 RNA distribution the model estimates that 90% of overall HIV-1 infections averted by a 0.74 copies/mL reduction in plasma HIV-1 RNA could be achieved by targeting this reduction to the 58% of the cohort with plasma HIV-1 levels >= 4 log10 copies/mL. Conclusions/Significance: This log-linear model of plasma HIV-1 levels and risk of sexual HIV-1 transmission may help estimate the impact on HIV-1 transmission and infections averted from candidate interventions that reduce plasma HIV-1 RNA levels.	[Lingappa, Jairam R.; Wang, Richard S.; Baeten, Jared M.; Celum, Connie; Campbell, Mary S.; Farquhar, Carey; Mullins, James I.; Coombs, Robert W.; Corey, Lawrence; Wald, Anna] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Lingappa, Jairam R.; Baeten, Jared M.; Celum, Connie; Campbell, Mary S.; Farquhar, Carey; Mullins, James I.; Coombs, Robert W.; Corey, Lawrence; Wald, Anna] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Lingappa, Jairam R.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Hughes, James P.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Baeten, Jared M.; Celum, Connie; Farquhar, Carey; Wald, Anna] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Gray, Glenda E.] Univ Witwatersrand, Perinatal HIV Res Unit, Johannesburg, South Africa; [Stevens, Wendy S.] Univ Witwatersrand, Dept Mol Med & Haematol, Johannesburg, South Africa; [Stevens, Wendy S.] Univ Witwatersrand, Natl Hlth Lab Serv, Johannesburg, South Africa; [Donnell, Deborah] Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS, Seattle, WA 98104 USA; [Donnell, Deborah; Corey, Lawrence; Wald, Anna] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Essex, M.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Mullins, James I.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Mullins, James I.; Coombs, Robert W.; Corey, Lawrence; Wald, Anna] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Rees, Helen] Univ Witwatersrand, Reprod Hlth & HIV Res Unit, Johannesburg, South Africa	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Witwatersrand; University of Witwatersrand; National Health Laboratory Service; University of Witwatersrand; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Harvard University; Harvard T.H. Chan School of Public Health; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Witwatersrand	Lingappa, JR (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	lingappa@uw.edu	Wald, Anna/B-6272-2012; Corey, Lawrence/AAE-1796-2020; Lingappa, Jairam/N-7760-2017	Wald, Anna/0000-0003-3486-6438; Corey, Lawrence/0000-0002-2179-2436; Rees, Helen/0000-0003-1442-6734; Were, Edwin/0000-0002-4783-0795; Kapiga, Saidi/0000-0003-1753-4060; Donnell, Deborah/0000-0002-0587-7480	Bill and Melinda Gates Foundation [26469]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757, P01AI057005] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by a research grant from the Bill and Melinda Gates Foundation (grant ID #26469), http://www.gatesfoundation.org/Pages/home. aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeten JM, 2008, J INFECT DIS, V198, P1804, DOI 10.1086/593214; Baggaley RF, 2009, AIDS, V23, P1005, DOI 10.1097/QAD.0b013e32832aadf2; CAMPBELL M, 2009, 5 INT AIDS SOC C HIV; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; Cohen MS, 2008, J CLIN INVEST, V118, P1244, DOI 10.1172/JCI34706; Collier AC, 1996, NEW ENGL J MED, V334, P1011, DOI 10.1056/NEJM199604183341602; Corey L, 2004, JAIDS-J ACQ IMM DEF, V35, P435, DOI 10.1097/00126334-200404150-00001; Delany S, 2009, AIDS, V23, P461, DOI 10.1097/QAD.0b013e32831db217; DONNELL D, 2010, ART RISK HETEROSEXUA; Dunne EF, 2008, JAIDS-J ACQ IMM DEF, V49, P77, DOI 10.1097/QAI.0b013e3181831832; Fideli OS, 2001, AIDS RES HUM RETROV, V17, P901, DOI 10.1089/088922201750290023; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Gray RH, 2004, J INFECT DIS, V189, P1209, DOI 10.1086/382750; Gurunathan S, 2009, VACCINE, V27, P1997, DOI 10.1016/j.vaccine.2009.01.039; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; MARKOWITZ M, 1995, NEW ENGL J MED, V333, P1534, DOI 10.1056/NEJM199512073332304; Modjarrad K, 2008, AIDS, V22, P2179, DOI 10.1097/QAD.0b013e328312c756; Modjarrad K, 2010, LANCET INFECT DIS, V10, P455, DOI 10.1016/S1473-3099(10)70093-1; Nagot N, 2007, NEW ENGL J MED, V356, P790, DOI 10.1056/NEJMoa062607; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Stevens WS, 2010, J INFECT DIS, V201, pS78, DOI 10.1086/650383; Walson JL, 2008, AIDS, V22, P1601, DOI 10.1097/QAD.0b013e32830a502e; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Zuckerman RA, 2007, J INFECT DIS, V196, P1500, DOI 10.1086/522523	24	101	103	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2010	5	9							e12598	10.1371/journal.pone.0012598	http://dx.doi.org/10.1371/journal.pone.0012598			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648ZZ	20856886	Green Published, Green Submitted, gold			2022-12-27	WOS:000281735700005
J	Le Saout, C; Villard, M; Cabasse, C; Jacquet, C; Taylor, N; Hernandez, J				Le Saout, Cecile; Villard, Marine; Cabasse, Clemence; Jacquet, Chantal; Taylor, Naomi; Hernandez, Javier			IL-2 Mediates CD4(+) T Cell Help in the Breakdown of Memory-Like CD8(+) T Cell Tolerance under Lymphopenic Conditions	PLOS ONE			English	Article							HOMEOSTATIC PROLIFERATION; CUTTING EDGE; PERIPHERAL TOLERANCE; IN-VIVO; AUTOIMMUNE-DISEASE; TCR REPERTOIRE; INTERLEUKIN-2; LYMPHOCYTES; NAIVE; SELF	Background: Lymphopenia results in the proliferation and differentiation of naive T cells into memory-like cells in the apparent absence of antigenic stimulation. This response, at least in part due to a greater availability of cytokines, is thought to promote anti-self responses. Although potentially autoreactive memory-like CD8(+) T cells generated in a lymphopenic environment are subject to the mechanisms of peripheral tolerance, they can induce autoimmunity in the presence of antigen-specific memory-like CD4(+) T helper cells. Methodology/Principal Findings: Here, we studied the mechanisms underlying CD4 help under lymphopenic conditions in transgenic mice expressing a model antigen in the beta cells of the pancreas. Surprisingly, we found that the self-reactivity mediated by the cooperation of memory-like CD8(+) and CD4(+) T cells was not abrogated by CD40L blockade. In contrast, treatment with anti-IL-2 antibodies inhibited the onset of autoimmunity. IL-2 neutralization prevented the CD4-mediated differentiation of memory-like CD8(+) T cells into pathogenic effectors in response to self-antigen cross-presentation. Furthermore, in the absence of helper cells, induction of IL-2 signaling by an IL-2 immune complex was sufficient to promote memory-like CD8(+) T cell self-reactivity. Conclusions/Significance: IL-2 mediates the cooperation of memory-like CD4(+) and CD8(+) T cells in the breakdown of crosstolerance, resulting in effector cytotoxic T lymphocyte differentiation and the induction of autoimmune disease.	[Le Saout, Cecile] Univ Montpellier 2, Inst Genet Mol Montpellier, UMR 5535, CNRS, Montpellier, France; Univ Montpellier 1, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier	Le Saout, C (corresponding author), Univ Montpellier 2, Inst Genet Mol Montpellier, UMR 5535, CNRS, Montpellier, France.	javier.hernandez@igmm.cnrs.fr	Taylor, Naomi/H-4016-2014	Hernandez, Javier/0000-0002-7218-7519; VILLARD, Marine/0000-0002-3905-8993	European Community [SOE1/P1/E014, 2005-018914]	European Community(European Commission)	CL was supported by the Association pour la Recherche contre le Cancer and IMMUNONET. MV is supported by the Ministere de l'Enseignement Superieur et de la Recherche. NT is supported by Inserm and a Contrat d' interface with the Centre Hospitalier Universitaire (C.H.U.) d'Amiens. JH is supported by Inserm and a Contrat d'interface with the C. H. U. de Montellier. This work was supported by grants from the European Community SUDOE- FEDER (Contract # IMMUNONET SOE1/P1/E014), Association pour la Recherche contre le Cancer and the Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques to JH and the European Community (contract LSHC-CT-2005-018914 ATTACK) to NT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahonen CL, 2004, J EXP MED, V199, P775, DOI 10.1084/jem.20031591; Bachmann MF, 2007, EUR J IMMUNOL, V37, P1502, DOI 10.1002/eji.200637023; Behrens GMN, 2004, J IMMUNOL, V172, P5420, DOI 10.4049/jimmunol.172.9.5420; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Brode S, 2006, J IMMUNOL, V177, P6603, DOI 10.4049/jimmunol.177.10.6603; Calzascia T, 2008, P NATL ACAD SCI USA, V105, P2999, DOI 10.1073/pnas.0712135105; Castellino F, 2006, ANNU REV IMMUNOL, V24, P519, DOI 10.1146/annurev.immunol.23.021704.115825; Cheung KP, 2009, J IMMUNOL, V183, P3364, DOI 10.4049/jimmunol.0900641; Cho BK, 2000, J EXP MED, V192, P549, DOI 10.1084/jem.192.4.549; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Dummer W, 2002, J CLIN INVEST, V110, P185, DOI 10.1172/JCI200215175; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Gleeson PA, 1996, IMMUNOL REV, V149, P97, DOI 10.1111/j.1600-065X.1996.tb00901.x; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; Goldrath AW, 2000, J EXP MED, V192, P557, DOI 10.1084/jem.192.4.557; GUILLOUX Y, 1994, EUR J IMMUNOL, V24, P1966, DOI 10.1002/eji.1830240905; Hamilton SE, 2008, P NATL ACAD SCI USA, V105, P18484, DOI 10.1073/pnas.0806487105; Hamilton SE, 2006, NAT IMMUNOL, V7, P475, DOI 10.1038/ni1326; Hernandez J, 2000, J IMMUNOL, V164, P596, DOI 10.4049/jimmunol.164.2.596; Hernandez J, 2002, J EXP MED, V196, P323, DOI 10.1084/jem.20011612; Janas ML, 2005, J IMMUNOL, V175, P8003, DOI 10.4049/jimmunol.175.12.8003; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Kamimura D, 2006, J IMMUNOL, V177, P306, DOI 10.4049/jimmunol.177.1.306; KEENE JA, 1982, J EXP MED, V155, P768, DOI 10.1084/jem.155.3.768; Khoruts A, 2005, IMMUNOL LETT, V98, P23, DOI 10.1016/j.imlet.2004.10.022; Kieper WC, 2005, J IMMUNOL, V174, P3158, DOI 10.4049/jimmunol.174.6.3158; Kieper WC, 1999, P NATL ACAD SCI USA, V96, P13306, DOI 10.1073/pnas.96.23.13306; Knoechel B, 2005, J EXP MED, V202, P1375, DOI 10.1084/jem.20050855; KUNDIG TM, 1993, SCIENCE, V262, P1059, DOI 10.1126/science.8235625; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978; Le Bon A, 2006, J IMMUNOL, V176, P4682, DOI 10.4049/jimmunol.176.8.4682; Le Saout C, 2008, P NATL ACAD SCI USA, V105, P19414, DOI 10.1073/pnas.0807743105; LO D, 1992, EUR J IMMUNOL, V22, P1013, DOI 10.1002/eji.1830220421; Lu ZB, 2000, J EXP MED, V191, P541, DOI 10.1084/jem.191.3.541; Malek TR, 2004, NAT REV IMMUNOL, V4, P665, DOI 10.1038/nri1435; McHugh RS, 2002, J IMMUNOL, V168, P5979, DOI 10.4049/jimmunol.168.12.5979; Morgan DJ, 1996, J IMMUNOL, V157, P978; Murali-Krishna K, 2000, J IMMUNOL, V165, P1733, DOI 10.4049/jimmunol.165.4.1733; NOELLE RJ, 1992, P NATL ACAD SCI USA, V89, P6550, DOI 10.1073/pnas.89.14.6550; Obar JJ, 2010, P NATL ACAD SCI USA, V107, P193, DOI 10.1073/pnas.0909945107; Ohashi PS, 2002, NAT REV IMMUNOL, V2, P427, DOI 10.1038/nri822; Paulos CM, 2007, J CLIN INVEST, V117, P2197, DOI 10.1172/JCI32205; Phelan JD, 2008, J IMMUNOL, V180, P44, DOI 10.4049/jimmunol.180.1.44; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Prlic M, 2001, J IMMUNOL, V167, P5664, DOI 10.4049/jimmunol.167.10.5664; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Redmond WL, 2005, IMMUNITY, V22, P275, DOI 10.1016/j.immuni.2005.01.010; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Schildknecht A, 2010, P NATL ACAD SCI USA, V107, P199, DOI 10.1073/pnas.0910620107; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; SCOTT B, 1994, IMMUNITY, V1, P73, DOI 10.1016/1074-7613(94)90011-6; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Staveley-O'Carroll K, 1998, P NATL ACAD SCI USA, V95, P1178, DOI 10.1073/pnas.95.3.1178; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Verdeil G, 2008, P NATL ACAD SCI USA, V105, P16683, DOI 10.1073/pnas.0805054105; Viret C, 1999, IMMUNITY, V10, P559, DOI 10.1016/S1074-7613(00)80055-2; Waithman J, 2008, J IMMUNOL, V180, P5789, DOI 10.4049/jimmunol.180.9.5789; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Wilson EB, 2008, J IMMUNOL, V181, P7445, DOI 10.4049/jimmunol.181.11.7445; Wu ZH, 2004, NAT MED, V10, P87, DOI 10.1038/nm965	67	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2010	5	9							e12659	10.1371/journal.pone.0012659	http://dx.doi.org/10.1371/journal.pone.0012659			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IX	20856822	Green Published, Green Submitted, gold			2022-12-27	WOS:000281687300006
J	Briefer, E; Rybak, F; Aubin, T				Briefer, Elodie; Rybak, Fanny; Aubin, Thierry			Are Unfamiliar Neighbours Considered to Be Dear-Enemies?	PLOS ONE			English	Article							STRANGER DISCRIMINATION; SONG; RECOGNITION; SIGNATURE	Background: Discriminating threatening individuals from non-threatening ones allow territory owners to modulate their territorial responses according to the threat posed by each intruder. This ability reduces costs associated with territorial defence. Reduced aggression towards familiar adjacent neighbours, termed the dear-enemy effect, has been shown in numerous species. An important question that has never been investigated is whether territory owners perceive distant neighbours established in the same group as strangers because of their unfamiliarity, or as dear-enemies because of their group membership. Methodology/Principal Findings: To investigate this question, we played back to male skylarks (Alauda arvensis) songs of adjacent neighbours, distant neighbours established a few territories away in the same microdialect area and strangers. Additionally, we carried out a propagation experiment to investigate how far skylark songs are propagated in their natural habitat and we estimated repertoire similarity between adjacent neighbours, distant neighbours and strangers. We show that skylarks, in the field, respond less aggressively to songs of their distant and likely unfamiliar neighbours, as shown by the propagation experiment, compared to stranger songs. The song analysis revealed that individuals share a high amount of syllables and sequences with both their adjacent and distant neighbours, but only few syllables and no sequences with strangers. Conclusions: The observed reduction of aggression between distant neighbours thus probably results from their familiarity with the vocal group signature shared by all members of the neighbourhood. Therefore, in skylarks, dear-enemy-like relationships can be established between unfamiliar individuals who share a common acoustic code.	[Briefer, Elodie; Rybak, Fanny; Aubin, Thierry] Univ Paris 11, CNRS, UMR 8195, CNPS, F-91405 Orsay, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite Jean Monnet	Briefer, E (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London, England.	e.briefer@qmul.ac.uk	Briefer, Elodie/A-3584-2010		Centre National de la Recherche Scientifique; Universite Paris Sud; French Minister of Research and Technology	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Paris Sud; French Minister of Research and Technology	This study was supported by the Centre National de la Recherche Scientifique (http://www.cnrs.fr/index.php) - Universite Paris Sud (http://www.u-psud.fr/en/index.html). Elodie Briefer was funded by a French Minister of Research and Technology (http://www.enseignementsup-recherche.gouv.fr/) fellowship during the data collection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUBIN T, 1983, Z TIERPSYCHOL, V61, P141; Baker MC, 2004, ETHOLOGY, V110, P21, DOI 10.1046/j.1439-0310.2003.00941.x; Botero CA, 2008, ETHOLOGY, V114, P1227, DOI 10.1111/j.1439-0310.2008.01576.x; Botero CA, 2007, ANIM BEHAV, V73, P661, DOI 10.1016/j.anbehav.2006.10.007; Briefer E, 2008, ANIM BEHAV, V76, P1319, DOI 10.1016/j.anbehav.2008.06.017; Briefer E, 2008, J EXP BIOL, V211, P317, DOI 10.1242/jeb.013359; Briefer E, 2010, J THEOR BIOL, V262, P151, DOI 10.1016/j.jtbi.2009.09.020; Briefer E, 2009, NATURWISSENSCHAFTEN, V96, P1067, DOI 10.1007/s00114-009-0567-0; BRINDLEY EL, 1991, ANIM BEHAV, V41, P503, DOI 10.1016/S0003-3472(05)80853-X; CRAIG C, 2000, GOLDWAVE V 5 11 GOLD; DONALD PF, 2004, SKYLARK, P72; Gentner TQ, 2000, J NEUROBIOL, V42, P117, DOI 10.1002/(SICI)1097-4695(200001)42:1<117::AID-NEU11>3.0.CO;2-M; Gentner TQ, 2000, J ACOUST SOC AM, V107, P3369, DOI 10.1121/1.429408; Hausberger Martine, 1997, P128, DOI 10.1017/CBO9780511758843.008; HULTSCH H, 1981, BEHAV ECOL SOCIOBIOL, V8, P183, DOI 10.1007/BF00299828; Khanna H., 1997, Bioacoustics, V7, P209; Lambrechts Marcel M., 1995, Current Ornithology, V12, P115; Lehongre K, 2008, ETHOLOGY, V114, P425, DOI 10.1111/j.1439-0310.2008.01486.x; MAMMEN DL, 1981, BEHAV ECOL SOCIOBIOL, V9, P179, DOI 10.1007/BF00302935; MANTEL N, 1967, CANCER RES, V27, P209; MCGREGOR PK, 1992, NATO ADV SCI I A-LIF, V228, P1; Mundinger P. C., 1982, ACOUSTIC COMMUNICATI, P147; Mundry R, 1999, ANIM BEHAV, V58, P1143, DOI 10.1006/anbe.1999.1246; Naguib M, 1998, J AVIAN BIOL, V29, P155, DOI 10.2307/3677193; Naguib Marc, 2006, P300; R- Development-Core-Team, 2009, R FDN STAT COMP; Radford AN, 2005, ANIM BEHAV, V70, P1227, DOI 10.1016/j.anbehav.2005.04.002; Skierczynski M, 2010, BEHAVIOUR, V147, P333, DOI 10.1163/000579509X12549112908535; Sokal R.R., 2012, BIOMETRY; SPECHT R, 2004, AVISOFT SASLAB PRO V; SPECHT R, 2001, AVISOFT CORRELATOR V; Stoddard Philip Kraft, 1996, P356; STODDARD PK, 1991, BEHAV ECOL SOCIOBIOL, V29, P211, DOI 10.1007/BF00166403; Sueur J, 2008, BIOACOUSTICS, V18, P213, DOI 10.1080/09524622.2008.9753600; TEMELES EJ, 1994, ANIM BEHAV, V47, P339, DOI 10.1006/anbe.1994.1047; WEARY DM, 1992, ANIM BEHAV, V43, P283, DOI 10.1016/S0003-3472(05)80223-4; Wilson PL, 2001, ANIM BEHAV, V62, P1197, DOI 10.1006/anbe.2001.1863	37	15	15	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12428	10.1371/journal.pone.0012428	http://dx.doi.org/10.1371/journal.pone.0012428			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865148	Green Submitted, Green Published, gold			2022-12-27	WOS:000281292100023
J	Amini-Nik, S; Kraemer, D; Cowan, ML; Gunaratne, K; Nadesan, P; Alman, BA; Miller, RJD				Amini-Nik, Saeid; Kraemer, Darren; Cowan, Michael L.; Gunaratne, Keith; Nadesan, Puviindran; Alman, Benjamin A.; Miller, R. J. Dwayne			Ultrafast Mid-IR Laser Scalpel: Protein Signals of the Fundamental Limits to Minimally Invasive Surgery	PLOS ONE			English	Article							HYPERPLASTIC CUTANEOUS WOUNDS; BETA-CATENIN STABILIZATION; SKIN; REGENERATION; TISSUES	Lasers have in principle the capability to cut at the level of a single cell, the fundamental limit to minimally invasive procedures and restructuring biological tissues. To date, this limit has not been achieved due to collateral damage on the macroscale that arises from thermal and shock wave induced collateral damage of surrounding tissue. Here, we report on a novel concept using a specifically designed Picosecond IR Laser (PIRL) that selectively energizes water molecules in the tissue to drive ablation or cutting process faster than thermal exchange of energy and shock wave propagation, without plasma formation or ionizing radiation effects. The targeted laser process imparts the least amount of energy in the remaining tissue without any of the deleterious photochemical or photothermal effects that accompanies other laser wavelengths and pulse parameters. Full thickness incisional and excisional wounds were generated in CD1 mice using the Picosecond IR Laser, a conventional surgical laser (DELight Er:YAG) or mechanical surgical tools. Transmission and scanning electron microscopy showed that the PIRL laser produced minimal tissue ablation with less damage of surrounding tissues than wounds formed using the other modalities. The width of scars formed by wounds made by the PIRL laser were half that of the scars produced using either a conventional surgical laser or a scalpel. Aniline blue staining showed higher levels of collagen in the early stage of the wounds produced using the PIRL laser, suggesting that these wounds mature faster. There were more viable cells extracted from skin using the PIRL laser, suggesting less cellular damage. beta-catenin and TGF-beta signalling, which are activated during the proliferative phase of wound healing, and whose level of activation correlates with the size of wounds was lower in wounds generated by the PIRL system. Wounds created with the PIRL systsem also showed a lower rate of cell proliferation. Direct comparison of wound healing responses to a conventional surgical laser, and standard mechanical instruments shows far less damage and near absence of scar formation by using PIRL laser. This new laser source appears to have achieved the long held promise of lasers in minimally invasive surgery.	[Amini-Nik, Saeid; Gunaratne, Keith; Nadesan, Puviindran; Alman, Benjamin A.] Univ Toronto, Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Kraemer, Darren; Cowan, Michael L.; Miller, R. J. Dwayne] Univ Toronto, Dept Chem, Toronto, ON M5G 1X8, Canada; [Kraemer, Darren; Cowan, Michael L.; Miller, R. J. Dwayne] Univ Toronto, Dept Phys, Toronto, ON M5G 1X8, Canada; [Kraemer, Darren; Cowan, Michael L.; Miller, R. J. Dwayne] Univ Toronto, Inst Opt Sci, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto	Amini-Nik, S (corresponding author), Univ Toronto, Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada.	dmiller@lphys.chem.utoronto.ca	Nik, Saeid Amini/B-6640-2014	Nik, Saeid Amini/0000-0002-9185-9456	Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council of Canada (NSERC)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Canadian Institutes of Health Research (CIHR) and Natural Sciences and Engineering Research Council of Canada (NSERC) are funding this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashcroft GS, 1997, NAT MED, V3, P1209, DOI 10.1038/nm1197-1209; Cheon S, 2005, LAB INVEST, V85, P416, DOI 10.1038/labinvest.3700237; Cheon SS, 2006, FASEB J, V20, P692, DOI 10.1096/fj.05-4759com; Cheon SS, 2002, P NATL ACAD SCI USA, V99, P6973, DOI 10.1073/pnas.102657399; FitzGibbon G M, 1968, Br J Plast Surg, V21, P226, DOI 10.1016/S0007-1226(68)80028-1; Flanders KC, 2003, AM J PATHOL, V163, P2247, DOI 10.1016/S0002-9440(10)63582-1; FRANJIC K, 2010, DESORPTION IMP UNPUB; Franjic K, 2009, OPT EXPRESS, V17, P22937, DOI 10.1364/OE.17.022937; Girard B, 2007, LASER SURG MED, V39, P273, DOI 10.1002/lsm.20466; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Muro AF, 2003, J CELL BIOL, V162, P149, DOI 10.1083/jcb.200212079; Paltauf G, 2003, CHEM REV, V103, P487, DOI 10.1021/cr010436c; Sakimoto T, 2006, LANCET, V367, P1432, DOI 10.1016/S0140-6736(06)68275-5; Sanders DL, 2000, LASER SURG MED, V26, P22, DOI 10.1002/(SICI)1096-9101(2000)26:1<22::AID-LSM5>3.0.CO;2-R; SOLON LR, 1961, SCIENCE, V134, P1506, DOI 10.1126/science.134.3489.1506; Wadman M, 2005, NATURE, V436, P1079, DOI 10.1038/4361079a	17	130	135	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2010	5	9							e13053	10.1371/journal.pone.0013053	http://dx.doi.org/10.1371/journal.pone.0013053			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654ZQ	20927391	gold, Green Submitted, Green Published			2022-12-27	WOS:000282210700022
J	Wong, TKF; Lam, TW; Sung, WK; Yiu, SM				Wong, Thomas K. F.; Lam, Tak-Wah; Sung, Wing-Kin; Yiu, Siu-Ming			Adjacent Nucleotide Dependence in ncRNA and Order-1 SCFG for ncRNA Identification	PLOS ONE			English	Article							RNA GENES; SEQUENCE; HELICES	Background: Non-coding RNAs (ncRNAs) are known to be involved in many critical biological processes, and identification of ncRNAs is an important task in biological research. A popular software, Infernal, is the most successful prediction tool and exhibits high sensitivity. The application of Infernal has been mainly focused on small suspected regions. We tried to apply Infernal on a chromosome level; the results have high sensitivity, yet contain many false positives. Further enhancing Infernal for chromosome level or genome wide study is desirable. Methodology: Based on the conjecture that adjacent nucleotide dependence affects the stability of the secondary structure of an ncRNA, we first conduct a systematic study on human ncRNAs and find that adjacent nucleotide dependence in human ncRNA should be useful for identifying ncRNAs. We then incorporate this dependence in the SCFG model and develop a new order-1 SCFG model for identifying ncRNAs. Conclusions: With respect to our experiments on human chromosomes, the proposed new model can eliminate more than 50% false positives reported by Infernal while maintaining the same sensitivity. The executable and the source code of programs are freely available at http://i.cs.hku.hk/similar to kfwong/order1scfg.	[Wong, Thomas K. F.; Lam, Tak-Wah; Yiu, Siu-Ming] Univ Hong Kong, Dept Comp Sci, Hong Kong, Hong Kong, Peoples R China; [Sung, Wing-Kin] Natl Univ Singapore, Sch Comp, Singapore 117548, Singapore	University of Hong Kong; National University of Singapore	Wong, TKF (corresponding author), Univ Hong Kong, Dept Comp Sci, Hong Kong, Hong Kong, Peoples R China.	kfwong@cs.hku.hk	Wong, Thomas/J-7623-2013; Yiu, Siu Ming/C-1843-2009	Wong, Thomas/0000-0002-0580-6324; Yiu, Siu Ming/0000-0002-3975-8500; Lam, Tak-Wah/0000-0003-4676-8587; Sung, Wing-Kin/0000-0001-7806-7086				BACKOFEN R, 2007, J EXPT ZOOLOGY B, V38, P1; Eddy SR, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-18; EDDY SR, 1994, NUCLEIC ACIDS RES, V22, P2079, DOI 10.1093/nar/22.11.2079; Frank DN, 1998, ANNU REV BIOCHEM, V67, P153, DOI 10.1146/annurev.biochem.67.1.153; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Griffiths-Jones S, 2007, ANNU REV GENOM HUM G, V8, P279, DOI 10.1146/annurev.genom.8.080706.092419; Kim J, 1996, BIOCHEMISTRY-US, V35, P13753, DOI 10.1021/bi960913z; Klein RJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-44; Larsson P, 2008, GENOME RES, V18, P888, DOI 10.1101/gr.069104.107; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Nawrocki EP, 2007, PLOS COMPUT BIOL, V3, P540, DOI 10.1371/journal.pcbi.0030056; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; WALTER AE, 1994, BIOCHEMISTRY-US, V33, P12715, DOI 10.1021/bi00208a024; WASHIETL S, 2004, PNAS, V102, P2454; Wu W, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni115; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575	17	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2010	5	9							e12848	10.1371/journal.pone.0012848	http://dx.doi.org/10.1371/journal.pone.0012848			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654ZQ	20927402	Green Published, gold, Green Submitted			2022-12-27	WOS:000282210700003
J	Iwawaki, T; Akai, R; Kohno, K				Iwawaki, Takao; Akai, Ryoko; Kohno, Kenji			IRE1 alpha Disruption Causes Histological Abnormality of Exocrine Tissues, Increase of Blood Glucose Level, and Decrease of Serum Immunoglobulin Level	PLOS ONE			English	Article							PLASMA-CELL DIFFERENTIATION; ENDOPLASMIC-RETICULUM; TRANSCRIPTION FACTOR; TRANSMEMBRANE PROTEIN; ER STRESS; QUALITY-CONTROL; MESSENGER-RNA; IRE1; KINASE; REQUIRES	Accumulation of unfolded proteins in the endoplasmic reticulum (ER) causes ER stress. As a cellular adaptive response to ER stress, unfolded protein response (UPR) activates molecules for the quality control of ER proteins. One enzyme that plays an important role in UPR is Inositol Requiring Enzyme-1 (IRE1), which is highly conserved from yeast to humans. In particular, mammalian IRE1 alpha activates X-box-binding protein 1 (XBP1) by unconventional splicing of XBP1 mRNA during ER stress. From analysis of knockout mice, both IRE1 alpha and XBP1 have been shown to be essential for development and that XBP1 is necessary for the secretory machinery of exocrine glands, plasma cell differentiation, and hepatic lipogenesis. However, the essentiality of IRE1 alpha in specific organs and tissues remains incompletely understood. Here, we analyzed the phenotype of IRE1 alpha conditional knockout mice and found that IRE1 alpha-deficient mice exhibit mild hypoinsulinemia, hyperglycemia, and a low-weight trend. Moreover, IRE1 alpha disruption causes histological abnormality of the pancreatic acinar and salivary serous tissues and decrease of serum level of immunoglobulin produced in the plasma cells, but not dysfunction of liver. Comparison of this report with previous reports regarding XBP1 conditional knockout mice might provide some clues for the discovery of the novel functions of IRE1 alpha and XBP1. (196 words)	[Iwawaki, Takao; Akai, Ryoko] RIKEN, Iwawaki Initiat Res Unit, Wako, Saitama, Japan; [Iwawaki, Takao] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan; [Kohno, Kenji] Nara Inst Sci & Technol, Lab Mol & Cell Genet, Nara, Japan	RIKEN; Japan Science & Technology Agency (JST); Nara Institute of Science & Technology	Iwawaki, T (corresponding author), RIKEN, Iwawaki Initiat Res Unit, Wako, Saitama, Japan.	iwawaki@riken.jp	Kohno, Kenji/AAZ-6573-2020	Kohno, Kenji/0000-0002-3503-6551; Iwawaki, Takao/0000-0001-8753-1979	Institute of Physical and Chemical Research; Japan Science and Technology Agency; Mochida Memorial Foundation; Suzuken Memorial Foundation; Takeda Science Foundation; Naito Memorial Foundation; Ministry of Education, Culture, Sports, Science and Technology [21790218, 14037240]	Institute of Physical and Chemical Research; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Mochida Memorial Foundation; Suzuken Memorial Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Memorial Foundation(Naito Memorial Foundation); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Institute of Physical and Chemical Research (to T. I.), Japan Science and Technology Agency (to T.I.), the Mochida Memorial Foundation (to T.I.), the Suzuken Memorial Foundation (to T. I.), the Takeda Science Foundation (to T.I.), the Naito Memorial Foundation (to T.I.), and Ministry of Education, Culture, Sports, Science and Technology (No. 21790218 to T. I. and No. 14037240 to K.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Bertolotti A, 2001, J CLIN INVEST, V107, P585, DOI 10.1172/JCI11476; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hosoda A, 2010, BIOCHEM J, V425, P117, DOI 10.1042/BJ20091269; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Iwawaki T, 2001, NAT CELL BIOL, V3, P158, DOI 10.1038/35055065; Iwawaki T, 2009, P NATL ACAD SCI USA, V106, P16657, DOI 10.1073/pnas.0903775106; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lipson KL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001648; Lipson KL, 2006, CELL METAB, V4, P245, DOI 10.1016/j.cmet.2006.07.007; MORI K, 1993, CELL, V74, P743; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Reimold AM, 2000, GENE DEV, V14, P152; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; Shamu CE, 1996, EMBO J, V15, P3028, DOI 10.1002/j.1460-2075.1996.tb00666.x; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Zhang KZ, 2005, J CLIN INVEST, V115, P268, DOI 10.1172/JCI200521848	32	76	81	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e13052	10.1371/journal.pone.0013052	http://dx.doi.org/10.1371/journal.pone.0013052			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20885949	Green Submitted, Green Published, gold			2022-12-27	WOS:000282167100031
J	Vinberg, F; Koskelainen, A				Vinberg, Frans; Koskelainen, Ari			Calcium Sets the Physiological Value of the Dominant Time Constant of Saturated Mouse Rod Photoresponse Recovery	PLOS ONE			English	Article							RETINAL RODS; GUANYLATE-CYCLASE; LIGHT ADAPTATION; EXCISED PATCHES; MODULATION; CGMP; PHOTORECEPTORS; DEPENDENCE; RESPONSES; CHANNEL	Background: The rate-limiting step that determines the dominant time constant (tau(D)) of mammalian rod photoresponse recovery is the deactivation of the active phosphodiesterase (PDE6). Physiologically relevant Ca2+-dependent mechanisms that would affect the PDE inactivation have not been identified. However, recently it has been shown that tD is modulated by background light in mouse rods. Methodology/Principal Findings: We used ex vivo ERG technique to record pharmacologically isolated photoreceptor responses (fast PIII component). We show a novel static effect of calcium on mouse rod phototransduction: Ca2+ shortens the dominant time constant (tau(D)) of saturated photoresponse recovery, i.e., when extracellular free Ca2+ is decreased from 1 mM to similar to 25 nM, the tau(D) is reversibly increased similar to 1.5-2-fold. Conclusions: We conclude that the increase in tau(D) during low Ca2+ treatment is not due to increased [cGMP], increased [Na+] or decreased [ATP] in rod outer segment (ROS). Also it cannot be due to protein translocation mechanisms. We suggest that a Ca2+-dependent mechanism controls the life time of active PDE.	[Vinberg, Frans; Koskelainen, Ari] Aalto Univ Sch Sci & Technol, Dept Biomed Engn & Computat Sci BECS, Espoo, Finland	Aalto University	Vinberg, F (corresponding author), Aalto Univ Sch Sci & Technol, Dept Biomed Engn & Computat Sci BECS, Espoo, Finland.	ari.koskelainen@tkk.fi	Vinberg, Frans/AAK-8615-2021	Vinberg, Frans/0000-0003-3439-4979	Academy of Finland [111866]	Academy of Finland(Academy of Finland)	This work was supported by the Academy of Finland (http://www.aka.fi/en-gb/A/), grant 111866. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARSHAVSKY VY, 1992, J BIOL CHEM, V267, P24501; BAYLOR DA, 1986, J PHYSIOL-LONDON, V371, P115, DOI 10.1113/jphysiol.1986.sp015964; Chen CK, 2010, J NEUROSCI, V30, P1213, DOI 10.1523/JNEUROSCI.4353-09.2010; Chen CK, 2000, NATURE, V403, P557, DOI 10.1038/35000601; CHEN CK, 1995, J BIOL CHEM, V270, P18060, DOI 10.1074/jbc.270.30.18060; CHEN TY, 1994, P NATL ACAD SCI USA, V91, P11757, DOI 10.1073/pnas.91.24.11757; Doan T, 2009, J NEUROSCI, V29, P11867, DOI 10.1523/JNEUROSCI.0819-09.2009; DONNER K, 1988, ACTA PHYSIOL SCAND, V134, P535, DOI 10.1111/j.1365-201X.1988.tb10632.x; FAIN GL, 1978, NATURE, V272, P467, DOI 10.1038/272467a0; HAYNES LW, 1986, NATURE, V321, P66, DOI 10.1038/321066a0; Heikkinen H, 2008, VISION RES, V48, P264, DOI 10.1016/j.visres.2007.11.005; HODGKIN AL, 1986, J PHYSIOL-LONDON, V372, pP54; HSU YT, 1993, NATURE, V361, P76, DOI 10.1038/361076a0; KAWAMURA S, 1993, NATURE, V362, P855, DOI 10.1038/362855a0; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; KOUTALOS Y, 1995, J GEN PHYSIOL, V106, P863, DOI 10.1085/jgp.106.5.863; Krispel CM, 2006, NEURON, V51, P409, DOI 10.1016/j.neuron.2006.07.010; LOLLEY RN, 1982, VISION RES, V22, P1481, DOI 10.1016/0042-6989(82)90213-9; Lyubarsky AL, 1996, J NEUROSCI, V16, P563, DOI 10.1523/jneurosci.16-02-00563.1996; Makino CL, 2005, J GEN PHYSIOL, V126, P81, DOI 10.1085/jgp.200308994061405c; Makino CL, 2004, J GEN PHYSIOL, V123, P729, DOI 10.1085/jgp.200308994; MATTHEWS HR, 1995, J PHYSIOL-LONDON, V484, P267, DOI 10.1113/jphysiol.1995.sp020664; Nymark S, 2005, J PHYSIOL-LONDON, V567, P923, DOI 10.1113/jphysiol.2005.090662; Nymark S, 2006, INVEST OPHTH VIS SCI, V47, P2583, DOI 10.1167/iovs.05-1116; Okawa H, 2008, CURR BIOL, V18, P1917, DOI 10.1016/j.cub.2008.10.029; PEPPERBERG DR, 1992, VISUAL NEUROSCI, V8, P9, DOI 10.1017/S0952523800006441; PEPPERBERG DR, 1994, VISUAL NEUROSCI, V11, P53, DOI 10.1017/S095252380001110X; PORTZEHL H, 1964, BIOCHIM BIOPHYS ACTA, V79, P581, DOI 10.1016/0926-6577(64)90224-4; Rebrik TI, 2004, J GEN PHYSIOL, V123, P63, DOI 10.1085/jgp.200308952; STERN JH, 1987, SCIENCE, V236, P1674, DOI 10.1126/science.3037695; Vinberg FJ, 2009, J VISION, V9, DOI 10.1167/9.12.9; WINKLER BS, 1980, INVEST OPHTH VIS SCI, V19, P562; WINKLER BS, 1977, INVEST OPHTH VIS SCI, V16, P1151; Woodruff ML, 2008, J NEUROSCI, V28, P2064, DOI 10.1523/JNEUROSCI.2973-07.2008; Woodruff ML, 2007, J NEUROSCI, V27, P8805, DOI 10.1523/JNEUROSCI.2751-07.2007; Woodruff ML, 2002, J PHYSIOL-LONDON, V542, P843, DOI 10.1113/jphysiol.2001.013987; YAU KW, 1981, NATURE, V292, P502, DOI 10.1038/292502a0; Zhang XJ, 2008, J BIOL CHEM, V283, P29699, DOI 10.1074/jbc.M803948200	38	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e13025	10.1371/journal.pone.0013025	http://dx.doi.org/10.1371/journal.pone.0013025			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20885958	Green Published, gold, Green Submitted			2022-12-27	WOS:000282167100023
J	Onnis, A; De Falco, G; Antonicelli, G; Onorati, M; Bellan, C; Sherman, O; Sayed, S; Leoncini, L				Onnis, Anna; De Falco, Giulia; Antonicelli, Giuseppina; Onorati, Monica; Bellan, Cristiana; Sherman, Omar; Sayed, Shasheen; Leoncini, Lorenzo			Alteration of MicroRNAs Regulated by c-Myc in Burkitt Lymphoma	PLOS ONE			English	Article							ORGAN SIZE; GENE; EXPRESSION; TRANSLOCATION; MECHANISM; CELLS	Background: Burkitt lymphoma (BL) is an aggressive B-cell lymphoma, with a characteristic clinical presentation, morphology and immunophenotype. Over the past years, the typical translocation t(8;14) and its variants have been considered the molecular hallmark of this tumor. However, BL cases with no detectable MYC rearrangement have been identified. Intriguingly, these cases express MYC at levels comparable with cases carrying the translocation. In normal cells c-Myc expression is tightly regulated through a complex feedback loop mechanism. In cancer, MYC is often dysregulated, commonly due to genomic abnormalities. It has recently emerged that this phenomenon may rely on an alteration of post-transcriptional regulation mediated by microRNAs (miRNAs), whose functional alterations are associated with neoplastic transformation. It is also emerging that c-Myc modulates miRNA expression, revealing an intriguing crosstalk between c-Myc and miRNAs. Principal Findings: Here, we investigated the expression of miRNAs possibly regulated by c-Myc in BL cases positive or negative for the translocation. A common trend of miRNA expression, with the exception of hsa-miR-9*, was observed in all of the cases. Intriguingly, down-regulation of this miRNA seems to specifically identify a particular subset of BL cases, lacking MYC translocation. Here, we provided evidence that hsa-miR-9-1 gene is heavily methylated in those cases. Finally, we showed that hsa-miR-9* is able to modulate E2F1 and c-Myc expression. Conclusions: Particularly, this study identifies hsa-miR-9* as potentially relevant for malignant transformation in BL cases with no detectable MYC translocation. Deregulation of hsa-miR-9* may therefore be useful as a diagnostic tool, suggesting it as a promising novel candidate for tumor cell marker.	[Onnis, Anna; De Falco, Giulia; Antonicelli, Giuseppina; Onorati, Monica; Bellan, Cristiana; Leoncini, Lorenzo] Univ Siena, Dept Human Pathol & Oncol, I-53100 Siena, Italy; [Sherman, Omar; Sayed, Shasheen] Aga Khan Hosp, Nairobi, Kenya	University of Siena	Onnis, A (corresponding author), Univ Siena, Dept Human Pathol & Oncol, Via Laterina 8, I-53100 Siena, Italy.	leoncinil@unisi.it	leoncini, lorenzo/P-8361-2018; BELLAN, CRISTIANA/ABG-4750-2021; BELLAN, CRISTIANA/L-3903-2013; LEONCINI, Lorenzo/U-4413-2019	leoncini, lorenzo/0000-0002-7457-300X; BELLAN, CRISTIANA/0000-0001-6119-9007; BELLAN, CRISTIANA/0000-0001-6119-9007; LEONCINI, Lorenzo/0000-0002-7457-300X; Onnis, Anna/0000-0003-3199-9868	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR); Monte dei Paschi (MPS) foundation	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); Monte dei Paschi (MPS) foundation	This work has been supported by Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) and Monte dei Paschi (MPS) foundation grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baudino TA, 2003, MOL CELL, V11, P905, DOI 10.1016/S1097-2765(03)00102-3; Bellan C, 2005, BLOOD, V106, P1031, DOI 10.1182/blood-2005-01-0168; Chung HJ, 2005, MOL CELLS, V20, P157; Coller HA, 2007, PLOS GENET, V3, P1319, DOI 10.1371/journal.pgen.0030146; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Dave SS, 2006, NEW ENGL J MED, V354, P2431, DOI 10.1056/NEJMoa055759; De Falco G, 2007, BLOOD, V110, P1301, DOI 10.1182/blood-2006-12-064865; de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4; Deng S, 2008, CELL CYCLE, V7, P2643, DOI 10.4161/cc.7.17.6597; Gallant P, 2005, CANCER RES, V65, P6485, DOI 10.1158/0008-5472.CAN-05-1101; Hasenclever D, 1998, NEW ENGL J MED, V339, P1506, DOI 10.1056/NEJM199811193392104; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; Johnston LA, 2002, BIOESSAYS, V24, P54, DOI 10.1002/bies.10021; Lazzi S, 2009, HUM PATHOL, V40, P1252, DOI 10.1016/j.humpath.2009.01.007; Lehmann U, 2008, J PATHOL, V214, P17, DOI 10.1002/path.2251; Leone G, 1997, NATURE, V387, P422, DOI 10.1038/387422a0; Leone G, 1997, NATURE, V387, P932, DOI 10.1038/43230; Leucci E, 2008, J PATHOL, V216, P440, DOI 10.1002/path.2410; Leucci E, 2010, INT J CANCER, V126, P1316, DOI 10.1002/ijc.24655; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Mestdagh P, 2010, ONCOGENE, V29, P1394, DOI 10.1038/onc.2009.429; Moreno E, 2004, CELL, V117, P117, DOI 10.1016/S0092-8674(04)00262-4; Motsch N, 2007, RNA BIOL, V4, P131, DOI 10.4161/rna.4.3.5206; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Scaria V, 2007, CELL MICROBIOL, V9, P2784, DOI 10.1111/j.1462-5822.2007.01050.x; Scaria V, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-68; Sethupathy P, 2006, RNA, V12, P192, DOI 10.1261/rna.2239606; Sevilla DW, 2007, AM J CLIN PATHOL, V128, P981, DOI 10.1309/C1PP15P7CDB8UY39; Sun Y, 2009, BREAST CANCER RES TR, V118, P185, DOI 10.1007/s10549-008-0171-6; Swerdlow SH, 2008, WHO CLASSIFICATION T; TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837	36	52	62	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2010	5	9							e12960	10.1371/journal.pone.0012960	http://dx.doi.org/10.1371/journal.pone.0012960			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653UN	20930934	Green Published, Green Submitted, gold			2022-12-27	WOS:000282122600004
J	Liao, YL; Lonnerdal, B				Liao, Yalin; Loennerdal, Bo			Global MicroRNA Characterization Reveals That miR-103 Is Involved in IGF-1 Stimulated Mouse Intestinal Cell Proliferation	PLOS ONE			English	Article							CDNA MICROARRAY DATA; GROWTH-FACTOR-ALPHA; HUMAN CYCLIN-E; EPITHELIAL-CELLS; HUMAN COLOSTRUM; PROTEIN-KINASE; MINOR PROTEINS; STEM-CELLS; EXPRESSION; MILK	MicroRNAs play extensive roles in cellular development. Analysis of the microRNA expression pattern during intestinal cell proliferation in early life is likely to unravel molecular mechanisms behind intestinal development and have implications for therapeutic intervention. In this study, we isolated mouse intestinal crypt cells, examined the differences in microRNA expression upon IGF-1 stimulated proliferation and identified miR-103 as a one of the key regulators. Mouse intestinal crypt cells were cultured and treated with IGF-1 for 24 h. MicroRNA microarray showed that multiple microRNAs are regulated by IGF-1, and miR-103 was the most sharply down-regulated. Expression of miR-103 in mouse intestinal crypt cells was confirmed by real-time Q-PCR. Sequence analyses showed that, among the 1040 predicted miR-103 target genes, CCNE1, CDK2, and CREB1 contain complementary sequences to the miR-103 seed region that are conserved between human and mouse. We further demonstrated that miR-103 controls the expression level of these three genes in mouse crypt cells by luciferase assay and immunoblotting assay. Taken together, our data suggest that in mouse intestinal crypt cells, miR-103 is part of the G1/S transition regulatory network, which targets CCNE1, CDK2, and CREB1 during IGF-1 stimulated proliferation.	[Liao, Yalin; Loennerdal, Bo] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA	University of California System; University of California Davis	Liao, YL (corresponding author), Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA.	bllonnerdal@ucdavis.edu	Xie, Huangming/B-2260-2012		UC Davis Clinical Nutrition Research Unit (NIH) [DK 35747]; Mead Johnson Nutrition; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK035747] Funding Source: NIH RePORTER	UC Davis Clinical Nutrition Research Unit (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mead Johnson Nutrition; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Real-time Q-PCR analyses instrument is under the support of the UC Davis Clinical Nutrition Research Unit (NIH grant number DK 35747); this work was funded by Mead Johnson Nutrition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chen K, 1999, JPEN-PARENTER ENTER, V23, pS89; Chen YC, 2003, MOL CELL BIOL, V23, P4066, DOI 10.1128/MCB.23.12.4066-4082.2003; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Cummins AG, 2008, J PEDIATR GASTR NUTR, V47, P153, DOI 10.1097/MPG.0b013e3181604d27; DONOVAN SM, 1994, ANNU REV NUTR, V14, P147, DOI 10.1146/annurev.nu.14.070194.001051; Elmlinger MW, 1999, PEDIATR RES, V46, P76, DOI 10.1203/00006450-199907000-00013; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hino K, 2008, RNA, V14, P1433, DOI 10.1261/rna.810208; Hino Kimihiro, 2007, Nucleic Acids Symp Ser (Oxf), P415, DOI 10.1093/nass/nrm208; Kang TH, 2008, J CELL SCI, V121, P3035, DOI 10.1242/jcs.026757; Kellogg DR, 2003, J CELL SCI, V116, P4883, DOI 10.1242/jcs.00908; Keyomarsi K, 1997, Prog Cell Cycle Res, V3, P171; KOFF A, 1991, CELL, V66, P1217, DOI 10.1016/0092-8674(91)90044-Y; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; Liao Y, 2010, CELL MOL LIFE SCI, V67, P2969, DOI 10.1007/s00018-010-0366-y; Liao Y, 2010, INT J BIOCHEM CELL B, V42, P1363, DOI 10.1016/j.biocel.2009.07.019; Lonnerdal B, 2003, AM J CLIN NUTR, V77, p1537S; MACDONALD TT, 1992, ANN NY ACAD SCI, V664, P202, DOI 10.1111/j.1749-6632.1992.tb39761.x; Murakami K, 1998, ELECTROPHORESIS, V19, P2521, DOI 10.1002/elps.1150191427; Nishimura S, 1998, J GASTROENTEROL, V33, P172, DOI 10.1007/s005350050066; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; OLIVER BL, 1995, P SOC EXP BIOL MED, V210, P162; OLIVER BL, 1994, BIOCHEM J, V303, P455, DOI 10.1042/bj3030455; Palmer DJ, 2006, PROTEOMICS, V6, P2208, DOI 10.1002/pmic.200500558; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Sheng G, 2006, GASTROENTEROLOGY, V131, P153, DOI 10.1053/j.gastro.2006.05.007; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Takada S, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl653; Wang YM, 2009, CANCER RES, V69, P4093, DOI 10.1158/0008-5472.CAN-09-0309; Wolgemuth DJ, 2008, CELL CYCLE, V7, P3509, DOI 10.4161/cc.7.22.6978; Won YJ, 2009, BIOCHEM BIOPH RES CO, V380, P655, DOI 10.1016/j.bbrc.2009.01.159; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yen TH, 2006, STEM CELL REV, V2, P203, DOI 10.1007/s12015-006-0048-1	41	30	33	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12976	10.1371/journal.pone.0012976	http://dx.doi.org/10.1371/journal.pone.0012976			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886090	Green Published, Green Submitted, gold			2022-12-27	WOS:000282091100059
J	La Starza, R; Matteucci, C; Gorello, P; Brandimarte, L; Pierini, V; Crescenzi, B; Nofrini, V; Rosati, R; Gottardi, E; Saglio, G; Santucci, A; Berchicci, L; Arcioni, F; Falini, B; Martelli, MF; Sambani, C; Aventin, A; Mecucci, C				La Starza, Roberta; Matteucci, Caterina; Gorello, Paolo; Brandimarte, Lucia; Pierini, Valentina; Crescenzi, Barbara; Nofrini, Valeria; Rosati, Roberto; Gottardi, Enrico; Saglio, Giuseppe; Santucci, Antonella; Berchicci, Laura; Arcioni, Francesco; Falini, Brunangelo; Martelli, Massimo Fabrizio; Sambani, Constantina; Aventin, Anna; Mecucci, Cristina			NPM1 Deletion Is Associated with Gross Chromosomal Rearrangements in Leukemia	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; RESIDUAL DISEASE DETECTION; POLYMERASE-CHAIN-REACTION; FUSION GENE TRANSCRIPTS; MYELODYSPLASTIC SYNDROME; DE-NOVO; NUCLEOPHOSMIN; DAMAGE; 5Q; DISORDERS	Background: NPM1 gene at chromosome 5q35 is involved in recurrent translocations in leukemia and lymphoma. It also undergoes mutations in 60% of adult acute myeloid leukemia (AML) cases with normal karyotype. The incidence and significance of NPM1 deletion in human leukemia have not been elucidated. Methodology and Principal Findings: Bone marrow samples from 145 patients with myelodysplastic syndromes (MDS) and AML were included in this study. Cytogenetically 43 cases had isolated 5q-, 84 cases had 5q- plus other changes and 18 cases had complex karyotype without 5q deletion. FISH and direct sequencing investigated the NPM1 gene. NPM1 deletion was an uncommon event in the "5q- syndrome'' but occurred in over 40% of cases with high risk MDS/AML with complex karyotypes and 5q loss. It originated from large 5q chromosome deletions. Simultaneous exon 12 mutations were never found. NPM1 gene status was related to the pattern of complex cytogenetic aberrations. NPM1 haploinsufficiency was significantly associated with monosomies (p<0.001) and gross chromosomal rearrangements, i.e., markers, rings, and double minutes (p<0.001), while NPM1 disomy was associated with structural changes (p = 0.013). Interestingly, in complex karyotypes with 5q- TP53 deletion and/or mutations are not specifically associated with NPM1 deletion. Conclusions and Significance: NPM1/5q35 deletion is a consistent event in MDS/AML with a 5q-/-5 in complex karyotypes. NPM1 deletion and NPM1 exon 12 mutations appear to be mutually exclusive and are associated with two distinct cytogenetic subsets of MDS and AML.	[La Starza, Roberta; Matteucci, Caterina; Gorello, Paolo; Brandimarte, Lucia; Pierini, Valentina; Crescenzi, Barbara; Nofrini, Valeria; Rosati, Roberto; Santucci, Antonella; Berchicci, Laura; Arcioni, Francesco; Falini, Brunangelo; Martelli, Massimo Fabrizio; Mecucci, Cristina] Univ Perugia, I-06100 Perugia, Italy; [Rosati, Roberto] Inst Pele Pequeno Principe, Fac Pequeno Principe, Curitiba, Parana, Brazil; [Gottardi, Enrico; Saglio, Giuseppe] Univ Turin, Dept Clin & Biol Sci, Turin, Italy; [Sambani, Constantina] Demokritos Canc Ctr, Athens, Greece; [Aventin, Anna] Hosp De La Santa Creu I Sant Pau, Servei Hematol, Barcelona, Spain	University of Perugia; Hospital Pequeno Principe; University of Turin	La Starza, R (corresponding author), Univ Perugia, I-06100 Perugia, Italy.	crimecux@unipg.it	La Starza, Roberta/ABD-0836-2022; Rosati, Roberto/AAF-3708-2020	Rosati, Roberto/0000-0002-0475-3654; Saglio, Giuseppe/0000-0002-1046-3514; FALINI, Brunangelo/0000-0002-7198-5965	Ministero per I'Istruzione, I'Universita e la Ricerca Scientifica - Fondo per gli Investimenti per la Ricerca di Base (MIUR-FIRB); Associazione Italiana Ricerca sul Cancro (AIRC)	Ministero per I'Istruzione, I'Universita e la Ricerca Scientifica - Fondo per gli Investimenti per la Ricerca di Base (MIUR-FIRB)(Ministry of Education, Universities and Research (MIUR)); Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Ministero per I'Istruzione, I'Universita e la Ricerca Scientifica - Fondo per gli Investimenti per la Ricerca di Base (MIUR-FIRB, http://firb.miur.it/) and Associazione Italiana Ricerca sul Cancro ( AIRC, http://www.airc.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow JL, 2010, NAT MED, V16, P59, DOI 10.1038/nm.2063; Beillard E, 2003, LEUKEMIA, V17, P2474, DOI 10.1038/sj.leu.2403136; Berger R, 2006, LEUKEMIA, V20, P319, DOI 10.1038/sj.leu.2404063; Boultwood J, 2002, BLOOD, V99, P4638, DOI 10.1182/blood.V99.12.4638; Bowen D, 2009, LEUKEMIA, V23, P203, DOI 10.1038/leu.2008.173; Colombo E, 2005, MOL CELL BIOL, V25, P8874, DOI 10.1128/MCB.25.20.8874-8886.2005; Crescenzi B, 2004, HAEMATOLOGICA, V89, P281; Dohner K, 2008, HAEMATOL-HEMATOL J, V93, P976, DOI 10.3324/haematol.13345; Ebert BL, 2009, LEUKEMIA, V23, P1252, DOI 10.1038/leu.2009.53; Eisenmann KM, 2009, ONCOGENE, V28, P3429, DOI 10.1038/onc.2009.207; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Gabert J, 2003, LEUKEMIA, V17, P2318, DOI 10.1038/sj.leu.2403135; Gjerset RA, 2006, J MOL HISTOL, V37, P239, DOI 10.1007/s10735-006-9040-y; Graubert TA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004583; Grisendi S, 2005, NATURE, V437, P147, DOI 10.1038/nature03915; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Kurki S, 2004, CELL CYCLE, V3, P976; Latonen L, 2005, BBA-REV CANCER, V1755, P71, DOI 10.1016/j.bbcan.2005.04.003; Lessard M, 2007, CANCER GENET CYTOGEN, V176, P1, DOI 10.1016/j.cancergencyto.2007.01.013; Pedersen-Bjergaard J, 2006, LEUKEMIA, V20, P1943, DOI 10.1038/sj.leu.2404381; Royer-Pokora B, 2006, CANCER GENET CYTOGEN, V167, P66, DOI 10.1016/j.cancergencyto.2005.08.003; Shaffer LG., 2005, INT SYSTEM HUMAN CYT; Starczynowski DT, 2010, NAT MED, V16, P49, DOI 10.1038/nm.2054; Thiede C, 2006, BLOOD, V107, P4011, DOI 10.1182/blood-2005-08-3167; van Dongen JJM, 1999, LEUKEMIA, V13, P1901, DOI 10.1038/sj.leu.2401592; VANDENBERGHE H, 1974, NATURE, V251, P437, DOI 10.1038/251437a0	26	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2010	5	9							e12855	10.1371/journal.pone.0012855	http://dx.doi.org/10.1371/journal.pone.0012855			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652JO	20877721	gold, Green Submitted, Green Published			2022-12-27	WOS:000282002900010
J	Wiese, M; Antebi, A; Zheng, H				Wiese, Mary; Antebi, Adam; Zheng, Hui			Intracellular Trafficking and Synaptic Function of APL-1 in Caenorhabditis elegans	PLOS ONE			English	Article							AMYLOID-PRECURSOR-PROTEIN; ANTEROGRADE AXONAL-TRANSPORT; CORE VESICLE MATURATION; C-ELEGANS; MICE LACKING; ALZHEIMERS-DISEASE; DEFICIENT MICE; GENE; PATHWAY; APP	Background: Alzheimer's disease (AD) is a neurodegenerative disorder primarily characterized by the deposition of beta-amyloid plaques in the brain. Plaques are composed of the amyloid-beta peptide derived from cleavage of the amyloid precursor protein (APP). Mutations in APP lead to the development of Familial Alzheimer's Disease (FAD), however, the normal function of this protein has proven elusive. The organism Caenorhabditis elegans is an attractive model as the amyloid precursor-like protein (APL-1) is the single ortholog of APP, and loss of apl-1 leads to a severe molting defect and early larval lethality. Methodology/Principal Findings: We report here that lethality and molting can be rescued by full length APL-1, C-terminal mutations as well as a C-terminal truncation, suggesting that the extracellular region of the protein is essential for viability. RNAi knock-down of apl-1 followed by drug testing on the acetylcholinesterase inhibitor aldicarb showed that loss of apl-1 leads to aldicarb hypersensitivity, indicating a defect in synaptic function. The aldicarb hypersensitivity can be rescued by full length APL-1 in a dose dependent fashion. At the cellular level, kinesins UNC-104/KIF-1A and UNC-116/kinesin-1 are positive regulators of APL-1 expression in the neurons. Knock-down of the small GTPase rab-5 also leads to a dramatic decrease in the amount of apl-1 expression in neurons, suggesting that trafficking from the plasma membrane to the early endosome is important for apl-1 function. Loss of function of a different small GTPase, UNC-108, on the contrary, leads to the retention of APL-1 in the cell body. Conclusions/Significance: Our results reveal novel insights into the intracellular trafficking of APL-1 and we report a functional role for APL-1 in synaptic transmission.	[Wiese, Mary; Antebi, Adam; Zheng, Hui] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; [Wiese, Mary; Antebi, Adam; Zheng, Hui] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Antebi, Adam] Max Planck Inst Biol Aging, Cologne, Germany	Baylor College of Medicine; Baylor College of Medicine; Max Planck Society	Wiese, M (corresponding author), Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA.	aantebi@bcm.edu; huiz@bcm.edu			National Institutes of Health [AG032051, AG033467, AG027498]; American Health and Assistance Foundation [A2008-052]; NATIONAL INSTITUTE ON AGING [R01AG032051, R01AG027498, R01AG033467] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health and Assistance Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by the National Institutes of Health (AG032051 and AG033467 and AG027498) and the American Health and Assistance Foundation (A2008-052). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando K, 2001, J BIOL CHEM, V276, P40353, DOI 10.1074/jbc.M104059200; Borgonovo B, 2006, CURR OPIN CELL BIOL, V18, P365, DOI 10.1016/j.ceb.2006.06.010; BRENNER S, 1974, GENETICS, V77, P71; Brundage L, 1996, NEURON, V16, P999, DOI 10.1016/S0896-6273(00)80123-3; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Chun DK, 2008, MOL BIOL CELL, V19, P2682, DOI 10.1091/mbc.E07-11-1120; DAIGLE I, 1993, P NATL ACAD SCI USA, V90, P12045, DOI 10.1073/pnas.90.24.12045; Dawson GR, 1999, NEUROSCIENCE, V90, P1, DOI 10.1016/S0306-4522(98)00410-2; Edwards SL, 2009, J CELL BIOL, V186, P881, DOI 10.1083/jcb.200902095; Frand AR, 2005, PLOS BIOL, V3, P1719, DOI 10.1371/journal.pbio.0030312; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Grigorenko AP, 2004, P NATL ACAD SCI USA, V101, P14955, DOI 10.1073/pnas.0406462101; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; Heber S, 2000, J NEUROSCI, V20, P7951; Hornsten A, 2007, P NATL ACAD SCI USA, V104, P1971, DOI 10.1073/pnas.0603997104; Ikin AF, 1996, J BIOL CHEM, V271, P31783, DOI 10.1074/jbc.271.50.31783; Jacob TC, 2003, J NEUROSCI, V23, P2122; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; King GD, 2004, EXP NEUROL, V185, P208, DOI 10.1016/j.expneurol.2003.10.011; Koo EH, 2002, TRAFFIC, V3, P763, DOI 10.1034/j.1600-0854.2002.31101.x; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; KOUNNAS MZ, 1995, CELL, V82, P331, DOI 10.1016/0092-8674(95)90320-8; Leyssen M, 2005, EMBO J, V24, P2944, DOI 10.1038/sj.emboj.7600757; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; LUO LQ, 1992, NEURON, V9, P595, DOI 10.1016/0896-6273(92)90024-8; Mangahas PM, 2008, J CELL BIOL, V180, P357, DOI 10.1083/jcb.200708130; MarquezSterling NR, 1997, J NEUROSCI, V17, P140, DOI 10.1523/JNEUROSCI.17-01-00140.1997; MARTINMORRIS LE, 1990, DEVELOPMENT, V110, P185; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; Miller KG, 1999, NEURON, V24, P323, DOI 10.1016/S0896-6273(00)80847-8; Muresan Z, 2005, J NEUROSCI, V25, P3741, DOI 10.1523/JNEUROSCI.0152-05.2005; NISHIMOTO I, 1993, NATURE, V362, P75, DOI 10.1038/362075a0; Niwa R, 2008, DEV BIOL, V315, P418, DOI 10.1016/j.ydbio.2007.12.044; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; Phinney AL, 1999, NEUROSCIENCE, V90, P1207, DOI 10.1016/S0306-4522(98)00645-9; Ramelot TA, 2001, J MOL BIOL, V307, P871, DOI 10.1006/jmbi.2001.4535; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; SCHINKMANN K, 1994, MOL BRAIN RES, V24, P238, DOI 10.1016/0169-328X(94)90137-6; Seabrook GR, 1999, NEUROPHARMACOLOGY, V38, P349, DOI 10.1016/S0028-3908(98)00204-4; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; SLUNT HH, 1994, J BIOL CHEM, V269, P2637; Sumakovic M, 2009, J CELL BIOL, V186, P897, DOI 10.1083/jcb.200902096; Tisdale EJ, 1996, J BIOL CHEM, V271, P29372, DOI 10.1074/jbc.271.46.29372; Torroja L, 1999, J NEUROSCI, V19, P7793; Vashlishan AB, 2008, NEURON, V58, P346, DOI 10.1016/j.neuron.2008.02.019; Von Koch CS, 1997, NEUROBIOL AGING, V18, P661, DOI 10.1016/S0197-4580(97)00151-6; Wang P, 2005, J NEUROSCI, V25, P1219, DOI 10.1523/JNEUROSCI.4660-04.2005; WASCO W, 1993, NAT GENET, V5, P95, DOI 10.1038/ng0993-95; WASCO W, 1992, P NATL ACAD SCI USA, V89, P10758, DOI 10.1073/pnas.89.22.10758; WOOD WB, 1988, NEMATODE CAENORHABDI, P167; Yochem J, 1999, DEVELOPMENT, V126, P597; Zahn TR, 2004, TRAFFIC, V5, P544, DOI 10.1111/j.1600-0854.2004.00195.x; Zambrano N, 2002, J CELL SCI, V115, P1411; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X; Zheng H, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-5	56	36	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2010	5	9							e12790	10.1371/journal.pone.0012790	http://dx.doi.org/10.1371/journal.pone.0012790			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651YH	20862215	Green Published, Green Submitted, gold			2022-12-27	WOS:000281963200004
J	Fuss, J; Ben Abdallah, NMB; Hensley, FW; Weber, KJ; Hellweg, R; Gass, P				Fuss, Johannes; Ben Abdallah, Nada M. B.; Hensley, Frank W.; Weber, Klaus-Josef; Hellweg, Rainer; Gass, Peter			Deletion of Running-Induced Hippocampal Neurogenesis by Irradiation Prevents Development of an Anxious Phenotype in Mice	PLOS ONE			English	Article							DENTATE GYRUS; ADULT NEUROGENESIS; CELL-PROLIFERATION; FOS EXPRESSION; C-FOS; ANXIETY; BEHAVIOR; MEMORY; NEURONS; INTEGRATION	Recent evidence postulates a role of hippocampal neurogenesis in anxiety behavior. Here we report that elevated levels of neurogenesis elicit increased anxiety in rodents. Mice performing voluntary wheel running displayed both highly elevated levels of neurogenesis and increased anxiety in three different anxiety-like paradigms: the open field, elevated O-maze, and dark-light box. Reducing neurogenesis by focalized irradiation of the hippocampus abolished this exercise-induced increase of anxiety, suggesting a direct implication of hippocampal neurogenesis in this phenotype. On the other hand, irradiated mice explored less frequently the lit compartment of the dark-light box test irrespective of wheel running, suggesting that irradiation per se induced anxiety as well. Thus, our data suggest that intermediate levels of neurogenesis are related to the lowest levels of anxiety. Moreover, using c-Fos immunocytochemistry as cellular activity marker, we observed significantly different induction patterns between runners and sedentary controls when exposed to a strong anxiogenic stimulus. Again, this effect was altered by irradiation. In contrast, the well-known induction of brain-derived neurotrophic factor ( BDNF) by voluntary exercise was not disrupted by focal irradiation, indicating that hippocampal BDNF levels were not correlated with anxiety under our experimental conditions. In summary, our data demonstrate to our knowledge for the first time that increased neurogenesis has a causative implication in the induction of anxiety.	[Fuss, Johannes; Ben Abdallah, Nada M. B.; Gass, Peter] Heidelberg Univ, Dept Psychiat & Psychotherapy, Cent Inst Mental Hlth Mannheim ZI, D-6800 Mannheim, Germany; [Hensley, Frank W.; Weber, Klaus-Josef] Heidelberg Univ, Dept Radiooncol, Heidelberg, Germany; [Hellweg, Rainer] Univ Med Berlin, Dept Psychiat, Berlin, Germany	Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Fuss, J (corresponding author), Heidelberg Univ, Dept Psychiat & Psychotherapy, Cent Inst Mental Hlth Mannheim ZI, D-6800 Mannheim, Germany.	johannes.fuss@zi-mannheim.de	Fuss, Johannes/AAI-6580-2021; Weber, Klaus/P-8241-2019	Weber, Klaus/0000-0002-2421-6178; Hellweg, Rainer/0000-0001-8033-389X	Deutsche Forschungsgemeinschaft [GA427/9-1, HE 1392/3-1, SFB636-B3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by grant sponsor Deutsche Forschungsgemeinschaft (http://www.dfg.de/en/index.jsp), under grant numbers: GA427/9-1, HE 1392/3-1, SFB636-B3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acsady L, 1998, J NEUROSCI, V18, P3386; Amrein I, 2004, EUR J NEUROSCI, V20, P3342, DOI 10.1111/j.1460-9568.2004.03795.x; Augustsson H, 2004, PHYSIOL BEHAV, V81, P685, DOI 10.1016/j.physbeh.2004.03.014; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; BELZUNG C, 2007, NEURAL PLAST; Ben Abdallah NMB, 2007, HIPPOCAMPUS, V17, P1230, DOI 10.1002/hipo.20358; Bergami M, 2008, P NATL ACAD SCI USA, V105, P15570, DOI 10.1073/pnas.0803702105; BLANCHARD RJ, 1993, BEHAV BRAIN RES, V58, P155, DOI 10.1016/0166-4328(93)90100-5; BRAGIN A, 1995, J NEUROSCI, V15, P47; Castro JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008618; Cazorla M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009777; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; CLARK PJ, 2010, BEHAV BRAIN RES; DRAGUNOW M, 1989, J NEUROSCI METH, V29, P261, DOI 10.1016/0165-0270(89)90150-7; Drapeau E, 2003, P NATL ACAD SCI USA, V100, P14385, DOI 10.1073/pnas.2334169100; Earnheart JC, 2007, J NEUROSCI, V27, P3845, DOI 10.1523/JNEUROSCI.3609-06.2007; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Feng RB, 2001, NEURON, V32, P911, DOI 10.1016/S0896-6273(01)00523-2; Freud S, 1926, HEMMUNG SYMPTOM ANGS; Fuss J, 2010, HIPPOCAMPUS, V20, P364, DOI 10.1002/hipo.20634; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Govindarajan A, 2006, P NATL ACAD SCI USA, V103, P13208, DOI 10.1073/pnas.0605180103; Grace L, 2009, METAB BRAIN DIS, V24, P643, DOI 10.1007/s11011-009-9162-5; Gray JA, 2000, NEUROPSYCHOLOGY ANXI, pxvi; Hale MW, 2008, NEUROSCIENCE, V155, P659, DOI 10.1016/j.neuroscience.2008.05.054; Heidegger M., 1949, SEIN ZEIT; Hellweg R, 2003, EXP NEUROL, V183, P346, DOI 10.1016/S0014-4886(03)00127-4; Holmes MM, 2004, J NEUROSCI RES, V76, P216, DOI 10.1002/jnr.20039; Kornack DR, 1999, P NATL ACAD SCI USA, V96, P5768, DOI 10.1073/pnas.96.10.5768; Lee E, 2009, BMB REP, V42, P239, DOI 10.5483/BMBRep.2009.42.5.239; Menard J, 2001, BRAIN RES, V888, P163, DOI 10.1016/S0006-8993(00)03046-8; Mizumatsu S, 2003, CANCER RES, V63, P4021; Pereira AC, 2007, P NATL ACAD SCI USA, V104, P5638, DOI 10.1073/pnas.0611721104; Petrovich GD, 2001, BRAIN RES REV, V38, P247, DOI 10.1016/S0165-0173(01)00080-7; Revest JM, 2009, MOL PSYCHIATR, V14, P959, DOI 10.1038/mp.2009.15; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Salome N, 2004, BIOL PSYCHIAT, V55, P715, DOI 10.1016/j.biopsych.2003.10.021; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Saxe MD, 2007, P NATL ACAD SCI USA, V104, P4642, DOI 10.1073/pnas.0611718104; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Scobie KN, 2009, J NEUROSCI, V29, P9875, DOI 10.1523/JNEUROSCI.2260-09.2009; Shimazu K, 2006, LEARN MEMORY, V13, P307, DOI 10.1101/lm.76006; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Troakes C, 2009, STRESS, V12, P362, DOI 10.1080/10253890802506391; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao XY, 2003, P NATL ACAD SCI USA, V100, P6777, DOI 10.1073/pnas.1131928100	50	87	87	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2010	5	9							e12769	10.1371/journal.pone.0012769	http://dx.doi.org/10.1371/journal.pone.0012769			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650QH	20862278	Green Published, gold, Green Submitted			2022-12-27	WOS:000281864100014
J	Lebouvier, T; Neunlist, M; des Varannes, SB; Coron, E; Drouard, A; N'Guyen, JM; Chaumette, T; Tasselli, M; Paillusson, S; Flamand, M; Galmiche, JP; Damier, P; Derkinderen, P				Lebouvier, Thibaud; Neunlist, Michel; des Varannes, Stanislas Bruley; Coron, Emmanuel; Drouard, Anne; N'Guyen, Jean-Michel; Chaumette, Tanguy; Tasselli, Maddalena; Paillusson, Sebastien; Flamand, Mathurin; Galmiche, Jean-Paul; Damier, Philippe; Derkinderen, Pascal			Colonic Biopsies to Assess the Neuropathology of Parkinson's Disease and Its Relationship with Symptoms	PLOS ONE			English	Article							ENTERIC NERVOUS-SYSTEM; ALPHA-SYNUCLEIN; MYENTERIC PLEXUS; NONMOTOR SYMPTOMS; FISCHER-344 RATS; LEWY BODIES; CONSTIPATION; AGE; QUESTIONNAIRE; DEGENERATION	Background: The presence of Lewy bodies and Lewy neurites (LN) has been demonstrated in the enteric nervous system (ENS) of Parkinson's disease (PD) patients. The aims of the present research were to use routine colonoscopy biopsies (1) to analyze, in depth, enteric pathology throughout the colonic submucosal plexus (SMP), and (2) to correlate the pathological burden with neurological and gastrointestinal (GI) symptoms. Methodology/Principal Findings: A total of 10 control and 29 PD patients divided into 3 groups according to disease duration were included. PD and GI symptoms were assessed using the Unified Parkinson's Disease Rating Scale part III and the Rome III questionnaire, respectively. Four biopsies were taken from the ascending and descending colon during the course of a total colonoscopy. Immunohistochemical analysis was performed using antibodies against phosphorylated alpha-synuclein, neurofilaments NF 220 kDa (NF) and tyrosine hydroxylase (TH). The density of LN, labeled by anti-phosphorylated alpha-synuclein antibodies, was evaluated using a quantitative rating score. Lewy pathology was apparent in the colonic biopsies from 21 patients and in none of the controls. A decreased number of NF-immunoreactive neurons per ganglion was observed in the SMP of PD patients compared to controls. The amount of LN in the ENS was inversely correlated with neuronal count and positively correlated with levodopa-unresponsive features and constipation. Conclusion/Significance: Analysis of the ENS by routine colonoscopy biopsies is a useful tool for pre-mortem neuropathological diagnosis of PD, and also provides insight into the progression of motor and non-motor symptoms.	[Lebouvier, Thibaud; Neunlist, Michel; des Varannes, Stanislas Bruley; Coron, Emmanuel; Chaumette, Tanguy; Tasselli, Maddalena; Paillusson, Sebastien; Flamand, Mathurin; Galmiche, Jean-Paul; Derkinderen, Pascal] INSERM, UMR 913, Nantes, France; [Lebouvier, Thibaud; des Varannes, Stanislas Bruley; Coron, Emmanuel; Drouard, Anne; Flamand, Mathurin; Galmiche, Jean-Paul; Damier, Philippe; Derkinderen, Pascal] CIC 04, Nantes, France; [Lebouvier, Thibaud; des Varannes, Stanislas Bruley; Coron, Emmanuel; Flamand, Mathurin; Galmiche, Jean-Paul; Damier, Philippe; Derkinderen, Pascal] Univ Nantes, UFR Med, Nantes, France; [Lebouvier, Thibaud; Neunlist, Michel; Chaumette, Tanguy; Tasselli, Maddalena; Paillusson, Sebastien] Univ Nantes, UFR Sci & Tech, Nantes, France; [Damier, Philippe; Derkinderen, Pascal] CHU Nantes, Serv Neurol, F-44035 Nantes 01, France; [Neunlist, Michel; des Varannes, Stanislas Bruley; Coron, Emmanuel; Flamand, Mathurin; Galmiche, Jean-Paul; Derkinderen, Pascal] CHU Nantes, IMAD, F-44035 Nantes 01, France; [N'Guyen, Jean-Michel] CHU Nantes, PIMESP, F-44035 Nantes 01, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes	Lebouvier, T (corresponding author), INSERM, UMR 913, Nantes, France.	thibaud.lebouvier@univ-nantes.fr; michel.neunlist@univ-nantes.fr; pascal.derkinderen@chu-nantes.fr	Bruley des Varannes, Stanislas/K-2434-2015; Neunlist, Michel/K-2388-2015; Coron, Emmanuel/K-2415-2015; NGUYEN, JEAN-MICHEL/K-7665-2015; Bourreille, Arnaud/K-2398-2015; Damier, Philippe/T-7829-2019; Derkinderen, Pascal/K-2393-2015; Chaumette, Tanguy/C-4219-2019; Lebouvier, Thibaud/G-7053-2018	NGUYEN, JEAN-MICHEL/0000-0001-8815-7640; Lebouvier, Thibaud/0000-0002-4386-6045; Chaumette, Tanguy/0000-0002-5830-8767; Paillusson, sebastien/0000-0001-7013-5582	Michael J. Fox Foundation for Parkinson's Research; Nantes University Hospital (Direction de la Recherche Clinique); France Parkinson, CECAP (Comite d'Entente et de Coordination des Associations de Parkinsoniens); ADPLA (Association des Parkinsoniens de Loire Atlantique); FFPG (Federation francaise des groupements parkinsoniens); Parkinsoniens de Vendee; Poste d'accueil Inserm; Contrats d'Interface Inserm	Michael J. Fox Foundation for Parkinson's Research; Nantes University Hospital (Direction de la Recherche Clinique); France Parkinson, CECAP (Comite d'Entente et de Coordination des Associations de Parkinsoniens); ADPLA (Association des Parkinsoniens de Loire Atlantique); FFPG (Federation francaise des groupements parkinsoniens); Parkinsoniens de Vendee; Poste d'accueil Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)); Contrats d'Interface Inserm	This work was supported by a biomarker grant from the Michael J. Fox Foundation for Parkinson's Research and by a grant from Nantes University Hospital (Direction de la Recherche Clinique). Work in Michel Neunlist's lab is supported by France Parkinson, CECAP (Comite d'Entente et de Coordination des Associations de Parkinsoniens), ADPLA (Association des Parkinsoniens de Loire Atlantique), FFPG (Federation francaise des groupements parkinsoniens) and Parkinsoniens de Vendee. TL is a recipient of a Poste d'accueil Inserm. MN and PDe are both recipients of Contrats d'Interface Inserm.	Aarsland D, 2004, ARCH NEUROL-CHICAGO, V61, P1906, DOI 10.1001/archneur.61.12.1906; Allcock LM, 2006, MOVEMENT DISORD, V21, P1851, DOI 10.1002/mds.20996; Alves G, 2006, MOVEMENT DISORD, V21, P1123, DOI 10.1002/mds.20897; Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Anlauf M, 2003, J COMP NEUROL, V459, P90, DOI 10.1002/cne.10599; [Anonymous], 2006, J GASTROINTEST LIVER, V15, P307; Basilisco G, 2005, EUR J GASTROEN HEPAT, V17, P449, DOI 10.1097/00042737-200504000-00010; BEACH TG, 2010, ACTA NEUROPATHOL; Beach TG, 2009, ACTA NEUROPATHOL, V117, P169, DOI 10.1007/s00401-008-0450-7; Benarroch EE, 2007, NEUROLOGY, V69, P1953, DOI 10.1212/01.wnl.0000281999.56102.b5; Braak H, 2000, J NEUROL, V247, P3; Braak H, 2006, NEUROSCI LETT, V396, P67, DOI 10.1016/j.neulet.2005.11.012; Buhner S, 2009, GASTROENTEROLOGY, V137, P1425, DOI 10.1053/j.gastro.2009.07.005; Camilleri M, 2008, NEUROGASTROENT MOTIL, V20, P417, DOI 10.1111/j.1365-2982.2008.01134.x; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; Dafnis G, 2001, GASTROINTEST ENDOSC, V54, P302, DOI 10.1067/mge.2001.117545; DE GIORGIO R, 2004, NEUROGASTROENT MOTIL, V16, P515; Dickson DW, 2009, PARKINSONISM RELAT D, V15, pS1, DOI 10.1016/S1353-8020(09)70769-2; Diederich NJ, 2003, ARCH NEUROL-CHICAGO, V60, P529, DOI 10.1001/archneur.60.4.529; Espay AJ, 2005, J NEUROL NEUROSUR PS, V76, P1355, DOI 10.1136/jnnp.2005.062950; Fahn S., 1987, RECENT DEV PARKINSON, P153; Frank L, 1999, SCAND J GASTROENTERO, V34, P870, DOI 10.1080/003655299750025327; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Furness JB, 2008, NEUROGASTROENT MOTIL, V20, P32, DOI 10.1111/j.1365-2982.2008.01094.x; Ganns D, 2006, HISTOL HISTOPATHOL, V21, P41, DOI 10.14670/HH-21.41; GERSHON MD, 1998, 2 BRAIN SCI BASIS GU, V16; Haik S, 2004, TRENDS MOL MED, V10, P109, DOI 10.1016/j.molmed.2004.01.008; Hawkes CH, 2007, NEUROPATH APPL NEURO, V33, P599, DOI 10.1111/j.1365-2990.2007.00874.x; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Ikemura M, 2008, J NEUROPATH EXP NEUR, V67, P945, DOI 10.1097/NEN.0b013e318186de48; Joiner S, 2005, GUT, V54, P1506, DOI 10.1136/gut.2005.072447; Kaye J, 2006, MOVEMENT DISORD, V21, P1270, DOI 10.1002/mds.20942; Kim JS, 2008, J NEUROL SCI, V270, P122, DOI 10.1016/j.jns.2008.02.017; Kuo YM, 2010, HUM MOL GENET, V19, P1633, DOI 10.1093/hmg/ddq038; Lebouvier T, 2008, GUT, V57, P1741, DOI 10.1136/gut.2008.162503; LEBOUVIER T, 2009, NEUROGASTRO IN PRESS; LEBOUVIER T, 2009, NEUROGASTROENTEROL M; LEBOUVIER T, 2010, FRONT NEURO IN PRESS; Lebouvier T, 2009, EUR J NEUROSCI, V30, P735, DOI 10.1111/j.1460-9568.2009.06873.x; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Martinez-Martin P, 2007, MOVEMENT DISORD, V22, P1623, DOI 10.1002/mds.21586; Miki Y, 2010, NEUROSCI LETT, V469, P357, DOI 10.1016/j.neulet.2009.12.027; Orimo S, 2008, BRAIN, V131, P642, DOI 10.1093/brain/awm302; Pfeiffer RF, 2003, LANCET NEUROL, V2, P107, DOI 10.1016/S1474-4422(03)00307-7; Phillips RJ, 2007, NEUROBIOL AGING, V28, P1124, DOI 10.1016/j.neurobiolaging.2006.05.019; Phillips RJ, 2007, AUTON NEUROSCI-BASIC, V136, P1, DOI 10.1016/j.autneu.2007.04.005; Phillips RJ, 2006, ANAT EMBRYOL, V211, P673, DOI 10.1007/s00429-006-0123-z; Phillips RJ, 2009, EXP NEUROL, V220, P109, DOI 10.1016/j.expneurol.2009.07.025; QUALMAN SJ, 1984, GASTROENTEROLOGY, V87, P848; Reed DE, 2003, J PHYSIOL-LONDON, V553, P911, DOI 10.1113/jphysiol.2003.053140; SINGARAM C, 1995, LANCET, V346, P861, DOI 10.1016/S0140-6736(95)92707-7; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; VAN ROODEN SM, 2009, J NEUROL NEUROSUR PS, V80, P846; Wade PR, 2004, NEUROGASTROENT MOTIL, V16, P19, DOI 10.1111/j.1743-3150.2004.00469.x; Wedel T, 2002, GASTROENTEROLOGY, V123, P1459, DOI 10.1053/gast.2002.36600; Witt M, 2009, MOVEMENT DISORD, V24, P906, DOI 10.1002/mds.22464	56	297	310	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2010	5	9							e12728	10.1371/journal.pone.0012728	http://dx.doi.org/10.1371/journal.pone.0012728			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZO	20856865	Green Published, Green Submitted, gold			2022-12-27	WOS:000281815700015
J	Pericolini, E; Gabrielli, E; Bistoni, G; Cenci, E; Perito, S; Chow, SK; Riuzzi, F; Donato, R; Casadevall, A; Vecchiarelli, A				Pericolini, Eva; Gabrielli, Elena; Bistoni, Giovanni; Cenci, Elio; Perito, Stefano; Chow, Siu-Kei; Riuzzi, Francesca; Donato, Rosario; Casadevall, Arturo; Vecchiarelli, Anna			Role of CD45 Signaling Pathway in Galactoxylomannan-Induced T Cell Damage	PLOS ONE			English	Article							CRYPTOCOCCUS-NEOFORMANS; NEGATIVE REGULATION; CDC25 PHOSPHATASES; INDUCED APOPTOSIS; TYROSINE KINASE; IMMUNE CELLS; ACTIVATION; DEATH; EXPRESSION; LCK	Previously, we reported that Galactoxylomannan (GalXM) activates the extrinsic and intrinsic apoptotic pathways through an interaction with the glycoreceptors on T cells. In this study we establish the role of the glycoreceptor CD45 in GalXM-induced T cell apoptosis, using CD45(+/+) and CD45(-/-) cell lines, derived from BW5147 murine T cell lymphoma. Our results show that whereas CD45 expression is not required for GalXM association by the cells, it is essential for apoptosis induction. In CD45(+/+) cells, CD45 triggering by GalXM reduces the activation of Lck, ZAP70 and Erk1/2. Conversely, in CD45(-/-) cells, Lck was hyperphosphorylated and did not show any modulation after GalXM stimulation. On the whole, our findings provide evidence that the negative regulation of Lck activation occurs via CD45 engagement. This appears to be related to the capacity of GalXM to antagonize T cell activation and induce T cell death. Overall this mechanism may be responsible for the immune paralysis that follows GalXM administration and could explain the powerful immunosuppression that accompanies cryptococcosis.	[Pericolini, Eva; Gabrielli, Elena; Cenci, Elio; Perito, Stefano; Riuzzi, Francesca; Donato, Rosario; Vecchiarelli, Anna] Univ Perugia, Dept Expt Med & Biochem Sci, Microbiol Sect, I-06100 Perugia, Italy; [Pericolini, Eva; Gabrielli, Elena; Cenci, Elio; Perito, Stefano; Riuzzi, Francesca; Donato, Rosario; Vecchiarelli, Anna] Univ Perugia, Dept Expt Med & Biochem Sci, Anat Sect, I-06100 Perugia, Italy; [Bistoni, Giovanni] Univ Roma La Sapienza, Sch Med, Dept Plast & Reconstruct Surg, Rome, Italy; [Chow, Siu-Kei; Casadevall, Arturo] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY USA	University of Perugia; University of Perugia; Sapienza University Rome; Yeshiva University; Albert Einstein College of Medicine	Pericolini, E (corresponding author), Univ Perugia, Dept Expt Med & Biochem Sci, Microbiol Sect, I-06100 Perugia, Italy.	vecchiar@unipg.it	Donato, Rosario/I-3943-2019; Pericolini, Eva/AAZ-5848-2021	CENCI, ELIO/0000-0003-0752-7262; Pericolini, Eva/0000-0002-5299-8197; Vecchiarelli, Anna/0000-0002-3185-6720; Riuzzi, Francesca/0000-0001-7908-3379; PERITO, STEFANO/0000-0003-3181-523X	European Commission (FINSysB Marie Curie Initial Training Network) [PITN-GA-2008-214004]; Istituto Superiore di Sanita [A.DMSS.SEZ8.SPAL09AVEC]; National Institutes of Health [AI33774, AI33142, AI51519, HL59842-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI051519, R01AI033142, R37AI033142, R01AI033774] Funding Source: NIH RePORTER	European Commission (FINSysB Marie Curie Initial Training Network)(European CommissionEuropean Commission Joint Research Centre); Istituto Superiore di Sanita; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research is funded by the European Commission (FINSysB Marie Curie Initial Training Network, PITN-GA-2008-214004) and the Istituto Superiore di Sanita (Spallanzani Project, A.DMSS.SEZ8.SPAL09AVEC). AC is supported by National Institutes of Health Grants AI33774, AI33142, AI51519, and HL59842-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin S, 2008, INT J BIOCHEM CELL B, V40, P1654, DOI 10.1016/j.biocel.2007.05.016; Arimura Y, 2001, J BIOL CHEM, V276, P8550, DOI 10.1074/jbc.M009242200; BELL EB, 1990, NATURE, V348, P163, DOI 10.1038/348163a0; Bickers DR, 2006, J INVEST DERMATOL, V126, P2565, DOI 10.1038/sj.jid.5700340; Brezak MC, 2004, CANCER RES, V64, P3320, DOI 10.1158/0008-5472.CAN-03-3984; Chaka W, 1997, INFECT IMMUN, V65, P272, DOI 10.1128/IAI.65.1.272-278.1997; Chou YK, 2004, J NEUROSCI RES, V77, P670, DOI 10.1002/jnr.20201; Contour-Galcera MO, 2004, BIOORG MED CHEM LETT, V14, P5809, DOI 10.1016/j.bmcl.2004.09.041; Dang AM, 1996, CELL IMMUNOL, V169, P196, DOI 10.1006/cimm.1996.0110; DE JESUS M, 2009, J IMMUNOL, V183, P3885; DEBELDER AN, 1975, CARBOHYD RES, V44, P251, DOI 10.1016/S0008-6215(00)84168-3; DEJESUS M, EUKARYOT CELL; Doro U, 1996, MOL CELL BIOL, V16, P4996; Dupere-Minier G, 2010, APOPTOSIS, V15, P1, DOI 10.1007/s10495-009-0413-z; Earl LA, 2008, IMMUNOL CELL BIOL, V86, P608, DOI 10.1038/icb.2008.46; Fukumori T, 2003, CANCER RES, V63, P8302; Haas A, 2008, CYTOM PART A, V73A, P799, DOI 10.1002/cyto.a.20598; Hermiston ML, 2009, IMMUNOL REV, V228, P288, DOI 10.1111/j.1600-065X.2008.00752.x; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Hernandez JD, 2002, GLYCOBIOLOGY, V12, p127R, DOI 10.1093/glycob/cwf081; Hsu DK, 2002, GLYCOCONJUGATE J, V19, P507, DOI 10.1023/B:GLYC.0000014080.95829.52; Hur YG, 2004, J IMMUNOL, V172, P79, DOI 10.4049/jimmunol.172.1.79; HYMAN R, 1974, J NATL CANCER I, V52, P429, DOI 10.1093/jnci/52.2.429; Irie-Sasaki J, 2003, CURR TOP MED CHEM, V3, P783, DOI 10.2174/1568026033452339; JAMES PG, 1992, INFECT IMMUN, V60, P1084, DOI 10.1128/IAI.60.3.1084-1088.1992; Kirchberger S, 2008, BLOOD, V112, P1240, DOI 10.1182/blood-2008-02-138131; KORETZKY GA, 1991, P NATL ACAD SCI USA, V88, P2037, DOI 10.1073/pnas.88.6.2037; Kunte DP, 2005, FEBS LETT, V579, P3497, DOI 10.1016/j.febslet.2005.05.030; Latinis KM, 1996, BLOOD, V87, P871, DOI 10.1182/blood.V87.3.871.bloodjournal873871; LIM TS, 1980, INFECT IMMUN, V30, P5, DOI 10.1128/IAI.30.1.5-11.1980; Liu FT, 2000, CLIN IMMUNOL, V97, P79, DOI 10.1006/clim.2000.4912; Majeti R, 2000, CELL, V103, P1059, DOI 10.1016/S0092-8674(00)00209-9; McNeill L, 2007, IMMUNITY, V27, P425, DOI 10.1016/j.immuni.2007.07.015; MIGLIORATI G, 1993, BLOOD, V81, P1352; Mustelin T, 2003, BIOCHEM J, V371, P15, DOI 10.1042/BJ20021637; Nguyen JT, 2001, J IMMUNOL, V167, P5697, DOI 10.4049/jimmunol.167.10.5697; Pajusto M, 2004, EUR J IMMUNOL, V34, P2771, DOI 10.1002/eji.200324761; Pericolini E, 2006, CELL MICROBIOL, V8, P267, DOI 10.1111/j.1462-5822.2005.00619.x; Pericolini E, 2009, J IMMUNOL, V182, P6003, DOI 10.4049/jimmunol.0803833; PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0; Rabinovich GA, 2002, TRENDS IMMUNOL, V23, P313, DOI 10.1016/S1471-4906(02)02232-9; SCHRAVEN B, 1995, FEBS LETT, V368, P491, DOI 10.1016/0014-5793(95)00720-T; Sharif-Askari E, 2007, J BIOL CHEM, V282, P36048, DOI 10.1074/jbc.M706007200; Steff AM, 2003, CRIT REV IMMUNOL, V23, P421, DOI 10.1615/CritRevImmunol.v23.i56.40; THOMAS ML, 1989, ANNU REV IMMUNOL, V7, P339, DOI 10.1146/annurev.immunol.7.1.339; TROWBRIDGE IS, 1994, ANNU REV IMMUNOL, V12, P85, DOI 10.1146/annurev.iy.12.040194.000505; UITTENBOGAART CH, 1990, INT IMMUNOL, V2, P1180; Vaishnav VV, 1998, CARBOHYD RES, V306, P315, DOI 10.1016/S0008-6215(97)10058-1; Villena SN, 2008, CELL MICROBIOL, V10, P1274, DOI 10.1111/j.1462-5822.2008.01125.x; WALLACE VA, 1992, J EXP MED, V176, P1657, DOI 10.1084/jem.176.6.1657; Wang HY, 2001, MOL CELL, V7, P331, DOI 10.1016/S1097-2765(01)00181-2; Wang XT, 2000, J BIOL CHEM, V275, P39435, DOI 10.1074/jbc.M004583200; Wang YN, 2005, J BIOL CHEM, V280, P14318, DOI 10.1074/jbc.M413265200; WEGENER AMK, 1992, CELL, V68, P83, DOI 10.1016/0092-8674(92)90208-T; Xu Z, 2002, NAT IMMUNOL, V3, P764, DOI 10.1038/ni822; Zaragoza O, 2009, ADV APPL MICROBIOL, V68, P133, DOI 10.1016/S0065-2164(09)01204-0	56	22	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2010	5	9							e12720	10.1371/journal.pone.0012720	http://dx.doi.org/10.1371/journal.pone.0012720			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZO	20856869	Green Published, Green Submitted, gold			2022-12-27	WOS:000281815700010
J	Hartbauer, M; Ofner, E; Grossauer, V; Siemers, BM				Hartbauer, Manfred; Ofner, Elisabeth; Grossauer, Viktoria; Siemers, Bjoern M.			The Cercal Organ May Provide Singing Tettigoniids a Backup Sensory System for the Detection of Eavesdropping Bats	PLOS ONE			English	Article							COCKROACH PERIPLANETA-AMERICANA; GIANT INTERNEURON SYSTEM; MOUSE-EARED BATS; PARASPHENDALE-AGRIONINA; TELEOGRYLLUS-OCEANICUS; ECHOLOCATION CALLS; AVOIDANCE-BEHAVIOR; FORAGING STRATEGY; FEEDING-BEHAVIOR; MYOTIS-MYOTIS	Conspicuous signals, such as the calling songs of tettigoniids, are intended to attract mates but may also unintentionally attract predators. Among them bats that listen to prey-generated sounds constitute a predation pressure for many acoustically communicating insects as well as frogs. As an adaptation to protect against bat predation many insect species evolved auditory sensitivity to bat-emitted echolocation signals. Recently, the European mouse-eared bat species Myotis myotis and M. blythii oxygnathus were found to eavesdrop on calling songs of the tettigoniid Tettigonia cantans. These gleaning bats emit rather faint echolocation signals when approaching prey and singing insects may have difficulty detecting acoustic predator-related signals. The aim of this study was to determine (1) if loud self-generated sound produced by European tettigoniids impairs the detection of pulsed ultrasound and (2) if wind-sensors on the cercal organ function as a sensory backup system for bat detection in tettigoniids. We addressed these questions by combining a behavioral approach to study the response of two European tettigoniid species to pulsed ultrasound, together with an electrophysiological approach to record the activity of wind-sensitive interneurons during real attacks of the European mouse-eared bat species Myotis myotis. Results showed that singing T. cantans males did not respond to sequences of ultrasound pulses, whereas singing T. viridissima did respond with predominantly brief song pauses when ultrasound pulses fell into silent intervals or were coincident with the production of soft hemi-syllables. This result, however, strongly depended on ambient temperature with a lower probability for song interruption observable at 21 degrees C compared to 28 degrees C. Using extracellular recordings, dorsal giant interneurons of tettigoniids were shown to fire regular bursts in response to attacking bats. Between the first response of wind-sensitive interneurons and contact, a mean time lag of 860 ms was found. This time interval corresponds to a bat-to-prey distance of ca. 72 cm. This result demonstrates the efficiency of the cercal system of tettigoniids in detecting attacking bats and suggests this sensory system to be particularly valuable for singing insects that are targeted by eavesdropping bats.	[Hartbauer, Manfred; Ofner, Elisabeth; Grossauer, Viktoria] Karl Franzens Univ Graz, Dept Zool, Graz, Austria; [Siemers, Bjoern M.] Max Planck Inst Ornithol, Sensory Ecol Grp, Seewiesen, Germany	University of Graz; Max Planck Society	Hartbauer, M (corresponding author), Karl Franzens Univ Graz, Dept Zool, Graz, Austria.	manfred.hartbauer@uni-graz.at			Austrian Science fund [P 21808-B09]; Max Planck Society; Austrian Science Fund (FWF) [P 21808] Funding Source: researchfish	Austrian Science fund(Austrian Science Fund (FWF)); Max Planck Society(Max Planck SocietyFoundation CELLEX); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Dr. Heinrich Joerg Stiftung (Graz, Austria) generously supported E. Ofner's visit to perform experiments at the Max Planck Institute for Ornithology in Seewiesen. This study was further funded by the Austrian Science fund project P 21808-B09 and the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya L, 1998, BEHAV ECOL, V9, P552, DOI 10.1093/beheco/9.6.552; ANDERSON ME, 1991, ANIM BEHAV, V42, P489, DOI 10.1016/S0003-3472(05)80048-X; Andersson Malte, 1994; Arlettaz R, 1996, ANIM BEHAV, V51, P1, DOI 10.1006/anbe.1996.0001; Arlettaz R, 2001, NATURE, V414, P742, DOI 10.1038/414742a; Arlettaz R, 1995, SYM ZOOL S, P361; Bailey WJ, 1998, J ZOOL, V244, P505, DOI 10.1111/j.1469-7998.1998.tb00056.x; Belwood J. J, 1990, TETTIGONIIDAE BIOL S, P8; BELWOOD JJ, 1987, SCIENCE, V238, P64, DOI 10.1126/science.238.4823.64; BOYAN GS, 1989, J COMP PHYSIOL A, V165, P523, DOI 10.1007/BF00611239; BOYAN GS, 1990, PROG NEUROBIOL, V35, P217, DOI 10.1016/0301-0082(90)90028-F; BOYAN GS, 1988, J NEUROSCI, V8, P2748; BUCHLER ER, 1981, ANIM BEHAV, V29, P428, DOI 10.1016/S0003-3472(81)80102-9; CAMHI JM, 1978, J COMP PHYSIOL, V128, P193, DOI 10.1007/BF00656852; EDWARDS JS, 1986, J COMP NEUROL, V243, P535, DOI 10.1002/cne.902430408; ENDLER JA, 1980, EVOLUTION, V34, P76, DOI 10.1111/j.1558-5646.1980.tb04790.x; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; Eyherabide HG, 2008, FRONT COMPUT NEUROSC, V2, DOI 10.3389/neuro.10.003.2008; FAURE PA, 1993, J EXP BIOL, V178, P173; Faure PA, 2000, J COMP PHYSIOL A, V186, P129, DOI 10.1007/s003590050013; FULLARD JH, 1993, TRENDS ECOL EVOL, V8, P248, DOI 10.1016/0169-5347(93)90200-9; GANIHAR D, 1994, J COMP PHYSIOL A, V175, P49, DOI 10.1007/BF00217436; GNATZY W, 1990, J COMP PHYSIOL A, V167, P551, DOI 10.1007/BF00190826; GNATZY W, 1986, NATURWISSENSCHAFTEN, V73, P212, DOI 10.1007/BF00417728; Goerlitz HR, 2008, J EXP BIOL, V211, P2799, DOI 10.1242/jeb.019596; GRAS H, 1992, J EXP BIOL, V171, P189; Greenfield MD, 2003, ETHOLOGY, V109, P427, DOI 10.1046/j.1439-0310.2003.00886.x; Hartbauer M, 2010, J EXP BIOL, V213, P3036, DOI 10.1242/jeb.042432; Heller K.-G., 1988, BIOAKUSTIK EUROPAISC; HOY RR, 1992, EVOLUTIONARY BIOLOGY OF HEARING, P115; HOY RR, 1989, ANNU REV NEUROSCI, V12, P355, DOI 10.1146/annurev.ne.12.030189.002035; Hoy RR, 1996, ANNU REV ENTOMOL, V41, P433, DOI 10.1146/annurev.en.41.010196.002245; JATHO M, 1992, RHYTHMOGENESIS NEURO; JONES PL, 2010, BEHAV ECOL IN PRESS; Krahe R, 2004, NAT REV NEUROSCI, V5, P13, DOI 10.1038/nrn1296; Land BR, 2001, J NEUROSCI METH, V106, P47, DOI 10.1016/S0165-0270(01)00328-4; Lehmann GUC, 1998, BEHAV ECOL SOCIOBIOL, V43, P239, DOI 10.1007/s002650050488; LIBERSAT F, 1991, J COMP PHYSIOL A, V169, P507, DOI 10.1007/BF00197663; Marsat G, 2006, J NEUROSCI, V26, P10542, DOI 10.1523/JNEUROSCI.2221-06.2006; Millar JS, 2001, BRIT J GEN PRACT, V51, P570; MILLER LA, 1979, J COMP PHYSIOL, V131, P113, DOI 10.1007/BF00619071; Miller Lee A., 1993, Bioacoustics, V5, P67; MORRIS GK, 1994, J ZOOL, V233, P129, DOI 10.1111/j.1469-7998.1994.tb05266.x; NEUWEILER G, 1989, TRENDS ECOL EVOL, V4, P160, DOI 10.1016/0169-5347(89)90120-1; Neuweiler G., 2000, BIOL BATS; NIELSEN E T, 1970, Behaviour, V37, P205, DOI 10.1163/156853970X00358; Norman AP, 1999, ANIM BEHAV, V57, P829, DOI 10.1006/anbe.1998.1028; Poulet JFA, 2002, NATURE, V418, P872, DOI 10.1038/nature00919; RAMME W, 1920, ARCH NATURG A, V12, P123; Ratcliffe JM, 2003, ANIM BEHAV, V66, P847, DOI 10.1006/anbe.2003.2297; RHEINLAENDER J, 1972, J COMP PHYSIOL, V77, P208, DOI 10.1007/BF00693607; RHEINLAENDER J, 1980, J COMP PHYSIOL, V140, P101, DOI 10.1007/BF00606302; RITZMANN RE, 1981, J COMP PHYSIOL, V143, P61, DOI 10.1007/BF00606069; RITZMANN RE, 1978, J COMP PHYSIOL, V125, P305, DOI 10.1007/BF00656865; RITZMANN RE, 1982, J COMP PHYSIOL, V147, P313, DOI 10.1007/BF00609665; Russo D, 2007, J EXP BIOL, V210, P166, DOI 10.1242/jeb.02644; RYAN MJ, 1987, J COMP PHYSIOL A, V161, P59, DOI 10.1007/BF00609455; SAKALUK SK, 1984, ANIM BEHAV, V32, P659, DOI 10.1016/S0003-3472(84)80141-4; Sales GD, 1974, ULTRASONIC COMMUNICA; Schul J, 1998, J COMP PHYSIOL A, V182, P687, DOI 10.1007/s003590050213; Schul J, 2000, P ROY SOC B-BIOL SCI, V267, P1711, DOI 10.1098/rspb.2000.1199; Schulze W, 2001, J EXP BIOL, V204, P733; Siemers BM, 2006, CURR BIOL, V16, pR157, DOI 10.1016/j.cub.2006.02.056; Siemers BM, 2006, BEHAV ECOL SOCIOBIOL, V59, P373, DOI 10.1007/s00265-005-0060-5; SPANGLER HG, 1984, SOUTHWEST NAT, V29, P481, DOI 10.2307/3671001; Surlykke A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002036; Swift SM, 2002, BEHAV ECOL SOCIOBIOL, V52, P408, DOI 10.1007/s00265-002-0531-x; TER HOFSTEDE HM, 2009, J COMP PHYSIOL A, V195, P769; TER HOFSTEDE HM, 2010, J COMP PHYSIOL A, V196, P349; TER HOFSTEDE HM, 2008, J EXP BIOL, V211, P2431; TER HOFSTEDE HM, 2008, BEHAV ECOL SOCIOBIOL, V63, P217; TOBIAS M, 1979, J COMP PHYSIOL, V129, P51, DOI 10.1007/BF00679911; Triblehorn JD, 2008, J EXP BIOL, V211, P555, DOI 10.1242/jeb.005736; Triblehorn JD, 2006, J EXP BIOL, V209, P1430, DOI 10.1242/jeb.02132; TUTTLE MD, 1985, ANIM BEHAV, V33, P1369, DOI 10.1016/S0003-3472(85)80204-9; TUTTLE MD, 1981, SCIENCE, V214, P677, DOI 10.1126/science.214.4521.677; Waters DA, 1996, J EXP BIOL, V199, P847; WATERS DA, 1995, J EXP BIOL, V198, P475; WERNER TK, 1981, CAN J ZOOL, V59, P525, DOI 10.1139/z81-076; Wyttenbach RA, 1996, SCIENCE, V273, P1542, DOI 10.1126/science.273.5281.1542; YAGER DD, 1990, J EXP BIOL, V152, P17; Yager DD, 1999, MICROSC RES TECHNIQ, V47, P380, DOI 10.1002/(SICI)1097-0029(19991215)47:6<380::AID-JEMT3>3.0.CO;2-P; Zuk M, 1998, EVOLUTION, V52, P166, DOI 10.2307/2410931; Zuk M, 1998, Q REV BIOL, V73, P415, DOI 10.1086/420412	84	5	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2010	5	9							e12698	10.1371/journal.pone.0012698	http://dx.doi.org/10.1371/journal.pone.0012698			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648ZZ	20856887	Green Published, gold, Green Submitted			2022-12-27	WOS:000281735700016
J	Nicastro, G; Todi, SV; Karaca, E; Bonvin, AMJJ; Paulson, HL; Pastore, A				Nicastro, Giuseppe; Todi, Sokol V.; Karaca, Ezgi; Bonvin, Alexandre M. J. J.; Paulson, Henry L.; Pastore, Annalisa			Understanding the Role of the Josephin Domain in the PolyUb Binding and Cleavage Properties of Ataxin-3	PLOS ONE			English	Article							POLYGLUTAMINE DISEASE PROTEIN; UBIQUITIN CHAINS; POLYUBIQUITIN CHAINS; STRUCTURAL DETERMINANTS; MEDIATED PROTEOLYSIS; TRANSGENIC MICE; IN-VITRO; PROTEASOME; PATHWAY; RECOGNITION	Ataxin-3, the disease protein in the neurodegenerative disorder Spinocerebellar Ataxia Type 3 or Machado Joseph disease, is a cysteine protease implicated in the ubiquitin proteasome pathway. It contains multiple ubiquitin binding sites through which it anchors polyubiquitin chains of different linkages that are then cleaved by the N-terminal catalytic (Josephin) domain. The properties of the ubiquitin interacting motifs (UIMs) in the C-terminus of ataxin-3 are well established. Very little is known, however, about how two recently identified ubiquitin-binding sites in the Josephin domain contribute to ubiquitin chain binding and cleavage. In the current study, we sought to define the specific contribution of the Josephin domain to the catalytic properties of ataxin-3 and assess how the topology and affinity of these binding sites modulate ataxin-3 activity. Using NMR we modeled the structure of diUb/Josephin complexes and showed that linkage preferences are imposed by the topology of the two binding sites. Enzymatic studies further helped us to determine a precise hierarchy between the sites. We establish that the structure of Josephin dictates specificity for K48-linked chains. Site 1, which is close to the active site, is indispensable for cleavage. Our studies open the way to understand better the cellular function of ataxin-3 and its link to pathology.	[Nicastro, Giuseppe; Pastore, Annalisa] Natl Inst Med Res, MRC, London NW7 1AA, England; [Todi, Sokol V.; Paulson, Henry L.] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Karaca, Ezgi; Bonvin, Alexandre M. J. J.] Univ Utrecht, Fac Sci, Bijvoet Ctr Biomol Res, Utrecht, Netherlands	MRC National Institute for Medical Research; University of Michigan System; University of Michigan; Utrecht University	Nicastro, G (corresponding author), Natl Inst Med Res, MRC, London NW7 1AA, England.	apastor@nimr.mrc.ac.uk	Bonvin, Alexandre M.J.J./A-5420-2009	Bonvin, Alexandre M.J.J./0000-0001-7369-1322; Karaca, Ezgi/0000-0002-4926-7991; TODI, SOKOL/0000-0003-4399-5549	Netherlands Organization for Scientific Research [700.56.442];  [1K99NS064097];  [R01 NS38712]; MRC [MC_U117533887, MC_U117584256] Funding Source: UKRI; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS064097, R01NS038712] Funding Source: NIH RePORTER; Medical Research Council [MC_U117584256, MC_U117533887] Funding Source: researchfish	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); ; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported by 1K99NS064097 (SVT), R01 NS38712 (HLP) and a VICI grant (700.56.442) from the Netherlands Organization for Scientific Research (AMJJB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Saadon R, 2006, MOL CELL, V24, P701, DOI 10.1016/j.molcel.2006.10.022; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Berke SJS, 2004, J NEUROCHEM, V89, P908, DOI 10.1111/j.1471-4159.2004.02369.x; Burnett B, 2003, HUM MOL GENET, V12, P3195, DOI 10.1093/hmg/ddg344; Chai YH, 1999, HUM MOL GENET, V8, P673, DOI 10.1093/hmg/8.4.673; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Doss-Pepe EW, 2003, MOL CELL BIOL, V23, P6469, DOI 10.1128/MCB.23.18.6469-6483.2003; Eddins MJ, 2007, J MOL BIOL, V367, P204, DOI 10.1016/j.jmb.2006.12.065; Ellisdon AM, 2006, J BIOL CHEM, V281, P16888, DOI 10.1074/jbc.M601470200; Gales L., 2005, J MOL BIOL, V26, P26; Goti D, 2004, J NEUROSCI, V24, P10266, DOI 10.1523/JNEUROSCI.2734-04.2004; Gould VFC, 2007, NEUROBIOL DIS, V27, P362, DOI 10.1016/j.nbd.2007.06.005; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Jung J, 2009, HUM MOL GENET, V18, P4843, DOI 10.1093/hmg/ddp456; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Krzeminski M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-51; Lee LK, 1997, J BIOMOL NMR, V9, P287, DOI 10.1023/A:1018631009583; Maciejewski MW, 2000, J MOL BIOL, V296, P229, DOI 10.1006/jmbi.1999.3455; Masino L, 2004, J MOL BIOL, V344, P1021, DOI 10.1016/j.jmb.2004.09.065; Masino L, 2003, FEBS LETT, V549, P21, DOI 10.1016/S0014-5793(03)00748-8; Nicastro G, 2005, P NATL ACAD SCI USA, V102, P10493, DOI 10.1073/pnas.0501732102; Nicastro G, 2004, J BIOMOL NMR, V30, P457, DOI 10.1007/s10858-004-4343-3; Nicastro G, 2009, BIOPOLYMERS, V91, P1203, DOI 10.1002/bip.21210; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pickart CM, 2005, METHOD ENZYMOL, V399, P21, DOI 10.1016/S0076-6879(05)99002-2; Pickart CM, 1997, FASEB J, V11, P1055, DOI 10.1096/fasebj.11.13.9367341; RIESS O, 2007, CEREBELLUM, V30, P1; Sims JJ, 2009, MOL CELL, V33, P775, DOI 10.1016/j.molcel.2009.02.011; Todi SV, 2007, J BIOL CHEM, V282, P29348, DOI 10.1074/jbc.M704126200; Varadan R, 2005, MOL CELL, V18, P687, DOI 10.1016/j.molcel.2005.05.013; Varadan R, 2002, J MOL BIOL, V324, P637, DOI 10.1016/S0022-2836(02)01198-1; Varshavsky A, 2005, TRENDS BIOCHEM SCI, V30, P283, DOI 10.1016/j.tibs.2005.04.005; Wang GH, 2000, HUM MOL GENET, V9, P1795, DOI 10.1093/hmg/9.12.1795; Winborn BJ, 2008, J BIOL CHEM, V283, P26436, DOI 10.1074/jbc.M803692200	41	50	50	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12430	10.1371/journal.pone.0012430	http://dx.doi.org/10.1371/journal.pone.0012430			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865150	Green Published, Green Submitted, gold			2022-12-27	WOS:000281292100025
J	Aronsson, L; Huang, Y; Parini, P; Korach-Andre, M; Hakansson, J; Gustafsson, JA; Pettersson, S; Arulampalam, V; Rafter, J				Aronsson, Linda; Huang, Ying; Parini, Paolo; Korach-Andre, Marion; Hakansson, Janet; Gustafsson, Jan-Ake; Pettersson, Sven; Arulampalam, Velmurugesan; Rafter, Joseph			Decreased Fat Storage by Lactobacillus Paracasei Is Associated with Increased Levels of Angiopoietin-Like 4 Protein (ANGPTL4)	PLOS ONE			English	Article							CHOLESTEROL ACYLTRANSFERASE-2; LIPOPROTEIN-LIPASE; GASSERI SBT2055; GUT MICROBIOME; TARGET GENE; MICE; MODULATION; PROBIOTICS; OBESITY; PLASMA	Background: Intervention strategies for obesity are global issues that require immediate attention. One approach is to exploit the growing consensus that beneficial gut microbiota could be of use in intervention regimes. Our objective was to determine the mechanism by which the probiotic bacteria Lactobacillus paracasei ssp paracasei F19 (F19) could alter fat storage. Angiopoietin-like 4 (ANGPTL4) is a circulating lipoprotein lipase (LPL) inhibitor that controls triglyceride deposition into adipocytes and has been reported to be regulated by gut microbes. Methodology/Principal Findings: A diet intervention study of mice fed high-fat chow supplemented with F19 was carried out to study potential mechanistic effects on fat storage. Mice given F19 displayed significantly less body fat, as assessed by magnetic resonance imaging, and a changed lipoprotein profile. Given that previous studies on fat storage have identified ANGPTL4 as an effector, we also investigated circulating levels of ANGPTL4, which proved to be higher in the F19-treated group. This increase, together with total body fat and triglyceride levels told a story of inhibited LPL action through ANGPTL4 leading to decreased fat storage. Co-culture experiments of colonic cell lines and F19 were set up in order to monitor any ensuing alterations in ANGPTL4 expression by qPCR. We observed that potentially secreted factors from F19 can induce ANGPTL4 gene expression, acting in part through the peroxisome proliferator activated receptors alpha and gamma. To prove validity of in vitro findings, germ-free mice were monocolonized with F19. Here we again found changes in serum triglycerides as well as ANGPTL4 in response to F19. Conclusions/Significance: Our results provide an interesting mechanism whereby modifying ANGPTL4, a central player in fat storage regulation, through manipulating gut flora could be an important gateway upon which intervention trials of weight management can be based.	[Aronsson, Linda; Huang, Ying; Pettersson, Sven; Arulampalam, Velmurugesan] Karolinska Inst, Dept Microbiol Cell & Tumor Biol, Stockholm, Sweden; [Huang, Ying; Parini, Paolo; Korach-Andre, Marion; Gustafsson, Jan-Ake; Rafter, Joseph] Karolinska Inst, Dept Biosci & Nutr NOVUM, Huddinge, Sweden; [Parini, Paolo] Karolinska Inst, Dept Lab Med, Huddinge, Sweden; [Hakansson, Janet] Arla Foods Nord Innovat, Stockholm, Sweden; [Gustafsson, Jan-Ake] Univ Houston, Dept Biol & Biochem, Houston, TX USA	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; University of Houston System; University of Houston	Aronsson, L (corresponding author), Karolinska Inst, Dept Microbiol Cell & Tumor Biol, Stockholm, Sweden.	velmurugesan.arulampalam@ki.se; joseph.rafter@ki.se	Korach-André, Marion/AAC-3545-2022; Korach-André, Marion/A-8920-2017; Pettersson, Sven/F-9511-2015	Korach-André, Marion/0000-0003-3292-9124; 	Vinnova Sweden; Swedish Research Council; Soderberg Foundation; Heart-Lung Foundation; EU [222720-2]	Vinnova Sweden(Vinnova); Swedish Research Council(Swedish Research CouncilEuropean Commission); Soderberg Foundation; Heart-Lung Foundation(Swedish Heart-Lung Foundation); EU(European Commission)	This work was supported by Vinnova Sweden, the Swedish Research Council, the Soderberg Foundation, the Heart-Lung Foundation, and the EU project TORNADO (Framework 7, grant no. 222720-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed W, 2007, J INTERN MED, V262, P184, DOI 10.1111/j.1365-2796.2007.01825.x; Ali AA, 2005, J NUTR BIOCHEM, V16, P693, DOI 10.1016/j.jnutbio.2005.03.011; Are A, 2008, P NATL ACAD SCI USA, V105, P1943, DOI 10.1073/pnas.0711734105; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Fernandez ML, 2007, NUTR REV, V65, pS30, DOI [10.1111/j.1753-4887.2007.tb00325.x, 10.1301/nr.2007.jun.S30-S34]; Hamad EM, 2009, BRIT J NUTR, V101, P716, DOI 10.1017/S0007114508043808; HENNIG J, 1986, MAGNET RESON MED, V3, P823, DOI 10.1002/mrm.1910030602; Kadooka Y, 2010, EUR J CLIN NUTR, V64, P636, DOI 10.1038/ejcn.2010.19; Kersten S, 2000, J BIOL CHEM, V275, P28488, DOI 10.1074/jbc.M004029200; Lee HY, 2006, BBA-MOL CELL BIOL L, V1761, P736, DOI 10.1016/j.bbalip.2006.05.007; Lee RG, 2004, CIRC RES, V95, P998, DOI 10.1161/01.RES.0000147558.15554.67; Lichtenstein L, 2007, ARTERIOSCL THROM VAS, V27, P2420, DOI 10.1161/ATVBAHA.107.151894; Lundin A, 2008, CELL MICROBIOL, V10, P1093, DOI 10.1111/j.1462-5822.2007.01108.x; Mandard S, 2004, J BIOL CHEM, V279, P34411, DOI 10.1074/jbc.M403058200; Parini P, 2006, EUR J CLIN INVEST, V36, P98, DOI 10.1111/j.1365-2362.2006.01597.x; Rastall RA, 2005, FEMS MICROBIOL ECOL, V52, P145, DOI 10.1016/j.femsec.2005.01.003; Sukonina V, 2006, P NATL ACAD SCI USA, V103, P17450, DOI 10.1073/pnas.0604026103; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Willner EL, 2003, P NATL ACAD SCI USA, V100, P1262, DOI 10.1073/pnas.0336398100; Yoon JC, 2000, MOL CELL BIOL, V20, P5343, DOI 10.1128/MCB.20.14.5343-5349.2000; Yoshida K, 2002, J LIPID RES, V43, P1770, DOI 10.1194/jlr.C200010-JLR200	23	199	213	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e13087	10.1371/journal.pone.0013087	http://dx.doi.org/10.1371/journal.pone.0013087			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20927337	Green Submitted, Green Published, gold			2022-12-27	WOS:000282312600020
J	Elze, T				Elze, Tobias			Misspecifications of Stimulus Presentation Durations in Experimental Psychology: A Systematic Review of the Psychophysics Literature	PLOS ONE			English	Review							MASKING; CONTOUR	Background: In visual psychophysics, precise display timing, particularly for brief stimulus presentations, is often required. The aim of this study was to systematically review the commonly applied methods for the computation of stimulus durations in psychophysical experiments and to contrast them with the true luminance signals of stimuli on computer displays. Methodology/Principal Findings: In a first step, we systematically scanned the citation index Web of Science for studies with experiments with stimulus presentations for brief durations. Articles which appeared between 2003 and 2009 in three different journals were taken into account if they contained experiments with stimuli presented for less than 50 milliseconds. The 79 articles that matched these criteria were reviewed for their method of calculating stimulus durations. For those 75 studies where the method was either given or could be inferred, stimulus durations were calculated by the sum of frames (SOF) method. In a second step, we describe the luminance signal properties of the two monitor technologies which were used in the reviewed studies, namely cathode ray tube (CRT) and liquid crystal display (LCD) monitors. We show that SOF is inappropriate for brief stimulus presentations on both of these technologies. In extreme cases, SOF specifications and true stimulus durations are even unrelated. Furthermore, the luminance signals of the two monitor technologies are so fundamentally different that the duration of briefly presented stimuli cannot be calculated by a single method for both technologies. Statistics over stimulus durations given in the reviewed studies are discussed with respect to different duration calculation methods. Conclusions/Significance: The SOF method for duration specification which was clearly dominating in the reviewed studies leads to serious misspecifications particularly for brief stimulus presentations. We strongly discourage its use for brief stimulus presentations on CRT and LCD monitors.	Max Planck Inst Math Sci, Res Grp Complex Struct Biol & Cognit, Leipzig, Germany	Max Planck Society	Elze, T (corresponding author), Max Planck Inst Math Sci, Res Grp Complex Struct Biol & Cognit, Leipzig, Germany.	Tobias.Elze@mis.mpg.de		Elze, Tobias/0000-0002-2032-0496				Bacon-Mace N, 2005, VISION RES, V45, P1459, DOI 10.1016/j.visres.2005.01.004; Becker ME, 2008, SID INT SYMP DIG TEC, V39, P24, DOI 10.1889/1.3069637; Brainard D.H., 2002, ENCY IMAGING SCI TEC, P172, DOI DOI 10.1002/0471443395.IMG011; Breitmeyer B., 2006, VISUAL MASKING; Breitmeyer BG, 2006, VISION RES, V46, P2645, DOI 10.1016/j.visres.2005.10.020; Bridgeman B, 1998, PSYCHOL SCI, V9, P232, DOI 10.1111/1467-9280.00045; Chappell M, 2006, VISION RES, V46, P3205, DOI 10.1016/j.visres.2006.04.017; Cheong AMY, 2007, VISION RES, V47, P2943, DOI 10.1016/j.visres.2007.07.010; Elze T, 2010, J NEUROSCI METH, V191, P171, DOI 10.1016/j.jneumeth.2010.06.018; Elze T, 2009, MED PHYS, V36, P4984, DOI 10.1118/1.3238154; KANWISHER NG, 1987, COGNITION, V27, P117, DOI 10.1016/0010-0277(87)90016-3; Liang HY, 2007, MED PHYS, V34, P639, DOI 10.1118/1.2428403; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lleras A, 2003, J EXP PSYCHOL HUMAN, V29, P106, DOI 10.1037/0096-1523.29.1.106; METHA AB, 1993, BEHAV RES METH INSTR, V25, P371, DOI 10.3758/BF03204528; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moore CM, 2005, J EXP PSYCHOL HUMAN, V31, P1171, DOI 10.1037/0096-1523.31.6.1171; Nieuwenstein MR, 2005, J EXP PSYCHOL HUMAN, V31, P1463, DOI 10.1037/0096-1523.31.6.1463; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Robson T, 1998, VISION RES PRACTICAL, P81; Sanborn AN, 2004, VISION RES, V44, P1427, DOI 10.1016/j.visres.2004.01.004; SHERR S, 1993, ELECT DISPLAYS; SPERLING G, 1971, BEHAV RES METH INSTR, V3, P151, DOI 10.3758/BF03209940; Travis D, 1991, EFFECTIVE COLOR DISP; van Gaal S, 2009, J EXP PSYCHOL HUMAN, V35, P1129, DOI 10.1037/a0013551; Werner H, 1935, AM J PSYCHOL, V47, P40, DOI 10.2307/1416707	26	32	32	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e12792	10.1371/journal.pone.0012792	http://dx.doi.org/10.1371/journal.pone.0012792			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	655SI	20927362	Green Submitted, Green Published, gold			2022-12-27	WOS:000282269400002
J	Ho, BK; Agard, DA				Ho, Bosco K.; Agard, David A.			An Improved Strategy for Generating Forces in Steered Molecular Dynamics: The Mechanical Unfolding of Titin, e2lip3 and Ubiquitin	PLOS ONE			English	Article							IMMUNOGLOBULIN DOMAINS; SIMULATION; PROTEIN; MICROSCOPY; KINASE; AFM	One of the applications of Molecular Dynamics (MD) simulations is to explore the energetic barriers to mechanical unfolding of proteins such as occurs in response to the mechanical pulling of single molecules in Atomic Force Microscopy (AFM) experiments. Although Steered Molecular Dynamics simulations have provided microscopic details of the unfolding process during the pulling, the simulated forces required for unfolding are typically far in excess of the measured values. To rectify this, we have developed the Pulsed Unconstrained Fluctuating Forces (PUFF) method, which induces constant-momentum motions by applying forces directly to the instantaneous velocity of selected atoms in a protein system. The driving forces are applied in pulses, which allows the system to relax between pulses, resulting in more accurate unfolding force estimations than in previous methods. In the cases of titin, ubiquitin and e2lip3, the PUFF trajectories produce force fluctuations that agree quantitatively with AFM experiments. Another useful property of PUFF is that simulations get trapped if the target momentum is too low, simplifying the discovery and analysis of unfolding intermediates.	[Ho, Bosco K.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biophys & Biochem, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ho, BK (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	boscoh@gmail.com			Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was funded by the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banavali NK, 2007, PROTEINS, V67, P1096, DOI 10.1002/prot.21334; Bockmann RA, 2002, NAT STRUCT BIOL, V9, P198, DOI 10.1038/nsb760; Brockwell DJ, 2003, NAT STRUCT BIOL, V10, P731, DOI 10.1038/nsb968; Carrion-Vazquez M, 2003, NAT STRUCT BIOL, V10, P738, DOI 10.1038/nsb965; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Duan Y, 1998, SCIENCE, V282, P740, DOI 10.1126/science.282.5389.740; Fowler SB, 2002, J MOL BIOL, V322, P841, DOI 10.1016/S0022-2836(02)00805-7; Gao M, 2001, BIOPHYS J, V81, P2268, DOI 10.1016/S0006-3495(01)75874-2; Grubmuller H, 1996, SCIENCE, V271, P997, DOI 10.1126/science.271.5251.997; GUILBERT C, 1995, COMPUT PHYS COMMUN, V91, P263, DOI 10.1016/0010-4655(95)00052-H; Ho BK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000343; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Klepeis JL, 2009, CURR OPIN STRUC BIOL, V19, P120, DOI 10.1016/j.sbi.2009.03.004; Lei HX, 2007, CURR OPIN STRUC BIOL, V17, P187, DOI 10.1016/j.sbi.2007.03.003; Lu H, 1999, CHEM PHYS, V247, P141, DOI 10.1016/S0301-0104(99)00164-0; Lu H, 2000, BIOPHYS J, V79, P51, DOI 10.1016/S0006-3495(00)76273-4; Lu H, 1998, BIOPHYS J, V75, P662, DOI 10.1016/S0006-3495(98)77556-3; Ma JP, 2002, STRUCTURE, V10, P921, DOI 10.1016/S0969-2126(02)00789-X; Marszalek PE, 1999, NATURE, V402, P100, DOI 10.1038/47083; NORTHRUP SH, 1982, P NATL ACAD SCI-BIOL, V79, P4035, DOI 10.1073/pnas.79.13.4035; Oberhauser AF, 2001, P NATL ACAD SCI USA, V98, P468, DOI 10.1073/pnas.021321798; PACI E, 2000, UNFOLDING PROTEINS E, P6521; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Wang JY, 2006, BIOPHYS J, V91, P2798, DOI 10.1529/biophysj.106.084301	24	10	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e13068	10.1371/journal.pone.0013068	http://dx.doi.org/10.1371/journal.pone.0013068			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20927369	Green Published, gold, Green Submitted			2022-12-27	WOS:000282269400019
J	Nishino, K; Toyoda, M; Yamazaki-Inoue, M; Makino, H; Fukawatase, Y; Chikazawa, E; Takahashi, Y; Miyagawa, Y; Okita, H; Kiyokawa, N; Akutsu, H; Umezawa, A				Nishino, Koichiro; Toyoda, Masashi; Yamazaki-Inoue, Mayu; Makino, Hatsune; Fukawatase, Yoshihiro; Chikazawa, Emi; Takahashi, Yoriko; Miyagawa, Yoshitaka; Okita, Hajime; Kiyokawa, Nobutaka; Akutsu, Hidenori; Umezawa, Akihiro			Defining Hypo-Methylated Regions of Stem Cell-Specific Promoters in Human iPS Cells Derived from Extra-Embryonic Amnions and Lung Fibroblasts	PLOS ONE			English	Article							GENE-EXPRESSION; DNA METHYLATION; SOMATIC-CELLS; PLURIPOTENT; QUANTIFICATION; GENERATION; INDUCTION; LINKING; SYSTEM; LINES	Background: Human induced pluripotent stem (iPS) cells are currently used as powerful resources in regenerative medicine. During very early developmental stages, DNA methylation decreases to an overall low level at the blastocyst stage, from which embryonic stem cells are derived. Therefore, pluripotent stem cells, such as ES and iPS cells, are considered to have hypo-methylated status compared to differentiated cells. However, epigenetic mechanisms of "stemness'' remain unknown in iPS cells derived from extra-embryonic and embryonic cells. Methodology/Principal Findings: We examined genome-wide DNA methylation (24,949 CpG sites covering 1,3862 genes, mostly selected from promoter regions) with six human iPS cell lines derived from human amniotic cells and fetal lung fibroblasts as well as two human ES cell lines, and eight human differentiated cell lines using Illumina's Infinium HumanMethylation27. A considerable fraction (807 sites) exhibited a distinct difference in the methylation level between the iPS/ES cells and differentiated cells, with 87.6% hyper-methylation seen in iPS/ES cells. However, a limited fraction of CpG sites with hypo-methylation was found in promoters of genes encoding transcription factors. Thus, a group of genes becomes active through a decrease of methylation in their promoters. Twenty-three genes including SOX15, SALL4, TDGF1, PPP1R16B and SOX10 as well as POU5F1 were defined as genes with hypo-methylated SS-DMR (Stem cell-Specific Differentially Methylated Region) and highly expression in iPS/ES cells. Conclusions/Significance: We show that DNA methylation profile of human amniotic iPS cells as well as fibroblast iPS cells, and defined the SS-DMRs. Knowledge of epigenetic information across iPS cells derived from different cell types can be used as a signature for "stemness'' and may allow us to screen for optimum iPS/ES cells and to validate and monitor iPS/ES cell derivatives for human therapeutic applications.	[Nishino, Koichiro; Toyoda, Masashi; Yamazaki-Inoue, Mayu; Makino, Hatsune; Fukawatase, Yoshihiro; Chikazawa, Emi; Takahashi, Yoriko; Akutsu, Hidenori; Umezawa, Akihiro] Natl Inst Child Hlth & Dev, Dept Reprod Biol, Tokyo, Japan; [Miyagawa, Yoshitaka; Okita, Hajime; Kiyokawa, Nobutaka] Natl Inst Child Hlth & Dev, Dept Dev Biol, Tokyo, Japan	National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan	Nishino, K (corresponding author), Natl Inst Child Hlth & Dev, Dept Reprod Biol, Tokyo, Japan.	umezawa@1985.jukuin.keio.ac.jp		Miyagawa, Yoshitaka/0000-0003-2629-7503	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Ministry of Health, Labour and Welfare Sciences (MHLW); Japan Health Science Foundation; Pharmaceuticals and Medical Devices Agency	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare Sciences (MHLW)(Ministry of Health, Labour and Welfare, Japan); Japan Health Science Foundation; Pharmaceuticals and Medical Devices Agency	This study was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Ministry of Health, Labour and Welfare Sciences (MHLW) research grants; by a Research Grant on Health Science focusing on Drug Innovation from the Japan Health Science Foundation; by the program for the promotion of Fundamental Studies in Health Science of the Pharmaceuticals and Medical Devices Agency; by a Research Grant for Cardiovascular Disease from the MHLW; and by a Grant for Child Health and Development from the MHLW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bibikova M, 2008, CELL STEM CELL, V2, P123, DOI 10.1016/j.stem.2008.01.005; Bibikova M, 2006, GENOME RES, V16, P1075, DOI 10.1101/gr.5319906; Brena RM, 2006, NAT PROTOC, V1, P52, DOI 10.1038/nprot.2006.8; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Cui CH, 2007, MOL BIOL CELL, V18, P1586, DOI 10.1091/mbc.E06-09-0872; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Hattori N, 2004, J BIOL CHEM, V279, P17063, DOI 10.1074/jbc.M309002200; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; JACOBS JP, 1970, NATURE, V227, P168, DOI 10.1038/227168a0; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Maherali N, 2009, CURR BIOL, V19, P1718, DOI 10.1016/j.cub.2009.08.025; Makino H, 2009, EXP CELL RES, V315, P2727, DOI 10.1016/j.yexcr.2009.06.016; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mori T, 2005, MOL CELL BIOL, V25, P5183, DOI 10.1128/MCB.25.12.5183-5195.2005; Nagata S, 2009, GENES CELLS, V14, P1395, DOI 10.1111/j.1365-2443.2009.01356.x; Nishino K, 2004, J BIOL CHEM, V279, P22306, DOI 10.1074/jbc.M309513200; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sharov AA, 2005, BIOINFORMATICS, V21, P2548, DOI 10.1093/bioinformatics/bti343; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004; ZINGG JM, 1994, NUCLEIC ACIDS RES, V22, P2234, DOI 10.1093/nar/22.12.2234	43	42	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e13017	10.1371/journal.pone.0013017	http://dx.doi.org/10.1371/journal.pone.0013017			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20885964	Green Submitted, Green Published, gold			2022-12-27	WOS:000282167100018
J	Melnychuk, MC; Welch, DW; Walters, CJ				Melnychuk, Michael C.; Welch, David W.; Walters, Carl J.			Spatio-Temporal Migration Patterns of Pacific Salmon Smolts in Rivers and Coastal Marine Waters	PLOS ONE			English	Article							JUVENILE COHO SALMON; STOCK-SPECIFIC MIGRATIONS; WIRE TAG RECOVERIES; SOCKEYE-SALMON; ONCORHYNCHUS-KISUTCH; ATLANTIC SALMON; CONTINENTAL-SHELF; VANCOUVER-ISLAND; WEST-COAST; SURVIVAL	Background: Migrations allow animals to find food resources, rearing habitats, or mates, but often impose considerable predation risk. Several behavioural strategies may reduce this risk, including faster travel speed and taking routes with shorter total distance. Descriptions of the natural range of variation in migration strategies among individuals and populations is necessary before the ecological consequences of such variation can be established. Methodology/Principal Findings: Movements of tagged juvenile coho, steelhead, sockeye, and Chinook salmon were quantified using a large-scale acoustic tracking array in southern British Columbia, Canada. Smolts from 13 watersheds (49 watershed/species/year combinations) were tagged between 2004-2008 and combined into a mixed-effects model analysis of travel speed. During the downstream migration, steelhead were slower on average than other species, possibly related to freshwater residualization. During the migration through the Strait of Georgia, coho were slower than steelhead and sockeye, likely related to some degree of inshore summer residency. Hatchery-reared smolts were slower than wild smolts during the downstream migration, but after ocean entry, average speeds were similar. In small rivers, downstream travel speed increased with body length, but in the larger Fraser River and during the coastal migration, average speed was independent of body length. Smolts leaving rivers located towards the northern end of the Strait of Georgia ecosystem migrated strictly northwards after ocean entry, but those from rivers towards the southern end displayed split-route migration patterns within populations, with some moving southward. Conclusions/Significance: Our results reveal a tremendous diversity of behavioural migration strategies used by juvenile salmon, across species, rearing histories, and habitats, as well as within individual populations. During the downstream migration, factors that had strong effects on travel speeds included species, wild or hatchery-rearing history, watershed size and, in smaller rivers, body length. During the coastal migration, travel speeds were only strongly affected by species differences.	[Melnychuk, Michael C.; Walters, Carl J.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Melnychuk, Michael C.; Walters, Carl J.] Univ British Columbia, Fisheries Ctr, Vancouver, BC V5Z 1M9, Canada; [Welch, David W.] Kintama Res Corp, Nanaimo, BC, Canada	University of British Columbia; University of British Columbia	Melnychuk, MC (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA.	mmel@u.washington.edu	Walters, Carl/D-5714-2012; Melnychuk, Michael/A-4680-2013	Melnychuk, Michael/0000-0002-6088-7657	Alfred P. Sloan Foundation; Gordon and Betty Moore Foundation; Pacific Salmon Foundation [07350-35/FSWP 07 I D1]; Pacific Salmon Commission; CN Railway through the Cheakamus Ecosystem Restoration Technical Committee [17R32878]; B.C. Pacific Salmon Forum; Natural Sciences and Engineering Research Council of Canada	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Pacific Salmon Foundation; Pacific Salmon Commission; CN Railway through the Cheakamus Ecosystem Restoration Technical Committee; B.C. Pacific Salmon Forum; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Sources of funding were: Alfred P. Sloan Foundation (www.sloan.org), Gordon and Betty Moore Foundation (www.moore.org), Pacific Salmon Foundation (Grant number 07350-35/FSWP 07 I D1; www.psf.ca), Pacific Salmon Commission (www.psc.org), CN Railway through the Cheakamus Ecosystem Restoration Technical Committee (Grant numbers 17R32878, and Monitor2-ProjectF; www.cn.ca/en/ and www.certc.ca), B.C. Pacific Salmon Forum (www.pacificsalmonforum.ca). M. M. was supported by a Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JJ, 2005, ECOL MODEL, V186, P196, DOI 10.1016/j.ecolmodel.2005.01.014; [Anonymous], 1981, CAN SPEC PUBL FISH A; Bauer S, 2009, BIOL LETTERS, V5, P433, DOI 10.1098/rsbl.2009.0324; BEAMISH RJ, 1992, T AM FISH SOC, V121, P444, DOI 10.1577/1548-8659(1992)121<0444:SDPOCA>2.3.CO;2; Brodeur RD, 2007, AM FISH S S, V57, P183; Brodeur Richard D., 2003, North Pacific Anadromous Fish Commission Bulletin, V3, P89; Chittenden CM, 2009, T AM FISH SOC, V138, P1220, DOI 10.1577/T09-037.1; Collis K, 2001, T AM FISH SOC, V130, P385, DOI 10.1577/1548-8659(2001)130<0385:CWPOJS>2.0.CO;2; Giorgi A. E., 1997, North American Journal of Fisheries Management, V17, P268, DOI 10.1577/1548-8675(1997)017<0268:FTITDM>2.3.CO;2; Godfrey H., 1975, Bulletin Int N Pacif Fish Commn, VNo. 31, P1; GROOT C, 1987, FISH B-NOAA, V85, P455; Groot C., 1987, Canadian Special Publication of Fisheries and Aquatic Sciences, V96, P53; Healey MC, 1980, SALMONID ECOSYSTEMS, P203; Hedger RD, 2008, MAR ECOL PROG SER, V355, P235, DOI 10.3354/meps07239; Heupel MR, 2006, MAR FRESHWATER RES, V57, P1, DOI 10.1071/MF05091; Hobbs NT, 2006, ECOL APPL, V16, P5, DOI 10.1890/04-0645; Kallio-Nyberg I, 1999, CAN J FISH AQUAT SCI, V56, P853, DOI 10.1139/cjfas-56-5-853; Laake JL, 2002, FISH B-NOAA, V100, P434; Labelle M, 1997, CAN J FISH AQUAT SCI, V54, P1433, DOI 10.1139/cjfas-54-7-1433; McKinnell S, 1999, FISH OCEANOGR, V8, P104, DOI 10.1046/j.1365-2419.1999.00098.x; Melnychuk M.C., 2009, THESIS U BRIT COLUMB; Melnychuk MC, 2007, HYDROBIOLOGIA, V582, P55, DOI 10.1007/s10750-006-0541-1; Melnychuk MC, 2010, CAN J FISH AQUAT SCI, V67, P641, DOI 10.1139/F09-199; Miller BA, 2003, T AM FISH SOC, V132, P546, DOI 10.1577/1548-8659(2003)132<0546:RTASMO>2.0.CO;2; MOORE A, 1990, J FISH BIOL, V37, P713, DOI 10.1111/j.1095-8649.1990.tb02535.x; Moore ME, 2010, T AM FISH SOC, V139, P49, DOI 10.1577/T09-012.1; Morris JFT, 2007, AM FISH S S, V57, P81; MOSER ML, 1991, CAN J FISH AQUAT SCI, V48, P1670, DOI 10.1139/f91-198; Olesiuk PF, 1996, S9510 PSARC; PEARCY WG, 1988, FISH B-NOAA, V86, P173; Pinheiro J, 2001, MIXED EFFECTS MODELS; Quinn T. P, 2018, BEHAV ECOLOGY PACIFI; RICKER W. E., 1938, JOUR FISH RES BD CANADA, V4, P192; ROSE GA, 1993, NATURE, V366, P458, DOI 10.1038/366458a0; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Secor DH, 1999, FISH RES, V43, P13, DOI 10.1016/S0165-7836(99)00064-8; SKALSKI JR, 2006, DESIGN ANAL SALMONID, V20; Trudel M, 2009, T AM FISH SOC, V138, P1369, DOI 10.1577/T08-181.1; Tucker S, 2009, T AM FISH SOC, V138, P1458, DOI 10.1577/T08-211.1; Welch DW, 2007, HYDROBIOLOGIA, V582, P289, DOI 10.1007/s10750-006-0553-x; Welch DW, 2009, CAN J FISH AQUAT SCI, V66, P736, DOI 10.1139/F09-032; Welch DW, 2002, OCEANOL ACTA, V25, P243, DOI 10.1016/S0399-1784(02)01206-9; WOOD CC, 1993, CAN J FISH AQUAT SCI, V50, P1329, DOI 10.1139/f93-151; WOOD CC, 1987, CAN J FISH AQUAT SCI, V44, P941, DOI 10.1139/f87-112; WOOD CC, AM FISH SOC IN PRESS; Zimmerman CE, 2000, CAN J FISH AQUAT SCI, V57, P2152, DOI 10.1139/cjfas-57-10-2152; Zuur Alain F., 2009, P1; [No title captured]	48	51	51	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12916	10.1371/journal.pone.0012916	http://dx.doi.org/10.1371/journal.pone.0012916			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886121	Green Submitted, gold, Green Published			2022-12-27	WOS:000282091100021
J	Papp, M; Norman, GL; Vitalis, Z; Tornai, I; Altorjay, I; Foldi, I; Udvardy, M; Shums, Z; Dinya, T; Orosz, P; Lombay, B; Par, G; Par, A; Veres, G; Csak, T; Osztovits, J; Szalay, F; Lakatos, PL				Papp, Maria; Norman, Gary L.; Vitalis, Zsuzsanna; Tornai, Istvan; Altorjay, Istvan; Foldi, Ildiko; Udvardy, Miklos; Shums, Zakera; Dinya, Tamas; Orosz, Peter; Lombay, Bela, Jr.; Par, Gabriella; Par, Alajos; Veres, Gabor; Csak, Timea; Osztovits, Janos; Szalay, Ferenc; Lakatos, Peter Laszlo			Presence of Anti-Microbial Antibodies in Liver Cirrhosis - A Tell-Tale Sign of Compromised Immunity?	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE ANTIBODIES; SPONTANEOUS BACTERIAL PERITONITIS; LIPOPOLYSACCHARIDE-BINDING PROTEIN; PRIMARY SCLEROSING CHOLANGITIS; SMALL-BOWEL; ANTIBIOTIC-PROPHYLAXIS; ALCOHOLIC CIRRHOSIS; SEROLOGICAL MARKERS; MICROBIAL ANTIGENS; CELIAC-DISEASE	Background: Bacterial translocation plays important role in the complications of liver cirrhosis. Antibody formation against various microbial antigens is common in Crohn's disease and considered to be caused by sustained exposure to gut microflora constituents. We hypothesized that anti-microbial antibodies are present in patients with liver cirrhosis and may be associated with the development of bacterial infections. Methodology/Principal Findings: Sera of 676 patients with various chronic liver diseases (autoimmune diseases: 266, viral hepatitis C: 124, and liver cirrhosis of different etiology: 286) and 100 controls were assayed for antibodies to Saccharomyces cerevisiae(ASCA) and to antigens derived from two intestinal bacterial isolates (one gram positive, one gram negative, neither is Escherichia coli). In patients with liver cirrhosis, we also prospectively recorded the development of severe episodes of bacterial infection. ASCA and anti-OMP Plus (TM) antibodies were present in 38.5% and 62.6% of patients with cirrhosis and in 16% and 20% of controls, respectively (p<0.001). Occurrence of these antibodies was more frequent in cases of advanced cirrhosis (according to Child-Pugh and MELD score; p<0.001) or in the presence of ascites (p<0.001). During the median follow-up of 425 days, 81 patients (28.3%) presented with severe bacterial infections. Anti-microbial antibody titers (p = 0.003), as well as multiple seroreactivity (p = 0.036), was associated with infectious events. In logistic regression analysis, the presence of ascites (OR: 1.62, 95% CI: 1.16-2.25), co-morbidities (OR: 2.22, 95% CI: 1.27-3.86), and ASCA positivity (OR: 1.59, 95% CI: 1.07-2.36) were independent risk factors for severe infections. A shorter time period until the first infection was associated with the presence of ASCA (p = 0.03) and multiple seropositivity (p = 0.037) by Kaplan-Meier analysis, and with Child-Pugh stage (p = 0.018, OR: 1.85) and co-morbidities (p<0.001, OR: 2.02) by Cox-regression analysis. Conclusions/Significance: The present study suggests that systemic reactivity to microbial components reflects compromised mucosal immunity in patients with liver cirrhosis, further supporting the possible role of bacterial translocation in the formation of anti-microbial antibodies.	[Papp, Maria; Vitalis, Zsuzsanna; Tornai, Istvan; Altorjay, Istvan; Foldi, Ildiko; Udvardy, Miklos] Univ Debrecen, Dept Med 2, H-4012 Debrecen, Hungary; [Norman, Gary L.; Shums, Zakera] INOVA Diagnost Inc, San Diego, CA USA; [Dinya, Tamas] Univ Debrecen, Inst Surg, H-4012 Debrecen, Hungary; [Orosz, Peter] Borsod Abauj Zemplen Cty Hosp, Gastroenterol Dept Med, Miskolc, Hungary; [Lombay, Bela, Jr.] Szent Ferenc Hosp, Dept Med, Miskolc, Hungary; [Par, Gabriella; Par, Alajos] Univ Pecs, Dept Med 1, Pecs, Hungary; [Veres, Gabor] Semmelweis Univ, Dept Pediat 1, H-1085 Budapest, Hungary; [Csak, Timea; Osztovits, Janos; Szalay, Ferenc; Lakatos, Peter Laszlo] Semmelweis Univ, Dept Med 1, H-1085 Budapest, Hungary	University of Debrecen; Inova Diagnostics, Inc.; University of Debrecen; University of Pecs; Semmelweis University; Semmelweis University	Papp, M (corresponding author), Univ Debrecen, Dept Med 2, H-4012 Debrecen, Hungary.	drpappm@yahoo.com	Lakatos, Peter L/B-2131-2008; Lakatos, Peter/Q-4797-2019	Lakatos, Peter L/0000-0002-3948-6488; Lakatos, Peter/0000-0002-3948-6488	Institute of Internal Medicine	Institute of Internal Medicine	Maria Papp was supported by the Research Development Grant (Institute of Internal Medicine). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Gary L. Norman and Zakera Shums are employees of INOVA Diagnostics, Inc. and as such INOVA Diagnostics also played a role in the study design, data analysis and preparation of the manuscript.	Albillos A, 2004, LANCET, V363, P1608, DOI 10.1016/S0140-6736(04)16206-5; Albillos A, 2004, J HEPATOL, V40, P624, DOI 10.1016/j.jhep.2003.12.010; Albillos A, 2003, HEPATOLOGY, V37, P208, DOI 10.1053/jhep.2003.50038; ALTORJAY I, 2010, J HEPATOL        JUN; Alvarez E, 1999, J HEPATOL, V31, P929, DOI 10.1016/S0168-8278(99)80297-9; [Anonymous], 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002907; Appenrodt B, 2010, HEPATOLOGY, V51, P1327, DOI 10.1002/hep.23440; Balzan S, 2007, J GASTROEN HEPATOL, V22, P464, DOI 10.1111/j.1440-1746.2007.04933.x; Bauer TM, 2001, AM J GASTROENTEROL, V96, P2962, DOI 10.1111/j.1572-0241.2001.04668.x; Bernard B, 1999, HEPATOLOGY, V29, P1655, DOI 10.1002/hep.510290608; Bhonchal S, 2008, J GASTROEN HEPATOL, V23, pE43, DOI 10.1111/j.1440-1746.2007.05080.x; Borzio M, 2001, DIGEST LIVER DIS, V33, P41, DOI 10.1016/S1590-8658(01)80134-1; CALY WR, 1993, J HEPATOL, V18, P353, DOI 10.1016/S0168-8278(05)80280-6; Cirera I, 2001, J HEPATOL, V34, P32, DOI 10.1016/S0168-8278(00)00013-1; De Palma GD, 2005, GASTROINTEST ENDOSC, V62, P529, DOI 10.1016/S0016-5107(05)01588-9; Durand F, 2005, J HEPATOL, V42, pS100, DOI 10.1016/j.jhep.2004.11.015; Fernandez J, 2007, GASTROENTEROLOGY, V133, P818, DOI 10.1053/j.gastro.2007.06.065; Gaj P, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-81; Garcia-Tsao G, 2004, BEST PRACT RES CL GA, V18, P353, DOI 10.1016/j.bpg.2003.10.005; GARCIATSAO G, 1995, GASTROENTEROLOGY, V108, P1835, DOI 10.1016/0016-5085(95)90147-7; Granito A, 2006, GUT, V55, P296; Guarner C, 2005, EUR J GASTROEN HEPAT, V17, P27, DOI 10.1097/00042737-200501000-00006; Gunnarsdottir SA, 2003, AM J GASTROENTEROL, V98, P1362, DOI 10.1016/S0002-9270(03)00250-8; Henckaerts L, 2007, GUT, V56, P1536, DOI 10.1136/gut.2007.125468; Hill PG, 2008, ALIMENT PHARM THER, V27, P572, DOI 10.1111/j.1365-2036.2008.03609.x; Kamath PS, 2007, HEPATOLOGY, V45, P797, DOI 10.1002/hep.21563; Kaplan MM, 2005, NEW ENGL J MED, V353, P1261, DOI 10.1056/NEJMra043898; LAKATOS PL, 2004, Z GASTROENTEROL, V42, P423; Maria P, 2007, INFLAMM BOWEL DIS, V13, P984, DOI 10.1002/ibd.20146; MEHTA A, 2009, DISCOVERY ANTIBODY P; Mei L, 2006, GASTROENTEROLOGY, V130, P1078, DOI 10.1053/j.gastro.2006.02.013; Morencos FC, 1996, DIGEST DIS SCI, V41, P552, DOI 10.1007/BF02282340; Mow WS, 2004, GASTROENTEROLOGY, V126, P414, DOI 10.1053/j.gastro.2003.11.015; Muratori P, 2003, CLIN EXP IMMUNOL, V132, P473, DOI 10.1046/j.1365-2249.2003.02166.x; Norman K, 2008, CURR OPIN CLIN NUTR, V11, P613, DOI 10.1097/MCO.0b013e32830a70bc; Papp M, 2008, AM J GASTROENTEROL, V103, P665, DOI 10.1111/j.1572-0241.2007.01652.x; Papp M, 2007, WORLD J GASTROENTERO, V13, P2028, DOI 10.3748/wjg.v13.i14.2028; Papp M, 2009, WORLD J GASTROENTERO, V15, P3891, DOI 10.3748/wjg.15.3891; Pohl J, 2006, EUR J GASTROEN HEPAT, V18, P69, DOI 10.1097/00042737-200601000-00012; Reddy KR, 2001, AM J GASTROENTEROL, V96, P252; Rieder F, 2010, INFLAMM BOWEL DIS, V16, P263, DOI 10.1002/ibd.21046; Saab S, 2009, AM J GASTROENTEROL, V104, P993, DOI 10.1038/ajg.2009.3; Saitoh O, 1999, WORLD J GASTROENTERO, V5, P391; Sakly W, 2008, DIGEST DIS SCI, V53, P1983, DOI 10.1007/s10620-007-0092-y; Singh N, 2003, CLIN MICROBIOL INFEC, V9, P531, DOI 10.1046/j.1469-0691.2003.00691.x; Tandon P, 2008, SEMIN LIVER DIS, V28, P26, DOI 10.1055/s-2008-1040319; Thalheimer U, 2005, GUT, V54, P556, DOI 10.1136/gut.2004.048181; Toumi D, 2007, SCAND J GASTROENTERO, V42, P821, DOI 10.1080/00365520601154996; Vermeire S, 2008, GASTROENTEROL CLIN N, V37, P429, DOI 10.1016/j.gtc.2008.03.001; Weismueller TJ, 2008, J HEPATOL, V48, pS38, DOI 10.1016/j.jhep.2008.01.020; Wiest R, 2005, HEPATOLOGY, V41, P422, DOI 10.1002/hep.20632; Yagmur E, 2006, DEUT MED WOCHENSCHR, V131, P1930, DOI 10.1055/s-2006-949189; YOSHIDA H, 1993, AM J GASTROENTEROL, V88, P2067; Zapater P, 2008, HEPATOLOGY, V48, P1924, DOI 10.1002/hep.22564	54	43	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12957	10.1371/journal.pone.0012957	http://dx.doi.org/10.1371/journal.pone.0012957			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886039	Green Submitted, Green Published, gold			2022-12-27	WOS:000282091100052
J	Yamada, A; Ishimaru, N; Arakaki, R; Katunuma, N; Hayashi, Y				Yamada, Akiko; Ishimaru, Naozumi; Arakaki, Rieko; Katunuma, Nobuhiko; Hayashi, Yoshio			Cathepsin L Inhibition Prevents Murine Autoimmune Diabetes via Suppression of CD8(+) T Cell Activity	PLOS ONE			English	Article							DIPEPTIDYL PEPTIDASE-I; LYSOSOMAL CYSTEINE PROTEASES; ANTIGEN PRESENTATION; INVARIANT CHAIN; NOD MICE; VITRO; TOLERANCE; VIVO; CYCLOPHOSPHAMIDE; ACTIVATION	Background: Type 1 diabetes (T1D) is an autoimmune disease resulting from defects in central and peripheral tolerance and characterized by T cell-mediated destruction of islet beta cells. To determine whether specific lysosomal proteases might influence the outcome of a T cell-mediated autoimmune response, we examined the functional significance of cathepsin inhibition on autoimmune T1D-prone non-obese diabetic (NOD) mice. Methods and Findings: Here it was found that specific inhibition of cathepsin L affords strong protection from cyclophosphamide (CY)-induced insulitis and diabetes of NOD mice at the advanced stage of CD8(+) T cell infiltration via inhibiting granzyme activity. It was discovered that cathepsin L inhibition prevents cytotoxic activity of CD8(+) T cells in the pancreatic islets through controlling dipeptidyl peptidase I activity. Moreover, the gene targeting for cathepsin L with application of in vivo siRNA administration successfully prevented CY-induced diabetes of NOD mice. Finally, cathepsin L mRNA expression of peripheral CD8(+) T cells from NOD mice developing spontaneous T1D was significantly increased compared with that from control mice. Conclusions: Our results identified a novel function of cathepsin L as an enzyme whose activity is essential for the progression of CD8(+) T cell-mediated autoimmune diabetes, and inhibition of cathepsin L as a powerful therapeutic strategy for autoimmune diabetes.	[Yamada, Akiko; Ishimaru, Naozumi; Arakaki, Rieko; Hayashi, Yoshio] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Oral Mol Pathol, Tokushima 770, Japan; [Katunuma, Nobuhiko] Tokushima Bunri Univ, Inst Hlth Sci, Tokushima, Japan	Tokushima University; Tokushima Bunri University	Yamada, A (corresponding author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Oral Mol Pathol, Tokushima 770, Japan.	hayashi@dent.tokushima-u.ac.jp			Ministry of Education, Science, Sport, and Culture of Japan [17109016, 17689049]; Uehara Memorial Foundation; Takeda Science Foundation	Ministry of Education, Science, Sport, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF))	This study was supported in part by a Grant-in-Aid for Scientific Research (nos. 17109016 and 17689049) from the Ministry of Education, Science, Sport, and Culture of Japan, from the Uehara Memorial Foundation, and Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asagiri M, 2008, SCIENCE, V319, P624, DOI 10.1126/science.1150110; Atkinson MA, 1999, NAT MED, V5, P601, DOI 10.1038/9442; Bertolino P, 1996, CRIT REV IMMUNOL, V16, P359; Brode S, 2006, J IMMUNOL, V177, P6603, DOI 10.4049/jimmunol.177.10.6603; BROWN GR, 1993, J IMMUNOL, V150, P4733; CHARLTON B, 1989, DIABETES, V38, P441, DOI 10.2337/diabetes.38.4.441; Chen ZB, 2005, J EXP MED, V202, P1387, DOI 10.1084/jem.20051409; Conus S, 2008, BIOCHEM PHARMACOL, V76, P1374, DOI 10.1016/j.bcp.2008.07.041; Cryer PE, 2002, DIABETOLOGIA, V45, P937, DOI 10.1007/s00125-002-0822-9; Dahl SW, 2001, BIOCHEMISTRY-US, V40, P1671, DOI 10.1021/bi001693z; Delovitch TL, 1997, IMMUNITY, V7, P727, DOI 10.1016/S1074-7613(00)80392-1; Di Lorenzo TP, 2007, CLIN EXP IMMUNOL, V148, P1, DOI 10.1111/j.1365-2249.2006.03244.x; DiLorenzo TP, 2005, IMMUNOL REV, V204, P250, DOI 10.1111/j.0105-2896.2005.00244.x; GOLDBERG RB, 2009, J CLIN ENDOCR METAB, V94, P9172; HARADA M, 1984, DIABETOLOGIA, V27, P604, DOI 10.1007/BF00276978; Herman AE, 2004, J EXP MED, V199, P1479, DOI 10.1084/jem.20040179; Honey K, 2002, J EXP MED, V195, P1349, DOI 10.1084/jem.20011904; Hsieh CS, 2002, J IMMUNOL, V168, P2618, DOI 10.4049/jimmunol.168.6.2618; Hsing LC, 2005, IMMUNOL REV, V207, P229, DOI 10.1111/j.0105-2896.2005.00310.x; Hsing LC, 2010, J AUTOIMMUN, V34, P96, DOI 10.1016/j.jaut.2009.07.003; Ishidoh K, 2002, BIOL CHEM, V383, P1827, DOI 10.1515/BC.2002.206; Katunuma N, 1999, FEBS LETT, V458, P6, DOI 10.1016/S0014-5793(99)01107-2; Kinouchi N, 2008, GENE THER, V15, P1126, DOI 10.1038/gt.2008.24; Kopitar-Jerala N, 2006, FEBS LETT, V580, P6295, DOI 10.1016/j.febslet.2006.10.055; Kreuwel HTC, 2001, J IMMUNOL, V167, P1112, DOI 10.4049/jimmunol.167.2.1112; Mabee CL, 1998, J IMMUNOL, V160, P5880; Maehr R, 2005, J CLIN INVEST, V115, P2934, DOI 10.1172/JCI25485; Mao JN, 2008, J CELL BIOCHEM, V105, P1073, DOI 10.1002/jcb.21910; Minakuchi Y, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh093; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; Nakagawa TY, 1999, IMMUNITY, V10, P207, DOI 10.1016/S1074-7613(00)80021-7; Papaccio G, 2000, ENDOCRINOLOGY, V141, P1500, DOI 10.1210/en.141.4.1500; Pham CTN, 1999, P NATL ACAD SCI USA, V96, P8627, DOI 10.1073/pnas.96.15.8627; Quinn A, 2001, J IMMUNOL, V167, P1748, DOI 10.4049/jimmunol.167.3.1748; Saegusa K, 2002, J CLIN INVEST, V110, P361, DOI 10.1172/JCI200214682; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Sant AJ, 2005, IMMUNOL REV, V207, P261, DOI 10.1111/j.0105-2896.2005.00307.x; Singh B, 2001, IMMUNOL REV, V182, P190, DOI 10.1034/j.1600-065X.2001.1820115.x; SMYTH MJ, 1995, J IMMUNOL, V154, P6299; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Thiele DL, 1997, J IMMUNOL, V158, P5200; Tsuge H, 1999, BIOCHEM BIOPH RES CO, V266, P411, DOI 10.1006/bbrc.1999.1830; Turk B, 2000, BBA-PROTEIN STRUCT M, V1477, P98, DOI 10.1016/S0167-4838(99)00263-0; Wu YL, 2003, DIABETES, V52, P2279, DOI 10.2337/diabetes.52.9.2279; Yang H, 2005, J IMMUNOL, V174, P1729, DOI 10.4049/jimmunol.174.3.1729; Yang M, 2007, NAT CELL BIOL, V9, P970, DOI 10.1038/ncb1623; Zhang TQ, 2001, BIOCHEM BIOPH RES CO, V283, P499, DOI 10.1006/bbrc.2001.4795	50	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12894	10.1371/journal.pone.0012894	http://dx.doi.org/10.1371/journal.pone.0012894			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877570	gold, Green Published, Green Submitted			2022-12-27	WOS:000282053100028
J	Bader, HL; Ruhe, AL; Wang, LW; Wong, AK; Walsh, KF; Packer, RA; Mitelman, J; Robertson, KR; O'Brien, DP; Broman, KW; Shelton, GD; Apte, SS; Neff, MW				Bader, Hannah L.; Ruhe, Alison L.; Wang, Lauren W.; Wong, Aaron K.; Walsh, Kari F.; Packer, Rebecca A.; Mitelman, Jonathan; Robertson, Kathryn R.; O'Brien, Dennis P.; Broman, Karl W.; Shelton, G. Diane; Apte, Suneel S.; Neff, Mark W.			An ADAMTSL2 Founder Mutation Causes Musladin-Lueke Syndrome, a Heritable Disorder of Beagle Dogs, Featuring Stiff Skin and Joint Contractures	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; WEILL-MARCHESANI-SYNDROME; MARFAN-SYNDROME; ECTOPIA LENTIS; MOUSE MODEL; FIBRILLIN; PROTEIN; DNA; MICROFIBRILS; PATHOGENESIS	Background: Musladin-Lueke Syndrome (MLS) is a hereditary disorder affecting Beagle dogs that manifests with extensive fibrosis of the skin and joints. In this respect, it resembles human stiff skin syndrome and the Tight skin mouse, each of which is caused by gene defects affecting fibrillin-1, a major component of tissue microfibrils. The objective of this work was to determine the genetic basis of MLS and the molecular consequence of the identified mutation. Methodology and Principal Findings: We mapped the locus for MLS by genome-wide association to a 3.05 Mb haplotype on canine chromosome 9 (CFA9 (50.11-54.26; p(raw) <10(-7))), which was homozygous and identical-by-descent among all affected dogs, consistent with recessive inheritance of a founder mutation. Sequence analysis of a candidate gene at this locus, ADAMTSL2, which is responsible for the human TGF beta dysregulation syndrome, Geleophysic Dysplasia (GD), uncovered a mutation in exon 7 (c.660C>T; p.R221C) perfectly associated with MLS (p-value = 10(-12)). Murine ADAMTSL2 containing the p.R221C mutation formed anomalous disulfide-bonded dimers when transiently expressed in COS-1, HEK293F and CHO cells, and was present in the medium of these cells at lower levels than wild-type ADAMTSL2 expressed in parallel. Conclusions/Significance: The genetic basis of MLS is a founder mutation in ADAMTSL2, previously shown to interact with latent TGF-beta binding protein, which binds fibrillin-1. The molecular effect of the founder mutation on ADAMTSL2 is formation of disulfide-bonded dimers. Although caused by a distinct mutation, and having a milder phenotype than human GD, MLS nevertheless offers a new animal model for study of GD, and for prospective insights on mechanisms and pathways of skin fibrosis and joint contractures.	[Bader, Hannah L.; Wang, Lauren W.; Apte, Suneel S.] Cleveland Clin, Lerner Res Inst, Dept Biomed Engn, Cleveland, OH 44106 USA; [Ruhe, Alison L.; Wong, Aaron K.; Walsh, Kari F.; Robertson, Kathryn R.; Neff, Mark W.] Univ Calif Davis, Vet Genet Lab, Davis, CA 95616 USA; [Packer, Rebecca A.] Purdue Univ, Dept Vet Clin Sci, W Lafayette, IN 47907 USA; [Mitelman, Jonathan] Kingston Rd Anim Hosp, Toronto, ON, Canada; [O'Brien, Dennis P.] Univ Missouri, Dept Vet Med & Surg, Columbia, MO USA; [Broman, Karl W.] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI USA; [Shelton, G. Diane] Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92093 USA	Cleveland Clinic Foundation; University of California System; University of California Davis; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Missouri System; University of Missouri Columbia; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California San Diego	Bader, HL (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Biomed Engn, Cleveland, OH 44106 USA.	mark.neff@vai.org		Apte, Suneel/0000-0001-8441-1226; Wong, Aaron/0000-0002-7294-0646; Broman, Karl/0000-0002-4914-6671	Veterinary Genetics Laboratory of UC Davis; National Institutes of Health [AR53890, T32HL007914-08]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053890] Funding Source: NIH RePORTER	Veterinary Genetics Laboratory of UC Davis; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by intramural funds from the Veterinary Genetics Laboratory of UC Davis and by National Institutes of Health award AR53890 (S. Apte) and T32HL007914-08 (Training Program in Vascular Biology and Pathology, Principal Investigator: Edward Plow) awarded to H. Bader. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahram D, 2009, AM J HUM GENET, V84, P274, DOI 10.1016/j.ajhg.2009.01.007; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Apte SS, 2009, J BIOL CHEM, V284, P31493, DOI 10.1074/jbc.R109.052340; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; Bona C A, 1997, DNA Res, V4, P267, DOI 10.1093/dnares/4.4.267; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; Carta L, 2006, J BIOL CHEM, V281, P8016, DOI 10.1074/jbc.M511599200; Dagoneau N, 2004, AM J HUM GENET, V75, P801, DOI 10.1086/425231; Dallas SL, 2000, J BONE MINER RES, V15, P68, DOI 10.1359/jbmr.2000.15.1.68; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Faivre L, 2003, AM J MED GENET A, V123A, P204, DOI 10.1002/ajmg.a.20289; Faivre L, 2003, J MED GENET, V40, P34, DOI 10.1136/jmg.40.1.34; Fontana L, 2005, FASEB J, V19, P1798, DOI 10.1096/fj.05-4134com; Gayraud B, 2000, J CELL BIOL, V150, P667, DOI 10.1083/jcb.150.3.667; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Judge DP, 2004, J CLIN INVEST, V114, P172, DOI 10.1172/JCI200420641; Kielty CM, 1998, J CELL BIOL, V140, P1159, DOI 10.1083/jcb.140.5.1159; Koo BH, 2007, MATRIX BIOL, V26, P431, DOI 10.1016/j.matbio.2007.03.003; KUTZ WE, 2008, HUM MUTAT; Lange K, 2005, GENET EPIDEMIOL, V29, P36, DOI 10.1002/gepi.20073; Le Goff Carine, 2009, Pediatr Endocrinol Rev, V6, P418; LEGOFF C, 2008, NAT GENET; Loeys BL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000488; LONNQVIST L, 1994, GENOMICS, V19, P573, DOI 10.1006/geno.1994.1110; Morales J, 2009, AM J HUM GENET, V85, P558, DOI 10.1016/j.ajhg.2009.09.011; Musladin JM, 1998, NEW BEAGLE DOG ALL S, Vsecond; Nakajima Y, 1997, J CELL BIOL, V136, P193, DOI 10.1083/jcb.136.1.193; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Oberbauer AM, 2003, VET RES COMMUN, V27, P27, DOI 10.1023/A:1022006606796; Oetting WS, 1995, GENOMICS, V30, P450, DOI 10.1006/geno.1995.1264; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; Robinson PN, 2006, J MED GENET, V43, P769, DOI 10.1136/jmg.2005.039669; Saharinen J, 1996, EMBO J, V15, P245, DOI 10.1002/j.1460-2075.1996.tb00355.x; SPRANGER J, 1984, AM J MED GENET, V19, P487, DOI 10.1002/ajmg.1320190310; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TSUTSUI K, 2009, J BIOL CHEM; Wong AK, 2009, ANIM GENET, V40, P569, DOI 10.1111/j.1365-2052.2009.01875.x	40	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2010	5	9							e12817	10.1371/journal.pone.0012817	http://dx.doi.org/10.1371/journal.pone.0012817			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651XL	20862248	Green Submitted, Green Published, gold			2022-12-27	WOS:000281960800018
J	Miquel, S; Peyretaillade, E; Claret, L; de Vallee, A; Dossat, C; Vacherie, B; Zineb, E; Segurens, B; Barbe, V; Sauvanet, P; Neut, C; Colombel, JF; Medigue, C; Mojica, FJM; Peyret, P; Bonnet, R; Darfeuille-Michaud, A				Miquel, Sylvie; Peyretaillade, Eric; Claret, Laurent; de Vallee, Amelie; Dossat, Carole; Vacherie, Benoit; Zineb, El Hajji; Segurens, Beatrice; Barbe, Valerie; Sauvanet, Pierre; Neut, Christel; Colombel, Jean-Frederic; Medigue, Claudine; Mojica, Francisco J. M.; Peyret, Pierre; Bonnet, Richard; Darfeuille-Michaud, Arlette			Complete Genome Sequence of Crohn's Disease-Associated Adherent-Invasive E. coli Strain LF82	PLOS ONE			English	Article							PATHOGENIC ESCHERICHIA-COLI; ENTERICA SEROVAR TYPHIMURIUM; INFLAMMATORY-BOWEL-DISEASE; PHYLOGENETIC GROUP; ILEAL MUCOSA; VI SECRETION; SALMONELLA-TYPHIMURIUM; FIMBRIAL OPERON; BINDING-PROTEIN; BACTERIAL-FLORA	Background: Ileal lesions of Crohn's disease (CD) patients are abnormally colonized by pathogenic adherent-invasive Escherichia coli (AIEC) able to invade and to replicate within intestinal epithelial cells and macrophages. Principal Findings: We report here the complete genome sequence of E. coli LF82, the reference strain of adherent-invasive E. coli associated with ileal Crohn's disease. The LF82 genome of 4,881,487 bp total size contains a circular chromosome with a size of 4,773,108 bp and a plasmid of 108,379 bp. The analysis of predicted coding sequences (CDSs) within the LF82 flexible genome indicated that this genome is close to the avian pathogenic strain APEC_01, meningitis-associated strain S88 and urinary-isolated strain UTI89 with regards to flexible genome and single nucleotide polymorphisms in various virulence factors. Interestingly, we observed that strains LF82 and UTI89 adhered at a similar level to Intestine-407 cells and that like LF82, APEC_01 and UTI89 were highly invasive. However, A1EC strain LF82 had an intermediate killer phenotype compared to APEC-01 and UTI89 and the LF82 genome does not harbour most of specific virulence genes from ExPEC. LF82 genome has evolved from those of ExPEC B2 strains by the acquisition of Salmonella and Yersinia isolated or clustered genes or CDSs located on pLF82 plasmid and at various loci on the chromosome. Conclusion: LF82 genome analysis indicated that a number of genes, gene clusters and pathoadaptative mutations which have been acquired may play a role in virulence of AIEC strain LF82.	[Miquel, Sylvie; Claret, Laurent; de Vallee, Amelie; Sauvanet, Pierre; Bonnet, Richard; Darfeuille-Michaud, Arlette] Univ Auvergne, Clermont Univ, JE2526, INRA,USC 2018, Clermont Ferrand, France; [Miquel, Sylvie; Peyretaillade, Eric; Claret, Laurent; de Vallee, Amelie; Peyret, Pierre; Darfeuille-Michaud, Arlette] Univ Auvergne, Inst Univ Technol, Aubiere, France; [Peyretaillade, Eric; Peyret, Pierre] Univ Clermont 2, Lab Microorganismes Genome & Environm, CNRS, UMR 6023, Aubiere, France; [Dossat, Carole; Vacherie, Benoit; Zineb, El Hajji; Segurens, Beatrice; Barbe, Valerie; Medigue, Claudine] Inst Genom, Direct Sci Vivant, CEA, Evry, France; [Sauvanet, Pierre] Ctr Hosp Univ, Clermont Ferrand, France; [Neut, Christel; Colombel, Jean-Frederic] INSERM, U995, F-59045 Lille, France; [Medigue, Claudine] CNRS, Lab Analyse Bioinformat Genom & Metab, UMR 8030, Evry, France; [Mojica, Francisco J. M.] Univ Alicante, Dept Fisiol, E-03080 Alicante, Spain; [Bonnet, Richard] Ctr Hosp Univ, Clermont Ferrand, France	INRAE; Universite Clermont Auvergne (UCA); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Clermont Auvergne (UCA); CEA; UDICE-French Research Universities; Universite Paris Saclay; CHU Clermont Ferrand; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; Universitat d'Alacant; CHU Clermont Ferrand	Miquel, S (corresponding author), Univ Auvergne, Clermont Univ, JE2526, INRA,USC 2018, Clermont Ferrand, France.	arlette.darfeuille-michaud@u-clermont1.fr	Neut, Christel/S-2521-2018; Neut, Christel/AAA-5153-2021; Bonnet, Richard/C-8544-2015; Mojica, Francisco/M-8478-2019; Mojica, Francisco J.M./K-2414-2014	Neut, Christel/0000-0002-2036-6152; Mojica, Francisco J.M./0000-0002-6660-4996; Miquel, Sylvie/0000-0001-8405-5073; Mangan, Rachel/0000-0002-2984-3699; Vacherie, Benoit/0000-0002-1564-0575; PEYRET, Pierre/0000-0003-3114-0586	Ministere de la Recherche et de la Technologie [JE2526]; Institut National de Recherche Agronomique [USC 2018]; Association F. Aupetit (AFA), Bourse de Recherche fondamentale sur les Maladies Inflammatoires Chroniques de l'Intestin (BREMICI, Schering-Plough)	Ministere de la Recherche et de la Technologie; Institut National de Recherche Agronomique; Association F. Aupetit (AFA), Bourse de Recherche fondamentale sur les Maladies Inflammatoires Chroniques de l'Intestin (BREMICI, Schering-Plough)	This study was supported by the Ministere de la Recherche et de la Technologie (JE2526), by the Institut National de Recherche Agronomique (USC 2018) and by grants from the Association F. Aupetit (AFA), Bourse de Recherche fondamentale sur les Maladies Inflammatoires Chroniques de l'Intestin (BREMICI, Schering-Plough). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aprikian P, 2007, J BIOL CHEM, V282, P23437, DOI 10.1074/jbc.M702037200; Barnich N, 2007, J CLIN INVEST, V117, P1566, DOI 10.1172/JCI30504; Barnich N, 2007, CURR OPIN GASTROEN, V23, P16, DOI 10.1097/MOG.0b013e3280105a38; Barrett B, 2002, CURR TOP MICROBIOL, V264, P137; Baumgart M, 2007, ISME J, V1, P403, DOI 10.1038/ismej.2007.52; Baumler AJ, 1996, INFECT IMMUN, V64, P1862; Baumler AJ, 1996, P NATL ACAD SCI USA, V93, P279, DOI 10.1073/pnas.93.1.279; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Boudeau J, 2001, MOL MICROBIOL, V39, P1272, DOI 10.1046/j.1365-2958.2001.02315.x; Boudeau J, 1999, INFECT IMMUN, V67, P4499, DOI 10.1128/IAI.67.9.4499-4509.1999; Bronowski C, 2008, MICROBIOL-SGM, V154, P571, DOI 10.1099/mic.0.2007/013086-0; Brzuszkiewicz E, 2006, P NATL ACAD SCI USA, V103, P12879, DOI 10.1073/pnas.0603038103; Buchrieser C, 1999, INFECT IMMUN, V67, P4851, DOI 10.1128/IAI.67.9.4851-4861.1999; BURKE DA, 1988, BMJ-BRIT MED J, V297, P102, DOI 10.1136/bmj.297.6641.102; Carvalho FA, 2009, J EXP MED, V206, P2179, DOI 10.1084/jem.20090741; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; Conte MP, 2006, GUT, V55, P1760, DOI 10.1136/gut.2005.078824; Cortes MAM, 2008, INFECT IMMUN, V76, P4129, DOI 10.1128/IAI.00334-08; Darfeuille-Michaud A, 1998, GASTROENTEROLOGY, V115, P1405, DOI 10.1016/S0016-5085(98)70019-8; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Dudley EG, 2006, MOL MICROBIOL, V61, P1267, DOI 10.1111/j.1365-2958.2006.05281.x; EAVESPYLES T, 2007, INT J MED MICROBIOL; Elson CO, 2000, GASTROENTEROLOGY, V119, P254, DOI 10.1053/gast.2000.9159; Flannery EL, 2009, INFECT IMMUN, V77, P4887, DOI 10.1128/IAI.00705-09; Glasser AL, 2001, INFECT IMMUN, V69, P5529, DOI 10.1128/IAI.69.9.5529-5537.2001; Glasser AL, 2008, ARCH IMMUNOL THER EX, V56, P237, DOI 10.1007/s00005-008-0026-1; Gordon DM, 2008, ENVIRON MICROBIOL, V10, P2484, DOI 10.1111/j.1462-2920.2008.01669.x; Gullberg E, 2006, ANN NY ACAD SCI, V1072, P218, DOI 10.1196/annals.1326.028; Hancock V, 2007, INFECT IMMUN, V75, P966, DOI 10.1128/IAI.01748-06; Heithoff DM, 1999, J BACTERIOL, V181, P799, DOI 10.1128/JB.181.3.799-807.1999; HERZER PJ, 1990, J BACTERIOL, V172, P6175, DOI 10.1128/jb.172.11.6175-6181.1990; Hochhut B, 2006, MOL MICROBIOL, V61, P584, DOI 10.1111/j.1365-2958.2006.05255.x; Hommais F, 2003, INFECT IMMUN, V71, P3619, DOI 10.1128/IAI.71.6.3619-3622.2003; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hu P, 1998, J BACTERIOL, V180, P5192, DOI 10.1128/JB.180.19.5192-5202.1998; Huang SH, 1999, INFECT IMMUN, V67, P2103, DOI 10.1128/IAI.67.5.2103-2109.1999; Huebner Claudia, 2009, BMC Res Notes, V2, P52, DOI 10.1186/1756-0500-2-52; Hung CS, 2002, MOL MICROBIOL, V44, P903, DOI 10.1046/j.1365-2958.2002.02915.x; Iguchi A, 2009, J BACTERIOL, V191, P347, DOI 10.1128/JB.01238-08; Jaureguy F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-560; Johnson JR, 2006, J INFECT DIS, V194, P1141, DOI 10.1086/507305; Johnson TJ, 2007, J BACTERIOL, V189, P3228, DOI 10.1128/JB.01726-06; Jordan DM, 2004, INFECT IMMUN, V72, P6168, DOI 10.1128/IAI.72.10.6168-6171.2004; Klumpp J, 2007, MICROBIOL-SGM, V153, P1207, DOI 10.1099/mic.0.2006/004747-0; Kotlowski R, 2007, GUT, V56, P669, DOI 10.1136/gut.2006.099796; La Ferla K, 2004, INT J COLORECTAL DIS, V19, P334, DOI 10.1007/s00384-004-0583-7; Lamps LW, 2003, ADV ANAT PATHOL, V10, P319, DOI 10.1097/00125480-200311000-00002; Lapaquette P, 2010, CELL MICROBIOL, V12, P99, DOI 10.1111/j.1462-5822.2009.01381.x; Lavigne JP, 2008, INFECT GENET EVOL, V8, P217, DOI 10.1016/j.meegid.2007.11.005; LIU CD, 1995, AM SURGEON, V61, P1054; Lloyd AL, 2009, J BACTERIOL, V191, P3469, DOI 10.1128/JB.01717-08; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Martin HM, 2004, GASTROENTEROLOGY, V127, P80, DOI 10.1053/j.gastro.2004.03.054; MARTINEZMEDINA M, 2009, INFLAMM BOWEL DIS; Meconi S, 2007, CELL MICROBIOL, V9, P1252, DOI 10.1111/j.1462-5822.2006.00868.x; Miller DA, 2002, CHEM BIOL, V9, P333, DOI 10.1016/S1074-5521(02)00115-1; Mizoguchi E, 2006, GASTROENTEROLOGY, V130, P398, DOI 10.1053/j.gastro.2005.12.007; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; MORSON BC, 1972, NEW ENGL J MED, V287, P1337, DOI 10.1056/NEJM197212282872607; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Mylonaki M, 2005, INFLAMM BOWEL DIS, V11, P481, DOI 10.1097/01.MIB.0000159663.62651.4f; Neut C, 2002, AM J GASTROENTEROL, V97, P939, DOI 10.1111/j.1572-0241.2002.05613.x; OCHMAN H, 1984, J BACTERIOL, V157, P690, DOI 10.1128/JB.157.2.690-693.1984; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Pautsch A, 1998, NAT STRUCT BIOL, V5, P1013, DOI 10.1038/2983; Picard B, 1999, INFECT IMMUN, V67, P546, DOI 10.1128/IAI.67.2.546-553.1999; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Prasadarao NV, 1999, INFECT IMMUN, V67, P1131, DOI 10.1128/IAI.67.3.1131-1138.1999; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; RAKIN A, 1994, MOL MICROBIOL, V13, P253, DOI 10.1111/j.1365-2958.1994.tb00420.x; Rao PSS, 2004, MOL MICROBIOL, V53, P573, DOI 10.1111/j.1365-2958.2004.04123.x; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sartor RB, 1996, GASTROENTEROLOGY, V110, P1467, DOI 10.1053/gast.1996.v110.pm8613052; Sasaki M, 2007, LAB INVEST, V87, P1042, DOI 10.1038/labinvest.3700661; Schell MA, 2007, MOL MICROBIOL, V64, P1466, DOI 10.1111/j.1365-2958.2007.05734.x; Schneider G, 2004, INFECT IMMUN, V72, P5993, DOI 10.1128/IAI.72.10.5993-6001.2004; Schultsz C, 1997, J CLIN PATHOL, V50, P573, DOI 10.1136/jcp.50.7.573; SELANDER RK, 1980, SCIENCE, V210, P545, DOI 10.1126/science.6999623; Semiramoth N, 2009, J LEUKOCYTE BIOL, V85, P310, DOI 10.1189/jlb.0608350; Shalom G, 2007, MICROBIOL-SGM, V153, P2689, DOI 10.1099/mic.0.2007/006585-0; Shanahan F, 2002, EUR J SURG, V168, P47; Stanley TL, 2000, J BACTERIOL, V182, P4406, DOI 10.1128/JB.182.16.4406-4413.2000; Subramanian S, 2008, ANTIMICROB AGENTS CH, V52, P427, DOI 10.1128/AAC.00375-07; Sutherland J, 2009, INT J FOOD SCI NUTR, V60, P717, DOI 10.3109/09637480802165650; Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Torres AG, 2002, INFECT IMMUN, V70, P5416, DOI 10.1128/IAI.70.10.5416-5427.2002; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Vallenet D, 2006, NUCLEIC ACIDS RES, V34, P53, DOI 10.1093/nar/gkj406; Vallenet D, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap021; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Wiles TJ, 2008, EXP MOL PATHOL, V85, P11, DOI 10.1016/j.yexmp.2008.03.007; Wine E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-180; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Zou YM, 2007, MED MICROBIOL IMMUN, V196, P135, DOI 10.1007/s00430-006-0034-x	99	128	127	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2010	5	9							e12714	10.1371/journal.pone.0012714	http://dx.doi.org/10.1371/journal.pone.0012714			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651XL	20862302	gold, Green Published, Green Submitted			2022-12-27	WOS:000281960800007
J	Brown, JW; Sorhannus, U				Brown, Joseph W.; sorhannus, Ulf			A Molecular Genetic Timescale for the Diversification of Autotrophic Stramenopiles (Ochrophyta): Substantive Underestimation of Putative Fossil Ages	PLOS ONE			English	Article							DIVERGENCE TIMES; RIBOSOMAL-RNA; PHYLOGENETIC TREES; CRYPTIC SPECIATION; ECOLOGICAL LIMITS; SYNCHROMA-GRANDE; HETEROKONT ALGAE; MARINE DIATOMS; BROWN ALGA; EVOLUTION	Background: Stramenopiles constitute a large and diverse eukaryotic clade that is currently poorly characterized from both phylogenetic and temporal perspectives at deeper taxonomic levels. To better understand this group, and in particular the photosynthetic stramenopiles (Ochrophyta), we analyzed sequence data from 135 taxa representing most major lineages. Our analytical approach utilized several recently developed methods that more realistically model the temporal evolutionary process. Methodology/Principal Findings: Phylogenetic reconstruction employed a Bayesian joint rate-and pattern-heterogeneity model to reconstruct the evolutionary history of these taxa. Inferred phylogenetic resolution was generally high at all taxonomic levels, sister-class relationships in particular receiving good statistical support. A signal for heterotachy was detected in clustered portions of the tree, although this does not seem to have had a major influence on topological inference. Divergence time estimates, assuming a lognormally-distributed relaxed molecular clock while accommodating topological uncertainty, were broadly congruent over alternative temporal prior distributions. These data suggest that Ochrophyta originated near the Proterozoic-Phanerozoic boundary, diverging from their sister-taxon Oomycota. The evolution of the major ochrophyte lineages appears to have proceeded gradually thereafter, with most lineages coming into existence by,200 million years ago. Conclusions/Significance: The evolutionary timescale of the autotrophic stramenopiles reconstructed here is generally older than previously inferred from molecular clocks. However, this more ancient timescale nevertheless casts serious doubt on the taxonomic validity of putative xanthophyte/phaeophyte fossils from the Proterozoic, which predate by as much as a half billion years or more the age suggested by our molecular genetic data. If these fossils truly represent crown stramenopile lineages, then this would imply that molecular rate evolution in this group proceeds in a fashion that is fundamentally incompatible with the relaxed molecular clock model employed here. A more likely scenario is that there is considerable convergent morphological evolution within Heterokonta, and that these fossils have been taxonomically misdiagnosed.	[Brown, Joseph W.] Univ Michigan, Museum Zool, Ann Arbor, MI 48109 USA; [Brown, Joseph W.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [sorhannus, Ulf] Edinboro Univ Penn, Dept Biol & Hlth Serv, Edinboro, PA USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Pennsylvania State System of Higher Education (PASSHE); Edinboro University	Brown, JW (corresponding author), Univ Michigan, Museum Zool, Ann Arbor, MI 48109 USA.	usorhannus@edinboro.edu	Brown, Joseph W/A-7713-2009	Brown, Joseph W/0000-0002-3835-8062	University of Michigan	University of Michigan(University of Michigan System)	JWB is funded through a Rackham Predoctoral Fellowship from the University of Michigan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro ME, 2007, EVOLUTION, V61, P2104, DOI 10.1111/j.1558-5646.2007.00182.x; ALLISON CW, 1986, J PALEONTOL, V60, P973, DOI 10.1017/S0022336000022538; Amato A, 2007, PROTIST, V158, P193, DOI 10.1016/j.protis.2006.10.001; ANDERSEN R.A, 2007, UNRAVELING ALGAE PRE, P283; Andersen RA, 2004, AM J BOT, V91, P1508, DOI 10.3732/ajb.91.10.1508; ANDERSEN RA, 1992, BIODIVERS CONSERV, V1, P267, DOI 10.1007/BF00693765; ANDERSEN RA, 2009, INT M CONN COLL NEW, V160, P5; Ben Ali A, 2001, INT J SYST EVOL MICR, V51, P737, DOI 10.1099/00207713-51-3-737; Berney C, 2006, P ROY SOC B-BIOL SCI, V273, P1867, DOI 10.1098/rspb.2006.3537; Beszteri B, 2005, PROTIST, V156, P317, DOI 10.1016/j.protis.2005.07.002; Bown P., 1998, CALCAREOUS NANNOFOSS; BRITTON T, 2006, PATHD8 NEW METHOD ES; Britton T, 2007, SYSTEMATIC BIOL, V56, P741, DOI 10.1080/10635150701613783; Brown JW, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-6; Brown JW, 2007, BIOL LETTERS, V3, P257, DOI 10.1098/rsbl.2006.0611; BROWN JW, 2011, EVOLUTIONAR IN PRESS; Burki F, 2008, BIOL LETTERS, V4, P366, DOI 10.1098/rsbl.2008.0224; Burki F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000790; BUTTERFIELD N.J., 1994, LETHAIA, V27, P76; Butterfield NJ, 2007, PALAEONTOLOGY, V50, P41, DOI 10.1111/j.1475-4983.2006.00613.x; Butterfield NJ, 2000, PALEOBIOLOGY, V26, P386, DOI 10.1666/0094-8373(2000)026<0386:BPNGNS>2.0.CO;2; Butterfield NJ, 2004, PALEOBIOLOGY, V30, P231, DOI 10.1666/0094-8373(2004)030<0231:AVAFTM>2.0.CO;2; Cavalier-Smith T, 2006, J MOL EVOL, V62, P388, DOI 10.1007/s00239-004-0353-8; CAVALIERSMITH T, 1986, PROGR PHYCOLOGICAL R, P309; Damste JSS, 2004, SCIENCE, V304, P584, DOI 10.1126/science.1096806; Daugbjerg N, 1997, J PHYCOL, V33, P1031, DOI 10.1111/j.0022-3646.1997.01031.x; de Vargas C, 1999, P NATL ACAD SCI USA, V96, P2864, DOI 10.1073/pnas.96.6.2864; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Eikrem W, 2004, PHYCOLOGIA, V43, P658, DOI 10.2216/i0031-8884-43-6-658.1; GERMAN TN, 1990, ORGANIC WORLD ONE BI; Girard V, 2009, GEOLOGY, V37, P83, DOI 10.1130/G25009A.1; Goertzen LR, 2003, J PHYCOL, V39, P423, DOI 10.1046/j.1529-8817.2003.01238.x; Grant J, 2009, PROTIST, V160, P376, DOI 10.1016/j.protis.2009.01.001; Guillou L, 1999, J PHYCOL, V35, P368, DOI 10.1046/j.1529-8817.1999.3520368.x; Hackett JD, 2007, MOL BIOL EVOL, V24, P1702, DOI 10.1093/molbev/msm089; Hackett Jeremiah D., 2007, P109; HARWOOD D. M., 2007, PALEONTOL SOC PAP, V13, P33, DOI DOI 10.1017/S1089332600001455; HARWOOD DM, 1990, P OCEAN DRILLING PRO, V13, P403; Haug GH, 1998, NATURE, V393, P673, DOI 10.1038/31447; Hiller N, 1996, REV PALAEOBOT PALYNO, V91, P143, DOI 10.1016/0034-6667(95)00062-3; Ho SYW, 2009, BIOL LETTERS, V5, P421, DOI 10.1098/rsbl.2008.0729; Horn S, 2007, PROTIST, V158, P277, DOI 10.1016/j.protis.2007.02.004; Hug LA, 2007, MOL BIOL EVOL, V24, P1889, DOI 10.1093/molbev/msm115; John U, 2003, MOL BIOL EVOL, V20, P1015, DOI 10.1093/molbev/msg105; Kai A, 2008, PROTIST, V159, P435, DOI 10.1016/j.protis.2007.12.003; Kato Mitsuru, 2005, Genome Inform, V16, P22; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kishino H, 2001, MOL BIOL EVOL, V18, P352, DOI 10.1093/oxfordjournals.molbev.a003811; Kitazoe Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000384; Kooistra WHCF, 1996, MOL PHYLOGENET EVOL, V6, P391, DOI 10.1006/mpev.1996.0088; Leander BS, 2008, J EUKARYOT MICROBIOL, V55, P59, DOI 10.1111/j.1550-7408.2008.00308.x; LEARY RL, 1986, AM J BOT, V73, P369, DOI 10.2307/2444080; LIM BL, 1986, JPN J GENET, V61, P169, DOI 10.1266/jjg.61.169; Linder HP, 2005, MOL PHYLOGENET EVOL, V35, P569, DOI 10.1016/j.ympev.2004.12.006; Liu H, 2009, P NATL ACAD SCI USA, V106, P12803, DOI 10.1073/pnas.0905841106; LOEBLICH A R JR, 1974, Taxon, V23, P277, DOI 10.2307/1218707; Macdonald FA, 2010, SCIENCE, V327, P1241, DOI 10.1126/science.1183325; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Magallon SA, 2004, INT J PLANT SCI, V165, pS7, DOI 10.1086/383336; Medlin LK, 2008, MAR MICROPALEONTOL, V67, P69, DOI 10.1016/j.marmicro.2007.08.007; Medlin LK, 1997, PLANT SYST EVOL, P187; Negrisolo E, 2004, MOL PHYLOGENET EVOL, V33, P156, DOI 10.1016/j.ympev.2004.04.016; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Pagel M, 2004, SYST BIOL, V53, P571, DOI 10.1080/10635150490468675; Pagel M, 2008, PHILOS T R SOC B, V363, P3955, DOI 10.1098/rstb.2008.0178; Patil V, 2009, J EUKARYOT MICROBIOL, V56, P394, DOI 10.1111/j.1550-7408.2009.00389.x; PHILIPPE H, 1994, J EVOLUTION BIOL, V7, P247, DOI 10.1046/j.1420-9101.1994.7020247.x; Phillips N, 2008, J PHYCOL, V44, P15, DOI 10.1111/j.1529-8817.2007.00435.x; Porter S. M., 2004, PALEONTOL SOC PAP, V10, P35, DOI [DOI 10.1017/S1089332600002321, 10.1017/s1089332600002321]; Porter Susannah M., 2006, V27, P1; Rabosky DL, 2009, ECOL LETT, V12, P735, DOI 10.1111/j.1461-0248.2009.01333.x; Rabosky DL, 2009, AM NAT, V173, P662, DOI 10.1086/597378; RAJANIKANTH A, 1989, CURR SCI INDIA, V58, P78; Rambaut A, 2013, TRACER VERSION 1 6; Rannala B, 2007, SYST BIOL, V56, P453, DOI 10.1080/10635150701420643; Renner SS, 2008, SYST BIOL, V57, P795, DOI 10.1080/10635150802422282; Riisberg I, 2009, PROTIST, V160, P191, DOI 10.1016/j.protis.2008.11.004; ROTHPLETZ A., 1896, Z DTSCH GEOLOGISCHEN, V48, P854; Rothpletz A., 1900, Z DEUTSCH GEOLOGISCH, V52, P154; Rutschmann F, 2006, DIVERS DISTRIB, V12, P35, DOI 10.1111/j.1366-9516.2006.00210.x; Rynearson TA, 2004, J PHYCOL, V40, P34, DOI 10.1046/j.1529-8817.2004.03089.x; Saez AG, 2003, P NATL ACAD SCI USA, V100, P7163, DOI 10.1073/pnas.1132069100; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; SAUNDERS GW, 1995, P NATL ACAD SCI USA, V92, P244, DOI 10.1073/pnas.92.1.244; Schmid A. M.-M., 2000, ORIGIN EARLY EVOLUTI, P13; SIEMINSKA J, 2000, ORIGIN EARLY EVOLUTI, P117; Sieminska Jadwiga, 2002, Acta Palaeobotanica, V42, P3; Sims PA, 2006, PHYCOLOGIA, V45, P361, DOI 10.2216/05-22.1; Siver PA, 2007, CAN J BOT, V85, P83, DOI 10.1139/B06-143; Sorhannus U, 2001, CLADISTICS, V17, P227, DOI 10.1111/j.1096-0031.2001.tb00119.x; Sorhannus U, 2007, MAR MICROPALEONTOL, V65, P1, DOI 10.1016/j.marmicro.2007.05.002; Sorhannus U, 2010, PROTIST, V161, P237, DOI 10.1016/j.protis.2009.10.003; STRELNIKOVA NI, 1975, NOVA HEDWIGIA S, V53, P311; Svennblad B, 2008, SYST BIOL, V57, P947, DOI 10.1080/10635150802562400; TAGGART RE, 1976, AM J BOT, V63, P1390, DOI 10.2307/2441848; TAPPAN HN, 1990, PALEOBIOLOGY PLANT P; Tsui CKM, 2009, MOL PHYLOGENET EVOL, V50, P129, DOI 10.1016/j.ympev.2008.09.027; Welch JJ, 2005, TRENDS ECOL EVOL, V20, P320, DOI 10.1016/j.tree.2005.02.007; WILGENBUSCH JC, 2004, AWTY SYSTEM GRAPHICA; Woods K., 1998, GEOL SOC AM ABSTR, V30; XIA X, 2000, DATA ANAL MOL BIOL E; Xiao SH, 1998, J PALEONTOL, V72, P1072, DOI 10.1017/S0022336000027414; Zhong BJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005297	104	86	87	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2010	5	9							e12759	10.1371/journal.pone.0012759	http://dx.doi.org/10.1371/journal.pone.0012759			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650QH	20862282	Green Published, gold, Green Submitted			2022-12-27	WOS:000281864100011
J	Hagopian, K; Weber, KL; Hwee, DT; Van Eenennaam, AL; Lopez-Lluch, G; Villalba, JM; Buron, I; Navas, P; German, JB; Watkins, SM; Chen, YN; Wei, A; McDonald, RB; Ramsey, JJ				Hagopian, Kevork; Weber, Kristina L.; Hwee, Darren T.; Van Eenennaam, Alison L.; Lopez-Lluch, Guillermo; Villalba, Jose M.; Buron, Isabel; Navas, Placido; German, J. Bruce; Watkins, Steven M.; Chen, Yana; Wei, Alfreda; McDonald, Roger B.; Ramsey, Jon J.			Complex I-Associated Hydrogen Peroxide Production Is Decreased and Electron Transport Chain Enzyme Activities Are Altered in n-3 Enriched fat-1 Mice	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; MAXIMUM LIFE-SPAN; DOCOSAHEXAENOIC ACID; H2O2 PRODUCTION; PROTON LEAK; CARDIOLIPIN REQUIREMENT; MITOCHONDRIAL-FUNCTION; CYTOCHROME-OXIDASE; RESPIRATORY-CHAIN; OXIDATIVE STRESS	The polyunsaturated nature of n-3 fatty acids makes them prone to oxidative damage. However, it is not clear if n-3 fatty acids are simply a passive site for oxidative attack or if they also modulate mitochondrial reactive oxygen species (ROS) production. The present study used fat-1 transgenic mice, that are capable of synthesizing n-3 fatty acids, to investigate the influence of increases in n-3 fatty acids and resultant decreases in the n-6: n-3 ratio on liver mitochondrial H2O2 production and electron transport chain (ETC) activity. There was an increase in n-3 fatty acids and a decrease in the n-6:n-3 ratio in liver mitochondria from the fat-1 compared to control mice. This change was largely due to alterations in the fatty acid composition of phosphatidylcholine and phosphatidylethanolamine, with only a small percentage of fatty acids in cardiolipin being altered in the fat-1 animals. The lipid changes in the fat-1 mice were associated with a decrease (p<0.05) in the activity of ETC complex I and increases (p<0.05) in the activities of complexes III and IV. Mitochondrial H2O2 production with either succinate or succinate/glutamate/malate substrates was also decreased (p<0.05) in the fat-1 mice. This change in H2O2 production was due to a decrease in ROS production from ETC complex I in the fat-1 animals. These results indicate that the fatty acid changes in fat-1 liver mitochondria may at least partially oppose oxidative stress by limiting ROS production from ETC complex I.	[Hagopian, Kevork; Chen, Yana; Wei, Alfreda; Ramsey, Jon J.] Univ Calif Davis, VM Mol Biosci, Davis, CA 95616 USA; [Weber, Kristina L.; Van Eenennaam, Alison L.] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; [Hwee, Darren T.] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Lopez-Lluch, Guillermo; Navas, Placido] Univ Pablo de Olavide, CSIC, CIBERER, Ctr Andaluz Biol Desarrollo,Inst Salud Carl III, Seville, Spain; [Villalba, Jose M.; Buron, Isabel] Univ Cordoba, Dept Biol Celular Fisiol & Immunol, Cordoba, Spain; [German, J. Bruce] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA; [Watkins, Steven M.] Lip Technol, W Sacramento, CA USA; [McDonald, Roger B.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); Universidad de Cordoba; University of California System; University of California Davis; University of California System; University of California Davis	Hagopian, K (corresponding author), Univ Calif Davis, VM Mol Biosci, Davis, CA 95616 USA.	jjramsey@ucdavis.edu	Van Eenennaam, Alison L/G-3481-2011; Lopez-Lluch, Guillermo/N-4742-2014; NAVAS, PLACIDO/R-5943-2019	Van Eenennaam, Alison L/0000-0003-1562-162X; Lopez-Lluch, Guillermo/0000-0001-9830-8502; NAVAS, PLACIDO/0000-0002-4115-7966; Villalba Montoro, Jose Manuel/0000-0001-8554-3802	National Institutes of Health [RO1 AG-028125]; NATIONAL INSTITUTE ON AGING [R01AG028125] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health (www.nia.nih.gov) Grant RO1 AG-028125 (to J.J.R., K.H., J.M.V., P.N.). This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. S. M. W. was an employee of Lipomics Technologies. Lipomics completed fatty analysis on the mitochondrial samples. This funder/company had no role in study design, decision to publish, or preparation of the manuscript.	Arroyo A, 1998, PROTOPLASMA, V205, P107, DOI 10.1007/BF01279300; Arvier M, 2007, AM J PHYSIOL-ENDOC M, V293, pE1320, DOI 10.1152/ajpendo.00138.2007; Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1; BARZANTI V, 1994, BRIT J NUTR, V71, P193, DOI 10.1079/BJN19940126; Benard G, 2006, AM J PHYSIOL-CELL PH, V291, pC1172, DOI 10.1152/ajpcell.00195.2006; Berger A, 1993, Adv Food Nutr Res, V37, P259, DOI 10.1016/S1043-4526(08)60118-7; Bhattacharya A, 2006, BIOCHEM BIOPH RES CO, V349, P925, DOI 10.1016/j.bbrc.2006.08.093; Birch-Machin MA, 1993, METHODS TOXICOL, V2, P51; BIRCHMACHIN MA, 1994, BIOCHEM MED METAB B, V51, P35, DOI 10.1006/bmmb.1994.1004; Brand M. D., 1995, BIOENERGETICS, V154, P62; Breslow JL, 2006, AM J CLIN NUTR, V83, p1477S, DOI 10.1093/ajcn/83.6.1477S; CARO P, 2008, BIOGERONTOLOGY; Caro P, 2008, REJUV RES, V11, P621, DOI 10.1089/rej.2008.0704; CLARKE SD, 1994, ANNU REV NUTR, V14, P83, DOI 10.1146/annurev.nu.14.070194.000503; Cortes-Rojo C, 2009, J BIOENERG BIOMEMBR, V41, P15, DOI 10.1007/s10863-009-9200-3; DAUM G, 1985, BIOCHIM BIOPHYS ACTA, V822, P1, DOI 10.1016/0304-4157(85)90002-4; DEMAISON L, 1994, BBA-MOL BASIS DIS, V1227, P53, DOI 10.1016/0925-4439(94)90106-6; Fernandez-Ayala DJM, 2005, BBA-BIOENERGETICS, V1706, P174, DOI 10.1016/j.bbabio.2004.10.009; Flachs P, 2005, DIABETOLOGIA, V48, P2365, DOI 10.1007/s00125-005-1944-7; FOLCH J, 1957, J BIOL CHEM, V226, P497; FRY M, 1980, BIOCHEM BIOPH RES CO, V93, P1238, DOI 10.1016/0006-291X(80)90622-1; FRY M, 1981, J BIOL CHEM, V256, P1874; Gerard-Monnier D, 1998, CHEM RES TOXICOL, V11, P1176, DOI 10.1021/tx9701790; Gomez B, 1999, BIOCHEMISTRY-US, V38, P9031, DOI 10.1021/bi990603r; Grimm H, 2002, BRIT J NUTR, V87, pS59, DOI 10.1079/BJN2001457; Herrero A, 2001, MECH AGEING DEV, V122, P427, DOI 10.1016/S0047-6374(01)00214-7; HOCH FL, 1992, BIOCHIM BIOPHYS ACTA, V1113, P71, DOI 10.1016/0304-4157(92)90035-9; Hoffman DL, 2009, J BIOL CHEM, V284, P16236, DOI 10.1074/jbc.M809512200; Hong MY, 2002, CARCINOGENESIS, V23, P1919, DOI 10.1093/carcin/23.11.1919; Hulbert AJ, 2005, J THEOR BIOL, V234, P277, DOI 10.1016/j.jtbi.2004.11.024; HYSLOP PA, 1984, ANAL BIOCHEM, V141, P280, DOI 10.1016/0003-2697(84)90457-3; Kang JX, 2005, J MEMBRANE BIOL, V206, P165, DOI 10.1007/s00232-005-0790-3; Kang JX, 2004, NATURE, V427, P504, DOI 10.1038/427504a; Kubo K, 1997, BRIT J NUTR, V78, P655, DOI 10.1079/BJN19970181; Kwong LK, 2000, ARCH BIOCHEM BIOPHYS, V373, P16, DOI 10.1006/abbi.1999.1495; Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200; Lemieux H, 2008, COMP BIOCHEM PHYS A, V149, P20, DOI 10.1016/j.cbpa.2007.09.015; Lenaz G, 2009, INT J BIOCHEM CELL B, V41, P1750, DOI 10.1016/j.biocel.2009.04.003; Lopez-Torres M, 2002, FREE RADICAL BIO MED, V32, P882, DOI 10.1016/S0891-5849(02)00773-6; MALIS CD, 1990, P NATL ACAD SCI USA, V87, P8845, DOI 10.1073/pnas.87.22.8845; Martinez M, 1996, BRAIN RES, V731, P246, DOI 10.1016/0006-8993(96)00708-1; MCMILLIN JB, 1992, AM J PHYSIOL, V263, pH1479, DOI 10.1152/ajpheart.1992.263.5.H1479; Mozaffarian D, 2006, JAMA-J AM MED ASSOC, V296, P1885, DOI 10.1001/jama.296.15.1885; Murase T, 2002, J LIPID RES, V43, P1312, DOI 10.1194/jlr.M200094-JLR200; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Pamplona R, 2002, ANN NY ACAD SCI, V959, P475, DOI 10.1111/j.1749-6632.2002.tb02118.x; Pamplona R, 1998, J LIPID RES, V39, P1989; Parise G, 2005, EXP GERONTOL, V40, P173, DOI 10.1016/j.exger.2004.09.002; Parker G, 2006, AM J PSYCHIAT, V163, P969, DOI 10.1176/appi.ajp.163.6.969; Porter RK, 1996, AM J PHYSIOL-REG I, V271, pR1550, DOI 10.1152/ajpregu.1996.271.6.R1550; Price PT, 2000, CURR OPIN LIPIDOL, V11, P3, DOI 10.1097/00041433-200002000-00002; Rahman MM, 2009, OXID MED CELL LONGEV, V2, P307, DOI 10.4161/oxim.2.5.9579; Ramsey JJ, 2005, COMP BIOCHEM PHYS B, V140, P99, DOI 10.1016/j.cbpc.2004.09.016; Ramsey JJ, 2004, AM J PHYSIOL-ENDOC M, V286, pE31, DOI 10.1152/ajpendo.00283.2003; Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594; Schmocker C, 2007, HEPATOLOGY, V45, P864, DOI 10.1002/hep.21626; Schultz JR, 1996, BIOCHEMISTRY-US, V35, P6595, DOI 10.1021/bi960245h; Sedlak E, 1999, BIOCHEMISTRY-US, V38, P14966, DOI 10.1021/bi9914053; Spychalla JP, 1997, P NATL ACAD SCI USA, V94, P1142, DOI 10.1073/pnas.94.4.1142; Stillwell W, 1997, LIPIDS, V32, P497, DOI 10.1007/s11745-997-0064-6; SWANSON JE, 1986, J NUTR, V116, P514, DOI 10.1093/jn/116.4.514; Toroser D, 2007, BIOCHEM BIOPH RES CO, V363, P418, DOI 10.1016/j.bbrc.2007.08.193; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Valencak TG, 2007, AGING CELL, V6, P15, DOI 10.1111/j.1474-9726.2006.00257.x; Venditti P, 2004, FREE RADICAL BIO MED, V36, P348, DOI 10.1016/j.freeradbiomed.2003.11.012; Watkins SM, 1998, J LIPID RES, V39, P1583; Watkins SM, 2001, LIPIDS, V36, P247, DOI 10.1007/s11745-001-0714-8; YAMAOKA S, 1988, J NUTR, V118, P290, DOI 10.1093/jn/118.3.290	68	49	49	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2010	5	9							e12696	10.1371/journal.pone.0012696	http://dx.doi.org/10.1371/journal.pone.0012696			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648ZZ	20856881	gold, Green Published, Green Submitted			2022-12-27	WOS:000281735700015
J	Gomez-Gardenes, J; Zamora-Lopez, G; Moreno, Y; Arenas, A				Gomez-Gardenes, Jesus; Zamora-Lopez, Gorka; Moreno, Yamir; Arenas, Alex			From Modular to Centralized Organization of Synchronization in Functional Areas of the Cat Cerebral Cortex	PLOS ONE			English	Article							HIERARCHICAL ORGANIZATION; CORTICAL AREAS; CONNECTIVITY; INTEGRATION; CLUSTERS; KURAMOTO; MACAQUE	Recent studies have pointed out the importance of transient synchronization between widely distributed neural assemblies to understand conscious perception. These neural assemblies form intricate networks of neurons and synapses whose detailed map for mammals is still unknown and far from our experimental capabilities. Only in a few cases, for example the C. elegans, we know the complete mapping of the neuronal tissue or its mesoscopic level of description provided by cortical areas. Here we study the process of transient and global synchronization using a simple model of phase-coupled oscillators assigned to cortical areas in the cerebral cat cortex. Our results highlight the impact of the topological connectivity in the developing of synchronization, revealing a transition in the synchronization organization that goes from a modular decentralized coherence to a centralized synchronized regime controlled by a few cortical areas forming a Rich-Club connectivity pattern.	[Gomez-Gardenes, Jesus; Moreno, Yamir; Arenas, Alex] Univ Zaragoza, Inst Biocomputac & Fis Sistemas Complejos BIFI, Zaragoza, Spain; [Gomez-Gardenes, Jesus] Univ Rey Juan Carlos ESCET, Dept Matemat Aplicada, Mostoles, Madrid, Spain; [Zamora-Lopez, Gorka] Univ Potsdam, Interdisciplinary Ctr Dynam Complex Syst, Potsdam, Germany; [Moreno, Yamir] Univ Zaragoza, Dept Fis Teor, E-50009 Zaragoza, Spain; [Arenas, Alex] Univ Rovira & Virgili, Dept Engn Informat & Matemat, Tarragona, Spain	University of Zaragoza; Universidad Rey Juan Carlos; University of Potsdam; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - UAM - Institut de Fisica Teorica (IFT); University of Zaragoza; Universitat Rovira i Virgili	Gomez-Gardenes, J (corresponding author), Univ Zaragoza, Inst Biocomputac & Fis Sistemas Complejos BIFI, Zaragoza, Spain.	gardenes@gmail.com	Gomez-Gardenes, Jesus/M-9825-2019; Gomez-Gardenes, Jesus/A-3226-2009; Arenas, Alex/A-5216-2009; Zamora-López, Gorka/A-2648-2012; Gomez-Gardeñes, Jesus/B-5818-2009; Moreno, Yamir/A-1076-2009	Gomez-Gardenes, Jesus/0000-0001-5204-1937; Arenas, Alex/0000-0003-0937-0334; Zamora-López, Gorka/0000-0001-9361-9619; Gomez-Gardeñes, Jesus/0000-0001-5204-1937; Moreno, Yamir/0000-0002-0895-1893	Spanish Ministerio de Ciencia e Innovacion (MICINN) [FIS2008-01240, MTM2009-13848]; Deutsche Forschungsgemeinschaft [FOR 868, KU 837/23-1]; BioSim network of excellence [LSHB-CT-2004-005137]; Spanish MICINN [FIS2008-01240, FIS2009-13364-C02-01, FIS2009-13730-C02-02]; Office of Science, Computational and Technology Research, U.S. Department of Energy [DE-AC02-05CH11231]	Spanish Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BioSim network of excellence(European Commission); Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Office of Science, Computational and Technology Research, U.S. Department of Energy(United States Department of Energy (DOE))	J.G.-G. is supported by the Spanish Ministerio de Ciencia e Innovacion (MICINN) through projects FIS2008-01240 and MTM2009-13848. G.Z.-L. is supported by the Deutsche Forschungsgemeinschaft, research group FOR 868 (KU 837/23-1) and the BioSim network of excellence (LSHB-CT-2004-005137). Y.M. is supported by Spanish MICINN through projects FIS2008-01240 and FIS2009-13364-C02-01. A.A. acknowledges partial support by the Director, Office of Science, Computational and Technology Research, U.S. Department of Energy under Contract DE-AC02-05CH11231 and the Spanish MICINN through project FIS2009-13730-C02-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acebron JA, 2005, REV MOD PHYS, V77, P137, DOI 10.1103/RevModPhys.77.137; Arenas A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.114102; Arenas A, 2008, PHYS REP, V469, P93, DOI 10.1016/j.physrep.2008.09.002; Boccaletti S, 2009, HDB BIOL NETWORKS; Bressler SL, 2001, TRENDS COGN SCI, V5, P26, DOI 10.1016/S1364-6613(00)01564-3; Colizza V, 2006, NAT PHYS, V2, P110, DOI 10.1038/nphys209; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Engel AK, 2001, TRENDS COGN SCI, V5, P16, DOI 10.1016/S1364-6613(00)01568-0; FAHLE M, 1993, P ROY SOC B-BIOL SCI, V254, P199, DOI 10.1098/rspb.1993.0146; Gomez-Gardenes J, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.066106; Gomez-Gardenes J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.034101; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hilgetag CC, 2000, PHILOS T ROY SOC B, V355, P91, DOI 10.1098/rstb.2000.0551; Hilgetag CC, 2004, NEUROINFORMATICS, V2, P353, DOI 10.1385/NI:2:3:353; Hilgetag CC, 2000, PHILOS T R SOC B, V355, P71, DOI 10.1098/rstb.2000.0550; Kuramoto Y., 1984, PROG THEOR PHYS SUPP, V79, P223, DOI DOI 10.1143/PTPS.79.223; Melloni L, 2007, J NEUROSCI, V27, P2858, DOI 10.1523/JNEUROSCI.4623-06.2007; Morgan RJ, 2008, P NATL ACAD SCI USA, V105, P6179, DOI 10.1073/pnas.0801372105; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Rulkov NF, 2001, PHYS REV LETT, V86, P183, DOI 10.1103/PhysRevLett.86.183; Scannell JW, 1999, CEREB CORTEX, V9, P277, DOI 10.1093/cercor/9.3.277; SCANNELL JW, 1995, J NEUROSCI, V15, P1463; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Stein BE, 2008, NAT REV NEUROSCI, V9, P255, DOI 10.1038/nrn2331; Strogatz SH, 2000, PHYSICA D, V143, P1, DOI 10.1016/S0167-2789(00)00094-4; Uhlhaas PJ, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.017.2009; Zamora-Lopez G, 2009, CHAOS, V19, DOI 10.1063/1.3089559; ZAMORALOPEZ G, 2010, FRONTIERS N IN PRESS; Zemanova L, 2006, PHYSICA D, V224, P202, DOI 10.1016/j.physd.2006.09.008; Zhou CS, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/178; Zhou CS, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.238103; Zhou S, 2004, IEEE COMMUN LETT, V8, P180, DOI 10.1109/LCOMM.2004.823426	34	64	64	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12313	10.1371/journal.pone.0012313	http://dx.doi.org/10.1371/journal.pone.0012313			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865046	Green Published, Green Submitted, gold			2022-12-27	WOS:000281292100006
J	Zykova, SN; Tveita, AA; Rekvig, OP				Zykova, Svetlana N.; Tveita, Anders A.; Rekvig, Ole Petter			Renal Dnase1 Enzyme Activity and Protein Expression Is Selectively Shut Down in Murine and Human Membranoproliferative Lupus Nephritis	PLOS ONE			English	Article							DEOXYRIBONUCLEASE I DNASE; APOPTOTIC CELLS; PLASMA-LEVELS; T-ANTIGEN; HUMAN SLE; ANTIBODIES; SERUM; ERYTHEMATOSUS; CHROMATIN; NUCLEOSOMES	Background: Deposition of chromatin-IgG complexes within glomerular membranes is a key event in the pathogenesis of lupus nephritis. We recently reported an acquired loss of renal Dnase1 expression linked to transformation from mild to severe membranoproliferative lupus nephritis in (NZBxNZW)F1 mice. As this may represent a basic mechanism in the progression of lupus nephritis, several aspects of Dnase1 expression in lupus nephritis were analyzed. Methodology/Principal Findings: Total nuclease activity and Dnase1 expression and activity was evaluated using in situ and in vitro analyses of kidneys and sera from (NZBxNZW) F1 mice of different ages, and from age-matched healthy controls. Immunofluorescence staining for Dnase1 was performed on kidney biopsies from (NZBxNZW) F1 mice as well as from human SLE patients and controls. Reduced serum Dnase1 activity was observed in both mesangial and end-stage lupus nephritis. A selective reduction in renal Dnase1 activity was seen in mice with massive deposition of chromatin-containing immune complexes in glomerular capillary walls. Mice with mild mesangial nephritis showed normal renal Dnase1 activity. Similar differences were seen when comparing human kidneys with severe and mild lupus nephritis. Dnase1 was diffusely expressed within the kidney in normal and mildly affected kidneys, whereas upon progression towards end-stage renal disease, Dnase1 was down-regulated in all renal compartments. This demonstrates that the changes associated with development of severe nephritis in the murine model are also relevant to human lupus nephritis. Conclusions/Significance: Reduction in renal Dnase1 expression and activity is limited to mice and SLE patients with signs of membranoproliferative nephritis, and may be a critical event in the development of severe forms of lupus nephritis. Reduced Dnase1 activity reflects loss in the expression of the protein and not inhibition of enzyme activity.	[Zykova, Svetlana N.; Tveita, Anders A.; Rekvig, Ole Petter] Univ Tromso, Inst Med Biol, Fac Med, Dept Biochem, Tromso, Norway; [Rekvig, Ole Petter] Univ Hosp No Norway, Dept Rheumatol, Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway	Zykova, SN (corresponding author), Univ Tromso, Inst Med Biol, Fac Med, Dept Biochem, Tromso, Norway.	Ole.Petter.Rekvig@uit.no	Rekvig, Ole Petter/V-7113-2019	Tveita, Anders/0000-0002-0668-9262	Health and Rehabilitation organisation Norway; Northern Norway Regional Health Authority [SFP-100-04, SFP-101-04]; University of Tromsoe	Health and Rehabilitation organisation Norway; Northern Norway Regional Health Authority; University of Tromsoe	This study was supported by grants from The Health and Rehabilitation organisation Norway, The Northern Norway Regional Health Authority Medical Research Program (Grants SFP-100-04, SFP-101-04), and from University of Tromsoe as a Milieu support given to OPR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoura Z, 1997, ARTHRITIS RHEUM, V40, P2217, DOI 10.1002/art.1780401217; Basnakian AG, 2005, J AM SOC NEPHROL, V16, P697, DOI 10.1681/ASN.2004060494; Berden JHM, 2002, J NEPHROL, V15, pS1; CHITRABAMRUNG S, 1981, RHEUMATOL INT, V1, P55, DOI 10.1007/BF00541153; CHITRABAMRUNG S, 1981, RHEUMATOL INT, V1, P49, DOI 10.1007/BF00541152; Davis JC, 1999, LUPUS, V8, P68, DOI 10.1191/096120399678847380; Fenton K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008474; Fenton KA, 2008, MOL IMMUNOL, V45, P3117, DOI 10.1016/j.molimm.2008.03.001; FROST P. G., 1968, CLIN EXP IMMUNOL, V3, P447; Gaipl US, 2006, CURR DIRECT AUTOIMMU, V9, P173; Gaipl US, 2006, CURR TOP MICROBIOL, V305, P161, DOI 10.1007/3-540-29714-6_8; Gaipl US, 2004, ARTHRITIS RHEUM-US, V50, P640, DOI 10.1002/art.20034; Hahn BH, 1998, NEW ENGL J MED, V338, P1359, DOI 10.1056/NEJM199805073381906; Holdenrieder S, 2008, ANN NY ACAD SCI, V1137, P180, DOI 10.1196/annals.1448.012; JOHNSON AJ, 1954, J CLIN INVEST, V33, P1670, DOI 10.1172/JCI103048; Kalaaji M, 2007, KIDNEY INT, V71, P664, DOI 10.1038/sj.ki.5002133; Kalaaji M, 2006, ARTHRITIS RHEUM-US, V54, P914, DOI 10.1002/art.21622; Kalaaji M, 2006, AM J PATHOL, V168, P1779, DOI 10.2353/ajpath.2006.051329; Kawane K, 2008, METHOD ENZYMOL, V442, P271, DOI 10.1016/S0076-6879(08)01414-6; Koizumi T, 1996, EXP ANIM TOKYO, V45, P245, DOI 10.1538/expanim.45.245; Kuenkele Susanne, 2003, Curr Rheumatol Rep, V5, P175, DOI 10.1007/s11926-003-0061-1; LACKS SA, 1981, J BIOL CHEM, V256, P2644; LAZARIDES E, 1974, P NATL ACAD SCI USA, V71, P4742, DOI 10.1073/pnas.71.12.4742; Licht R, 2004, J AUTOIMMUN, V22, P139, DOI 10.1016/j.jaut.2003.11.003; Licht R, 2001, ARTHRITIS RHEUM-US, V44, P1320, DOI 10.1002/1529-0131(200106)44:6<1320::AID-ART224>3.0.CO;2-X; LINDBERG MU, 1966, J BIOL CHEM, V241, P1246; Lo YMD, 2000, CLIN CHEM, V46, P319; Macanovic M, 1997, CLIN EXP IMMUNOL, V108, P220, DOI 10.1046/j.1365-2249.1997.3571249.x; MALIDE D, 1993, AM J PATHOL, V143, P304; Manderson AP, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1936; MIESCHER P, 1954, EXPERIENTIA, V10, P252, DOI 10.1007/BF02157392; Mizuta R, 2009, BIOMED RES-TOKYO, V30, P165, DOI 10.2220/biomedres.30.165; Nephritis L, 2008, AM J PATHOL, V172, P275, DOI 10.2353/ajpath.2008.070563; Mortensen ES, 2009, J AM SOC NEPHROL, V20, P696, DOI 10.1681/ASN.2008010112; Napirei M, 2006, INT J BIOCHEM CELL B, V38, P297, DOI 10.1016/j.biocel.2005.10.023; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; Napirei M, 2004, BIOCHEM J, V380, P929, DOI 10.1042/BJ20040046; Napirei M, 2004, ARTHRITIS RHEUM-US, V50, P1873, DOI 10.1002/art.20267; ORDONEZ NG, 1981, J PATHOL, V135, P259, DOI 10.1002/path.1711350403; RAPTIS L, 1980, J CLIN INVEST, V66, P1391, DOI 10.1172/JCI109992; Rekvig OP, 1997, J CLIN INVEST, V99, P2045, DOI 10.1172/JCI119373; ROSENTHAL AL, 1977, ANAL BIOCHEM, V80, P76, DOI 10.1016/0003-2697(77)90627-3; Sallai K, 2005, CLIN DIAGN LAB IMMUN, V12, P56, DOI 10.1128/CDLI.12.1.56-59.2005; Samejima K, 2005, NAT REV MOL CELL BIO, V6, P677, DOI 10.1038/nrm1715; SBARRA AJ, 1963, NATURE, V198, P159, DOI 10.1038/198159a0; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Shiokawa D, 1997, BIOCHEM J, V326, P675, DOI 10.1042/bj3260675; Shiokawa D, 2001, BIOCHEMISTRY-US, V40, P143, DOI 10.1021/bi001041a; Su KY, 2009, SCAND J IMMUNOL, V70, P175, DOI 10.1111/j.1365-3083.2009.02300.x; Takeshita H, 2000, BIOCHEM BIOPH RES CO, V269, P481, DOI 10.1006/bbrc.2000.2300; TAN EM, 1966, J CLIN INVEST, V45, P1732, DOI 10.1172/JCI105479; Tew MB, 2001, ARTHRITIS RHEUM, V44, P2446, DOI 10.1002/1529-0131(200110)44:10<2446::AID-ART409>3.0.CO;2-U; Verthelyi D, 1998, LUPUS, V7, P223, DOI 10.1191/096120398678920037; Wilber A, 2003, CLIN EXP IMMUNOL, V134, P46, DOI 10.1046/j.1365-2249.2003.02267.x; Williams RC, 2001, J RHEUMATOL, V28, P81; Yasutomo K, 2001, NAT GENET, V28, P313, DOI 10.1038/91070; Zeerleder S, 2003, CRIT CARE MED, V31, P1947, DOI 10.1097/01.CCM.0000074719.40109.95; Zykova SN, 2008, ARTHRITIS RHEUM-US, V58, P813, DOI 10.1002/art.23276	58	46	49	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12096	10.1371/journal.pone.0012096	http://dx.doi.org/10.1371/journal.pone.0012096			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20856893	Green Published, gold			2022-12-27	WOS:000280811900033
J	Guerrero-Bosagna, C; Settles, M; Lucker, B; Skinner, MK				Guerrero-Bosagna, Carlos; Settles, Matthew; Lucker, Ben; Skinner, Michael K.			Epigenetic Transgenerational Actions of Vinclozolin on Promoter Regions of the Sperm Epigenome	PLOS ONE			English	Article							CTCF-BINDING-SITES; ENDOCRINE DISRUPTOR VINCLOZOLIN; DNA METHYLATION PATTERNS; BISPHENOL-A; GENE-EXPRESSION; BROAD-COMPLEX; DISEASE; MOUSE; EXPOSURE; INHERITANCE	Previous observations have demonstrated that embryonic exposure to the endocrine disruptor vinclozolin during gonadal sex determination promotes transgenerational adult onset disease such as male infertility, kidney disease, prostate disease, immune abnormalities and tumor development. The current study investigates genome-wide promoter DNA methylation alterations in the sperm of F3 generation rats whose F0 generation mother was exposed to vinclozolin. A methylated DNA immunoprecipitation with methyl-cytosine antibody followed by a promoter tilling microarray (MeDIP-Chip) procedure was used to identify 52 different regions with statistically significant altered methylation in the sperm promoter epigenome. Mass spectrometry bisulfite analysis was used to map the CpG DNA methylation and 16 differential DNA methylation regions were confirmed, while the remainder could not be analyzed due to bisulfite technical limitations. Analysis of these validated regions identified a consensus DNA sequence (motif) that associated with 75% of the promoters. Interestingly, only 16.8% of a random set of 125 promoters contained this motif. One candidate promoter (Fam111a) was found to be due to a copy number variation (CNV) and not a methylation change, suggesting initial alterations in the germline epigenome may promote genetic abnormalities such as induced CNV in later generations. This study identifies differential DNA methylation sites in promoter regions three generations after the initial exposure and identifies common genome features present in these regions. In addition to primary epimutations, a potential indirect genetic abnormality was identified, and both are postulated to be involved in the epigenetic transgenerational inheritance observed. This study confirms that an environmental agent has the ability to induce epigenetic transgenerational changes in the sperm epigenome.	[Guerrero-Bosagna, Carlos; Settles, Matthew; Lucker, Ben; Skinner, Michael K.] Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA	Washington State University	Guerrero-Bosagna, C (corresponding author), Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA.	skinner@wsu.edu	Settles, Matthew L/F-2031-2011; Guerrero-Bosagna, Carlos/W-7319-2019	Settles, Matthew L/0000-0002-3424-1086; Guerrero-Bosagna, Carlos/0000-0003-1935-5875	Department of Defense; National Institutes of Health, National Institute of Environmental Health Sciences; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012974] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institutes of Health, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by a Department of Defense and a National Institutes of Health, National Institute of Environmental Health Sciences grant to MKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Anway MD, 2008, GENOMICS, V91, P30, DOI 10.1016/j.ygeno.2007.10.002; Anway MD, 2006, J ANDROL, V27, P868, DOI 10.2164/jandrol.106.000349; Anway MD, 2006, ENDOCRINOLOGY, V147, pS43, DOI 10.1210/en.2005-1058; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bertram C, 2008, J PHYSIOL-LONDON, V586, P2217, DOI 10.1113/jphysiol.2007.147967; Burghardt B, 2001, PEPTIDES, V22, P1119, DOI 10.1016/S0196-9781(01)00433-8; Chen ZX, 2005, BIOCHEM CELL BIOL, V83, P438, DOI 10.1139/O05-138; Cheng ASL, 2008, CANCER RES, V68, P1786, DOI 10.1158/0008-5472.CAN-07-5547; Cheng RYS, 2004, MOL CARCINOGEN, V40, P1, DOI 10.1002/mc.20022; Choi SH, 2009, INT J CANCER, V125, P723, DOI 10.1002/ijc.24384; Clark SJ, 2006, NAT PROTOC, V1, P2353, DOI 10.1038/nprot.2006.324; Constancia M, 1998, GENOME RES, V8, P881, DOI 10.1101/gr.8.9.881; Cooney CA, 2002, J NUTR, V132, p2393S; Crews D, 2007, P NATL ACAD SCI USA, V104, P5942, DOI 10.1073/pnas.0610410104; Das MK, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S21; Datta J, 2008, CANCER RES, V68, P5049, DOI 10.1158/0008-5472.CAN-07-6655; Dindot SV, 2009, GENOME RES, V19, P1374, DOI 10.1101/gr.089185.108; Dolinoy DC, 2007, P NATL ACAD SCI USA, V104, P13056, DOI 10.1073/pnas.0703739104; Dolinoy DC, 2006, ENVIRON HEALTH PERSP, V114, P567, DOI 10.1289/ehp.8700; Edwards TM, 2007, ENVIRON HEALTH PERSP, V115, P1264, DOI 10.1289/ehp.9951; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Elzeinova F, 2008, REPROD TOXICOL, V26, P231, DOI 10.1016/j.reprotox.2008.09.007; Engel N, 2006, HUM MOL GENET, V15, P2945, DOI 10.1093/hmg/ddl237; Fantozzi I, 2006, AM J PHYSIOL-LUNG C, V291, pL993, DOI 10.1152/ajplung.00191.2005; Feltus FA, 2006, GENOMICS, V87, P572, DOI 10.1016/j.ygeno.2005.12.016; FRANKLIN TB, 2009, NEUROBIOL DIS; Frith MC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000071; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Gebelein B, 1996, CANCER LETT, V105, P225, DOI 10.1016/0304-3835(96)04286-3; Gluckman PD, 2007, BIOESSAYS, V29, P145, DOI 10.1002/bies.20522; Guerrero-Bosagna C, 2005, EVOL DEV, V7, P341, DOI 10.1111/j.1525-142X.2005.05033.x; Guerrero-Bosagna Carlos M., 2008, BMC Physiology, V8, P17, DOI 10.1186/1472-6793-8-17; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hakme A, 2008, DEV DYNAM, V237, P209, DOI 10.1002/dvdy.21399; Hilder TL, 2007, METHOD ENZYMOL, V428, P297, DOI 10.1016/S0076-6879(07)28017-6; Ho SM, 2006, CANCER RES, V66, P5624, DOI 10.1158/0008-5472.CAN-06-0516; Howdeshell KL, 1999, NATURE, V401, P763, DOI 10.1038/44517; Inokuchi J, 2009, CARCINOGENESIS, V30, P1082, DOI 10.1093/carcin/bgp078; Irizarry RA, 2008, GENOME RES, V18, P780, DOI 10.1101/gr.7301508; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; KELCE WR, 1994, TOXICOL APPL PHARM, V126, P276, DOI 10.1006/taap.1994.1117; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kundu P, 2008, MOL CELL ENDOCRINOL, V292, P50, DOI 10.1016/j.mce.2008.06.003; Laird PW, 1996, ANNU REV GENET, V30, P441, DOI 10.1146/annurev.genet.30.1.441; Lamb HK, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.133pe38; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; Lin CH, 2009, GENOMICS, V94, P241, DOI 10.1016/j.ygeno.2009.06.004; Mahony S, 2007, NUCLEIC ACIDS RES, V35, pW253, DOI 10.1093/nar/gkm272; MATSUZAKI H, 2010, HUM MOL GENET; Newbold RR, 2008, INT J ANDROL, V31, P201, DOI 10.1111/j.1365-2605.2007.00858.x; Newbold RR, 2006, ENDOCRINOLOGY, V147, pS11, DOI 10.1210/en.2005-1164; Nilsson EE, 2008, REPRODUCTION, V135, P713, DOI 10.1530/REP-07-0542; Novikova SI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001919; Ottinger MA, 2008, BRAIN RES REV, V57, P376, DOI 10.1016/j.brainresrev.2007.08.011; Pan YL, 2007, CANCER LETT, V246, P129, DOI 10.1016/j.canlet.2006.02.010; POPP C, 2010, NATURE; Pothuluri JV, 2000, J AGR FOOD CHEM, V48, P6138, DOI 10.1021/jf0008543; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Reza AMS, 2004, COMP BIOCHEM PHYS B, V139, P753, DOI 10.1016/j.cbpc.2004.09.009; Rodenhiser DI, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2121; Roepke TK, 2006, J BIOL CHEM, V281, P23740, DOI 10.1074/jbc.M604155200; Rompler M, 2005, J BIOL CHEM, V280, P31068, DOI 10.1074/jbc.M503586200; SALIAN S, 2009, LIFE SCI; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Skinner MK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003745; SKINNER MK, 2010, TRENDS ENDOCRINOLOGY; Slattery MG, 2006, EUKARYOT CELL, V5, P313, DOI 10.1128/EC.5.2.313-320.2006; Stouder C, 2010, REPRODUCTION, V139, P373, DOI 10.1530/REP-09-0340; Surani MA, 2001, NATURE, V414, P122, DOI 10.1038/35102186; Szabo PE, 2004, MOL CELL BIOL, V24, P4791, DOI 10.1128/MCB.24.11.4791-4800.2004; Tanimoto K, 2005, P NATL ACAD SCI USA, V102, P10250, DOI 10.1073/pnas.0409541102; Tomazou EM, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-19; Tost J, 2007, NAT PROTOC, V2, P2265, DOI 10.1038/nprot.2007.314; Wain LV, 2009, LANCET, V374, P340, DOI 10.1016/S0140-6736(09)60249-X; Waterland RA, 2008, INT J OBESITY, V32, P1373, DOI 10.1038/ijo.2008.100; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Whitelaw NC, 2008, CURR OPIN GENET DEV, V18, P273, DOI 10.1016/j.gde.2008.07.001; Wilson TG, 2006, GENETICS, V172, P253, DOI 10.1534/genetics.105.046631; WONG CI, 1995, J BIOL CHEM, V270, P19998, DOI 10.1074/jbc.270.34.19998; Xie HH, 2009, GENOMICS, V93, P434, DOI 10.1016/j.ygeno.2009.01.005; YAMASAKI H, 1992, ENVIRON HEALTH PERSP, V98, P39, DOI 10.2307/3431245; Yaoi T, 2008, BIOCHEM BIOPH RES CO, V376, P563, DOI 10.1016/j.bbrc.2008.09.028; Youngson NA, 2008, ANNU REV GENOM HUM G, V9, P233, DOI 10.1146/annurev.genom.9.081307.164445; Zhang X, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000032	86	293	307	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e13100	10.1371/journal.pone.0013100	http://dx.doi.org/10.1371/journal.pone.0013100			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20927350	Green Published, Green Submitted, gold			2022-12-27	WOS:000282312600026
J	Hickner, PV; deBruyn, B; Lovin, DD; Mori, A; Behura, SK; Pinger, R; Severson, DW				Hickner, Paul V.; deBruyn, Becky; Lovin, Diane D.; Mori, Akio; Behura, Susanta K.; Pinger, Robert; Severson, David W.			Genome-Based Microsatellite Development in the Culex pipiens Complex and Comparative Microsatellite Frequency with Aedes aegypti and Anopheles gambiae	PLOS ONE			English	Article							INTEGRATED GENETIC-MAP; LINKAGE MAP; CULICIDAE; MOSQUITO; DIPTERA; VECTOR; QUINQUEFASCIATUS; MARKERS; LOCI; SOFTWARE	Background: Mosquitoes in the Culex pipiens complex are among the most medically important vectors for human disease worldwide and include major vectors for lymphatic filariasis and West Nile virus transmission. However, detailed genetic studies in the complex are limited by the number of genetic markers available. Here, we describe methods for the rapid and efficient identification and development of single locus, highly polymorphic microsatellite markers for Cx. pipiens complex mosquitoes via in silico screening of the Cx. quinquefasciatus genome sequence. Methodology/Principal Findings: Six lab colonies representing four Cx. pipiens and two Cx. quinquefasciatus populations were utilized for preliminary assessment of 38 putative loci identified within 16 Cx. quinquefasciatus supercontig assemblies (CpipJ1) containing previously mapped genetic marker sequences. We identified and validated 12 new microsatellite markers distributed across all three linkage groups that amplify consistently among strains representing the complex. We also developed four groups of 3-5 microsatellite loci each for multiplex-ready PCR. Field collections from three cities in Indiana were used to assess the multiplex groups for their application to natural populations. All were highly polymorphic (Mean = 13.0 alleles) per locus and reflected high polymorphism information content (PIC) (Mean = 0.701). Pairwise F-ST indicated population structuring between Terre Haute and Fort Wayne and between Terre Haute and Indianapolis, but not between Fort Wayne and Indianapolis. In addition, we performed whole genome comparisons of microsatellite motifs and abundance between Cx. quinquefasciatus and the primary vectors for dengue virus and malaria parasites, Aedes aegypti and Anopheles gambiae, respectively. Conclusions/Significance: We demonstrate a systematic approach for isolation and validation of microsatellites for the Cx. pipiens complex by direct screen of the Cx. quinquefasciatus genome supercontig assemblies. The genome density of microsatellites is greater in Cx. quinquefasciatus (0.26%) than in Ae. aegypti (0.14%), but considerably lower than in An. gambiae (0.77%).	[Hickner, Paul V.; deBruyn, Becky; Lovin, Diane D.; Mori, Akio; Behura, Susanta K.; Severson, David W.] Univ Notre Dame, Dept Biol Sci, Eck Inst Global Hlth, Notre Dame, IN 46556 USA; [Pinger, Robert] Ball State Univ, Dept Physiol & Hlth Sci, Muncie, IN 47306 USA	University of Notre Dame; Ball State University	Hickner, PV (corresponding author), Univ Notre Dame, Dept Biol Sci, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.	severson.1@nd.edu		BEHURA, SUSANTA/0000-0002-0654-6288; behura, Susanta/0000-0003-1057-2435	Indiana Vector Control Association; Ball State University; Indiana Academy of Sciences; Department of Physiology and Health Science (Ball State University); National Institute of Allergy and Infectious Diseases, National Institutes of Health [RO1-AI079125-A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079125] Funding Source: NIH RePORTER	Indiana Vector Control Association; Ball State University; Indiana Academy of Sciences; Department of Physiology and Health Science (Ball State University); National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for the collection and rearing of field samples was supported by the Dunn-Foster Research Award from the Indiana Vector Control Association, Aspire Graduate Student Research Grant (Ball State University), a research grant from the Indiana Academy of Sciences, and the Russell E. Siverly Research Award from the Department of Physiology and Health Science (Ball State University). All other work was supported by grant RO1-AI079125-A1 from the National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archak S, 2007, NUCLEIC ACIDS RES, V35, pD36, DOI 10.1093/nar/gkl778; BARR AR, 1957, AM J TROP MED HYG, V6, P153, DOI 10.4269/ajtmh.1957.6.153; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Chambers EW, 2007, J HERED, V98, P202, DOI 10.1093/jhered/esm015; Cornuet JM, 1996, GENETICS, V144, P2001; Day JF, 2001, ANNU REV ENTOMOL, V46, P111, DOI 10.1146/annurev.ento.46.1.111; Dimopoulos G, 1996, GENETICS, V143, P953; Edillo FE, 2007, J MED ENTOMOL, V44, P145, DOI 10.1603/0022-2585(2007)44[145:ASOBAM]2.0.CO;2; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fonseca DM, 1998, MOL ECOL, V7, P1617; Fonseca DM, 2004, SCIENCE, V303, P1535, DOI 10.1126/science.1094247; Fulton RE, 2001, GENETICS, V158, P715; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hayden MJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-80; Huang SM, 2008, AM J TROP MED HYG, V79, P518, DOI 10.4269/ajtmh.2008.79.518; Keyghobadi N, 2004, MOL ECOL NOTES, V4, P20, DOI 10.1046/j.1471-8286.2003.00557.x; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Kofler R, 2007, BIOINFORMATICS, V23, P1683, DOI 10.1093/bioinformatics/btm157; Kothera L, 2009, J MED ENTOMOL, V46, P236, DOI 10.1603/033.046.0208; Krida G, 1998, PARASITOL RES, V84, P139, DOI 10.1007/s004360050371; LEWIS LF, 1974, MOSQ NEWS, V34, P436; Lovin DD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-590; Meglecz E, 2007, INSECT MOL BIOL, V16, P175, DOI 10.1111/j.1365-2583.2006.00713.x; Mori A, 2007, INSECT MOL BIOL, V16, P515, DOI 10.1111/j.1365-2583.2007.00746.x; Mori A, 1999, J HERED, V90, P160, DOI 10.1093/jhered/90.1.160; Park SDE, 2001, THESIS U DUBLIN; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Rudbeck L, 1998, BIOTECHNIQUES, V25, P588, DOI 10.2144/98254bm09; Severson D. W., 1997, The molecular biology of insect disease vectors: a methods manual., P309; SEVERSON DW, 1993, J HERED, V84, P241, DOI 10.1093/oxfordjournals.jhered.a111333; Severson DW, 2002, INSECT MOL BIOL, V11, P371, DOI 10.1046/j.1365-2583.2002.00347.x; Sharakhov IV, 2002, SCIENCE, V298, P182, DOI 10.1126/science.1076803; Siverly R.E., 1972, MOSQUITOES INDIANA; Smith JL, 2005, MOL ECOL NOTES, V5, P697, DOI 10.1111/j.1471-8286.2005.01034.x; Turell MJ, 2001, J MED ENTOMOL, V38, P130, DOI 10.1603/0022-2585-38.2.130; Vinogradova E.B., 2000, CULEX PIPIENS PIPIEN; Wang R, 1999, PARASITOL TODAY, V15, P33, DOI 10.1016/S0169-4758(98)01360-X; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Zane L, 2002, MOL ECOL, V11, P1, DOI 10.1046/j.0962-1083.2001.01418.x; Zheng LB, 1996, GENETICS, V143, P941; 2010, VECTORBASE CX PIPIEN	43	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e13062	10.1371/journal.pone.0013062	http://dx.doi.org/10.1371/journal.pone.0013062			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20927334	Green Submitted, gold, Green Published			2022-12-27	WOS:000282312600015
J	Lonchamp, E; Dupont, JL; Wioland, L; Courjaret, R; Mbebi-Liegeois, C; Jover, E; Doussau, F; Popoff, MR; Bossu, JL; de Barry, J; Poulain, B				Lonchamp, Etienne; Dupont, Jean-Luc; Wioland, Laetitia; Courjaret, Raphael; Mbebi-Liegeois, Corinne; Jover, Emmanuel; Doussau, Frederic; Popoff, Michel R.; Bossu, Jean-Louis; de Barry, Jean; Poulain, Bernard			Clostridium perfringens Epsilon Toxin Targets Granule Cells in the Mouse Cerebellum and Stimulates Glutamate Release	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; NEURONAL CELLS; MDCK CELLS; PERMEABILITY; MEMBRANES; BINDING; MICE; PORE; LOCALIZATION; PROTEINS	Epsilon toxin (ET) produced by C. perfringens types B and D is a highly potent pore-forming toxin. ET-intoxicated animals express severe neurological disorders that are thought to result from the formation of vasogenic brain edemas and indirect neuronal excitotoxicity. The cerebellum is a predilection site for ET damage. ET has been proposed to bind to glial cells such as astrocytes and oligodendrocytes. However, the possibility that ET binds and attacks the neurons remains an open question. Using specific anti-ET mouse polyclonal antibodies and mouse brain slices preincubated with ET, we found that several brain structures were labeled, the cerebellum being a prominent one. In cerebellar slices, we analyzed the costaining of ET with specific cell markers, and found that ET binds to the cell body of granule cells, oligodendrocytes, but not astrocytes or nerve endings. Identification of granule cells as neuronal ET targets was confirmed by the observation that ET induced intracellular Ca2+ rises and glutamate release in primary cultures of granule cells. In cultured cerebellar slices, whole cell patch-clamp recordings of synaptic currents in Purkinje cells revealed that ET greatly stimulates both spontaneous excitatory and inhibitory activities. However, pharmacological dissection of these effects indicated that they were only a result of an increased granule cell firing activity and did not involve a direct action of the toxin on glutamatergic nerve terminals or inhibitory interneurons. Patch-clamp recordings of granule cell somata showed that ET causes a decrease in neuronal membrane resistance associated with pore-opening and depolarization of the neuronal membrane, which subsequently lead to the firing of the neuronal network and stimulation of glutamate release. This work demonstrates that a subset of neurons can be directly targeted by ET, suggesting that part of ET-induced neuronal damage observed in neuronal tissue is due to a direct effect of ET on neurons.	[Lonchamp, Etienne; Dupont, Jean-Luc; Wioland, Laetitia; Courjaret, Raphael; Mbebi-Liegeois, Corinne; Jover, Emmanuel; Doussau, Frederic; Bossu, Jean-Louis; de Barry, Jean; Poulain, Bernard] CNRS, Inst Neurosci Cellulaires & Integrat, UPR3212, Strasbourg, France; [Popoff, Michel R.] Inst Pasteur, Unite Anaerobies & Leurs Toxines, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Lonchamp, E (corresponding author), CNRS, Inst Neurosci Cellulaires & Integrat, UPR3212, Strasbourg, France.	poulain@inci-cnrs.unistra.fr	Blasi, Juan/K-7943-2014; Popoff, Michel/O-7719-2016	Blasi, Juan/0000-0002-0482-9444; Popoff, Michel/0000-0001-9305-8989; Doussau, Frederic/0000-0002-3769-1402	Mission pour la Recherche et l'Innovation Scientifique - Delegation Generale l'Armement (MRIS/DGA); Association Francaise contre les Myopathies (AFM); DGA [03 34 046]; Sanofi-Aventis France; Bayer Pharma; European Neuroscience Institutes Network, EU [LSHM-CT-2005-019063]	Mission pour la Recherche et l'Innovation Scientifique - Delegation Generale l'Armement (MRIS/DGA); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); DGA; Sanofi-Aventis France(Sanofi-Aventis); Bayer Pharma; European Neuroscience Institutes Network, EU	EL and LW are recipients of a doctoral grant from the Mission pour la Recherche et l'Innovation Scientifique - Delegation Generale l'Armement (MRIS/DGA). RC has been supported by a grant from Association Francaise contre les Myopathies (AFM). Part of the experimental work has been supported by grants from DGA (contract no. 03 34 046 to MRP and BP) and from Sanofi-Aventis France and Bayer Pharma as part of the BIOTOX multi-organism program, and the European Neuroscience Institutes Network project (ENINET, contract N<SUP>o</SUP> LSHM-CT-2005-019063 from the EU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson RH, 2005, INFECT IMMUN, V73, P4879, DOI 10.1128/IAI.73.8.4879-4887.2005; Barski JJ, 2003, J NEUROSCI, V23, P3469; BUXTON D, 1978, J MED MICROBIOL, V11, P299, DOI 10.1099/00222615-11-3-299; Castejon OJ, 2004, DEV BRAIN RES, V151, P25, DOI 10.1016/j.devbrainres.2004.03.019; Chapman J, 1999, ANAL CHIM ACTA, V402, P47, DOI 10.1016/S0003-2670(99)00533-4; Chassin C, 2007, AM J PHYSIOL-RENAL, V293, pF927, DOI 10.1152/ajprenal.00199.2007; Cole AR, 2004, NAT STRUCT MOL BIOL, V11, P797, DOI 10.1038/nsmb804; de Barry J, 2006, J BIOL CHEM, V281, P18098, DOI 10.1074/jbc.M509842200; Dietschy JM, 2004, J LIPID RES, V45, P1375, DOI 10.1194/jlr.R400004-JLR200; Dorca-Arevalo J, 2008, VET MICROBIOL, V131, P14, DOI 10.1016/j.vetmic.2008.02.015; Dupont JL, 2006, CEREBELLUM, V5, P243, DOI 10.1080/14734220600905317; Fernandez-Miyakawa ME, 2007, INFECT IMMUN, V75, P4282, DOI 10.1128/IAI.00562-07; Finnie JW, 1999, J COMP PATHOL, V120, P415, DOI 10.1053/jcpa.1998.0289; Finnie JW, 2004, ANAEROBE, V10, P145, DOI 10.1016/j.anaerobe.2003.08.003; FINNIE JW, 1984, J COMP PATHOL, V94, P363, DOI 10.1016/0021-9975(84)90024-0; Fox MA, 2007, J COMP NEUROL, V503, P280, DOI 10.1002/cne.21381; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; GAHWILER BH, 1981, J NEUROSCI METH, V4, P329, DOI 10.1016/0165-0270(81)90003-0; GILL DM, 1987, TOXINS ENZYMES, V8, P127; Goldstein J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007065; Greenfield RA, 2002, AM J MED SCI, V323, P326, DOI 10.1097/00000441-200206000-00005; HUBER G, 1984, J NEUROSCI, V4, P151; Imura T, 2003, J NEUROSCI, V23, P2824; KADOTA T, 1991, ARCH HISTOL CYTOL, V54, P519, DOI 10.1679/aohc.54.519; Knapp O, 2009, BBA-BIOMEMBRANES, V1788, P2584, DOI 10.1016/j.bbamem.2009.09.020; Lamanauskas N, 2008, EUR J NEUROSCI, V27, P2501, DOI 10.1111/j.1460-9568.2008.06211.x; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Lonchamp E, 2009, EUR J NEUROSCI, V30, P2293, DOI 10.1111/j.1460-9568.2009.07023.x; Melton JA, 2004, J BIOL CHEM, V279, P14315, DOI 10.1074/jbc.M313758200; MELTON JA, 2006, COMPREHENSIVE SOURCE, P623; Miyamoto O, 1998, INFECT IMMUN, V66, P2501, DOI 10.1128/IAI.66.6.2501-2508.1998; Miyamoto O, 2000, FEMS MICROBIOL LETT, V189, P109, DOI 10.1111/j.1574-6968.2000.tb09215.x; Miyata S, 2002, J BIOL CHEM, V277, P39463, DOI 10.1074/jbc.M206731200; Miyata S, 2001, J BIOL CHEM, V276, P13778, DOI 10.1074/jbc.M011527200; Munro P, 2001, BIOCHEM BIOPH RES CO, V289, P623, DOI 10.1006/bbrc.2001.6031; Nagahama M, 2006, BIOCHEMISTRY-US, V45, P296, DOI 10.1021/bi051805s; NAGAHAMA M, 1992, INFECT IMMUN, V60, P1237, DOI 10.1128/IAI.60.3.1237-1240.1992; NAGAHAMA M, 1993, TOXICON, V31, P427, DOI 10.1016/0041-0101(93)90178-L; Ottico E, 2003, J LIPID RES, V44, P2142, DOI 10.1194/jlr.M300247-JLR200; Palay S. L., 1974, CEREBELLAR CORTEX CY; PAYNE DW, 1994, FEMS MICROBIOL LETT, V116, P161, DOI 10.1016/0378-1097(94)90068-X; Petit L, 1997, J BACTERIOL, V179, P6480, DOI 10.1128/jb.179.20.6480-6487.1997; Petit L, 2003, CELL MICROBIOL, V5, P155, DOI 10.1046/j.1462-5822.2003.00262.x; Petit L, 2001, J BIOL CHEM, V276, P15736, DOI 10.1074/jbc.M010412200; POPOFF MR, 1987, INFECT IMMUN, V55, P35, DOI 10.1128/IAI.55.1.35-43.1987; Ribaut-Barassin C, 2003, NEUROSCIENCE, V120, P405, DOI 10.1016/S0306-4522(03)00332-4; Sakurai J., 1995, Reviews in Medical Microbiology, V6, P175; Shimamoto S, 2005, MICROBIOL IMMUNOL, V49, P245, DOI 10.1111/j.1348-0421.2005.tb03726.x; Soler-Jover A, 2004, J HISTOCHEM CYTOCHEM, V52, P931, DOI 10.1369/jhc.4A6254.2004; Soler-Jover A, 2007, TOXICON, V50, P530, DOI 10.1016/j.toxicon.2007.04.025; THOMPSON CL, 1994, J NEUROCHEM, V62, P2037; TRAPP BD, 1988, J NEUROCHEM, V51, P859, DOI 10.1111/j.1471-4159.1988.tb01822.x; Uzal FA, 2004, J VET DIAGN INVEST, V16, P403, DOI 10.1177/104063870401600506; Uzal FA, 2004, ANAEROBE, V10, P135, DOI 10.1016/j.anaerobe.2003.08.005; WEISER M, 1995, J NEUROSCI, V15, P4298; Zhu C, 2001, EXP NEUROL, V169, P72, DOI 10.1006/exnr.2001.7652	56	51	52	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e13046	10.1371/journal.pone.0013046	http://dx.doi.org/10.1371/journal.pone.0013046			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20941361	Green Published, gold			2022-12-27	WOS:000282312600013
J	Mena, AL; Lam, EWF; Chatterjee, S				Mena, Ana Lucia; Lam, Eric W. -F.; Chatterjee, Sukalyan			Sustained Spindle-Assembly Checkpoint Response Requires De Novo Transcription and Translation of Cyclin B1	PLOS ONE			English	Article							MITOTIC CHECKPOINT; HELA-CELLS; MITOSIS; DESTRUCTION; INHIBITION; ANAPHASE; SLIPPAGE; BUBR1; PROGRESSION; ATTACHMENT	Background: Microtubule-targeting drugs induce mitotic delay at pro-metaphase by preventing the spindle assembly checkpoint to be satisfied. However, especially after prolonged treatments, cells can escape this arrest in a process called mitotic slippage. The mechanisms underlying the spindle assembly checkpoint and slippage are not fully understood. It has been generally accepted that during mitosis there is a temporary shutdown of high-energy-consuming processes, such as transcription and translation. However, the synthesis of specific proteins is maintained or up-regulated since protein synthesis is necessary for entry into and progression through mitosis. Methodology/Principal Findings: In this work we investigated whether the mitotic arrest caused by the mitotic checkpoint is independent of transcription and translation. By using immunofluorescent microscopy and western blotting, we demonstrate that inhibition of either of these processes induces a shortening of the mitotic arrest caused by the nocodazole treatment, and ultimately leads to mitotic slippage. Our western blotting and RTQ-PCR results show that inhibition of transcription during mitotic arrest does not affect the expression of the spindle checkpoint proteins, whereas it induces a significant decrease in the mRNA and protein levels of Cyclin B1. The exogenous expression of Cyclin B1 substantially rescued the mitotic phenotype in nocodazole cells treated with the inhibitors of transcription and translation. Conclusions/Significance: This work emphasizes the importance of transcription and translation for the maintenance of the spindle assembly checkpoint, suggesting the existence of a mechanism dependent on cyclin B1 gene regulation during mitosis. We propose that continuous transcription of mitotic regulators is required to sustain the activation of the spindle assembly checkpoint.	[Mena, Ana Lucia; Chatterjee, Sukalyan] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Lam, Eric W. -F.] Univ London Imperial Coll Sci Technol & Med, Dept Canc & Surg, London, England	Instituto Gulbenkian de Ciencia; Imperial College London	Mena, AL (corresponding author), Inst Gulbenkian Ciencias, Oeiras, Portugal.	sukalyan@yahoo.com	Lam, Eric W-F/AAW-8566-2020	Lam, Eric W-F/0000-0003-1274-3576; Mena, Ana Lucia/0000-0003-2111-4077	Fundacao para a Ciencia e a Tecnologia (FCT) [POCTI/BCI/42249/01, CBO/47565/02, SFRH/BD/9607/2002]; Fundacao Calouste Gulbenkian; POCI; FSE	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundacao Calouste Gulbenkian(European Commission); POCI(European Commission); FSE(European Social Fund (ESF))	This work was funded by grants (POCTI/BCI/42249/01 and CBO/47565/02) from Fundacao para a Ciencia e a Tecnologia (FCT). A.L. Mena, as a student of Instituto Gulbenkian de Ciencia's PhD Programme in Biomedicine (sponsored by FCT and Fundacao Calouste Gulbenkian) was supported by the FCT fellowship SFRH/BD/9607/2002, financed by POCI 2010 and FSE (http://alfa.fct.mctes.pt/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker DJ, 2007, CELL MOL LIFE SCI, V64, P589, DOI 10.1007/s00018-007-6443-1; Baker DJ, 2005, CURR OPIN CELL BIOL, V17, P583, DOI 10.1016/j.ceb.2005.09.011; Brito DA, 2006, CURR BIOL, V16, P1194, DOI 10.1016/j.cub.2006.04.043; Chen JG, 2003, CANCER RES, V63, P7891; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Dai W, 2004, CANCER RES, V64, P440, DOI 10.1158/0008-5472.CAN-03-3119; Elhajouji A, 1998, MUTAGENESIS, V13, P193; Gottesfeld JM, 1997, TRENDS BIOCHEM SCI, V22, P197, DOI 10.1016/S0968-0004(97)01045-1; GROLLMAN AP, 1966, P NATL ACAD SCI USA, V56, P1867, DOI 10.1073/pnas.56.6.1867; JORDAN MA, 1992, J CELL SCI, V102, P401; JORDAN MA, 1993, P NATL ACAD SCI USA, V90, P9552, DOI 10.1073/pnas.90.20.9552; Kim M, 2005, MOL CELL BIOL, V25, P9232, DOI 10.1128/MCB.25.21.9232-9248.2005; Le Breton M, 2005, BIOCHIMIE, V87, P805, DOI 10.1016/j.biochi.2005.04.014; LEE J, CELL CYCLE, P1792; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nilsson J, 2008, NAT CELL BIOL, V10, P1411, DOI 10.1038/ncb1799; Pyronnet S, 2001, CURR OPIN GENET DEV, V11, P13, DOI 10.1016/S0959-437X(00)00150-7; RIEDER CL, 1994, J CELL BIOL, V127, P1301, DOI 10.1083/jcb.127.5.1301; RIEDER CL, 1995, J CELL BIOL, V130, P941, DOI 10.1083/jcb.130.4.941; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Sciortino S, 2001, EMBO REP, V2, P1018, DOI 10.1093/embo-reports/kve223; Skoufias DA, 2007, J CELL BIOL, V179, P671, DOI 10.1083/jcb.200704117; SOBELL HM, 1985, P NATL ACAD SCI USA, V82, P5328, DOI 10.1073/pnas.82.16.5328; STEVENS FE, 2007, ONCOGENE; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Taylor SS, 1997, CELL, V89, P727, DOI 10.1016/S0092-8674(00)80255-X; Weaver BAA, 2005, CANCER CELL, V8, P7, DOI 10.1016/j.ccr.2005.06.011; Zhou J, 2002, J CELL SCI, V115, P3547, DOI 10.1242/jcs.00029	29	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2010	5	9							e13037	10.1371/journal.pone.0013037	http://dx.doi.org/10.1371/journal.pone.0013037			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654ZQ	20927403	Green Published, Green Submitted, gold			2022-12-27	WOS:000282210700016
J	Boyd, LK; Mercer, B; Thompson, D; Main, E; Watts, FZ				Boyd, Lara K.; Mercer, Brenda; Thompson, Darren; Main, Ewan; Watts, Felicity Z.			Characterisation of the SUMO-Like Domains of Schizosaccharomyces pombe Rad60	PLOS ONE			English	Article							DNA-REPAIR; SACCHAROMYCES-CEREVISIAE; FISSION YEAST; RECOMBINATION REPAIR; CONJUGATING ENZYME; GENOME STABILITY; SMC5-6 COMPLEX; UBIQUITIN; PROTEIN; LIGASE	The S. pombe Rad60 protein is required for the repair of DNA double strand breaks, recovery from replication arrest, and is essential for cell viability. It has two SUMO-like domains (SLDs) at its C-terminus, an SXS motif and three sequences that have been proposed to be SUMO-binding motifs (SBMs). SMB1 is located in the middle of the protein, SBM2 is in SLD1 and SBM3 is at the C-terminus of SLD2. We have probed the functions of the two SUMO-like domains, SLD1 and SLD2, and the putative SBMs. SLD1 is essential for viability, while SLD2 is not. rad60-SLD2 Delta cells are sensitive to DNA damaging agents and hydroxyurea. Neither ubiquitin nor SUMO can replace SLD1 or SLD2. Cells in which either SBM1 or SBM2 has been mutated are viable and are wild type for response to MMS and HU. In contrast mutation of SBM3 results in significant sensitivity to MMS and HU. These results indicate that the lethality resulting from deletion of SLD1 is not due to loss of SBM2, but that mutation of SBM3 produces a more severe phenotype than does deletion of SLD2. Using chemical denaturation studies, FPLC and dynamic light scattering we show this is likely due to the destabilisation of SLD2. Thus we propose that the region corresponding to the putative SBM3 forms part of the hydrophobic core of SLD2 and is not a SUMO-interacting motif. Overexpression of Hus5, which is the SUMO conjugating enzyme and known to interact with Rad60, does not rescue rad60-SLD2 Delta, implying that as well as having a role in the sumoylation process as previously described [1], Rad60 has a Hus5-independent function.	[Boyd, Lara K.; Mercer, Brenda; Watts, Felicity Z.] Univ Sussex, Sch Life Sci, Genome Damage & Stabil Ctr, Brighton, E Sussex, England; [Thompson, Darren] Univ Sussex, Sch Life Sci, Div Biochem & Biomed Sci, Brighton, E Sussex, England; [Main, Ewan] Univ Sussex, Sch Life Sci, Div Chem, Brighton, E Sussex, England	University of Sussex; University of Sussex; University of Sussex	Boyd, LK (corresponding author), Univ Sussex, Sch Life Sci, Genome Damage & Stabil Ctr, Brighton, E Sussex, England.	f.z.watts@sussex.ac.uk		Main, Ewan/0000-0001-6087-9000	Biotechnology and Biological Sciences Research Council (BBSRC) [S03/G152, BB/D526861/1]; Leverhulme Trust [RFG/10839]; Medical Research Council [G0500308, G0801130B] Funding Source: researchfish; MRC [G0500308] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Leverhulme Trust(Leverhulme Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Biotechnology and Biological Sciences Research Council (BBSRC) S03/G152, http://www.bbsrc.ac.uk/; BBSRC BB/D526861/1; and Leverhulme Trust RFG/10839, http://www.leverhulme.ac.uk/. The funders had no role in study design, data collection and analysis, decsion to publish, or preparation of the manuscript.	ALKHODAIRY F, 1995, J CELL SCI, V108, P475; Andrews EA, 2005, MOL CELL BIOL, V25, P185, DOI 10.1128/MCB.25.1.185-196.2005; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; Boddy MN, 2003, MOL CELL BIOL, V23, P5939, DOI 10.1128/MCB.23.16.5939-5946.2003; Cuperus G, 2002, GENETICS, V162, P633; Duan XY, 2009, J BIOL CHEM, V284, P8507, DOI 10.1074/jbc.M809139200; Fousteri MI, 2000, EMBO J, V19, P1691, DOI 10.1093/emboj/19.7.1691; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Hardeland U, 2002, EMBO J, V21, P1456, DOI 10.1093/emboj/21.6.1456; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Hodge MR, 1996, SCIENCE, V274, P1903, DOI 10.1126/science.274.5294.1903; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; JACKSON SE, 1993, BIOCHEMISTRY-US, V32, P11259, DOI 10.1021/bi00093a001; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; Laursen LV, 2003, MOL CELL BIOL, V23, P3692, DOI 10.1128/MCB.23.10.3692-3705.2003; LEHMANN AR, 1995, MOL CELL BIOL, V15, P7067; Main ERG, 1998, BIOCHEMISTRY-US, V37, P6145, DOI 10.1021/bi973111s; Mankouri HW, 2009, MOL BIOL CELL, V20, P1683, DOI 10.1091/mbc.E08-08-0877; Minty A, 2000, J BIOL CHEM, V275, P36316, DOI 10.1074/jbc.M004293200; Miyabe I, 2006, MOL CELL BIOL, V26, P343, DOI 10.1128/MCB.26.1.343-353.2006; Morikawa H, 2004, MOL CELL BIOL, V24, P9401, DOI 10.1128/MCB.24.21.9401-9413.2004; Morishita T, 2002, MOL CELL BIOL, V22, P3537, DOI 10.1128/MCB.22.10.3537-3548.2002; MURIS DFR, 1993, NUCLEIC ACIDS RES, V21, P4586, DOI 10.1093/nar/21.19.4586; Murray JM, 1997, MOL CELL BIOL, V17, P6868, DOI 10.1128/MCB.17.12.6868; MURRAY JM, 1991, NUCLEIC ACIDS RES, V19, P3525, DOI 10.1093/nar/19.13.3525; Murray JM, 2008, NAT REV MOL CELL BIO, V9, P177, DOI 10.1038/nrm2309; Novatchkova M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-22; Ohya T, 2008, GENETICS, V180, P41, DOI 10.1534/genetics.107.086249; Palecek J, 2006, J BIOL CHEM, V281, P36952, DOI 10.1074/jbc.M608004200; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Pebernard S, 2006, MOL CELL BIOL, V26, P1617, DOI 10.1128/MCB.26.5.1617-1630.2006; Pebernard S, 2008, MOL BIOL CELL, V19, P4099, DOI 10.1091/mbc.E08-02-0226; Perry JJP, 2008, TRENDS BIOCHEM SCI, V33, P201, DOI 10.1016/j.tibs.2008.02.001; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Potts PR, 2005, MOL CELL BIOL, V25, P7021, DOI 10.1128/MCB.25.16.7021-7032.2005; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Prudden J, 2009, NAT STRUCT MOL BIOL, V16, P509, DOI 10.1038/nsmb.1582; Raffa GD, 2006, J BIOL CHEM, V281, P27973, DOI 10.1074/jbc.M601943200; Sacher M, 2006, NAT CELL BIOL, V8, P1284, DOI 10.1038/ncb1488; Seeler JS, 2001, MOL CELL BIOL, V21, P3314, DOI 10.1128/MCB.21.10.3314-3324.2001; SEKIYAMA N, PROTEINS, V78, P1491; Sergeant J, 2005, MOL CELL BIOL, V25, P172, DOI 10.1128/MCB.25.1.172-184.2005; SERRANO L, 1992, J MOL BIOL, V224, P783, DOI 10.1016/0022-2836(92)90562-X; Sollier J, 2009, MOL BIOL CELL, V20, P1671, DOI 10.1091/mbc.E08-08-0875; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Verkade HM, 1999, MOL BIOL CELL, V10, P2905, DOI 10.1091/mbc.10.9.2905; Watson AT, 2008, GENE, V407, P63, DOI 10.1016/j.gene.2007.09.024; Watts FZ, 2007, CHROMOSOMA, V116, P15, DOI 10.1007/s00412-006-0079-z; Xhemalce B, 2004, EMBO J, V23, P3844, DOI 10.1038/sj.emboj.7600394; Xie Y, 2007, J BIOL CHEM, V282, P34176, DOI 10.1074/jbc.M706025200; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102	55	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e13009	10.1371/journal.pone.0013009	http://dx.doi.org/10.1371/journal.pone.0013009			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20885950	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000282167100013
J	Maupin, KA; Sinha, A; Eugster, E; Miller, J; Ross, J; Paulino, V; Keshamouni, VG; Tran, N; Berens, M; Webb, C; Haab, BB				Maupin, Kevin A.; Sinha, Arkadeep; Eugster, Emily; Miller, Jeremy; Ross, Julianna; Paulino, Vincent; Keshamouni, Venkateshwar G.; Tran, Nhan; Berens, Michael; Webb, Craig; Haab, Brian B.			Glycogene Expression Alterations Associated with Pancreatic Cancer Epithelial-Mesenchymal Transition in Complementary Model Systems	PLOS ONE			English	Article							CELL-ADHESION; LINKED OLIGOSACCHARIDES; MONOCLONAL-ANTIBODIES; CADHERIN EXPRESSION; CARCINOMA CELLS; GROWTH; TRANSFERASES; CLONING; GLYCANS; GLYCOSYLPHOSPHATIDYLINOSITOL	Background: The ability to selectively detect and target cancer cells that have undergone an epithelial-mesenchymal transition (EMT) may lead to improved methods to treat cancers such as pancreatic cancer. The remodeling of cellular glycosylation previously has been associated with cell differentiation and may represent a valuable class of molecular targets for EMT. Methodology/Principal Findings: As a first step toward investigating the nature of glycosylation alterations in EMT, we characterized the expression of glycan-related genes in three in-vitro model systems that each represented a complementary aspect of pancreatic cancer EMT. These models included: 1) TGF beta-induced EMT, which provided a look at the active transition between states; 2) a panel of 22 pancreatic cancer cell lines, which represented terminal differentiation states of either epithelial-like or mesenchymal-like; and 3) actively-migrating and stationary cells, which provided a look at the mechanism of migration. We analyzed expression data from a list of 587 genes involved in glycosylation (biosynthesis, sugar transport, glycan-binding, etc.) or EMT. Glycogenes were altered at a higher prevalence than all other genes in the first two models (p<0.05 and <0.005, respectively) but not in the migration model. Several functional themes were shared between the induced-EMT model and the cell line panel, including alterations to matrix components and proteoglycans, the sulfation of glycosaminoglycans; mannose receptor family members; initiation of O-glycosylation; and certain forms of sialylation. Protein-level changes were confirmed by Western blot for the mannose receptor MRC2 and the O-glycosylation enzyme GALNT3, and cell-surface sulfation changes were confirmed using Alcian Blue staining. Conclusions/Significance: Alterations to glycogenes are a major component of cancer EMT and are characterized by changes to matrix components, the sulfation of GAGs, mannose receptors, O-glycosylation, and specific sialylated structures. These results provide leads for targeting aggressive and drug resistant forms of pancreatic cancer cells.	[Maupin, Kevin A.; Sinha, Arkadeep; Eugster, Emily; Miller, Jeremy; Webb, Craig; Haab, Brian B.] Van Andel Res Inst, Grand Rapids, MI USA; [Ross, Julianna; Paulino, Vincent; Tran, Nhan; Berens, Michael] Translat Genom Res Inst, Phoenix, AZ USA; [Keshamouni, Venkateshwar G.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA	Van Andel Institute; Translational Genomics Research Institute; University of Michigan System; University of Michigan	Maupin, KA (corresponding author), Van Andel Res Inst, Grand Rapids, MI USA.	Brian.Haab@vai.org	Webb, Craig/I-8123-2012	sinha, arkadeep/0000-0002-9432-3956; Keshamouni, Venkateshwar/0000-0003-1947-791X	National Cancer Institute, National Institutes of Health [NIH] [R03CA139225, R01 CA132571, R01 CA130940 NT]; American Cancer Society [CSM-116801]; National Institute of Neurological Disorders and Stroke [NIH R01 NS042262]; Van Andel Research Institute; NATIONAL CANCER INSTITUTE [R03CA139225, R01CA130940, R01CA132571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042262] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health [NIH](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Van Andel Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Cancer Institute (www.cancer.gov) (R03CA139225 to B.H., National Institutes of Health [NIH] R01 CA132571 to V.K., and NIH R01 CA130940 NT), the American Cancer Society (www. cancer. org) (CSM-116801 to V.K.), The National Institute of Neurological Disorders and Stroke (www.ninds.nih.gov) (NIH R01 NS042262 to M.B.) and the Van Andel Research Institute (www.vai.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLIEL PM, 1993, EUR J BIOCHEM, V214, P347, DOI 10.1111/j.1432-1033.1993.tb17930.x; Almeida AM, 2006, NAT MED, V12, P846, DOI 10.1038/nm1410; American Cancer Society, 2022, CANC FACTS FIGURES 2; Barthel SR, 2009, P NATL ACAD SCI USA, V106, P19491, DOI 10.1073/pnas.0906074106; Berens ME, 2004, METH MOLEC MED, V88, P219; Brockhausen I, 2006, EMBO REP, V7, P599, DOI 10.1038/sj.embor.7400705; Brown JR, 2006, CLIN CANCER RES, V12, P2894, DOI 10.1158/1078-0432.CCR-05-2745; BUCK CA, 1971, SCIENCE, V172, P169, DOI 10.1126/science.172.3979.169; Buck E, 2007, MOL CANCER THER, V6, P532, DOI 10.1158/1535-7163.MCT-06-0462; Capela A, 2006, DEV BIOL, V291, P300, DOI 10.1016/j.ydbio.2005.12.030; Chen SM, 2007, NAT METHODS, V4, P437, DOI 10.1038/NMETH1035; CHEN WC, BLOOD; Clausen H, 1996, GLYCOBIOLOGY, V6, P635, DOI 10.1093/glycob/6.6.635; Comelli EM, 2006, J IMMUNOL, V177, P2431, DOI 10.4049/jimmunol.177.4.2431; Comelli EM, 2006, GLYCOBIOLOGY, V16, P117, DOI 10.1093/glycob/cwj048; Demuth T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-54; DENNIS JW, 1987, SCIENCE, V236, P582, DOI 10.1126/science.2953071; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Engelholm LH, 2009, FRONT BIOSCI-LANDMRK, V14, P2103, DOI 10.2741/3365; FEIZI T, 1985, NATURE, V314, P53, DOI 10.1038/314053a0; FUKUDA M, 1991, Glycobiology, V1, P347, DOI 10.1093/glycob/1.4.347; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Goss PE, 1995, CLIN CANCER RES, V1, P935; Gu C, 2004, BRIT J CANCER, V90, P436, DOI 10.1038/sj.bjc.6601531; Harduin-Lepers A, 2000, BIOCHEM J, V352, P37, DOI 10.1042/0264-6021:3520037; Heiskanen A, 2009, GLYCOCONJUGATE J, V26, P367, DOI 10.1007/s10719-008-9217-6; Hotz B, 2007, CLIN CANCER RES, V13, P4769, DOI 10.1158/1078-0432.CCR-06-2926; Hruban RH, 2009, HUM PATHOL, V40, P612, DOI 10.1016/j.humpath.2009.01.008; Hruban RH, 2004, AM J SURG PATHOL, V28, P977, DOI 10.1097/01.pas.0000126675.59108.80; IOZZO RV, 2007, PROTEOGLYCAN PROTOCO; Javle MM, 2007, ANN SURG ONCOL, V14, P3527, DOI 10.1245/s10434-007-9540-3; Julien S, 2005, BREAST CANCER RES TR, V90, P77, DOI 10.1007/s10549-004-3137-3; Kariya Y, 2010, J BIOL CHEM, V285, P3330, DOI 10.1074/jbc.M109.038836; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Kroes RA, 2007, J NEUROCHEM, V103, P14, DOI 10.1111/j.1471-4159.2007.04780.x; Lemjabbar-Alaoui H, 2010, ONCOGENE, V29, P635, DOI 10.1038/onc.2009.365; Lowe JB, 2003, ANNU REV BIOCHEM, V72, P643, DOI 10.1146/annurev.biochem.72.121801.161809; Luttges J, 2000, J PATHOL, V191, P154; Maeda Y, 2001, EMBO J, V20, P250, DOI 10.1093/emboj/20.1.250; Mandel U, 1999, GLYCOBIOLOGY, V9, P43, DOI 10.1093/glycob/9.1.43; Miyahara N, 2004, CLIN CANCER RES, V10, P2090, DOI 10.1158/1078-0432.CCR-1024-03; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Mungul A, 2004, INT J ONCOL, V25, P937; Muramatsu T, 2004, GLYCOCONJUGATE J, V21, P41, DOI 10.1023/B:GLYC.0000043746.77504.28; Nairn AV, 2008, J BIOL CHEM, V283, P17298, DOI 10.1074/jbc.M801964200; Nakajima S, 2004, CLIN CANCER RES, V10, P4125, DOI 10.1158/1078-0432.CCR-0578-03; NAKAYAMA J, 1995, P NATL ACAD SCI USA, V92, P7031, DOI 10.1073/pnas.92.15.7031; Nawroth R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000392; Nemoto-Sasaki Y, 2001, GLYCOCONJUGATE J, V18, P895, DOI 10.1023/A:1022252509765; Oida Y, 2006, ONCOL REP, V16, P457; Onitsuka K, 2003, CANCER SCI, V94, P32, DOI 10.1111/j.1349-7006.2003.tb01348.x; REITMAN ML, 1981, J CLIN INVEST, V67, P1574, DOI 10.1172/JCI110189; Ricciardelli C, 2009, CANCER METAST REV, V28, P233, DOI 10.1007/s10555-009-9182-y; Rosenberg L, 2000, DRUGS, V59, P1071, DOI 10.2165/00003495-200059050-00004; Sabbah M, 2008, DRUG RESIST UPDATE, V11, P123, DOI 10.1016/j.drup.2008.07.001; Schreiber SC, 2008, GASTROENTEROLOGY, V134, P1555, DOI 10.1053/j.gastro.2008.02.023; Shah AN, 2007, ANN SURG ONCOL, V14, P3629, DOI 10.1245/s10434-007-9583-5; Skandalis SS, 2006, BBA-GEN SUBJECTS, V1760, P1217, DOI 10.1016/j.bbagen.2006.03.021; Sturge J, 2003, J CELL BIOL, V162, P789, DOI 10.1083/jcb.200302124; Sutherlin ME, 1997, CANCER RES, V57, P4744; Thomson S, 2005, CANCER RES, V65, P9455, DOI 10.1158/0008-5472.CAN-05-1058; Trombetta ES, 2002, ADV PROTEIN CHEM, V59, P303; Tsuboi S, 2001, BIOESSAYS, V23, P46, DOI 10.1002/1521-1878(200101)23:1<46::AID-BIES1006>3.3.CO;2-V; Varki A., 2009, ESSENTIALS GLYCOBIOL; von Burstin J, 2009, GASTROENTEROLOGY, V137, P361, DOI 10.1053/j.gastro.2009.04.004; Wu YM, 2009, J PROTEOME RES, V8, P1876, DOI 10.1021/pr8008379; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yeo Theresa Pluth, 2002, Curr Probl Cancer, V26, P176, DOI 10.1067/mcn.2002.129579; Yin T, 2007, J SURG RES, V141, P196, DOI 10.1016/j.jss.2006.09.027; Yue TT, 2009, MOL CELL PROTEOMICS, V8, P1697, DOI 10.1074/mcp.M900135-MCP200	70	80	82	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e13002	10.1371/journal.pone.0013002	http://dx.doi.org/10.1371/journal.pone.0013002			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20885998	gold, Green Published, Green Submitted			2022-12-27	WOS:000282167100010
J	Peltonen, K; Colis, L; Liu, H; Jaamaa, S; Moore, HM; Enback, J; Laakkonen, P; Vaahtokari, A; Jones, RJ; af Hallstrom, TM; Laiho, M				Peltonen, Karita; Colis, Laureen; Liu, Hester; Jaamaa, Sari; Moore, Henna M.; Enback, Juulia; Laakkonen, Pirjo; Vaahtokari, Anne; Jones, Richard J.; af Hallstrom, Taija M.; Laiho, Marikki			Identification of Novel p53 Pathway Activating Small-Molecule Compounds Reveals Unexpected Similarities with Known Therapeutic Agents	PLOS ONE			English	Article							NF-KAPPA-B; IN-VIVO; DNA-DAMAGE; TARGETING DNA; CANCER; TUMORS; RESTORATION; BINDING; MECHANISM; DRUGS	Manipulation of the activity of the p53 tumor suppressor pathway has demonstrated potential benefit in preclinical mouse tumor models and has entered human clinical trials. We describe here an improved, extensive small-molecule chemical compound library screen for p53 pathway activation in a human cancer cell line devised to identify hits with potent antitumor activity. We uncover six novel small-molecule lead compounds, which activate p53 and repress the growth of human cancer cells. Two tested compounds suppress in vivo tumor growth in an orthotopic mouse model of human B-cell lymphoma. All compounds interact with DNA, and two activate p53 pathway in a DNA damage signaling-dependent manner. A further screen of a drug library of approved drugs for medicinal uses and analysis of gene-expression signatures of the novel compounds revealed similarities to known DNA intercalating and topoisomerase interfering agents and unexpected connectivities to known drugs without previously demonstrated anticancer activities. These included several neuroleptics, glycosides, antihistamines and adrenoreceptor antagonists. This unbiased screen pinpoints interference with the DNA topology as the predominant mean of pharmacological activation of the p53 pathway and identifies potential novel antitumor agents.	[Peltonen, Karita; Jaamaa, Sari; Moore, Henna M.; af Hallstrom, Taija M.; Laiho, Marikki] Univ Helsinki, Haartman Inst, Mol Canc Biol Program, Helsinki, Finland; [Peltonen, Karita; Jaamaa, Sari; Moore, Henna M.; af Hallstrom, Taija M.; Laiho, Marikki] Univ Helsinki, Haartman Inst, Dept Virol, Helsinki, Finland; [Colis, Laureen; Liu, Hester; Jones, Richard J.; Laiho, Marikki] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Jaamaa, Sari] Univ Helsinki, Lab Div, Helsinki, Finland; [Enback, Juulia; Laakkonen, Pirjo] Univ Helsinki, Inst Biomed, Helsinki, Finland; [Vaahtokari, Anne; Laiho, Marikki] Univ Helsinki, Mol Imaging Unit, Helsinki, Finland	University of Helsinki; University of Helsinki; Johns Hopkins University; Johns Hopkins Medicine; University of Helsinki; University of Helsinki; University of Helsinki	Peltonen, K (corresponding author), Univ Helsinki, Haartman Inst, Mol Canc Biol Program, Helsinki, Finland.	mlaiho1@jhmi.edu		Peltonen, Karita Dolores/0000-0002-3063-451X; Laakkonen, Pirjo/0000-0002-9620-095X	Academy of Finland; Finnish Cancer Organization; Foundation for the Finnish Cancer Institute; Biocentrum Helsinki; Sigrid Juselius Foundation; Finnish Cultural Foundation; Biomedicum Helsinki Foundation; Helsinki Biomedical Graduate School	Academy of Finland(Academy of Finland); Finnish Cancer Organization; Foundation for the Finnish Cancer Institute; Biocentrum Helsinki; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Biomedicum Helsinki Foundation; Helsinki Biomedical Graduate School	Funding for M.L. was from the Academy of Finland Center of Excellence Program, Finnish Cancer Organization, Foundation for the Finnish Cancer Institute, Biocentrum Helsinki and Sigrid Juselius Foundation. K.P. received support from the Finnish Cultural Foundation and the Biomedicum Helsinki Foundation. H.M.M. and J.E. were supported by the Helsinki Biomedical Graduate School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BEDI A, 1994, CANCER RES, V54, P5535; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Bykov VJN, 2002, NAT MED, V8, P282, DOI 10.1038/nm0302-282; Dalton SO, 2006, BRIT J CANCER, V95, P934, DOI 10.1038/sj.bjc.6603259; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Ferguson LR, 2007, MUTAT RES-FUND MOL M, V623, P14, DOI 10.1016/j.mrfmmm.2007.03.014; Gurova KV, 2005, P NATL ACAD SCI USA, V102, P17448, DOI 10.1073/pnas.0508888102; Hallstrom TMKA, 2007, P NATL ACAD SCI USA, V104, P7211, DOI 10.1073/pnas.0609299104; Harris AM, 2007, J UROLOGY, V178, P2176, DOI 10.1016/j.juro.2007.06.043; Hendry LB, 2007, MUTAT RES-FUND MOL M, V623, P53, DOI 10.1016/j.mrfmmm.2007.03.009; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Hurley LH, 2002, NAT REV CANCER, V2, P188, DOI 10.1038/nrc749; Issaeva N, 2004, NAT MED, V10, P1321, DOI 10.1038/nm1146; KASTAN MB, 1991, CANCER RES, V51, P6304; Kastan MB, 2007, CELL, V128, P837, DOI 10.1016/j.cell.2007.02.022; Keller SA, 2006, BLOOD, V107, P3295, DOI 10.1182/blood-2005-07-2730; Lain S, 2008, CANCER CELL, V13, P454, DOI 10.1016/j.ccr.2008.03.004; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Levesque AA, 2007, CARCINOGENESIS, V28, P13, DOI 10.1093/carcin/bgl214; Lin SC, 2007, NEOPLASIA, V9, P830, DOI 10.1593/neo.07475; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Ljungman M, 2004, NAT REV CANCER, V4, P727, DOI 10.1038/nrc1435; MALKIN D, 1994, ANNU REV GENET, V28, P443; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Newman RA, 2008, MOL INTERV, V8, P36, DOI 10.1124/mi.8.1.8; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Palchaudhuri R, 2007, CURR OPIN BIOTECH, V18, P497, DOI 10.1016/j.copbio.2007.09.006; Boer DR, 2009, DALTON T, P399, DOI 10.1039/b809873p; Sarek G, 2007, J CLIN INVEST, V117, P1019, DOI 10.1172/JCI30945; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Shangary S, 2008, P NATL ACAD SCI USA, V105, P3933, DOI 10.1073/pnas.0708917105; Sohn TA, 2002, CARCINOGENESIS, V23, P949, DOI 10.1093/carcin/23.6.949; Soussi T, 2001, NAT REV CANCER, V1, P233, DOI 10.1038/35106009; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Tse WC, 2004, CHEM BIOL, V11, P1607, DOI 10.1016/j.chembiol.2003.08.012; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang WG, 2006, P NATL ACAD SCI USA, V103, P11003, DOI 10.1073/pnas.0604507103; Webb MR, 2003, ANAL BIOCHEM, V321, P22, DOI 10.1016/S0003-2697(03)00459-7; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Ye RQ, 2004, DNA REPAIR, V3, P235, DOI 10.1016/j.dnarep.2003.10.014; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhao RB, 2000, GENE DEV, V14, P981	49	72	77	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e12996	10.1371/journal.pone.0012996	http://dx.doi.org/10.1371/journal.pone.0012996			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20885994	gold, Green Published, Green Submitted			2022-12-27	WOS:000282167100007
J	Shiller, DM; Gracco, VL; Rvachew, S				Shiller, Douglas M.; Gracco, Vincent L.; Rvachew, Susan			Auditory-Motor Learning during Speech Production in 9-11-Year-Old Children	PLOS ONE			English	Article							NEURAL-NETWORK MODEL; SENSORIMOTOR ADAPTATION; DEVELOPMENTAL-CHANGES; ACOUSTIC CHARACTERISTICS; TEMPORAL VARIABILITY; DYNAMIC MEASURES; VOCAL INTENSITY; FEEDBACK; JAW; PERCEPTION	Background: Hearing ability is essential for normal speech development, however the precise mechanisms linking auditory input and the improvement of speaking ability remain poorly understood. Auditory feedback during speech production is believed to play a critical role by providing the nervous system with information about speech outcomes that is used to learn and subsequently fine-tune speech motor output. Surprisingly, few studies have directly investigated such auditory-motor learning in the speech production of typically developing children. Methodology/Principal Findings: In the present study, we manipulated auditory feedback during speech production in a group of 9-11-year old children, as well as in adults. Following a period of speech practice under conditions of altered auditory feedback, compensatory changes in speech production and perception were examined. Consistent with prior studies, the adults exhibited compensatory changes in both their speech motor output and their perceptual representations of speech sound categories. The children exhibited compensatory changes in the motor domain, with a change in speech output that was similar in magnitude to that of the adults, however the children showed no reliable compensatory effect on their perceptual representations. Conclusions: The results indicate that 9-11-year-old children, whose speech motor and perceptual abilities are still not fully developed, are nonetheless capable of auditory-feedback-based sensorimotor adaptation, supporting a role for such learning processes in speech motor development. Auditory feedback may play a more limited role, however, in the fine-tuning of children's perceptual representations of speech sound categories.	[Shiller, Douglas M.] Univ Montreal, Ecole Orthophonie & Audiol, Montreal, PQ, Canada; [Shiller, Douglas M.] CHU St Justine Res Ctr, Montreal, PQ, Canada; [Shiller, Douglas M.; Gracco, Vincent L.; Rvachew, Susan] McGill Univ, Ctr Res Language Mind & Brain, Montreal, PQ, Canada; [Gracco, Vincent L.; Rvachew, Susan] McGill Univ, Sch Commun Sci & Disorders, Montreal, PQ, Canada; [Gracco, Vincent L.] Haskins Labs Inc, New Haven, CT USA	Universite de Montreal; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; McGill University; McGill University; Yale University; Haskins Laboratories	Shiller, DM (corresponding author), Univ Montreal, Ecole Orthophonie & Audiol, Montreal, PQ, Canada.	douglas.shiller@umontreal.ca			Canadian Child Health Clinician Scientist Training Program; CHU Sainte-Justine Research Center	Canadian Child Health Clinician Scientist Training Program; CHU Sainte-Justine Research Center	Research funding was provided by the Canadian Child Health Clinician Scientist Training Program (http://cchcsp.ca/) and startup funds from the CHU Sainte-Justine Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allport FH., 1924, SOC PSYCHOL-GERMANY; AMAZI DK, 1982, J SPEECH HEAR RES, V25, P581, DOI 10.1044/jshr.2504.581; ASLIN RN, 1980, CHILD PHONOLOGY, V2, P67; BAUM SR, 1988, J ACOUST SOC AM, V84, P1662, DOI 10.1121/1.397181; Baum SR, 1997, J ACOUST SOC AM, V102, P2353, DOI 10.1121/1.419619; Baum SR, 2000, J ACOUST SOC AM, V107, P3572, DOI 10.1121/1.429429; BEHRENS SJ, 1988, J PHONETICS, V16, P295, DOI 10.1016/S0095-4470(19)30504-2; BELMORE NF, 1973, J SPEECH HEAR RES, V16, P709, DOI 10.1044/jshr.1604.709; Callan DE, 2000, J SPEECH LANG HEAR R, V43, P721, DOI 10.1044/jslhr.4303.721; CHASE RA, 1961, J GENET PSYCHOL, V99, P101, DOI 10.1080/00221325.1961.10534396; Cheng HY, 2007, J SPEECH LANG HEAR R, V50, P352, DOI 10.1044/1092-4388(2007/025); COPLAN J, 1988, PEDIATRICS, V82, P447; DEJARNETTE G, 1988, PERCEPT MOTOR SKILL, V67, P963, DOI 10.2466/pms.1988.67.3.963; EDWARDS J, 1992, J PHONETICS, V20, P189, DOI 10.1016/S0095-4470(19)30622-9; Edwards J, 2002, J SPEECH LANG HEAR R, V45, P231, DOI 10.1044/1092-4388(2002/018); Eguchi S, 1969, Acta Otolaryngol Suppl, V257, P1; Goffman L, 1999, J EXP PSYCHOL HUMAN, V25, P649, DOI 10.1037/0096-1523.25.3.649; Green JR, 2002, J SPEECH LANG HEAR R, V45, P66, DOI 10.1044/1092-4388(2002/005); GUENTHER FH, 1995, PSYCHOL REV, V102, P594, DOI 10.1037/0033-295X.102.3.594; Houde JF, 1998, SCIENCE, V279, P1213, DOI 10.1126/science.279.5354.1213; Houde JF, 2002, J SPEECH LANG HEAR R, V45, P295, DOI 10.1044/1092-4388(2002/023); Huber JE, 1999, J ACOUST SOC AM, V106, P1532, DOI 10.1121/1.427150; Jones JA, 2000, J ACOUST SOC AM, V108, P1246, DOI 10.1121/1.1288414; Jones JA, 2005, CURR BIOL, V15, P1768, DOI 10.1016/j.cub.2005.08.063; Jongman A, 2000, J ACOUST SOC AM, V108, P1252, DOI 10.1121/1.1288413; Kawahara H., 1993, J ACOUST SOC AM, V94, P1883; KENT RD, 1976, J SPEECH HEAR RES, V19, P421, DOI 10.1044/jshr.1903.421; KENT RD, 1982, J ACOUST SOC AM, V72, P353, DOI 10.1121/1.388089; KENT RD, 1980, J PHONETICS, V8, P157, DOI 10.1016/S0095-4470(19)31460-3; Kramer AF, 2004, J GERONTOL A-BIOL, V59, P940; Lane H, 2007, J SPEECH LANG HEAR R, V50, P2, DOI 10.1044/1092-4388(2007/001); Lee S, 1999, J ACOUST SOC AM, V105, P1455, DOI 10.1121/1.426686; Lombard E, 1911, ANN MALADIES OREILLE, P101; MACKAY DG, 1968, J ACOUST SOC AM, V43, P811, DOI 10.1121/1.1910900; Max L, 2003, P 15 INT C PHONETIC, P1053; Menard L, 2008, J ACOUST SOC AM, V124, P1192, DOI 10.1121/1.2945704; Mowrer OH, 1952, J SPEECH HEAR DISORD, V17, P263, DOI 10.1044/jshd.1703.263; Munson B, 2004, J SPEECH LANG HEAR R, V47, P58, DOI 10.1044/1092-4388(2004/006); Munson B, 2001, J ACOUST SOC AM, V110, P1203, DOI 10.1121/1.1387093; Oller D. Kimbrough, 1983, PRODUCTION SPEECH, P91; Orhan AE, 2010, J VISION, V10, DOI 10.1167/10.2.2; Perkell J, 1997, SPEECH COMMUN, V22, P227, DOI 10.1016/S0167-6393(97)00026-5; Perkell JS, 2000, J PHONETICS, V28, P233, DOI 10.1006/jpho.2000.0116; Purcell DW, 2006, J ACOUST SOC AM, V120, P966, DOI 10.1121/1.2217714; RATNER SC, 1964, PSYCHOL REC, V14, P47, DOI 10.1007/BF03393561; Sadagopan N, 2008, J SPEECH LANG HEAR R, V51, P1138, DOI 10.1044/1092-4388(2008/06-0222); SHARKEY SG, 1985, J SPEECH HEAR RES, V28, P8, DOI 10.1044/jshr.2801.08; Shiller DM, 2009, J ACOUST SOC AM, V125, P1103, DOI 10.1121/1.3058638; SIEGEL GM, 1984, J SPEECH HEAR RES, V27, P56, DOI 10.1044/jshr.2701.56; SIEGEL GM, 1980, J SPEECH HEAR RES, V23, P802, DOI 10.1044/jshr.2304.802; SIEGEL GM, 1976, DEV PSYCHOL, V12, P255, DOI 10.1037/0012-1649.12.3.255; Smith A, 2004, DEV PSYCHOBIOL, V45, P22, DOI 10.1002/dev.20009; Smith A, 1998, J SPEECH LANG HEAR R, V41, P18, DOI 10.1044/jslhr.4101.18; Smith B.L., 1978, J PHON, V6, P37, DOI [10.1016/S0095-4470(19)31084-8, DOI 10.1016/S0095-4470(19)31084-8]; Smith BL, 1996, J ACOUST SOC AM, V99, P2344, DOI 10.1121/1.415421; Smith BL, 1999, PHONETICA, V56, P73, DOI 10.1159/000028442; SMITH BL, 1987, J ACOUST SOC AM, V81, P747, DOI 10.1121/1.394843; SMITH BL, 1994, J PHONETICS, V22, P155, DOI 10.1016/S0095-4470(19)30191-3; Stoel-Gammon C., 1985, NORMAL DISORDERED PH; Strange W., 1995, SPEECH PERCEPTION LI, P121; SUSSMAN JE, 1989, J SPEECH HEAR RES, V32, P151, DOI 10.1044/jshr.3201.151; SUSSMAN JE, 1993, J SPEECH HEAR RES, V36, P380, DOI 10.1044/jshr.3602.380; TINGLEY BM, 1975, CHILD DEV, V46, P186; Villacorta VM, 2007, J ACOUST SOC AM, V122, P2306, DOI 10.1121/1.2773966; Vorperian HK, 2007, J SPEECH LANG HEAR R, V50, P1510, DOI 10.1044/1092-4388(2007/104); Walsh B, 2002, J SPEECH LANG HEAR R, V45, P1119, DOI 10.1044/1092-4388(2002/090); Walsh B, 2006, DEV PSYCHOBIOL, V48, P660, DOI 10.1002/dev.20185; YENIKOMSHIAN G, 1968, J SPEECH HEAR RES, V11, P307, DOI 10.1044/jshr.1102.307; ZLATIN MA, 1976, J SPEECH HEAR RES, V19, P93, DOI 10.1044/jshr.1901.93	69	32	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2010	5	9							e12975	10.1371/journal.pone.0012975	http://dx.doi.org/10.1371/journal.pone.0012975			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	653UN	20886033	gold, Green Published			2022-12-27	WOS:000282122600013
J	Cleynen, I; John, JMM; Henckaerts, L; Van Moerkercke, W; Rutgeerts, P; Van Steen, K; Vermeire, S				Cleynen, Isabelle; John, Jestinah M. Mahachie; Henckaerts, Liesbet; Van Moerkercke, Wouter; Rutgeerts, Paul; Van Steen, Kristel; Vermeire, Severine			Molecular Reclassification of Crohn's Disease by Cluster Analysis of Genetic Variants	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; CLASSIFICATION; AUTOPHAGY; GENOTYPE; RISK	Background: Crohn's Disease (CD) has a heterogeneous presentation, and is typically classified according to extent and location of disease. The genetic susceptibility to CD is well known and genome-wide association scans (GWAS) and meta-analysis thereof have identified over 30 susceptibility loci. Except for the association between ileal CD and NOD2 mutations, efforts in trying to link CD genetics to clinical subphenotypes have not been very successful. We hypothesized that the large number of confirmed genetic variants enables (better) classification of CD patients. Methodology/Principal Findings: To look for genetic-based subgroups, genotyping results of 46 SNPs identified from CD GWAS were analyzed by Latent Class Analysis (LCA) in CD patients and in healthy controls. Six genetic-based subgroups were identified in CD patients, which were significantly different from the five subgroups found in healthy controls. The identified CD-specific clusters are therefore likely to contribute to disease behavior. We then looked at whether we could relate the genetic-based subgroups to the currently used clinical parameters. Although modest differences in prevalence of disease location and behavior could be observed among the CD clusters, Random Forest analysis showed that patients could not be allocated to one of the 6 genetic-based subgroups based on the typically used clinical parameters alone. This points to a poor relationship between the genetic-based subgroups and the used clinical subphenotypes. Conclusions/Significance: This approach serves as a first step to reclassify Crohn's disease. The used technique can be applied to other common complex diseases as well, and will help to complete patient characterization, in order to evolve towards personalized medicine.	[Cleynen, Isabelle; Van Moerkercke, Wouter; Rutgeerts, Paul; Vermeire, Severine] Katholieke Univ Leuven, Dept Gastroenterol, Louvain, Belgium; [John, Jestinah M. Mahachie; Van Steen, Kristel] Univ Liege, Dept Elect Engn & Comp Sci, Syst & Modeling Unit, Liege, Belgium; [John, Jestinah M. Mahachie; Van Steen, Kristel] Univ Liege, GIGA R, Liege, Belgium; [Henckaerts, Liesbet] UZ Leuven, Dept Med, Louvain, Belgium	KU Leuven; University of Liege; University of Liege; KU Leuven; University Hospital Leuven	Cleynen, I (corresponding author), Katholieke Univ Leuven, Dept Gastroenterol, Louvain, Belgium.	isabelle.cleynen@med.kuleuven.be	Henckaerts, Liesbet/AAB-5706-2021	Van Steen, Kristel/0000-0001-9868-5033; Vermeire, Severine/0000-0001-9942-3019; Henckaerts, Liesbet/0000-0003-2880-1400	Fund for Scientific Research (FWO) Flanders, Belgium	Fund for Scientific Research (FWO) Flanders, Belgium(FWO)	This work was supported by the Fund for Scientific Research (FWO) Flanders, Belgium, to I. C. and S. V.; the Geconcerteerde Onderzoekacties (GOA) of the KU Leuven [grant number GOA/11/015]; the Belgian Network BioMAGNet (Bioinformatics and Modelling: from Genomes to Networks), funded by the Interuniversity Attraction Poles Programme (Phase VI/4) and initiated by the Belgian State, Science Policy Office to J.M.M.J. and K. V. S.; the IST Programme of the European Community, under the PASCAL2 Network of Excellence (Pattern Analysis, Statistical Modelling and Computational Learning) [IST-2007-216886 to J.M.M.J. and K. V. S.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad T, 2002, GASTROENTEROLOGY, V122, P854, DOI 10.1053/gast.2002.32413; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Cuthbert AP, 2002, GASTROENTEROLOGY, V122, P867, DOI 10.1053/gast.2002.32415; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Hampe J, 2002, LANCET, V359, P1661, DOI 10.1016/S0140-6736(02)08590-2; HENCKAERTS L, 2009, CLIN GASTROENTEROL H; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hunt L, 2003, COMPUT STAT DATA AN, V41, P429, DOI 10.1016/S0167-9473(02)00190-1; Hunt L, 1999, AUST NZ J STAT, V41, P153; McGovern DPB, 2009, INFLAMM BOWEL DIS, V15, P883, DOI 10.1002/ibd.20855; McLachlan G., 2000, WILEY SER PROB STAT; Mow WS, 2004, GASTROENTEROLOGY, V126, P414, DOI 10.1053/j.gastro.2003.11.015; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Vasiliauskas EA, 2000, GUT, V47, P487, DOI 10.1136/gut.47.4.487; Vermeire S, 2002, AM J HUM GENET, V71, P74, DOI 10.1086/341124; Wang K, 2009, AM J HUM GENET, V84, P399, DOI 10.1016/j.ajhg.2009.01.026; Weersma RK, 2009, GUT, V58, P388, DOI 10.1136/gut.2007.144865	21	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12952	10.1371/journal.pone.0012952	http://dx.doi.org/10.1371/journal.pone.0012952			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886065	Green Published, Green Submitted, gold			2022-12-27	WOS:000282091100047
J	Greenough, TC; Campellone, SC; Brody, R; Jain, S; Sanchez-Merino, V; Somasundaran, M; Luzuriaga, K				Greenough, Thomas C.; Campellone, Shalyn C.; Brody, Robin; Jain, Surbhi; Sanchez-Merino, Victor; Somasundaran, Mohan; Luzuriaga, Katherine			Programmed Death-1 Expression on Epstein Barr Virus Specific CD8+T Cells Varies by Stage of Infection, Epitope Specificity, and T-Cell Receptor Usage	PLOS ONE			English	Article							CHRONIC VIRAL-INFECTION; PD-1 EXPRESSION; HIV-INFECTION; EBV INFECTION; CD8(+); RESPONSES; EXHAUSTION; EVOLUTION; PROLIFERATION; MONONUCLEOSIS	Background: Programmed Death-1 (PD-1) is an inhibitory member of the CD28 family of molecules expressed on CD8+ T cells in response to antigenic stimulation. To better understand the role of PD-1 in antiviral immunity we examined the expression of PD-1 on Epstein-Barr virus (EBV) epitope-specific CD8+ T cells during acute infectious mononucleosis (AIM) and convalescence. Methodology/Principal Findings: Using flow cytometry, we observed higher frequencies of EBV-specific CD8+ T cells and higher intensity of PD-1 expression on EBV-specific CD8+ T cells during AIM than during convalescence. PD-1 expression during AIM directly correlated with viral load and with the subsequent degree of CD8+ T cell contraction in convalescence. Consistent differences in PD-1 expression were observed between CD8+ T cells with specificity for two different EBV lytic antigen epitopes. Similar differences were observed in the degree to which PD-1 was upregulated on these epitope-specific CD8+ T cells following peptide stimulation in vitro. EBV epitope-specific CD8+ T cell proliferative responses to peptide stimulation were diminished during AIM regardless of PD-1 expression and were unaffected by blocking PD-1 interactions with PD-L1. Significant variability in PD-1 expression was observed on EBV epitope-specific CD8+ T cell subsets defined by Vbeta usage. Conclusions/Significance: These observations suggest that PD-1 expression is not only dependent on the degree of antigen presentation, but also on undefined characteristics of the responding cell that segregate with epitope specificity and V-beta usage.	[Greenough, Thomas C.; Brody, Robin; Jain, Surbhi; Sanchez-Merino, Victor; Somasundaran, Mohan; Luzuriaga, Katherine] Univ Massachusetts, Sch Med, Worcester, MA 01605 USA; [Campellone, Shalyn C.] Medarex Inc, Bloomsbury, NJ USA	University of Massachusetts System; University of Massachusetts Worcester	Greenough, TC (corresponding author), Univ Massachusetts, Sch Med, Worcester, MA 01605 USA.	thomas.greenough@umassmed.edu		Sanchez-Merino, Victor/0000-0001-9400-427X	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) [P01 AI049320-08]; NIH/CFAR (Centers for AIDS Research) [P30-AI042845-10]; Medarex, Inc. Medarex, Inc; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042845, P01AI049320] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/CFAR (Centers for AIDS Research)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medarex, Inc. Medarex, Inc; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) grant P01 AI049320-08 with additional support from NIH/CFAR (Centers for AIDS Research) P30-AI042845-10 and Medarex, Inc. Medarex, Inc. provided reagents and salary support for one author (S.C.). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Blackburn SD, 2008, P NATL ACAD SCI USA, V105, P15016, DOI 10.1073/pnas.0801497105; Blattman JN, 2009, J VIROL, V83, P4386, DOI 10.1128/JVI.02524-08; Brown KE, 2010, CURR OPIN IMMUNOL, V22, P397, DOI 10.1016/j.coi.2010.03.007; Callan MFC, 2003, VIRAL IMMUNOL, V16, P3, DOI 10.1089/088282403763635401; Callan MFC, 1998, J EXP MED, V187, P1395, DOI 10.1084/jem.187.9.1395; Catalina MD, 2002, J IMMUNOL, V168, P4184, DOI 10.4049/jimmunol.168.8.4184; Catalina MD, 2001, J IMMUNOL, V167, P4450, DOI 10.4049/jimmunol.167.8.4450; Cellerai C, 2010, J VIROL, V84, P3868, DOI 10.1128/JVI.02565-09; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Dong HD, 1999, NAT MED, V5, P1365; Freeman GJ, 2006, J EXP MED, V203, P2223, DOI 10.1084/jem.20061800; Hadinoto V, 2008, BLOOD, V111, P1420, DOI 10.1182/blood-2007-06-093278; Hadinoto V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000496; Hislop AD, 2005, J CLIN INVEST, V115, P2546, DOI 10.1172/JCI24810; Hislop AD, 2002, J EXP MED, V195, P893, DOI 10.1084/jem.20011692; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; Kasprowicz V, 2008, J VIROL, V82, P3154, DOI 10.1128/JVI.02474-07; Kaufmann DE, 2009, J IMMUNOL, V182, P5891, DOI 10.4049/jimmunol.0803771; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Luzuriaga K, 2000, J VIROL, V74, P6984, DOI 10.1128/JVI.74.15.6984-6991.2000; Nakamura Masahiko, 2009, Ornithological Science, V8, P1, DOI 10.2326/048.008.0101; Petrovas C, 2007, BLOOD, V110, P928, DOI 10.1182/blood-2007-01-069112; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Petrovas C, 2009, J IMMUNOL, V183, P1120, DOI 10.4049/jimmunol.0900182; Precopio ML, 2003, J IMMUNOL, V170, P2590, DOI 10.4049/jimmunol.170.5.2590; Price DA, 2005, J EXP MED, V202, P1349, DOI 10.1084/jem.20051357; Pudney VA, 2005, J EXP MED, V201, P349, DOI 10.1084/jem.20041542; Radziewicz H, 2007, J VIROL, V81, P2545, DOI 10.1128/JVI.02021-06; Salisch NC, 2010, J IMMUNOL, V184, P476, DOI 10.4049/jimmunol.0902781; Sauce D, 2007, J INFECT DIS, V195, P268, DOI 10.1086/510248; Sauce D, 2009, J VIROL, V83, P9068, DOI 10.1128/JVI.00141-09; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Velu V, 2007, J VIROL, V81, P5819, DOI 10.1128/JVI.00024-07; Vetsika Eleni-Kyriaki, 2004, Expert Reviews in Molecular Medicine, V6, P1, DOI 10.1017/S1462399404008440; Vollbrecht T, 2010, J MED VIROL, V82, P358, DOI 10.1002/jmv.21723; Zhang Z, 2008, GASTROENTEROLOGY, V134, P1938, DOI 10.1053/j.gastro.2008.03.037	39	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12926	10.1371/journal.pone.0012926	http://dx.doi.org/10.1371/journal.pone.0012926			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886079	Green Published, Green Submitted, gold			2022-12-27	WOS:000282091100030
J	Vincent, M; Sayre, NL; Graham, MJ; Crooke, RM; Shealy, DJ; Liscum, L				Vincent, Melanie; Sayre, Naomi L.; Graham, Mark J.; Crooke, Rosanne M.; Shealy, David J.; Liscum, Laura			Evaluation of an Anti-Tumor Necrosis Factor Therapeutic in a Mouse Model of Niemann-Pick C Liver Disease	PLOS ONE			English	Article							CELL DEATH; CHOLESTEROL; MICE; APOPTOSIS; BRAIN	Background: Niemann-Pick type C (NPC) disease is a lysosomal storage disease characterized by the accumulation of cholesterol and glycosphingolipids. The majority of NPC patients die in their teen years due to progressive neurodegeneration; however, half of NPC patients also suffer from cholestasis, prolonged jaundice, and hepatosplenomegaly. We previously showed that a key mediator of NPC liver disease is tumor necrosis factor (TNF) alpha, which is involved in both proinflammatory and apoptotic signaling cascades. In this study, we tested the hypothesis that blocking TNF action with an anti-TNF monoclonal antibody (CNTO5048) will slow the progression of NPC liver disease. Methodology/Principal Findings: Treatment of wild-type C57BL/6 mice with NPC1-specific antisense oligonucleotides led to knockdown of NPC1 protein expression in the liver. This caused classical symptoms of NPC liver disease, including hepatic cholesterol accumulation, hepatomegaly, elevated serum liver enzymes, and lipid laden macrophage accumulation. In addition, there was a significant increase in the number of apoptotic cells and a proliferation of stellate cells. Concurrent treatment of NPC1 knockdown mice with anti-TNF had no effect on the primary lipid storage or accumulation of lipid-laden macrophages. However, anti-TNF treatment slightly blunted the increase in hepatic apoptosis and stellate cell activation that was seen with NPC1 knockdown. Conclusions/Significance: Current therapeutic options for NPC disease are limited. Our results provide proof of principle that pharmacologically blocking the TNF-alpha inflammatory cascade can slightly reduce certain markers of NPC disease. Small molecule inhibitors of TNF that penetrate tissues and cross the blood-brain barrier may prove even more beneficial.	[Vincent, Melanie; Sayre, Naomi L.; Liscum, Laura] Tufts Univ, Sch Med, Dept Physiol, Boston, MA 02111 USA; [Graham, Mark J.; Crooke, Rosanne M.] Isis Pharmaceut Inc, Cardiovasc Dis Antisense Drug Discovery, Carlsbad, CA USA; [Shealy, David J.] Centocor Res & Dev Inc, Radnor, PA USA	Tufts University; Isis Pharmaceuticals Inc; Johnson & Johnson; Johnson & Johnson USA	Vincent, M (corresponding author), Tufts Univ, Sch Med, Dept Physiol, Boston, MA 02111 USA.	laura.liscum@tufts.edu		Liscum, Laura/0000-0002-8399-2222; Sayre, Naomi/0000-0002-6124-2535	National Institutes of Health [RO1 DK-49564, T32 DK-07542]; Tufts Center for Neurosciences Research [P30 NS047243]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047243] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tufts Center for Neurosciences Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grants RO1 DK-49564 and T32 DK-07542, and the Tufts Center for Neurosciences Research P30 NS047243. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MJG and RMC are employees of Isis Pharmaceuticals. DJS is an employee of Centocor Research and Development, a subsidiary of Johnson & Johnson. They played a role in study design, data analysis, decision to publish, and preparation of the manuscript.	Beltroy EP, 2007, J LIPID RES, V48, P869, DOI 10.1194/jlr.M600488-JLR200; Beltroy EP, 2005, HEPATOLOGY, V42, P886, DOI 10.1002/hep.20868; BEUTLER BA, 1985, J IMMUNOL, V135, P3972; Crooke RM, 2005, J LIPID RES, V46, P872, DOI 10.1194/jlr.M400492-JLR200; Erickson RP, 2005, AM J PHYSIOL-GASTR L, V289, pG300, DOI 10.1152/ajpgi.00568.2004; FOLCH J, 1957, J BIOL CHEM, V226, P497; Garver WS, 2007, AM J MED GENET A, V143A, P1204, DOI 10.1002/ajmg.a.31735; Garver WS, 2007, J CELL BIOCHEM, V101, P498, DOI 10.1002/jcb.21200; Geary RS, 2001, J PHARMACOL EXP THER, V296, P890; Karten B, 2009, BBA-MOL CELL BIOL L, V1791, P659, DOI 10.1016/j.bbalip.2009.01.025; KELLY DA, 1993, J PEDIATR-US, V123, P242, DOI 10.1016/S0022-3476(05)81695-6; Kulinski A, 2007, J BIOL CHEM, V282, P1627, DOI 10.1074/jbc.M610001200; Li H, 2005, J NEUROPATH EXP NEUR, V64, P323, DOI 10.1093/jnen/64.4.323; Patterson M. C., 2001, METABOLIC MOL BASES, VIII, P3611; Repa JJ, 2007, J NEUROSCI, V27, P14470, DOI 10.1523/JNEUROSCI.4823-07.2007; Rimkunas VM, 2008, HEPATOLOGY, V47, P1504, DOI 10.1002/hep.22327; Rimkunas VM, 2009, J LIPID RES, V50, P327, DOI 10.1194/jlr.M800415-JLR200; SAYRE NL, J LIPID RES IN PRESS; Shealy D. J., 2008, V181, P101; Vanier MT, 2003, CLIN GENET, V64, P269, DOI 10.1034/j.1399-0004.2003.00147.x; Wraith JE, 2009, MOL GENET METAB, V98, P152, DOI 10.1016/j.ymgme.2009.06.008; Wu YP, 2005, MOL GENET METAB, V84, P9, DOI 10.1016/j.ymgme.2004.08.017; Yerushalmi B, 2002, J PEDIATR GASTR NUTR, V35, P44, DOI 10.1097/00005176-200207000-00011	23	12	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12941	10.1371/journal.pone.0012941	http://dx.doi.org/10.1371/journal.pone.0012941			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886067	gold, Green Published, Green Submitted			2022-12-27	WOS:000282091100040
J	Khandelia, H; Duelund, L; Pakkanen, KI; Ipsen, JH				Khandelia, Himanshu; Duelund, Lars; Pakkanen, Kirsi I.; Ipsen, John H.			Triglyceride Blisters in Lipid Bilayers: Implications for Lipid Droplet Biogenesis and the Mobile Lipid Signal in Cancer Cell Membranes	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; PLASMA-MEMBRANES; NEUTRAL LIPIDS; PHOSPHOLIPID MONOLAYER; BODY FORMATION; PHOSPHATIDYLCHOLINE; SOLUBILIZATION; CHOLESTEROL; MECHANISMS; CURVATURE	Triglycerides have a limited solubility, around 3%, in phosphatidylcholine lipid bilayers. Using millisecond-scale course grained molecular dynamics simulations, we show that the model lipid bilayer can accommodate a higher concentration of triolein (TO) than earlier anticipated, by sequestering triolein molecules to the bilayer center in the form of a disordered, isotropic, mobile neutral lipid aggregate, at least 17 nm in diameter, which forms spontaneously, and remains stable on at least the microsecond time scale. The results give credence to the hotly debated existence of mobile neutral lipid aggregates of unknown function present in malignant cells, and to the early biogenesis of lipid droplets accommodated between the two leaflets of the endoplasmic reticulum membrane. The TO aggregates give the bilayer a blister-like appearance, and will hinder the formation of multi-lamellar phases in model, and possibly living membranes. The blisters will result in anomalous membrane probe partitioning, which should be accounted for in the interpretation of probe-related measurements.	[Khandelia, Himanshu; Duelund, Lars; Pakkanen, Kirsi I.; Ipsen, John H.] Univ So Denmark, Dept Chem & Phys, MEMPHYS Ctr Biomembrane Phys, Odense, Denmark	University of Southern Denmark	Khandelia, H (corresponding author), Univ So Denmark, Dept Chem & Phys, MEMPHYS Ctr Biomembrane Phys, Odense, Denmark.	hkhandel@memphys.sdu.dk	Duelund, Lars/AHB-2952-2022; Duelund, Lars/AAC-7110-2019; Ipsen, John/X-3216-2019	Duelund, Lars/0000-0002-3786-2822; Pakkanen, Kirsi/0000-0002-3215-6937; Ipsen, John/0000-0002-1268-6180; Khandelia, Himanshu/0000-0001-9913-6394	Danish National Research Foundation	Danish National Research Foundation(Danmarks Grundforskningsfond)	This work is funded by The Danish National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartz R, 2007, J LIPID RES, V48, P837, DOI 10.1194/jlr.M600413-JLR200; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BROTHERUS J, 1977, J LIPID RES, V18, P191; CATES ME, 1988, LANGMUIR, V4, P802, DOI 10.1021/la00082a004; Daniels TF, 2009, INT J BIOL SCI, V5, P474; Ellena JF, 1999, DRUG DELIV, V6, P97, DOI 10.1080/107175499267011; Ferretti A, 1999, BBA-MOL CELL BIOL L, V1438, P329, DOI 10.1016/S1388-1981(99)00071-2; Fujimoto T, 2008, HISTOCHEM CELL BIOL, V130, P263, DOI 10.1007/s00418-008-0449-0; GIL J, 1973, J CELL BIOL, V58, P152, DOI 10.1083/jcb.58.1.152; Hakumaki JM, 2000, TRENDS BIOCHEM SCI, V25, P357, DOI 10.1016/S0968-0004(00)01614-5; Hall A, 2008, J PHYS CHEM B, V112, P13772, DOI 10.1021/jp803950w; HALLMAN M, 1976, J LIPID RES, V17, P257; HAMILTON JA, 1991, BIOCHEMISTRY-US, V30, P2894, DOI 10.1021/bi00225a024; HAMILTON JA, 1991, J BIOL CHEM, V266, P1177; HAMILTON JA, 1989, BIOCHEMISTRY-US, V28, P2514, DOI 10.1021/bi00432a025; HAMILTON JA, 1981, P NATL ACAD SCI-BIOL, V78, P6878, DOI 10.1073/pnas.78.11.6878; HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209; Hennere G, 2009, CHEM PHYS LIPIDS, V157, P86, DOI 10.1016/j.chemphyslip.2008.10.002; Henriksen J, 2004, EUR BIOPHYS J BIOPHY, V33, P732, DOI 10.1007/s00249-004-0420-5; HERNELL O, 1990, BIOCHEMISTRY-US, V29, P2041, DOI 10.1021/bi00460a012; HOLMES KT, 1990, MAGNET RESON MED, V16, P1, DOI 10.1002/mrm.1910160102; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Israelachvili J. N., 1991, INTERMOLECULAR SURFA, Vxxi; JACKSON RL, 1976, PHYSIOL REV, V56, P259, DOI 10.1152/physrev.1976.56.2.259; King N J, 1994, Immunomethods, V4, P188, DOI 10.1006/immu.1994.1019; Lee YC, 1996, BIOCHEMISTRY-US, V35, P3677, DOI 10.1021/bi9517502; LI KL, 1993, BIOCHEMISTRY-US, V32, P9926, DOI 10.1021/bi00089a008; Li R, 2003, J AGR FOOD CHEM, V51, P477, DOI 10.1021/jf025676n; MACKINNON WB, 1992, EUR J BIOCHEM, V205, P827, DOI 10.1111/j.1432-1033.1992.tb16847.x; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Marsh D, 1996, BIOPHYS J, V70, P2248, DOI 10.1016/S0006-3495(96)79790-4; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; MAY GL, 1986, J BIOL CHEM, V261, P3048; May GL, 1997, J LIPID RES, V38, P1562; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; MOUNTFORD CE, 1988, TRENDS BIOCHEM SCI, V13, P172, DOI 10.1016/0968-0004(88)90145-4; Murphy DJ, 1999, TRENDS BIOCHEM SCI, V24, P109, DOI 10.1016/S0968-0004(98)01349-8; Nakano M, 2009, J PHYS CHEM B, V113, P6745, DOI 10.1021/jp900913w; Napier JA, 1996, PLANT MOL BIOL, V31, P945, DOI 10.1007/BF00040714; Ohsaki Y, 2009, BBA-MOL CELL BIOL L, V1791, P399, DOI 10.1016/j.bbalip.2008.10.002; Pakkanen KI, 2010, CHEM PHYS LIPIDS, V163, P218, DOI 10.1016/j.chemphyslip.2009.11.007; Ploegh HL, 2007, NATURE, V448, P435, DOI 10.1038/nature06004; Prades J, 2003, J LIPID RES, V44, P1720, DOI 10.1194/jlr.M300092-JLR200; Quintero M, 2007, BBA-MOL CELL BIOL L, V1771, P31, DOI 10.1016/j.bbalip.2006.10.003; Rosi A, 1999, MAGNET RESON MED, V42, P248, DOI 10.1002/(SICI)1522-2594(199908)42:2<248::AID-MRM6>3.0.CO;2-I; Ruiz JI, 1997, J LIPID RES, V38, P1482; SPOONER PJR, 1987, BIOCHEMISTRY-US, V26, P5820, DOI 10.1021/bi00392a036; Tauchi-Sato K, 2002, J BIOL CHEM, V277, P44507, DOI 10.1074/jbc.M207712200; Tulenko TN, 2002, J NUCL CARDIOL, V9, P638, DOI 10.1067/mnc.2002.128959; Veale MF, 1996, BBA-LIPID LIPID MET, V1303, P215, DOI 10.1016/0005-2760(96)00104-X; Waltermann M, 2005, MOL MICROBIOL, V55, P750, DOI 10.1111/j.1365-2958.2004.04441.x; Walther TC, 2009, BBA-MOL CELL BIOL L, V1791, P459, DOI 10.1016/j.bbalip.2008.10.009; WANNER G, 1981, PLANTA, V151, P109, DOI 10.1007/BF00387812; YETUKURI L, 2010, J LIPID RES; ZACHOWSKI A, 1990, EXPERIENTIA, V46, P644, DOI 10.1007/BF01939703; Zanghellini J, 2010, J THEOR BIOL, V264, P952, DOI 10.1016/j.jtbi.2010.02.025	56	95	99	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12811	10.1371/journal.pone.0012811	http://dx.doi.org/10.1371/journal.pone.0012811			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877640	gold, Green Published, Green Submitted			2022-12-27	WOS:000282053100010
J	Krall, P; Canales, CP; Kairath, P; Carmona-Mora, P; Molina, J; Carpio, JD; Ruiz, P; Mezzano, SA; Li, J; Wei, C; Reiser, J; Young, JI; Walz, K				Krall, Paola; Canales, Cesar P.; Kairath, Pamela; Carmona-Mora, Paulina; Molina, Jessica; Carpio, J. Daniel; Ruiz, Phillip; Mezzano, Sergio A.; Li, Jing; Wei, Changli; Reiser, Jochen; Young, Juan I.; Walz, Katherina			Podocyte-Specific Overexpression of Wild Type or Mutant Trpc6 in Mice Is Sufficient to Cause Glomerular Disease	PLOS ONE			English	Article							FOCAL SEGMENTAL GLOMERULOSCLEROSIS; TRANSIENT RECEPTOR; CRE RECOMBINASE; CATION CHANNEL; SLIT DIAPHRAGM; ANIMAL-MODELS; EXPRESSION; ACTIVATION; PROTEIN; GENE	Mutations in the TRPC6 calcium channel (Transient receptor potential channel 6) gene have been associated with familiar forms of Focal and Segmental Glomerulosclerosis (FSGS) affecting children and adults. In addition, acquired glomerular diseases are associated with increased expression levels of TRPC6. However, the exact role of TRPC6 in the pathogenesis of FSGS remains to be elucidated. In this work we describe the generation and phenotypic characterization of three different transgenic mouse lines with podocyte-specific overexpression of the wild type or any of two mutant forms of Trpc6 (P111Q and E896K) previously related to FSGS. Consistent with the human phenotype a non-nephrotic range of albuminuria was detectable in almost all transgenic lines. The histological analysis demonstrated that the transgenic mice developed a kidney disease similar to human FSGS. Differences of 2-3 folds in the presence of glomerular lesions were found between the non transgenic and transgenic mice expressing Trpc6 in its wild type or mutant forms specifically in podocytes. Electron microscopy of glomerulus from transgenic mice showed extensive podocyte foot process effacement. We conclude that overexpression of Trpc6 (wild type or mutated) in podocytes is sufficient to cause a kidney disease consistent with FSGS. Our results contribute to reinforce the central role of podocytes in the etiology of FSGS. These mice constitute an important new model in which to study future therapies and outcomes of this complex disease.	[Krall, Paola; Canales, Cesar P.; Kairath, Pamela; Carmona-Mora, Paulina; Molina, Jessica; Young, Juan I.; Walz, Katherina] Ctr Estudios Cient, Valdivia, Chile; [Krall, Paola; Kairath, Pamela] Univ Austral Chile, Valdivia, Chile; [Canales, Cesar P.; Carmona-Mora, Paulina; Young, Juan I.; Walz, Katherina] Univ Miami, John P Hussman Inst Human Genom, Miami, FL USA; [Carpio, J. Daniel] Univ Austral Chile, Sch Med, Inst Anat Histol & Pathol, Valdivia, Chile; [Carpio, J. Daniel; Mezzano, Sergio A.] Univ Austral Chile, Sch Med, Nephrol Lab, Valdivia, Chile; [Ruiz, Phillip] Univ Miami, Leonard Miller Sch Med, Dept Pathol, Miami, FL USA; [Young, Juan I.] CIN Ctr Ingn Innovac CECS, Valdivia, Chile; [Li, Jing; Wei, Changli; Reiser, Jochen] Univ Miami, Leonard Miller Sch Med, Div Nephrol & Hypertens, Miami, FL USA	Universidad Austral de Chile; University of Miami; Universidad Austral de Chile; Universidad Austral de Chile; University of Miami; University of Miami	Krall, P (corresponding author), Ctr Estudios Cient, Valdivia, Chile.	kwalz@med.miami.edu	Carmona-Mora, Paulina/H-9055-2019	Carmona-Mora, Paulina/0000-0001-8560-1232	FONDECYT [1061067, 1051079]; FIC (Fogarty International Center) [R03 TW07536]; DID (Departamento de Investigacion y Desarrollo) [2007-10]; Chilean Government through the Millennium Science Initiative; Conicyt; NIH [DK073495]; FOGARTY INTERNATIONAL CENTER [R03TW007536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073495] Funding Source: NIH RePORTER	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); FIC (Fogarty International Center)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); DID (Departamento de Investigacion y Desarrollo); Chilean Government through the Millennium Science Initiative; Conicyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Support was provided by FONDECYT (grant 1061067, 1051079), FIC (Fogarty International Center; R03 TW07536) and DID (Departamento de Investigacion y Desarrollo; #2007-10. The Centro de Estudios Cienti-ficos (CECS) is funded by the Chilean Government through the Millennium Science Initiative and the Centers of Excellence Base Financing Program of Conicyt. CECS is also supported by a group of private companies, which at present includes Antofagasta Minerals, Arauco, Empresas CMPC, Indura, Naviera Ultragas and Telefonica del Sur. CIN (Centro de Ingenieria de la Innovacion) is funded by Conicyt and the Gobierno Regional de Los Rios. This work was also supported by NIH grants DK073495 (to J.R.). C. W. was the Halpin Scholar of the American Society of Nephrology 2007-2009. P. K acknowledges Conicyt (Comision Nacional de Investigacion Cientifica y Tecnologica) fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulay G, 1997, J BIOL CHEM, V272, P29672, DOI 10.1074/jbc.272.47.29672; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Brown EJ, 2010, NAT GENET, V42, P72, DOI 10.1038/ng.505; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Crowley SD, 2009, J CLIN INVEST, V119, P943, DOI 10.1172/JCI34862; D'Agati VD, 2008, KIDNEY INT, V73, P399, DOI 10.1038/sj.ki.5002655; D'Agati VD, 2008, CURR OPIN NEPHROL HY, V17, P271, DOI 10.1097/MNH.0b013e3282f94a96; Donoviel DB, 2001, MOL CELL BIOL, V21, P4829, DOI 10.1128/MCB.21.14.4829-4836.2001; Eder P, 2005, PFLUG ARCH EUR J PHY, V451, P99, DOI 10.1007/s00424-005-1434-2; El-Aouni C, 2006, J AM SOC NEPHROL, V17, P1334, DOI 10.1681/ASN.2005090921; Estacion M, 2006, J PHYSIOL-LONDON, V572, P359, DOI 10.1113/jphysiol.2005.103143; Faul C, 2008, NAT MED, V14, P931, DOI 10.1038/nm.1857; Fogo AB, 2003, SEMIN NEPHROL, V23, P161, DOI 10.1053/snep.2003.50015; Heeringa SF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007771; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Huber TB, 2006, J CLIN INVEST, V116, P1337, DOI 10.1172/JCI27400; Juhila J, 2006, J AM SOC NEPHROL, V17, P648, DOI 10.1681/ASN.2005050547; Kajiyama H, 2009, AM J NEPHROL, V29, P153, DOI 10.1159/000151770; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kitiyakara C, 2003, SEMIN NEPHROL, V23, P172, DOI 10.1053/snep.2003.50025; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; Kriz W, 1999, CURR OPIN NEPHROL HY, V8, P489, DOI 10.1097/00041552-199907000-00014; Michaud JL, 2003, J AM SOC NEPHROL, V14, P1200, DOI 10.1097/01.ASN.0000059864.88610.5E; Moeller CC, 2007, J AM SOC NEPHROL, V18, P29, DOI 10.1681/ASN.2006091010; Moeller MJ, 2003, GENESIS, V35, P39, DOI 10.1002/gene.10164; Moeller MJ, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000015614.68893.0B; Monteiro EJB, 2006, J NEPHROL, V19, P366; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Mundel P, 1997, J CELL BIOL, V139, P193, DOI 10.1083/jcb.139.1.193; Okada T, 1999, J BIOL CHEM, V274, P27359, DOI 10.1074/jbc.274.39.27359; Pollak MR, 2003, SEMIN NEPHROL, V23, P141, DOI 10.1053/snep.2003.50014; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; Reiser J, 2000, J AM SOC NEPHROL, V11, P1, DOI 10.1681/ASN.V1111; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Roselli S, 2004, MOL CELL BIOL, V24, P550, DOI 10.1128/MCB.24.2.550-560.2004; Santin S, 2009, NEPHROL DIAL TRANSPL, V24, P3089, DOI 10.1093/ndt/gfp229; Schlondorff J, 2009, AM J PHYSIOL-CELL PH, V296, pC558, DOI 10.1152/ajpcell.00077.2008; Shigehara T, 2003, J AM SOC NEPHROL, V14, P1998, DOI 10.1681/ASN.V1481998; Shih NY, 1999, SCIENCE, V286, P312, DOI 10.1126/science.286.5438.312; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P16586, DOI 10.1073/pnas.0606894103; Thomas DB, 2009, ARCH PATHOL LAB MED, V133, P217, DOI 10.1043/1543-2165-133.2.217; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Yu CCK, 2001, CURR BIOL, V11, P34, DOI 10.1016/S0960-9822(00)00024-5; Yu Y, 2004, P NATL ACAD SCI USA, V101, P13861, DOI 10.1073/pnas.0405908101	44	97	100	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2010	5	9							e12859	10.1371/journal.pone.0012859	http://dx.doi.org/10.1371/journal.pone.0012859			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651YH	20877463	Green Published, gold, Green Submitted			2022-12-27	WOS:000281963200019
J	Nobrega, RH; Greebe, CD; van de Kant, H; Bogerd, J; de Franca, LR; Schulz, RW				Nobrega, Rafael Henrique; Greebe, Caaj Douwe; van de Kant, Henk; Bogerd, Jan; de Franca, Luiz Renato; Schulz, Rudiger W.			Spermatogonial Stem Cell Niche and Spermatogonial Stem Cell Transplantation in Zebrafish	PLOS ONE			English	Article							LABEL-RETAINING CELLS; GERM-CELLS; IN-VITRO; SEMINIFEROUS EPITHELIUM; SERTOLI-CELLS; JAPANESE EEL; DANIO-RERIO; STEREOLOGICAL EVALUATION; EXPRESSION ANALYSIS; ANGUILLA-JAPONICA	Background: Spermatogonial stem cells (SSCs) are the foundation of spermatogenesis, and reside within a specific microenvironment in the testes called "niche'' which regulates stem cell properties, such as, self-renewal, pluripotency, quiescence and their ability to differentiate. Methodology/Principal Findings: Here, we introduce zebrafish as a new model for the study of SSCs in vertebrates. Using 59-bromo-29-deoxyuridine (BrdU), we identified long term BrdU-retaining germ cells, type A undifferentiated spermatogonia as putative stem cells in zebrafish testes. Similar to rodents, these cells were preferentially located near the interstitium, suggesting that the SSC niche is related to interstitial elements and might be conserved across vertebrates. This localization was also confirmed by analyzing the topographical distribution of type A undifferentiated spermatogonia in normal, vasa:: egfp and fli::egfp zebrafish testes. In the latter one, the topographical arrangement suggested that the vasculature is important for the SSC niche, perhaps as a supplier of nutrients, oxygen and/or signaling molecules. We also developed an SSC transplantation technique for both male and female recipients as an assay to evaluate the presence, biological activity, and plasticity of the SSC candidates in zebrafish. Conclusions/Significance: We demonstrated donor-derived spermato- and oogenesis in male and female recipients, respectively, indicating the stemness of type A undifferentiated spermatogonia and their plasticity when placed into an environment different from their original niche. Similar to other vertebrates, the transplantation efficiency was low. This might be attributed to the testicular microenvironment created after busulfan depletion in the recipients, which may have caused an imbalance between factors regulating self-renewal or differentiation of the transplanted SSCs.	[Nobrega, Rafael Henrique; Greebe, Caaj Douwe; van de Kant, Henk; Bogerd, Jan; Schulz, Rudiger W.] Univ Utrecht, Fac Sci, Dept Biol, Div Dev Biol, Utrecht, Netherlands; [Nobrega, Rafael Henrique; de Franca, Luiz Renato] Univ Fed Minas Gerais, Inst Biol Sci, Dept Morphol, Lab Cellular Biol, Belo Horizonte, MG, Brazil; [Schulz, Rudiger W.] Inst Marine Res, Res Grp Reprod & Growth Fish, N-5024 Bergen, Norway	Utrecht University; Universidade Federal de Minas Gerais; Institute of Marine Research - Norway	Nobrega, RH (corresponding author), Univ Utrecht, Fac Sci, Dept Biol, Div Dev Biol, Utrecht, Netherlands.	lrfranca@icb.ufmg.br; r.w.schulz@uu.nl	Bogerd, Jan/B-8858-2011; Nóbrega, Rafael Henrique/C-3680-2015; Nóbrega, Rafael Henrique RHN/H-5976-2013; DE FRANCA, LUIZ/AAA-6923-2021; Schulz, Rüdiger Winfried/B-9046-2011	Bogerd, Jan/0000-0003-1120-7974; Nóbrega, Rafael Henrique/0000-0001-9796-5076; Schulz, Rüdiger Winfried/0000-0001-9115-669X	Norwegian Research Council; Utrecht University; National Council for Scientific and Technological Development (CNPq); Research Foundation of the State of Minas Gerais (FAPEMIG)	Norwegian Research Council(Research Council of NorwayEuropean Commission); Utrecht University; National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Research Foundation of the State of Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by the Norwegian Research Council, Utrecht University, the National Council for Scientific and Technological Development (CNPq), and Research Foundation of the State of Minas Gerais (FAPEMIG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braat AK, 2000, MECH DEVELOP, V95, P271, DOI 10.1016/S0925-4773(00)00344-0; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11303, DOI 10.1073/pnas.91.24.11303; Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Chan RWS, 2006, STEM CELLS, V24, P1529, DOI 10.1634/stemcells.2005-0411; Chiarini-Garcia H, 2003, REPRODUCTION, V126, P669, DOI 10.1530/reprod/126.5.669; Chiarini-Garcia H, 2001, BIOL REPROD, V65, P1179, DOI 10.1095/biolreprod65.4.1179; Conboy MJ, 2007, PLOS BIOL, V5, P1120, DOI 10.1371/journal.pbio.0050102; de Rooij D. G., 2006, Animal Reproduction, V3, P130; De Rooij DG, 2009, MICROSC RES TECHNIQ, V72, P580, DOI 10.1002/jemt.20699; de Waal PP, 2008, REPRODUCTION, V136, P225, DOI 10.1530/REP-08-0055; de Waal PP, 2009, J ENDOCRINOL, V202, P287, DOI 10.1677/JOE-09-0050; Dobrinski I., 2006, Animal Reproduction, V3, P135; Garcia-Lopez A, 2009, ENDOCRINOLOGY, V150, P357, DOI 10.1210/en.2008-0447; Garcia-Lopez A, 2010, ENDOCRINOLOGY, V151, P2349, DOI 10.1210/en.2009-1227; Glauche I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000447; GOMES WR, 1973, ENDOCRINOLOGY, V93, P800, DOI 10.1210/endo-93-4-800; Good-Avila SV, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-293; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; Hofmann MC, 2008, MOL CELL ENDOCRINOL, V288, P95, DOI 10.1016/j.mce.2008.04.012; Honaramooz A, 2003, BIOL REPROD, V69, P1260, DOI 10.1095/biolreprod.103.018788; Kanatsu-Shinohara M, 2010, J REPROD DEVELOP, V56, P145, DOI 10.1262/jrd.09-153N; Krawetz SA, 2009, EMBO REP, V10, P1087, DOI 10.1038/embor.2009.211; Krovel AV, 2002, MECH DEVELOP, V116, P141, DOI 10.1016/S0925-4773(02)00154-5; Kuwahara R, 2008, HEPATOLOGY, V47, P1994, DOI 10.1002/hep.22218; Lacerda SMSN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010740; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Leal MC, 2009, BIOL REPROD, V81, P177, DOI 10.1095/biolreprod.109.076299; Leal MC, 2009, GEN COMP ENDOCR, V162, P134, DOI 10.1016/j.ygcen.2009.03.003; Li YW, 2008, GEN COMP ENDOCR, V159, P80, DOI 10.1016/j.ygcen.2008.07.023; Majhi SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006132; McLean DJ, 2005, CELL TISSUE RES, V322, P21, DOI 10.1007/s00441-005-0009-z; Meistrich ML, 2003, INT J ANDROL, V26, P141, DOI 10.1046/j.1365-2605.2003.00400.x; Miura C, 2007, MOL REPROD DEV, V74, P420, DOI 10.1002/mrd.20653; MIURA T, 1991, P NATL ACAD SCI USA, V88, P5774, DOI 10.1073/pnas.88.13.5774; Miura T, 1999, BIOCHEM BIOPH RES CO, V264, P230, DOI 10.1006/bbrc.1999.1494; Miura T, 2003, ENDOCRINOLOGY, V144, P5504, DOI 10.1210/en.2003-0800; Miura T, 2002, DEVELOPMENT, V129, P2689; MORRIS ID, 1987, INT J ANDROL, V10, P691, DOI 10.1111/j.1365-2605.1987.tb00371.x; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; Nakamura S, 2010, SCIENCE, V328, P1561, DOI 10.1126/science.1185473; Neumann JC, 2009, ZEBRAFISH, V6, P319, DOI 10.1089/zeb.2009.0613; Nikolova G, 2007, TRENDS CELL BIOL, V17, P19, DOI 10.1016/j.tcb.2006.11.005; Nobrega RH, 2009, FISH PHYSIOL BIOCHEM, V35, P197, DOI 10.1007/s10695-008-9252-z; O'Shaughnessy PJ, 2008, REPRODUCTION, V135, P839, DOI 10.1530/REP-08-0012; Oatley JA, 2008, ANNU REV CELL DEV BI, V24, P263, DOI 10.1146/annurev.cellbio.24.110707.175355; Oatley JM, 2009, DEVELOPMENT, V136, P1191, DOI 10.1242/dev.032243; Ohta T, 2007, BIOL REPROD, V77, P970, DOI 10.1095/biolreprod.107.062299; QUINTEROHUNTER I, 1991, BIOTECH HISTOCHEM, V66, P169, DOI 10.3109/10520299109109964; Rando TA, 2007, CELL, V129, P1239, DOI 10.1016/j.cell.2007.06.019; Rehbein H, 2007, J VERBRAUCH LEBENSM, V2, P122, DOI 10.1007/s00003-007-0179-6; Sadri-Ardekani H, 2009, JAMA-J AM MED ASSOC, V302, P2127, DOI 10.1001/jama.2009.1689; Sakai N, 2006, METHODS, V39, P239, DOI 10.1016/j.ymeth.2005.12.008; Schulz RW, 2010, GEN COMP ENDOCR, V165, P390, DOI 10.1016/j.ygcen.2009.02.013; Schulz RW, 2005, BIOL REPROD, V73, P891, DOI 10.1095/biolreprod.105.039891; SCHULZ RW, 1994, J ENDOCRINOL, V140, P265, DOI 10.1677/joe.0.1400265; SCHULZE C, 1988, CELL TISSUE RES, V251, P31, DOI 10.1007/BF00215444; SCHULZE C, 1979, CELL TISSUE RES, V198, P191; Simon L, 2007, EXP CELL RES, V313, P3090, DOI 10.1016/j.yexcr.2007.05.002; Szotek PP, 2008, P NATL ACAD SCI USA, V105, P12469, DOI 10.1073/pnas.0805012105; VANDEKANT HJG, 1992, HISTOCHEM J, V24, P170, DOI 10.1007/BF01047467; VANKEULEN CJ, 1974, CELL TISSUE KINET, V7, P549, DOI 10.1111/j.1365-2184.1974.tb00438.x; Wu X, 2009, P NATL ACAD SCI USA, V106, P21672, DOI 10.1073/pnas.0912432106; Yoshida S, 2007, SCIENCE, V317, P1722, DOI 10.1126/science.1144885; Zhang Z, 2007, J CELL PHYSIOL, V211, P149, DOI 10.1002/jcp.20910; Zou SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007026	68	107	115	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2010	5	9							e12808	10.1371/journal.pone.0012808	http://dx.doi.org/10.1371/journal.pone.0012808			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651YH	20862221	gold, Green Published, Green Submitted			2022-12-27	WOS:000281963200008
J	Yap, LJ; Luo, DH; Chung, KY; Lim, SP; Bodenreider, C; Noble, C; Shi, PY; Lescar, J				Yap, Li Jian; Luo, Dahai; Chung, Ka Yan; Lim, Siew Pheng; Bodenreider, Christophe; Noble, Christian; Shi, Pei-Yong; Lescar, Julien			Crystal Structure of the Dengue Virus Methyltransferase Bound to a 5 '-Capped Octameric RNA	PLOS ONE			English	Article							YELLOW-FEVER VIRUS; DE-NOVO SYNTHESIS; VIRAL-RNA; CATALYTIC DOMAIN; NTPASE ACTIVITY; POLYMERASE NS5; IN-VITRO; CAP; METHYLATION; SEQUENCE	The N-terminal domain of the flavivirus NS5 protein functions as a methyltransferase (MTase). It sequentially methylates the N7 and 2'-O positions of the viral RNA cap structure (GpppA ->(7me)GpppA ->(7me)GpppA(2'-O- me)). The same NS5 domain could also have a guanylyltransferase activity (GTP+ppA-RNA -> GpppA). The mechanism by which this protein domain catalyzes these three distinct functions is currently unknown. Here we report the crystallographic structure of DENV-3 MTase in complex with a 5'-capped RNA octamer (G(ppp)AGAACCUG) at a resolution of 2.9 angstrom. Two RNA octamers arranged as kissing loops are encircled by four MTase monomers around a 2-fold non-crystallography symmetry axis. Only two of the four monomers make direct contact with the 5' end of RNA. The RNA structure is stabilised by the formation of several intra and intermolecular base stacking and non- canonical base pairs. The structure may represent the product of guanylylation of the viral genome prior to the subsequent methylation events that require repositioning of the RNA substrate to reach to the methyl-donor sites. The crystal structure provides a structural explanation for the observed trans-complementation of MTases with different methylation defects.	[Yap, Li Jian; Luo, Dahai; Chung, Ka Yan; Lescar, Julien] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Yap, Li Jian; Chung, Ka Yan; Lim, Siew Pheng; Bodenreider, Christophe; Noble, Christian; Shi, Pei-Yong] Novartis Inst Trop Dis, Singapore, Singapore; [Lescar, Julien] CNRS, AFMB, UMR6098, Marseille, France	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Novartis; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Yap, LJ (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.	pei_yong.shi@novartis.com; julien@ntu.edu.sg	Lim, Siew Pheng/P-8528-2016; Pheng, Lim Siew/AAG-4368-2021; Luo, Dahai/J-6022-2012	Pheng, Lim Siew/0000-0002-7377-5662; Luo, Dahai/0000-0001-7637-7275	BMRC [06/1/22/19/447]; ARC [ARC5/07]; CNRS	BMRC(Agency for Science Technology & Research (A*STAR)); ARC(Australian Research Council); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by a BMRC grant (06/1/22/19/447) and an ARC grant ARC5/07 to the laboratory of JL. Support from an ATIP from the CNRS is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2001, J BIOL CHEM, V276, P39926, DOI 10.1074/jbc.M104248200; Assenberg R, 2007, J GEN VIROL, V88, P2228, DOI 10.1099/vir.0.82757-0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Batey RT, 1999, ANGEW CHEM INT EDIT, V38, P2327; Bollati M, 2009, J MOL BIOL, V385, P140, DOI 10.1016/j.jmb.2008.10.028; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CLEAVES GR, 1979, VIROLOGY, V96, P159, DOI 10.1016/0042-6822(79)90181-8; Dong HP, 2008, ANTIVIR RES, V80, P1, DOI 10.1016/j.antiviral.2008.05.003; Dong HP, 2008, J VIROL, V82, P4295, DOI 10.1128/JVI.02202-07; Dong HP, 2008, VIROLOGY, V377, P1, DOI 10.1016/j.virol.2008.04.026; Dong HP, 2007, J VIROL, V81, P4412, DOI 10.1128/JVI.02455-06; Egloff MP, 2007, J MOL BIOL, V372, P723, DOI 10.1016/j.jmb.2007.07.005; Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Furuichi Y, 2000, ADV VIRUS RES, V55, P135, DOI 10.1016/S0065-3527(00)55003-9; Geiss BJ, 2009, J MOL BIOL, V385, P1643, DOI 10.1016/j.jmb.2008.11.058; Gu MG, 2005, CURR OPIN STRUC BIOL, V15, P99, DOI 10.1016/j.sbi.2005.01.009; Guyatt KJ, 2001, J VIROL METHODS, V92, P37, DOI 10.1016/S0166-0934(00)00270-6; Issur M, 2009, RNA, V15, P2340, DOI 10.1261/rna.1609709; Johansson M, 2001, J GEN VIROL, V82, P735, DOI 10.1099/0022-1317-82-4-735; KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100; KOONIN EV, 1993, J GEN VIROL, V74, P733, DOI 10.1099/0022-1317-74-4-733; Krissinel E., 2005, DETECTION PROTEIN AS, P163; Kuo MD, 1996, J GEN VIROL, V77, P2077, DOI 10.1099/0022-1317-77-9-2077; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LESLIE A, 1992, JOINT CCP4 ESF EAMCB, V4, P26; Lim SP, 2008, ANTIVIR RES, V80, P360, DOI 10.1016/j.antiviral.2008.08.005; LINDENBACH BD, 2007, FIELDS VIROLOGY, V1, P991; Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232; Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200; Nomaguchi M, 2003, J VIROL, V77, P8831, DOI 10.1128/JVI.77.16.8831-8842.2003; Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06; Reinisch KM, 2000, NATURE, V404, P960, DOI 10.1038/35010041; RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707; Shuman S, 2001, PROG NUCLEIC ACID RE, V66, P1; SHUMAN S, 1981, P NATL ACAD SCI-BIOL, V78, P187, DOI 10.1073/pnas.78.1.187; Tan BH, 1996, VIROLOGY, V216, P317, DOI 10.1006/viro.1996.0067; WARRENER P, 1993, J VIROL, V67, P989, DOI 10.1128/JVI.67.2.989-996.1993; Xu T, 2005, J VIROL, V79, P10278, DOI 10.1128/JVI.79.16.10278-10288.2005; Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06; You S, 1999, J BIOL CHEM, V274, P33714, DOI 10.1074/jbc.274.47.33714; Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06	42	34	35	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2010	5	9							e12836	10.1371/journal.pone.0012836	http://dx.doi.org/10.1371/journal.pone.0012836			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651XL	20862256	Green Published, gold, Green Submitted			2022-12-27	WOS:000281960800024
J	Leskinen, T; Rinnankoski-Tuikka, R; Rintala, M; Seppanen-Laakso, T; Pollanen, E; Alen, M; Sipila, S; Kaprio, J; Kovanen, V; Rahkila, P; Oresic, M; Kainulainen, H; Kujala, UM				Leskinen, Tuija; Rinnankoski-Tuikka, Rita; Rintala, Mirva; Seppanen-Laakso, Tuulikki; Pollanen, Eija; Alen, Markku; Sipila, Sarianna; Kaprio, Jaakko; Kovanen, Vuokko; Rahkila, Paavo; Oresic, Matej; Kainulainen, Heikki; Kujala, Urho M.			Differences in Muscle and Adipose Tissue Gene Expression and Cardio-Metabolic Risk Factors in the Members of Physical Activity Discordant Twin Pairs	PLOS ONE			English	Article							INSULIN-RESISTANCE; SKELETAL-MUSCLE; EXERCISE; MORTALITY; TRIACYLGLYCEROL; ADAPTATIONS; SELECTION; WOMEN; ACIDS; FAT	High physical activity/aerobic fitness predicts low morbidity and mortality. Our aim was to identify the most up-regulated gene sets related to long-term physical activity vs. inactivity in skeletal muscle and adipose tissues and to obtain further information about their link with cardio-metabolic risk factors. We studied ten same-sex twin pairs (age range 50-74 years) who had been discordant for leisure-time physical activity for 30 years. The examinations included biopsies from m. vastus lateralis and abdominal subcutaneous adipose tissue. RNA was analyzed with the genome-wide Illumina Human WG-6 v3.0 Expression BeadChip. For pathway analysis we used Gene Set Enrichment Analysis utilizing active vs. inactive co-twin gene expression ratios. Our findings showed that among the physically active members of twin pairs, as compared to their inactive co-twins, gene expression in the muscle tissue samples was chronically up-regulated for the central pathways related to energy metabolism, including oxidative phosphorylation, lipid metabolism and supportive metabolic pathways. Up-regulation of these pathways was associated in particular with aerobic fitness and high HDL cholesterol levels. In fat tissue we found physical activity-associated increases in the expression of polyunsaturated fatty acid metabolism and branched-chain amino acid degradation gene sets both of which associated with decreased 'high-risk' ectopic body fat and plasma glucose levels. Consistent with other findings, plasma lipidomics analysis showed up-regulation of the triacylglycerols containing the polyunsaturated fatty acids. Our findings identified skeletal muscle and fat tissue pathways which are associated with the long-term physical activity and reduced cardio-metabolic disease risk, including increased aerobic fitness. In particular, improved skeletal muscle oxidative energy and lipid metabolism as well as changes in adipocyte function and redistribution of body fat are associated with reduced cardio-metabolic risk.	[Leskinen, Tuija; Rintala, Mirva; Pollanen, Eija; Sipila, Sarianna; Kovanen, Vuokko; Rahkila, Paavo; Kujala, Urho M.] Univ Jyvaskyla, Dept Hlth Sci, Jyvaskyla, Finland; [Rinnankoski-Tuikka, Rita; Kainulainen, Heikki] Univ Jyvaskyla, Dept Biol Phys Act, Jyvaskyla, Finland; [Seppanen-Laakso, Tuulikki] VTT Tech Res Ctr Finland, Espoo, Finland; [Alen, Markku] Oulu Univ Hosp, Dept Rehabil Med, Oulu, Finland; [Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Kaprio, Jaakko] Univ Helsinki, Inst Mol Med, Helsinki, Finland; [Kaprio, Jaakko] Natl Inst Hlth & Welf, Helsinki, Finland	University of Jyvaskyla; University of Jyvaskyla; VTT Technical Research Center Finland; University of Oulu; University of Helsinki; University of Helsinki; Finland National Institute for Health & Welfare	Leskinen, T (corresponding author), Univ Jyvaskyla, Dept Hlth Sci, Jyvaskyla, Finland.	urho.m.kujala@jyu.fi	Kujala, Urho/AAP-2547-2020; Oresic, Matej/K-7673-2016; Kaprio, Jaakko/A-1820-2008; Laakkonen, Eija/G-3345-2017; Oresic, Matej/AAV-3978-2020	Oresic, Matej/0000-0002-2856-9165; Kaprio, Jaakko/0000-0002-3716-2455; Laakkonen, Eija/0000-0001-6655-9489; Sipila, Sarianna/0000-0001-5934-7728; Leskinen, Tuija/0000-0001-7499-6128; Kujala, Urho/0000-0002-9262-1992; Kainulainen, Heikki/0000-0001-5102-4350; Rottensteiner, Mirva/0000-0003-1988-0952	Academy of Finland [114 866]; Finnish Ministry of Education; Juho Vainio Foundation; Finnish Cultural Foundation	Academy of Finland(Academy of Finland); Finnish Ministry of Education; Juho Vainio Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science)	The TWINACTIVE study was supported by the Academy of Finland (Grant 114 866 and Centre of Excellence in Complex Disease Genetics) and Finnish Ministry of Education. Dr. Kujala was supported by the Juho Vainio Foundation. M.Sc. Leskinen was supported by the Finnish Cultural Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Hawley JA, 2008, ACTA PHYSIOL, V192, P127, DOI 10.1111/j.1748-1716.2007.01783.x; Heilbronn L, 2004, INT J OBESITY, V28, pS12, DOI 10.1038/sj.ijo.0802853; Hinault C, 2006, J NUTR BIOCHEM, V17, P374, DOI 10.1016/j.jnutbio.2006.02.008; HOLLOSZY JO, 1967, J BIOL CHEM, V242, P2278; Hood DA, 2001, J APPL PHYSIOL, V90, P1137, DOI 10.1152/jappl.2001.90.3.1137; Kivela R, 2010, FASEB J, V24, P4565, DOI 10.1096/fj.10-157313; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Kotronen A, 2009, DIABETOLOGIA, V52, P684, DOI 10.1007/s00125-009-1282-2; Kujala UM, 2009, BRIT J SPORT MED, V43, P550, DOI 10.1136/bjsm.2009.059808; Kujala UM, 2003, SPORTS MED, V33, P553, DOI 10.2165/00007256-200333080-00001; Kujala UM, 1998, JAMA-J AM MED ASSOC, V279, P440, DOI 10.1001/jama.279.6.440; Laaksonen R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000097; Leon AS, 2001, MED SCI SPORT EXER, V33, pS502, DOI 10.1097/00005768-200106001-00021; Leskinen T, 2009, INT J OBESITY, V33, P1211, DOI 10.1038/ijo.2009.170; Leskinen T, 2009, TWIN RES HUM GENET, V12, P108, DOI 10.1375/twin.12.1.108; Ma HQ, 2009, J BONE MINER RES, V24, P1427, DOI [10.1359/JBMR.090309, 10.1359/jbmr.090309]; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Muoio DM, 2010, BBA-MOL CELL BIOL L, V1801, P281, DOI 10.1016/j.bbalip.2009.11.007; Mustelin L, 2008, AM J PHYSIOL-ENDOC M, V295, pE148, DOI 10.1152/ajpendo.00580.2007; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Paatela H, 2009, STEROIDS, V74, P814, DOI 10.1016/j.steroids.2009.04.013; PETTE D, 1983, J PHYSIOL-LONDON, V338, P1; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Pietilainen KH, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050051; Pollanen E, 2007, REJUV RES, V10, P485, DOI 10.1089/rej.2007.0536; RINTALA M, 2010, PUBLIC HEALTH NUTR, V4, P1; Rockl KSC, 2008, IUBMB LIFE, V60, P145, DOI 10.1002/iub.21; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Short KR, 2009, AM J CLIN NUTR, V89, p453S, DOI 10.3945/ajcn.2008.26717A; Slentz CA, 2009, OBESITY, V17, pS27, DOI 10.1038/oby.2009.385; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Waller K, 2008, INT J OBESITY, V32, P353, DOI 10.1038/sj.ijo.0803692; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x; Wisloff U, 2005, SCIENCE, V307, P418, DOI 10.1126/science.1108177; Yuhanna IS, 2001, NAT MED, V7, P853, DOI 10.1038/89986	40	58	58	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2010	5	9							e12609	10.1371/journal.pone.0012609	http://dx.doi.org/10.1371/journal.pone.0012609			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650QH	20862330	Green Published, Green Submitted, gold			2022-12-27	WOS:000281864100003
J	Yue, GH; Chang, A				Yue, Gen Hua; Chang, Alex			Molecular Evidence for High Frequency of Multiple Paternity in a Freshwater Shrimp Species Caridina ensifera	PLOS ONE			English	Article							PARENT-OFFSPRING CONFLICT; MATING SYSTEMS; SPERM-STORAGE; NATURAL-POPULATIONS; GENETIC PARENTAGE; SEXUAL SELECTION; FIELD CRICKET; EVOLUTION; CRUSTACEA; DECAPODA	Background: Molecular genetic analyses of parentage provide insights into mating systems. Although there are 22,000 members in Malacostraca, not much has been known about mating systems in Malacostraca. The freshwater shrimp Caridina ensifera blue, is a new species belonging to Malacostraca which was discovered recently in Sulawesi, Indonesia. Due to its small body size and low fecundity, this species is an ideal species to study the occurrence and frequency of multiple paternity and to understand of how the low fecundity species persist and evolve. Methodology/Principal Findings: In this study, we developed four polymorphic microsatellites from C. ensifera and applied them to investigate the occurrence and frequency of multiple paternity in 20 C. ensifera broods caught from Lake Matano, Sulawesi. By genotyping the mother and all offspring from each brood we discovered multiple paternity in all 20 broods. In most of the 20 broods, fathers contributed skewed numbers of offspring and there was an apparent inverse correlation between reproductive success of sires and their relatedness to mothers. Conclusions/Significance: Our results in combination with recent reports on multiple paternity in crayfish, crab and lobster species suggests that multiple paternity is common in Malacostraca. Skewed contribution of fathers to the numbers of offspring and inverse correlation between reproductive success of sires and their relatedness to mothers suggest that sperm competition occurred and/or pre- and postcopulatory female choice happen, which may be important for avoiding the occurrence of inbreeding and optimize genetic variation in offspring and for persistence and evolution of low fecundity species.	[Yue, Gen Hua; Chang, Alex] Natl Univ Singapore, Temasek Life Sci Lab, Mol Populat Genet Grp, Singapore 117548, Singapore; [Chang, Alex] Qian Hu Fish Farm, R&D Dept, Singapore, Singapore	National University of Singapore	Yue, GH (corresponding author), Natl Univ Singapore, Temasek Life Sci Lab, Mol Populat Genet Grp, Singapore 117548, Singapore.	genhua@tll.org.sg	Yue, GH/F-4801-2015	Yue, GH/0000-0002-3537-2248	Temasek Life Sciences Laboratory, Singapore	Temasek Life Sciences Laboratory, Singapore	This work was supported by the internal fund of the Temasek Life Sciences Laboratory, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise JC, 2002, ANNU REV GENET, V36, P19, DOI 10.1146/annurev.genet.36.030602.090831; Avise JC, 2001, J HERED, V92, P99, DOI 10.1093/jhered/92.2.99; BAUER RT, 1991, CRUSLACEAN SEXUAL BI, P83; BERG ABV, 1984, J CRUSTACEAN BIOL, V4, P417, DOI 10.2307/1548041; Bretman A, 2005, MOL ECOL, V14, P2169, DOI 10.1111/j.1365-294X.2005.02556.x; Bretman A, 2004, P ROY SOC B-BIOL SCI, V271, P159, DOI 10.1098/rspb.2003.2563; Bretman A, 2009, MOL ECOL, V18, P3340, DOI 10.1111/j.1365-294X.2009.04301.x; Buckland-Nicks J, 1998, MICRON, V29, P267, DOI 10.1016/S0968-4328(97)00064-4; Cai Y, 2007, RAFFLES B ZOOL, V55, P311; Calsbeek R, 2008, EVOLUTION, V62, P1137, DOI 10.1111/j.1558-5646.2008.00356.x; Calsbeek R, 2007, EVOL ECOL RES, V9, P495; Crespi B, 2004, AM NAT, V163, P635, DOI 10.1086/382734; Croshaw DA, 2009, GENET RES, V91, P313, DOI 10.1017/S0016672309990231; DeWoody JA, 2001, J HERED, V92, P167, DOI 10.1093/jhered/92.2.167; Dick JTA, 2006, BIOL LETT-UK, V2, P501, DOI 10.1098/rsbl.2006.0512; Fischer D, 1998, BIOTECHNIQUES, V24, P796, DOI 10.2144/98245st03; Fox CW, 2000, ANNU REV ENTOMOL, V45, P341, DOI 10.1146/annurev.ento.45.1.341; Fretter V., 1994, BRIT PROSOBRANCH MOL; Goossens B, 1998, BEHAV ECOL SOCIOBIOL, V43, P281, DOI 10.1007/s002650050492; Gosselin T, 2005, MOL ECOL, V14, P1517, DOI 10.1111/j.1365-294X.2005.02498.x; HAASE M, 1995, INVERTEBR REPROD DEV, V28, P33, DOI 10.1080/07924259.1995.9672461; Ilmonen P, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-104; JAMES DF, 1974, P 2 INT CRAYF S, V2, P125; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Jensen PC, 1996, BIOL BULL, V190, P336, DOI 10.2307/1543026; Johnson SL, 2007, MOL ECOL, V16, P3253, DOI 10.1111/j.1365-294X.2007.03366.x; Jones AG, 2010, MOL ECOL RESOUR, V10, P6, DOI 10.1111/j.1755-0998.2009.02778.x; Jones AG, 2005, MOL ECOL NOTES, V5, P708, DOI 10.1111/j.1471-8286.2005.01029.x; Jones AG, 2003, MOL ECOL, V12, P2511, DOI 10.1046/j.1365-294X.2003.01928.x; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Lewis PO, 2000, GENETIC DATA ANAL; Makinen T, 2007, J HERED, V98, P705, DOI 10.1093/jhered/esm097; Martinez JL, 2000, MOL ECOL, V9, P293, DOI 10.1046/j.1365-294x.2000.00857.x; Mathews D, 1956, PAC SCI, V10, P303; Mobley KB, 2007, MOL ECOL, V16, P2596, DOI 10.1111/j.1365-294X.2007.03337.x; Mobley KB, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-6; Neff BD, 2005, MOL ECOL, V14, P19, DOI 10.1111/j.1365-294X.2004.02395.x; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Pearse DE, 2001, J HERED, V92, P206, DOI 10.1093/jhered/92.2.206; Reynolds JD, 1996, TRENDS ECOL EVOL, V11, pA68, DOI 10.1016/0169-5347(96)81045-7; Salmon M., 1983, STUDIES ADAPTATION B; Schram F.R., 1986, CRUSTACEA; SCHRAM FR, 1974, SYST ZOOL, V23, P323, DOI 10.2307/2412539; Sefc KM, 2009, J HERED, V100, P197, DOI 10.1093/jhered/esn095; Simmons LW, 2008, J HERED, V99, P610, DOI 10.1093/jhered/esn053; Smiseth PT, 2008, P ROY SOC B-BIOL SCI, V275, P1823, DOI 10.1098/rspb.2008.0199; Song SD, 2007, MOL ECOL, V16, P2353, DOI 10.1111/j.1365-294X.2007.03277.x; Streiff R, 2004, MAR BIOTECHNOL, V6, P60, DOI 10.1007/s10126-003-0015-7; Suzuki S, 2005, ARTHROPOD STRUCT DEV, V34, P441, DOI 10.1016/j.asd.2005.06.002; Thiel M, 2004, BEHAV ECOL SOCIOBIOL, V57, P62, DOI 10.1007/s00265-004-0828-z; Thomas ML, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-162; Toonen RJ, 2004, MAR ECOL PROG SER, V270, P259, DOI 10.3354/meps270259; Uller T, 2008, TRENDS ECOL EVOL, V23, P432, DOI 10.1016/j.tree.2008.04.005; Uller T, 2008, MOL ECOL, V17, P2566, DOI 10.1111/j.1365-294X.2008.03772.x; Villesen P, 1999, MOL ECOL, V8, P1819, DOI 10.1046/j.1365-294x.1999.00767.x; von Rintelen K, 2007, MOL PHYLOGENET EVOL, V45, P1033, DOI 10.1016/j.ympev.2007.07.002; Walker D, 2002, MOL ECOL, V11, P2115, DOI 10.1046/j.1365-294X.2002.01609.x; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; [王娟 Wang Juan], 2008, [分析仪器, Analytical Instrumentation], P21; Wilson AJ, 2002, CAN J FISH AQUAT SCI, V59, P1696, DOI [10.1139/f02-127, 10.1139/F02-127]; Yue GH, 2010, INT J BIOL SCI, V6, P107; Yue GH, 2000, MOL ECOL, V9, P1007, DOI 10.1046/j.1365-294x.2000.00939-10.x; Yue GH, 2005, ELECTROPHORESIS, V26, P3081, DOI 10.1002/elps.200410411; Zeh JA, 1996, P ROY SOC B-BIOL SCI, V263, P1711, DOI 10.1098/rspb.1996.0250; Zhang DX, 2003, MOL ECOL, V12, P563, DOI 10.1046/j.1365-294X.2003.01773.x; Zitzler K, 2006, RAFFLES B ZOOL, V54, P271	66	28	31	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2010	5	9							e12721	10.1371/journal.pone.0012721	http://dx.doi.org/10.1371/journal.pone.0012721			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZO	20856862	Green Submitted, Green Published, gold			2022-12-27	WOS:000281815700011
J	Hauri, C; Fabricius, KE; Schaffelke, B; Humphrey, C				Hauri, Claudine; Fabricius, Katharina E.; Schaffelke, Britta; Humphrey, Craig			Chemical and Physical Environmental Conditions Underneath Mat- and Canopy-Forming Macroalgae, and Their Effects on Understorey Corals	PLOS ONE			English	Article							ORGANIC-CARBON; BENTHIC ALGAE; REEF; LIGHT; MICROENVIRONMENT; PHOTOSYNTHESIS; DISSOCIATION; COMPETITION; RESILIENCE; EXPRESSION	Disturbed coral reefs are often dominated by dense mat- or canopy-forming assemblages of macroalgae. This study investigated how such dense macroalgal assemblages change the chemical and physical microenvironment for understorey corals, and how the altered environmental conditions affect the physiological performance of corals. Field measurements were conducted on macroalgal-dominated inshore reefs in the Great Barrier Reef in quadrats with macroalgal biomass ranging from 235 to 1029 g DW m(-2) dry weight. Underneath mat- forming assemblages, the mean concentration of dissolved oxygen was reduced by 26% and irradiance by 96% compared with conditions above the mat, while concentrations of dissolved organic carbon and soluble reactive phosphorous increased by 26% and 267%, respectively. The difference was significant but less pronounced under canopy-forming assemblages. Dissolved oxygen declined and dissolved inorganic carbon and alkalinity increased with increasing algal biomass underneath mat- forming but not under canopy-forming assemblages. The responses of corals to conditions similar to those found underneath algal assemblages were investigated in an aquarium experiment. Coral nubbins of the species Acropora millepora showed reduced photosynthetic yields and increased RNA/DNA ratios when exposed to conditions simulating those underneath assemblages (pre-incubating seawater with macroalgae, and shading). The magnitude of these stress responses increased with increasing proportion of pre-incubated algal water. Our study shows that mat- forming and, to a lesser extent, canopy-forming macroalgal assemblages alter the physical and chemical microenvironment sufficiently to directly and detrimentally affect the metabolism of corals, potentially impeding reef recovery from algal to coral-dominated states after disturbance. Macroalgal dominance on coral reefs therefore simultaneously represents a consequence and cause of coral reef degradation.	[Hauri, Claudine] ETH, Inst Biogeochem & Pollutant Dynam, Zurich, Switzerland; [Hauri, Claudine; Fabricius, Katharina E.; Schaffelke, Britta; Humphrey, Craig] Australian Inst Marine Sci, Townsville, Qld 4810, Australia	Swiss Federal Institutes of Technology Domain; ETH Zurich; Australian Institute of Marine Science	Hauri, C (corresponding author), ETH, Inst Biogeochem & Pollutant Dynam, Zurich, Switzerland.	claudine.hauri@env.ethz.ch	Fabricius, Katharina E/F-1759-2010	Fabricius, Katharina E/0000-0001-7671-4358; Humphrey, Craig/0000-0002-1303-036X	Australian Institute of Marine Science; Sarasin Foundation; University of Basel; Mathieu Foundation; Josef and Olga Tomcsik Foundation	Australian Institute of Marine Science; Sarasin Foundation; University of Basel; Mathieu Foundation; Josef and Olga Tomcsik Foundation	This study was funded by the Australian Institute of Marine Science, the Sarasin Foundation, the University of Basel, the Mathieu Foundation and the Josef and Olga Tomcsik Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony KRN, 2003, FUNCT ECOL, V17, P246, DOI 10.1046/j.1365-2435.2003.00731.x; Birrell CL, 2008, OCEANOGR MAR BIOL, V46, P25; BLACK NA, 1995, BIOL BULL, V188, P234, DOI 10.2307/1542301; Bruno JF, 2009, ECOLOGY, V90, P1478, DOI 10.1890/08-1781.1; Buckley BA, 2004, MAR ECOL PROG SER, V282, P143, DOI 10.3354/meps282143; Cooper TF, 2008, MAR FRESHWATER RES, V59, P703, DOI 10.1071/MF08016; Cooper TF, 2007, ESTUAR COAST SHELF S, V74, P458, DOI 10.1016/j.ecss.2007.05.020; DENYS R, 1991, MAR BIOL, V108, P315, DOI 10.1007/BF01344346; Diaz-Pulido G, 2002, MAR ECOL PROG SER, V232, P115, DOI 10.3354/meps232115; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; ESCARTIN J, 1995, ESTUAR COAST SHELF S, V40, P451, DOI 10.1006/ecss.1995.0031; Ferrier-Pages C, 1998, MAR ECOL PROG SER, V172, P265, DOI 10.3354/meps172265; Gardella DJ, 1999, MAR BIOL, V135, P289, DOI 10.1007/s002270050626; Hendriks IE, 2010, MAR BIOL, V157, P473, DOI 10.1007/s00227-009-1333-8; Jompa J, 2003, MAR ECOL PROG SER, V258, P79, DOI 10.3354/meps258079; Jompa J, 2002, LIMNOL OCEANOGR, V47, P527, DOI 10.4319/lo.2002.47.2.0527; KUHL M, 1995, MAR ECOL PROG SER, V117, P159, DOI 10.3354/meps117159; Kuntz NM, 2005, MAR ECOL PROG SER, V294, P173, DOI 10.3354/meps294173; Kyle M, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.1; Levy O, 2003, J EXP BIOL, V206, P4041, DOI 10.1242/jeb.00622; Lewis E., 1998, ORNLCDIAC105 US DEP; LITTLER DS, 2003, S PACIFIC PLANTS; Marubini F, 2001, MAR ECOL PROG SER, V220, P153, DOI 10.3354/meps220153; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; MILLER D, 1992, J THERM BIOL, V17, P217, DOI 10.1016/0306-4565(92)90058-N; MILLERO FJ, 1993, MAR CHEM, V44, P153, DOI 10.1016/0304-4203(93)90200-8; Nugues MM, 2004, ECOL LETT, V7, P919, DOI 10.1111/j.1461-0248.2004.00651.x; Nystrom M, 2008, CORAL REEFS, V27, P795, DOI 10.1007/s00338-008-0426-z; R Core Team, 2020, R LANG ENV STAT COMP; Ralph PJ, 2005, J PHYCOL, V41, P335, DOI 10.1111/j.1529-8817.2005.04034.x; River GF, 2001, J EXP MAR BIOL ECOL, V261, P159, DOI 10.1016/S0022-0981(01)00266-0; Rossi S, 2006, HELGOLAND MAR RES, V60, P7, DOI 10.1007/s10152-005-0009-0; RYLE VD, 1981, OCEANOGRAPHY SERIES, V3; Sarmiento J.L., 2013, OCEAN BIOGEOCHEMICAL, DOI [DOI 10.2307/J.CTT3FGXQX, 10.1515/9781400849079, DOI 10.1515/9781400849079]; Schaffelke B, 1999, MAR ECOL PROG SER, V182, P305, DOI 10.3354/meps182305; Schaffelke B, 1997, BOT MAR, V40, P373, DOI 10.1515/botm.1997.40.1-6.373; Schreiber U, 2004, ADV PHOTO RESPIRAT, V19, P279; Sebens KP, 2003, CORAL REEFS, V22, P35, DOI 10.1007/s00338-003-0277-6; SEGEL LA, 1982, B MAR SCI, V32, P919; Skelton PA, 2007, NOVA HEDWIGIA, P1; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; SUNDBACK K, 1990, MAR ECOL PROG SER, V58, P261; Titlyanov EA, 2007, J EXP MAR BIOL ECOL, V342, P282, DOI 10.1016/j.jembe.2006.11.007	44	34	36	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2010	5	9							e12685	10.1371/journal.pone.0012685	http://dx.doi.org/10.1371/journal.pone.0012685			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648ZZ	20856882	Green Published, Green Submitted, gold			2022-12-27	WOS:000281735700011
J	Lucas, A; Kim, Y; Rivera-Pabon, O; Chae, S; Kim, DH; Kim, B				Lucas, Amanda; Kim, Yuri; Rivera-Pabon, Omayra; Chae, Sunju; Kim, Dong-Hyun; Kim, Baek			Targeting the PI3K/Akt Cell Survival Pathway to Induce Cell Death of HIV-1 Infected Macrophages with Alkylphospholipid Compounds	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MICROGLIAL CELLS; AKT INHIBITOR; TAT PROTEIN; PERIFOSINE; APOPTOSIS; ACTIVATION; DEMENTIA; TUMOR; LINES	Background: HIV-1 infected macrophages and microglia are long-lived viral reservoirs persistently producing viral progenies. HIV-1 infection extends the life span of macrophages by promoting the stress-induced activation of the PI3K/Akt cell survival pathway. Importantly, various cancers also display the PI3K/Akt activation for long-term cell survival and outgrowth, and Akt inhibitors have been extensively searched as anti-cancer agents. This led us to investigate whether Akt inhibitors could antagonize long-term survival and cytoprotective phenotype of HIV-1 infected macrophages. Principal Findings: Here, we examined the effect of one such class of drugs, alkylphospholipids (ALPs), on cell death and Akt pathway signals in human macrophages and a human microglial cell line, CHME5, infected with HIV-1 BaL or transduced with HIV-1 vector, respectively. Our findings revealed that the ALPs, perifosine and edelfosine, specifically induced the death of HIV-1 infected primary human macrophages and CHME5 cells. Furthermore, these two compounds reduced phosphorylation of both Akt and GSK3 beta, a downstream substrate of Akt, in the transduced CHME5 cells. Additionally, we observed that perifosine effectively reduced viral production in HIV-1 infected primary human macrophages. These observations demonstrate that the ALP compounds tested are able to promote cell death in both HIV-1 infected macrophages and HIV-1 expressing CHME5 cells by inhibiting the action of the PI3K/Akt pathway, ultimately restricting viral production from the infected cells. Significance: This study suggests that Akt inhibitors, such as ALP compounds, may serve as potential anti-HIV-1 agents specifically targeting long-living HIV-1 macrophages and microglia reservoirs.	[Lucas, Amanda; Rivera-Pabon, Omayra; Kim, Baek] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Kim, Yuri; Chae, Sunju; Kim, Dong-Hyun] Kyung Hee Univ, Coll Pharm, Dept Pharm, Seoul, South Korea	University of Rochester; Kyung Hee University	Lucas, A (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA.	dhkim@khu.ac.kr; baek_kim@urmc.rochester.edu			National Center for Research Resources [TL1 RR024135]; Korean Government [R33-2008-000-100018]; NIH [AI077401]; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077401] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Korean Government(Korean Government); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by NIH AI077401 (B.K.), TL1 RR024135 from the National Center for Research Resources, NIH (A.L.L.) and National Research Foundation of Korea Grant funded by the Korean Government R33-2008-000-100018 (D.H.K). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquaro S, 2002, J MED VIROL, V68, P479, DOI 10.1002/jmv.10245; Chugh P, 2007, J MOL BIOL, V366, P67, DOI 10.1016/j.jmb.2006.11.011; Chugh P, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-11; Cosenza MA, 2004, NEUROPATH APPL NEURO, V30, P478, DOI 10.1111/j.1365-2990.2004.00563.x; Dieterle A, 2009, INT J CANCER, V125, P932, DOI 10.1002/ijc.24374; Duijsings D, 2004, EUR J PHARMACOL, V502, P185, DOI 10.1016/j.ejphar.2004.09.015; Engel JB, 2008, EUR J OBSTET GYN R B, V141, P64, DOI 10.1016/j.ejogrb.2008.06.007; Ernst DS, 2005, INVEST NEW DRUG, V23, P569, DOI 10.1007/s10637-005-1157-4; Gajate C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005044; Gills JJ, 2009, CURR ONCOL REP, V11, P102, DOI 10.1007/s11912-009-0016-4; Grosman N, 2001, INT IMMUNOPHARMACOL, V1, P1321, DOI 10.1016/S1567-5769(01)00064-9; JANABI N, 1995, NEUROSCI LETT, V195, P105, DOI 10.1016/0304-3940(94)11792-H; Kondapaka SB, 2003, MOL CANCER THER, V2, P1093; Konstantinov SM, 1999, CANCER LETT, V144, P153, DOI 10.1016/S0304-3835(99)00219-0; Lee P, 2001, BRAIN RES, V892, P380, DOI 10.1016/S0006-8993(00)03257-1; Leonard R, 2001, J CLIN ONCOL, V19, P4150, DOI 10.1200/JCO.2001.19.21.4150; Liu DX, 2009, CANCER RES, V69, P7311, DOI 10.1158/0008-5472.CAN-09-1077; Mattson MP, 2005, CELL DEATH DIFFER, V12, P893, DOI 10.1038/sj.cdd.4401577; Osaki M, 2004, APOPTOSIS, V9, P667, DOI 10.1023/B:APPT.0000045801.15585.dd; Shi B, 1998, J NEUROVIROL, V4, P281, DOI 10.3109/13550289809114529; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; van Blitterswijk WJ, 2008, CURR PHARM DESIGN, V14, P2061, DOI 10.2174/138161208785294636; van Weeren PC, 1998, J BIOL CHEM, V273, P13150, DOI 10.1074/jbc.273.21.13150; Vink SR, 2005, INVEST NEW DRUG, V23, P279, DOI 10.1007/s10637-005-1436-0; Vitolo MI, 2009, CANCER RES, V69, P8275, DOI 10.1158/0008-5472.CAN-09-1067; Zhao RY, 2005, CELL RES, V15, P143, DOI 10.1038/sj.cr.7290279	26	36	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e13121	10.1371/journal.pone.0013121	http://dx.doi.org/10.1371/journal.pone.0013121			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20927348	Green Submitted, Green Published, gold			2022-12-27	WOS:000282312600034
J	Heuberger, AL; Lewis, MR; Chen, MH; Brick, MA; Leach, JE; Ryan, EP				Heuberger, Adam L.; Lewis, Matthew R.; Chen, Ming-Hsuan; Brick, Mark A.; Leach, Jan E.; Ryan, Elizabeth P.			Metabolomic and Functional Genomic Analyses Reveal Varietal Differences in Bioactive Compounds of Cooked Rice	PLOS ONE			English	Article							VITAMIN-E; OXIDATIVE STRESS; GAMMA-TOCOPHEROL; ALPHA-TOCOPHEROL; GENETICS; INHIBIT; PLANTS; GENES; DEATH	Emerging evidence supports that cooked rice (Oryza sativa L.) contains metabolites with biomedical activities, yet little is known about the genetic diversity that is responsible for metabolite variation and differences in health traits. Metabolites from ten diverse varieties of cooked rice were detected using ultra performance liquid chromatography coupled to mass spectrometry. A total of 3,097 compounds were detected, of which 25% differed among the ten varieties. Multivariate analyses of the metabolite profiles showed that the chemical diversity among the varieties cluster according to their defined subspecies classifications: indica, japonica, and aus. Metabolite-specific genetic diversity in rice was investigated by analyzing a collection of single nucleotide polymorphisms (SNPs) in genes from biochemical pathways of nutritional importance. Two classes of bioactive compounds, phenolics and vitamin E, contained nonsynonymous SNPs and SNPs in the 5' and 3' untranslated regions for genes in their biosynthesis pathways. Total phenolics and tocopherol concentrations were determined to examine the effect of the genetic diversity among the ten varieties. Per gram of cooked rice, total phenolics ranged from 113.7 to 392.6 mu g (gallic acid equivalents), and total tocopherols ranged between 7.2 and 20.9 mu g. The variation in the cooked rice metabolome and quantities of bioactive components supports that the SNP-based genetic diversity influenced nutritional components in rice, and that this approach may guide rice improvement strategies for plant and human health.	[Heuberger, Adam L.; Brick, Mark A.] Colorado State Univ, Dept Soil & Crop Sci, Ft Collins, CO 80523 USA; [Lewis, Matthew R.] Colorado State Univ, Dept Vice President Res, Prote & Metab Facil, Ft Collins, CO 80523 USA; [Chen, Ming-Hsuan] ARS, Rice Res Unit, USDA, Beaumont, TX USA; [Leach, Jan E.] Colorado State Univ, Dept Bioagr Sci & Pest Management, Ft Collins, CO 80523 USA; [Ryan, Elizabeth P.] Colorado State Univ, Dept Clin Sci, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University; United States Department of Agriculture (USDA); Colorado State University; Colorado State University	Heuberger, AL (corresponding author), Colorado State Univ, Dept Soil & Crop Sci, Ft Collins, CO 80523 USA.	e.p.ryan@colostate.edu		Lewis, Matthew/0000-0001-5760-5359	United States Department of Agriculture-Cooperative State Research, Education, and Extension Service (USDA-CSREES) [2006-35604-16628]; National Institute of Food and Agriculture [2007-38420-17766]; National Institutes of Health [R03CA150070]; Shipley Foundation; NATIONAL CANCER INSTITUTE [R03CA150070] Funding Source: NIH RePORTER	United States Department of Agriculture-Cooperative State Research, Education, and Extension Service (USDA-CSREES)(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); National Institute of Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shipley Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by grants from the United States Department of Agriculture-Cooperative State Research, Education, and Extension Service (USDA-CSREES) (2006-35604-16628), USDA National Needs Graduate Fellowship Competitive Grant from the National Institute of Food and Agriculture (2007-38420-17766), National Institutes of Health (R03CA150070), and the Shipley Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Billman GE, 1999, CIRCULATION, V99, P2452, DOI 10.1161/01.CIR.99.18.2452; Boateng J., 2009, International Journal of Cancer Research (USA), V5, P153, DOI 10.3923/ijcr.2009.153.166; Chaudhary N, 2009, PLANT SCI, V177, P479, DOI 10.1016/j.plantsci.2009.07.014; Chen MH, 2005, J FOOD COMPOS ANAL, V18, P317, DOI 10.1016/j.jfca.2004.12.001; DellaPenna D, 2005, J PLANT PHYSIOL, V162, P729, DOI 10.1016/j.jplph.2005.04.004; Demurin Y, 1996, PLANT BREEDING, V115, P33, DOI 10.1111/j.1439-0523.1996.tb00867.x; Duthie G, 2000, CURR OPIN LIPIDOL, V11, P43, DOI 10.1097/00041433-200002000-00007; Fitzgerald MA, 2009, TRENDS PLANT SCI, V14, P133, DOI 10.1016/j.tplants.2008.12.004; Goffman FD, 2004, J SCI FOOD AGR, V84, P1235, DOI 10.1002/jsfa.1780; Grassmann J, 2002, PLANT PHYSIOL BIOCH, V40, P471, DOI 10.1016/S0981-9428(02)01395-5; Hudson EA, 2000, CANCER EPIDEM BIOMAR, V9, P1163; Ishikawa T, 2010, PLANT CELL PHYSIOL, V51, P9, DOI 10.1093/pcp/pcp162; Jiang Q, 2000, P NATL ACAD SCI USA, V97, P11494, DOI 10.1073/pnas.200357097; Keurentjes JJB, 2006, NAT GENET, V38, P842, DOI 10.1038/ng1815; Leonard SW, 2005, FREE RADICAL BIO MED, V38, P857, DOI 10.1016/j.freeradbiomed.2004.12.001; Lin XB, 2009, AM J PHYSIOL-GASTR L, V296, pG931, DOI 10.1152/ajpgi.00001.2009; Lisec J, 2008, PLANT J, V53, P960, DOI 10.1111/j.1365-313X.2007.03383.x; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; McNally KL, 2006, PLANT PHYSIOL, V141, P26, DOI 10.1104/pp.106.077313; MOCHIDA K, 2009, BMC GENOMICS, V10; Morris CE, 2006, NAT BIOTECHNOL, V24, P1078, DOI 10.1038/nbt0906-1078; Nes WD, 1999, CRIT REV BIOCHEM MOL, V34, P81, DOI 10.1080/10409239991209219; Oksman-Caldentey KM, 2005, CURR OPIN BIOTECH, V16, P174, DOI 10.1016/j.copbio.2005.02.007; Pryor WA, 2000, FREE RADICAL BIO MED, V28, P141, DOI 10.1016/S0891-5849(99)00224-5; Saldeen T, 1999, J AM COLL CARDIOL, V34, P1208, DOI 10.1016/S0735-1097(99)00333-2; Sands DC, 2009, PLANT SCI, V177, P377, DOI 10.1016/j.plantsci.2009.07.011; Schauer N, 2006, NAT BIOTECHNOL, V24, P447, DOI 10.1038/nbt1192; Shanklin J, 1998, ANNU REV PLANT PHYS, V49, P611, DOI 10.1146/annurev.arplant.49.1.611; Shintani D, 1998, SCIENCE, V282, P2098, DOI 10.1126/science.282.5396.2098; Sierra S, 2005, EUR J NUTR, V44, P509, DOI 10.1007/s00394-005-0554-y; Simon PW., 2009, PLANT BREED REV, V31, P325, DOI DOI 10.1002/9780470593783.CH7; Singh U, 2005, ANNU REV NUTR, V25, P151, DOI 10.1146/annurev.nutr.24.012003.132446; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Skogerson K, 2010, J AGR FOOD CHEM, V58, P3600, DOI 10.1021/jf903705y; Tarpley L, 2005, BMC PLANT BIOL, V5, DOI 10.1186/1471-2229-5-8; *UN FAO, 2010, FAO STAT DAT AN GRAP; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Van Eenennaam AL, 2004, METAB ENG, V6, P101, DOI 10.1016/j.ymben.2003.11.001; Xia XD, 2006, J NUTR, V136, P2220, DOI 10.1093/jn/136.8.2220; Zhao KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010780; Zhou JM, 2008, PHARM BIOL, V46, P26, DOI 10.1080/13880200701729745	41	61	63	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12915	10.1371/journal.pone.0012915	http://dx.doi.org/10.1371/journal.pone.0012915			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886119	gold, Green Submitted, Green Published			2022-12-27	WOS:000282091100020
J	Wu, WI; Voegtli, WC; Sturgis, HL; Dizon, FP; Vigers, GPA; Brandhuber, BJ				Wu, Wen-I; Voegtli, Walter C.; Sturgis, Hillary L.; Dizon, Faith P.; Vigers, Guy P. A.; Brandhuber, Barbara J.			Crystal Structure of Human AKT1 with an Allosteric Inhibitor Reveals a New Mode of Kinase Inhibition	PLOS ONE			English	Article							PLECKSTRIN-HOMOLOGY-DOMAIN; MOLECULAR-MECHANISM; MAP KINASE; PH DOMAIN; ACTIVATION; PHOSPHORYLATION; DISCOVERY; MUTATION; BINDING; SYSTEM	AKT1 (NP_005154.2) is a member of the serine/threonine AGC protein kinase family involved in cellular metabolism, growth, proliferation and survival. The three human AKT isozymes are highly homologous multi-domain proteins with both overlapping and distinct cellular functions. Dysregulation of the AKT pathway has been identified in multiple human cancers. Several clinical trials are in progress to test the efficacy of AKT pathway inhibitors in treating cancer. Recently, a series of AKT isozyme-selective allosteric inhibitors have been reported. They require the presence of both the pleckstrin-homology (PH) and kinase domains of AKT, but their binding mode has not yet been elucidated. We present here a 2.7 angstrom resolution co-crystal structure of human AKT1 containing both the PH and kinase domains with a selective allosteric inhibitor bound in the interface. The structure reveals the interactions between the PH and kinase domains, as well as the critical amino residues that mediate binding of the inhibitor to AKT1. Our work also reveals an intricate balance in the enzymatic regulation of AKT, where the PH domain appears to lock the kinase in an inactive conformation and the kinase domain disrupts the phospholipid binding site of the PH domain. This information advances our knowledge in AKT1 structure and regulation, thereby providing a structural foundation for interpreting the effects of different classes of AKT inhibitors and designing selective ones.	[Wu, Wen-I; Voegtli, Walter C.; Sturgis, Hillary L.; Dizon, Faith P.; Vigers, Guy P. A.; Brandhuber, Barbara J.] Array BioPharma Inc, Dept Biol Struct, Boulder, CO USA	Pfizer; Array BioPharma	Wu, WI (corresponding author), Array BioPharma Inc, Dept Biol Struct, Boulder, CO USA.	bbrandhuber@arraybiopharma.com		Vigers, Guy/0000-0003-4451-8453	Array BioPharma Inc.; Genentech, Inc.	Array BioPharma Inc.; Genentech, Inc.(Roche HoldingGenentech)	Array BioPharma Inc. and Genentech, Inc. funded and approved the publication of this work. The companies had a role in this study due to employment of one or more authors of this study.	Ananthanarayanan B, 2007, J BIOL CHEM, V282, P36634, DOI 10.1074/jbc.M706227200; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Barnett SF, 2005, BIOCHEM J, V385, P399, DOI 10.1042/BJ20041140; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Calleja V, 2007, PLOS BIOL, V5, P780, DOI 10.1371/journal.pbio.0050095; Calleja Veronique, 2009, J Chem Biol, V2, P11, DOI 10.1007/s12154-009-0016-8; Calleja V, 2009, PLOS BIOL, V7, P189, DOI 10.1371/journal.pbio.1000017; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Converso A, 2009, BIOORG MED CHEM LETT, V19, P1240, DOI 10.1016/j.bmcl.2008.12.076; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Green CJ, 2008, J BIOL CHEM, V283, P27653, DOI 10.1074/jbc.M802623200; Huang L, 2003, BIOORGAN MED CHEM, V11, P21, DOI 10.1016/S0968-0896(02)00427-3; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; Landgraf KE, 2008, BIOCHEMISTRY-US, V47, P12260, DOI 10.1021/bi801683k; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB, P26; Lindsley CW, 2010, CURR TOP MED CHEM, V10, P458, DOI 10.2174/156802610790980602; Lindsley CW, 2005, BIOORG MED CHEM LETT, V15, P761, DOI 10.1016/j.bmcl.2004.11.011; Lippa B, 2008, BIOORG MED CHEM LETT, V18, P3359, DOI 10.1016/j.bmcl.2008.04.034; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Milburn CC, 2003, BIOCHEM J, V375, P531, DOI 10.1042/BJ20031229; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Ohren JF, 2004, NAT STRUCT MOL BIOL, V11, P1192, DOI 10.1038/nsmb859; Okuzumi T, 2009, NAT CHEM BIOL, V5, P484, DOI 10.1038/nchembio.183; Pargellis C, 2002, NAT STRUCT BIOL, V9, P268, DOI 10.1038/nsb770; Tolcher AW, 2009, J CLIN ONCOL, V27; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Zhao ZJ, 2005, BIOORG MED CHEM LETT, V15, P905, DOI 10.1016/j.bmcl.2004.12.062	31	184	192	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12913	10.1371/journal.pone.0012913	http://dx.doi.org/10.1371/journal.pone.0012913			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886116	Green Published, Green Submitted, gold			2022-12-27	WOS:000282091100019
J	Zhang, JL; Patterson, LJ; Qiu, LY; Graziussi, D; Sebald, W; Hammerschmidt, M				Zhang, Jin-Li; Patterson, Lucy J.; Qiu, Li-Yan; Graziussi, Daria; Sebald, Walter; Hammerschmidt, Matthias			Binding between Crossveinless-2 and Chordin Von Willebrand Factor Type C Domains Promotes BMP Signaling by Blocking Chordin Activity	PLOS ONE			English	Article							TWISTED GASTRULATION; XENOPUS-EMBRYOS; ZEBRAFISH EMBRYO; EXTRACELLULAR REGULATION; SPEMANNS ORGANIZER; DROSOPHILA EMBRYO; PATTERN-FORMATION; PROTEIN; EXPRESSION; GENES	Background: Crossveinless-2 (CV2) is an extracellular BMP modulator protein of the Chordin family, which can either enhance or inhibit BMP activity. CV2 binds to BMP2 via subdomain 1 of the first of its five N-terminal von Willebrand factor type C domains (VWC1). Previous studies showed that this BMP binding is required for the anti-, but not for the pro-BMP effect of CV2. More recently, it was shown that CV2 can also bind to the BMP inhibitor Chordin. However, it remained unclear which domains mediate this binding, and whether it accounts for an anti-or pro-BMP effect. Principal Findings: Here we report that a composite interface of CV2 consisting of subdomain 2 of VWC1 and of VWC2-4, which are dispensable for BMP binding, binds to the VWC2 domain of Chordin. Functional data obtained in zebrafish embryos indicate that this binding of Chordin is required for CV2's pro-BMP effect, which actually is an anti-Chordin effect and, at least to a large extent, independent of Tolloid-mediated Chordin degradation. We further demonstrate that CV2 mutant versions that per se are incapable of BMP binding can attenuate the Chordin/BMP interaction. Conclusions: We have physically dissected the anti-and pro-BMP effects of CV2. Its anti-BMP effect is obtained by binding to BMP via subdomain1 of the VWC1 domain, a binding that occurs in competition with Chordin. In contrast, its pro-BMP effect is achieved by direct binding to Chordin via subdomain 2 of VWC1 and VWC2-4. This binding seems to induce conformational changes within the Chordin protein that weaken Chordin's affinity to BMP. We propose that in ternary Chordin-CV2-BMP complexes, both BMP and Chordin are directly associated with CV2, whereas Chordin is pushed away from BMP, ensuring that BMPs can be more easily delivered to their receptors.	[Zhang, Jin-Li; Patterson, Lucy J.; Graziussi, Daria; Hammerschmidt, Matthias] Univ Cologne, Inst Dev Biol, Cologne Bioctr, Cologne, Germany; [Zhang, Jin-Li; Qiu, Li-Yan; Sebald, Walter] Univ Wurzburg, Dept Physiol Chem 2, Bioctr, Wurzburg, Germany; [Hammerschmidt, Matthias] Univ Cologne, Ctr Mol Med Cologne, Cologne, Germany; [Hammerschmidt, Matthias] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany	University of Cologne; University of Wurzburg; University of Cologne; University of Cologne	Zhang, JL (corresponding author), Univ Cologne, Inst Dev Biol, Cologne Bioctr, Cologne, Germany.	zhangj1@uni-koeln.de; mhammers@uni-koeln.de	Patterson, Lucy/G-1803-2011	Patterson, Lucy/0000-0002-2578-381X	DGF [SFB 572, KFO 103]	DGF(German Research Foundation (DFG))	Work in M.H.'s laboratory was supported by SFB 572 of the DGF, work in W.S.'s laboratory by DGF Grant KFO 103, part C (www.DGF.de). The funders had no role in study design, data collection and analysis, decision to publish, or prepatation of the manuscript.	Ambrosio AL, 2008, DEV CELL, V15, P248, DOI 10.1016/j.devcel.2008.06.013; Ashe HL, 1999, NATURE, V398, P427, DOI 10.1038/18892; Ben-Zvi D, 2008, NATURE, V453, P1205, DOI 10.1038/nature07059; Bier E, 2008, DEV CELL, V15, P176, DOI 10.1016/j.devcel.2008.07.012; Binnerts ME, 2004, BIOCHEM BIOPH RES CO, V315, P272, DOI 10.1016/j.bbrc.2004.01.048; Blair SS, 2007, ANNU REV CELL DEV BI, V23, P293, DOI 10.1146/annurev.cellbio.23.090506.123606; Coles E, 2004, DEVELOPMENT, V131, P5309, DOI 10.1242/dev.01419; Conley CA, 2000, DEVELOPMENT, V127, P3947; Dal-Pra S, 2006, DEV BIOL, V298, P514, DOI 10.1016/j.ydbio.2006.07.002; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; De Robertis EM, 2000, NAT REV GENET, V1, P171, DOI 10.1038/35042039; De Robertis EM, 2006, NAT REV MOL CELL BIO, V7, P296, DOI 10.1038/nrm1855; Decotto E, 2001, DEVELOPMENT, V128, P3831; Fisher S, 1997, DEVELOPMENT, V124, P1301; Fujisawa T, 2009, BIOCHEM BIOPH RES CO, V385, P215, DOI 10.1016/j.bbrc.2009.05.041; Hammerschmidt M, 1996, DEVELOPMENT, V123, P95; Hammerschmidt M, 1999, METHOD CELL BIOL, V59, P87; HAMMERSCHMIDT M, DORSOVENTRAL PATTERN, P72; Ikeya M, 2006, DEVELOPMENT, V133, P4463, DOI 10.1242/dev.02647; JOLY JS, 1993, DEVELOPMENT, V119, P1261; Kamimura M, 2004, DEV DYNAM, V230, P434, DOI 10.1002/dvdy.20069; Keller S, 2004, NAT STRUCT MOL BIOL, V11, P481, DOI 10.1038/nsmb756; Kelley R, 2009, J CELL BIOL, V184, P597, DOI 10.1083/jcb.200808064; Kirsch T, 2000, EMBO J, V19, P3314, DOI 10.1093/emboj/19.13.3314; Kishimoto Y, 1997, DEVELOPMENT, V124, P4457; Larrain J, 2001, DEVELOPMENT, V128, P4439; LI YB, 1994, MECH DEVELOP, V48, P229, DOI 10.1016/0925-4773(94)90062-0; Lin JM, 2005, NAT MED, V11, P387, DOI 10.1038/nm1217; Little SC, 2004, DEVELOPMENT, V131, P5825, DOI 10.1242/dev.01464; Matsui M, 2000, P NATL ACAD SCI USA, V97, P5291, DOI 10.1073/pnas.090020497; Miller-Bertoglio VE, 1997, DEV BIOL, V192, P537, DOI 10.1006/dbio.1997.8788; Moser M, 2007, J MOL CELL CARDIOL, V43, P243, DOI 10.1016/j.yjmcc.2007.05.008; Mullins MC, 1996, DEVELOPMENT, V123, P81; Muraoka O, 2006, NAT CELL BIOL, V8, P329, DOI 10.1038/ncb1379; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; O'Connor MB, 2006, DEVELOPMENT, V133, P183; Oelgeschlager M, 2003, DEVELOPMENT, V130, P4047, DOI 10.1242/dev.00633; Oelgeschlager M, 2003, DEV CELL, V4, P219, DOI 10.1016/S1534-5807(02)00404-5; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Rentzsch F, 2006, DEVELOPMENT, V133, P801, DOI 10.1242/dev.02250; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; SASAI Y, 1995, NATURE, V377, P757, DOI 10.1038/377757a0; SchulteMerker S, 1997, NATURE, V387, P862, DOI 10.1038/43092; Serpe M, 2008, DEV CELL, V14, P940, DOI 10.1016/j.devcel.2008.03.023; Shimmi O, 2005, CELL, V120, P873, DOI 10.1016/j.cell.2005.02.009; Umulis D, 2009, DEVELOPMENT, V136, P3715, DOI 10.1242/dev.031534; Wagner DS, 2002, DEV BIOL, V245, P109, DOI 10.1006/dbio.2002.0614; Xie J, 2005, DEVELOPMENT, V132, P383, DOI 10.1242/dev.01577; Zhang JL, 2008, DEV CELL, V14, P739, DOI 10.1016/j.devcel.2008.02.017; Zhang JL, 2007, J BIOL CHEM, V282, P20002, DOI 10.1074/jbc.M700456200	50	26	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12846	10.1371/journal.pone.0012846	http://dx.doi.org/10.1371/journal.pone.0012846			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886103	Green Submitted, gold, Green Published			2022-12-27	WOS:000282091100001
J	Chakraborty, M; Mangiamele, LA; Burmeister, SS				Chakraborty, Mukta; Mangiamele, Lisa A.; Burmeister, Sabrina S.			Neural Activity Patterns in Response to Interspecific and Intraspecific Variation in Mating Calls in the Tungara Frog	PLOS ONE			English	Article							EARLY GENE-EXPRESSION; FEMALE MATE CHOICE; AUDITORY FOREBRAIN; RECEIVER PERMISSIVENESS; VENTRAL HYPOTHALAMUS; ACOUSTIC MODULATION; ADVERTISEMENT CALLS; SEX-DIFFERENCES; PREOPTIC AREA; RECOGNITION	Background: During mate choice, individuals must classify potential mates according to species identity and relative attractiveness. In many species, females do so by evaluating variation in the signals produced by males. Male tungara frogs (Physalaemus pustulosus) can produce single note calls (whines) and multi-note calls (whine-chucks). While the whine alone is sufficient for species recognition, females greatly prefer the whine-chuck when given a choice. Methodology/Principal Findings: To better understand how the brain responds to variation in male mating signals, we mapped neural activity patterns evoked by interspecific and intraspecific variation in mating calls in tungara frogs by measuring expression of egr-1. We predicted that egr-1 responses to conspecific calls would identify brain regions that are potentially important for species recognition and that at least some of those brain regions would vary in their egr-1 responses to mating calls that vary in attractiveness. We measured egr-1 in the auditory brainstem and its forebrain targets and found that conspecific whine-chucks elicited greater egr-1 expression than heterospecific whines in all but three regions. We found no evidence that preferred whine-chuck calls elicited greater egr-1 expression than conspecific whines in any of eleven brain regions examined, in contrast to predictions that mating preferences in tungara frogs emerge from greater responses in the auditory system. Conclusions: Although selectivity for species-specific signals is apparent throughout the tungara frog brain, further studies are necessary to elucidate how neural activity patterns vary with the attractiveness of conspecific mating calls.	[Chakraborty, Mukta; Mangiamele, Lisa A.; Burmeister, Sabrina S.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Burmeister, Sabrina S.] Univ N Carolina, Curriculum Neurobiol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Chakraborty, M (corresponding author), Duke Univ, Dept Neurobiol, Durham, NC 27710 USA.	sburmeister@unc.edu		Burmeister, Sabrina/0000-0001-5612-692X	Smithsonian Tropical Research Institute; Friends of the Osa; Organization for Tropical Studies; NSF IOB [0445682]	Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute); Friends of the Osa; Organization for Tropical Studies; NSF IOB(National Science Foundation (NSF))	We thank Christina Lebonville, Mihnea (Mike) Mangalea, Sera Haith, Stuart Jeckel, Joan Winter, and Rachel Glaeser for their contributions to data collection. We also thank Dr. Michael J. Ryan, the Smithsonian Tropical Research Institute, Friends of the Osa, and the Organization for Tropical Studies for research support and assistance in obtaining permits.; This research was supported by NSF IOB 0445682 to SSB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON JD, 1992, J COMP PHYSIOL A, V171, P387; ALLISON JD, 1991, BRAIN BEHAV EVOLUT, V38, P322, DOI 10.1159/000114398; Andersson Malte, 1994; Arnold M. L., 1997, NATURAL HYBRIDIZATIO; Bernal XE, 2007, ANIM BEHAV, V73, P955, DOI 10.1016/j.anbehav.2006.10.018; Bernal XE, 2009, BEHAV ECOL SOCIOBIOL, V63, P1269, DOI 10.1007/s00265-009-0795-5; Burmeister SS, 2008, BRAIN RES, V1190, P105, DOI 10.1016/j.brainres.2007.11.008; Clayton DF, 2000, NEUROBIOL LEARN MEM, V74, P185, DOI 10.1006/nlme.2000.3967; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; Gentner TQ, 2001, J NEUROBIOL, V46, P48, DOI 10.1002/1097-4695(200101)46:1<48::AID-NEU5>3.0.CO;2-3; GERHARDT HC, 1991, ANIM BEHAV, V42, P615, DOI 10.1016/S0003-3472(05)80245-3; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; Grace JA, 2003, J NEUROPHYSIOL, V89, P472, DOI 10.1152/jn.00088.2002; Hauber ME, 2007, J COMP PHYSIOL A, V193, P765, DOI 10.1007/s00359-007-0231-0; Hoke KL, 2008, BIOL LETTERS, V4, P518, DOI 10.1098/rsbl.2008.0192; Hoke KL, 2004, J NEUROSCI, V24, P11264, DOI 10.1523/JNEUROSCI.2079-04.2004; Leitner S, 2005, J NEUROBIOL, V64, P275, DOI 10.1002/neu.20135; Mangiamele LA, 2008, BRAIN BEHAV EVOLUT, V72, P239, DOI 10.1159/000171481; MANGIAMELE LM, 2010, DEV NEUROBI IN PRESS; MELLO CV, 1992, P NATL ACAD SCI USA, V89, P6818, DOI 10.1073/pnas.89.15.6818; Michael J Ryan, 2003, [动物学报, Acta Zoologica Sinica], V49, P713; MUDRY KM, 1980, BRAIN RES, V182, P303, DOI 10.1016/0006-8993(80)91190-7; Pfennig KS, 1998, P ROY SOC B-BIOL SCI, V265, P1743, DOI 10.1098/rspb.1998.0497; RAND AS, 1992, AM ZOOL, V32, P81; Ryan M. J., 1985, TUNGARA FROG STUDY S; Ryan MJ, 2000, BRAIN BEHAV EVOLUT, V56, P45, DOI 10.1159/000006677; Ryan MJ, 1999, ANIM BEHAV, V57, P945, DOI 10.1006/anbe.1998.1057; Ryan MJ, 2003, AM NAT, V161, P380, DOI 10.1086/367588; RYAN MJ, 1980, SCIENCE, V209, P523, DOI 10.1126/science.209.4455.523; RYAN MJ, 1990, EVOLUTION, V44, P305, DOI 10.1111/j.1558-5646.1990.tb05200.x; Safi K, 2006, ETHOLOGY, V112, P1225, DOI 10.1111/j.1439-0310.2006.01282.x; Sockman KW, 2002, P ROY SOC B-BIOL SCI, V269, P2479, DOI 10.1098/rspb.2002.2180; Terpstra NJ, 2005, J COMP NEUROL, V488, P342, DOI 10.1002/cne.20592; Walkowiak W, 1999, EUR J MORPHOL, V37, P177, DOI 10.1076/ejom.37.2.177.4740; WILCZYNSKI W, 1995, ANIM BEHAV, V49, P911, DOI 10.1006/anbe.1995.0123; Wilczynski W, 2001, BRAIN BEHAV EVOLUT, V58, P137, DOI 10.1159/000047268; WILCZYNSKI W, 2007, HEARING SOUND COMMUN; Woolley SC, 2008, PLOS BIOL, V6, P525, DOI 10.1371/journal.pbio.0060062	38	20	22	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12898	10.1371/journal.pone.0012898	http://dx.doi.org/10.1371/journal.pone.0012898			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877560	Green Published, Green Submitted, gold			2022-12-27	WOS:000282053100030
J	He, XH; McMahon, S; Henderson, TD; Griffey, SM; Cheng, LW				He, Xiaohua; McMahon, Stephanie; Henderson, Thomas D., II; Griffey, Stephen M.; Cheng, Luisa W.			Ricin Toxicokinetics and Its Sensitive Detection in Mouse Sera or Feces Using Immuno-PCR	PLOS ONE			English	Article							TOXICITY; COMMUNIS; LECTINS; ABRIN; WARFARE; CHAIN; FOOD	Background: Ricin (also called RCA-II or RCA(60)), one of the most potent toxins and documented bioweapons, is derived from castor beans of Ricinus communis. Several in vitro methods have been designed for ricin detection in complex food matrices in the event of intentional contamination. Recently, a novel Immuno-PCR (IPCR) assay was developed with a limit of detection of 10 fg/ml in a buffer matrix and about 10-1000-fold greater sensitivity than other methods in various food matrices. Methods and Findings: In order to devise a better diagnostic test for ricin, the IPCR assay was adapted for the detection of ricin in biological samples collected from mice after intoxication. The limit of detection in both mouse sera and feces was as low as 1 pg/ml. Using the mouse intravenous (iv) model for ricin intoxication, a biphasic half-life of ricin, with a rapid t(1/2)alpha of 4 min and a slower t(1/2)beta of 86 min were observed. The molecular biodistribution time for ricin following oral ingestion was estimated using an antibody neutralization assay. Ricin was detected in the blood stream starting at approximately 6-7 h post- oral intoxication. Whole animal histopathological analysis was performed on mice treated orally or systemically with ricin. Severe lesions were observed in the pancreas, spleen and intestinal mesenteric lymph nodes, but no severe pathology in other major organs was observed. Conclusions: The determination of in vivo toxicokinetics and pathological effects of ricin following systemic and oral intoxication provide a better understanding of the etiology of intoxication and will help in the future design of more effective diagnostic and therapeutic methods.	[He, Xiaohua; McMahon, Stephanie; Henderson, Thomas D., II; Cheng, Luisa W.] ARS, Foodborne Contaminants Res Unit, Western Reg Res Ctr, USDA, Albany, CA USA; [Griffey, Stephen M.] Univ Calif Davis, Sch Vet Med, Comparat Pathol Lab, Davis, CA 95616 USA	United States Department of Agriculture (USDA); University of California System; University of California Davis	He, XH (corresponding author), ARS, Foodborne Contaminants Res Unit, Western Reg Res Ctr, USDA, Albany, CA USA.	luisa.cheng@ars.usda.gov	Pacific-Southwest, RCE/B-6155-2009		United States Department of Agriculture, Agricultural Research Service [NP108, CRIS 5325-42000-043-00D]; United States Public Health Service [U54 AI065359]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065359] Funding Source: NIH RePORTER	United States Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the United States Department of Agriculture, Agricultural Research Service, National Program project NP108, CRIS 5325-42000-043-00D, and United States Public Health Service Grant U54 AI065359 (to L. W. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audi J, 2005, JAMA-J AM MED ASSOC, V294, P2342, DOI 10.1001/jama.294.18.2342; BALINT GA, 1974, TOXICOLOGY, V2, P77, DOI 10.1016/0300-483X(74)90044-4; Brzezinski JL, 2007, J FOOD PROTECT, V70, P2377, DOI 10.4315/0362-028X-70.10.2377; Chen GQ, 2004, J AM OIL CHEM SOC, V81, P867, DOI 10.1007/s11746-004-0993-5; Cheng LW, 2009, INFECT IMMUN, V77, P4305, DOI 10.1128/IAI.00405-09; Darby SM, 2001, J FORENSIC SCI, V46, P1033; Doan LG, 2004, J TOXICOL-CLIN TOXIC, V42, P201, DOI 10.1081/CLT-120030945; ENDO Y, 1988, J BIOL CHEM, V263, P8735; FODSTAD O, 1976, BRIT J CANCER, V34, P418, DOI 10.1038/bjc.1976.187; Franz DR, 1997, MED ASPECTS CHEM BIO, P631; Garber EAE, 2008, J FOOD PROTECT, V71, P1875, DOI 10.4315/0362-028X-71.9.1875; GODAL A, 1984, CANCER CHEMOTH PHARM, V13, P157, DOI 10.1007/BF00269021; Greenfield RA, 2002, AM J MED SCI, V323, P326, DOI 10.1097/00000441-200206000-00005; He XH, 2008, J FOOD PROTECT, V71, P2053, DOI 10.4315/0362-028X-71.10.2053; He XH, 2007, J AGR FOOD CHEM, V55, P545, DOI 10.1021/jf062381r; He XH, 2010, J FOOD PROTECT, V73, P695, DOI 10.4315/0362-028X-73.4.695; Kalb SR, 2009, ANAL CHEM, V81, P2037, DOI 10.1021/ac802769s; LEEK MD, 1990, MED SCI LAW, V30, P141, DOI 10.1177/002580249003000212; Ler SG, 2006, J CHROMATOGR A, V1133, P1, DOI 10.1016/j.chroma.2006.08.078; LIN JY, 1986, TOXICON, V24, P757, DOI 10.1016/0041-0101(86)90100-5; LIN TTS, 1980, EUR J BIOCHEM, V105, P453; LORD JM, 1994, FASEB J, V8, P201, DOI 10.1096/fasebj.8.2.8119491; Mouser P, 2007, J VET DIAGN INVEST, V19, P216, DOI 10.1177/104063870701900217; Niemeyer CM, 2007, NAT PROTOC, V2, P1918, DOI 10.1038/nprot.2007.267; Olsnes S, 2004, TOXICON, V44, P361, DOI 10.1016/j.toxicon.2004.05.003; PAPPENHEIMER AM, 1974, J IMMUNOL, V113, P835; Pauly D, 2009, ANALYST, V134, P2028, DOI 10.1039/b911525k; RAMSDEN CS, 1989, TOXICOLOGY, V55, P161, DOI 10.1016/0300-483X(89)90183-2; Shyu HF, 2002, HYBRIDOMA HYBRIDOM, V21, P69, DOI 10.1089/15368590252917665; TEWFIK S, 1949, AM J BOT, V36, P567, DOI 10.2307/2437800; WEIL CS, 1952, BIOMETRICS, V8, P249, DOI 10.2307/3001557; Zhan JB, 2003, TOXICOLOGY, V186, P119, DOI 10.1016/S0300-483X(02)00726-6	33	42	45	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12858	10.1371/journal.pone.0012858	http://dx.doi.org/10.1371/journal.pone.0012858			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877567	Green Published, Green Submitted, gold			2022-12-27	WOS:000282053100018
J	Mahdy, MAK; Al-Mekhlafi, HM; Al-Mekhlafi, AM; Lim, YAL; Bin Shuaib, NOM; Azazy, AA; Mahmud, R				Mahdy, Mohammed A. K.; Al-Mekhlafi, Hesham M.; Al-Mekhlafi, Abdulsalam M.; Lim, Yvonne A. L.; Bin Shuaib, Naemah O. M.; Azazy, Ahmed A.; Mahmud, Rohela			Molecular Characterization of Leishmania Species Isolated from Cutaneous Leishmaniasis in Yemen	PLOS ONE			English	Article							OPERATION-DESERT-STORM; VISCERAL INFECTION; SAUDI-ARABIA; TROPICA; IDENTIFICATION; DISEASE; KENYA; DIAGNOSIS; INFANTUM; FOCUS	Background: Cutaneous leishmaniasis (CL) is a neglected tropical disease endemic in the tropics and subtropics with a global yearly incidence of 1.5 million. Although CL is the most common form of leishmaniasis, which is responsible for 60% of DALYs lost due to tropical-cluster diseases prevalent in Yemen, available information is very limited. Methodology/Principal Findings: This study was conducted to determine the molecular characterization of Leishmania species isolated from human cutaneous lesions in Yemen. Dermal scrapes were collected and examined for Leishmania amastigotes using the Giemsa staining technique. Amplification of the ribosomal internal transcribed spacer 1(ITS-1) gene was carried out using nested PCR and subsequent sequencing. The sequences from Leishmania isolates were subjected to phylogenetic analysis using the neighbor-joining and maximum parsimony methods. The trees identified Leishmania tropica from 16 isolates which were represented by two sequence types. Conclusions/Significance: The predominance of the anthroponotic species (i.e. L. tropica) indicates the probability of anthroponotic transmission of cutaneous leishmaniasis in Yemen. These findings will help public health authorities to build an effective control strategy taking into consideration person-to-person transmission as the main dynamic of transmission of CL.	[Mahdy, Mohammed A. K.; Al-Mekhlafi, Hesham M.; Al-Mekhlafi, Abdulsalam M.; Lim, Yvonne A. L.; Mahmud, Rohela] Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia; [Bin Shuaib, Naemah O. M.] Cent Hlth Lab, Sanaa, Yemen; [Mahdy, Mohammed A. K.; Al-Mekhlafi, Hesham M.; Azazy, Ahmed A.] Sanaa Univ, Fac Med, Dept Parasitol, Sanaa, Yemen	Universiti Malaya	Mahdy, MAK (corresponding author), Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia.	alsharaby9@yahoo.com	MAHMUD, ROHELA/B-9593-2010; Al-Mekhlafi, Hesham Mahyoub Sarhan/R-3568-2016; Mahdy, Mohammed A.K./C-1187-2010; LIM, YVONNE AL/B-5276-2010	Al-Mekhlafi, Hesham Mahyoub Sarhan/0000-0003-2582-7410; Mahdy, Mohammed A.K./0000-0002-8340-5219; LIM, YVONNE AL/0000-0003-4050-6332; kamal, amera/0000-0002-9154-9415				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvar J, 2006, TRENDS PARASITOL, V22, P552, DOI 10.1016/j.pt.2006.09.004; ALZAHRANI MA, 1988, T ROY SOC TROP MED H, V82, P416, DOI 10.1016/0035-9203(88)90142-3; Bern C, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000313; BOZZA M, 1995, T ROY SOC TROP MED H, V89, P333, DOI 10.1016/0035-9203(95)90569-3; BRAY RS, 1973, T ROY SOC TROP MED H, V67, P345, DOI 10.1016/0035-9203(73)90111-9; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; GARIFALLOU A, 1984, ANN TROP MED PARASIT, V78, P369, DOI 10.1080/00034983.1984.11811834; GRAMICCIA M, 1987, T ROY SOC TROP MED H, V81, P235, DOI 10.1016/0035-9203(87)90225-2; Hotez PJ, 2009, LANCET, V373, P1570, DOI 10.1016/S0140-6736(09)60233-6; Hotez PJ, 2004, CLIN INFECT DIS, V38, P871, DOI 10.1086/382077; Karunaweera ND, 2003, T ROY SOC TROP MED H, V97, P380, DOI 10.1016/S0035-9203(03)90061-7; Khatri Mishri Lal, 2009, J Am Acad Dermatol, V61, pe15, DOI 10.1016/j.jaad.2009.04.047; Khatri ML, 2006, INT J DERMATOL, V45, P40, DOI 10.1111/j.1365-4632.2004.02588.x; Khatri ML, 1999, INT J DERMATOL, V38, P587, DOI 10.1046/j.1365-4362.1999.00756.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KREUTZER RD, 1993, AM J TROP MED HYG, V49, P357, DOI 10.4269/ajtmh.1993.49.357; MAGILL AJ, 1993, NEW ENGL J MED, V328, P1383, DOI 10.1056/NEJM199305133281904; MAGILL AJ, 1994, CLIN INFECT DIS, V19, P805, DOI 10.1093/clinids/19.4.805; MEBRAHTU YB, 1992, AM J TROP MED HYG, V47, P852, DOI 10.4269/ajtmh.1992.47.852; MEBRAHTU YB, 1992, T ROY SOC TROP MED H, V86, P381, DOI 10.1016/0035-9203(92)90230-A; Nei M., 2000, MOL EVOLUTION PHYLOG; PRATLONG F, 1995, T ROY SOC TROP MED H, V89, P398, DOI 10.1016/0035-9203(95)90025-X; Ramirez JR, 2000, J CLIN MICROBIOL, V38, P3768; RIOUX JA, 1989, B SOC PATHOL EXOT, V82, P658; SABROSKY CW, 1953, J WASHINGTON ACAD SC, V43, P119; Saliba EK, 1997, ANN TROP MED PARASIT, V91, P453, DOI 10.1080/00034989760815; SANG DK, 1994, T ROY SOC TROP MED H, V88, P35, DOI 10.1016/0035-9203(94)90486-3; Schonian G, 2003, DIAGN MICR INFEC DIS, V47, P349, DOI 10.1016/S0732-8893(03)00093-2; *UNDP, 2007, YEM POV ASS REP UN D; *WHO, 1984, WHO TECH REP SER, V701; World Health Organization, 2008, GLOB BURD DIS 2004 U; Wright JH, 1904, J MED RES, V10, P472; YAKIMOV W. L., 1914, Bulletin de la Societe de Pathologie Exotique, V7, P186	34	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2010	5	9							e12879	10.1371/journal.pone.0012879	http://dx.doi.org/10.1371/journal.pone.0012879			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651YH	20862227	Green Published, gold			2022-12-27	WOS:000281963200022
J	Schillaci, MA; Waitzkin, H; Carson, EA; Romain, SJ				Schillaci, Michael A.; Waitzkin, Howard; Carson, E. Ann; Romain, Sandra J.			Prenatal Care Utilization for Mothers from Low-Income Areas of New Mexico, 1989-1999	PLOS ONE			English	Article							MEDICAID MANAGED CARE; LOW-BIRTH-WEIGHT; HEALTH; PRETERM; MORBIDITY; INSURANCE; ADEQUACY; WOMEN; COST	Background: Prenatal care is considered to be an important component of primary health care. Our study compared prenatal care utilization and rates of adverse birth outcomes for mothers from low-and higher-income areas of New Mexico between 1989 and 1999. Methodology/Principal Findings: Prenatal care indicators included the number of prenatal care visits and the first month of prenatal care. Birth outcome indicators included low birth weight, premature birth, and births linked with death certificates. The results of our study indicated that mothers from low-income areas started their prenatal care significantly later in their pregnancies between 1989 and 1999, and had significantly fewer prenatal visits between 1989 and 1997. For the most part, there were not significant differences in birth outcome indicators between income groupings. Conclusions/Significance: These findings suggest that while mothers from low-income areas received lower levels of prenatal care, they did not experience a higher level of adverse birth outcomes.	[Schillaci, Michael A.] Univ Toronto, Dept Social Sci, Scarborough, ON M1C 1A4, Canada; [Waitzkin, Howard] Univ New Mexico, Dept Sociol, Albuquerque, NM 87131 USA; [Waitzkin, Howard] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA; [Waitzkin, Howard] Univ New Mexico, Dept Family & Community Med, Albuquerque, NM 87131 USA; [Carson, E. Ann] Intellica Corp, San Antonio, TX USA; [Romain, Sandra J.] Univ Toronto, Dept Anthropol, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Scarborough; University of New Mexico; University of New Mexico; University of New Mexico; University of Toronto	Schillaci, MA (corresponding author), Univ Toronto, Dept Social Sci, Scarborough, ON M1C 1A4, Canada.	schillaci@utsc.utoronto.ca			Agency for Healthcare Research and Quality [R01 HS09703]; New Mexico Department of Health [98.665.42.194]; Hospital of the University of New Mexico; University of New Mexico School of Medicine; University of Toronto; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS009703] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); New Mexico Department of Health; Hospital of the University of New Mexico; University of New Mexico School of Medicine; University of Toronto(University of Toronto); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Partial funding for this research was provided by the Agency for Healthcare Research and Quality (R01 HS09703), the New Mexico Department of Health (98.665.42.194), the Hospital of the University of New Mexico, the Dedicated Health Research Funds of the University of New Mexico School of Medicine, and the University of Toronto. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandrini EA, 2001, PEDIATRICS, V107, P1335, DOI 10.1542/peds.107.6.1335; ALEXANDER GR, 1995, FUTURE CHILD, V5, P103, DOI 10.2307/1602510; Alexander GR, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.1.e61; Alexander GR, 2001, PUBLIC HEALTH REP, V116, P306; Braveman P, 2000, OBSTET GYNECOL, V95, P874, DOI 10.1016/S0029-7844(00)00780-8; Conway KS, 2006, HEALTH ECON, V15, P461, DOI 10.1002/hec.1097; Dubay L, 2007, HEALTH AFFAIR, V26, pW22, DOI 10.1377/hlthaff.26.1.w22; Fanaroff Avroy A, 2007, Am J Obstet Gynecol, V196, DOI 10.1016/j.ajog.2006.09.014; Goffinet F, 2005, BJOG-INT J OBSTET GY, V112, P38, DOI 10.1111/j.1471-0528.2005.00583.x; Herbst MA, 2003, AM J OBSTET GYNECOL, V189, P930, DOI 10.1067/S0002-9378(03)01055-X; Hueston WJ, 2003, J COMMUN HEALTH, V28, P199, DOI 10.1023/A:1022908307844; Kogan MD, 1998, PEDIATRICS, V102, P25, DOI 10.1542/peds.102.1.25; KOTELCHUCK M, 1994, AM J PUBLIC HEALTH, V84, P1414, DOI 10.2105/AJPH.84.9.1414; Markestad T, 2005, PEDIATRICS, V115, P1289, DOI 10.1542/peds.2004-1482; Moos MK, 2006, JOGNN-J OBST GYN NEO, V35, P278, DOI 10.1111/J.1552-6909.2006.00039.x; Nothnagle M, 2000, Matern Child Health J, V4, P251; Petrou S, 2005, BJOG-INT J OBSTET GY, V112, P10, DOI 10.1111/j.1471-0528.2005.00577.x; PIANTADOSI S, 1988, AM J EPIDEMIOL, V127, P893, DOI 10.1093/oxfordjournals.aje.a114892; Robinson WS, 1950, AM SOCIOL REV, V15, P351, DOI 10.2307/2087176; Russell RB, 2007, PEDIATRICS, V120, pE1, DOI 10.1542/peds.2006-2386; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; Schillaci MA, 2004, ANN FAM MED, V2, P13, DOI 10.1370/afm.100; Schillaci MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003953; Schmitt SK, 2006, PEDIATRICS, V117, P154, DOI 10.1542/peds.2005-0484; Shi L, 2004, J EPIDEMIOL COMMUN H, V58, P374, DOI 10.1136/jech.2003.013078; Stringer M, 2005, JOGNN-J OBST GYN NEO, V34, P551, DOI 10.1177/0884217505280276; Waitzkin H, 2002, AM J PUBLIC HEALTH, V92, P598, DOI 10.2105/AJPH.92.4.598; Waitzkin H, 2008, HEALTH SERV RES, V43, P1325, DOI 10.1111/j.1475-6773.2008.00842.x; *WHO, 2008, INT STAT DIS REL HLT; Willging CE, 2005, MED ANTHROPOL Q, V19, P84, DOI 10.1525/maq.2005.19.1.084	30	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2010	5	9							e12809	10.1371/journal.pone.0012809	http://dx.doi.org/10.1371/journal.pone.0012809			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	651XL	20862298	Green Submitted, gold, Green Published			2022-12-27	WOS:000281960800015
J	Khoshnevis, S; Neumann, P; Ficner, R				Khoshnevis, Sohail; Neumann, Piotr; Ficner, Ralf			Crystal Structure of the RNA Recognition Motif of Yeast Translation Initiation Factor eIF3bw Reveals Differences to Human eIF3b	PLOS ONE			English	Article							BINDING; DOMAIN; INSIGHTS; PRT1	Background: The multi-subunit eukaryotic initiation factor3 (eIF3) plays a central role in the initiation step of protein synthesis in eukaryotes. One of its large subunits, eIF3b, serves as a scaffold within eIF3 as it interacts with several other subunits. It harbors an RNA Recognition Motif (RRM), which is shown to be a non-canonical RRM in human as it is not capable to interact with oligonucleotides, but rather interacts with eIF3j, a sub-stoichiometric subunit of eIF3. Principal Finding: We have analyzed the high-resolution crystal structure of the eIF3b RRM domain from yeast. It exhibits the same fold as its human ortholog, with similar charge distribution on the surface interacting with the eIF3j in human. Thermodynamic analysis of the interaction between yeast eIF3b-RRM and eIF3j revealed the same range of enthalpy change and dissociation constant as for the human proteins, providing another line of evidence for the same mode of interaction between eIF3b and eIF3j in both organisms. However, analysis of the surface charge distribution of the putative RNA-binding beta-sheet suggested that in contrast to its human ortholog, it potentially could bind oligonucleotides. Three-dimensional positioning of the so called "RNP1" motif in this domain is similar to other canonical RRMs, suggesting that this domain might indeed be a canonical RRM, conferring oligonucleotide binding capability to eIF3 in yeast. Interaction studies with yeast total RNA extract confirmed the proposed RNA binding activity of yeast eIF3b-RRM. Conclusion: We showed that yeast eIF3b-RRM interacts with eIF3j in a manner similar to its human ortholog. However, it shows similarities in the oligonucleotide binding surface to canonical RRMs and interacts with yeast total RNA. The proposed RNA binding activity of eIF3b-RRM may help eIF3 to either bind to the ribosome or recruit the mRNA to the 43S pre-initiation complex.	[Khoshnevis, Sohail; Neumann, Piotr; Ficner, Ralf] Univ Gottingen, Dept Mol Struct Biol, Inst Microbiol & Genet, Gottingen, Germany	University of Gottingen	Khoshnevis, S (corresponding author), Univ Gottingen, Dept Mol Struct Biol, Inst Microbiol & Genet, Gottingen, Germany.	rficner@gwdg.de			State of Lower Saxony	State of Lower Saxony(European Commission)	S. K. was supported by a Georg-Christoph-Lichtenberg stipend granted by the State of Lower Saxony. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker MG, 2007, METHOD ENZYMOL, V430, P111, DOI 10.1016/S0076-6879(07)30006-2; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Clery A, 2008, CURR OPIN STRUC BIOL, V18, P290, DOI 10.1016/j.sbi.2008.04.002; Crowder SM, 1999, P NATL ACAD SCI USA, V96, P4892, DOI 10.1073/pnas.96.9.4892; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Ding JZ, 1999, GENE DEV, V13, P1102, DOI 10.1101/gad.13.9.1102; ElAntak L, 2007, J BIOL CHEM, V282, P8165, DOI 10.1074/jbc.M610860200; ElAntak L, 2010, J MOL BIOL, V396, P1097, DOI 10.1016/j.jmb.2009.12.047; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Handa N, 1999, NATURE, V398, P579, DOI 10.1038/19242; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Khoshnevis S, 2010, EMBO REP, V11, P214, DOI 10.1038/embor.2009.272; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuo PH, 2009, NUCLEIC ACIDS RES, V37, P1799, DOI 10.1093/nar/gkp013; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Martin-Tumasz S, 2010, RNA, V16, P792, DOI 10.1261/rna.1913310; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nielsen KH, 2006, MOL CELL BIOL, V26, P2984, DOI 10.1128/MCB.26.8.2984-2998.2006; Oberstrass FC, 2005, SCIENCE, V309, P2054, DOI 10.1126/science.1114066; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Tsuda K, 2009, NUCLEIC ACIDS RES, V37, P5151, DOI 10.1093/nar/gkp546; Valasek L, 2001, J BIOL CHEM, V276, P43351, DOI 10.1074/jbc.M106887200; Valasek L, 2001, EMBO J, V20, P891, DOI 10.1093/emboj/20.4.891	26	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2010	5	9							e12784	10.1371/journal.pone.0012784	http://dx.doi.org/10.1371/journal.pone.0012784			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650QH	20862284	Green Published, gold, Green Submitted			2022-12-27	WOS:000281864100019
J	Uhler, LM; Kumarasamy, N; Mayer, KH; Saxena, A; Losina, E; Muniyandi, M; Stoler, AW; Lu, ZG; Walensky, RP; Flanigan, TP; Bender, MA; Freedberg, KA; Swaminathan, S				Uhler, Lauren M.; Kumarasamy, Nagalingeswaran; Mayer, Kenneth H.; Saxena, Anjali; Losina, Elena; Muniyandi, Malaisamy; Stoler, Adam W.; Lu, Zhigang; Walensky, Rochelle P.; Flanigan, Timothy P.; Bender, Melissa A.; Freedberg, Kenneth A.; Swaminathan, Soumya		CEPAC Int Investigators	Cost-Effectiveness of HIV Testing Referral Strategies among Tuberculosis Patients in India	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; SEXUAL-BEHAVIOR; COTRIMOXAZOLE PROPHYLAXIS; HIV-1-INFECTED ADULTS; COTE-DIVOIRE; VIRAL LOAD; IMPACT; RISK; PREVENTION; SEROPREVALENCE	Background: Indian guidelines recommend routine referral for HIV testing of all tuberculosis (TB) patients in the nine states with the highest HIV prevalence, and selective referral for testing elsewhere. We assessed the clinical impact and cost-effectiveness of alternative HIV testing referral strategies among TB patients in India. Methods and Findings: We utilized a computer model of HIV and TB disease to project outcomes for patients with active TB in India. We compared life expectancy, cost, and cost-effectiveness for three HIV testing referral strategies: 1) selective referral for HIV testing of those with increased HIV risk, 2) routine referral of patients in the nine highest HIV prevalence states with selective referral elsewhere (current standard), and 3) routine referral of all patients for HIV testing. TB-related data were from the World Health Organization. HIV prevalence among TB patients was 9.0% in the highest prevalence states, 2.9% in the other states, and 4.9% overall. The selective referral strategy, beginning from age 33.50 years, had a projected discounted life expectancy of 16.88 years and a mean lifetime HIV/TB treatment cost of US$ 100.The current standard increased mean life expectancy to 16.90 years with additional per-person cost of US$ 10; the incremental cost-effectiveness ratio was US$650/year of life saved (YLS) compared to selective referral. Routine referral of all patients for HIV testing increased life expectancy to 16.91 years, with an incremental cost-effectiveness ratio of US$730/YLS compared to the current standard. For HIV-infected patients cured of TB, receiving antiretroviral therapy increased survival from 4.71 to 13.87 years. Results were most sensitive to the HIV prevalence and the cost of second-line antiretroviral therapy. Conclusions: Referral of all patients with active TB in India for HIV testing will be both effective and cost-effective. While effective implementation of this strategy would require investment, routine, voluntary HIV testing of TB patients in India should be recommended.	[Uhler, Lauren M.; Saxena, Anjali; Stoler, Adam W.; Lu, Zhigang; Walensky, Rochelle P.; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA; [Walensky, Rochelle P.; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Losina, Elena; Walensky, Rochelle P.; Freedberg, Kenneth A.] Harvard Univ, Sch Med, Ctr AIDS Res CFAR, Boston, MA USA; [Losina, Elena] Brigham & Womens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA; [Walensky, Rochelle P.] Brigham & Womens Hosp, Dept Med, Div Infect Dis, Boston, MA 02115 USA; [Kumarasamy, Nagalingeswaran] YR Gaitonde Ctr AIDS Res & Educ, Chennai, Tamil Nadu, India; [Mayer, Kenneth H.; Flanigan, Timothy P.] Brown Univ, Miriam Hosp, Providence, RI USA; [Muniyandi, Malaisamy; Swaminathan, Soumya] Indian Council Med Res, TB Res Ctr, Chennai, Tamil Nadu, India; [Bender, Melissa A.] NYU, Sch Med, Div Infect Dis, New York, NY USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Brown University; Lifespan Health Rhode Island; Miriam Hospital; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); New York University	Uhler, LM (corresponding author), Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA.	luhler@partners.org; kfreedberg@partners.org	Kumarasasmy, Nagalingeswaran/AAB-7348-2021; Muniyandi, Malaisamy/AAF-2076-2021	Lipsitch, Marc/0000-0003-1504-9213; Walensky, Rochelle P./0000-0002-8795-379X; Losina, ELENA/0000-0002-3424-0892	U.S. National Institute of Allergy and Infectious Disease [R01 AI058736, K24 AI062476]; Doris Duke Charitable Foundation [2007015]; Indian Council of Medical Research and Central TB Division, Ministry of Health, Government of India; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058736, K24AI062476] Funding Source: NIH RePORTER	U.S. National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Indian Council of Medical Research and Central TB Division, Ministry of Health, Government of India; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the U.S. National Institute of Allergy and Infectious Disease (R01 AI058736 and K24 AI062476), the Doris Duke Charitable Foundation (Operations Research on AIDS Care and Treatment in Africa (ORACTA) Award 2007015), and the Indian Council of Medical Research and Central TB Division, Ministry of Health, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen S, 2003, AIDS, V17, P733, DOI 10.1097/00002030-200303280-00012; Anglaret X, 1999, LANCET, V353, P1463, DOI 10.1016/S0140-6736(98)07399-1; [Anonymous], 2009, INT DRUG PRIC IND GU; BASSETT IV, AIDS S1, V24, pS37; Bender MA, 2010, CLIN INFECT DIS, V50, P416, DOI 10.1086/649884; Bunnell R, 2006, AIDS, V20, P85, DOI 10.1097/01.aids.0000196566.40702.28; Coates TJ, 2000, LANCET, V356, P103, DOI 10.1016/S0140-6736(00)02446-6; Denison JA, 2008, AIDS BEHAV, V12, P363, DOI 10.1007/s10461-007-9349-x; Dewan PK, 2010, INT J TUBERC LUNG D, V14, P247; FREEDBERG KA, 2007, AIDS 21 S4, V4, pS117; Gold R, 1996, COST EFFECTIVENESS H; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; Homan R, 2000, EC ANALYSES YRG CARE; IMF-International Monetary Fund, 2009, WORLD EC OUTL DAT; Khan FA, 2010, CLIN INFECT DIS, V50, P1288, DOI 10.1086/651686; Krishnan AKS, 2007, AIDS EDUC PREV, V19, P334, DOI 10.1521/aeap.2007.19.4.334; Lawn SD, 2009, CLIN CHEST MED, V30, P685, DOI 10.1016/j.ccm.2009.08.010; Lawn SD, 2009, AIDS, V23, P1717, DOI 10.1097/QAD.0b013e32832d3b6d; Liechty Cheryl A, 2005, Curr Infect Dis Rep, V7, P154, DOI 10.1007/s11908-005-0076-z; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; MUNIYANDI M, 2006, INDIAN J TUBERC, P12; NACO, 2010, CAR SUPP TREATM NAT; *NACO, 2007, ANTIRETROVIRAL THERA; National AIDS Control Organization (NACO), 2010, NAT AIDS CONTR PROGR; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Raizada N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005999; Raizada N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002970; Rajeswari R, 1999, INT J TUBERC LUNG D, V3, P869; Reid A, 2006, LANCET INFECT DIS, V6, P483, DOI 10.1016/S1473-3099(06)70549-7; Revised National Tuberculosis Control Programme (RNTCP), 2010, TB IND 2010 RNTCP ST; Sadacharam K, 2007, Indian J Tuberc, V54, P199; Sharma Aman, 2007, Indian J Pathol Microbiol, V50, P905; Sogarwal R., 2009, J INDIAN MED ASSOC, V107, P307; Sogarwal R, 2009, J INDIAN MED ASSOC, V107, P228; Steinbrook R, 2007, NEW ENGL J MED, V356, P1197, DOI 10.1056/NEJMp078011; Swaminathan S, 2008, NATL MED J INDIA, V21, P3; Tuboi SH, 2007, JAIDS-J ACQ IMM DEF, V45, P52, DOI 10.1097/QAI.0b013e318042e1c3; *UNAIDS WHO, 2007, 2007 AIDS EP UP; Vijay S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007899; Walensky RP, 2008, J INFECT DIS, V197, P1324, DOI 10.1086/587184; Walensky RP, 2009, ANN INTERN MED, V151, P157, DOI 10.7326/0003-4819-151-3-200908040-00138; Wang B, 2006, 16 INT AIDS C TOR CA; WHO, 2010, ANT THER HIV INF AD; *WHO, 2009, WHO REP 2009 GLOB TU; WHO, 2008, EPI SEM 2008; *WHO, 2007, UGID PROV IN HIV TES; Williams BG, 2005, P NATL ACAD SCI USA, V102, P9619, DOI 10.1073/pnas.0501615102; World Health Organization, 2008, GLOB TUB CONTR SURV; World Health Organization, 2006, ANTIRETROVIRAL THERA; World Health Organization, 2001, MACR HLTH INV HLTH E; Yazdanpanah Y, 2005, AIDS, V19, P1299, DOI 10.1097/01.aids.0000180101.80888.c6; Zhou J, 2005, JAIDS-J ACQ IMM DEF, V38, P174, DOI 10.1097/01.qai.0000145351.96815.d5	53	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2010	5	9							e12747	10.1371/journal.pone.0012747	http://dx.doi.org/10.1371/journal.pone.0012747			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650QH	20862279	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000281864100009
J	Prasad, BD; Goel, S; Krishna, P				Prasad, Bishun D.; Goel, Shilpi; Krishna, Priti			In Silico Identification of Carboxylate Clamp Type Tetratricopeptide Repeat Proteins in Arabidopsis and Rice As Putative Co-Chaperones of Hsp90/Hsp70	PLOS ONE			English	Article							HSP90 MOLECULAR CHAPERONE; DOMAIN; RECEPTOR; IMMUNOPHILINS; ACCUMULATION; COCHAPERONE; INTERACTS; MECHANISM; RESPONSES; COMPLEX	The essential eukaryotic molecular chaperone Hsp90 operates with the help of different co-chaperones, which regulate its ATPase activity and serve as adaptors to recruit client proteins and other molecular chaperones, such as Hsp70, to the Hsp90 complex. Several Hsp90 and Hsp70 co-chaperones contain the tetratricopeptide repeat (TPR) domain, which interacts with the highly conserved EEVD motif at the C-terminal ends of Hsp90 and Hsp70. The acidic side chains in EEVD interact with a subset of basic residues in the TPR binding pocket called a 'carboxylate clamp'. Since the carboxylate clamp residues are conserved in the TPR domains of known Hsp90/Hsp70 co-chaperones, we carried out an in silico search for TPR proteins in Arabidopsis and rice comprising of at least one three-motif TPR domain with conserved amino acid residues required for Hsp90/Hsp70 binding. This approach identified in Arabidopsis a total of 36 carboxylate clamp (CC)-TPR proteins, including 24 novel proteins, with potential to interact with Hsp90/Hsp70. The newly identified CC-TPR proteins in Arabidopsis and rice contain additional protein domains such as ankyrin, SET, octicosapeptide/Phox/Bem1p (Phox/PB1), DnaJ-like, thioredoxin, FBD and F-box, and protein kinase and U-box, indicating varied functions for these proteins. To provide proof-of-concept of the newly identified CC-TPR proteins for interaction with Hsp90, we demonstrated interaction of AtTPR1 and AtTPR2 with AtHsp90 in yeast two-hybrid and in vitro pull down assays. These findings indicate that the in silico approach used here successfully identified in a genome-wide context CC-TPR proteins with potential to interact with Hsp90/Hsp70, and further suggest that the Hsp90/Hsp70 system relies on TPR co-chaperones more than it was previously realized.	[Prasad, Bishun D.; Goel, Shilpi; Krishna, Priti] Univ Western Ontario, Dept Biol, London, ON, Canada	Western University (University of Western Ontario)	Prasad, BD (corresponding author), Univ Western Ontario, Dept Biol, London, ON, Canada.	pkrishna@uwo.ca	Prasad, Bishun Deo/AAP-2957-2021	Krishna, Priti/0000-0001-6394-3012; Prasad, Bishun Deo/0000-0002-8037-8534	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was supported by a grant to P.K. from the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Farha M, 2008, MOL CELL PROTEOMICS, V7, P560, DOI 10.1074/mcp.M700271-MCP200; Aviezer-Hagai K, 2007, PLANT MOL BIOL, V63, P237, DOI 10.1007/s11103-006-9085-z; Bhangoo MK, 2007, MOL BIOL CELL, V18, P3414, DOI 10.1091/mbc.E07-01-0088; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Bouchard R, 2006, J BIOL CHEM, V281, P30603, DOI 10.1074/jbc.M604604200; Brychzy A, 2003, EMBO J, V22, P3613, DOI 10.1093/emboj/cdg362; Caplan AJ, 2003, CELL STRESS CHAPERON, V8, P105, DOI 10.1379/1466-1268(2003)008<0105:WIAC>2.0.CO;2; Carrello A, 1999, J BIOL CHEM, V274, P2682, DOI 10.1074/jbc.274.5.2682; Cheung-Flynn J, 2003, J BIOL CHEM, V278, P17388, DOI 10.1074/jbc.M300955200; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; CYR DM, 1994, TRENDS BIOCHEM SCI, V19, P176, DOI 10.1016/0968-0004(94)90281-X; Hainzl O, 2004, J BIOL CHEM, V279, P23267, DOI 10.1074/jbc.M402189200; Heazlewood JL, 2007, NUCLEIC ACIDS RES, V35, pD213, DOI 10.1093/nar/gkl863; Hubert DA, 2003, EMBO J, V22, P5679, DOI 10.1093/emboj/cdg547; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Ito T, 2001, EMBO J, V20, P3938, DOI 10.1093/emboj/20.15.3938; Kamphausen T, 2002, PLANT J, V32, P263, DOI 10.1046/j.1365-313X.2002.01420.x; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Krishna P, 1997, PLANT MOL BIOL, V33, P457, DOI 10.1023/A:1005709308096; Krishna P, 2003, J PLANT GROWTH REGUL, V22, P289, DOI 10.1007/s00344-003-0058-z; KRISHNA P, 1995, PLANT PHYSIOL, V107, P915, DOI 10.1104/pp.107.3.915; Krishna P, 2001, CELL STRESS CHAPERON, V6, P238, DOI 10.1379/1466-1268(2001)006<0238:THFOPI>2.0.CO;2; Lassle M, 1997, J BIOL CHEM, V272, P1876, DOI 10.1074/jbc.272.3.1876; Lin ZF, 2008, J EXP BOT, V59, P4271, DOI 10.1093/jxb/ern276; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Min JR, 2002, NAT STRUCT BIOL, V9, P828, DOI 10.1038/nsb860; Moffatt NSC, 2008, BIOCHEMISTRY-US, V47, P8203, DOI 10.1021/bi800770g; Montrichard F, 2009, J PROTEOMICS, V72, P452, DOI 10.1016/j.jprot.2008.12.002; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Mulder NJ, 2005, NUCLEIC ACIDS RES, V33, pD201, DOI 10.1093/nar/gki106; Murata S, 2003, INT J BIOCHEM CELL B, V35, P572, DOI 10.1016/S1357-2725(02)00394-1; Okamoto T, 2006, EMBO J, V25, P5015, DOI 10.1038/sj.emboj.7601367; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Qbadou S, 2006, EMBO J, V25, P1836, DOI 10.1038/sj.emboj.7601091; Reddy RK, 1998, PLANT PHYSIOL, V118, P1395, DOI 10.1104/pp.118.4.1395; Rosado A, 2006, PLANT PHYSIOL, V142, P1113, DOI 10.1104/pp.106.085191; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Shen GX, 2007, PLANT J, V49, P228, DOI 10.1111/j.1365-313X.2006.02963.x; Shirasu K, 2009, ANNU REV PLANT BIOL, V60, P139, DOI 10.1146/annurev.arplant.59.032607.092906; Smith DF, 2004, CELL STRESS CHAPERON, V9, P109, DOI 10.1379/CSC-31.1; Smith MR, 2009, P NATL ACAD SCI USA, V106, P5424, DOI 10.1073/pnas.0812729106; Smyczynski C, 2006, J BIOL CHEM, V281, P25475, DOI 10.1074/jbc.M601815200; Stancato LF, 1996, BIOCHEMISTRY-US, V35, P554, DOI 10.1021/bi9511649; Toufighi K, 2005, PLANT J, V43, P153, DOI 10.1111/j.1365-313X.2005.02437.x; van Bentem SDF, 2005, PLANT J, V43, P284, DOI 10.1111/j.1365-313X.2005.02450.x; Verslues PE, 2005, BIOCHEM SOC T, V33, P375, DOI 10.1042/BST0330375; Vert G, 2005, ANNU REV CELL DEV BI, V21, P177, DOI 10.1146/annurev.cellbio.21.090704.151241; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Zhang ZM, 2010, CELL STRESS CHAPERON, V15, P703, DOI 10.1007/s12192-010-0182-1; Zhang ZM, 2003, PLANT PHYSIOL, V131, P525, DOI 10.1104/pp.011940	55	68	79	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12761	10.1371/journal.pone.0012761	http://dx.doi.org/10.1371/journal.pone.0012761			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856808	Green Published, Green Submitted, gold			2022-12-27	WOS:000281815800023
J	Harris, IM; Little, MJJ				Harris, Irina M.; Little, Michael J. J.			Priming the Semantic Neighbourhood during the Attentional Blink	PLOS ONE			English	Article							SERIAL VISUAL PRESENTATION; DISTRACTOR INHIBITION; SUPPRESSION; TARGETS; FAILURE; MEMORY; NORMS	Background: When two targets are presented in close temporal proximity amongst a rapid serial visual stream of distractors, a period of disrupted attention and attenuated awareness lasting 200-500 ms follows identification of the first target (T1). This phenomenon is known as the "attentional blink'' (AB) and is generally attributed to a failure to consolidate information in visual short-term memory due to depleted or disrupted attentional resources. Previous research has shown that items presented during the AB that fail to reach conscious awareness are still processed to relatively high levels, including the level of meaning. For example, missed word stimuli have been shown to prime later targets that are closely associated words. Although these findings have been interpreted as evidence for semantic processing during the AB, closely associated words (e. g., day-night) may also rely on specific, well-worn, lexical associative links which enhance attention to the relevant target. Methodology/Principal Findings: We used a measure of semantic distance to create prime-target pairs that are conceptually close, but have low word associations (e. g., wagon and van) and investigated priming from a distractor stimulus presented during the AB to a subsequent target (T2). The stimuli were words (concrete nouns) in Experiment 1 and the corresponding pictures of objects in Experiment 2. In both experiments, report of T2 was facilitated when this item was preceded by a semantically-related distractor. Conclusions/Significance: This study is the first to show conclusively that conceptual information is extracted from distractor stimuli presented during a period of attenuated awareness and that this information spreads to neighbouring concepts within a semantic network.	[Harris, Irina M.; Little, Michael J. J.] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia	University of Sydney	Harris, IM (corresponding author), Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia.	irina.harris@sydney.edu.au		Harris, Irina/0000-0001-9777-2290	Australian Research Council [DP0557590]; Queen Elizabeth II Fellowship	Australian Research Council(Australian Research Council); Queen Elizabeth II Fellowship	This work was supported by Australian Research Council grant DP0557590 and a Queen Elizabeth II Fellowship awarded to IM Harris. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basnight-Brown DM, 2007, MEM COGNITION, V35, P953, DOI 10.3758/BF03193468; BROADBENT DE, 1987, PERCEPT PSYCHOPHYS, V42, P105, DOI 10.3758/BF03210498; Chua FK, 2001, J EXP PSYCHOL HUMAN, V27, P1229, DOI 10.1037//0096-1523.27.5.1229; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; Dux PE, 2007, PSYCHON B REV, V14, P723, DOI 10.3758/BF03196828; Dux PE, 2009, ATTEN PERCEPT PSYCHO, V71, P1683, DOI 10.3758/APP.71.8.1683; Dux PE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003330; Dux PE, 2006, COGNITION, V99, P355, DOI 10.1016/j.cognition.2005.04.002; Evans KK, 2005, J EXP PSYCHOL HUMAN, V31, P1476, DOI 10.1037/0096-1523.31.6.1476; Forster KI, 2003, BEHAV RES METH INS C, V35, P116, DOI 10.3758/BF03195503; HARRIS IM, J EXPT PSYC IN PRESS; Jiang J.J., 1997, P INT C RES COMP LIN; Jolicoeur P, 1998, COGNITIVE PSYCHOL, V36, P138, DOI 10.1006/cogp.1998.0684; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Luck SJ, 1996, NATURE, V383, P616, DOI 10.1038/383616a0; Maki WS, 2004, BEHAV RES METH INS C, V36, P421, DOI 10.3758/BF03195590; MAKI WS, 1994, PSYCHON B REV, V1, P499, DOI 10.3758/BF03210954; Maki WS, 1997, J EXP PSYCHOL HUMAN, V23, P1014, DOI 10.1037/0096-1523.23.4.1014; Martens S, 2002, J EXP PSYCHOL HUMAN, V28, P1275, DOI 10.1037//0096-1523.28.6.1275; Nelson DL, 2004, BEHAV RES METH INS C, V36, P402, DOI 10.3758/BF03195588; Nieuwenstein MR, 2005, J EXP PSYCHOL HUMAN, V31, P1463, DOI 10.1037/0096-1523.31.6.1463; Olivers CNL, 2008, PSYCHOL REV, V115, P836, DOI 10.1037/a0013395; Olivers CNL, 2006, J EXP PSYCHOL HUMAN, V32, P1083, DOI 10.1037/0096-1523.32.5.1083; Pesciarelli F, 2007, BIOL PSYCHOL, V76, P21, DOI 10.1016/j.biopsycho.2007.05.003; Potter MC, 2005, PSYCHON B REV, V12, P460, DOI 10.3758/BF03193788; QUILLIAN MR, 1968, SEMANTIC INFORMATION, P227; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Rogers T. T., 2004, SEMANTIC COGNITION P; Rogers TT, 2004, PSYCHOL REV, V111, P205, DOI 10.1037/0033-295X.111.1.205; Rolke B, 2001, PSYCHOPHYSIOLOGY, V38, P165, DOI 10.1017/S0048577201991504; Shapiro K, 1997, PSYCHOL SCI, V8, P95, DOI 10.1111/j.1467-9280.1997.tb00689.x; SHAPIRO KL, 1994, J EXP PSYCHOL HUMAN, V20, P357, DOI 10.1037/0096-1523.20.2.357; Wyble B, 2009, J EXP PSYCHOL HUMAN, V35, P324, DOI 10.1037/a0013903	33	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2010	5	9							e12645	10.1371/journal.pone.0012645	http://dx.doi.org/10.1371/journal.pone.0012645			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	649ZO	20856854	Green Published, Green Submitted, gold			2022-12-27	WOS:000281815700005
J	Campanella, GSV; Colvin, RA; Luster, AD				Campanella, Gabriele S. V.; Colvin, Richard A.; Luster, Andrew D.			CXCL10 Can Inhibit Endothelial Cell Proliferation Independently of CXCR3	PLOS ONE			English	Article							INTERFERON-INDUCIBLE PROTEIN-10; PLATELET FACTOR-IV; X-C-CHEMOKINE; GROWTH-FACTOR; MICE LACKING; RECEPTOR; IP-10; EXPRESSION; HEPARIN; BINDING	CXCL10 (or Interferon-inducible protein of 10 kDa, IP-10) is an interferon-inducible chemokine with potent chemotactic activity on activated effector T cells and other leukocytes expressing its high affinity G protein-coupled receptor CXCR3. CXCL10 is also active on other cell types, including endothelial cells and fibroblasts. The mechanisms through which CXCL10 mediates its effects on non-leukocytes is not fully understood. In this study, we focus on the anti-proliferative effect of CXCL10 on endothelial cells, and demonstrate that CXCL10 can inhibit endothelial cell proliferation in vitro independently of CXCR3. Four main findings support this conclusion. First, primary mouse endothelial cells isolated from CXCR3-deficient mice were inhibited by CXCL10 as efficiently as wildtype endothelial cells. We also note that the proposed alternative splice form CXCR3-B, which is thought to mediate CXCL10's angiostatic activity, does not exist in mice based on published mouse CXCR3 genomic sequences as an in-frame stop codon would terminate the proposed CXCR3-B splice variant in mice. Second, we demonstrate that human umbilical vein endothelial cells and human lung microvascular endothelial cells that were inhibited by CXL10 did not express CXCR3 by FACS analysis. Third, two different neutralizing CXCR3 antibodies did not inhibit the anti-proliferative effect of CXCL10. Finally, fourth, utilizing a panel of CXCL10 mutants, we show that the ability to inhibit endothelial cell proliferation correlates with CXCL10's glycosaminoglycan binding affinity and not with its CXCR3 binding and signaling. Thus, using a very defined system, we show that CXCL10 can inhibit endothelial cell proliferation through a CXCR3-independent mechanism.	[Campanella, Gabriele S. V.; Colvin, Richard A.; Luster, Andrew D.] Harvard Univ, Sch Med, Div Rheumatol Allergy & Immunol, Ctr Immunol & Inflammatory Dis,Massachusetts Gen, Charlestown, MA USA	Harvard University	Campanella, GSV (corresponding author), Harvard Univ, Sch Med, Div Rheumatol Allergy & Immunol, Ctr Immunol & Inflammatory Dis,Massachusetts Gen, Charlestown, MA USA.	aluster@mgh.harvard.edu	Luster, Andrew/ABE-6504-2020	Luster, Andrew/0000-0001-9679-7912	NIH [R01CA0169215, T32AR007258]; NATIONAL CANCER INSTITUTE [R01CA069212] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007258] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants R01CA0169215 to ADL and T32AR007258 to GSC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aidoudi S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002657; Aksoy MO, 2006, AM J PHYSIOL-LUNG C, V290, pL909, DOI 10.1152/ajplung.00430.2005; Allport JR, 2002, J LEUKOCYTE BIOL, V71, P821; ANGIOLILLO AL, 1995, J EXP MED, V182, P155, DOI 10.1084/jem.182.1.155; Bodnar RJ, 2009, J CELL SCI, V122, P2064, DOI 10.1242/jcs.048793; Campanella GSV, 2006, J IMMUNOL, V177, P6991, DOI 10.4049/jimmunol.177.10.6991; Campanella GSV, 2003, J BIOL CHEM, V278, P17066, DOI 10.1074/jbc.M212077200; Chang TLY, 2002, J VIROL, V76, P2245, DOI 10.1128/JVI.76.5.2245-2254.2002; Charnaux N, 2005, FEBS J, V272, P1937, DOI 10.1111/j.1742-4658.2005.04624.x; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Datta D, 2006, CANCER RES, V66, P9509, DOI 10.1158/0008-5472.CAN-05-4345; GENGRINOVITCH S, 1995, J BIOL CHEM, V270, P15059, DOI 10.1074/jbc.270.25.15059; Giuliani N, 2006, HAEMATOLOGICA, V91, P1489; Glaser J, 2004, J NEUROSCI RES, V77, P701, DOI 10.1002/jnr.20204; Kawasawa Y, 2003, GENOME RES, V13, P1466, DOI 10.1101/gr.1087603; Kozak M, 2001, NUCLEIC ACIDS RES, V29, P5226, DOI 10.1093/nar/29.24.5226; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; Lasagni L, 2003, J EXP MED, V197, P1537, DOI 10.1084/jem.20021897; Loetscher M, 1996, J EXP MED, V184, P963, DOI 10.1084/jem.184.3.963; Luster AD, 1998, P ASSOC AM PHYSICIAN, V110, P183; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; LUSTER AD, 1993, J EXP MED, V178, P1057, DOI 10.1084/jem.178.3.1057; LUSTER AD, 1995, J EXP MED, V182, P219, DOI 10.1084/jem.182.1.219; LUSTER AD, 1985, NATURE, V315, P672, DOI 10.1038/315672a0; LUSTER AD, 1987, J EXP MED, V166, P1084, DOI 10.1084/jem.166.4.1084; LUUKKONEN BGM, 1995, J VIROL, V69, P4086, DOI 10.1128/JVI.69.7.4086-4094.1995; MAIONE TE, 1991, CANCER RES, V51, P2077; Means TK, 2003, J IMMUNOL, V170, P5165, DOI 10.4049/jimmunol.170.10.5165; Murdoch C, 1999, CYTOKINE, V11, P704, DOI 10.1006/cyto.1998.0465; Proost P, 2001, BLOOD, V98, P3554, DOI 10.1182/blood.V98.13.3554; Romagnani P, 2001, J CLIN INVEST, V107, P53, DOI 10.1172/JCI9775; Salcedo R, 2000, FASEB J, V14, P2055, DOI 10.1096/fj.99-0963com; SATO Y, 1993, JPN J CANCER RES, V84, P485, DOI 10.1111/j.1349-7006.1993.tb00163.x; Schutyser E, 2007, EUR CYTOKINE NETW, V18, P59, DOI 10.1684/ecn.2007.0087; Sfriso P, 2006, J IMMUNOL, V176, P2581, DOI 10.4049/jimmunol.176.4.2581; Sgadari C, 1996, BLOOD, V87, P3877, DOI 10.1182/blood.V87.9.3877.bloodjournal8793877; Sgadari C, 1996, P NATL ACAD SCI USA, V93, P13791, DOI 10.1073/pnas.93.24.13791; STRIETER RM, 1995, BIOCHEM BIOPH RES CO, V210, P51, DOI 10.1006/bbrc.1995.1626; Sulpice E, 2004, EUR J BIOCHEM, V271, P3310, DOI 10.1111/j.1432-1033.2004.04263.x; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; TAUB DD, 1995, J IMMUNOL, V155, P3877; TAUB DD, 1993, J EXP MED, V177, P1809, DOI 10.1084/jem.177.6.1809; Thomas SY, 2003, J IMMUNOL, V171, P2571, DOI 10.4049/jimmunol.171.5.2571; Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841; Waeckel L, 2005, CIRC RES, V96, P576, DOI 10.1161/01.RES.0000159389.55544.20; Weng YM, 1998, J BIOL CHEM, V273, P18288, DOI 10.1074/jbc.273.29.18288; Yates CC, 2007, AM J PATHOL, V171, P484, DOI 10.2353/ajpath.2007.061092; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W	48	69	73	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2010	5	9							e12700	10.1371/journal.pone.0012700	http://dx.doi.org/10.1371/journal.pone.0012700			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648ZZ	20856926	Green Submitted, Green Published, gold			2022-12-27	WOS:000281735700018
J	Sorbye, SW; Fismen, S; Gutteberg, T; Mortensen, ES				Sorbye, Sveinung Wergeland; Fismen, Silje; Gutteberg, Tore; Mortensen, Elin Synnove			Triage of Women with Minor Cervical Lesions: Data Suggesting a "Test and Treat" Approach for HPV E6/E7 mRNA Testing	PLOS ONE			English	Article							2-YEAR FOLLOW-UP; INTRAEPITHELIAL NEOPLASIA; DNA; METAANALYSIS; PERFORMANCE; OUTCOMES; PROOFER; SMEARS; ASCUS; AGE	Background: Human papillomavirus (HPV) testing is included in the cervical cancer screening program in the triage of women with equivocal (ASC-US) or low-grade (LSIL) cytological lesions. These women have an increased risk for developing high grade dysplasia and cancer (CIN2+) compared to women with normal cytology. However, in order to avoid unnecessary follow-up, as well as overtreatment, a high positive predictive value (PPV) of the triage test is important. Methodology/Principal Findings: The HPV test PreTect HPV-Proofer, detecting E6/E7 mRNA from the HPV types 16, 18, 31, 33 and 45, is used as triage test together with repeat cytology. PPV data for HPV E6/E7 mRNA testing during the period from January 2006 up to June 2009 are reported. In total, 406 of 2099 women (19.3%) had a positive HPV test result. Of the women with a positive test result and with a histological diagnosis (n = 347), 243 women had histological high-grade dysplasia or cancer (CIN2+), giving a PPV of 70.0% (95% confidence interval [CI], 65.2%-74.8%). For HPV 16 or HPV 33 positive women above 40 years of age, the PPV was 83.7% (95% CI, 73.3%-94.0%) and 84.6% (95% CI, 65.0%-100.0%) respectively. The PPV of test positive women with HSIL cytology was 94.2% (95% CI, 88.7%-99.7%). Conclusions: When the result in triage is HPV mRNA positive, our data suggest direct treatment for women above 40 years of age or for women with a concurrent cytological HSIL diagnosis, contributing to better clinical safety for these women. In addition, by decreasing the time to treatment, thereby reducing the number of recalls, the patient management algorithm will be considerably improved, in turn reducing follow-up costs as well as unnecessary psychological stress among patients.	[Sorbye, Sveinung Wergeland; Fismen, Silje; Mortensen, Elin Synnove] Univ Hosp N Norway, Dept Clin Pathol, Tromso, Norway; [Gutteberg, Tore] Univ Hosp N Norway, Dept Microbiol & Infect Control, Tromso, Norway; [Gutteberg, Tore; Mortensen, Elin Synnove] Univ Tromso, Dept Med Biol, Fac Hlth Sci, Tromso, Norway	UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso	Sorbye, SW (corresponding author), Univ Hosp N Norway, Dept Clin Pathol, Tromso, Norway.	sveinung.sorbye@unn.no	Sorbye, Sveinung Wergeland/AAE-7208-2020	Sorbye, Sveinung Wergeland/0000-0002-8250-3992	University Hospital of North Norway	University Hospital of North Norway	This research was supported by the University Hospital of North Norway (http://www.unn.no/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrechtsen S, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1343; Arbyn M, 2004, JNCI-J NATL CANCER I, V96, P280, DOI 10.1093/jnci/djh037; Arbyn M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1284; *CANC REG NORW, NORW CERV CANC SCREE; Cancer Registry of Norway, CANC NORW 2008 CANC; Cattani P, 2009, J CLIN MICROBIOL, V47, P3895, DOI 10.1128/JCM.01275-09; Jeronimo J, 2006, AM J OBSTET GYNECOL, V195, P349, DOI 10.1016/j.ajog.2006.01.091; Kovacic MB, 2006, CANCER RES, V66, P10112, DOI 10.1158/0008-5472.CAN-06-1812; Kyrgiou M, 2006, LANCET, V367, P489, DOI 10.1016/S0140-6736(06)68181-6; Lie AK, 2005, GYNECOL ONCOL, V97, P908, DOI 10.1016/j.ygyno.2005.02.026; Molden T, 2005, CANCER EPIDEM BIOMAR, V14, P367, DOI 10.1158/1055-9965.EPI-04-0410; Molden T, 2005, INT J CANCER, V114, P973, DOI 10.1002/ijc.20839; Ratnam S, 2010, J CLIN MICROBIOL, V48, P2779, DOI 10.1128/JCM.00382-10; Sjoborg KD, 2007, ACTA OBSTET GYN SCAN, V86, P423, DOI 10.1080/11038120701208158; SORBYE SW, 2010, J VIROL MET IN PRESS; Stoler MH, 2001, JAMA-J AM MED ASSOC, V285, P1500, DOI 10.1001/jama.285.11.1500; Szarewski A, 2008, CANCER EPIDEM BIOMAR, V17, P3033, DOI 10.1158/1055-9965.EPI-08-0508; Trope A, 2009, J CLIN MICROBIOL, V47, P2458, DOI 10.1128/JCM.01863-08; ZUR HAUSEN H, 2002, NAT REV CANCER, V2, P342	19	44	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2010	5	9							e12724	10.1371/journal.pone.0012724	http://dx.doi.org/10.1371/journal.pone.0012724			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648ZZ	20856930	Green Published, gold			2022-12-27	WOS:000281735700023
J	Ahonen, MT; Diaconu, I; Pesonen, S; Kanerva, A; Baumann, M; Parviainen, ST; Spiller, B; Cerullo, V; Hemminki, A				Ahonen, Marko T.; Diaconu, Iulia; Pesonen, Sari; Kanerva, Anna; Baumann, Marc; Parviainen, Suvi T.; Spiller, Brad; Cerullo, Vincenzo; Hemminki, Akseli			Calcium Gluconate in Phosphate Buffered Saline Increases Gene Delivery with Adenovirus Type 5	PLOS ONE			English	Article							IN-VIVO; CARDIAC AMYLOIDOSIS; SODIUM HYALURONATE; NONHUMAN-PRIMATES; CONTROLLED-TRIAL; INNATE IMMUNITY; OVARIAN-CANCER; BREAST-CANCER; DOUBLE-BLIND; VECTORS	Background: Adenoviruses are attractive vectors for gene therapy because of their stability in vivo and the possibility of production at high titers. Despite exciting preclinical data with various approaches, there are only a few examples of clear efficacy in clinical trials. Effective gene delivery to target cells remains the key variable determining efficacy and thus enhanced transduction methods are important. Methods/Results: We found that heated serum could enhance adenovirus 5 mediated gene delivery up to twentyfold. A new protein-level interaction was found between fiber knob and serum transthyretin, but this was not responsible for the observed effect. Instead, we found that heating caused the calcium and phosphate present in the serum mix to precipitate, and this was responsible for enhanced gene delivery. This finding could have relevance for designing preclinical experiments with adenoviruses, since calcium and phosphate are present in many solutions. To translate this into an approach potentially testable in patients, we used calcium gluconate in phosphate buffered saline, both of which are clinically approved, to increase adenoviral gene transfer up to 300-fold in vitro. Gene transfer was increased with or without heating and in a manner independent from the coxsackie-adenovirus receptor. In vivo, in mouse studies, gene delivery was increased 2-, 110-, 12- and 13-fold to tumors, lungs, heart and liver and did not result in increased pro-inflammatory cytokine induction. Antitumor efficacy of a replication competent virus was also increased significantly. Conclusion: In summary, adenoviral gene transfer and antitumor efficacy can be enhanced by calcium gluconate in phosphate buffered saline.	[Ahonen, Marko T.; Diaconu, Iulia; Pesonen, Sari; Kanerva, Anna; Parviainen, Suvi T.; Cerullo, Vincenzo; Hemminki, Akseli] Univ Helsinki, Canc Gene Therapy Grp, Mol Canc Biol Program, Helsinki, Finland; [Ahonen, Marko T.; Diaconu, Iulia; Pesonen, Sari; Kanerva, Anna; Parviainen, Suvi T.; Cerullo, Vincenzo; Hemminki, Akseli] Univ Helsinki, Transplantat Lab, Helsinki, Finland; [Ahonen, Marko T.; Diaconu, Iulia; Pesonen, Sari; Kanerva, Anna; Parviainen, Suvi T.; Cerullo, Vincenzo; Hemminki, Akseli] Univ Helsinki, Haartman Inst, Helsinki, Finland; [Ahonen, Marko T.; Diaconu, Iulia; Pesonen, Sari; Kanerva, Anna; Parviainen, Suvi T.; Cerullo, Vincenzo; Hemminki, Akseli] Univ Helsinki, Finnish Inst Mol Med, Helsinki, Finland; [Ahonen, Marko T.; Diaconu, Iulia; Pesonen, Sari; Parviainen, Suvi T.; Cerullo, Vincenzo; Hemminki, Akseli] Helsinki Univ Cent Hosp, HUSLAB, Helsinki, Finland; [Kanerva, Anna] Helsinki Univ Cent Hosp, Dept Obstet & Gynecol, Helsinki, Finland; [Baumann, Marc] Univ Helsinki, Inst Biomed, Prot Chem Unit, Helsinki, Finland; [Spiller, Brad] Cardiff Univ, Sch Med, Dept Child Hlth, Cardiff, S Glam, Wales	University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Cardiff University	Ahonen, MT (corresponding author), Univ Helsinki, Canc Gene Therapy Grp, Mol Canc Biol Program, Helsinki, Finland.	vincenzo.cerullo@helsinki.fi; akseli.hemminki@helsinki.fi	Spiller, Owen Brad/AAC-2474-2020; Cerullo, Vincenzo/B-9075-2015	Spiller, Owen Brad/0000-0002-9117-6911; Cerullo, Vincenzo/0000-0003-4901-3796; Baumann, Marc/0000-0002-2991-889X	Helsinki Biomedical Graduate School, Suomen hammaslaakariliitto Apollonia; European Research Council, EU; Finnish Cancer Society; Sigrid Juselius Foundation; Academy of Finland; Biocentrum Helsinki; University of Helsinki	Helsinki Biomedical Graduate School, Suomen hammaslaakariliitto Apollonia; European Research Council, EU(European Research Council (ERC)); Finnish Cancer Society; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Biocentrum Helsinki; University of Helsinki	This work was supported by the Helsinki Biomedical Graduate School, Suomen hammaslaakariliitto Apollonia, the European Research Council, EU FP6 APOTHERAPY and THERADPOX, Helsinki University Central Hospital (HUCH) Research Funds (EVO), the Finnish Cancer Society, the Sigrid Juselius Foundation, the Academy of Finland, Biocentrum Helsinki, and the University of Helsinki. AH is K. Albin Johansson Research Professor of the Finnish Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemany Ramon, 2009, V542, P57, DOI 10.1007/978-1-59745-561-9_2; Bauerschmitz GJ, 2002, INT J ONCOL, V21, P1161; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Blaine T, 2008, J BONE JOINT SURG AM, V90A, P970, DOI 10.2106/JBJS.F.01116; BLAKE CCF, 1978, J MOL BIOL, V121, P339, DOI 10.1016/0022-2836(78)90368-6; Brunetti-Pierri N, 2004, HUM GENE THER, V15, P35, DOI 10.1089/10430340460732445; Brunetti-Pierri N, 2006, CURR OPIN MOL THER, V8, P446; Cohen MM, 2008, FOOT ANKLE INT, V29, P657, DOI 10.3113/FAI.2008.0657; COMPSTON JE, 1995, CLIN ENDOCRINOL, V42, P195, DOI 10.1111/j.1365-2265.1995.tb01862.x; Connors LH, 2009, AM HEART J, V158, P607, DOI 10.1016/j.ahj.2009.08.006; Diaconu I, 2010, J GENE MED, V12, P435, DOI 10.1002/jgm.1453; Eneqvist T, 2000, MOL CELL, V6, P1207, DOI 10.1016/S1097-2765(00)00117-9; Fasbender A, 1998, J CLIN INVEST, V102, P184, DOI 10.1172/JCI2732; Gaggar Anuj, 2007, Methods Mol Med, V131, P141; Ghosh SS, 2006, APPL BIOCHEM BIOTECH, V133, P9, DOI 10.1385/ABAB:133:1:9; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GRAHAM FL, 1973, VIROLOGY, V54, P536, DOI 10.1016/0042-6822(73)90163-3; Gray SJ, 2008, EXPERT OPIN BIOL TH, V8, P911, DOI 10.1517/14712598.8.7.911 ; Hedman M, 2003, CIRCULATION, V107, P2677, DOI 10.1161/01.CIR.0000070540.80780.92; Hitt MM, 2000, ADV VIRUS RES, V55, P479, DOI 10.1016/S0065-3527(00)55014-3; Immonen A, 2004, MOL THER, V10, P967, DOI 10.1016/j.ymthe.2004.08.002; Jacobson DR, 1997, NEW ENGL J MED, V336, P466, DOI 10.1056/NEJM199702133360703; Jager L, 2007, CURR GENE THER, V7, P272; Kanerva A, 2002, CLIN CANCER RES, V8, P275; Kanerva A, 2002, MOL THER, V5, P695, DOI 10.1006/mthe.2002.0599; Kankirawatana S, 2007, J CLIN APHERESIS, V22, P265, DOI 10.1002/jca.20142; Khuri FR, 2000, NAT MED, V6, P879, DOI 10.1038/78638; Kim TD, 2000, BIOCHEMISTRY-US, V39, P14839, DOI 10.1021/bi001441y; Kirn D, 2001, GENE THER, V8, P89, DOI 10.1038/sj.gt.3301377; KRARI N, 1991, BIOL TRACE ELEM RES, V29, P125, DOI 10.1007/BF03032689; Lee JH, 1999, GENE THER, V6, P676, DOI 10.1038/sj.gt.3300857; Miller CR, 1998, CANCER RES, V58, P5738; Muruve DA, 2004, J VIROL, V78, P5966, DOI 10.1128/JVI.78.11.5966-5972.2004; Nguan C, 2005, BJU INT, V95, P91, DOI 10.1111/j.1464-410X.2004.05257.x; Okegawa T, 2001, CANCER RES, V61, P6592; Pan JJ, 2009, J CLIN ONCOL, V27, P799, DOI 10.1200/JCO.2008.18.9670; Parker AL, 2006, BLOOD, V108, P2554, DOI 10.1182/blood-2006-04-008532; Raki M, 2006, MOL THER, V14, P154, DOI 10.1016/j.ymthe.2006.02.019; Ranki T, 2007, INT J CANCER, V121, P165, DOI 10.1002/ijc.22627; Raper SE, 2003, MOL GENET METAB, V80, P148, DOI 10.1016/j.ymgme.2003.08.016; Richardson C, 2005, J GEN VIROL, V86, P1669, DOI 10.1099/vir.0.80806-0; ROBBINS J, 1960, PHYSIOL REV, V40, P415, DOI 10.1152/physrev.1960.40.3.415; Sarkioja M, 2008, GENE THER, V15, P921, DOI 10.1038/gt.2008.56; Schnell MA, 2001, MOL THER, V3, P708, DOI 10.1006/mthe.2001.0330; Seiler MP, 2007, MOL THER, V15, P386, DOI 10.1038/sj.mt.6300029; Sharma A, 2010, VIRUS RES, V153, P134, DOI 10.1016/j.virusres.2010.07.021; Shayakhmetov DM, 2005, J VIROL, V79, P7478, DOI 10.1128/JVI.79.12.7478-7491.2005; Shayakhmetov DM, 2002, CANCER RES, V62, P1063; Suzuyama K, 2004, MOL BRAIN RES, V129, P44, DOI 10.1016/j.molbrainres.2004.06.021; Toyoda K, 2000, GENE THER, V7, P1284, DOI 10.1038/sj.gt.3301214; Vidovic S, 2008, J CHROMATOGR A, V1202, P155, DOI 10.1016/j.chroma.2008.06.039; Walters RW, 1999, GENE THER, V6, P1845, DOI 10.1038/sj.gt.3301020; Yi SMP, 2001, LARYNGOSCOPE, V111, P1290; Yu W, 2007, CURR CANCER DRUG TAR, V7, P141, DOI 10.2174/156800907780058817; Zhang Y, 2001, MOL THER, V3, P697, DOI 10.1006/mthe.2001.0329	55	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e13103	10.1371/journal.pone.0013103	http://dx.doi.org/10.1371/journal.pone.0013103			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20927353	Green Submitted, Green Published, gold			2022-12-27	WOS:000282312600027
J	Gautier, M; Laloe, D; Moazami-Goudarzi, K				Gautier, Mathieu; Laloe, Denis; Moazami-Goudarzi, Katayoun			Insights into the Genetic History of French Cattle from Dense SNP Data on 47 Worldwide Breeds	PLOS ONE			English	Article							TAURINE BOS-TAURUS; POPULATION-STRUCTURE; EUROPEAN CATTLE; DOMESTIC CATTLE; DIVERSITY; MICROSATELLITES; EVOLUTION; ORIGINS; VARIABILITY; ADMIXTURE	Background: Modern cattle originate from populations of the wild extinct aurochs through a few domestication events which occurred about 8,000 years ago. Newly domesticated populations subsequently spread worldwide following breeder migration routes. The resulting complex historical origins associated with both natural and artificial selection have led to the differentiation of numerous different cattle breeds displaying a broad phenotypic variety over a short period of time. Methodology/Principal Findings: This study gives a detailed assessment of cattle genetic diversity based on 1,121 individuals sampled in 47 populations from different parts of the world (with a special focus on French cattle) genotyped for 44,706 autosomal SNPs. The analyzed data set consisted of new genotypes for 296 individuals representing 14 French cattle breeds which were combined to those available from three previously published studies. After characterizing SNP polymorphism in the different populations, we performed a detailed analysis of genetic structure at both the individual and population levels. We further searched for spatial patterns of genetic diversity among 23 European populations, most of them being of French origin, under the recently developed spatial Principal Component analysis framework. Conclusions/Significance: Overall, such high throughput genotyping data confirmed a clear partitioning of the cattle genetic diversity into distinct breeds. In addition, patterns of differentiation among the three main groups of populations-the African taurine, the European taurine and zebus-may provide some additional support for three distinct domestication centres. Finally, among the European cattle breeds investigated, spatial patterns of genetic diversity were found in good agreement with the two main migration routes towards France, initially postulated based on archeological evidence.	[Gautier, Mathieu] INRA, CBGP, UMR 1031, Montferrier Sur Lez, France; [Laloe, Denis; Moazami-Goudarzi, Katayoun] INRA, GABI, UMR 1313, Jouy En Josas, France	INRAE; Institut de Recherche pour le Developpement (IRD); AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Gautier, M (corresponding author), INRA, CBGP, UMR 1031, Montferrier Sur Lez, France.	gautierm@supagro.inra.fr	Laloe, Denis/O-7045-2019; gautier, mathieu/AAU-8789-2020; gautier, mathieu/F-7429-2010	gautier, mathieu/0000-0001-7257-5880; gautier, mathieu/0000-0001-7257-5880; Laloe, Denis/0000-0001-8359-0760	French Ministry of Education and Research; National Institute of Agronomic Research	French Ministry of Education and Research; National Institute of Agronomic Research	Genotyping was supported by the French Ministry of Education and Research and the National Institute of Agronomic Research (INRA AIP "BioRessources''). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005753; AMMERMAN AJ, 1984, NEOLITHIC TRANSITION; BAKER CMA, 1980, ANIM BLOOD GROUPS BI, V11, P127; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beja-Pereira A, 2006, P NATL ACAD SCI USA, V103, P8113, DOI 10.1073/pnas.0509210103; CAVALLIS.LL, 1966, PROC R SOC SER B-BIO, V164, P362, DOI 10.1098/rspb.1966.0038; Chen SY, 2010, MOL BIOL EVOL, V27, P1, DOI 10.1093/molbev/msp213; Chessel D., 2004, R NEWS, V4, P5; Culhane AC, 2002, BIOINFORMATICS, V18, P1600, DOI 10.1093/bioinformatics/18.12.1600; Cymbron T, 2005, P ROY SOC B-BIOL SCI, V272, P1837, DOI 10.1098/rspb.2005.3138; DENIS B., 2010, RACES BOVINES HIST A; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Flori L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006595; Freeman AR, 2006, ANIM GENET, V37, P1, DOI 10.1111/j.1365-2052.2005.01363.x; Gautier M, 2007, GENETICS, V177, P1059, DOI 10.1534/genetics.107.075804; Gautier M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-550; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Groeneveld LF, 2010, ANIM GENET, V41, P6, DOI 10.1111/j.1365-2052.2010.02038.x; GROSCLAUDE F, 1990, GENET SEL EVOL, V22, P317, DOI 10.1051/gse:19900306; Hanotte O, 2002, SCIENCE, V296, P336, DOI 10.1126/science.1069878; Hanotte O, 2000, MOL ECOL, V9, P387, DOI 10.1046/j.1365-294x.2000.00858.x; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Jombart T, 2008, HEREDITY, V101, P92, DOI 10.1038/hdy.2008.34; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Laloe D., 2010, Diversity, V2, P932, DOI 10.3390/d2060932; Liu Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-180; LOFTUS RT, 1994, P NATL ACAD SCI USA, V91, P2757, DOI 10.1073/pnas.91.7.2757; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; MoazamiGoudarzi K, 1997, ANIM GENET, V28, P338, DOI 10.1111/j.1365-2052.1997.00176.x; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Payne W.J.A., 1997, TROPICAL CATTLE ORIG; Perez-Pardal L, 2010, HEREDITY, V105, P511, DOI 10.1038/hdy.2010.30; Perez-Pardal L, 2010, ANIM GENET, V41, P232, DOI 10.1111/j.1365-2052.2009.01988.x; REYNOLDS J, 1983, GENETICS, V105, P767; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; Thioulouse J, 1995, ENVIRON ECOL STAT, V2, P1, DOI 10.1007/BF00452928; Troy CS, 2001, NATURE, V410, P1088, DOI 10.1038/35074088; WARTENBERG D, 1985, GEOGR ANAL, V17, P263, DOI 10.1111/j.1538-4632.1985.tb00849.x; Weir BS, 2005, GENOME RES, V15, P1468, DOI 10.1101/gr.4398405; Wendorf Fred, 1994, Evolutionary Anthropology, V3, P118, DOI 10.1002/evan.1360030406; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Zenger KR, 2007, ANIM GENET, V38, P7, DOI 10.1111/j.1365-2052.2006.01543.x	51	116	119	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e13038	10.1371/journal.pone.0013038	http://dx.doi.org/10.1371/journal.pone.0013038			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20927341	Green Published, Green Submitted, gold			2022-12-27	WOS:000282312600012
J	Cao, KJ; Chen-Plotkin, AS; Plotkin, JB; Wang, LS				Cao, Kajia; Chen-Plotkin, Alice S.; Plotkin, Joshua B.; Wang, Li-San			Age-Correlated Gene Expression in Normal and Neurodegenerative Human Brain Tissues	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; MOTOR-NEURON DISEASE; ALZHEIMERS-DISEASE; TRANSCRIPTIONAL PROFILES; TDP-43 PROTEINOPATHY; DEMENTIA; NETWORKS; POPULATION; PREVALENCE; AUTOPHAGY	Background: Human brain aging has received special attention in part because of the elevated risks of neurodegenerative disorders such as Alzheimer's disease in seniors. Recent technological advances enable us to investigate whether similar mechanisms underlie aging and neurodegeneration, by quantifying the similarities and differences in their genome-wide gene expression profiles. Principal Findings: We have developed a computational method for assessing an individual's "physiological brain age'' by comparing global mRNA expression datasets across a range of normal human brain samples. Application of this method to brains samples from select regions in two diseases - Alzheimer's disease (AD, superior frontal gyrus), frontotemporal lobar degeneration (FTLD, in rostral aspect of frontal cortex, similar to BA10) - showed that while control cohorts exhibited no significant difference between physiological and chronological ages, FTLD and AD exhibited prematurely aged expression profiles. Conclusions: This study establishes a quantitative scale for measuring premature aging in neurodegenerative disease cohorts, and it identifies specific physiological mechanisms common to aging and some forms of neurodegeneration. In addition, accelerated expression profiles associated with AD and FTLD suggest some common mechanisms underlying the risk of developing these diseases.	[Cao, Kajia; Wang, Li-San] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Chen-Plotkin, Alice S.] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Chen-Plotkin, Alice S.; Wang, Li-San] Univ Penn, Inst Aging, Philadelphia, PA 19104 USA; [Chen-Plotkin, Alice S.] Univ Penn, Ctr Neurodegenerat Dis, Philadelphia, PA 19104 USA; [Plotkin, Joshua B.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Cao, Kajia; Wang, Li-San] Univ Penn, Penn Ctr Bioinformat, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Cao, KJ (corresponding author), Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	lswang@mail.med.upenn.edu	Plotkin, Joshua B/E-6947-2013		University of Pennsylvania Research Foundation; Burroughs Wellcome Fund Career Award for Medical Scientists; NIH [K08AG033101-01]; AAN-ALS Association; James S. McDonnell Foundation; Alfred P. Sloan Foundation; David and Lucille Packard Foundation; NATIONAL INSTITUTE ON AGING [K08AG033101] Funding Source: NIH RePORTER	University of Pennsylvania Research Foundation; Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AAN-ALS Association; James S. McDonnell Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); David and Lucille Packard Foundation(The David & Lucile Packard Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research is funded by a University of Pennsylvania Research Foundation Pilot Grant (KC and LW). ACP is supported by a Burroughs Wellcome Fund Career Award for Medical Scientists, NIH K08AG033101-01, and an AAN-ALS Association Clinician Scientist Development Award. JBP is supported by a Burroughs Wellcome Fund Career Award at the Scientific Interface, the James S. McDonnell Foundation, and the Alfred P. Sloan Foundation, and the David and Lucille Packard Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT MS, 1988, PSYCHOL AGING, V3, P173, DOI 10.1037/0882-7974.3.2.173; ALBERT MS, 1990, PSYCHOL AGING, V5, P94, DOI 10.1037/0882-7974.5.1.94; Arenberg D, 1990, Adv Neurol, V51, P207; Berchtold NC, 2008, P NATL ACAD SCI USA, V105, P15605, DOI 10.1073/pnas.0806883105; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Boeve BF, 2008, ARCH NEUROL-CHICAGO, V65, P460, DOI 10.1001/archneur.65.4.460; Bossy-Wetzel E, 2004, NAT MED, V10, pS2, DOI 10.1038/nm1067; Celone KA, 2006, J NEUROSCI, V26, P10222, DOI 10.1523/JNEUROSCI.2250-06.2006; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Chen-Plotkin AS, 2008, HUM MOL GENET, V17, P1349, DOI 10.1093/hmg/ddn023; Colsher Patricia L., 1991, Annals of Epidemiology, V1, P215; Cook PE, 2007, NAT PROTOC, V2, P2796, DOI 10.1038/nprot.2007.396; Cook PE, 2006, P NATL ACAD SCI USA, V103, P18060, DOI 10.1073/pnas.0604875103; Cruts M, 2008, TRENDS GENET, V24, P186, DOI 10.1016/j.tig.2008.01.004; Cuervo AM, 2008, TRENDS GENET, V24, P604, DOI 10.1016/j.tig.2008.10.002; Dhahbi JM, 2004, P NATL ACAD SCI USA, V101, P5524, DOI 10.1073/pnas.0305300101; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Erraji-Benchekroun L, 2005, BIOL PSYCHIAT, V57, P549, DOI 10.1016/j.biopsych.2004.10.034; Ertekin-Taner N, 2007, NEUROL CLIN, V25, P611, DOI 10.1016/j.ncl.2007.03.009; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Forman MS, 2006, ANN NEUROL, V59, P952, DOI 10.1002/ana.20873; Fu CX, 2006, MECH AGEING DEV, V127, P905, DOI 10.1016/j.mad.2006.09.006; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Golden TR, 2008, AGING CELL, V7, P850, DOI 10.1111/j.1474-9726.2008.00433.x; Hawse JR, 2004, EXP EYE RES, V79, P935, DOI 10.1016/j.exer.2004.04.007; HEBERT LE, 1995, JAMA-J AM MED ASSOC, V273, P1354, DOI 10.1001/jama.273.17.1354; Kumar-Singh S, 2007, BRAIN PATHOL, V17, P104, DOI 10.1111/j.1750-3639.2007.00055.x; Kwong LK, 2007, ACTA NEUROPATHOL, V114, P63, DOI 10.1007/s00401-007-0226-5; Liang WS, 2008, P NATL ACAD SCI USA, V105, P4441, DOI 10.1073/pnas.0709259105; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Mackenzie IRA, 2009, ACTA NEUROPATHOL, V117, P15, DOI 10.1007/s00401-008-0460-5; Martinez-Vicente M, 2007, LANCET NEUROL, V6, P352, DOI 10.1016/S1474-4422(07)70076-5; McKhann GM, 2001, ARCH NEUROL-CHICAGO, V58, P1803, DOI 10.1001/archneur.58.11.1803; Mishra M, 2007, ACTA NEUROPATHOL, V114, P81, DOI 10.1007/s00401-007-0240-7; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Neumann M, 2007, ARCH NEUROL-CHICAGO, V64, P1388, DOI 10.1001/archneur.64.10.1388; Rodwell GEJ, 2004, PLOS BIOL, V2, P2191, DOI 10.1371/journal.pbio.0020427; Rosso SM, 2003, BRAIN, V126, P2016, DOI 10.1093/brain/awg204; Skovronsky DM, 2006, ANNU REV PATHOL-MECH, V1, P151, DOI 10.1146/annurev.pathol.1.110304.100113; Soto C, 2008, ARCH NEUROL-CHICAGO, V65, P184, DOI 10.1001/archneurol.2007.56; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wu JZ, 2007, GERMA BACKGROUND ADJ; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044; Zahn JM, 2006, PLOS GENET, V2, P1058, DOI 10.1371/journal.pgen.0020115; Zelinski EM, 1997, PSYCHOL AGING, V12, P503, DOI 10.1037/0882-7974.12.3.503	47	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e13098	10.1371/journal.pone.0013098	http://dx.doi.org/10.1371/journal.pone.0013098			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20927326	Green Submitted, gold, Green Published			2022-12-27	WOS:000282269400032
J	Accetturo, M; Creanza, TM; Santoro, C; Tria, G; Giordano, A; Battagliero, S; Vaccina, A; Scioscia, G; Leo, P				Accetturo, Matteo; Creanza, Teresa M.; Santoro, Claudia; Tria, Giancarlo; Giordano, Antonio; Battagliero, Simone; Vaccina, Antonella; Scioscia, Gaetano; Leo, Pietro			Finding New Genes for Non-Syndromic Hearing Loss through an In Silico Prioritization Study	PLOS ONE			English	Article							AUTOSOMAL RECESSIVE DEAFNESS; HUMAN NONSYNDROMIC DEAFNESS; TRANSCRIPTION FACTOR; ALLELIC MUTATIONS; JUNCTION PROTEIN; HUMAN HOMOLOG; HAIR-CELLS; DOMINANT; COCHLEAR; SIMILARITY	At present, 51 genes are already known to be responsible for Non-Syndromic hereditary Hearing Loss (NSHL), but the knowledge of 121 NSHL-linked chromosomal regions brings to the hypothesis that a number of disease genes have still to be uncovered. To help scientists to find new NSHL genes, we built a gene-scoring system, integrating Gene Ontology, NCBI Gene and Map Viewer databases, which prioritizes the candidate genes according to their probability to cause NSHL. We defined a set of candidates and measured their functional similarity with respect to the disease gene set, computing a score (S S M-avg) that relies on the assumption that functionally related genes might contribute to the same (disease) phenotype. A Kolmogorov-Smirnov test, comparing the pair-wise S S M-avg distribution on the disease gene set with the distribution on the remaining human genes, provided a statistical assessment of this assumption. We found at a p-value<2.2.10(-16) that the former pair-wise S S M-avg is greater than the latter, justifying a prioritization strategy based on the functional similarity of candidate genes respect to the disease gene set. A cross-validation test measured to what extent the S S M-avg ranking for NSHL is different from a random ordering: adding 15% of the disease genes to the candidate gene set, the ranking of the disease genes in the first eight positions resulted statistically different from a hypergeometric distribution with a p-value=2.04.10(-5) and a power>0.99. The twenty top-scored genes were finally examined to evaluate their possible involvement in NSHL. We found that half of them are known to be expressed in human inner ear or cochlea and are mainly involved in remodeling and organization of actin formation and maintenance of the cilia and the endocochlear potential. These findings strongly indicate that our metric was able to suggest excellent NSHL candidates to be screened in patients and controls for causative mutations.	[Accetturo, Matteo] IBM Corp, GBS BAO Adv Analyt Serv, Bari, Italy; IBM Corp, MBLab, Bari, Italy	International Business Machines (IBM); International Business Machines (IBM)	Accetturo, M (corresponding author), IBM Corp, GBS BAO Adv Analyt Serv, Bari, Italy.	pietro_leo@it.ibm.com	CREANZA, TERESA MARIA/AAX-6584-2020	CREANZA, TERESA MARIA/0000-0003-4926-6451; TRIA, Giancarlo/0000-0003-4736-471X	Ministero dell'Universita e della Ricerca (MUR) [DM19410]	Ministero dell'Universita e della Ricerca (MUR)(Ministry of Education, Universities and Research (MIUR))	The authors acknowledge support of the Ministero dell'Universita e della Ricerca (MUR), under the project DM19410 "Laboratorio di Bioinformatica per la Biodiversita' Molecolare'' MBLab (www.mblabproject.it). Given the educational spirit of this work and of the entire project, this study was conducted by the authors in total autonomy, and the funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are employed with IBM Italy SpA. They serve as investigators for the research and educational project DM19410 "Laboratorio di Bioinformatica per la Biodiversita' Molecolare'' MBLab. The authors confirm their adherence to all the PLoS ONE policies on sharing data and materials.	Abe S, 2003, J HUM GENET, V48, P564, DOI 10.1007/s10038-003-0079-2; Abe S, 2003, AM J HUM GENET, V72, P73, DOI 10.1086/345398; Ahmed ZM, 2003, HUM MOL GENET, V12, P3215, DOI 10.1093/hmg/ddg358; Ahmed ZM, 2002, HUM GENET, V110, P527, DOI 10.1007/s00439-002-0732-4; Ahmed ZM, 2008, NAT GENET, V40, P1335, DOI 10.1038/ng.245; Ansar M, 2003, EUR J HUM GENET, V11, P77, DOI 10.1038/sj.ejhg.5200905; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bespalova IN, 2001, HUM MOL GENET, V10, P2501, DOI 10.1093/hmg/10.22.2501; *BGEE, DATABASE GEN EXPR EV; BODENREIDER O, 2005, PAC S BIOCOMPUT, V7, P91; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; Bulfone A, 2000, HUM MOL GENET, V9, P1443, DOI 10.1093/hmg/9.9.1443; Cheng Jill, 2004, J Biopharm Stat, V14, P687, DOI 10.1081/BIP-200025659; Collin GB, 2002, NAT GENET, V31, P74, DOI 10.1038/ng867; Collin RWJ, 2008, AM J HUM GENET, V82, P125, DOI 10.1016/j.ajhg.2007.09.008; Couto F.M., 2005, P 14 ACM INT C INF K, P343, DOI DOI 10.1145/1099554.1099658; Crew VK, 2004, BLOOD, V104, P2217, DOI 10.1182/blood-2004-04-1512; DEKOK YJM, 1995, SCIENCE, V267, P685, DOI 10.1126/science.7839145; del Castillo I, 2002, NEW ENGL J MED, V346, P243, DOI 10.1056/NEJMoa012052; del Pozo A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-50; Delmaghani S, 2006, NAT GENET, V38, P770, DOI 10.1038/ng1829; Donaudy F, 2004, AM J HUM GENET, V74, P770, DOI 10.1086/383285; Donaudy F, 2003, AM J HUM GENET, V72, P1571, DOI 10.1086/375654; Ficarella R, 2007, P NATL ACAD SCI USA, V104, P1516, DOI 10.1073/pnas.0609775104; Grifa A, 1999, NAT GENET, V23, P16, DOI 10.1038/12612; *IHR, TABL GEN EXPR DEV EA; Jiang J. J., 1997, P INT C RES COMP LIN, P19; Jin H, 1996, NAT GENET, V14, P177, DOI 10.1038/ng1096-177; Kalay E, 2006, HUM MUTAT, V27, P633, DOI 10.1002/humu.20368; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Khan SY, 2007, HUM MUTAT, V28, P417, DOI 10.1002/humu.20469; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Kurima K, 2002, NAT GENET, V30, P277, DOI 10.1038/ng842; Lalwani AK, 2000, AM J HUM GENET, V67, P1121, DOI 10.1016/S0002-9297(07)62942-5; Lei ZD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-491; Li GC, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030008; Li XC, 1998, NAT GENET, V18, P215, DOI 10.1038/ng0398-215; Lin D, 1998, P INT C MACH LEARN; Linghu B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r91; Liu XZ, 2010, AM J HUM GENET, V86, P65, DOI 10.1016/j.ajhg.2009.11.015; Liu XZ, 2003, HUM MOL GENET, V12, P1155, DOI 10.1093/hmg/ddg127; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; LORD P, 2003, PAC S BIOCOMPUT, V8, P601; Lynch ED, 1997, SCIENCE, V278, P1315, DOI 10.1126/science.278.5341.1315; Maglott D, 2007, NUCLEIC ACIDS RES, V35, pD26, DOI 10.1093/nar/gkl993; Mburu P, 2003, NAT GENET, V34, P421, DOI 10.1038/ng1208; McGuirt WT, 1999, NAT GENET, V23, P413, DOI 10.1038/70516; Melchionda S, 2001, AM J HUM GENET, V69, P635, DOI 10.1086/323156; Mencia A, 2009, NAT GENET, V41, P609, DOI 10.1038/ng.355; Modamio-Hoybjor S, 2007, AM J HUM GENET, V80, P1076, DOI 10.1086/518311; *MORT LAB, MORT LAB COCHL EST D; Naz S, 2002, AM J HUM GENET, V71, P632, DOI 10.1086/342193; Naz S, 2004, J MED GENET, V41, P591, DOI 10.1136/jmg.2004.018523; *NCBI, NCBI UNIGENE ORG VIE; *NCBI, NCBI GEO GEN EXPR OM; OTHMAN R, 2007, J BIOMED INFORM, V23, P529; Ouyang XM, 2002, HUM GENET, V111, P26, DOI 10.1007/s00439-002-0736-0; Pesquita C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000443; Peters LM, 2002, HUM MOL GENET, V11, P2877, DOI 10.1093/hmg/11.23.2877; Piccini M, 1999, GENOMICS, V60, P251, DOI 10.1006/geno.1999.5904; Resnik P, 1995, INT JOINT CONF ARTIF, P448; Riazuddin S, 2006, AM J HUM GENET, V78, P137, DOI 10.1086/499164; Riazuddin S, 2006, AM J HUM GENET, V79, P1040, DOI 10.1086/510022; RIENSCHE RM, 2007, IEEE C, P99; Robertson NG, 1998, NAT GENET, V20, P299, DOI 10.1038/3118; Schlicker A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-302; Schrijver I, 2004, J MOL DIAGN, V6, P275, DOI 10.1016/S1525-1578(10)60522-3; Schultz JM, 2005, NEW ENGL J MED, V352, P1557, DOI 10.1056/NEJMoa043899; Schultz JM, 2009, AM J HUM GENET, V85, P25, DOI 10.1016/j.ajhg.2009.06.003; Scott HS, 2001, NAT GENET, V27, P59, DOI 10.1038/83768; Sevilla JL, 2005, IEEE ACM T COMPUT BI, V2, P330, DOI 10.1109/TCBB.2005.50; Shabbir MI, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039834; Shahin H, 2006, AM J HUM GENET, V78, P144, DOI 10.1086/499495; Stover EH, 2002, J MED GENET, V39, P796, DOI 10.1136/jmg.39.11.796; Tlili A, 2005, HUM HERED, V60, P123, DOI 10.1159/000088974; Tranebjaerg L, 1997, AM J HUM GENET, V61, pA349; Tulipano A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-329; Vahava O, 1998, SCIENCE, V279, P1950, DOI 10.1126/science.279.5358.1950; Van Laer L, 1998, NAT GENET, V20, P194; van Wijk E, 2003, J MED GENET, V40, P879, DOI 10.1136/jmg.40.12.879; Verhoeven K, 1998, NAT GENET, V19, P60, DOI 10.1038/ng0598-60; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; Verpy E, 2001, NAT GENET, V29, P345, DOI 10.1038/ng726; Walsh T, 2002, P NATL ACAD SCI USA, V99, P7518, DOI 10.1073/pnas.102091699; Wang AH, 1998, SCIENCE, V280, P1447, DOI 10.1126/science.280.5368.1447; Wang JZ, 2007, BIOINFORMATICS, V23, P1274, DOI 10.1093/bioinformatics/btm087; Wangemann P, 2006, J PHYSIOL-LONDON, V576, P11, DOI 10.1113/jphysiol.2006.112888; Wayne S, 2001, HUM MOL GENET, V10, P195, DOI 10.1093/hmg/10.3.195; Weil D, 2003, HUM MOL GENET, V12, P463, DOI 10.1093/hmg/ddg051; Wilcox ER, 2001, CELL, V104, P165, DOI 10.1016/S0092-8674(01)00200-8; Wu HW, 2005, NUCLEIC ACIDS RES, V33, P2822, DOI 10.1093/nar/gki573; Wu XM, 2006, NUCLEIC ACIDS RES, V34, P2137, DOI 10.1093/nar/gkl219; Xia JH, 1998, NAT GENET, V20, P370, DOI 10.1038/3845; Yang T, 2009, AM J HUM GENET, V84, P651, DOI 10.1016/j.ajhg.2009.04.014; Yasunaga S, 1999, NAT GENET, V21, P363, DOI 10.1038/7693; Young TL, 2001, HUM MOL GENET, V10, P2509, DOI 10.1093/hmg/10.22.2509; Yu H, 2005, GENE, V352, P75, DOI 10.1016/j.gene.2005.03.033; Zhu M, 2003, AM J HUM GENET, V73, P1082, DOI 10.1086/379286; Zwaenepoel I, 2002, P NATL ACAD SCI USA, V99, P6240, DOI 10.1073/pnas.082515999; R PACKAGE MATCHING; GENE ANALOGUE FINDER	101	12	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2010	5	9							e12742	10.1371/journal.pone.0012742	http://dx.doi.org/10.1371/journal.pone.0012742			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654ZQ	20927407	Green Published, Green Submitted, gold			2022-12-27	WOS:000282210700001
J	Lahnalampi, M; Heinaniemi, M; Sinkkonen, L; Wabitsch, M; Carlberg, C				Lahnalampi, Mari; Heinaeniemi, Merja; Sinkkonen, Lasse; Wabitsch, Martin; Carlberg, Carsten			Time-Resolved Expression Profiling of the Nuclear Receptor Superfamily in Human Adipogenesis	PLOS ONE			English	Article							REV-ERB-ALPHA; PERIPHERAL CIRCADIAN CLOCKS; GLUCOCORTICOID-RECEPTOR; PPAR-GAMMA; ADIPOCYTE DIFFERENTIATION; ACTIVATED RECEPTOR; GENE-EXPRESSION; INHIBITION; CELLS; IDENTIFICATION	Background: The differentiation of fibroblast-like pre-adipocytes to lipid-loaded adipocytes is regulated by a network of transcription factors, the most prominent one being the nuclear receptor peroxisome proliferator-activated receptor (PPAR) c. However, many of the other 47 members of the nuclear receptor superfamily have an impact on adipogenesis, which in human cells has not been investigated in detail. Methodology/Principal Findings: We analyzed by quantitative PCR all human nuclear receptors at multiple time points during differentiation of SGBS pre-adipocytes. The earliest effect was the down-regulation of the genes RARG, PPARD, REV-ERBA, REV-ERBB, VDR and GR followed by the up-regulation of PPARG, LXRA and AR. These observations are supported with data from 3T3-L1 mouse pre-adipocytes and primary human adipocytes. Investigation of the effects of the individual differentiation mix components in short-term treatments and of their omission from the full mix showed that the expression levels of the early-regulated nuclear receptor genes were most affected by the glucocorticoid receptor (GR) ligand cortisol and the phosophodiesterase inhibitor IBMX. Interestingly, the effects of both compounds converged to repress the genes PPARD, REV-ERBA, REV-ERBB, VDR and GR, whereas cortisol and IBMX showed antagonistic interaction for PPARG, LXRA and AR causing a time lag in their up-regulation. We hypothesize that the well-known auto-repression of GR fine-tunes the detected early responses. Consistently, chromatin immunoprecipitation experiments showed that GR association increased on the transcription start sites of the genes RARG, REV-ERBB, VDR and GR. Conclusions/Significance: Adipocyte differentiation is a process, in which many members of the nuclear receptor superfamily change their mRNA expression. The actions of cortisol and IBMX converged to repress several nuclear receptors early in differentiation, while up-regulation of other nuclear receptor genes showed a time lag due to antagonisms of the signals. Our results place GR and its ligand cortisol as central regulatory factors controlling early regulatory events in human adipogenesis that precedes the regulation of the later events by PPARG.	[Lahnalampi, Mari; Carlberg, Carsten] Univ Eastern Finland, Dept Biosci, Kuopio, Finland; [Heinaeniemi, Merja; Sinkkonen, Lasse; Carlberg, Carsten] Univ Luxembourg, Life Sci Res Unit, Luxembourg, Luxembourg; [Wabitsch, Martin] Univ Ulm, Div Pediat Endocrinol & Diabet, Ulm, Germany	University of Eastern Finland; University of Luxembourg; Ulm University	Lahnalampi, M (corresponding author), Univ Eastern Finland, Dept Biosci, Kuopio, Finland.	carsten.carlberg@uni.lu	Sinkkonen, Lasse/AAL-7906-2021; Heinaniemi, Merja/AAS-4530-2020; Heinäniemi, Merja/C-5051-2014; Carlberg, Carsten/C-9075-2011	Sinkkonen, Lasse/0000-0002-4223-3027; Heinaniemi, Merja/0000-0001-6190-3439; Heinäniemi, Merja/0000-0001-6190-3439; Carlberg, Carsten/0000-0003-2633-0684	University of Luxembourg; Luxembourgish Research Foundation FNR; Academy of Finland; Juselius Foundation	University of Luxembourg; Luxembourgish Research Foundation FNR(Luxembourg National Research Fund); Academy of Finland(Academy of Finland); Juselius Foundation	Grants from the University of Luxembourg, the Luxembourgish Research Foundation FNR, the Academy of Finland and the Juselius Foundation supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Auwerx J, 1999, CELL, V97, P161; Beaven SW, 2006, ANNU REV MED, V57, P313, DOI 10.1146/annurev.med.57.121304.131428; Benoit G, 2006, PHARMACOL REV, V58, P798, DOI 10.1124/pr.58.4.10; Berry DC, 2009, MOL CELL BIOL, V29, P3286, DOI 10.1128/MCB.01742-08; Bertrand W, 2004, MOL BIOL EVOL, V21, P1923, DOI 10.1093/molbev/msh200; Blouin K, 2009, MOL CELL ENDOCRINOL, V301, P97, DOI 10.1016/j.mce.2008.10.035; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; BRENTANI MM, 1986, HORM RES, V24, P9, DOI 10.1159/000180534; Burris TP, 2008, MOL ENDOCRINOL, V22, P1509, DOI 10.1210/me.2007-0519; Cermakian N, 2009, OBES REV, V10, P25, DOI 10.1111/j.1467-789X.2009.00660.x; Chao LC, 2008, MOL ENDOCRINOL, V22, P2596, DOI 10.1210/me.2008-0161; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; CIDLOWSKI JA, 1981, ENDOCRINOLOGY, V109, P1975; Diamant M, 2003, DRUGS, V63, P1373, DOI 10.2165/00003495-200363130-00004; DONG Y, 1988, MOL ENDOCRINOL, V2, P1256, DOI 10.1210/mend-2-12-1256; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Elgadi A, 2010, BIOCHEM BIOPH RES CO, V393, P526, DOI 10.1016/j.bbrc.2010.02.042; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Fischer-Posovszky P, 2008, OBESITY FACTS, V1, P184, DOI 10.1159/000145784; Floyd ZE, 2003, DIABETES, V52, P308, DOI 10.2337/diabetes.52.2.308; Fontaine C, 2003, J BIOL CHEM, V278, P37672, DOI 10.1074/jbc.M304664200; Fu MG, 2005, MOL ENDOCRINOL, V19, P2437, DOI 10.1210/me.2004-0539; Fumoto T, 2007, J BIOCHEM, V141, P181, DOI 10.1093/jb/mvm018; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Hummasti S, 2004, J LIPID RES, V45, P616, DOI 10.1194/jlr.M300312-JLR200; Kong J, 2006, AM J PHYSIOL-ENDOC M, V290, pE916, DOI 10.1152/ajpendo.00410.2005; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Maglich JM, 2001, GENOME BIOL, V2; Matsusue K, 2004, FASEB J, V18, P1477, DOI 10.1096/fj.04-1944fje; Mishra A, 2010, J MOL ENDOCRINOL, V44, P247, DOI 10.1677/JME-09-0137; Mohan R, 2003, CURR TOP MED CHEM, V3, P1637, DOI 10.2174/1568026033451709; Nettles KW, 2005, ANNU REV PHYSIOL, V67, P309, DOI 10.1146/annurev.physiol.66.032802.154710; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; O'Neill JS, 2008, SCIENCE, V320, P949, DOI 10.1126/science.1152506; Pantoja C, 2008, MOL BIOL CELL, V19, P4032, DOI 10.1091/mbc.E08-04-0420; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; ROSEWICZ S, 1988, J BIOL CHEM, V263, P2581; SCHLECHTE JA, 1982, J STEROID BIOCHEM, V16, P69, DOI 10.1016/0022-4731(82)90145-5; Steger DJ, 2010, GENE DEV, V24, P1035, DOI 10.1101/gad.1907110; Tchkonia T, 2007, AM J PHYSIOL-ENDOC M, V292, pE298, DOI 10.1152/ajpendo.00202.2006; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; VEDECKIS WV, 1989, CANCER RES, V49, pS2295; Wabitsch M, 2001, INT J OBESITY, V25, P8, DOI 10.1038/sj.ijo.0801520; Wang J, 2008, MOL CELL BIOL, V28, P2213, DOI 10.1128/MCB.01608-07; Xue JC, 1996, MOL CELL BIOL, V16, P1567; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Zvonic S, 2006, DIABETES, V55, P962, DOI 10.2337/diabetes.55.04.06.db05-0873	53	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e12991	10.1371/journal.pone.0012991	http://dx.doi.org/10.1371/journal.pone.0012991			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20885999	Green Submitted, Green Published, gold			2022-12-27	WOS:000282167100006
J	James, MH; Charnley, JL; Jones, E; Levi, EM; Yeoh, JW; Flynn, JR; Smith, DW; Dayas, CV				James, Morgan H.; Charnley, Janine L.; Jones, Emma; Levi, Emily M.; Yeoh, Jiann Wei; Flynn, Jamie R.; Smith, Douglas W.; Dayas, Christopher V.			Cocaine- and Amphetamine-Regulated Transcript (CART) Signaling within the Paraventricular Thalamus Modulates Cocaine-Seeking Behaviour	PLOS ONE			English	Article							CONTEXT-INDUCED REINSTATEMENT; CONDITIONED PLACE PREFERENCE; INDUCED LOCOMOTOR-ACTIVITY; NUCLEUS-ACCUMBENS SHELL; PREFRONTAL CORTEX; BASOLATERAL AMYGDALA; HYPOTHALAMIC CART; REWARD SEEKING; PEPTIDE 55-102; RAT	Background: Cocaine- and amphetamine-regulated transcript (CART) has been demonstrated to play a role in regulating the rewarding and reinforcing effects of various drugs of abuse. A recent study demonstrated that i.c.v. administration of CART negatively modulates reinstatement of alcohol seeking, however, the site(s) of action remains unclear. We investigated the paraventricular thalamus (PVT) as a potential site of relapse-relevant CART signaling, as this region is known to receive dense innervation from CART-containing hypothalamic cells and to project to a number of regions known to be involved in mediating reinstatement, including the nucleus accumbens (NAC), medial prefrontal cortex (mPFC) and basolateral amygdala (BLA). Methodology/Principal Findings: Male rats were trained to self-administer cocaine before being extinguished to a set criterion. One day following extinction, animals received intra-PVT infusions of saline, tetrodotoxin (TTX; 2.5 ng), CART (0.625 mg or 2.5 mg) or no injection, followed by a cocaine prime (10 mg/kg, i.p.). Animals were then tested under extinction conditions for one hour. Treatment with either TTX or CART resulted in a significant attenuation of drug-seeking behaviour following cocaine-prime, with the 2.5 mg dose of CART having the greatest effect. This effect was specific to the PVT region, as misplaced injections of both TTX and CART resulted in responding that was identical to controls. Conclusions/Significance: We show for the first time that CART signaling within the PVT acts to inhibit drug-primed reinstatement of cocaine seeking behaviour, presumably by negatively modulating PVT efferents that are important for drug seeking, including the NAC, mPFC and BLA. In this way, we identify a possible target for future pharmacological interventions designed to suppress drug seeking.	[James, Morgan H.] Univ Newcastle, Sch Biomed Sci & Pharm, Neurobiol Addict Lab, Newcastle, NSW 2308, Australia; Univ Newcastle, Ctr Brain & Mental Hlth Res, Newcastle, NSW 2308, Australia; Hunter Med Res Inst, Newcastle, NSW, Australia	University of Newcastle; University of Newcastle; Hunter Medical Research Institute; University of Newcastle	James, MH (corresponding author), Univ Newcastle, Sch Biomed Sci & Pharm, Neurobiol Addict Lab, Newcastle, NSW 2308, Australia.	Christopher.Dayas@newcastle.edu.au	Smith, Doug/ABC-3773-2021; Dayas, Chris/ABE-9173-2020; James, Morgan/AEM-8428-2022; Dayas, Chris/C-2158-2009	James, Morgan/0000-0001-9298-8607; Dayas, Christopher/0000-0002-9175-3854; Smith, Doug/0000-0002-4406-8061; Flynn, Jamie/0000-0002-3429-9421; Yeoh, Jiann Wei/0000-0001-8746-3769	National Health and Medical Research Council of Australia; Hunter Medical Research Institute	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Hunter Medical Research Institute	This work was supported by project grants from the National Health and Medical Research Council of Australia and the Hunter Medical Research Institute to C. V. D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SM, 2006, NEUROPSYCHOPHARMACOL, V31, P1452, DOI 10.1038/sj.npp.1300922; Bhatnagar S, 2002, J NEUROENDOCRINOL, V14, P403, DOI 10.1046/j.0007-1331.2002.00792.x; Bubser M, 1998, BRAIN RES, V787, P304, DOI 10.1016/S0006-8993(97)01373-5; CAINE B, 1992, BEHAV NEUROSCIENCE P, P117; CHRISTIE MJ, 1987, NEUROSCIENCE, V22, P425, DOI 10.1016/0306-4522(87)90345-9; CORNWALL J, 1988, BRAIN RES BULL, V21, P147, DOI 10.1016/0361-9230(88)90227-4; Couceyro PR, 2005, J PHARMACOL EXP THER, V315, P1091, DOI 10.1124/jpet.105.091678; Dallvechia-Adams S, 2002, J COMP NEUROL, V448, P360, DOI 10.1002/cne.10268; Davidowa H, 2005, NEUROENDOCRINOL LETT, V26, P29; Dayas CV, 2008, BIOL PSYCHIAT, V63, P152, DOI 10.1016/j.biopsych.2007.02.002; Dayas CV, 2007, BIOL PSYCHIAT, V61, P979, DOI 10.1016/j.biopsych.2006.07.034; DONG WK, 1978, J NEUROPHYSIOL, V41, P1592, DOI 10.1152/jn.1978.41.6.1592; Douglass J, 1996, GENE, V169, P241, DOI 10.1016/0378-1119(96)88651-3; Fuchs RA, 2005, NEUROPSYCHOPHARMACOL, V30, P296, DOI 10.1038/sj.npp.1300579; Fuchs RA, 2008, PSYCHOPHARMACOLOGY, V200, P545, DOI 10.1007/s00213-008-1234-4; Ghitza UE, 2003, J NEUROSCI, V23, P7239; GIESLER GJ, 1981, J COMP NEUROL, V195, P243, DOI 10.1002/cne.901950205; Hamlin AS, 2009, EUR J NEUROSCI, V29, P802, DOI 10.1111/j.1460-9568.2009.06623.x; Huang H, 2006, J NEUROPHYSIOL, V95, P1656, DOI 10.1152/jn.00927.2005; Hubert GW, 2010, NEUROSCIENCE, V165, P179, DOI 10.1016/j.neuroscience.2009.10.013; HUBERT GW, 2007, BIOCH PHARM; Jaworski JN, 2007, NEUROPEPTIDES, V41, P65, DOI 10.1016/j.npep.2006.12.003; Jaworski JN, 2003, J PHARMACOL EXP THER, V307, P1038, DOI 10.1124/jpet.103.052332; Kelley AE, 2005, J COMP NEUROL, V493, P72, DOI 10.1002/cne.20769; Kim JH, 2003, NEUROPEPTIDES, V37, P369, DOI 10.1016/j.npep.2003.10.001; Kimmel HL, 2000, J PHARMACOL EXP THER, V294, P784; King BJ, 2010, BEHAV NEUROSCI, V124, P423, DOI 10.1037/a0019540; Kirouac GJ, 2006, J COMP NEUROL, V497, P155, DOI 10.1002/cne.20971; Kirouac GJ, 2005, BRAIN RES, V1059, P179, DOI 10.1016/j.brainres.2005.08.035; Koylu EO, 1998, J COMP NEUROL, V391, P115; Kristensen P, 1998, NATURE, V393, P72, DOI 10.1038/29993; Li S, 2008, J COMP NEUROL, V506, P263, DOI 10.1002/cne.21502; Nakahara K, 2004, J VET MED SCI, V66, P1297, DOI 10.1292/jvms.66.1297; Otake K, 1998, NEUROSCIENCE, V86, P635, DOI 10.1016/S0306-4522(98)00062-1; Parsons MP, 2007, J COMP NEUROL, V500, P1050, DOI 10.1002/cne.21224; Parsons MP, 2006, SYNAPSE, V59, P480, DOI 10.1002/syn.20264; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Pinto A, 2003, J COMP NEUROL, V459, P142, DOI 10.1002/cne.10596; Rademacher DJ, 2010, PSYCHOPHARMACOLOGY, V208, P499, DOI 10.1007/s00213-009-1748-4; Rogge G, 2008, NAT REV NEUROSCI, V9, P747, DOI 10.1038/nrn2493; Spencer SJ, 2004, BRAIN RES, V997, P234, DOI 10.1016/j.brainres.2003.10.054; Vertes RP, 2008, J COMP NEUROL, V508, P212, DOI 10.1002/cne.21679; Yoon HS, 2010, BEHAV BRAIN RES, V207, P169, DOI 10.1016/j.bbr.2009.10.003; Young CD, 1998, PHARMACOL BIOCHEM BE, V60, P753, DOI 10.1016/S0091-3057(98)00051-3	44	87	88	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12980	10.1371/journal.pone.0012980	http://dx.doi.org/10.1371/journal.pone.0012980			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886038	Green Published, Green Submitted, gold			2022-12-27	WOS:000282091100061
J	Kil, DY; Boler, BMV; Apanavicius, CJ; Schook, LB; Swanson, KS				Kil, Dong Yong; Boler, Brittany M. Vester; Apanavicius, Carolyn J.; Schook, Lawrence B.; Swanson, Kelly S.			Gene Expression Profiles of Colonic Mucosa in Healthy Young Adult and Senior Dogs	PLOS ONE			English	Article							TISSUE-GROWTH-FACTOR; GLUCAGON-LIKE PEPTIDE-1; NITRIC-OXIDE; MICROARRAY ANALYSIS; PROTEIN; DIET; AGE; METASTASIS; METABOLISM; PHOSPHORYLATION	Background: We have previously reported the effects of age and diet on nutrient digestibility, intestinal morphology, and large intestinal fermentation patterns in healthy young adult and senior dogs. However, a genome-wide molecular analysis of colonic mucosa as a function of age and diet has not yet been performed in dogs. Methodology/Principal Findings: Colonic mucosa samples were collected from six senior (12-year old) and six young adult (1-year old) female beagles fed one of two diets (animal protein-based vs. plant protein-based) for 12 months. Total RNA in colonic mucosa was extracted and hybridized to Affymetrix GeneChip (R) Canine Genome Arrays. Results indicated that the majority of gene expression changes were due to age (212 genes) rather than diet (66 genes). In particular, the colonic mucosa of senior dogs had increased expression of genes associated with cell proliferation, inflammation, stress response, and cellular metabolism, whereas the expression of genes associated with apoptosis and defensive mechanisms were decreased in senior vs. young adult dogs. No consistent diet-induced alterations in gene expression existed in both age groups, with the effects of diet being more pronounced in senior dogs than in young adult dogs. Conclusion: Our results provide molecular insight pertaining to the aged canine colon and its predisposition to dysfunction and disease. Therefore, our data may aid in future research pertaining to age-associated gastrointestinal physiological changes and highlight potential targets for dietary intervention to limit their progression.	[Kil, Dong Yong; Boler, Brittany M. Vester; Apanavicius, Carolyn J.; Schook, Lawrence B.; Swanson, Kelly S.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Schook, Lawrence B.; Swanson, Kelly S.] Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA; [Swanson, Kelly S.] Univ Illinois, Dept Vet Clin Med, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Kil, DY (corresponding author), Univ Illinois, Dept Anim Sci, 328 Mumford Hall, Urbana, IL 61801 USA.	ksswanso@illinois.edu		Swanson, Kelly/0000-0001-5518-3076; Schook, Lawrence/0000-0002-6580-8364	Pyxis Genomics, Inc., Chicago, Illinois; National Center for Supercomputing Applications; University of Illinois under NCSA/UIUC	Pyxis Genomics, Inc., Chicago, Illinois; National Center for Supercomputing Applications; University of Illinois under NCSA/UIUC	This research was supported by Pyxis Genomics, Inc., Chicago, Illinois, and the National Center for Supercomputing Applications and the University of Illinois, under the auspices of the NCSA/UIUC Faculty Fellows Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AAFCO, 2004, OFF PUBL; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chang WJ, 2009, INT J CANCER, V125, P2844, DOI 10.1002/ijc.24699; Chen D, 2004, FRONT BIOSCI-LANDMRK, V9, P349, DOI 10.2741/1090; Choi SW, 2003, J NUTR, V133, P1206, DOI 10.1093/jn/133.4.1206; Commane DM, 2009, WORLD J GASTROENTERO, V15, P2479, DOI 10.3748/wjg.15.2479; DELEVE LD, 1991, PHARMACOL THERAPEUT, V52, P287, DOI 10.1016/0163-7258(91)90029-L; Deng YZ, 2007, J BIOL CHEM, V282, P36571, DOI 10.1074/jbc.M704141200; Diehn M, 2003, NUCLEIC ACIDS RES, V31, P219, DOI 10.1093/nar/gkg014; Drucker DJ, 2003, MOL ENDOCRINOL, V17, P161, DOI 10.1210/me.2002-0306; Eklof V, 2008, SCAND J CLIN LAB INV, V68, P393, DOI 10.1080/00365510701805431; Fitch MD, 1999, AM J PHYSIOL-GASTR L, V277, pG31, DOI 10.1152/ajpgi.1999.277.1.G31; Gamlem H, 2008, APMIS, V116, P5, DOI 10.1111/j.1600-0463.2008.125m2.x; Ghatei MA, 2001, DIGEST DIS SCI, V46, P1255, DOI 10.1023/A:1010615429639; Hameed S, 2009, ORAL DIS, V15, P18, DOI 10.1111/j.1601-0825.2008.01492.x; Harding MA, 2007, UROL ONCOL-SEMIN ORI, V25, P401, DOI 10.1016/j.urolonc.2007.05.006; Henderson B, 2010, CELL BIOCHEM FUNCT, V28, P1, DOI 10.1002/cbf.1609; Henderson NC, 2009, IMMUNOL REV, V230, P160, DOI 10.1111/j.1600-065X.2009.00794.x; Hoops TC, 1997, HEMATOL ONCOL CLIN N, V11, P609, DOI 10.1016/S0889-8588(05)70453-6; Hunt ND, 2006, AGEING RES REV, V5, P125, DOI 10.1016/j.arr.2006.03.006; IGARASHI A, 1993, MOL BIOL CELL, V4, P637, DOI 10.1091/mbc.4.6.637; JAMES SP, 1993, DIGEST DIS, V11, P146, DOI 10.1159/000171407; Kato T, 2001, NEOPLASIA, V3, P4, DOI 10.1038/sj.neo.7900132; Keklikoglu N, 2008, DIGEST DIS SCI, V53, P1437, DOI 10.1007/s10620-007-0061-5; Kersten C, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-9; Kiss-Toth E, 2004, J BIOL CHEM, V279, P42703, DOI 10.1074/jbc.M407732200; Kiyokawa N, 2004, MODERN PATHOL, V17, P423, DOI 10.1038/modpathol.3800079; Kleinschmidt S, 2008, RES VET SCI, V84, P41, DOI 10.1016/j.rvsc.2007.03.009; Kone BC, 2003, AM J PHYSIOL-RENAL, V285, pF178, DOI 10.1152/ajprenal.00048.2003; Kuzmuk KN, 2005, J NUTR, V135, P1940, DOI 10.1093/jn/135.8.1940; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Lee DM, 2009, ASIAN AUSTRAL J ANIM, V22, P1091, DOI 10.5713/ajas.2009.90009; Lee HM, 2001, MECH AGEING DEV, V122, P355, DOI 10.1016/S0047-6374(00)00254-2; Lee RHK, 2007, EMBO J, V26, P3592, DOI 10.1038/sj.emboj.7601781; Lefevre M, 2008, METABOLISM, V57, pS52, DOI 10.1016/j.metabol.2008.03.005; Lin BR, 2005, GASTROENTEROLOGY, V128, P9, DOI 10.1053/j.gastro.2004.10.007; LUK GD, 1990, BIOCHEM SOC T, V18, P1090, DOI 10.1042/bst0181090; MacFarlane G.T., 1991, LARGE INTESTINE PHYS, P51; Middelbos IS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004481; Mollenhauer J, 2002, CANCER DETECT PREV, V26, P266, DOI 10.1016/S0361-090X(02)00094-6; Mori M, 1999, BRIT J CANCER, V79, P211, DOI 10.1038/sj.bjc.6690035; Mukherjee AB, 2007, ENDOCR REV, V28, P707, DOI 10.1210/er.2007-0018; Notterman DA, 2001, CANCER RES, V61, P3124; O'Keefe SJD, 2008, CURR OPIN GASTROEN, V24, P51, DOI 10.1097/MOG.0b013e3282f323f3; Ozawa H, 1995, CELL STRUCT FUNCT, V20, P415, DOI 10.1247/csf.20.415; Pal R, 2006, STEM CELLS DEV, V15, P29, DOI 10.1089/scd.2006.15.29; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pederson L, 2008, P NATL ACAD SCI USA, V105, P20764, DOI 10.1073/pnas.0805133106; Pool-Zobel B, 2005, MUTAT RES-FUND MOL M, V591, P74, DOI 10.1016/j.mrfmmm.2005.04.020; Pyronnet S, 2008, MOL CELL ENDOCRINOL, V286, P230, DOI 10.1016/j.mce.2008.02.002; Rodriguez-Cabezas ME, 2002, J NUTR, V132, P3263, DOI 10.1093/jn/132.11.3263; Saksena S, 2009, AM J PHYSIOL-GASTR L, V297, pG878, DOI 10.1152/ajpgi.00283.2009; Scharlau D, 2009, MUTAT RES-REV MUTAT, V682, P39, DOI 10.1016/j.mrrev.2009.04.001; SCHJOLDAGER BTG, 1989, DIGEST DIS SCI, V34, P703, DOI 10.1007/BF01540341; Shouse GP, 2008, MOL CELL BIOL, V28, P448, DOI 10.1128/MCB.00983-07; Smyth G., 2004, LINEAR MODELS EMPIRI; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Swanson KS, 2009, NEUROBIOL AGING, V30, P1314, DOI 10.1016/j.neurobiolaging.2007.10.017; Swanson KS, 2009, ARCH ANIM NUTR, V63, P160, DOI 10.1080/17450390902733934; Swanson KS, 2004, J ANIM SCI, V82, P1713; Swanson KS, 2003, J NUTR, V133, P3033, DOI 10.1093/jn/133.10.3033; Tardy C, 2009, BBA-MOL CELL RES, V1793, P1250, DOI 10.1016/j.bbamcr.2009.03.007; Tulassay Z, 1998, SCAND J GASTROENTERO, V33, P115, DOI 10.1080/003655298750026642; Urieli-Shoval S, 1998, J HISTOCHEM CYTOCHEM, V46, P1377, DOI 10.1177/002215549804601206; VANSCHAFTINGEN E, 1994, FASEB J, V8, P414, DOI 10.1096/fasebj.8.6.8168691; Velayos-Baeza A, 2004, GENOMICS, V84, P536, DOI 10.1016/j.ygeno.2004.04.012; Velazquez OC, 1997, ADV EXP MED BIOL, V427, P123; Vester BM, 2009, BRIT J NUTR, V102, P1136, DOI 10.1017/S0007114509371652; VOGEL VG, 1989, HEMATOL ONCOL CLIN N, V3, P35, DOI 10.1016/S0889-8588(18)30566-5; Voutsadakis IA, 2008, BBA-MOL BASIS DIS, V1782, P800, DOI 10.1016/j.bbadis.2008.06.007; Wang YL, 1999, J BIOL CHEM, V274, P22095, DOI 10.1074/jbc.274.31.22095; Watson AJM, 2006, CRIT REV ONCOL HEMAT, V57, P107, DOI 10.1016/j.critrevonc.2005.06.005; Williams EA, 2003, P NUTR SOC, V62, P107, DOI 10.1079/PNS2002230; Willms B, 1996, J CLIN ENDOCR METAB, V81, P327, DOI 10.1210/jc.81.1.327; Wu CC, 2006, EUR J CANCER, V42, P557, DOI 10.1016/j.ejca.2005.11.015; Xie D, 2001, CANCER RES, V61, P8917; XU LL, 1995, J IMMUNOL, V155, P1184; Xu YF, 2007, HUM MOL GENET, V16, pR14, DOI 10.1093/hmg/ddl486; Yang F, 2005, CANCER RES, V65, P8887, DOI 10.1158/0008-5472.CAN-05-1702; Yang GY, 2009, METHODS MOL BIOL, V512, P119, DOI 10.1007/978-1-60327-530-9_8; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814; Zhou X, 2007, P NATL ACAD SCI USA, V104, P3919, DOI 10.1073/pnas.0608360104	82	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12882	10.1371/journal.pone.0012882	http://dx.doi.org/10.1371/journal.pone.0012882			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877568	Green Published, Green Submitted, gold			2022-12-27	WOS:000282053100027
J	Li, LC; Preuss, TM; Rilling, JK; Hopkins, WD; Glasser, MF; Kumar, B; Nana, R; Zhang, XD; Hu, XP				Li, Longchuan; Preuss, Todd M.; Rilling, James K.; Hopkins, William D.; Glasser, Matthew F.; Kumar, Bhargav; Nana, Roger; Zhang, Xiaodong; Hu, Xiaoping			Chimpanzee (Pan troglodytes) Precentral Corticospinal System Asymmetry and Handedness: A Diffusion Magnetic Resonance Imaging Study	PLOS ONE			English	Article							PRIMARY MOTOR CORTEX; COORDINATED BIMANUAL TASK; ECHO-PLANAR IMAGES; WHITE-MATTER; TOOL-USE; HUMAN BRAIN; SPATIAL STATISTICS; WILD CHIMPANZEES; HAND PREFERENCES; STRUCTURAL ASYMMETRIES	Background: Most humans are right handed, and most humans exhibit left-right asymmetries of the precentral corticospinal system. Recent studies indicate that chimpanzees also show a population-level right-handed bias, although it is less strong than in humans. Methodology/Principal Findings: We used in vivo diffusion-weighted and T1-weighted magnetic resonance imaging (MRI) to study the relationship between the corticospinal tract (CST) and handedness in 36 adult female chimpanzees. Chimpanzees exhibited a hemispheric bias in fractional anisotropy (FA, left. right) and mean diffusivity (MD, right. left) of the CST, and the left CST was centered more posteriorly than the right. Handedness correlated with central sulcus depth, but not with FA or MD. Conclusions/Significance: These anatomical results are qualitatively similar to those reported in humans, despite the differences in handedness. The existence of a left. right FA, right. left MD bias in the corticospinal tract that does not correlate with handedness, a result also reported in some human studies, suggests that at least some of the structural asymmetries of the corticospinal system are not exclusively related to laterality of hand preference.	[Li, Longchuan; Hu, Xiaoping] Emory Univ, Biomed Imaging Technol Ctr, Atlanta, GA 30322 USA; [Preuss, Todd M.; Zhang, Xiaodong] Yerkes Natl Primate Res Ctr, Div Neurosci, Atlanta, GA USA; [Preuss, Todd M.] Emory Univ, Dept Pathol, Atlanta, GA 30322 USA; [Preuss, Todd M.; Rilling, James K.] Emory Univ, Ctr Behav Neurosci, Atlanta, GA 30322 USA; [Rilling, James K.; Hopkins, William D.] Yerkes Natl Primate Res Ctr, Div Psychobiol, Atlanta, GA USA; [Rilling, James K.; Glasser, Matthew F.] Emory Univ, Dept Anthropol, Atlanta, GA 30322 USA; [Rilling, James K.] Emory Univ, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA; [Hopkins, William D.] Agnes Scott Coll, Dept Psychol, Decatur, GA 30030 USA; [Kumar, Bhargav; Nana, Roger; Hu, Xiaoping] Emory Univ, Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Emory University; Emory University; Emory University; University System of Georgia; Georgia Institute of Technology	Li, LC (corresponding author), Emory Univ, Biomed Imaging Technol Ctr, Atlanta, GA 30322 USA.	xhu3@emory.edu	Preuss, Todd/GSI-6571-2022; Glasser, Matthew Frederick/AAE-7291-2019; Li, Longchuan/C-7619-2012	Li, Longchuan/0000-0002-0559-0754; Hu, Xiaoping/0000-0001-7014-5983	National Institutes of Health [5P01 AG026423-03, NS-42867, HD-56232]; Yerkes National Primate Research Center [RR-00165]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD056232] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG026423] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yerkes National Primate Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was kindly supported by the National Institutes of Health (http://www.nih.gov/; 5P01 AG026423-03, NS-42867 and HD-56232) and Yerkes National Primate Research Center (http://www.yerkes.emory.edu/; RR-00165). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2004, NMR BIOMED, V17, P411, DOI 10.1002/nbm.907; Alexander AL, 1997, MAGN RESON MED, V38, P1016, DOI 10.1002/mrm.1910380623; Amunts K, 1996, NEUROIMAGE, V4, P216, DOI 10.1006/nimg.1996.0073; Amunts K, 2000, NEUROPSYCHOLOGIA, V38, P304, DOI 10.1016/S0028-3932(99)00075-5; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Anjari M, 2007, NEUROIMAGE, V35, P1021, DOI 10.1016/j.neuroimage.2007.01.035; Annett M, 2004, BRIT J PSYCHOL, V95, P339, DOI 10.1348/0007126041528130; Annett M, 1996, NEUROSCI BIOBEHAV R, V20, P631, DOI 10.1016/0149-7634(95)00076-3; Annett M, 2002, HANDEDNESS BRAIN ASY; Bailey P, 1950, ISOCORTEX CHIMPANZEE; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Biro D, 2003, ANIM COGN, V6, P213, DOI 10.1007/s10071-003-0183-x; Boesch C, 2009, J HUM EVOL, V56, P560, DOI 10.1016/j.jhevol.2009.04.001; Bradshaw JL., 1993, EVOLUTION LATERAL AS; Bradshaw John., 1998, HUMAN EVOLUTION NEUR; Bril B, 2009, ANIM COGN, V12, P217, DOI 10.1007/s10071-008-0184-x; Buchel C, 2004, CEREB CORTEX, V14, P945, DOI 10.1093/cercor/bhh055; Burgel U, 2006, NEUROIMAGE, V29, P1092, DOI 10.1016/j.neuroimage.2005.08.040; BYRNE RW, 1991, CORTEX, V27, P521, DOI 10.1016/S0010-9452(13)80003-2; Ciccarelli O, 2006, BRAIN, V129, P1859, DOI 10.1093/brain/awl100; Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422; Corballis M. C, 1992, LOPSIDED BRAIN EVOLU; Corp N, 2004, AM J PHYS ANTHROPOL, V123, P62, DOI 10.1002/ajpa.10218; Crow T, 2004, LATERALITY, V9, P233, DOI 10.1080/13576500342000374; Dadda M, 2006, NEUROPSYCHOLOGIA, V44, P2582, DOI 10.1016/j.neuropsychologia.2006.03.037; DAVIDOFF RA, 1990, NEUROLOGY, V40, P332; Della Nave R, 2008, NEUROIMAGE, V43, P10, DOI 10.1016/j.neuroimage.2008.06.036; Dubois J, 2010, NEUROIMAGE, V52, P32, DOI 10.1016/j.neuroimage.2010.03.054; Dubois J, 2009, CEREB CORTEX, V19, P414, DOI 10.1093/cercor/bhn097; EBELING U, 1992, ACTA NEUROCHIR, V118, P164, DOI 10.1007/BF01401303; Foundas AL, 1998, NEUROPSY NEUROPSY BE, V11, P65; Frey SH, 2005, J COGNITIVE NEUROSCI, V17, P262, DOI 10.1162/0898929053124974; Gong GL, 2005, NEUROREPORT, V16, P1701, DOI 10.1097/01.wnr.0000183327.98370.6a; Guye M, 2003, NEUROIMAGE, V19, P1349, DOI 10.1016/S1053-8119(03)00165-4; Habas C, 2007, NEURORADIOLOGY, V49, P849, DOI 10.1007/s00234-007-0267-4; Hammond G, 2002, NEUROSCI BIOBEHAV R, V26, P285, DOI 10.1016/S0149-7634(02)00003-9; Herve PY, 2009, HUM BRAIN MAPP, V30, P3151, DOI 10.1002/hbm.20734; Hopkins W. D., 2007, EVOLUTIONARY COGNITI, P99; Hopkins WD, 2005, LATERALITY, V10, P121, DOI 10.1080/13576500342000347; Hopkins WD, 2004, BEHAV NEUROSCI, V118, P1176, DOI 10.1037/0735-7044.118.6.1176; Hopkins WD, 2004, BEHAV NEUROSCI, V118, P659, DOI 10.1037/0735-7044.118.3.659; Hopkins WD, 2003, AM J PHYS ANTHROPOL, V121, P378, DOI 10.1002/ajpa.10170; Hopkins WD, 2001, J COMP PSYCHOL, V115, P294, DOI 10.1037/0735-7036.115.3.294; HOPKINS WD, 1995, J COMP PSYCHOL, V109, P291, DOI 10.1037/0735-7036.109.3.291; Hopkins WD, 2007, PSYCHOL SCI, V18, P971, DOI 10.1111/j.1467-9280.2007.02011.x; Hopkins WD, 2007, EUR J NEUROSCI, V25, P2565, DOI 10.1111/j.1460-9568.2007.05502.x; Hopkins WD, 2006, PSYCHOL BULL, V132, P538, DOI 10.1037/0033-2909.132.4.538; Humle T, 2009, AM J PRIMATOL, V71, P40, DOI 10.1002/ajp.20616; Jones DK, 2008, CORTEX, V44, P936, DOI 10.1016/j.cortex.2008.05.002; Jones DK, 1999, MAGN RESON MED, V42, P37, DOI 10.1002/(SICI)1522-2594(199907)42:1<37::AID-MRM7>3.0.CO;2-O; KERTESZ A, 1971, ARCH NEUROL-CHICAGO, V24, P326, DOI 10.1001/archneur.1971.00480340058006; Kochunov P, 2007, NEUROIMAGE, V35, P478, DOI 10.1016/j.neuroimage.2006.12.021; Kroliczak G, 2009, CEREB CORTEX, V19, P2396, DOI 10.1093/cercor/bhn261; Kumar A, 2009, AM J NEURORADIOL, V30, P1963, DOI 10.3174/ajnr.A1742; Li LC, 2009, HUM BRAIN MAPP, V30, P3265, DOI 10.1002/hbm.20747; Lonsdorf EV, 2005, P NATL ACAD SCI USA, V102, P12634, DOI 10.1073/pnas.0505806102; Marchant LF, 2007, PRIMATES, V48, P22, DOI 10.1007/s10329-006-0020-3; Martin RF, 1996, NEUROIMAGE, V4, P119, DOI 10.1006/nimg.1996.0036; MCMANUS C, 2002, RIGHT HAND LEFT HAND; Morecraft RJ, 2002, BRAIN, V125, P176, DOI 10.1093/brain/awf011; Nagae-Poetscher LM, 2004, AM J NEURORADIOL, V25, P1325; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nieuwenhuys R, 2007, HUMAN CENTRAL NERVOU; Okada T, 2006, RADIOLOGY, V240, P849, DOI 10.1148/radiol.2403050916; Park HJ, 2004, NEUROIMAGE, V23, P213, DOI 10.1016/j.neuroimage.2004.04.036; Parker GJM, 2005, NEUROIMAGE, V24, P656, DOI 10.1016/j.neuroimage.2004.08.047; PERELLE IB, 1994, BEHAV GENET, V24, P217, DOI 10.1007/BF01067189; Phillips KA, 2005, BEHAV NEUROSCI, V119, P1701, DOI 10.1037/0735-7044.119.6.1701; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Porac C, 1981, LATERAL PREFERENCES; Rademacher J, 2001, BRAIN, V124, P2232, DOI 10.1093/brain/124.11.2232; Raymond M, 2004, LATERALITY, V9, P35, DOI 10.1080/13576500244000274; Reich DS, 2006, AM J NEURORADIOL, V27, P2168; Richards T, 2008, AM J NEURORADIOL, V29, P1134, DOI 10.3174/ajnr.A1007; Rogers LJ, 2002, COMP VERTEBRATE LATE; Schmahmann JD, 2004, J COMP NEUROL, V478, P248, DOI 10.1002/cne.20286; Sherwood CC, 2003, ANAT REC PART A, V271A, P276, DOI 10.1002/ar.a.10046; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 1997, INT J COMPUT VISION, V23, P45, DOI 10.1023/A:1007963824710; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Stieltjes B, 2001, NEUROIMAGE, V14, P723, DOI 10.1006/nimg.2001.0861; Taglialatela JP, 2006, NEUROREPORT, V17, P923, DOI 10.1097/01.wnr.0000221835.26093.5e; THATCHER RW, 1987, SCIENCE, V236, P1110, DOI 10.1126/science.3576224; Toga AW, 2003, NAT REV NEUROSCI, V4, P37, DOI 10.1038/nrn1009; Vallortigara G, 2005, BEHAV BRAIN SCI, V28, P575, DOI 10.1017/S0140525X05000105; WARREN JM, 1980, PHYSIOL PSYCHOL, V8, P351, DOI 10.3758/BF03337470; Westerhausen R, 2007, NEUROIMAGE, V37, P379, DOI 10.1016/j.neuroimage.2007.05.047; WHITE LE, 1994, NATURE, V368, P197, DOI 10.1038/368197a0; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	99	27	27	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2010	5	9							e12886	10.1371/journal.pone.0012886	http://dx.doi.org/10.1371/journal.pone.0012886			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652JO	20877630	Green Published, gold, Green Submitted			2022-12-27	WOS:000282002900018
J	Lefevre, L; Gales, A; Olagnier, D; Bernad, J; Perez, L; Burcelin, R; Valentin, A; Auwerx, J; Pipy, B; Coste, A				Lefevre, Lise; Gales, Amandine; Olagnier, David; Bernad, Jose; Perez, Laurence; Burcelin, Remy; Valentin, Alexis; Auwerx, Johan; Pipy, Bernard; Coste, Agnes			PPAR gamma Ligands Switched High Fat Diet-Induced Macrophage M2b Polarization toward M2a Thereby Improving Intestinal Candida Elimination	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; ADIPOSE-TISSUE; INSULIN-RESISTANCE; DIABETIC-PATIENTS; GENE-EXPRESSION; OBESITY; TOLL-LIKE-RECEPTOR-4; INDUCTION; PHENOTYPE; IMMUNITY	Obesity is associated with a chronic low-grade inflammation that predisposes to insulin resistance and the development of type 2 diabetes. In this metabolic context, gastrointestinal (GI) candidiasis is common. We recently demonstrated that the PPAR gamma ligand rosiglitazone promotes the clearance of Candida albicans through the activation of alternative M2 macrophage polarization. Here, we evaluated the impact of high fat diet (HFD)-induced obesity and the effect of rosiglitazone (PPAR gamma ligand) or WY14643 (PPAR alpha ligand) both on the phenotypic M1/M2 polarization of peritoneal and cecal tissue macrophages and on the outcome of GI candidiasis. We demonstrated that the peritoneal macrophages and the cell types present in the cecal tissue from HF fed mice present a M2b polarization (TNF-alpha(high), IL-10(high), MR, Dectin-1). Interestingly, rosiglitazone induces a phenotypic M2b-to-M2a (TNF-alpha(low), IL-10(low), MRhigh, Dectin-1(high)) switch of peritoneal macrophages and of the cells present in the cecal tissue. The incapacity of WY14643 to switch this polarization toward M2a state, strongly suggests the specific involvement of PPAR gamma in this mechanism. We showed that in insulin resistant mice, M2b polarization of macrophages present on the site of infection is associated with an increased susceptibility to GI candidiasis, whereas M2a polarization after rosiglitazone treatment favours the GI fungal elimination independently of reduced blood glucose. In conclusion, our data demonstrate a dual benefit of PPAR gamma ligands because they promote mucosal defence mechanisms against GI candidiasis through M2a macrophage polarization while regulating blood glucose level.	[Lefevre, Lise; Gales, Amandine; Olagnier, David; Bernad, Jose; Valentin, Alexis; Pipy, Bernard; Coste, Agnes] Univ Toulouse 3, Polarisat Macrophages & Recepteurs Nucl Pathol In, UMR MD3, EA2405, F-31062 Toulouse, France; [Lefevre, Lise; Gales, Amandine; Olagnier, David; Bernad, Jose; Valentin, Alexis; Pipy, Bernard; Coste, Agnes] Univ Mediterranee, Minist Defense, UMR MD3, RH2PT, Marseille, France; [Perez, Laurence; Burcelin, Remy] Rangueil Inst Mol Med, INSERM, U858, IFR31,I2MR, Toulouse, France; [Auwerx, Johan] Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol LISP, Lausanne, Switzerland	UDICE-French Research Universities; Aix-Marseille Universite; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Lefevre, L (corresponding author), Univ Toulouse 3, Polarisat Macrophages & Recepteurs Nucl Pathol In, UMR MD3, EA2405, F-31062 Toulouse, France.	agnes.coste@cict.fr	Agnès, Coste/AAK-9408-2020; Galès, Amandine/M-9066-2014; è-, ä/F-9947-2012; Valentin, Alexis/I-6821-2015; Auwerx, Johan/ABE-9307-2021; burcelin, remy/M-6013-2014	Valentin, Alexis/0000-0002-2133-112X; Pipy, Bernard/0000-0001-8060-7029; Auwerx, Johan/0000-0002-5065-5393; Lefevre, Lise/0000-0003-0237-6696; Coste, Agnes/0000-0001-7781-3323; Olagnier, David/0000-0001-6912-0674	Region Midi-Pyrenees [07005642]; Paul Sabatier Toulouse 3 University	Region Midi-Pyrenees(Region OccitanieRegion Provence-Alpes-Cote d'Azur); Paul Sabatier Toulouse 3 University	This work was supported by the Region Midi-Pyrenees grants (number: 07005642) and by Paul Sabatier Toulouse 3 University institutional funds (URL: http://www.ups-tlse.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors have no financial interest in this manuscript.	Aleshin S, 2009, MOL PHARMACOL, V76, P414, DOI 10.1124/mol.109.056010; Belazi M, 2005, MYCOSES, V48, P192, DOI 10.1111/j.1439-0507.2005.01124.x; Berry A, 2007, EUR J IMMUNOL, V37, P1642, DOI 10.1002/eji.200636625; Bourlier V, 2008, CIRCULATION, V117, P806, DOI 10.1161/CIRCULATIONAHA.107.724096; Caimi G, 2003, ACTA DIABETOL, V40, P14, DOI 10.1007/s005920300003; CHANG FY, 1995, DIABETES RES CLIN PR, V28, P137, DOI 10.1016/0168-8227(95)00168-8; Cho HY, 2010, AM J RESP CRIT CARE, V181; Coste A, 2003, IMMUNITY, V19, P329, DOI 10.1016/S1074-7613(03)00229-2; Coste A, 2002, J ANTIMICROB CHEMOTH, V49, P731, DOI 10.1093/jac/dkf011; Coste A, 2008, J IMMUNOL, V180, P4939, DOI 10.4049/jimmunol.180.7.4939; Fernandes-Santos C, 2009, NUTRITION, V25, P818, DOI 10.1016/j.nut.2008.12.010; Fernandez-Real JM, 2008, TRENDS ENDOCRIN MET, V19, P10, DOI 10.1016/j.tem.2007.10.004; Forsyth CB, 1998, J IMMUNOL, V161, P6198; Fruchart JC, 2009, ATHEROSCLEROSIS, V205, P1, DOI 10.1016/j.atherosclerosis.2009.03.008; Gales A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000714; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Greenfield JR, 2006, CURR DIABETES REV, V2, P195, DOI 10.2174/157339906776818532; Jiang T, 2010, DIABETES, V59, P850, DOI 10.2337/db09-1342; Khovidhunkit Siribang-on Piboonniyom, 2009, Journal of the Medical Association of Thailand, V92, P1220; Kim H, 2004, DIABETOLOGIA, V47, P2215, DOI 10.1007/s00125-004-1581-6; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lutsey PL, 2009, DIABETIC MED, V26, P149, DOI 10.1111/j.1464-5491.2008.02632.x; Ma XW, 2009, CHINESE MED J-PEKING, V122, P2123, DOI 10.3760/cma.j.issn.0366-6999.2009.18.009; MACEDO DP, 2010, MED MYCOL, P1; Mantovani A, 2004, SEMIN CANCER BIOL, V14, P155, DOI 10.1016/j.semcancer.2003.10.001; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Necela BM, 2008, IMMUNOLOGY, V125, P344, DOI 10.1111/j.1365-2567.2008.02849.x; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Shaul ME, 2010, DIABETES, V59, P1171, DOI 10.2337/db09-1402; Soysa NS, 2006, DIABETIC MED, V23, P455, DOI 10.1111/j.1464-5491.2005.01701.x; Szanto A, 2008, IMMUNOBIOLOGY, V213, P789, DOI 10.1016/j.imbio.2008.07.015; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; VidalPuig A, 1996, J CLIN INVEST, V97, P2553, DOI 10.1172/JCI118703; Viswanathan V, 2002, J Assoc Physicians India, V50, P1013; Zeyda M, 2007, INT J OBESITY, V31, P1420, DOI 10.1038/sj.ijo.0803632; Zhou JM, 2002, BIOCHEM BIOPH RES CO, V293, P274, DOI 10.1016/S0006-291X(02)00138-9; Zhou M, 2008, AM J PHYSIOL-REG I, V294, pR84, DOI 10.1152/ajpregu.00340.2007	39	60	65	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2010	5	9							e12828	10.1371/journal.pone.0012828	http://dx.doi.org/10.1371/journal.pone.0012828			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651YH	20877467	Green Published, gold, Green Submitted			2022-12-27	WOS:000281963200010
J	Thaker, M; Vanak, AT; Owen, CR; Ogden, MB; Slotow, R				Thaker, Maria; Vanak, Abi T.; Owen, Cailey R.; Ogden, Monika B.; Slotow, Rob			Group Dynamics of Zebra and Wildebeest in a Woodland Savanna: Effects of Predation Risk and Habitat Density	PLOS ONE			English	Article							LIONS PANTHERA-LEO; GROUP-SIZE; MAMMALIAN HERBIVORES; HUNTING SUCCESS; PREY; MECHANISMS; SELECTION; BEHAVIOR; CHOICE	Background: Group dynamics of gregarious ungulates in the grasslands of the African savanna have been well studied, but the trade-offs that affect grouping of these ungulates in woodland habitats or dense vegetation are less well understood. We examined the landscape-level distribution of groups of blue wildebeest, Connochaetes taurinus, and Burchell's zebra, Equus burchelli, in a predominantly woodland area (Karongwe Game Reserve, South Africa; KGR) to test the hypothesis that group dynamics are a function of minimizing predation risk from their primary predator, lion, Panthera leo. Methodology/Principal Findings: Using generalized linear models, we examined the relative importance of habitat type (differing in vegetation density), probability of encountering lion (based on utilization distribution of all individual lions in the reserve), and season in predicting group size and composition. We found that only in open scrub habitat, group size for both ungulate species increased with the probability of encountering lion. Group composition differed between the two species and was driven by habitat selection as well as predation risk. For both species, composition of groups was, however, dominated by males in open scrub habitats, irrespective of the probability of encountering lion. Conclusions/Significance: Distribution patterns of wildebeest and zebra groups at the landscape level directly support the theoretical and empirical evidence from a range of taxa predicting that grouping is favored in open habitats and when predation risk is high. Group composition reflected species-specific social, physiological and foraging constraints, as well as the importance of predation risk. Avoidance of high resource open scrub habitat by females can lead to loss of foraging opportunities, which can be particularly costly in areas such as KGR, where this resource is limited. Thus, landscape-level grouping dynamics are species specific and particular to the composition of the group, arising from a tradeoff between maximizing resource selection and minimizing predation risk.	[Thaker, Maria; Vanak, Abi T.; Owen, Cailey R.; Slotow, Rob] Univ KwaZulu Natal, Sch Biol & Conservat Sci, Durban, South Africa; [Owen, Cailey R.; Ogden, Monika B.] Karongwe Ecol Res Inst, Schagen, South Africa	University of Kwazulu Natal	Thaker, M (corresponding author), Univ KwaZulu Natal, Sch Biol & Conservat Sci, Durban, South Africa.	thaker@ukzn.ac.za	Slotow, Rob/AAM-9053-2020; Vanak, Abi/F-8519-2010	Vanak, Abi/0000-0003-2435-4260; Slotow, Rob/0000-0001-9469-1508; Thaker, Maria/0000-0001-6019-2639	Landowners of Karongwe Game Reserve; Global Vision International, University of KwaZulu-Natal (UKZN); National Research Foundation [2069358]; University of KwaZulu-Natal (UKZN)	Landowners of Karongwe Game Reserve; Global Vision International, University of KwaZulu-Natal (UKZN); National Research Foundation; University of KwaZulu-Natal (UKZN)	This project was funded by the landowners of Karongwe Game Reserve, and grants from Global Vision International, University of KwaZulu-Natal (UKZN), and the National Research Foundation (to RS, 2069358). ATV and MT were supported by postdoctoral fellowships from UKZN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cherry S, 1996, J WILDLIFE MANAGE, V60, P653, DOI 10.2307/3802084; Creel S, 2005, ANIM BEHAV, V69, P1181, DOI 10.1016/j.anbehav.2004.07.022; Cresswell W, 2004, OIKOS, V104, P71, DOI 10.1111/j.0030-1299.2004.12814.x; Ebensperger LA, 2002, OIKOS, V98, P491, DOI 10.1034/j.1600-0706.2002.980313.x; ESTES RD, 1991, BEHAV GUIDE AFRICAN; Fernandez-Juricic E, 2006, ANIM BEHAV, V71, P901, DOI 10.1016/j.anbehav.2005.09.008; Fischhoff IR, 2007, BEHAV ECOL, V18, P725, DOI 10.1093/beheco/arm036; FITZGIBBON CD, 1990, ANIM BEHAV, V40, P837, DOI 10.1016/S0003-3472(05)80984-4; Fortin D, 2004, ECOLOGY, V85, P2312, DOI 10.1890/03-0485; Fortin D, 2009, ECOLOGY, V90, P2480, DOI 10.1890/08-0345.1; FRYXELL JM, 1995, SERENGETI, V2, P257; Funston PJ, 2001, J ZOOL, V253, P419, DOI 10.1017/S0952836901000395; Galef BG, 2001, ANIM BEHAV, V61, P3, DOI 10.1006/anbe.2000.1557; Garton Edward O., 2001, P15, DOI 10.1016/B978-012497781-5/50003-7; Gitzen RA, 2006, J WILDLIFE MANAGE, V70, P1334, DOI 10.2193/0022-541X(2006)70[1334:BSFFAO]2.0.CO;2; Gude JA, 2006, ECOL APPL, V16, P285, DOI 10.1890/04-0623; Hebblewhite M, 2002, CAN J ZOOL, V80, P800, DOI 10.1139/Z02-059; Hill RA, 1998, J ZOOL, V245, P447, DOI 10.1111/j.1469-7998.1998.tb00119.x; HIRST SM, 1969, J WILDLIFE MANAGE, V33, P40, DOI 10.2307/3799648; Hobbs NT, 1996, ECOL APPL, V6, P200, DOI 10.2307/2269564; Hopcraft JGC, 2005, J ANIM ECOL, V74, P559, DOI 10.1111/j.1365-2656.2005.00955.x; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; Kauffman MJ, 2007, ECOL LETT, V10, P690, DOI 10.1111/j.1461-0248.2007.01059.x; Krause J, 2000, P ROY SOC B-BIOL SCI, V267, P2011, DOI 10.1098/rspb.2000.1243; KRAUSE J, 1995, ANIM BEHAV, V50, P465, DOI 10.1006/anbe.1995.0260; Krause J, 2002, LIVING GROUPS; Lehmann MB, 2008, S AFR J WILDL RES, V38, P66, DOI 10.3957/0379-4369-38.1.66; Lehmann MB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003998; Lett C, 2004, THEOR POPUL BIOL, V65, P263, DOI 10.1016/j.tpb.2003.10.005; Millspaugh JJ, 2006, J WILDLIFE MANAGE, V70, P384, DOI 10.2193/0022-541X(2006)70[384:AORSUU]2.0.CO;2; Molinari-Jobin A, 2004, ECOGRAPHY, V27, P323, DOI 10.1111/j.0906-7590.2004.03862.x; Mucina L., 2006, VEGETATION S AFRICA; Neuhaus P, 2002, CAN J ZOOL, V80, P1437, DOI 10.1139/Z02-126; Owen-Smith N, 2008, OIKOS, V117, P602, DOI 10.1111/j.0030-1299.2008.16309.x; Owen-Smith RN., 2002, ADAPTIVE HERBIVORE E, VStudent; PARRISH JK, 1993, ETHOLOGY, V95, P233; Pays O, 2007, ANIM BEHAV, V74, P1429, DOI 10.1016/j.anbehav.2007.02.012; Ranta Esa, 1994, Ecoscience, V1, P99; Redfern JV, 2006, OECOLOGIA, V146, P632, DOI 10.1007/s00442-005-0235-9; RODGERS AR, 2007, HRT HOME RANGE TOOLS; SCHEEL D, 1993, BEHAV ECOL, V4, P90, DOI 10.1093/beheco/4.1.90; Spieler M, 2003, ANIM BEHAV, V65, P179, DOI 10.1006/anbe.2002.2030; THAKER M, ECOLOGY IN PRESS, DOI DOI 10.1890/1810-0126.1891; Valeix M, 2009, BEHAV ECOL SOCIOBIOL, V63, P1483, DOI 10.1007/s00265-009-0760-3	45	39	39	5	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2010	5	9							e12758	10.1371/journal.pone.0012758	http://dx.doi.org/10.1371/journal.pone.0012758			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651YH	20862216	gold, Green Submitted, Green Published			2022-12-27	WOS:000281963200003
J	Schulz, E; Frechero, M; Appignanesi, G; Fernandez, A				Schulz, Erica; Frechero, Marisa; Appignanesi, Gustavo; Fernandez, Ariel			Sub-Nanoscale Surface Ruggedness Provides a Water-Tight Seal for Exposed Regions in Soluble Protein Structure	PLOS ONE			English	Article							HYDROPHOBICITY; DYNAMICS	Soluble proteins must maintain backbone hydrogen bonds (BHBs) water-tight to ensure structural integrity. This protection is often achieved by burying the BHBs or wrapping them through intermolecular associations. On the other hand, water has low coordination resilience, with loss of hydrogen-bonding partnerships carrying significant thermodynamic cost. Thus, a core problem in structural biology is whether natural design actually exploits the water coordination stiffness to seal the backbone in regions that are exposed to the solvent. This work explores the molecular design features that make this type of seal operative, focusing on the side-chain arrangements that shield the protein backbone. We show that an efficient sealing is achieved by adapting the sub-nanoscale surface topography to the stringency of water coordination: an exposed BHB may be kept dry if the local concave curvature is small enough to impede formation of the coordination shell of a penetrating water molecule. Examination of an exhaustive database of uncomplexed proteins reveals that exposed BHBs invariably occur within such sub-nanoscale cavities in native folds, while this level of local ruggedness is absent in other regions. By contrast, BHB exposure in misfolded proteins occurs with larger local curvature promoting backbone hydration and consequently, structure disruption. These findings unravel physical constraints fitting a spatially dependent least-action for water coordination, introduce a molecular design concept, and herald the advent of water-tight peptide-based materials with sufficient backbone exposure to remain flexible.	[Schulz, Erica; Frechero, Marisa; Appignanesi, Gustavo] Univ Nacl Sur, Secc Fisicoquim, Inst Quim Sur, Consejo Nacl Invest Cientif & Tecn, RA-8000 Bahia Blanca, Buenos Aires, Argentina; [Schulz, Erica; Frechero, Marisa; Appignanesi, Gustavo] Univ Nacl Sur, Dept Quim, RA-8000 Bahia Blanca, Buenos Aires, Argentina; [Fernandez, Ariel] Rice Univ, Dept Bioengn, Houston, TX USA; [Fernandez, Ariel] Univ Chicago, Dept Comp Sci, Chicago, IL 60637 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the South; National University of the South; Rice University; University of Chicago	Schulz, E (corresponding author), Univ Nacl Sur, Secc Fisicoquim, Inst Quim Sur, Consejo Nacl Invest Cientif & Tecn, RA-8000 Bahia Blanca, Buenos Aires, Argentina.	arifer@rice.edu	Frechero, Marisa A./B-8286-2011; Fernandez, Ariel/I-7925-2016	Fernandez, Ariel/0000-0002-5102-4294	NIH [R01GM072614]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072614] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research of Ariel Fernandez is supported by NIH grant R01GM072614. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin RL, 2003, J BIOL CHEM, V278, P17581, DOI 10.1074/jbc.X200009200; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Fernandez A, 2004, NAT BIOTECHNOL, V22, P1081, DOI 10.1038/nbt0904-1081; Fernandez A, 2003, P NATL ACAD SCI USA, V100, P113, DOI 10.1073/pnas.0136888100; Fernandez A, 2010, TRANSFORMATIVE CONCEPTS FOR DRUG DESIGN: TARGET WRAPPING, P1, DOI 10.1007/978-3-642-11792-3_1; Gerstein M, 1996, P NATL ACAD SCI USA, V93, P10167, DOI 10.1073/pnas.93.19.10167; Giovambattista N, 2008, P NATL ACAD SCI USA, V105, P2274, DOI 10.1073/pnas.0708088105; Giovambattista N, 2009, P NATL ACAD SCI USA, V106, P15181, DOI 10.1073/pnas.0905468106; HOLM L, 1992, J MOL BIOL, V225, P93, DOI 10.1016/0022-2836(92)91028-N; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kumar P, 2009, P NATL ACAD SCI USA, V106, P22130, DOI 10.1073/pnas.0911094106; Lazaridis T, 1999, J MOL BIOL, V288, P477, DOI 10.1006/jmbi.1999.2685; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; MACKINNON R, 1988, NEURON, V1, P997, DOI 10.1016/0896-6273(88)90156-0; Malaspina DC, 2010, EUR PHYS J E, V32, P35, DOI 10.1140/epje/i2010-10594-2; Pietrosemoli N, 2007, J PROTEOME RES, V6, P3519, DOI 10.1021/pr070208k; POWERS ET, 2006, ADV PROTEIN CHEM, V72, P40; Rizzo RC, 1999, J AM CHEM SOC, V121, P4827, DOI 10.1021/ja984106u; Stokely K, 2010, P NATL ACAD SCI USA, V107, P1301, DOI 10.1073/pnas.0912756107; Street AG, 1998, FOLD DES, V3, P253, DOI 10.1016/S1359-0278(98)00036-4; Zhang NG, 2004, PROTEINS, V57, P565, DOI 10.1002/prot.20191	23	15	16	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2010	5	9							e12844	10.1371/journal.pone.0012844	http://dx.doi.org/10.1371/journal.pone.0012844			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651XL	20862253	gold, Green Published, Green Submitted			2022-12-27	WOS:000281960800029
J	Govindaraj, RG; Manavalan, B; Lee, G; Choi, S				Govindaraj, Rajiv Gandhi; Manavalan, Balachandran; Lee, Gwang; Choi, Sangdun			Molecular Modeling-Based Evaluation of hTLR10 and Identification of Potential Ligands in Toll-Like Receptor Signaling	PLOS ONE			English	Article							LEUCINE-RICH REPEATS; PATHOGEN RECOGNITION; GLYCOSYLATION SITES; STRUCTURAL BASIS; PROTEIN-DOCKING; SERVER; SIMULATIONS; EXPRESSION; BINDING; CELLS	Toll-like receptors (TLRs) are pattern recognition receptors that recognize pathogens based on distinct molecular signatures. The human (h) TLR1, 2, 6 and 10 belong to the hTLR1 subfamilies, which are localized in the extracellular regions and activated in response to diverse ligand molecules. Due to the unavailability of the hTLR10 crystal structure, the understanding of its homo and heterodimerization with hTLR2 and hTLR1 and the ligand responsible for its activation is limited. To improve our understanding of the TLR10 receptor-ligand interaction, we used homology modeling to construct a three dimensional (3D) structure of hTLR10 and refined the model through molecular dynamics (MD) simulations. We utilized the optimized structures for the molecular docking in order to identify the potential site of interactions between the homo and heterodimer (hTLR10/2 and hTLR10/1). The docked complexes were then used for interaction with ligands (Pam3CSK4 and PamCysPamSK(4)) using MOE-Dock and ASEDock. Our docking studies have shown the binding orientations of hTLR10 heterodimer to be similar with other TLR2 family members. However, the binding orientation of hTLR10 homodimer is different from the heterodimer due to the presence of negative charged surfaces at the LRR11-14, thereby providing a specific cavity for ligand binding. Moreover, the multiple protein-ligand docking approach revealed that Pam3CSK4 might be the ligand for the hTLR10/2 complex and PamCysPamSK(4), a di-acylated peptide, might activate hTLR10/1 hetero and hTLR10 homodimer. Therefore, the current modeled complexes can be a useful tool for further experimental studies on TLR biology.	[Govindaraj, Rajiv Gandhi; Manavalan, Balachandran; Lee, Gwang; Choi, Sangdun] Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea; [Lee, Gwang] Ajou Univ, Inst Med Sci, Sch Med, Suwon 441749, South Korea	Ajou University; Ajou University	Govindaraj, RG (corresponding author), Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea.	sangdunchoi@ajou.ac.kr	Govindaraj, Rajiv Gandhi/X-1809-2019; Manavalan, Balachandran/Q-8279-2019	Govindaraj, Rajiv Gandhi/0000-0003-2364-5429; Manavalan, Balachandran/0000-0003-0697-9419	Ministry of Education, Science, and Technology [2010-0016256]; Korea Food and Drug Administration [10182KFDA992]; Ajou University; NRF [2009-0093826]	Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Food and Drug Administration(Food & Drug Administration (KFDA), Republic of Korea); Ajou University; NRF	This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (2010-0016256). This work was also partly supported by a grant (10182KFDA992) from the Korea Food and Drug Administration, the Ajou University Research Fellowship and the Priority Research Centers Program through the NRF (2009-0093826). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Gibbard RJ, 2006, J BIOL CHEM, V281, P27503, DOI 10.1074/jbc.M605003200; GONG J, 2007, P 2 IAPR INT WORKSH; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Hasan U, 2005, J IMMUNOL, V174, P2942, DOI 10.4049/jimmunol.174.5.2942; Hasan UA, 2004, BIOCHEM BIOPH RES CO, V321, P124, DOI 10.1016/j.bbrc.2004.06.134; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kaisho T, 2006, J ALLERGY CLIN IMMUN, V117, P979, DOI 10.1016/j.jaci.2006.02.023; Kajava AV, 1998, J MOL BIOL, V277, P519, DOI 10.1006/jmbi.1998.1643; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; KOBE B, 1995, CURR OPIN STRUC BIOL, V5, P409, DOI 10.1016/0959-440X(95)80105-7; KORTEMME T, 2004, SCI STKE, P12, DOI DOI 10.1126/STKE.2192004P12; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; Manavalan B, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-1; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Nagase H, 2003, J IMMUNOL, V171, P3977, DOI 10.4049/jimmunol.171.8.3977; Omueti KO, 2007, J IMMUNOL, V178, P6387, DOI 10.4049/jimmunol.178.10.6387; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; SHUICHI M, 1992, J COMPUT CHEM, V13, P952; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Weber ANR, 2004, J BIOL CHEM, V279, P34589, DOI 10.1074/jbc.M403830200; Wei T, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-47; Wei TD, 2009, PROTEIN SCI, V18, P1684, DOI 10.1002/pro.186	41	61	62	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2010	5	9							e12713	10.1371/journal.pone.0012713	http://dx.doi.org/10.1371/journal.pone.0012713			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650QH	20877634	Green Published, Green Submitted, gold			2022-12-27	WOS:000281864100006
J	Ball, SK; Field, MC; Tippins, JR				Ball, Stephen K.; Field, Mark C.; Tippins, John R.			Regulation of Thromboxane Receptor Signaling at Multiple Levels by Oxidative Stress-Induced Stabilization, Relocation and Enhanced Responsiveness	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; PROTEIN-KINASE; BETA-ISOFORM; EXPRESSION; ISOPROSTANE; ALPHA; CELLS; PHOSPHORYLATION; TRAFFICKING; GENERATION	Background: Thromboxane A(2) (TxA(2)) is a major, unstable arachidonic acid metabolite, and plays a key role in normal physiology and control of vascular tone. The human thromboxane receptor (TP beta), expressed in COS-7 cells, is located predominantly in the endoplasmic reticulum (ER). Brief hydrogen peroxide exposure increases the efficiency of translocation of TP beta from the ER into the Golgi complex, inducing maturation and stabilization of TP beta. However, the ultimate fate of this post-ER TP beta pool is not known, nor is its capacity to initiate signal transduction. Here we specifically assessed if functional TP beta was transported to the plasma membrane following H2O2 exposure. Results: We demonstrate, by biotinylation and confocal microscopy, that exposure to H2O2 results in rapid delivery of a cohort of TP beta to the cell surface, which is stable for at least eight hours. Surface delivery is brefeldin A-sensitive, indicating that translocation of this receptor cohort is from internal pools and via the Golgi complex. H2O2 treatment results in potentiation of the increase to intracellular calcium concentrations in response to TP beta agonists U46619 and 8-iso PGF(2 alpha) and also in the loss of ligand-dependent receptor internalization. Further there is increased responsiveness to a second application of the agonist. Finally we demonstrate that the effect of H2O2 on stimulating surface delivery is shared with the FP prostanoid receptor but not the EP3 or EP4 receptors. Conclusions/Significance: In summary, brief exposure to H2O2 results in an immediate and sustained increase in the surface pool of thromboxane receptor that is capable of mediating a persistent hyper-responsiveness of the cell and suggests a highly sophisticated mechanism for rapidly regulating thromboxane signaling.	[Ball, Stephen K.; Tippins, John R.] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, London, England; [Ball, Stephen K.; Field, Mark C.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England	Imperial College London; University of Cambridge	Ball, SK (corresponding author), UCL, Inst Urol, London, England.	mcf34@cam.ac.uk	Field, Mark/AAD-6455-2021	Field, Mark/0000-0002-4866-2885	British Heart Foundation	British Heart Foundation(British Heart Foundation)	This work was funded by the British Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cipollone F, 2000, CIRCULATION, V102, P1007, DOI 10.1161/01.CIR.102.9.1007; DAngelo DD, 1996, J BIOL CHEM, V271, P6233, DOI 10.1074/jbc.271.11.6233; DORN GW, 1990, CIRCULATION, V81, P212, DOI 10.1161/01.CIR.81.1.212; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; Habib A, 1997, J BIOL CHEM, V272, P7191, DOI 10.1074/jbc.272.11.7191; Hamelin E, 2005, J BIOL CHEM, V280, P36195, DOI 10.1074/jbc.M503438200; HIRATA M, 1991, NATURE, V349, P617, DOI 10.1038/349617a0; Hu QH, 1998, CIRCULATION, V97, P268, DOI 10.1161/01.CIR.97.3.268; KINSELLA BT, 1994, J BIOL CHEM, V269, P29914; KRIPPEITDREWS P, 1995, BIOCHEM BIOPH RES CO, V209, P139, DOI 10.1006/bbrc.1995.1481; Kromer BM, 1999, BRIT J PHARMACOL, V126, P1171, DOI 10.1038/sj.bjp.0702433; Kromer BM, 1996, BRIT J PHARMACOL, V119, P1276, DOI 10.1111/j.1476-5381.1996.tb16033.x; Laroche G, 2005, CELL SIGNAL, V17, P1373, DOI 10.1016/j.cellsig.2005.02.008; Lippincott-Schwartz J, 2003, NAT CELL BIOL, pS7, DOI 10.1038/ncb1032; Liu XP, 2001, FREE RADICAL BIO MED, V31, P894, DOI 10.1016/S0891-5849(01)00665-7; Mehrabi MR, 1999, CARDIOVASC RES, V43, P492; Molavi B, 2004, CURR OPIN CARDIOL, V19, P488, DOI 10.1097/01.hco.0000133657.77024.bd; MONCADA S, 1978, PHARMACOL REV, V30, P293; MORROW JD, 1994, BBA-LIPID LIPID MET, V1210, P244, DOI 10.1016/0005-2760(94)90128-7; Nakagawa H, 2004, CARCINOGENESIS, V25, P1567, DOI 10.1093/carcin/bgh168; NEEDLEMAN P, 1986, ANNU REV BIOCHEM, V55, P69, DOI 10.1146/annurev.biochem.55.1.69; Nie DT, 2008, CANCER RES, V68, P115, DOI 10.1158/0008-5472.CAN-07-1018; Parent JL, 2001, J BIOL CHEM, V276, P7079, DOI 10.1074/jbc.M009375200; Parent JL, 1999, J BIOL CHEM, V274, P8941, DOI 10.1074/jbc.274.13.8941; Redondo PC, 2004, BIOCHEM PHARMACOL, V67, P491, DOI 10.1016/j.bcp.2003.09.031; Reznikov K, 2000, FASEB J, V14, P1754, DOI 10.1096/fj.99-0890com; ROBERTS LJ, 1977, J BIOL CHEM, V252, P7415; Sasaki M, 2007, PROSTAG OTH LIPID M, V83, P237, DOI 10.1016/j.prostaglandins.2006.12.001; Taniyama Y, 2003, HYPERTENSION, V42, P1075, DOI 10.1161/01.HYP.0000100443.09293.4F; Valentin F, 2005, BIOCHEM BIOPH RES CO, V329, P898, DOI 10.1016/j.bbrc.2005.02.058; Valentin FO, 2004, J BIOL CHEM, V279, P8316, DOI 10.1074/jbc.M306761200; Wilson SJ, 2007, BIOCHEM BIOPH RES CO, V352, P397, DOI 10.1016/j.bbrc.2006.11.040; Wilson SJ, 2009, J LIPID RES, V50, P1047, DOI 10.1194/jlr.M800447-JLR200; Wu MX, 2009, FREE RADICAL BIO MED, V46, P62, DOI 10.1016/j.freeradbiomed.2008.09.021; Wu YM, 1997, AM J PHYSIOL-HEART C, V273, pH2161, DOI 10.1152/ajpheart.1997.273.5.H2161; Yin W, 2008, INT J BIOCHEM CELL B, V40, P942, DOI 10.1016/j.biocel.2007.10.036; Zhang M, 2008, CIRC RES, V102, P328, DOI 10.1161/CIRCRESAHA.107.163253	37	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12798	10.1371/journal.pone.0012798	http://dx.doi.org/10.1371/journal.pone.0012798			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856817	Green Published, gold, Green Submitted			2022-12-27	WOS:000281815800032
J	Fadok, JP; Darvas, M; Dickerson, TMK; Palmiter, RD				Fadok, Jonathan P.; Darvas, Martin; Dickerson, Tavis M. K.; Palmiter, Richard D.			Long-Term Memory for Pavlovian Fear Conditioning Requires Dopamine in the Nucleus Accumbens and Basolateral Amygdala	PLOS ONE			English	Article							DEFICIENT MICE; NEURONS; CONSOLIDATION; INHIBITION; MODULATION; STRESS; BRAIN; SHELL; NEUROBIOLOGY; FACILITATION	The neurotransmitter dopamine (DA) is essential for learning in a Pavlovian fear conditioning paradigm known as fear-potentiated startle (FPS). Mice lacking the ability to synthesize DA fail to learn the association between the conditioned stimulus and the fear-inducing footshock. Previously, we demonstrated that restoration of DA synthesis to neurons of the ventral tegmental area (VTA) was sufficient to restore FPS. Here, we used a target-selective viral restoration approach to determine which mesocorticolimbic brain regions receiving DA signaling from the VTA require DA for FPS. We demonstrate that restoration of DA synthesis to both the basolateral amygdala (BLA) and nucleus accumbens (NAc) is required for long-term memory of FPS. These data provide crucial insight into the dopamine-dependent circuitry involved in the formation of fear-related memory.	[Fadok, Jonathan P.] Univ Washington, Grad Program Neurobiol & Behav, Seattle, WA 98195 USA; [Fadok, Jonathan P.; Darvas, Martin; Dickerson, Tavis M. K.; Palmiter, Richard D.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Fadok, Jonathan P.; Darvas, Martin; Dickerson, Tavis M. K.; Palmiter, Richard D.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Fadok, JP (corresponding author), Univ Washington, Grad Program Neurobiol & Behav, Seattle, WA 98195 USA.	palmiter@u.washington.edu	Darvas, Martin/E-2935-2015; Fadok, Jonathan/AAX-2999-2020	Darvas, Martin/0000-0002-7942-2526; Fadok, Jonathan/0000-0002-0608-5151	Howard Hughes Medical Institute; Public Health Service; National Research Service; National Institute of General Medical Sciences [T32 GM07270]; NIH National Institutes of General Medical Science [4 R25 GM 058501-05]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270, R25GM058501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS062684] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Research Service; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH National Institutes of General Medical Science; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This investigation was supported in part by the Howard Hughes Medical Institute, Public Health Service, National Research Service Award, T32 GM07270, from the National Institute of General Medical Sciences and NIH National Institutes of General Medical Sciences' Grant 4 R25 GM 058501-05. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE ED, 1989, J NEUROCHEM, V52, P1655, DOI 10.1111/j.1471-4159.1989.tb09224.x; Bissiere S, 2003, NAT NEUROSCI, V6, P587, DOI 10.1038/nn1058; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; Brischoux F, 2009, P NATL ACAD SCI USA, V106, P4894, DOI 10.1073/pnas.0811507106; de Oliveira AR, 2006, PHARMACOL BIOCHEM BE, V84, P102, DOI 10.1016/j.pbb.2006.04.012; Fadok JP, 2009, J NEUROSCI, V29, P11089, DOI 10.1523/JNEUROSCI.1616-09.2009; Fields HL, 2007, ANNU REV NEUROSCI, V30, P289, DOI 10.1146/annurev.neuro.30.051606.094341; Ford CP, 2006, J NEUROSCI, V26, P2788, DOI 10.1523/JNEUROSCI.4331-05.2006; Guarraci FA, 1999, BEHAV BRAIN RES, V99, P169, DOI 10.1016/S0166-4328(98)00102-8; Hnasko TS, 2006, P NATL ACAD SCI USA, V103, P8858, DOI 10.1073/pnas.0603081103; Inglis FM, 1999, J NEUROCHEM, V72, P1088, DOI 10.1046/j.1471-4159.1999.0721088.x; Joshua M, 2008, J NEUROSCI, V28, P11673, DOI 10.1523/JNEUROSCI.3839-08.2008; KALIVAS PW, 1995, BRAIN RES, V675, P325, DOI 10.1016/0006-8993(95)00013-G; Koch M, 1999, PROG NEUROBIOL, V59, P107, DOI 10.1016/S0301-0082(98)00098-7; Kroner S, 2005, J NEUROPHYSIOL, V93, P1598, DOI 10.1152/jn.00843.2004; LaLumiere RT, 2005, LEARN MEMORY, V12, P296, DOI 10.1101/lm.93205; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Manago F, 2009, LEARN MEMORY, V16, P46, DOI 10.1101/lm.1177509; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Margolis EB, 2006, P NATL ACAD SCI USA, V103, P2938, DOI 10.1073/pnas.0511159103; Margolis EB, 2008, J NEUROSCI, V28, P8908, DOI 10.1523/JNEUROSCI.1526-08.2008; Marowsky A, 2005, NEURON, V48, P1025, DOI 10.1016/j.neuron.2005.10.029; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; McGaugh JL, 2002, NEUROBIOL LEARN MEM, V78, P539, DOI 10.1006/nlme.2002.4082; Pezze MA, 2004, PROG NEUROBIOL, V74, P301, DOI 10.1016/j.pneurobio.2004.09.004; Pezze MA, 2001, NEUROSCIENCE, V108, P91, DOI 10.1016/S0306-4522(01)00403-1; Ponnusamy R, 2005, LEARN MEMORY, V12, P399, DOI 10.1101/lm.96605; Popescu AT, 2007, P NATL ACAD SCI USA, V104, P341, DOI 10.1073/pnas.0609831104; Rosenkranz JA, 2002, NATURE, V417, P282, DOI 10.1038/417282a; Rossato JI, 2009, SCIENCE, V325, P1017, DOI 10.1126/science.1172545; Sesack SR, 2010, NEUROPSYCHOPHARMACOL, V35, P27, DOI 10.1038/npp.2009.93; Soudais C, 2001, FASEB J, V15, P2283, DOI 10.1096/fj.01-0321fje; Swerdlow NR, 2000, BEHAV PHARMACOL, V11, P185, DOI 10.1097/00008877-200006000-00002; Szczypka MS, 1999, P NATL ACAD SCI USA, V96, P12138, DOI 10.1073/pnas.96.21.12138; Wolf ME, 2004, NEUROPHARMACOLOGY, V47, P61, DOI 10.1016/j.neuropharm.2004.07.006; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0	36	60	60	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12751	10.1371/journal.pone.0012751	http://dx.doi.org/10.1371/journal.pone.0012751			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	649ZP	20856811	gold, Green Submitted, Green Published			2022-12-27	WOS:000281815800018
J	Gong, Y; Bourhis, E; Chiu, C; Stawicki, S; DeAlmeida, VI; Liu, BY; Phamluong, K; Cao, TC; Carano, RAD; Ernst, JA; Solloway, M; Rubinfeld, B; Hannoush, RN; Wu, Y; Polakis, P; Costa, M				Gong, Yan; Bourhis, Eric; Chiu, Cecilia; Stawicki, Scott; DeAlmeida, Venita I.; Liu, Bob Y.; Phamluong, Khanhky; Cao, Tim C.; Carano, Richard A. D.; Ernst, James A.; Solloway, Mark; Rubinfeld, Bonnee; Hannoush, Rami N.; Wu, Yan; Polakis, Paul; Costa, Mike			Wnt Isoform-Specific Interactions with Coreceptor Specify Inhibition or Potentiation of Signaling by LRP6 Antibodies	PLOS ONE			English	Article							BETA-CATENIN; DOMAIN; ACTIVATION; MECHANISM; PATHWAY; LIGAND; GROWTH; AXIN; PHOSPHORYLATION; OSTEOBLASTS	beta-catenin-dependent Wnt signaling is initiated as Wnt binds to both the receptor FZD and coreceptor LRP5/6, which then assembles a multimeric complex at the cytoplasmic membrane face to recruit and inactivate the kinase GSK3. The large number and sequence diversity of Wnt isoforms suggest the possibility of domain-specific ligand-coreceptor interactions, and distinct binding sites on LRP6 for Wnt3a and Wnt9b have recently been identified in vitro. Whether mechanistically different interactions between Wnts and coreceptors might mediate signaling remains to be determined. It is also not clear whether coreceptor homodimerization induced extracellularly can activate Wnt signaling, as is the case for receptor tyrosine kinases. We generated monoclonal antibodies against LRP6 with the unexpected ability to inhibit signaling by some Wnt isoforms and potentiate signaling by other isoforms. In cell culture, two antibodies characterized further show reciprocal activities on most Wnts, with one antibody antagonizing and the other potentiating. We demonstrate that these antibodies bind to different regions of LRP6 protein, and inhibition of signaling results from blocking Wnt binding. Antibody-mediated dimerization of LRP6 can potentiate signaling only when a Wnt isoform is also able to bind the complex, presumably recruiting FZD. Endogenous autocrine Wnt signaling in different tumor cell lines can be either antagonized or enhanced by the LRP6 antibodies, indicating expression of different Wnt isoforms. As anticipated from the roles of Wnt signaling in cancer and bone development, antibody activities can also be observed in mice for inhibition of tumor growth and in organ culture for enhancement of bone mineral density. Collectively, our results indicate that separate binding sites for different subsets of Wnt isoforms determine the inhibition or potentiation of signaling conferred by LRP6 antibodies. This complexity of coreceptor-ligand interactions may allow for differential regulation of signaling by Wnt isoforms during development, and can be exploited with antibodies to differentially manipulate Wnt signaling in specific tissues or disease states.	[Gong, Yan; DeAlmeida, Venita I.; Liu, Bob Y.; Rubinfeld, Bonnee; Polakis, Paul; Costa, Mike] Genentech Res & Early Dev, Dept Canc Targets, San Francisco, CA USA; [Bourhis, Eric; Ernst, James A.; Hannoush, Rami N.] Genentech Res & Early Dev, Dept Prot Engn, San Francisco, CA USA; [Chiu, Cecilia; Stawicki, Scott; Wu, Yan] Genentech Res & Early Dev, Dept Antibody Engn, San Francisco, CA USA; [Phamluong, Khanhky; Solloway, Mark] Genentech Res & Early Dev, Dept Mol Biol, San Francisco, CA USA; [Cao, Tim C.; Carano, Richard A. D.] Genentech Res & Early Dev, Dept Tumor Biol & Angiogenesis, San Francisco, CA USA; [Ernst, James A.] Genentech Res & Early Dev, Dept Prot Chem, San Francisco, CA USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Gong, Y (corresponding author), Genentech Res & Early Dev, Dept Canc Targets, San Francisco, CA USA.	mcosta@gene.com		Rubinfeld, Bonnee/0000-0001-9861-6775	Genentech Research & Early Development	Genentech Research & Early Development	This work was supported by Genentech Research & Early Development. The funder did have roles in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Adams C, 2008, CELL DEATH DIFFER, V15, P751, DOI 10.1038/sj.cdd.4402306; Akiri G, 2009, ONCOGENE, V28, P2163, DOI 10.1038/onc.2009.82; Atwell S, 1997, J MOL BIOL, V270, P26, DOI 10.1006/jmbi.1997.1116; Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Binnerts ME, 2009, MOL BIOL CELL, V20, P3552, DOI 10.1091/mbc.E08-12-1252; Bourhis E, 2010, J BIOL CHEM, V285, P9172, DOI 10.1074/jbc.M109.092130; Cho SJ, 2010, MOL BIOL EVOL, V27, P1645, DOI 10.1093/molbev/msq052; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Cselenyi CS, 2008, P NATL ACAD SCI USA, V105, P8032, DOI 10.1073/pnas.0803025105; Cunningham SA, 1997, BIOCHEM BIOPH RES CO, V231, P596, DOI 10.1006/bbrc.1997.6156; DavisSmyth T, 1996, EMBO J, V15, P4919, DOI 10.1002/j.1460-2075.1996.tb00872.x; DeAlmeida VI, 2007, CANCER RES, V67, P5371, DOI 10.1158/0008-5472.CAN-07-0266; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; Guo Y, 2008, CANCER RES, V68, P3350, DOI 10.1158/0008-5472.CAN-07-3220; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Jeon H, 2001, NAT STRUCT BIOL, V8, P499, DOI 10.1038/88556; Khan Z, 2007, MOL CELL BIOL, V27, P7291, DOI 10.1128/MCB.00773-07; Lee CV, 2004, J MOL BIOL, V340, P1073, DOI 10.1016/j.jmb.2004.05.051; Liu BY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008611; Liu GZ, 2003, MOL CELL BIOL, V23, P5825, DOI 10.1128/MCB.23.16.5825-5835.2003; Mi KH, 2006, J BIOL CHEM, V281, P4787, DOI 10.1074/jbc.M508657200; Mohammad Khalid S., 2008, V455, P37, DOI 10.1007/978-1-59745-104-8_3; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Piao S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004046; QUARTO N, 2009, J BONE MINER RES, DOI DOI 10.1359/JBMR.091116; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; Schwarz-Romond T, 2007, J CELL SCI, V120, P2402, DOI 10.1242/jcs.002956; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; VAN AMERONGEN R, 2009, DEVELOPMENT, V136, P3205; Wu G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004926; Yasui N, 2010, J IMMUNOL METHODS, V352, P153, DOI 10.1016/j.jim.2009.11.016; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540; Zhang YN, 2009, NAT CHEM BIOL, V5, P217, DOI 10.1038/nchembio.152; Zhou H, 2009, DEVELOPMENT, V136, P427, DOI 10.1242/dev.027706; Zoltewicz JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006191	40	90	108	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2010	5	9							e12682	10.1371/journal.pone.0012682	http://dx.doi.org/10.1371/journal.pone.0012682			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648ZZ	20856934	Green Submitted, Green Published, gold			2022-12-27	WOS:000281735700009
J	Fureix, C; Menguy, H; Hausberger, M				Fureix, Carole; Menguy, Herve; Hausberger, Martine			Partners with Bad Temper: Reject or Cure? A Study of Chronic Pain and Aggression in Horses	PLOS ONE			English	Article							RANDOMIZED CLINICAL-TRIAL; BACK-PAIN; BEHAVIOR; MANIPULATION; HUMANS; WORK; PERFORMANCE; TRAIT; TIME	Background: Experiencing acute pain can affect the social behaviour of both humans and animals and can increase the risk that they exhibit aggressive or violent behaviour. However, studies have focused mainly on the impact of acute rather than chronic painful experiences. As recent results suggest that chronic pain or chronic discomfort could increase aggressiveness in humans and other mammals, we tested here the hypothesis that, in horses, aggression towards humans (a common source of accidents for professionals) could be linked to regularly reported vertebral problems of riding horses. Methodology/Principal Findings: Vertebral examination and standardized behavioural tests were made independently on the same horses. Here we showed that most horses severely affected by vertebral problems were prone to react aggressively towards humans (33/43 horses, chi-square test, df = 1, chi(2) = 12.30, p 0.001), which was not the case for unaffected or slightly affected horses (9/16 horses, chi-square test, df = 1, chi(2) = 0.25, p > 0.05). The more affected they were, the fewer positive reactions they exhibited (rs = -0.31, p = 0.02). Conclusions/Significance: This is to our knowledge the first experimental evidence of such a link between chronic discomfort/potential pain (inferred from the presence of vertebral problems) and aggression, suggesting that chronic painful experiences may act in ways similar to those of acute experiences. Chronic discomfort or pain may often be overlooked when facing "bad tempered'' individuals, whether humans or animals. This experimental study confirms the importance of including chronic discomfort or pain as a major factor in interpersonal relations and models of aggression.	[Fureix, Carole; Hausberger, Martine] Univ Rennes 1, CNRS, Lab Ethol Anim & Humaine, UMR 6552, Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes	Fureix, C (corresponding author), Univ Rennes 1, CNRS, Lab Ethol Anim & Humaine, UMR 6552, Rennes, France.	carole.fureix@univ-rennes1.fr			Caisse Centrale de la Mutualite Sociale Agricole (MSA); CNRS; French Ministry of Research	Caisse Centrale de la Mutualite Sociale Agricole (MSA); CNRS(Centre National de la Recherche Scientifique (CNRS)); French Ministry of Research(Ministry of Research, FranceEuropean Commission)	This study was supported by the Caisse Centrale de la Mutualite Sociale Agricole (MSA), the CNRS and the French Ministry of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CA, 2002, ANNU REV PSYCHOL, V53, P27, DOI 10.1146/annurev.psych.53.100901.135231; Anderson CA, 2000, ADV EXP SOC PSYCHOL, V32, P63, DOI 10.1016/S0065-2601(00)80004-0; Anderson KB, 1998, AGGRESSIVE BEHAV, V24, P161, DOI 10.1002/(SICI)1098-2337(1998)24:3<161::AID-AB1>3.0.CO;2-O; Ashley FH, 2005, EQUINE VET J, V37, P565, DOI 10.2746/042516405775314826; Benhajali H, 2008, APPL ANIM BEHAV SCI, V112, P196, DOI 10.1016/j.applanim.2007.08.007; BERKOWITZ L, 1990, AM PSYCHOL, V45, P494, DOI 10.1037/0003-066X.45.4.494; BERKOWITZ L, 1981, J PERS SOC PSYCHOL, V40, P687, DOI 10.1037/0022-3514.40.4.687; Bruns Daniel, 2003, Curr Pain Headache Rep, V7, P127, DOI 10.1007/s11916-003-0022-4; Cannon WB., BODILY CHANGES PAIN, DOI [10.1037/10013-000, DOI 10.1037/10013-000]; Cauvin E, 1997, IN PRACTICE, V19, P522; Cook WR, 1999, J EQUINE VET SCI, V19, P196, DOI 10.1016/S0737-0806(99)80067-7; Day JEL, 2008, APPL ANIM BEHAV SCI, V109, P249, DOI 10.1016/j.applanim.2007.02.006; Dionne CE, 2005, CAN MED ASSOC J, V172, P1559, DOI 10.1503/cmaj.1041159; Faber M, 2000, AM J VET RES, V61, P399, DOI 10.2460/ajvr.2000.61.399; Feh C, 2005, DOMESTIC HORSE: THE ORIGINS, DEVELOPMENT AND MANAGEMENT OF ITS BEHAVIOUR, P83; Fonseca BPA, 2006, J EQUINE VET SCI, V26, P507, DOI 10.1016/j.jevs.2006.09.007; Fureix C, 2009, ANIM COGN, V12, P643, DOI 10.1007/s10071-009-0223-2; Gillis C, 1999, VET CLIN N AM-EQUINE, V15, P97; Hansen B, 1997, SEMIN VET MED SURG, V12, P61, DOI 10.1016/S1096-2867(97)80003-5; Hansen BD, 2003, ILAR J, V44, P197, DOI 10.1093/ilar.44.3.197; Hardie EM, 1997, APPL ANIM BEHAV SCI, V51, P111, DOI 10.1016/S0168-1591(96)01078-7; Hausberger M, 2004, J COMP PSYCHOL, V118, P434, DOI 10.1037/0735-7036.118.4.434; Hausberger M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007625; Hausberger M, 2008, APPL ANIM BEHAV SCI, V109, P1, DOI 10.1016/j.applanim.2007.04.015; Haussler KK, 1996, J EQUINE VET SCI, V16, P279, DOI 10.1016/S0737-0806(96)80220-6; Haussler KK, 2006, EQUINE VET J, V38, P76, DOI 10.2746/042516406775374225; Henry S, 2006, DEV PSYCHOBIOL, V48, P712, DOI 10.1002/dev.20189; Henry S, 2005, APPL ANIM BEHAV SCI, V93, P341, DOI 10.1016/j.applanim.2005.01.008; HOUTMAN ILD, 1994, SCAND J WORK ENV HEA, V20, P139, DOI 10.5271/sjweh.1419; Izard C.E., 1991, PSYCHOL EMOTION; Jeffcoat LB, 1999, VET J, V158, P113, DOI 10.1053/tvjl.1998.0334; JEFFCOTT LB, 1979, EQUINE VET J, V11, P129, DOI 10.1111/j.2042-3306.1979.tb01324.x; KIRKALDYWILLIS WH, 1985, CAN FAM PHYSICIAN, V31, P535; Landman MAAM, 2004, VET REC, V155, P165, DOI 10.1136/vr.155.6.165; Lansade L, 2008, APPL ANIM BEHAV SCI, V114, P492, DOI 10.1016/j.applanim.2008.04.012; Lesimple C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010257; Licka T, 1998, EQUINE VET J, V30, P412, DOI 10.1111/j.2042-3306.1998.tb04511.x; Lloyd AS, 2008, APPL ANIM BEHAV SCI, V112, P369, DOI 10.1016/j.applanim.2007.08.010; MCDONNELL SM, 1995, APPL ANIM BEHAV SCI, V43, P147, DOI 10.1016/0168-1591(94)00550-X; *NAT I OCC SAF HLT, 1996, VIOL WORKPL RISK FAC; Popa T, 2007, EXP BRAIN RES, V177, P411, DOI 10.1007/s00221-006-0683-4; Pritchett LC, 2003, APPL ANIM BEHAV SCI, V80, P31, DOI 10.1016/S0168-1591(02)00205-8; Sankey C, 2010, ANIM BEHAV, V79, P869, DOI 10.1016/j.anbehav.2009.12.037; Seaman SC, 2002, APPL ANIM BEHAV SCI, V78, P175, DOI 10.1016/S0168-1591(02)00095-3; Shearar KA, 2005, J MANIP PHYSIOL THER, V28, P493, DOI 10.1016/j.jmpt.2005.07.006; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Sondergaard E, 2003, APPL ANIM BEHAV SCI, V84, P265, DOI 10.1016/j.applanim.2003.08.011; Sullivan KA, 2008, EQUINE VET J, V40, P14, DOI 10.2746/042516407X240456; Turner SP, 2000, LIVEST PROD SCI, V66, P47, DOI 10.1016/S0301-6226(00)00159-7; Vieira ER, 2004, J OCCUP REHABIL, V14, P143, DOI 10.1023/B:JOOR.0000018330.46029.05; Waring G.H., 2003, HORSE BEHAV, V2; Wood TG, 2001, J MANIP PHYSIOL THER, V24, P260, DOI 10.1067/mmt.2001.114365; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	57	61	60	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12434	10.1371/journal.pone.0012434	http://dx.doi.org/10.1371/journal.pone.0012434			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865160	Green Published, gold			2022-12-27	WOS:000281292100027
J	Kabakchiev, B; Turner, D; Hyams, J; Mack, D; Leleiko, N; Crandall, W; Markowitz, J; Otley, AR; Xu, W; Hu, PZ; Griffiths, AM; Silverberg, MS				Kabakchiev, Boyko; Turner, Dan; Hyams, Jeffrey; Mack, David; Leleiko, Neal; Crandall, Wallace; Markowitz, James; Otley, Anthony R.; Xu, Wei; Hu, Pingzhao; Griffiths, Anne M.; Silverberg, Mark S.			Gene Expression Changes Associated with Resistance to Intravenous Corticosteroid Therapy in Children with Severe Ulcerative Colitis	PLOS ONE			English	Article							ACTIVITY INDEX; IN-VITRO; GLUCOCORTICOID SENSITIVITY; INCREASING PROTEIN; MEDICAL THERAPY; MESSENGER-RNA; HAPTOGLOBIN; RECEPTOR; IL-8; PREDICTORS	Background and Aims: Microarray analysis of RNA expression allows gross examination of pathways operative in inflammation. We aimed to determine whether genes expressed in whole blood early following initiation of intravenous corticosteroid treatment can be associated with response. Methods: From a prospectively accrued cohort of 128 pediatric patients hospitalized for intravenous corticosteroid treatment of severe UC, we selected for analysis 20 corticosteroid responsive (hospital discharge or PUCAI <= 45 by day 5) and 20 corticosteroid resistant patients (need for second line medical therapy or colectomy, or PUCAI >45 by day 5). Total RNA was extracted from blood samples collected on day 3 of intravenous corticosteroid therapy. The eluted transcriptomes were quantified on Affymetrix Human Gene 1.0 ST arrays. The data was analysed by the local-pooled error method for discovery of differential gene expression and false discovery rate correction was applied to adjust for multiple comparisons. Results: A total of 41 genes differentially expressed between responders and non-responders were detected with statistical significance. Two of these genes, CEACAM1 and MMP8, possibly inhibited by methylprednisolone through IL8, were both found to be over-expressed in non-responsive patients. ABCC4 (MRP4) as a member of the multi-drug resistance superfamily was a novel candidate gene for corticosteroid resistance. The expression pattern of a cluster of 10 genes selected from the 41 significant hits were able to classify the patients with 80% sensitivity and 80% specificity. Conclusions: Elevated expression of several genes involved in inflammatory pathways was associated with resistance to intravenous corticosteroid therapy early in the course of treatment. Gene expression profiles may be useful to classify resistance to intravenous corticosteroids in children with severe UC and assist with clinical management decisions.	[Kabakchiev, Boyko; Silverberg, Mark S.] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; [Hu, Pingzhao; Griffiths, Anne M.] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Otley, Anthony R.] Izaak Walton Killam Hosp Children, Halifax, NS B3J 3G9, Canada; [Mack, David] Childrens Hosp Eastern Ontario, Ottawa, ON K1H 8L1, Canada; [Hyams, Jeffrey] Connecticut Childrens Med Ctr, Hartford, CT USA; [Markowitz, James] Schneider Childrens Hosp, New Hyde Pk, NY USA; [Leleiko, Neal] Brown Univ, Providence, RI 02912 USA; [Crandall, Wallace] Columbus Childrens Hosp, Columbus, OH USA; [Turner, Dan] Shaare Zedek Med Ctr, Jerusalem, Israel; [Kabakchiev, Boyko; Silverberg, Mark S.] Univ Toronto, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Dalhousie University; University of Ottawa; Children's Hospital of Eastern Ontario; Connecticut Children's Medical Center; Northwell Health; North Shore University Hospital; Steven & Alexandra Cohen Children's Medical Center of New York; Brown University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Hebrew University of Jerusalem; Shaare Zedek Medical Center; University of Toronto	Kabakchiev, B (corresponding author), Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada.	kabakchiev@lunenfeld.ca	Silverberg, Mark/B-4183-2008; LeLeiko, Neal/GRJ-6855-2022	Otley, Anthony/0000-0002-7371-9302; leleiko, neal/0000-0001-7699-1400; Hu, Pingzhao/0000-0002-9546-2245	Schering-Plough Canada Inc.; Crohn's and Colitis Foundation of Canada; National Institutes of Health; Proctor and Gamble; Centocor Ortho Biotech; Abbott; UCB; Astra Zeneca; Prometheus Laboratories; Centocor; Axcan Pharma	Schering-Plough Canada Inc.; Crohn's and Colitis Foundation of Canada; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Proctor and Gamble(Procter & Gamble); Centocor Ortho Biotech; Abbott(Abbott Laboratories); UCB(UCB Pharma SA); Astra Zeneca(AstraZeneca); Prometheus Laboratories; Centocor; Axcan Pharma(Dexcel Pharma)	This investigator-initiated study was funded by Schering-Plough Canada Inc. (http://www.schering-plough.ca/), the Crohn's and Colitis Foundation of Canada (http://www.ccfc.ca/), and the National Institutes of Health (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Study participants were aware of the following potential conflicts of interest: Dan Turner: Proctor and Gamble - consultant; Medici medical - consultant, research support; Jeffrey Hyams: Centocor Ortho Biotech - research support, consultant, speaker's bureau; Abbott - research support, consultant; UCB - research support, consultant; Astra Zeneca - research support; Anne M Griffiths: Proctor and Gamble - consultant; Centocor Ortho Biotech research support, consultant; UCB - consultant; Abbott - consultant; James Markowitz: Centocor Ortho Biotech - research support, consultant; Abbott - research support; UCB - research support, consultant; Astra Zeneca - research support; Prometheus Laboratories - research support, consultant, honorarium; Abbott Nutritionals - speaker's bureau, honoraria; Wallace Crandall: Centocor Ortho Biotech - consultant, research support; Abbott - research support; Neal LeLeiko: Centocor - research support; Astra Zeneca - research support; Proctor and Gamble - research support; Anthony Otley: Abbott - research support, consultant, speaker's bureau; UCB - research support; Schering - research support; Proctor and Gamble - research support; David Mack: Axcan Pharma - consultant; Schering-Plough - speaker's bureau, consultant; Abbott - speaker, research support; AstraZeneca - speaker; Merck-Frosst - speaker; Proctor and Gamble - research support; Novartis - consultant; Bristol-Myers Squibb - consultant, speaker; all others have nothing to declare.	Aarbiou J, 2004, AM J RESP CELL MOL, V30, P193, DOI 10.1165/rcmb.2002-0267OC; [Anonymous], 2007, J PEDIATR GASTR NUTR, V44, P653; Arredouani M, 2001, REDOX REP, V6, P369; Azuz-Lieberman N, 2005, INT IMMUNOL, V17, P837, DOI 10.1093/intimm/dxh270; Barnich N, 2005, J BIOL CHEM, V280, P19021, DOI 10.1074/jbc.M413776200; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bokarewa MI, 2003, J RHEUMATOL, V30, P1719; Bray PJ, 2003, HUM MUTAT, V21, P557, DOI 10.1002/humu.10213; Celik JB, 2004, PERFUSION-UK, V19, P185, DOI 10.1191/0267659104pf733oa; Chen ZS, 2002, CANCER RES, V62, P3144; Conrotto P, 2008, INT J CANCER, V123, P2856, DOI 10.1002/ijc.23861; Dentener MA, 1997, J INFECT DIS, V175, P108, DOI 10.1093/infdis/175.1.108; Donn R, 2007, FASEB J, V21, P402, DOI 10.1096/fj.06-7236com; Farrell RJ, 2000, GASTROENTEROLOGY, V118, P279, DOI 10.1016/S0016-5085(00)70210-1; Flood L, 2001, INFLAMM BOWEL DIS, V7, P202, DOI 10.1097/00054725-200108000-00004; Gohring K, 2004, BRIT J HAEMATOL, V126, P252, DOI 10.1111/j.1365-2141.2004.05027.x; GOLD DM, 1995, AM J GASTROENTEROL, V90, P732; Goleva E, 2008, J ALLERGY CLIN IMMUN, V122, P550, DOI 10.1016/j.jaci.2008.07.007; Hakonarson H, 2005, P NATL ACAD SCI USA, V102, P14789, DOI 10.1073/pnas.0409904102; Hearing SD, 1999, GUT, V45, P382, DOI 10.1136/gut.45.3.382; Ho GT, 2009, AM J GASTROENTEROL, V104, P673, DOI 10.1038/ajg.2008.119; Ho GT, 2004, ALIMENT PHARM THER, V19, P1079, DOI 10.1111/j.1365-2036.2004.01945.x; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ito K, 2006, J ALLERGY CLIN IMMUN, V117, P522, DOI 10.1016/j.jaci.2006.01.032; Jain N, 2003, BIOINFORMATICS, V19, P1945, DOI 10.1093/bioinformatics/btg264; Kelly RW, 2002, J REPROD IMMUNOL, V57, P217, DOI 10.1016/S0165-0378(02)00007-4; KUHN M, 2002, NUCLEIC ACIDS RES, V38, pD552; LEUNG DYM, 1995, J EXP MED, V181, P33, DOI 10.1084/jem.181.1.33; Lindgren SC, 1998, EUR J GASTROEN HEPAT, V10, P831, DOI 10.1097/00042737-199810000-00003; LIU W, 2004, P NATL ACAD SCI USA, V107, P11056; Liu WL, 2008, CLIN CANCER RES, V14, P1041, DOI 10.1158/1078-0432.CCR-07-4125; Liu WL, 2006, EXP CELL RES, V312, P1785, DOI 10.1016/j.yexcr.2006.02.011; Matsuda R, 2009, INFLAMM BOWEL DIS, V15, P328, DOI 10.1002/ibd.20759; METROPOLIS N, 1949, J AM STAT ASSOC, V44, P335, DOI 10.2307/2280232; Papp M, 2007, DIGEST DIS SCI, V52, P1279, DOI 10.1007/s10620-006-9615-1; PETERSEN F, 1991, LYMPHOKINE CYTOK RES, V10, P35; Reid G, 2003, P NATL ACAD SCI USA, V100, P9244, DOI 10.1073/pnas.1033060100; Sachs UJH, 2007, J BIOL CHEM, V282, P23603, DOI 10.1074/jbc.M701120200; Schaaf Bernhard, 2008, BMC Pulm Med, V8, P12, DOI 10.1186/1471-2466-8-12; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Sharpe-Timms KL, 2002, FERTIL STERIL, V78, pS88, DOI 10.1016/S0015-0282(02)03612-9; Shinozaki S, 2001, GUT, V48, P623, DOI 10.1136/gut.48.5.623; Tantisira KG, 2004, HUM MOL GENET, V13, P1353, DOI 10.1093/hmg/ddh149; Thirumangalakudi L, 2007, J ALZHEIMERS DIS, V11, P305; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Travis SPL, 1996, GUT, V38, P905, DOI 10.1136/gut.38.6.905; Turner D, 2008, GUT, V57, DOI 10.1136/gut.2007.136481; TURNER D, 2009, INFLAMM BOWEL DIS; Turner D, 2007, GASTROENTEROLOGY, V133, P423, DOI 10.1053/j.gastro.2007.05.029; Turner D, 2007, CLIN GASTROENTEROL H, V5, P103, DOI 10.1016/j.cgh.2006.09.033; Turner D, 2010, GASTROENTEROLOGY, V138, P2282, DOI 10.1053/j.gastro.2010.02.047; Turner D, 2009, GASTROENTEROLOGY, V136, pA571; Turner D, 2009, CLIN GASTROENTEROL H, V7, P1081, DOI 10.1016/j.cgh.2009.06.024; Turner D, 2009, INFLAMM BOWEL DIS, V15, P1218, DOI 10.1002/ibd.20867; Turner D, 2009, J CLIN EPIDEMIOL, V62, P738, DOI 10.1016/j.jclinepi.2008.09.008; Utgaard JO, 1998, J EXP MED, V188, P1751, DOI 10.1084/jem.188.9.1751; Yan L, 2001, J BIOL CHEM, V276, P37258, DOI 10.1074/jbc.M106089200; Zelcer N, 2003, BIOCHEM J, V371, P361, DOI 10.1042/BJ20021886; Zhang XW, 2004, CANCER RES, V64, P2474, DOI 10.1158/0008-5472.CAN-03-3443	60	27	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e13085	10.1371/journal.pone.0013085	http://dx.doi.org/10.1371/journal.pone.0013085			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20941359	Green Published, gold, Green Submitted			2022-12-27	WOS:000282312600018
J	Kido, S; Kuriwaka-Kido, R; Umino-Miyatani, Y; Endo, I; Inoue, D; Taniguchi, H; Inoue, Y; Imamura, T; Matsumoto, T				Kido, Shinsuke; Kuriwaka-Kido, Rika; Umino-Miyatani, Yuka; Endo, Itsuro; Inoue, Daisuke; Taniguchi, Hisaaki; Inoue, Yasumichi; Imamura, Takeshi; Matsumoto, Toshio			Mechanical Stress Activates Smad Pathway through PKC delta to Enhance Interleukin-11 Gene Transcription in Osteoblasts	PLOS ONE			English	Article							PROTEIN-KINASE-C; MARROW STROMAL CELLS; BONE-FORMATION; FLUID SHEAR; MC3T3-E1 OSTEOBLASTS; MESSENGER-RNA; SPACE-FLIGHT; BED REST; INDUCTION; MICE	Background: Mechanical stress rapidly induces Delta FosB expression in osteoblasts, which binds to interleukin (IL)-11 gene promoter to enhance IL-11 expression, and IL-11 enhances osteoblast differentiation. Because bone morphogenetic proteins (BMPs) also stimulate IL-11 expression in osteoblasts, there is a possibility that BMP-Smad signaling is involved in the enhancement of osteoblast differentiation by mechanical stress. The present study was undertaken to clarify whether mechanical stress affects BMP-Smad signaling, and if so, to elucidate the role of Smad signaling in mechanical stress-induced enhancement of IL-11 gene transcription. Methodology/Principal Findings: Mechanical loading by fluid shear stress (FSS) induced phosphorylation of BMP-specific receptor-regulated Smads (BR-Smads), Smad1/5, in murine primary osteoblasts (mPOBs). FSS rapidly phosphorylated Y311 of protein kinase C (PKC)delta, and phosphorylated PKC delta interacted with BR-Smads to phosphorylate BR-Smads. Transfection of PKC delta siRNA or Y311F mutant PKC delta abrogated BR-Smads phosphorylation and suppressed IL-11 gene transcription enhanced by FSS. Activated BR-Smads bound to the Smad-binding element (SBE) of IL-11 gene promoter and formed complex with Delta FosB/JunD heterodimer via binding to the C-terminal region of JunD. Site-directed mutagenesis in the SBE and the AP-1 site revealed that both SBE and AP-1 sites were required for full activation of IL-11 gene promoter by FSS. Conclusions/Significance: These results demonstrate that PKC delta-BR-Smads pathway plays an important role in the intracellular signaling in response to mechanical stress, and that a cross-talk between PKC delta-BR-Smads and Delta FosB/JunD pathways synergistically stimulates IL-11 gene transcription in response to mechanical stress.	[Kido, Shinsuke; Kuriwaka-Kido, Rika; Endo, Itsuro; Inoue, Daisuke; Matsumoto, Toshio] Univ Tokushima, Dept Med & Bioregulatory Sci, Grad Sch Med Sci, Tokushima 770, Japan; [Kido, Shinsuke; Matsumoto, Toshio] Univ Tokushima, 21st Century Ctr Excellence COE Program, Grad Sch Med Sci, Tokushima 770, Japan; [Umino-Miyatani, Yuka] Univ Tokushima, Dept Obstet & Gynecol, Grad Sch Med Sci, Tokushima 770, Japan; [Taniguchi, Hisaaki] Univ Tokushima, Div Mol Enzyme Physiol, Inst Enzyme Res, Tokushima 770, Japan; [Inoue, Yasumichi; Imamura, Takeshi] JFCR, Inst Canc, Div Biochem, Tokyo, Japan	Tokushima University; Tokushima University; Tokushima University; Tokushima University; Japanese Foundation for Cancer Research	Kido, S (corresponding author), Univ Tokushima, Dept Med & Bioregulatory Sci, Grad Sch Med Sci, Tokushima 770, Japan.	toshimat@clin.med.tokushima-u.ac.jp	Taniguchi, Hisaaki/I-9171-2012		Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was carried out as a part of "Ground Research Announcement for Space Utilization'' promoted by Japan Science Forum. The study was also supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by Center-of-Excellence Program of the 21st Century from the Ministry of Education, Science, Sports and Culture of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrakhte M, 1998, BIOCHEM BIOPH RES CO, V249, P505, DOI 10.1006/bbrc.1998.9170; Burr DB, 2002, BONE, V30, P781, DOI 10.1016/S8756-3282(02)00707-X; CARVALHO RS, 1994, J BONE MINER RES, V9, P999; GRIGORIADIS AE, 1993, J CELL BIOL, V122, P685, DOI 10.1083/jcb.122.3.685; Hofmann J, 1997, FASEB J, V11, P649, DOI 10.1096/fasebj.11.8.9240967; Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838; Hung CT, 1996, J BIOMECH, V29, P1411, DOI 10.1016/0021-9290(96)84536-2; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Inoue D, 2004, J BIOL CHEM, V279, P49795, DOI 10.1074/jbc.M404096200; Inoue M, 2000, BONE, V26, P281, DOI 10.1016/S8756-3282(99)00282-3; Jaken S, 1996, CURR OPIN CELL BIOL, V8, P168, DOI 10.1016/S0955-0674(96)80062-7; Jordan NJ, 1996, BRIT J PHARMACOL, V117, P1245, DOI 10.1111/j.1476-5381.1996.tb16722.x; Kido S, 2009, BONE, V45, P1125, DOI 10.1016/j.bone.2009.07.087; Kodama Y, 1998, J BONE MINER RES, V13, P1370, DOI 10.1359/jbmr.1998.13.9.1370; Kodama Y, 1997, J BONE MINER RES, V12, P1058, DOI 10.1359/jbmr.1997.12.7.1058; Konishi H, 2001, P NATL ACAD SCI USA, V98, P6587, DOI 10.1073/pnas.111158798; Kveiborg M, 2004, MOL CELL BIOL, V24, P2820, DOI 10.1128/MCB.24.7.2820-2830.2004; Liu DW, 2008, BONE, V42, P644, DOI 10.1016/j.bone.2007.09.058; MOREY ER, 1978, SCIENCE, V201, P1138, DOI 10.1126/science.150643; Rawlinson SCF, 1996, BONE, V19, P609, DOI 10.1016/S8756-3282(96)00260-8; Sabatakos G, 2000, NAT MED, V6, P985, DOI 10.1038/79683; Sakai K, 1999, J BONE MINER RES, V14, P2089, DOI 10.1359/jbmr.1999.14.12.2089; Schneider V, 1995, ACTA ASTRONAUT, V36, P463, DOI 10.1016/0094-5765(95)00131-X; Takase M, 1998, BIOCHEM BIOPH RES CO, V244, P26, DOI 10.1006/bbrc.1998.8200; Takeuchi Y, 2002, J BIOL CHEM, V277, P49011, DOI 10.1074/jbc.M207804200; Tate MLK, 2003, J BIOMECH, V36, P1409, DOI 10.1016/S0021-9290(03)00123-4; Tohjima E, 2003, J BONE MINER RES, V18, P1461, DOI 10.1359/jbmr.2003.18.8.1461; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Walker LM, 2000, J CELL BIOCHEM, V79, P648, DOI 10.1002/1097-4644(20001215)79:4<648::AID-JCB130>3.0.CO;2-Q; Watanabe Y, 2004, J BONE MINER RES, V19, P1771, DOI 10.1359/JBMR.040811; WEINBAUM S, 1994, J BIOMECH, V27, P339, DOI 10.1016/0021-9290(94)90010-8; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; You J, 2001, J BIOL CHEM, V276, P13365, DOI 10.1074/jbc.M009846200	33	36	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e13090	10.1371/journal.pone.0013090	http://dx.doi.org/10.1371/journal.pone.0013090			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20927330	Green Submitted, Green Published, gold			2022-12-27	WOS:000282269400030
J	Appanna, R; Ponnampalavanar, S; See, LLC; Sekaran, SD				Appanna, Ramapraba; Ponnampalavanar, Sasheela; See, Lucy Lum Chai; Sekaran, Shamala Devi			Susceptible and Protective HLA Class 1 Alleles against Dengue Fever and Dengue Hemorrhagic Fever Patients in a Malaysian Population	PLOS ONE			English	Article							T-CELL RESPONSES; CLASS-I; VIRUS-INFECTION; DISEASE SEVERITY; IDENTIFICATION; POLYMORPHISM; ASSOCIATION; EPITOPES; FREQUENCIES; CLEARANCE	The human leukocyte antigen alleles have been implicated as probable genetic markers in predicting the susceptibility and/or protection to severe manifestations of dengue virus (DENV) infection. In this present study, we aimed to investigate for the first time, the genotype variants of HLA Class 1(-A and -B) of DENV infected patients against healthy individuals in Malaysia. Methodology/Principal Findings: This study was carried out with 92 dengue disease patients and 95 healthy controls from three different ethnic groups (Malay, Chinese and Indian) in Malaysia. All patients with clinical and laboratory confirmation of DENV infection were typed for the HLA-A and B loci, using polymerase chain reaction-sequence specific primer techniques. In our total population, a significant increase for HLA-B*53 (P=0.042, Pc=1.008) allele and a significant decrease for A*03 (P=0.015, Pc=0.18, OR=5.23, 95% CI=1.19-23.02) and B*18 (P=0.017, Pc=0.408) alleles were noted in DHF patients as compared to healthy donors. We also observed that in the Malay DHF patients, allele B*13 (P=0.049, Pc=1.176, OR=0.18, 95% CI=0.03-0.90) was present at a significantly higher frequency in this population while allele HLA-B*18 (P=0.024, Pc=0.576) was seen to be negatively associated with DHF. Conclusions/Significance: These are the first findings on genetic polymorphisms in our population and we conclude that: (1) In our total population, HLA-B*53 probably involve in disease susceptibility, while the HLA-A*03 and HLA-B*18 may confer protection from progression to severe disease; (2) In the Malay population, HLA-B*13 and B*18 are probably associated in disease susceptibility and protection, respectively. These results could furnish as a valuable predictive tool to identify ethnically different individuals at risk and/or protection from severe forms of DENV infection and would provide valuable informations for the design of future dengue vaccine.	[Appanna, Ramapraba; Sekaran, Shamala Devi] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Ponnampalavanar, Sasheela] Univ Malaya, Med Ctr, Dept Infect Dis, Kuala Lumpur, Malaysia; [See, Lucy Lum Chai] Univ Malaya, Dept Pediat, Fac Med, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Appanna, R (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia.	shamalamy@yahoo.com	Sekaran, Shamala Devi/B-8482-2008; Devi, Shamala Devi/B-9735-2010; LA SRI PONNAMPALAVANAR, SASHEELA SRI/B-9703-2010; Lum, Lucy/Q-9871-2017	Sekaran, Shamala Devi/0000-0002-0478-0425; Devi, Shamala Devi/0000-0002-0478-0425; Lum, Lucy/0000-0002-7452-4208; sri la sri ponnampalavanar, sasheela/0000-0002-4506-1304	Academy of Science Malaysia [SAGA 66-02-03-0041]; University Malaya Vote PPP [PS169/2007C]; University Malaya Vote PJP [FS245/2008B]	Academy of Science Malaysia; University Malaya Vote PPP; University Malaya Vote PJP	This study was funded by the Academy of Science Malaysia Grant [SAGA 66-02-03-0041], University Malaya Vote PPP [PS169/2007C] and University Malaya Vote PJP [FS245/2008B]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Falcon-Lezama JA, 2009, ACTA TROP, V112, P193, DOI 10.1016/j.actatropica.2009.07.025; AIKEN SR, 1978, T I BRIT GEOGR, V3, P476, DOI 10.2307/622125; Appanna R, 2007, CLIN VACCINE IMMUNOL, V14, P969, DOI 10.1128/CVI.00069-07; *BUR E AS PAC AFF, BACKGR NOT; CHAN SH, 1985, BRIT J CANCER, V51, P389, DOI 10.1038/bjc.1985.52; Chandanayingyong D, 1997, HUM IMMUNOL, V53, P174, DOI 10.1016/S0198-8859(96)00284-4; Chaturvedi UC, 2006, FEMS IMMUNOL MED MIC, V47, P155, DOI 10.1111/j.1574-695X.2006.00058.x; CHIEWSILP P, 1981, AM J TROP MED HYG, V30, P1100, DOI 10.4269/ajtmh.1981.30.1100; CLARKE DH, 1958, AM J TROP MED HYG, V7, P561, DOI 10.4269/ajtmh.1958.7.561; Dawson DV, 2001, GENET EPIDEMIOL, V20, P87, DOI 10.1002/1098-2272(200101)20:1<87::AID-GEPI8>3.0.CO;2-R; Dhaliwal JS, 2007, ASIAN PAC J ALLERGY, V25, P47; Edinur HA, 2009, HUM IMMUNOL, V70, P518, DOI 10.1016/j.humimm.2009.04.003; Endy TP, 2002, AM J EPIDEMIOL, V156, P40, DOI 10.1093/aje/kwf005; FANG R, 1984, Southeast Asian Journal of Tropical Medicine and Public Health, V15, P51; Farquhar C, 2004, AIDS RES HUM RETROV, V20, P692, DOI 10.1089/0889222041524616; GOLDSBY RA, 2003, IMMUNOLOGY, P161; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; HALSTEAD SB, 1979, J INFECT DIS, V140, P527, DOI 10.1093/infdis/140.4.527; HENCHAL EA, 1990, CLIN MICROBIOL REV, V3, P376, DOI 10.1128/CMR.3.4.376-396.1990; Imirizaldu JJZ, 2003, J NEUROL NEUROSUR PS, V74, P1080, DOI 10.1136/jnnp.74.8.1080; Jeffery KJM, 2000, J IMMUNOL, V165, P7278, DOI 10.4049/jimmunol.165.12.7278; Kawashima Y, 2005, HUM IMMUNOL, V66, P1155, DOI 10.1016/j.humimm.2005.10.015; LAM S K, 1987, Southeast Asian Journal of Tropical Medicine and Public Health, V18, P532; Lan NTP, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000304; Loke H, 2001, J INFECT DIS, V184, P1369, DOI 10.1086/324320; Louie LG, 2004, J INFECT DIS, V189, P1084, DOI 10.1086/382030; Malavige GN, 2004, POSTGRAD MED J, V80, P588, DOI 10.1136/pgmj.2004.019638; Mathieu A, 2009, AUTOIMMUN REV, V8, P420, DOI 10.1016/j.autrev.2009.01.003; McKiernan SM, 2004, HEPATOLOGY, V40, P108, DOI 10.1002/hep.20261; McNeil AJ, 1996, QJM-INT J MED, V89, P177; McNicholl J, 1998, EMERG INFECT DIS, V4, P423, DOI 10.3201/eid0403.980322; Neumann-Haefelin C, 2006, HEPATOLOGY, V43, P563, DOI 10.1002/hep.21049; Novitsky V, 2001, HUM IMMUNOL, V62, P146, DOI 10.1016/S0198-8859(00)00236-6; PEREZ MLP, 1987, HAEMATOLOGIA, V20, P83; Rajendra S, 2005, ALIMENT PHARM THER, V21, P1377, DOI 10.1111/j.1365-2036.2005.02496.x; Rudnick A, 1986, DENGUE FEVER STUDIES, P9; SEKHAR KC, 1992, ASIA-PAC J PUBLIC HE, V6, P126; Sierra B, 2007, HUM IMMUNOL, V68, P531, DOI 10.1016/j.humimm.2007.03.001; Simmons CP, 2005, J VIROL, V79, P5665, DOI 10.1128/JVI.79.9.5665-5675.2005; Skae FMT, 1902, BRIT MED J, V1902, P1581, DOI 10.1136/bmj.2.2185.1581-a; Stephens HAF, 2002, TISSUE ANTIGENS, V60, P309, DOI 10.1034/j.1399-0039.2002.600405.x; Subklewe M, 2006, TRANSPLANTATION, V82, P1093, DOI 10.1097/01.tp.0000235889.05171.12; Takedatsu H, 2004, CLIN CANCER RES, V10, P1112, DOI 10.1158/1078-0432.CCR-0797-3; Thio CL, 2003, J VIROL, V77, P12083, DOI 10.1128/JVI.77.22.12083-12087.2003; Van Epps HL, 1999, J VIROL, V73, P5301, DOI 10.1128/JVI.73.7.5301-5308.1999; Wagenaar J. F. P., 2004, Dengue Bulletin, V28, P126; WALLACE H G, 1980, Southeast Asian Journal of Tropical Medicine and Public Health, V11, P1; WHO, 2009, DENG DENG HAEM FEV; Yong Y. K., 2007, SMJ Singapore Medical Journal, V48, P662; Zivna I, 2002, J IMMUNOL, V168, P5959, DOI 10.4049/jimmunol.168.11.5959; HIST MALAYSIA	51	46	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2010	5	9							e13029	10.1371/journal.pone.0013029	http://dx.doi.org/10.1371/journal.pone.0013029			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654ZQ	20927388	Green Published, Green Submitted, gold			2022-12-27	WOS:000282210700010
J	Safonov, LA; Isomura, Y; Kang, S; Struzik, ZR; Fukai, T; Cateau, H				Safonov, Leonid A.; Isomura, Yoshikazu; Kang, Siu; Struzik, Zbigniew R.; Fukai, Tomoki; Cateau, Hideyuki			Near Scale-Free Dynamics in Neural Population Activity of Waking/Sleeping Rats Revealed by Multiscale Analysis	PLOS ONE			English	Article							NEURONAL AVALANCHES; SINGLE-NEURON; CASCADES; TURBULENCE; LAYER-2/3; NETWORKS; BEHAVIOR; MODELS	A neuron embedded in an intact brain, unlike an isolated neuron, participates in network activity at various spatial resolutions. Such multiple scale spatial dynamics is potentially reflected in multiple time scales of temporal dynamics. We identify such multiple dynamical time scales of the inter-spike interval (ISI) fluctuations of neurons of waking/sleeping rats by means of multiscale analysis. The time scale of large non-Gaussianity in the ISI fluctuations, measured with the Castaing method, ranges up to several minutes, markedly escaping the low-pass filtering characteristics of neurons. A comparison between neural activity during waking and sleeping reveals that non-Gaussianity is stronger during waking than sleeping throughout the entire range of scales observed. We find a remarkable property of near scale independence of the magnitude correlations as the primary cause of persistent non-Gaussianity. Such scale-invariance of correlations is characteristic of multiplicative cascade processes and raises the possibility of the existence of a scale independent memory preserving mechanism.	[Safonov, Leonid A.; Isomura, Yoshikazu; Kang, Siu; Fukai, Tomoki; Cateau, Hideyuki] RIKEN BSI, Lab Neural Circuit Theory, Wako, Saitama, Japan; [Isomura, Yoshikazu] Tamagawa Univ, Brain Sci Inst, Machida, Tokyo, Japan; [Kang, Siu] Yamagata Univ, Dept Biosyst Engn, Grad Sch Sci & Engn, Yonezawa, Yamagata, Japan; [Struzik, Zbigniew R.] Univ Tokyo, Grad Sch Educ, Educ Physiol Lab, Tokyo, Japan; [Fukai, Tomoki] JST, CREST, Kawaguchi, Saitama, Japan; [Fukai, Tomoki] RIKEN Computat Sci Res Program, Brain & Neural Syst Team, Wako, Saitama, Japan; [Cateau, Hideyuki] Kyushu Inst Technol, Grad Sch Life Sci & Sci Engn, Kitakyushu, Fukuoka 804, Japan	RIKEN; Yamagata University; University of Tokyo; Japan Science & Technology Agency (JST); RIKEN; Kyushu Institute of Technology	Safonov, LA (corresponding author), RIKEN BSI, Lab Neural Circuit Theory, Wako, Saitama, Japan.	cateau@brain.riken.jp	Cateau, Hideyuki/R-9446-2016; Struzik, Zbigniew/E-4295-2012; Fukai, Tomoki/A-3936-2015	Cateau, Hideyuki/0000-0002-8861-0916; Struzik, Zbigniew/0000-0002-1352-8897; Fukai, Tomoki/0000-0001-6977-5638	RIKEN; Japanese Ministry of Education, Culture, Sports, Science and Technology [18019041, 19700284]	RIKEN; Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The present study was supported by the President's Discretionary Fund (2007-2009) of RIKEN. The study was also supported by Grants-in-Aid for Scientific Research on Priority Areas (No. 18019041) to Y.I., on Innovative Areas (No. 22115013) to T.F., and Wakate (B) (No. 19700284) to S.K. from the Japanese Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archambeau C, 2007, NEURAL NETWORKS, V20, P129, DOI 10.1016/j.neunet.2006.06.009; Arneodo A, 1998, PHYS REV LETT, V80, P708, DOI 10.1103/PhysRevLett.80.708; Bacry E, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.026103; Beggs JM, 2003, J NEUROSCI, V23, P11167; Bhattacharya J, 2005, NEUROSCIENCE, V131, P547, DOI 10.1016/j.neuroscience.2004.11.013; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; CASTAING B, 1990, PHYSICA D, V46, P177, DOI 10.1016/0167-2789(90)90035-N; CHABAUD B, 1994, PHYS REV LETT, V73, P3227, DOI 10.1103/PhysRevLett.73.3227; Chainais P, 2005, IEEE T INFORM THEORY, V51, P1063, DOI 10.1109/TIT.2004.842570; CHAINAIS P, 1998, PHYS REV LETT, V80, P708; Esser SK, 2007, SLEEP, V30, P1617, DOI 10.1093/sleep/30.12.1617; FURUICHI T, 1995, J NEUROCHEM, V64, P953, DOI 10.1046/j.1471-4159.1995.64030953.x; Fusi S, 2005, NEURON, V45, P599, DOI 10.1016/j.neuron.2005.02.001; GERSTEIN GL, 1964, BIOPHYS J, V4, P41, DOI 10.1016/S0006-3495(64)86768-0; Ghashghaie S, 1996, NATURE, V381, P767, DOI 10.1038/381767a0; Ghil M., 1985, TURBULENCE PREDICTAB; Gilboa G, 2005, J NEUROSCI, V25, P6479, DOI 10.1523/JNEUROSCI.0763-05.2005; Gireesh ED, 2008, P NATL ACAD SCI USA, V105, P7576, DOI 10.1073/pnas.0800537105; Hazan L, 2006, J NEUROSCI METH, V155, P207, DOI 10.1016/j.jneumeth.2006.01.017; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Isomura Y, 2009, NAT NEUROSCI, V12, P1586, DOI 10.1038/nn.2431; Kandel E., 2000, PRINCIPLES NEURAL SC; Kiyono K, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.058101; Kiyono K, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.068701; Kiyono K, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.178103; Kiyono K, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.041113; Lungarella M, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.056117; Nakamura T, 2000, J NEUROSCI, V20, P8365, DOI 10.1523/JNEUROSCI.20-22-08365.2000; PENG CK, 1993, PHYS REV LETT, V70, P1343, DOI 10.1103/PhysRevLett.70.1343; Persi E, 2004, NEURAL COMPUT, V16, P2577, DOI 10.1162/0899766042321823; Plenz D, 2007, TRENDS NEUROSCI, V30, P101, DOI 10.1016/j.tins.2007.01.005; Segev R, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.118102; TAKEKAWA T, 2009, ETOS EFFICIENT TECHN; TAKEKAWA T, 2008, SOC NEUR 38 ANN M; Takekawa T, 2010, EUR J NEUROSCI, V31, P263, DOI 10.1111/j.1460-9568.2009.07068.x; Takekawa T, 2009, NEUROCOMPUTING, V72, P3366, DOI 10.1016/j.neucom.2009.04.003; Teramae JN, 2007, J COMPUT NEUROSCI, V22, P301, DOI 10.1007/s10827-006-0014-6; TSUBO Y, 2009, SOC NEUR 39 ANN M; Volman V, 2004, PHYSICA A, V335, P249, DOI 10.1016/j.physa.2003.11.015; Yamada WM, 1989, METHODS NEURONAL MOD, P97	40	5	5	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2010	5	9							e12869	10.1371/journal.pone.0012869	http://dx.doi.org/10.1371/journal.pone.0012869			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654ZQ	20927400	gold, Green Published, Green Submitted			2022-12-27	WOS:000282210700004
J	Aran, A; Weiner, K; Lin, L; Finn, LA; Greco, MA; Peppard, P; Young, T; Ofran, Y; Mignot, E				Aran, Adi; Weiner, Karin; Lin, Ling; Finn, Laurel Ann; Greco, Mary Ann; Peppard, Paul; Young, Terry; Ofran, Yanay; Mignot, Emmanuel			Post-Streptococcal Auto-Antibodies Inhibit Protein Disulfide Isomerase and Are Associated with Insulin Resistance	PLOS ONE			English	Article							PLATELET-AGGREGATION; ANTISTREPTOCOCCAL ANTIBODIES; METABOLIC SYNDROME; CELL DEATH; TISSUE; DISEASE; PREVALENCE; ANTIGENS; FUSION	Post-streptococcal autoimmunity affects millions worldwide, targeting multiple organs including the heart, brain, and kidneys. To explore the post-streptococcal autoimmunity spectrum, we used western blot analyses, to screen 310 sera from healthy subjects with (33%) and without (67%) markers of recent streptococcal infections [ anti-Streptolysin O (ASLO) or anti-DNAse B (ADB)]. A 58 KDa protein, reacting strongly with post-streptococcal sera, was identified as Protein Disulfide Isomerase (PDI), an abundant protein with pleiotropic metabolic, immunologic, and thrombotic effects. Anti-PDI autoantibodies, purified from human sera, targeted similar epitopes in Streptolysin O (SLO, P51-61) and PDI (P328-338). The correlation between post-streptococcal status and anti-human PDI auto-immunity was further confirmed in a total of 2987 samples (13.6% in 530 ASLO positive versus 5.6% in 2457 ASLO negative samples, p<0.0001). Finally, anti-PDI autoantibodies inhibited PDI-mediated insulin degradation in vitro (n = 90, p<0.001), and correlated with higher serum insulin (14.1 iu/ml vs. 12.2 iu/ml, n = 1215, p = 0.039) and insulin resistance (Homeostatic Model Assessment (HOMA) 4.1 vs. 3.1, n = 1215, p = 0.004), in a population-based cohort. These results identify PDI as a major target of post-streptococcal autoimmunity, and establish a new link between infection, autoimmunity, and metabolic disturbances.	[Aran, Adi; Weiner, Karin; Lin, Ling; Mignot, Emmanuel] Stanford Univ, Stanford, CA 94305 USA; [Aran, Adi] Hebrew Univ Jerusalem, Jerusalem, Israel; [Finn, Laurel Ann; Peppard, Paul; Young, Terry] Univ Wisconsin, Dept Populat Hlth Sci, Madison, WI USA; [Greco, Mary Ann] SRI Int, Behav Biochem Lab, Menlo Pk, CA 94025 USA; [Ofran, Yanay] Bar Ilan Univ, Goodman Fac Life Sci, Lab Syst Biol & Funct Genom, Ramat Gan, Israel	Stanford University; Hebrew University of Jerusalem; University of Wisconsin System; University of Wisconsin Madison; SRI International; Bar Ilan University	Aran, A (corresponding author), Stanford Univ, Stanford, CA 94305 USA.	mignot@stanford.edu		Aran, Adi/0000-0001-9460-4689	U.S. National Institutes of Health [NS23724, MH73073435]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS023724, P50NS023724] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by U.S. National Institutes of Health grants NS23724, MH73073435. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abromaitis S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000357; Aran A, 2009, SLEEP, V32, P979, DOI 10.1093/sleep/32.8.979; Bennett TA, 2000, J IMMUNOL, V164, P4120, DOI 10.4049/jimmunol.164.8.4120; Blyth CC, 2006, PATHOLOGY, V38, P152, DOI 10.1080/00313020600557060; Cho J, 2008, J CLIN INVEST, V118, P1123, DOI 10.1172/JCI34134; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Essex DW, 2009, ANTIOXID REDOX SIGN, V11, P1191, DOI [10.1089/ars.2008.2322, 10.1089/ARS.2008.2322]; Essex DW, 1999, BRIT J HAEMATOL, V104, P448, DOI 10.1046/j.1365-2141.1999.01197.x; Essex DW, 1999, THROMB RES, V96, P445, DOI 10.1016/S0049-3848(99)00133-4; Fae KC, 2008, J AUTOIMMUN, V31, P136, DOI 10.1016/j.jaut.2008.04.023; Fenouillet E, 2001, J INFECT DIS, V183, P744, DOI 10.1086/318823; FLORESRIVEROS JR, 1993, P NATL ACAD SCI USA, V90, P512, DOI 10.1073/pnas.90.2.512; Fonseca C, 2009, BLOOD, V113, P1681, DOI 10.1182/blood-2007-09-114157; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI [10.1089/ars.2009.2466, 10.1089/ARS.2009.2466]; Hogg PJ, 2003, TRENDS BIOCHEM SCI, V28, P210, DOI 10.1016/S0968-0004(03)00057-4; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; KAPLAN EL, 1974, J PEDIATR-US, V84, P21, DOI 10.1016/S0022-3476(74)80548-2; Lovat PE, 2008, CANCER RES, V68, P5363, DOI 10.1158/0008-5472.CAN-08-0035; Maeda R, 2007, BBA-PROTEINS PROTEOM, V1774, P1619, DOI 10.1016/j.bbapap.2007.08.016; Marijon E, 2007, NEW ENGL J MED, V357, P470, DOI 10.1056/NEJMoa065085; Markovic I, 2004, BLOOD, V103, P1586, DOI 10.1182/blood-2003-05-1390; Obeid M, 2008, J IMMUNOL, V181, P2533, DOI 10.4049/jimmunol.181.4.2533; POPESCU NI, 2010, BLOOD; Raturi A, 2008, BBA-BIOMEMBRANES, V1778, P2790, DOI 10.1016/j.bbamem.2008.07.003; Reinhardt C, 2008, J CLIN INVEST, V118, P1110, DOI 10.1172/JCI32376; Shah CM, 2007, NITRIC OXIDE-BIOL CH, V16, P135, DOI 10.1016/j.niox.2006.08.001; Stern SE, 2005, DIABETES, V54, P333, DOI 10.2337/diabetes.54.2.333; Swedo SE, 1998, AM J PSYCHIAT, V155, P264; Tian F, 2009, AM J PHYSIOL-HEART C, V297, pH1078, DOI 10.1152/ajpheart.00937.2008; Turano C, 2002, J CELL PHYSIOL, V193, P154, DOI 10.1002/jcp.10172; Versteeg HH, 2007, J BIOL CHEM, V282, P25416, DOI 10.1074/jbc.M702410200; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Vincent A, 2004, BRAIN, V127, P2, DOI 10.1093/brain/awh063; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Wentworth JM, 2010, DIABETES, V59, P1648, DOI 10.2337/db09-0287; Yaddanapudi K, 2010, MOL PSYCHIATR, V15, P712, DOI 10.1038/mp.2009.77; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	40	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12875	10.1371/journal.pone.0012875	http://dx.doi.org/10.1371/journal.pone.0012875			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886095	Green Submitted, Green Published, gold			2022-12-27	WOS:000282091100004
J	O'Driscoll, C; Bressler, JP				O'Driscoll, Cliona; Bressler, Joseph P.			Hairless Expression Attenuates Apoptosis in a Mouse Model and the COS Cell Line; Involvement of p53	PLOS ONE			English	Article							VITAMIN-D-RECEPTOR; TUMOR-SUPPRESSOR P53; DEVELOPING BRAIN; DEVELOPING CEREBELLUM; ENHANCED APOPTOSIS; CASPASE ACTIVATION; NERVOUS-SYSTEM; HR GENE; DEATH; COREPRESSOR	Background: Neurons are more likely to die through apoptosis in the immature brain after injury whereas adult neurons in the mature brain die by necrosis. Several studies have suggested that this maturational change in the mechanism of cell death is regulated, in part, by thyroid hormone. We examined the involvement of the hairless ( Hr) gene which has been suspected of having a role in cell cycle regulation and apoptosis in the hair follicle and is strongly regulated by the thyroid hormone in the brain. Methodology: Forced expression of Hr by transfection decreased the number of apoptotic nuclei, levels of caspase-3 activity, and cytosolic cytochrome C in COS cells exposed to staurosporine and tunicamycin. Similarly, capsase-3 activity was lower and the decrease in mitochondrial membrane potential was smaller in cultures of adult cerebellar granule neurons from wild type mice compared to Hr knockout mice induced to undergo apoptosis. In vivo, apoptosis as detected by positive TUNEL labeling and caspase 3 activity was lower in wild-type mice compared to Hr knockouts after exposure to trimethyltin. Hr expression lowered levels of p53, p53 mediated reporter gene activity, and lower levels of the pro-apoptotic Bcl2 family member Bax in COS cells. Finally, Hr expression did not attenuate apoptosis in mouse embryonic fibroblasts from p53 knockout mice but was effective in mouse embryonic fibroblasts from wild type mice. Conclusions/Significance: Overall, our studies demonstrate that Hr evokes an anti-apoptotic response by repressing expression of p53 and pro-apoptotic events regulated by p53.	[O'Driscoll, Cliona] Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Div Toxicol, Baltimore, MD 21205 USA; Hugo Moser Res Inst Kennedy Krieger, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	O'Driscoll, C (corresponding author), Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Div Toxicol, Baltimore, MD 21205 USA.	bressler@kennedykrieger.org			U.S. Army [W81XWH-09-0430]; ROAR foundation	U.S. Army(United States Department of DefenseUnited States Army); ROAR foundation	This work was supported by U.S. Army grant W81XWH-09-0430 (https://cdmrp.org/) and the ROAR foundation (www.roar.kennedykrieger.org/). The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae BI, 2005, NEURON, V47, P29, DOI 10.1016/j.neuron.2005.06.005; Blomgren K, 2003, BIOCHEM BIOPH RES CO, V304, P551, DOI 10.1016/S0006-291X(03)00628-4; Boyd SD, 2000, NAT CELL BIOL, V2, P563, DOI 10.1038/35023500; Bratton SB, 2001, TRENDS PHARMACOL SCI, V22, P306, DOI 10.1016/S0165-6147(00)01718-1; Breckenridge DG, 2003, ONCOGENE, V22, P8608, DOI 10.1038/sj.onc.1207108; Buss RR, 2006, ANNU REV NEUROSCI, V29, P1, DOI 10.1146/annurev.neuro.29.051605.112800; DeGracia DJ, 2002, J CEREBR BLOOD F MET, V22, P127, DOI 10.1097/00004647-200202000-00001; Freedman DA, 1999, CELL MOL LIFE SCI, V55, P96, DOI 10.1007/s000180050273; Gunasekar P, 2001, TOXICOL SCI, V64, P83, DOI 10.1093/toxsci/64.1.83; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Howdeshell KL, 2002, ENVIRON HEALTH PERSP, V110, P337, DOI 10.1289/ehp.02110s3337; Hsieh JC, 2003, J BIOL CHEM, V278, P38665, DOI 10.1074/jbc.M304886200; Hu BR, 2000, J CEREBR BLOOD F MET, V20, P1294, DOI 10.1097/00004647-200009000-00003; Ikonomidou C, 2009, BRAIN DEV-JPN, V31, P488, DOI 10.1016/j.braindev.2009.02.006; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Johnson MD, 1999, J NEUROSCI, V19, P2996; Johnston MV, 2002, NEUROSCIENTIST, V8, P212, DOI 10.1177/1073858402008003007; Kumar A, 2006, ENDOCRINOLOGY, V147, P4893, DOI 10.1210/en.2006-0027; Malloy PJ, 2009, ENDOCRINOLOGY, V150, P4950, DOI 10.1210/en.2009-0358; Matsuyama S, 2000, NAT CELL BIOL, V2, P318, DOI 10.1038/35014006; MIYASHITA T, 1995, CELL, V80, P293; Moraitis AN, 2002, MOL CELL BIOL, V22, P6831, DOI 10.1128/MCB.22.19.6831-6841.2002; Nakamura S, 2002, ONCOGENE, V21, P2605, DOI 10.1038/sj.onc.1205343; Olney JW, 2002, BRAIN PATHOL, V12, P488, DOI 10.1111/j.1750-3639.2002.tb00467.x; Panteleyev AA, 1999, AM J PATHOL, V155, P159, DOI 10.1016/S0002-9440(10)65110-3; Panteleyev AA, 1998, EXP DERMATOL, V7, P249, DOI 10.1111/j.1600-0625.1998.tb00295.x-i1; Potter GB, 2002, MOL ENDOCRINOL, V16, P2547, DOI 10.1210/me.2002-0115; Potter GB, 2001, GENE DEV, V15, P2687, DOI 10.1101/gad.916701; Rasheva VI, 2009, APOPTOSIS, V14, P996, DOI 10.1007/s10495-009-0341-y; Rodriguez MS, 2000, MOL CELL BIOL, V20, P8458, DOI 10.1128/MCB.20.22.8458-8467.2000; Singh R, 2003, J ENDOCRINOL, V176, P39, DOI 10.1677/joe.0.1760039; Soane L, 2008, J NEUROSCI RES, V86, P1267, DOI 10.1002/jnr.21584; Thompson CC, 1996, J NEUROSCI, V16, P7832; Thompson CC, 1997, P NATL ACAD SCI USA, V94, P8527, DOI 10.1073/pnas.94.16.8527; Thompson TA, 1996, J PHARMACOL EXP THER, V276, P1201; Vaseva AV, 2009, BBA-BIOENERGETICS, V1787, P414, DOI 10.1016/j.bbabio.2008.10.005; Vekrellis K, 1997, DEVELOPMENT, V124, P1239; Wang J, 2007, J BIOL CHEM, V282, P25231, DOI 10.1074/jbc.M702939200; WIGLER M, 1978, CELL, V14, P725, DOI 10.1016/0092-8674(78)90254-4; Xiang H, 1996, J NEUROSCI, V16, P6753; Xiao Y, 1999, NEUROTOXICOLOGY, V20, P761; Xie ZJ, 2006, ENDOCRINOLOGY, V147, P314, DOI 10.1210/en.2005-1111; Zarach JM, 2004, DEVELOPMENT, V131, P4189, DOI 10.1242/dev.01303; ZHANG L, 2009, NEUROBIOL DIS	44	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12911	10.1371/journal.pone.0012911	http://dx.doi.org/10.1371/journal.pone.0012911			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886113	Green Published, Green Submitted, gold			2022-12-27	WOS:000282091100018
J	Straschil, U; Talman, AM; Ferguson, DJP; Bunting, KA; Xu, ZY; Bailes, E; Sinden, RE; Holder, AA; Smith, EF; Coates, JC; Tewari, R				Straschil, Ursula; Talman, Arthur M.; Ferguson, David J. P.; Bunting, Karen A.; Xu, Zhengyao; Bailes, Elizabeth; Sinden, Robert E.; Holder, Anthony A.; Smith, Elizabeth F.; Coates, Juliet C.; Tewari, Rita			The Armadillo Repeat Protein PF16 Is Essential for Flagellar Structure and Function in Plasmodium Male Gametes	PLOS ONE			English	Article							TRYPANOSOMA-BRUCEI; CENTRAL APPARATUS; CHLAMYDOMONAS-REINHARDTII; MOTILITY; COMPONENTS; KINASE; GENE; TRANSMISSION; MICROTUBULES; CYTOKINESIS	Malaria, caused by the apicomplexan parasite Plasmodium, threatens 40% of the world's population. Transmission between vertebrate and insect hosts depends on the sexual stages of the life-cycle. The male gamete of Plasmodium parasite is the only developmental stage that possesses a flagellum. Very little is known about the identity or function of proteins in the parasite's flagellar biology. Here, we characterise a Plasmodium PF16 homologue using reverse genetics in the mouse malaria parasite Plasmodium berghei. PF16 is a conserved Armadillo-repeat protein that regulates flagellar structure and motility in organisms as diverse as green algae and mice. We show that P. berghei PF16 is expressed in the male gamete flagellum, where it plays a crucial role maintaining the correct microtubule structure in the central apparatus of the axoneme as studied by electron microscopy. Disruption of the PF16 gene results in abnormal flagellar movement and reduced fertility, but does not lead to complete sterility, unlike pf16 mutations in other organisms. Using homology modelling, bioinformatics analysis and complementation studies in Chlamydomonas, we show that some regions of the PF16 protein are highly conserved across all eukaryotes, whereas other regions may have species-specific functions. PF16 is the first ARM-repeat protein characterised in the malaria parasite genus Plasmodium and this study opens up a novel model for analysis of Plasmodium flagellar biology that may provide unique insights into an ancient organelle and suggest novel intervention strategies to control the malaria parasite.	[Straschil, Ursula; Bunting, Karen A.; Xu, Zhengyao; Bailes, Elizabeth; Tewari, Rita] Univ Nottingham, Sch Biol, Inst Genet, Nottingham NG7 2RD, England; [Straschil, Ursula; Talman, Arthur M.; Sinden, Robert E.; Tewari, Rita] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, London, England; [Ferguson, David J. P.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Oxford OX3 9DU, England; [Holder, Anthony A.] MRC Natl Inst Med Res, Div Parasitol, London, England; [Smith, Elizabeth F.] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Coates, Juliet C.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England	University of Nottingham; Imperial College London; University of Oxford; MRC National Institute for Medical Research; Dartmouth College; University of Birmingham	Straschil, U (corresponding author), Univ Nottingham, Sch Biol, Inst Genet, Nottingham NG7 2RD, England.	rita.tewari@nottingham.ac.uk	Talman, Arthur/GMW-9116-2022; Holder, Anthony A/A-7554-2013; Coates, Juliet C/A-3608-2013; Tewari, Rita/M-5698-2014	Holder, Anthony A/0000-0002-8490-6058; Coates, Juliet C/0000-0002-2381-0298; Talman, Arthur/0000-0003-2584-3672; Ferguson, David/0000-0001-5045-819X; Tewari, Rita/0000-0003-3943-1847	UK Medical Research Council [G0900109, U117532067]; Wellcome Trust; Leverhulme Trust [ID20070575]; Bio Mal Par PhD studentship; Medical Research Council [G0900109, MC_U117532067] Funding Source: researchfish; MRC [MC_U117532067, G0900109] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Leverhulme Trust(Leverhulme Trust); Bio Mal Par PhD studentship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the UK Medical Research Council (G0900109 to RT; U117532067 to AH), the Wellcome Trust (equipment grant to DJPF), the Leverhulme Trust (ID20070575 to JC) and a Bio Mal Par PhD studentship to AT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aurrecoechea C, 2007, NUCLEIC ACIDS RES, V35, pD427, DOI 10.1093/nar/gkl880; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baron DM, 2007, J CELL SCI, V120, P478, DOI 10.1242/jcs.03352; Billker O, 1998, NATURE, V392, P289, DOI 10.1038/32667; Billker O, 2004, CELL, V117, P503, DOI 10.1016/S0092-8674(04)00449-0; Branche C, 2006, J CELL SCI, V119, P3443, DOI 10.1242/jcs.03078; Briggs LJ, 2004, CURR BIOL, V14, pR611, DOI 10.1016/j.cub.2004.07.041; Briggs LJ, 2004, J CELL SCI, V117, P1641, DOI 10.1242/jcs.00995; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Coates JC, 2003, TRENDS CELL BIOL, V13, P463, DOI 10.1016/S0962-8924(03)00167-3; COX FEG, 1983, NATURE, V304, P394, DOI 10.1038/304394b0; DEBUCHY R, 1989, EMBO J, V8, P2803, DOI 10.1002/j.1460-2075.1989.tb08426.x; DUTCHER SK, 1984, J CELL BIOL, V98, P229, DOI 10.1083/jcb.98.1.229; Ferguson DJP, 2005, EUKARYOT CELL, V4, P814, DOI 10.1128/EC.4.4.814-826.2005; Ferguson DJP, 2002, TRENDS PARASITOL, V18, P355, DOI 10.1016/S1471-4922(02)02330-9; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guirao B, 2010, NAT CELL BIOL, V12, P341, DOI 10.1038/ncb2040; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Kilburn CL, 2007, J CELL BIOL, V178, P905, DOI 10.1083/jcb.200703109; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu YJ, 2008, GENE DEV, V22, P1051, DOI 10.1101/gad.1656508; Lumbreras V, 1998, PLANT J, V14, P441, DOI 10.1046/j.1365-313X.1998.00145.x; Mitchell DR, 2004, BIOL CELL, V96, P691, DOI 10.1016/j.biolcel.2004.07.004; Mitchison TJ, 2010, NATURE, V463, P308, DOI 10.1038/463308a; Pearson CG, 2009, MOL BIOL CELL, V20, P904, DOI 10.1091/mbc.E08-08-0835; PEIFER M, 1994, CELL, V76, P789, DOI 10.1016/0092-8674(94)90353-0; Ralston KS, 2006, EUKARYOT CELL, V5, P696, DOI 10.1128/EC.5.4.696-711.2006; RAWLINGS DJ, 1992, MOL BIOCHEM PARASIT, V56, P239, DOI 10.1016/0166-6851(92)90173-H; Reininger L, 2009, J BIOL CHEM, V284, P20858, DOI 10.1074/jbc.M109.017988; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; RUDZINSKA MA, 1983, P NATL ACAD SCI-BIOL, V80, P2966, DOI 10.1073/pnas.80.10.2966; Sapiro R, 2002, MOL CELL BIOL, V22, P6298, DOI 10.1128/MCB.22.17.6298-6305.2002; SCHOLTYSECK E, 1972, Z PARASITENK, V38, P95, DOI 10.1007/BF00329023; Sharma N, 2008, CURR TOP DEV BIOL, V85, P371, DOI 10.1016/S0070-2153(08)00813-2; Silflow CD, 2001, PLANT PHYSIOL, V127, P1500, DOI 10.1104/pp.127.4.1500; SINDEN RE, 1976, PROC R SOC SER B-BIO, V193, P55, DOI 10.1098/rspb.1976.0031; Smith EF, 2000, CELL MOTIL CYTOSKEL, V46, P157, DOI 10.1002/1097-0169(200007)46:3<157::AID-CM1>3.0.CO;2-D; Smith EF, 1997, CELL MOTIL CYTOSKEL, V38, P1; Smith EF, 1996, J CELL BIOL, V132, P359, DOI 10.1083/jcb.132.3.359; Tewari R, 2005, MOL MICROBIOL, V58, P1253, DOI 10.1111/j.1365-2958.2005.04793.x; Tewari R, 2010, TRENDS CELL BIOL, V20, P470, DOI 10.1016/j.tcb.2010.05.003; Wilson CW, 2009, NATURE, V459, P98, DOI 10.1038/nature07883; Woodland HR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003778	48	37	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12901	10.1371/journal.pone.0012901	http://dx.doi.org/10.1371/journal.pone.0012901			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886115	Green Published, Green Submitted, gold			2022-12-27	WOS:000282091100011
J	Olivares-Hernandez, R; Sunner, H; Frisvad, JC; Olsson, L; Nielsen, J; Panagiotou, G				Olivares-Hernandez, Roberto; Sunner, Hampus; Frisvad, Jens C.; Olsson, Lisbeth; Nielsen, Jens; Panagiotou, Gianni			Combining Substrate Specificity Analysis with Support Vector Classifiers Reveals Feruloyl Esterase as a Phylogenetically Informative Protein Group	PLOS ONE			English	Article							CLASSIFICATION	Background: Our understanding of how fungi evolved to develop a variety of ecological niches, is limited but of fundamental biological importance. Specifically, the evolution of enzymes affects how well species can adapt to new environmental conditions. Feruloyl esterases (FAEs) are enzymes able to hydrolyze the ester bonds linking ferulic acid to plant cell wall polysaccharides. The diversity of substrate specificities found in the FAE family shows that this family is old enough to have experienced the emergence and loss of many activities. Methodology/Principal Findings: In this study we evaluate the relative activity of FAEs against a variety of model substrates as a novel predictive tool for Ascomycota taxonomic classification. Our approach consists of two analytical steps; (1) an initial unsupervised analysis to cluster the FAEs substrate specificity data which were generated by cultivation of 34 Ascomycota strains and then an analysis of the produced enzyme cocktail against 10 substituted cinnamate and phenylalkanoate methyl esters, (2) a second, supervised analysis for training a predictor built on these substrate activities. By applying both linear and non-linear models we were able to correctly predict the taxonomic Class (similar to 86% correct classification), Order (similar to 88% correct classification) and Family (similar to 88% correct classification) that the 34 Ascomycota belong to, using the activity profiles of the FAEs. Conclusion/Significance: The good correlation with the FAEs substrate specificities that we have defined via our phylogenetic analysis not only suggests that FAEs are phylogenetically informative proteins but it is also a considerable step towards improved FAEs functional prediction.	[Frisvad, Jens C.; Panagiotou, Gianni] Tech Univ Denmark, Dept Syst Biol, Ctr Microbial Biotechnol, DK-2800 Lyngby, Denmark; [Olivares-Hernandez, Roberto; Sunner, Hampus; Olsson, Lisbeth; Nielsen, Jens] Chalmers Univ Technol, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden	Technical University of Denmark; Chalmers University of Technology	Olivares-Hernandez, R (corresponding author), Chalmers Univ Technol, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden.	gpa@bio.dtu.dk	Panagiotou, Ioannis/B-7083-2013; Frisvad, Jens C/K-2818-2017; Nielsen, Jens/Q-1347-2017	Frisvad, Jens C/0000-0002-0573-4340; /0000-0002-0827-5442; Olivares-Hernandez, Roberto/0000-0002-8431-4052; Nielsen, Jens/0000-0002-9955-6003	Danish Research Council for Technology and Production Sciences; Wallenberg Wood Science Center; CONACYT-Mexico; Chalmers Foundation	Danish Research Council for Technology and Production Sciences; Wallenberg Wood Science Center; CONACYT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Chalmers Foundation	GPA would like to thank the Danish Research Council for Technology and Production Sciences for financial support. HS and LO thank Wallenberg Wood Science Center for financial support. ROH would like to thank the CONACYT-Mexico and the Chalmers Foundation for scholarship to support doctoral studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXOPOULOS CJ, 1996, INTRODUCTORY MYCOLOG; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BARR ME, 1990, MYCOTAXON, V39, P43; Benoit I, 2008, BIOTECHNOL LETT, V30, P387, DOI 10.1007/s10529-007-9564-6; CHRISTENSEN M, 1962, MYCOLOGIA, V54, P573, DOI 10.2307/3756326; Crepin VF, 2004, APPL MICROBIOL BIOT, V63, P647, DOI 10.1007/s00253-003-1476-3; Desper R, 2002, J COMPUT BIOL, V9, P687, DOI 10.1089/106652702761034136; Domsch KH, 2007, COMPENDIUM SOIL FUNG; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eriksson O., 1993, SYSTEMA ASCOMYCETUM, V12, P1; Fausset L, 1994, FUNDAMENTALS NEURAL; Fitzpatrick DA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-99; Hawksworth DL, 2001, MYCOL RES, V105, P1422, DOI 10.1017/S0953756201004725; Heckman DS, 2001, SCIENCE, V293, P1129, DOI 10.1126/science.1061457; HONEGGER R, 1991, ANNU REV PLANT PHYS, V42, P553, DOI 10.1146/annurev.arplant.42.1.553; Kirk P., 2008, Ainsworth and Bisby�s Dictionary of the Fungi, DOI 10.1079/9780851998268.0000; KIRK PM, DICT FUNGI; Kroon PA, 1997, EUR J BIOCHEM, V248, P245, DOI 10.1111/j.1432-1033.1997.00245.x; Kuramae EE, 2006, FEMS YEAST RES, V6, P1213, DOI 10.1111/j.1567-1364.2006.00119.x; Kurtzman CP, 2003, FEMS YEAST RES, V3, P417, DOI 10.1016/S1567-1356(03)00012-6; LOBUGLIO KF, 1993, FUNGAL HOLOMORPH : MITOTIC, MEIOTIC AND PLEOMORPHIC SPECIATION IN FUNGAL SYSTEMATICS, P115; McCullagh P, 1989, GEN LINEAR MODELS; PETERSON SW, 2000, INTEGRATION MODERN T, P163; Robbertse B, 2006, FUNGAL GENET BIOL, V43, P715, DOI 10.1016/j.fgb.2006.05.001; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Tehler A, 2003, MYCOL RES, V107, P901, DOI 10.1017/S0953756203008128; Topakas E, 2005, J BIOTECHNOL, V115, P355, DOI 10.1016/j.jbiotec.2004.10.001; Vafiadi C, 2008, J BIOTECHNOL, V133, P497, DOI 10.1016/j.jbiotec.2007.11.004; Vafiadi C, 2007, BIOTECHNOL LETT, V29, P1771, DOI 10.1007/s10529-007-9440-4; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Witten I. H., 2005, DATA MINING PRACTICA; Yuan XL, 2005, SCIENCE, V308, P1017, DOI 10.1126/science.1111347; Zmasek CM, 2001, BIOINFORMATICS, V17, P383, DOI 10.1093/bioinformatics/17.4.383	33	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12781	10.1371/journal.pone.0012781	http://dx.doi.org/10.1371/journal.pone.0012781			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877647	Green Published, Green Submitted, gold			2022-12-27	WOS:000282053100008
J	Richmond, OMW; McEntee, JP; Hijmans, RJ; Brashares, JS				Richmond, Orien M. W.; McEntee, Jay P.; Hijmans, Robert J.; Brashares, Justin S.			Is the Climate Right for Pleistocene Rewilding? Using Species Distribution Models to Extrapolate Climatic Suitability for Mammals across Continents	PLOS ONE			English	Article							HABITAT DISTRIBUTION MODELS; SAMPLE-SIZE; POTENTIAL DISTRIBUTION; ASSISTED MIGRATION; CHANGE PROJECTIONS; ENVELOPE MODELS; ROC CURVE; CONSERVATION; PERFORMANCE; PREDICTION	Species distribution models (SDMs) are increasingly used for extrapolation, or predicting suitable regions for species under new geographic or temporal scenarios. However, SDM predictions may be prone to errors if species are not at equilibrium with climatic conditions in the current range and if training samples are not representative. Here the controversial "Pleistocene rewilding" proposal was used as a novel example to address some of the challenges of extrapolating modeled species-climate relationships outside of current ranges. Climatic suitability for three proposed proxy species (Asian elephant, African cheetah and African lion) was extrapolated to the American southwest and Great Plains using Maxent, a machine-learning species distribution model. Similar models were fit for Oryx gazella, a species native to Africa that has naturalized in North America, to test model predictions. To overcome biases introduced by contracted modern ranges and limited occurrence data, random pseudo-presence points generated from modern and historical ranges were used for model training. For all species except the oryx, models of climatic suitability fit to training data from historical ranges produced larger areas of predicted suitability in North America than models fit to training data from modern ranges. Four naturalized oryx populations in the American southwest were correctly predicted with a generous model threshold, but none of these locations were predicted with a more stringent threshold. In general, the northern Great Plains had low climatic suitability for all focal species and scenarios considered, while portions of the southern Great Plains and American southwest had low to intermediate suitability for some species in some scenarios. The results suggest that the use of historical, in addition to modern, range information and randomly sampled pseudo-presence points may improve model accuracy. This has implications for modeling range shifts of organisms in response to climate change.	[Richmond, Orien M. W.; Brashares, Justin S.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [McEntee, Jay P.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Hijmans, Robert J.] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Davis	Richmond, OMW (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	orien.richmond@gmail.com	Hijmans, Robert/N-3299-2016	Hijmans, Robert/0000-0001-5872-2872	National Science Foundation-Integrative Organismal Systems [0818185]; United States Department of Agriculture-National Research Initiative [2008-03116]	National Science Foundation-Integrative Organismal Systems; United States Department of Agriculture-National Research Initiative(United States Department of Agriculture (USDA))	This work was supported in part by the following grants: National Science Foundation-Integrative Organismal Systems 0818185 and United States Department of Agriculture-National Research Initiative 2008-03116 to JSB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, WORLDCLIM INTERPOLAT; [Anonymous], [No title captured]; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Bar-David S, 2006, ECOLOGY, V87, P1215, DOI 10.1890/0012-9658(2006)87[1215:DAMOID]2.0.CO;2; BAUER H, 2008, IUCN 2009 RED LIST T; Beyer HL, 2004, HAWTHS ANAL TOOLS AR; Brito JC, 2009, BIOL CONSERV, V142, P3020, DOI 10.1016/j.biocon.2009.08.001; Broennimann O, 2008, BIOL LETTERS, V4, P585, DOI 10.1098/rsbl.2008.0254; Channell R, 2000, J BIOGEOGR, V27, P169, DOI 10.1046/j.1365-2699.2000.00382.x; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; Donlan CJ, 2006, AM NAT, V168, P660, DOI 10.1086/508027; Donlan J, 2005, NATURE, V436, P913, DOI 10.1038/436913a; Dormann CF, 2007, BASIC APPL ECOL, V8, P387, DOI 10.1016/j.baae.2006.11.001; Dudik M, 2007, J MACH LEARN RES, V8, P1217; Early R, 2008, J APPL ECOL, V45, P228, DOI 10.1111/j.1365-2664.2007.01424.x; EAST R, 1989, ANTELOPES GLOBAL S 2; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; *ENV SYST RES I, 2009, ARCMAP VERS 9 3 1; Ficetola GF, 2007, DIVERS DISTRIB, V13, P476, DOI 10.1111/j.1472-4642.2007.00377.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fitzpatrick MC, 2009, BIODIVERS CONSERV, V18, P2255, DOI 10.1007/s10531-009-9584-8; Graham CH, 2008, J APPL ECOL, V45, P239, DOI 10.1111/j.1365-2664.2007.01408.x; Graham CH, 2006, GLOBAL ECOL BIOGEOGR, V15, P578, DOI 10.1111/j.1466-8238.2006.00257.x; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2000, CONSERV BIOL, V14, P1755, DOI [10.1046/j.1523-1739.2000.98543.x, 10.1111/j.1523-1739.2000.98543.x]; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Hurlbert AH, 2007, P NATL ACAD SCI USA, V104, P13384, DOI 10.1073/pnas.0704469104; IUCN SSC Antelope Specialist Group, 2008, IUCN 2010 IUCN RED L; Jackson P., 1996, BIOL CONSERVATION; Jetz W, 2008, CONSERV BIOL, V22, P110, DOI 10.1111/j.1523-1739.2007.00847.x; Jimenez-Valverde A, 2007, ACTA OECOL, V31, P361, DOI 10.1016/j.actao.2007.02.001; Kadmon R, 2003, ECOL APPL, V13, P853, DOI 10.1890/1051-0761(2003)013[0853:ASAOFA]2.0.CO;2; Kadoya T, 2009, BIOL CONSERV, V142, P1011, DOI 10.1016/j.biocon.2009.01.012; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Loiselle BA, 2003, CONSERV BIOL, V17, P1591, DOI 10.1111/j.1523-1739.2003.00233.x; Lutolf M, 2006, J APPL ECOL, V43, P802, DOI 10.1111/j.1365-2664.2006.01191.x; Mackey BG, 2001, J BIOGEOGR, V28, P1147, DOI 10.1046/j.1365-2699.2001.00626.x; Martinez-Meyer E, 2004, GLOBAL ECOL BIOGEOGR, V13, P305, DOI 10.1111/j.1466-822X.2004.00107.x; Martinez-Meyer E, 2006, ORYX, V40, P411, DOI 10.1017/S0030605306001360; Masembe C, 2006, CONSERV GENET, V7, P551, DOI 10.1007/s10592-005-9066-9; Mayewski PA, 2004, QUATERNARY RES, V62, P243, DOI 10.1016/j.yqres.2004.07.001; McLachlan JS, 2007, CONSERV BIOL, V21, P297, DOI 10.1111/j.1523-1739.2007.00676.x; Morueta-Holme N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010360; Mueller JM, 2008, CONSERV BIOL, V22, P562, DOI 10.1111/j.1523-1739.2008.00952.x; Olivier R., 1978, Oryx, V14, P379, DOI 10.1017/S003060530001601X; Rodriguez JP, 2007, DIVERS DISTRIB, V13, P243, DOI 10.1111/j.1472-4642.2007.00356.x; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Randin CF, 2006, J BIOGEOGR, V33, P1689, DOI 10.1111/j.1365-2699.2006.01466.x; Reddy S, 2003, J BIOGEOGR, V30, P1719, DOI 10.1046/j.1365-2699.2003.00946.x; REID WH, 1983, SOUTHWEST NAT, V28, P97, DOI 10.2307/3670599; Santiapillai C., 1990, ASIAN ELEPHANT ACTIO; Schaefer HC, 2008, GLOBAL ECOL BIOGEOGR, V17, P38, DOI 10.1111/j.1466-8238.2007.00341.x; Seidel DJ, 2008, NAT GEOSCI, V1, P21, DOI 10.1038/ngeo.2007.38; Steig EJ, 1999, SCIENCE, V286, P1485, DOI 10.1126/science.286.5444.1485; Stockwell DRB, 2002, ECOL MODEL, V148, P1, DOI 10.1016/S0304-3800(01)00388-X; Svenning JC, 2007, ECOL LETT, V10, P453, DOI 10.1111/j.1461-0248.2007.01038.x; Syphard AD, 2009, ECOGRAPHY, V32, P907, DOI 10.1111/j.1600-0587.2009.05883.x; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thompson Robert S., 1993, P468; Thuiller W, 2005, GLOBAL CHANGE BIOL, V11, P2234, DOI 10.1111/j.1365-2486.2005.001018.x; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Varela S, 2009, J BIOGEOGR, V36, P1645, DOI 10.1111/j.1365-2699.2009.02125.x; Vaughan IP, 2005, J APPL ECOL, V42, P720, DOI 10.1111/j.1365-2664.2005.01052.x; Vaughan IP, 2003, CONSERV BIOL, V17, P1601, DOI 10.1111/j.1523-1739.2003.00359.x; Vitt P, 2010, BIOL CONSERV, V143, P18, DOI 10.1016/j.biocon.2009.08.015; Ward DF, 2007, BIOL INVASIONS, V9, P723, DOI 10.1007/s10530-006-9072-y; WEB T, 1993, GLOBAL CLIMATES SINC, P415; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Wrogemann N., 1975, CHEETAH SUN; Yunsheng Wang, 2007, Shengwu Duoyangxing, V15, P365, DOI 10.1360/biodiv.060280; Zanini F, 2009, DIVERS DISTRIB, V15, P469, DOI 10.1111/j.1472-4642.2008.00556.x; [No title captured]	81	34	34	3	161	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12899	10.1371/journal.pone.0012899	http://dx.doi.org/10.1371/journal.pone.0012899			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877563	gold, Green Published, Green Submitted			2022-12-27	WOS:000282053100031
J	Sheldon, IM; Roberts, MH				Sheldon, Iain Martin; Roberts, Mark H.			Toll-Like Receptor 4 Mediates the Response of Epithelial and Stromal Cells to Lipopolysaccharide in the Endometrium	PLOS ONE			English	Article							PELVIC-INFLAMMATORY-DISEASE; FEMALE REPRODUCTIVE-TRACT; INDUCED PRETERM BIRTH; CUTTING EDGE; EXPRESSION; IMMUNITY; CULTURE; GENE; MICE; RESPONSIVENESS	Background: Ascending infections of the female genital tract with bacteria causes pelvic inflammatory disease (PID), preterm labour and infertility. Lipopolysaccharide (LPS) is the main component of the cell wall of Gram-negative bacteria. Innate immunity relies on the detection of LPS by Toll-like receptor 4 (TLR4) on host cells. Binding of LPS to TLR4 on immune cells stimulates secretion of pro-inflammatory cytokines such as IL-6, chemokines such as CXCL1 and CCL20, and prostaglandin E(2). The present study tested the hypothesis that TLR4 on endometrial epithelial and stromal cells is essential for the innate immune response to LPS in the female genital tract. Methodology/Principal Findings: Wild type (WT) mice expressed TLR4 in the endometrium. Intrauterine infusion of purified LPS caused pelvic inflammatory disease, with accumulation of granulocytes throughout the endometrium of WT but not Tlr4(-/-) mice. Intra-peritoneal infusion of LPS did not cause PID in WT or Tlr4(-/-) mice, indicating the importance of TLR4 in the endometrium for the detection of LPS in the female genital tract. Stromal and epithelial cells isolated from the endometrium of WT but not Tlr4(-/-) mice, secreted IL-6, CXCL1, CCL20 and prostaglandin E(2) in response to LPS, in a concentration and time dependent manner. Co-culture of combinations of stromal and epithelial cells from WT and Tlr4(-/-) mice provided little evidence of stromal-epithelial interactions in the response to LPS. Conclusions/Significance: The innate immune response to LPS in the female genital tract is dependent on TLR4 on the epithelial and stromal cells of the endometrium.	[Sheldon, Iain Martin; Roberts, Mark H.] Swansea Univ, Sch Med, Inst Life Sci, Swansea, W Glam, Wales	Swansea University	Sheldon, IM (corresponding author), Swansea Univ, Sch Med, Inst Life Sci, Singleton Pk, Swansea, W Glam, Wales.	I.M.Sheldon@swansea.ac.uk	Sheldon, I Martin/E-1567-2013	Sheldon, I Martin/0000-0001-7902-5558	United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC) [BB/D02028X/1]; BBSRC [BB/D02028X/1, BB/D02028X/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D02028X/1, BB/D02028X/2] Funding Source: researchfish	United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC) through the award of a Research Development Fellowship (Grant No. BB/D02028X/1) to IMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aflatoonian R, 2007, HUM REPROD, V22, P586, DOI 10.1093/humrep/del388; Beutler B, 2003, J LEUKOCYTE BIOL, V74, P479, DOI 10.1189/jlb.0203082; COOKE PS, 1986, P NATL ACAD SCI USA, V83, P2109, DOI 10.1073/pnas.83.7.2109; Davies D, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-53; Elovitz MA, 2003, AM J PATHOL, V163, P2103, DOI 10.1016/S0002-9440(10)63567-5; Ernst RK, 1999, SCIENCE, V286, P1561, DOI 10.1126/science.286.5444.1561; Fazeli A, 2005, HUM REPROD, V20, P1372, DOI 10.1093/humrep/deh775; Grant KS, 2003, BIOL REPROD, V69, P1091, DOI 10.1095/biolreprod.103.015495; Herath S, 2006, ENDOCRINOLOGY, V147, P562, DOI 10.1210/en.2005-1113; Herath S, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-55; Herath S, 2009, ENDOCRINOLOGY, V150, P1912, DOI 10.1210/en.2008-1379; Hirata T, 2005, J CLIN ENDOCR METAB, V90, P548, DOI 10.1210/jc.2004-0241; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hoshino K, 1999, J IMMUNOL, V162, P3749; Jones HE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008205; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; *NIAID, 2008, PELV INFL DIS; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; POYSER NL, 1987, J REPROD FERTIL, V81, P269, DOI 10.1530/jrf.0.0810269; Reznikov LL, 1999, BIOL REPROD, V60, P1231, DOI 10.1095/biolreprod60.5.1231; Ross JDC, 2002, SEX TRANSM INFECT, V78, P18, DOI 10.1136/sti.78.1.18; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sheldon IM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009192; Soboll G, 2006, BIOL REPROD, V75, P131, DOI 10.1095/biolreprod.106.050690; Soboll G, 2006, IMMUNOLOGY, V118, P185, DOI 10.1111/j.1365-2567.2006.02353.x; Sweet R. L., 2009, INFECT DIS FEMALE GE; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Uematsu S, 2002, J IMMUNOL, V168, P5811, DOI 10.4049/jimmunol.168.11.5811; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Wira CR, 2005, IMMUNOL REV, V206, P306, DOI 10.1111/j.0105-2896.2005.00287.x; Wira CR, 2005, AM J REPROD IMMUNOL, V53, P65, DOI 10.1111/j.1600-0897.2004.00248.x; Young SL, 2004, AM J REPROD IMMUNOL, V52, P67, DOI 10.1111/j.1600-0897.2004.00189.x; Zitvogel L, 2010, CELL, V140, P798, DOI 10.1016/j.cell.2010.02.015	35	60	64	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12906	10.1371/journal.pone.0012906	http://dx.doi.org/10.1371/journal.pone.0012906			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877575	Green Published, gold, Green Submitted			2022-12-27	WOS:000282053100032
J	Rabinovich, MI; Muezzinoglu, MK; Strigo, I; Bystritsky, A				Rabinovich, Mikhail I.; Muezzinoglu, Mehmet K.; Strigo, Irina; Bystritsky, Alexander			Dynamical Principles of Emotion-Cognition Interaction: Mathematical Images of Mental Disorders	PLOS ONE			English	Article							OBSESSIVE-COMPULSIVE DISORDER; NEURAL MASS MODEL; FUNCTIONAL CONNECTIVITY; TRANSIENT DYNAMICS; WORKING-MEMORY; BRAIN NETWORKS; STATES; NEUROSCIENCE; ANXIETY; NEURONS	The key contribution of this work is to introduce a mathematical framework to understand self-organized dynamics in the brain that can explain certain aspects of itinerant behavior. Specifically, we introduce a model based upon the coupling of generalized Lotka-Volterra systems. This coupling is based upon competition for common resources. The system can be regarded as a normal or canonical form for any distributed system that shows self-organized dynamics that entail winnerless competition. Crucially, we will show that some of the fundamental instabilities that arise in these coupled systems are remarkably similar to endogenous activity seen in the brain (using EEG and fMRI). Furthermore, by changing a small subset of the system's parameters we can produce bifurcations and metastable sequential dynamics changing, which bear a remarkable similarity to pathological brain states seen in psychiatry. In what follows, we will consider the coupling of two macroscopic modes of brain activity, which, in a purely descriptive fashion, we will label as cognitive and emotional modes. Our aim is to examine the dynamical structures that emerge when coupling these two modes and relate them tentatively to brain activity in normal and non-normal states.	[Rabinovich, Mikhail I.; Muezzinoglu, Mehmet K.; Strigo, Irina] Univ Calif San Diego, BioCircuits Inst, La Jolla, CA 92093 USA; [Strigo, Irina] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Bystritsky, Alexander] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Los Angeles	Rabinovich, MI (corresponding author), Univ Calif San Diego, BioCircuits Inst, La Jolla, CA 92093 USA.	mrabinovich@ucsd.edu	strigo, irina A/L-9882-2016	strigo, irina A/0000-0002-8799-716X; Rabinovich, Mikhail I./0000-0003-4499-5348	ONR [N00014-07-1-0741]; Jet Propulsion Laboratory [1396686]; National Institutes of Health (NIH) [NH080003]; Saban Family Foundation	ONR(Office of Naval Research); Jet Propulsion Laboratory(National Aeronautics & Space Administration (NASA)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Saban Family Foundation	M.I.R. and M. K. M. acknowledge the support from ONR grant N00014-07-1-0741. M. K. M. acknowledges the support from the Jet Propulsion Laboratory (1396686). I. S. is supported by the National Institutes of Health (NIH) grant NH080003. A. B. is partially supported by Saban Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELES M, 1995, P NATL ACAD SCI USA, V92, P8616, DOI 10.1073/pnas.92.19.8616; Afraimovich V, 2008, CHAOS, V18, DOI 10.1063/1.2991108; Afraimovich VS, 2004, CHAOS, V14, P1123, DOI 10.1063/1.1819625; Aron AR, 2007, NEUROSCIENTIST, V13, P214, DOI 10.1177/1073858407299288; Baliki MN, 2008, J NEUROSCI, V28, P1398, DOI 10.1523/JNEUROSCI.4123-07.2008; Bressler SL, 2001, TRENDS COGN SCI, V5, P26, DOI 10.1016/S1364-6613(00)01564-3; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2010, P NATL ACAD SCI USA, V107, P10769, DOI 10.1073/pnas.1005987107; Buzsaki G, 2007, NEURON, V56, P771, DOI 10.1016/j.neuron.2007.11.008; CALLAHAN J, 1990, BEHAV SCI, V35, P60, DOI 10.1002/bs.3830350107; CHEN Y, 2009, COMPUT MATH IN PRESS; COHEN MA, 1983, IEEE T SYST MAN CYB, V13, P815, DOI 10.1109/TSMC.1983.6313075; CURETON RD, 1994, J LITERARY SEMANTICS, V23, P220, DOI 10.1515/jlse.1994.23.3.220; Fales CL, 2008, COGN AFFECT BEHAV NE, V8, P239, DOI 10.3758/CABN.8.3.239; Fingelkurts Andrew A, 2006, Cogn Process, V7, P135, DOI 10.1007/s10339-006-0035-0; Fornito A, 2010, CURR OPIN PSYCHIATR, V23, P239, DOI 10.1097/YCO.0b013e328337d78d; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Friston K, 2000, PHILOS T ROY SOC B, V355, P135, DOI 10.1098/rstb.2000.0554; Friston KJ, 2010, BIOL CYBERN, V102, P227, DOI 10.1007/s00422-010-0364-z; Friston KJ, 2000, PHILOS T R SOC B, V355, P215, DOI 10.1098/rstb.2000.0560; Friston KJ, 1997, NEUROIMAGE, V5, P164, DOI 10.1006/nimg.1997.0259; Globerson A, 2009, P NATL ACAD SCI USA, V106, P3490, DOI 10.1073/pnas.0806782106; Gros C, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/4/109; GUSTAFSON JP, 2004, PSYCHODYNAMIC PRACTI, V10, P470; Hollander E, 2007, CNS SPECTRUMS, V12, P12, DOI 10.1017/S1092852900020447; Hollnagel E., 2003, HDB COGNITIVE TASK D; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Huber MT, 1999, BIOL PSYCHIAT, V46, P256, DOI 10.1016/S0006-3223(98)00311-4; Huber MT, 2000, BIOL PSYCHIAT, V47, P634, DOI 10.1016/S0006-3223(99)00174-2; Huerta R, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.238104; Huppert Jonathan D, 2005, Curr Psychiatry Rep, V7, P268, DOI 10.1007/s11920-005-0080-x; Ito J, 2007, HUM BRAIN MAPP, V28, P904, DOI 10.1002/hbm.20316; Jaffard M, 2008, NEUROIMAGE, V42, P1196, DOI 10.1016/j.neuroimage.2008.05.041; James W., 1890, PRINCIPLES PSYCHOL, V2, P283; Jones LM, 2007, P NATL ACAD SCI USA, V104, P18772, DOI 10.1073/pnas.0705546104; Katerndahl David, 2007, Prim Care Companion J Clin Psychiatry, V9, P183; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Kiebel SJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000464; Koenig T, 2001, NEUROIMAGE, V14, P383, DOI 10.1006/nimg.2001.0825; Krumhansl CL, 2000, PSYCHOL BULL, V126, P159, DOI 10.1037/0033-2909.126.1.159; Kubota S, 2002, MED HYPOTHESES, V59, P16, DOI 10.1016/S0306-9877(02)00196-2; Landau L.D., 1959, FLUID MECH COURSE TH, V6; LANE RD, 2002, WISDOM FEELING PSYCH; Lashley K., 1951, CEREBRAL MECH BEHAV, P112, DOI DOI 10.1093/RFS/HHQ153; Lee JH, 1999, J EXP EDUC, V67, P218, DOI 10.1080/00220979909598354; Lotka A. J., 1956, ELEMENTS MATH BIOL, DOI DOI 10.2307/1909476; MAGOR L, 2009, PLOS ONE, V4, pE4447; Mannell MV, 2010, HUM BRAIN MAPP, V31, P424, DOI 10.1002/hbm.20876; Masterpasqua F, 1997, PSYCHOL MEANING CHAO; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; MCCLURE SM, 2007, HDB EMOTION REGULATI, V32, P204; McKeown MJ, 1998, HUM BRAIN MAPP, V6, P160, DOI 10.1002/(SICI)1097-0193(1998)6:3<160::AID-HBM5>3.0.CO;2-1; Moran A. P., 2004, SPORT EXERCISE PSYCH; Moran RJ, 2007, NEUROIMAGE, V37, P706, DOI 10.1016/j.neuroimage.2007.05.032; MUEZZINOGLU MK, 2009, INT J BIFUR IN PRESS; Nunez P.L., 2005, ELECT FIELDS BRAIN N; Nutt DJ, 2001, J CLIN PSYCHIAT, V62, P22; Ott E., 1993, CHAOS DYNAMICAL SYST; Oullier O, 2006, TRENDS COGN SCI, V10, P353, DOI 10.1016/j.tics.2006.06.009; Pariitt C.G., 1990, STRESS PERFORMANCE S, P43; Pessoa L, 2005, P NATL ACAD SCI USA, V102, P5612, DOI 10.1073/pnas.0500566102; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; Poincare H., 1958, VALUE SCI; Ponzi A, 2010, J NEUROSCI, V30, P5894, DOI 10.1523/JNEUROSCI.5540-09.2010; Port R., 1995, MIND MOTION EXPLORAT; PRICE DD, 1985, MOTIV EMOTION, V9, P19, DOI 10.1007/BF00991548; Rabinovich MI, 2006, REV MOD PHYS, V78, P1213, DOI 10.1103/RevModPhys.78.1213; Reichle ME, 2010, TRENDS COGN SCI, V14, P180, DOI 10.1016/j.tics.2010.01.008; Rolls ET, 2008, EUR J NEUROSCI, V28, P782, DOI 10.1111/j.1460-9568.2008.06379.x; SABELLI HC, 1995, CHAOS THEORY PSYCHOL, P65; Salvador R, 2005, PHILOS T R SOC B, V360, P937, DOI 10.1098/rstb.2005.1645; SCHERER KR, 1993, COGNITION EMOTION, V7, P1, DOI 10.1080/02699939308409174; Schraagen J.M., 2000, COGNITIVE TASK ANAL; Schurger A, 2010, SCIENCE, V327, P97, DOI 10.1126/science.1180029; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Taylor KS, 2009, HUM BRAIN MAPP, V30, P2731, DOI 10.1002/hbm.20705; Temam R., 1988, INFINITE DIMENSIONAL, DOI DOI 10.1007/978-1-4684-0313-8; Thagard P, 2008, CONSCIOUS COGN, V17, P811, DOI 10.1016/j.concog.2007.05.014; Tomasi D, 2010, P NATL ACAD SCI USA, V107, P9885, DOI 10.1073/pnas.1001414107; Varona P, 2004, NEUROCOMPUTING, V58, P549, DOI 10.1016/j.neucom.2004.01.093; Werner G, 2007, BIOSYSTEMS, V90, P496, DOI 10.1016/j.biosystems.2006.12.001; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905; WILSON HR, 1973, KYBERNETIK, V13, P55, DOI 10.1007/BF00288786; Yuste R, 2005, NAT REV NEUROSCI, V6, P477, DOI 10.1038/nrn1686; Zavaglia M, 2006, J NEUROSCI METH, V157, P317, DOI 10.1016/j.jneumeth.2006.04.022; ZOR R, 2007, WORLD J BIOL PSYCHIA, P1	88	43	43	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2010	5	9							e12547	10.1371/journal.pone.0012547	http://dx.doi.org/10.1371/journal.pone.0012547			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652JO	20877723	Green Published, gold, Green Submitted			2022-12-27	WOS:000282002900001
J	Kraatz, BP; Meng, J; Weksler, M; Li, CK				Kraatz, Brian P.; Meng, Jin; Weksler, Marcelo; Li, Chuankui			Evolutionary Patterns in the Dentition of Duplicidentata (Mammalia) and a Novel Trend in the Molarization of Premolars	PLOS ONE			English	Article							TEETH; MODEL; LAGOMORPHS; PHYLOGENY; GLIRES	Background: The cusp homology of Lagomorpha has long been problematic largely because their teeth are highly derived relative to their more typically tribosphenic ancestors. Within this context, the lagomorph central cusp has been particularly difficult to homologize with other tribosphenic cusps; authors have previously considered it the paracone, protocone, metacone, amphicone, or an entirely new cusp. Methodology/Principal Findings: Here we present newly described fossil duplicidentates (Lagomorpha and Mimotonidae) in the context of a well-constrained phylogeny to establish a nomenclatural system for cusps based on the tribosphenic pattern. We show that the central cusp of lagomorphs is homologous with the metaconule of other mammals. We also show that the buccal acquisition of a second cusp on the premolars (molarization) within duplicidentates is atypical with respect to other mammalian lineages; within the earliest lagomorphs, a second buccal cusp is added mesially to an isolated buccal cusp. Conclusions/Significance: The distal shift of the 'ancestral' paracone within early duplicidentates amounts to the changing of a paracone into a metacone in these lineages. For this reason, we support a strictly topological approach to cusp names, and suggest a discontinuity in nomenclature to capture the complexity of the interplay between evolutionary history and the developmental process that have produced cusp patterns in duplicidentates.	[Kraatz, Brian P.] Western Univ Hlth Sci, Dept Anat, Pomona, CA USA; [Kraatz, Brian P.; Meng, Jin; Weksler, Marcelo] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Li, Chuankui] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Dept Vertebrate Paleontol, Beijing, Peoples R China	Western University of Health Sciences; American Museum of Natural History (AMNH); Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Kraatz, BP (corresponding author), Western Univ Hlth Sci, Dept Anat, Pomona, CA USA.	bkraatz@westernu.edu	Weksler, Marcelo/A-7420-2010	Weksler, Marcelo/0000-0001-8111-4779	American Museum of Natural History; National Science Foundation (NSF) [EAR-0120727, BCS-0309800]; MST of China [2006CB806400]	American Museum of Natural History; National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); MST of China(Ministry of Science and Technology, China)	BPK was supported by a research fellowship at the American Museum of Natural History. Funding was provided via National Science Foundation (NSF) grants EAR-0120727, BCS-0309800 and Major Basic Research Projects of MST of China (2006CB806400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asher RJ, 2005, SCIENCE, V307, P1091, DOI 10.1126/science.1107808; Aversa S, 1998, QUAL LIFE RES, V7, P205, DOI 10.1023/A:1008869829358; Bair AR, 2007, PALEOBIOLOGY, V33, P53, DOI 10.1666/06044.1; Bohlin B., 1942, Paleont sinica NSO, V8a, P1; Bohlin B, 1937, PALAEONTOLOGIA SIN C, V3, P1; Bown T.M., 1979, P172; Burke J J, 1936, ANN CARNEGIE MUS, V25, P135; Burke J.T., 1934, Annals of the Carnegie Museum, V23, P399; Butler PM., 1985, EVOLUTIONARY RELATIO, P381; BUTLER PM, 1952, P ZOOL SOC LOND, V121, P810; COPE ED, 1875, P ACAD NAT SCI PHILA, V27, P20; Crompton AW, 1971, ZOOLOGICAL J LINN S1, P65; Dawson M.R., 1967, ESSAYS PALEONTOLOGY, V2, P287; de Chardin P. Teilhard, 1926, ANN PALEONTOL, V15, P1; DICE LEER, 1929, JOUR MAMMALOGY, V10, P340, DOI 10.2307/1374124; EHIK J, 1926, ANN MUSEI NATL HUNGA, V22, P178; Forsyth Major CI., 1899, T LINN SOC LOND, V7, P433, DOI 10.1111/j.1096-3642.1899.tb002021.x.; Hillis DM, 1994, HOMOLOGY HIERARCHICA; Jernvall J, 2000, P NATL ACAD SCI USA, V97, P2641, DOI 10.1073/pnas.050586297; Jernvall J, 2000, P NATL ACAD SCI USA, V97, P14444, DOI 10.1073/pnas.97.26.14444; Jernvall J, 2008, DEV PRIMATOL-PROG PR, P335, DOI 10.1007/978-0-387-73896-3_22; Kangas AT, 2004, NATURE, V432, P211, DOI 10.1038/nature02927; Li Chuankui, 2007, Bulletin of Carnegie Museum of Natural History, V39, P97, DOI 10.2992/0145-9058(2007)39[97:DAAPLF]2.0.CO;2; Lopez-Martinez Nieves, 2008, P27, DOI 10.1007/978-3-540-72446-9_3; LOPEZMARTINEZ N, 1985, EVOLUTIONARY RELATIO, P151; Major C. I. F., 1873, PALAEONTOGRAPHICA, V22, P75; MAJOR CJF, 1893, P ZOOLOGICAL SOC, V10, P179; MATHEW WD, 1923, AM MUS NOVIT, P10; MCKENNA MC, 1982, GEOBIOS MEM SPEC, V6, P213; Meng J, 2003, B AM MUS NAT HIST, P1; MENG J, 2004, AM MUS NOVIT, P24; MENG J, 2009, AM MUS NOVIT, P11; Meng Jin, 2004, Vertebrata Palasiatica, V42, P261; Meng Jin, 2001, Journal of Mammalian Evolution, V8, P1, DOI 10.1023/A:1011328616715; Osborn HF, 1904, AM J SCI, V17, P321; OSBORN HF, 2007, EVOLUTION MAMMALIAN; OSBORN HF, 1895, INT DENT J, V7, P1; Osborn JW, 2008, J THEOR BIOL, V255, P338, DOI 10.1016/j.jtbi.2008.09.008; RUSSELL LS, 1958, NAT MUS CANADA, V166, P41; Salazar-Ciudad I, 2010, NATURE, V464, P583, DOI 10.1038/nature08838; SIMPSON GG, 1936, DENT COSMOS, P1; SYCH L, 1975, Palaeontologia Polonica, V33, P183; SYCH L, 1977, Acta Zoologica Cracoviensia, V22, P1; SYCH L, 1976, Acta Zoologica Cracoviensia, V21, P33; SYCH L, 1967, ACTA ZOOLOGICA CRACO, V12, P1; Tobien H., 1975, Notizblatt Hess Landesamt Bodenforsch Wiesbaden, V103, P103; Tobien H., 1974, Mainzer geowiss. Mitt., V3, P95; TONG YS, 1987, VERTEBRAT PALASIATIC, V25, P208; Van Valen Leigh, 2002, Evolutionary Theory & Review, V12, P101; VANVALEN L, 1964, EVOLUTION, V18, P484, DOI 10.1111/j.1558-5646.1964.tb01624.x; VANVALEN LM, 1982, J MORPHOL, V173, P305, DOI 10.1002/jmor.1051730307; White J.A., 1991, Journal of Vertebrate Paleontology, V11, P67; Wible JR, 2009, B AM MUS NAT HIST, P1, DOI 10.1206/623.1; Wible John R., 2007, Bulletin of Carnegie Museum of Natural History, V39, P213, DOI 10.2992/0145-9058(2007)39[213:OTCOOT]2.0.CO;2; Wible JR, 2004, B AM MUS NAT HIST, P1, DOI 10.1206/0003-0090(2004)281<0001:NDOTSA>2.0.CO;2; Wood A. E., 1940, Transactions of the American Philosophical Society Philadelphia NS, V28, P271; WOOD AE, 1957, EVOLUTION, V11, P417, DOI 10.1111/j.1558-5646.1957.tb02913.x	57	79	86	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2010	5	9							e12838	10.1371/journal.pone.0012838	http://dx.doi.org/10.1371/journal.pone.0012838			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651YH	20877465	Green Published, Green Submitted, gold			2022-12-27	WOS:000281963200014
J	VanDalen, KK; Franklin, AB; Mooers, NL; Sullivan, HJ; Shriner, SA				VanDalen, Kaci K.; Franklin, Alan B.; Mooers, Nicole L.; Sullivan, Heather J.; Shriner, Susan A.			Shedding Light on Avian Influenza H4N6 Infection in Mallards: Modes of Transmission and Implications for Surveillance	PLOS ONE			English	Article							WILD BIRDS; A VIRUS; RT-PCR; PREVALENCE; PERSISTENCE; EVOLUTION; DIAGNOSIS	Background: Wild mallards (Anas platyrhychos) are considered one of the primary reservoir species for avian influenza viruses (AIV). Because AIV circulating in wild birds pose an indirect threat to agriculture and human health, understanding the ecology of AIV and developing risk assessments and surveillance systems for prevention of disease is critical. Methodology/Principal Findings: In this study, mallards were experimentally infected with an H4N6 subtype of AIV by oral inoculation or contact with an H4N6 contaminated water source. Cloacal swabs, oropharyngeal swabs, fecal samples, and water samples were collected daily and tested by real-time RT-PCR (RRT-PCR) for estimation of viral shedding. Fecal samples had significantly higher virus concentrations than oropharyngeal or cloacal swabs and 6 month old ducks shed significantly more viral RNA than 3 month old ducks regardless of sample type. Use of a water source contaminated by AIV infected mallards, was sufficient to transmit virus to naive mallards, which shed AIV at higher or similar levels as orally-inoculated ducks. Conclusions: Bodies of water could serve as a transmission pathway for AIV in waterfowl. For AIV surveillance purposes, water samples and fecal samples appear to be excellent alternatives or additions to cloacal and oropharyngeal swabbing. Furthermore, duck age (even within hatch-year birds) may be important when interpreting viral shedding results from experimental infections or surveillance. Differential shedding among hatch-year mallards could affect prevalence estimates, modeling of AIV spread, and subsequent risk assessments.	[VanDalen, Kaci K.; Franklin, Alan B.; Mooers, Nicole L.; Sullivan, Heather J.; Shriner, Susan A.] USDA, Natl Wildlife Res Ctr, Wildlife Serv, Anim & Plant Hlth Inspect Serv, Ft Collins, CO USA	United States Department of Agriculture (USDA)	VanDalen, KK (corresponding author), USDA, Natl Wildlife Res Ctr, Wildlife Serv, Anim & Plant Hlth Inspect Serv, Ft Collins, CO USA.	Kaci.vandalen@aphis.usda.gov		Shriner, Susan/0000-0003-0349-7182; Franklin, Alan/0000-0001-9491-795X	United States Department of Agriculture	United States Department of Agriculture(United States Department of Agriculture (USDA))	This study was funded by the United States Department of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguero M, 2007, AVIAN DIS, V51, P235, DOI 10.1637/7634-042806R1.1; Baigent SJ, 2003, BIOESSAYS, V25, P657, DOI 10.1002/bies.10303; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cattoli G, 2007, AVIAN DIS, V51, P414, DOI 10.1637/7562-033106R.1; Costa TP, 2010, AVIAN DIS, V54, P581, DOI 10.1637/8692-031309-ResNote.1; Das A, 2009, J VET DIAGN INVEST, V21, P771, DOI 10.1177/104063870902100603; Ferro PJ, 2010, AVIAN DIS, V54, P655, DOI 10.1637/8810-040109-ResNote.1; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Halvorson DA, 2003, AVIAN DIS, V47, P36; Hanson BA, 2003, AVIAN DIS, V47, P867, DOI 10.1637/0005-2086-47.s3.867; HINSHAW VS, 1979, INTERVIROLOGY, V11, P66, DOI 10.1159/000149014; Horimoto T, 2005, NAT REV MICROBIOL, V3, P591, DOI 10.1038/nrmicro1208; Khalenkov A, 2008, J VIROL METHODS, V149, P180, DOI 10.1016/j.jviromet.2008.01.001; KIDA H, 1980, INFECT IMMUN, V30, P547; Lang AS, 2008, J GEN VIROL, V89, P509, DOI 10.1099/vir.0.83369-0; Lira J, 2010, AVIAN DIS, V54, P606, DOI 10.1637/8838-040309-Reg.1; MCLEAN R., 2007, P 12 WILDL DAM MAN C, P87; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Nicholls JM, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-73; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Parmley EJ, 2008, EMERG INFECT DIS, V14, P84, DOI 10.3201/eid1401.061562; Pasick J, 2008, TRANSBOUND EMERG DIS, V55, P329, DOI 10.1111/j.1865-1682.2008.01047.x; Rohani P, 2009, P NATL ACAD SCI USA, V106, P10365, DOI 10.1073/pnas.0809026106; SLEMONS RD, 1977, J AM VET MED ASSOC, V171, P947; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Spackman E, 2003, AVIAN DIS, V47, P1079, DOI 10.1637/0005-2086-47.s3.1079; STALLKNECHT DE, 1990, AVIAN DIS, V34, P406, DOI 10.2307/1591428; STALLKNECHT DE, 1990, AVIAN DIS, V34, P412, DOI 10.2307/1591429; Suarez DL, 2000, VET MICROBIOL, V74, P15, DOI 10.1016/S0378-1135(00)00161-9; Sullivan HJ, 2009, J VIROL METHODS, V161, P141, DOI 10.1016/j.jviromet.2009.06.001; SZRETTER KJ, 2006, CUR PROTOC MICROBI S, V3; *USDA, 2008, EARL DET SYST HIGHL; Vandekerckhove C, 2009, J SCI COMPUT, V39, P167, DOI 10.1007/s10915-008-9256-y; WEBSTER RG, 1978, VIROLOGY, V84, P268, DOI 10.1016/0042-6822(78)90247-7; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Webster RG, 1998, EMERG INFECT DIS, V4, P436, DOI 10.3201/eid0403.980325	36	53	54	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2010	5	9							e12851	10.1371/journal.pone.0012851	http://dx.doi.org/10.1371/journal.pone.0012851			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651YH	20877466	gold, Green Published, Green Submitted			2022-12-27	WOS:000281963200017
J	Libby, E; Glass, L				Libby, Eric; Glass, Leon			The Calculus of Committee Composition	PLOS ONE			English	Article							GRANT APPLICATIONS; DECISIONS; CONSENSUS; PROGRAMS; CHANCE; SYSTEM; ARRAY; SIZE	Modern institutions face the recurring dilemma of designing accurate evaluation procedures in settings as diverse as academic selection committees, social policies, elections, and figure skating competitions. In particular, it is essential to determine both the number of evaluators and the method for combining their judgments. Previous work has focused on the latter issue, uncovering paradoxes that underscore the inherent difficulties. Yet the number of judges is an important consideration that is intimately connected with the methodology and the success of the evaluation. We address the question of the number of judges through a cost analysis that incorporates the accuracy of the evaluation method, the cost per judge, and the cost of an error in decision. We associate the optimal number of judges with the lowest cost and determine the optimal number of judges in several different scenarios. Through analytical and numerical studies, we show how the optimal number depends on the evaluation rule, the accuracy of the judges, the ( cost per judge)/( cost per error) ratio. Paradoxically, we find that for a panel of judges of equal accuracy, the optimal panel size may be greater for judges with higher accuracy than for judges with lower accuracy. The development of any evaluation procedure requires knowledge about the accuracy of evaluation methods, the costs of judges, and the costs of errors. By determining the optimal number of judges, we highlight important connections between these quantities and uncover a paradox that we show to be a general feature of evaluation procedures. Ultimately, our work provides policy-makers with a simple and novel method to optimize evaluation procedures.	[Libby, Eric] Massey Univ, New Zealand Inst Adv Study, Auckland, New Zealand; [Glass, Leon] McGill Univ, Dept Physiol, Montreal, PQ, Canada	Massey University; McGill University	Libby, E (corresponding author), Massey Univ, New Zealand Inst Adv Study, Auckland, New Zealand.	e.libby@massey.ac.nz	Glass, Leon/C-5732-2008		National Sciences and Engineering Research Council of Canada (NSERC)	National Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	The authors thank the National Sciences and Engineering Research Council of Canada (NSERC) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Arrow K., 1963, SOCIAL CHOICE INDIVI; Aspinall W, 2010, NATURE, V463, P294, DOI 10.1038/463294a; Bornmann L, 2009, J INFORMETR, V3, P348, DOI 10.1016/j.joi.2009.05.002; Bornmann L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003480; CHUBIN DE, 1994, EVALUATION REV, V18, P20, DOI 10.1177/0193841X9401800103; Clemen RT, 1999, RISK ANAL, V19, P187, DOI 10.1023/A:1006917509560; COLE S, 1981, SCIENCE, V214, P881, DOI 10.1126/science.7302566; Condorcet J.-A.-N.d.C, 1785, ESSAI APPL ANAL PROB; Cooke R. M., 1991, EXPERTS UNCERTAINTY; Cooke RM, 1997, SAFETY SCI, V26, P49, DOI 10.1016/S0925-7535(97)00028-3; Cozzens SE, 1997, EVAL PROGRAM PLANN, V20, P77, DOI 10.1016/S0149-7189(96)00038-9; Fang FC, 2009, INFECT IMMUN, V77, P929, DOI 10.1128/IAI.01567-08; FELD SL, 1984, PUBLIC CHOICE, V42, P273, DOI 10.1007/BF00124946; HARARY F, 1966, AM MATH MON, V73, P231, DOI 10.2307/2315334; Harvey N, 1997, TRENDS COGN SCI, V1, P78, DOI 10.1016/S1364-6613(97)01014-0; Hastie R, 2005, PSYCHOL REV, V112, P494, DOI 10.1037/0033-295X.112.2.494; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Johnson VE, 2008, P NATL ACAD SCI USA, V105, P11076, DOI 10.1073/pnas.0804538105; Kang Sawoong, 2004, Journal of Economic Research (JER), V9, P217; Kaplan D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002761; Karotkin D, 2003, SOC CHOICE WELFARE, V20, P429, DOI 10.1007/s003550200190; Kreps DM, 1988, NOTES THEORY CHOICE; Lander ES, 1999, NAT GENET, V21, P3, DOI 10.1038/4427; Larrick RP, 2006, MANAGE SCI, V52, P111, DOI 10.1287/mnsc.1050.0459; MacKay D. J. C., 2003, INFORM THEORY INFERE; MAY RM, 1983, NATURE, V303, P16, DOI 10.1038/303016a0; Mayo NE, 2006, J CLIN EPIDEMIOL, V59, P842, DOI 10.1016/j.jclinepi.2005.12.007; Miller G, 2007, SCIENCE, V316, P358, DOI 10.1126/science.316.5823.358; Moore DA, 2008, PSYCHOL REV, V115, P502, DOI 10.1037/0033-295X.115.2.502; Ordeshook P.C., 1986, CAMBRIDGE BOOKS; Saari D.G., 2001, DECISIONS ELECTIONS; Seife C, 2003, SCIENCE, V299, P651; Sorkin RD, 1998, PSYCHOL SCI, V9, P456, DOI 10.1111/1467-9280.00085; Wessely S, 1998, LANCET, V352, P301, DOI 10.1016/S0140-6736(97)11129-1; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	40	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2010	5	9							e12642	10.1371/journal.pone.0012642	http://dx.doi.org/10.1371/journal.pone.0012642			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	651XL	20877471	gold, Green Published, Green Submitted			2022-12-27	WOS:000281960800002
J	Mayorek, N; Naftali-Shani, N; Grunewald, M				Mayorek, Nina; Naftali-Shani, Nili; Grunewald, Myriam			Diclofenac Inhibits Tumor Growth in a Murine Model of Pancreatic Cancer by Modulation of VEGF Levels and Arginase Activity	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; SUPPRESSOR-CELLS; IN-VIVO; INDUCED ANGIOGENESIS; COLORECTAL-CANCER; CYCLOOXYGENASE-2; ARGININE; MACROPHAGES; PROGRESSION; PREVENTION	Background: Diclofenac is one of the oldest anti-inflammatory drugs in use. In addition to its inhibition of cyclooxygenases (COX), diclofenac potently inhibits phospholipase A(2) (PLA(2)), thus yielding a broad anti-inflammatory effect. Since inflammation is an important factor in the development of pancreatic tumors we explored the potential of diclofenac to inhibit tumor growth in mice inoculated with PANCO2 cells orthotopically. Methodology/Principal Findings: We found that diclofenac treatment (30 mg/kg/bw for 11 days) of mice inoculated with PANC02 cells, reduced the tumor weight by 60%, correlating with increased apoptosis of tumor cells. Since this effect was not observed in vitro on cultured PANCO2 cells, we theorized that diclofenac beneficial treatment involved other mediators present in vivo. Indeed, diclofenac drastically decreased tumor vascularization by downregulating VEGF in the tumor and in abdominal cavity fluid. Furthermore, diclofenac directly inhibited vascular sprouting ex vivo. Surprisingly, in contrast to other COX-2 inhibitors, diclofenac increased arginase activity/arginase 1 protein content in tumor stroma cells, peritoneal macrophages and white blood cells by 2.4, 4.8 and 2 fold, respectively. We propose that the subsequent arginine depletion and decrease in NO levels, both in serum and peritoneal cavity, adds to tumor growth inhibition by malnourishment and poor vasculature development. Conclusion/Significance: In conclusion, diclofenac shows pronounced antitumoral properties in pancreatic cancer model that can contribute to further treatment development. The ability of diclofenac to induce arginase activity in tumor stroma, peritoneal macrophages and white blood cells provides a tool to study a controversial issue of pro-and antitumoral effects of arginine depletion.	[Mayorek, Nina; Naftali-Shani, Nili; Grunewald, Myriam] Hebrew Univ Jerusalem, Hadassah Med Sch, IMRIC, IL-91010 Jerusalem, Israel	Hebrew University of Jerusalem	Mayorek, N (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, IMRIC, IL-91010 Jerusalem, Israel.	ninam@ekmd.huji.ac.il		Mayorek, Nina/0000-0002-5989-4884	Hebrew University-Hadassah Medical School [0463435]	Hebrew University-Hadassah Medical School	This work was supported by the Hebrew University-Hadassah Medical School (grant # 0463435). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beloussow K, 2002, CANCER LETT, V183, P155, DOI 10.1016/S0304-3835(01)00793-5; BENSASSON SA, 1995, METHOD CELL BIOL, V46, P29; Bertagnolli MM, 2006, NEW ENGL J MED, V355, P873, DOI 10.1056/NEJMoa061355; Caso G, 2004, CLIN SCI, V107, P371, DOI 10.1042/CS20040096; Chang CI, 2001, CANCER RES, V61, P1100; Cheng PNM, 2007, CANCER RES, V67, P309, DOI 10.1158/0008-5472.CAN-06-1945; Chiang CS, 2008, INT IMMUNOL, V20, P215, DOI 10.1093/intimm/dxm137; Colby JK, 2008, NEOPLASIA, V10, P782, DOI 10.1593/neo.08330; CORRALIZA IM, 1994, J IMMUNOL METHODS, V174, P231, DOI 10.1016/0022-1759(94)90027-2; CURRIE GA, 1978, NATURE, V273, P758, DOI 10.1038/273758a0; Davel LE, 2002, FEBS LETT, V532, P216, DOI 10.1016/S0014-5793(02)03682-7; Davies NM, 1997, CLIN PHARMACOKINET, V33, P184, DOI 10.2165/00003088-199733030-00003; Farrow B, 2008, J SURG RES, V149, P319, DOI 10.1016/j.jss.2007.12.757; Funahashi H, 2007, CANCER RES, V67, P7068, DOI 10.1158/0008-5472.CAN-07-0970; GONZALEZ GG, 1991, CANCER RES, V51, P2932; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Gupta RA, 2001, NAT REV CANCER, V1, P11, DOI 10.1038/35094017; HARTVEIT F, 1966, NATURE, V210, P1123, DOI 10.1038/2101123a0; Jackson PG, 2000, J SURG ONCOL, V75, P146, DOI 10.1002/1096-9098(200010)75:2<146::AID-JSO14>3.0.CO;2-1; Johnsen JI, 2004, CANCER RES, V64, P7210, DOI 10.1158/0008-5472.CAN-04-1795; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Lagas JS, 2010, MOL PHARMACOL, V77, P687, DOI 10.1124/mol.109.062364; LAM TL, 2009, CANC LETT; Le Bitoux MA, 2008, HISTOCHEM CELL BIOL, V130, P1079, DOI 10.1007/s00418-008-0527-3; Makela A, 1997, SCAND J CLIN LAB INV, V57, P401, DOI 10.3109/00365519709084587; Michaud D S, 2004, Minerva Chir, V59, P99; Muller-Decker K, 2006, GASTROENTEROLOGY, V130, P2165, DOI 10.1053/j.gastro.2006.03.053; Murray B, 2003, GASTROENTEROLOGY, V124, P1786, DOI 10.1016/S0016-5085(03)00384-6; MURTHY SM, 1989, CANCER, V64, P2035, DOI 10.1002/1097-0142(19891115)64:10<2035::AID-CNCR2820641012>3.0.CO;2-L; Nachtsheim R, 2006, J SURG RES, V134, P28, DOI 10.1016/j.jss.2006.03.008; NICOSIA RF, 1990, IN VITRO CELL DEV B, V26, P119; Reymond MA, 1998, DIGEST SURG, V15, P105, DOI 10.1159/000018602; Rodriguez PC, 2008, IMMUNOL REV, V222, P180, DOI 10.1111/j.1600-065X.2008.00608.x; Rodriguez PC, 2005, J EXP MED, V202, P931, DOI 10.1084/jem.20050715; Rostom A, 2007, ANN INTERN MED, V146, P376, DOI 10.7326/0003-4819-146-5-200703060-00010; Rudge JS, 2007, P NATL ACAD SCI USA, V104, P18363, DOI 10.1073/pnas.0708865104; Seed MP, 1997, CANCER RES, V57, P1625; Sinha P, 2007, CANCER RES, V67, P4507, DOI 10.1158/0008-5472.CAN-06-4174; Van Hecken A, 2000, J CLIN PHARMACOL, V40, P1109; von Rahden BHA, 2005, CANCER RES, V65, P5038, DOI 10.1158/0008-5472.CAN-04-1107	41	52	52	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12715	10.1371/journal.pone.0012715	http://dx.doi.org/10.1371/journal.pone.0012715			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856806	Green Submitted, gold, Green Published			2022-12-27	WOS:000281815800011
J	Guo, XL; Harada, C; Namekata, K; Mitamura, Y; Yoshida, H; Matsumoto, Y; Harada, T				Guo, Xiaoli; Harada, Chikako; Namekata, Kazuhiko; Mitamura, Yoshinori; Yoshida, Hiroshi; Matsumoto, Yoh; Harada, Takayuki			Delayed Onset of Experimental Autoimmune Encephalomyelitis in Olig1 Deficient Mice	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; OPTIC NEURITIS; PRECURSOR CELLS; SPINAL-CORD; REMYELINATION; LESIONS; CNS; OLIGODENDROCYTES; POPULATION; MECHANISMS	Background: Olig1 is a basic helix-loop-helix (bHLH) transcription factor that is essential for oligodendrogenesis and efficient remyelination. However, its role in neurodegenerative disorders has not been well-elucidated. Methodology/Principal Findings: Here we investigated the effects of Olig1 deficiency on experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis (MS). We show that the mean disease onset of myelin oligodendrocyte glycoprotein (MOG)-induced EAE in Olig1(-/-) mice is significantly slower than wide-type (WT) mice (19.8 +/- 2.2 in Olig1(-/-) mice and 9.5 +/- 0.3 days in WT mice). In addition, 10% of Olig1(-/-) mice did not develop EAE by the end of the observation periods (60 days). The severity of EAE, the extent of demyelination, and the activation of microglial cells and astrocytes in spinal cords, were significantly milder in Olig1(-/-) mice compared with WT mice in the early stage. Moreover, the visual function, as assessed by the second-kernel of multifocal electroretinograms, was better preserved, and the number of degenerating axons in the optic nerve was significantly reduced in Olig1(-/-) mice. Interestingly, Olig1 deficiency had no effect on T cell response capability, however, it reduced the expression of myelin proteins such as MOG, myelin basic protein (MBP) and myelin-associated glycoprotein (MAG). The expression of Olig2 remained unchanged in the optic nerve and brain, and it was reduced in the spinal cord of Olig1(-/-) mice. Conclusions/Significance: Our results suggest that the Olig1 signaling pathways may be involved in the incidence rate and the severity of neurological symptoms in MS.	[Guo, Xiaoli; Harada, Chikako; Namekata, Kazuhiko; Harada, Takayuki] Tokyo Metropolitan Inst Neurosci, Dept Mol Neurobiol, Tokyo, Japan; [Mitamura, Yoshinori] Univ Tokushima, Inst Hlth Biosci, Dept Ophthalmol, Grad Sch, Tokushima 770, Japan; [Yoshida, Hiroshi] Tokyo Metropolitan Neurol Hosp, Dept Neuroophthalmol, Tokyo, Japan; [Matsumoto, Yoh] Tokyo Metropolitan Inst Neurosci, Dept Mol Neuropathol, Tokyo, Japan	Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science; Tokushima University; Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science	Guo, XL (corresponding author), Tokyo Metropolitan Inst Neurosci, Dept Mol Neurobiol, Tokyo, Japan.	harada-tk@igakuken.or.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science for Young Scientists; Tokyo Metropolitan Government; Ministry of Health, Labour, and Welfare of Japan; Japan Medical Association	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Tokyo Metropolitan Government(Tokyo Metropolitan Government); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Medical Association	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (X. G., K.N., T. H.); Japan Society for the Promotion of Science for Young Scientists (C. H.); the Welfare and Health Funds from Tokyo Metropolitan Government (Y.M.); the Ministry of Health, Labour, and Welfare of Japan (Y.M., T. H.); and the Japan Medical Association (T. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnett HA, 2004, SCIENCE, V306, P2111, DOI 10.1126/science.1103709; Burton A, 2005, LANCET NEUROL, V4, P80, DOI 10.1016/S1474-4422(05)00978-6; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; Chen Y, 2009, NAT NEUROSCI, V12, P1398, DOI 10.1038/nn.2410; Delarasse C, 2003, J CLIN INVEST, V112, P544, DOI 10.1172/JCI200315861; Goris A, 2006, J NEUROL NEUROSUR PS, V77, P1296, DOI 10.1136/jnnp.2006.090639; Guo X, 2007, NEUROSCI RES, V59, P457, DOI 10.1016/j.neures.2007.08.014; Guo XL, 2009, NEUROSCI LETT, V462, P281, DOI 10.1016/j.neulet.2009.07.028; Harada T, 2002, J NEUROSCI, V22, P9228, DOI 10.1523/jneurosci.22-21-09228.2002; Harada T, 2007, J CLIN INVEST, V117, P1763, DOI 10.1172/JCI30178; Hickman SJ, 2002, LANCET, V360, P1953, DOI 10.1016/S0140-6736(02)11919-2; Jarius S, 2008, NAT CLIN PRACT NEURO, V4, P202, DOI 10.1038/ncpneuro0764; John GR, 2002, NAT MED, V8, P1115, DOI 10.1038/nm781; Korner H, 1997, J EXP MED, V186, P1585, DOI 10.1084/jem.186.9.1585; Krishnamoorthy G, 2009, NAT MED, V15, P626, DOI 10.1038/nm.1975; Liu Y, 2004, GLIA, V45, P67, DOI 10.1002/glia.10303; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Magnus T, 2005, J CELL MOL MED, V9, P303, DOI 10.1111/j.1582-4934.2005.tb00357.x; Matiello M, 2008, NEUROLOGY, V70, P2197, DOI 10.1212/01.wnl.0000303817.82134.da; Mi S, 2007, NAT MED, V13, P1228, DOI 10.1038/nm1664; Namekata K, 2008, MOL CELL BIOL, V28, P3273, DOI 10.1128/MCB.02159-07; Namekata K, 2010, P NATL ACAD SCI USA, V107, P7586, DOI 10.1073/pnas.0914514107; Prineas J. W., 1997, GREENFIELDS NEUROPAT, P813; Prinz M, 2006, J CLIN INVEST, V116, P456, DOI 10.1172/JCI26078; RAINE CS, 1997, TXB NEUROPATHOLOGY, P243; Wolswijk G, 1998, J NEUROSCI, V18, P601; Xin M, 2005, J NEUROSCI, V25, P1354, DOI 10.1523/JNEUROSCI.3034-04.2005; Zhang Y, 2009, P NATL ACAD SCI USA, V106, P19162, DOI 10.1073/pnas.0902834106; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	29	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e13083	10.1371/journal.pone.0013083	http://dx.doi.org/10.1371/journal.pone.0013083			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20927333	gold, Green Published, Green Submitted			2022-12-27	WOS:000282269400028
J	Pouvreau, S				Pouvreau, Sandrine			Superoxide Flashes in Mouse Skeletal Muscle Are Produced by Discrete Arrays of Active Mitochondria Operating Coherently	PLOS ONE			English	Article							PERMEABILITY TRANSITION; SINGLE MITOCHONDRIA; TRANSMITTING CABLES; CARDIAC MYOCYTES; OXIDATIVE STRESS; FREE-RADICALS; ROS RELEASE; OSCILLATIONS; FIBERS; DEPOLARIZATIONS	Reactive Oxygen Species (ROS) constitute important intracellular signaling molecules. Mitochondria are admitted sources of ROS, especially of superoxide anions through the electron transport chain. Here the mitochondria-targeted ratiometric pericam (RPmt) was used as a superoxide biosensor, by appropriate choice of the excitation wavelength. RPmt was transfected in vivo into mouse muscles. Confocal imaging of isolated muscle fibers reveals spontaneous flashes of RPmt fluorescence. Flashes correspond to increases in superoxide production, as shown by simultaneous recordings of the fluorescence from MitoSox, a mitochondrial superoxide probe. Flashes occur in all subcellular populations of mitochondria. Spatial analysis of the flashes pattern over time revealed that arrays of mitochondria work as well-defined superoxide-production-units. Increase of superoxide production at the muscle fiber level involves recruitment of supplemental units with no increase in per-unit production. Altogether, these results demonstrate that superoxide flashes in muscle fibers correspond to physiological signals linked to mitochondrial metabolism. They also suggest that superoxide, or one of its derivatives, modulates its own production at the mitochondrial level.	Univ Lyon 1, UMR CNRS 5123, F-69622 Villeurbanne, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Pouvreau, S (corresponding author), Univ Lyon 1, UMR CNRS 5123, F-69622 Villeurbanne, France.	sandrine.pouvreau@univ-lyon1.fr	Pouvreau, Sandrine/AFV-8178-2022		Universite Lyon 1; Centre National de la Recherche Scientifique	Universite Lyon 1; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	This work was supported by grants from the Universite Lyon 1 and the Centre National de la Recherche Scientifique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMCHENKOVA AA, 1988, J CELL BIOL, V107, P481, DOI 10.1083/jcb.107.2.481; Aon MA, 2004, P NATL ACAD SCI USA, V101, P4447, DOI 10.1073/pnas.0307156101; Aon MA, 2003, J BIOL CHEM, V278, P44735, DOI 10.1074/jbc.M302673200; Bejma J, 1999, J APPL PHYSIOL, V87, P465, DOI 10.1152/jappl.1999.87.1.465; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Boncompagni S, 2009, MOL BIOL CELL, V20, P1058, DOI 10.1091/mbc.E08-07-0783; Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034; Chalmers S, 2008, J CELL SCI, V121, P75, DOI 10.1242/jcs.014522; Csordas G, 2009, BBA-BIOENERGETICS, V1787, P1352, DOI 10.1016/j.bbabio.2009.06.004; DiFranco M, 2006, PROTEIN EXPRES PURIF, V47, P281, DOI 10.1016/j.pep.2005.10.018; Duchen MR, 1998, J CELL BIOL, V142, P975, DOI 10.1083/jcb.142.4.975; Franzini-Armstrong C, 2007, PHYSIOLOGY, V22, P261, DOI 10.1152/physiol.00017.2007; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Hidalgo C, 2008, ANTIOXID REDOX SIGN, V10, P1275, DOI 10.1089/ars.2007.1886; Huser J, 1999, BIOCHEM J, V343, P311, DOI 10.1042/0264-6021:3430311; Huser J, 1998, BIOPHYS J, V74, P2129, DOI 10.1016/S0006-3495(98)77920-2; Isaev NK, 2008, BIOCHEMISTRY-MOSCOW+, V73, P149, DOI 10.1134/S0006297908020053; Jackson MJ, 2008, FREE RADICAL BIO MED, V44, P132, DOI 10.1016/j.freeradbiomed.2007.06.003; Jacquemond V, 1997, BIOPHYS J, V73, P920, DOI 10.1016/S0006-3495(97)78124-4; Kudin AP, 2005, BIOMED PHARMACOTHER, V59, P163, DOI 10.1016/j.biopha.2005.03.012; Kuznetsov AV, 2006, BBA-BIOENERGETICS, V1757, P686, DOI 10.1016/j.bbabio.2006.03.014; Kuznetsov AV, 1998, J CELL BIOL, V140, P1091, DOI 10.1083/jcb.140.5.1091; LOEW LM, 1993, BIOPHYS J, V65, P2396, DOI 10.1016/S0006-3495(93)81318-3; Moylan JS, 2007, MUSCLE NERVE, V35, P411, DOI 10.1002/mus.20743; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; O'Reilly CM, 2003, BIOPHYS J, V85, P3350, DOI 10.1016/S0006-3495(03)74754-7; OGATA T, 1985, CELL TISSUE RES, V241, P251, DOI 10.1007/BF00217168; Powers SK, 2005, AM J PHYSIOL-REG I, V288, pR337, DOI 10.1152/ajpregu.00469.2004; Reid MB, 2008, FREE RADICAL BIO MED, V44, P169, DOI 10.1016/j.freeradbiomed.2007.03.002; Romashko DN, 1998, P NATL ACAD SCI USA, V95, P1618, DOI 10.1073/pnas.95.4.1618; Skulachev VP, 2001, TRENDS BIOCHEM SCI, V26, P23, DOI 10.1016/S0968-0004(00)01735-7; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Zima AV, 2006, CARDIOVASC RES, V71, P310, DOI 10.1016/j.cardiores.2006.02.019; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001; Zorov DB, 2006, BBA-BIOENERGETICS, V1757, P509, DOI 10.1016/j.bbabio.2006.04.029	35	75	75	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2010	5	9							e13035	10.1371/journal.pone.0013035	http://dx.doi.org/10.1371/journal.pone.0013035			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654ZQ	20927399	Green Submitted, gold, Green Published			2022-12-27	WOS:000282210700015
J	Belch, Y; Yang, JY; Liu, Y; Malkaram, SA; Liu, R; Riethoven, JJM; Ladunga, I				Belch, Yaakov; Yang, Jingyi; Liu, Yang; Malkaram, Sridhar A.; Liu, Rong; Riethoven, Jean-Jack M.; Ladunga, Istvan			Weakly Positioned Nucleosomes Enhance the Transcriptional Competency of Chromatin	PLOS ONE			English	Article							RNA-POLYMERASE-II; IN-VIVO; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; HISTONE EVICTION; DNA INTERACTIONS; CORE PARTICLE; GENOMIC CODE; CHIP-SEQ; ELONGATION	Background: Transcription is affected by nucleosomal resistance against polymerase passage. In turn, nucleosomal resistance is determined by DNA sequence, histone chaperones and remodeling enzymes. The contributions of these factors are widely debated: one recent title claims "... DNA-encoded nucleosome organization..." while another title states that "histone-DNA interactions are not the major determinant of nucleosome positions." These opposing conclusions were drawn from similar experiments analyzed by idealized methods. We attempt to resolve this controversy to reveal nucleosomal competency for transcription. Methodology/Principal Findings: To this end, we analyzed 26 in vivo, nonlinked, and in vitro genome-wide nucleosome maps/replicates by new, rigorous methods. Individual H2A nucleosomes are reconstituted inaccurately by transcription, chaperones and remodeling enzymes. At gene centers, weakly positioned nucleosome arrays facilitate rapid histone eviction and remodeling, easing polymerase passage. Fuzzy positioning is not due to artefacts. At the regional level, transcriptional competency is strongly influenced by intrinsic histone-DNA affinities. This is confirmed by reproducing the high in vivo occupancy of translated regions and the low occupancy of intergenic regions in reconstitutions from purified DNA and histones. Regional level occupancy patterns are protected from invading histones by nucleosome excluding sequences and barrier nucleosomes at gene boundaries and within genes. Conclusions/Significance: Dense arrays of weakly positioned nucleosomes appear to be necessary for transcription. Weak positioning at exons facilitates temporary remodeling, polymerase passage and hence the competency for transcription. At regional levels, the DNA sequence plays a major role in determining these features but positions of individual nucleosomes are typically modified by transcription, chaperones and enzymes. This competency is reduced at intergenic regions by sequence features, barrier nucleosomes, and proteins, preventing accessibility regulation of untargeted genes. This combination of DNA-and protein-influenced positioning regulates DNA accessibility and competence for regulatory protein binding and transcription. Interactive nucleosome displays are offered at http://chromatin.unl.edu/cgi-bin/skyline.cgi.	[Belch, Yaakov; Liu, Yang] Univ Nebraska Lincoln, Dept Stat, Lincoln, NE USA; [Yang, Jingyi] Univ Nebraska Lincoln, Dept Comp Sci & Engn, Lincoln, NE USA; [Malkaram, Sridhar A.; Liu, Rong; Riethoven, Jean-Jack M.] Univ Nebraska Lincoln, Ctr Biotechnol, Lincoln, NE USA; [Riethoven, Jean-Jack M.; Ladunga, Istvan] Univ Nebraska Lincoln, Sch Biol Sci, Lincoln, NE USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Belch, Y (corresponding author), LINUX Consulting, Karmiel, Israel.	sladunga@unl.edu		Riethoven, Jean-Jack/0000-0002-2709-7880	National Science Foundation (NSF) [EPS-0701892]; University of Nebraska-Lincoln	National Science Foundation (NSF)(National Science Foundation (NSF)); University of Nebraska-Lincoln	The study was supported by National Science Foundation (NSF) grant EPS-0701892 and grants from the University of Nebraska-Lincoln to IL. Funding for the Open Access Charge was obtained by NSF grant EPS-0701892 to IL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Barski A, 2009, J CELL BIOCHEM, V107, P11, DOI 10.1002/jcb.22077; Becker PB, 2002, EMBO J, V21, P4749, DOI 10.1093/emboj/cdf486; Boeger H, 2008, CELL, V133, P716, DOI 10.1016/j.cell.2008.02.051; Bondarenko VA, 2006, MOL CELL, V24, P469, DOI 10.1016/j.molcel.2006.09.009; Bowman GD, 2010, CURR OPIN STRUC BIOL, V20, P73, DOI 10.1016/j.sbi.2009.12.002; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Engeholm M, 2009, NAT STRUCT MOL BIOL, V16, P151, DOI 10.1038/nsmb.1551; FEDOR MJ, 1988, J MOL BIOL, V204, P109, DOI 10.1016/0022-2836(88)90603-1; Fejes AP, 2008, BIOINFORMATICS, V24, P1729, DOI 10.1093/bioinformatics/btn305; Field Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000216; Fraser RM, 2006, J MOL BIOL, V364, P582, DOI 10.1016/j.jmb.2006.08.092; Fraser RM, 2009, J MOL BIOL, V390, P292, DOI 10.1016/j.jmb.2009.04.079; Gencheva M, 2006, J MOL BIOL, V361, P216, DOI 10.1016/j.jmb.2006.06.039; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; Hodges C, 2009, SCIENCE, V325, P626, DOI 10.1126/science.1172926; HORZ W, 1981, NUCLEIC ACIDS RES, V9, P2643, DOI 10.1093/nar/9.12.2643; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; IYER V, 1995, EMBO J, V14, P2570, DOI 10.1002/j.1460-2075.1995.tb07255.x; Johnson SM, 2006, GENOME RES, V16, P1505, DOI 10.1101/gr.5560806; Kaplan N, 2010, NAT STRUCT MOL BIOL, V17, P918, DOI 10.1038/nsmb0810-918; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kireeva ML, 2005, MOL CELL, V18, P97, DOI 10.1016/j.molcel.2005.02.027; Kireeva ML, 2002, MOL CELL, V9, P541, DOI 10.1016/S1097-2765(02)00472-0; KORNBERG RD, 1988, NUCLEIC ACIDS RES, V16, P6677, DOI 10.1093/nar/16.14.6677; KORNBERG RD, 1991, CELL, V67, P833, DOI 10.1016/0092-8674(91)90354-2; Kulish D, 2001, MOL CELL BIOL, V21, P4162, DOI 10.1128/MCB.21.13.4162-4168.2001; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luk E, 2007, MOL CELL, V25, P357, DOI 10.1016/j.molcel.2006.12.015; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; MEERSSEMAN G, 1992, EMBO J, V11, P2951, DOI 10.1002/j.1460-2075.1992.tb05365.x; Park YJ, 2008, CURR OPIN STRUC BIOL, V18, P282, DOI 10.1016/j.sbi.2008.04.003; Partensky PD, 2009, J MOL BIOL, V391, P12, DOI 10.1016/j.jmb.2009.04.085; Pepke S, 2009, NAT METHODS, V6, pS22, DOI [10.1038/NMETH.1371, 10.1038/nmeth.1371]; Pugh BF, 2010, NAT STRUCT MOL BIOL, V17, P923, DOI 10.1038/nsmb0810-923; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Schwabish MA, 2004, MOL CELL BIOL, V24, P10111, DOI 10.1128/MCB.24.23.10111-10117.2004; Schwabish MA, 2007, MOL CELL BIOL, V27, P6987, DOI 10.1128/MCB.00717-07; Schwabish MA, 2006, MOL CELL, V22, P415, DOI 10.1016/j.molcel.2006.03.014; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Shivaswamy S, 2008, PLOS BIOL, V6, P618, DOI 10.1371/journal.pbio.0060065; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Smith CL, 2005, CURR TOP DEV BIOL, V65, P115; Studitsky VM, 2004, TRENDS BIOCHEM SCI, V29, P127, DOI 10.1016/j.tibs.2004.01.003; Suto RK, 2000, NAT STRUCT BIOL, V7, P1121; Wang XP, 1998, J BACTERIOL, V180, P822, DOI 10.1128/JB.180.4.822-830.1998; Weiner A, 2010, GENOME RES, V20, P90, DOI 10.1101/gr.098509.109; Yassour M, 2009, P NATL ACAD SCI USA, V106, P3264, DOI 10.1073/pnas.0812841106; Yin SY, 2009, BIOCHEM BIOPH RES CO, V385, P363, DOI 10.1016/j.bbrc.2009.05.072; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zhang Y, 2010, NAT STRUCT MOL BIOL, V17, P920, DOI 10.1038/nsmb0810-920; Zhang Y, 2009, NAT STRUCT MOL BIOL, V16, P847, DOI 10.1038/nsmb.1636	58	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2010	5	9							e12984	10.1371/journal.pone.0012984	http://dx.doi.org/10.1371/journal.pone.0012984			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653UN	20886052	Green Published, gold			2022-12-27	WOS:000282122600018
J	Popendorf, K; Tsuyoshi, H; Osana, Y; Sakakibara, Y				Popendorf, Kris; Tsuyoshi, Hachiya; Osana, Yasunori; Sakakibara, Yasubumi			Murasaki: A Fast, Parallelizable Algorithm to Find Anchors from Multiple Genomes	PLOS ONE			English	Article							ALIGNMENT; SEQUENCE; EVOLUTION; DATABASE; IDENTIFICATION	Background: With the number of available genome sequences increasing rapidly, the magnitude of sequence data required for multiple-genome analyses is a challenging problem. When large-scale rearrangements break the collinearity of gene orders among genomes, genome comparison algorithms must first identify sets of short well-conserved sequences present in each genome, termed anchors. Previously, anchor identification among multiple genomes has been achieved using pairwise alignment tools like BLASTZ through progressive alignment tools like TBA, but the computational requirements for sequence comparisons of multiple genomes quickly becomes a limiting factor as the number and scale of genomes grows. Methodology/Principal Findings: Our algorithm, named Murasaki, makes it possible to identify anchors within multiple large sequences on the scale of several hundred megabases in few minutes using a single CPU. Two advanced features of Murasaki are (1) adaptive hash function generation, which enables efficient use of arbitrary mismatch patterns (spaced seeds) and therefore the comparison of multiple mammalian genomes in a practical amount of computation time, and (2) parallelizable execution that decreases the required wall-clock and CPU times. Murasaki can perform a sensitive anchoring of eight mammalian genomes (human, chimp, rhesus, orangutan, mouse, rat, dog, and cow) in 21 hours CPU time (42 minutes wall time). This is the first single-pass in-core anchoring of multiple mammalian genomes. We evaluated Murasaki by comparing it with the genome alignment programs BLASTZ and TBA. We show that Murasaki can anchor multiple genomes in near linear time, compared to the quadratic time requirements of BLASTZ and TBA, while improving overall accuracy. Conclusions/Significance: Murasaki provides an open source platform to take advantage of long patterns, cluster computing, and novel hash algorithms to produce accurate anchors across multiple genomes with computational efficiency significantly greater than existing methods. Murasaki is available under GPL at http://murasaki.sourceforge.net.	[Popendorf, Kris; Tsuyoshi, Hachiya; Sakakibara, Yasubumi] Keio Univ, Dept Biosci & Informat, Yokohama, Kanagawa 223, Japan; [Osana, Yasunori] Seikei Univ, Dept Comp & Informat Sci, Musashino, Tokyo, Japan	Keio University; Seikei University	Popendorf, K (corresponding author), Keio Univ, Dept Biosci & Informat, Yokohama, Kanagawa 223, Japan.	yasu@bio.keio.ac.jp	Sakakibara, Yasubumi/D-9008-2014; Osana, Yasunori/I-5160-2014		Ministry of Education, Culture, Sports, Science, and Technology Japan [17018029]; Takeda Science Foundation; Keio University	Ministry of Education, Culture, Sports, Science, and Technology Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Keio University	This work was supported in part by a grant-in-aid for scientific research on the priority area "Comparative Genomics" (No. 17018029) from the Ministry of Education, Culture, Sports, Science, and Technology Japan (http://www.genome-sci.jp/), the Takeda Science Foundation, and by Keio University (http://www.keio.ac.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Bourque G, 2002, GENOME RES, V12, P26; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P2369, DOI 10.1093/nar/27.11.2369; Dewey CN, 2006, PLOS COMPUT BIOL, V2, P606, DOI 10.1371/journal.pcbi.0020073; FARACH M, 1995, PROCEEDINGS OF THE SIXTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P48; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Hachiya T, 2009, BIOINFORMATICS, V25, P853, DOI 10.1093/bioinformatics/btp070; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Kemena C, 2009, BIOINFORMATICS, V25, P2455, DOI 10.1093/bioinformatics/btp452; Kish LB, 2002, PHYS LETT A, V305, P144, DOI 10.1016/S0375-9601(02)01365-8; Liolios K, 2008, NUCLEIC ACIDS RES, V36, pD475, DOI 10.1093/nar/gkm884; Ma B, 2002, BIOINFORMATICS, V18, P440, DOI 10.1093/bioinformatics/18.3.440; Mathee K, 2008, P NATL ACAD SCI USA, V105, P3100, DOI 10.1073/pnas.0711982105; Miller W, 2007, GENOME RES, V17, P1797, DOI 10.1101/gr.6761107; *NIST, 2002, FIPS 180 2 SEC HASH; Ohlebusch E, 2008, J COMPUT BIOL, V15, P357, DOI 10.1089/cmb.2007.0105; OSANA Y, 2010, GMV INTERACTIVE REND; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Pevzner P, 2003, GENOME RES, V13, P37, DOI 10.1101/gr.757503; Preparata FP, 2005, J COMPUT BIOL, V12, P1137, DOI 10.1089/cmb.2005.12.1137; QUINLAN S, 2002, VENTI NEW APPROACH A; RIVEST R, 1992, MD5 MESSAGE DIGEST A; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Smit A.F.A, 1996, REPEATMASKER OPEN 3; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Tabus L, 2008, 2008 IEEE INFORMATION THEORY WORKSHOP, P261, DOI 10.1109/ITW.2008.4578663; Vallender EJ, 2006, BIOINFORMATICS, V22, P2835, DOI 10.1093/bioinformatics/btl471; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262	34	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2010	5	9							e12651	10.1371/journal.pone.0012651	http://dx.doi.org/10.1371/journal.pone.0012651			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653UN	20885980	Green Submitted, Green Published, gold			2022-12-27	WOS:000282122600001
J	Akhtar, AM; Schneider, JE; Chapman, SJ; Jefferson, A; Digby, JE; Mankia, K; Chen, Y; McAteer, MA; Wood, KJ; Choudhury, RP				Akhtar, Asim M.; Schneider, Jurgen E.; Chapman, Stephanie J.; Jefferson, Andrew; Digby, Janet E.; Mankia, Kulveer; Chen, Ye; McAteer, Martina A.; Wood, Kathryn J.; Choudhury, Robin P.			In Vivo Quantification of Vcam-1 Expression in Renal Ischemia Reperfusion Injury Using Non-Invasive Magnetic Resonance Molecular Imaging	PLOS ONE			English	Article							CELL-ADHESION MOLECULES; ACUTE KIDNEY INJURY; MYOCARDIAL REPERFUSION; P-SELECTIN; PARTICLES; INFLAMMATION; LEUKOCYTE; MRI; ATHEROSCLEROSIS; MICROPARTICLES	Rationale and Objective: Vascular cell adhesion molecule-1 (VCAM-1) is upregulated in ischemia reperfusion injury (IRI), persisting after restoration of blood flow. We hypothesized that microparticles of iron oxide targeting VCAM-1 (VCAM-MPIO) would depict "ischemic memory'' and enable in vivo assessment of VCAM-1 expression. Methodology and Findings: Mice subject to unilateral, transient (30 minutes) renal ischemia and subsequent reperfusion received intravenous VCAM-MPIO (4.5 mg iron/kg body weight). Contrast agent bound rapidly (, 30 minutes) in IRI-kidneys and appeared as intensely low signal areas by MRI in vivo. Automated segmentation and quantification yielded MPIO contrast volumes of 5991 +/- 354x10(6) mu m(3) in IRI vs. 87 +/- 7x10(6) mu m(3) in kidneys with no surgical intervention (P<0.001); 90 +/- 8x10(6) mu m(3) in IRI kidneys exposed to control (IgG-MPIO) and 625 +/- 80x10(6) mu m(3), in IRI kidneys pre-treated with a blocking dose of VCAM-1 antibody (P<0.001). In keeping with quantitative MRI data, VCAM-1 mRNA expression in IRI was 65-fold higher than in kidneys without surgical intervention (3.06 +/- 60.63 vs. 0.05 +/- 0.02, P<0.001). Indeed VCAM-1 mRNA expression and VCAM-MPIO contrast volume were highly correlated (R-2 = 0.901, P<0.01), indicating that quantification of contrast volume reflected renal VCAM-1 transcription. Serial imaging showed VCAM-MPIO accumulation at target within 30 minutes, persisting for >= 90 minutes, while unbound VCAM-MPIO was cleared rapidly from blood, with sequestration by mac-3 positive Kupffer cells in the liver and monocyte/macrophages in the spleen. Conclusions: (1) VCAM-MPIO detected VCAM-1 expression and defined its 3-dimensional distribution, revealing " ischemic memory'' in renal IRI; (2) automated volumetric quantification of VCAM-MPIO accurately reflected tissue levels of VCAM-1 mRNA; and (3) VCAM-MPIO bound rapidly to target with active sequestration of unbound MPIO in the liver and spleen.	[Akhtar, Asim M.; Schneider, Jurgen E.; Jefferson, Andrew; Digby, Janet E.; Mankia, Kulveer; McAteer, Martina A.; Choudhury, Robin P.] Univ Oxford, John Radcliffe Hosp, Dept Cardiovasc Med, Oxford OX3 9DU, England; [Chapman, Stephanie J.; Chen, Ye; Wood, Kathryn J.] Univ Oxford, John Radcliffe Hosp, Transplantat Res Immunol Grp, Nuffield Dept Surg Sci, Oxford OX3 9DU, England	University of Oxford; University of Oxford	Akhtar, AM (corresponding author), Univ Oxford, John Radcliffe Hosp, Dept Cardiovasc Med, Oxford OX3 9DU, England.	robin.choudhury@cardiov.ox.ac.uk	McAteer, Martina/AAD-8628-2022	McAteer (Duric), Martina/0000-0002-7350-4651	Wellcome Trust [088291, 082519]; British Heart Foundation [BS/06/001]	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation)	This work was funded by The Wellcome Trust (www.wellcome.ac.uk) (grants to RPC #088291 and KJW #082519) and the British Heart Foundation (www.bhf.org.uk/) (to JES BS/06/001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascon DB, 2008, J LEUKOCYTE BIOL, V84, P1400, DOI 10.1189/jlb.0907651; Ascon DB, 2006, J IMMUNOL, V177, P3380, DOI 10.4049/jimmunol.177.5.3380; Beyersdorf F, 2009, CARDIOVASC RES, V83, P262, DOI 10.1093/cvr/cvp110; BRAUNWALD E, 1985, J CLIN INVEST, V76, P1713, DOI 10.1172/JCI112160; Burne MJ, 2001, J LEUKOCYTE BIOL, V70, P192; Burne-Taney MJ, 2003, CURR OPIN NEPHROL HY, V12, P85, DOI 10.1097/00041552-200301000-00014; Cassidy PJ, 2004, J MAGN RESON IMAGING, V19, P229, DOI 10.1002/jmri.10454; Cheng SS, 2005, J AGR FOOD CHEM, V53, P614, DOI 10.1021/jf0484529; CHOUDHURY RP, 2009, ARTERIOSCLER THROMB; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; FRIES JWU, 1993, AM J PATHOL, V143, P725; Frijns CJM, 2002, STROKE, V33, P2115, DOI 10.1161/01.STR.0000021902.33129.69; Golab F, 2009, KIDNEY INT, V75, P783, DOI 10.1038/ki.2008.683; IADEMARCO MF, 1992, J BIOL CHEM, V267, P16323; Kaufmann BA, 2007, CIRCULATION, V116, P276, DOI 10.1161/CIRCULATIONAHA.106.684738; Kelly KA, 2005, CIRC RES, V96, P327, DOI 10.1161/01.RES.0000155722.17881.dd; Kelly KJ, 2003, J AM SOC NEPHROL, V14, P1549, DOI 10.1097/01.ASN.0000064946.94590.46; Klein CL, 2008, KIDNEY INT, V74, P901, DOI 10.1038/ki.2008.314; KUROSE I, 1994, CIRC RES, V74, P336, DOI 10.1161/01.RES.74.2.336; Liu MC, 2008, J AM SOC NEPHROL, V19, P1360, DOI 10.1681/ASN.2007080901; McAteer MA, 2008, ARTERIOSCL THROM VAS, V28, P77, DOI 10.1161/ATVBAHA.107.145466; McAteer MA, 2007, NAT MED, V13, P1253, DOI 10.1038/nm1631; Nahrendorf M, 2009, JACC-CARDIOVASC IMAG, V2, P1213, DOI 10.1016/j.jcmg.2009.04.016; NEISH AS, 1992, J EXP MED, V176, P1583, DOI 10.1084/jem.176.6.1583; OKADA Y, 1994, STROKE, V25, P202, DOI 10.1161/01.STR.25.1.202; Piot C, 2008, NEW ENGL J MED, V359, P473, DOI 10.1056/NEJMoa071142; Reinhardt M, 2005, NEUROIMAGE, V27, P267, DOI 10.1016/j.neuroimage.2005.04.019; Sakhalkar HS, 2003, P NATL ACAD SCI USA, V100, P15895, DOI 10.1073/pnas.2631433100; Shapiro EM, 2004, P NATL ACAD SCI USA, V101, P10901, DOI 10.1073/pnas.0403918101; Shapiro EM, 2005, MAGNET RESON MED, V53, P329, DOI 10.1002/mrm.20342; Singbartl K, 2000, FASEB J, V14, P48, DOI 10.1096/fasebj.14.1.48; Stoica SC, 2005, J HEART LUNG TRANSPL, V24, P593, DOI 10.1016/j.healun.2004.01.021; Sumner JP, 2009, NEUROIMAGE, V44, P671, DOI 10.1016/j.neuroimage.2008.07.050; Thiagarajan RR, 1997, THROMB HAEMOSTASIS, V78, P310; van Kasteren SI, 2009, P NATL ACAD SCI USA, V106, P18, DOI 10.1073/pnas.0806787106; Villanueva FS, 2007, CIRCULATION, V115, P345, DOI 10.1161/CIRCULATIONAHA.106.633917; von zur Muhlen C, 2009, J VASC RES, V46, P6, DOI 10.1159/000135660; Wu YL, 2006, P NATL ACAD SCI USA, V103, P1852, DOI 10.1073/pnas.0507198103; WUTHRICH RP, 1993, TRANSPLANTATION, V55, P172, DOI 10.1097/00007890-199301000-00032; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667	40	47	48	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2010	5	9							e12800	10.1371/journal.pone.0012800	http://dx.doi.org/10.1371/journal.pone.0012800			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652JO	20877722	Green Published, Green Submitted, gold			2022-12-27	WOS:000282002900003
J	Hernandez-Martinez, P; Navarro-Cerrillo, G; Caccia, S; de Maagd, RA; Moar, WJ; Ferre, J; Escriche, B; Herrero, S				Hernandez-Martinez, Patricia; Navarro-Cerrillo, Gloria; Caccia, Silvia; de Maagd, Ruud A.; Moar, William J.; Ferre, Juan; Escriche, Baltasar; Herrero, Salvador			Constitutive Activation of the Midgut Response to Bacillus thuringiensis in Bt-Resistant Spodoptera exigua	PLOS ONE			English	Article							MEDIATED INSECT RESISTANCE; POSTERIOR MIDGUT; AMINOPEPTIDASE-N; KINASE PATHWAYS; MANDUCA-SEXTA; TOXIN; DROSOPHILA; CRY1AC; PROTEIN; LEPIDOPTERA	Bacillus thuringiensis is the most effective microbial control agent for controlling numerous species from different insect orders. The main threat for the long term use of B. thuringiensis in pest control is the ability of insects to develop resistance. Thus, the identification of insect genes involved in conferring resistance is of paramount importance. A colony of Spodoptera exigua (Lepidoptera: Noctuidae) was selected for 15 years in the laboratory for resistance to Xentari (TM), a B. thuringiensis-based insecticide, reaching a final resistance level of greater than 1,000-fold. Around 600 midgut ESTs were analyzed by DNA-macroarray in order to find differences in midgut gene expression between susceptible and resistant insects. Among the differentially expressed genes, repat and arylphorin were identified and their increased expression was correlated with B. thuringiensis resistance. We also found overlap among genes that were constitutively over-expressed in resistant insects with genes that were up-regulated in susceptible insects after exposure to Xentari (TM), suggesting a permanent activation of the response to Xentari (TM) in resistant insects. Increased aminopeptidase activity in the lumen of resistant insects in the absence of exposure to Xentari (TM) corroborated the hypothesis of permanent activation of response genes. Increase in midgut proliferation has been proposed as a mechanism of response to pathogens in the adult from several insect species. Analysis of S. exigua larvae revealed that midgut proliferation was neither increased in resistant insects nor induced by exposure of susceptible larvae to Xentari (TM), suggesting that mechanisms other than midgut proliferation are involved in the response to B. thuringiensis by S. exigua larvae.	[Hernandez-Martinez, Patricia; Navarro-Cerrillo, Gloria; Caccia, Silvia; Ferre, Juan; Escriche, Baltasar; Herrero, Salvador] Univ Valencia, Dept Genet, E-46100 Burjassot, Spain; [de Maagd, Ruud A.] Univ Wageningen & Res Ctr, Plant Res Int BV, Wageningen, Netherlands; [Moar, William J.] Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA	University of Valencia; Plant Research International; Wageningen University & Research; Auburn University System; Auburn University	Hernandez-Martinez, P (corresponding author), Univ Valencia, Dept Genet, E-46100 Burjassot, Spain.	sherrero@uv.es	Patricia, Hernandez-Martinez/Q-3082-2019; Herrero, Salva/ABE-5123-2020; Herrero, Salvador/J-5767-2013; Escriche, Baltasar/N-5136-2014; de Maagd, Ruud A/A-5859-2012; Ferré, Juan/L-9426-2014	Patricia, Hernandez-Martinez/0000-0002-3263-5786; Herrero, Salva/0000-0001-5690-2108; Herrero, Salvador/0000-0001-5690-2108; Escriche, Baltasar/0000-0003-4889-793X; de Maagd, Ruud A/0000-0001-7049-2029; Ferré, Juan/0000-0001-5535-0612; CACCIA, Silvia/0000-0003-1954-7180	Spanish Ministry of Science and Innovation [AGL2008-05456-C03-03, AGL2006-11914, BES-2006-13999]; European FEDER; EU [PIEF-GA-2008-219993]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European FEDER(European Commission); EU(European Commission)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors want to thank COST 862 Action from the EU for facilitating the interaction of different groups. This research was supported by the Spanish Ministry of Science and Innovation (AGL2008-05456-C03-03, AGL2006-11914 and grant BES-2006-13999 for GNC) and European FEDER funds. SC was supported by a Marie Curie fellowship PIEF-GA-2008-219993 from the EU.	Anilkumar KJ, 2009, J CHEM ECOL, V35, P785, DOI 10.1007/s10886-009-9665-x; BALDWIN KM, 1991, TISSUE CELL, V23, P411, DOI 10.1016/0040-8166(91)90058-2; Basset A, 2000, P NATL ACAD SCI USA, V97, P3376, DOI 10.1073/pnas.070357597; Baton LA, 2007, J INVERTEBR PATHOL, V96, P244, DOI 10.1016/j.jip.2007.05.005; Belli G, 2004, J BIOL CHEM, V279, P12386, DOI 10.1074/jbc.M311879200; BENZ G, 1967, EXPERIENTIA, V23, P871, DOI 10.1007/BF02146902; Bischof LJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000176; Blackburn MB, 2004, ARCH INSECT BIOCHEM, V55, P26, DOI 10.1002/arch.10119; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bravo A, 2008, TRENDS BIOTECHNOL, V26, P573, DOI 10.1016/j.tibtech.2008.06.005; Bravo A, 2007, TOXICON, V49, P423, DOI 10.1016/j.toxicon.2006.11.022; Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Cancino-Rodezno A, 2010, INSECT BIOCHEM MOLEC, V40, P58, DOI 10.1016/j.ibmb.2009.12.010; Cronin SJF, 2009, SCIENCE, V325, P340, DOI 10.1126/science.1173164; de Maagd RA, 1999, TRENDS PLANT SCI, V4, P9, DOI 10.1016/S1360-1385(98)01356-9; de Maagd RA, 2001, TRENDS GENET, V17, P193, DOI 10.1016/S0168-9525(01)02237-5; Estruch JJ, 1996, P NATL ACAD SCI USA, V93, P5389, DOI 10.1073/pnas.93.11.5389; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; Ferre Juan, 2008, V5, P41; Freitak D, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-56; Gahan LJ, 2001, SCIENCE, V293, P857, DOI 10.1126/science.1060949; Griffitts JS, 2001, SCIENCE, V293, P860, DOI 10.1126/science.1062441; Griffitts JS, 2005, SCIENCE, V307, P922, DOI 10.1126/science.1104444; Gunning RV, 2005, APPL ENVIRON MICROB, V71, P2558, DOI 10.1128/AEM.71.5.2558-2563.2005; Hakim RS, 2007, ARCH INSECT BIOCHEM, V64, P63, DOI 10.1002/arch.20155; Heckel DG, 2007, J INVERTEBR PATHOL, V95, P192, DOI 10.1016/j.jip.2007.03.008; Herfs W., 1965, Zeitschrift fur Pflanzenkrankheiten, Pflanzenpathologie und Pflanzenschutz, V72, P584; Hernandez-Martinez P, 2008, J INVERTEBR PATHOL, V97, P245, DOI 10.1016/j.jip.2007.11.001; Herrero S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-96; Herrero S, 2004, BIOCHEM J, V384, P507, DOI 10.1042/BJ20041094; Herrero S, 2007, INSECT BIOCHEM MOLEC, V37, P1109, DOI 10.1016/j.ibmb.2007.06.007; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; Jurat-Fuentes JL, 2004, EUR J BIOCHEM, V271, P3127, DOI 10.1111/j.1432-1033.2004.04238.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Loeb MJ, 2001, J INSECT PHYSIOL, V47, P599, DOI 10.1016/S0022-1910(00)00150-5; Ma G, 2005, INSECT BIOCHEM MOLEC, V35, P729, DOI 10.1016/j.ibmb.2005.02.011; MACINTOSH SC, 1990, J AGR FOOD CHEM, V38, P1145, DOI 10.1021/jf00094a051; Martinez-Ramirez AC, 1999, BIOCONTROL SCI TECHN, V9, P239, DOI 10.1080/09583159929811; MCGAUGHEY WH, 1985, SCIENCE, V229, P193, DOI 10.1126/science.229.4709.193; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Negre V, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-322; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Oppert B, 1997, J BIOL CHEM, V272, P23473, DOI 10.1074/jbc.272.38.23473; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Rodrigo-Simon A, 2008, APPL ENVIRON MICROB, V74, P1710, DOI 10.1128/AEM.02827-07; Rodriguez-Cabrera L, 2008, TOXICON, V51, P681, DOI 10.1016/j.toxicon.2007.12.002; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sampson MN, 1998, MICROBIOL-SGM, V144, P2189, DOI 10.1099/00221287-144-8-2189; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; TABASHNIK BE, 1993, APPL ENVIRON MICROB, V59, P1332, DOI 10.1128/AEM.59.5.1332-1335.1993; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Valaitis AP, 2008, INSECT BIOCHEM MOLEC, V38, P611, DOI 10.1016/j.ibmb.2008.03.003; van Munster M, 2007, INSECT MOL BIOL, V16, P25, DOI 10.1111/j.1365-2583.2006.00692.x; Wang P, 2007, APPL ENVIRON MICROB, V73, P1199, DOI 10.1128/AEM.01834-06; Zhang XP, 2009, J IND MICROBIOL BIOT, V36, P815, DOI 10.1007/s10295-009-0556-5	58	58	60	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2010	5	9							e12792	10.1371/journal.pone.0012795	http://dx.doi.org/10.1371/journal.pone.0012795			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651XL	20862260	Green Published, Green Submitted, gold			2022-12-27	WOS:000281960800012
J	Stamatopoulos, B; Meuleman, N; De Bruyn, C; Pieters, K; Anthoine, G; Mineur, P; Bron, D; Lagneaux, L				Stamatopoulos, Basile; Meuleman, Nathalie; De Bruyn, Cecile; Pieters, Karlien; Anthoine, Geraldine; Mineur, Philippe; Bron, Dominique; Lagneaux, Laurence			A Molecular Score by Quantitative PCR as a New Prognostic Tool at Diagnosis for Chronic Lymphocytic Leukemia Patients	PLOS ONE			English	Article							ZAP70 MESSENGER-RNA; CD38 EXPRESSION; B-CELLS; GENOMIC ABERRATIONS; MUTATION STATUS; DOUBLING TIME; SOLUBLE CD23; SURVIVAL; RISK; GENES	Background: Several markers have been proposed to predict the outcome of chronic lymphocytic leukemia (CLL) patients. However, discordances exist between the current prognostic factors, indicating that none of these factors are totally perfect. Methodology/Principal Findings: Here, we compared the prognostic power of new RNA-based markers in order to construct a quantitative PCR (qPCR) score composed of the most powerful factors. ZAP70, LPL, CLLU1, microRNA-29c and microRNA-223 were measured by real time PCR in a cohort of 170 patients with a median follow-up of 64 months (range 3-330). For each patient, cells were obtained at diagnosis and RNA was extracted from purified CD19 cells. The best markers were included in a qPCR score, which was thereafter compared to each individual factor. Statistical analysis showed that all five RNA-based markers can predict treatment-free survival (TFS), but only ZAP70, LPL and microRNA-29c could significantly predict overall survival (OS). These three markers were thus included in a simple qPCR score that was able to significantly predict TFS and OS by dividing patients into three groups (0/3, 1-2/3 and 3/3). Median TFS were.210, 61 and 24 months (P<0.0001) and median OS were.330, 242 and 137 months (P<0.0001), respectively. Interestingly, TFS results were also confirmed in Binet stage A patients (P<0.0001). When compared to other classical factors, this score displays the highest univariate Cox hazard ratio (TFS: HR = 9.45 and OS: HR = 13.88) but also provides additional prognostic information. Conclusions: In our hands, this score is the most powerful tool for CLL risk stratification at the time of diagnosis.	[Stamatopoulos, Basile; Meuleman, Nathalie; De Bruyn, Cecile; Pieters, Karlien; Bron, Dominique; Lagneaux, Laurence] Univ Libre Bruxelles, Lab Expt Hematol, Fac Med, Inst Jules Bordet, Brussels, Belgium; [Anthoine, Geraldine] Univ Libre Bruxelles, Dept Intens & Thorac Oncol, Inst Jules Bordet, Brussels, Belgium; [Mineur, Philippe] Grand Hop Charleroi, Dept Hematooncol, Gilly, Belgium	Institut Jules Bordet; Universite Libre de Bruxelles; Institut Jules Bordet; Universite Libre de Bruxelles; Grand Hopital De Charleroi	Stamatopoulos, B (corresponding author), Univ Libre Bruxelles, Lab Expt Hematol, Fac Med, Inst Jules Bordet, Brussels, Belgium.	bstamato@ulb.ac.be			F.R.I.A (Fonds de Recherche pour l'Industrie et l'Agriculture); F.R.S-F.N.R.S. - Fonds de la Recherche Scientifique - FNRS; Federation Belge Contre le Cancer	F.R.I.A (Fonds de Recherche pour l'Industrie et l'Agriculture); F.R.S-F.N.R.S. - Fonds de la Recherche Scientifique - FNRS(Fonds de la Recherche Scientifique - FNRS); Federation Belge Contre le Cancer	This research was supported by an F.R.I.A. grant (Fonds de Recherche pour l'Industrie et l'Agriculture), the televie fund (both of which are affiliated with the F.R.S-F.N.R.S. - Fonds de la Recherche Scientifique - FNRS) and the Federation Belge Contre le Cancer. B. S. (Postdoctoral Researcher), C.D.B. (Scientific Research Worker), and L.L. (Senior Research Associate) are members of the F.N.R.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilban M, 2006, LEUKEMIA, V20, P1080, DOI 10.1038/sj.leu.2404220; BINET JL, 1981, CANCER-AM CANCER SOC, V48, P198, DOI 10.1002/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V; Buhl AM, 2006, EUR J HAEMATOL, V76, P455, DOI 10.1111/j.0902-4441.2005.t01-1-EJH2530.x; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; Deaglio S, 2007, BLOOD, V110, P4012, DOI 10.1182/blood-2007-06-094029; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Durig J, 2002, LEUKEMIA, V16, P30, DOI 10.1038/sj.leu.2402339; Hamblin T, 2002, ANN HEMATOL, V81, P299, DOI 10.1007/s00277-002-0476-1; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Josefsson P, 2007, BLOOD, V109, P4973, DOI 10.1182/blood-2006-11-054916; Kienle D, 2010, HAEMATOL-HEMATOL J, V95, P102, DOI 10.3324/haematol.2009.010298; Klein U, 2001, J EXP MED, V194, P1625, DOI 10.1084/jem.194.11.1625; Krober A, 2002, BLOOD, V100, P1410, DOI 10.1182/blood.V100.4.1410.h81602001410_1410_1416; Lagneaux L, 1998, BLOOD, V91, P2387, DOI 10.1182/blood.V91.7.2387.2387_2387_2396; Meuleman N, 2008, LEUKEMIA, V22, P1882, DOI 10.1038/leu.2008.190; Molica S, 1999, EUR J HAEMATOL, V62, P117; MONTSERRAT E, 1986, BRIT J HAEMATOL, V62, P567, DOI 10.1111/j.1365-2141.1986.tb02969.x; Pallasch CP, 2008, LEUKEMIA, V22, P585, DOI 10.1038/sj.leu.2405058; RAI KR, 1975, BLOOD, V46, P219, DOI 10.1182/blood.V46.2.219.219; Stamatopoulos B, 2007, CLIN CHEM, V53, P1757, DOI 10.1373/clinchem.2007.089326; Stamatopoulos B, 2009, HAEMATOL-HEMATOL J, V94, P790, DOI 10.3324/haematol.2008.002626; Stamatopoulos B, 2009, BLOOD, V113, P5237, DOI 10.1182/blood-2008-11-189407; Van Bockstaele F, 2007, CLIN CHEM, V53, P204, DOI 10.1373/clinchem.2006.076331; Van Bockstaele F, 2009, BLOOD REV, V23, P25, DOI 10.1016/j.blre.2008.05.003; Wierda WG, 2007, BLOOD, V109, P4679, DOI 10.1182/blood-2005-12-051458; Wiestner A, 2003, BLOOD, V101, P4944, DOI 10.1182/blood-2002-10-3306; Zucchetto A, 2006, J CELL PHYSIOL, V207, P354, DOI 10.1002/jcp.20570	28	23	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2010	5	9							e12780	10.1371/journal.pone.0012780	http://dx.doi.org/10.1371/journal.pone.0012780			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650QH	20862275	gold, Green Submitted, Green Published			2022-12-27	WOS:000281864100018
J	Martin, J; Anamika, K; Srinivasan, N				Martin, Juliette; Anamika, Krishanpal; Srinivasan, Narayanaswamy			Classification of Protein Kinases on the Basis of Both Kinase and Non-Kinase Regions	PLOS ONE			English	Article							DATABASE; KINOME; SEQUENCE; PHOSPHORYLATION; DIVERSITY; GENOMICS; FAMILY; ARABIDOPSIS; ALIGNMENTS; EXPRESSION	Background: Protein phosphorylation is a generic way to regulate signal transduction pathways in all kingdoms of life. In many organisms, it is achieved by the large family of Ser/Thr/Tyr protein kinases which are traditionally classified into groups and subfamilies on the basis of the amino acid sequence of their catalytic domains. Many protein kinases are multidomain in nature but the diversity of the accessory domains and their organization are usually not taken into account while classifying kinases into groups or subfamilies. Methodology: Here, we present an approach which considers amino acid sequences of complete gene products, in order to suggest refinements in sets of pre-classified sequences. The strategy is based on alignment-free similarity scores and iterative Area Under the Curve (AUC) computation. Similarity scores are computed by detecting common patterns between two sequences and scoring them using a substitution matrix, with a consistent normalization scheme. This allows us to handle full-length sequences, and implicitly takes into account domain diversity and domain shuffling. We quantitatively validate our approach on a subset of 212 human protein kinases. We then employ it on the complete repertoire of human protein kinases and suggest few qualitative refinements in the subfamily assignment stored in the KinG database, which is based on catalytic domains only. Based on our new measure, we delineate 37 cases of potential hybrid kinases: sequences for which classical classification based entirely on catalytic domains is inconsistent with the full-length similarity scores computed here, which implicitly consider multi-domain nature and regions outside the catalytic kinase domain. We also provide some examples of hybrid kinases of the protozoan parasite Entamoeba histolytica. Conclusions: The implicit consideration of multi-domain architectures is a valuable inclusion to complement other classification schemes. The proposed algorithm may also be employed to classify other families of enzymes with multidomain architecture.	[Martin, Juliette; Anamika, Krishanpal; Srinivasan, Narayanaswamy] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Martin, Juliette] INRA, UR1077, Unite Math Informat & Genome, Jouy En Josas, France	Indian Institute of Science (IISC) - Bangalore; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Martin, J (corresponding author), Univ Lyon, Lyon, France.	martin@ibcp.fr	Martin, Juliette/T-9457-2019; Martin, Juliette/N-5545-2016	Martin, Juliette/0000-0002-4787-0885; Martin, Juliette/0000-0002-4787-0885	Department of Science and Technology, New Delhi under the Mathematical Biology initiative; Department of Biotechnology, New Delhi; INRA, France	Department of Science and Technology, New Delhi under the Mathematical Biology initiative(Department of Science & Technology (India)); Department of Biotechnology, New Delhi(Department of Biotechnology (DBT) India); INRA, France	This research is supported by Department of Science and Technology, New Delhi under the Mathematical Biology initiative and also by the Department of Biotechnology, New Delhi. JM had a fellowship from INRA, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anamika, 2005, PROTEINS, V58, P180, DOI 10.1002/prot.20278; Anamika K, 2008, PROTEINS, V71, P995, DOI 10.1002/prot.21790; Anamika K, 2007, PROTEIN PEPTIDE LETT, V14, P509; Anamika K, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-622; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bradham CA, 2006, DEV BIOL, V300, P180, DOI 10.1016/j.ydbio.2006.08.074; Buzko O, 2002, BIOINFORMATICS, V18, P1274, DOI 10.1093/bioinformatics/18.9.1274; Caenepeel S, 2004, P NATL ACAD SCI USA, V101, P11707, DOI 10.1073/pnas.0306880101; Champion A., 2004, Functional & Integrative Genomics, V4, P163, DOI 10.1007/s10142-003-0096-4; Cheek S, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-6; Cheek S, 2002, J MOL BIOL, V320, P855, DOI 10.1016/S0022-2836(02)00538-7; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Dardick C, 2007, PLANT PHYSIOL, V143, P579, DOI 10.1104/pp.106.087270; Datta S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-397; DESHMUKH K, 2009, PROG BIOPHYS MOL BIO; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Goldberg JM, 2006, PLOS GENET, V2, P291, DOI 10.1371/journal.pgen.0020038; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Gowri VS, 2007, PROTEINS, V67, P789, DOI 10.1002/prot.21356; Gribskov M, 2001, NUCLEIC ACIDS RES, V29, P111, DOI 10.1093/nar/29.1.111; Han EKH, 2007, ANTI-CANCER AGENT ME, V7, P681, DOI 10.2174/187152007784111296; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Hunter T, 1997, TRENDS BIOCHEM SCI, V22, P18, DOI 10.1016/S0968-0004(96)10068-2; Jacobs MD, 2008, PROTEINS, V70, P1451, DOI 10.1002/prot.21633; Kannan N, 2007, PLOS BIOL, V5, P467, DOI 10.1371/journal.pbio.0050017; KATAMINE S, 1988, MOL CELL BIOL, V8, P259, DOI 10.1128/MCB.8.1.259; Kelil A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-286; Kostich M, 2002, GENOME BIOL, V3; Krupa A, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-129; Krupa A, 2002, GENOME BIOL, V3; Krupa A, 2004, NUCLEIC ACIDS RES, V32, pD153, DOI 10.1093/nar/gkh019; Krupa A, 2006, GENE, V380, P1, DOI 10.1016/j.gene.2006.05.016; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; Marchler-Bauer A, 2002, NUCLEIC ACIDS RES, V30, P281, DOI 10.1093/nar/30.1.281; Martin DMA, 2009, NUCLEIC ACIDS RES, V37, pD244, DOI 10.1093/nar/gkn834; Miranda-Saavedra D, 2007, PROTEINS, V68, P893, DOI 10.1002/prot.21444; Niedner RH, 2006, PROTEINS, V63, P78, DOI 10.1002/prot.20825; Plowman GD, 1999, P NATL ACAD SCI USA, V96, P13603, DOI 10.1073/pnas.96.24.13603; R Development Core Team, 2007, R LANG ENV STAT COMP; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Scheeff ED, 2005, PLOS COMPUT BIOL, V1, P359, DOI 10.1371/journal.pcbi.0010049; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Smith CM, 1997, TRENDS BIOCHEM SCI, V22, P444, DOI 10.1016/S0968-0004(97)01131-6; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tchieu JH, 2003, NUCLEIC ACIDS RES, V31, P342, DOI 10.1093/nar/gkg025; Toshima J, 2001, J BIOL CHEM, V276, P31449, DOI 10.1074/jbc.M102988200; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; ZHENG JH, 1993, BIOCHEMISTRY-US, V32, P2154, DOI 10.1021/bi00060a005	52	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12460	10.1371/journal.pone.0012460	http://dx.doi.org/10.1371/journal.pone.0012460			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856812	Green Published, gold, Green Submitted			2022-12-27	WOS:000281815800002
J	Stridh, P; Hedreul, MT; Beyeen, AD; Adzemovic, MZ; Laaksonen, H; Gillett, A; Ockinger, J; Marta, M; Lassmann, H; Becanovic, K; Jagodic, M; Olsson, T				Stridh, Pernilla; Hedreul, Melanie Thessen; Beyeen, Amennai Daniel; Adzemovic, Milena Z.; Laaksonen, Hannes; Gillett, Alan; Ockinger, Johan; Marta, Monica; Lassmann, Hans; Becanovic, Kristina; Jagodic, Maja; Olsson, Tomas			Fine-Mapping Resolves Eae23 into Two QTLs and Implicates ZEB1 as a Candidate Gene Regulating Experimental Neuroinflammation in Rat	PLOS ONE			English	Article							MYELIN OLIGODENDROCYTE GLYCOPROTEIN; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; QUANTITATIVE TRAIT LOCI; MULTIPLE-SCLEROSIS; LINKAGE ANALYSIS; T-CELLS; INTERLEUKIN-7 RECEPTOR; CONFIDENCE-INTERVALS; MILK PROTEIN	Background: To elucidate mechanisms involved in multiple sclerosis (MS), we studied genetic regulation of experimental autoimmune encephalomyelitis (EAE) in rats, assuming a conservation of pathogenic pathways. In this study, we focused on Eae23, originally identified to regulate EAE in a (LEW. 1AV1xPVG. 1AV1) F2 cross. Our aim was to determine whether one or more genes within the 67 Mb region regulate EAE and to define candidate risk genes. Methodology/Principal Findings: We used high resolution quantitative trait loci (QTL) analysis in the 10th generation (G10) of an advanced intercross line (AIL) to resolve Eae23 into two QTLs that independently regulate EAE, namely Eae23a and Eae23b. We established a congenic strain to validate the effect of this region on disease. PVG alleles in Eae23 resulted in significant protection from EAE and attenuated CNS inflammation/demyelination. Disease amelioration was accompanied with increased levels of Foxp3(+) cells in the CNS of the congenic strain compared to DA. We then focused on candidate gene investigation in Eae23b, a 9 Mb region linked to all clinical phenotypes. Affymetrix exon arrays were used to study expression of the genes in Eae23b in the parental strains, where none showed differential expression. However, we found lower expression of exon 4 of ZEB1, which is specific for splice-variant Zfhep1. ZEB1 is an interleukin 2 (IL2) repressor involved in T cell development. The splice-specific variance prompted us to next analyze the expression of ZEB1 and its two splice variants, Zfhep1 and Zfhep2, in both lymph node and spleen. We demonstrated that ZEB1 splice-variants are differentially expressed; severity of EAE and higher IL2 levels were associated with down-regulation of Zfhep1 and up-regulation of Zfhep2. Conclusions/Significance: We speculate that the balance between splice-variants of ZEB1 could influence the regulation of EAE. Further functional studies of ZEB1 and the splice-variants may unravel novel pathways contributing to MS pathogenesis and inflammation in general.	[Stridh, Pernilla; Hedreul, Melanie Thessen; Beyeen, Amennai Daniel; Laaksonen, Hannes; Gillett, Alan; Ockinger, Johan; Marta, Monica; Becanovic, Kristina; Jagodic, Maja; Olsson, Tomas] Karolinska Inst, Ctr Mol Med, Neuroimmunol Unit, Dept Clin Neurosci, Stockholm, Sweden; [Adzemovic, Milena Z.; Lassmann, Hans] Med Univ Vienna, Ctr Brain Res, Vienna, Austria	Karolinska Institutet; Medical University of Vienna	Stridh, P (corresponding author), Karolinska Inst, Ctr Mol Med, Neuroimmunol Unit, Dept Clin Neurosci, Stockholm, Sweden.	pernilla.strid@ki.se	Lassmann, Hans/Z-2269-2019; Marta, Monica/H-5804-2019; Becanovic, Kristina/A-4479-2016; Stridh, Pernilla/J-2918-2012; Öckinger, Johan/F-4543-2010; Marta, Monica/H-3376-2019	Lassmann, Hans/0000-0001-8617-5052; Marta, Monica/0000-0002-5464-9070; Stridh, Pernilla/0000-0003-4855-0039; Öckinger, Johan/0000-0003-4300-3415; Marta, Monica/0000-0002-5464-9070; Lindahl, Hannes/0000-0002-4447-9426; Olsson, Tomas/0000-0002-2938-1877	Swedish Research Council; Wadsworth Foundation; Soderbergs Foundation; Petrus and Augusta Hedlunds Foundation; Bibbi and Niels Jensens Foundation; Montel Williams Foundation; Ake-Wibergs Stiftelse; Swedish Foundation for Neurologically Disabled; EU [LSHG-CT-2005-019015, LSHM-CT-2005-018637]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Wadsworth Foundation; Soderbergs Foundation; Petrus and Augusta Hedlunds Foundation; Bibbi and Niels Jensens Foundation; Montel Williams Foundation; Ake-Wibergs Stiftelse; Swedish Foundation for Neurologically Disabled; EU(European Commission)	This study was supported by grants from the Swedish Research Council, The Wadsworth Foundation, Soderbergs Foundation, Petrus and Augusta Hedlunds Foundation, Bibbi and Niels Jensens Foundation, Montel Williams Foundation, Ake-Wibergs Stiftelse, the Swedish Foundation for Neurologically Disabled and the EU 6TH Framework EURATools (LSHG-CT-2005-019015) and Neuropromise (LSHM-CT-2005-018637). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afuwape AO, 2003, GENE THER, V10, P1950, DOI 10.1038/sj.gt.3302104; AMOR S, 1994, J IMMUNOL, V153, P4349; Becanovic K, 2003, J IMMUNOL, V170, P1062, DOI 10.4049/jimmunol.170.2.1062; Becanovic K, 2006, J IMMUNOL, V176, P6055, DOI 10.4049/jimmunol.176.10.6055; Becker KG, 1998, P NATL ACAD SCI USA, V95, P9979, DOI 10.1073/pnas.95.17.9979; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Black DL, 2000, CELL, V103, P367, DOI 10.1016/S0092-8674(00)00128-8; Brand OJ, 2007, CLIN ENDOCRINOL, V66, P508, DOI 10.1111/j.1365-2265.2007.02762.x; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Cabanillas AM, 1996, DNA CELL BIOL, V15, P643, DOI 10.1089/dna.1996.15.643; CHURCHILL GA, 1994, GENETICS, V138, P963; COPEMAN JB, 1995, NAT GENET, V9, P80, DOI 10.1038/ng0195-80; Costantino CM, 2008, J CLIN IMMUNOL, V28, P697, DOI 10.1007/s10875-008-9236-x; Dahlman I, 1999, HUM MOL GENET, V8, P2183, DOI 10.1093/hmg/8.12.2183; Dahlman I, 1999, J IMMUNOL, V162, P2581; EBERS GC, 1995, NATURE, V377, P150, DOI 10.1038/377150a0; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Foxwell BMJ, 2001, ANN RHEUM DIS, V60, pIII13; Gillett A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007773; GREENBERG SJ, 1988, NEW ENGL J MED, V319, P1019; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; Grooteclaes ML, 2000, ONCOGENE, V19, P3823, DOI 10.1038/sj.onc.1203721; Gschwind A, 2004, NAT REV CANCER, V4, P361, DOI 10.1038/nrc1360; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hemavathy K, 2000, GENE, V257, P1, DOI 10.1016/S0378-1119(00)00371-1; HILLERT J, 1993, NEUROLOGY, V43, P163, DOI 10.1212/WNL.43.1_Part_1.163; HOPPENBROUWERS IA, 2009, J HUM GENET; Hoyer KK, 2008, IMMUNOL REV, V226, P19, DOI 10.1111/j.1600-065X.2008.00697.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; JACOB HJ, 1995, NAT GENET, V9, P63, DOI 10.1038/ng0195-63; Jagodic M, 2005, J IMMUNOL, V174, P918, DOI 10.4049/jimmunol.174.2.918; Jagodic M, 2004, J IMMUNOL, V173, P1366, DOI 10.4049/jimmunol.173.2.1366; Jagodic M, 2001, IMMUNOGENETICS, V53, P410, DOI 10.1007/s002510100342; JERSILD C, 1972, LANCET, V1, P1240; JERSILD C, 1973, LANCET, V2, P1221; Jin P, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2447; Klein AP, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S73; Kouki T, 2002, J ENDOCRINOL INVEST, V25, P208, DOI 10.1007/BF03343992; Kryczek I, 2007, J IMMUNOL, V178, P6730, DOI 10.4049/jimmunol.178.11.6730; KUNDIG TM, 1993, SCIENCE, V262, P1059, DOI 10.1126/science.8235625; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1989, GENETICS, V121, P185; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Letourneau S, 2009, J ALLERGY CLIN IMMUN, V123, P758, DOI 10.1016/j.jaci.2009.02.011; Lincoln MR, 2009, P NATL ACAD SCI USA, V106, P7542, DOI 10.1073/pnas.0812664106; Lincoln MR, 2005, NAT GENET, V37, P1108, DOI 10.1038/ng1647; Liu YW, 2006, NAT MED, V12, P518, DOI 10.1038/nm1402; Lowe CE, 2007, NAT GENET, V39, P1074, DOI 10.1038/ng2102; Luth S, 2008, J CLIN INVEST, V118, P3403, DOI 10.1172/JCI32132; Lundmark F, 2007, NAT GENET, V39, P1108, DOI 10.1038/ng2106; Maier LM, 2009, J IMMUNOL, V182, P1541, DOI 10.4049/jimmunol.182.3.1541; Mana P, 2004, INT IMMUNOL, V16, P489, DOI 10.1093/intimm/dxh049; Manavella PA, 2007, BIOCHEM BIOPH RES CO, V360, P621, DOI 10.1016/j.bbrc.2007.06.088; Manichaikul A, 2006, GENETICS, V174, P481, DOI 10.1534/genetics.106.061549; MARTA M, 2009, GENES IMMUN; Martino G, 2002, LANCET NEUROL, V1, P499, DOI 10.1016/S1474-4422(02)00223-5; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; MUMFORD CJ, 1994, NEUROLOGY, V44, P11, DOI 10.1212/WNL.44.1.11; Naor D, 2007, ANN NY ACAD SCI, V1110, P233, DOI 10.1196/annals.1423.025; Nithiyananthan R, 2002, THYROID, V12, P3, DOI 10.1089/105072502753451896; OCKINGER J, 2009, GENES IMMUN; Ockinger J, 2006, GENETICS, V173, P1539, DOI 10.1534/genetics.106.057406; Paleolog EM, 1996, BRIT J RHEUMATOL, V35, P917; Papiernik M, 1998, INT IMMUNOL, V10, P371, DOI 10.1093/intimm/10.4.371; Parkinson H, 2007, NUCLEIC ACIDS RES, V35, pD747, DOI 10.1093/nar/gkl995; Postigo AA, 1999, P NATL ACAD SCI USA, V96, P6683, DOI 10.1073/pnas.96.12.6683; Postigo AA, 2000, P NATL ACAD SCI USA, V97, P6391, DOI 10.1073/pnas.97.12.6391; Rubio JP, 2008, GENES IMMUN, V9, P624, DOI 10.1038/gene.2008.59; Sadovnick AD, 1996, LANCET, V347, P1728, DOI 10.1016/S0140-6736(96)90807-7; Sawcer S, 1996, NAT GENET, V13, P464, DOI 10.1038/ng0896-464; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Stefferl A, 2000, J IMMUNOL, V165, P2859, DOI 10.4049/jimmunol.165.5.2859; Storch MK, 1998, BRAIN PATHOL, V8, P681, DOI 10.1111/j.1750-3639.1998.tb00194.x; Teuscher C, 2006, GENETICS, V172, P1147, DOI 10.1534/genetics.105.049049; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Vijayakrishnan L, 2004, IMMUNITY, V20, P563, DOI 10.1016/S1074-7613(04)00110-4; Visscher PM, 1996, GENETICS, V143, P1013; von Budingen HC, 2004, EUR J IMMUNOL, V34, P2072, DOI 10.1002/eji.200425050; Wakeland E, 1997, IMMUNOL TODAY, V18, P472, DOI 10.1016/S0167-5699(97)01126-2; Weissert R, 1998, J CLIN INVEST, V102, P1265, DOI 10.1172/JCI3022; Wenz HM, 1998, GENOME RES, V8, P69, DOI 10.1101/gr.8.1.69; WILLIAMS TM, 1991, SCIENCE, V254, P1791, DOI 10.1126/science.1840704; Yamanouchi J, 2007, NAT GENET, V39, P329, DOI 10.1038/ng1958; Yasui DH, 1998, J IMMUNOL, V160, P4433; Zeiser R, 2008, CELL CYCLE, V7, P458, DOI 10.4161/cc.7.4.5454; Zhang Z, 2006, NEUROSCIENCE, V141, P637, DOI 10.1016/j.neuroscience.2006.04.027; Zhu J, 2003, SCIENCE, V301, P836, DOI 10.1126/science.1085792	88	18	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12716	10.1371/journal.pone.0012716	http://dx.doi.org/10.1371/journal.pone.0012716			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856809	Green Published, gold, Green Submitted			2022-12-27	WOS:000281815800012
J	Friis, C; Wassenaar, TM; Javed, MA; Snipen, L; Lagesen, K; Hallin, PF; Newell, DG; Toszeghy, M; Ridley, A; Manning, G; Ussery, DW				Friis, Carsten; Wassenaar, Trudy M.; Javed, Muhammad A.; Snipen, Lars; Lagesen, Karin; Hallin, Peter F.; Newell, Diane G.; Toszeghy, Monique; Ridley, Anne; Manning, Georgina; Ussery, David W.			Genomic Characterization of Campylobacter jejuni Strain M1	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISM; CLINICAL ISOLATE; SEQUENCE; PROTEIN; IDENTIFICATION; COLONIZATION; POULTRY; FIBRONECTIN; INFECTION; CHICKEN	Campylobacter jejuni strain M1 (laboratory designation 99/308) is a rarely documented case of direct transmission of C. jejuni from chicken to a person, resulting in enteritis. We have sequenced the genome of C. jejuni strain M1, and compared this to 12 other C. jejuni sequenced genomes currently publicly available. Compared to these, M1 is closest to strain 81116. Based on the 13 genome sequences, we have identified the C. jejuni pan-genome, as well as the core genome, the auxiliary genes, and genes unique between strains M1 and 81116. The pan-genome contains 2,427 gene families, whilst the core genome comprised 1,295 gene families, or about two-thirds of the gene content of the average of the sequenced C. jejuni genomes. Various comparison and visualization tools were applied to the 13 C. jejuni genome sequences, including a species pan- and core genome plot, a BLAST Matrix and a BLAST Atlas. Trees based on 16S rRNA sequences and on the total gene families in each genome are presented. The findings are discussed in the background of the proven virulence potential of M1.	[Friis, Carsten; Snipen, Lars; Lagesen, Karin; Hallin, Peter F.; Ussery, David W.] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Wassenaar, Trudy M.] Mol Microbiol & Genom Consultants, Zotzenheim, Germany; [Javed, Muhammad A.; Manning, Georgina] Nottingham Trent Univ, Sch Sci & Technol, Nottingham, England; [Snipen, Lars] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway; [Lagesen, Karin] Oslo Univ Hosp, Inst Med Microbiol, Oslo, Norway; [Lagesen, Karin] Univ Oslo, Dept Informat, N-0316 Oslo, Norway; [Newell, Diane G.; Toszeghy, Monique; Ridley, Anne] Vet Labs Agencies, Addlestone, Surrey, England; [Newell, Diane G.] Food Borne Zoonoses Consultancy, Andover, England	Technical University of Denmark; Nottingham Trent University; Norwegian University of Life Sciences; University of Oslo; University of Oslo; Veterinary Laboratories Agency	Friis, C (corresponding author), Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark.	carsten@cbs.dtu.dk	Ussery, David/J-2026-2019; Ridley, Anne M/E-2294-2011; Ridley, Anne/AAH-5205-2019	Ussery, David/0000-0003-3632-5512; Wassenaar, Trudy/0000-0002-7024-1139; Manning, Georgina/0000-0003-2198-0880; Lagesen, Karin/0000-0003-1329-9032	Danish Center for Scientific Computing (DCSC); Danish Natural Science Research Council [26-06-0349]; Defra, Great Britain; The Technical University of Denmark; Molecular Microbiology and Genomics Consultants MMGC	Danish Center for Scientific Computing (DCSC); Danish Natural Science Research Council(Danish Natural Science Research Council); Defra, Great Britain(Department for Environment, Food & Rural Affairs (DEFRA)); The Technical University of Denmark; Molecular Microbiology and Genomics Consultants MMGC	Danish Center for Scientific Computing (DCSC) http://www.dcsc.dk/; Danish Natural Science Research Council (FNU grant 26-06-0349) http://en.fi.dk/councils-commissions/the-danish-council-for-independent-research; Defra, Great Britain, funded the work leading to the isolation and characterization of C. jejuni 99/308 http://www.defra.gov.uk/. Dr. Wassenaar's salary was co-financed between The Technical University of Denmark and by Molecular Microbiology and Genomics Consultants MMGC (http://www.mmgc.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuOun M, 2005, INFECT IMMUN, V73, P3053, DOI 10.1128/IAI.73.5.3053-3062.2005; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashgar SSA, 2007, J BACTERIOL, V189, P1856, DOI 10.1128/JB.01427-06; Ayling RD, 1996, RES VET SCI, V60, P168, DOI 10.1016/S0034-5288(96)90013-2; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Barnes HA, 2007, MICROB PATHOGENESIS, V43, P198, DOI 10.1016/j.micpath.2007.05.007; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Batzoglou S, 2002, GENOME RES, V12, P177, DOI 10.1101/gr.208902; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Binnewies TT, 2005, MICROBIOL-SGM, V151, P1, DOI 10.1099/mic.0.27760-0; BLACK RE, 1988, J INFECT DIS, V157, P472, DOI 10.1093/infdis/157.3.472; Carrillo CD, 2004, J BIOL CHEM, V279, P20327, DOI 10.1074/jbc.M401134200; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; CHRISTENSEN JE, 2009, MOL MICROBIOL; Dingle KE, 2005, J CLIN MICROBIOL, V43, P340, DOI 10.1128/JCM.43.1.340-347.2005; Duim B, 1999, APPL ENVIRON MICROB, V65, P2369; Fearnley C, 2008, J MED MICROBIOL, V57, P570, DOI 10.1099/jmm.0.47803-0; Flanagan RC, 2009, INFECT IMMUN, V77, P2399, DOI 10.1128/IAI.01266-08; Fouts DE, 2005, PLOS BIOL, V3, P72, DOI 10.1371/journal.pbio.0030015; FRIIS C, 2009, SUPPLEMENTARY SECTIO; Frost JA, 1998, J CLIN MICROBIOL, V36, P335, DOI 10.1128/JCM.36.2.335-339.1998; Gaynor EC, 2004, J BACTERIOL, V186, P503, DOI 10.1128/JB.186.2.503-517.2004; Gibson J, 1997, J MED MICROBIOL, V46, P157, DOI 10.1099/00222615-46-2-157; Hallin PF, 2008, MOL BIOSYST, V4, P363, DOI 10.1039/b717118h; *HLTH PROT AG, CELL LIN WER OBT EUR; Hofreuter D, 2008, CELL HOST MICROBE, V4, P425, DOI 10.1016/j.chom.2008.10.002; HUMPHREY T, 1995, INT J FOOD MICROBIOL, V26, P295, DOI 10.1016/0168-1605(94)00135-S; Jacobs-Reitsma W., 2000, CAMPYLOBACTER, P467; Jensen LJ, 1999, RES MICROBIOL, V150, P773, DOI 10.1016/S0923-2508(99)00116-3; Jin SM, 2001, MOL MICROBIOL, V39, P1225, DOI 10.1046/j.1365-2958.2001.02294.x; Jorgensen F, 2002, INT J FOOD MICROBIOL, V76, P151, DOI 10.1016/S0168-1605(02)00027-2; KERVELLA M, 1993, INFECT IMMUN, V61, P3440, DOI 10.1128/IAI.61.8.3440-3448.1993; Koga M, 2005, NEUROLOGY, V64, P1605, DOI 10.1212/01.WNL.0000160399.08456.7C; Konkel ME, 1997, MOL MICROBIOL, V24, P953, DOI 10.1046/j.1365-2958.1997.4031771.x; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lan RT, 2000, TRENDS MICROBIOL, V8, P396, DOI 10.1016/S0966-842X(00)01791-1; Larsen TS, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-21; Lefebure T, 2009, GENOME RES, V19, P1224, DOI 10.1101/gr.089250.108; Little CL, 2008, INT J ENVIRON HEAL R, V18, P403, DOI 10.1080/09603120802100220; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; Manning G, 2001, APPL ENVIRON MICROB, V67, P1185, DOI 10.1128/AEM.67.3.1185-1189.2001; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; Medini D, 2008, NAT REV MICROBIOL, V6, P419, DOI 10.1038/nrmicro1901; Miller WG, 2006, MICROBIOL-SGM, V152, P245, DOI 10.1099/mic.0.28348-0; Miller WG, 2005, MICROBIOL-SGM, V151, P337, DOI 10.1099/mic.0.27327-0; Miller WG, 2008, FOODBORNE PATHOG DIS, V5, P371, DOI 10.1089/fpd.2008.0101; Monteville MR, 2003, MICROBIOL-SGM, V149, P153, DOI 10.1099/mic.0.25820-0; Moser I, 1997, FEMS MICROBIOL LETT, V157, P233, DOI 10.1016/S0378-1097(97)00480-1; Nauta M, 2009, INT J FOOD MICROBIOL, V129, P107, DOI 10.1016/j.ijfoodmicro.2008.12.001; Newell D. G., 2001, Society for Applied Microbiology Symposium Series, p57S; Newell DG, 2001, APPL ENVIRON MICROB, V67, P2636, DOI 10.1128/AEM.67.6.2636-2640.2001; Nielsen P, 2005, BIOINFORMATICS, V21, P4322, DOI 10.1093/bioinformatics/bti701; PALMER SR, 1983, LANCET, V1, P287, DOI 10.1016/S0140-6736(83)91698-7; Parker CT, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-50; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Pearson BM, 2007, J BACTERIOL, V189, P8402, DOI 10.1128/JB.01404-07; Pedersen AG, 2000, J MOL BIOL, V299, P907, DOI 10.1006/jmbi.2000.3787; Poly F, 2008, INFECT IMMUN, V76, P5655, DOI 10.1128/IAI.00780-08; Poly F, 2007, INFECT IMMUN, V75, P3425, DOI 10.1128/IAI.00050-07; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Raphael BH, 2005, CAMPYLOBACTER: MOLECULAR AND CELLULAR BIOLOGY, P397; Raskin DM, 2006, CELL, V124, P703, DOI 10.1016/j.cell.2006.02.002; RUSSELL RG, 1989, INFECT IMMUN, V57, P1438, DOI 10.1128/IAI.57.5.1438-1444.1989; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Sheppard SK, 2009, INT J FOOD MICROBIOL, V134, P96, DOI 10.1016/j.ijfoodmicro.2009.02.010; SIMONSEN B, 1971, METHODS DETERMINING, P27; Sinden RR, 1999, ANN NY ACAD SCI, V870, P173, DOI 10.1111/j.1749-6632.1999.tb08878.x; SKIRROW MB, 1977, BRIT MED J, V2, P9, DOI 10.1136/bmj.2.6078.9; Skovgaard M, 2001, TRENDS GENET, V17, P425, DOI 10.1016/S0168-9525(01)02372-1; Snipen L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-385; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Ussery DW, 2009, COMPUTING COMP MICRO; Wagenaar JA, 2006, REV SCI TECH OIE, V25, P581, DOI 10.20506/rst.25.2.1680; Wassenaar TM, 1997, CLIN MICROBIOL REV, V10, P466, DOI 10.1128/CMR.10.3.466; WASSENAAR TM, 2009, LETT APPL MICROBIOL; Wingstrand A, 2006, EMERG INFECT DIS, V12, P280; Ziprin RL, 1999, AVIAN DIS, V43, P586, DOI 10.2307/1592660	79	70	72	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12253	10.1371/journal.pone.0012253	http://dx.doi.org/10.1371/journal.pone.0012253			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865039	Green Published, gold			2022-12-27	WOS:000281292100001
J	Mazuet, C; Dano, J; Popoff, MR; Creminon, C; Volland, H				Mazuet, Christelle; Dano, Julie; Popoff, Michel R.; Creminon, Christophe; Volland, Herve			Characterization of Botulinum Neurotoxin Type A Neutralizing Monoclonal Antibodies and Influence of Their Half-Lives on Therapeutic Activity	PLOS ONE			English	Article							BINDING DOMAIN; FRAGMENTS; IGG; PHARMACOKINETICS; F(AB')(2); GENE	Botulinum toxins, i.e. BoNT/A to/G, include the most toxic substances known. Since botulism is a potentially fatal neuroparalytic disease with possible use as a biowarfare weapon (Centers for Disease Control and Prevention category A bioterrorism agent), intensive efforts are being made to develop vaccines or neutralizing antibodies. The use of active fragments from non-human immunoglobulins (F(ab')(2), Fab', scFv), chemically modified or not, may avoid side effects, but also largely modify the in vivo half-life and effectiveness of these reagents. We evaluated the neutralizing activity of several monoclonal anti-BoNT/A antibodies (mAbs). F(ab')(2) fragments, native or treated with polyethyleneglycol (PEG), were prepared from selected mAbs to determine their half-life and neutralizing activity as compared with the initial mAbs. We compared the protective efficiency of the different biochemical forms of anti-toxin mAbs providing the same neutralizing activity. Among fourteen tested mAbs, twelve exhibited neutralizing activity. Fragments from two of the best mAbs (TA12 and TA17), recognizing different epitopes, were produced. These two mAbs neutralized the A1 subtype of the toxin more efficiently than the A2 or A3 subtypes. Since mAb TA12 and its fragments both exhibited the greatest neutralizing activity, they were further evaluated in the therapeutic experiments. These showed that, in a mouse model, a 2- to 4-h interval between toxin and antitoxin injection allows the treatment to remain effective, but also suggested an absence of correlation between the half-life of the antitoxins and the length of time before treatment after botulinum toxin A contamination. These experiments demonstrate that PEG treatment has a strong impact on the half-life of the fragments, without affecting the effectiveness of neutralization, which was maintained after preparation of the fragments. These reagents may be useful for rapid treatment after botulinum toxin A contamination.	[Mazuet, Christelle; Popoff, Michel R.] Inst Pasteur, Unite Bacteries Anaerobies & Toxines, Paris, France; [Dano, Julie; Creminon, Christophe; Volland, Herve] CEA, iBiTecS, Serv Pharmacol & Immunoanal, Gif Sur Yvette, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; CEA; UDICE-French Research Universities; Universite Paris Saclay	Mazuet, C (corresponding author), Inst Pasteur, Unite Bacteries Anaerobies & Toxines, Paris, France.	herve.volland@cea.fr	Popoff, Michel/O-7719-2016; Mazuet, Christelle/O-7731-2016	Popoff, Michel/0000-0001-9305-8989; Mazuet, Christelle/0000-0001-7619-9050	Institut de Aerospatiale du service de sante des armees (IMASSA)	Institut de Aerospatiale du service de sante des armees (IMASSA)	This work was supported by grants from Institut de Aerospatiale du service de sante des armees (IMASSA) (contrat de recherche #2 BIS IMASSA/TOXBOT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amersdorfer P, 1997, INFECT IMMUN, V65, P3743, DOI 10.1128/IAI.65.9.3743-3752.1997; Arndt JW, 2006, J MOL BIOL, V362, P733, DOI 10.1016/j.jmb.2006.07.040; ARNON SS, 1993, BOTULINUM AND TETANUS NEUROTOXINS, P477; Batra SK, 2002, CURR OPIN BIOTECH, V13, P603, DOI 10.1016/S0958-1669(02)00352-X; BLACK RE, 1980, AM J MED, V69, P567, DOI 10.1016/0002-9343(80)90469-6; Broussard LA, 2001, MOL DIAGN, V6, P323, DOI 10.1054/modi.2001.29155; Carter AT, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-115; Chapman AP, 1999, NAT BIOTECHNOL, V17, P780, DOI 10.1038/11717; Chapman AP, 2002, ADV DRUG DELIVER REV, V54, P531, DOI 10.1016/S0169-409X(02)00026-1; CLAYTON MA, 1995, INFECT IMMUN, V63, P2738, DOI 10.1128/IAI.63.7.2738-2742.1995; Dover N, 2009, J CLIN MICROBIOL, V47, P2349, DOI 10.1128/JCM.00799-09; FRANZ DR, 1993, BOTULINUM AND TETANUS NEUROTOXINS, P473; HATHEWAY CL, 1994, IMMUNOGENICITY NEURO, P93; Hill KK, 2007, J BACTERIOL, V189, P818, DOI 10.1128/JB.01180-06; Jones RGA, 2006, TOXICON, V48, P246, DOI 10.1016/j.toxicon.2006.05.007; KNAUF MJ, 1988, J BIOL CHEM, V263, P15064; Koumenis IL, 2000, INT J PHARM, V198, P83, DOI 10.1016/S0378-5173(99)00458-5; LAMOYI E, 1983, J IMMUNOL METHODS, V56, P235, DOI 10.1016/0022-1759(83)90415-5; Leong SR, 2001, CYTOKINE, V16, P106, DOI 10.1006/cyto.2001.0936; Liu W, 2003, P NATL ACAD SCI USA, V100, P13621, DOI 10.1073/pnas.2233819100; Lobo ED, 2004, J PHARM SCI-US, V93, P2645, DOI 10.1002/jps.20178; Mayers CN, 2003, IMMUNOPHARM IMMUNOT, V25, P397, DOI 10.1081/IPH-120024507; Nowakowski A, 2002, P NATL ACAD SCI USA, V99, P11346, DOI 10.1073/pnas.172229899; Pless DD, 2001, INFECT IMMUN, V69, P570, DOI 10.1128/IAI.69.1.570-574.2001; Sheridan RE, 2001, TOXICON, V39, P651, DOI 10.1016/S0041-0101(00)00189-6; Shone CC, 1995, CURR TOP MICROBIOL, V195, P143; Smith LA, 1998, TOXICON, V36, P1539, DOI 10.1016/S0041-0101(98)00146-9; Smith TJ, 2005, INFECT IMMUN, V73, P5450, DOI 10.1128/IAI.73.9.5450-5457.2005; SMITH TW, 1979, CLIN EXP IMMUNOL, V36, P384; Tavallaie M, 2004, FEBS LETT, V572, P299, DOI 10.1016/j.febslet.2004.06.094; Torii Y, 2002, VACCINE, V20, P2556, DOI 10.1016/S0264-410X(02)00157-3; Volland H, 2008, J IMMUNOL METHODS, V330, P120, DOI 10.1016/j.jim.2007.11.006; Wheeler MW, 1923, J IMMUNOL, V8, P501; Wu HC, 2001, APPL ENVIRON MICROB, V67, P3201, DOI 10.1128/AEM.67.7.3201-3207.2001	34	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12416	10.1371/journal.pone.0012416	http://dx.doi.org/10.1371/journal.pone.0012416			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865035	gold, Green Submitted, Green Published			2022-12-27	WOS:000281292100016
J	Verhoeven, KJF; Casella, G; McIntyre, LM				Verhoeven, Koen J. F.; Casella, George; McIntyre, Lauren M.			Epistasis: Obstacle or Advantage for Mapping Complex Traits?	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LINKAGE DISEQUILIBRIUM; GENETIC ARCHITECTURE; MULTIPLE LOCI; MODEL SELECTION; HIGH-RESOLUTION; SNP DISCOVERY; IDENTIFICATION; RECOMBINATION; MARKERS	Identification of genetic loci in complex traits has focused largely on one-dimensional genome scans to search for associations between single markers and the phenotype. There is mounting evidence that locus interactions, or epistasis, are a crucial component of the genetic architecture of biologically relevant traits. However, epistasis is often viewed as a nuisance factor that reduces power for locus detection. Counter to expectations, recent work shows that fitting full models, instead of testing marker main effect and interaction components separately, in exhaustive multi-locus genome scans can have higher power to detect loci when epistasis is present than single-locus scans, and improvement that comes despite a much larger multiple testing alpha-adjustment in such searches. We demonstrate, both theoretically and via simulation, that the expected power to detect loci when fitting full models is often larger when these loci act epistatically than when they act additively. Additionally, we show that the power for single locus detection may be improved in cases of epistasis compared to the additive model. Our exploration of a two step model selection procedure shows that identifying the true model is difficult. However, this difficulty is certainly not exacerbated by the presence of epistasis, on the contrary, in some cases the presence of epistasis can aid in model selection. The impact of allele frequencies on both power and model selection is dramatic.	[Verhoeven, Koen J. F.] Netherlands Inst Ecol NIOO KNAW, Dept Terr Ecol, Heteren, Netherlands; [Casella, George; McIntyre, Lauren M.] Univ Florida, Dept Stat, Gainesville, FL 32611 USA; [McIntyre, Lauren M.] Univ Florida, Genet Inst, Dept Mol Genet & Microbiol, Gainesville, FL USA	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); State University System of Florida; University of Florida; State University System of Florida; University of Florida	Verhoeven, KJF (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Terr Ecol, Heteren, Netherlands.	mcintyre@ufl.edu	McIntyre, Lauren/J-8414-2012; Verhoeven, Koen JF/C-9920-2010	McIntyre, Lauren/0000-0002-0077-3359; Verhoeven, Koen JF/0000-0003-3002-4102	National Science Foundation Division of Biological Sciences [0821954]; National Institutes of Health (NIH) [1R01GM077618, NIH 1R01GM081704]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077618, R01GM081704] Funding Source: NIH RePORTER	National Science Foundation Division of Biological Sciences; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors gratefully acknowledge support from National Science Foundation Division of Biological Sciences 0821954, National Institutes of Health (NIH) 1R01GM077618 and NIH 1R01GM081704. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; Brem RB, 2005, NATURE, V436, P701, DOI 10.1038/nature03865; Broman KW, 2002, J R STAT SOC B, V64, P641, DOI 10.1111/1467-9868.00354; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carlborg O, 2006, NAT GENET, V38, P418, DOI 10.1038/ng1761; Carlborg O, 2005, MAMM GENOME, V16, P481, DOI 10.1007/s00335-004-2425-4; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Carlborg O, 2003, GENOME RES, V13, P413, DOI 10.1101/gr.528003; Coffman CJ, 2005, GENETICS, V170, P1281, DOI 10.1534/genetics.104.033910; Cohen J., 1990, STAT POWER ANAL BEHA; Doerge RW, 2002, NAT REV GENET, V3, P43, DOI 10.1038/nrg703; Duran C, 2009, NUCLEIC ACIDS RES, V37, pD951, DOI 10.1093/nar/gkn650; EAVES LJ, 1994, HEREDITY, V72, P175, DOI 10.1038/hdy.1994.25; Ehrenreich IM, 2007, GENETICS, V176, P1223, DOI 10.1534/genetics.107.071928; Elena SF, 1997, NATURE, V390, P395, DOI 10.1038/37108; Evans DM, 2006, PLOS GENET, V2, P1424, DOI 10.1371/journal.pgen.0020157; Ewens WJ, 2001, THEOR POPUL BIOL, V60, P135, DOI 10.1006/tpbi.2001.1547; Gurganus MC, 1999, GENETICS, V152, P1585; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; HARTL DL, 2004, GENETICS ANAL GENES; Holland JB, 1997, CROP SCI, V37, P1306, DOI 10.2135/cropsci1997.0011183X003700040047x; Hudson RR, 1990, OXFORD SURVEYS EVOLU, V1, P1; Jannink JL, 2001, TRENDS PLANT SCI, V6, P337, DOI 10.1016/S1360-1385(01)02017-9; Jannink JL, 2001, GENETICS, V157, P445; JANSEN RC, 1994, GENETICS, V136, P1447; JANSEN RC, 1993, GENETICS, V135, P205; KAPLAN N, 1985, THEOR POPUL BIOL, V28, P382, DOI 10.1016/0040-5809(85)90036-X; Kim S, 2007, NAT GENET, V39, P1151, DOI 10.1038/ng2115; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; LANDER ES, 1989, GENETICS, V121, P185; Lehmann E.L., 2006, TESTING STAT HYPOTHE, V3rd ed; Li ZK, 1997, GENETICS, V145, P453; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; MARTINEZ O, 1992, THEOR APPL GENET, V85, P480, DOI 10.1007/BF00222330; Moore JH, 2006, J THEOR BIOL, V241, P252, DOI 10.1016/j.jtbi.2005.11.036; Neter J., 1996, APPL LINEAR STAT MOD; Nordborg M, 2002, TRENDS GENET, V18, P83, DOI 10.1016/S0168-9525(02)02557-X; Nordborg M, 2008, NATURE, V456, P720, DOI 10.1038/nature07629; Ober C, 2001, AM J HUM GENET, V69, P1068, DOI 10.1086/324025; Park M, 2007, COMPUT STAT DATA AN, V51, P3145, DOI 10.1016/j.csda.2006.09.002; Peripato AC, 2002, GENETICS, V162, P1341; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Phillips PC, 1998, GENETICS, V149, P1167; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Remold SK, 2004, NAT GENET, V36, P423, DOI 10.1038/ng1324; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Routman EJ, 1997, EVOLUTION, V51, P1654, DOI 10.1111/j.1558-5646.1997.tb01488.x; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schulze TG, 2002, AM J MED GENET, V114, P1, DOI 10.1002/ajmg.10042; Shao HF, 2008, P NATL ACAD SCI USA, V105, P19910, DOI 10.1073/pnas.0810388105; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Simonsen KL, 1997, THEOR POPUL BIOL, V52, P43, DOI 10.1006/tpbi.1997.1307; Strahs A, 2000, AM J HUM GENET, V67, P316; Templeton A. R., 2000, EPISTASIS EVOLUTIONA, P41; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; Verhoeven KJF, 2005, MOL BIOL EVOL, V22, P735, DOI 10.1093/molbev/msi058; Wade MJ, 2001, GENETICA, V112, P59, DOI 10.1023/A:1013316611768; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Xiao J, 1996, THEOR APPL GENET, V92, P230, DOI 10.1007/BF00223380; XU SH, 1995, GENETICS, V141, P1189; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; ZENG ZB, 1994, GENETICS, V136, P1457; Zheng MX, 2007, AM J HUM GENET, V80, P112, DOI 10.1086/510685	65	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12264	10.1371/journal.pone.0012264	http://dx.doi.org/10.1371/journal.pone.0012264			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865037	Green Submitted, Green Published, gold			2022-12-27	WOS:000281292100003
J	Weingartner, A; Drobot, B; Herrmann, A; Sanchez-Canete, MP; Gamarro, F; Castanys, S; Pomorski, TG				Weingaertner, Adrien; Drobot, Bjoern; Herrmann, Andreas; Sanchez-Canete, Maria P.; Gamarro, Francisco; Castanys, Santiago; Pomorski, Thomas Gunther			Disruption of the Lipid-Transporting LdMT-LdRos3 Complex in Leishmania donovani Affects Membrane Lipid Asymmetry but Not Host Cell Invasion	PLOS ONE			English	Article							P-TYPE ATPASE; PLASMA-MEMBRANE; MILTEFOSINE TRANSPORTER; PHOSPHOLIPID TRANSLOCATION; APOPTOTIC MIMICRY; DRUG-RESISTANCE; PROTEIN; YEAST; EXPRESSION; PHOSPHATIDYLETHANOLAMINE	Maintenance and regulation of the asymmetric lipid distribution across eukaryotic plasma membranes is governed by the concerted action of specific membrane proteins controlling lipid movement across the bilayer. Here, we show that the miltefosine transporter (LdMT), a member of the P4-ATPase subfamily in Leishmania donovani, and the Cdc50-like protein LdRos3 form a stable complex that plays an essential role in maintaining phospholipid asymmetry in the parasite plasma membrane. Loss of either LdMT or LdRos3 abolishes ATP-dependent transport of NBD-labelled phosphatidylethanolamine (PE) and phosphatidylcholine from the outer to the inner plasma membrane leaflet and results in an increased cell surface exposure of endogenous PE. We also find that promastigotes of L. donovani lack any detectable amount of phosphatidylserine (PS) but retain their infectivity in THP-1-derived macrophages. Likewise, infectivity was unchanged for parasites without LdMT-LdRos3 complexes. We conclude that exposure of PS and PE to the exoplasmic leaflet is not crucial for the infectivity of L. donovani promastigotes.	[Weingaertner, Adrien; Drobot, Bjoern; Herrmann, Andreas] Humboldt Univ, Inst Biol & Biophys, Berlin, Germany; [Sanchez-Canete, Maria P.; Gamarro, Francisco; Castanys, Santiago] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [Pomorski, Thomas Gunther] Univ Copenhagen, Dept Plant Biol & Biotechnol, Copenhagen, Denmark	Humboldt University of Berlin; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); University of Copenhagen	Weingartner, A (corresponding author), Humboldt Univ, Inst Biol & Biophys, Berlin, Germany.	tgp@life.ku.dk	Castanys, Santiago/Y-3981-2019; Pomorski, Thomas Günther/G-4804-2014; Drobot, Björn/AAZ-3694-2021	Castanys, Santiago/0000-0002-3460-844X; Pomorski, Thomas Günther/0000-0002-4889-0829; Drobot, Björn/0000-0003-1245-0466; Sanchez-Canete, Maria P./0000-0002-9418-8942; Gamarro, Francisco/0000-0003-1347-3440	German Research Foundation; ISCIII-Red de Investigacion Cooperativa en Enfermedades Tropicales (RICET) [RD06/0021/0002]; Plan Andaluz de Investigacion [Cod. BIO130]; Marie Curie Flippase Network; FAZIT; Carlsberg Foundation; Deutsche Forschungsgemeinschaft [PO748/9];  [SAF2005-01639]	German Research Foundation(German Research Foundation (DFG)); ISCIII-Red de Investigacion Cooperativa en Enfermedades Tropicales (RICET)(Instituto de Salud Carlos III); Plan Andaluz de Investigacion; Marie Curie Flippase Network; FAZIT; Carlsberg Foundation(Carlsberg Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); 	This work was supported by Research Training Group 1121 of the German Research Foundation (AW, AH and TGP), the Spanish grants SAF2005-01639 (SC), the ISCIII-Red de Investigacion Cooperativa en Enfermedades Tropicales (RICET) RD06/0021/0002 (FG) and by the Plan Andaluz de Investigacion (Cod. BIO130), the Marie Curie Flippase Network (AW, AH and FG), FAZIT (AW), the Carlsberg Foundation (TGP) and the Deutsche Forschungsgemeinschaft (TGP, grant PO748/9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTTILA HSI, 1992, CLIN EXP IMMUNOL, V89, P509; Araujo-Santos JM, 2003, BIOCHEM BIOPH RES CO, V306, P250, DOI 10.1016/S0006-291X(03)00947-1; Balanco JMD, 2001, CURR BIOL, V11, P1870, DOI 10.1016/S0960-9822(01)00563-2; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRAJTBURG J, 1990, ANTIMICROB AGENTS CH, V34, P183, DOI 10.1128/AAC.34.2.183; Castanys-Munoz E, 2008, ANTIMICROB AGENTS CH, V52, P3573, DOI 10.1128/AAC.00587-08; Castanys-Munoz E, 2007, MOL MICROBIOL, V64, P1141, DOI 10.1111/j.1365-2958.2007.05653.x; COLEMAN JA, 2009, J BIOL CHEM; Dasgupta B, 2003, SCAND J IMMUNOL, V57, P366, DOI 10.1046/j.1365-3083.2003.01227.x; DEVAUX PF, 1991, BIOCHEMISTRY-US, V30, P1163, DOI 10.1021/bi00219a001; Emoto K, 1996, P NATL ACAD SCI USA, V93, P12867, DOI 10.1073/pnas.93.23.12867; Fadeel B, 2009, CRIT REV BIOCHEM MOL, V44, P264, DOI 10.1080/10409230903193307; Furuta N, 2007, MOL BIOL CELL, V18, P295, DOI 10.1091/mbc.E06-05-0461; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Guenther UP, 2009, J MOL MED, V87, P31, DOI 10.1007/s00109-008-0402-7; Iwamoto K, 2004, GENES CELLS, V9, P891, DOI 10.1111/j.1365-2443.2004.00782.x; Wanderley JLM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005733; Naderer T, 2004, CURR MOL MED, V4, P649, DOI 10.2174/1566524043360069; Naderer T, 2008, CELL MICROBIOL, V10, P301, DOI 10.1111/j.1462-5822.2007.01096.x; Parodi-Talice A, 2003, BBA-BIOMEMBRANES, V1612, P195, DOI 10.1016/S0005-2736(03)00131-7; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; Paulusma CC, 2008, HEPATOLOGY, V47, P268, DOI 10.1002/hep.21950; Perez-Victoria FJ, 2006, J BIOL CHEM, V281, P23766, DOI 10.1074/jbc.M605214200; Perez-Victoria FJ, 2006, DRUG RESIST UPDATE, V9, P26, DOI 10.1016/j.drup.2006.04.001; Perez-Victoria FJ, 2003, J BIOL CHEM, V278, P49965, DOI 10.1074/jbc.M308352200; Perez-Victoria FJ, 2003, ANTIMICROB AGENTS CH, V47, P2397, DOI 10.1128/AAC.47.8.2397-2403.2003; Pomorski T, 2004, J CELL SCI, V117, P805, DOI 10.1242/jcs.01055; Poulsen LR, 2008, PLANT CELL, V20, P658, DOI 10.1105/tpc.107.054767; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; Sanchez-Canete MP, 2009, ANTIMICROB AGENTS CH, V53, P1305, DOI 10.1128/AAC.01694-08; Saxena A, 2007, MOL BIOCHEM PARASIT, V152, P53, DOI 10.1016/j.molbiopara.2006.11.011; Seifert K, 2007, INT J ANTIMICROB AG, V30, P229, DOI 10.1016/j.ijantimicag.2007.05.007; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; Wanderley JLM, 2005, BRAZ J MED BIOL RES, V38, P807, DOI 10.1590/S0100-879X2005000600001; Wanderley JLM, 2006, J IMMUNOL, V176, P1834, DOI 10.4049/jimmunol.176.3.1834; Yeung T, 2009, J CELL BIOL, V185, P917, DOI 10.1083/jcb.200903020; Zhang K, 2007, EMBO J, V26, P1094, DOI 10.1038/sj.emboj.7601565; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P16586, DOI 10.1073/pnas.0904293106; Zufferey R, 2003, J BIOL CHEM, V278, P44708, DOI 10.1074/jbc.M308063200	39	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12443	10.1371/journal.pone.0012443	http://dx.doi.org/10.1371/journal.pone.0012443			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865154	gold, Green Published, Green Submitted			2022-12-27	WOS:000281292100031
J	Andereck, JW; King, JG; Hillyer, JF				Andereck, Jonathan W.; King, Jonas G.; Hillyer, Julian F.			Contraction of the Ventral Abdomen Potentiates Extracardiac Retrograde Hemolymph Propulsion in the Mosquito Hemocoel	PLOS ONE			English	Article							ACCESSORY PULSATILE ORGANS; HEARTBEAT REVERSAL; ACTIVE REGULATION; INSECT; CIRCULATION; MOVEMENTS; PRESSURE; MELANIZATION; PHAGOCYTOSIS; NEUROPEPTIDE	Background: Hemolymph circulation in mosquitoes is primarily controlled by the contractile action of a dorsal vessel that runs underneath the dorsal midline and is subdivided into a thoracic aorta and an abdominal heart. Wave-like peristaltic contractions of the heart alternate in propelling hemolymph in anterograde and retrograde directions, where it empties into the hemocoel at the terminal ends of the insect. During our analyses of hemolymph propulsion in Anopheles gambiae, we observed periodic ventral abdominal contractions and hypothesized that they promote extracardiac hemolymph circulation in the abdominal hemocoel. Methodology/Principal Findings: We devised methods to simultaneously analyze both heart and abdominal contractions, as well as to measure hemolymph flow in the abdominal hemocoel. Qualitative and quantitative analyses revealed that ventral abdominal contractions occur as series of bursts that propagate in the retrograde direction. Periods of ventral abdominal contraction begin only during periods of anterograde heart contraction and end immediately following a heartbeat directional reversal, suggesting that ventral abdominal contractions function to propel extracardiac hemolymph in the retrograde direction. To test this functional role, fluorescent microspheres were intrathoracically injected and their trajectory tracked throughout the hemocoel. Quantitative measurements of microsphere movement in extracardiac regions of the abdominal cavity showed that during periods of abdominal contractions hemolymph flows in dorsal and retrograde directions at a higher velocity and with greater acceleration than during periods of abdominal rest. Histochemical staining of the abdominal musculature then revealed that ventral abdominal contractions result from the contraction of intrasegmental lateral muscle fibers, intersegmental ventral muscle bands, and the ventral transverse muscles that form the ventral diaphragm. Conclusions/Significance: These data show that abdominal contractions potentiate extracardiac retrograde hemolymph propulsion in the abdominal hemocoel during periods of anterograde heart flow.	[Andereck, Jonathan W.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; Vanderbilt Univ, Inst Global Hlth, Nashville, TN USA	Vanderbilt University; Vanderbilt University	Andereck, JW (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA.	julian.hillyer@vanderbilt.edu		King, Jonas/0000-0003-2270-4212; Hillyer, Julian/0000-0002-3178-0201	National Science Foundation [IOS-0817644]; Vanderbilt University	National Science Foundation(National Science Foundation (NSF)); Vanderbilt University	This work was funded by National Science Foundation Grant IOS-0817644 to JFH and a fellowship from the Vanderbilt University Summer Research Program (VUSRP) to JWA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliota MT, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000666; Baton LA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-257; Dulcis D, 2005, J NEUROBIOL, V64, P259, DOI 10.1002/neu.20136; Dulcis D, 2005, J NEUROSCI, V25, P271, DOI 10.1523/JNEUROSCI.2906-04.2005; Dulcis D, 2001, J COMP PHYSIOL A, V187, P837, DOI 10.1007/s00359-001-0254-x; Duttlinger A, 2003, NEUROPEPTIDES, V37, P120, DOI 10.1016/S0143-4179(03)00023-4; Ejaz A, 2008, PEPTIDES, V29, P214, DOI 10.1016/j.peptides.2007.07.036; Gerould JH, 1933, BIOL BULL-US, V64, P424, DOI 10.2307/1537208; GILLETT JD, 1982, PROC R SOC SER B-BIO, V215, P127, DOI 10.1098/rspb.1982.0032; Glenn JD, 2010, J EXP BIOL, V213, P541, DOI 10.1242/jeb.035014; HEINRICH B, 1976, J EXP BIOL, V64, P561; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Hillyer JF, 2003, CELL TISSUE RES, V313, P117, DOI 10.1007/s00441-003-0744-y; Hillyer JF, 2003, J PARASITOL, V89, P62, DOI 10.1645/0022-3395(2003)089[0062:RPAMOB]2.0.CO;2; Hillyer JF, 2010, INVERTEBRATE IMMUNIT; Hillyer JF, 2007, INT J PARASITOL, V37, P673, DOI 10.1016/j.ijpara.2006.12.007; Ichikawa T, 2008, COMP BIOCHEM PHYS A, V150, P8, DOI 10.1016/j.cbpa.2008.02.012; Jones J. C., 1977, CIRCULATORY SYSTEM I; Klowden Marc J., 2007, P357; Koladich PM, 2002, J EXP BIOL, V205, P3123; Kuusik A, 2004, PHYSIOL ENTOMOL, V29, P152, DOI 10.1111/j.0307-6962.2004.00379.x; Kuusik A, 1996, EUR J ENTOMOL, V93, P23; NATION JL, 2008, INSECT PHYSL BIOCH, P339; Nichols R, 2006, PEPTIDES, V27, P1130, DOI 10.1016/j.peptides.2005.07.032; Pass G, 2000, ANNU REV ENTOMOL, V45, P495, DOI 10.1146/annurev.ento.45.1.495; PEDIGO LP, 2002, ENTOMOLOGY PEST MANA, P381; Slama K, 1999, ANN ENTOMOL SOC AM, V92, P916, DOI 10.1093/aesa/92.6.916; SLAMA K, 1979, J INSECT PHYSIOL, V25, P825, DOI 10.1016/0022-1910(79)90085-4; SLAMA K, 1984, J COMP PHYSIOL, V154, P635, DOI 10.1007/BF00684418; SLAMA K, 1976, ACTA ENTOMOL BOHEMOS, V73, P65; Slama K, 2001, J INSECT PHYSIOL, V47, P1321, DOI 10.1016/S0022-1910(01)00122-6; Slama Karel, 2008, Terrestrial Arthropod Reviews, V1, P39, DOI 10.1163/187498308X345433; Tartes U, 2002, COMP BIOCHEM PHYS A, V133, P611, DOI 10.1016/S1095-6433(02)00173-3; WASSERTHAL LT, 1980, J COMP PHYSIOL, V139, P145, DOI 10.1007/BF00691029; WASSERTHAL LT, 1976, EXPERIENTIA, V32, P577, DOI 10.1007/BF01990172; Wasserthal LT, 2007, J EXP BIOL, V210, P3707, DOI 10.1242/jeb.007864; Westneat MW, 2003, SCIENCE, V299, P558, DOI 10.1126/science.1078008	37	36	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12943	10.1371/journal.pone.0012943	http://dx.doi.org/10.1371/journal.pone.0012943			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886066	Green Published, gold, Green Submitted			2022-12-27	WOS:000282091100041
J	Drury, LJ; Wendt, MK; Dwinell, MB				Drury, Luke J.; Wendt, Michael K.; Dwinell, Michael B.			CXCL12 Chemokine Expression and Secretion Regulates Colorectal Carcinoma Cell Anoikis through Bim-Mediated Intrinsic Apoptosis	PLOS ONE			English	Article							MCL-1; ACTIVATION; RECEPTORS; SURVIVAL; CXCR4; BCL-2; BAK; RESISTANCE; RELEVANCE; MIGRATION	Background: Resistance to anoikis, apoptosis triggered by a loss of cellular adhesion to the underlying extracellular matrix, is a hallmark of metastatic cancer. Previously we have shown re-establishment of CXCL12 expression in colorectal carcinoma cells inhibits metastasis by enhancing anoikis sensitivity. The objective of these studies was to define the signaling mechanisms regulating CXCL12-mediated anoikis. Methodology/Principal Findings: Adhesion, examined by crystal violet staining, immunofluorescence microscopy, and immunoblot analysis indicated decreased focal adhesion signaling corresponding with loss of adhesion in cells constitutively simulated by CXCL12. Loss of adhesion was inhibited by pertussis toxin treatment, indicating CXCL12 regulating anoikis through G(alpha i)-protein coupled receptors. Non-adherent HCT116 and HT29 colorectal carcinoma cells expressing CXCL12 exhibited enhanced anoikis sensitivity by propidium iodide staining, caspase activity assays, and immunoblot compared to GFP control cells. CXCL12 producing carcinomas cultured on poly-HEMA displayed heightened Bim and loss of Mcl-1 and Bcl-2 preceding cytochrome c release, and caspase-9 activation. RNAi knockdown of Bim reversed anoikis sensitivity of CXCL12-expressing cells and fostered increased soft-agar foci formation and hepatic tumors in an orthotopic mouse model of metastasis. Conclusions/Significance: These data indicate CXCL12 provides a barrier to metastasis by increasing anoikis via activation of a Bim-mediated intrinsic apoptotic pathway. These results underscore the importance of retaining CXCL12 expression to sensitize colorectal carcinomas to anoikis and minimize tumor progression.	[Drury, Luke J.; Wendt, Michael K.; Dwinell, Michael B.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Drury, LJ (corresponding author), Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA.	mdwinell@mcw.edu		Wendt, Mike/0000-0002-3665-7413	Medical College of Wisconsin Cancer Center [NIDDK 062066]; Bobbie Nick Voss Charitable Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062066] Funding Source: NIH RePORTER	Medical College of Wisconsin Cancer Center; Bobbie Nick Voss Charitable Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Medical College of Wisconsin Cancer Center, NIDDK 062066 and the Bobbie Nick Voss Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backus HHJ, 2001, ANN ONCOL, V12, P779, DOI 10.1023/A:1011112227044; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Boisvert-Adamo K, 2009, MOL CANCER RES, V7, P549, DOI 10.1158/1541-7786.MCR-08-0358; Bouchard V, 2008, APOPTOSIS, V13, P531, DOI 10.1007/s10495-008-0192-y; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Cao YN, 2006, SURGERY, V140, P322, DOI 10.1016/j.surg.2006.05.006; Colamussi ML, 2001, J LEUKOCYTE BIOL, V69, P263; Duckworth CA, 2009, GASTROENTEROLOGY, V136, P943, DOI 10.1053/j.gastro.2008.11.036; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723; Grossmann J, 2002, APOPTOSIS, V7, P247, DOI 10.1023/A:1015312119693; Hartmann TN, 2008, J LEUKOCYTE BIOL, V84, P1130, DOI 10.1189/jlb.0208088; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; KOCHETKOVA M, 2009, CELL DEATH DIFFER; Krajewska M, 1996, CANCER RES, V56, P2422; Krajewski S, 1996, CANCER RES, V56, P2849; Laguri C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001110; Locati M, 1999, ANNU REV MED, V50, P425, DOI 10.1146/annurev.med.50.1.425; Marani M, 2004, ONCOGENE, V23, P2431, DOI 10.1038/sj.onc.1207364; Moyer RA, 2007, LAB INVEST, V87, P807, DOI 10.1038/labinvest.3700595; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; Shanmugathasan M, 2000, PATHOL INT, V50, P273, DOI 10.1046/j.1440-1827.2000.01047.x; Simpson CD, 2008, CANCER LETT, V272, P177, DOI 10.1016/j.canlet.2008.05.029; Sinicrope FA, 2008, CLIN CANCER RES, V14, P5810, DOI 10.1158/1078-0432.CCR-07-5202; Smith JM, 2005, AM J PHYSIOL-GASTR L, V288, pG316, DOI 10.1152/ajpgi.00208.2004; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Wendt MK, 2008, ONCOGENE, V27, P1461, DOI 10.1038/sj.onc.1210751; Wendt MK, 2006, ONCOGENE, V25, P4986, DOI 10.1038/sj.onc.1209505; Wendt MK, 2008, GASTROENTEROLOGY, V135, P508, DOI 10.1053/j.gastro.2008.05.033; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Woods NT, 2007, CANCER RES, V67, P10744, DOI 10.1158/0008-5472.CAN-07-3148; Zabel BA, 2009, J IMMUNOL, V183, P3204, DOI 10.4049/jimmunol.0900269; Zimmerman NP, 2008, INFLAMM BOWEL DIS, V14, P1000, DOI 10.1002/ibd.20480; Zlotnik A, 2006, INT J CANCER, V119, P2026, DOI 10.1002/ijc.22024	37	36	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12895	10.1371/journal.pone.0012895	http://dx.doi.org/10.1371/journal.pone.0012895			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877573	Green Submitted, Green Published, gold			2022-12-27	WOS:000282053100029
J	Ma, JZ; Amos, CI				Ma, Jianzhong; Amos, Christopher I.			Theoretical Formulation of Principal Components Analysis to Detect and Correct for Population Stratification	PLOS ONE			English	Article							INFERENCE; SUBSTRUCTURE; LOCI	The Eigenstrat method, based on principal components analysis (PCA), is commonly used both to quantify population relationships in population genetics and to correct for population stratification in genome-wide association studies. However, it can be difficult to make appropriate inference about population relationships from the principal component (PC) scatter plot. Here, to better understand the working mechanism of the Eigenstrat method, we consider its theoretical or "population" formulation. The eigen-equation for samples from an arbitrary number (K) of populations is reduced to that of a matrix of dimension K, the elements of which are determined by the variance-covariance matrix for the random vector of the K allele frequencies. Solving the reduced eigen-equation is numerically trivial and yields eigenvectors that are the axes of variation required for differentiating the populations. Using the reduced eigen-equation, we investigate the within-population fluctuations around the axes of variation on the PC scatter plot for simulated datasets. Specifically, we show that there exists an asymptotically stable pattern of the PC plot for large sample size. Our results provide theoretical guidance for interpreting the pattern of PC plot in terms of population relationships. For applications in genetic association tests, we demonstrate that, as a method of correcting for population stratification, regressing out the theoretical PCs corresponding to the axes of variation is equivalent to simply removing the population mean of allele counts and works as well as or better than the Eigenstrat method.	[Ma, Jianzhong; Amos, Christopher I.] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Ma, JZ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA.	jzma@mdanderson.org			National Institutes of Health [RO1ES09912, R01CA133996, P01CA034936, P30ES007784, P50CA016672]; NATIONAL CANCER INSTITUTE [R01CA133996, P01CA034936, P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009912, P30ES007784] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health grants RO1ES09912, R01CA133996, P01CA034936, P30ES007784, and P50CA016672. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDING DJ, 1995, GENETICA, V96, P3, DOI 10.1007/BF01441146; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Falush D, 2003, GENETICS, V164, P1567; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Heath SC, 2008, EUR J HUM GENET, V16, P1413, DOI 10.1038/ejhg.2008.210; Johnson R, 1982, APPL MULTIVARIATE ST; Lee C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S73; McVean G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000686; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; PRICE AL, 2008, PLOS GENET, V4; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2001, THEOR POPUL BIOL, V60, P227, DOI 10.1006/tpbi.2001.1543; Pritchard JK, 2000, GENETICS, V155, P945; Tang H, 2006, AM J HUM GENET, V79, P1, DOI 10.1086/504302; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019; Yu K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002551; Zhu XF, 2002, GENET EPIDEMIOL, V23, P181, DOI 10.1002/gepi.210	21	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2010	5	9							e12510	10.1371/journal.pone.0012510	http://dx.doi.org/10.1371/journal.pone.0012510			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651XL	20862251	Green Published, Green Submitted, gold			2022-12-27	WOS:000281960800001
J	Liu, XM; Li, YP; Yin, SL; Song, SQ				Liu Xuemei; Li Youping; Yin Senlin; Song Shangqi			Result Publication of Chinese Trials in World Health Organization Primary Registries	PLOS ONE			English	Article							CLINICAL-TRIALS; RANDOMIZED-TRIALS; REGISTRATION; BIAS; PROTOCOLS; INDUSTRY; OUTCOMES	Background: Result publication is the key step to improve the transparency of clinical trials. Objective: To investigate the result publication rate of Chinese trials registered in World Health Organization (WHO) primary registries. Method: We searched 11 WHO primary registries for Chinese trials records. The progress of each trial was analyzed. We searched for the full texts of result publications cited in the registration records. For completed trials without citations, we searched PubMed, Embase, Chinese Biomedical Literature Database (Chinese), China Knowledge Resource Integrated Database, and Chinese Science and Technology Periodicals Database for result publications. The search was conducted on July 14, 2009. We also called the investigators of completed trials to ask about results publication. Results: We identified 1294 Chinese trials records (428 in ChiCTR, 743 in clinicaltrials.gov, 55 in ISRCTN, 21 in ACTRN). A total of 443 trials had been completed. The publication rate of the Chinese trials in WHO primary registries is 35.2%(156/443). The publication rate of Chinese trials in clinicaltrials.gov, ChiCTR, ISRCTN, and ACRTN was 36.5% (53/145), 36.3% (89/245), 26.0%(9/44), and 55.6%(5/9), respectively. The publication rate of trials sponsored by industry(23.8%) was lower than that of sponsored by central and local government(31.7%), hospital(35.1%), and universities (40.7%). The publication rate for randomized trials was higher than that of cohort study and case-control study (33.2% versus 16.7%, 22.2%). The publication rate for interventional studies and observational studies was similar(33.4% versus 33.3%). Conclusion: The publication rate of the registered Chinese trials was low, with no significant difference between ChiCTR and clinicaltrials.gov. An effective mechanism is needed to promote publication of results for registered trials in China.	[Liu Xuemei] Sichuan Univ, Chinese Journal Evidence Based Med, W China Period Press, W China Hosp, Chengdu 610064, Peoples R China; [Li Youping] Sichuan Univ, Chinese Evidence Based Med Ctr, W China Hosp, Chengdu 610064, Peoples R China; [Yin Senlin; Song Shangqi] Sichuan Univ, W China Sch Med, Chengdu 610064, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Liu, XM (corresponding author), Sichuan Univ, Chinese Journal Evidence Based Med, W China Period Press, W China Hosp, Chengdu 610064, Peoples R China.	yzmylab@hotmail.com						Abaid LN, 2007, CONTRACEPTION, V76, P339, DOI 10.1016/j.contraception.2007.06.013; Al-Marzouki S, 2008, LANCET, V372, P201, DOI 10.1016/S0140-6736(08)61060-0; CERIVASTATIN CA, 2001, RECENTI PROG MED, V92, P641; Chan AW, 2005, LANCET, V365, P1159, DOI 10.1016/S0140-6736(05)71879-1; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; DeAngelis CD, 2004, JAMA-J AM MED ASSOC, V292, P1363, DOI 10.1001/jama.292.11.1363; DEBELLEFEUILLE C, 1992, ANN ONCOL, V3, P187, DOI 10.1093/oxfordjournals.annonc.a058147; Dickersin K., 1993, ONLINE J CURR CLIN T, pDoc No 50; Doucet M, 2008, J MED ETHICS, V34, DOI 10.1136/jme.2007.022467; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Ghersi D, 2008, B WORLD HEALTH ORGAN, V86, P492, DOI 10.2471/BLT.08.053769; Ghersi Davina, 2009, J Evid Based Med, V2, P1, DOI 10.1111/j.1756-5391.2009.01014.x; JIA H, 2010, CHINA BECKONS CLIN T; Krleza-Jeric K, 2005, PLOS MED, V2, P1093, DOI 10.1371/journal.pmed.0020378; KRZTZABIWSKA MK, 2010, JAMA-J AM MED ASSOC, V290, P495; Laine C, 2007, LANCET, V369, P1909, DOI 10.1016/S0140-6736(07)60894-0; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Liebeskind DS, 2006, NEUROLOGY, V67, P973, DOI 10.1212/01.wnl.0000237331.16541.ac; Liu Xuemei, 2009, J Evid Based Med, V2, P8, DOI 10.1111/j.1756-5391.2009.01007.x; Mathieu S, 2009, JAMA-J AM MED ASSOC, V302, P977, DOI 10.1001/jama.2009.1242; Ramsey S, 2008, ONCOLOGIST, V13, P925, DOI 10.1634/theoncologist.2008-0133; Ross JS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000144; SONG FJ, 2009, BMC MED RES METHODOL, V9, DOI DOI 10.1186/1471-228-9-79; TIMMER A, 2007, BMC MED RES METHODOL, V2, P7; Tuma RS, 2010, J NATL CANCER I, V102, P290, DOI 10.1093/jnci/djq051; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Weber EJ, 1998, JAMA-J AM MED ASSOC, V280, P257, DOI 10.1001/jama.280.3.257; Wessely S, 2004, JAMA-J AM MED ASSOC, V292, P379, DOI 10.1001/jama.292.3.379; WHO, INT CLIN TRIALS REG; Young NS, 2008, PLOS MED, V5, P1418, DOI 10.1371/journal.pmed.0050201; Zarin DA, 2008, SCIENCE, V319, P1340, DOI 10.1126/science.1153632	31	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2010	5	9							e12676	10.1371/journal.pone.0012676	http://dx.doi.org/10.1371/journal.pone.0012676			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648ZZ	20856888	Green Published, gold			2022-12-27	WOS:000281735700007
J	Saisongkorh, W; Robert, C; La Scola, B; Raoult, D; Rolain, JM				Saisongkorh, Watcharee; Robert, Catherine; La Scola, Bernard; Raoult, Didier; Rolain, Jean-Marc			Evidence of Transfer by Conjugation of Type IV Secretion System Genes between Bartonella Species and Rhizobium radiobacter in Amoeba	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; GENOMIC SEQUENCE; HENSELAE; IMMUNOFLUORESCENCE; RESISTANCE; EVOLUTION; QUINTANA; BACTERIA; INVASION; BINDING	Background: Bartonella species cospeciate with mammals and live within erythrocytes. Even in these specific niches, it has been recently suggested by bioinformatic analysis of full genome sequences that Lateral Gene Transfer (LGT) may occur but this has never been demonstrated biologically. Here we describe the sequence of the B. rattaustraliani (AUST/NH4 T) circular plasmid (pNH4) that encodes the tra cluster of the Type IV secretion system (T4SS) and we eventually provide evidence that Bartonella species may conjugate and exchange this plasmid inside amoeba. Principal Findings: The T4SS of pNH4 is critical for intracellular viability of bacterial pathogens, exhibits bioinformatic evidence of LGT among bacteria living in phagocytic protists. For instance, 3 out of 4 T4SS encoding genes from pNH4 appear to be closely related to Rhizobiales, suggesting that gene exchange occurs between intracellular bacteria from mammals (bartonellae) and plants (Rhizobiales). We show that B. rattaustraliani and Rhizobium radiobacter both survived within the amoeba Acanthamoeba polyphaga and can conjugate together. Our findings further support the hypothesis that tra genes might also move into and out of bacterial communities by conjugation, which might be the primary means of genomic evolution for intracellular adaptation by cross-talk of interchangeable genes between Bartonella species and plant pathogens. Conclusions: Based on this, we speculate that amoeba favor the transfer of genes as phagocytic protists, which allows for intraphagocytic survival and, as a consequence, promotes the creation of potential pathogenic organisms.	[Saisongkorh, Watcharee; Robert, Catherine; La Scola, Bernard; Raoult, Didier; Rolain, Jean-Marc] Univ Mediterranee, URMITE, CNRS, Fac Med & Pharm,IRD UMR 6236, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD)	Saisongkorh, W (corresponding author), Univ Mediterranee, URMITE, CNRS, Fac Med & Pharm,IRD UMR 6236, Marseille, France.	didier.raoult@gmail.com; jean-marc.rolain@univmed.fr	LA SCOLA, Bernard/P-6477-2016; RAOULT, Didier/A-8434-2008; Rolain, Jean-Marc/Y-3788-2019	LA SCOLA, Bernard/0000-0001-8006-7704; RAOULT, Didier/0000-0002-0633-5974; Rolain, Jean-Marc/0000-0002-2402-4467	Centre National de la Recherche Scientifique France (CNRS)	Centre National de la Recherche Scientifique France (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This work was funded by the Centre National de la Recherche Scientifique France (CNRS, credits recurrents). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsmark CM, 2004, P NATL ACAD SCI USA, V101, P9716, DOI 10.1073/pnas.0305659101; Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r81; Angelakis E, 2008, J ANTIMICROB CHEMOTH, V61, P1252, DOI 10.1093/jac/dkn094; Babic A, 2008, SCIENCE, V319, P1533, DOI 10.1126/science.1153498; Beranek A, 2004, J BACTERIOL, V186, P6999, DOI 10.1128/JB.186.20.6999-7006.2004; Berglund EC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000546; Biswas S, 2006, ANTIMICROB AGENTS CH, V50, P3192, DOI 10.1128/AAC.00263-06; Blanc G, 2007, GENOME RES, V17, P1657, DOI 10.1101/gr.6742107; Burns DL, 2003, CURR OPIN MICROBIOL, V6, P29, DOI 10.1016/S1369-5274(02)00006-1; Chen I, 2005, SCIENCE, V310, P1456, DOI 10.1126/science.1114021; Chien MC, 2004, SCIENCE, V305, P1966, DOI 10.1126/science.1099776; Christie PJ, 2001, MOL MICROBIOL, V40, P294, DOI 10.1046/j.1365-2958.2001.02302.x; Christie PJ, 2000, TRENDS MICROBIOL, V8, P354, DOI 10.1016/S0966-842X(00)01792-3; Couturier M, 1998, TRENDS MICROBIOL, V6, P269, DOI 10.1016/S0966-842X(98)01311-0; Deng WY, 1999, MOL MICROBIOL, V31, P1795, DOI 10.1046/j.1365-2958.1999.01316.x; Engelberg-Kulka H, 1999, ANNU REV MICROBIOL, V53, P43, DOI 10.1146/annurev.micro.53.1.43; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fournier PE, 2007, EMERG INFECT DIS, V13, P1961, DOI 10.3201/eid1312.060559; Frank AC, 2005, MOL BIOL EVOL, V22, P1325, DOI 10.1093/molbev/msi124; Frank DW, 2007, ANN NY ACAD SCI, V1105, P67, DOI 10.1196/annals.1409.008; Greub G, 2003, APPL ENVIRON MICROB, V69, P5530, DOI 10.1128/AEM.69.9.5530-5535.2003; Guglielmini J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-104; Gundi VAKB, 2009, INT J SYST EVOL MICR, V59, P2956, DOI 10.1099/ijs.0.002865-0; Halary S, 2010, P NATL ACAD SCI USA, V107, P127, DOI 10.1073/pnas.0908978107; JENSEN RB, 1995, MOL MICROBIOL, V17, P205, DOI 10.1111/j.1365-2958.1995.mmi_17020205.x; JEON KW, 1976, J CELL PHYSIOL, V89, P337, DOI 10.1002/jcp.1040890216; Juhas M, 2008, CELL MICROBIOL, V10, P2377, DOI 10.1111/j.1462-5822.2008.01187.x; Kaneko T, 2002, DNA RES, V9, P189, DOI 10.1093/dnares/9.6.189; Koesling J, 2001, J IMMUNOL, V167, P11, DOI 10.4049/jimmunol.167.1.11; LA SCOLA B, 2003, SCIENCE, V299, P2033; Llosa M, 2009, MOL MICROBIOL, V73, P141, DOI 10.1111/j.1365-2958.2009.06751.x; MAURIN M, 1994, J CLIN MICROBIOL, V32, P1166, DOI 10.1128/JCM.32.5.1166-1171.1994; Merhej V, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-13; MOLINER C, 2010, FEMS MICROBIOL REV, DOI DOI 10.1111/J.1574-6976.00209.X; Nystedt B, 2008, MOL BIOL EVOL, V25, P287, DOI 10.1093/molbev/msm252; Ogata H, 2005, PLOS BIOL, V3, P1391, DOI 10.1371/journal.pbio.0030248; Ogata H, 2006, PLOS GENET, V2, P733, DOI 10.1371/journal.pgen.0020076; Ohnishi H, 2004, INFECT IMMUN, V72, P3592, DOI 10.1128/IAI.72.6.3592-3603.2004; Padmalayam I, 2000, DNA CELL BIOL, V19, P377, DOI 10.1089/10445490050043344; Raoult D, 2010, LANCET, V375, P104, DOI 10.1016/S0140-6736(09)61958-9; Rolain JM, 2003, CLIN DIAGN LAB IMMUN, V10, P686, DOI 10.1128/CDLI.10.4.686-691.2003; Saenz HL, 2007, NAT GENET, V39, P1469, DOI 10.1038/ng.2007.38; SCHANDEL KA, 1992, J BACTERIOL, V174, P3800, DOI 10.1128/JB.174.11.3800-3806.1992; Schmid MC, 2004, MOL MICROBIOL, V52, P81, DOI 10.1111/j.1365-2958.2003.03964.x; Schmiederer M, 2000, DNA CELL BIOL, V19, P141, DOI 10.1089/104454900314528; Schroder G, 2003, J BACTERIOL, V185, P4371, DOI 10.1128/JB.185.15.4371-4381.2003; Schulein R, 2002, MOL MICROBIOL, V46, P1053, DOI 10.1046/j.1365-2958.2002.03208.x; Schulein R, 2001, J EXP MED, V193, P1077, DOI 10.1084/jem.193.9.1077; Seubert A, 2003, MOL MICROBIOL, V49, P1253, DOI 10.1046/j.1365-2958.2003.03650.x; Shamaei-Tousi A, 2004, J BACTERIOL, V186, P4796, DOI 10.1128/JB.186.14.4796-4801.2004; THOMAS V, 2010, INTEROVIROL IN PRESS; Wang YA, 2009, J MOL BIOL, V385, P22, DOI 10.1016/j.jmb.2008.10.054; YARMOLINSKY MB, 1995, SCIENCE, V267, P836, DOI 10.1126/science.7846528	53	30	31	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2010	5	9							e12666	10.1371/journal.pone.0012666	http://dx.doi.org/10.1371/journal.pone.0012666			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648ZZ	20856925	Green Published, gold, Green Submitted			2022-12-27	WOS:000281735700006
J	Youssef, NH; Couger, MB; Elshahed, MS				Youssef, Noha H.; Couger, M. B.; Elshahed, Mostafa S.			Fine-Scale Bacterial Beta Diversity within a Complex Ecosystem (Zodletone Spring, OK, USA): The Role of the Rare Biosphere	PLOS ONE			English	Article							HUMAN GUT MICROBIOTA; SPECIES RICHNESS; SEASONAL-CHANGES; ARCTIC-OCEAN; SOIL; COMMUNITY; TIME; DNA; PHYLLOSPHERE; SIMILARITY	Background: The adaptation of pyrosequencing technologies for use in culture-independent diversity surveys allowed for deeper sampling of ecosystems of interest. One extremely well suited area of interest for pyrosequencing-based diversity surveys that has received surprisingly little attention so far, is examining fine scale (e.g. micrometer to millimeter) beta diversity in complex microbial ecosystems. Methodology/Principal Findings: We examined the patterns of fine scale Beta diversity in four adjacent sediment samples (1mm apart) from the source of an anaerobic sulfide and sulfur rich spring (Zodletone spring) in southwestern Oklahoma, USA. Using pyrosequencing, a total of 292,130 16S rRNA gene sequences were obtained. The beta diversity patterns within the four datasets were examined using various qualitative and quantitative similarity indices. Low levels of Beta diversity (high similarity indices) were observed between the four samples at the phylum-level. However, at a putative species (OTU(0.03)) level, higher levels of beta diversity (lower similarity indices) were observed. Further examination of beta diversity patterns within dominant and rare members of the community indicated that at the putative species level, beta diversity is much higher within rare members of the community. Finally, sub-classification of rare members of Zodletone spring community based on patterns of novelty and uniqueness, and further examination of fine scale beta diversity of each of these subgroups indicated that members of the community that are unique, but non novel showed the highest beta diversity within these subgroups of the rare biosphere. Conclusions/Significance: The results demonstrate the occurrence of high inter-sample diversity within seemingly identical samples from a complex habitat. We reason that such unexpected diversity should be taken into consideration when exploring gamma diversity of various ecosystems, as well as planning for sequencing-intensive metagenomic surveys of highly complex ecosystems.	[Youssef, Noha H.; Couger, M. B.; Elshahed, Mostafa S.] Oklahoma State Univ, Dept Microbiol & Mol Genet, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater	Youssef, NH (corresponding author), Oklahoma State Univ, Dept Microbiol & Mol Genet, Stillwater, OK 74078 USA.	Mostafa@Okstate.edu	Youssef, Noha H./T-5198-2019	Youssef, Noha H./0000-0001-9159-3785; Couger, Matthew/0000-0003-3692-1613	National Science Foundation [EF0801858]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation Microbial Observatories Program (Grant EF0801858). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Anderberg M. R., 1973, CLUSTER ANAL APPL; Andersson AF, 2010, ISME J, V4, P171, DOI 10.1038/ismej.2009.108; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Brazelton WJ, 2010, P NATL ACAD SCI USA, V107, P1612, DOI 10.1073/pnas.0905369107; Brown MV, 2009, ISME J, V3, P1374, DOI 10.1038/ismej.2009.86; BUHRING SI, 2010, GEOBIOL UNPUB; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Chariton AA, 2010, FRONT ECOL ENVIRON, V8, P233, DOI 10.1890/090115; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Clarke J, 2009, NAT NANOTECHNOL, V4, P265, DOI [10.1038/NNANO.2009.12, 10.1038/nnano.2009.12]; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Elshahed MS, 2003, APPL ENVIRON MICROB, V69, P5609, DOI 10.1128/AEM.69.9.5609-5621.2003; Franklin RB, 2001, APPL ENVIRON MICROB, V67, P702, DOI 10.1128/AEM.67.2.702-712.2001; Fuhrman JA, 2008, P NATL ACAD SCI USA, V105, P7774, DOI 10.1073/pnas.0803070105; Furlong MA, 2002, APPL ENVIRON MICROB, V68, P1265, DOI 10.1128/AEM.68.3.1265-1279.2002; Galand PE, 2009, P NATL ACAD SCI USA, V106, P22427, DOI 10.1073/pnas.0908284106; Galand PE, 2009, ISME J, V3, P860, DOI 10.1038/ismej.2009.23; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hiatt JB, 2010, NAT METHODS, V7, P119, DOI [10.1038/NMETH.1416, 10.1038/nmeth.1416]; Hong SH, 2006, P NATL ACAD SCI USA, V103, P117, DOI 10.1073/pnas.0507245102; Jaccard P., 1901, B SOC VAUD SCI N, V37, P241, DOI DOI 10.5169/SEALS-266450; Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127; LEGARD DE, 1994, AGR ECOSYST ENVIRON, V50, P87, DOI 10.1016/0167-8809(94)90128-7; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Levin I. P., 1999, QUANTITATIVE APPL SO, V125; LIGGENSTOFFER AS, 2010, ISME J IN PRESS, DOI DOI 10.1038/ISMEJ.2010.1049; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; Miller SR, 2009, APPL ENVIRON MICROB, V75, P4565, DOI 10.1128/AEM.02792-08; Mitra S, 2010, ISME J, V4, P1236, DOI 10.1038/ismej.2010.51; OCHIAI AKIRA, 1957, BULL JAPANESE SOC SCI FISH, V22, P526; Oksanen J, 2022, COMMUNITY ECOLOGY PA; Pati A, 2010, NAT METHODS, V7, P455, DOI [10.1038/nmeth.1457, 10.1038/NMETH.1457]; Pommier T, 2007, MOL ECOL, V16, P867, DOI 10.1111/j.1365-294X.2006.03189.x; Quince C, 2008, ISME J, V2, P997, DOI 10.1038/ismej.2008.69; R Core Team, 2020, R LANG ENV STAT COMP; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Savage KN, 2010, FEMS MICROBIOL ECOL, V72, P485, DOI 10.1111/j.1574-6941.2010.00866.x; Schloss PD, 2008, ISME J, V2, P265, DOI 10.1038/ismej.2008.5; Schloss PD, 2006, PLOS COMPUT BIOL, V2, P786, DOI 10.1371/journal.pcbi.0020092; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Senko JM, 2004, GEOCHIM COSMOCHIM AC, V68, P773, DOI 10.1016/j.gca.2003.07.008; Singh BK, 2009, NAT REV MICROBIOL, V7, DOI 10.1038/nrmicro2119-c1; Smith W, 1996, BIOMETRICS, V52, P1472, DOI 10.2307/2532861; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Sorensen T, 1948, BIOL SKRIFTER, V5, P1; THOMPSON IP, 1993, PLANT SOIL, V150, P177, DOI 10.1007/BF00013015; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Vogel TM, 2009, NAT REV MICROBIOL, V7, P252, DOI 10.1038/nrmicro2119; Youssef NH, 2008, J MICROBIOL METH, V75, P86, DOI 10.1016/j.mimet.2008.05.009; Yue JC, 2005, COMMUN STAT-THEOR M, V34, P2123, DOI 10.1080/STA-200066418; ZHU W, 2010, NUCLEIC ACIDS RES	57	50	50	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12414	10.1371/journal.pone.0012414	http://dx.doi.org/10.1371/journal.pone.0012414			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865128	gold, Green Published, Green Submitted			2022-12-27	WOS:000281292100014
J	Grunewald, A; Voges, L; Rakovic, A; Kasten, M; Vandebona, H; Hemmelmann, C; Lohmann, K; Orolicki, S; Ramirez, A; Schapira, AHV; Pramstaller, PP; Sue, CM; Klein, C				Gruenewald, Anne; Voges, Lisa; Rakovic, Aleksandar; Kasten, Meike; Vandebona, Himesha; Hemmelmann, Claudia; Lohmann, Katja; Orolicki, Slobodanka; Ramirez, Alfredo; Schapira, Anthony H. V.; Pramstaller, Peter P.; Sue, Carolyn M.; Klein, Christine			Mutant Parkin Impairs Mitochondrial Function and Morphology in Human Fibroblasts	PLOS ONE			English	Article							COMPLEX I DEFICIENCY; PINK1; DISEASE; PATHOGENESIS; DYSFUNCTION; MUTATIONS; PATHOLOGY; DOMAIN; MICE	Background: Mutations in Parkin are the most common cause of autosomal recessive Parkinson disease (PD). The mitochondrially localized E3 ubiquitin-protein ligase Parkin has been reported to be involved in respiratory chain function and mitochondrial dynamics. More recent publications also described a link between Parkin and mitophagy. Methodology/Principal Findings: In this study, we investigated the impact of Parkin mutations on mitochondrial function and morphology in a human cellular model. Fibroblasts were obtained from three members of an Italian PD family with two mutations in Parkin (homozygous c.1072delT, homozygous delEx7, compound-heterozygous c.1072delT/delEx7), as well as from two relatives without mutations. Furthermore, three unrelated compound-heterozygous patients (delEx3-4/duplEx7-12, delEx4/c.924C>T and delEx1/c.924C>T) and three unrelated age-matched controls were included. Fibroblasts were cultured under basal or paraquat-induced oxidative stress conditions. ATP synthesis rates and cellular levels were detected luminometrically. Activities of complexes I-IV and citrate synthase were measured spectrophotometrically in mitochondrial preparations or cell lysates. The mitochondrial membrane potential was measured with 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolylcarbocyanine iodide. Oxidative stress levels were investigated with the OxyBlot technique. The mitochondrial network was investigated immunocytochemically and the degree of branching was determined with image processing methods. We observed a decrease in the production and overall concentration of ATP coinciding with increased mitochondrial mass in Parkin-mutant fibroblasts. After an oxidative insult, the membrane potential decreased in patient cells but not in controls. We further determined higher levels of oxidized proteins in the mutants both under basal and stress conditions. The degree of mitochondrial network branching was comparable in mutants and controls under basal conditions and decreased to a similar extent under paraquat-induced stress. Conclusions: Our results indicate that Parkin mutations cause abnormal mitochondrial function and morphology in non-neuronal human cells.	[Gruenewald, Anne; Voges, Lisa; Rakovic, Aleksandar; Kasten, Meike; Lohmann, Katja; Orolicki, Slobodanka; Ramirez, Alfredo; Klein, Christine] Univ Lubeck, Dept Neurol, Sect Clin & Mol Neurogenet, Lubeck, Germany; [Gruenewald, Anne; Vandebona, Himesha; Sue, Carolyn M.] Royal N Shore Hosp, Kolling Inst Med Res, Dept Neurogenet, Sydney, NSW, Australia; [Gruenewald, Anne; Vandebona, Himesha; Sue, Carolyn M.] Univ Sydney, Sydney, NSW 2006, Australia; [Hemmelmann, Claudia] Univ Lubeck, Inst Med Biometry & Stat, Lubeck, Germany; [Schapira, Anthony H. V.] UCL, Inst Neurol, Dept Clin Neurosci, London, England; [Pramstaller, Peter P.] European Acad, Inst Med Genet, Bolzano, Italy	University of Lubeck; Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; University of Sydney; University of Lubeck; University of London; University College London; European Academy of Bozen-Bolzano	Grunewald, A (corresponding author), Univ Lubeck, Dept Neurol, Sect Clin & Mol Neurogenet, Lubeck, Germany.	christine.klein@neuro.uni-luebeck.de	Schapira, Anthony H V/A-1245-2010; Pramstaller, Peter P/C-2357-2008; Klein, Christine/AGK-8003-2022; Grünewald, Anne/ABD-1255-2021; Ramirez, Alfredo/S-5126-2019	Schapira, Anthony H V/0000-0002-3018-3966; Grünewald, Anne/0000-0002-4179-2994; Ramirez, Alfredo/0000-0003-4991-763X; Klein, Christine/0000-0003-2102-3431; Pramstaller, Peter P/0000-0002-9831-8302; Kasten, Meike/0000-0003-1910-6035	German Research Foundation [GR 3731/1-1]; Fritz Thyssen Foundation; Boehringer Ingelheim Foundation; German Academic Exchange Service; EU [EU-LSHB-CT-2006-037544]; Deutsches Bundesministerium fur Bildung und Forschung [PNP-01GS08135-3]; Volkswagen Foundation; Hermann and Lilly Schilling Foundation; Hilde Ulrichs Foundation for Parkinson Disease Research; Australian Brain Foundation; University of Lubeck; Kattan Trust; Medical Research Council [G0601943] Funding Source: researchfish; MRC [G0601943] Funding Source: UKRI	German Research Foundation(German Research Foundation (DFG)); Fritz Thyssen Foundation; Boehringer Ingelheim Foundation(Boehringer Ingelheim); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); EU(European Commission); Deutsches Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Volkswagen Foundation(Volkswagen); Hermann and Lilly Schilling Foundation; Hilde Ulrichs Foundation for Parkinson Disease Research; Australian Brain Foundation; University of Lubeck; Kattan Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the German Research Foundation (GR 3731/1-1), the Fritz Thyssen Foundation, the Boehringer Ingelheim Foundation, the German Academic Exchange Service, the EU Grant GENEPARK (EU-LSHB-CT-2006-037544), the Deutsches Bundesministerium fur Bildung und Forschung (Nationales Genomforschungsnetz plus, PNP-01GS08135-3), the Volkswagen Foundation, the Hermann and Lilly Schilling Foundation, the Hilde Ulrichs Foundation for Parkinson Disease Research, the Australian Brain Foundation and the Medical Faculty of the University of Lubeck. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Schapira is a board member of the Royal Free Hospital trust, served as a consultant for BI, GSK, Teva-Lundbeck, Orion-Novartis and EMD Serono, and received research support from the Kattan Trust. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Beasley SA, 2007, P NATL ACAD SCI USA, V104, P3095, DOI 10.1073/pnas.0610548104; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Esposti MD, 2001, METHOD CELL BIOL, V65, P75; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Flinn L, 2009, BRAIN, V132, P1613, DOI 10.1093/brain/awp108; Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013; Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Grunewald A, 2009, EXP NEUROL, V219, P266, DOI 10.1016/j.expneurol.2009.05.027; Hristova VA, 2009, J BIOL CHEM, V284, P14978, DOI 10.1074/jbc.M808700200; Itier JM, 2003, HUM MOL GENET, V12, P2277, DOI 10.1093/hmg/ddg239; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Moore DJ, 2006, BIOCHEM SOC T, V34, P749, DOI 10.1042/BST0340749; Mortiboys H, 2008, ANN NEUROL, V64, P555, DOI 10.1002/ana.21492; Muftuoglu M, 2004, MOVEMENT DISORD, V19, P544, DOI 10.1002/mds.10695; Narendra D, 2009, AUTOPHAGY, V5, P706, DOI 10.4161/auto.5.5.8505; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; Perez FA, 2005, P NATL ACAD SCI USA, V102, P2174, DOI 10.1073/pnas.0409598102; Pesah Y, 2004, DEVELOPMENT, V131, P2183, DOI 10.1242/dev.01095; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Poole AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010054; Pramstaller PP, 2005, ANN NEUROL, V58, P411, DOI 10.1002/ana.20587; SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; Shepherd RK, 2006, J INHERIT METAB DIS, V29, P86, DOI 10.1007/s10545-006-0148-8; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wild P, 2010, NAT CELL BIOL, V12, P104, DOI 10.1038/ncb0210-104; Ziviani E, 2010, AUTOPHAGY, V6, P660, DOI 10.4161/auto.6.5.12242; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	32	104	107	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e12962	10.1371/journal.pone.0012962	http://dx.doi.org/10.1371/journal.pone.0012962			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20885945	Green Published, Green Submitted, gold			2022-12-27	WOS:000282167100003
J	Kai, L; Kaldenhoff, R; Lian, JZ; Zhu, XC; Dotsch, V; Bernhard, F; Cen, PL; Xu, ZN				Kai, Lei; Kaldenhoff, Ralf; Lian, Jiazhang; Zhu, Xiangcheng; Doetsch, Volker; Bernhard, Frank; Cen, Peilin; Xu, Zhinan			Preparative Scale Production of Functional Mouse Aquaporin 4 Using Different Cell-Free Expression Modes	PLOS ONE			English	Article							INTEGRAL MEMBRANE-PROTEINS; WATER CHANNEL PROTEIN; ESCHERICHIA-COLI; EFFICIENT EXPRESSION; M23 ISOFORMS; BRAIN; RECONSTITUTION; PROTEOLIPOSOMES; PERMEABILITY; SELECTIVITY	The continuous progress in the structural and functional characterization of aquaporins increasingly attracts attention to study their roles in certain mammalian diseases. Although several structures of aquaporins have already been solved by crystallization, the challenge of producing sufficient amounts of functional proteins still remains. CF (cell free) expression has emerged in recent times as a promising alternative option in order to synthesize large quantities of membrane proteins, and the focus of this report was to evaluate the potential of this technique for the production of eukaryotic aquaporins. We have selected the mouse aquaporin 4 as a representative of mammalian aquaporins. The protein was synthesized in an E. coli extract based cell-free system with two different expression modes, and the efficiencies of two modes were compared. In both, the P-CF (cell-free membrane protein expression as precipitate) mode generating initial aquaporin precipitates as well as in the D-CF (cell-free membrane protein expression in presence of detergent) mode, generating directly detergent solubilized samples, we were able to obtain mg amounts of protein per ml of cell-free reaction. Purified aquaporin samples solubilized in different detergents were reconstituted into liposomes, and analyzed for the water channel activity. The calculated P(f) value of proteoliposome samples isolated from the D-CF mode was 133 mu m/s at 10 degrees C, which was 5 times higher as that of the control. A reversible inhibitory effect of mercury chloride was observed, which is consistent with previous observations of in vitro reconstituted aquaporin 4. In this study, a fast and convenient protocol was established for functional expression of aquaporins, which could serve as basis for further applications such as water filtration.	[Kai, Lei; Lian, Jiazhang; Zhu, Xiangcheng; Cen, Peilin; Xu, Zhinan] Zhejiang Univ, Inst Biol Engn, Dept Chem & Biol Engn, Hangzhou 310003, Zhejiang, Peoples R China; [Kai, Lei; Doetsch, Volker; Bernhard, Frank] Goethe Univ Frankfurt, Inst Biophys Chem, Ctr Biomol Magnet Resonance, Frankfurt, Germany; [Kaldenhoff, Ralf] Tech Univ Darmstadt, Inst Bot, Darmstadt, Germany	Zhejiang University; Goethe University Frankfurt; Technical University of Darmstadt	Kai, L (corresponding author), Zhejiang Univ, Inst Biol Engn, Dept Chem & Biol Engn, Hangzhou 310003, Zhejiang, Peoples R China.	znxu@zju.edu.cn	Doetsch, Volker/D-5697-2011; Lian, Jiazhang/I-2087-2015; Kai, Lei/ABI-2652-2020; zhu, xiangcheng/M-1017-2018	Lian, Jiazhang/0000-0001-9784-9876; Kai, Lei/0000-0003-0879-7918; Bernhard, Frank/0000-0002-4860-1783; Dotsch, Volker/0000-0001-5720-212X; zhu, xiangcheng/0000-0002-9191-6676	Nature Science Foundation of China [20736008]; European Drug Initiative on Channels and Transporters [HEALTH-F4-2007-201924]; European Initiative on Structural Biology of Membrane Proteins (SBMP) [PITN-GA-2008-211800]; SonderForschungsBereich (SFB, collaborative research centers) [807]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); European Drug Initiative on Channels and Transporters; European Initiative on Structural Biology of Membrane Proteins (SBMP); SonderForschungsBereich (SFB, collaborative research centers)(German Research Foundation (DFG))	This work was financially supported by the Nature Science Foundation of China grant no. 20736008 (Z. Xu), the European Drug Initiative on Channels and Transporters grant HEALTH-F4-2007-201924 and the European Initiative on Structural Biology of Membrane Proteins (SBMP) grant PITN-GA-2008-211800 (F. Bernhard). The authors are also grateful for financial support from the SonderForschungsBereich (SFB, collaborative research centers) 807, and further thank Daniel Schwarz and Sven Siegfart for valuable assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badaut J, 2007, PEDIATR RES, V62, P248, DOI 10.1203/PDR.0b013e3180db291b; Berrier C, 2004, BIOCHEMISTRY-US, V43, P12585, DOI 10.1021/bi049049y; Borgnia MJ, 1999, J MOL BIOL, V291, P1169, DOI 10.1006/jmbi.1999.3032; BORSOOK H, 1950, PHYSIOL REV, V30, P206, DOI 10.1152/physrev.1950.30.2.206; Costa C, 2007, BRAIN RES, V1175, P96, DOI 10.1016/j.brainres.2007.06.088; Daniels BV, 2004, ACTA CRYSTALLOGR D, V60, P561, DOI 10.1107/S090744490302972X; Elbaz Y, 2004, P NATL ACAD SCI USA, V101, P1519, DOI 10.1073/pnas.0306533101; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Furman CS, 2003, P NATL ACAD SCI USA, V100, P13609, DOI 10.1073/pnas.2235843100; Harries WEC, 2004, P NATL ACAD SCI USA, V101, P14045, DOI 10.1073/pnas.0405274101; Hiroaki Y, 2006, J MOL BIOL, V355, P628, DOI 10.1016/j.jmb.2005.10.081; Ho JD, 2009, P NATL ACAD SCI USA, V106, P7437, DOI 10.1073/pnas.0902725106; Horsefield R, 2008, P NATL ACAD SCI USA, V105, P13327, DOI 10.1073/pnas.0801466105; Hovijitra NT, 2009, BIOTECHNOL BIOENG, V104, P40, DOI 10.1002/bit.22385; JUNG JS, 1994, P NATL ACAD SCI USA, V91, P13052, DOI 10.1073/pnas.91.26.13052; Karlsson M, 2003, FEBS LETT, V537, P68, DOI 10.1016/S0014-5793(03)00082-6; Keller T, 2008, BIOCHEMISTRY-US, V47, P4552, DOI 10.1021/bi800060w; Klammt C, 2005, FEBS J, V272, P6024, DOI 10.1111/j.1742-4658.2005.05002.x; Klammt C, 2004, EUR J BIOCHEM, V271, P568, DOI 10.1111/j.1432-1033.2003.03959.x; Klammt C, 2007, J STRUCT BIOL, V158, P482, DOI 10.1016/j.jsb.2007.01.006; Klammt C, 2006, FEBS J, V273, P4141, DOI 10.1111/j.1742-4658.2006.05432.x; Kozono D, 2003, J BIOL CHEM, V278, P10649, DOI 10.1074/jbc.M212418200; Lian JZ, 2008, PROTEIN PEPTIDE LETT, V15, P687, DOI 10.2174/092986608785133717; Lian JZ, 2009, APPL MICROBIOL BIOT, V82, P463, DOI 10.1007/s00253-008-1774-x; Lu MQ, 1996, P NATL ACAD SCI USA, V93, P10908, DOI 10.1073/pnas.93.20.10908; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Misu T, 2007, BRAIN, V130, P1224, DOI 10.1093/brain/awm047; Neely JD, 1999, BIOCHEMISTRY-US, V38, P11156, DOI 10.1021/bi990941s; Papadopoulos MC, 2008, PROG BRAIN RES, V170, P589, DOI 10.1016/S0079-6123(08)00446-9; Perez E, 2007, BRAIN RES, V1128, P164, DOI 10.1016/j.brainres.2006.09.109; Rojek A, 2008, ANNU REV PHYSIOL, V70, P301, DOI 10.1146/annurev.physiol.70.113006.100452; SCHNEIDER B, METHODS MOL BIOL, V601, P165; Schwarz D, 2007, METHODS, V41, P355, DOI 10.1016/j.ymeth.2006.07.001; Silberstein C, 2004, AM J PHYSIOL-RENAL, V287, pF501, DOI 10.1152/ajprenal.00439.2003; Splinter PL, 2004, HEPATOLOGY, V39, P109, DOI 10.1002/hep.20033; Strand L, 2009, BIOCHEMISTRY-US, V48, P5785, DOI 10.1021/bi802231q; Swartz J, 2006, J IND MICROBIOL BIOT, V33, P476, DOI 10.1007/s10295-006-0127-y; Werten PJL, 2001, FEBS LETT, V504, P200, DOI 10.1016/S0014-5793(01)02703-X; WINNICK T, 1950, ARCH BIOCHEM, V27, P65; WINNICK T, 1950, ARCH BIOCHEM, V28, P338; Xu ZN, 2010, PROTEIN PEPTIDE LETT, V17, P181, DOI 10.2174/092986610790225996; Yang BX, 1997, BIOCHEMISTRY-US, V36, P7625, DOI 10.1021/bi970231r; Yukutake Y, 2008, BIOL CELL, V100, P355, DOI 10.1042/BC20070132; Yukutake Y, 2009, BIOCHEMISTRY-US, V48, P12059, DOI 10.1021/bi901762y; ZEIDEL ML, 1994, BIOCHEMISTRY-US, V33, P1606, DOI 10.1021/bi00172a042	45	32	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2010	5	9							e12972	10.1371/journal.pone.0012972	http://dx.doi.org/10.1371/journal.pone.0012972			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653UN	20885983	Green Published, Green Submitted, gold			2022-12-27	WOS:000282122600011
J	Jobichen, C; Chakraborty, S; Li, M; Zheng, J; Joseph, L; Mok, YK; Leung, KY; Sivaraman, J				Jobichen, Chacko; Chakraborty, Smarajit; Li, Mo; Zheng, Jun; Joseph, Lissa; Mok, Yu-Keung; Leung, Ka Yin; Sivaraman, J.			Structural Basis for the Secretion of EvpC: A Key Type VI Secretion System Protein from Edwardsiella tarda	PLOS ONE			English	Article							VIBRIO-CHOLERAE; IDENTIFICATION; COMPLEXES; TRANSPORT; SIGNAL	The recently identified type VI secretion system (T6SS) is implicated in the virulence of many Gram-negative bacteria. Edwardsiella tarda is an important cause of hemorrhagic septicemia in fish and also gastro- and extra-intestinal infections in humans. The E. tarda virulent protein (EVP) gene cluster encodes a conserved T6SS which contains 16 open reading frames. EvpC is one of the three major EVP secreted proteins and shares high sequence similarity with Hcp1, a key T6SS virulence factor from Pseudomonas aeruginosa. EvpC contributes to the virulence of E. tarda by playing an essential role in functional T6SS. Here, we report the crystal structure of EvpC from E. tarda PPD130/91 at a 2.8 angstrom resolution, along with functional studies of the protein. EvpC has a beta-barrel domain with extended loops. The beta-barrel consists of 11 anti-parallel beta-strands with an alpha-helix located on one side. In solution, EvpC exists as a dimer at low concentration and as a hexamer at higher concentration. In the crystal, the symmetry related EvpC molecules form hexameric rings which stack together to form a tube similar to Hcp1. Structure based mutagenesis revealed that N-terminal negatively charged residues, Asp4, Glu15 and Glu26, and C-terminal positively charged residues, Lys161, Lys162 and Lys163, played crucial roles in the secretion of EvpC. Moreover, the localization study indicates the presence of wild type EvpC in cytoplasm, periplasm and secreted fractions, whereas the N-terminal and C-terminal mutants were found mostly in the periplasmic region and was completely absent in the secreted fraction. Results reported here provide insight into the structure, assembly and function of EvpC. Further, these findings can be extended to other EvpC homologs for understanding the mechanism of T6SS and targeting T6SS mediated virulence in Gram-negative pathogens.	[Jobichen, Chacko; Chakraborty, Smarajit; Li, Mo; Zheng, Jun; Joseph, Lissa; Mok, Yu-Keung; Sivaraman, J.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Leung, Ka Yin] Trinity Western Univ, Fac Nat & Appl Sci, Dept Biol, Langley, BC, Canada	National University of Singapore; Trinity Western University	Jobichen, C (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbsjayar@nus.edu.sg	Zheng, Jun/AAN-4698-2020; Mok, Yu Keung/H-8019-2012; Sivaraman, J/H-8028-2012; Jobichen, Chacko/D-1978-2014; Jobichen, Chacko/AAR-7637-2020	Zheng, Jun/0000-0001-6329-4518; Mok, Yu Keung/0000-0002-2829-4878; Jobichen, Chacko/0000-0001-5927-1815; J, Sivaraman/0000-0001-9781-5326	Biomedical research Council (BMRC), Agency for Science Technology and Research, Singapore [07/1/21/19/495]; National University of Singapore [R154000438112]; National University of Singapore	Biomedical research Council (BMRC), Agency for Science Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR)); National University of Singapore(National University of Singapore); National University of Singapore(National University of Singapore)	This work was supported by a Biomedical research Council (BMRC) grant (07/1/21/19/495) from the Agency for Science Technology and Research (http://www.a-star.edu.sg), Singapore. J. Sivaraman thanks the funding support from Academic Research Fund (AcRF), National University of Singapore (R154000438112) (www.nus.edu.sg). Jobichen Chacko is a graduate scholar in receipt of a research scholarship from the National University of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ballister ER, 2008, P NATL ACAD SCI USA, V105, P3733, DOI 10.1073/pnas.0712247105; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; CAROL F, 1996, ENCYME MICROB TECHNO, V19, P332; Cascales E, 2008, EMBO REP, V9, P735, DOI 10.1038/embor.2008.131; Das Soumita, 2003, In Silico Biology, V3, P287; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Filloux A, 2008, MICROBIOL-SGM, V154, P1570, DOI 10.1099/mic.0.2008/016840-0; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; HEIJNE GV, 1988, BIOCHIM BIOPHYS ACTA, V947, P307; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Hohlfeld S, 2006, MOL MICROBIOL, V59, P1624, DOI 10.1111/j.1365-2958.2006.05050.x; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; JANDA JM, 1993, CLIN INFECT DIS, V17, P742, DOI 10.1093/clinids/17.4.742; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mougous JD, 2007, NAT CELL BIOL, V9, P797, DOI 10.1038/ncb1605; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pallen MJ, 2003, CURR OPIN MICROBIOL, V6, P519, DOI 10.1016/j.mib.2003.09.005; Pell LG, 2009, P NATL ACAD SCI USA, V106, P4160, DOI 10.1073/pnas.0900044106; Plumb J. A., 1993, P61; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Pukatzki S, 2009, CURR OPIN MICROBIOL, V12, P11, DOI 10.1016/j.mib.2008.11.010; Rao PSS, 2004, MOL MICROBIOL, V53, P573, DOI 10.1111/j.1365-2958.2004.04123.x; Tan YP, 2005, MICROBIOL-SGM, V151, P2301, DOI 10.1099/mic.0.28005-0; Tan YP, 2002, INFECT IMMUN, V70, P6475, DOI 10.1128/IAI.70.11.6475-6480.2002; Thune Ronald L., 1993, Annual Review of Fish Diseases, V3, P37, DOI 10.1016/0959-8030(93)90028-A; Vergunst AC, 2005, P NATL ACAD SCI USA, V102, P832, DOI 10.1073/pnas.0406241102; Zheng J, 2007, MOL MICROBIOL, V66, P1192, DOI 10.1111/j.1365-2958.2007.05993.x; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	42	43	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12910	10.1371/journal.pone.0012910	http://dx.doi.org/10.1371/journal.pone.0012910			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886112	Green Published, Green Submitted, gold			2022-12-27	WOS:000282091100017
J	Mesure, L; De Visscher, G; Vranken, I; Lebacq, A; Flameng, W				Mesure, Lindsay; De Visscher, Geofrey; Vranken, Ilse; Lebacq, An; Flameng, Willem			Gene Expression Study of Monocytes/Macrophages during Early Foreign Body Reaction and Identification of Potential Precursors of Myofibroblasts	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; CIRCULATING FIBROCYTES; CELLS; DIFFERENTIATION; MACROPHAGES; RESPONSES	Foreign body reaction (FBR), initiated by adherence of macrophages to biomaterials, is associated with several complications. Searching for mechanisms potentially useful to overcome these complications, we have established the signaling role of monocytes/macrophages in the development of FBR and the presence of CD34(+) cells that potentially differentiate into myofibroblasts. Therefore, CD68(+) cells were in vitro activated with fibrinogen and also purified from the FBR after 3 days of implantation in rats. Gene expression profiles showed a switch from monocytes and macrophages attracted by fibrinogen to activated macrophages and eventually wound-healing macrophages. The immature FBR also contained a subpopulation of CD34(+) cells, which could be differentiated into myofibroblasts. This study showed that macrophages are the clear driving force of FBR, dependent on milieu, and myofibroblast deposition and differentiation.	[Mesure, Lindsay; De Visscher, Geofrey; Vranken, Ilse; Lebacq, An; Flameng, Willem] KULeuven, Dept Cardiovasc Dis, Lab Expt Cardiac Surg, Louvain, Belgium	KU Leuven	Mesure, L (corresponding author), KULeuven, Dept Cardiovasc Dis, Lab Expt Cardiac Surg, Louvain, Belgium.	geofrey.devisscher@hotmail.com	De Visscher, geofrey/B-9318-2012; De Visscher, Geofrey/ABH-8607-2020	De Visscher, Geofrey/0000-0002-2317-392X	National Fund for Scientific Research (Fonds voor Wetenschappelijk Onderzoek-Vlaanderen) [G.0549.06]	National Fund for Scientific Research (Fonds voor Wetenschappelijk Onderzoek-Vlaanderen)(FWO)	This project was partially funded by the National Fund for Scientific Research (Fonds voor Wetenschappelijk Onderzoek-Vlaanderen); Grant No. G.0549.06. Additional funding was provided by the Catholic University of Leuven. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe R, 2001, J IMMUNOL, V166, P7556, DOI 10.4049/jimmunol.166.12.7556; Bahnelli C, 2007, IMMUNOBIOLOGY, V212, P693, DOI 10.1016/j.imbio.2007.09.009; Bellini A, 2007, LAB INVEST, V87, P858, DOI 10.1038/labinvest.3700654; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Butler KR, 2001, J INVEST SURG, V14, P139, DOI 10.1080/089419301300343291; Campbell JH, 2000, J VASC RES, V37, P364, DOI 10.1159/000025752; CAMPBELL JH, 2006, VASCUL PHARM, V45, pE33; Chang CI, 1998, AM J PHYSIOL-HEART C, V274, pH342, DOI 10.1152/ajpheart.1998.274.1.H342; De Visscher G, 2008, J THORAC CARDIOV SUR, V135, P395, DOI 10.1016/j.jtcvs.2007.09.016; De Visscher G, 2010, BIOMATERIALS, V31, P20, DOI 10.1016/j.biomaterials.2009.09.016; Devey L, 2009, MOL THER, V17, P65, DOI 10.1038/mt.2008.237; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Hocevar BA, 2001, EMBO J, V20, P2789, DOI 10.1093/emboj/20.11.2789; Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jabs A, 2005, J VASC RES, V42, P174, DOI 10.1159/000084406; Kang YB, 2003, MOL CELL, V11, P915, DOI 10.1016/S1097-2765(03)00109-6; Klinge U, 1999, EUR J SURG, V165, P665; Konttinen YT, 2005, CLIN ORTHOP RELAT R, P28, DOI 10.1097/01.blo.0000150451.50452.da; Krauter J, 2001, J HEMATOTH STEM CELL, V10, P863, DOI 10.1089/152581601317210953; Kuwana M, 2003, J LEUKOCYTE BIOL, V74, P833, DOI 10.1189/jlb.0403170; Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Ninomiya K, 2006, HYPERTENS RES, V29, P269, DOI 10.1291/hypres.29.269; Pico AR, 2008, PLOS BIOL, V6, P1403, DOI 10.1371/journal.pbio.0060184; Quan TE, 2004, INT J BIOCHEM CELL B, V36, P598, DOI 10.1016/j.biocel.2003.10.005; Schmidt M, 2003, J IMMUNOL, V171, P380, DOI 10.4049/jimmunol.171.1.380; Subramanian R, 2003, CATHETER CARDIO INTE, V59, P205, DOI 10.1002/ccd.10468; TANG LP, 1995, AM J CLIN PATHOL, V103, P466; Varcoe RL, 2006, J THROMB HAEMOST, V4, P1125, DOI 10.1111/j.1538-7836.2006.01924.x; Verrecchia F, 2001, J BIOL CHEM, V276, P17058, DOI 10.1074/jbc.M100754200; Vidal B, 2008, GENE DEV, V22, P1747, DOI 10.1101/gad.465908; Vranken I, 2008, BIOMATERIALS, V29, P797, DOI 10.1016/j.biomaterials.2007.10.041; Waldegger S, 1999, GASTROENTEROLOGY, V116, P1081, DOI 10.1016/S0016-5085(99)70011-9	36	25	25	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12949	10.1371/journal.pone.0012949	http://dx.doi.org/10.1371/journal.pone.0012949			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886081	Green Submitted, gold, Green Published			2022-12-27	WOS:000282091100044
J	Dayan, J; Creveuil, C; Dreyfus, M; Herlicoviez, M; Baleyte, JM; O'Keane, V				Dayan, Jacques; Creveuil, Christian; Dreyfus, Michel; Herlicoviez, Michel; Baleyte, Jean-Marc; O'Keane, Veronica			Developmental Model of Depression Applied to Prenatal Depression: Role of Present and Past Life Events, Past Emotional Disorders and Pregnancy Stress	PLOS ONE			English	Article							PSYCHOSOCIAL RISK-FACTORS; NATIONAL SWEDISH SAMPLE; POSTNATAL DEPRESSION; ANTENATAL DEPRESSION; MENTAL-HEALTH; SCALE EPDS; PROSPECTIVE COHORT; MAJOR DEPRESSION; SOUTH-AUSTRALIA; ETIOLOGIC MODEL	Background: Several risk factors for depression during pregnancy have already been established. However, very few studies have conducted a multivariate analysis incorporating both the major predictors of depression in women, in accordance with comprehensive developmental models of depression, and specific stressors associated with the biological and psychosocial state of the mother-to-be. Methodology/Principal Findings: We used a cross-sectional cohort design to analyze the associations between prenatal depression and potential risk factors. 693 French-speaking women with singleton pregnancies at 20-28 weeks' gestation were consecutively recruited at Caen University Hospital. Fifty women with missing values were subsequently excluded from the analysis. Depressive symptoms were assessed on the Edinburgh Postnatal Depression Scale. Risk factors were either extracted from the computerized obstetric records or assessed by means of self-administered questionnaires. The associations between prenatal depression and the potential risk factors were assessed using log-binomial regression models to obtain a direct estimate of relative risk (RR). The following factors were found to be significant in the multivariate analysis: level of education (p<0.001), past psychiatric history (adjusted RR = 1.8, 95% confidence interval (CI): 1.1;2.8, p = 0.014), stress related to the health and viability of the fetus (adjusted RR = 2.6, 95% CI: 1.6;4.1, p<0.001), and stress related to severe marital conflicts (adjusted RR = 2.4, 95% CI: 1.5;3.9, p<0.001) or to serious difficulties at work (adjusted RR = 1.6, 95% CI : 1.04;2.4, p = 0.031). An association was also found with the previous delivery of a child with a major or minor birth defect (adjusted RR = 2.0, 95% CI: 1.04;4.0, p = 0.038). Univariate analyses revealed a strong association with childhood adversity (parental rejection: RR = 1.8, 95% CI: 1.2;2.8, p = 0.0055 and family secrets: RR = 2.0, 95% CI: 1.2;3.1, p = 0.0046) and with lack of partner support (RR = 0.50, 95% CI: 0.30;0.84, p = 0.0086). Conclusions/Significance: Our study identifies several risk factors that could easily be assessed in clinical practice. It draws attention to the impact of previously delivering a child with a birth defect. The association with childhood adversity warrants further study.	[Dayan, Jacques; Baleyte, Jean-Marc] Caen Univ Hosp, INSERM, U923, Dept Child Psychiat, Caen, France; [Creveuil, Christian] Caen Univ Hosp, Biostat & Clin Res Unit, Caen, France; [Dreyfus, Michel; Herlicoviez, Michel] Caen Univ Hosp, Dept Obstet & Gynecol, Caen, France; [O'Keane, Veronica] St James Hosp, Jonathan Swift Unit, Dept Psychiat, Dublin, Ireland	CHU de Caen NORMANDIE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie; Trinity College Dublin	Dayan, J (corresponding author), Caen Univ Hosp, INSERM, U923, Dept Child Psychiat, Caen, France.	jcdayan@gmail.com	Dayan, Jacques/G-3371-2013; CREVEUIL, Christian/L-7215-2015	CREVEUIL, Christian/0000-0002-5506-5296; o'keane, veronica/0000-0002-1519-099X	French Ministry of Social Affairs [ORS 617136]; University Hospital of Caen [AOI 97-101]	French Ministry of Social Affairs; University Hospital of Caen	This work was supported by grants from the French Ministry of Social Affairs (ORS 617136) and the University Hospital of Caen (AOI 97-101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adouard F, 2005, ARCH WOMEN MENT HLTH, V8, P89, DOI 10.1007/s00737-005-0077-9; AKISKAL HS, 1973, SCIENCE, V182, P20, DOI 10.1126/science.182.4107.20; Alder J, 2007, J MATERN-FETAL NEO M, V20, P189, DOI 10.1080/14767050701209560; Andersson L, 2003, AM J OBSTET GYNECOL, V189, P148, DOI 10.1067/mob.2003.336; Andersson L, 2004, OBSTET GYNECOL, V104, P467, DOI 10.1097/01.AOG.0000135277.04565.e9; Andersson L, 2006, ACTA OBSTET GYN SCAN, V85, P937, DOI 10.1080/00016340600697652; Bennett HA, 2004, OBSTET GYNECOL, V103, P698, DOI 10.1097/01.AOG.0000116689.75396.5f; BERNSTEIN DP, 1994, AM J PSYCHIAT, V151, P1132, DOI 10.1176/ajp.151.8.1132; BIFULCO A, 1994, J CHILD PSYCHOL PSYC, V35, P1419, DOI 10.1111/j.1469-7610.1994.tb01284.x; Bilszta JLC, 2008, AUST NZ J PSYCHIAT, V42, P56, DOI 10.1080/00048670701732731; Bolton HL, 1998, J PSYCHOSOM OBST GYN, V19, P202, DOI 10.3109/01674829809025698; Bowen A, 2009, J EPIDEMIOL COMMUN H, V63, P414, DOI 10.1136/jech.2008.078832; Broen AN, 2006, ACTA OBSTET GYN SCAN, V85, P317, DOI 10.1080/00016340500438116; BROWN GW, 1987, BRIT J PSYCHIAT, V150, P30, DOI 10.1192/bjp.150.1.30; Bunevicius R, 2009, ACTA OBSTET GYN SCAN, V88, P599, DOI 10.1080/00016340902846049; Chung TKH, 2001, PSYCHOSOM MED, V63, P830, DOI 10.1097/00006842-200109000-00017; Clarke DM, 2009, MED J AUSTRALIA, V190, pS54; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Dayan J, 2002, AM J EPIDEMIOL, V155, P293, DOI 10.1093/aje/155.4.293; Dayan J, 2007, J Gynecol Obstet Biol Reprod (Paris), V36, P530; Dayan J, 2006, PSYCHOSOM MED, V68, P938, DOI 10.1097/01.psy.0000244025.20549.bd; Diego MA, 2009, EARLY HUM DEV, V85, P65, DOI 10.1016/j.earlhumdev.2008.07.002; Dieter J N, 2001, J Obstet Gynaecol, V21, P468; Edwards B, 2008, AUST NZ J PSYCHIAT, V42, P45, DOI 10.1080/00048670701732673; Edwards B, 2008, AUST NZ J PSYCHIAT, V42, P51, DOI 10.1080/00048670701739629; Faisal-Cury A, 2007, ARCH WOMEN MENT HLTH, V10, P25, DOI 10.1007/s00737-006-0164-6; Faisal-Cury A, 2009, ARCH WOMEN MENT HLTH, V12, P335, DOI 10.1007/s00737-009-0081-6; Fanos JH, 2009, J PEDIATR-US, V154, P849, DOI 10.1016/j.jpeds.2008.11.053; Fergusson DM, 2008, BRIT J PSYCHIAT, V193, P444, DOI 10.1192/bjp.bp.108.056499; Field T, 2003, DEPRESS ANXIETY, V17, P140, DOI 10.1002/da.10071; Florio P, 2002, ENDOCRINE, V19, P91, DOI 10.1385/ENDO:19:1:91; Gavin NI, 2005, OBSTET GYNECOL, V106, P1071, DOI 10.1097/01.AOG.0000183597.31630.db; Gotzmann L, 2002, ULTRASCHALL MED, V23, P33, DOI 10.1055/s-2002-20073; Groves BM, 1999, FUTURE CHILD, V9, P122, DOI 10.2307/1602786; Guedeney N, 1998, EUR PSYCHIAT, V13, P83, DOI 10.1016/S0924-9338(98)80023-0; Hoffman S, 2000, HEALTH PSYCHOL, V19, P535, DOI 10.1037/0278-6133.19.6.535; Kallen B, 2004, ARCH PEDIAT ADOL MED, V158, P312, DOI 10.1001/archpedi.158.4.312; Kendler KS, 2002, AM J PSYCHIAT, V159, P1133, DOI 10.1176/appi.ajp.159.7.1133; KENDLER KS, 1993, AM J PSYCHIAT, V150, P1139; Kurki T, 2000, OBSTET GYNECOL, V95, P487, DOI 10.1016/S0029-7844(99)00602-X; Laine K, 2003, ARCH GEN PSYCHIAT, V60, P720, DOI 10.1001/archpsyc.60.7.720; Lau Y, 2008, JOGNN-J OBST GYN NEO, V37, P556, DOI 10.1111/j.1552-6909.2008.00273.x; Lau Y, 2007, SOC SCI MED, V64, P1802, DOI 10.1016/j.socscimed.2007.01.001; Le HN, 2004, HISPANIC J BEHAV SCI, V26, P463, DOI 10.1177/0739986304269165; Leigh B, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-24; Leithner K, 2004, ULTRASOUND OBST GYN, V23, P240, DOI 10.1002/uog.978; Li D, 2009, HUM REPROD, V24, P146, DOI 10.1093/humrep/den342; Limlomwongse N, 2006, ARCH WOMEN MENT HLTH, V9, P131, DOI 10.1007/s00737-005-0115-7; Marcus SM, 2003, J WOMEN HEALTH GEN-B, V12, P373, DOI 10.1089/154099903765448880; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Misri S, 2004, CAN J PSYCHIAT, V49, P684, DOI 10.1177/070674370404901006; Mora PA, 2009, AM J EPIDEMIOL, V169, P24, DOI 10.1093/aje/kwn283; Murray D, 1990, J REPROD INFANT PSYC, V8, P99, DOI DOI 10.1080/02646839008403615; Oates MR, 2004, BRIT J PSYCHIAT, V184, pS10, DOI 10.1192/bjp.184.46.s10; Orr ST, 2002, AM J EPIDEMIOL, V156, P797, DOI 10.1093/aje/kwf131; Orr ST, 2007, J WOMENS HEALTH, V16, P535, DOI 10.1089/jwh.2006.0116; PARKER G, 1992, PSYCHOL MED, V22, P657, DOI 10.1017/S0033291700038101; Parker G, 1998, AUST NZ J PSYCHIAT, V32, P104, DOI 10.3109/00048679809062716; Rich-Edwards JW, 2006, J EPIDEMIOL COMMUN H, V60, P221, DOI 10.1136/jech.2005.039370; Ritter C, 2000, HEALTH PSYCHOL, V19, P576, DOI 10.1037/0278-6133.19.6.576; Rodgers CS, 2003, J WOMENS HEALTH, V12, P961, DOI 10.1089/154099903322643884; Rubertsson C, 2005, ARCH WOMEN MENT HLTH, V8, P97, DOI 10.1007/s00737-005-0078-8; Rubertsson C, 2003, J REPROD INFANT PSYC, V21, P113, DOI 10.1080/0264683031000124073; Rubin DC, 2009, MEM COGNITION, V37, P679, DOI 10.3758/37.5.679; Wallis AB, 2009, AM J HYPERTENS, V22, P345, DOI 10.1038/ajh.2009.28; WOODSIDE M, 1988, PUBLIC HEALTH REP, V103, P643; Wu J, 2002, AM J OBSTET GYNECOL, V187, P864, DOI 10.1067/mob.2002.127126; Zeskind PS, 2004, PEDIATRICS, V113, P368, DOI 10.1542/peds.113.2.368	68	60	63	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12942	10.1371/journal.pone.0012942	http://dx.doi.org/10.1371/journal.pone.0012942			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	653AC	20877652	gold, Green Published, Green Submitted			2022-12-27	WOS:000282053100036
J	Ramos-Cabrer, P; Justicia, C; Wiedermann, D; Hoehn, M				Ramos-Cabrer, Pedro; Justicia, Carles; Wiedermann, Dirk; Hoehn, Mathias			Stem Cell Mediation of Functional Recovery after Stroke in the Rat	PLOS ONE			English	Article							NEURAL PROGENITOR CELLS; BONE-MARROW; IN-VIVO; INTRACEREBRAL TRANSPLANTATION; NEURONAL DIFFERENTIATION; MOTOR FUNCTION; STROMAL CELLS; BRAIN; MIGRATION; DEFICITS	Background: Regenerative strategies of stem cell grafting have been demonstrated to be effective in animal models of stroke. In those studies, the effectiveness of stem cells promoting functional recovery was assessed by behavioral testing. These behavioral studies do, however, not provide access to the understanding of the mechanisms underlying the observed functional outcome improvement. Methodology/Principal Findings: In order to address the underlying mechanisms of stem cell mediated functional improvement, this functional improvement after stroke in the rat was investigated for six months after stroke by use of fMRI, somatosensory evoked potentials by electrophysiology, and sensorimotor behavior testing. Stem cells were grafted ipsilateral to the ischemic lesion. Rigorous exclusion of spontaneous recovery as confounding factor permitted to observe graft-related functional improvement beginning after 7 weeks and continuously increasing during the 6-month observation period. The major findings were i) functional improvement causally related to the stem cells grafting; ii) tissue replacement can be excluded as dominant factor for stem cell mediated functional improvement; iii) functional improvement occurs by exclusive restitution of the function in the original representation field, without clear contributions from reorganization processes, and iv) stem cells were not detectable any longer after six months. Conclusions/Significance: A delayed functional improvement due to stem cell implantation has been documented by electrophysiology, fMRI and behavioral testing. This functional improvement occurred without cells acting as a tissue replacement for the necrotic tissue after the ischemic event. Combination of disappearance of grafted cells after six months on histological sections with persistent functional recovery was interpreted as paracrine effects by the grafted stem cells being the dominant mechanism of cell activity underlying the observed functional restitution of the original activation sites. Future studies will have to investigate whether the stem cell mediated improvement reactivates the original representation target field by using original connectivity pathways or by generating/activating new ones for the stimulus.	[Ramos-Cabrer, Pedro; Justicia, Carles; Wiedermann, Dirk; Hoehn, Mathias] Max Planck Inst Neurol Res, In vivo NMR Lab, Cologne, Germany	Max Planck Society	Ramos-Cabrer, P (corresponding author), Univ Santiago de Compostela, Univ Clin Hosp Santiago, Dept Neurol, Clin Neurosci Res Lab, Santiago De Compostela, Spain.	mathias@nf.mpg.de	Ramos-Cabrer, Pedro/J-5306-2014; Ramos-Cabrer, Pedro/AAF-1467-2020; Justicia, Carles/H-7762-2015	Ramos-Cabrer, Pedro/0000-0003-0368-7031; Ramos-Cabrer, Pedro/0000-0003-0368-7031; Justicia, Carles/0000-0003-0969-6158	Hertie Foundation (Germany); EU [LSHB-CT-2005-512146, LSHC-CT-2004-503569, LSHB-CT-2006-037526]	Hertie Foundation (Germany); EU(European Commission)	Financial support from the Hertie Foundation (Germany), and EU grants of the FP-6: DiMI (LSHB-CT-2005-512146), EMIL (LSHC-CT-2004-503569) and Stem Stroke (LSHB-CT-2006-037526) are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Bakondi B, 2009, MOL THER, V17, P1938, DOI 10.1038/mt.2009.185; Bakshi A, 2006, EUR J NEUROSCI, V23, P2119, DOI 10.1111/j.1460-9568.2006.04743.x; Buhnemann C, 2006, BRAIN, V129, P3238, DOI 10.1093/brain/awl261; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Chen JR, 2008, J ANAT, V213, P249, DOI 10.1111/j.1469-7580.2008.00948.x; Chen JL, 2000, NEUROPHARMACOLOGY, V39, P711, DOI 10.1016/S0028-3908(00)00006-X; Chen SJ, 2010, STEM CELLS DEV, V19, P1757, DOI 10.1089/scd.2009.0452; Chopp M, 2009, STROKE, V40, pS143, DOI 10.1161/STROKEAHA.108.533141; Chu K, 2004, BRAIN RES, V1016, P145, DOI 10.1016/j.brainres.2004.04.038; Cramer SC, 2008, ANN NEUROL, V63, P549, DOI 10.1002/ana.21412; Fong SP, 2007, J NEUROSCI RES, V85, P1851, DOI 10.1002/jnr.21319; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Guzman R, 2008, J NEUROSCI RES, V86, P873, DOI 10.1002/jnr.21542; Helene J, 2003, BEHAV BRAIN RES, V143, P177, DOI 10.1016/S0166-4328(03)00032-9; Hoehn M, 2002, P NATL ACAD SCI USA, V99, P16267, DOI 10.1073/pnas.242435499; Kang SK, 2003, EXP NEUROL, V183, P355, DOI 10.1016/S0014-4886(03)00089-X; Kim DH, 2007, CELL TRANSPLANT, V16, P1007, DOI 10.3727/000000007783472381; Kleindorfer D, 2009, STROKE, V40, P3580, DOI 10.1161/STROKEAHA.109.554626; Kurozumi K, 2004, MOL THER, V9, P189, DOI 10.1016/j.ymthe.2003.10.012; Lee HJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000156; Li Y, 2001, NEUROLOGY, V56, P1666, DOI 10.1212/WNL.56.12.1666; Liu H, 2006, BRAIN, V129, P2734, DOI 10.1093/brain/awl207; Locatelli F, 2009, CELL MOL LIFE SCI, V66, P757, DOI 10.1007/s00018-008-8346-1; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; Modo M, 2004, NEUROIMAGE, V21, P311, DOI 10.1016/j.neuroimage.2003.08.030; Modo M, 2000, J NEUROSCI METH, V104, P99, DOI 10.1016/S0165-0270(00)00329-0; Modo M, 2002, STROKE, V33, P2270, DOI 10.1161/01.STR.0000027693.50675.C5; Modo M, 2009, NEUROIMAGE, V47, pT133, DOI 10.1016/j.neuroimage.2008.06.017; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Rasband W., 2006, IMAGEJ; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Roitberg B, 2004, NEUROL RES, V26, P256, DOI 10.1179/016164104225014076; SCHALLERT T, 1982, PHARMACOL BIOCHEM BE, V16, P455, DOI 10.1016/0091-3057(82)90452-X; Shyu WC, 2007, STROKE, V38, P367, DOI 10.1161/01.STR.0000254463.24655.14; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; Snyder EY, 1997, P NATL ACAD SCI USA, V94, P11663, DOI 10.1073/pnas.94.21.11663; Stroemer P, 2009, NEUROREHAB NEURAL RE, V23, P895, DOI 10.1177/1545968309335978; Strupp JP, 1996, NEUROIMAGE, V3, pS607; Sykova E, 2007, PROG BRAIN RES, V161, P367, DOI 10.1016/S0079-6123(06)61026-1; Vendrame M, 2004, STROKE, V35, P2390, DOI 10.1161/01.STR.0000141681.06735.9b; Weber R, 2006, NEUROIMAGE, V29, P1303, DOI 10.1016/j.neuroimage.2005.08.028; Weber R, 2008, J NEUROSCI, V28, P1022, DOI 10.1523/JNEUROSCI.4147-07.2008; Wu WF, 2010, J CLIN NEUROSCI, V17, P92, DOI 10.1016/j.jocn.2009.03.039; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4	45	59	60	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12779	10.1371/journal.pone.0012779	http://dx.doi.org/10.1371/journal.pone.0012779			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877642	Green Published, Green Submitted, gold			2022-12-27	WOS:000282053100007
J	Burgess, GC; Braver, TS				Burgess, Gregory C.; Braver, Todd S.			Neural Mechanisms of Interference Control in Working Memory: Effects of Interference Expectancy and Fluid Intelligence	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; PREFRONTAL CORTEX; PROACTIVE-INTERFERENCE; COGNITIVE CONTROL; BRAIN MECHANISMS; CONFLICT; ATTENTION; CAPACITY; MIND	Background: A critical aspect of executive control is the ability to limit the adverse effects of interference. Previous studies have shown activation of left ventrolateral prefrontal cortex after the onset of interference, suggesting that interference may be resolved in a reactive manner. However, we suggest that interference control may also operate in a proactive manner to prevent effects of interference. The current study investigated the temporal dynamics of interference control by varying two factors - interference expectancy and fluid intelligence (gF) - that could influence whether interference control operates proactively versus reactively. Methodology/Principal Findings: A modified version of the recent negatives task was utilized. Interference expectancy was manipulated across task blocks by changing the proportion of recent negative (interference) trials versus recent positive (facilitation) trials. Furthermore, we explored whether gF affected the tendency to utilize specific interference control mechanisms. When interference expectancy was low, activity in lateral prefrontal cortex replicated prior results showing a reactive control pattern (i.e., interference-sensitivity during probe period). In contrast, when interference expectancy was high, bilateral prefrontal cortex activation was more indicative of proactive control mechanisms (interference-related effects prior to the probe period). Additional results suggested that the proactive control pattern was more evident in high gF individuals, whereas the reactive control pattern was more evident in low gF individuals. Conclusions/Significance: The results suggest the presence of two neural mechanisms of interference control, with the differential expression of these mechanisms modulated by both experimental (e. g., expectancy effects) and individual difference (e. g., gF) factors.	[Burgess, Gregory C.] Univ Colorado, Inst Cognit Sci, Boulder, CO 80309 USA; [Braver, Todd S.] Washington Univ, Dept Psychol, St Louis, MO 63130 USA	University of Colorado System; University of Colorado Boulder; Washington University (WUSTL)	Burgess, GC (corresponding author), Univ Colorado, Inst Cognit Sci, Boulder, CO 80309 USA.	greg.burgess@colorado.edu		Braver, Todd/0000-0002-2631-3393	National Institute of Mental Health [RO1 MH66078]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066078] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by National Institute of Mental Health grant (RO1 MH66078) to the second author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts E, 2008, J NEUROSCI, V28, P4671, DOI 10.1523/JNEUROSCI.4400-07.2008; Baddeley A.D., 1974, MOTIV ADV RES THEORY, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Badre D, 2005, CEREB CORTEX, V15, P2003, DOI 10.1093/cercor/bhi075; Badre D, 2007, NEUROPSYCHOLOGIA, V45, P2883, DOI 10.1016/j.neuropsychologia.2007.06.015; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Braver T. S., 2007, VARIATION WORKING ME, P76, DOI DOI 10.1093/ACPROF:OSO/9780195168648.003.0004; Braver TS, 2009, P NATL ACAD SCI USA, V106, P7351, DOI 10.1073/pnas.0808187106; Bunge SA, 2001, BRAIN, V124, P2074, DOI 10.1093/brain/124.10.2074; Bunting M, 2006, J EXP PSYCHOL LEARN, V32, P183, DOI 10.1037/0278-7393.32.2.183; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; COHEN JD, 1990, PSYCHOL REV, V97, P332, DOI 10.1037/0033-295X.97.3.332; D'Esposito M, 1999, P NATL ACAD SCI USA, V96, P7514, DOI 10.1073/pnas.96.13.7514; De Pisapia N, 2006, NEUROCOMPUTING, V69, P1322, DOI 10.1016/j.neucom.2005.12.100; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Diamond A, 2009, DEV PSYCHOL, V45, P130, DOI 10.1037/a0014025; Engle RW, 1999, J EXP PSYCHOL GEN, V128, P309, DOI 10.1037/0096-3445.128.3.309; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Gray JR, 2003, NAT NEUROSCI, V6, P316, DOI 10.1038/nn1014; Hamilton AC, 2005, COGN AFFECT BEHAV NE, V5, P1; Hasher L., 1988, PSYCHOL LEARNING MOT, V22, P193, DOI [10.1016/S0079-7421(08)60041-9, DOI 10.1016/S0079-7421(08)60041-9]; Hasher L., 2008, VARIATION WORKING ME, P227, DOI [10.1093/acprof:oso/9780195168648.001.0001, DOI 10.1093/ACPROF:OSO/9780195168648.001.0001, DOI 10.1093/ACPROF:OSO/9780195168648.003.0009]; Jonides J, 2006, NEUROSCIENCE, V139, P181, DOI 10.1016/j.neuroscience.2005.06.042; Kan IP, 2004, COGN AFFECT BEHAV NE, V4, P43, DOI 10.3758/CABN.4.1.43; Kane MJ, 2002, PSYCHON B REV, V9, P637, DOI 10.3758/BF03196323; Mecklinger A, 2003, COGNITIVE BRAIN RES, V18, P26, DOI 10.1016/j.cogbrainres.2003.08.008; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Nee DE, 2007, NEUROIMAGE, V38, P740, DOI 10.1016/j.neuroimage.2007.07.066; O'Reilly RC, 2006, SCIENCE, V314, P91, DOI 10.1126/science.1127242; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Raven J.C., 1998, ADV PROGR MATRICES; Sohn MH, 2007, P NATL ACAD SCI USA, V104, P10330, DOI 10.1073/pnas.0703225104; Speer NK, 2003, COGN AFFECT BEHAV NE, V3, P155, DOI 10.3758/CABN.3.3.155; Thompson-Schill SL, 2006, PSYCHON B REV, V13, P402, DOI 10.3758/BF03193860; Thompson-Schill SL, 2002, COGN AFFECT BEHAV NE, V2, P109, DOI 10.3758/CABN.2.2.109; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Ward B. D., 2000, SIMULTANEOUS INFEREN, DOI https://afni.nimh.nih.gov/pub/dist/doc/manuals/AlphaSim.pdf; Whitney P, 2001, BRAIN COGNITION, V45, P1, DOI 10.1006/brcg.2000.1243	37	85	87	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2010	5	9							e12861	10.1371/journal.pone.0012861	http://dx.doi.org/10.1371/journal.pone.0012861			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	651YH	20877464	Green Published, gold			2022-12-27	WOS:000281963200021
J	Ma, T; Hoeffer, CA; Capetillo-Zarate, E; Yu, FM; Wong, H; Lin, MT; Tampellini, D; Klann, E; Blitzer, RD; Gouras, GK				Ma, Tao; Hoeffer, Charles A.; Capetillo-Zarate, Estibaliz; Yu, Fangmin; Wong, Helen; Lin, Michael T.; Tampellini, Davide; Klann, Eric; Blitzer, Robert D.; Gouras, Gunnar K.			Dysregulation of the mTOR Pathway Mediates Impairment of Synaptic Plasticity in a Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							AMYLOID-BETA; A-BETA; PROTEIN-SYNTHESIS; UP-REGULATION; S6 KINASE; LIFE-SPAN; MEMORY; INHIBITION; INDUCTION; DEFICITS	Background: The mammalian target of rapamycin (mTOR) is an evolutionarily conserved Ser/Thr protein kinase that plays a pivotal role in multiple fundamental biological processes, including synaptic plasticity. We explored the relationship between the mTOR pathway and beta-amyloid (A beta)-induced synaptic dysfunction, which is considered to be critical in the pathogenesis of Alzheimer's disease (AD). Methodology/Principal Findings: We provide evidence that inhibition of mTOR signaling correlates with impairment in synaptic plasticity in hippocampal slices from an AD mouse model and in wild-type slices exposed to exogenous A beta 1-42. Importantly, by up-regulating mTOR signaling, glycogen synthase kinase 3 (GSK3) inhibitors rescued LTP in the AD mouse model, and genetic deletion of FK506-binding protein 12 (FKBP12) prevented A beta-induced impairment in long-term potentiation (LTP). In addition, confocal microscopy demonstrated co-localization of intraneuronal A beta 42 with mTOR. Conclusions/Significance: These data support the notion that the mTOR pathway modulates A beta-related synaptic dysfunction in AD.	[Ma, Tao; Capetillo-Zarate, Estibaliz; Yu, Fangmin; Lin, Michael T.; Tampellini, Davide; Gouras, Gunnar K.] Weill Cornell Med Coll, Dept Neurol & Neurosci, New York, NY USA; [Hoeffer, Charles A.; Wong, Helen; Klann, Eric] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Blitzer, Robert D.] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY USA; [Gouras, Gunnar K.] Rockefeller Univ, New York, NY 10021 USA	Cornell University; New York University; Icahn School of Medicine at Mount Sinai; Rockefeller University	Ma, T (corresponding author), Weill Cornell Med Coll, Dept Neurol & Neurosci, New York, NY USA.	gkgouras@med.cornell.edu	Capetillo-Zarate, Estibaliz/Z-5772-2019; Gouras, Gunnar/B-3021-2010	Capetillo-Zarate, Estibaliz/0000-0002-8416-0495; Gouras, Gunnar/0000-0002-5500-6325; Tampellini, Davide/0000-0003-3188-0293	National Institutes of Health [NS034007, GM054508, AG027140, AG28174, AG09464]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034007, R29NS034007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG009464, R01AG027140, K02AG028174, R01AG020729] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants NS034007 (EK), GM054508 (RDB), AG027140, AG28174, and AG09464 (GKG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; An WL, 2003, AM J PATHOL, V163, P591, DOI 10.1016/S0002-9440(10)63687-5; Balaraman Y, 2006, CELL MOL LIFE SCI, V63, P1226, DOI 10.1007/s00018-005-5597-y; Banko JL, 2006, J NEUROSCI, V26, P2167, DOI 10.1523/JNEUROSCI.5196-05.2006; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Caccamo A, 2010, J BIOL CHEM, V285, P13107, DOI 10.1074/jbc.M110.100420; Choo AY, 2006, CELL, V126, P834, DOI 10.1016/j.cell.2006.08.025; Cohen E, 2009, CELL, V139, P1157, DOI 10.1016/j.cell.2009.11.014; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106; Flinn RJ, 2010, MOL BIOL CELL, V21, P833, DOI 10.1091/mbc.E09-09-0756; Fumagalli S, 2000, COLD SPRING HARBOR M, V39, P695; Gobert D, 2008, J NEUROCHEM, V106, P1160, DOI 10.1111/j.1471-4159.2008.05470.x; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hernandez F, 2010, EXP NEUROL, V223, P322, DOI 10.1016/j.expneurol.2009.09.011; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Hoeffer CA, 2008, NEURON, V60, P832, DOI 10.1016/j.neuron.2008.09.037; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Jaworski J, 2006, MOL NEUROBIOL, V34, P205, DOI 10.1385/MN:34:3:205; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Kimura T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003540; Lafay-Chebassier C, 2005, J NEUROCHEM, V94, P215, DOI 10.1111/j.1471-4159.2005.03187.x; Lee HK, 2009, MOL BIOL CELL, V20, P1533, DOI 10.1091/mbc.E08-07-0777; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Peineau S, 2008, BRIT J PHARMACOL, V153, pS428, DOI 10.1038/bjp.2008.2; Piper MDW, 2008, J INTERN MED, V263, P179, DOI 10.1111/j.1365-2796.2007.01906.x; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Reger MA, 2008, NEUROLOGY, V70, P440, DOI 10.1212/01.WNL.0000265401.62434.36; Reiling JH, 2006, ONCOGENE, V25, P6373, DOI 10.1038/sj.onc.1209889; Runz H, 2002, J NEUROSCI, V22, P1679, DOI 10.1523/JNEUROSCI.22-05-01679.2002; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Tampellini D, 2009, J NEUROSCI, V29, P9704, DOI 10.1523/JNEUROSCI.2292-09.2009; Terwel D, 2008, AM J PATHOL, V172, P786, DOI 10.2353/ajpath.2008.070904; Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010; Townsend M, 2007, J BIOL CHEM, V282, P33305, DOI 10.1074/jbc.M610390200; Tsokas P, 2005, J NEUROSCI, V25, P5833, DOI 10.1523/JNEUROSCI.0599-05.2005; Wesson DW, 2010, J NEUROSCI, V30, P505, DOI 10.1523/JNEUROSCI.4622-09.2010; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X; Zhu LQ, 2007, J NEUROSCI, V27, P12211, DOI 10.1523/JNEUROSCI.3321-07.2007	49	181	189	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2010	5	9							e12845	10.1371/journal.pone.0012845	http://dx.doi.org/10.1371/journal.pone.0012845			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651YH	20862226	Green Published, Green Submitted, gold			2022-12-27	WOS:000281963200015
J	Boue, S; Paramonov, I; Barrero, MJ; Belmonte, JCI				Boue, Stephanie; Paramonov, Ida; Jose Barrero, Maria; Izpisua Belmonte, Juan Carlos			Analysis of Human and Mouse Reprogramming of Somatic Cells to Induced Pluripotent Stem Cells. What Is in the Plate?	PLOS ONE			English	Article							GENE-EXPRESSION; IPS CELLS; CHROMATIN-STRUCTURE; DEFINED FACTORS; GENERATION; FIBROBLASTS; INDUCTION; MURINE; MICE; DIFFERENTIATION	After the hope and controversy brought by embryonic stem cells two decades ago for regenerative medicine, a new turn has been taken in pluripotent cells research when, in 2006, Yamanaka's group reported the reprogramming of fibroblasts to pluripotent cells with the transfection of only four transcription factors. Since then many researchers have managed to reprogram somatic cells from diverse origins into pluripotent cells, though the cellular and genetic consequences of reprogramming remain largely unknown. Furthermore, it is still unclear whether induced pluripotent stem cells (iPSCs) are truly functionally equivalent to embryonic stem cells (ESCs) and if they demonstrate the same differentiation potential as ESCs. There are a large number of reprogramming experiments published so far encompassing genome-wide transcriptional profiling of the cells of origin, the iPSCs and ESCs, which are used as standards of pluripotent cells and allow us to provide here an in-depth analysis of transcriptional profiles of human and mouse cells before and after reprogramming. When compared to ESCs, iPSCs, as expected, share a common pluripotency/self-renewal network. Perhaps more importantly, they also show differences in the expression of some genes. We concentrated our efforts on the study of bivalent domain-containing genes (in ESCs) which are not expressed in ESCs, as they are supposedly important for differentiation and should possess a poised status in pluripotent cells, i.e. be ready to but not yet be expressed. We studied each iPSC line separately to estimate the quality of the reprogramming and saw a correlation of the lowest number of such genes expressed in each respective iPSC line with the stringency of the pluripotency test achieved by the line. We propose that the study of expression of bivalent domain-containing genes, which are normally silenced in ESCs, gives a valuable indication of the quality of the iPSC line, and could be used to select the best iPSC lines out of a large number of lines generated in each reprogramming experiment.	[Boue, Stephanie; Paramonov, Ida; Jose Barrero, Maria; Izpisua Belmonte, Juan Carlos] Ctr Regenerat Med Barcelona CMRB, Barcelona, Spain; [Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; Salk Institute	Boue, S (corresponding author), Ctr Regenerat Med Barcelona CMRB, Barcelona, Spain.	belmonte@salk.edu	Barrero, Maria J./Q-1785-2017	Barrero, Maria J./0000-0002-5990-7040; Boue, Stephanie/0000-0003-0680-4168	G. Harold and Leila Y. Mathers Charitable Foundation; Sanofi-Aventis; Fundacion Cellex; Networking Center of Biomedical Research (CIBER); Terapia Celular (TERCEL); Ministerio de Ciencia e Innovacion (MICINN)	G. Harold and Leila Y. Mathers Charitable Foundation; Sanofi-Aventis(Sanofi-Aventis); Fundacion Cellex(Foundation CELLEX); Networking Center of Biomedical Research (CIBER); Terapia Celular (TERCEL); Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by The G. Harold and Leila Y. Mathers Charitable Foundation, Sanofi-Aventis, Fundacion Cellex, Networking Center of Biomedical Research (CIBER), Terapia Celular (TERCEL) and Ministerio de Ciencia e Innovacion (MICINN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Allegrucci C, 2007, HUM REPROD UPDATE, V13, P103, DOI 10.1093/humupd/dml041; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Belting HG, 1998, J EXP ZOOL, V282, P196, DOI 10.1002/(SICI)1097-010X(199809/10)282:1/2&lt;196::AID-JEZ22&gt;3.0.CO;2-R; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chin MH, 2010, CELL STEM CELL, V7, P263, DOI 10.1016/j.stem.2010.06.019; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Choi KD, 2009, STEM CELLS, V27, P559, DOI 10.1634/stemcells.2008-0922; Daley GQ, 2009, CELL STEM CELL, V4, P200, DOI 10.1016/j.stem.2009.02.009; DIMOS JT, 2008, SCIENCE; EBERT AD, 2008, NATURE; Ellis J, 2009, CELL STEM CELL, V4, P198, DOI 10.1016/j.stem.2009.02.010; Enver T, 2009, CELL STEM CELL, V4, P387, DOI 10.1016/j.stem.2009.04.011; Feng B, 2009, CELL STEM CELL, V4, P301, DOI 10.1016/j.stem.2009.03.005; Ghosh Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008975; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; HENG JC, CELL STEM CELL, V6, P167; Hirami Y, 2009, NEUROSCI LETT, V458, P126, DOI 10.1016/j.neulet.2009.04.035; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; HONG H, 2009, NATURE; Hooper SD, 2005, BIOINFORMATICS, V21, P4432, DOI 10.1093/bioinformatics/bti696; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kang L., 2009, CELL STEM CELL; KAWAMURA T, 2009, NATURE; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; LEE G, 2009, NATURE; LI H, 2009, NATURE; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Marchetto MCN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007076; MARION RM, 2009, NATURE; Marion RM, 2009, CELL STEM CELL, V4, P141, DOI 10.1016/j.stem.2008.12.010; Markoulaki S, 2009, NAT BIOTECHNOL, V27, P169, DOI 10.1038/nbt.1520; Masaki H, 2008, STEM CELL RES, V1, P105, DOI 10.1016/j.scr.2008.01.001; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; MIKKELSEN TS, 2008, NATURE; MIURA K, 2009, NAT BIOTECHNOL; MULLER FJ, 2008, NATURE; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Newman AM, 2010, CELL STEM CELL, V7, P258, DOI 10.1016/j.stem.2010.06.016; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Polo JM, 2010, NAT BIOTECHNOL; Raya A, 2009, NATURE, V460, P53, DOI 10.1038/nature08129; Schenke-Layland K, 2008, STEM CELLS, V26, P1537, DOI 10.1634/stemcells.2008-0033; Schulz TC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-478; Shao LJ, 2009, CELL RES, V19, P296, DOI 10.1038/cr.2009.20; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; SOMMER CA, 2008, STEM CELLS; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tateishi K, 2008, J BIOL CHEM, V283, P31601, DOI 10.1074/jbc.M806597200; Taura D, 2009, FEBS LETT, V583, P1029, DOI 10.1016/j.febslet.2009.02.031; Tsai KN, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/917084; UTIKAL J, 2009, NATURE; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; YU J, 2007, SCIENCE; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	83	48	48	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2010	5	9							e12664	10.1371/journal.pone.0012664	http://dx.doi.org/10.1371/journal.pone.0012664			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651XL	20862250	Green Published, Green Submitted, gold			2022-12-27	WOS:000281960800004
J	Song, MJ; Dean, D; Tate, MLK				Song, Min Jae; Dean, David; Tate, Melissa L. Knothe			In Situ Spatiotemporal Mapping of Flow Fields around Seeded Stem Cells at the Subcellular Length Scale	PLOS ONE			English	Article							MARROW STROMAL CELLS; FLUID SHEAR-STRESS; GENE-EXPRESSION; MECHANICAL MODULATION; EXTRACELLULAR-MATRIX; HYDROSTATIC-PRESSURE; BONE-CELLS; DIFFERENTIATION; CHONDROGENESIS; MECHANOTRANSDUCTION	A major hurdle to understanding and exploiting interactions between the stem cell and its environment is the lack of a tool for precise delivery of mechanical cues concomitant to observing sub-cellular adaptation of structure. These studies demonstrate the use of microscale particle image velocimetry (mu-PIV) for in situ spatiotemporal mapping of flow fields around mesenchymal stem cells, i.e. murine embryonic multipotent cell line C3H10T1/2, at the subcellular length scale, providing a tool for real time observation and analysis of stem cell adaptation to the prevailing mechanical milieu. In the absence of cells, computational fluid dynamics (CFD) predicts flow regimes within 12% of m-PIV measures, achieving the technical specifications of the chamber and the flow rates necessary to deliver target shear stresses at a particular height from the base of the flow chamber. However, our mu-PIV studies show that the presence of cells per se as well as the density at which cells are seeded significantly influences local flow fields. Furthermore, for any given cell or cell seeding density, flow regimes vary significantly along the vertical profile of the cell. Hence, the mechanical milieu of the stem cell exposed to shape changing shear stresses, induced by fluid drag, varies with respect to proximity of surrounding cells as well as with respect to apical height. The current study addresses a previously unmet need to predict and observe both flow regimes as well as mechanoadaptation of cells in flow chambers designed to deliver precisely controlled mechanical signals to live cells. An understanding of interactions and adaptation in response to forces at the interface between the surface of the cell and its immediate local environment may be key for de novo engineering of functional tissues from stem cell templates as well as for unraveling the mechanisms underlying multiscale development, growth and adaptation of organisms.	[Song, Min Jae] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Dean, David] Case Western Reserve Univ, Dept Neurol Surg, Cleveland, OH 44106 USA; [Tate, Melissa L. Knothe] Case Western Reserve Univ, Dept Biomed Engn, Dept Mech & Aerosp Engn, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Song, MJ (corresponding author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.	knothetate@case.edu	Dean, David/F-9605-2017; Knothe Tate, Melissa L./O-2086-2015	Dean, David/0000-0002-1217-3764; Knothe Tate, Melissa L./0000-0002-3552-2525	National Institutes of Health [R01-DE013740]; National Science Foundation [CMMI-0826435]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013740] Funding Source: NIH RePORTER; Div Of Civil, Mechanical, & Manufact Inn [0826435] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Div Of Civil, Mechanical, & Manufact Inn(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	National Institutes of Health grant (NIDCR, R01-DE013740) (http://www.nih.gov/), National Science Foundation Grant # CMMI-0826435 (Nano/Bio Mechanics Program) (http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto T, 2005, BIOCHEM BIOPH RES CO, V329, P381, DOI 10.1016/j.bbrc.2005.01.136; Anderson EJ, 2007, BIOMED ENG ONLINE, V6, DOI 10.1186/1475-925X-6-46; Anderson EJ, 2007, TISSUE ENG, V13, P2525, DOI 10.1089/ten.2006.0443; Anderson EJ, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-27; Angele P, 2003, J ORTHOPAED RES, V21, P451, DOI 10.1016/S0736-0266(02)00230-9; Bakker AD, 2001, J BIOMECH, V34, P671, DOI 10.1016/S0021-9290(00)00231-1; Baksh D, 2007, J CELL PHYSIOL, V212, P817, DOI 10.1002/jcp.21080; Bielby RC, 2004, TISSUE ENG, V10, P1518, DOI 10.1089/ten.2004.10.1518; Billotte W G, 2001, Biomed Sci Instrum, V37, P1; Brangwynne CP, 2006, J CELL BIOL, V173, P733, DOI 10.1083/jcb.200601060; Campbell JJ, 2006, BIORHEOLOGY, V43, P455; CARTER DR, 1988, J ORTHOPAED RES, V6, P148, DOI 10.1002/jor.1100060120; Chen CS, 2008, J CELL SCI, V121, P3285, DOI 10.1242/jcs.023507; Christ KV, 2010, BIOMED MICRODEVICES, V12, P443, DOI 10.1007/s10544-010-9401-x; Datta N, 2006, P NATL ACAD SCI USA, V103, P2488, DOI 10.1073/pnas.0505661103; David V, 2007, ENDOCRINOLOGY, V148, P2553, DOI 10.1210/en.2006-1704; Derfoul A, 2004, DIFFERENTIATION, V72, P209, DOI 10.1111/j.1432-0436.2004.07205003.x; Elder SH, 2005, BIOMECH MODEL MECHAN, V3, P141, DOI 10.1007/s10237-004-0058-3; Estes BT, 2004, CURR TOP DEV BIOL, V60, P91; FALLS TD, 2007, THESIS CASE W RESERV; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Freeman M, 2002, ANNU REV CELL DEV BI, V18, P515, DOI 10.1146/annurev.cellbio.18.012502.083458; HANACHANG, 2010, 722 ORS; Illi B, 2005, CIRC RES, V96, P501, DOI 10.1161/01.RES.0000159181.06379.63; Kearney EM, 2010, ANN BIOMED ENG, V38, P1767, DOI 10.1007/s10439-010-9979-4; Knippenberg M, 2005, TISSUE ENG, V11, P1780, DOI 10.1089/ten.2005.11.1780; KURPINSKI K, 2010, STEM CELLS, P9999, DOI DOI 10.1002/STEM.319; McBride SH, 2008, TISSUE ENG PT A, V14, P1561, DOI 10.1089/ten.tea.2008.0112; McBride SH, 2008, TISSUE ENG PT A, V14, P1573, DOI 10.1089/ten.tea.2008.0113; Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4; MELISSA L, 2010, ENG ECOSYSTEM TAKING, P57; Miyanishi K, 2006, TISSUE ENG, V12, P1419, DOI 10.1089/ten.2006.12.1419; OSTER GF, 1985, J EMBRYOL EXP MORPH, V89, P93; OSTER GF, 1983, J EMBRYOL EXP MORPH, V78, P83; PAUWELS F, 1960, Z Anat Entwicklungsgesch, V121, P478, DOI 10.1007/BF00523401; Roelofsen J, 1995, J BIOMECH, V28, P1493, DOI 10.1016/0021-9290(95)00097-6; Salek MM, 2009, BIOFOULING, V25, P711, DOI 10.1080/08927010903114603; Shea CM, 2003, J CELL BIOCHEM, V90, P1112, DOI 10.1002/jcb.10734; Siddappa R, 2008, P NATL ACAD SCI USA, V105, P7281, DOI 10.1073/pnas.0711190105; Sikavitsas VI, 2005, ANN BIOMED ENG, V33, P63, DOI 10.1007/s10439-005-8963-x; Sorkin AM, 2004, AM J PHYSIOL-CELL PH, V287, pC1527, DOI 10.1152/ajpcell.00059.2004; Stops AJF, 2010, J BIOMECH, V43, P618, DOI 10.1016/j.jbiomech.2009.10.037; Takahashi I, 1998, J CELL SCI, V111, P2067; Tate MLK, 2008, INT J BIOCHEM CELL B, V40, P2720, DOI 10.1016/j.biocel.2008.05.011; Tate MLK, 2007, J BONE JOINT SURG AM, V89A, P307, DOI 10.2106/JBJS.E.00512; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Walker E, 2010, CELL STEM CELL, V6, P153, DOI 10.1016/j.stem.2009.12.014; Wang H, 2005, ARTERIOSCL THROM VAS, V25, P1817, DOI 10.1161/01.ATV.0000175840.90510.a8	48	23	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2010	5	9							e12796	10.1371/journal.pone.0012796	http://dx.doi.org/10.1371/journal.pone.0012796			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651XL	20862249	gold, Green Submitted, Green Published			2022-12-27	WOS:000281960800013
J	Karlsson, K; Eroukhmanoff, F; Svensson, EI				Karlsson, Kristina; Eroukhmanoff, Fabrice; Svensson, Erik I.			Phenotypic Plasticity in Response to the Social Environment: Effects of Density and Sex Ratio on Mating Behaviour Following Ecotype Divergence	PLOS ONE			English	Article							ASELLUS-AQUATICUS L; MALE-MALE COMPETITION; FRESH-WATER ISOPOD; FEMALE RESISTANCE; MATE CHOICE; ADAPTIVE PLASTICITY; LIFE-HISTORY; EVOLUTION; INVESTMENT; SELECTION	The ability to express phenotypically plastic responses to environmental cues might be adaptive in changing environments. We studied phenotypic plasticity in mating behaviour as a response to population density and adult sex ratio in a freshwater isopod (Asellus aquaticus). A. aquaticus has recently diverged into two distinct ecotypes, inhabiting different lake habitats (reed Phragmites australis and stonewort Chara tomentosa, respectively). In field surveys, we found that these habitats differ markedly in isopod population densities and adult sex ratios. These spatially and temporally demographic differences are likely to affect mating behaviour. We performed behavioural experiments using animals from both the ancestral ecotype ("reed" isopods) and from the novel ecotype ("stonewort" isopods) population. We found that neither ecotype adjusted their behaviour in response to population density. However, the reed ecotype had a higher intrinsic mating propensity across densities. In contrast to the effects of density, we found ecotype differences in plasticity in response to sex ratio. The stonewort ecotype show pronounced phenotypic plasticity in mating propensity to adult sex ratio, whereas the reed ecotype showed a more canalised behaviour with respect to this demographic factor. We suggest that the lower overall mating propensity and the phenotypic plasticity in response to sex ratio have evolved in the novel stonewort ecotype following invasion of the novel habitat. Plasticity in mating behaviour may in turn have effects on the direction and intensity of sexual selection in the stonewort habitat, which may fuel further ecotype divergence.	[Karlsson, Kristina; Eroukhmanoff, Fabrice; Svensson, Erik I.] Lund Univ, Sect Anim Ecol, Dept Biol, Lund, Sweden	Lund University	Karlsson, K (corresponding author), Lund Univ, Sect Anim Ecol, Dept Biol, Lund, Sweden.	kristina.karlsson@zooekol.lu.se	Eroukhmanoff, Fabrice/F-8319-2010; Svensson, Erik/E-8324-2010; eroukhmanoff, fabrice/D-1414-2015	Svensson, Erik/0000-0001-9006-016X; 	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was funded by grants from the Swedish Research Council (VR) http://www.vr.se/ and FORMAS http://www.formas.se/ to E.I.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Alonzo SH, 2001, BEHAV ECOL SOCIOBIOL, V49, P176, DOI 10.1007/s002650000265; Bonduriansky R, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000255; Bouchon D, 1998, P ROY SOC B-BIOL SCI, V265, P1081, DOI 10.1098/rspb.1998.0402; Chaine AS, 2008, SCIENCE, V319, P459, DOI 10.1126/science.1149167; Chevin LM, 2010, EVOLUTION, V64, P1143, DOI 10.1111/j.1558-5646.2009.00875.x; Cornwallis CK, 2010, TRENDS ECOL EVOL, V25, P145, DOI 10.1016/j.tree.2009.09.008; Cothran RD, 2004, ANIM BEHAV, V68, P1133, DOI 10.1016/j.anbehav.2003.09.021; Duckworth RA, 2009, EVOL ECOL, V23, P513, DOI 10.1007/s10682-008-9252-6; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Eroukhmanoff F, 2009, J EVOLUTION BIOL, V22, P1098, DOI 10.1111/j.1420-9101.2009.01723.x; EROUKHMANOFF F, 2009, THESIS LUND U LUND, P241; Eroukhmanoff F, 2009, MOL ECOL, V18, P4912, DOI 10.1111/j.1365-294X.2009.04408.x; Eroukhmanoff F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006173; Evans JP, 1999, ANIM BEHAV, V58, P1001, DOI 10.1006/anbe.1999.1212; Forsgren E, 2004, NATURE, V429, P551, DOI 10.1038/nature02562; Gavrilets S, 2000, NATURE, V403, P886, DOI 10.1038/35002564; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Gosden TP, 2009, AM NAT, V173, P709, DOI 10.1086/598491; Hargeby A, 2005, J EVOLUTION BIOL, V18, P713, DOI 10.1111/j.1420-9101.2004.00837.x; Hargeby A, 2004, EVOLUTION, V58, P81; Hargeby A, 2007, ECOSYSTEMS, V10, P29, DOI 10.1007/s10021-006-9008-5; Harris S, 2010, THESIS LUND U LUND; Hendry AP, 2008, MOL ECOL, V17, P20, DOI 10.1111/j.1365-294X.2007.03428.x; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Jirotkul M, 1999, ANIM BEHAV, V58, P287, DOI 10.1006/anbe.1999.1149; JORMALAINEN V, 1994, ETHOLOGY, V96, P46; JORMALAINEN V, 1994, BEHAV PROCESS, V32, P265, DOI 10.1016/0376-6357(94)90047-7; JORMALAINEN V, 1995, BIOL J LINN SOC, V55, P45, DOI 10.1111/j.1095-8312.1995.tb01049.x; JORMALAINEN V, 1995, BEHAV ECOL SOCIOBIOL, V36, P43; Jormalainen V, 1998, Q REV BIOL, V73, P275, DOI 10.1086/420306; JORMALAINEN V, 1993, BEHAVIOUR, V125, P219, DOI 10.1163/156853993X00254; JORMALAINEN V, 1992, ANN ZOOL FENN, V29, P161; Kokko H, 2006, PHILOS T R SOC B, V361, P319, DOI 10.1098/rstb.2005.1784; Kokko H, 2008, J EVOLUTION BIOL, V21, P919, DOI 10.1111/j.1420-9101.2008.01540.x; KRUPA JJ, 1993, BEHAV ECOL SOCIOBIOL, V33, P107, DOI 10.1007/BF00171662; Losos JB, 2000, EVOLUTION, V54, P301, DOI 10.1111/j.0014-3820.2000.tb00032.x; MANNING JT, 1975, BEHAVIOUR, V55, P1, DOI 10.1163/156853975X00380; MANNING JT, 1980, BEHAVIOUR, V74, P264, DOI 10.1163/156853980X00483; OKLAND KA, 1978, HYDROBIOLOGIA, V59, P243, DOI 10.1007/BF00036504; PARKER GA, 1974, BEHAVIOUR, V48, P157, DOI 10.1163/156853974X00327; Pettersson LB, 2004, BEHAV ECOL SOCIOBIOL, V55, P461, DOI 10.1007/s00265-003-0727-8; Price TD, 2003, P ROY SOC B-BIOL SCI, V270, P1433, DOI 10.1098/rspb.2003.2372; Qvarnstrom A, 2000, NATURE, V405, P344, DOI 10.1038/35012605; Reznick DN, 1997, SCIENCE, V275, P1934, DOI 10.1126/science.275.5308.1934; RIDLEY M, 1979, Z TIERPSYCHOL, V51, P380; Sparkes TC, 2000, BEHAV ECOL SOCIOBIOL, V47, P145, DOI 10.1007/s002650050005; Svensson E, 2001, EVOLUTION, V55, P2053; Svensson EI, 2007, AM NAT, V170, P101, DOI 10.1086/518181; TULSA L, 2004, STATISTICA 7 STATSOF; VIA S, 1995, TRENDS ECOL EVOL, V10, P212, DOI 10.1016/S0169-5347(00)89061-8; Wagner BMA, 1998, HYDROBIOLOGIA, V368, P75, DOI 10.1023/A:1003213224327; West-Eberhard Mary Jane, 2003, pi; WESTEBERHARD MJ, 1989, ANNU REV ECOL SYST, V20, P249, DOI 10.1146/annurev.es.20.110189.001341; Whitlock MC, 2008, MOL ECOL, V17, P1885, DOI 10.1111/j.1365-294X.2008.03712.x	55	19	19	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2010	5	9							e12755	10.1371/journal.pone.0012755	http://dx.doi.org/10.1371/journal.pone.0012755			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650QH	20862332	Green Published, Green Submitted, gold			2022-12-27	WOS:000281864100010
J	Hong, S; Chung, T; Kim, D				Hong, Seungpyo; Chung, Taesu; Kim, Dongsup			SH3 Domain-Peptide Binding Energy Calculations Based on Structural Ensemble and Multiple Peptide Templates	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; SPOT-SYNTHESIS; FORCE-FIELD; PREDICTION; PARALLEL; RECOGNITION; SIMULATIONS; PROTEINS; SUPPORT; ARRAYS	SH3 domains mediate signal transduction by recognizing short peptides. Understanding of the driving forces in peptide recognitions will help us to predict the binding specificity of the domain-peptide recognition and to understand the molecular interaction networks of cells. However, accurate calculation of the binding energy is a tough challenge. In this study, we propose three ideas for improving our ability to predict the binding energy between SH3 domains and peptides: (1) utilizing the structural ensembles sampled from a molecular dynamics simulation trajectory, (2) utilizing multiple peptide templates, and (3) optimizing the sequence-structure mapping. We tested these three ideas on ten previously studied SH3 domains for which SPOT analysis data were available. The results indicate that calculating binding energy using the structural ensemble was most effective, clearly increasing the prediction accuracy, while the second and third ideas tended to give better binding energy predictions. We applied our method to the five SH3 targets in DREAM4 Challenge and selected the best performing method.	[Hong, Seungpyo; Chung, Taesu; Kim, Dongsup] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST)	Hong, S (corresponding author), Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea.	kds@kaist.ac.kr	Kim, Dongsup/C-1612-2011; Hong, Seungpyo/ABA-4461-2021	Hong, Seungpyo/0000-0003-1273-0740	Ministry of Education, Science and Technology [2008-2000220]	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the Pioneer Research Center Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2008-2000220). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benedix A, 2009, NAT METHODS, V6, P3, DOI 10.1038/nmeth0109-3; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brannetti B, 2000, J MOL BIOL, V298, P313, DOI 10.1006/jmbi.2000.3670; Comeau SR, 2007, PROTEINS, V69, P781, DOI 10.1002/prot.21795; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Doytchinova IA, 2001, J MED CHEM, V44, P3572, DOI 10.1021/jm010021j; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Fernandez-Ballester G, 2009, J MOL BIOL, V388, P902, DOI 10.1016/j.jmb.2009.03.038; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; Gerek ZN, 2009, PROTEINS, V77, P796, DOI 10.1002/prot.22492; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hilpert K, 2007, NAT PROTOC, V2, P1333, DOI 10.1038/nprot.2007.160; Hou TJ, 2008, J MOL BIOL, V376, P1201, DOI 10.1016/j.jmb.2007.12.054; Hou TJ, 2006, PLOS COMPUT BIOL, V2, P46, DOI 10.1371/journal.pcbi.0020001; Hou TJ, 2009, MOL CELL PROTEOMICS, V8, P639, DOI 10.1074/mcp.M800450-MCP200; Kuriyan J, 1997, ANNU REV BIOPH BIOM, V26, P259, DOI 10.1146/annurev.biophys.26.1.259; Landgraf C, 2004, PLOS BIOL, V2, P94, DOI 10.1371/journal.pbio.0020014; Lehrach WP, 2006, BIOINFORMATICS, V22, P532, DOI 10.1093/bioinformatics/bti804; Nguyen JT, 1998, SCIENCE, V282, P2088, DOI 10.1126/science.282.5396.2088; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Reineke U, 2001, CURR OPIN BIOTECH, V12, P59, DOI 10.1016/S0958-1669(00)00178-6; Reiss DJ, 2004, BIOINFORMATICS, V20, P274, DOI 10.1093/bioinformatics/bth922; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Sorin EJ, 2005, BIOPHYS J, V88, P2472, DOI 10.1529/biophysj.104.051938; Suenaga A, 2003, BIOCHEMISTRY-US, V42, P5195, DOI 10.1021/bi034113h; Wunderlich Z, 2009, NUCLEIC ACIDS RES, V37, P4629, DOI 10.1093/nar/gkp394; Zarrinpar Ali, 2003, Sci STKE, V2003, pRE8, DOI 10.1126/stke.2003.179.re8	29	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12654	10.1371/journal.pone.0012654	http://dx.doi.org/10.1371/journal.pone.0012654			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856816	Green Published, gold, Green Submitted			2022-12-27	WOS:000281815800004
J	Deruy, E; Gosselin, K; Vercamer, C; Martien, S; Bouali, F; Slomianny, C; Bertout, J; Bernard, D; Pourtier, A; Abbadie, C				Deruy, Emeric; Gosselin, Karo; Vercamer, Chantal; Martien, Sebastien; Bouali, Fatima; Slomianny, Christian; Bertout, Julie; Bernard, David; Pourtier, Albin; Abbadie, Corinne			MnSOD Upregulation Induces Autophagic Programmed Cell Death in Senescent Keratinocytes	PLOS ONE			English	Article							HUMAN ENDOTHELIAL-CELLS; OXIDATIVE STRESS; PIECEMEAL MICROAUTOPHAGY; REPLICATIVE SENESCENCE; POLYETHYLENE-GLYCOL; IN-VITRO; PROTEIN; MITOCHONDRIA; NUCLEUS; DIE	Senescence is a state of growth arrest resulting mainly from telomere attrition and oxidative stress. It ultimately leads to cell death. We have previously shown that, in keratinocytes, senescence is induced by NF-kappaB activation, MnSOD upregulation and H2O2 overproduction. We have also shown that senescent keratinocytes do not die by apoptosis but as a result of high macroautophagic activity that targets the primary vital cell components. Here, we investigated the mechanisms that activate this autophagic cell death program. We show that corpses occurring at the senescence plateau display oxidatively-damaged mitochondria and nucleus that colocalize with autophagic vacuoles. The occurrence of such corpses was decreased by specifically reducing the H2O2 level with catalase, and, conversely, reproduced by overexpressing MnSOD or applying subtoxic doses of H2O2. This H2O2-induced cell death did occur through autophagy since it was accompanied by an accumulation of autophagic vesicles as evidenced by Lysotracker staining, LC3 vesiculation and transmission electron microscopy. Most importantly, it was partly abolished by 3-methyladenine, the specific inhibitor of autophagosome formation, and by anti-Atg5 siRNAs. Taken together these results suggest that autophagic cell death is activated in senescent keratinocytes because of the upregulation of MnSOD and the resulting accumulation of oxidative damages to nucleus and mitochondria.	[Deruy, Emeric; Gosselin, Karo; Vercamer, Chantal; Martien, Sebastien; Bouali, Fatima; Slomianny, Christian; Bertout, Julie; Pourtier, Albin; Abbadie, Corinne] Univ Lille Nord France, Lille, France; [Deruy, Emeric; Gosselin, Karo; Vercamer, Chantal; Martien, Sebastien; Bouali, Fatima; Bertout, Julie; Pourtier, Albin; Abbadie, Corinne] Inst Biol Lille, CNRS, UMR8161, Lille, France; [Deruy, Emeric; Gosselin, Karo; Vercamer, Chantal; Martien, Sebastien; Bouali, Fatima; Slomianny, Christian; Bertout, Julie; Pourtier, Albin; Abbadie, Corinne] USTL, Villeneuve Dascq, France; [Deruy, Emeric; Gosselin, Karo; Vercamer, Chantal; Martien, Sebastien; Bouali, Fatima; Bertout, Julie; Pourtier, Albin; Abbadie, Corinne] UDSL, Lille, France; [Deruy, Emeric; Gosselin, Karo; Vercamer, Chantal; Martien, Sebastien; Bouali, Fatima; Bertout, Julie; Pourtier, Albin; Abbadie, Corinne] Inst Pasteur, F-59019 Lille, France; [Slomianny, Christian] INSERM, Lab Physiol Cellulaire, U600, Villeneuve Dascq, France; [Bernard, David] Ctr Leon Berard, CNRS, UMR5238, F-69373 Lyon, France	Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UNICANCER; Centre Leon Berard	Deruy, E (corresponding author), Univ Lille Nord France, Lille, France.	corinne.abbadie@ibl.fr	Slomianny, Christian/L-8285-2018; POURTIER, ALBIN/G-7401-2012; ABBADIE, Corinne/F-4949-2018; Bernard, David/D-6265-2018	POURTIER, ALBIN/0000-0002-1576-3946; ABBADIE, Corinne/0000-0002-8174-2393; Bernard, David/0000-0002-1557-2074	Centre National de la Recherche Scientifique; Universite Lille 1; Ligue contre le Cancer (Comites du Nord et de l Aisne); Institut Pasteur de Lille; Region Nord/Pas-de-Calais; Societe Francaise du Cancer; French Research Ministry; Fondation pour la Recherche Medicale	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Lille 1; Ligue contre le Cancer (Comites du Nord et de l Aisne); Institut Pasteur de Lille; Region Nord/Pas-de-Calais(Region Hauts-de-France); Societe Francaise du Cancer; French Research Ministry(Ministry of Research, France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by the Centre National de la Recherche Scientifique, the Universite Lille 1, the Ligue contre le Cancer (Comites du Nord et de l Aisne), the Institut Pasteur de Lille. E. D. has a fellowship from the Institut Pasteur de Lille and the Region Nord/Pas-de-Calais. K. G. had a fellowship from the Institut Pasteur de Lille and the Region Nord/Pas-de-Calais and from the Societe Francaise du Cancer. S. M. had a fellowship from the French Research Ministry and the Fondation pour la Recherche Medicale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUCHOWSKI A, 1977, J BIOL CHEM, V252, P3582; Arico S, 2001, J BIOL CHEM, V276, P35243, DOI 10.1074/jbc.C100319200; BECKMAN JS, 1988, J BIOL CHEM, V263, P6884; Bernard D, 2004, CANCER RES, V64, P472, DOI 10.1158/0008-5472.CAN-03-0005; Bernard D, 2001, CANCER RES, V61, P2656; Bienert GP, 2007, J BIOL CHEM, V282, P1183, DOI 10.1074/jbc.M603761200; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; BOYCE ST, 1983, J INVEST DERMATOL, V81, pS33, DOI 10.1111/1523-1747.ep12540422; Chartier C, 1996, J VIROL, V70, P4805, DOI 10.1128/JVI.70.7.4805-4810.1996; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; Cristofalo VJ, 2004, MECH AGEING DEV, V125, P827, DOI 10.1016/j.mad.2004.07.010; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Daido S, 2005, CANCER RES, V65, P4368, DOI 10.1158/0008-5472.CAN-04-4202; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Ding GH, 2001, EXP MOL PATHOL, V70, P43, DOI 10.1006/exmp.2000.2346; Gosselin K, 2009, AM J PATHOL, V174, P423, DOI 10.2353/ajpath.2009.080332; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Gozuacik D, 2007, CURR TOP DEV BIOL, V78, P217, DOI 10.1016/S0070-2153(06)78006-1; Hampel B, 2004, EXP GERONTOL, V39, P1713, DOI 10.1016/j.exger.2004.05.010; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Huang Q, 2009, AUTOPHAGY, V5, P273, DOI 10.4161/auto.5.2.7640; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Keyes WM, 2005, GENE DEV, V19, P1986, DOI 10.1101/gad.342305; Kiffin R, 2006, ANTIOXID REDOX SIGN, V8, P152, DOI 10.1089/ars.2006.8.152; Kim EH, 2008, AUTOPHAGY, V4, P76, DOI 10.4161/auto.5119; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kirkland RA, 2002, NEUROSCIENCE, V115, P587, DOI 10.1016/S0306-4522(02)00512-2; Kourtis N, 2009, CELL DEATH DIFFER, V16, P21, DOI 10.1038/cdd.2008.120; Kovacs AL, 2000, CELL TISSUE RES, V302, P253, DOI 10.1007/s004410000275; Krick R, 2008, MOL BIOL CELL, V19, P4492, DOI 10.1091/mbc.E08-04-0363; Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x; Lee HC, 2000, BIOCHEM J, V348, P425, DOI 10.1042/0264-6021:3480425; Martin JA, 2003, J BONE JOINT SURG AM, V85A, P106, DOI 10.2106/00004623-200300002-00014; MARTINON O, 1994, BIOCHEM MOL BIOL INT, V34, P135; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Park YE, 2009, AUTOPHAGY, V5, P795, DOI 10.4161/auto.8901; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Roberts P, 2003, MOL BIOL CELL, V14, P129, DOI 10.1091/mbc.E02-08-0483; Sansal I, 2004, J CLIN ONCOL, V22, P2954, DOI 10.1200/jco.2004.02.141; SASAKI M, 2010, LAB INVEST; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Schiedner G, 2000, HUM GENE THER, V11, P2105, DOI 10.1089/104303400750001417; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Sekiguchi M, 2002, ONCOGENE, V21, P8895, DOI 10.1038/sj.onc.1206023; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777; Unterluggauer H, 2003, EXP GERONTOL, V38, P1149, DOI 10.1016/j.exger.2003.08.007; Wagner M, 2001, EXP GERONTOL, V36, P1327, DOI 10.1016/S0531-5565(01)00105-X; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yin DZ, 1996, FREE RADICAL BIO MED, V21, P871, DOI 10.1016/0891-5849(96)00175-X; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709; Yu L, 2006, P NATL ACAD SCI USA, V103, P4952, DOI 10.1073/pnas.0511288103; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zwerschke W, 2003, BIOCHEM J, V376, P403, DOI 10.1042/BJ20030816	58	39	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2010	5	9							e12712	10.1371/journal.pone.0012712	http://dx.doi.org/10.1371/journal.pone.0012712			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZO	20856861	gold, Green Submitted, Green Published			2022-12-27	WOS:000281815700008
J	Stevenson, IH; Cronin, B; Sur, M; Kording, KP				Stevenson, Ian H.; Cronin, Beau; Sur, Mriganka; Kording, Konrad P.			Sensory Adaptation and Short Term Plasticity as Bayesian Correction for a Changing Brain	PLOS ONE			English	Article							VISUAL-CORTEX; MOTION; STATISTICS; EXCITABILITY; DYNAMICS; DEPRESSION; INVARIANCE; REDUCTION; CONTRAST; NOISE	Neurons in the sensory system exhibit changes in excitability that unfold over many time scales. These fluctuations produce noise and could potentially lead to perceptual errors. However, to prevent such errors, postsynaptic neurons and synapses can adapt and counteract changes in the excitability of presynaptic neurons. Here we ask how neurons could optimally adapt to minimize the influence of changing presynaptic neural properties on their outputs. The resulting model, based on Bayesian inference, explains a range of physiological results from experiments which have measured the overall properties and detailed time-course of sensory tuning curve adaptation in the early visual cortex. We show how several experimentally measured short term plasticity phenomena can be understood as near-optimal solutions to this adaptation problem. This framework provides a link between high level computational problems, the properties of cortical neurons, and synaptic physiology.	[Stevenson, Ian H.; Kording, Konrad P.] Northwestern Univ, Dept Physiol, Rehabil Inst Chicago, Chicago, IL 60611 USA; [Cronin, Beau; Sur, Mriganka] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA	Northwestern University; Shirley Ryan AbilityLab; Massachusetts Institute of Technology (MIT); Northwell Health	Stevenson, IH (corresponding author), Northwestern Univ, Dept Physiol, Rehabil Inst Chicago, Chicago, IL 60611 USA.	i-stevenson@northwestern.edu	Kording, Konrad P/A-1233-2007	Kording, Konrad P/0000-0001-8408-4499; Stevenson, Ian/0000-0002-1428-5946	National Eye Institute [EY-07023]; Chicago Community Trust; National Institutes of Health (NIH) [1R01NS063399, 2P01NS044393]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY007023, F32EY007023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063399, P01NS044393] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Chicago Community Trust; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	BC and MS were supported by National Eye Institute Grant EY-07023. IHS and KPK were supported by the Chicago Community Trust and National Institutes of Health (NIH) grants 1R01NS063399 and 2P01NS044393. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Ahern GP, 2002, TRENDS NEUROSCI, V25, P510, DOI 10.1016/S0166-2236(02)02254-3; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; ANDREWS DP, 1964, Q J EXP PSYCHOL, V16, P104, DOI 10.1080/17470216408416355; Anstis S, 1998, TRENDS COGN SCI, V2, P111, DOI 10.1016/S1364-6613(98)01142-5; Azouz R, 1999, J NEUROSCI, V19, P2209; Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; BARNES CA, 1977, SCIENCE, V197, P91, DOI 10.1126/science.194313; Berkes P, 2005, J VISION, V5, P579, DOI 10.1167/5.6.9; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Carandini M, 2002, J NEUROSCI, V22, P10053; Chance FS, 2001, NEUROCOMPUTING, V38, P141, DOI 10.1016/S0925-2312(01)00550-1; Chance FS, 1998, J NEUROSCI, V18, P4785; Clifford CWG, 2000, P ROY SOC B-BIOL SCI, V267, P1705, DOI 10.1098/rspb.2000.1198; DeWeese M, 1998, NEURAL COMPUT, V10, P1179, DOI 10.1162/089976698300017403; Dittman JS, 2000, J NEUROSCI, V20, P1374; DONG DW, 1995, NETWORK-COMP NEURAL, V6, P345, DOI 10.1088/0954-898X/6/3/003; Dragoi V, 2000, NEURON, V28, P287, DOI 10.1016/S0896-6273(00)00103-3; Dragoi V, 2002, NAT NEUROSCI, V5, P883, DOI 10.1038/nn900; Drew PJ, 2006, J NEUROPHYSIOL, V96, P826, DOI 10.1152/jn.00134.2006; Duke PA, 2006, VISION RES, V46, P228, DOI 10.1016/j.visres.2005.09.004; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Felsen G, 2002, NEURON, V36, P945, DOI 10.1016/S0896-6273(02)01011-5; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Foldiak P, 1991, NEURAL COMPUT, V3, P194, DOI 10.1162/neco.1991.3.2.194; Gibson JJ, 1933, J EXP PSYCHOL, V16, P1, DOI 10.1037/h0074626; Goldman MS, 2002, J NEUROSCI, V22, P584, DOI 10.1523/JNEUROSCI.22-02-00584.2002; HAMMOND P, 1985, EXP BRAIN RES, V60, P411; Hoyer PO, 2003, ADV NEUR INF PROC SY; Huang CQ, 1998, HEARING RES, V116, P55, DOI 10.1016/S0378-5955(97)00196-2; JIANG C, 1994, P NATL ACAD SCI USA, V91, P7198, DOI 10.1073/pnas.91.15.7198; Jin DZ, 2005, J NEUROPHYSIOL, V94, P4038, DOI 10.1152/jn.00571.2004; KASDIN NJ, 1995, P IEEE, V83, P802, DOI 10.1109/5.381848; Kohn A, 2004, NAT NEUROSCI, V7, P764, DOI 10.1038/nn1267; Kording KP, 2007, NAT NEUROSCI, V10, P779, DOI 10.1038/nn1901; Kording KP, 2004, J NEUROPHYSIOL, V91, P206, DOI 10.1152/jn.00149.2003; Mather G, 1998, MOTION AFTEREFFECT M, P220; Minka Thomas P., 2001, P 17 C UNC ART INT; Olshausen BA, 1996, NETWORK-COMP NEURAL, V7, P333, DOI 10.1088/0954-898X/7/2/014; PFISTER JP, 2009, ADV NEURAL INFORM PR, V22; Schrater PR, 1998, VISION RES, V38, P3899, DOI 10.1016/S0042-6989(98)00088-1; SRINIVASAN MV, 1982, PROC R SOC SER B-BIO, V216, P427, DOI 10.1098/rspb.1982.0085; STOCKER AA, 2006, ADV NEURAL INFORM PR, P1291; Teich AF, 2003, J NEUROPHYSIOL, V89, P2086, DOI 10.1152/jn.00970.2002; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Turner R, 2007, NEURAL COMPUT, V19, P1022, DOI 10.1162/neco.2007.19.4.1022; ULLMAN S, 1982, PROC R SOC SER B-BIO, V216, P299, DOI 10.1098/rspb.1982.0076; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; WADE NJ, 1994, PERCEPTION, V23, P1111, DOI 10.1068/p231111; Wainwright MJ, 1999, VISION RES, V39, P3960, DOI 10.1016/S0042-6989(99)00101-7; Wark B, 2007, CURR OPIN NEUROBIOL, V17, P423, DOI 10.1016/j.conb.2007.07.001; Wark B, 2009, NEURON, V61, P750, DOI 10.1016/j.neuron.2009.01.019; Xu H, 2008, J NEUROSCI, V28, P3374, DOI 10.1523/JNEUROSCI.0182-08.2008	53	12	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12436	10.1371/journal.pone.0012436	http://dx.doi.org/10.1371/journal.pone.0012436			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865056	Green Published, Green Submitted, gold			2022-12-27	WOS:000281292100029
J	van der Aa, LM; Chadzinska, M; Tijhaar, E; Boudinot, P; Verburg-van Kemenade, BML				van der Aa, Lieke M.; Chadzinska, Magdalena; Tijhaar, Edwin; Boudinot, Pierre; Verburg-van Kemenade, B. M. Lidy			CXCL8 Chemokines in Teleost Fish: Two Lineages with Distinct Expression Profiles during Early Phases of Inflammation	PLOS ONE			English	Article							NEUTROPHIL-ACTIVATING FACTOR; TROUT ONCORHYNCHUS-MYKISS; CYPRINUS-CARPIO L.; INTERLEUKIN-8 RECEPTORS; MOLECULAR EVOLUTION; CHEMOTACTIC FACTOR; ESCHERICHIA-COLI; GENE-EXPRESSION; GRO-ALPHA; TNF-ALPHA	Background: During the inflammatory process, chemokine CXCL8 plays a pivotal role in recruitment of human neutrophilic granulocytes. A diversity of sequences similar to CXCL8 was reported in fish, but their evolutionary relationships and functional homology with their human homolog remain unclear. Principal Findings: We screened fish genomes to seek for sequences related to CXCL8. A first lineage was retrieved in all teleosts, while a second CXCL8 lineage was found in zebrafish and carp only. An early inflammatory function for both lineages was indicated by several lines of evidence. The induction of carp CXCL8s, CXCb, and CXC receptor-1 and -2 was analyzed after in vitro stimulation of leukocyte subpopulations and in two in vivo inflammation models. Recombinant proteins of carp CXCL8 proteins were produced and showed significant chemotactic activity for carp leukocytes. Conclusions: While both carp CXCL8s appear to be functional homologs of mammalian CXCL8, their different induction requirements and kinetics evoke a gene-specific sub-functionalization.	[van der Aa, Lieke M.; Chadzinska, Magdalena; Tijhaar, Edwin; Verburg-van Kemenade, B. M. Lidy] Wageningen Univ, Dept Anim Sci, Cell Biol & Immunol Grp, Wageningen, Netherlands; [van der Aa, Lieke M.; Boudinot, Pierre] INRA, Virol & Immunol Mol, Jouy En Josas, France; [Chadzinska, Magdalena] Jagiellonian Univ, Inst Zool, Dept Evolutionary Immunobiol, PL-30060 Krakow, Poland	Wageningen University & Research; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Jagiellonian University	van der Aa, LM (corresponding author), Wageningen Univ, Dept Anim Sci, Cell Biol & Immunol Grp, Wageningen, Netherlands.	Lidy.vanKemenade@wur.nl	boudinot, pierre/L-4246-2016	van Kemenade, Lidy/0000-0002-5031-7335; boudinot, pierre/0000-0002-7490-9677	 [FP7-People-ERG-2008-228583];  [MNiSW/999/7.PR/UE/2009/7]	; 	This work was supported by FP7-People-ERG-2008-228583 and MNiSW/999/7.PR/UE/2009/7 (MC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkhalek NK, 2009, FISH SHELLFISH IMMUN, V27, P763, DOI 10.1016/j.fsi.2009.08.004; Arts JAJ, 2010, FISH SHELLFISH IMMUN, V29, P793, DOI 10.1016/j.fsi.2010.07.010; Bacon K, 2002, J INTERF CYTOK RES, V22, P1067; BAGGIOLINI M, 1989, J CLIN INVEST, V84, P1045, DOI 10.1172/JCI114265; Cai ZH, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-66; Chadzinska M, 2009, DEV COMP IMMUNOL, V33, P88, DOI 10.1016/j.dci.2008.07.004; Chadzinska M, 2008, DEV COMP IMMUNOL, V32, P509, DOI 10.1016/j.dci.2007.08.008; Chen LQ, 2005, DEV COMP IMMUNOL, V29, P135, DOI 10.1016/j.dci.2004.06.011; Corripio-Miyar Y, 2007, MOL IMMUNOL, V44, P1361, DOI 10.1016/j.molimm.2006.05.010; Covello JM, 2009, FISH SHELLFISH IMMUN, V26, P773, DOI 10.1016/j.fsi.2009.03.012; DeVries ME, 2006, J IMMUNOL, V176, P401, DOI 10.4049/jimmunol.176.1.401; FANGE R, 1986, VET IMMUNOL IMMUNOP, V12, P153, DOI 10.1016/0165-2427(86)90119-4; FREVERT CW, 1995, J IMMUNOL, V154, P335; GEISER T, 1993, J BIOL CHEM, V268, P15419; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harun NO, 2008, DEV COMP IMMUNOL, V32, P673, DOI 10.1016/j.dci.2007.10.005; Huising MO, 2004, EUR J BIOCHEM, V271, P4094, DOI 10.1111/j.1432-1033.2004.04347.x; Huising MO, 2003, VACCINE, V21, P4178, DOI 10.1016/S0264-410X(03)00497-3; Huising MO, 2003, DEV COMP IMMUNOL, V27, P875, DOI 10.1016/S0145-305X(03)00082-X; Huising MO, 2003, TRENDS IMMUNOL, V24, P307, DOI 10.1016/S1471-4906(03)00120-0; IRNAZAROW I, 1995, AQUACULTURE, V129, P215, DOI 10.1016/0044-8486(95)91961-T; KAATTARI SL, 1985, DEV COMP IMMUNOL, V9, P433, DOI 10.1016/0145-305X(85)90006-0; Kaiser P, 1999, IMMUNOGENETICS, V49, P673, DOI 10.1007/s002510050664; Kakinuma T, 2006, J LEUKOCYTE BIOL, V79, P639, DOI 10.1189/jlb.1105633; Kemenade B, 1994, J EXP BIOL, V187, P143; Laing KJ, 2002, DEV COMP IMMUNOL, V26, P433, DOI 10.1016/S0145-305X(01)00092-1; LARSEN CG, 1989, IMMUNOLOGY, V68, P31; Lee EY, 2001, GENE, V274, P237, DOI 10.1016/S0378-1119(01)00600-X; LEE J, 1992, J BIOL CHEM, V267, P16283; LINDLEY I, 1988, P NATL ACAD SCI USA, V85, P9199, DOI 10.1073/pnas.85.23.9199; LOETSCHER P, 1994, FEBS LETT, V341, P187, DOI 10.1016/0014-5793(94)80454-0; Martin D, 2009, J BIOL CHEM, V284, P6038, DOI 10.1074/jbc.C800207200; Montero J, 2008, DEV COMP IMMUNOL, V32, P1374, DOI 10.1016/j.dci.2008.05.004; MOSER B, 1993, BIOCHEM J, V294, P285, DOI 10.1042/bj2940285; Najakshin AM, 1999, EUR J IMMUNOL, V29, P375, DOI 10.1002/(SICI)1521-4141(199902)29:02<375::AID-IMMU375>3.3.CO;2-Y; Nomiyama H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-222; Oehlers SHB, 2010, DEV COMP IMMUNOL, V34, P352, DOI 10.1016/j.dci.2009.11.007; OQUENDO P, 1989, J BIOL CHEM, V264, P4133; PEVERI P, 1988, J EXP MED, V167, P1547, DOI 10.1084/jem.167.5.1547; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Roche JK, 2007, AM J PATHOL, V170, P526, DOI 10.2353/ajpath.2007.060366; Roebuck KA, 1999, J INTERF CYTOK RES, V19, P429, DOI 10.1089/107999099313866; Roest Crollius H, 2005, GENOME RES, V15, P1675, DOI 10.1101/gr.3735805; Saha NR, 2007, FISH SHELLFISH IMMUN, V23, P1324, DOI 10.1016/j.fsi.2007.06.008; Sanchez X, 1998, J IMMUNOL, V160, P906; Scapini P, 2000, IMMUNOL REV, V177, P195, DOI 10.1034/j.1600-065X.2000.17706.x; Seppola M, 2008, MOL IMMUNOL, V45, P887, DOI 10.1016/j.molimm.2007.08.003; SHIBATA F, 1995, EUR J BIOCHEM, V231, P306, DOI 10.1111/j.1432-1033.1995.tb20701.x; Stolte EH, 2008, DEV COMP IMMUNOL, V32, P1467, DOI 10.1016/j.dci.2008.06.012; STRIETER RM, 1989, SCIENCE, V243, P1467, DOI 10.1126/science.2648570; STRIETER RM, 1995, J BIOL CHEM, V270, P27348, DOI 10.1074/jbc.270.45.27348; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tran TL, 2009, J VIROL, V83, P6363, DOI 10.1128/JVI.00335-09; WALZ A, 1987, BIOCHEM BIOPH RES CO, V149, P755, DOI 10.1016/0006-291X(87)90432-3; WATANABE K, 1989, J BIOL CHEM, V264, P19559; WATANABE K, 1991, EXP MOL PATHOL, V55, P30, DOI 10.1016/0014-4800(91)90016-Q; Wiens GD, 2006, IMMUNOGENETICS, V58, P308, DOI 10.1007/s00251-006-0084-7; YOSHIMURA T, 1987, J IMMUNOL, V139, P788; Zlotnik A, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-243	60	86	89	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12384	10.1371/journal.pone.0012384	http://dx.doi.org/10.1371/journal.pone.0012384			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865040	Green Published, gold			2022-12-27	WOS:000281292100010
J	Kao, CS; Dietrich, R; Sommer, W				Kao, Chung-Shan; Dietrich, Rainer; Sommer, Werner			Processing Interrogative Sentence Mood at the Semantic-Syntactic Interface: An Electrophysiological Research in Chinese, German, and Polish	PLOS ONE			English	Article							WORD INTERFERENCE EXPERIMENTS; TIME-COURSE; SPEECH PRODUCTION; LATENCY DIFFERENCES; BRAIN POTENTIALS; INFORMATION; ONSET; CONTINGENT; RETRIEVAL; SPEAKING	Background: Languages differ in the marking of the sentence mood of a polar interrogative (yes/no question). For instance, the interrogative mood is marked at the beginning of the surface structure in Polish, whereas the marker appears at the end in Chinese. In order to generate the corresponding sentence frame, the syntactic specification of the interrogative mood is early in Polish and late in Chinese. In this report, German belongs to an interesting intermediate class. The yes/no question is expressed by a shift of the finite verb from its final position in the underlying structure into the utterance initial position, a move affecting, hence, both the sentence's final and the sentence's initial constituents. The present study aimed to investigate whether during generation of the semantic structure of a polar interrogative, i.e., the processing preceding the grammatical formulation, the interrogative mood is encoded according to its position in the syntactic structure at distinctive time points in Chinese, German, and Polish. Methodology/Principal Findings: In a two-choice go/nogo experimental design, native speakers of the three languages responded to pictures by pressing buttons and producing utterances in their native language while their brain potentials were recorded. The emergence and latency of lateralized readiness potentials (LRP) in nogo conditions, in which speakers asked a yes/no question, should indicate the time point of processing the interrogative mood. The results revealed that Chinese, German, and Polish native speakers did not differ from each other in the electrophysiological indicator. Conclusions/Significance: The findings suggest that the semantic encoding of the interrogative mood is temporally consistent across languages despite its disparate syntactic specification. The consistent encoding may be ascribed to economic processing of interrogative moods at various sentential positions of the syntactic structures in languages or, more generally, to the overarching status of sentence mood in the semantic structure.	[Kao, Chung-Shan] Univ Fribourg, Dept Psychol, CH-1700 Fribourg, Switzerland; [Dietrich, Rainer] Humboldt Univ, Inst Deutsch Sprache & Linguist, Berlin, Germany; [Sommer, Werner] Humboldt Univ, Inst Psychol, Berlin, Germany	University of Fribourg; Humboldt University of Berlin; Humboldt University of Berlin	Kao, CS (corresponding author), Univ Fribourg, Dept Psychol, CH-1700 Fribourg, Switzerland.	chung-shan.kao@unifr.ch	Sommer, Werner/N-1945-2019; Sommer, Werner/H-4672-2011	Sommer, Werner/0000-0001-5266-3445; Sommer, Werner/0000-0001-5266-3445	state government of Berlin; interdisziplinaere Zentrum fuer sprachliche Bedeutung	state government of Berlin; interdisziplinaere Zentrum fuer sprachliche Bedeutung	The research was supported by grants from the state government of Berlin (the scholarship of the Nachwuchsfoerderung) and from the interdisziplinaere Zentrum fuer sprachliche Bedeutung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham Werner, 1995, DTSCH SYNTAX SPRACHE; American Electroencephalographic Society, 1994, J CLIN NEUROPHYSIOL, V11, P77, DOI 10.1097/00004691-199401000-00012; BACH E, 1962, LANGUAGE, V38, P263, DOI 10.2307/410785; BERG P, 1994, ELECTROEN CLIN NEURO, V90, P229, DOI 10.1016/0013-4694(94)90094-9; Bock J. K., 2004, INTERFACE LANGUAGE V, P249; Bock K, 2003, J MEM LANG, V48, P653, DOI 10.1016/S0749-596X(03)00007-X; Brandt Margareta., 1993, SATZ ILLOKUTION, V1, P1; BRUNIA CHM, 1980, BIOL PSYCHOL, V11, P181, DOI 10.1016/0301-0511(80)90054-X; Chomsky N., 1986, KNOWLEDGE LANGUAGE I; COLES MGH, 1989, PSYCHOPHYSIOLOGY, V26, P251, DOI 10.1111/j.1469-8986.1989.tb01916.x; De Smedt K. J. M. J., 1990, Current Research in Natural Language Generation, P167; DEJONG R, 1988, J EXP PSYCHOL HUMAN, V14, P682, DOI 10.1037/0096-1523.14.4.682; DIETRICH R, 1999, REPRESENTATIONS PROC, P57; Dietrich Rainer, 2007, PSYCHOLINGUISTIK; Ferreira VS, 1996, J MEM LANG, V35, P724, DOI 10.1006/jmla.1996.0038; GRATTON G, 1988, J EXP PSYCHOL HUMAN, V14, P331, DOI 10.1037/0096-1523.14.3.331; Grewendorf Gunther, 1989, SPRACHLICHES WISSEN; Griffin ZM, 2000, PSYCHOL SCI, V11, P274, DOI 10.1111/1467-9280.00255; Griffin ZM, 2001, COGNITION, V82, pB1, DOI 10.1016/S0010-0277(01)00138-X; Haider H., 1997, GERMAN SYNTACTIC PRO, P83; KEMPEN G, 1987, COGNITIVE SCI, V11, P201, DOI 10.1207/s15516709cog1102_5; KEMPEN G, 1982, P 9 INT C COMP LING, P151; Kiesel A, 2008, PSYCHOPHYSIOLOGY, V45, P250, DOI 10.1111/j.1469-8986.2007.00618.x; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; Levelt W., 1989, SPEAKING INTENTION A; Lippold O. C. J., 1967, MANUAL PSYCHOPHYSIOL, P245; Low KA, 1999, PSYCHOPHYSIOLOGY, V36, P288, DOI 10.1017/S0048577299980332; Masaki H, 2004, PSYCHOPHYSIOLOGY, V41, P220, DOI 10.1111/j.1469-8986.2004.00150.x; Meyer AS, 1996, J MEM LANG, V35, P477, DOI 10.1006/jmla.1996.0026; Miller J, 1998, PSYCHOPHYSIOLOGY, V35, P99, DOI 10.1111/1469-8986.3510099; MILLER J, 1992, J EXP PSYCHOL GEN, V121, P195, DOI 10.1037/0096-3445.121.2.195; Mordkoff JT, 2000, PSYCHOPHYSIOLOGY, V37, P347; OSMAN A, 1993, J EXP PSYCHOL HUMAN, V19, P1292, DOI 10.1037/0096-1523.19.6.1292; Rahman RA, 2003, J EXP PSYCHOL LEARN, V29, P850, DOI 10.1037/0278-7393.29.5.850; Rahman RA, 2003, COGNITIVE BRAIN RES, V16, P372, DOI 10.1016/S0926-6410(02)00305-1; Rodriguez-Fornells A, 2002, NEUROPSYCHOLOGIA, V40, P778, DOI 10.1016/S0028-3932(01)00188-9; Roelofs A, 1998, J EXP PSYCHOL LEARN, V24, P904, DOI 10.1037/0278-7393.24.4.904; Schmitt BM, 2000, PSYCHOPHYSIOLOGY, V37, P473, DOI 10.1017/S0048577200981782; Schmitt BM, 2001, NEUROSCI RES, V41, P293, DOI 10.1016/S0168-0102(01)00286-3; Schmitt BM, 2001, J COGNITIVE NEUROSCI, V13, P510, DOI 10.1162/08989290152001925; Schriefers H, 1998, J MEM LANG, V39, P609, DOI 10.1006/jmla.1998.2578; Sommer W, 1996, PSYCHOL RUNDSCH, V47, P1; Ulrich R, 2001, PSYCHOPHYSIOLOGY, V38, P816, DOI 10.1111/1469-8986.3850816; van Turennout M, 1999, J PSYCHOLINGUIST RES, V28, P649, DOI 10.1023/A:1023221028150; vanTurennout M, 1997, J EXP PSYCHOL LEARN, V23, P787, DOI 10.1037/0278-7393.23.4.787; VAUGHAN HG, 1968, ELECTROEN CLIN NEURO, V25, P1, DOI 10.1016/0013-4694(68)90080-1; Wheeldon L., 2003, ENCY COGNITIVE SCI, P760, DOI [10.1002/0470018860.s00252/abstract, DOI 10.1002/0470018860.S00252/ABSTRACT]	47	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e13036	10.1371/journal.pone.0013036	http://dx.doi.org/10.1371/journal.pone.0013036			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	655SI	20927373	Green Published, gold, Green Submitted			2022-12-27	WOS:000282269400012
J	Van Houtan, KS; Hargrove, SK; Balazs, GH				Van Houtan, Kyle S.; Hargrove, Stacy K.; Balazs, George H.			Land Use, Macroalgae, and a Tumor-Forming Disease in Marine Turtles	PLOS ONE			English	Article							CHELONIA-MYDAS; GREEN TURTLES; HAWAIIAN-ISLANDS; SOMATIC GROWTH; ARGININE; VIRUS; FIBROPAPILLOMATOSIS; REGION; TRANSMISSION; REPLICATION	Wildlife diseases are an increasing concern for endangered species conservation, but their occurrence, causes, and human influences are often unknown. We analyzed 3,939 records of stranded Hawaiian green sea turtles (Chelonia mydas) over 28 years to understand fibropapillomatosis, a tumor-forming disease linked to a herpesvirus. Turtle size is a consistent risk factor and size-standardized models revealed considerable spatial and temporal variability. The disease peaked in some areas in the 1990s, in some regions rates remained constant, and elsewhere rates increased. Land use, onshore of where the turtles feed, may play a role. Elevated disease rates were clustered in watersheds with high nitrogen-footprints; an index of natural and anthropogenic factors that affect coastal eutrophication. Further analysis shows strong epidemiological links between disease rates, nitrogen-footprints, and invasive macroalgae and points to foraging ecology. These turtles now forage on invasive macroalgae, which can dominate nutrient rich waters and sequester environmental N in the amino acid arginine. Arginine is known to regulate immune activity, promote herpesviruses, and contribute to tumor formation. Our results have implications for understanding diseases in aquatic organisms, eutrophication, herpesviruses, and tumor formation.	[Van Houtan, Kyle S.; Hargrove, Stacy K.; Balazs, George H.] Fisheries Serv, Pacific Isl Fisheries Sci Ctr, NOAA, Honolulu, HI USA; [Van Houtan, Kyle S.] Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC USA	National Oceanic Atmospheric Admin (NOAA) - USA; Duke University	Van Houtan, KS (corresponding author), Fisheries Serv, Pacific Isl Fisheries Sci Ctr, NOAA, Honolulu, HI USA.	Kyle.VanHoutan@gmail.com	Van Houtan, Kyle S/GRY-0874-2022; Van Houtan, Kyle Schuyler/A-4695-2008	Van Houtan, Kyle/0000-0001-5725-1773				ABBOT IA, 1999, MARINE RED ALGAE HAW; Aguirre AA, 2000, COMP HAEMATOL INT, V10, P132, DOI 10.1007/s005800070004; ANDERSON R M, 1991; Arthur KE, 2008, PAC SCI, V62, P205, DOI 10.2984/1534-6188(2008)62[205:ACOIGT]2.0.CO;2; BALAZS G H, 1976, Biological Conservation, V9, P125, DOI 10.1016/0006-3207(76)90045-8; Balazs GH, 2004, MAR BIOL, V145, P1043, DOI 10.1007/s00227-004-1387-6; Balazs GH, 2004, BIOL CONSERV, V117, P491, DOI 10.1016/j.biocon.2003.08.008; Bjorndal KA, 1999, CONSERV BIOL, V13, P126, DOI 10.1046/j.1523-1739.1999.97329.x; Brunsdon C, 1998, J ROY STAT SOC D-STA, V47, P431, DOI 10.1111/1467-9884.00145; Chaloupka M, 2005, MAR BIOL, V147, P1251, DOI 10.1007/s00227-005-0026-1; Chaloupka M, 2008, MAR BIOL, V154, P887, DOI 10.1007/s00227-008-0981-4; Chaloupka M, 2009, J WILDLIFE DIS, V45, P1138, DOI 10.7589/0090-3558-45.4.1138; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; Dailer ML, 2010, MAR POLLUT BULL, V60, P655, DOI 10.1016/j.marpolbul.2009.12.021; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; dos Santos RG, 2010, DIS AQUAT ORGAN, V89, P87, DOI 10.3354/dao02178; Ene A, 2005, J WILDLIFE DIS, V41, P489, DOI 10.7589/0090-3558-41.3.489; *ENV SYST RES I, ARCGIS 9 3 1; Greenblatt RJ, 2004, VIROLOGY, V321, P101, DOI 10.1016/j.virol.2003.12.026; Hall SR, 2007, ECOL LETT, V10, P207, DOI 10.1111/j.1461-0248.2007.01011.x; Halley J, 2002, OIKOS, V99, P518, DOI 10.1034/j.1600-0706.2002.11962.x; Hart KM, 2006, BIOL CONSERV, V129, P283, DOI 10.1016/j.biocon.2005.10.047; Herbst L, 2004, CURR BIOL, V14, pR697, DOI 10.1016/j.cub.2004.08.040; Herbst Lawrence H., 1994, Annual Review of Fish Diseases, V4, P389, DOI 10.1016/0959-8030(94)90037-X; HERBST LH, 1995, ENVIRON HEALTH PERSP, V103, P27, DOI 10.2307/3432408; HERBST LH, 1995, DIS AQUAT ORGAN, V22, P1, DOI 10.3354/dao022001; HIBBARD MK, 1995, J VIROL, V69, P4656, DOI 10.1128/JVI.69.8.4656-4667.1995; Hurvich CM, 1998, J ROY STAT SOC B, V60, P271, DOI 10.1111/1467-9868.00125; INGLIS VBM, 1968, J GEN VIROL, V3, P9, DOI 10.1099/0022-1317-3-1-9; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; KAHAN IL, 1979, A GRAEF ARCH KLIN EX, V209, P219, DOI 10.1007/BF00414614; Klyachkin YM, 2008, VIROLOGY, V374, P23, DOI 10.1016/j.virol.2007.11.014; Lackovich JK, 1999, DIS AQUAT ORGAN, V37, P89, DOI 10.3354/dao037089; Landsberg JH, 1999, J AQUAT ANIM HEALTH, V11, P199, DOI 10.1577/1548-8667(1999)011&lt;0199:TPRONT&gt;2.0.CO;2; Lapointe BE, 2004, J EXP MAR BIOL ECOL, V298, P275, DOI 10.1016/S0022-0981(03)00363-0; LAPOINTE BE, 1992, ESTUARIES, V15, P75, DOI 10.2307/1352712; Larned ST, 1998, MAR BIOL, V132, P409, DOI 10.1007/s002270050407; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Llacer JL, 2008, CURR OPIN STRUC BIOL, V18, P673, DOI 10.1016/j.sbi.2008.11.002; Lu Y, 2000, ARCH VIROL, V145, P1885, DOI 10.1007/s007050070063; MANNICK JB, 1994, CELL, V79, P1137, DOI 10.1016/0092-8674(94)90005-1; McDermid KJ, 2007, B MAR SCI, V81, P55; McPherson R.A., 2017, HENRYS CLIN DIAGNOSI; MIKAMI T, 1974, J GEN VIROL, V22, P115, DOI 10.1099/0022-1317-22-1-115; Mistry SK, 2001, VIRUS RES, V73, P177, DOI 10.1016/S0168-1702(00)00243-4; Ng TFF, 2009, J VIROL, V83, P2500, DOI 10.1128/JVI.01946-08; OLSHEVSKY U, 1970, NATURE, V226, P851, DOI 10.1038/226851a0; Peranzoni E, 2007, IMMUNOBIOLOGY, V212, P795, DOI 10.1016/j.imbio.2007.09.008; Russell DF, 2009, PAC SCI, V63, P181, DOI 10.2984/049.063.0202; RUSSELL DJ, 1994, AQUAT BOT, V47, P53, DOI 10.1016/0304-3770(94)90048-5; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Schlesinger WH, 1997, BIOGEOCHEMISTRY; Shuman LM, 2002, J ENVIRON QUAL, V31, P1710, DOI 10.2134/jeq2002.1710; Smith Jennifer E., 2002, Pacific Science, V56, P299, DOI 10.1353/psc.2002.0030; SMITH SV, 1981, PAC SCI, V35, P279; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Van Houtan KS, 2007, CURR BIOL, V17, pR590, DOI 10.1016/j.cub.2007.06.021; Van Houtan KS, 2007, ECOL LETT, V10, P219, DOI 10.1111/j.1461-0248.2007.01004.x; Waller L.A., 2004, APPL SPATIAL STAT PU; WILLIAMS B. K., 2001, ANAL MANAGEMENT ANIM; Work TM, 2005, J PARASITOL, V91, P871, DOI 10.1645/GE-454R.1; Work TM, 2004, DIS AQUAT ORGAN, V62, P163, DOI 10.3354/dao062163; Zug GR, 2002, FISH B-NOAA, V100, P117	63	91	94	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e12900	10.1371/journal.pone.0012900	http://dx.doi.org/10.1371/journal.pone.0012900			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20927370	Green Submitted, gold, Green Published			2022-12-27	WOS:000282269400005
J	Huynh-Thu, VA; Irrthum, A; Wehenkel, L; Geurts, P				Huynh-Thu, Van Anh; Irrthum, Alexandre; Wehenkel, Louis; Geurts, Pierre			Inferring Regulatory Networks from Expression Data Using Tree-Based Methods	PLOS ONE			English	Article							GENE NETWORKS; MODELS; TRANSCRIPTION; ALGORITHM; INFERENCE; SELECTION	One of the pressing open problems of computational systems biology is the elucidation of the topology of genetic regulatory networks (GRNs) using high throughput genomic data, in particular microarray gene expression data. The Dialogue for Reverse Engineering Assessments and Methods (DREAM) challenge aims to evaluate the success of GRN inference algorithms on benchmarks of simulated data. In this article, we present GENIE3, a new algorithm for the inference of GRNs that was best performer in the DREAM4 In Silico Multifactorial challenge. GENIE3 decomposes the prediction of a regulatory network between p genes into p different regression problems. In each of the regression problems, the expression pattern of one of the genes (target gene) is predicted from the expression patterns of all the other genes (input genes), using tree-based ensemble methods Random Forests or Extra-Trees. The importance of an input gene in the prediction of the target gene expression pattern is taken as an indication of a putative regulatory link. Putative regulatory links are then aggregated over all genes to provide a ranking of interactions from which the whole network is reconstructed. In addition to performing well on the DREAM4 In Silico Multifactorial challenge simulated data, we show that GENIE3 compares favorably with existing algorithms to decipher the genetic regulatory network of Escherichia coli. It doesn't make any assumption about the nature of gene regulation, can deal with combinatorial and non-linear interactions, produces directed GRNs, and is fast and scalable. In conclusion, we propose a new algorithm for GRN inference that performs well on both synthetic and real gene expression data. The algorithm, based on feature selection with tree-based ensemble methods, is simple and generic, making it adaptable to other types of genomic data and interactions.	[Huynh-Thu, Van Anh; Irrthum, Alexandre; Wehenkel, Louis; Geurts, Pierre] Univ Liege, Dept Elect Engn & Comp Sci, Liege, Belgium; [Huynh-Thu, Van Anh; Irrthum, Alexandre; Wehenkel, Louis; Geurts, Pierre] Univ Liege, GIGA Res Bioinformat & Modeling, Liege, Belgium	University of Liege; University of Liege	Huynh-Thu, VA (corresponding author), Univ Liege, Dept Elect Engn & Comp Sci, Liege, Belgium.	vahuynh@ulg.ac.be			Interuniversity Attraction Poles Programme [IAP P6/25 BIOMAGNET]; Belgian State, Science Policy Office; French Community of Belgium (ARC Biomod); European Network of Excellence PASCAL2; Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture	Interuniversity Attraction Poles Programme(Belgian Federal Science Policy Office); Belgian State, Science Policy Office(Belgian Federal Science Policy Office); French Community of Belgium (ARC Biomod); European Network of Excellence PASCAL2; Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture(Fonds de la Recherche Scientifique - FNRS)	This work was partially funded by the Interuniversity Attraction Poles Programme (IAP P6/25 BIOMAGNET), initiated by the Belgian State, Science Policy Office, by the French Community of Belgium (ARC Biomod), and by the European Network of Excellence PASCAL2. VAHT is recipient of a Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (F. R. I. A.) fellowship and PG is Research Associate of the Fonds de la Recherche Scientifique - Fonds National de la Recherche Scientifique (F.R.S.- FNRS), Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambroise C, 2009, ELECTRON J STAT, V3, P205, DOI 10.1214/08-EJS314; Auliac C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-91; Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Bolouri H, 2008, COMPUTATIONAL MODELI; Bonneau R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r36; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Butte A J, 2000, Pac Symp Biocomput, P418; Castelo R, 2009, J COMPUT BIOL, V16, P213, DOI 10.1089/cmb.2008.08TT; COVER T. M., 2012, ELEMENTS INFORM THEO, DOI 10.1002/0471200611; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Faith JJ, 2008, NUCLEIC ACIDS RES, V36, pD866, DOI 10.1093/nar/gkm815; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; FAITH JJ, LARGE SCALE MAPPING; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Gama-Castro S, 2008, NUCLEIC ACIDS RES, V36, pD120, DOI 10.1093/nar/gkm994; Gardner TS, 2005, PHYS LIFE REV, V2, P65, DOI 10.1016/j.plrev.2005.01.001; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Geurts P, 2006, MACH LEARN, V63, P3, DOI 10.1007/s10994-006-6226-1; Geurts P, 2009, MOL BIOSYST, V5, P1593, DOI 10.1039/b907946g; HUYNHTHU V, 2008, JMLR WORKSH C P, V4, P60; Kauffman Stuart A., 1993; Lee WP, 2009, BRIEF BIOINFORM, V10, P408, DOI 10.1093/bib/bbp028; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Marbach D, 2009, J COMPUT BIOL, V16, P229, DOI 10.1089/cmb.2008.09TT; Margolin AA, 2006, NAT PROTOC, V1, P663, DOI 10.1038/nprot.2006.106; Markowetz F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S5; Meinshausen N, 2006, ANN STAT, V34, P1436, DOI 10.1214/009053606000000281; Meyer PE, 2007, EURASIP J BIOINFORM, DOI 10.1155/2007/79879; Meyer PE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-461; Opgen-Rhein R, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-37; Perrin BE, 2003, BIOINFORMATICS, V19, pII138, DOI 10.1093/bioinformatics/btg1071; Phuong TM, 2004, BIOINFORMATICS, V20, P750, DOI 10.1093/bioinformatics/btg480; Pournara I, 2004, BIOINFORMATICS, V20, P2934, DOI 10.1093/bioinformatics/bth337; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Ruan JH, 2006, BIOINFORMATICS, V22, P332, DOI 10.1093/bioinformatics/bti792; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Schafer J, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1175; Schafer J, 2006, R NEWS, V6, P50; Segal E, 2005, J MACH LEARN RES, V6, P557; Stolovitzky G, 2007, ANN NY ACAD SCI, V1115, P1, DOI 10.1196/annals.1407.021; Stolovitzky G, 2009, ANN NY ACAD SCI, V1158, P159, DOI 10.1111/j.1749-6632.2009.04497.x; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Werhli AV, 2006, BIOINFORMATICS, V22, P2523, DOI 10.1093/bioinformatics/btl391; Xiao Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000414; Yu J, 2004, BIOINFORMATICS, V20, P3594, DOI 10.1093/bioinformatics/bth448; DREAM4 SILICO NETWOR; DREAM PROJECT	50	811	823	7	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2010	5	9							e12776	10.1371/journal.pone.0012776	http://dx.doi.org/10.1371/journal.pone.0012776			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654ZQ	20927193	Green Published, Green Submitted, gold			2022-12-27	WOS:000282210700002
J	Liu, YC; Tozeren, A				Liu, Yichuan; Tozeren, Aydin			Domain Altering SNPs in the Human Proteome and Their Impact on Signaling Pathways	PLOS ONE			English	Article							GENE-GENE INTERACTIONS; ASSOCIATION; DATABASE; SELECTION; DISCOVERY	Single nucleotide polymorphisms (n-SNPs) constitute an important mode of genetic variations observed in the human genome. A small fraction of SNPs, about four thousand out of the ten million, has been associated with genetic disorders and complex diseases. The present study focuses on SNPs that fall on protein domains, 3D structures that facilitate connectivity of proteins in cell signaling and metabolic pathways. We scanned the human proteome using the PROSITE web tool and identified proteins with SNP containing domains. We showed that SNPs that fall on protein domains are highly statistically enriched among SNPs linked to hereditary disorders and complex diseases. Proteins whose domains are dramatically altered by the presence of an SNP are even more likely to be present among proteins linked to hereditary disorders. Proteins with domain-altering SNPs comprise highly connected nodes in cellular pathways such as the focal adhesion, the axon guidance pathway and the autoimmune disease pathways. Statistical enrichment of domain/motif signatures in interacting protein pairs indicates extensive loss of connectivity of cell signaling pathways due to domain-altering SNPs, potentially leading to hereditary disorders.	[Liu, Yichuan; Tozeren, Aydin] Drexel Univ, Ctr Integrated Bioinformat, Philadelphia, PA 19104 USA	Drexel University	Liu, YC (corresponding author), Drexel Univ, Ctr Integrated Bioinformat, Philadelphia, PA 19104 USA.	at62@drexel.edu	Liu, Yichuan/AAF-3893-2021	LIU, YICHUAN/0000-0003-2023-072X	Drexel University; BioAdvance	Drexel University; BioAdvance	The research presented in this manuscript was funded by Drexel University Calhoun Endowment fellowship to Yichuan Liu and by BioAdvance support to Greater Philadelphia Bioinformatics Alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arking DE, 2009, TRENDS GENET, V25, P387, DOI 10.1016/j.tig.2009.07.007; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Bourne PE, 2004, NUCLEIC ACIDS RES, V32, pD223, DOI 10.1093/nar/gkh096; Brookes AJ, 1999, GENE, V234, P177, DOI 10.1016/S0378-1119(99)00219-X; Cichon S, 2009, AM J PSYCHIAT, V166, P540, DOI 10.1176/appi.ajp.2008.08091354; Clark TG, 2005, HUM HERED, V60, P97, DOI 10.1159/000088845; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Eglen RM, 2009, ASSAY DRUG DEV TECHN, V7, P22, DOI 10.1089/adt.2008.164; Evans P, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-27; Evans WE, 2001, ANNU REV GENOM HUM G, V2, P9, DOI 10.1146/annurev.genom.2.1.9; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Hubley RM, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-30; Hulo N, 2008, NUCLEIC ACIDS RES, V36, pD245, DOI 10.1093/nar/gkm977; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kelemen A, 2009, IEEE T INF TECHNOL B, V13, P841, DOI 10.1109/TITB.2009.2024144; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Kronenberg F, 2008, EXP GERONTOL, V43, P39, DOI 10.1016/j.exger.2007.09.005; MAIOROV VN, 1994, J MOL BIOL, V235, P625, DOI 10.1006/jmbi.1994.1017; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Motsinger AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-39; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Raghavachari B, 2008, NUCLEIC ACIDS RES, V36, pD656, DOI 10.1093/nar/gkm761; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Reumers J, 2005, NUCLEIC ACIDS RES, V33, pD527; Ritchie MD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-28; Shastry BS, 2007, J HUM GENET, V52, P871, DOI 10.1007/s10038-007-0200-z; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Wjst M, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-92; Yue P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-166; Zhang Y, 2010, MOL CANCER THER, V9, P279, DOI 10.1158/1535-7163.MCT-09-0508	36	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12890	10.1371/journal.pone.0012890	http://dx.doi.org/10.1371/journal.pone.0012890			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886114	Green Published, Green Submitted, gold			2022-12-27	WOS:000282091100007
J	Inderjit; Bajpai, D; Rajeswari, MS				Inderjit; Bajpai, Devika; Rajeswari, M. S.			Interaction of 8-Hydroxyquinoline with Soil Environment Mediates Its Ecological Function	PLOS ONE			English	Article							GLORY SEEDLING BIOMASS; P-COUMARIC ACID; MICROBIAL-METABOLISM; CENTAUREA-DIFFUSA; QUINOLINE; DEGRADATION; ROOT; ALLELOCHEMICALS; CHEMISTRY; BACTERIUM	Background: Allelopathic functions of plant-released chemicals are often studied through growth bioassays assuming that these chemicals will directly impact plant growth. This overlooks the role of soil factors in mediating allelopathic activities of chemicals, particularly non-volatiles. Here we examined the allelopathic potential of 8-hydroxyquinoline (HQ), a chemical reported to be exuded from the roots of Centaurea diffusa. Methodology/Principal Findings: Growth bioassays and HQ recovery experiments were performed in HQ-treated soils (non-sterile, sterile, organic matter-enriched and glucose-amended) and untreated control soil. Root growth of either Brassica campestris or Phalaris minor was not affected in HQ-treated non-sterile soil. Soil modifications (organic matter and glucose amendments) could not enhance the recovery of HQ in soil, which further supports the observation that HQ is not likely to be an allelopathic compound. Hydroxyquinoline-treated soil had lower values for the CO2 release compared to untreated non-sterile soil. Soil sterilization significantly influenced the organic matter content, PO4-P and total organic nitrogen levels. Conclusion/Significance: Here, we concluded that evaluation of the effect of a chemical on plant growth is not enough in evaluating the ecological role of a chemical in plant-plant interactions. Interaction of the chemical with soil factors largely determines the impact of HQ on plant growth.	[Inderjit] Univ Delhi, Dept Environm Biol, Delhi 110007, India; [Inderjit; Bajpai, Devika] Univ Delhi, CEMDE, Delhi 110007, India; [Rajeswari, M. S.] Univ Delhi, Dept Bot, Acharya Narendra Dev Coll, Delhi 110007, India	University of Delhi; University of Delhi; University of Delhi	Inderjit (corresponding author), Univ Delhi, Dept Environm Biol, Delhi 110007, India.	inderjit@cemde.du.ac.in			University of Delhi; Department of Science and Technology	University of Delhi(University of Delhi); Department of Science and Technology(Department of Science & Technology (India))	This research was funded by the University of Delhi and the Department of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SE, 1989, CHEM ANAL ECOLOGICAL; Anderson J. P. E., 1982, METHODS SOIL ANAL 2; [Anonymous], 1944, SOIL PLANT ANAL; Appel HM, 2001, J CHEM ECOL, V27, P761, DOI 10.1023/A:1010306103643; Bai YH, 2010, BIODEGRADATION, V21, P335, DOI 10.1007/s10532-009-9304-9; Blair AC, 2005, ECOL LETT, V8, P1039, DOI 10.1111/j.1461-0248.2005.00805.x; BLUM U, 1993, J CHEM ECOL, V19, P2791, DOI 10.1007/BF00980584; BOX JD, 1983, WATER RES, V17, P511, DOI 10.1016/0043-1354(83)90111-2; Chobot V, 2009, J CHEM ECOL, V35, P980, DOI 10.1007/s10886-009-9681-x; Chon SU, 2004, J AGRON CROP SCI, V190, P145, DOI 10.1111/j.1439-037X.2004.00088.x; Duke SO, 2009, J CHEM ECOL, V35, P141, DOI 10.1007/s10886-008-9587-z; Erdem B, 2010, APPL SURF SCI, V256, P5422, DOI 10.1016/j.apsusc.2009.12.126; GRANT DJW, 1976, MICROBIOS, V15, P177; Huang PM, 1999, PRINCIPLES AND PRACTICES IN PLANT ECOLOGY, P287; Inderjit, 2006, SOIL BIOL BIOCHEM, V38, P256, DOI 10.1016/j.soilbio.2005.05.004; Inderjit, 1996, BOT REV, V62, P186, DOI 10.1007/BF02857921; Inderjit, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002536; Kaiser JP, 1996, MICROBIOL REV, V60, P483, DOI 10.1128/MMBR.60.3.483-498.1996; Kaur H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004700; Kilbane JJ, 2000, APPL ENVIRON MICROB, V66, P688, DOI 10.1128/AEM.66.2.688-693.2000; KUITERS AT, 1986, SOIL BIOL BIOCHEM, V18, P475, DOI 10.1016/0038-0717(86)90003-9; Lan Y, 2002, ARCH ENVIRON CON TOX, V43, P168, DOI 10.1007/s00244-002-1178-3; Norton AP, 2008, BIOL INVASIONS, V10, P79, DOI 10.1007/s10530-007-9111-3; Oliva A, 1999, J CHEM ECOL, V25, P519, DOI 10.1023/A:1020949703205; PUE KJ, 1995, J CHEM ECOL, V21, P833, DOI 10.1007/BF02033464; Schmidt IK, 1997, OECOLOGIA, V112, P557, DOI 10.1007/s004420050345; SCHWARZ G, 1988, SYST APPL MICROBIOL, V10, P185, DOI 10.1016/S0723-2020(88)80035-3; SHUKLA OP, 1986, APPL ENVIRON MICROB, V51, P1332, DOI 10.1128/AEM.51.6.1332-1342.1986; Suding KN, 2004, OECOLOGIA, V141, P526, DOI 10.1007/s00442-004-1678-0; Sutton SD, 1996, APPL ENVIRON MICROB, V62, P2910, DOI 10.1128/AEM.62.8.2910-2914.1996; Tharayil N, 2009, NEW PHYTOL, V181, P424, DOI 10.1111/j.1469-8137.2008.02647.x; Troelstra SR, 2001, NEW PHYTOL, V150, P697, DOI 10.1046/j.1469-8137.2001.00133.x; Vivanco JM, 2004, ECOL LETT, V7, P285, DOI 10.1111/j.1461-0248.2004.00576.x; Watkins AJ, 2009, SOIL BIOL BIOCHEM, V41, P580, DOI 10.1016/j.soilbio.2008.12.019; Weidenhamer JD, 2004, J CHEM ECOL, V30, P1067, DOI 10.1023/B:JOEC.0000028468.97851.7a; Weidenhamer JD, 2010, J CHEM ECOL, V36, P59, DOI 10.1007/s10886-009-9735-0; Weidenhamer JD, 2009, PLANT SOIL, V322, P177, DOI 10.1007/s11104-009-9905-4; Zhu SN, 2008, J HAZARD MATER, V160, P289, DOI 10.1016/j.jhazmat.2008.02.112	38	21	21	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2010	5	9							e12852	10.1371/journal.pone.0012852	http://dx.doi.org/10.1371/journal.pone.0012852			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652JO	20877629	Green Published, gold, Green Submitted			2022-12-27	WOS:000282002900009
J	Kuffner, R; Petri, T; Windhager, L; Zimmer, R				Kueffner, Robert; Petri, Tobias; Windhager, Lukas; Zimmer, Ralf			Petri Nets with Fuzzy Logic (PNFL): Reverse Engineering and Parametrization	PLOS ONE			English	Article							GENE REGULATORY NETWORKS; SYSTEMS; RECONSTRUCTION; SIMULATION; INFERENCE; ALGORITHM; MODELS	Background: The recent DREAM4 blind assessment provided a particularly realistic and challenging setting for network reverse engineering methods. The in silico part of DREAM4 solicited the inference of cycle-rich gene regulatory networks from heterogeneous, noisy expression data including time courses as well as knockout, knockdown and multifactorial perturbations. Methodology and Principal Findings: We inferred and parametrized simulation models based on Petri Nets with Fuzzy Logic (PNFL). This completely automated approach correctly reconstructed networks with cycles as well as oscillating network motifs. PNFL was evaluated as the best performer on DREAM4 in silico networks of size 10 with an area under the precision-recall curve (AUPR) of 81%. Besides topology, we inferred a range of additional mechanistic details with good reliability, e. g. distinguishing activation from inhibition as well as dependent from independent regulation. Our models also performed well on new experimental conditions such as double knockout mutations that were not included in the provided datasets. Conclusions: The inference of biological networks substantially benefits from methods that are expressive enough to deal with diverse datasets in a unified way. At the same time, overly complex approaches could generate multiple different models that explain the data equally well. PNFL appears to strike the balance between expressive power and complexity. This also applies to the intuitive representation of PNFL models combining a straightforward graphical notation with colloquial fuzzy parameters.	[Kueffner, Robert; Petri, Tobias; Windhager, Lukas; Zimmer, Ralf] Univ Munich, Inst Informat, D-8000 Munich, Germany	University of Munich	Kuffner, R (corresponding author), Univ Munich, Inst Informat, D-8000 Munich, Germany.	Robert.Kueffner@bio.ifi.lmu.de	Zimmer, Ralf/L-9295-2019		Helmholtz Alliance on Systems Biology	Helmholtz Alliance on Systems Biology	This work was supported by Helmholtz Alliance on Systems Biology, Project CoReNe (http://www.helmholtz.de/en/joint_initiative_for_innovation_and_research/initiating_and_networking/helmholtz_alliances/systembiologie/helmholtz_alliance_on_systems_biology/networks_in_detail/corene_control_of_regulatory_networks_with_focus_on_non_coding_rna/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Brazhnik P, 2002, TRENDS BIOTECHNOL, V20, P467, DOI 10.1016/S0167-7799(02)02053-X; Chaouiya C, 2007, BRIEF BIOINFORM, V8, P210, DOI 10.1093/bib/bbm029; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; de la Fuente A, 2002, TRENDS GENET, V18, P395, DOI 10.1016/S0168-9525(02)02692-6; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Hache H, 2009, EURASIP J BIOINFORM, DOI 10.1155/2009/617281; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Heiner M, 2004, BIOSYSTEMS, V75, P15, DOI 10.1016/j.biosystems.2004.03.003; Istrail S, 2005, P NATL ACAD SCI USA, V102, P4954, DOI 10.1073/pnas.0409624102; Li C, 2007, J BIOSCIENCES, V32, P113; Li H, 2008, FRONT BIOSCI-LANDMRK, V13, P263, DOI 10.2741/2677; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Marbach D, 2009, ANN NY ACAD SCI, V1158, P102, DOI 10.1111/j.1749-6632.2008.03945.x; Marbach D, 2009, J COMPUT BIOL, V16, P229, DOI 10.1089/cmb.2008.09TT; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Markowetz F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S5; Marwan W, 2008, MATH METHOD OPER RES, V67, P117, DOI 10.1007/s00186-007-0178-5; Matsuno Hiroshi, 2003, In Silico Biology, V3, P389; MENDEL JM, 1995, P IEEE, V83, P345, DOI 10.1109/5.364485; Michoel T, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-49; MURATA T, 1989, P IEEE, V77, P541, DOI 10.1109/5.24143; Nachman I, 2004, BIOINFORMATICS, V20, P248, DOI 10.1093/bioinformatics/bth941; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Sackmann A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-482; Sima C, 2009, CURR GENOMICS, V10, P416, DOI 10.2174/138920209789177610; Soranzo N, 2007, BIOINFORMATICS, V23, P1640, DOI 10.1093/bioinformatics/btm163; WINDHAGER L, 2008, LECT NOTES INFORMA P, V136, P106; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X; Zou CL, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-122	31	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2010	5	9							e12807	10.1371/journal.pone.0012807	http://dx.doi.org/10.1371/journal.pone.0012807			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651YH	20862218	Green Published, Green Submitted, gold			2022-12-27	WOS:000281963200007
J	Mallet, C; Barriere, DA; Ermund, A; Jonsson, BAG; Eschalier, A; Zygmunt, PM; Hogestatt, ED				Mallet, Christophe; Barriere, David A.; Ermund, Anna; Jonsson, Bo A. G.; Eschalier, Alain; Zygmunt, Peter M.; Hogestatt, Edward D.			TRPV1 in Brain Is Involved in Acetaminophen-Induced Antinociception	PLOS ONE			English	Article							ACID AMIDE HYDROLASE; TRANSPORT INHIBITOR AM404; CANNABINOID CB1 RECEPTOR; ANANDAMIDE TRANSPORT; INFLAMMATORY PAIN; SEROTONERGIC SYSTEMS; PARACETAMOL EXERTS; MICE LACKING; RAT; MODEL	Background: Acetaminophen, the major active metabolite of acetanilide in man, has become one of the most popular overthe- counter analgesic and antipyretic agents, consumed by millions of people daily. However, its mechanism of action is still a matter of debate. We have previously shown that acetaminophen is further metabolized to N-(4-hydroxyphenyl)-5Z,8Z,11Z,14Z-eicosatetraenamide (AM404) by fatty acid amide hydrolase (FAAH) in the rat and mouse brain and that this metabolite is a potent activator of transient receptor potential vanilloid 1 (TRPV1) in vitro. Pharmacological activation of TRPV1 in the midbrain periaqueductal gray elicits antinociception in rats. It is therefore possible that activation of TRPV1 in the brain contributes to the analgesic effect of acetaminophen. Methodology/Principal Findings: Here we show that the antinociceptive effect of acetaminophen at an oral dose lacking hypolocomotor activity is absent in FAAH and TRPV1 knockout mice in the formalin, tail immersion and von Frey tests. This dose of acetaminophen did not affect the global brain contents of prostaglandin E-2 (PGE(2)) and endocannabinoids. Intracerebroventricular injection of AM404 produced a TRPV1-mediated antinociceptive effect in the mouse formalin test. Pharmacological inhibition of TRPV1 in the brain by intracerebroventricular capsazepine injection abolished the antinociceptive effect of oral acetaminophen in the same test. Conclusions: This study shows that TRPV1 in brain is involved in the antinociceptive action of acetaminophen and provides a strategy for developing central nervous system active oral analgesics based on the coexpression of FAAH and TRPV1 in the brain.	[Mallet, Christophe; Barriere, David A.; Eschalier, Alain] Univ Auvergne, Clermont Univ, Clermont Ferrand, France; [Mallet, Christophe; Barriere, David A.; Eschalier, Alain] INSERM, U766, Clermont Ferrand, France; [Jonsson, Bo A. G.] Lund Univ, Dept Occupat & Environm Med, Lund, Sweden; [Ermund, Anna; Zygmunt, Peter M.; Hogestatt, Edward D.] Lund Univ, Dept Clin Chem, Lund, Sweden; [Ermund, Anna; Zygmunt, Peter M.; Hogestatt, Edward D.] Lund Univ, Pain Res Ctr, Lund, Sweden	Universite Clermont Auvergne (UCA); Institut National de la Sante et de la Recherche Medicale (Inserm); Lund University; Lund University; Lund University	Mallet, C (corresponding author), Univ Auvergne, Clermont Univ, Clermont Ferrand, France.	peter.zygmunt@med.lu.se	ESCHALIER, Alain/L-9957-2015; Nada, Aly/H-4219-2015; Ermund, Anna/AAG-3160-2020; Barrière, David André/ABC-3925-2021; Mallet, Christophe/K-2918-2015	Nada, Aly/0000-0003-4628-3475; Barrière, David André/0000-0003-4355-3329; Zygmunt, Peter/0000-0002-5102-8199; Ermund, Anna/0000-0002-3233-043X; Mallet, Christophe/0000-0002-0873-6763; Jonsson, Bo/0000-0002-8767-0589	INSERM; Universite d'Auvergne-Clermont1; Swedish Medical Research Council [2007-3095]; Medical Faculty of Lund; School of Pharmaceutical Sciences at Lund University; Association Nationale de la Recherche Technique; University of Auvergne; Bristol-Myers-Squibb	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite d'Auvergne-Clermont1; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Medical Faculty of Lund; School of Pharmaceutical Sciences at Lund University; Association Nationale de la Recherche Technique; University of Auvergne; Bristol-Myers-Squibb(Bristol-Myers Squibb)	This work was supported by fundings from INSERM, Universite d'Auvergne-Clermont1, the Swedish Medical Research Council (2007-3095), the Medical Faculty of Lund and the School of Pharmaceutical Sciences at Lund University. CM and DB have received a PhD grant ("Bourse Cifre") funded by Association Nationale de la Recherche Technique, the University of Auvergne, INSERM and Bristol-Myers-Squibb. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alloui A, 2002, EUR J PHARMACOL, V443, P71, DOI 10.1016/S0014-2999(02)01578-9; Alloui A, 1996, FUNDAM CLIN PHARM, V10, P406, DOI 10.1111/j.1472-8206.1996.tb00593.x; Ayoub SS, 2006, EUR J PHARMACOL, V538, P57, DOI 10.1016/j.ejphar.2006.03.061; Ballou LR, 2000, P NATL ACAD SCI USA, V97, P10272, DOI 10.1073/pnas.180319297; Beltramo M, 1997, SCIENCE, V277, P1094, DOI 10.1126/science.277.5329.1094; BJORKMAN R, 1994, PAIN, V57, P259, DOI 10.1016/0304-3959(94)90001-9; BJORKMAN R, 1995, ACTA ANAESTH SCAND, V39, P3; Bolcskei K, 2005, PAIN, V117, P368, DOI 10.1016/j.pain.2005.06.024; Bonnefont J, 2005, PAIN, V114, P482, DOI 10.1016/j.pain.2005.01.019; Borsani E, 2007, BRAIN RES, V1152, P87, DOI 10.1016/j.brainres.2007.03.071; BRODIE BB, 1948, J PHARMACOL EXP THER, V94, P29; Bujalska M, 2001, POL J PHARMACOL, V53, P341; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Choi SS, 2001, BRAIN RES, V921, P233, DOI 10.1016/S0006-8993(01)03126-2; Costa B, 2006, BRIT J PHARMACOL, V148, P1022, DOI 10.1038/sj.bjp.0706798; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; De Petrocellis L, 2000, FEBS LETT, V483, P52, DOI 10.1016/S0014-5793(00)02082-2; Fegley D, 2004, P NATL ACAD SCI USA, V101, P8756, DOI 10.1073/pnas.0400997101; Fioravanti B, 2008, J NEUROSCI, V28, P11593, DOI 10.1523/JNEUROSCI.3322-08.2008; FLOWER RJ, 1972, NATURE, V240, P410, DOI 10.1038/240410a0; Fowler CJ, 1997, PHARMACOL TOXICOL, V80, P103, DOI 10.1111/j.1600-0773.1997.tb00291.x; Glaser ST, 2009, NEUROSCIENCE, V163, P594, DOI 10.1016/j.neuroscience.2009.06.043; Guhring H, 2002, EUR J PHARMACOL, V454, P153, DOI 10.1016/S0014-2999(02)02485-8; Hasanein P, 2009, CLIN EXP PHARMACOL P, V36, P1127, DOI 10.1111/j.1440-1681.2009.05197.x; Hermann H, 2003, CELL MOL LIFE SCI, V60, P607, DOI 10.1007/s000180300052; Hogestatt ED, 2005, J BIOL CHEM, V280, P31405, DOI 10.1074/jbc.M501489200; HUNSKAAR S, 1987, PAIN, V30, P103, DOI 10.1016/0304-3959(87)90088-1; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Jung J, 1999, J NEUROSCI, V19, P529; Khanolkar AD, 1996, J MED CHEM, V39, P4515, DOI 10.1021/jm960152y; Knotkova H, 2008, CLIN J PAIN, V24, P142, DOI 10.1097/AJP.0b013e318158ed9e; La Rana G, 2006, J PHARMACOL EXP THER, V317, P1365, DOI 10.1124/jpet.105.100792; Lever IJ, 2009, J NEUROSCI, V29, P3766, DOI 10.1523/JNEUROSCI.4071-08.2009; Maione S, 2006, J PHARMACOL EXP THER, V316, P969, DOI 10.1124/jpet.105.093286; Mallet C, 2008, PAIN, V139, P190, DOI 10.1016/j.pain.2008.03.030; McPartland JM, 2004, BRAIN RES REV, V45, P18, DOI 10.1016/j.brainresrev.2003.11.005; Mitchell VA, 2007, CLIN EXP PHARMACOL P, V34, P1186, DOI 10.1111/j.1440-1681.2007.04692.x; Ong CKS, 2010, ANESTH ANALG, V110, P1170, DOI 10.1213/ANE.0b013e3181cf9281; Ottani A, 2006, EUR J PHARMACOL, V531, P280, DOI 10.1016/j.ejphar.2005.12.015; Palazzo E, 2002, EUR J PHARMACOL, V439, P69, DOI 10.1016/S0014-2999(02)01367-5; Palazzo E, 2006, EUR J NEUROSCI, V24, P2011, DOI 10.1111/j.1460-9568.2006.05086.x; Patapoutian A, 2009, NAT REV DRUG DISCOV, V8, P55, DOI 10.1038/nrd2757; Pelissier T, 1996, J PHARMACOL EXP THER, V278, P8; Pickering G, 2006, CLIN PHARMACOL THER, V79, P371, DOI 10.1016/j.clpt.2005.12.307; PILETTA P, 1991, CLIN PHARMACOL THER, V49, P350, DOI 10.1038/clpt.1991.40; Pini LA, 1996, EUR J PHARMACOL, V308, P31, DOI 10.1016/0014-2999(96)00261-0; Rouzer CA, 2002, CHEM PHYS LIPIDS, V119, P69, DOI 10.1016/S0009-3084(02)00068-3; Ruggieri V, 2008, N-S ARCH PHARMACOL, V377, P219, DOI 10.1007/s00210-008-0284-9; Seal RP, 2009, NATURE, V462, P651, DOI 10.1038/nature08505; Starowicz K, 2007, J NEUROSCI, V27, P13739, DOI 10.1523/JNEUROSCI.3258-07.2007; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; Toth A, 2005, MOL BRAIN RES, V135, P162, DOI 10.1016/j.molbrainres.2004.12.003; Tsou K, 1998, NEUROSCI LETT, V254, P137, DOI 10.1016/S0304-3940(98)00700-9; Zygmunt PM, 2000, EUR J PHARMACOL, V396, P39, DOI 10.1016/S0014-2999(00)00207-7	54	105	107	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2010	5	9							e12748	10.1371/journal.pone.0012748	http://dx.doi.org/10.1371/journal.pone.0012748			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651XL	20862299	Green Published, gold, Green Submitted			2022-12-27	WOS:000281960800008
J	Egusa, H; Okita, K; Kayashima, H; Yu, GN; Fukuyasu, S; Saeki, M; Matsumoto, T; Yamanaka, S; Yatani, H				Egusa, Hiroshi; Okita, Keisuke; Kayashima, Hiroki; Yu, Guannan; Fukuyasu, Sho; Saeki, Makio; Matsumoto, Takuya; Yamanaka, Shinya; Yatani, Hirofumi			Gingival Fibroblasts as a Promising Source of Induced Pluripotent Stem Cells	PLOS ONE			English	Article							BONE-MARROW; GENERATION; MOUSE; DIFFERENTIATION; AUGMENTATION; REGENERATION; SUPPRESSION; TELOMERASE; EXPRESSION; INDUCTION	Background: Induced pluripotent stem (iPS) cells efficiently generated from accessible tissues have the potential for clinical applications. Oral gingiva, which is often resected during general dental treatments and treated as biomedical waste, is an easily obtainable tissue, and cells can be isolated from patients with minimal discomfort. Methodology/Principal Findings: We herein demonstrate iPS cell generation from adult wild-type mouse gingival fibroblasts (GFs) via introduction of four factors (Oct3/4, Sox2, Klf4 and c-Myc; GF-iPS-4F cells) or three factors (the same as GF-iPS-4F cells, but without the c-Myc oncogene; GF-iPS-3F cells) without drug selection. iPS cells were also generated from primary human gingival fibroblasts via four-factor transduction. These cells exhibited the morphology and growth properties of embryonic stem (ES) cells and expressed ES cell marker genes, with a decreased CpG methylation ratio in promoter regions of Nanog and Oct3/4. Additionally, teratoma formation assays showed ES cell-like derivation of cells and tissues representative of all three germ layers. In comparison to mouse GF-iPS-4F cells, GF-iPS-3F cells showed consistently more ES cell-like characteristics in terms of DNA methylation status and gene expression, although the reprogramming process was substantially delayed and the overall efficiency was also reduced. When transplanted into blastocysts, GF-iPS-3F cells gave rise to chimeras and contributed to the development of the germline. Notably, the four-factor reprogramming efficiency of mouse GFs was more than 7-fold higher than that of fibroblasts from tail-tips, possibly because of their high proliferative capacity. Conclusions/Significance: These results suggest that GFs from the easily obtainable gingival tissues can be readily reprogrammed into iPS cells, thus making them a promising cell source for investigating the basis of cellular reprogramming and pluripotency for future clinical applications. In addition, high-quality iPS cells were generated from mouse GFs without Myc transduction or a specific system for reprogrammed cell selection.	[Egusa, Hiroshi; Kayashima, Hiroki; Yu, Guannan; Fukuyasu, Sho; Yatani, Hirofumi] Osaka Univ, Grad Sch Dent, Dept Fixed Prosthodont, Osaka, Japan; [Okita, Keisuke; Yamanaka, Shinya] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Kyoto, Japan; [Saeki, Makio] Osaka Univ, Grad Sch Dent, Dept Pharmacol, Osaka, Japan; [Matsumoto, Takuya] Osaka Univ, Grad Sch Dent, Dept Oromaxillofacial Regenerat, Osaka, Japan	Osaka University; Kyoto University; Osaka University; Osaka University	Egusa, H (corresponding author), Osaka Univ, Grad Sch Dent, Dept Fixed Prosthodont, Osaka, Japan.	egu@dent.osaka-u.ac.jp	Egusa, Hiroshi/AFT-9694-2022	Egusa, Hiroshi/0000-0002-0200-8132; Okita, Keisuke/0000-0001-5806-1090	Ministry of Education, Culture, Sports, Science and Technology, Japan [A: 22689049]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This investigation was supported by a Grant-in-Aid for Young Scientists (A: 22689049, H. E.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (http://www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Egusa H, 2005, J BIOL CHEM, V280, P23691, DOI 10.1074/jbc.M413796200; Egusa H, 2007, TISSUE ENG, V13, P2589, DOI 10.1089/ten.2007.0080; Egusa H, 2010, J ORAL BIOSCI, V52, P107, DOI 10.2330/joralbiosci.52.107; Egusa H, 2009, BIOMATERIALS, V30, P4676, DOI 10.1016/j.biomaterials.2009.05.032; Ezashi T, 2009, P NATL ACAD SCI USA, V106, P10993, DOI 10.1073/pnas.0905284106; Giannopoulou C, 1996, J DENT RES, V75, P895, DOI 10.1177/00220345960750030601; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Li WL, 2010, TRENDS PHARMACOL SCI, V31, P36, DOI 10.1016/j.tips.2009.10.002; Lin A, 2010, AM J PATHOL, V176, P108, DOI 10.2353/ajpath.2010.090256; Liu HS, 2008, CELL STEM CELL, V3, P587, DOI 10.1016/j.stem.2008.10.014; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Martin-Rivera L, 1998, P NATL ACAD SCI USA, V95, P10471, DOI 10.1073/pnas.95.18.10471; Meijer GJ, 2008, BIOMATERIALS, V29, P3053, DOI 10.1016/j.biomaterials.2008.03.012; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nikawa H, 2006, MYCOSES, V49, P14, DOI 10.1111/j.1439-0507.2005.01176.x; ODA Y, J BIOL CHEM IN PRESS; Ohnuki M, 2009, CURR PROTOC STEM CEL, DOI DOI 10.1002/9780470151808.SC04A02S9; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; SCIUBBA JJ, 1978, J ORAL PATHOL MED, V7, P214, DOI 10.1111/j.1600-0714.1978.tb01596.x; Seki T, 2010, CELL STEM CELL, V7, P11, DOI 10.1016/j.stem.2010.06.003; Shimada H, 2010, MOL REPROD DEV, V77, P2, DOI 10.1002/mrd.21117; Stadtfeld M, 2008, CURR BIOL, V18, P890, DOI 10.1016/j.cub.2008.05.010; Stephens P, 2001, BRIT J DERMATOL, V144, P229, DOI 10.1046/j.1365-2133.2001.04006.x; Sukotjo C, 2003, J BIOL CHEM, V278, P51527, DOI 10.1074/jbc.M309616200; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tamaoki N, 2010, J DENT RES, V89, P773, DOI 10.1177/0022034510366846; Tsai SY, 2010, STEM CELLS, V28, P221, DOI 10.1002/stem.281; Ueda M, 2008, IMPLANT DENT, V17, P82, DOI 10.1097/ID.0b013e31815cd591; Walsh LJ, 1996, AUST DENT J, V41, P75, DOI 10.1111/j.1834-7819.1996.tb05916.x; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Yamada Y, 2008, TISSUE ENG PT A, V14, P1699, DOI 10.1089/ten.tea.2007.0189; Yamada Y, 2006, INT J PERIODONT REST, V26, P363; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Yan X, 2010, STEM CELLS DEV, V19, P469, DOI 10.1089/scd.2009.0314; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zaky SH, 2009, J DENT RES, V88, P1077, DOI 10.1177/0022034509349926; Zeuschner D, 2010, STEM CELLS DEV, V19, P615, DOI 10.1089/scd.2009.0159	50	114	117	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2010	5	9							e12743	10.1371/journal.pone.0012743	http://dx.doi.org/10.1371/journal.pone.0012743			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZO	20856871	Green Submitted, Green Published, gold			2022-12-27	WOS:000281815700023
J	Delaney, A; Keighren, M; Fleetwood-Walker, SM; Jackson, IJ				Delaney, Ada; Keighren, Margaret; Fleetwood-Walker, Susan M.; Jackson, Ian J.			Involvement of the Melanocortin-1 Receptor in Acute Pain and Pain of Inflammatory but Not Neuropathic Origin	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; SEX-DIFFERENCES; FORMALIN TEST; PROOPIOMELANOCORTIN DEFICIENCY; MORPHINE ANTINOCICEPTION; DIFFERENTIAL EXPRESSION; THERMAL NOCICEPTION; HAIR PIGMENTATION; OPIOID ANALGESIA; SENSORY NEURONS	Background: Response to painful stimuli is susceptible to genetic variation. Numerous loci have been identified which contribute to this variation, one of which, MC1R, is better known as a gene involved in mammalian hair colour. MC1R is a G protein-coupled receptor expressed in melanocytes and elsewhere and mice lacking MC1R have yellow hair, whilst humans with variant MC1R protein have red hair. Previous work has found differences in acute pain perception, and response to analgesia in mice and humans with mutations or variants in MC1R. Methodology and Principal Findings: We have tested responses to noxious and non-noxious stimuli in mutant mice which lack MC1R, or which overexpress an endogenous antagonist of the receptor, as well as controls. We have also examined the response of these mice to inflammatory pain, assessing the hyperalgesia and allodynia associated with persistent inflammation, and their response to neuropathic pain. Finally we tested by a paired preference paradigm their aversion to oral administration of capsaicin, which activates the noxious heat receptor TRPV1. Female mice lacking MC1R showed increased tolerance to noxious heat and no alteration in their response to non-noxious mechanical stimuli. MC1R mutant females, and females overexpressing the endogenous MC1R antagonist, agouti signalling protein, had a reduced formalin-induced inflammatory pain response, and a delayed development of inflammation-induced hyperalgesia and allodynia. In addition they had a decreased aversion to capsaicin at moderate concentrations. Male mutant mice showed no difference from their respective controls. Mice of either sex did not show any effect of mutant genotype on neuropathic pain. Conclusions: We demonstrate a sex-specific role for MC1R in acute noxious thermal responses and pain of inflammatory origin.	[Delaney, Ada; Keighren, Margaret; Jackson, Ian J.] Univ Edinburgh, Human Genet Unit, MRC, Inst Genet & Mol Med,Western Gen Hosp, Edinburgh EH8 9YL, Midlothian, Scotland; [Delaney, Ada; Fleetwood-Walker, Susan M.] Univ Edinburgh, Ctr Neuroregenerat, Edinburgh EH8 9YL, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Delaney, A (corresponding author), Univ Edinburgh, Human Genet Unit, MRC, Inst Genet & Mol Med,Western Gen Hosp, Edinburgh EH8 9YL, Midlothian, Scotland.	Ian.Jackson@hgu.mrc.ac.uk		delaney, ada/0000-0003-4040-1186; Jackson, Ian/0000-0001-6526-0688	Medical Research Council, UK; Medical Research Council [MC_U127527200] Funding Source: researchfish; MRC [MC_U127527200] Funding Source: UKRI	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASBAUM AI, 1984, ANNU REV NEUROSCI, V7, P309, DOI 10.1146/annurev.ne.07.030184.001521; Becher E, 1999, ANN NY ACAD SCI, V885, P188; Bellasio S, 2003, EUR J PHARMACOL, V482, P127, DOI 10.1016/j.ejphar.2003.09.017; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Bergeson SE, 2001, MAMM GENOME, V12, P546, DOI 10.1007/s003350020022; Berkley KJ, 1997, BEHAV BRAIN SCI, V20, P371, DOI 10.1017/S0140525X97221485; Bertorelli R, 2005, BEHAV BRAIN RES, V157, P55, DOI 10.1016/j.bbr.2004.06.008; Bhardwaj R, 1997, J IMMUNOL, V158, P3378; Catania A, 1996, PEPTIDES, V17, P675, DOI 10.1016/0196-9781(96)00037-X; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Craft RM, 2003, CLIN J PAIN, V19, P175, DOI 10.1097/00002508-200305000-00005; DUBUISSON D, 1977, PAIN, V4, P161, DOI 10.1016/0304-3959(77)90130-0; Dyck P. J., 1993, PERIPHERAL NEUROPATH, V3rd, P1065; Elitt CM, 2008, BRAIN RES, V1230, P80, DOI 10.1016/j.brainres.2008.06.119; Furuse T, 2003, PAIN, V105, P169, DOI 10.1016/S0304-3959(03)00178-7; GIROS B, 1995, LIFE SCI, V56, pPL369, DOI 10.1016/0024-3205(95)00119-Q; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Jackson IJ, 2007, HUM MOL GENET, V16, P2341, DOI 10.1093/hmg/ddm191; Ji RR, 2002, NEURON, V36, P57, DOI 10.1016/S0896-6273(02)00908-X; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Kavaliers M, 1997, BRAIN RES, V768, P30, DOI 10.1016/S0006-8993(97)00569-6; Kest B, 1999, J PHARMACOL EXP THER, V289, P1370; Kishi T, 2003, J COMP NEUROL, V457, P213, DOI 10.1002/cne.10454; Krude H, 2003, J CLIN ENDOCR METAB, V88, P4633, DOI 10.1210/jc.2003-030502; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Liem EB, 2005, ANESTHESIOLOGY, V102, P509, DOI 10.1097/00000542-200503000-00006; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; MILLER MW, 1993, GENE DEV, V7, P454, DOI 10.1101/gad.7.3.454; Mogil JS, 2006, PAIN, V126, P24, DOI 10.1016/j.pain.2006.06.004; Mogil JS, 2005, P NATL ACAD SCI USA, V102, P12938, DOI 10.1073/pnas.0503264102; Mogil JS, 2005, J MED GENET, V42, P583, DOI 10.1136/jmg.2004.027698; Mogil JS, 1997, PAIN, V70, P267, DOI 10.1016/S0304-3959(97)03333-2; Mogil JS, 2003, P NATL ACAD SCI USA, V100, P4867, DOI 10.1073/pnas.0730053100; Mogil JS, 2000, NEUROSCI BIOBEHAV R, V24, P375, DOI 10.1016/S0149-7634(00)00015-4; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; Ollmann MM, 1998, GENE DEV, V12, P316, DOI 10.1101/gad.12.3.316; Riley JL, 1998, PAIN, V74, P181, DOI 10.1016/S0304-3959(97)00199-1; Sakai C, 1997, EMBO J, V16, P3544, DOI 10.1093/emboj/16.12.3544; Simons CT, 2001, CHEM SENSES, V26, P491, DOI 10.1093/chemse/26.5.491; Slominski A, 2005, ENDOCRINOLOGY, V146, P1245, DOI 10.1210/en.2004-0733; Starowicz K, 2004, NEUROSCI LETT, V358, P79, DOI 10.1016/j.neulet.2003.12.096; Starowicz K, 2009, PHARMACOL REP, V61, P1086, DOI 10.1016/S1734-1140(09)70171-9; Sufka KJ, 1998, EUR J PAIN-LONDON, V2, P351, DOI 10.1016/S1090-3801(98)90033-7; Suzuki I, 1997, J INVEST DERMATOL, V108, P838, DOI 10.1111/1523-1747.ep12292572; Tanabe K, 2007, J NEUROCHEM, V101, P1145, DOI 10.1111/j.1471-4159.2006.04432.x; TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T; Vrinten DH, 2000, J NEUROSCI, V20, P8131; Wiesenfeld-Hallin Zsuzsanna, 2005, Gend Med, V2, P137, DOI 10.1016/S1550-8579(05)80042-7; Wilson SG, 2002, PAIN, V96, P385, DOI 10.1016/S0304-3959(01)00489-4; XIA Y, 1995, NEUROREPORT, V6, P2193, DOI 10.1097/00001756-199511000-00022; Yaswen L, 1999, NAT MED, V5, P1066, DOI 10.1038/12506; Zvejniece L, 2006, PHARMACOL BIOCHEM BE, V85, P287, DOI 10.1016/j.pbb.2006.08.001	52	27	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2010	5	9							e12498	10.1371/journal.pone.0012498	http://dx.doi.org/10.1371/journal.pone.0012498			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648ZZ	20856883	Green Submitted, Green Published, gold			2022-12-27	WOS:000281735700001
J	Huo, LF; Yao, H; Wang, XC; Wong, GW; Kung, HF; Lin, MC				Huo, Longfei; Yao, Hong; Wang, Xicai; Wong, Gee Wan; Kung, Hsiang-fu; Lin, Marie C.			Inhibition of Melanoma Growth by Subcutaneous Administration of hTERTC27 Viral Cocktail in C57BL/6 Mice	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; TELOMERASE REVERSE-TRANSCRIPTASE; RECOMBINANT ADENOASSOCIATED VIRUS; TRYPANOSOMA-CRUZI INFECTION; CYTOTOXIC T-LYMPHOCYTES; CANCER GENE-THERAPY; METASTATIC MELANOMA; CUTANEOUS MELANOMA; MALIGNANT-MELANOMA; ANTITUMOR-ACTIVITY	Background: hTERTC27 is a 27 kDa C-terminal polypeptide of human telomerase reverse transcriptase that has previously been shown to reduce tumorigenicity of HeLa cells and suppress growth of xenografted glioblastoma in nude mice. Although ectopic expression of hTERTC27 upregulated genes that are involved in apoptosis, cell cycle, and immune response, the mechanism for hTERTC27-induced tumor suppression has not been completely elucidated. Since hTERT was identified as a universal tumor-associated antigen, we hypothesize that hTERTC27 inhibits tumor growth in vivo through activation of anti-tumor immune response. Methodology/Principal Finding: Immunocopetent C57BL/6 mice were used for mouse B16 melanoma model. Mice bearing B16 melanoma were administered rAAV-/rAdv viral cocktail expressing hTERTC27, and tumor growth was monitored after viral cocktail treatment. Blood and splenocytes were used to determine the level of cytokines and the activity of immune cells, respectively. B16 tumor growth was significantly inhibited by subcutaneous administration of a single dose of 1.5x10(11) vg rAAV-hTERTC27 and 2.5x10(9) pfu rAdv-hTERTC27 viral cocktail (rAAV-/rAdv-hTERTC27). The population and cytotoxicity of NK cells in the mice were significantly augmented by rAAV-/rAdv-hTERTC27 treatment, and selective depletion of the NK cell population in mice by intraperitoneal injection of anti-GM1 antibody abrogated the growth suppression of melanoma induced by rAAV-/rAdv-hTERTC27 administration. Conclusion: Activation of NK cells by administration of rAAV-/rAdv-hTERTC27 is critical for growth suppression of melanoma in mouse model.	[Huo, Longfei; Yao, Hong; Wong, Gee Wan; Lin, Marie C.] Univ Hong Kong, Open Lab Chem Biol, Inst Mol Technol, Dept Chem, Pokfulam, Hong Kong, Peoples R China; [Yao, Hong] Third Mil Med Univ, Inst Pathol, Chongqing, Peoples R China; [Yao, Hong] Third Mil Med Univ, SW Canc Ctr, SW Hosp, Chongqing, Peoples R China; [Wong, Gee Wan; Kung, Hsiang-fu] Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Shatin, Hong Kong, Peoples R China; [Lin, Marie C.] Chinese Univ Hong Kong, Prince Wales Hosp, Brain Tumor Ctr, Fac Med, Shatin, Hong Kong, Peoples R China; [Wang, Xicai] Kunming Med Coll, Tumor Hosp Yunnan Prov, Tumor Inst Yunnan Prov, Canc Res Dept,Biomed Engn Res Ctr, Kunming, Peoples R China	University of Hong Kong; Army Medical University; Army Medical University; Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital; Kunming Medical University	Huo, LF (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.	mcllin@surgery.cuhk.edu.hk	Huo, Longfei/F-9233-2010		Innovation and Technology Fund [ITS/105/02, ITS/173/08]	Innovation and Technology Fund	The work was supported by grants from the Innovation and Technology Fund (ITS/105/02 and ITS/173/08 to M.C.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2002, J LEUKOCYTE BIOL, V71, P1; Bhatia S, 2009, ONCOLOGY-NY, V23, P488; Blesa JMG, 2009, CANC THERAPY, V7, P188; Brockstedt DG, 1999, CLIN IMMUNOL, V92, P67, DOI 10.1006/clim.1999.4724; Brown CK, 2003, SURG CLIN N AM, V83, P283, DOI 10.1016/S0039-6109(02)00187-1; Chen Y, 2004, BIOCHEM BIOPH RES CO, V317, P675, DOI 10.1016/j.bbrc.2004.03.098; Clark PR, 2000, CELL IMMUNOL, V204, P96, DOI 10.1006/cimm.2000.1699; Duthie MS, 2006, IMMUNOLOGY, V119, P355, DOI 10.1111/j.1365-2567.2006.02439.x; Eckert A, 2009, DERMATOLOGY, V218, P69, DOI 10.1159/000161122; Eggermont AMM, 2004, EUR J CANCER, V40, P1825, DOI 10.1016/j.ejca.2004.04.030; Fadel F, 2009, NEW ENGL J MED, V361, P211, DOI 10.1056/NEJMc0904283; Ferrari FK, 1996, J VIROL, V70, P3227, DOI 10.1128/JVI.70.5.3227-3234.1996; Flaherty LE, 2001, J CLIN ONCOL, V19, P3194, DOI 10.1200/JCO.2001.19.13.3194; Gao Y, 2008, CANCER GENE THER, V15, P723, DOI 10.1038/cgt.2008.33; Huang JJ, 2002, CANCER RES, V62, P3226; Huncharek M, 2001, MELANOMA RES, V11, P75, DOI 10.1097/00008390-200102000-00009; Huo LF, 2006, CELL MOL IMMUNOL, V3, P1; Ishikawa H, 2000, INT IMMUNOL, V12, P1267, DOI 10.1093/intimm/12.9.1267; Kijima M, 2005, INT J ONCOL, V26, P679; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kim NW, 1997, EUR J CANCER, V33, P781, DOI 10.1016/S0959-8049(97)00057-9; KUROSAWA S, 1995, IMMUNOLOGY, V85, P338; Lens M, 2008, RECENT PAT ANTI-CANC, V3, P105, DOI 10.2174/157489208784638767; Linn YC, 2003, LEUKEMIA LYMPHOMA, V44, P1457, DOI 10.1080/1042819031000083082; Minev B, 2000, P NATL ACAD SCI USA, V97, P4796, DOI 10.1073/pnas.070560797; Misawa E, 2003, J IMMUNOTHER, V26, P21, DOI 10.1097/00002371-200301000-00003; Nair S, 2003, BLOOD, V102, P964, DOI 10.1182/blood-2002-12-3738; Nair SK, 2000, NAT MED, V6, P1011, DOI 10.1038/79519; Ng SSM, 2007, CANCER GENE THER, V14, P561, DOI 10.1038/sj.cgt.7701038; Ortaldo JR, 2005, J IMMUNOL, V175, P693, DOI 10.4049/jimmunol.175.2.693; Pawlik TM, 2003, CRIT REV ONCOL HEMAT, V45, P245, DOI 10.1016/S1040-8428(02)00080-X; Pilla L, 2006, EXPERT REV ANTICANC, V6, P1305, DOI 10.1586/14737140.6.8.1305; Pilla L, 2009, EXPERT OPIN BIOL TH, V9, P1043, DOI 10.1517/14712590903085109; Queirolo P, 2005, MELANOMA RES, V15, P471, DOI 10.1097/00008390-200510000-00018; Ramakrishnan S, 1998, CANCER RES, V58, P622; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; ROTTENBERG M, 1988, SCAND J IMMUNOL, V28, P573, DOI 10.1111/j.1365-3083.1988.tb01489.x; Sato A, 2006, J IMMUNOL, V176, P7686, DOI 10.4049/jimmunol.176.12.7686; Scardino A, 2002, J IMMUNOL, V168, P5900, DOI 10.4049/jimmunol.168.11.5900; Schadendorf D, 2009, ANN ONCOL, V20, P41, DOI 10.1093/annonc/mdp253; Schroers R, 2002, CANCER RES, V62, P2600; Schroers R, 2003, CLIN CANCER RES, V9, P4743; Shay JW, 2008, BRIT J CANCER, V98, P677, DOI 10.1038/sj.bjc.6604209; Smyth MJ, 2005, J EXP MED, V201, P1973, DOI 10.1084/jem.20042280; Sun R, 2004, J IMMUNOL, V172, P5648, DOI 10.4049/jimmunol.172.9.5648; TALMADGE JE, 1987, CANCER RES, V47, P5725; TALMADGE JE, 1987, CANCER RES, V47, P2563; Tarhini AA, 2006, DERMATOL THER, V19, P19, DOI 10.1111/j.1529-8019.2005.00052.x; Thompson JF, 2009, LANCET, V374, P362, DOI 10.1016/S0140-6736(09)61397-0; Tsao H, 2004, NEW ENGL J MED, V351, P998, DOI 10.1056/NEJMra041245; Vonderheide RH, 2001, CLIN CANCER RES, V7, P3343; Vonderheide RH, 1999, IMMUNITY, V10, P673, DOI 10.1016/S1074-7613(00)80066-7; Waldhauer I, 2008, ONCOGENE, V27, P5932, DOI 10.1038/onc.2008.267; Wang G, 2003, CANCER RES, V63, P9016; Yajima T, 2002, INT J CANCER, V99, P573, DOI 10.1002/ijc.10395; YE JP, 1995, J LEUKOCYTE BIOL, V58, P225, DOI 10.1002/jlb.58.2.225; Zimmermann S, 2007, CELL MOL LIFE SCI, V64, P906, DOI 10.1007/s00018-007-6481-8	57	9	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2010	5	9							e12705	10.1371/journal.pone.0012705	http://dx.doi.org/10.1371/journal.pone.0012705			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648ZZ	20856939	Green Published, Green Submitted, gold			2022-12-27	WOS:000281735700020
J	Jamali, Y; Azimi, M; Mofrad, MRK				Jamali, Yousef; Azimi, Mohammad; Mofrad, Mohammad R. K.			A Sub-Cellular Viscoelastic Model for Cell Population Mechanics	PLOS ONE			English	Article							SHAPE	Understanding the biomechanical properties and the effect of biomechanical force on epithelial cells is key to understanding how epithelial cells form uniquely shaped structures in two or three-dimensional space. Nevertheless, with the limitations and challenges posed by biological experiments at this scale, it becomes advantageous to use mathematical and 'in silico' (computational) models as an alternate solution. This paper introduces a single-cell-based model representing the cross section of a typical tissue. Each cell in this model is an individual unit containing several sub-cellular elements, such as the elastic plasma membrane, enclosed viscoelastic elements that play the role of cytoskeleton, and the viscoelastic elements of the cell nucleus. The cell membrane is divided into segments where each segment (or point) incorporates the cell's interaction and communication with other cells and its environment. The model is capable of simulating how cells cooperate and contribute to the overall structure and function of a particular tissue; it mimics many aspects of cellular behavior such as cell growth, division, apoptosis and polarization. The model allows for investigation of the biomechanical properties of cells, cell-cell interactions, effect of environment on cellular clusters, and how individual cells work together and contribute to the structure and function of a particular tissue. To evaluate the current approach in modeling different topologies of growing tissues in distinct biochemical conditions of the surrounding media, we model several key cellular phenomena, namely monolayer cell culture, effects of adhesion intensity, growth of epithelial cell through interaction with extra-cellular matrix (ECM), effects of a gap in the ECM, tensegrity and tissue morphogenesis and formation of hollow epithelial acini. The proposed computational model enables one to isolate the effects of biomechanical properties of individual cells and the communication between cells and their microenvironment while simultaneously allowing for the formation of clusters or sheets of cells that act together as one complex tissue.	[Jamali, Yousef; Azimi, Mohammad; Mofrad, Mohammad R. K.] Univ Calif Berkeley, Dept Bioengn, Mol Cell Biomech Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Jamali, Y (corresponding author), Univ Calif Berkeley, Dept Bioengn, Mol Cell Biomech Lab, Berkeley, CA 94720 USA.	mofrad@berkeley.edu	Jamali, Yousef/V-5156-2019; /R-6010-2019	Jamali, Yousef/0000-0002-5709-3821; /0000-0001-7004-4859	National Science Foundation; Institute for Research in Fundamental Sciences	National Science Foundation(National Science Foundation (NSF)); Institute for Research in Fundamental Sciences	Financial support by National Science Foundation is gratefully acknowledged. Dr. Jamali was supported by a generous fellowship support from the Institute for Research in Fundamental Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affolter M, 2003, DEV CELL, V4, P11, DOI 10.1016/S1534-5807(02)00410-0; ALBER M, 2003, MATH SYSTEMS THEORY; Anderson ARA, 2005, MATH MED BIOL, V22, P163, DOI 10.1093/imammb/dqi005; Anderson ARA, 2003, MATH BIOSCI INTERAC, P261; Araujo RP, 2004, B MATH BIOL, V66, P1039, DOI 10.1016/j.bulm.2003.11.002; BEREITERHAHN J, 1985, ACTA BIOTHEOR, V34, P139, DOI 10.1007/BF00046779; Bottino D, 2002, J CELL SCI, V115, P367; Bray D, 2001, CELL MOVEMENTS MOL M; Brodland GW, 2000, J BIOMECH ENG-T ASME, V122, P402, DOI 10.1115/1.1288205; BUCK CA, 1993, CR ACAD SCI III-VIE, V316, P849; CANADAS P, 2002, J THEOR BIOL, V218, P19; CASTANO E, 2010, HISTOCHEM CELL BIOL; Chandran PL, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.031920; Chaplain MAJ, 1996, MATH COMPUT MODEL, V23, P47, DOI 10.1016/0895-7177(96)00019-2; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; CHEN CS, 1999, OSTEOARTHR CARTILAGE, V7, P14; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; COSKUNA H, 2007, J THEOR BIOL, V244, P11; Dahl KN, 2008, CIRC RES, V102, P1307, DOI 10.1161/CIRCRESAHA.108.173989; Dallon JC, 2004, J THEOR BIOL, V231, P203, DOI 10.1016/j.jtbi.2004.06.015; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; DEBNATH J, 2005, NATURE REV CANC, V5, P14; DORMANN S, 2002, IN SILICO BIOL, V2, P14; DRASDO D, 1995, PHYS REV E, V52, P6635, DOI 10.1103/PhysRevE.52.6635; Drasdo D, 2007, J STAT PHYS, V128, P287, DOI 10.1007/s10955-007-9289-x; DUCHTING W, 1996, EUR J CANCER, V32, P10; ERMENTROUT GB, 1993, J THEOR BIOL, V160, P37; ETTINGER L, 1992, BIOL REV, V67, P459, DOI 10.1111/j.1469-185X.1992.tb01190.x; Fabry B, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.041914; Flaherty B, 2007, CELL BIOCHEM BIOPHYS, V49, P14, DOI 10.1007/s12013-007-0045-2; Freed LE, 1998, ADV DRUG DELIVER REV, V33, P15, DOI 10.1016/S0169-409X(98)00017-9; Galle J, 2005, BIOPHYS J, V88, P62, DOI 10.1529/biophysj.104.041459; GALLI C, 2005, ACTA BIOL MED GER, V76, P8; Goldmann WH, 2002, CELL BIOL INT, V26, P313, DOI 10.1006/cbir.2002.0857; Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796; Gruber H E, 2000, BMC Musculoskelet Disord, V1, P1, DOI 10.1186/1471-2474-1-1; GUMBINER BM, 2005, NATURE REV MOL CELL, V6, P13; GUNST SJ, 2003, AM PHYSL SOC, P413; HAGIOS C, 1998, PHILTRANS R SOC LO B, V353, P4; HALL HG, 1982, P NATL ACAD SCI-BIOL, V79, P4672, DOI 10.1073/pnas.79.15.4672; HOCHMUTH RM, 1993, BIOPHYS J, V64, P5; Hogan BLM, 2002, NAT REV GENET, V3, P513, DOI 10.1038/nrg840; HOWARD J, 2009, ANN REV BIOPHYSICS, V38; Ingber DE, 2006, INT J DEV BIOL, V50, P255, DOI 10.1387/ijdb.052044di; INGBER DE, 2003, J CELL SCI, V116, P12; INGBER DE, 2003, J CELL SCI, V116, P17; INGBER DE, 2000, J APPL PHYSIOL, V89, P8; KAMM RD, 2004, MCB, V1, P10; KANSAL AR, 2000, J THEOR BIOL, V203, P16; Lecuit T, 2005, TRENDS CELL BIOL, V15, P34, DOI 10.1016/j.tcb.2004.11.007; Lecuit T, 2003, NAT CELL BIOL, V5, P103, DOI 10.1038/ncb0203-103; LECUIT T, 2007, NATURE REV MOL CELL, V8, P12; Lee SE, 2007, J BIOMECH, V40, P2096, DOI 10.1016/j.jbiomech.2007.04.006; LODISH H, 2003, MOL CELL BIOL; Mofrad M.R.K., 2006, CYTOSKELETAL MECH; Mofrad M.R.K., 2009, CELLULAR MECHANOTRAN; Mogilner A, 2003, J STAT PHYS, V110, P1169, DOI 10.1023/A:1022153028488; NEWMAN TJ, 2005, MATH BIOSCI ENG, V2, P11; OBRIEN LE, 2002, NATURE REV MOL CELL, V3, P7; Ostlund C, 2009, J CELL SCI, V122, P4099, DOI 10.1242/jcs.057075; OJAKIAN GK, 2001, INTEGRIN REGULATION; PALSSON E, 2001, FUTURE GENER COMP SY, V17, P18; PALSSON E, 2000, PNAS, V97, P6; REJNIAK KA, 2007, COMP MATH MATH PHYS, V8, P9; REJNIAK KA, 2007, B MATH BIOL; REJNIAK KA, 2007, J THEOR BIOL, V247, P19; REJNIAK KA, 2004, B MATH BIOL; Sandersius SA, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015002; Siegrist SE, 2006, DEVELOPMENT, V133, P529, DOI 10.1242/dev.02211; SULTAN C, 2004, ANN BIOMED ENG, V32, P11; Thery M, 2007, NATURE, V447, P493, DOI 10.1038/nature05786; TRANSONTAY R, 1987, BIOPHYS J, V51, P10; TURNER S, 2002, J THEOR BIOL, V216, P16; VOGEL V, 2009, CURRENT OPINION CELL; WANG AZ, 1990, STEPS MORPHOGENESIS; Wang N, 2001, P NATL ACAD SCI USA, V98, P7765, DOI 10.1073/pnas.141199598; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; WEI C, 2003, J THEOR BIOL, V224, P8; YEUNG A, 1989, BIOPHYS J, P56; Yoshida K, 2006, J CELL SCI, V119, P3833, DOI 10.1242/jcs.03152; Zegers MMP, 2003, TRENDS CELL BIOL, V13, P169, DOI 10.1016/S0962-8924(03)00036-9	81	41	42	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12097	10.1371/journal.pone.0012097	http://dx.doi.org/10.1371/journal.pone.0012097			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20856895	gold, Green Published, Green Submitted			2022-12-27	WOS:000280811900034
J	Bilgin, CC; Lund, AW; Can, A; Plopper, GE; Yener, B				Bilgin, Cemal Cagatay; Lund, Amanda W.; Can, Ali; Plopper, George E.; Yener, Buelent			Quantification of Three-Dimensional Cell-Mediated Collagen Remodeling Using Graph Theory	PLOS ONE			English	Article							2ND-HARMONIC GENERATION; TISSUE; FIBRILLOGENESIS; ORGANIZATION; FIBRILS	Background: Cell cooperation is a critical event during tissue development. We present the first precise metrics to quantify the interaction between mesenchymal stem cells (MSCs) and extra cellular matrix (ECM). In particular, we describe cooperative collagen alignment process with respect to the spatio-temporal organization and function of mesenchymal stem cells in three dimensions. Methodology/Principal Findings: We defined two precise metrics: Collagen Alignment Index and Cell Dissatisfaction Level, for quantitatively tracking type I collagen and fibrillogenesis remodeling by mesenchymal stem cells over time. Computation of these metrics was based on graph theory and vector calculus. The cells and their three dimensional type I collagen microenvironment were modeled by three dimensional cell-graphs and collagen fiber organization was calculated from gradient vectors. With the enhancement of mesenchymal stem cell differentiation, acceleration through different phases was quantitatively demonstrated. The phases were clustered in a statistically significant manner based on collagen organization, with late phases of remodeling by untreated cells clustering strongly with early phases of remodeling by differentiating cells. The experiments were repeated three times to conclude that the metrics could successfully identify critical phases of collagen remodeling that were dependent upon cooperativity within the cell population. Conclusions/Significance: Definition of early metrics that are able to predict long-term functionality by linking engineered tissue structure to function is an important step toward optimizing biomaterials for the purposes of regenerative medicine.	[Bilgin, Cemal Cagatay; Yener, Buelent] Rensselaer Polytech Inst, Dept Comp Sci, Troy, NY 12180 USA; [Lund, Amanda W.; Plopper, George E.] Rensselaer Polytech Inst, Dept Biol, Troy, NY 12180 USA; [Can, Ali] Gen Elect Global Res Ctr, Niskayuna, NY USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; General Electric	Bilgin, CC (corresponding author), Rensselaer Polytech Inst, Dept Comp Sci, Troy, NY 12180 USA.	yener@cs.rpi.edu		Lund, Amanda/0000-0001-7389-9983	National Institutes of Health [RO1 EB008016]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008016] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was partially supported by National Institutes of Health Grant RO1 EB008016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albeck JG, 2008, MOL CELL, V30, P11, DOI 10.1016/j.molcel.2008.02.012; Aldridge BB, 2006, NAT CELL BIOL, V8, P1195, DOI 10.1038/ncb1497; Bilgin C, 2007, P ANN INT IEEE EMBS, P5311, DOI 10.1109/IEMBS.2007.4353540; Bilgin CC, 2010, DATA MIN KNOWL DISC, V20, P416, DOI 10.1007/s10618-009-0153-2; CHAUDHURI S, 1987, IEEE T BIO-MED ENG, V34, P509, DOI 10.1109/TBME.1987.325980; CLARK JM, 1990, J ANAT, V171, P117; Dahl SLM, 2007, ANN BIOMED ENG, V35, P1749, DOI 10.1007/s10439-007-9340-8; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Elbischger PJ, 2005, ST HEAL T, V113, P97; FREUND I, 1986, BIOPHYS J, V50, P693, DOI 10.1016/S0006-3495(86)83510-X; Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858; Grinnell F, 2003, MOL BIOL CELL, V14, P384, DOI 10.1091/mbc.E02-08-0493; GUIDRY C, 1985, J CELL SCI, V79, P67; Gunduz C, 2004, BIOINFORMATICS, V20, P145, DOI 10.1093/bioinformatics/bth933; Gurcan Metin N, 2009, IEEE Rev Biomed Eng, V2, P147, DOI 10.1109/RBME.2009.2034865; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Ibanez L., 2005, ITK SOFTWARE GUIDE; Keenan SJ, 2000, J PATHOL, V192, P351, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH708>3.0.CO;2-I; Kim BM, 2000, LASER SURG MED, V27, P329, DOI 10.1002/1096-9101(2000)27:4<329::AID-LSM5>3.0.CO;2-C; Lazzara MJ, 2009, EXP CELL RES, V315, P717, DOI 10.1016/j.yexcr.2008.10.033; Lund AW, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/928286; Lund AW, 2009, STEM CELLS DEV, V18, P331, DOI 10.1089/scd.2008.0075; Meineke FA, 2001, CELL PROLIFERAT, V34, P253, DOI 10.1046/j.0960-7722.2001.00216.x; Mohler W, 2003, METHODS, V29, P97, DOI 10.1016/S1046-2023(02)00292-X; Ng CP, 2005, J CELL SCI, V118, P4731, DOI 10.1242/jcs.02605; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pedersen JA, 2005, ANN BIOMED ENG, V33, P1469, DOI 10.1007/s10439-005-8159-4; Rhee S, 2007, ADV DRUG DELIVER REV, V59, P1299, DOI 10.1016/j.addr.2007.08.006; Schenke-Layland K, 2006, ADV DRUG DELIVER REV, V58, P878, DOI 10.1016/j.addr.2006.07.004; Schroeder W, 2002, VISUALIZATION TOOLKI; Stein AM, 2008, J MICROSC-OXFORD, V232, P463, DOI 10.1111/j.1365-2818.2008.02141.x; Theodossiou T, 2002, LASER MED SCI, V17, P34, DOI 10.1007/s10103-002-8264-7; Weyn B, 1999, CYTOMETRY, V35, P23, DOI 10.1002/(SICI)1097-0320(19990101)35:1<23::AID-CYTO4>3.0.CO;2-P; Xia Y, 2001, J MICROSC-OXFORD, V204, P3, DOI 10.1046/j.1365-2818.2001.00925.x; Xu R, 2009, CANCER METAST REV, V28, P167, DOI 10.1007/s10555-008-9178-z; Zhou XM, 2008, GENE DEV, V22, P1231, DOI 10.1101/gad.1643308	36	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e12783	10.1371/journal.pone.0012783	http://dx.doi.org/10.1371/journal.pone.0012783			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20927339	Green Published, Green Submitted, gold			2022-12-27	WOS:000282312600002
J	Freedman, AH; Buermann, W; Mitchard, ETA; DeFries, RS; Smith, TB				Freedman, Adam H.; Buermann, Wolfgang; Mitchard, Edward T. A.; DeFries, Ruth S.; Smith, Thomas B.			Human Impacts Flatten Rainforest-Savanna Gradient and Reduce Adaptive Diversity in a Rainforest Bird	PLOS ONE			English	Article							GENE FLOW; SPECIATION; DEFORESTATION; DIVERGENCE; COVER; BIODIVERSITY; DIVERSIFICATION; DISTURBANCE; EXTINCTION; EVOLUTION	Ecological gradients have long been recognized as important regions for diversification and speciation. However, little attention has been paid to the evolutionary consequences or conservation implications of human activities that fundamentally change the environmental features of such gradients. Here we show that recent deforestation in West Africa has homogenized the rainforest-savanna gradient, causing a loss of adaptive phenotypic diversity in a common rainforest bird, the little greenbul (Andropadus virens). Previously, this species was shown to exhibit morphological and song divergence along this gradient in Central Africa. Using satellite-based estimates of forest cover, recent morphological data, and historical data from museum specimens collected prior to widespread deforestation, we show that the gradient has become shallower in West Africa and that A. virens populations there have lost morphological variation in traits important to fitness. In contrast, we find no loss of morphological variation in Central Africa where there has been less deforestation and gradients have remained more intact. While rainforest deforestation is a leading cause of species extinction, the potential of deforestation to flatten gradients and inhibit rainforest diversification has not been previously recognized. More deforestation will likely lead to further flattening of the gradient and loss of diversity, and may limit the ability of species to persist under future environmental conditions.	[Freedman, Adam H.; Buermann, Wolfgang; Smith, Thomas B.] Univ Calif Los Angeles, Ctr Trop Res, Inst Environm, Los Angeles, CA 90024 USA; [Freedman, Adam H.; Smith, Thomas B.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Buermann, Wolfgang] Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, Los Angeles, CA USA; [Mitchard, Edward T. A.] Univ Edinburgh, Sch Geosci, Edinburgh, Midlothian, Scotland; [DeFries, Ruth S.] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Edinburgh; Columbia University	Freedman, AH (corresponding author), Univ Calif Los Angeles, Ctr Trop Res, Inst Environm, Los Angeles, CA 90024 USA.	afreedma@ucla.edu		Mitchard, Edward/0000-0002-5690-4055; Freedman, Adam/0000-0003-4714-3925	University of California Los Angeles; Department of Ecology and Evolutionary Biology; Environmental Protection Agency; Gatsby Plants; National Institutes of Health [EF-0430146]; National Geographic; National Science Foundation [DEB-9726425, IR-CEB9977072]; NASA [IDS/03-0169-0347]	University of California Los Angeles(University of California System); Department of Ecology and Evolutionary Biology; Environmental Protection Agency(United States Environmental Protection Agency); Gatsby Plants; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Geographic(National Geographic Society); National Science Foundation(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA))	This work was supported by University of California Los Angeles, Department of Ecology and Evolutionary Biology fellowship grants and by an Environmental Protection Agency Science to Achieve Results Fellowship to AHF, a Ph.D. Studentship from Gatsby Plants to ETAM, a National Institutes of Health-funded supplement to National Science Foundation grant EF-0430146 (under the Ecology of Infectious Diseases program) to TBS, and National Geographic, National Science Foundation (DEB-9726425 and IR-CEB9977072), and NASA (IDS/03-0169-0347) grants to TBS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; Agbu P. A., 1994, NOAA NASA PATHFINDER; [Anonymous], 2003, DEFORESTING EARTH PR; BARNES RFW, 1990, AFR J ECOL, V28, P161, DOI 10.1111/j.1365-2028.1990.tb01150.x; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Bradshaw WE, 2001, P NATL ACAD SCI USA, V98, P14509, DOI 10.1073/pnas.241391498; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; BUYS P, 2006, 4097 WPS WORLD BANK; Cowling RM, 2001, P NATL ACAD SCI USA, V98, P5452, DOI 10.1073/pnas.101093498; DEBASTOS M, 2005, REV BRAS ZOOL, V22, P812; DeFries RS, 1999, J GEOPHYS RES-ATMOS, V104, P16911, DOI 10.1029/1999JD900057; DeFries RS, 2002, P NATL ACAD SCI USA, V99, P14256, DOI 10.1073/pnas.182560099; DEFRIES RS, 1995, J GEOPHYS RES-ATMOS, V100, P20867, DOI 10.1029/95JD01536; Defries RS, 2000, GLOBAL CHANGE BIOL, V6, P247, DOI 10.1046/j.1365-2486.2000.00296.x; Desrochers A, 2010, ECOLOGY, V91, P1577, DOI 10.1890/09-2202.1; Doebeli M, 2003, NATURE, V421, P259, DOI 10.1038/nature01274; Ellegren H, 1996, P ROY SOC B-BIOL SCI, V263, P1635, DOI 10.1098/rspb.1996.0239; Endler J.A., 1977, Monographs in Population Biology, pi; *ESRI INC, 2006, ARCGIS 9; Flury B, 1988, COMMON PRINCIPAL COM; Freedman AH, 2010, MOL ECOL, V19, P3773, DOI 10.1111/j.1365-294X.2010.04684.x; Freedman AH, 2009, CONSERV BIOL, V23, P81, DOI 10.1111/j.1523-1739.2008.01039.x; Friedl MA, 2002, REMOTE SENS ENVIRON, V83, P287, DOI 10.1016/S0034-4257(02)00078-0; Gavrilets S, 2000, P ROY SOC B-BIOL SCI, V267, P2483, DOI 10.1098/rspb.2000.1309; *GOOGL INC, 2007, GOOGL EARTH VERS 5 0; Grant P. R., 1986, ECOLOGY EVOLUTION DA, P458; Hansen MC, 2002, REMOTE SENS ENVIRON, V83, P303, DOI 10.1016/S0034-4257(02)00079-2; Hendry AP, 2008, MOL ECOL, V17, P20, DOI 10.1111/j.1365-294X.2007.03428.x; Jullien M, 1996, J BIOGEOGR, V23, P7, DOI 10.1046/j.1365-2699.1996.00963.x; Keith S., 1992, BIRDS AFRICA, V4; Kirschel ANG, 2009, P NATL ACAD SCI USA, V106, P8256, DOI 10.1073/pnas.0810124106; Kitano J, 2008, CURR BIOL, V18, P769, DOI 10.1016/j.cub.2008.04.027; Kofron CP, 1995, TROP ZOOL, V8, P239, DOI 10.1080/03946975.1995.10539284; Laporte NT, 2007, SCIENCE, V316, P1451, DOI 10.1126/science.1141057; Lawton JH, 1998, NATURE, V391, P72, DOI 10.1038/34166; Lens L, 1999, P ROY SOC B-BIOL SCI, V266, P1241, DOI 10.1098/rspb.1999.0769; Lens L, 2002, SCIENCE, V298, P1236, DOI 10.1126/science.1075664; LETOUZEY R, 1968, ETUDE PHYTOGEOGRAPHI, V69; LONGMAN KA, 1992, NATURE AND DYNAMICS OF FOREST-SAVANNA BOUNDARIES, P3; Louette M, 1981, VERHANDELINGEN KON W, V43, P1; Mace G., 2005, ECOSYSTEMS HUMAN WEL, V1, P77; Mila B, 2009, MOL ECOL, V18, P2979, DOI 10.1111/j.1365-294X.2009.04251.x; MYERS N, 1986, TROPICAL RAIN FOREST, P9; Nosil P, 2008, MOL ECOL, V17, P2103, DOI 10.1111/j.1365-294X.2008.03715.x; Ogden R, 2002, P NATL ACAD SCI USA, V99, P13612, DOI 10.1073/pnas.212248499; Parry M., 2007, CLIMATE CHANGE 2007, P7, DOI DOI 10.2134/JEQ2008.0015BR; Pimm SL, 2000, NATURE, V403, P843, DOI 10.1038/35002708; Rasanen K, 2008, ECOL LETT, V11, P624, DOI 10.1111/j.1461-0248.2008.01176.x; Rayner J.M.V., 1988, Current Ornithology, V5, P1; Rice KJ, 2003, FRONT ECOL ENVIRON, V1, P469, DOI 10.1890/1540-9295(2003)001[0469:MMRITF]2.0.CO;2; RICE WR, 1993, EVOLUTION, V47, P1637, DOI [10.2307/2410209, 10.1111/j.1558-5646.1993.tb01257.x]; Sankaran M, 2005, NATURE, V438, P846, DOI 10.1038/nature04070; SAS Institute Inc, 2007, JMP VERS 7; Schneider CJ, 1999, P NATL ACAD SCI USA, V96, P13869, DOI 10.1073/pnas.96.24.13869; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Slabbekoorn H, 2002, EVOLUTION, V56, P1849; Smith PM, 1997, PHOTOGRAMM ENG REM S, V63, P12; Smith T.B., 1993, Biodiversity Letters, V1, P164, DOI 10.2307/2999740; Smith TB, 2005, CONSERV BIOL SER, V8, P166; Smith TB, 2005, J EVOLUTION BIOL, V18, P257, DOI 10.1111/j.1420-9101.2004.00825.x; SMITH TB, 1990, EVOLUTION, V44, P832, DOI 10.1111/j.1558-5646.1990.tb03808.x; Smith TB, 2001, GENETICA, V112, P383, DOI 10.1023/A:1013312510860; Smith TB, 1997, SCIENCE, V276, P1855, DOI 10.1126/science.276.5320.1855; Smith TB, 2000, MOL ECOL, V9, P1505, DOI 10.1046/j.1365-294x.2000.01032.x; SMITH TB, 2005, RAINFORESTS PAST PRE, P148; Smith TB, 2008, MOL ECOL, V17, P58, DOI 10.1111/j.1365-294X.2007.03478.x; Smith TB, 2008, MOL ECOL, V17, P1, DOI 10.1111/j.1365-294X.2007.03607.x; Smith Thomas B., 2008, P85; Smith Thomas Bates, 1993, Bird Conservation International, V3, P13; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; Sokal R.R., 2012, BIOMETRY; Stockwell CA, 2003, TRENDS ECOL EVOL, V18, P94, DOI 10.1016/S0169-5347(02)00044-7; Sumner J, 1999, BIOL CONSERV, V91, P159, DOI 10.1016/S0006-3207(99)00089-0; Thiollay JM, 1996, J TROP ECOL, V12, P535, DOI 10.1017/S0266467400009767; Thiollay JM, 1998, BIODIVERS CONSERV, V7, P1291, DOI 10.1023/A:1008898505534; White F., 1983, VEGETATION AFRICA DE; WINKLER H, 1992, IBIS, V134, P21	77	8	8	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e13088	10.1371/journal.pone.0013088	http://dx.doi.org/10.1371/journal.pone.0013088			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20941360	Green Published, Green Submitted, gold			2022-12-27	WOS:000282312600021
J	Hughes, NK; Price, CJ; Banks, PB				Hughes, Nelika K.; Price, Catherine J.; Banks, Peter B.			Predators Are Attracted to the Olfactory Signals of Prey	PLOS ONE			English	Article							SCENT MARKS; FERAL CATS; MICE; PREFERENCE; WEASELS; RISK; BEHAVIOR; FOXES; CUES	Background: Predator attraction to prey social signals can force prey to trade-off the social imperatives to communicate against the profound effect of predation on their future fitness. These tradeoffs underlie theories on the design and evolution of conspecific signalling systems and have received much attention in visual and acoustic signalling modes. Yet while most territorial mammals communicate using olfactory signals and olfactory hunting is widespread in predators, evidence for the attraction of predators to prey olfactory signals under field conditions is lacking. Methodology/Principal Findings: To redress this fundamental issue, we examined the attraction of free-roaming predators to discrete patches of scents collected from groups of two and six adult, male house mice, Mus domesticus, which primarily communicate through olfaction. Olfactorily-hunting predators were rapidly attracted to mouse scent signals, visiting mouse scented locations sooner, and in greater number, than control locations. There were no effects of signal concentration on predator attraction to their prey's signals. Conclusions/Significance: This implies that communication will be costly if conspecific receivers and eavesdropping predators are simultaneously attracted to a signal. Significantly, our results also suggest that receivers may be at greater risk of predation when communicating than signallers, as receivers must visit risky patches of scent to perform their half of the communication equation, while signallers need not.	[Hughes, Nelika K.; Price, Catherine J.; Banks, Peter B.] Univ New S Wales, Sch Biol Earth & Environm Sci, Evolut & Ecol Res Ctr, Sydney, NSW, Australia	University of New South Wales Sydney	Hughes, NK (corresponding author), Univ New S Wales, Sch Biol Earth & Environm Sci, Evolut & Ecol Res Ctr, Sydney, NSW, Australia.	nelika@unsw.edu.au	Price, Catherine/AAZ-2069-2020	Price, Catherine/0000-0001-9631-2479; Banks, Peter/0000-0002-4340-6495	Australian Research Council [DP0881455]	Australian Research Council(Australian Research Council)	This research was funded by an Australian Research Council Discovery grant to PB Banks (DP0881455); see http://www.arc.gov.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amo L, 2004, J HERPETOL, V38, P451, DOI 10.1670/177-03N; Banks PB, 2000, P ROY SOC B-BIOL SCI, V267, P1621, DOI 10.1098/rspb.2000.1187; Brown R. E., 1985, SOCIAL ODOURS MAMMAL, V1-2; Brown RE, 1985, SOCIAL ODOURS MAMMAL, VII; Chiszar D, 1997, J CHEM ECOL, V23, P829, DOI 10.1023/B:JOEC.0000006414.01873.12; CLAPPERTON BK, 1994, WILDLIFE RES, V21, P389, DOI 10.1071/WR9940389; CUSHING BS, 1984, ANIM BEHAV, V32, P1263, DOI 10.1016/S0003-3472(84)80250-X; DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081; DESJARDINS C, 1973, SCIENCE, V182, P939, DOI 10.1126/science.182.4115.939; Hughes NK, 2010, OIKOS, V119, P1210, DOI 10.1111/j.1600-0706.2010.18006.x; Hughes NK, 2010, J ANIM ECOL, V79, P88, DOI 10.1111/j.1365-2656.2009.01630.x; Hughes NK, 2009, OECOLOGIA, V160, P609, DOI 10.1007/s00442-009-1320-2; Hurst JL, 2004, BIOESSAYS, V26, P1288, DOI 10.1002/bies.20147; Kats LB, 1998, ECOSCIENCE, V5, P361, DOI 10.1080/11956860.1998.11682468; Koivula M, 2001, OIKOS, V95, P275, DOI 10.1034/j.1600-0706.2001.950209.x; Mahon PS, 1998, WILDLIFE RES, V25, P11, DOI 10.1071/WR97007; NEWSOME AE, 1997, POTENTIAL IMPACTS RE; Paltridge R, 2002, WILDLIFE RES, V29, P389, DOI 10.1071/WR00010; Read J, 2001, WILDLIFE RES, V28, P195, DOI 10.1071/WR99065; Ruxton GD, 2004, AVOIDING ATTACK EVOL; Smith TL, 2000, BEHAVIOUR, V137, P691, DOI 10.1163/156853900502295; Sundell J, 2003, OIKOS, V101, P615, DOI 10.1034/j.1600-0706.2003.12264.x; SUTHERLAND D. R., 2003, RATS MICE PEOPLE ROD, P159; Swan Michael, 2005, SNAKES LIZARDS FROGS; Triggs B., 1984, MAMMAL TRACKS SIGNS; Van Loo PLP, 2000, ANIM WELFARE, V9, P281; VIITALA J, 1995, NATURE, V373, P425, DOI 10.1038/373425a0; WELLS MC, 1978, BEHAV PROCESS, V3, P149, DOI 10.1016/0376-6357(78)90041-4; Whitaker PB, 2003, HERPETOL MONOGR, V17, P130, DOI 10.1655/0733-1347(2003)017[0130:ARSOMA]2.0.CO;2; Ylonen H, 2003, ECOLOGY, V84, P1447, DOI 10.1890/0012-9658(2003)084[1447:WMNNPF]2.0.CO;2	30	76	77	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e13114	10.1371/journal.pone.0013114	http://dx.doi.org/10.1371/journal.pone.0013114			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20927352	Green Published, gold			2022-12-27	WOS:000282312600030
J	Zhang, X; Yu, CH; Wilson, K; Zhang, HY; Melton, SD; Huo, XF; Wang, DH; Genta, RM; Spechler, SJ; Souza, RF				Zhang, Xi; Yu, Chunhua; Wilson, Kathleen; Zhang, Hui Ying; Melton, Shelby D.; Huo, Xiaofang; Wang, David H.; Genta, Robert M.; Spechler, Stuart J.; Souza, Rhonda F.			Malignant Transformation of Non-Neoplastic Barrett's Epithelial Cells through Well-Defined Genetic Manipulations	PLOS ONE			English	Article							ESOPHAGEAL SQUAMOUS-CELLS; HUMAN TUMOR-CELLS; ONCOGENIC TRANSFORMATION; ADENOCARCINOMA; TELOMERASE; RAS; PROGRESSION; EXPRESSION; CANCER; ACID	Background: Human Barrett's cancer cell lines have numerous, poorly-characterized genetic abnormalities and, consequently, those lines have limited utility as models for studying the early molecular events in carcinogenesis. Cell lines with well-defined genetic lesions that recapitulate various stages of neoplastic progression in Barrett's esophagus would be most useful for such studies. Methodology/Principal Findings: To develop such model cell lines, we started with telomerase-immortalized, nonneoplastic Barrett's epithelial (BAR-T) cells, which are spontaneously deficient in p16, and proceeded to knock down p53 using RNAi, to activate Ras by introducing oncogenic H-Ras(G12V), or both. BAR-T cells infected with either p53 RNAi or oncogenic H-Ras(G12V) alone maintained cell-to-cell contact inhibition and did not exhibit anchorage-independent growth in soft agar. In contrast, the combination of p53 RNAi knockdown with expression of oncogenic H-Ras(G12V) transformed the p16-deficient BAR-T cells, as evidenced by their loss of contact inhibition, by their formation of colonies in soft agar, and by their generation of tumors in immunodeficient mice. Conclusions/Significance: Through these experiments, we have generated a number of transformed and non-transformed cell lines with well-characterized genetic abnormalities recapitulating various stages of carcinogenesis in Barrett's esophagus. These lines should be useful models for the study of carcinogenesis in Barrett's esophagus, and for testing the efficacy of chemopreventive and chemotherapeutic agents.	[Zhang, Xi; Yu, Chunhua; Zhang, Hui Ying; Huo, Xiaofang; Wang, David H.; Spechler, Stuart J.; Souza, Rhonda F.] VA N Texas Hlth Care Syst, Dept Med, Dallas, TX USA; [Zhang, Xi; Yu, Chunhua; Wilson, Kathleen; Zhang, Hui Ying; Melton, Shelby D.; Huo, Xiaofang; Wang, David H.; Genta, Robert M.; Spechler, Stuart J.; Souza, Rhonda F.] Univ Texas SW Med Ctr Dallas, Med Sch Dallas, Dallas, TX 75390 USA; [Wilson, Kathleen; Melton, Shelby D.; Genta, Robert M.] VA N Texas Hlth Care Syst, Dept Pathol, Dallas, TX USA; [Melton, Shelby D.; Genta, Robert M.] Caris Life Sci Inc, Irving, TX USA; [Wang, David H.; Souza, Rhonda F.] Univ Texas SW Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; University of Texas System; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhang, X (corresponding author), VA N Texas Hlth Care Syst, Dept Med, Dallas, TX USA.	rhonda.souza@utsouthwestern.edu			Office of Medical Research, Department of Veterans Affairs; National Institutes of Health [R01-DK63621, R01-CA134571]; Caris LifeSciences Inc; NATIONAL CANCER INSTITUTE [R01CA134571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063621] Funding Source: NIH RePORTER	Office of Medical Research, Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Caris LifeSciences Inc; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Office of Medical Research, Department of Veterans Affairs (R.F.S., S.J.S.), the National Institutes of Health (R01-DK63621 to R.F.S, R01-CA134571 to R.F.S. and S.J.S.) and Caris LifeSciences Inc (R.M.G.). Caris LifeSciences Inc. provided salary support to R.M.G. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELATIF OMA, 1991, ARCH PATHOL LAB MED, V115, P880; Barch MJ, 1997, AGT CYTOGENETICS LAB; Barrett MT, 1999, NAT GENET, V22, P106, DOI 10.1038/8816; BLOUNT PL, 1993, P NATL ACAD SCI USA, V90, P3221, DOI 10.1073/pnas.90.8.3221; Carpenter G, 2000, BIOESSAYS, V22, P697, DOI 10.1002/1521-1878(200008)22:8<697::AID-BIES3>3.3.CO;2-T; El-Serag HB, 1998, GUT, V43, P327, DOI 10.1136/gut.43.3.327; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Feagins LA, 2007, AM J GASTROENTEROL, V102, P10, DOI 10.1111/j.1572-0241.2006.01005.x; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harley CB, 2002, ONCOGENE, V21, P494, DOI 10.1038/sj.onc.1205076; Hormi-Carver K, 2007, AM J PHYSIOL-GASTR L, V292, pG18, DOI 10.1152/ajpgi.00237.2006; Hormi-Carver K, 2009, CANCER RES, V69, P672, DOI 10.1158/0008-5472.CAN-08-3703; Jaiswal KR, 2007, DIS ESOPHAGUS, V20, P256, DOI 10.1111/j.1442-2050.2007.00683.x; JANKOWSKI J, 1991, CLIN SCI, V81, P663, DOI 10.1042/cs0810663; Kim SH, 2006, CANCER RES, V66, P10415, DOI 10.1158/0008-5472.CAN-06-2104; Klump B, 1998, GASTROENTEROLOGY, V115, P1381, DOI 10.1016/S0016-5085(98)70016-2; Lazarov M, 2002, NAT MED, V8, P1105, DOI 10.1038/nm779; LGSM Shaffer, 2009, ISCN 2009 INT SYSTEM, DOI DOI 10.1007/S00439-009-0726-6; Lord RV, 2000, J GASTROEN HEPATOL, V15, P730, DOI 10.1046/j.1440-1746.2000.02163.x; Lord RVN, 2000, J GASTROINTEST SURG, V4, P135, DOI 10.1016/S1091-255X(00)80049-9; Lundberg AS, 2002, ONCOGENE, V21, P4577, DOI 10.1038/sj.onc.1205550; Maley CC, 2004, CANCER RES, V64, P7629, DOI 10.1158/0008-5472.CAN-04-1738; MELTZER SJ, 1994, CANCER RES, V54, P3379; MELTZER SJ, 1990, CANCER RES, V50, P3627; Mooi WJ, 2006, NEW ENGL J MED, V355, P1037, DOI 10.1056/NEJMra062285; Morales CP, 1998, CANCER, V83, P652, DOI 10.1002/(SICI)1097-0142(19980815)83:4<652::AID-CNCR4>3.0.CO;2-M; Morales CP, 2003, GUT, V52, P327, DOI 10.1136/gut.52.3.327; Pohl H, 2005, J NATL CANCER I, V97, P142, DOI 10.1093/jnci/dji024; Ramirez RD, 2001, GENE DEV, V15, P398, DOI 10.1101/gad.859201; Sasaki R, 2009, CARCINOGENESIS, V30, P423, DOI 10.1093/carcin/bgp007; Sommerer F, 2004, ONCOGENE, V23, P554, DOI 10.1038/sj.onc.1207189; Takaoka M, 2004, ONCOGENE, V23, P6760, DOI 10.1038/sj.onc.1207923; Wong DJ, 1997, CANCER RES, V57, P2619; Zhang HY, 2007, CANCER RES, V67, P8580, DOI 10.1158/0008-5472.CAN-07-2023; Zongaro S, 2005, CANCER RES, V65, P11411, DOI 10.1158/0008-5472.CAN-05-1140	38	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e13093	10.1371/journal.pone.0013093	http://dx.doi.org/10.1371/journal.pone.0013093			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20927195	Green Submitted, Green Published, gold			2022-12-27	WOS:000282312600024
J	De Regge, N; Van Opdenbosch, N; Nauwynck, HJ; Efstathiou, S; Favoreel, HW				De Regge, Nick; Van Opdenbosch, Nina; Nauwynck, Hans J.; Efstathiou, Stacey; Favoreel, Herman W.			Interferon Alpha Induces Establishment of Alphaherpesvirus Latency in Sensory Neurons In Vitro	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; TRIGEMINAL GANGLION NEURONS; PSEUDORABIES VIRUS; GAMMA-INTERFERON; TYPE-1 INFECTION; NERVOUS-SYSTEM; ICP0 TRANSCRIPTS; PROTECTS MICE; CELL-DEATH; REACTIVATION	Background: Several alphaherpesviruses, including herpes simplex virus 1 (HSV-1) and pseudorabies virus (PRV), establish lifelong latency in neurons of the trigeminal ganglion (TG). Although it is thought that efficient establishment of alphaherpesvirus latency is based on a subtle interplay between virus, neurons and the immune system, it is not clear which immune components are of major importance for the establishment of latency. Methodology/Principal Findings: Here, using an in vitro model that enables a natural route of infection, we show that interferon alpha (IFNalpha) has the previously uncharacterized capacity to induce a quiescent HSV-1 and PRV infection in porcine TG neurons that shows strong similarity to in vivo latency. IFNalpha induced a stably suppressed HSV-1 and PRV infection in TG neurons in vitro. Subsequent treatment of neurons containing stably suppressed virus with forskolin resulted in reactivation of both viruses. HSV and PRV latency in vivo is often accompanied by the expression of latency associated transcripts (LATs). Infection of TG neurons with an HSV-1 mutant expressing LacZ under control of the LAT promoter showed activation of the LAT promoter and RT-PCR analysis confirmed that both HSV-1 and PRV express LATs during latency in vitro. Conclusions/Significance: These data represent a unique in vitro model of alphaherpesvirus latency and indicate that IFNalpha may be a driving force in promoting efficient latency establishment.	[De Regge, Nick; Van Opdenbosch, Nina; Nauwynck, Hans J.; Favoreel, Herman W.] Univ Ghent, Dept Virol Parasitol & Immunol, Fac Vet Med, Merelbeke, Belgium; [Efstathiou, Stacey] Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England	Ghent University; University of Cambridge	De Regge, N (corresponding author), Univ Ghent, Dept Virol Parasitol & Immunol, Fac Vet Med, Merelbeke, Belgium.	herman.favoreel@ugent.be	Favoreel, Herman W/H-8712-2013	Favoreel, Herman W/0000-0003-4993-6857; Nauwynck, Hans/0000-0001-5470-0713	Institute for the Promotion of Innovation through Science and Technology in Flanders; Research Foundation Flanders (FWO-Vlaanderen); Research Council of Ghent University; MRC [G9800943] Funding Source: UKRI; Medical Research Council [G9800943] Funding Source: researchfish	Institute for the Promotion of Innovation through Science and Technology in Flanders(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Research Foundation Flanders (FWO-Vlaanderen)(FWO); Research Council of Ghent University(Ghent University); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Nick De Regge was supported by a post-doctoral research grant of the Institute for the Promotion of Innovation through Science and Technology in Flanders. Further financial support was obtained from grants from the Research Foundation Flanders (FWO-Vlaanderen) and the Research Council of Ghent University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALAN P, 1994, J GEN VIROL, V75, P1245, DOI 10.1099/0022-1317-75-6-1245; CANTIN EM, 1995, J VIROL, V69, P4898, DOI 10.1128/JVI.69.8.4898-4905.1995; CARD JP, 1990, J NEUROSCI, V10, P1974; Carr DJJ, 1998, J IMMUNOL, V161, P4859; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Chen SH, 2002, J VIROL, V76, P4764, DOI 10.1128/JVI.76.10.4764-4772.2002; CHEUNG AK, 1989, J VIROL, V63, P2908, DOI 10.1128/JVI.63.7.2908-2913.1989; Colgin MA, 2001, J VIROL, V75, P2912, DOI 10.1128/JVI.75.6.2912-2920.2001; CROEN KD, 1987, NEW ENGL J MED, V317, P1427, DOI 10.1056/NEJM198712033172302; Danaher RJ, 1999, J NEUROVIROL, V5, P258, DOI 10.3109/13550289909015812; Danaher RJ, 2003, J NEUROVIROL, V9, P489, DOI 10.1080/713831593; De Regge N, 2006, VET MICROBIOL, V113, P251, DOI 10.1016/j.vetmic.2005.11.004; De Regge N, 2006, J CELL BIOL, V174, P267, DOI 10.1083/jcb.200510156; Decman V, 2005, VIRAL IMMUNOL, V18, P466, DOI 10.1089/vim.2005.18.466; Derfuss T, 2009, ANN NY ACAD SCI, V1164, P300, DOI 10.1111/j.1749-6632.2009.03871.x; EJERCITO PM, 1968, J GEN VIROL, V2, P357, DOI 10.1099/0022-1317-2-3-357; Geenen K, 2005, J GEN VIROL, V86, P1251, DOI 10.1099/vir.0.80760-0; GUTEKUNST DE, 1980, AM J VET RES, V41, P1315; Halford WP, 2001, J VIROL, V75, P6143, DOI 10.1128/JVI.75.13.6143-6153.2001; HENDRICKS RL, 1991, J GEN VIROL, V72, P1601, DOI 10.1099/0022-1317-72-7-1601; HO DY, 1989, P NATL ACAD SCI USA, V86, P7596, DOI 10.1073/pnas.86.19.7596; Jones C, 2003, CLIN MICROBIOL REV, V16, P79, DOI 10.1128/CMR.16.1.79-95.2003; Jones CA, 2003, J VIROL, V77, P11139, DOI 10.1128/JVI.77.20.11139-11149.2003; Khanna KM, 2004, TRENDS IMMUNOL, V25, P230, DOI 10.1016/j.it.2004.02.010; Knickelbein JE, 2008, SCIENCE, V322, P268, DOI 10.1126/science.1164164; KONDO Y, 1990, CANCER RES, V50, P7852; Lachmann RH, 1997, J VIROL, V71, P3197, DOI 10.1128/JVI.71.4.3197-3207.1997; Leib DA, 1999, J EXP MED, V189, P663, DOI 10.1084/jem.189.4.663; Liu T, 2001, J VIROL, V75, P11178, DOI 10.1128/JVI.75.22.11178-11184.2001; Maillet S, 2006, J VIROL, V80, P9310, DOI 10.1128/JVI.02615-05; Mikloska Z, 1998, J INFECT DIS, V177, P827, DOI 10.1086/515236; Mikloska Z, 2001, J VIROL, V75, P11821, DOI 10.1128/JVI.75.23.11821-11826.2001; NAUWYNCK HJ, 1995, ARCH VIROL, V140, P1137, DOI 10.1007/BF01315422; ROIZMAN B, 1987, ANNU REV MICROBIOL, V41, P543, DOI 10.1146/annurev.mi.41.100187.002551; Sainz B, 2002, J VIROL, V76, P11541, DOI 10.1128/JVI.76.22.11541-11550.2002; SMITH RL, 1992, VIROLOGY, V188, P311, DOI 10.1016/0042-6822(92)90760-M; STEVENS JG, 1987, SCIENCE, V235, P1056, DOI 10.1126/science.2434993; Thompson RL, 2003, J VIROL, V77, P12319, DOI 10.1128/JVI.77.22.12319-12330.2003; Umbach JL, 2008, NATURE, V454, P780, DOI 10.1038/nature07103; Wang KN, 2005, J VIROL, V79, P14079, DOI 10.1128/JVI.79.22.14079-14087.2005; WIGDAHL B, 1984, P NATL ACAD SCI-BIOL, V81, P6217, DOI 10.1073/pnas.81.19.6217; WIGDAHL B, 1984, J VIROL, V49, P205, DOI 10.1128/JVI.49.1.205-213.1984; WIGDAHL BL, 1982, SCIENCE, V217, P1145, DOI 10.1126/science.6180477; Wilcox CL, 1997, J VIROL, V71, P6777, DOI 10.1128/JVI.71.9.6777-6785.1997; WILCOX CL, 1992, VIROLOGY, V187, P348, DOI 10.1016/0042-6822(92)90326-K; WRZOS H, 1987, VIRUS RES, V8, P301, DOI 10.1016/0168-1702(87)90002-5; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522	47	43	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e13076	10.1371/journal.pone.0013076	http://dx.doi.org/10.1371/journal.pone.0013076			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20927329	Green Submitted, Green Published, gold			2022-12-27	WOS:000282269400024
J	Kirkby, CA; Giudice-Granados, R; Day, B; Turner, K; Velarde-Andrade, LM; Duenas-Duenas, A; Lara-Rivas, JC; Yu, DW				Kirkby, Christopher A.; Giudice-Granados, Renzo; Day, Brett; Turner, Kerry; Velarde-Andrade, Luz Marina; Duenas-Duenas, Agusto; Lara-Rivas, Juan Carlos; Yu, Douglas W.			The Market Triumph of Ecotourism: An Economic Investigation of the Private and Social Benefits of Competing Land Uses in the Peruvian Amazon	PLOS ONE			English	Article							BIODIVERSITY CONSERVATION; OPPORTUNITY COSTS; FOREST; DEFORESTATION; DEGRADATION	Annual revenue flow to developing countries for ecotourism (or nature-based tourism) could be as large as US$ 210 x 10(12), providing an enormous financial incentive against habitat loss and exploitation. However, is ecotourism the most privately and/or socially valuable use of rainforest land? The question is rarely answered because the relevant data, estimates of profits and fixed costs, are rarely available. We present a social cost-benefit analysis of land use in an ecotourism cluster in the Tambopata region of Amazonian Peru. The net present value of ecotourism-controlled land is given by the producer surplus (profits plus fixed costs of ecotourism lodges): US$ 1,158 ha(-1), which is higher than all currently practiced alternatives, including unsustainable logging, ranching, and agriculture. To our knowledge, this is the first sector-wide study of profitability and producer surplus in a developing-country ecotourism sector and the first to compare against equivalent measures for a spectrum of alternative uses. We also find that ecotourism-controlled land sequesters between 5.3 to 8.7 million tons of above-ground carbon, which is equivalent to between 3000-5000 years of carbon emissions from the domestic component of air and surface travel between the gateway city of Cusco and the lodges, at 2005 emission rates. Ecotourism in Tambopata has successfully monetized the hedonic value of wild nature in Amazonian Peru, and justifies the maintenance of intact rainforest over all alternative uses on narrow economic grounds alone.	[Kirkby, Christopher A.; Yu, Douglas W.] Chinese Acad Sci, State Key Lab Genet Resources & Evolut, ECEC, Kunming Inst Zool, Kunming, Yunnan, Peoples R China; [Kirkby, Christopher A.; Giudice-Granados, Renzo; Yu, Douglas W.] Univ E Anglia, Sch Biol Sci, CEEC, Norwich NR4 7TJ, Norfolk, England; [Kirkby, Christopher A.; Day, Brett; Turner, Kerry] Univ E Anglia, Sch Environm Sci, CSERGE, Norwich NR4 7TJ, Norfolk, England; [Velarde-Andrade, Luz Marina] CAMDE PERU, Puerto Maldonado, Madre De Dios, Peru; [Duenas-Duenas, Agusto] Cooperaz & Sviluppo CESVI, Puerto Maldonado, Madre De Dios, Peru; [Lara-Rivas, Juan Carlos] UNSAAC, Puerto Maldonado, Madre De Dios, Peru	Chinese Academy of Sciences; Kunming Institute of Zoology; University of East Anglia; University of East Anglia; Universidad Nacional de San Antonio Abad del Cusco	Kirkby, CA (corresponding author), Chinese Acad Sci, State Key Lab Genet Resources & Evolut, ECEC, Kunming Inst Zool, Kunming, Yunnan, Peoples R China.	dougwyu@gmail.com	Yu, Douglas W./D-2536-2009	Yu, Douglas W./0000-0001-8551-5609; Giudice, Renzo/0000-0003-3802-633X; Day, Brett/0000-0001-7519-5672	United Kingdom Economic and Social Research Council/Natural Environment Research Council [PTA-036-2005-00028]; Yunnan provincial government [20080A001]; Chinese Academy of Sciences [0902281081]	United Kingdom Economic and Social Research Council/Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)Economic & Social Research Council (ESRC)); Yunnan provincial government; Chinese Academy of Sciences(Chinese Academy of Sciences)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by a United Kingdom Economic and Social Research Council/Natural Environment Research Council Interdisciplinary studentship to CK (PTA-036-2005-00028). DY received support from the Yunnan provincial government (20080A001) and the Chinese Academy of Sciences (0902281081).	Alpizar F, 2006, ECOL ECON, V56, P294, DOI 10.1016/j.ecolecon.2005.02.005; ARANACARDO A, 2002, MEJORAMIENTO SISTEMA; Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; Balmford A, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000144; Barany M. E., 2001, Journal of Sustainable Tourism, V9, P95, DOI 10.1080/09669580108667392; Batagoda B., 2000, POLICY RELEVANT ECOS; Blom A., 2000, Journal of Sustainable Tourism, V8, P175, DOI 10.1080/09669580008667357; *BLS, 2009, INFL CALC; BROWN CR, 2001, VISITOR USE FEES PRO; CANCHAYATOLEDO JL, 2006, PERFIL EC COMUNIDAD; Ceballos-Lascurain H., 1987, MEX J, V2, P13; *CEPF, 2005, TROP AND HOTSP VILC; Chomitz KM, 2005, ENVIRON DEV ECON, V10, P293, DOI 10.1017/S1355770X05002081; CTAR-Madre de Dios IIAP, 2000, ZON EC EC REG MADR D; Damania R, 2005, ECOL ECON, V53, P339, DOI 10.1016/j.ecolecon.2004.09.015; Doan T. M., 2000, Journal of Sustainable Tourism, V8, P288, DOI 10.1080/09669580008667365; Drumm A., 2004, ECOTOURISM DEV MANUA; Drumm A., 1991, INTEGRATED IMPACT AS; Duellman W.E., 2005, CUSCO AMAZONICO THE; EPA, 2005, EM FACTS AV CARB DIO; Escobal J, 2003, WORLD DEV, V31, P1873, DOI 10.1016/j.worlddev.2003.08.001; ETTER A, 1994, CARACTERIZACION ECOL; Fearnside PM, 1996, FOREST ECOL MANAG, V80, P21, DOI 10.1016/0378-1127(95)03647-4; Gavin MC, 2007, ECOL ECON, V60, P752, DOI 10.1016/j.ecolecon.2006.01.010; GIUDICE R, 2010, CONSERVATION SE PERU; *GOREMAD, 2005, PLAN ESTR REG SECT A; Gossling S, 1999, ECOL ECON, V29, P303, DOI 10.1016/S0921-8009(99)00012-9; GRIFFITHS M, 1993, CONSERV BIOL, V94, P153; GROOM MJ, 1991, NEOTROPICAL WILDLIFE; Honey M., 2008, ECOTOURISM SUSTAINAB; Just RE., 2004, WELFARE EC PUBLIC PO; Kainer KA, 2007, FOREST ECOL MANAG, V250, P244, DOI 10.1016/j.foreco.2007.05.024; KARP DS, 2009, BIODIVERSITY CONSERV; KIRKBY C, ENV CONSERV IN PRESS; KIRKBY C, 2010, INTRO TROPICAL RAIN; KIRKBY CA, 2000, TOURISM DEV STATUS N; Kiss A, 2004, TRENDS ECOL EVOL, V19, P232, DOI 10.1016/j.tree.2004.03.010; Kvist L. P., 1995, Commonwealth Forestry Review, V74, P293; Mackoy R. D., 2004, Journal of Tourism Studies, V15, P13; MALKYHARB A, 2007, EFECTO CHALALAN EJER; Menkhaus S, 1996, J ENVIRON MANAGE, V47, P1, DOI 10.1006/jema.1996.0031; MIYOSHI C, 2008, PRESENT CARBON DIOXI; Muchagata M, 2003, AGR SYST, V76, P797, DOI 10.1016/S0308-521X(02)00015-X; Naidoo R, 2005, P NATL ACAD SCI USA, V102, P16712, DOI 10.1073/pnas.0508036102; NORTONGRIFFITHS M, 1995, ECOL ECON, V12, P125, DOI 10.1016/0921-8009(94)00041-S; Ohl-Schacherer J, 2008, ENVIRON CONSERV, V35, P14, DOI 10.1017/S0376892908004517; PEARCE D, 2001, VALUABLE ARE TROPICA; Pearce D, 2007, ENVIRON RESOUR ECON, V37, P313, DOI 10.1007/s10640-007-9118-3; *PRONATURALEZA, 2005, PLAN GEN EST MAN FOR; REED SE, 2008, CONSERV LETT, V1, P1; Ricketts TH, 2004, P NATL ACAD SCI USA, V101, P12579, DOI 10.1073/pnas.0405147101; Salafsky N, 2001, CONSERV BIOL, V15, P1585, DOI 10.1046/j.1523-1739.2001.00220.x; Sheil D, 2002, CONSERV ECOL, V6; Soares B, 2004, GLOBAL CHANGE BIOL, V10, P745, DOI 10.1111/j.1529-8817.2003.00769.x; Soares BS, 2002, ECOL MODEL, V154, P217, DOI 10.1016/S0304-3800(02)00059-5; Soares BS, 2006, NATURE, V440, P520, DOI 10.1038/nature04389; *SPDA, 2007, B INF SPDA, V3; Stronza A.L., 2000, THESIS U FLORIDA GAI; Taylor J.E., 2006, ECOTOURISM EC GROWTH; Theobald DM, 2005, ECOL APPL, V15, P1906, DOI 10.1890/03-5331; Torras M, 2000, ECOL ECON, V33, P283, DOI 10.1016/S0921-8009(99)00149-4; TORRESPADILLA J, 2006, PLAN NEGOCIOS 2006 A; van Lier HN, 1998, LANDSCAPE URBAN PLAN, V41, P83, DOI 10.1016/S0169-2046(97)00061-3; Walpole MJ, 2005, PEOPLE WILDLIFE CONF; WEARING S, 1999, ECOTOURISM IMPACTS P; Wight P., 1993, Journal of Travel Research, V31, P3, DOI 10.1177/004728759303100301; WINROCK, 2006, CARBON STORAGE LOS A; Wunder S, 2000, ECOL ECON, V32, P465, DOI 10.1016/S0921-8009(99)00119-6; WUNDER S, 1999, PROMOTING FOREST CON; WUNDER S, 2001, DEFORESTATION EC ECU; Yu DW, 1997, ENVIRON CONSERV, V24, P130, DOI 10.1017/S0376892997000192; YU DW, 2010, BIOTROPICA; YU DW, BIOTROPICA IN PRESS; [No title captured]	74	51	51	2	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e13015	10.1371/journal.pone.0013015	http://dx.doi.org/10.1371/journal.pone.0013015			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	655SI	20927377	Green Submitted, Green Published, gold			2022-12-27	WOS:000282269400010
J	Bernasconi, R; Solda, T; Galli, C; Pertel, T; Luban, J; Molinari, M				Bernasconi, Riccardo; Solda, Tatiana; Galli, Carmela; Pertel, Thomas; Luban, Jeremy; Molinari, Maurizio			Cyclosporine A-Sensitive, Cyclophilin B-Dependent Endoplasmic Reticulum-Associated Degradation	PLOS ONE			English	Article							UBIQUITIN LIGASE COMPLEX; QUALITY-CONTROL; MISFOLDED GLYCOPROTEINS; CA2+ HOMEOSTASIS; ER; RECOGNITION; PROTEASOME; SECRETION; ISOMERASE; VARIANTS	Peptidyl-prolyl cis/trans isomerases (PPIs) catalyze cis/trans isomerization of peptide bonds preceding proline residues. The involvement of PPI family members in protein refolding has been established in test tube experiments. Surprisingly, however, no data is available on the involvement of endoplasmic reticulum (ER)-resident members of the PPI family in protein folding, quality control or disposal in the living cell. Here we report that the immunosuppressive drug cyclosporine A (CsA) selectively inhibits the degradation of a subset of misfolded proteins generated in the ER. We identify cyclophilin B (CyPB) as the ER-resident target of CsA that catalytically enhances disposal from the ER of ERAD-L(S) substrates containing cis proline residues. Our manuscript presents the first evidence for enzymatic involvement of a PPI in protein quality control in the ER of living cells.	[Bernasconi, Riccardo; Solda, Tatiana; Galli, Carmela; Pertel, Thomas; Luban, Jeremy; Molinari, Maurizio] Inst Res Biomed, Bellinzona, Switzerland; [Pertel, Thomas; Luban, Jeremy] Univ Geneva, Dept Microbiol & Mol Med, Geneva, Switzerland; [Molinari, Maurizio] Ecole Polytech Fed Lausanne, Sch Life Sci, Lausanne, Switzerland	Universita della Svizzera Italiana; University of Geneva; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Bernasconi, R (corresponding author), Inst Res Biomed, Bellinzona, Switzerland.	maurizio.molinari@irb.unisi.ch	Molinari, Maurizio/N-2587-2019	Molinari, Maurizio/0000-0002-7636-5829; Luban, Jeremy/0000-0001-5650-4054; Pertel, Thomas/0000-0002-2286-6011	Foundation for Research on Neurodegenerative Diseases; Fondazione San Salvatore; Swiss National Center of Competence in Research on Neural Plasticity and Repair; Swiss National Science Foundation; ONELIFE Advisors SA; NIH [AI059159]; EU; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059159] Funding Source: NIH RePORTER	Foundation for Research on Neurodegenerative Diseases; Fondazione San Salvatore; Swiss National Center of Competence in Research on Neural Plasticity and Repair(Swiss National Science Foundation (SNSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ONELIFE Advisors SA; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU(European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	M.M. is supported by grants from the Foundation for Research on Neurodegenerative Diseases, the Fondazione San Salvatore, the Swiss National Center of Competence in Research on Neural Plasticity and Repair, the Swiss National Science Foundation and ONELIFE Advisors SA. J.L. is supported by grants from the Swiss National Science Foundation, the NIH (AI059159) and the EU project HIV-ACE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; Bernasconi R, 2008, J BIOL CHEM, V283, P16446, DOI 10.1074/jbc.M802272200; Bernasconi R, 2010, J CELL BIOL, V188, P223, DOI 10.1083/jcb.200910042; Bhamidipati A, 2005, MOL CELL, V19, P741, DOI 10.1016/j.molcel.2005.07.027; Caramelo JJ, 2008, J BIOL CHEM, V283, P10221, DOI 10.1074/jbc.R700048200; Carpentier M, 1999, J BIOL CHEM, V274, P10990, DOI 10.1074/jbc.274.16.10990; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Cohen E, 2003, EMBO J, V22, P404, DOI 10.1093/emboj/cdg045; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Feige MJ, 2009, MOL CELL, V34, P569, DOI 10.1016/j.molcel.2009.04.028; Frenkel Z, 2003, J BIOL CHEM, V278, P34119, DOI 10.1074/jbc.M305929200; Halloran PF, 2004, NEW ENGL J MED, V351, P2715, DOI 10.1056/NEJMra033540; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Hebert DN, 2010, SEMIN CELL DEV BIOL, V21, P526, DOI 10.1016/j.semcdb.2009.12.007; Hebert DN, 2009, MOL CELL, V34, P635, DOI 10.1016/j.molcel.2009.06.006; Hosokawa N, 2008, J BIOL CHEM, V283, P20914, DOI 10.1074/jbc.M709336200; Jessop CE, 2004, BIOCHEM SOC T, V32, P655, DOI 10.1042/BST0320655; Kaul A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000546; Kim J, 2008, J CELL SCI, V121, P3636, DOI 10.1242/jcs.028654; Liu Y, 1999, J BIOL CHEM, V274, P5861, DOI 10.1074/jbc.274.9.5861; Maattanen P, 2010, SEMIN CELL DEV BIOL, V21, P500, DOI 10.1016/j.semcdb.2010.03.006; Molinari M, 2003, SCIENCE, V299, P1397, DOI 10.1126/science.1079474; Molinari M, 2002, J CELL BIOL, V158, P247, DOI 10.1083/jcb.200204122; Nagradova N, 2007, CURR PROTEIN PEPT SC, V8, P273, DOI 10.2174/138920307780831866; Olivari S, 2005, J BIOL CHEM, V280, P2424, DOI 10.1074/jbc.C400534200; Olivari S, 2006, BIOCHEM BIOPH RES CO, V349, P1278, DOI 10.1016/j.bbrc.2006.08.186; PRICE ER, 1991, P NATL ACAD SCI USA, V88, P1903, DOI 10.1073/pnas.88.5.1903; Rogers TB, 1995, BIOSCIENCE REP, V15, P341, DOI 10.1007/BF01788366; Schiene C, 2000, CURR OPIN STRUC BIOL, V10, P40, DOI 10.1016/S0959-440X(99)00046-9; SCHREIBER SL, 1991, SCIENCE, V251, P283, DOI 10.1126/science.1702904; SU K, 1993, J BIOL CHEM, V268, P14301; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Zohar O, 2003, MOL BRAIN RES, V115, P63, DOI 10.1016/S0169-328X(03)00182-7	36	37	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2010	5	9							e13008	10.1371/journal.pone.0013008	http://dx.doi.org/10.1371/journal.pone.0013008			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654ZQ	20927389	gold, Green Published, Green Submitted			2022-12-27	WOS:000282210700007
J	Held, NL; Herrera, A; Cadillo-Quiroz, H; Whitaker, RJ				Held, Nicole L.; Herrera, Alfa; Cadillo-Quiroz, Hinsby; Whitaker, Rachel J.			CRISPR Associated Diversity within a Population of Sulfolobus islandicus	PLOS ONE			English	Article							STREPTOCOCCUS-THERMOPHILUS; MICROBIAL COMMUNITIES; ACQUIRED-RESISTANCE; RESOURCE ENRICHMENT; VIRUS-RESISTANCE; BACTERIA; PHAGE; HOST; EVOLUTION; DYNAMICS	Background: Predator-prey models for virus-host interactions predict that viruses will cause oscillations of microbial host densities due to an arms race between resistance and virulence. A new form of microbial resistance, CRISPRs (clustered regularly interspaced short palindromic repeats) are a rapidly evolving, sequence-specific immunity mechanism in which a short piece of invading viral DNA is inserted into the host's chromosome, thereby rendering the host resistant to further infection. Few studies have linked this form of resistance to population dynamics in natural microbial populations. Methodology/Principal Findings: We examined sequence diversity in 39 strains of the archeaon Sulfolobus islandicus from a single, isolated hot spring from Kamchatka, Russia to determine the effects of CRISPR immunity on microbial population dynamics. First, multiple housekeeping genetic markers identify a large clonal group of identical genotypes coexisting with a diverse set of rare genotypes. Second, the sequence-specific CRISPR spacer arrays split the large group of isolates into two very different groups and reveal extensive diversity and no evidence for dominance of a single clone within the population. Conclusions/Significance: The evenness of resistance genotypes found within this population of S. islandicus is indicative of a lack of strain dominance, in contrast to the prediction for a resistant strain in a simple predator-prey interaction. Based on evidence for the independent acquisition of resistant sequences, we hypothesize that CRISPR mediated clonal interference between resistant strains promotes and maintains diversity in this natural population.	[Held, Nicole L.; Herrera, Alfa; Cadillo-Quiroz, Hinsby; Whitaker, Rachel J.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Held, NL (corresponding author), Univ Illinois, Dept Microbiol, 131 Burrill Hall, Urbana, IL 61801 USA.	rwhitaker@life.illinois.edu		Cadillo-Quiroz, Hinsby/0000-0002-4908-4597	National Science Foundation [DEB-0816885]; Division Of Environmental Biology [0816885] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding for this work was provided by National Science Foundation award number DEB-0816885, http://www.nsf.gov/div/index.jsp?div=DEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 1997, EVOLUTION, V51, P1742, DOI 10.1111/j.1558-5646.1997.tb05098.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Banfield JF, 2009, SCIENCE, V326, P1198, DOI 10.1126/science.1181501; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bize A, 2009, P NATL ACAD SCI USA, V106, P11306, DOI 10.1073/pnas.0901238106; Bohannan BJM, 1999, AM NAT, V153, P73, DOI 10.1086/303151; Bohannan BJM, 1997, ECOLOGY, V78, P2303; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Brockhurst MA, 2005, P ROY SOC B-BIOL SCI, V272, P1385, DOI 10.1098/rspb.2005.3086; Brockhurst MA, 2004, P ROY SOC B-BIOL SCI, V271, P107, DOI 10.1098/rspb.2003.2556; CHAO A, 1984, SCAND J STAT, V11, P265; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Heidelberg JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004169; Held NL, 2009, ENVIRON MICROBIOL, V11, P457, DOI 10.1111/j.1462-2920.2008.01784.x; Holmfeldt K, 2007, APPL ENVIRON MICROB, V73, P6730, DOI 10.1128/AEM.01399-07; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Lennon JT, 2007, ISME J, V1, P300, DOI 10.1038/ismej.2007.37; LENSKI RE, 1985, AM NAT, V125, P585, DOI 10.1086/284364; Lillestol RK, 2009, MOL MICROBIOL, V72, P259, DOI 10.1111/j.1365-2958.2009.06641.x; Lythgoe KA, 2003, ECOL LETT, V6, P326, DOI 10.1046/j.1461-0248.2003.00433.x; MADDISON WP, 2005, MACCLADE ANLAYSIS PH; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Middelboe M, 2000, MICROBIAL ECOL, V40, P114; Middelboe M, 2009, ENVIRON MICROBIOL, V11, P1971, DOI 10.1111/j.1462-2920.2009.01920.x; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pancer Z, 2006, ANNU REV IMMUNOL, V24, P497, DOI 10.1146/annurev.immunol.24.021605.090542; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Prangishvili D, 2005, TRENDS MICROBIOL, V13, P535, DOI 10.1016/j.tim.2005.08.013; Reno ML, 2009, P NATL ACAD SCI USA, V106, P8605, DOI 10.1073/pnas.0808945106; Rodriguez-Brito B, 2010, ISME J, V4, P739, DOI 10.1038/ismej.2010.1; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schrag SJ, 1996, AM NAT, V148, P348, DOI 10.1086/285929; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Thingstad TF, 2000, LIMNOL OCEANOGR, V45, P1320, DOI 10.4319/lo.2000.45.6.1320; Tyson GW, 2008, ENVIRON MICROBIOL, V10, P200, DOI 10.1111/j.1462-2920.2007.01444.x; van Embden JDA, 2000, J BACTERIOL, V182, P2393, DOI 10.1128/JB.182.9.2393-2401.2000; Weitz JS, 2005, P NATL ACAD SCI USA, V102, P9535, DOI 10.1073/pnas.0504062102; Whitaker RJ, 2005, MOL BIOL EVOL, V22, P2354, DOI 10.1093/molbev/msi233; Whitaker RJ, 2003, SCIENCE, V301, P976, DOI 10.1126/science.1086909; Winter C, 2010, MICROBIOL MOL BIOL R, V74, P42, DOI 10.1128/MMBR.00034-09; Yoshida T, 2007, PLOS BIOL, V5, P1868, DOI 10.1371/journal.pbio.0050235	50	73	74	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2010	5	9							e12988	10.1371/journal.pone.0012988	http://dx.doi.org/10.1371/journal.pone.0012988			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654ZQ	20927396	Green Submitted, Green Published, gold			2022-12-27	WOS:000282210700006
J	Waterman, JM				Waterman, Jane M.			The Adaptive Function of Masturbation in a Promiscuous African Ground Squirrel	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; SPERM COMPETITION RISK; XERUS-INAURIS; JAPANESE MACAQUES; EJACULATE QUALITY; SIZE; ALLOCATION; CONSEQUENCES; SCIURIDAE; EVOLUTION	Background: Studies of animal mating systems increasingly emphasize female multiple mating and cryptic sexual selection, particularly sperm competition. Males under intense sperm competition may manipulate sperm quantity and quality through masturbation, which could waste sperm and decrease fertility. I examined the factors influencing masturbation by male Cape ground squirrels (Xerus inauris) in light of a number of functional hypotheses. Methodology: Observational data on a marked population of squirrels were collected in east-central Namibia using scan and all-occurrences sampling. Findings: Masturbation was far more frequent on days of female oestrus and mostly occurred after copulation. Masturbation rates were higher in dominant males, which copulate more, than in subordinates and increased with number of mates a female accepts. Conclusions: These results suggest that masturbation in this species was not a response to sperm competition nor a sexual outlet by subordinates that did not copulate. Instead masturbation could function as a form of genital grooming. Female Cape ground squirrels mate with up to 10 males in a 3-hr oestrus, and by masturbating after copulation males could reduce the chance of infection. Sexually transmitted infections (STIs) can profoundly affect fertility, and their consequences for mating strategies need to be examined more fully.	Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida	Waterman, JM (corresponding author), Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA.	jane_waterman@umanitoba.ca			National Science Foundation [IBN0130600]	National Science Foundation(National Science Foundation (NSF))	This research was funded in part by a National Science Foundation (http://www.nsf.gov/) grant (IBN0130600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Ambriz D, 2002, ARCH ANDROLOGY, V48, P389, DOI 10.1080/01485010290099255; BAGEMIHL B, 1999, BIOLOGICAL EXUBERANC; BAKER RR, 1993, ANIM BEHAV, V46, P861, DOI 10.1006/anbe.1993.1271; Birkhead TR, 1998, SPERM COMPETITION SE; CONOVER W. J, 1980, PRACTICAL NONPARAMET; DEWSBURY DA, 1982, AM NAT, V119, P601, DOI 10.1086/283938; Dixson AF, 2004, PHYSIOL BEHAV, V83, P361, DOI 10.1016/j.physbeh.2004.08.022; Dixson AF, 1998, PRIMATE SEXUALITY; Donovan B, 2000, SEX TRANSM INFECT, V76, P88, DOI 10.1136/sti.76.2.88; Engqvist L, 2007, P ROY SOC B-BIOL SCI, V274, P209, DOI 10.1098/rspb.2006.3722; GAGE MJG, 1991, ANIM BEHAV, V42, P1036, DOI 10.1016/S0003-3472(05)80162-9; HAIM A, 1987, S AFR J ZOOL, V22, P45; HART BL, 1988, ANN NY ACAD SCI, V525, P397, DOI 10.1111/j.1749-6632.1988.tb38624.x; HARTL P, 1987, FREQUENZ, V41, P321, DOI 10.1515/FREQ.1987.41.11-12.321; HOGLUND J, 1990, BEHAVIOUR, V114, P221, DOI 10.1163/156853990X00130; KENAGY GJ, 1986, J MAMMAL, V67, P1, DOI 10.2307/1380997; Lehner PN, 1996, HDB ETHOLOGICAL METH; LOEHLE C, 1995, ECOLOGY, V76, P326, DOI 10.2307/1941192; Manjerovic MB, 2008, J ZOOL, V275, P375, DOI 10.1111/j.1469-7998.2008.00449.x; MARDH PA, 1975, SCAND J UROL NEPHROL, V9, P17, DOI 10.3109/00365597509139907; MARSH A C, 1978, Madoqua, V11, P129; MELCHIOR HERBERT R., 1965, J WILDLIFE MANAGE, V29, P671, DOI 10.2307/3798540; Nunn CL, 2003, ANIM BEHAV, V66, P37, DOI 10.1006/anbe.2003.2130; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Pettitt BA, 2008, J ZOOL, V276, P291, DOI 10.1111/j.1469-7998.2008.00491.x; PIERCE JD, 1990, J REPROD FERTIL, V88, P141; Pitcher TE, 2005, J EVOLUTION BIOL, V18, P557, DOI 10.1111/j.1420-9101.2004.00874.x; Ramm SA, 2005, P ROY SOC B-BIOL SCI, V272, P949, DOI 10.1098/rspb.2004.3048; Ramm SA, 2007, BEHAV ECOL, V18, P491, DOI 10.1093/beheco/arm003; ROOD JP, 1980, J WILDLIFE MANAGE, V44, P500, DOI 10.2307/3807988; Simmons LW, 2007, BIOL LETTERS, V3, P520, DOI 10.1098/rsbl.2007.0328; SKARPE C, 1986, J ARID ENVIRON, V11, P147, DOI 10.1016/S0140-1963(18)31226-6; Skau PA, 2003, BEHAV ECOL, V14, P40, DOI 10.1093/beheco/14.1.40; Smith C, 2009, ANIM BEHAV, V77, P1227, DOI 10.1016/j.anbehav.2009.01.027; Snook RR, 2005, TRENDS ECOL EVOL, V20, P46, DOI 10.1016/j.tree.2004.10.011; STAMEY TA, 1968, NATURE, V218, P444, DOI 10.1038/218444a0; SYNNOTT AL, 1981, J REPROD FERTIL, V61, P355, DOI 10.1530/jrf.0.0610355; Tan M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007595; Thomsen R, 2004, INT J PRIMATOL, V25, P1033, DOI 10.1023/B:IJOP.0000043350.75897.89; Thomsen R, 2006, PRIMATES, V47, P272, DOI 10.1007/s10329-005-0171-7; Waterman Jane, 2007, P27; Waterman JM, 1996, J MAMMAL, V77, P134, DOI 10.2307/1382715; Waterman JM, 1998, ANIM BEHAV, V56, P459, DOI 10.1006/anbe.1998.0780; Waterman JM, 1997, ANIM BEHAV, V53, P809, DOI 10.1006/anbe.1996.0346; WATERMAN JM, 1995, ETHOLOGY, V101, P130, DOI 10.1111/j.1439-0310.1995.tb00352.x; Waterman JM, 2002, J ZOOL, V256, P113, DOI 10.1017/S0952836902000146; Zar JH, 1999, BIOSTATISTICAL ANAL	48	12	12	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2010	5	9							e13060	10.1371/journal.pone.0013060	http://dx.doi.org/10.1371/journal.pone.0013060			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654ZQ	20927404	Green Published, gold			2022-12-27	WOS:000282210700026
J	Tiffin, N; Meintjes, A; Ramesar, R; Bajic, VB; Rayner, B				Tiffin, Nicki; Meintjes, Ayton; Ramesar, Rajkumar; Bajic, Vladimir B.; Rayner, Brian			Computational Analysis of Candidate Disease Genes and Variants for Salt-Sensitive Hypertension in Indigenous Southern Africans	PLOS ONE			English	Article							BLOOD-PRESSURE; PARATHYROID-HORMONE; SIGNALING SYSTEMS; URINARY CALCIUM; SODIUM; ANGIOTENSIN; ALDOSTERONE; RECEPTOR; DATABASE; INSULIN	Multiple factors underlie susceptibility to essential hypertension, including a significant genetic and ethnic component, and environmental effects. Blood pressure response of hypertensive individuals to salt is heterogeneous, but salt sensitivity appears more prevalent in people of indigenous African origin. The underlying genetics of salt-sensitive hypertension, however, are poorly understood. In this study, computational methods including text-and data-mining have been used to select and prioritize candidate aetiological genes for salt-sensitive hypertension. Additionally, we have compared allele frequencies and copy number variation for single nucleotide polymorphisms in candidate genes between indigenous Southern African and Caucasian populations, with the aim of identifying candidate genes with significant variability between the population groups: identifying genetic variability between population groups can exploit ethnic differences in disease prevalence to aid with prioritisation of good candidate genes. Our top-ranking candidate genes include parathyroid hormone precursor (PTH) and type-1angiotensin II receptor (AGTR1). We propose that the candidate genes identified in this study warrant further investigation as potential aetiological genes for salt-sensitive hypertension.	[Tiffin, Nicki; Rayner, Brian] Univ Cape Town, Groote Schuur Hosp, Div Nephrol & Hypertens, ZA-7925 Cape Town, South Africa; [Ramesar, Rajkumar] Univ Cape Town, Inst Infect Dis & Mol Med, Div Human Genet, Med Res Council MRC Res Unit Human Genet, ZA-7925 Cape Town, South Africa; [Bajic, Vladimir B.] KAUST, CBRC, Thuwal, Saudi Arabia	University of Cape Town; University of Cape Town; King Abdullah University of Science & Technology	Tiffin, N (corresponding author), Univ Cape Town, Groote Schuur Hosp, Div Nephrol & Hypertens, ZA-7925 Cape Town, South Africa.	nickitiffin@imaginet.co.za	Tiffin, Nicki/ABA-9391-2020; Ramesar, Raj S/I-6941-2015; Tiffin, Nicki/A-5914-2013; Rayner, Brian/AAA-3174-2021; Bajic, Vladimir/D-2810-2009	Tiffin, Nicki/0000-0001-5083-2735; Ramesar, Raj S/0000-0001-5688-1634; Rayner, Brian/0000-0002-0167-9591; Bajic, Vladimir/0000-0001-5435-4750	National Research Foundation of South Africa; Medical Research Council of South Africa; Affymetrix (USA); Centre for Proteomic and Genomic Research at the University of Cape Town	National Research Foundation of South Africa(National Research Foundation - South Africa); Medical Research Council of South Africa(South African Medical Research Council); Affymetrix (USA); Centre for Proteomic and Genomic Research at the University of Cape Town	Funding for this study was provided by the National Research Foundation of South Africa (http://www.nrf.ac.za/) through the rated researcher grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Medical Research Council of South Africa, Affymetrix (USA), and the Centre for Proteomic and Genomic Research (notably Dr Reinhard Hiller) at the University of Cape Town, are acknowledged for their support of the generation of the SNP6 data on the indigenous Southern African populations.	Aloia John F, 2006, Endocr Pract, V12, P137; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Anan F, 2008, HYPERTENS RES, V31, P1913, DOI 10.1291/hypres.31.1913; Bajic VB, 2005, PLANT PHYSIOL, V138, P1914, DOI 10.1104/pp.105.060863; Deng AY, 2007, HUM MOL GENET, V16, pR195, DOI 10.1093/hmg/ddm126; ERNE P, 1984, NEW ENGL J MED, V310, P1084, DOI 10.1056/NEJM198404263101705; Essack M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-219; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; Fliser D, 1997, NEPHROL DIAL TRANSPL, V12, P933, DOI 10.1093/ndt/12.5.933; Garbers DL, 2006, TRENDS ENDOCRIN MET, V17, P251, DOI 10.1016/j.tem.2006.06.006; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Harris SS, 2006, J NUTR, V136, P1126, DOI 10.1093/jn/136.4.1126; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; HULTER H N, 1986, Journal of Clinical Hypertension, V2, P360; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Iwamoto T, 2004, NAT MED, V10, P1193, DOI 10.1038/nm1118; Jung JS, 2009, J CLIN ENDOCR METAB, V94, P1042, DOI 10.1210/jc.2008-1861; Kaur M, 2009, NUCLEIC ACIDS RES, V37, pD820, DOI 10.1093/nar/gkn593; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; KURTZ TW, 1990, AM J HYPERTENS, V3, pS152, DOI 10.1093/ajh/3.8.152; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Lombard Z, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-389; MACGREGOR GA, 1993, J HYPERTENS, V11, P781, DOI 10.1097/00004872-199308000-00003; MCCARRON DA, 1980, HYPERTENSION, V2, P162, DOI 10.1161/01.HYP.2.2.162; MURPHY TJ, 1991, NATURE, V351, P233, DOI 10.1038/351233a0; Muscogiuri G, 2008, CURR VASC PHARMACOL, V6, P301, DOI 10.2174/157016108785909715; NYBY MD, 1995, ENDOCRINOLOGY, V136, P2497, DOI 10.1210/en.136.6.2497; Pan H, 2004, NUCLEIC ACIDS RES, V32, pW230, DOI 10.1093/nar/gkh484; Puddu P, 2007, ACTA CARDIOL, V62, P281, DOI 10.2143/AC.62.3.2020818; Rayner BL, 2003, J HYPERTENS, V21, P921, DOI 10.1097/00004872-200305000-00016; Rayner BL, 2001, S AFR MED J, V91, P594; RESNICK LM, 1994, J CLIN INVEST, V94, P1269, DOI 10.1172/JCI117445; ROCCHINI AP, 1989, HYPERTENSION, V14, P367, DOI 10.1161/01.HYP.14.4.367; Rodriguez-Iturbe B, 2007, NEPHROL DIAL TRANSPL, V22, P992, DOI 10.1093/ndt/gfl757; Rothermund L, 2001, HYPERTENSION, V37, P275, DOI 10.1161/01.HYP.37.2.275; Sagar S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-622; Seedat YK, 2009, CARDIOVASC J AFR, V20, P39; Shih PAB, 2008, HYPERTENSION, V51, P1456, DOI 10.1161/HYPERTENSIONAHA.107.090480; Strazzullo P, 2003, HYPERTENSION, V41, P1000, DOI 10.1161/01.HYP.0000066844.63035.3A; Strazzullo P, 2007, CURR HYPERTENS REP, V9, P25, DOI 10.1007/s11906-007-0006-6; SULLIVAN JM, 1988, AM J MED SCI, V295, P370, DOI 10.1097/00000441-198804000-00025; Taylor EN, 2008, J HYPERTENS, V26, P1390, DOI 10.1097/HJH.0b013e3282ffb43b; Tiffin N, 2006, NUCLEIC ACIDS RES, V34, P3067, DOI 10.1093/nar/gkl381; Tiffin N, 2008, PHYSIOL GENOMICS, V35, P55, DOI 10.1152/physiolgenomics.90247.2008; VANHOOFT IMS, 1993, HYPERTENSION, V21, P267, DOI 10.1161/01.HYP.21.3.267; Velloso LA, 2006, DIABETES-METAB RES, V22, P98, DOI 10.1002/dmrr.611; Weder AB, 2009, HYPERTENSION, V53, P715, DOI 10.1161/HYPERTENSIONAHA.108.121665; Weinberger MH, 1996, HYPERTENSION, V27, P481, DOI 10.1161/01.HYP.27.3.481; Yancy CW, 2008, CURR HYPERTENS REP, V10, P276, DOI 10.1007/s11906-008-0052-8; Zhang KX, 2010, J HYPERTENS, V28, P1115, DOI 10.1097/HJH.0b013e328337f6bc; Zhao XY, 2003, HYPERTENSION, V42, P775, DOI [10.1161/01.HYP.0000085649.28268.DF, 10.1161/01.HYP.000008549.28268.DF]; AFFYMETRIX POWER TOO	52	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e12989	10.1371/journal.pone.0012989	http://dx.doi.org/10.1371/journal.pone.0012989			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20886000	Green Published, gold, Green Submitted			2022-12-27	WOS:000282167100005
J	Amico, P; Aran, C; Avila, C				Amico, Peter; Aran, Christian; Avila, Carlos			HIV Spending as a Share of Total Health Expenditure: An Analysis of Regional Variation in a Multi-Country Study	PLOS ONE			English	Article								Background: HIV has devastated numerous countries in sub-Saharan Africa and is a dominant health force in many other parts of the world. Its undeniable importance is reflected in the establishment of Millennium Development Goal No. 6. Unprecedented amounts of funding have been committed and disbursed over the past two decades. Many have argued that this enormous influx of funding has been detrimental to building stronger health systems in recipient countries. This paper examines the funding share for HIV measured against the total funding for health. Methodology/Principal Findings: A descriptive analysis of HIV and health expenditures in 2007 from 65 countries was conducted. Comparable data from individual countries was used by applying a consistent definition for HIV expenditures and total health expenditures from NHAs to align them with National AIDS Assessment Reports. In 2007, the total public and international expenditure in LMICs for HIV was 1.6 percent of the total spending on health, while the share in SSA was 19.4 percent. HIV prevalence was six-fold higher in SSA than the next highest region and it is the only region whose share of HIV spending exceeded the burden of HIV DALYs. Conclusions/Significance: The share of HIV spending across the 65 countries was quite moderate considering that the estimated share of deaths attributable to HIV stood at 3.8 percent and DALYs at 4.4 percent. Several high spending countries are using a large share of their total health spending for HIV health, but these countries are the exception rather than representative of the average SSA country. There is wide variation between regions, but the burden of disease also varies significantly. The percentage of HIV spending is a useful indicator for better understanding health care resources and their allocation patterns.	[Amico, Peter] Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA 02254 USA; [Aran, Christian; Avila, Carlos] UNAIDS, AIDS Financing & Econ Div, Geneva, Switzerland	Brandeis University; UNAIDS	Amico, P (corresponding author), Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA 02254 USA.	avilac@unaids.org						ATUM R, 2008, DO VERTICAL STAND AL; Bongaarts J, 2010, SCIENCE, V328, P1359, DOI 10.1126/science.1191804; BUSE K, 2006, SCAL UP HIV AIDS RES; Currie CSM, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-130; DUGGER C, 2010, S AFRICA REDOUBLES E; Farag M, 2009, HEALTH AFFAIR, V28, P1045, DOI 10.1377/hlthaff.28.4.1045; *GLOB FUND, 2008, COUNTR REQ HIGH EV A; *HLTH SYST 20 20 P, 2009, LINK NASA NHA CONC M; Izazola-Licea JA, 2009, JAIDS-J ACQ IMM DEF, V52, pS119, DOI 10.1097/QAI.0b013e3181baeeda; Loevinsohn B, 2002, AM J PUBLIC HEALTH, V92, P19, DOI 10.2105/AJPH.92.1.19; Marchal B, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000059; MATHERS C, 2005, UPD PROJ GLOB MORT B; Ooms G, 2008, GLOBAL HLTH, V4; *PEPFAR, 2009, CEL LIF 5 ANN REP C; *PEPFAR, 2009, EX SUMM PEPFARS STRA; Ravishankar N, 2009, LANCET, V373, P2113, DOI 10.1016/S0140-6736(09)60881-3; Reich MR, 2009, LANCET, V373, P508, DOI 10.1016/S0140-6736(08)61899-1; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3; Shiffman J, 2009, JAIDS-J ACQ IMM DEF, V52, pS45, DOI 10.1097/QAI.0b013e3181bbcb45; The Global Fund, 2008, GLOB FUND SUPP PROGR; UN, 2004, IMP AIDS; *UNAIDS, 2008, 2008 REP GLOB AIDS E; UNAIDS, 2009, NAT AIDS SPEND ASS N; UNAIDS, 2009, WHAT COUNTR NEED INV; *UNAIDS, 2010, UNAIDS OUTL REP 2010; UNAIDS, 2006, REP GLOB AIDS EP; UNAIDS & World Bank, 2009, GLOB EC CRIS HIV PRE; United Nations Development Programme, 2005, HUM DEV REP; United Nations Development Programme, 2010, WHAT AR MILL DEV GOA; *WORLD BANK, 2007, WORLD BANK EMP TAIL; *WORLD BANK, 2008, DATASTATISTICS; World Bank WHO and The United States Agency for International Development, 2003, GUID PROD NAT HLTH A; World Health Organization, 2008, GLOB BURD DIS 2004 U	33	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2010	5	9							e12997	10.1371/journal.pone.0012997	http://dx.doi.org/10.1371/journal.pone.0012997			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653UN	20885986	gold, Green Published, Green Submitted			2022-12-27	WOS:000282122600021
J	Mittag, J; Behrends, T; Hoefig, CS; Vennstrom, B; Schomburg, L				Mittag, Jens; Behrends, Thomas; Hoefig, Carolin S.; Vennstrom, Bjorn; Schomburg, Lutz			Thyroid Hormones Regulate Selenoprotein Expression and Selenium Status in Mice	PLOS ONE			English	Article							NONTHYROIDAL ILLNESS SYNDROME; ACUTE-PHASE RESPONSE; IODOTHYRONINE DEIODINASE; IMMUNE-RESPONSE; 5-DEIODINASE; METABOLISM; ACTIVATION; KIDNEY; BRAIN; RAT	Impaired expression of selenium-containing proteins leads to perturbed thyroid hormone (TH) levels, indicating the central importance of selenium for TH homeostasis. Moreover, critically ill patients with declining serum selenium develop a syndrome of low circulating TH and a central downregulation of the hypothalamus-pituitary-thyroid axis. This prompted us to test the reciprocal effect, i.e., if TH status would also regulate selenoprotein expression and selenium levels. To investigate the TH dependency of selenium metabolism, we analyzed mice expressing a mutant TH receptor alpha 1 (TR alpha 1+m) that confers a receptor-mediated hypothyroidism. Serum selenium was reduced in these animals, which was a direct consequence of the mutant TR alpha 1 and not related to their metabolic alterations. Accordingly, hyperthyroidism, genetically caused by the inactivation of TR beta or by oral TH treatment of adult mice, increased serum selenium levels in TR alpha 1+m and controls, thus demonstrating a novel and specific role for TR alpha 1 in selenium metabolism. Furthermore, TH affected the mRNA levels for several enzymes involved in selenoprotein biosynthesis as well as serum selenoprotein P concentrations and the expression of other antioxidative selenoproteins. Taken together, our results show that TH positively affects the serum selenium status and regulates the expression of several selenoproteins. This demonstrates that selenium and TH metabolism are interconnected through a feed-forward regulation, which can in part explain the rapid parallel downregulation of both systems in critical illness.	[Mittag, Jens; Vennstrom, Bjorn] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Behrends, Thomas; Hoefig, Carolin S.; Schomburg, Lutz] Charite, Inst Expt Endokrinol, D-13353 Berlin, Germany	Karolinska Institutet; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Mittag, J (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden.	Bjorn.Vennstrom@ki.se; lutz.schomburg@charite.de	Schomburg, Lutz/D-8096-2013; Mittag, Jens/ABE-7875-2020; Mittag, Jens/A-1387-2009	Schomburg, Lutz/0000-0001-9445-1555; Mittag, Jens/0000-0001-7778-5158; Mittag, Jens/0000-0001-7778-5158	Deutsche Forschungsgemeinschaft [Mi1242/1-1, Scho849/2-2, GraKo1208]; Swedish Research Council; Swedish Cancer Society; Soderberg Stiftelse; KaroBio AB stiftelse; Karolinska Institutet Funds; Deutsche Krebshilfe [10-1792 SchoII]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Soderberg Stiftelse; KaroBio AB stiftelse; Karolinska Institutet Funds; Deutsche Krebshilfe(Deutsche Krebshilfe)	The authors received funding from Deutsche Forschungsgemeinschaft (Mi1242/1-1, Scho849/2-2, GraKo1208; www.dfg.de), the Swedish Research Council (BV; www.vr.se), the Swedish Cancer Society (BV; www.cancerfonden.se), the Soderberg Stiftelse (BV; www.soderbergsstiftelser.se), KaroBio AB stiftelse (BV, JM; www.karobio.se), Karolinska Institutet Funds (BV, JM; www.ki.se), and the Deutsche Krebshilfe (10-1792 SchoII; www.krebshilfe.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angstwurm MWA, 2007, CRIT CARE MED, V35, P118, DOI 10.1097/01.CCM.0000251124.83436.0E; Angstwurm MWA, 2004, EUR J ENDOCRINOL, V151, P47, DOI 10.1530/eje.0.1510047; Arthur JR, 1999, NUTR RES REV, V12, P55, DOI 10.1079/095442299108728910; Ashton K, 2009, AM J CLIN NUTR, V89, p2025S, DOI 10.3945/ajcn.2009.27230F; Bellastella A, 1998, HORM RES, V49, P153, DOI 10.1159/000023163; Bello G, 2009, CURR DRUG TARGETS, V10, P778, DOI 10.2174/138945009788982414; Bernal J, 2005, VITAM HORM, V71, P95, DOI 10.1016/S0083-6729(05)71004-9; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; Boelaert K, 2005, J ENDOCRINOL, V187, P1, DOI 10.1677/joe.1.06131; Boelen A, 2008, THYROID, V18, P123, DOI 10.1089/thy.2007.0253; BURK RF, 2009, BIOCH BIOPHYS ACTA; Carlson BA, 2004, P NATL ACAD SCI USA, V101, P12848, DOI 10.1073/pnas.0402636101; CHANOINE JP, 1992, ENDOCRINOLOGY, V131, P479, DOI 10.1210/en.131.1.479; Chiamolera MI, 2009, ENDOCRINOLOGY, V150, P1091, DOI 10.1210/en.2008-1795; Combs GF, 2009, AM J CLIN NUTR, V89, P1808, DOI 10.3945/ajcn.2008.27356; Farwell Alan P, 2008, Endocr Pract, V14, P1180; Fekete C, 2004, ENDOCRINOLOGY, V145, P1649, DOI 10.1210/en.2003-1439; Fliers E, 2006, PROG BRAIN RES, V153, P189, DOI 10.1016/S0079-6123(06)53011-0; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Forceville X, 1998, CRIT CARE MED, V26, P1536, DOI 10.1097/00003246-199809000-00021; Gartner R, 2009, J TRACE ELEM MED BIO, V23, P71, DOI 10.1016/j.jtemb.2009.01.001; Geoghegan M, 2006, CURR OPIN CRIT CARE, V12, P136, DOI 10.1097/01.ccx.0000216581.80051.d6; Gereben B, 2008, CELL MOL LIFE SCI, V65, P570, DOI 10.1007/s00018-007-7396-0; Golombek SG, 2008, SEMIN PERINATOL, V32, P413, DOI 10.1053/j.semperi.2008.09.010; Gromadzinska J, 2008, EUR J NUTR, V47, P29, DOI 10.1007/s00394-008-2005-z; Holzer R, 2004, PEDIATR CARDIOL, V25, P522, DOI 10.1007/s00246-004-0659-8; Iervasi G, 2003, CIRCULATION, V107, P708, DOI 10.1161/01.CIR.0000048124.64204.3F; Kohrle J, 2005, THYROID, V15, P841, DOI 10.1089/thy.2005.15.841; KOHRLE J, 1995, MOL CELL ENDOCRINOL, V108, P17, DOI 10.1016/0303-7207(95)92574-8; Liu YY, 2007, ENDOCRINOLOGY, V148, P1206, DOI 10.1210/en.2006-0836; Miller MD, 2009, ENVIRON HEALTH PERSP, V117, P1033, DOI 10.1289/ehp.0800247; Olson GE, 2008, J BIOL CHEM, V283, P6854, DOI 10.1074/jbc.M709945200; OLSON GE, 2008, J BIOL CHEM; Peeters RP, 2007, ANN ENDOCRINOL-PARIS, V68, P224, DOI 10.1016/j.ando.2007.06.01; Peeters RP, 2003, J CLIN ENDOCR METAB, V88, P3202, DOI 10.1210/jc.2002-022013; Plateroti M, 2006, MOL CELL BIOL, V26, P3204, DOI 10.1128/MCB.26.8.3204-3214.2006; Plateroti M, 1999, GASTROENTEROLOGY, V116, P1367, DOI 10.1016/S0016-5085(99)70501-9; Quignodon L, 2007, MOL ENDOCRINOL, V21, P2350, DOI 10.1210/me.2007-0176; Rayman MP, 2008, AM J CLIN NUTR, V87, P370, DOI 10.1093/ajcn/87.2.370; RAYMAN MP, 2009, BIOCH BIOPHYS ACTA; REFETOFF S, 1967, J CLIN ENDOCR METAB, V27, P279, DOI 10.1210/jcem-27-2-279; Renko K, 2009, FASEB J, V23, P1758, DOI 10.1096/fj.08-119370; Riese C, 2006, ENDOCRINOLOGY, V147, P5883, DOI 10.1210/en.2006-0689; Schomburg L, 2003, BIOCHEM J, V370, P397, DOI 10.1042/BJ20021853; SCHOMBURG L, 2009, SHOCK IN PRESS; SCHOMBURG L, 2009, BIOCH BIOPHYS ACTA, V25; Schomburg L, 2008, MOL NUTR FOOD RES, V52, P1235, DOI 10.1002/mnfr.200700465; Schomburg L, 2007, CRIT CARE MED, V35, P995, DOI 10.1097/01.CCM.0000257479.88792.A5; Schweizer U, 2005, BIOCHEM J, V386, P221, DOI 10.1042/BJ20041973; Schweizer U, 2008, MOL CELL ENDOCRINOL, V289, P1, DOI 10.1016/j.mce.2008.04.007; Sjogren M, 2007, EMBO J, V26, P4535, DOI 10.1038/sj.emboj.7601882; St Germain DL, 2009, ENDOCRINOLOGY, V150, P1097, DOI 10.1210/en.2008-1588; STGERMAIN DL, 1988, J CLIN INVEST, V81, P1476, DOI 10.1172/JCI113479; Stoedter M, 2010, BIOCHEM J, V429, P43, DOI 10.1042/BJ20091868; Stosnach H, 2005, ANAL SCI, V21, P873, DOI 10.2116/analsci.21.873; Swaab DF, 2005, AGEING RES REV, V4, P141, DOI 10.1016/j.arr.2005.03.003; Thomson CD, 2005, BRIT J NUTR, V94, P962, DOI 10.1079/BJN20051564; Tinnikov A, 2002, EMBO J, V21, P5079, DOI 10.1093/emboj/cdf523; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; Vennstrom B, 2008, ACTA PAEDIATR, V97, P1605, DOI 10.1111/j.1651-2227.2008.01031.x; Vincent JL, 2008, CURR OPIN ANESTHESIO, V21, P148, DOI 10.1097/ACO.0b013e3282f49afe; Wallis K, 2008, J NEUROSCI, V28, P1904, DOI 10.1523/JNEUROSCI.5163-07.2008; Weiss RE, 1998, ENDOCRINOLOGY, V139, P4945, DOI 10.1210/en.139.12.4945; Wyne KL, 2005, CRIT CARE, V9, P333, DOI 10.1186/cc3738; Xu XM, 2007, PLOS BIOL, V5, P96, DOI 10.1371/journal.pbio.0050004; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Ying H, 2007, MOL CELL BIOL, V27, P2359, DOI 10.1128/MCB.02189-06; Zavacki AM, 2005, ENDOCRINOLOGY, V146, P1568, DOI 10.1210/en.2004-1392	68	35	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12931	10.1371/journal.pone.0012931	http://dx.doi.org/10.1371/journal.pone.0012931			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877559	Green Submitted, Green Published, gold			2022-12-27	WOS:000282053100035
J	Charles, N; Thomas, B; Watson, B; Sakthivel, RM; Chandrasekeran, V; Wares, F				Charles, Niruparani; Thomas, Beena; Watson, Basilea; Sakthivel, Raja M.; Chandrasekeran, V.; Wares, Fraser			Care Seeking Behavior of Chest Symptomatics: A Community Based Study Done in South India after the Implementation of the RNTCP	PLOS ONE			English	Article							SYSTEM DELAYS; TAMIL-NADU; TUBERCULOSIS; DIAGNOSIS; PATIENT	Introduction: With the creation of the Revised National TB Control Programme (RNTCP), tuberculosis services have become decentralized and more accessible. A 1997 study prior to RNTCP implementation reported that most chest symptomatics accessed first private health care facilities and a general dissatisfaction with government health facilities. The study was repeated post-RNTCP implementation to gain insight into the current care seeking behavior of chest symptomatics. Methodology: A cross-sectional community-based study carried out between March-August 2008 in 4 sites (2 rural [R] and 2 urban [U]) from the same two districts of Chennai and Madurai, southern India, as in the 1997 study. Six hundred and forty chest symptomatics were identified (R 314; U 326), and detailed interviews were done for 606 (R311; U295). Results: Prevalence of chest symptomatics in the urban and rural areas were 2.7% and 4.9% respectively (p < 0.01), and was found to increase with age (Chi-square for trend, p < 0.01). Longer delays in seeking care were seen amongst symptomatics above 45 years of age (p 0.01), and those who had taken previous TB treatment (p = 0.05). Overall, 50% (222/444) of the chest symptomatics approached a government health care facility first (R 142 (61%); U 80 (38%), p = < 0.001). This was significantly (p < 0.001) more than were observed in the 1997 study, where only 38.4% approached a government facility first. Sixty two (28%) of the 222 made a second visit to a government facility (R26%; U31%), while 17% shifted to a private facility (R14%; U21%). Dissatisfaction with the health care facility was one of the major reasons expressed. Conclusions: It appears that the RNTCP has had an impact in the community with regard to the availability and accessibility of TB services in government health facilities. However the relatively high levels of subsequent shifting to private health facilities calls for urgent action to make government facilities more patients friendly with quality care facilities in the delivery of RNTCP services.	[Charles, Niruparani; Thomas, Beena; Watson, Basilea; Sakthivel, Raja M.; Chandrasekeran, V.] Indian Council Med Res, TB Res Ctr, Madras, Tamil Nadu, India; [Wares, Fraser] Off WHO Representat India, New Delhi, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); World Health Organization	Charles, N (corresponding author), Indian Council Med Res, TB Res Ctr, Madras, Tamil Nadu, India.	niru_charles@hotmail.com	Watson, Basilea/AGH-6965-2022		World Health Organization (WHO); United States Agency for International Development (USAID); Medical and Rural Health Services; District TB Officers of Chennai and Madurai Corporation	World Health Organization (WHO)(World Health Organization); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); Medical and Rural Health Services; District TB Officers of Chennai and Madurai Corporation	The study was supported in part by the World Health Organization (WHO), with financial assistance provided by the United States Agency for International Development (USAID) under the Model DOTS Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge the support of the Additional Director of Medical and Rural Health Services, and the District TB Officers of Chennai and Madurai Corporation for providing the necessary support for the successful conduct of the study. We especially thank all the respondents and their family members without whose co-operation this study would not have been possible.	Ahsan Giasuddin, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P126; *GOV IND MIN HLTH, TB IND 2006 RNTCP ST; Grover A, 2006, INDIAN J COMMUNITY M, V31, P145; Rajeswari R, 2002, INT J TUBERC LUNG D, V6, P789; Selvam JM, 2007, INT J TUBERC LUNG D, V11, P161; Sherman LF, 1999, INT J TUBERC LUNG D, V3, P1088; Sudha G, 2003, TROP MED INT HEALTH, V8, P336, DOI 10.1046/j.1365-3156.2003.01010.x; UPLEKAR MW, 1996, TACKLING TB SEARCH S	8	36	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2010	5	9							e12379	10.1371/journal.pone.0012379	http://dx.doi.org/10.1371/journal.pone.0012379			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651YH	20862219	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000281963200001
J	Bakszt, R; Wernimont, A; Allali-Hassani, A; Mok, MW; Hills, T; Hui, R; Pizarro, JC				Bakszt, Rebecca; Wernimont, Amy; Allali-Hassani, Abdellah; Mok, Man Wai; Hills, Tanya; Hui, Raymond; Pizarro, Juan C.			The Crystal Structure of Toxoplasma gondii Pyruvate Kinase 1	PLOS ONE			English	Article							ALLOSTERIC REGULATION; CONFORMATIONAL-CHANGE; ESCHERICHIA-COLI; MOLECULAR-BASIS; RABBIT MUSCLE; M2; EXPRESSION; RESOLUTION; PROTEINS; BINDING	Background: Pyruvate kinase (PK), which catalyzes the final step in glycolysis converting phosphoenolpyruvate to pyruvate, is a central metabolic regulator in most organisms. Consequently PK represents an attractive therapeutic target in cancer and human pathogens, like Apicomplexans. The phylum Aplicomplexa, a group of exclusively parasitic organisms, includes the genera Plasmodium, Cryptosporidium and Toxoplasma, the etiological agents of malaria, cryptosporidiosis and toxoplasmosis respectively. Toxoplasma gondii infection causes a mild illness and is a very common infection affecting nearly one third of the world's population. Methodology/Principal Findings: We have determined the crystal structure of the PK1 enzyme from T. gondii, with the B domain in the open and closed conformations. We have also characterized its enzymatic activity and confirmed glucose-6-phosphate as its allosteric activator. This is the first description of a PK enzyme in a closed inactive conformation without any bound substrate. Comparison of the two tetrameric TgPK1 structures indicates a reorientation of the monomers with a concomitant change in the buried surface among adjacent monomers. The change in the buried surface was associated with significant B domain movements in one of the interacting monomers. Conclusions: We hypothesize that a loop in the interface between the A and B domains plays an important role linking the position of the B domain to the buried surface among monomers through two a-helices. The proposed model links the catalytic cycle of the enzyme with its domain movements and highlights the contribution of the interface between adjacent subunits. In addition, an unusual ordered conformation was observed in one of the allosteric binding domains and it is related to a specific apicomplexan insertion. The sequence and structural particularity would explain the atypical activation by a mono-phosphorylated sugar. The sum of peculiarities raises this enzyme as an emerging target for drug discovery.	[Bakszt, Rebecca; Wernimont, Amy; Allali-Hassani, Abdellah; Mok, Man Wai; Hills, Tanya; Hui, Raymond; Pizarro, Juan C.] Univ Toronto, SGC, Toronto, ON, Canada; [Bakszt, Rebecca] Linkoping Univ, Dept Phys & Measurement Technol, Biol & Chem IFM, Linkoping, Sweden	University of Toronto; Linkoping University	Bakszt, R (corresponding author), Univ Toronto, SGC, Toronto, ON, Canada.	juan.pizarro@utoronto.ca			Canadian Institutes for Health Research [1097737]; Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co. Inc.; Novartis Research Foundation; Petrus and Augusta Hedlund's Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute(Genome CanadaCanada Foundation for Innovation); GlaxoSmithKline(GlaxoSmithKline); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co. Inc.(Merck & Company); Novartis Research Foundation; Petrus and Augusta Hedlund's Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission)	The Structural Genomics Consortium (SGC) is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co. Inc., the Novartis Research Foundation, the Petrus and Augusta Hedlund's Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SC, 1996, ACTA CRYSTALLOGR D, V52, P499, DOI 10.1107/S0907444995016040; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bond CJ, 2000, BIOCHEMISTRY-US, V39, P15333, DOI 10.1021/bi001443i; Bui T, 2006, CANCER CELL, V9, P419, DOI 10.1016/j.ccr.2006.05.012; CALLENS M, 1991, MOL BIOCHEM PARASIT, V47, P19, DOI 10.1016/0166-6851(91)90144-U; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Denton H, 1996, MOL BIOCHEM PARASIT, V76, P23, DOI 10.1016/0166-6851(95)02527-8; Dombrauckas JD, 2005, BIOCHEMISTRY-US, V44, P9417, DOI 10.1021/bi0474923; Dubey JP, 2008, J EUKARYOT MICROBIOL, V55, P467, DOI 10.1111/j.1550-7408.2008.00345.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ERNEST I, 1994, MOL BIOCHEM PARASIT, V64, P43, DOI 10.1016/0166-6851(94)90133-3; Friesen RHE, 1998, BIOCHEMISTRY-US, V37, P2949, DOI 10.1021/bi971990c; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Jurica MS, 1998, STRUCTURE, V6, P195, DOI 10.1016/S0969-2126(98)00021-5; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KAHN A, 1982, METHOD ENZYMOL, V90, P131; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Larsen TM, 1998, BIOCHEMISTRY-US, V37, P6247, DOI 10.1021/bi980243s; Larsen TM, 1997, ARCH BIOCHEM BIOPHYS, V345, P199, DOI 10.1006/abbi.1997.0257; LEBRAS G, 1993, BIOCHIMIE, V75, P797, DOI 10.1016/0300-9084(93)90130-K; Lee JC, 2008, ACTA BIOCH BIOPH SIN, V40, P663, DOI 10.1111/j.1745-7270.2008.00445.x; LEVINE M, 1978, NATURE, V271, P626, DOI 10.1038/271626a0; Maeda T, 2003, PARASITOL RES, V89, P259, DOI 10.1007/s00436-002-0739-8; MATTEVI A, 1995, STRUCTURE, V3, P729, DOI 10.1016/S0969-2126(01)00207-6; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rigden DJ, 1999, J MOL BIOL, V291, P615, DOI 10.1006/jmbi.1999.2918; Saito T, 2008, J BIOL CHEM, V283, P14041, DOI 10.1074/jbc.M709015200; Suzuki K, 2008, J BIOCHEM, V144, P305, DOI 10.1093/jb/mvn069; Tulloch LB, 2008, J MOL BIOL, V383, P615, DOI 10.1016/j.jmb.2008.08.037; Valentin G, 2000, J BIOL CHEM, V275, P18145, DOI 10.1074/jbc.M001870200; Valentini G, 2002, J BIOL CHEM, V277, P23807, DOI 10.1074/jbc.M202107200; Vedadi M, 2007, MOL BIOCHEM PARASIT, V151, P100, DOI 10.1016/j.molbiopara.2006.10.011; Verlinde CLM, 2001, DRUG RESIST UPDATE, V4, P50, DOI 10.1054/drup.2000.0177; Zanella A, 2005, BRIT J HAEMATOL, V130, P11, DOI 10.1111/j.1365-2141.2005.05527.x	41	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2010	5	9							e12736	10.1371/journal.pone.0012736	http://dx.doi.org/10.1371/journal.pone.0012736			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZO	20856875	Green Published, gold, Green Submitted			2022-12-27	WOS:000281815700020
J	Rosen, S; Larson, B; Brennan, A; Long, L; Fox, M; Mongwenyana, C; Ketlhapile, M; Sanne, I				Rosen, Sydney; Larson, Bruce; Brennan, Alana; Long, Lawrence; Fox, Matthew; Mongwenyana, Constance; Ketlhapile, Mpefe; Sanne, Ian			Economic Outcomes of Patients Receiving Antiretroviral Therapy for HIV/AIDS in South Africa Are Sustained through Three Years on Treatment	PLOS ONE			English	Article							QUALITY-OF-LIFE; TREATMENT PROGRAM; COUNTRIES; ADULTS; HIV	Background: Although the medical outcomes of antiretroviral therapy (ART) for HIV/AIDS are well described, less is known about how ART affects patients' economic activities and quality of life, especially after the first year on ART. We assessed symptom prevalence, general health, ability to perform normal activities, and employment status among adult antiretroviral therapy patients in South Africa over three full years following ART initiation. Methodology/Principal Findings: A cohort of 855 adult pre-ART patients and patients on ART for <6 months was enrolled and interviewed an average of 4.4 times each during routine clinic visits for up to three years after treatment initiation using an instrument designed for the study. The probability of pain in the previous week fell from 74% before ART initiation to 32% after three years on ART, fatigue from 66% to 12%, nausea from 28% to 4%, and skin problems from 55% to 10%. The probability of not feeling well physically yesterday fell from 46% to 23%. Before starting ART, 39% of subjects reported not being able to perform their normal activities sometime during the previous week; after three years, this proportion fell to 10%. Employment rose from 27% to 42% of the cohort. Improvement in all outcomes was sustained over 3 years and for some outcomes increased in the second and third year. Conclusions/Significance: Improvements in adult ART patients' symptom prevalence, general health, ability to perform normal activities, and employment status were large and were sustained through the first three years on treatment. These results suggest that some of the positive economic and social externalities anticipated as a result of large-scale treatment provision, such as increases in workforce participation and productivity and the ability of patients to carry on normal lives, may indeed be accruing.	[Rosen, Sydney; Larson, Bruce; Brennan, Alana; Fox, Matthew] Boston Univ Ctr Global Hlth & Dev, Boston, MA USA; [Rosen, Sydney; Brennan, Alana; Long, Lawrence; Fox, Matthew; Mongwenyana, Constance; Ketlhapile, Mpefe; Sanne, Ian] Univ Witwatersrand, Fac Hlth Sci, Wits Hlth Consortium, Hlth Econ & Epidemiol Res Off, Johannesburg, South Africa; [Sanne, Ian] Univ Witwatersrand, Fac Hlth Sci, Clin HIV Res Unit, Johannesburg, South Africa	Boston University; University of Witwatersrand; University of Witwatersrand	Rosen, S (corresponding author), Boston Univ Ctr Global Hlth & Dev, Boston, MA USA.	sbrosen@bu.edu	Sanne, Ian/ABH-2231-2020; Fox, Matthew/K-2004-2019	Brennan, Alana/0000-0002-7746-0668; Rosen, Sydney/0000-0002-6560-2964; Larson, Bruce/0000-0002-9322-2387; Long, Lawrence/0000-0003-4986-4988	U.S. Agency for International Development GHSA-00-00020-00; NATIONAL CANCER INSTITUTE [R01CA122930] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI083097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS065661, P30NS057098] Funding Source: NIH RePORTER	U.S. Agency for International Development GHSA-00-00020-00(United States Agency for International Development (USAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding for this study was provided by the South Africa Mission of the U.S. Agency for International Development through Cooperative Agreement GHSA-00-00020-00, Country Research Activity (G/PHN/HN/CS) to Boston University, Associate Cooperative Agreement 674-A-00-09-00018-00 to Boston University, Cooperative Agreement 674-A-00-02-00018 to Right to Care, and by the US National Institutes of Health through National Institute of Allergies and Infectious Diseases Grant PEPFAR 13 to the Wits Health Consortium. The authors thank Melinda Wilson and Clint Cavanaugh of USAID/South Africa for their unwavering support for this study. The authors wish to acknowledge support by the APDA Advanced Center for Parkinson Research at UAB, NIH F30NS065661, NIH R01CA122930, and by NIH Neuroscience Blueprint Core Grant NS057098 to the University of Alabama at Birmingham. The opinions expressed herein are those of the authors and do not necessarily reflect the views of the funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. Fox was supported by Award Number K01AI083097 from the National Institute of Allergy and Infectious Diseases. The content does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health.	Beard J, 2009, AIDS CARE, V21, P1343, DOI 10.1080/09540120902889926; BOCK N, 2008, 15 C RETR OPP INF BO; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Bussmann H, 2008, AIDS, V22, P2303, DOI 10.1097/QAD.0b013e3283129db0; Etard JF, 2006, AIDS, V20, P1181, DOI 10.1097/01.aids.0000226959.87471.01; Fox MP, 2010, AIDS CARE, V22, P137, DOI 10.1080/09540120903038366; Ivers LC, 2005, CLIN INFECT DIS, V41, P217, DOI 10.1086/431199; Jelsma J, 2005, AIDS CARE, V17, P579, DOI 10.1080/09540120412331319714; Nash D, 2008, AIDS, V22, P2291, DOI 10.1097/QAD.0b013e3283121ca9; Rosen S, 2008, AIDS, V22, pS131, DOI 10.1097/01.aids.0000327634.92844.91; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Rosen S, 2007, SAMJ S AFR MED J, V97, P524; Rosen Sydney, 2008, J Int Assoc Physicians AIDS Care (Chic), V7, P200, DOI 10.1177/1545109708320684; Stangl AL, 2007, AIDS CARE, V19, P626, DOI 10.1080/09540120701203915; *STAT S AFR, 2009, LAB MARK DYN S AFR; Statistics South Africa, 2010, Q LAB FORC SURV QUAR, V3; [WHO UNAIDS UNICEF], 2009, UN ACC SCAL PRIOR HI; World Health Organization, 2010, WHO INT CLASS FUNCT	18	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2010	5	9							e12731	10.1371/journal.pone.0012731	http://dx.doi.org/10.1371/journal.pone.0012731			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	649ZO	20856821	Green Published, gold			2022-12-27	WOS:000281815700017
J	Sun, XA; He, Y; Hou, L; Yang, WX				Sun, Xiao; He, Ying; Hou, Lin; Yang, Wan-Xi			Myosin Va Participates in Acrosomal Formation and Nuclear Morphogenesis during Spermatogenesis of Chinese Mitten Crab Eriocheir sinensis	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; ACTIN-FILAMENTS; AMPA RECEPTORS; MESSENGER-RNA; KINESIN MOTOR; WILD-TYPE; TRANSPORT; PROTEIN; VESICLES	Background: The Chinese mitten crab Eriocheir sinensis belongs to the Class Crustacea, Decapoda, Brachyura. The spermatozoon of this species is of aflagellated type, it has a spherical acrosome surrounded by the cup-shaped nucleus, which are unique to brachyurans. For the past several decades, studies on the spermatogenesis of the mitten crab mainly focus on the morphology. Compared with the extensive study of molecular mechanism of spermatogenesis in mammals, relatively less information is available in crustacean species. Myosin Va, a member of Class V myosin, has been implicated in acrosome biogenesis and vesicle transport during spermatogenesis in mammals. In the present study we demonstrate the expression and cellular localization of myosin Va during spermatogenesis in E. sinensis. Methodology/Principal Findings: Western blot demonstrated that myosin Va is expressed during spermatogenesis. Immunocytochemical and ultrastructural analyses showed that myosin Va mainly localizes in the cytoplasm in spermatocytes. At the early stage of spermiogenesis, myosin Va binds to the endoplasmic reticulum vesicle (EV) and proacrosomal granule (PG). Subsequently, myosin Va localizes within the proacrosomal vesicle (PV) formed by PG and EV fusion and locates in the membrane complex (MC) at the mid spermatid stage. At the late spermatid stage, myosin Va is associated with the shaping nucleus and mitochondria. In mature spermatozoon, myosin Va predominates in acrosomal tubule (AT) and nucleus. Conclusions/Significance: Our study demonstrates that myosin Va may be involved in acrosome biogenesis and nuclear morphogenesis during spermatogenesis in E. sinensis. Considering the distribution and molecular characteristics of myosin Va, we also propose a hypothesis of AT formation in this species. It is the first time to uncover the role of myosin Va in crustacean spermatogenesis.	[Sun, Xiao; He, Ying; Yang, Wan-Xi] Zhejiang Univ, Coll Life Sci, Sperm Lab, Hangzhou 310003, Zhejiang, Peoples R China; [He, Ying; Hou, Lin] Liaoning Normal Univ, Coll Life Sci, Dalian, Peoples R China	Zhejiang University; Liaoning Normal University	Sun, XA (corresponding author), Zhejiang Univ, Coll Life Sci, Sperm Lab, Hangzhou 310003, Zhejiang, Peoples R China.	wxyang@spermlab.org	Yang, Wan-Xi/D-4401-2011	Yang, Wan-Xi/0000-0001-5695-0150; Yang, Wan-Xi/0000-0001-9304-195X	National Natural Science Foundation of China [40776079, 31072198]; National Basic Research Program of China (973 Program) [2007CB948104]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This study was supported in part by the following projects: National Natural Science Foundation of China (http://www.nsfc.gov.cn)(No. 40776079 and 31072198) and National Basic Research Program of China (973 Program) (Grant No 2007CB948104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alami NH, 2009, J NEUROSCI, V29, P6625, DOI 10.1523/JNEUROSCI.3829-08.2009; Ali MY, 2008, P NATL ACAD SCI USA, V105, P4691, DOI 10.1073/pnas.0711531105; Altmann K, 2008, J CELL BIOL, V181, P119, DOI 10.1083/jcb.200709099; Beningo KA, 2000, MOL BIOL CELL, V11, P691, DOI 10.1091/mbc.11.2.691; Bittins CM, 2009, CELL MOL NEUROBIOL, V29, P597, DOI 10.1007/s10571-009-9352-z; Blessing CA, 2004, TRENDS CELL BIOL, V14, P435, DOI 10.1016/j.tcb.2004.07.009; Cao TT, 2004, MOL BIOL CELL, V15, P151, DOI 10.1091/mbc.E03-07-0504; Chen MM, 2007, CURR OPIN CELL BIOL, V19, P326, DOI 10.1016/j.ceb.2007.04.009; CLERMONT Y, 1972, PHYSIOL REV, V52, P198, DOI 10.1152/physrev.1972.52.1.198; Desnos C, 2007, J NEUROSCI, V27, P10636, DOI 10.1523/JNEUROSCI.1228-07.2007; Du Nanshan, 1988, Oceanologia et Limnologia Sinica, V19, P71; Du Nanshan, 1987, Oceanologia et Limnologia Sinica, V18, P119; Du NS, 1998, FISHERIES SCI TECHNO, V25, P9; Dunn BD, 2007, J CELL BIOL, V178, P1193, DOI 10.1083/jcb.200707080; Espindola FS, 2008, CELL TISSUE RES, V333, P263, DOI 10.1007/s00441-008-0630-8; Hayasaka S, 2008, ASIAN J ANDROL, V10, P561, DOI 10.1111/j.1745-7262.2008.00392.x; Hodges AR, 2009, CURR BIOL, V19, P2121, DOI 10.1016/j.cub.2009.10.069; Hume AN, 2007, J CELL SCI, V120, P3111, DOI 10.1242/jcs.010207; Itoh T, 2002, MOL CELL BIOL, V22, P7744, DOI 10.1128/MCB.22.22.7744-7757.2002; Kierszenbaum AL, 2004, BIOL REPROD, V70, P1400, DOI 10.1095/biolreprod.103.025346; Kierszenbaum AL, 2004, ARCH HISTOL CYTOL, V67, P271, DOI 10.1679/aohc.67.271; Kierszenbaum AL, 2003, CYTOGENET GENOME RES, V103, P337, DOI 10.1159/000076822; Krauss J, 2009, CURR BIOL, V19, P1058, DOI 10.1016/j.cub.2009.04.062; Kurtz K, 2008, J CELL BIOCHEM, V105, P574, DOI 10.1002/jcb.21857; LI Z, 2010, INVERTEBR R IN PRESS; Mermall V, 2005, DEV BIOL, V286, P238, DOI 10.1016/j.ydbio.2005.07.028; Nascimento AAC, 1997, MOL BIOL CELL, V8, P1971, DOI 10.1091/mbc.8.10.1971; Ohashi S, 2002, J BIOL CHEM, V277, P37804, DOI 10.1074/jbc.M203608200; Pederson T, 2005, MOL BIOL CELL, V16, P5055, DOI 10.1091/mbc.E05-07-0656; Perlson E, 2008, CELL, V135, P414, DOI 10.1016/j.cell.2008.10.013; Pranchevicius MCS, 2008, CELL MOTIL CYTOSKEL, V65, P441, DOI 10.1002/cm.20269; PUDNEY J, 1995, MICROSC RES TECHNIQ, V32, P459, DOI 10.1002/jemt.1070320602; Reck-Peterson SL, 2000, BBA-MOL CELL RES, V1496, P36, DOI 10.1016/S0167-4889(00)00007-0; Salerno VP, 2008, CELL MOTIL CYTOSKEL, V65, P422, DOI 10.1002/cm.20272; Schmid M, 2006, CURR BIOL, V16, P1538, DOI 10.1016/j.cub.2006.06.025; Simeo CG, 2010, J MORPHOL, V271, P394, DOI 10.1002/jmor.10805; Sotelo-Silveira JR, 2004, J NEUROBIOL, V60, P187, DOI 10.1002/neu.20015; Stafford P, 2000, BIOL BULL-US, V199, P203, DOI 10.2307/1542899; Tabb JS, 1998, J CELL SCI, V111, P3221; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Wollert T, 2002, J CELL BIOL, V159, P571, DOI 10.1083/jcb.200204065; Wu XF, 2000, CURR OPIN CELL BIOL, V12, P42, DOI 10.1016/S0955-0674(99)00055-1; Yang Wan-Xi, 1998, Acta Zoologica Sinica, V44, P377; Yang Wan-Xi, 1999, Acta Zoologica Sinica, V45, P178; Yang WX, 2003, BIOL REPROD, V69, P1719, DOI 10.1095/biolreprod.102.014878; Yoshimura A, 2006, CURR BIOL, V16, P2345, DOI 10.1016/j.cub.2006.10.024; Yoshizaki T, 2007, MOL CELL BIOL, V27, P5172, DOI 10.1128/MCB.02298-06; Yu KM, 2009, CELL TISSUE RES, V337, P113, DOI 10.1007/s00441-009-0800-3	48	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2010	5	9							e12738	10.1371/journal.pone.0012738	http://dx.doi.org/10.1371/journal.pone.0012738			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZO	20856877	gold, Green Published, Green Submitted			2022-12-27	WOS:000281815700021
J	Sughra, K; Birbach, A; de Martin, R; Schmid, JA				Sughra, Kalsoom; Birbach, Andreas; de Martin, Rainer; Schmid, Johannes A.			Interaction of the TNFR-Receptor Associated Factor TRAF1 with I-Kappa B Kinase-2 and TRAF2 Indicates a Regulatory Function for NF-Kappa B Signaling	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; FACTOR (TRAF)-1; ACTIVATION; PROTEIN; BETA; IKK; MOLECULES; PATHWAYS; COMPLEX; FAMILY	Background: I-kappa B kinase 2 (IKK2 or IKK-beta) is one of the most crucial signaling kinases for activation of NF-kappa B, a transcription factor that is important for inflammation, cell survival and differentiation. Since many NF-kappa B activating pathways converge at the level of IKK2, molecular interactions of this kinase are pivotal for regulation of NF-kappa B signaling. Methodology/Principal Findings: We searched for proteins interacting with IKK2 using the C-terminal part (amino acids 466-756) as bait in a yeast two-hybrid system and identified the N-terminal part (amino acids 1-228) of the TNF-receptor associated factor TRAF1 as putative interaction partner. The interaction was confirmed in human cells by mammalian two-hybrid and coimmunoprecipitation experiments. The IKK2/TRAF1 interaction seemed weaker than the interaction between TRAF1 and TRAF2, an important activating adapter molecule of NF-kappa B signaling. Reporter gene and kinase assays using ectopic expression of TRAF1 indicated that it can both activate and inhibit IKK2 and NF-kappa B. Co-expression of fluorescently tagged TRAF1 and TRAF2 at different ratios implied that TRAF1 can affect clustering and presumably the activating function of TRAF2 in a dose dependent manner. Conclusions/Significance: The observation that TRAF1 can either activate or inhibit the NF-kappa B pathway and the fact that it influences the oligomerization of TRAF2 indicates that relative levels of IKK2, TRAF1 and TRAF2 may be important for regulation of NF-kappa B activity. Since TRAF1 is an NF-kappa B induced gene, it might act as a feedback effector molecule.	[Sughra, Kalsoom; Birbach, Andreas; de Martin, Rainer; Schmid, Johannes A.] Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, Ctr Physiol & Pharmacol, Vienna, Austria	Medical University of Vienna	Sughra, K (corresponding author), Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, Ctr Physiol & Pharmacol, Vienna, Austria.	Johannes.Schmid@meduniwien.ac.at	Schmid, Johannes A./C-7659-2009	Schmid, Johannes A./0000-0002-6586-3507	Medical University Vienna; Competence Center Bio-Molecular Therapeutics; Austrian Science Foundation (FWF) [P19217-B13, P21919]; Austrian Science Fund (FWF) [P 21919] Funding Source: researchfish	Medical University Vienna; Competence Center Bio-Molecular Therapeutics; Austrian Science Foundation (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was funded by the Medical University Vienna and the Competence Center Bio-Molecular Therapeutics and in part by the Austrian Science Foundation (FWF, Project P19217-B13 to R. dM. and FWF, Project P21919 to AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arron JR, 2002, J EXP MED, V196, P923, DOI 10.1084/jem.20020774; Birbach A, 2002, J BIOL CHEM, V277, P10842, DOI 10.1074/jbc.M112475200; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Carpentier I, 1999, FEBS LETT, V460, P246, DOI 10.1016/S0014-5793(99)01356-3; DEVIN A, 2001, ALPHA BETA SUBUNITS, P3986; Ebner K, 2003, BLOOD, V102, P192, DOI 10.1182/blood-2002-12-3753; Fotin-Mleczek M, 2004, J BIOL CHEM, V279, P677, DOI 10.1074/jbc.M310969200; Henkler F, 2003, J BIOL CHEM, V278, P29216, DOI 10.1074/jbc.M211090200; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piddini E, 2001, EMBO J, V20, P4076, DOI 10.1093/emboj/20.15.4076; Relaix F, 1998, NAT GENET, V18, P287, DOI 10.1038/ng0398-287; Schmid JA, 2000, J BIOL CHEM, V275, P17035, DOI 10.1074/jbc.M000291200; Schmid JA, 2003, CURR OPIN ONCOL, V15, P55, DOI 10.1097/00001622-200301000-00008; Schmid JA, 2008, CYTOKINE GROWTH F R, V19, P157, DOI 10.1016/j.cytogfr.2008.01.006; Schwenzer R, 1999, J BIOL CHEM, V274, P19368, DOI 10.1074/jbc.274.27.19368; Spahn L, 2003, ONCOGENE, V22, P6819, DOI 10.1038/sj.onc.1206810; Tsitsikov EN, 2001, IMMUNITY, V15, P647, DOI 10.1016/S1074-7613(01)00207-2; Wajant H, 2001, CELL SIGNAL, V13, P389, DOI 10.1016/S0898-6568(01)00160-7; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zandi E, 1999, MOL CELL BIOL, V19, P4547	22	21	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2010	5	9							e12683	10.1371/journal.pone.0012683	http://dx.doi.org/10.1371/journal.pone.0012683			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648ZZ	20856938	gold, Green Submitted, Green Published			2022-12-27	WOS:000281735700010
J	Sjoholm, LK; Backlund, L; Cheteh, EH; Ek, IR; Frisen, L; Schalling, M; Osby, U; Lavebratt, C; Nikamo, P				Sjoholm, Louise K.; Backlund, Lena; Cheteh, Emarndeena Haji; Ek, Inger Romer; Frisen, Louise; Schalling, Martin; Osby, Urban; Lavebratt, Catharina; Nikamo, Pernilla			CRY2 Is Associated with Rapid Cycling in Bipolar Disorder Patients	PLOS ONE			English	Article							CONVERGENT FUNCTIONAL GENOMICS; SEASONAL AFFECTIVE-DISORDER; SINGLE-NUCLEOTIDE POLYMORPHISMS; NEUROTROPHIC FACTOR BDNF; CIRCADIAN GENES; MOOD DISORDERS; CANDIDATE GENES; CLOCK GENES; I-DISORDER; DEPRESSION	Background: Bipolar disorder patients often display abnormalities in circadian rhythm, and they are sensitive to irregular diurnal rhythms. CRY2 participates in the core clock that generates circadian rhythms. CRY2 mRNA expression in blood mononuclear cells was recently shown to display a marked diurnal variation and to respond to total sleep deprivation in healthy human volunteers. It was also shown that bipolar patients in a depressive state had lower CRY2 mRNA levels, nonresponsive to total sleep deprivation, compared to healthy controls, and that CRY2 gene variation was associated with winter depression in both Swedish and Finnish cohorts. Principal Findings: Four CRY2 SNPs spanning from intron 2 to downstream 3'UTR were analyzed for association to bipolar disorder type 1 (n = 497), bipolar disorder type 2 (n = 60) and bipolar disorder with the feature rapid cycling (n = 155) versus blood donors (n = 1044) in Sweden. Also, the rapid cycling cases were compared with bipolar disorder cases without rapid cycling (n = 422). The haplotype GGAC was underrepresented among rapid cycling cases versus controls and versus bipolar disorder cases without rapid cycling (OR = 0.7, P = 0.006-0.02), whereas overrepresentation among rapid cycling cases was seen for AAAC (OR = 1.3-1.4, P = 0.03-0.04) and AGGA (OR = 1.5, P = 0.05). The risk and protective CRY2 haplotypes and their effect sizes were similar to those recently suggested to be associated with winter depression in Swedes. Conclusions: We propose that the circadian gene CRY2 is associated with rapid cycling in bipolar disorder. This is the first time a clock gene is implicated in rapid cycling, and one of few findings showing a molecular discrimination between rapid cycling and other forms of bipolar disorder.	[Sjoholm, Louise K.; Cheteh, Emarndeena Haji; Frisen, Louise; Schalling, Martin; Osby, Urban; Lavebratt, Catharina; Nikamo, Pernilla] Karolinska Inst, Dept Mol Med & Surg, Neurogenet Unit, Stockholm, Sweden; [Backlund, Lena; Ek, Inger Romer; Frisen, Louise; Osby, Urban] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Sjoholm, LK (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Neurogenet Unit, Stockholm, Sweden.	catharina.lavebratt@ki.se	Schalling, Martin/F-1518-2015	Schalling, Martin/0000-0001-5011-2922; H. Cheteh, Emarndeena/0000-0002-9216-6942; Backlund, Lena/0000-0001-9399-5024; Lavebratt, Catharina/0000-0003-4987-2718	Swedish Research Council [2002-6602, 2005-6245, 2008-3307]; Stockholm County Council (ALF); Karolinska Institutet Foundations; Soderstromska Foundation; Fredrik and Ingrid Thuring Foundation; Royal Physiographic Society in Lund	Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council (ALF)(Stockholm County Council); Karolinska Institutet Foundations(Karolinska Institutet); Soderstromska Foundation; Fredrik and Ingrid Thuring Foundation; Royal Physiographic Society in Lund	This study was supported in part by grants from the Swedish Research Council (2002-6602, 2005-6245, 2008-3307, www.vr.se), the Stockholm County Council (ALF, www.forskningsstod.sll.se), the Karolinska Institutet Foundations (www.ki.se), the Soderstromska Foundation, the Fredrik and Ingrid Thuring Foundation, and the Royal Physiographic Society in Lund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer M, 2008, BIPOLAR DISORD, V10, P153, DOI 10.1111/j.1399-5618.2007.00560.x; Colom F, 2003, J CLIN PSYCHIAT, V64, P1101, DOI 10.4088/JCP.v64n0917; Coryell W, 2003, ARCH GEN PSYCHIAT, V60, P914, DOI 10.1001/archpsyc.60.9.914; Cusin C, 2001, J PSYCHIAT RES, V35, P217, DOI 10.1016/S0022-3956(01)00026-7; CZEISLER CA, 1987, PSYCHIAT CLIN N AM, V10, P687; Daan S, 2001, J BIOL RHYTHM, V16, P105, DOI 10.1177/074873001129001809; ELSASS P, 1979, ACTA PSYCHIAT SCAND, V60, P263, DOI 10.1111/j.1600-0447.1979.tb00274.x; Frye MA, 2000, J CLIN PSYCHIAT, V61, P9, DOI 10.4088/JCP.v61n0104; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Germain A, 2008, HUM PSYCHOPHARM CLIN, V23, P571, DOI 10.1002/hup.964; Green EK, 2006, BRIT J PSYCHIAT, V188, P21, DOI 10.1192/bjp.bp.105.009969; Kirov G, 1998, MOL PSYCHIATR, V3, P342, DOI 10.1038/sj.mp.4000385; Kishi T, 2008, NEUROSCI RES, V62, P211, DOI 10.1016/j.neures.2008.08.008; Koorengevel KM, 2002, J BIOL RHYTHM, V17, P463, DOI 10.1177/074873002237140; Kripke Daniel F, 2009, J Circadian Rhythms, V7, P2, DOI 10.1186/1740-3391-7-2; Kupka RW, 2005, AM J PSYCHIAT, V162, P1273, DOI 10.1176/appi.ajp.162.7.1273; Kupka RW, 2003, J CLIN PSYCHIAT, V64, P1483, DOI 10.4088/JCP.v64n1213; Lamont Elaine Waddington, 2007, Dialogues Clin Neurosci, V9, P333; Lappalainen T, 2009, ANN HUM GENET, V73, P61, DOI 10.1111/j.1469-1809.2008.00487.x; Lavebratt C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009407; Le-Niculescu H, 2008, AM J MED GENET B, V147B, P134, DOI 10.1002/ajmg.b.30707; Le-Niculescu H, 2009, AM J MED GENET B, V150B, P155, DOI 10.1002/ajmg.b.30887; Lewy A.J., 1983, PINEAL GLAND, P77; Lincoln GA, 2003, J NEUROENDOCRINOL, V15, P390, DOI 10.1046/j.1365-2826.2003.00990.x; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Mansour HA, 2006, GENES BRAIN BEHAV, V5, P150, DOI 10.1111/j.1601-183X.2005.00147.x; McClung CA, 2007, PHARMACOL THERAPEUT, V114, P222, DOI 10.1016/j.pharmthera.2007.02.003; McGrath CL, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-70; Muller DJ, 2006, BRIT J PSYCHIAT, V189, P317, DOI 10.1192/bjp.bp.105.010587; Nievergelt CM, 2006, AM J MED GENET B, V141B, P234, DOI 10.1002/ajmg.b.30252; Nurnberger JI, 2000, ARCH GEN PSYCHIAT, V57, P572, DOI 10.1001/archpsyc.57.6.572; Nurnberger JI, 1997, AM J MED GENET, V74, P227, DOI 10.1002/(SICI)1096-8628(19970531)74:3<227::AID-AJMG1>3.0.CO;2-N; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Ogden CA, 2004, MOL PSYCHIATR, V9, P1007, DOI 10.1038/sj.mp.4001547; Oster H, 2002, GENE DEV, V16, P2633, DOI 10.1101/gad.233702; Ozgur S, 2003, BIOCHEMISTRY-US, V42, P2926, DOI 10.1021/bi026963n; Patel SD, 2010, AM J MED GENET B, V153B, P850, DOI 10.1002/ajmg.b.31087; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Development Core Team, 2007, R LANG ENV STAT COMP; Rousseva A, 2003, PHARMACOGENOMICS J, V3, P101, DOI 10.1038/sj.tpj.6500156; Salvatore P, 2008, BIPOLAR DISORD, V10, P256, DOI 10.1111/j.1399-5618.2007.00505.x; Schneck CD, 2006, J CLIN PSYCHIAT, V67, P22; Shi JJ, 2008, AM J MED GENET B, V147B, P1047, DOI 10.1002/ajmg.b.30714; Solomon DA, 2008, BIPOLAR DISORD, V10, P798, DOI 10.1111/j.1399-5618.2008.00624.x; Soria V, 2010, NEUROPSYCHOPHARMACOL, V35, P1279, DOI 10.1038/npp.2009.230; SOUETRE E, 1989, PSYCHIAT RES, V28, P263, DOI 10.1016/0165-1781(89)90207-2; Spoelstra K, 2008, J COMP PHYSIOL A, V194, P235, DOI 10.1007/s00359-007-0301-3; Srinivasan V, 2009, PSYCHIAT RES, V165, P201, DOI 10.1016/j.psychres.2007.11.020; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Teicher MH, 1997, ARCH GEN PSYCHIAT, V54, P124; Thompson C, 1997, BRIT J PSYCHIAT, V170, P431, DOI 10.1192/bjp.170.5.431; Thompson CL, 2002, ONCOGENE, V21, P9043, DOI 10.1038/sj.onc.1205958; Yin L, 2006, SCIENCE, V311, P1002, DOI 10.1126/science.1121613	53	56	58	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2010	5	9							e12632	10.1371/journal.pone.0012632	http://dx.doi.org/10.1371/journal.pone.0012632			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648IW	20856823	Green Submitted, Green Published, gold			2022-12-27	WOS:000281687200003
J	Norrman, K; Fischer, Y; Bonnamy, B; Sand, FW; Ravassard, P; Semb, H				Norrman, Karin; Fischer, Yvonne; Bonnamy, Blandine; Sand, Fredrik Wolfhagen; Ravassard, Philippe; Semb, Henrik			Quantitative Comparison of Constitutive Promoters in Human ES cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; SUSTAINED TRANSGENE EXPRESSION; LENTIVIRAL VECTORS; GENE-EXPRESSION; IN-VITRO; DIFFERENTIATION; EFFICIENT; INFECTION; TRANSDUCTION; DERIVATION	Background: Constitutive promoters that ensure sustained and high level gene expression are basic research tools that have a wide range of applications, including studies of human embryology and drug discovery in human embryonic stem cells (hESCs). Numerous cellular/viral promoters that ensure sustained gene expression in various cell types have been identified but systematic comparison of their activities in hESCs is still lacking. Methodology/Principal Findings: We have quantitatively compared promoter activities of five commonly used constitutive promoters, including the human beta-actin promoter (ACTB), cytomegalovirus (CMV), elongation factor-1 alpha, (EF1 alpha), phosphoglycerate kinase (PGK) and ubiquitinC (UbC) in hESCs. Lentiviral gene transfer was used to ensure stable integration of promoter-eGFP constructs into the hESCs genome. Promoter activities were quantitatively compared in long term culture of undifferentiated hESCs and in their differentiated progenies. Conclusion/Significance: The ACTB, EF1 alpha and PGK promoters showed stable activities during long term culture of undifferentiated hESCs. The ACTB promoter was superior by maintaining expression in 75-80% of the cells after 50 days in culture. During embryoid body (EB) differentiation, promoter activities of all five promoters decreased. Although the EF1 alpha promoter was downregulated in approximately 50% of the cells, it was the most stable promoter during differentiation. Gene expression analysis of differentiated eGFP+ and eGFP- cells indicate that promoter activities might be restricted to specific cell lineages, suggesting the need to carefully select optimal promoters for constitutive gene expression in differentiated hESCs.	[Norrman, Karin; Fischer, Yvonne; Sand, Fredrik Wolfhagen; Semb, Henrik] Lund Univ, Dept Lab Med, Lund Ctr Stem Cell Biol & Cell Therapy, Lund, Sweden; [Bonnamy, Blandine; Ravassard, Philippe] Univ Paris 06, Hop La Pitie Salpetriere, Biotechnol & Biotherapy Lab,CNRS,UMR 7225, Ctr Rech,Inst Cerveau & Moelle,INSERM,UMRS 975, Paris, France	Lund University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Norrman, K (corresponding author), Lund Univ, Dept Lab Med, Lund Ctr Stem Cell Biol & Cell Therapy, Lund, Sweden.	henrik.semb@med.lu.se		Semb, Henrik/0000-0002-6747-787X; ravassard, philippe/0000-0002-0393-9262	Juvenile Diabetes Research Foundation (JDRF); Swedish Research Council; Swedish Diabetes Association Research Foundation; Stem Cell Center; Lund University; JDRF Center for Beta Cell Therapy in Europe	Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Association Research Foundation; Stem Cell Center; Lund University; JDRF Center for Beta Cell Therapy in Europe	The work has been supported by Juvenile Diabetes Research Foundation (JDRF), Swedish Research Council, Swedish Diabetes Association Research Foundation, Stem Cell Center, Lund University and JDRF Center for Beta Cell Therapy in Europe (supported by JDRF and EU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bemelmans AP, 2005, J GENE MED, V7, P1367, DOI 10.1002/jgm.788; CASTAING M, 2005, DIABETOLOGIA CLIN EX, V48; Cherry SR, 2000, MOL CELL BIOL, V20, P7419, DOI 10.1128/MCB.20.20.7419-7426.2000; Costa M, 2005, NAT METHODS, V2, P259, DOI 10.1038/NMETH748; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Gropp M, 2003, MOL THER, V7, P281, DOI 10.1016/S1525-0016(02)00047-3; Haas DL, 2000, MOL THER, V2, P71, DOI 10.1006/mthe.2000.0094; Hamaguchi I, 2000, J VIROL, V74, P10778, DOI 10.1128/JVI.74.22.10778-10784.2000; Heins N, 2004, STEM CELLS, V22, P367, DOI 10.1634/stemcells.22-3-367; Hong S, 2007, MOL THER, V15, P1630, DOI 10.1038/sj.mt.6300251; JAHNER D, 1982, NATURE, V298, P623, DOI 10.1038/298623a0; Johannesson M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004794; Kim S, 2007, STEM CELLS DEV, V16, P537, DOI 10.1089/scd.2006.0088; Liew CG, 2007, STEM CELLS, V25, P1521, DOI 10.1634/stemcells.2006-0634; Liu J, 2009, MOL REPROD DEV, V76, P580, DOI 10.1002/mrd.20983; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Ma Y, 2003, STEM CELLS, V21, P111, DOI 10.1634/stemcells.21-1-111; Mao Gensheng, 2008, Acta Biomed, V79, P192; NIWA O, 1983, CELL, V32, P1105, DOI 10.1016/0092-8674(83)90294-5; Pfeifer A, 2002, P NATL ACAD SCI USA, V99, P2140, DOI 10.1073/pnas.251682798; Philippe S, 2006, P NATL ACAD SCI USA, V103, P17684, DOI 10.1073/pnas.0606197103; Seguin CA, 2008, CELL STEM CELL, V3, P182, DOI 10.1016/j.stem.2008.06.018; Siemen H, 2005, STEM CELLS DEV, V14, P378, DOI 10.1089/scd.2005.14.378; SPEERS WC, 1980, VIROLOGY, V105, P241, DOI 10.1016/0042-6822(80)90171-3; St George JA, 2003, GENE THER, V10, P1135, DOI 10.1038/sj.gt.3302071; Suzuki K, 2008, P NATL ACAD SCI USA, V105, P13781, DOI 10.1073/pnas.0806976105; Swindle CS, 2004, J BIOL CHEM, V279, P34, DOI 10.1074/jbc.M309128200; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TEICH NM, 1977, CELL, V12, P973, DOI 10.1016/0092-8674(77)90162-3; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wang R, 2008, STEM CELLS DEV, V17, P279, DOI 10.1089/scd.2007.0084; Yao SY, 2004, MOL THER, V10, P27, DOI 10.1016/j.ymthe.2004.04.007; YEE JK, 1994, P NATL ACAD SCI USA, V91, P9564, DOI 10.1073/pnas.91.20.9564; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4; Zennou V, 2001, NAT BIOTECHNOL, V19, P446, DOI 10.1038/88115; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	40	82	84	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12413	10.1371/journal.pone.0012413	http://dx.doi.org/10.1371/journal.pone.0012413			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865032	Green Published, gold, Green Submitted			2022-12-27	WOS:000281292100013
J	Berentzen, TL; Jakobsen, MU; Halkjaer, J; Tjonneland, A; Overvad, K; Sorensen, TIA				Berentzen, Tina Landsvig; Jakobsen, Marianne Uhre; Halkjaer, Jytte; Tjonneland, Anne; Overvad, Kim; Sorensen, Thorkild I. A.			Changes in Waist Circumference and Mortality in Middle-Aged Men and Women	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; BODY-MASS INDEX; FAT-FREE MASS; FOOD FREQUENCY QUESTIONNAIRE; INTENTIONAL WEIGHT-LOSS; 2ND NATIONAL-HEALTH; FOLLOW-UP; PROSPECTIVE COHORT; HIP CIRCUMFERENCE; VISCERAL FAT	Background: Waist circumference (WC) adjusted for body mass index (BMI) is positively associated with mortality, but the association with changes in WC is less clear. We investigated the association between changes in WC and mortality in middle-aged men and women, and evaluated the influence from concurrent changes in BMI. Methodology/Principal Findings: Data on 26,625 healthy men and women from the Danish Diet, Cancer and Health study was analyzed. WC and BMI were assessed in 1993-97 and in 1999-02. Information on mortality was obtained by linkage to the Danish central Person Register. Hazard ratios (HR) were estimated with Cox regression models. During 6.7 years of follow-up, 568 and 361 deaths occurred among men and women, respectively. Changes in WC were positively associated with mortality (HR per 5 cm for the sexes combined = 1.09 (1.02:1.16) with adjustment for covariates, baseline WC, BMI and changes in BMI), whereas changes in BMI were inversely associated with mortality (HR per kg/m2 for the sexes combined = 0.91 (0.86, 0.97) with adjustment for covariates, baseline WC, BMI and changes in WC). Associations between changes in WC and mortality were not notably different in sub-groups stratified according to changes in BMI, baseline WC or when smokers or deaths occurring within the first years of follow-up were excluded. Conclusions/Significance: Changes in WC were positively associated with mortality in healthy middle-aged men and women throughout the range of concurrent changes in BMI. These findings suggest a need for development of prevention and treatment strategies targeted against redistribution of fat mass towards the abdominal region.	[Berentzen, Tina Landsvig; Sorensen, Thorkild I. A.] Copenhagen Univ Hosp, Inst Prevent Med, Ctr Hlth & Soc, Copenhagen, Denmark; [Jakobsen, Marianne Uhre; Overvad, Kim] Aarhus Univ Hosp, Aalborg Hosp, Dept Cardiol, Cardiovasc Res Ctr, Aalborg, Denmark; [Jakobsen, Marianne Uhre; Overvad, Kim] Aarhus Univ, Sch Publ Hlth, Dept Epidemiol, Aarhus, Denmark; [Halkjaer, Jytte; Tjonneland, Anne] Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark	University of Copenhagen; Aalborg University; Aalborg University Hospital; Aarhus University; Aarhus University; Danish Cancer Society	Berentzen, TL (corresponding author), Copenhagen Univ Hosp, Inst Prevent Med, Ctr Hlth & Soc, Copenhagen, Denmark.	tb@ipm.regionh.dk	Jakobsen, Marianne Uhre/I-8550-2018	Jakobsen, Marianne Uhre/0000-0001-6518-4136; Overvad, Kim/0000-0001-6429-7921; Tjonneland, Anne/0000-0003-4385-2097	European Commission [LSHM-CT-2005-018734]; Danish Council for Strategic Research [2101-06-0005]; Danish Graduate School in Public Health, Institute of Public Health, University of Copenhagen	European Commission(European CommissionEuropean Commission Joint Research Centre); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Danish Graduate School in Public Health, Institute of Public Health, University of Copenhagen	This work is part of the project Hepatic and Adipose Tissue and Functions in the Metabolic Syndrome (HEPADIP; www.hepadip.org), which is supported by the European Commission as an Integrated Project under the 6th Framework Programme (contract LSHM-CT-2005-018734), and part of the research program of the Danish Obesity Research Centre (DanORC; www.danorc.dk), which is supported by the Danish Council for Strategic Research (contract 2101-06-0005). Funding was also obtained from The Danish Graduate School in Public Health, Institute of Public Health, University of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 1999, INT J OBESITY, V23, P603, DOI 10.1038/sj.ijo.0800875; Allison DB, 2002, INT J OBESITY, V26, P410, DOI 10.1038/sj.ijo.0801925; Andersen TF, 1999, DAN MED BULL, V46, P263; Berentzen T, 2006, NUTR REV, V64, P502, DOI [10.1301/nr.2006.nov.502507, 10.1111/j.1753-4887.2006.tb00183.x]; Bigaard J, 2005, J NUTR, V135, P2263; Bigaard J, 2004, OBES RES, V12, P1042, DOI 10.1038/oby.2004.131; Bigaard J, 2004, INT J OBESITY, V28, P741, DOI 10.1038/sj.ijo.0802635; Bigaard J, 2003, OBES RES, V11, P895, DOI 10.1038/oby.2003.123; Billington CJ, 2000, ARCH INTERN MED, V160, P898, DOI 10.1001/archinte.160.7.898; Carstensen B, 2008, DIABETOLOGIA, V51, P2187, DOI 10.1007/s00125-008-1156-z; Coffey CS, 2005, STAT MED, V24, P941, DOI 10.1002/sim.1964; DESPRES JP, 1990, ARTERIOSCLEROSIS, V10, P497, DOI 10.1161/01.ATV.10.4.497; Fontaine K R, 2001, Eat Behav, V2, P87, DOI 10.1016/S1471-0153(01)00024-1; GREENLAND S, 1995, EPIDEMIOLOGY, V6, P356, DOI 10.1097/00001648-199507000-00005; Gupta AK, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-36; Harrel jF, 2002, APPL LINEAR MODELS L; Harrington M, 2009, NUTR RES REV, V22, P93, DOI 10.1017/S0954422409990035; Heitmann BL, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3292; Heitmann BL, 2004, OBES RES, V12, P482, DOI 10.1038/oby.2004.54; Heitmann BL, 2000, INT J OBESITY, V24, P33, DOI 10.1038/sj.ijo.0801082; Janssen I, 2005, J AM GERIATR SOC, V53, P2112, DOI 10.1111/j.1532-5415.2005.00505.x; Janssen I, 2002, AM J CLIN NUTR, V75, P683, DOI 10.1093/ajcn/75.4.683; Kanaya AM, 2003, AM J EPIDEMIOL, V158, P1161, DOI 10.1093/aje/kwg271; Kristensen JK, 2001, DAN MED BULL, V48, P33; Kuk JL, 2006, OBESITY, V14, P336, DOI 10.1038/oby.2006.43; Lissner L, 2001, OBES RES, V9, P644, DOI 10.1038/oby.2001.85; Manolopoulos KN, 2010, INT J OBESITY, V34, P949, DOI 10.1038/ijo.2009.286; Mikkelsen KL, 1999, EPIDEMIOLOGY, V10, P671, DOI 10.1097/00001648-199911000-00005; Myrskyla M, 2009, EPIDEMIOLOGY, V20, P840, DOI 10.1097/EDE.0b013e3181b5f520; OVERVAD K, 1991, INT J EPIDEMIOL, V20, P900, DOI 10.1093/ije/20.4.900; Pedersen CB, 2006, DAN MED BULL, V53, P441; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Pischon T, 2010, INT J EPIDEMIOL, V39, P528, DOI 10.1093/ije/dyp388; Ross R, 2008, OBES REV, V9, P312, DOI 10.1111/j.1467-789X.2007.00411.x; Simonsen MK, 2008, NUTR REV, V66, P375, DOI 10.1111/j.1753-4887.2008.00047.x; TJONNELAND A, 1991, INT J EPIDEMIOL, V20, P906, DOI 10.1093/ije/20.4.906; Tjonneland A, 2007, SCAND J PUBLIC HEALT, V35, P432, DOI 10.1080/14034940601047986; Trichopoulou A, 2005, BMJ-BRIT MED J, V330, P991, DOI 10.1136/bmj.38415.644155.8F; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; Zhang C, 2008, CIRCULATION, V117, P1658, DOI 10.1161/CIRCULATIONAHA.107.739714; Zhu SK, 2003, ANN EPIDEMIOL, V13, P286, DOI 10.1016/S1047-2797(02)00417-9	41	47	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e13097	10.1371/journal.pone.0013097	http://dx.doi.org/10.1371/journal.pone.0013097			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20927346	gold, Green Published, Green Submitted			2022-12-27	WOS:000282312600025
J	Zilman, A; Ganusov, VV; Perelson, AS				Zilman, Anton; Ganusov, Vitaly V.; Perelson, Alan S.			Stochastic Models of Lymphocyte Proliferation and Death	PLOS ONE			English	Article							T-CELL RESPONSE; CFSE DATA; CHORIOMENINGITIS VIRUS; PRECURSOR FREQUENCY; IMMUNE-SYSTEM; DIVISION; ANTIGEN; DIFFERENTIATION; INFECTION; DYNAMICS	Quantitative understanding of the kinetics of lymphocyte proliferation and death upon activation with an antigen is crucial for elucidating factors determining the magnitude, duration and efficiency of the immune response. Recent advances in quantitative experimental techniques, in particular intracellular labeling and multi-channel flow cytometry, allow one to measure the population structure of proliferating and dying lymphocytes for several generations with high precision. These new experimental techniques require novel quantitative methods of analysis. We review several recent mathematical approaches used to describe and analyze cell proliferation data. Using a rigorous mathematical framework, we show that two commonly used models that are based on the theories of age-structured cell populations and of branching processes, are mathematically identical. We provide several simple analytical solutions for a model in which the distribution of interdivision times follows a gamma distribution and show that this model can fit both simulated and experimental data. We also show that the estimates of some critical kinetic parameters, such as the average inter-division time, obtained by fitting models to data may depend on the assumed distribution of inter-division times, highlighting the challenges in quantitative understanding of cell kinetics.	[Zilman, Anton; Perelson, Alan S.] Los Alamos Natl Lab, Div Theoret, Theoret Biol & Biophys Grp, Los Alamos, NM USA; [Zilman, Anton] Los Alamos Natl Lab, Ctr Nonlinear Studies, Div Theoret, Los Alamos, NM 87545 USA; [Ganusov, Vitaly V.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; University of Tennessee System; University of Tennessee Knoxville	Zilman, A (corresponding author), Los Alamos Natl Lab, Div Theoret, Theoret Biol & Biophys Grp, Los Alamos, NM USA.	zilmana@lanl.gov	Perelson, Alan S/Z-1959-2019	Perelson, Alan S/0000-0002-2455-0002; Ganusov, Vitaly/0000-0001-6572-1691	United States Department of Energy [DE-AC52-06NA25396]; National Institutes of Health [R37-AI28433, R01-RR06555, PO1 AI071195-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR006555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI028433, P01AI071195] Funding Source: NIH RePORTER	United States Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was performed under the auspices of the United States Department of Energy under contract DE-AC52-06NA25396 and supported by National Institutes of Health grants R37-AI28433, R01-RR06555, and PO1 AI071195-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED R, 2005, J IMMUNOL METHODS, V298, P183; Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Badovinac VP, 2002, NAT IMMUNOL, V3, P619, DOI 10.1038/ni804; Bernard S, 2003, BIOPHYS J, V84, P3414, DOI 10.1016/S0006-3495(03)70063-0; Bharucha-Reid A. T, 1960, ELEMENTS THEORY MARK; Blattman JN, 2002, J EXP MED, V195, P657, DOI 10.1084/jem.20001021; Callard R, 2007, IMMUNOL REV, V216, P119; De Boer RJ, 2005, J COMPUT APPL MATH, V184, P140, DOI 10.1016/j.cam.2004.08.020; De Boer RJ, 2003, J IMMUNOL, V171, P3928, DOI 10.4049/jimmunol.171.8.3928; De Boer RJ, 2001, J VIROL, V75, P10663, DOI 10.1128/JVI.75.22.10663-10669.2001; De Boer RJ, 2006, B MATH BIOL, V68, P1011, DOI 10.1007/s11538-006-9094-8; Deenick EK, 2003, J IMMUNOL, V170, P4963, DOI 10.4049/jimmunol.170.10.4963; Doherty PC, 2000, ANNU REV IMMUNOL, V18, P561, DOI 10.1146/annurev.immunol.18.1.561; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Evans LC, 1996, PARTIAL DIFFERENTIAL; Ganusov VV, 2007, J IMMUNOL, V179, P950, DOI 10.4049/jimmunol.179.2.950; Ganusov VV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000666; Ganusov VV, 2005, J IMMUNOL METHODS, V298, P183, DOI 10.1016/j.jim.2005.01.011; GETT A, 1998, P NATL ACAD SCI USA, V104, P5032; Gett AV, 2000, NAT IMMUNOL, V1, P239, DOI 10.1038/79782; Harris T. E., 1963, THEORY BRANCHING PRO; Hawkins ED, 2007, P NATL ACAD SCI USA, V104, P5032, DOI 10.1073/pnas.0700026104; Hawkins ED, 2009, P NATL ACAD SCI USA, V106, P13457, DOI 10.1073/pnas.0905629106; Hawkins ED, 2007, NAT PROTOC, V2, P2057, DOI 10.1038/nprot.2007.297; Hodgkin PD, 1998, IMMUNOL CELL BIOL, V76, P448, DOI 10.1046/j.1440-1711.1998.00776.x; Hommel M, 2007, J IMMUNOL, V179, P2250, DOI 10.4049/jimmunol.179.4.2250; Hyrien O, 2008, J AM STAT ASSOC, V103, P222, DOI 10.1198/016214507000000194; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kimmel M., 2002, BRANCHING PROCESSES; Kot M, 2001, ELEMENTS MATH ECOLOG, DOI 10.1017/CBO9780511608520; Lee HY, 2008, B MATH BIOL, V70, P21, DOI 10.1007/s11538-007-9239-4; Lee HY, 2009, B MATH BIOL, V71, P1649, DOI 10.1007/s11538-009-9418-6; Leon K, 2004, J THEOR BIOL, V229, P455, DOI 10.1016/j.jtbi.2004.04.011; Luzyanina T, 2007, J MATH BIOL, V54, P57, DOI 10.1007/s00285-006-0046-6; Lyons AB, 2000, J IMMUNOL METHODS, V243, P147, DOI 10.1016/S0022-1759(00)00231-3; Mercado R, 2000, J IMMUNOL, V165, P6833, DOI 10.4049/jimmunol.165.12.6833; Murphy K, 2008, JANEWAYS IMMUNOBIOLO; Perelson AS, 2002, NAT REV IMMUNOL, V2, P28, DOI 10.1038/nri700; Prlic M, 2008, P NATL ACAD SCI USA, V105, P16689, DOI 10.1073/pnas.0808997105; Prlic M, 2006, J EXP MED, V203, P2135, DOI 10.1084/jem.20060928; Revy P, 2001, NAT IMMUNOL, V2, P925, DOI 10.1038/ni713; SMITH JA, 1973, P NATL ACAD SCI USA, V70, P1263, DOI 10.1073/pnas.70.4.1263; Subramanian VG, 2008, J MATH BIOL, V56, P861, DOI 10.1007/s00285-007-0142-2; Wong P, 2001, J IMMUNOL, V166, P5864, DOI 10.4049/jimmunol.166.10.5864; Wong P, 2003, ANNU REV IMMUNOL, V21, P29, DOI 10.1146/annurev.immunol.21.120601.141114; Yates A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-196; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657	48	44	44	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e12775	10.1371/journal.pone.0012775	http://dx.doi.org/10.1371/journal.pone.0012775			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20941358	Green Submitted, gold, Green Published			2022-12-27	WOS:000282312600001
J	Choi, JH; Li, YJ; Guo, JY; Pei, LR; Rauch, TA; Kramer, RS; Macmil, SL; Wiley, GB; Bennett, LB; Schnabel, JL; Taylor, KH; Kim, S; Xu, D; Sreekumar, A; Pfeifer, GP; Roe, BA; Caldwell, CW; Bhalla, KN; Shi, HD				Choi, Jeong-Hyeon; Li, Yajun; Guo, Juyuan; Pei, Lirong; Rauch, Tibor A.; Kramer, Robin S.; Macmil, Simone L.; Wiley, Graham B.; Bennett, Lynda B.; Schnabel, Jennifer L.; Taylor, Kristen H.; Kim, Sun; Xu, Dong; Sreekumar, Arun; Pfeifer, Gerd P.; Roe, Bruce A.; Caldwell, Charles W.; Bhalla, Kapil N.; Shi, Huidong			Genome-Wide DNA Methylation Maps in Follicular Lymphoma Cells Determined by Methylation-Enriched Bisulfite Sequencing	PLOS ONE			English	Article							CPG ISLANDS; POLYCOMB; REVEALS; CANCER; PATTERNS; HYPERMETHYLATION; PLURIPOTENT; EXPRESSION	Background: Follicular lymphoma (FL) is a form of non-Hodgkin's lymphoma (NHL) that arises from germinal center (GC) B-cells. Despite the significant advances in immunotherapy, FL is still not curable. Beyond transcriptional profiling and genomics datasets, there currently is no epigenome-scale dataset or integrative biology approach that can adequately model this disease and therefore identify novel mechanisms and targets for successful prevention and treatment of FL. Methodology/Principal Findings: We performed methylation-enriched genome-wide bisulfite sequencing of FL cells and normal CD19(+) B-cells using 454 sequencing technology. The methylated DNA fragments were enriched with methyl-binding proteins, treated with bisulfite, and sequenced using the Roche-454 GS FLX sequencer. The total number of bases covered in the human genome was 18.2 and 49.3 million including 726,003 and 1.3 million CpGs in FL and CD19(+) B-cells, respectively. 11,971 and 7,882 methylated regions of interest (MRIs) were identified respectively. The genome-wide distribution of these MRIs displayed significant differences between FL and normal B-cells. A reverse trend in the distribution of MRIs between the promoter and the gene body was observed in FL and CD19+ B-cells. The MRIs identified in FL cells also correlated well with transcriptomic data and ChIP-on-Chip analyses of genome-wide histone modifications such as tri-methyl-H3K27, and tri-methyl-H3K4, indicating a concerted epigenetic alteration in FL cells. Conclusions/Significance: This study is the first to provide a large scale and comprehensive analysis of the DNA methylation sequence composition and distribution in the FL epigenome. These integrated approaches have led to the discovery of novel and frequent targets of aberrant epigenetic alterations. The genome-wide bisulfite sequencing approach developed here can be a useful tool for profiling DNA methylation in clinical samples.	[Choi, Jeong-Hyeon; Kim, Sun] Indiana Univ, Ctr Genom & Bioinformat, Bloomington, IN 47405 USA; [Li, Yajun; Pei, Lirong; Sreekumar, Arun; Bhalla, Kapil N.; Shi, Huidong] Med Coll Georgia, Med Coll Georgia Canc Ctr, Augusta, GA 30912 USA; [Guo, Juyuan; Bennett, Lynda B.; Schnabel, Jennifer L.; Taylor, Kristen H.; Caldwell, Charles W.] Univ Missouri, Dept Pathol & Anat Sci, Columbia, MO USA; [Rauch, Tibor A.; Xu, Dong] City Hope Beckman Res Inst, Div Biol, Duarte, CA USA; [Kramer, Robin S.; Pfeifer, Gerd P.] Univ Missouri, Dept Comp Sci, Columbia, MO USA; [Macmil, Simone L.; Wiley, Graham B.; Roe, Bruce A.] Univ Oklahoma, Adv Ctr Genome Technol, Norman, OK 73019 USA	Indiana University System; Indiana University Bloomington; University System of Georgia; Augusta University; University of Missouri System; University of Missouri Columbia; City of Hope; Beckman Research Institute of City of Hope; University of Missouri System; University of Missouri Columbia; University of Oklahoma System; University of Oklahoma - Norman	Choi, JH (corresponding author), Indiana Univ, Ctr Genom & Bioinformat, Bloomington, IN 47405 USA.	hshi@mcg.edu	Choi, Justin/F-8792-2014; Choi, Jeong-Hyeon/E-3084-2010	Bennett, Lynda/0000-0001-7491-5797; Cree, Simone/0000-0002-7349-422X; Shi, Huidong/0000-0003-1137-3390; Taylor, Kristen/0000-0001-9336-9824; Bhalla, Kapil/0000-0001-5209-5126	National Cancer Institute [CA123018, CA123565, CA 132706, DA025779]; Department of Defense [W81XWH-07-1-0560]; NIH [LM07089]; NATIONAL CANCER INSTITUTE [R01CA133458, R21CA123018, R03CA123565, R33CA134304] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025779] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007089] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by National Cancer Institute grants CA123018, CA123565, CA 132706, DA025779 (H. S.) and Department of Defense grant W81XWH-07-1-0560 (D. X. and H. S.). H. S. is a Georgia Cancer Coalition Distinguished Cancer Scientist. C. W. C. is CRC Missouri Chair in Cancer Research. R. S. K. was supported by an NIH Biomedical and Health Informatics Research Training Program (LM07089). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bennett LB, 2009, GENE CHROMOSOME CANC, V48, P828, DOI 10.1002/gcc.20687; Choi JH, 2005, COMPUT BIOL CHEM, V29, P244, DOI 10.1016/j.compbiolchem.2005.04.004; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Coolen MW, 2010, NAT CELL BIOL, V12, P235, DOI 10.1038/ncb2023; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105; GU H, NATURE METHODS, V7, P133; Hodges E, 2009, GENOME RES, V19, P1593, DOI 10.1101/gr.095190.109; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Issa JPJ, 2007, CLIN CANCER RES, V13, P1634, DOI 10.1158/1078-0432.CCR-06-2076; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Killian JK, 2009, CANCER RES, V69, P758, DOI 10.1158/0008-5472.CAN-08-2984; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Martin-Subero JI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006986; Mayor R, 2009, BRIT J CANCER, V100, P1534, DOI 10.1038/sj.bjc.6605045; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; O'Riain C, 2009, LEUKEMIA, V23, P1858, DOI 10.1038/leu.2009.114; Raaphorst FM, 2005, HUM MOL GENET, V14, pR93, DOI 10.1093/hmg/ddi111; Rahmatpanah FB, 2006, LEUKEMIA, V20, P1855, DOI 10.1038/sj.leu.2404345; Rauch T, 2007, P NATL ACAD SCI USA, V104, P5527, DOI 10.1073/pnas.0701059104; Rauch T, 2006, CANCER RES, V66, P7939, DOI 10.1158/0008-5472.CAN-06-1888; Rauch TA, 2009, P NATL ACAD SCI USA, V106, P671, DOI 10.1073/pnas.0812399106; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Saito M, 2007, CANCER CELL, V12, P280, DOI 10.1016/j.ccr.2007.08.011; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schwartz YB, 2008, CURR OPIN CELL BIOL, V20, P266, DOI 10.1016/j.ceb.2008.03.002; Shi H, 2007, EXPERT REV MOL DIAGN, V7, P519, DOI 10.1586/14737159.7.5.519; Shi HD, 2007, CARCINOGENESIS, V28, P60, DOI 10.1093/carcin/bgl092; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Taylor KH, 2007, CANCER RES, V67, P8511, DOI 10.1158/0008-5472.CAN-07-1016; van Kemenade FJ, 2001, BLOOD, V97, P3896, DOI 10.1182/blood.V97.12.3896; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Zeschnigk M, 2009, HUM MOL GENET, V18, P1439, DOI 10.1093/hmg/ddp054	41	29	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e13020	10.1371/journal.pone.0013020	http://dx.doi.org/10.1371/journal.pone.0013020			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20927367	Green Published, Green Submitted, gold			2022-12-27	WOS:000282269400011
J	Kupershmidt, I; Su, QJ; Grewal, A; Sundaresh, S; Halperin, I; Flynn, J; Shekar, M; Wang, H; Park, J; Cui, WW; Wall, GD; Wisotzkey, R; Alag, S; Akhtari, S; Ronaghi, M				Kupershmidt, Ilya; Su, Qiaojuan Jane; Grewal, Anoop; Sundaresh, Suman; Halperin, Inbal; Flynn, James; Shekar, Mamatha; Wang, Helen; Park, Jenny; Cui, Wenwu; Wall, Gregory D.; Wisotzkey, Robert; Alag, Satnam; Akhtari, Saeid; Ronaghi, Mostafa			Ontology-Based Meta-Analysis of Global Collections of High-Throughput Public Data	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; ADIPOCYTE DIFFERENTIATION; SKELETAL-MUSCLE; CANCER; BROWN; MICROARRAYS; SIGNATURES; IDENTIFICATION; PROBESETS; ARRAY	Background: The investigation of the interconnections between the molecular and genetic events that govern biological systems is essential if we are to understand the development of disease and design effective novel treatments. Microarray and next-generation sequencing technologies have the potential to provide this information. However, taking full advantage of these approaches requires that biological connections be made across large quantities of highly heterogeneous genomic datasets. Leveraging the increasingly huge quantities of genomic data in the public domain is fast becoming one of the key challenges in the research community today. Methodology/Results: We have developed a novel data mining framework that enables researchers to use this growing collection of public high-throughput data to investigate any set of genes or proteins. The connectivity between molecular states across thousands of heterogeneous datasets from microarrays and other genomic platforms is determined through a combination of rank-based enrichment statistics, meta-analyses, and biomedical ontologies. We address data quality concerns through dataset replication and meta-analysis and ensure that the majority of the findings are derived using multiple lines of evidence. As an example of our strategy and the utility of this framework, we apply our data mining approach to explore the biology of brown fat within the context of the thousands of publicly available gene expression datasets. Conclusions: Our work presents a practical strategy for organizing, mining, and correlating global collections of large-scale genomic data to explore normal and disease biology. Using a hypothesis-free approach, we demonstrate how a data-driven analysis across very large collections of genomic data can reveal novel discoveries and evidence to support existing hypothesis.	[Kupershmidt, Ilya; Su, Qiaojuan Jane; Grewal, Anoop; Sundaresh, Suman; Halperin, Inbal; Flynn, James; Shekar, Mamatha; Wang, Helen; Park, Jenny; Cui, Wenwu; Wall, Gregory D.; Wisotzkey, Robert; Alag, Satnam; Akhtari, Saeid; Ronaghi, Mostafa] NextBio, Cupertino, CA USA; [Kupershmidt, Ilya] Royal Inst Technol KTH, Stockholm, Sweden; [Ronaghi, Mostafa] Illumina, San Diego, CA USA	Royal Institute of Technology; Illumina	Kupershmidt, I (corresponding author), NextBio, Cupertino, CA USA.	ilya@nextbio.com			NextBio; NIH [R43 GM078602]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R43GM078602] Funding Source: NIH RePORTER	NextBio; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	A major part of this work was funded by NextBio, which employs all authors (with the exception of Mostafa Ronaghi, employed by Illumina). This work was also supported in part by NIH grant R43 GM078602. The funders provided resources necessary for the development of the presented methods and technology and played a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Almind K, 2007, P NATL ACAD SCI USA, V104, P2366, DOI 10.1073/pnas.0610416104; Atit R, 2006, DEV BIOL, V296, P164, DOI 10.1016/j.ydbio.2006.04.449; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bonal C, 2009, GASTROENTEROLOGY, V136, P309, DOI 10.1053/j.gastro.2008.10.015; Brazma A, 2003, NUCLEIC ACIDS RES, V31, P68, DOI 10.1093/nar/gkg091; Caramel J, 2008, ONCOGENE, V27, P2035, DOI 10.1038/sj.onc.1210847; Chan SK, 2008, CANCER EPIDEM BIOMAR, V17, P543, DOI 10.1158/1055-9965.EPI-07-2615; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; de Magalhaes JP, 2009, BIOINFORMATICS, V25, P875, DOI 10.1093/bioinformatics/btp073; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Farmer SR, 2008, CELL, V134, P726, DOI 10.1016/j.cell.2008.08.018; Fishel I, 2007, BIOINFORMATICS, V23, P1599, DOI 10.1093/bioinformatics/btm149; FREYTAG SO, 1992, SCIENCE, V256, P379, DOI 10.1126/science.256.5055.379; Gardiner-Garden M, 2001, Brief Bioinform, V2, P143, DOI 10.1093/bib/2.2.143; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Ghosh Debashis, 2003, Functional & Integrative Genomics, V3, P180; Griffith OL, 2006, J CLIN ONCOL, V24, P5043, DOI 10.1200/JCO.2006.06.7330; Grigoryev DN, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r34; Harbig J, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni027; Jiang HY, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-81; Kim YK, 2007, BIOCHEM BIOPH RES CO, V358, P553, DOI 10.1016/j.bbrc.2007.04.165; Kittleson MM, 2005, INT J CARDIOL, V102, P333, DOI 10.1016/j.ijcard.2005.03.075; Knowles LM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-168; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lee EK, 2009, J BIOL CHEM, V284, P2891, DOI 10.1074/jbc.M804055200; Lehnert SA, 2006, J ANIM SCI, V84, P3239, DOI 10.2527/jas.2006-192; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li Y, 2006, J CLIN ONCOL, V24, P1754, DOI 10.1200/JCO.2005.03.7598; Miller BG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009466; Newton MA, 2007, ANN APPL STAT, V1, P85, DOI 10.1214/07-AOAS104; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Park Yu Rang, 2005, AMIA Annu Symp Proc, P1073; Parrish Rudolph S, 2004, J Biopharm Stat, V14, P575, DOI 10.1081/BIP-200025650; Quinn P, 2006, APPL ENVIRON MICROB, V72, P5512, DOI 10.1128/AEM.00343-06; Rhodes DR, 2002, CANCER RES, V62, P4427; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Sherlock G, 2001, NUCLEIC ACIDS RES, V29, P152, DOI 10.1093/nar/29.1.152; Shi LM, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S2-S12; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang JX, 2006, CATAL COMMUN, V7, P59, DOI 10.1016/j.catcom.2005.08.013; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Yu H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-194	45	267	275	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e13066	10.1371/journal.pone.0013066	http://dx.doi.org/10.1371/journal.pone.0013066			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20927376	Green Published, gold, Green Submitted			2022-12-27	WOS:000282269400018
J	Coelho, PMBM; Salvador, A; Savageau, MA				Coelho, Pedro M. B. M.; Salvador, Armindo; Savageau, Michael A.			Relating Mutant Genotype to Phenotype via Quantitative Behavior of the NADPH Redox Cycle in Human Erythrocytes	PLOS ONE			English	Article							HEXOSE-MONOPHOSPHATE SHUNT; G6PD DEFICIENCY; GLUCOSE-6-PHOSPHATE DEHYDROGENASE; PLASMODIUM-FALCIPARUM; OXIDATIVE STRESS; SEVERE MALARIA; BLOOD-CELLS; RESISTANCE; ENZYME; SUSCEPTIBILITY	Background: The NADPH redox cycle plays a key role in antioxidant protection of human erythrocytes. It consists of two enzymes: glucose-6-phosphate dehydrogenase (G6PD) and glutathione reductase. Over 160 G6PD variants have been characterized and associated with several distinct clinical manifestations. However, the mechanistic link between the genotype and the phenotype remains poorly understood. Methodology/Principal Findings: We address this issue through a novel framework (design space) that integrates information at the genetic, biochemical and clinical levels. Our analysis predicts three qualitatively-distinct phenotypic regions that can be ranked according to fitness. When G6PD variants are analyzed in design space, a correlation is revealed between the phenotypic region and the clinical manifestation: the best region with normal physiology, the second best region with a pathology, and the worst region with a potential lethality. We also show that Plasmodium falciparum, by induction of its own G6PD gene in G6PD-deficient erythrocytes, moves the operation of the cycle to a region of the design space that yields robust performance. Conclusions/Significance: In conclusion, the design space for the NADPH redox cycle, which includes relationships among genotype, phenotype and environment, illuminates the function, design and fitness of the cycle, and its phenotypic regions correlate with the organism's clinical status.	[Coelho, Pedro M. B. M.] Univ Coimbra, Dept Chem, Biol Chem Grp, Coimbra, Portugal; [Coelho, Pedro M. B. M.; Savageau, Michael A.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Salvador, Armindo] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal	Universidade de Coimbra; University of California System; University of California Davis; Universidade de Coimbra	Coelho, PMBM (corresponding author), Univ Coimbra, Dept Chem, Biol Chem Grp, Coimbra, Portugal.	masavageau@ucdavis.edu	Salvador, Armindo/I-3469-2012; Coelho, Paulo Marcos Zech/ABE-6169-2021	Salvador, Armindo/0000-0002-4442-4900; Coelho, Paulo Marcos Zech/0000-0002-2443-8897; Coelho, Pedro/0000-0002-8192-4621	Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BD/8304/2002, PTDC/QUI/70523/2006]; US Public Health Service [RO1- GM30054]; Center for Non-Linear Studies of the Los Alamos National Laboratory; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030054] Funding Source: NIH RePORTER	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Center for Non-Linear Studies of the Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by a fellowship to PMBMC (SFRH/BD/8304/2002) from Fundacao para a Ciencia e Tecnologia, Portugal, and by grants to AS (PTDC/QUI/70523/2006) from Fundacao para a Ciencia e Tecnologia (http://alfa.fct.mctes.pt), Portugal, and to MAS (RO1- GM30054) from the US Public Health Service (http://www.nigms.nih.gov) and a Stanislaw Ulam Distinguished Scholar Award from the Center for Non-Linear Studies of the Los Alamos National Laboratory (http://cnls.lanl.gov).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell M.L.L., 1999, STAT MATH; ALLISON AC, 1960, NATURE, V186, P531, DOI 10.1038/186531a0; ATAMNA H, 1994, MOL BIOCHEM PARASIT, V67, P79, DOI 10.1016/0166-6851(94)90098-1; BERKOWITZ FE, 1991, REV INFECT DIS, V13, P1151; BEUTLER E, 1990, SEMIN HEMATOL, V27, P137; Beutler E., 1984, GLUTATHIONE RED CELL; BIENZLE U, 1972, LANCET, V1, P107; BIENZLE U, 1979, AM J TROP MED HYG, V28, P619, DOI 10.4269/ajtmh.1979.28.619; BUCKWITZ D, 1986, BIOMED BIOCHIM ACTA, V45, P429; Cheng YS, 1999, J BIOMED SCI, V6, P106, DOI 10.1159/000025377; Clark TD, 2008, J INFECT DIS, V198, P393, DOI 10.1086/589778; Coelho PMBM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000319; Cook GC., 2009, DISEASES-BASEL, DOI [10.1016/B978-1-4160-4470-3.50014-8, DOI 10.1016/B978-1-4160-4470-3.50014-8]; Fiorelli G, 2000, BEST PRACT RES CL HA, V13, P39, DOI 10.1053/beha.1999.0056; Guindo A, 2007, PLOS MED, V4, P516, DOI 10.1371/journal.pmed.0040066; Johnson MK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007246; KIRKMAN HN, 1980, J LAB CLIN MED, V95, P877; Lell B, 1999, CLIN INFECT DIS, V28, P794, DOI 10.1086/515193; Mason PJ, 2007, BLOOD REV, V21, P267, DOI 10.1016/j.blre.2007.05.002; MOTULSKY ARNO G., 1960, HUMAN BIOL, V32, P28; Mulquiney PJ, 1999, BIOCHEM J, V342, P581, DOI 10.1042/0264-6021:3420581; Murray CK, 2006, MIL MED, V171, P905, DOI 10.7205/MILMED.171.9.905; PANDOLFI PP, 1995, EMBO J, V14, P5209, DOI 10.1002/j.1460-2075.1995.tb00205.x; Parikh S, 2004, AM J TROP MED HYG, V71, P750, DOI 10.4269/ajtmh.2004.71.750; RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0; Salvador A, 2006, P NATL ACAD SCI USA, V103, P2226, DOI 10.1073/pnas.0510776103; Salvador A, 2003, P NATL ACAD SCI USA, V100, P14463, DOI 10.1073/pnas.2335687100; Savageau M, 1976, BIOCH SYSTEMS ANAL S; Savageau MA, 2009, FEBS LETT, V583, P3914, DOI 10.1016/j.febslet.2009.10.073; Savageau MA, 2009, P NATL ACAD SCI USA, V106, P6435, DOI 10.1073/pnas.0809869106; Siegel S, 1988, NONPARAMETRIC STAT B, V2; THORBURN DR, 1985, EUR J BIOCHEM, V150, P371, DOI 10.1111/j.1432-1033.1985.tb09030.x; USANGA EA, 1985, NATURE, V313, P793, DOI 10.1038/313793a0; WORTHINGTON DJ, 1976, EUR J BIOCHEM, V67, P231, DOI 10.1111/j.1432-1033.1976.tb10654.x; YOSHIDA A, 1987, BLOOD, V69, P1528; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	43	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2010	5	9							e13031	10.1371/journal.pone.0013031	http://dx.doi.org/10.1371/journal.pone.0013031			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654ZQ	20927393	Green Published, gold, Green Submitted			2022-12-27	WOS:000282210700012
J	Bruant, G; Levesque, MJ; Peter, C; Guiot, SR; Masson, L				Bruant, Guillaume; Levesque, Marie-Josee; Peter, Chardeen; Guiot, Serge R.; Masson, Luke			Genomic Analysis of Carbon Monoxide Utilization and Butanol Production by Clostridium carboxidivorans Strain P7(T)	PLOS ONE			English	Article							ACETOBUTYLICUM ATCC 824; WOOD-LJUNGDAHL PATHWAY; SP-NOV; SOLVENT PRODUCTION; MOLECULAR CHARACTERIZATION; BEIJERINCKII; GENES; FERMENTATION; ETHANOL; DEHYDROGENASE	Increasing demand for the production of renewable fuels has recently generated a particular interest in microbial production of butanol. Anaerobic bacteria, such as Clostridium spp., can naturally convert carbohydrates into a variety of primary products, including alcohols like butanol. The genetics of microorganisms like Clostridium acetobutylicum have been well studied and their solvent-producing metabolic pathways characterized. In contrast, less is known about the genetics of Clostridium spp. capable of converting syngas or its individual components into solvents. In this study, the type of strain of a new solventogenic Clostridium species, C. carboxidivorans, was genetically characterized by genome sequencing. C. carboxidivorans strain P7(T) possessed a complete Wood-Ljungdahl pathway gene cluster, involving CO and CO2 fixation and conversion to acetyl-CoA. Moreover, with the exception of an acetone production pathway, all the genetic determinants of canonical ABE metabolic pathways for acetate, butyrate, ethanol and butanol production were present in the P7T chromosome. The functionality of these pathways was also confirmed by growth of P7(T) on CO and production of CO2 as well as volatile fatty acids (acetate and butyrate) and solvents (ethanol and butanol). P7(T) was also found to harbour a 19 Kbp plasmid, which did not include essential or butanol production related genes. This study has generated in depth knowledge of the P7(T) genome, which will be helpful in developing metabolic engineering strategies to improve C. carboxidivorans's natural capacity to produce potential biofuels from syngas.	[Bruant, Guillaume; Levesque, Marie-Josee; Peter, Chardeen; Guiot, Serge R.; Masson, Luke] Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada; [Guiot, Serge R.; Masson, Luke] Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ H3C 3J7, Canada	National Research Council Canada; Universite de Montreal	Bruant, G (corresponding author), Natl Res Council Canada, Biotechnol Res Inst, 6100 Royalmount Ave, Montreal, PQ H4P 2R2, Canada.	luke.masson@cnrc-nrc.gc.ca		Guiot, Serge R/0000-0002-2532-0620	ecoENERGY Technology Initiative Program of Natural Resources Canada (NRCan)	ecoENERGY Technology Initiative Program of Natural Resources Canada (NRCan)	This research was partly supported by the ecoENERGY Technology Initiative Program of Natural Resources Canada (NRCan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRINI J, 1994, ARCH MICROBIOL, V161, P345, DOI 10.1007/BF00303591; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Berezina OV, 2009, SYST APPL MICROBIOL, V32, P449, DOI 10.1016/j.syapm.2009.07.005; Boynton ZL, 1996, APPL ENVIRON MICROB, V62, P2758, DOI 10.1128/AEM.62.8.2758-2766.1996; Chen CK, 1999, APPL ENVIRON MICROB, V65, P499; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cornillot E, 1997, J BACTERIOL, V179, P5442, DOI 10.1128/jb.179.17.5442-5447.1997; Cotter JL, 2009, BIOPROC BIOSYST ENG, V32, P369, DOI 10.1007/s00449-008-0256-y; DABROCK B, 1992, APPL ENVIRON MICROB, V58, P1233, DOI 10.1128/AEM.58.4.1233-1239.1992; Datar RP, 2004, BIOTECHNOL BIOENG, V86, P587, DOI 10.1002/bit.20071; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Desai RP, 1999, METAB ENG, V1, P206, DOI 10.1006/mben.1999.0118; DURRE P, 1995, FEMS MICROBIOL REV, V17, P251; Ezeji TC, 2007, CURR OPIN BIOTECH, V18, P220, DOI 10.1016/j.copbio.2007.04.002; Fischer CR, 2008, METAB ENG, V10, P295, DOI 10.1016/j.ymben.2008.06.009; Fontaine L, 2002, J BACTERIOL, V184, P821, DOI 10.1128/JB.184.3.821-830.2002; GEORGE HA, 1983, APPL ENVIRON MICROB, V46, P321, DOI 10.1128/AEM.46.2.321-327.1983; GEORGE HA, 1983, APPL ENVIRON MICROB, V45, P1160, DOI 10.1128/AEM.45.3.1160-1163.1983; Gheshlaghi R, 2009, BIOTECHNOL ADV, V27, P764, DOI 10.1016/j.biotechadv.2009.06.002; GOTTWALD M, 1984, APPL ENVIRON MICROB, V48, P573, DOI 10.1128/AEM.48.3.573-576.1984; GRETHLEIN AJ, 1991, J FERMENT BIOENG, V72, P58, DOI 10.1016/0922-338X(91)90147-9; Henstra AM, 2007, CURR OPIN BIOTECH, V18, P200, DOI 10.1016/j.copbio.2007.03.008; Inui M, 2008, APPL MICROBIOL BIOT, V77, P1305, DOI 10.1007/s00253-007-1257-5; Jones D. T., 1989, CLOSTRIDIA, P105; JONES DT, 1986, MICROBIOL REV, V50, P484, DOI 10.1128/MMBR.50.4.484-524.1986; Keis S, 2001, INT J SYST EVOL MICR, V51, P2095, DOI 10.1099/00207713-51-6-2095; Kopke M, 2010, P NATL ACAD SCI USA, V107, P13087, DOI 10.1073/pnas.1004716107; Lee SY, 2008, BIOTECHNOL BIOENG, V101, P209, DOI 10.1002/bit.22003; Liou JSC, 2005, INT J SYST EVOL MICR, V55, P2085, DOI 10.1099/ijs.0.63482-0; Munasinghe PC, 2010, BIORESOURCE TECHNOL, V101, P5013, DOI 10.1016/j.biortech.2009.12.098; NAIR RV, 1994, J BACTERIOL, V176, P871, DOI 10.1128/jb.176.3.871-885.1994; Papoutsakis ET, 2008, CURR OPIN BIOTECH, V19, P420, DOI 10.1016/j.copbio.2008.08.003; Pierce E, 2008, ENVIRON MICROBIOL, V10, P2550, DOI 10.1111/j.1462-2920.2008.01679.x; Ragsdale SW, 2008, ANN NY ACAD SCI, V1125, P129, DOI 10.1196/annals.1419.015; Ragsdale SW, 2008, BBA-PROTEINS PROTEOM, V1784, P1873, DOI 10.1016/j.bbapap.2008.08.012; Rajagopalan S, 2002, BIOMASS BIOENERG, V23, P487, DOI 10.1016/S0961-9534(02)00071-5; SCHWARZ WH, 2006, BUTANOL REDISCOVERIN, P16; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; TANNER RS, 1993, INT J SYST BACTERIOL, V43, P232, DOI 10.1099/00207713-43-2-232; Toth J, 1999, APPL ENVIRON MICROB, V65, P4973; VASCONCELOS I, 1994, J BACTERIOL, V176, P1443, DOI 10.1128/jb.176.5.1443-1450.1994; WALTER KA, 1993, GENE, V134, P107, DOI 10.1016/0378-1119(93)90182-3; YAN RT, 1988, APPL ENVIRON MICROB, V54, P642, DOI 10.1128/AEM.54.3.642-648.1988; Zheng YN, 2009, J IND MICROBIOL BIOT, V36, P1127, DOI 10.1007/s10295-009-0609-9	44	110	117	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e13033	10.1371/journal.pone.0013033	http://dx.doi.org/10.1371/journal.pone.0013033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20885952	gold, Green Submitted, Green Published			2022-12-27	WOS:000282167100026
J	de Wit, J; Souwer, Y; Jorritsma, T; Bos, HK; ten Brinke, A; Neefjes, J; van Ham, SM				de Wit, Jelle; Souwer, Yuri; Jorritsma, Tineke; Bos, Hanny Klaasse; ten Brinke, Anja; Neefjes, Jacques; van Ham, S. Marieke			Antigen-Specific B Cells Reactivate an Effective Cytotoxic T Cell Response against Phagocytosed Salmonella through Cross-Presentation	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; III SECRETION SYSTEM; GUT EPITHELIAL MONOLAYERS; IMMUNE-RESPONSES; INFECTIOUS ENTEROCOLITIS; PATHOGENICITY ISLAND-2; BACTERIAL-GROWTH; HOST-CELLS; VIRULENCE; PROTEINS	Background: The eradication of facultative intracellular bacterial pathogens, like Salmonella typhi, requires the concerted action of both the humoral immune response and the cytotoxic CD8(+) T cell response. Dendritic cells (DCs) are considered to orchestrate the cytotoxic CD8(+) T cell response via cross-presentation of bacterial antigens onto MHC class I molecules. Cross-presentation of Salmonella by DCs however, is accompanied by the induction of apoptosis in the DCs. Besides antibody production, B cells are required to clear Salmonella infection for other unknown reasons. Methodology/Principal Findings: Here we show that Salmonella-specific B cells that phagocytose Salmonella upon BCR-ligation reactivate human memory CD8(+) T cells via cross-presentation yielding a Salmonella-specific cytotoxic T cell response. The reactivation of CD8(+) T cells is dependent on CD4(+) T cell help. Unlike the DCs, B cell-mediated cross-presentation of Salmonella does not coincide with apoptosis. Conclusions/Significance: B cells form a new player in the activation of the cytotoxic effector arm of the immune response and the generation of effective adaptive immunity in Salmonella infection.	[de Wit, Jelle; Souwer, Yuri; Jorritsma, Tineke; Bos, Hanny Klaasse; ten Brinke, Anja; van Ham, S. Marieke] Univ Amsterdam, Acad Med Ctr, Dept Immunopathol, Sanquin Res & Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; [Neefjes, Jacques] Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Netherlands Cancer Institute	de Wit, J (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Immunopathol, Sanquin Res & Landsteiner Lab, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	m.vanham@sanquin.nl	Neefjes, Jacques J.C./H-8780-2017; de Wit, Jelle/W-7035-2019	Neefjes, Jacques J.C./0000-0001-6763-2211; de Wit, Jelle/0000-0003-2444-6050; ten Brinke, Anja/0000-0002-0135-7496	Landsteiner Foundation for Blood Research [0533]	Landsteiner Foundation for Blood Research	This work was supported by a grant from the Landsteiner Foundation for Blood Research (Grant 0533). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaghdadi H, 2009, J IMMUNOL, V183, P3778, DOI 10.4049/jimmunol.0900843; CARTER PB, 1974, J EXP MED, V139, P1189, DOI 10.1084/jem.139.5.1189; Chen LM, 1996, MOL MICROBIOL, V21, P1101, DOI 10.1046/j.1365-2958.1996.471410.x; Coburn B, 2005, INFECT IMMUN, V73, P3219, DOI 10.1128/IAI.73.6.3219-3227.2005; Coombes BK, 2005, INFECT IMMUN, V73, P7161, DOI 10.1128/IAI.73.11.7161-7169.2005; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; FOSTER JW, 1995, ANNU REV MICROBIOL, V49, P145, DOI 10.1146/annurev.micro.49.1.145; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Gullberg E, 2000, BIOCHEM BIOPH RES CO, V279, P808, DOI 10.1006/bbrc.2000.4038; Harty JT, 1999, CURR OPIN IMMUNOL, V11, P89, DOI 10.1016/S0952-7915(99)80016-8; Jensen VB, 1998, INFECT IMMUN, V66, P3758, DOI 10.1128/IAI.66.8.3758-3766.1998; Jones BD, 1996, ANNU REV IMMUNOL, V14, P533, DOI 10.1146/annurev.immunol.14.1.533; Kuijl C, 2007, NATURE, V450, P725, DOI 10.1038/nature06345; Marsman M, 2004, MOL BIOL CELL, V15, P2954, DOI 10.1091/mbc.E03-08-0614; Mastroeni P, 2000, INFECT IMMUN, V68, P46, DOI 10.1128/IAI.68.1.46-53.2000; Mittrucker HW, 2000, J IMMUNOL, V164, P1648, DOI 10.4049/jimmunol.164.4.1648; Monack DM, 1996, P NATL ACAD SCI USA, V93, P9833, DOI 10.1073/pnas.93.18.9833; Neutra MR, 1996, ANNU REV IMMUNOL, V14, P275, DOI 10.1146/annurev.immunol.14.1.275; Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800; Ravindran R, 2005, IMMUNOLOGY, V114, P450, DOI 10.1111/j.1365-2567.2005.02140.x; Rescigno M, 2001, IMMUNOBIOLOGY, V204, P572, DOI 10.1078/0171-2985-00094; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Rosales-Reyes R, 2005, INFECT IMMUN, V73, P3937, DOI 10.1128/IAI.73.7.3937-3944.2005; Russmann H, 2003, INT J MED MICROBIOL, V293, P107, DOI 10.1078/1438-4221-00249; Salerno-Goncalves R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005879; Shea JE, 1996, P NATL ACAD SCI USA, V93, P2593, DOI 10.1073/pnas.93.6.2593; Shea JE, 1999, INFECT IMMUN, V67, P213, DOI 10.1128/IAI.67.1.213-219.1999; Souwer Y, 2009, J IMMUNOL, V182, P7473, DOI 10.4049/jimmunol.0802831; Stemberger C, 2009, SEMIN IMMUNOL, V21, P62, DOI 10.1016/j.smim.2009.02.004; Ugrinovic S, 2003, INFECT IMMUN, V71, P6808, DOI 10.1128/IAI.71.12.6808-6819.2003; Waterman SR, 2003, CELL MICROBIOL, V5, P501, DOI 10.1046/j.1462-5822.2003.00294.x; Zhang SP, 2003, INFECT IMMUN, V71, P4795, DOI 10.1128/IAI.71.8.4795-4803.2003; Zhou DG, 2001, MICROBES INFECT, V3, P1293, DOI 10.1016/S1286-4579(01)01489-7	33	41	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e13016	10.1371/journal.pone.0013016	http://dx.doi.org/10.1371/journal.pone.0013016			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20885961	Green Published, gold, Green Submitted			2022-12-27	WOS:000282167100017
J	Njajou, OT; Blackburn, EH; Pawlikowska, L; Mangino, M; Damcott, CM; Kwok, PY; Spector, TD; Newman, AB; Harris, TB; Cummings, SR; Cawthon, RM; Shuldiner, AR; Valdes, AM; Hsueh, WC				Njajou, Omer T.; Blackburn, Elizabeth H.; Pawlikowska, Ludmila; Mangino, Massimo; Damcott, Coleen M.; Kwok, Pui-Yan; Spector, Timothy D.; Newman, Anne B.; Harris, Tamara B.; Cummings, Steven R.; Cawthon, Richard M.; Shuldiner, Alan R.; Valdes, Ana M.; Hsueh, Wen-Chi			A Common Variant in the Telomerase RNA Component Is Associated with Short Telomere Length	PLOS ONE			English	Article							DYSKERATOSIS-CONGENITA; GENE TERC; DISEASE; CELLS; MUTATIONS; PEDIGREES; BIOLOGY; HTERC	Background: Telomeres shorten as cells divide. This shortening is compensated by the enzyme telomerase. We evaluated the effect of common variants in the telomerase RNA component (TERC) gene on telomere length (TL) in the population-based Health Aging and Body Composition (Health ABC) Study and in two replication samples (the TwinsUK Study and the Amish Family Osteoporosis Study, AFOS). Methodology: Five variants were identified in the TERC region by sequence analysis and only one SNP was common (rs2293607, G/A). The frequency of the G allele was 0.26 and 0.07 in white and black, respectively. Testing for association between TL and rs2293607 was performed using linear regression models or variance component analysis conditioning on relatedness among subjects. Results: The adjusted mean TL was significantly shorter in 665 white carriers of the G allele compared to 887 non-carriers from the Health ABC Study (4.69 +/- 0.05 kbp vs. 4.86 +/- 0.04 kbp, measured by quantitative PCR, p = 0.005). This association was replicated in another white sample from the TwinsUK Study (6.90 +/- 0.03 kbp in 301 carriers compared to 7.06 +/- 0.03 kbp in 395 non-carriers, measured by Southern blots, p = 0.009). A similar pattern of association was observed in whites from the family-based AFOS and blacks from the Health ABC cohort, although not statistically significant, possibly due to the lower allele frequency in these populations. Combined analysis using 2,953 white subjects from 3 studies showed a significant association between TL and rs2293607 (beta = -0.19 +/- 0.04 kbp, p = 0.001). Conclusion: Our study shows a significant association between a common variant in TERC and TL in humans, suggesting that TERC may play a role in telomere homeostasis.	[Njajou, Omer T.; Hsueh, Wen-Chi] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Pawlikowska, Ludmila] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA; [Blackburn, Elizabeth H.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Kwok, Pui-Yan] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Mangino, Massimo; Spector, Timothy D.; Valdes, Ana M.] Kings Coll London, St Thomas Hosp, Twin Res & Genet Epidemiol Unit, London WC2R 2LS, England; [Damcott, Coleen M.; Shuldiner, Alan R.] Univ Maryland, Dept Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA; [Newman, Anne B.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Harris, Tamara B.] NIA, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; [Cummings, Steven R.] Calif Pacific Med Ctr, Res Inst, San Francisco, CA USA; [Cawthon, Richard M.] Univ Utah, Dept Human Genet, Salt Lake City, UT USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University System of Maryland; University of Maryland Baltimore; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); California Pacific Medical Center; California Pacific Medical Center Research Institute; Utah System of Higher Education; University of Utah	Njajou, OT (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	wen-chi.hsueh@ucsf.edu	Kwok, Pui-Yan/F-7725-2014; Mangino, Massimo/F-5134-2011; Newman, Anne B./C-6408-2013	Kwok, Pui-Yan/0000-0002-5087-3059; Mangino, Massimo/0000-0002-2167-7470; Newman, Anne B./0000-0002-0106-1150; Shuldiner, Alan/0000-0001-9921-4305; Valdes, Ana M./0000-0003-1141-4471	National Institutes of Health (NIH) [N01 AG-6-2101, N01 AG-6-2103, N01 AG-6-2106, K01 AG022782, R01 AG023692, U19 AG023122]; NIH, National Institute on Aging; Wellcome Trust; NIHR (TDS), NIHR Biomedical Research Centre; National Cancer Institute [R25 CA112355]; NATIONAL CANCER INSTITUTE [R25CA112355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [N01AG062101, U19AG023122, N01AG062103, N01AG062106, K01AG022782, R01AG023692] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Wellcome Trust(Wellcome Trust); NIHR (TDS), NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported in part by the National Institutes of Health (NIH) contracts (N01 AG-6-2101, N01 AG-6-2103 and N01 AG-6-2106) and grants (K01 AG022782, R01 AG023692 and U19 AG023122). This research was also supported in part by the Intramural Research Program of the NIH, National Institute on Aging and by the Wellcome Trust; NIHR (TDS), NIHR Biomedical Research Centre (grant to Guys' and St. Thomas' Hospitals and King's College London). Dr. Omer T. Njajou is supported by the Training in Molecular and Genetic Epidemiology of Cancer grant from the National Cancer Institute (R25 CA112355). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S., NATURE, V464, P292; Agarwala R, 1998, GENOME RES, V8, P211, DOI 10.1101/gr.8.3.211; Agarwala R, 2001, HUM BIOL, V73, P533, DOI 10.1353/hub.2001.0045; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; ATZMON G, 2009, P NATL ACAD SCI US; Aviv A, 2006, INT J EPIDEMIOL, V35, P1424, DOI 10.1093/ije/dyl169; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Brown LB, 2004, GENET EPIDEMIOL, V27, P153, DOI 10.1002/gepi.20009; Bryan TM, 1997, HUM MOL GENET, V6, P921, DOI 10.1093/hmg/6.6.921; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cheong C, 2003, EXP MOL MED, V35, P141, DOI 10.1038/emm.2003.20; CODD V, NAT GENET, V42, P197; Du HY, 2009, BLOOD, V113, P309, DOI 10.1182/blood-2008-07-166421; Goldman F, 2005, P NATL ACAD SCI USA, V102, P17119, DOI 10.1073/pnas.0505318102; Hoare SF, 2001, CANCER RES, V61, P27; Kirwan M, 2009, BRIT J HAEMATOL, V144, P771, DOI 10.1111/j.1365-2141.2008.07516.x; Koyanagi Y, 2000, ANTICANCER RES, V20, P773; Liti G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000659; Ly H, 2005, BLOOD, V106, P1246, DOI 10.1182/blood-2005-01-0247; Njajou OT, 2009, J GERONTOL A-BIOL, V64, P860, DOI 10.1093/gerona/glp061; Ohtsuka T, 2002, BRIT J DERMATOL, V147, P250, DOI 10.1046/j.1365-2133.2002.04937.x; Sethupathy P, 2008, TRENDS GENET, V24, P489, DOI 10.1016/j.tig.2008.07.004; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Vulliamy T, 2004, NAT GENET, V36, P447, DOI 10.1038/ng1346; Yamaguchi H, 2003, BLOOD, V102, P916, DOI 10.1182/blood-2003-01-0335	26	29	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e13048	10.1371/journal.pone.0013048	http://dx.doi.org/10.1371/journal.pone.0013048			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20885959	Green Published, gold			2022-12-27	WOS:000282167100030
J	Schindler, R; Nilsson, E; Skinner, MK				Schindler, Ryan; Nilsson, Eric; Skinner, Michael K.			Induction of Ovarian Primordial Follicle Assembly by Connective Tissue Growth Factor CTGF	PLOS ONE			English	Article							MESSENGER RIBONUCLEIC-ACIDS; RAT GRANULOSA-CELLS; GERM-CELLS; INITIATES FOLLICULOGENESIS; CCN FAMILY; OOCYTE; APOPTOSIS; FETAL; TRANSITION; EXPRESSION	Primordial follicle assembly is a process that occurs when oocyte nests break down to form individual primordial follicles. The size of this initial pool of primordial follicles in part determines the reproductive lifespan of the female. Connective tissue growth factor (CTGF) was identified as a potential regulatory candidate for this process in a previous microarray analysis of follicle development. The current study examines the effects of CTGF and associated transforming growth factor beta 1 (TGF beta-1) on follicle assembly. Ovaries were removed from newborn rat pups and placed in an organ culture system. The ovaries treated with CTGF for two days were found to have an increased proportion of assembled follicles. CTGF was found to regulate the ovarian transcriptome during primordial follicle assembly and an integrative network of genes was identified. TGF beta-1 had no effect on primordial follicle assembly and in combination with CTGF decreased oocyte number in the ovary after two days of culture. Over ten days of treatment only the combined treatment of CTGF and TGF beta-1 was found to cause an increase in the proportion of assembled follicles. Interestingly, treatment with TGF beta-1 alone resulted in fewer total oocytes in the ovary and decreased the primordial follicle pool size after ten days of culture. Observations indicate that CTGF alone or in combination with TGF beta-1 stimulates primordial follicle assembly and TGF beta-1 can decrease the primordial follicle pool size. These observations suggest the possibility of manipulating primordial follicle pool size and influencing female reproductive lifespan.	[Schindler, Ryan; Nilsson, Eric; Skinner, Michael K.] Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA	Washington State University	Schindler, R (corresponding author), Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA.	skinner@wsu.edu	Nilsson, Eric/AAR-5021-2020		NIH [NIH R01 HD043093-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043093] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by an NIH grant to MKS (NIH R01 HD043093-01 "Ovarian Primordial Follicle Development.") The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; BAKER TG, 1963, PROC R SOC SER B-BIO, V158, P417, DOI 10.1098/rspb.1963.0055; Brigstock David R., 2002, Angiogenesis, V5, P153, DOI 10.1023/A:1023823803510; Brigstock DR, 1999, ENDOCR REV, V20, P189, DOI 10.1210/er.20.2.189; Bristol-Gould SK, 2006, DEV BIOL, V298, P132, DOI 10.1016/j.ydbio.2006.06.025; BYSKOV AG, 1977, J ANAT, V123, P77; CRAN DG, 1980, SCI PROG, V66, P371; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Duncan MR, 1999, FASEB J, V13, P1774, DOI 10.1096/fasebj.13.13.1774; Faddy MJ, 1996, HUM REPROD, V11, P1484; FADDY MJ, 1992, HUM REPROD, V7, P1342, DOI 10.1093/oxfordjournals.humrep.a137570; Faddy MJ, 2000, MOL CELL ENDOCRINOL, V163, P43, DOI 10.1016/S0303-7207(99)00238-5; Fan WH, 2000, EUR J CELL BIOL, V79, P915, DOI 10.1078/0171-9335-00122; FENG P, 1988, ENDOCRINOLOGY, V122, P181, DOI 10.1210/endo-122-1-181; Fulton N, 2005, J CLIN ENDOCR METAB, V90, P4664, DOI 10.1210/jc.2005-0219; GOSDEN RG, 1983, BIOL REPROD, V28, P255, DOI 10.1095/biolreprod28.2.255; Harlow CR, 2007, J ENDOCRINOL, V192, P41, DOI 10.1677/joe.1.06689; HIRSHFIELD AN, 1994, BIOL REPROD, V50, P421, DOI 10.1095/biolreprod50.2.421; HIRSHFIELD AN, 1991, INT REV CYTOL, V124, P43; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; Hussein MR, 2005, HUM REPROD UPDATE, V11, P162, DOI 10.1093/humupd/dmi001; Johnson J, 2004, NATURE, V428, P145, DOI 10.1038/nature02316; Johnson J, 2005, CELL, V122, P303, DOI 10.1016/j.cell.2005.06.031; Juengel JL, 2002, MOL CELL ENDOCRINOL, V191, P1, DOI 10.1016/S0303-7207(02)00045-X; Kezele P, 2003, ENDOCRINOLOGY, V144, P3329, DOI 10.1210/en.2002-0131; Kezele PR, 2005, BIOL REPROD, V72, P241, DOI 10.1095/biolreprod.104.032060; Lei L, 2010, MOL CELL ENDOCRINOL, V315, P63, DOI 10.1016/j.mce.2009.09.021; Levacher C, 1996, DIFFERENTIATION, V61, P45, DOI 10.1046/j.1432-0436.1996.6110045.x; Lovasco LA, 2010, BIOL REPROD, V82, P23, DOI 10.1095/biolreprod.109.077495; McNatty KP, 2000, MOL CELL ENDOCRINOL, V163, P11, DOI 10.1016/S0303-7207(99)00235-X; Morita Y, 1999, DEV BIOL, V213, P1, DOI 10.1006/dbio.1999.9344; Nilsson E, 2001, MOL CELL ENDOCRINOL, V175, P123, DOI 10.1016/S0303-7207(01)00391-4; Nilsson EE, 2002, MOL CELL ENDOCRINOL, V188, P65, DOI 10.1016/S0303-7207(01)00746-8; Nilsson EE, 2006, REPRODUCTION, V132, P877, DOI 10.1530/REP-06-0045; Parrott JA, 1999, ENDOCRINOLOGY, V140, P4262, DOI 10.1210/en.140.9.4262; Pepling ME, 2001, DEV BIOL, V234, P339, DOI 10.1006/dbio.2001.0269; PETERS H, 1975, J REPROD FERTIL, V45, P559, DOI 10.1530/jrf.0.0450559; RAJAH R, 1992, DEV DYNAM, V194, P177, DOI 10.1002/aja.1001940303; Rajareddy S, 2007, MOL ENDOCRINOL, V21, P2189, DOI 10.1210/me.2007-0172; Reddy P, 2008, SCIENCE, V319, P611, DOI 10.1126/science.1152257; RICHARDSON SJ, 1987, J CLIN ENDOCR METAB, V65, P1231, DOI 10.1210/jcem-65-6-1231; Sawyer HR, 2002, BIOL REPROD, V66, P1134, DOI 10.1095/biolreprod66.4.1134; Schilling B, 1999, FERTIL STERIL, V72, P147, DOI 10.1016/S0015-0282(99)00182-X; SHIMA JE, 2004, BIOL REPROD; Skinner MK, 2005, HUM REPROD UPDATE, V11, P461, DOI 10.1093/humupd/dmi020; Slee RB, 2001, ENDOCRINOLOGY, V142, P1082, DOI 10.1210/en.142.3.1082; Tilly JL, 1998, TOXICOL LETT, V103, P497, DOI 10.1016/S0378-4274(98)00240-9; Visser JA, 2007, ENDOCRINOLOGY, V148, P2301, DOI 10.1210/en.2006-1265; Wandji SA, 2000, ENDOCRINOLOGY, V141, P2648, DOI 10.1210/en.141.7.2648; Zou K, 2009, NAT CELL BIOL, V11, P631, DOI 10.1038/ncb1869	50	39	39	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2010	5	9							e12979	10.1371/journal.pone.0012979	http://dx.doi.org/10.1371/journal.pone.0012979			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653UN	20886044	Green Submitted, Green Published, gold			2022-12-27	WOS:000282122600015
J	Jann, K; Kottlow, M; Dierks, T; Boesch, C; Koenig, T				Jann, Kay; Kottlow, Mara; Dierks, Thomas; Boesch, Chris; Koenig, Thomas			Topographic Electrophysiological Signatures of fMRI Resting State Networks	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; DEFAULT-MODE; FUNCTIONAL CONNECTIVITY; BRAIN OSCILLATIONS; EEG TOPOGRAPHY; ALPHA; THETA; SYNCHRONIZATION; CLASSIFICATION; TOMOGRAPHY	Background: fMRI Resting State Networks (RSNs) have gained importance in the present fMRI literature. Although their functional role is unquestioned and their physiological origin is nowadays widely accepted, little is known about their relationship to neuronal activity. The combined recording of EEG and fMRI allows the temporal correlation between fluctuations of the RSNs and the dynamics of EEG spectral amplitudes. So far, only relationships between several EEG frequency bands and some RSNs could be demonstrated, but no study accounted for the spatial distribution of frequency domain EEG. Methodology/Principal Findings: In the present study we report on the topographic association of EEG spectral fluctuations and RSN dynamics using EEG covariance mapping. All RSNs displayed significant covariance maps across a broad EEG frequency range. Cluster analysis of the found covariance maps revealed the common standard EEG frequency bands. We found significant differences between covariance maps of the different RSNs and these differences depended on the frequency band. Conclusions/Significance: Our data supports the physiological and neuronal origin of the RSNs and substantiates the assumption that the standard EEG frequency bands and their topographies can be seen as electrophysiological signatures of underlying distributed neuronal networks.	[Jann, Kay; Kottlow, Mara; Dierks, Thomas; Koenig, Thomas] Univ Hosp Psychiat, Dept Psychiat Neurophysiol, Bern, Switzerland; [Jann, Kay; Kottlow, Mara; Dierks, Thomas; Boesch, Chris; Koenig, Thomas] Univ Bern, Bern, Switzerland; [Boesch, Chris] Univ Bern, Inselspital, Dept Clin Res, AMSM, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University Hospital of Bern	Jann, K (corresponding author), Univ Hosp Psychiat, Dept Psychiat Neurophysiol, Bern, Switzerland.	jann@puk.unibe.ch	Boesch, Chris/F-2577-2010; Jann, Kay/AAF-2154-2020; Dierks, Thomas/B-7092-2012; Jann, Kay/E-8343-2010; Koenig, Thomas/F-6454-2010; Koenig, Thomas/ABD-2278-2020	Boesch, Chris/0000-0001-8498-8543; Dierks, Thomas/0000-0002-4173-5308; Koenig, Thomas/0000-0002-1472-4638; Koenig, Thomas/0000-0002-1472-4638; Jann, Kay/0000-0003-3574-0538	Swiss National Science Foundation [320000-108321/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was financed by the Swiss National Science Foundation grant 320000-108321/1 ( http://www.snf.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUELSEOUD A, HUM BRAIN MAPP; Allen PJ, 1998, NEUROIMAGE, V8, P229, DOI 10.1006/nimg.1998.0361; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; BRITZ J, NEUROIMAGE; Burgess AP, 1997, NEUROREPORT, V8, P1039, DOI 10.1097/00001756-199703030-00044; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; De Martino F, 2007, NEUROIMAGE, V34, P177, DOI 10.1016/j.neuroimage.2006.08.041; Esposito F, 2005, NEUROIMAGE, V25, P193, DOI 10.1016/j.neuroimage.2004.10.042; Fuchs M, 1998, ELECTROEN CLIN NEURO, V107, P93, DOI 10.1016/S0013-4694(98)00046-7; GASTAUT MH, 1952, REV NEUROL, V87, P176; GIBBS FA, 1949, ELECTROEN CLIN NEURO, V1, P223, DOI 10.1016/0013-4694(49)90026-7; Goldman RI, 2002, NEUROREPORT, V13, P2487, DOI 10.1097/00001756-200212200-00022; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Jann K, 2009, NEUROIMAGE, V45, P903, DOI 10.1016/j.neuroimage.2009.01.001; Jann K, 2008, NEUROIMAGE, V42, P635, DOI 10.1016/j.neuroimage.2008.05.001; JOHN ER, 1988, SCIENCE, V239, P162, DOI 10.1126/science.3336779; John ER, 2001, CONSCIOUS COGN, V10, P184, DOI 10.1006/ccog.2001.0508; JOHN ER, 1977, SCIENCE, V196, P1393, DOI 10.1126/science.867036; JOHN ER, 1980, SCIENCE, V210, P1255, DOI 10.1126/science.7434026; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Kim DI, 2009, HUM BRAIN MAPP, V30, P3795, DOI 10.1002/hbm.20807; Kiviniemi V, 2009, HUM BRAIN MAPP, V30, P3865, DOI 10.1002/hbm.20813; Klimesch W, 1996, INT J PSYCHOPHYSIOL, V24, P61, DOI 10.1016/S0167-8760(96)00057-8; Koenig T, 1999, EUR ARCH PSY CLIN N, V249, P205, DOI 10.1007/s004060050088; Koenig T., 2009, ELECT NEUROIMAGING, P169, DOI DOI 10.1017/CBO9780511596889; Koenig T, 2008, CLIN NEUROPHYSIOL, V119, P1262, DOI 10.1016/j.clinph.2007.12.023; Koenig T, 2010, BRAIN TOPOGR, V23, P233, DOI 10.1007/s10548-010-0142-1; KUHLMAN WN, 1978, ELECTROEN CLIN NEURO, V44, P83, DOI 10.1016/0013-4694(78)90107-4; Laufs H, 2003, P NATL ACAD SCI USA, V100, P11053, DOI 10.1073/pnas.1831638100; Laufs H, 2003, NEUROIMAGE, V19, P1463, DOI 10.1016/S1053-8119(03)00286-6; Laufs H, 2008, HUM BRAIN MAPP, V29, P762, DOI 10.1002/hbm.20600; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; McKeown MJ, 1997, NEUROLOGY, V48, P6056; McKeown MJ, 1998, P NATL ACAD SCI USA, V95, P803, DOI 10.1073/pnas.95.3.803; MICHEL CM, 1992, ELECTROEN CLIN NEURO, V82, P38, DOI 10.1016/0013-4694(92)90180-P; Michels L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010298; Neuper C, 2001, INT J PSYCHOPHYSIOL, V43, P41, DOI 10.1016/S0167-8760(01)00178-7; Nikulin VV, 2006, NEUROSCIENCE, V137, P647, DOI 10.1016/j.neuroscience.2005.10.031; Palva JM, 2005, J NEUROSCI, V25, P3962, DOI 10.1523/JNEUROSCI.4250-04.2005; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; PFURTSCHELLER G, 1981, ELECTROEN CLIN NEURO, V51, P253, DOI 10.1016/0013-4694(81)90139-5; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Ritter P, 2009, HUM BRAIN MAPP, V30, P1168, DOI 10.1002/hbm.20585; Saletu B, 2006, CLIN EEG NEUROSCI, V37, P66, DOI 10.1177/155005940603700205; Scheeringa R, 2008, INT J PSYCHOPHYSIOL, V67, P242, DOI 10.1016/j.ijpsycho.2007.05.017; Strik WK, 1998, EVOKED POTENTIAL, V108, P406, DOI 10.1016/S0168-5597(98)00021-5; TALAIRACH J, 1988, REFERENTIALLY ORIENT; Tinguely G, 2006, NEUROIMAGE, V32, P283, DOI 10.1016/j.neuroimage.2006.03.017; VOLKOW ND, 1987, BIOL PSYCHIAT, V22, P199, DOI 10.1016/0006-3223(87)90231-9; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727	57	118	121	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12945	10.1371/journal.pone.0012945	http://dx.doi.org/10.1371/journal.pone.0012945			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877577	Green Published, Green Submitted, gold			2022-12-27	WOS:000282053100037
J	Vivithanaporn, P; Maingat, F; Lin, LT; Na, H; Richardson, CD; Agrawal, B; Cohen, EA; Jhamandas, JH; Power, C				Vivithanaporn, Pornpun; Maingat, Ferdinand; Lin, Liang-Tzung; Na, Hong; Richardson, Christopher D.; Agrawal, Babita; Cohen, Eric A.; Jhamandas, Jack H.; Power, Christopher			Hepatitis C Virus Core Protein Induces Neuroimmune Activation and Potentiates Human Immunodeficiency Virus-1 Neurotoxicity	PLOS ONE			English	Article							LENTIVIRUS INFECTION; ALZHEIMERS-DISEASE; NEURONAL AUTOPHAGY; HIV-1; EXPRESSION; BRAIN; COINFECTION; MICROGLIA; CELLS; REPLICATION	Background: Hepatitis C virus (HCV) genomes and proteins are present in human brain tissues although the impact of HIV/ HCV co-infection on neuropathogenesis remains unclear. Herein, we investigate HCV infectivity and effects on neuronal survival and neuroinflammation in conjunction with HIV infection. Methodology: Human microglia, astrocyte and neuron cultures were infected with cell culture-derived HCV or exposed to HCV core protein with or without HIV-1 infection or HIV-1 Viral Protein R (Vpr) exposure. Host immune gene expression and cell viability were measured. Patch-clamp studies of human neurons were performed in the presence or absence of HCV core protein. Neurobehavioral performance and neuropathology were examined in HIV-1 Vpr-transgenic mice in which stereotaxic intrastriatal implants of HCV core protein were performed. Principal Findings: HCV-encoded RNA as well as HCV core and non-structural 3 (NS3) proteins were detectable in human microglia and astrocytes infected with HCV. HCV core protein exposure induced expression of pro-inflammatory cytokines including interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha in microglia (p<0.05) but not in astrocytes while increased chemokine (e. g. CXCL10 and interleukin-8) expression was observed in both microglia and astrocytes (p<0.05). HCV core protein modulated neuronal membrane currents and reduced both beta-III-tubulin and lipidated LC3-II expression (p<0.05). Neurons exposed to supernatants from HCV core-activated microglia exhibited reduced b-III-tubulin expression (p<0.05). HCV core protein neurotoxicity and interleukin-6 induction were potentiated by HIV-1 Vpr protein (p<0.05). HIV-1 Vpr transgenic mice implanted with HCV core protein showed gliosis, reduced neuronal counts together with diminished LC3 immunoreactivity. HCV core-implanted animals displayed neurobehavioral deficits at days 7 and 14 post-implantation (p<0.05). Conclusions: HCV core protein exposure caused neuronal injury through suppression of neuronal autophagy in addition to neuroimmune activation. The additive neurotoxic effects of HCV- and HIV-encoded proteins highlight extrahepatic mechanisms by which HCV infection worsens the disease course of HIV infection.	[Vivithanaporn, Pornpun; Maingat, Ferdinand; Na, Hong; Jhamandas, Jack H.; Power, Christopher] Univ Alberta, Div Neurol, Edmonton, AB, Canada; [Vivithanaporn, Pornpun] Mahidol Univ, Fac Sci, Dept Pharmacol, Bangkok 10400, Thailand; [Lin, Liang-Tzung; Richardson, Christopher D.] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada; [Agrawal, Babita] Univ Alberta, Dept Surg, Edmonton, AB, Canada; [Cohen, Eric A.] Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ H3C 3J7, Canada; [Cohen, Eric A.] Univ Montreal, IRCM, Montreal, PQ, Canada	University of Alberta; Mahidol University; Dalhousie University; University of Alberta; Universite de Montreal; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Vivithanaporn, P (corresponding author), Univ Alberta, Div Neurol, Edmonton, AB, Canada.	chris.power@ualberta.ca	Power, Christopher/C-7181-2013	Lin, Liang-Tzung/0000-0001-7374-7234; Power, Christopher/0000-0002-5131-9711	Alberta Heritage Foundation for Medical Research (AHFMR); Canadian Institutes of Health Research (CIHR) [HET-85517]	Alberta Heritage Foundation for Medical Research (AHFMR)(Alberta Heritage Foundation for Medical Research); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	PV holds a fellowship from the Alberta Heritage Foundation for Medical Research (AHFMR). CP holds a Canada Research Chair (CRC) (Tier 1) in Neurological Infection and Immunity and an AHFMR Senior Scholarship. BA holds an AHFMR Senior Scholarship. This study was supported by an Emerging Team Grant (HET-85517) from the Canadian Institutes of Health Research (CIHR). The authors have no financial interests. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Afkhami-Goli A, 2009, J NEUROVIROL, V15, P139, DOI 10.1080/13550280802534763; Alirezaei M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002906; Anthony IC, 2008, FRONT BIOSCI-LANDMRK, V13, P1294, DOI 10.2741/2762; Apolinario A, 2005, J VIRAL HEPATITIS, V12, P27, DOI 10.1111/j.1365-2893.2005.00540.x; Barbasz A, 2008, INT IMMUNOPHARMACOL, V8, P211, DOI 10.1016/j.intimp.2007.08.002; Boddi M, 2010, J CLIN VIROL, V47, P72, DOI 10.1016/j.jcv.2009.10.005; Bode JG, 2008, BIOL CHEM, V389, P1283, DOI 10.1515/BC.2008.147; Burlone ME, 2009, J GEN VIROL, V90, P1055, DOI 10.1099/vir.0.008300-0; Clifford DB, 2005, J NEUROVIROL, V11, P67, DOI 10.1080/13550280500513762; Dickie P, 2004, VIROLOGY, V322, P69, DOI 10.1016/j.virol.2004.01.026; Dijkstra S, 2000, J COMP NEUROL, V428, P266, DOI 10.1002/1096-9861(20001211)428:2<266::AID-CNE6>3.0.CO;2-0; Dolganiuc A, 2004, GASTROENTEROLOGY, V127, P1513, DOI 10.1053/j.gastro.2004.08.067; Dolganiuc A, 2003, J IMMUNOL, V170, P5615, DOI 10.4049/jimmunol.170.11.5615; Duffy HS, 2000, J NEUROSCI, V20; Eisen-Vandervelde AL, 2004, CLIN IMMUNOL, V111, P16, DOI 10.1016/j.clim.2003.12.003; Fernando LP, 2003, THROMB HAEMOSTASIS, V90, P787, DOI 10.1160/TH03-04-0231; Fischer R, 2007, WORLD J GASTROENTERO, V13, P4865, DOI 10.3748/wjg.v13.i36.4865; Fishman SL, 2008, J INFECT DIS, V197, P597, DOI 10.1086/526519; Forton DA, 2005, AIDS, V19, pS53, DOI 10.1097/01.aids.0000192071.72948.77; Forton DM, 2008, J HEPATOL, V49, P316, DOI 10.1016/j.jhep.2008.03.022; Giannini C, 2003, CELL DEATH DIFFER, V10, pS27, DOI 10.1038/sj.cdd.4401121; Greub G, 2000, LANCET, V356, P1800, DOI 10.1016/S0140-6736(00)03232-3; Hilsabeck RC, 2005, CLIN INFECT DIS, V41, pS38, DOI 10.1086/429494; Husemann J, 2002, GLIA, V40, P195, DOI 10.1002/glia.10148; Husemann J, 2001, AM J PATHOL, V158, P825, DOI 10.1016/S0002-9440(10)64030-8; Jack CS, 2005, J IMMUNOL, V175, P4320, DOI 10.4049/jimmunol.175.7.4320; Johnston JB, 2000, J VIROL, V74, P7211, DOI 10.1128/JVI.74.16.7211-7220.2000; Johnston JB, 2001, ANN NEUROL, V49, P230, DOI 10.1002/1531-8249(20010201)49:2<230::AID-ANA43>3.0.CO;2-O; Jones G, 2006, NEUROBIOL DIS, V21, P1, DOI 10.1016/j.nbd.2005.07.018; Jones GJ, 2007, J NEUROSCI, V27, P3703, DOI 10.1523/JNEUROSCI.5522-06.2007; Jones R, 2005, INT J CLIN PRACT, V59, P1082, DOI 10.1111/j.1742-1241.2005.00596.x; Kim AY, 2009, GASTROENTEROLOGY, V137, P795, DOI 10.1053/j.gastro.2009.06.040; Kittlesen DJ, 2000, J CLIN INVEST, V106, P1239, DOI 10.1172/JCI10323; Klein RS, 2004, J CELL BIOCHEM, V92, P213, DOI 10.1002/jcb.20052; Laskus T, 2005, AIDS, V19, pS140, DOI 10.1097/01.aids.0000192083.41561.00; Laskus T, 2002, J VIROL, V76, P10064, DOI 10.1128/JVI.76.19.10064-10068.2002; Letendre S, 2007, J INFECT DIS, V196, P361, DOI 10.1086/519285; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Loftis JM, 2008, NEUROSCI LETT, V430, P264, DOI 10.1016/j.neulet.2007.11.001; Maillard P, 2001, J VIROL, V75, P8240, DOI 10.1128/JVI.75.17.8240-8250.2001; Martinez-Vicente M, 2007, LANCET NEUROL, V6, P352, DOI 10.1016/S1474-4422(07)70076-5; Marukian S, 2008, HEPATOLOGY, V48, P1843, DOI 10.1002/hep.22550; Moorman JP, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-105; Moradpour D, 2003, ANTIVIR RES, V60, P103, DOI 10.1016/j.antiviral.2003.08.017; Moriishi K, 2007, REV MED VIROL, V17, P343, DOI 10.1002/rmv.542; Mukaida N, 2000, INT J HEMATOL, V72, P391; Murray J, 2008, J NEUROVIROL, V14, P17, DOI 10.1080/13550280701708427; NOORBAKHSH F, FASEB J; Orvedahl A, 2008, CELL MICROBIOL, V10, P1747, DOI 10.1111/j.1462-5822.2008.01175.x; Pais TF, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-43; Piller SC, 1998, P NATL ACAD SCI USA, V95, P4595, DOI 10.1073/pnas.95.8.4595; Power C, 1995, CURR TOP MICROBIOL, V202, P89; Power C, 1998, J VIROL, V72, P9045, DOI 10.1128/JVI.72.11.9045-9053.1998; Radkowski M, 2004, J GEN VIROL, V85, P47, DOI 10.1099/vir.0.19491-0; Radkowski M, 2002, J VIROL, V76, P600, DOI 10.1128/JVI.76.2.600-608.2002; Randall G, 2007, P NATL ACAD SCI USA, V104, P12884, DOI 10.1073/pnas.0704894104; REFAELI Y, 1995, P NATL ACAD SCI USA, V92, P3621, DOI 10.1073/pnas.92.8.3621; Romanitan MO, 2007, J CELL MOL MED, V11, P569, DOI 10.1111/j.1582-4934.2007.00047.x; Ruggieri A, 2007, BMC GASTROENTEROL, V7, DOI 10.1186/1471-230X-7-21; Ryan EL, 2004, NEUROLOGY, V62, P957, DOI 10.1212/01.WNL.0000115177.74976.6C; Sanchez MJ, 2008, MED SCI MONITOR, V14, pRA55; Sanders VJ, 1998, AIDS, V12, P1021, DOI 10.1097/00002030-199809000-00008; Soffredini R, 2004, AM J GASTROENTEROL, V99, P1738, DOI 10.1111/j.1572-0241.2004.30396.x; UNGERSTEDT U, 1970, Brain Research, V24, P485, DOI 10.1016/0006-8993(70)90187-3; Vecil GG, 2000, J NEUROSCI RES, V61, P212, DOI 10.1002/1097-4547(20000715)61:2<212::AID-JNR12>3.0.CO;2-9; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wilkinson J, 2009, J VIROL, V83, P1312, DOI 10.1128/JVI.01890-08; Yao ZQ, 2001, J IMMUNOL, V167, P5264, DOI 10.4049/jimmunol.167.9.5264; Yuki N, 2006, J HEPATOL, V44, P302, DOI 10.1016/j.jhep.2005.10.014; Zheng JC, 2008, J NEUROIMMUNOL, V200, P100, DOI 10.1016/j.jneuroim.2008.06.015; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Zhu Y, 2009, FASEB J, V23, P2928, DOI 10.1096/fj.08-128819; Zignego AL, 2007, DIGEST LIVER DIS, V39, P2, DOI 10.1016/j.dld.2006.06.008	73	59	61	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2010	5	9							e12856	10.1371/journal.pone.0012856	http://dx.doi.org/10.1371/journal.pone.0012856			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652JO	20877724	Green Published, gold, Green Submitted			2022-12-27	WOS:000282002900011
J	de Sousa, BC; Cunha, C				de Sousa, Bruno C.; Cunha, Celso			Development of Mathematical Models for the Analysis of Hepatitis Delta Virus Viral Dynamics	PLOS ONE			English	Article							B-VIRUS; COMBINATION THERAPY; REPLICATION; INFECTION; INTERFERON; LIVER; LAMIVUDINE; KINETICS; HBV; ANTIGEN	Background: Mathematical models have shown to be extremely helpful in understanding the dynamics of different virus diseases, including hepatitis B. Hepatitis D virus (HDV) is a satellite virus of the hepatitis B virus (HBV). In the liver, production of new HDV virions depends on the presence of HBV. There are two ways in which HDV can occur in an individual: coinfection and super-infection. Co-infection occurs when an individual is simultaneously infected by HBV and HDV, while super-infection occurs in persons with an existing chronic HBV infection. Methodology/Principal Findings: In this work a mathematical model based on differential equations is proposed for the viral dynamics of the hepatitis D virus (HDV) across different scenarios. This model takes into consideration the knowledge of the biology of the virus and its interaction with the host. In this work we will present the results of a simulation study where two scenarios were considered, co-infection and super-infection, together with different antiviral therapies. Although, in general the predicted course of HDV infection is similar to that observed for HBV, we observe a faster increase in the number of HBV infected cells and viral load. In most tested scenarios, the number of HDV infected cells and viral load values remain below corresponding predicted values for HBV. Conclusions/Significance: The simulation study shows that, under the most commonly used and generally accepted therapy approaches for HDV infection, such as lamivudine (LMV) or ribavirine, peggylated alpha-interferon (IFN) or a combination of both, LMV monotherapy and combination therapy of LMV and IFN were predicted to more effectively reduce the HBV and HDV viral loads in the case of super-infection scenarios when compared with the co-infection. In contrast, IFN monotherapy was found to reduce the HDV viral load more efficiently in the case of super-infection while the effect on the HBV viral load was more pronounced during co-infection. The results suggest that there is a need for development of high efficacy therapeutic approaches towards the specific inhibition of HDV replication. These approaches may additionally be directed to the reduction of the half-life of infected cells and life-span of newly produced circulating virions.	[de Sousa, Bruno C.] Univ Nova Lisboa, Ctr Malaria & Trop Dis, Associated Lab, Unit Epidemiol & Biostat,Inst Higiene & Med Trop, P-1200 Lisbon, Portugal; [Cunha, Celso] Univ Nova Lisboa, Ctr Malaria & Trop Dis, Associated Lab, Mol Biol Unit,Inst Higiene & Med Trop, P-1200 Lisbon, Portugal	Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL	de Sousa, BC (corresponding author), Univ Nova Lisboa, Ctr Malaria & Trop Dis, Associated Lab, Unit Epidemiol & Biostat,Inst Higiene & Med Trop, P-1200 Lisbon, Portugal.	bruno.desousa@ihmt.unl.pt	de Sousa, Bruno/S-2600-2019; Cunha, Celso/I-2371-2012; de Sousa, Bruno/A-1654-2012	Cunha, Celso/0000-0003-4745-3819; de Sousa, Bruno/0000-0001-9918-8100	MCI [MTM2008-01603]	MCI	This work was supported in part by MCI grant MTM2008-01603. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIANCHI L, 1980, VIRUS LIVER; BLIKKENDAALLIEFTINCK LF, 1977, EXP MOL PATHOL, V26, P184, DOI 10.1016/0014-4800(77)90048-X; Brunetto MR, 2009, WORLD J GASTROENTERO, V15, P531, DOI 10.3748/wjg.15.531; Casey J, 2005, ANTIMICROB AGENTS CH, V49, P4396, DOI 10.1128/AAC.49.10.4396-4399.2005; Chien RN, 2008, HEPATOL INT, V2, P296, DOI 10.1007/s12072-008-9066-1; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.iy.13.040195.000333; Colombatto P, 2006, ANTIVIR THER, V11, P197; D'Ugo E, 2008, ARCH VIROL, V153, P2069, DOI 10.1007/s00705-008-0236-1; Fattovich G, 2000, GUT, V46, P420, DOI 10.1136/gut.46.3.420; GOVINDARAJAN J, 1993, PROG CLIN BIOL, V382, P139; GOVINDARAJAN S, 2005, HEPATOLOGY, V11, P703; Gozlan J, 2009, J HEPATOL, V50, P432, DOI 10.1016/j.jhep.2008.05.029; GRISHAM JW, 1962, CANCER RES, V22, P842; Gudima S, 2002, J VIROL, V76, P3709, DOI 10.1128/JVI.76.8.3709-3719.2002; Guidotti LG, 1996, IMMUNITY, V4, P25, DOI 10.1016/S1074-7613(00)80295-2; HADZIYANNIS SJ, 1985, HEPATOLOGY, V5, P544, DOI 10.1002/hep.1840050404; HANSSON BG, 1982, J INFECT DIS, V146, P472, DOI 10.1093/infdis/146.4.472; HOOFNAGLE J, 1987, HEPATITIS DELTA VIRU; Hsieh TH, 2006, J FORMOS MED ASSOC, V105, P869, DOI 10.1016/S0929-6646(09)60172-8; JACOBSON IM, 1985, HEPATOLOGY, V5, P188, DOI 10.1002/hep.1840050205; KROGSGAARD K, 1987, HEPATOLOGY, V7, P42, DOI 10.1002/hep.1840070110; Lau DTY, 1999, GASTROENTEROLOGY, V117, P1229, DOI 10.1016/S0016-5085(99)70409-9; Lau DTY, 1999, HEPATOLOGY, V30, P546, DOI 10.1002/hep.510300217; Lewin SR, 2001, HEPATOLOGY, V34, P1012, DOI 10.1053/jhep.2001.28509; LIANJIE H, 1990, J HUAZHONG U SCI TEC, V10, P65; Mathurin P, 2000, J VIRAL HEPATITIS, V7, P15; Niro GA, 2005, J VIRAL HEPATITIS, V12, P2, DOI 10.1111/j.1365-2893.2005.00601.x; Nowak MA, 1996, P NATL ACAD SCI USA, V93, P4398, DOI 10.1073/pnas.93.9.4398; Oliveira MLA, 1999, BRAZ J MED BIOL RES, V32, P1107, DOI 10.1590/S0100-879X1999000900009; PONZETTO A, 1985, European Journal of Epidemiology, V1, P257, DOI 10.1007/BF00237100; Ribeiro RM, 2002, MICROBES INFECT, V4, P829, DOI 10.1016/S1286-4579(02)01603-9; RIZZETTO M, 1983, ANN INTERN MED, V98, P437, DOI 10.7326/0003-4819-98-4-437; Rizzetto M, 2009, J HEPATOL, V50, P1043, DOI 10.1016/j.jhep.2009.01.004; Romeo R, 2009, GASTROENTEROLOGY, V136, P1629, DOI 10.1053/j.gastro.2009.01.052; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Sakugawa H, 2001, J MED VIROL, V65, P478, DOI 10.1002/jmv.2061; Schaper M, 2010, J HEPATOL, V52, P658, DOI 10.1016/j.jhep.2009.10.036; SMEDILE A, 1991, HEPATOLOGY, V13, P413; Su CW, 2006, GASTROENTEROLOGY, V130, P1625, DOI 10.1053/j.gastro.2006.01.035; Taylor JM, 2006, CURR TOP MICROBIOL, V307, P1; Taylor JM, 2003, TRENDS MICROBIOL, V11, P185, DOI 10.1016/S0966-842X(03)00045-3; THOMAS HC, 1987, HEPATITIS DELTA VIRU; Tsiang M, 1999, HEPATOLOGY, V29, P1863, DOI 10.1002/hep.510290626; TSIANG M, 2004, METHODS MOL MED HEPA, V2, P361; Wolters LMM, 2000, J VIRAL HEPATITIS, V7, P428, DOI 10.1046/j.1365-2893.2000.00254.x; WU JC, 1995, LANCET, V346, P939, DOI 10.1016/S0140-6736(95)91558-3; Xiridou M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005247; Yamashiro T, 2004, J INFECT DIS, V189, P1151, DOI 10.1086/382133; Yurdaydin C, 2002, J HEPATOL, V37, P266, DOI 10.1016/S0168-8278(02)00162-9	49	11	12	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2010	5	9							e12512	10.1371/journal.pone.0012512	http://dx.doi.org/10.1371/journal.pone.0012512			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650QH	20862328	gold, Green Published, Green Submitted			2022-12-27	WOS:000281864100002
J	Love, CG; Graham, NS; Lochlainn, SO; Bowen, HC; May, ST; White, PJ; Broadley, MR; Hammond, JP; King, GJ				Love, Christopher G.; Graham, Neil S.; Lochlainn, Seosamh O.; Bowen, Helen C.; May, Sean T.; White, Philip J.; Broadley, Martin R.; Hammond, John P.; King, Graham J.			A Brassica Exon Array for Whole-Transcript Gene Expression Profiling	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; MICROARRAY; GENOME; RESOURCE; ANNOTATION; REPOSITORY; DISCOVERY; SEQUENCES; MAP	Affymetrix GeneChip (R) arrays are used widely to study transcriptional changes in response to developmental and environmental stimuli. GeneChip (R) arrays comprise multiple 25-mer oligonucleotide probes per gene and retain certain advantages over direct sequencing. For plants, there are several public GeneChip (R) arrays whose probes are localised primarily in 39 exons. Plant whole-transcript (WT) GeneChip (R) arrays are not yet publicly available, although WT resolution is needed to study complex crop genomes such as Brassica, which are typified by segmental duplications containing paralogous genes and/or allopolyploidy. Available sequence data were sampled from the Brassica A and C genomes, and 142,997 gene models identified. The assembled gene models were then used to establish a comprehensive public WT exon array for transcriptomics studies. The Affymetrix GeneChip (R) Brassica Exon 1.0 ST Array is a 5 mu M feature size array, containing 2.4 million 25-base oligonucleotide probes representing 135,201 gene models, with 15 probes per gene distributed among exons. Discrimination of the gene models was based on an E-value cut-off of 1E(-5), with <= 98% sequence identity. The 135 k Brassica Exon Array was validated by quantifying transcriptome differences between leaf and root tissue from a reference Brassica rapa line (R-o-18), and categorisation by Gene Ontologies (GO) based on gene orthology with Arabidopsis thaliana. Technical validation involved comparison of the exon array with a 60-mer array platform using the same starting RNA samples. The 135 k Brassica Exon Array is a robust platform. All data relating to the array design and probe identities are available in the public domain and are curated within the BrassEnsembl genome viewer at http://www.brassica.info/BrassEnsembl/index.html.	[Love, Christopher G.; King, Graham J.] Rothamsted Res, Harpenden, Herts, England; [Lochlainn, Seosamh O.; Broadley, Martin R.] Univ Nottingham, Sch Biosci, Loughborough, Leics, England; [Graham, Neil S.; May, Sean T.] Univ Nottingham, NASC, Loughborough, Leics, England; [Bowen, Helen C.; Hammond, John P.] Univ Warwick, Warwick HRI, Warwick, England; [White, Philip J.] Scottish Crop Res Inst, Dundee DD2 5DA, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of Nottingham; University of Nottingham; University of Warwick; James Hutton Institute	Love, CG (corresponding author), Rothamsted Res, Harpenden, Herts, England.	graham.king@bbsrc.ac.uk	may, sean t/B-6838-2012; Graham, Neil/C-5489-2008; Broadley, Martin/AAW-4638-2021; Hammond, John P/A-1876-2012; broadley, martin r/E-9081-2011; White, Philip John/C-5860-2008; King, Graham J/AAW-3368-2020	may, sean t/0000-0001-5282-3250; Graham, Neil/0000-0001-9080-8967; Broadley, Martin/0000-0003-3964-7226; Hammond, John P/0000-0002-6241-3551; broadley, martin r/0000-0003-3964-7226; White, Philip John/0000-0003-0827-288X; King, Graham J/0000-0002-5975-6051	UK Biotechnology and Biological Sciences Research Council (BBSRC) [BBG013969]; Scottish Government Rural and Environment Research and Analysis Directorate; BBSRC [BB/E022758/1, BB/G014159/1, BB/G013969/1, BB/E01772X/1, BB/I001271/1, BB/G014159/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G014159/1, BB/G014159/2, BB/E022758/1, BB/E01772X/1, BB/G013969/1, G17764, BB/I001271/1, G18881, BBS/B/1356X] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Scottish Government Rural and Environment Research and Analysis Directorate; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the UK Biotechnology and Biological Sciences Research Council (BBSRC, http://www.bbsrc.ac.uk/) Industry Partnering Award, BBG013969 to MRB, JPH, GJK. Rothamsted Research is an institute of the UK BBSRC. Scottish Crop Research Institute is funded by Scottish Government Rural and Environment Research and Analysis Directorate. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allemeersch J, 2005, PLANT PHYSIOL, V137, P588, DOI 10.1104/pp.104.051300; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bairoch A, 2009, NUCLEIC ACIDS RES, V37, pD169, DOI 10.1093/nar/gkn664; Bernardo AN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-251; Bradford JR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-282; Broadley MR, 2008, NEW PHYTOL, V180, P587, DOI 10.1111/j.1469-8137.2008.02640.x; Bruce J, 2009, PREV SCI, V10, P129, DOI 10.1007/s11121-008-0115-8; Craigon DJ, 2004, NUCLEIC ACIDS RES, V32, pD575, DOI 10.1093/nar/gkh133; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Hammond JP, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-10; Hammond JP, 2006, NEW PHYTOL, V170, P239, DOI 10.1111/j.1469-8137.2006.01662.x; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Kapur K, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r82; Kim JS, 2006, GENETICS, V174, P29, DOI 10.1534/genetics.106.060152; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Millenaar FF, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-137; Morinaga S, 2008, J ECOL, V96, P1086, DOI 10.1111/j.1365-2745.2008.01392.x; Parkin IAP, 2005, GENETICS, V171, P765, DOI 10.1534/genetics.105.042093; Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889; Rehrauer H, 2010, PLANT PHYSIOL, V152, P487, DOI 10.1104/pp.109.150185; Sanchez-Graillet O, 2008, J INTEGR BIOINFORMAT, V5, DOI 10.2390/biecoll-jib-2008-98; SANCHEZGRALLIET O, 2010, J INTEGRATIVE BIOINF, V7; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schranz ME, 2007, CURR OPIN PLANT BIOL, V10, P168, DOI 10.1016/j.pbi.2007.01.014; Stephenson P, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-62; Stolc V, 2005, P NATL ACAD SCI USA, V102, P4453, DOI 10.1073/pnas.0408203102; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Trick M, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-50; Trick M, 2009, PLANT BIOTECHNOL J, V7, P334, DOI 10.1111/j.1467-7652.2008.00396.x; Upton Graham J. G., 2009, Briefings in Functional Genomics & Proteomics, V8, P199, DOI 10.1093/bfgp/elp027; West MAL, 2006, GENOME RES, V16, P787, DOI 10.1101/gr.5011206; Willenbrock H, 2009, RNA, V15, P2028, DOI 10.1261/rna.1699809; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Yauk CL, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh123; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	37	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2010	5	9							e12812	10.1371/journal.pone.0012812	http://dx.doi.org/10.1371/journal.pone.0012812			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650QH	20862292	Green Published, Green Submitted, gold			2022-12-27	WOS:000281864100026
J	Comin-Anduix, B; Sazegar, H; Chodon, T; Matsunaga, D; Jalil, J; von Euw, E; Escuin-Ordinas, H; Balderas, R; Chmielowski, B; Gomez-Navarro, J; Koya, RC; Ribas, A				Comin-Anduix, Begona; Sazegar, Hooman; Chodon, Thinle; Matsunaga, Douglas; Jalil, Jason; von Euw, Erika; Escuin-Ordinas, Helena; Balderas, Robert; Chmielowski, Bartosz; Gomez-Navarro, Jesus; Koya, Richard C.; Ribas, Antoni			Modulation of Cell Signaling Networks after CTLA4 Blockade in Patients with Metastatic Melanoma	PLOS ONE			English	Article							ANTIGEN-4 MONOCLONAL-ANTIBODY; PHASE-I TRIAL; FLOW-CYTOMETRY; T-CELLS; ACTIVATION; TREMELIMUMAB; TUMOR; CD28; PHOSPHORYLATION; AUTOIMMUNITY	Background: The effects on cell signalling networks upon blockade of cytotoxic T lymphocyte-associated antigen-4 (CTLA4) using the monoclonal antibody tremelimumab were studied in peripheral blood mononuclear cell (PBMC) samples from patients with metastatic melanoma. Methodology/Principal: Findings Intracellular flow cytometry was used to detect phosphorylated (p) signaling molecules downstream of the T cell receptor (TCR) and cytokine receptors. PBMC from tremelimumab-treated patients were characterized by increase in pp38, pSTAT1 and pSTAT3, and decrease in pLck, pERK1/2 and pSTAT5 levels. These changes were noted in CD4 and CD8 T lymphocytes but also in CD14 monocytes. A divergent pattern of phosphorylation of Zap70, LAT, Akt and STAT6 was noted in patients with or without an objective tumor response. Conclusions/Significance: The administration of the CTLA4-blocking antibody tremelimumab to patients with metastatic melanoma influences signaling networks downstream of the TCR and cytokine receptors both in T cells and monocytes. The strong modulation of signaling networks in monocytes suggests that this cell subset may be involved in clinical responses to CTLA4 blockade. Clinical Trial Registration: clinicaltrials. gov; Registration numbers NCT00090896 and NCT00471887	[Comin-Anduix, Begona; Jalil, Jason; von Euw, Erika; Koya, Richard C.; Ribas, Antoni] Univ Calif Los Angeles, Dept Surg, Div Surg Oncol, Los Angeles, CA 90024 USA; [Comin-Anduix, Begona; Ribas, Antoni] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Sazegar, Hooman; Chodon, Thinle; Matsunaga, Douglas; Escuin-Ordinas, Helena; Chmielowski, Bartosz; Ribas, Antoni] Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, Los Angeles, CA 90024 USA; [Balderas, Robert] BD Biosci, San Jose, CA USA; [Gomez-Navarro, Jesus] Pfizer Global Res & Dev, New London, CT USA	University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Pfizer	Comin-Anduix, B (corresponding author), Univ Calif Los Angeles, Dept Surg, Div Surg Oncol, Los Angeles, CA 90024 USA.	bcomin@mednet.ucla.edu; aribas@mednet.ucla.edu		Chmielowski, Bartosz/0000-0002-2374-3320	Pfizer Inc.; National Institutes of Health (NIH) [U54 CA119347, CA-16042, AI-28697]; California Institute for Regenerative Medicine (CIRM) [RN2-00902-1]; Caltech-UCLA Joint Center for Translational Medicine; NATIONAL CANCER INSTITUTE [U54CA119347, P30CA016042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER	Pfizer Inc.(Pfizer); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); Caltech-UCLA Joint Center for Translational Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The clinical trials conduct was supported by research grants from Pfizer Inc., and the ex vivo cellular analysis by National Institutes of Health (NIH) grant U54 CA119347, the New Faculty Award RN2-00902-1 from the California Institute for Regenerative Medicine (CIRM) and the Caltech-UCLA Joint Center for Translational Medicine (all to A. R.). Flow cytometry was performed at the UCLA Jonsson Comprehensive Cancer Center (JCCC) Flow Cytometry Core Facility supported by NIH awards CA-16042 and AI-28697. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This includes no role of Pfizer (the company that provided the experimental agent tremelimumab and funded the conduct of the clinical trial from where the authors obtained the samples for this research) on the data collection, analysis or decision to publish, or the writing of the manuscript. Pfizer was involved in the design of the study, since the study protocol was reviewed by Pfizer and the conduct of the clinical trial was funded by them. However, this is an investigator-initiated clinical trial with an investigator-held IND. Dr. Jesus Gomez-Navarro, co-investigator in this research and at that time an employee of Pfizer, was not influenced by Pfizer on the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre ML, 2001, NAT REV IMMUNOL, V1, P220, DOI 10.1038/35105024; Butterfield LH, 2003, CLIN CANCER RES, V9, P998; Camacho LH, 2009, J CLIN ONCOL, V27, P1075, DOI 10.1200/JCO.2008.19.2435; Carey GB, 2007, CELL RES, V17, P942, DOI 10.1038/sj.cr.2007.90; Chambers CA, 2001, ANNU REV IMMUNOL, V19, P565, DOI 10.1146/annurev.immunol.19.1.565; Chen H, 2009, P NATL ACAD SCI USA, V106, P2729, DOI 10.1073/pnas.0813175106; Chuang E, 2000, IMMUNITY, V13, P313, DOI 10.1016/S1074-7613(00)00031-5; Comin-Anduix B, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-22; Critchley-Thorne RJ, 2007, PLOS MED, V4, P897, DOI 10.1371/journal.pmed.0040176; Di Giacomo AM, 2009, CANCER IMMUNOL IMMUN, V58, P1297, DOI 10.1007/s00262-008-0642-y; Greenwald RJ, 2001, IMMUNITY, V14, P145, DOI 10.1016/S1074-7613(01)00097-8; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Krummel MF, 1996, J EXP MED, V183, P2533, DOI 10.1084/jem.183.6.2533; Krutzik PO, 2006, NAT METHODS, V3, P361, DOI 10.1038/NMETH872; Krutzik PO, 2004, CLIN IMMUNOL, V110, P206, DOI 10.1016/j.clim.2003.11.009; Lee KM, 1998, SCIENCE, V282, P2263, DOI 10.1126/science.282.5397.2263; Liakou CI, 2008, P NATL ACAD SCI USA, V105, P14987, DOI 10.1073/pnas.0806075105; Maier LM, 2007, P NATL ACAD SCI USA, V104, P18607, DOI 10.1073/pnas.0706409104; Marengere LEM, 1996, SCIENCE, V272, P1170, DOI 10.1126/science.272.5265.1170; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; Parry RV, 1997, EUR J IMMUNOL, V27, P2495, DOI 10.1002/eji.1830271006; Perez Omar D, 2004, Methods Mol Biol, V263, P67; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Phan GQ, 2003, P NATL ACAD SCI USA, V100, P8372, DOI 10.1073/pnas.1533209100; Ribas A, 2004, J IMMUNOTHER, V27, P354, DOI 10.1097/00002371-200409000-00004; Ribas A, 2005, J CLIN ONCOL, V23, P8968, DOI 10.1200/JCO.2005.01.109; Ribas A, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.lba9011; Ribas A, 2007, ONCOLOGIST, V12, P873, DOI 10.1634/theoncologist.12-7-873; Ribas A, 2009, CLIN CANCER RES, V15, P390, DOI 10.1158/1078-0432.CCR-08-0783; Sanderson K, 2005, J CLIN ONCOL, V23, P741, DOI 10.1200/JCO.2005.01.128; Schneider H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003842; Sengupta TK, 1998, P NATL ACAD SCI USA, V95, P11107, DOI 10.1073/pnas.95.19.11107; Shrikant P, 1999, IMMUNITY, V11, P483, DOI 10.1016/S1074-7613(00)80123-5; So EY, 2007, MOL IMMUNOL, V44, P3416, DOI 10.1016/j.molimm.2007.02.022; Sotomayor EM, 1999, P NATL ACAD SCI USA, V96, P11476, DOI 10.1073/pnas.96.20.11476; Srahna M, 2006, IMMUNOLOGY, V117, P396, DOI 10.1111/j.1365-2567.2005.02313.x; Teft WA, 2006, ANNU REV IMMUNOL, V24, P65, DOI 10.1146/annurev.immunol.24.021605.090535; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; von Euw E, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-35; Wang XB, 2002, SCAND J IMMUNOL, V55, P53, DOI 10.1046/j.0300-9475.2001.01019.x; Wang YZ, 2000, ONCOGENE, V19, P2075, DOI 10.1038/sj.onc.1203548; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Weber J, 2009, CANCER IMMUNOL IMMUN, V58, P823, DOI 10.1007/s00262-008-0653-8	46	20	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12711	10.1371/journal.pone.0012711	http://dx.doi.org/10.1371/journal.pone.0012711			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856802	gold, Green Submitted, Green Published			2022-12-27	WOS:000281815800010
J	Goncalves, MD; Pistilli, EE; Balduzzi, A; Birnbaum, MJ; Lachey, J; Khurana, TS; Ahima, RS				Goncalves, Marcus D.; Pistilli, Emidio E.; Balduzzi, Anthony; Birnbaum, Morris J.; Lachey, Jennifer; Khurana, Tejvir S.; Ahima, Rexford S.			Akt Deficiency Attenuates Muscle Size and Function but Not the Response to ActRIIB Inhibition	PLOS ONE			English	Article							MICE LACKING; MYOTUBE HYPERTROPHY; MYOSTATIN; KINASE; GROWTH; MASS; TRANSCRIPTION; ACTIVATION; ATROPHY; DIFFERENTIATION	Background: Akt is a critical mediator of developmental skeletal muscle growth. Treatment with a soluble ActRIIB fusion protein (ActRIIB-mFc) increases skeletal muscle mass and strength by inhibiting myostatin and related peptides. Recent in vitro studies have suggested that Akt signaling is necessary for the ability of ActRIIB inhibition to induce muscle hypertrophy. Thus, we hypothesized that mice deficient in either Akt1 or Akt2 would not respond to in vivo inhibition of ActRIIB with ActRIIB-mFc treatment. Methodology and Principal Findings: We analyzed body composition and muscle parameters in wild-type C57BL/6J and Akt1 and Akt2 knockout mice, and compared the responses to blockade of ActRIIB signaling via ActRIIB-mFc treatment. Mice lacking Akt1 or Akt2 had reduced muscle mass, grip strength and contractile force. However, deficiency of Akt1 or Akt2 did not prevent the ability of ActRIIB-mFc treatment to induce muscle hypertrophy, or increase grip strength and contractile force. Akt1 and Akt2 deficient mice responded similarly as wild type mice to ActRIIB-mFc treatment by increasing fiber size. Conclusions and Significance: Akt1 and Akt2 are important for the regulation of skeletal muscle mass and function. However, these Akt isoforms are not essential for the ability of ActRIIB inhibition to regulate muscle size, fiber type, strength or contractile force.	[Goncalves, Marcus D.; Balduzzi, Anthony; Birnbaum, Morris J.; Ahima, Rexford S.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Pistilli, Emidio E.; Khurana, Tejvir S.] Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Pistilli, Emidio E.; Khurana, Tejvir S.] Univ Penn, Sch Med, Penn Muscle Inst, Philadelphia, PA 19104 USA; [Goncalves, Marcus D.; Birnbaum, Morris J.; Ahima, Rexford S.] Univ Penn, Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Lachey, Jennifer] Acceleron Pharma, Cambridge, MA USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Acceleron Pharma	Goncalves, MD (corresponding author), Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA.	ahima@mail.med.upenn.edu	Ahima, Rexford/W-1394-2019; Goncalves, Marcus/L-6073-2019	Goncalves, Marcus/0000-0002-0784-9248; Birnbaum, Morris/0000-0001-9972-8680	National Institutes of Health [RO1-DK062348, PO1-DK-049210]; World Anti-Doping Agency Institution [801619]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306, R01DK062348, P01DK049210] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); World Anti-Doping Agency Institution; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants: RO1-DK062348 and PO1-DK-049210 to R.S.A. and M.J.B., and the World Anti-Doping Agency Institution grant No: 801619 to T.S.K. Neither organization had any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Body composition was assessed by the Penn Diabetes and Endocrinology Research Center (DERC) Mouse Metabolic Phenotyping Core (P30-DK50306). Acceleron Pharma was responsibile for the initial characterization of ActRIIB-mFc and reviewed the manuscript prior to submission.	AKPAN I, 2009, INT J OBES LOND; Amirouche A, 2009, ENDOCRINOLOGY, V150, P286, DOI 10.1210/en.2008-0959; Asmussen G, 2003, EXP NEUROL, V184, P758, DOI 10.1016/S0014-4886(03)00294-2; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; CADENA SM, J APPL PHYSL; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Cleasby ME, 2007, MOL ENDOCRINOL, V21, P215, DOI 10.1210/me.2006-0154; Coffer PJ, 1998, BIOCHEM J, V335, P1; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Gilson H, 2007, ENDOCRINOLOGY, V148, P452, DOI 10.1210/en.2006-0539; Girgenrath S, 2005, MUSCLE NERVE, V31, P34, DOI 10.1002/mus.20175; Hajduch E, 1998, DIABETES, V47, P1006, DOI 10.2337/diabetes.47.7.1006; Hornberger TA, 2007, FEBS LETT, V581, P4562, DOI 10.1016/j.febslet.2007.08.045; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Ji M, 2008, CELL SIGNAL, V20, P1452, DOI 10.1016/j.cellsig.2008.03.013; Lai KMV, 2004, MOL CELL BIOL, V24, P9295, DOI 10.1128/MCB.24.21.9295-9304.2004; Lee SJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000789; Lee SJ, 2005, P NATL ACAD SCI USA, V102, P18117, DOI 10.1073/pnas.0505996102; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; McFarlane C, 2006, J CELL PHYSIOL, V209, P501, DOI 10.1002/jcp.20757; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Morissette MR, 2009, AM J PHYSIOL-CELL PH, V297, pC1124, DOI 10.1152/ajpcell.00043.2009; NEMETH P, 1981, J PHYSIOL-LONDON, V320, P73, DOI 10.1113/jphysiol.1981.sp013935; OGILVIE RW, 1990, STAIN TECHNOL, V65, P231, DOI 10.3109/10520299009105613; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Pistilli EE, 2010, AM J PHYSIOL-REG I, V298, pR96, DOI 10.1152/ajpregu.00138.2009; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sartori R, 2009, AM J PHYSIOL-CELL PH, V296, pC1248, DOI 10.1152/ajpcell.00104.2009; Scheid MP, 2003, FEBS LETT, V546, P108, DOI 10.1016/S0014-5793(03)00562-3; Sumitani S, 2002, ENDOCRINOLOGY, V143, P820, DOI 10.1210/en.143.3.820; Trendelenburg AU, 2009, AM J PHYSIOL-CELL PH, V296, pC1258, DOI 10.1152/ajpcell.00105.2009; Varela GM, 2008, AM J PHYSIOL-GASTR L, V295, pG621, DOI 10.1152/ajpgi.90204.2008; Whittemore LA, 2003, BIOCHEM BIOPH RES CO, V300, P965, DOI 10.1016/S0006-291X(02)02953-4; Yang W, 2007, J BIOL CHEM, V282, P3799, DOI 10.1074/jbc.M610185200; Zdychova J, 2005, PHYSIOL RES, V54, P1, DOI 10.33549/physiolres.930582; Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525	41	46	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12707	10.1371/journal.pone.0012707	http://dx.doi.org/10.1371/journal.pone.0012707			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856813	gold, Green Published, Green Submitted			2022-12-27	WOS:000281815800007
J	Spade, DJ; Griffitt, RJ; Liu, L; Brown-Peterson, NJ; Kroll, KJ; Feswick, A; Glazer, RA; Barber, DS; Denslow, ND				Spade, Daniel J.; Griffitt, Robert J.; Liu, Li; Brown-Peterson, Nancy J.; Kroll, Kevin J.; Feswick, April; Glazer, Robert A.; Barber, David S.; Denslow, Nancy D.			Queen Conch (Strombus gigas) Testis Regresses during the Reproductive Season at Nearshore Sites in the Florida Keys	PLOS ONE			English	Article							STUDYING ENDOCRINE DISRUPTION; GENE-EXPRESSION; REVERSE TRANSCRIPTION; SCHISTOSOMA-MANSONI; MESSENGER-RNA; HELIX-ASPERSA; MOLECULAR-CLONING; MICROARRAY DATA; STEM-CELL; DROSOPHILA	Background: Queen conch (Strombus gigas) reproduction is inhibited in nearshore areas of the Florida Keys, relative to the offshore environment where conchs reproduce successfully. Nearshore reproductive failure is possibly a result of exposure to environmental factors, including heavy metals, which are likely to accumulate close to shore. Metals such as Cu and Zn are detrimental to reproduction in many mollusks. Methodology/Principal Findings: Histology shows gonadal atrophy in nearshore conchs as compared to reproductively healthy offshore conchs. In order to determine molecular mechanisms leading to tissue changes and reproductive failure, a microarray was developed. A normalized cDNA library for queen conch was constructed and sequenced using the 454 Life Sciences GS-FLX pyrosequencer, producing 27,723 assembled contigs and 7,740 annotated transcript sequences. The resulting sequences were used to design the microarray. Microarray analysis of conch testis indicated differential regulation of 255 genes (p<0.01) in nearshore conch, relative to offshore. Changes in expression for three of four transcripts of interest were confirmed using real-time reverse transcription polymerase chain reaction. Gene Ontology enrichment analysis indicated changes in biological processes: respiratory chain (GO:0015992), spermatogenesis (GO:0007283), small GTPase-mediated signal transduction (GO:0007264), and others. Inductively coupled plasma-mass spectrometry analysis indicated that Zn and possibly Cu were elevated in some nearshore conch tissues. Conclusions/Significance: Congruence between testis histology and microarray data suggests that nearshore conch testes regress during the reproductive season, while offshore conch testes develop normally. Possible mechanisms underlying the testis regression observed in queen conch in the nearshore Florida Keys include a disruption of small GTPase (Ras)-mediated signaling in testis development. Additionally, elevated tissue levels of Cu (34.77 ng/mg in testis) and Zn (831.85 ng/mg in digestive gland, 83.96 ng/mg in testis) nearshore are similar to reported levels resulting in reproductive inhibition in other gastropods, indicating that these metals possibly contribute to NS conch reproductive failure.	[Spade, Daniel J.; Griffitt, Robert J.; Kroll, Kevin J.; Feswick, April; Barber, David S.; Denslow, Nancy D.] Univ Florida, Dept Physiol Sci, Gainesville, FL 32610 USA; [Spade, Daniel J.; Griffitt, Robert J.; Kroll, Kevin J.; Feswick, April; Barber, David S.; Denslow, Nancy D.] Univ Florida, Ctr Environm & Human Toxicol, Gainesville, FL 32610 USA; [Liu, Li] Univ Florida, Interdisciplinary Ctr Biotechnol Res, Gainesville, FL USA; [Brown-Peterson, Nancy J.] Univ So Mississippi, Dept Coastal Sci, Ocean Springs, MS USA; [Glazer, Robert A.] Florida Fish & Wildlife Conservat Commiss, Fish & Wildlife Res Inst, Marathon, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Southern Mississippi; Florida Fish & Wildlife Conservation Commission	Spade, DJ (corresponding author), Univ Florida, Dept Physiol Sci, Gainesville, FL 32610 USA.	ndenslow@ufl.edu		Spade, Daniel/0000-0002-4694-8724; kroll, kevin j/0000-0002-5374-6733	United States Environmental Protection Agency [X7974799-03]; Florida Fish and Wildlife Conservation Commission [F2410, NG06-106]; University of Florida College of Veterinary Medicine; University of Florida	United States Environmental Protection Agency(United States Environmental Protection Agency); Florida Fish and Wildlife Conservation Commission; University of Florida College of Veterinary Medicine(University of Florida); University of Florida(University of Florida)	This project was funded by the following sources: The United States Environmental Protection Agency (www.epa.gov; # X7974799-03), Florida Fish and Wildlife Conservation Commission (www.myfwc.com; # F2410 and # NG06-106) and the University of Florida College of Veterinary Medicine (www.vetmed.ufl.edu). Publication of this article was funded in part by the University of Florida Open-Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adema CM, 2010, MOL IMMUNOL, V47, P849, DOI 10.1016/j.molimm.2009.10.019; Al-Shahrour F, 2005, NUCLEIC ACIDS RES, V33, pW460, DOI 10.1093/nar/gki456; Aldana-Aranda, 2003, CARACOL STROMBUS GIG, P73; Alekseev OM, 2005, J BIOL CHEM, V280, P2904, DOI 10.1074/jbc.M410397200; Azami S, 2006, J NEUROSCI RES, V84, P1610, DOI 10.1002/jnr.21045; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; BUCHARDT B, 1978, SCIENCE, V199, P291, DOI 10.1126/science.199.4326.291; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Carnahan EA, 2008, J COASTAL RES, V24, P159, DOI 10.2112/06-0666.1; CHAKALALL B, 2007, WORLD MARKETS IND SE; Coeurdassier M, 2005, ENVIRON TOXICOL CHEM, V24, P198, DOI 10.1897/03-505.1; DAVIS M, 2000, RECENT ADV MARINE BI, V4, P27; Delgado GA, 2004, FISH B-NOAA, V102, P278; Desouky MMA, 2006, AQUAT TOXICOL, V77, P143, DOI 10.1016/j.aquatox.2005.11.009; Dillon GP, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000240; Doney SC, 2010, SCIENCE, V328, P1512, DOI 10.1126/science.1185198; Droege M, 2008, J BIOTECHNOL, V136, P3, DOI 10.1016/j.jbiotec.2008.03.021; Ducrot V, 2007, ENVIRON TOXICOL CHEM, V26, P1774, DOI 10.1897/06-556R.1; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Erkan M, 2002, TISSUE CELL, V34, P262, DOI 10.1016/S0040-8166(02)00016-2; Farmerie WG, 2005, DATA KNOWL ENG, V53, P75, DOI 10.1016/j.datak.2004.06.014; Fitzpatrick JM, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000323; Garcia-Reyero N, 2008, J FISH BIOL, V72, P2354, DOI 10.1111/j.1095-8649.2008.01904.x; Gimbert F, 2008, ENVIRON TOXICOL CHEM, V27, P1284, DOI 10.1897/07-503; Gobert GN, 2006, EXP PARASITOL, V114, P160, DOI 10.1016/j.exppara.2006.03.003; Gobert GN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-128; GROPPE JC, 1993, ANAL BIOCHEM, V210, P337, DOI 10.1006/abio.1993.1205; Gros O, 2009, J MOLLUS STUD, V75, P59, DOI 10.1093/mollus/eyn041; Guan J, 2008, MOL REPROD DEV, V75, P1379, DOI 10.1002/mrd.20874; Guan JK, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-23; Guiller A, 2006, GENET RES, V88, P27, DOI 10.1017/S0016672306008305; Iguchi T, 2007, GEN COMP ENDOCR, V153, P25, DOI 10.1016/j.ygcen.2007.01.013; Iguchi T, 2006, ENVIRON HEALTH PERSP, V114, P101, DOI 10.1289/ehp.8061; ISHIKAWA H, 1977, COMP BIOCHEM PHYS B, V58, P1, DOI 10.1016/0305-0491(77)90116-X; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Khor B, 2006, MOL CELL BIOL, V26, P2999, DOI 10.1128/MCB.26.8.2999-3007.2006; KOFOED TMN, 2010, 4 WORKSH GON HIST FI, P83; KRUCZYNSKI WL, 1999, WATER QUALITY CONCER; Laskowski R, 1996, ECOTOX ENVIRON SAFE, V34, P59, DOI 10.1006/eesa.1996.0045; Lee J, 2009, CELL STEM CELL, V5, P76, DOI 10.1016/j.stem.2009.04.020; Lee YS, 2008, P NATL ACAD SCI USA, V105, P18602, DOI 10.1073/pnas.0808893105; Lewis MA, 2007, ENVIRON POLLUT, V146, P206, DOI 10.1016/j.envpol.2006.04.041; Li L, 2009, MOL BIOL REP, V36, P1023, DOI 10.1007/s11033-008-9276-6; Lockyer AE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-634; Nishida H, 2002, BIOESSAYS, V24, P613, DOI 10.1002/bies.10099; NOTT JA, 1990, J MAR BIOL ASSOC UK, V70, P905, DOI 10.1017/S0025315400059130; O'Keefe DD, 2009, DEV BIOL, V333, P143, DOI 10.1016/j.ydbio.2009.06.032; Pena FJ, 2009, REPROD DOMEST ANIM, V44, P345, DOI 10.1111/j.1439-0531.2008.01211.x; Reeve S, 2007, GENESIS, V45, P66, DOI 10.1002/dvg.20265; Rogevich EC, 2009, ARCH ENVIRON CON TOX, V56, P450, DOI 10.1007/s00244-008-9231-5; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruppert EE, 2004, INVERTEBRATE ZOOLOGY; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Singh Shree Ram, 2008, V450, P45, DOI 10.1007/978-1-60327-214-8_3; Snyman RG, 2004, B ENVIRON CONTAM TOX, V73, P398, DOI 10.1007/s00128-004-0442-9; Ternes P, 2002, J BIOL CHEM, V277, P25512, DOI 10.1074/jbc.M202947200; van Rensburg MJ, 2009, FISH SHELLFISH IMMUN, V26, P171, DOI 10.1016/j.fsi.2008.09.016; vanHolde KE, 1995, ADV PROTEIN CHEM, V47, P1, DOI 10.1016/S0065-3233(08)60545-8; Waisberg M, 2008, EXP PARASITOL, V120, P357, DOI 10.1016/j.exppara.2008.09.005; Yaffe MP, 1997, CURR BIOL, V7, pR782, DOI 10.1016/S0960-9822(06)00404-0; Yamaguchi S, 2009, P NATL ACAD SCI USA, V106, P10859, DOI 10.1073/pnas.0900602106; Yang HM, 2005, DNA SEQUENCE, V16, P166, DOI 10.1080/10425170500129736	63	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12737	10.1371/journal.pone.0012737	http://dx.doi.org/10.1371/journal.pone.0012737			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856805	Green Submitted, gold, Green Published			2022-12-27	WOS:000281815800016
J	Edwards, RD; Roff, J				Edwards, Ryan D.; Roff, Jennifer			Negative Effects of Paternal Age on Children's Neurocognitive Outcomes Can Be Explained by Maternal Education and Number of Siblings	PLOS ONE			English	Article							SCHIZOPHRENIA; ACHIEVEMENT; FAMILY; MATTER; TIME	Background: Recent findings suggest advanced paternal age may be associated with impaired child outcomes, in particular, neurocognitive skills. Such patterns are worrisome given relatively universal trends in advanced countries toward delayed nuptiality and fertility. But nature and nurture are both important for child outcomes, and it is important to control for both when drawing inferences about either pathway. Methods and Findings: We examined cross-sectional patterns in six developmental outcome measures among children in the U. S. Collaborative Perinatal Project (n = 31,346). Many of these outcomes at 8 mo, 4 y, and 7 y of age (Bayley scales, Stanford Binet Intelligence Scale, Graham-Ernhart Block Sort Test, Wechsler Intelligence Scale for Children, Wide Range Achievement Test) are negatively correlated with paternal age when important family characteristics such as maternal education and number of siblings are not included as covariates. But controlling for family characteristics in general and mother's education in particular renders the effect of paternal age statistically insignificant for most developmental measures. Conclusions: Assortative mating produces interesting relationships between maternal and paternal characteristics that can inject spurious correlation into observational studies via omitted variable bias. Controlling for both nature and nurture reveals little residual evidence of a link between child neurocognitive outcomes and paternal age in these data. Results suggest that benefits associated with the upward trend in maternal education may offset any negative effects of advancing paternal age.	[Edwards, Ryan D.; Roff, Jennifer] CUNY, Queens Coll, Dept Econ, Flushing, NY USA; [Edwards, Ryan D.; Roff, Jennifer] CUNY, Grad Ctr, Flushing, NY USA; [Edwards, Ryan D.] Natl Bur Econ Res, Cambridge, MA 02138 USA	City University of New York (CUNY) System; Queens College NY (CUNY); City University of New York (CUNY) System; National Bureau of Economic Research	Edwards, RD (corresponding author), CUNY, Queens Coll, Dept Econ, Flushing, NY USA.	redwards@qc.cuny.edu			Queens College, City University of New York	Queens College, City University of New York	The authors are supported as instructional research faculty of Queens College, City University of New York. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker Gary S., 1991, TREATISE FAMILY, DOI DOI 10.4159/9780674020665; BERKOWITZ GS, 1990, NEW ENGL J MED, V322, P693; Bianchi SM, 1997, J MARRIAGE FAM, V59, P332, DOI 10.2307/353474; Cannon M, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000042; Dalman C, 2002, AM J PSYCHIAT, V159, P1591, DOI 10.1176/appi.ajp.159.9.1591; Fischer CS., 2006, CENTURY DIFFERENCE; Goldin C, 2006, AM ECON REV, V96, P1, DOI 10.1257/000282806777212350; Hamilton BE, 2006, INT J ANDROL, V29, P34, DOI 10.1111/j.1365-2605.2005.00638.x; Hardy JB, 2003, ANN EPIDEMIOL, V13, P303, DOI 10.1016/S1047-2797(02)00479-9; Hsin A, 2009, SOC INDIC RES, V93, P123, DOI 10.1007/s11205-008-9413-6; Lee R, 2003, J ECON PERSPECT, V17, P167, DOI 10.1257/089533003772034943; LEIBOWITZ A, 1977, J HUM RESOUR, V12, P242, DOI 10.2307/145387; LEIBOWITZ A, 1974, J POLITICAL EC, V82, P111, DOI DOI 10.1086/260295; Malaspina D, 2001, ARCH GEN PSYCHIAT, V58, P361, DOI 10.1001/archpsyc.58.4.361; *NAT CTR HLTH STAT, 2006, DAT FIL DOC NAT DAT; Nichols HB, 2006, AM J EPIDEMIOL, V164, P1003, DOI 10.1093/aje/kwj282; Niswander K.R., 1972, WOMEN THEIR PREGNANC; Pencavel J, 1998, AM ECON REV, V88, P326; Saha S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000040; Tuljapurkar SD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000785; White KM, 2002, POPUL DEV REV, V28, P59, DOI 10.1111/j.1728-4457.2002.00059.x	21	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2010	5	9							e12157	10.1371/journal.pone.0012157	http://dx.doi.org/10.1371/journal.pone.0012157			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	649ZO	20856853	Green Published, gold			2022-12-27	WOS:000281815700001
J	Godmann, M; May, E; Kimmins, S				Godmann, Maren; May, Erin; Kimmins, Sarah			Epigenetic Mechanisms Regulate Stem Cell Expressed Genes Pou5f1 and Gfra1 in a Male Germ Cell Line	PLOS ONE			English	Article							HISTONE H3 METHYLTRANSFERASE; INHIBITOR TRICHOSTATIN-A; CONTROLS DNA METHYLATION; SELF-RENEWAL; C-KIT; TRANSCRIPTION FACTOR; DEMETHYLASE LSD1; MOUSE SPERMATOGENESIS; CONTAINING COMPLEXES; MEIOTIC PROPHASE	Male fertility is declining and an underlying cause may be due to environment-epigenetic interactions in developing sperm, yet nothing is known of how the epigenome controls gene expression in sperm development. Histone methylation and acetylation are dynamically regulated in spermatogenesis and are sensitive to the environment. Our objectives were to determine how histone H3 methylation and acetylation contribute to the regulation of key genes in spermatogenesis. A germ cell line, GC-1, was exposed to either the control, or the chromatin modifying drugs tranylcypromine (T), an inhibitor of the histone H3 demethylase KDM1 (lysine specific demethylase 1), or trichostatin (TSA), an inhibitor of histone deacetylases, (HDAC). Quantitative PCR (qPCR) was used to identify genes that were sensitive to treatment. As a control for specificity the Myod1 (myogenic differentiation 1) gene was analyzed. Chromatin immunoprecipitation (ChIP) followed by qPCR was used to measure histone H3 methylation and acetylation at the promoters of target genes and the control, Myod1. Remarkably, the chromatin modifying treatment specifically induced the expression of spermatogonia expressed genes Pou5f1 and Gfra1. ChIP-qPCR revealed that induction of gene expression was associated with a gain in gene activating histone H3 methylation and acetylation in Pou5f1 and Gfra1 promoters, whereas CpG DNA methylation was not affected. Our data implicate a critical role for histone H3 methylation and acetylation in the regulation of genes expressed by spermatogonia - here, predominantly mediated by HDAC-containing protein complexes.	[Godmann, Maren; May, Erin; Kimmins, Sarah] McGill Univ, Dept Anim Sci, Ste Anne De Bellevue, PQ, Canada; [Kimmins, Sarah] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada	McGill University; McGill University	Godmann, M (corresponding author), McGill Univ, Dept Anim Sci, Ste Anne De Bellevue, PQ, Canada.	sarah.kimmins@mcgill.ca	Godmann, Maren/B-5899-2016	Godmann, Maren/0000-0002-0214-8012; Kimmins, Sarah/0000-0002-0168-7233	Canadian Institutes of Health Research [82820]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This research was funded by the Canadian Institutes of Health Research (SK grant # 82820). MG is supported by a post-doctoral fellowship from the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold HH, 1996, INT J DEV BIOL, V40, P345; Behr R, 2002, MECH DEVELOP, V115, P167, DOI 10.1016/S0925-4773(02)00127-2; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Buageaw A, 2005, BIOL REPROD, V73, P1011, DOI 10.1095/biolreprod.105.043810; Bulger M, 2005, J BIOL CHEM, V280, P21689, DOI 10.1074/jbc.R500004200; Chen C, 2005, NATURE, V436, P1030, DOI 10.1038/nature03894; CLERMONT Y, 1972, PHYSIOL REV, V52, P198, DOI 10.1152/physrev.1972.52.1.198; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; DE ROOIJ DG, 2001, REPRODUCTION, V121, P347; DE ROOIJ DG, 2000, J ANDROL, V21, P776; Dettin L, 2003, BIOL REPROD, V69, P1565, DOI 10.1095/biolreprod.103.016394; Durcova-Hills G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003531; Esteve PO, 2006, GENE DEV, V20, P3089, DOI 10.1101/gad.1463706; Fenic I, 2004, J ANDROL, V25, P811; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Forneris F, 2005, J BIOL CHEM, V280, P41360, DOI 10.1074/jbc.M509549200; Forneris F, 2006, J BIOL CHEM, V281, P35289, DOI 10.1074/jbc.M607411200; FOULKES NS, 1992, NATURE, V355, P80, DOI 10.1038/355080a0; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; GODMANN M, 2009, MICROSC RES TECH; Godmann M, 2007, BIOL REPROD, V77, P754, DOI 10.1095/biolreprod.107.062265; Godmann M, 2009, MECH DEVELOP, V126, P650, DOI 10.1016/j.mod.2009.06.1081; GRIMES SR, 1984, EXP CELL RES, V152, P91, DOI 10.1016/0014-4827(84)90232-5; Hakimi MA, 2003, J BIOL CHEM, V278, P7234, DOI 10.1074/jbc.M208992200; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Hazzouri M, 2000, EUR J CELL BIOL, V79, P950, DOI 10.1078/0171-9335-00123; He ZP, 2007, BIOL REPROD, V77, P723, DOI 10.1095/biolreprod.107.062513; HINTZ M, 1977, DEV BIOL, V57, P375, DOI 10.1016/0012-1606(77)90222-6; HOFMANN MC, 1992, EXP CELL RES, V201, P417, DOI 10.1016/0014-4827(92)90291-F; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jiang C, 2007, NUCLEIC ACIDS RES, V35, pD137, DOI 10.1093/nar/gkl1041; Kanatsu-Shinohara M, 2008, BIOL REPROD, V78, P681, DOI 10.1095/biolreprod.107.066068; Karantzali E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r65; Kimmins S, 2005, NATURE, V434, P583, DOI 10.1038/nature03368; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Lagarkova MA, 2006, CELL CYCLE, V5, P416, DOI 10.4161/cc.5.4.2440; Lee MG, 2006, METHODS, V40, P327, DOI 10.1016/j.ymeth.2006.07.030; Lee MG, 2006, MOL CELL BIOL, V26, P6395, DOI 10.1128/MCB.00723-06; Lee MG, 2006, CHEM BIOL, V13, P563, DOI 10.1016/j.chembiol.2006.05.004; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Liu RH, 2009, CANCER RES, V69, P2252, DOI 10.1158/0008-5472.CAN-08-3717; Ma J, 2001, BIOL REPROD, V64, P1713, DOI 10.1095/biolreprod64.6.1713; MANOVA K, 1990, DEVELOPMENT, V110, P1057; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Medina V, 1997, CANCER RES, V57, P3697; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Millar CB, 2006, NAT REV MOL CELL BIO, V7, P657, DOI 10.1038/nrm1986; Minucci S, 1997, P NATL ACAD SCI USA, V94, P11295, DOI 10.1073/pnas.94.21.11295; Nantel F, 1996, NATURE, V380, P159, DOI 10.1038/380159a0; Naughton CK, 2006, BIOL REPROD, V74, P314, DOI 10.1095/biolreprod.105.047365; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Oatley JM, 2006, P NATL ACAD SCI USA, V103, P9524, DOI 10.1073/pnas.0603332103; Ohbo K, 2003, DEV BIOL, V258, P209, DOI 10.1016/S0012-1606(03)00111-8; Ohmura M, 2004, ARCH HISTOL CYTOL, V67, P285, DOI 10.1679/aohc.67.285; Ohta H, 2000, DEVELOPMENT, V127, P2125; Okada Y, 2007, NATURE, V450, P119, DOI 10.1038/nature06236; Ou JN, 2007, BIOCHEM PHARMACOL, V73, P1297, DOI 10.1016/j.bcp.2006.12.032; Payne C, 2006, DEV BIOL, V293, P461, DOI 10.1016/j.ydbio.2006.02.013; Pesce M, 1998, MECH DEVELOP, V71, P89, DOI 10.1016/S0925-4773(98)00002-1; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Russell L. D., 1990, HISTOLOGICAL HISTOPA; Schmittwolf C, 2005, EMBO J, V24, P554, DOI 10.1038/sj.emboj.7600546; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; SORRENTINO V, 1991, ONCOGENE, V6, P149; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Svechnikova I, 2008, INT J ONCOL, V32, P821; Tachibana M, 2007, EMBO J, V26, P3346, DOI 10.1038/sj.emboj.7601767; Tadokoro Y, 2002, MECH DEVELOP, V113, P29, DOI 10.1016/S0925-4773(02)00004-7; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Taylor SJ, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-5; Vincent S, 1998, DEVELOPMENT, V125, P4585; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Vogelauer M, 2000, NATURE, V408, P495, DOI 10.1038/35044127; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Yeo S, 2007, BIOCHEM BIOPH RES CO, V359, P536, DOI 10.1016/j.bbrc.2007.05.120; Yeom YI, 1996, DEVELOPMENT, V122, P881; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675; YOSHINAGA K, 1991, DEVELOPMENT, V113, P689; Zhao F, 2005, NUCLEIC ACIDS RES, V33, pD103, DOI 10.1093/nar/gki004; Zhong XM, 2009, J BIOL CHEM, V284, P9168, DOI 10.1074/jbc.M805562200; Zhu QJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001446	91	19	20	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2010	5	9							e12727	10.1371/journal.pone.0012727	http://dx.doi.org/10.1371/journal.pone.0012727			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZO	20856864	Green Published, Green Submitted, gold			2022-12-27	WOS:000281815700014
J	Jelsbak, L; Ingmer, H; Valihrach, L; Cohn, MT; Christiansen, MHG; Kallipolitis, BH; Frees, D				Jelsbak, Lotte; Ingmer, Hanne; Valihrach, Lukas; Cohn, Marianne Thorup; Christiansen, Mie H. G.; Kallipolitis, Birgitte H.; Frees, Dorte			The Chaperone ClpX Stimulates Expression of Staphylococcus aureus Protein A by Rot Dependent and Independent Pathways	PLOS ONE			English	Article							ESCHERICHIA-COLI; VIRULENCE FACTOR; SPECIFICITY COMPONENT; GLOBAL REGULATOR; BINDING-PROTEIN; GENE-EXPRESSION; RNA; AGR; ROLES; IDENTIFICATION	The Clp ATPases (Hsp100) constitute a family of closely related proteins that have protein reactivating and remodelling activities typical of molecular chaperones. In Staphylococcus aureus the ClpX chaperone is essential for virulence and for transcription of spa encoding Protein A. The present study was undertaken to elucidate the mechanism by which ClpX stimulates expression of Protein A. For this purpose, we prepared antibodies directed against Rot, an activator of spa transcription, and demonstrated that cells devoid of ClpX contain three-fold less Rot than wild-type cells. By varying Rot expression from an inducible promoter we showed that expression of Protein A requires a threshold level of Rot. In the absence of ClpX the Rot content is reduced below this threshold level, hence, explaining the substantially reduced Protein A expression in the clpX mutant. Experiments addressed at pinpointing the role of ClpX in Rot synthesis revealed that ClpX is required for translation of Rot. Interestingly, translation of the spa mRNA was, like the rot mRNA, enhanced by ClpX. These data demonstrate that ClpX performs dual roles in regulating Protein A expression, as ClpX stimulates transcription of spa by enhancing translation of Rot, and that ClpX additionally is required for full translation of the spa mRNA. The current findings emphasize that ClpX has a central role in fine-tuning virulence regulation in S. aureus.	[Jelsbak, Lotte; Ingmer, Hanne; Valihrach, Lukas; Cohn, Marianne Thorup; Frees, Dorte] Univ Copenhagen, Fac Life Sci, Dept Vet Dis Biol, Frederiksberg C, Denmark; [Christiansen, Mie H. G.; Kallipolitis, Birgitte H.] Univ So Denmark, Dept Biochem & Mol Biol, Odense, Denmark	University of Copenhagen; University of Southern Denmark	Jelsbak, L (corresponding author), Univ Copenhagen, Fac Life Sci, Dept Vet Dis Biol, Frederiksberg C, Denmark.	df@life.ku.dk	Valihrach, Lukas/H-4368-2014	Valihrach, Lukas/0000-0002-6704-4337; Jelsbak, Lotte/0000-0002-6642-7424; Ingmer, Hanne/0000-0002-8350-5631; Kallipolitis, Birgitte H./0000-0003-1233-9776; Frees, Dorte/0000-0003-4946-2890	Danish Research Council on Technology and Production	Danish Research Council on Technology and Production	This work was supported by grants from the Danish Research Council on Technology and Production to Hanne Ingmer and Dorte Frees. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benito Y, 2000, RNA, V6, P668, DOI 10.1017/S1355838200992550; Bohn C, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-10; Boisset S, 2007, GENE DEV, V21, P1353, DOI 10.1101/gad.423507; Cassat J, 2006, MICROBIOL-SGM, V152, P3075, DOI 10.1099/mic.0.29033-0; CHEUNG AL, 1992, P NATL ACAD SCI USA, V89, P6462, DOI 10.1073/pnas.89.14.6462; Corrigan RM, 2009, PLASMID, V61, P126, DOI 10.1016/j.plasmid.2008.10.001; Douillard FP, 2008, J BACTERIOL, V190, P7975, DOI 10.1128/JB.00879-08; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; FOSTER TJ, 1994, FEMS MICROBIOL LETT, V118, P199, DOI 10.1016/0378-1097(94)90504-5; Frees D, 2005, INFECT IMMUN, V73, P8100, DOI 10.1128/IAI.73.12.8100-8108.2005; Frees D, 2003, MOL MICROBIOL, V48, P1565, DOI 10.1046/j.1365-2958.2003.03524.x; Frees D, 2007, MOL MICROBIOL, V63, P1285, DOI 10.1111/j.1365-2958.2007.05598.x; Gao JX, 2004, J BACTERIOL, V186, P3738, DOI 10.1128/JB.186.12.3738-3748.2004; Geisinger E, 2006, MOL MICROBIOL, V61, P1038, DOI 10.1111/j.1365-2958.2006.05292.x; Gomez MI, 2004, NAT MED, V10, P842, DOI 10.1038/nm1079; Gottesman S, 2004, ANNU REV MICROBIOL, V58, P303, DOI 10.1146/annurev.micro.58.030603.123841; GOTTESMAN S, 1993, J BIOL CHEM, V268, P22618; Gustafsson E, 2009, INT J MED MICROBIOL, V299, P65, DOI 10.1016/j.ijmm.2008.05.011; Hartleib J, 2000, BLOOD, V96, P2149; Hsieh HY, 2008, J BACTERIOL, V190, P546, DOI 10.1128/JB.00536-07; Huntzinger E, 2005, EMBO J, V24, P824, DOI 10.1038/sj.emboj.7600572; Jelsbak L, 2005, J BACTERIOL, V187, P2105, DOI 10.1128/JB.187.6.2105-2112.2005; Jelsbak L, 2010, INT J MED MICROBIOL, V300, P229, DOI 10.1016/j.ijmm.2009.07.003; Kornblum J., 1990, MOL BIOL STAPHYLOCOC, P373; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Levchenko I, 2000, SCIENCE, V289, P2354, DOI 10.1126/science.289.5488.2354; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; McNamara PJ, 2000, J BACTERIOL, V182, P3197, DOI 10.1128/JB.182.11.3197-3203.2000; McNamara PJ, 1998, J BACTERIOL, V180, P2609, DOI 10.1128/JB.180.10.2609-2615.1998; MORFELDT E, 1995, EMBO J, V14, P4569, DOI 10.1002/j.1460-2075.1995.tb00136.x; NOVICK R, 1967, VIROLOGY, V33, P155, DOI 10.1016/0042-6822(67)90105-5; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; NOVICK RP, 2006, STAPHYLOCOCCUS PATHO, P496; Oscarsson J, 2005, INT J MED MICROBIOL, V295, P253, DOI 10.1016/j.ijmm.2005.05.003; Palmqvist N, 2002, MICROB PATHOGENESIS, V33, P239, DOI 10.1006/mpat.2002.0533; PATEL AH, 1987, INFECT IMMUN, V55, P3103, DOI 10.1128/IAI.55.12.3103-3110.1987; SCHENK S, 1992, FEMS MICROBIOL LETT, V94, P133; Schumacher MA, 2002, EMBO J, V21, P3546, DOI 10.1093/emboj/cdf322; Singh SK, 2000, P NATL ACAD SCI USA, V97, P8898, DOI 10.1073/pnas.97.16.8898; Somerville GA, 2002, J BACTERIOL, V184, P1430, DOI 10.1128/JB.184.5.1430-1437.2002; Tegmark K, 2000, MOL MICROBIOL, V37, P398, DOI 10.1046/j.1365-2958.2000.02003.x; WAWRZYNOW A, 1995, EMBO J, V14, P1867, DOI 10.1002/j.1460-2075.1995.tb07179.x; Wells DR, 1998, GENE DEV, V12, P3236, DOI 10.1101/gad.12.20.3236; Yu GW, 2006, PROTEIN SCI, V15, P384, DOI 10.1110/ps.051927306; Zolkiewski M, 2006, MOL MICROBIOL, V61, P1094, DOI 10.1111/j.1365-2958.2006.05309.x	47	30	30	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2010	5	9							e12752	10.1371/journal.pone.0012752	http://dx.doi.org/10.1371/journal.pone.0012752			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZO	20856878	Green Published, gold, Green Submitted			2022-12-27	WOS:000281815700026
J	Brisbin, A; Weissman, MM; Fyer, AJ; Hamilton, SP; Knowles, JA; Bustamante, CD; Mezey, JG				Brisbin, Abra; Weissman, Myrna M.; Fyer, Abby J.; Hamilton, Steven P.; Knowles, James A.; Bustamante, Carlos D.; Mezey, Jason G.			Bayesian Linkage Analysis of Categorical Traits for Arbitrary Pedigree Designs	PLOS ONE			English	Article							CHAIN MONTE-CARLO; ORDINAL TRAITS; GENERAL PEDIGREES; LOCI; ASSOCIATION; STRATEGIES; INFERENCE; FAMILIES; CROSSES; MODELS	Background: Pedigree studies of complex heritable diseases often feature nominal or ordinal phenotypic measurements and missing genetic marker or phenotype data. Methodology: We have developed a Bayesian method for Linkage analysis of Ordinal and Categorical traits (LOCate) that can analyze complex genealogical structure for family groups and incorporate missing data. LOCate uses a Gibbs sampling approach to assess linkage, incorporating a simulated tempering algorithm for fast mixing. While our treatment is Bayesian, we develop a LOD (log of odds) score estimator for assessing linkage from Gibbs sampling that is highly accurate for simulated data. LOCate is applicable to linkage analysis for ordinal or nominal traits, a versatility which we demonstrate by analyzing simulated data with a nominal trait, on which LOCate outperforms LOT, an existing method which is designed for ordinal traits. We additionally demonstrate our method's versatility by analyzing a candidate locus (D2S1788) for panic disorder in humans, in a dataset with a large amount of missing data, which LOT was unable to handle. Conclusion: LOCate's accuracy and applicability to both ordinal and nominal traits will prove useful to researchers interested in mapping loci for categorical traits.	[Brisbin, Abra; Bustamante, Carlos D.; Mezey, Jason G.] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14850 USA; [Weissman, Myrna M.; Fyer, Abby J.] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY USA; [Weissman, Myrna M.; Fyer, Abby J.] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Hamilton, Steven P.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Hamilton, Steven P.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Knowles, James A.] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Bustamante, Carlos D.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Mezey, Jason G.] Weill Cornell Med Coll, Dept Med Genet, New York, NY USA	Cornell University; Columbia University; New York State Psychiatry Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Southern California; Stanford University; Cornell University	Brisbin, A (corresponding author), Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14850 USA.	agb36@cornell.edu		Weissman, Myrna/0000-0003-3490-3075; Hamilton, Steven/0000-0001-8106-6260; Bustamante, Carlos D./0000-0002-4187-7920	National Institutes of Health (NIH) [R01 GM083606, N01-HG-65403]; National Institute of Mental Health (NIMH) [MH28274, MH37592, MH30906, MH48858]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [N01HG065403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH030906, R01MH048858, R37MH028274, P50MH030906, R01MH028274, P01MH037592] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported in part by National Institutes of Health (NIH), www.nih.gov, grant R01 GM083606 and National Institute of Mental Health (NIMH), www.nimh.nih.gov, grants MH28274 (to MMW), MH37592 (to AJF), MH30906 (to DFK and AJF), and MH48858 (to SEH). Genotyping services were provided to JAK by the Center for Inherited Disease Research (CIDR). CIDR is fully funded through a federal contract from the NIH to Johns Hopkins University, contract number N01-HG-65403. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; *AM, 2010, AM EL COMP CLOUD; CHURCHILL GA, 1994, GENETICS, V138, P963; Corbett J, 2004, HUM HERED, V57, P21, DOI 10.1159/000077386; Diao G, 2010, GENET EPIDEMIOL, V34, P232, DOI 10.1002/gepi.20453; Dupuis J, 2009, GENET EPIDEMIOL, V33, P617, DOI 10.1002/gepi.20413; Feng R, 2004, P NATL ACAD SCI USA, V101, P16739, DOI 10.1073/pnas.0404623101; Fishelson M., 2002, BIOINFORMATICS, V18, pS189, DOI [10.1093/bioinformatics/18.suppl_1.S189, DOI 10.1093/BIOINFORMATICS/18.SUPPL_1.S189]; Fyer AJ, 2006, BIOL PSYCHIAT, V60, P388, DOI 10.1016/j.biopsych.2006.04.018; GEYER CJ, 1995, J AM STAT ASSOC, V90, P909, DOI 10.1080/01621459.1995.10476590; GEYER CJ, 1991, 568 U MINN SCH STAT; Gilks W.R., 1996, MARKOV CHAIN MONTE C, P89; Hackett CA, 1995, BIOMETRICS, V51, P1252, DOI 10.2307/2533257; Hayashi T, 2006, HEREDITY, V96, P185, DOI 10.1038/sj.hdy.6800783; Heath SC, 1997, AM J HUM GENET, V61, P748, DOI 10.1086/515506; Jordan MI, 2004, STAT SCI, V19, P140, DOI 10.1214/088342304000000026; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kuokkanen S, 1996, NAT GENET, V13, P477, DOI 10.1038/ng0896-477; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Li J, 2006, GENETICS, V173, P1649, DOI 10.1534/genetics.105.054619; Mackay DJC, 1998, NATO ADV SCI I D-BEH, V89, P175; Pritchard JK, 2000, GENETICS, V155, P945; Rao SQ, 1998, HEREDITY, V81, P214, DOI 10.1038/sj.hdy.6883780; Rao SQ, 2000, GENETICA, V109, P183, DOI 10.1023/A:1017507624695; ROM DM, 1990, BIOMETRIKA, V77, P663, DOI 10.2307/2337008; THOMAS A, 1994, IMA J MATH APPL MED, V11, P79; THOMAS DC, 1992, HUM HERED, V42, P63, DOI 10.1159/000154046; THOMAS DC, 1996, MARKOV CHAIN MONTE C, P419; Wang XQ, 2006, GENET EPIDEMIOL, V30, P728, DOI 10.1002/gepi.20184; Xu C, 2005, HEREDITY, V94, P119, DOI 10.1038/sj.hdy.6800583; Xu S, 2006, HEREDITY, V97, P409, DOI 10.1038/sj.hdy.6800885; Yandell BS, 2007, BIOINFORMATICS, V23, P641, DOI 10.1093/bioinformatics/btm011; Yi NJ, 2007, GENETICS, V176, P1855, DOI 10.1534/genetics.107.071142; Yi NJ, 2004, BEHAV GENET, V34, P3, DOI 10.1023/B:BEGE.0000009473.43185.43; Zhang HP, 2006, GENETICS, V172, P693, DOI 10.1534/genetics.105.049122; Zhang MZ, 2008, BIOINFORMATICS, V24, P1737, DOI 10.1093/bioinformatics/btn258	38	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12307	10.1371/journal.pone.0012307	http://dx.doi.org/10.1371/journal.pone.0012307			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865038	gold, Green Published, Green Submitted			2022-12-27	WOS:000281292100005
J	Khandelwal, G; Bhyravabhotla, J				Khandelwal, Garima; Bhyravabhotla, Jayaram			A Phenomenological Model for Predicting Melting Temperatures of DNA Sequences	PLOS ONE			English	Article							HELIX-COIL TRANSITION; THERMAL-DENATURATION; BASE-PAIRS; STABILITY; DUPLEX; STACKING; DYNAMICS; THERMODYNAMICS; RECOGNITION; OLIGOMERS	We report here a novel method for predicting melting temperatures of DNA sequences based on a molecular-level hypothesis on the phenomena underlying the thermal denaturation of DNA. The model presented here attempts to quantify the energetic components stabilizing the structure of DNA such as base pairing, stacking, and ionic environment which are partially disrupted during the process of thermal denaturation. The model gives a Pearson product-moment correlation coefficient (r) of similar to 0.98 between experimental and predicted melting temperatures for over 300 sequences of varying lengths ranging from 15-mers to genomic level and at different salt concentrations. The approach is implemented as a web tool (www.scfbio-iitd.res.in/chemgenome/Tm_predictor.jsp) for the prediction of melting temperatures of DNA sequences.	[Khandelwal, Garima; Bhyravabhotla, Jayaram] Indian Inst Technol Delhi, Dept Chem, New Delhi, India; [Khandelwal, Garima; Bhyravabhotla, Jayaram] Indian Inst Technol Delhi, Supercomp Facil Bioinformat & Computat Biol, New Delhi, India; [Bhyravabhotla, Jayaram] Indian Inst Technol Delhi, Sch Biol Sci, New Delhi, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Khandelwal, G (corresponding author), Indian Inst Technol Delhi, Dept Chem, New Delhi, India.	bjayaram@chemistry.iitd.ac.in	Jayaram, B/G-9130-2011	Jayaram, B/0000-0002-5495-2213	Department of Biotechnology, India	Department of Biotechnology, India(Department of Biotechnology (DBT) India)	The funding for the work has been provided by the Department of Biotechnology, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AN SOFTW LTD, AN IT MICR EXC VERS; Arora N, 1998, J PHYS CHEM B, V102, P6139, DOI 10.1021/jp9813692; Barbi M, 1999, PHYS LETT A, V253, P358, DOI 10.1016/S0375-9601(99)00059-6; Blake RD, 1996, NUCLEIC ACIDS RES, V24, P2095, DOI 10.1093/nar/24.11.2095; BLAKE RD, 1987, BIOPOLYMERS, V26, P1063, DOI 10.1002/bip.360260706; BRESLAUER KJ, 1986, P NATL ACAD SCI USA, V83, P3746, DOI 10.1073/pnas.83.11.3746; Campa A, 1998, PHYS REV E, V58, P3585, DOI 10.1103/PhysRevE.58.3585; Cantor C. R., 1980, BIOPHYSICAL CHEM 3; DAUXOIS T, 1993, PHYS REV E, V47, pR44, DOI 10.1103/PhysRevE.47.R44; DELCOURT SG, 1991, J BIOL CHEM, V266, P15160; Dixit SB, 2005, BIOPHYS J, V89, P3721, DOI 10.1529/biophysj.105.067397; DOKTYCZ MJ, 1995, J BIOL CHEM, V270, P8439, DOI 10.1074/jbc.270.15.8439; Dutta S, 2006, J CHEM INF MODEL, V46, P78, DOI 10.1021/ci050119x; Eldrup AB, 2002, J AM CHEM SOC, V124, P3254, DOI 10.1021/ja0117027; FRANKKAMENETSKII M, 1987, NATURE, V328, P17, DOI 10.1038/328017a0; Grigoryan AV, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2727456; Guckian KM, 1996, J AM CHEM SOC, V118, P8182, DOI 10.1021/ja961733f; Haaima G, 1997, NUCLEIC ACIDS RES, V25, P4639, DOI 10.1093/nar/25.22.4639; JAYARAM B, 1990, J PHYS CHEM-US, V94, P4666, DOI 10.1021/j100374a055; Jayaram B, 2004, ANNU REV BIOPH BIOM, V33, P343, DOI 10.1146/annurev.biophys.33.110502.140414; Jayaram B, 1997, J MOL EVOL, V45, P704, DOI 10.1007/PL00013144; Jiranusornkul S, 2008, J R SOC INTERFACE, V5, pS191, DOI 10.1098/rsif.2008.0304.focus; Kanhere A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-1; Kim JY, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2827471; Kohandel M, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.011905; Lafontaine I, 2000, BIOPHYS J, V79, P680, DOI 10.1016/S0006-3495(00)76326-0; Lewin B, 2004, GENE 8, VVIII; Licinio P, 2007, BIOPHYS J, V92, P2000, DOI 10.1529/biophysj.106.095059; LIFSON S, 1961, J CHEM PHYS, V34, P1963, DOI 10.1063/1.1731802; LISSER S, 1993, NUCLEIC ACIDS RES, V21, P1507, DOI 10.1093/nar/21.7.1507; MANDEL M, 1970, J BACTERIOL, V101, P333, DOI 10.1128/JB.101.2.333-338.1970; MARMUR J, 1962, J MOL BIOL, V5, P109, DOI 10.1016/S0022-2836(62)80066-7; Movileanu L, 2002, NUCLEIC ACIDS RES, V30, P3767, DOI 10.1093/nar/gkf471; Owczarzy R, 2004, BIOCHEMISTRY-US, V43, P3537, DOI 10.1021/bi034621r; OWEN RJ, 1982, J GEN MICROBIOL, V128, P2945; Panjkovich A, 2005, BIOINFORMATICS, V21, P711, DOI 10.1093/bioinformatics/bti066; PETRUSKA J, 1995, J BIOL CHEM, V270, P746, DOI 10.1074/jbc.270.2.746; PEYRARD M, 1993, PHYSICA D, V68, P104, DOI 10.1016/0167-2789(93)90035-Y; PORSCHKE D, 1971, BIOPOLYMERS, V10, P1989, DOI 10.1002/bip.360101016; Protozanova E, 2004, J MOL BIOL, V342, P775, DOI 10.1016/j.jmb.2004.07.075; PULLMAN B, 1966, J MOL BIOL, V22, P373, DOI 10.1016/0022-2836(66)90141-0; Rezac J, 2007, CHEM-EUR J, V13, P2983, DOI 10.1002/chem.200601120; Sandman K, 2000, ARCH MICROBIOL, V173, P165, DOI 10.1007/s002039900122; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; SCHILDKRAUT C, 1965, BIOPOLYMERS, V3, P195, DOI 10.1002/bip.360030207; Shaikh SA, 2007, J MED CHEM, V50, P2240, DOI 10.1021/jm060542c; SINDEN RR, 1997, CELL, V89, P999; Singhal P, 2008, BIOPHYS J, V94, P4173, DOI 10.1529/biophysj.107.116392; Sugimoto N, 1996, NUCLEIC ACIDS RES, V24, P4501, DOI 10.1093/nar/24.22.4501; Sundaralingam M, 2004, BIOCHEMISTRY-US, V43, P16467, DOI 10.1021/bi048158+; USSERY DW, 2001, DNA DENATURATION; Vamosi G, 2008, J PHYS CHEM B, V112, P13136, DOI 10.1021/jp8034055; WADA A, 1980, CRC CR REV BIOCH MOL, V9, P87, DOI 10.3109/10409238009105432; WADA A, 1986, PROG BIOPHYS MOL BIO, V47, P113, DOI 10.1016/0079-6107(86)90012-X; WARTELL RM, 1985, PHYS REP, V126, P67, DOI 10.1016/0370-1573(85)90060-2; Weber G, 2006, NAT PHYS, V2, P55, DOI 10.1038/nphys189; Yakovchuk P, 2006, NUCLEIC ACIDS RES, V34, P564, DOI 10.1093/nar/gkj454; Zhang YL, 1997, PHYS REV E, V56, P7100, DOI 10.1103/PhysRevE.56.7100; ZIMM BH, 1960, J CHEM PHYS, V33, P1349, DOI 10.1063/1.1731411	59	40	42	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12433	10.1371/journal.pone.0012433	http://dx.doi.org/10.1371/journal.pone.0012433			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865157	Green Submitted, Green Published, gold			2022-12-27	WOS:000281292100026
J	Breitling, LP; Arndt, V; Drath, C; Rothenbacher, D; Brenner, H				Breitling, Lutz P.; Arndt, Volker; Drath, Christoph; Rothenbacher, Dietrich; Brenner, Hermann			Smoking and gamma-Glutamyltransferase: Opposite Interactions with Alcohol Consumption and Body Mass Index	PLOS ONE			English	Article							CONSTRUCTION WORKERS; CIGARETTE-SMOKING; OXIDATIVE STRESS; LIVER-ENZYMES; RISK; COHORT; MEN; MORTALITY; DETERMINANTS; ASSOCIATION	Background: Smoking has recently been suggested to synergistically interact with alcohol intake as a determinant of serum gamma-glutamyltransferase (gamma-GT), an emergent powerful predictor of disease and mortality. This study investigated whether this also applies to higher smoking and alcohol exposure ranges and to body mass index (BMI), which likewise is strongly associated with gamma-GT. Methodology/Principal Findings: Analyses were based on occupational health examinations of more than 15,000 German male workers aged 16-64 years, predominantly from the construction industry. Sociodemographics and other health-related information were collected during the exam. Joint associations of smoking and alcohol consumption or BMI with elevated or log-transformed gamma-GT were examined by tabulation and multiple adjusted regression models. Cigarette smoking exerted no effect on gamma-GT in teetotalers, but there was a statistically significant effect of smoking among participants with higher alcohol consumption intensity, odds of elevated gamma-GT being increased by 24% and 27% per additional 10 cigarettes smoked per day in subjects drinking 61-90 and > 90 gram alcohol per day, respectively (P for interaction = 0.039). The interaction was opposite for BMI, where no association was seen in obese subjects, whereas odds of elevated gamma-GT were increased by 24% per 10 cigarettes below 25 kg/m(2) (P for interaction = 0.040). This novel interaction was replicable in an independent cohort. Conclusion: The evidence for opposite interactions of smoking with alcohol and BMI as determinants of serum gamma-GT suggests that different physiological pathways are responsible for the associations between these factors.	[Breitling, Lutz P.; Arndt, Volker; Rothenbacher, Dietrich; Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, D-6900 Heidelberg, Germany; [Drath, Christoph] Workmens Compensat Board Construct Workers, Occupat Hlth Serv, Boblingen, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Breitling, LP (corresponding author), German Canc Res Ctr, Div Clin Epidemiol & Aging Res, D-6900 Heidelberg, Germany.	L.Breitling@dkfz-heidelberg.de	Brenner, Hermann/ABE-6383-2020; /AAM-5330-2020; Brenner, Hermann/B-4627-2017; Arndt, Volker/AAI-7282-2020; Breitling, Lutz/C-7377-2008; Arndt, Volker/B-4999-2014	Brenner, Hermann/0000-0002-6129-1572; Brenner, Hermann/0000-0002-6129-1572; Arndt, Volker/0000-0001-9320-8684; Arndt, Volker/0000-0001-9320-8684; Rothenbacher, Dietrich/0000-0002-3563-2791	Association of the Workmen's Compensation Board for Construction Workers, Germany; German Research Foundation (DFG) [Br1704/11-1, SPP1226]	Association of the Workmen's Compensation Board for Construction Workers, Germany; German Research Foundation (DFG)(German Research Foundation (DFG))	Funding from the Association of the Workmen's Compensation Board for Construction Workers, Germany, is gratefully acknowledged. LPB was supported by grant Br1704/11-1 within the German Research Foundation (DFG) priority programme SPP1226 "Nicotine''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alatalo PI, 2008, AM J CLIN NUTR, V88, P1097, DOI 10.1093/ajcn/88.4.1097; Arndt V, 1998, INT ARCH OCC ENV HEA, V71, P405, DOI 10.1007/s004200050299; Bidel S, 2008, EUR J CLIN NUTR, V62, P178, DOI 10.1038/sj.ejcn.1602712; Breitling LP, 2010, J EPIDEMIOL COMMUN H, V64, P300, DOI 10.1136/jech.2009.089458; Breitling LP, 2009, HEPATOLOGY, V49, P802, DOI 10.1002/hep.22727; BRENNER H, 1992, EPIDEMIOLOGY, V3, P420, DOI 10.1097/00001648-199209000-00007; Brenner H, 1997, PREV MED, V26, P305, DOI 10.1006/pmed.1997.0144; Burke A, 2003, PROG CARDIOVASC DIS, V46, P79, DOI 10.1016/S0033-0620(03)00076-8; Claessen H, 2009, OCCUP ENVIRON MED, V66, P402, DOI 10.1136/oem.2008.042440; Claessen H, 2010, HEPATOLOGY, V51, P482, DOI 10.1002/hep.23324; Day CP, 2006, GASTROENTEROLOGY, V130, P207, DOI 10.1053/j.gastro.2005.11.017; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Husain K, 2001, ALCOHOL, V25, P89, DOI 10.1016/S0741-8329(01)00176-8; Kazemi-Shirazi L, 2007, CLIN CHEM, V53, P940, DOI 10.1373/clinchem.2006.081620; Lee DH, 2008, ARTERIOSCL THROM VAS, V28, pE26, DOI 10.1161/ATVBAHA.107.159376; Lee DH, 2006, EUR HEART J, V27, P2170, DOI 10.1093/eurheartj/ehl086; Low M, 2004, DEUT MED WOCHENSCHR, V129, P2643, DOI 10.1055/s-2004-836089; Meisinger C, 2006, ATHEROSCLEROSIS, V189, P297, DOI 10.1016/j.atherosclerosis.2006.01.010; Meisinger C, 2005, J INTERN MED, V258, P527, DOI 10.1111/j.1365-2796.2005.01572.x; POIKOLAINEN K, 1985, BRIT J ADDICT, V80, P215; Poikolainen K, 1997, AM J EPIDEMIOL, V146, P1019, DOI 10.1093/oxfordjournals.aje.a009230; Rebagliato M, 2002, J EPIDEMIOL COMMUN H, V56, P163, DOI 10.1136/jech.56.3.163; Ruhl CE, 2009, GASTROENTEROLOGY, V136, P477, DOI 10.1053/j.gastro.2008.10.052; Ruttmann E, 2005, CIRCULATION, V112, P2130, DOI 10.1161/CIRCULATIONAHA.105.552547; Sillanaukee P, 2000, AM J EPIDEMIOL, V152, P747, DOI 10.1093/aje/152.8.747; Steffensen FH, 1997, INT J EPIDEMIOL, V26, P92, DOI 10.1093/ije/26.1.92; Strasak AM, 2008, CANCER RES, V68, P3970, DOI 10.1158/0008-5472.CAN-07-6686; THORNTON RJ, 1989, J LABOR RES, V10, P443, DOI 10.1007/BF02685335; Wannamethee SG, 2010, ANN CLIN BIOCHEM, V47, P321, DOI 10.1258/acb.2010.009303; Whitehead TP, 1996, ANN CLIN BIOCHEM, V33, P530, DOI 10.1177/000456329603300607; WHO, 1995, 854 WHO TRS; Yamada Y, 2003, J OCCUP HEALTH, V45, P293, DOI 10.1539/joh.45.293	32	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e13116	10.1371/journal.pone.0013116	http://dx.doi.org/10.1371/journal.pone.0013116			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20927196	Green Published, gold, Green Submitted			2022-12-27	WOS:000282312600031
J	Cauda, F; Geminiani, G; D'Agata, F; Sacco, K; Duca, S; Bagshaw, AP; Cavanna, AE				Cauda, Franco; Geminiani, Giuliano; D'Agata, Federico; Sacco, Katiuscia; Duca, Sergio; Bagshaw, Andrew P.; Cavanna, Andrea E.			Functional Connectivity of the Posteromedial Cortex	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; POSTERIOR PARIETAL CORTEX; RESTING-STATE NETWORKS; ANTERIOR CINGULATE CORTEX; BOLD SIGNAL FLUCTUATIONS; DEFAULT-MODE NETWORK; FMRI TIME-SERIES; HUMAN BRAIN; STRUCTURAL CONNECTIVITY; CLUSTERING-ALGORITHM	As different areas within the PMC have different connectivity patterns with various cortical and subcortical regions, we hypothesized that distinct functional modules may be present within the PMC. Because the PMC appears to be the most active region during resting state, it has been postulated to play a fundamental role in the control of baseline brain functioning within the default mode network (DMN). Therefore one goal of this study was to explore which components of the PMC are specifically involved in the DMN. In a sample of seventeen healthy volunteers, we performed an unsupervised voxelwise ROI-based clustering based on resting state functional connectivity. Our results showed four clusters with different network connectivity. Each cluster showed positive and negative correlations with cortical regions involved in the DMN. Progressive shifts in PMC functional connectivity emerged from anterior to posterior and from dorsal to ventral ROIs. Ventral posterior portions of PMC were found to be part of a network implicated in the visuo-spatial guidance of movements, whereas dorsal anterior portions of PMC were interlinked with areas involved in attentional control. Ventral retrosplenial PMC selectively correlated with a network showing considerable overlap with the DMN, indicating that it makes essential contributions in self-referential processing, including autobiographical memory processing. Finally, ventral posterior PMC was shown to be functionally connected with a visual network. The paper represents the first attempt to provide a systematic, unsupervised, voxelwise clustering of the human posteromedial cortex (PMC), using resting-state functional connectivity data. Moreover, a ROI-based parcellation was used to confirm the results.	[Cauda, Franco; Geminiani, Giuliano; D'Agata, Federico; Sacco, Katiuscia; Duca, Sergio] Koelliker Hosp, CCS fMRI, Turin, Italy; [Cauda, Franco; Geminiani, Giuliano; D'Agata, Federico; Sacco, Katiuscia] Univ Turin, Dept Psychol, Turin, Italy; [D'Agata, Federico] AOU S Giovanni Battista, Dept Neurosci, Turin, Italy; [Bagshaw, Andrew P.] Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England; [Cavanna, Andrea E.] Univ Birmingham, Dept Neuropsychiat, Birmingham, W Midlands, England; [Cavanna, Andrea E.] Birmingham & Solihull Mental Hlth NHS Fdn Trust B, Birmingham, W Midlands, England; [Cavanna, Andrea E.] UCL, Inst Neurol, London, England	University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Birmingham; University of Birmingham; University of London; University College London	Cauda, F (corresponding author), Koelliker Hosp, CCS fMRI, Turin, Italy.	franco.cauda@unito.it	Sacco, Katiuscia/J-2133-2012; Cauda, Franco/G-5021-2010; D'Agata, Federico/ABG-8839-2021	Sacco, Katiuscia/0000-0002-9660-5236; Cauda, Franco/0000-0003-1526-8475; D'Agata, Federico/0000-0001-9432-0248; Bagshaw, Andrew/0000-0001-6217-1292	Regione Piemonte, bando Scienze Umane e Sociali	Regione Piemonte, bando Scienze Umane e Sociali(Regione Piemonte)	This study has been supported by Regione Piemonte, bando Scienze Umane e Sociali 2008, L. R. n. 4/2006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Baliki MN, 2008, J NEUROSCI, V28, P1398, DOI 10.1523/JNEUROSCI.4123-07.2008; Bandettini PA, 2008, HUM BRAIN MAPP, V29, P737, DOI 10.1002/hbm.20607; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BEZDEK JC, 1984, COMPUT GEOSCI, V10, P191, DOI 10.1016/0098-3004(84)90020-7; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; BLUM JS, 1950, J COMP NEUROL, V93, P53, DOI 10.1002/cne.900930105; Brodmann K, 1909, VERGLEICHENDE LOKALI; Brown W, 1910, BRIT J PSYCHOL, V3, P296, DOI 10.1111/j.2044-8295.1910.tb00207.x; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Burgess N, 2008, ANN NY ACAD SCI, V1124, P77, DOI 10.1196/annals.1440.002; CAMINITI R, 1996, VISION MOVEMENT MECH, P42; Canavero S, 2009, J NEUROL, V256, P834, DOI 10.1007/s00415-009-5019-4; Cauda F, 2009, J NEUROL NEUROSUR PS, V80, P429, DOI 10.1136/jnnp.2007.142349; Cauda F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004542; CAVADA C, 1989, J COMP NEUROL, V287, P422, DOI 10.1002/cne.902870403; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Crick FC, 2005, PHILOS T R SOC B, V360, P1271, DOI 10.1098/rstb.2005.1661; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Damoiseaux JS, 2009, BRAIN STRUCT FUNCT, V213, P525, DOI 10.1007/s00429-009-0208-6; de Munck JC, 2009, NEUROIMAGE, V47, P69, DOI 10.1016/j.neuroimage.2009.04.029; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Epstein RA, 2008, TRENDS COGN SCI, V12, P388, DOI 10.1016/j.tics.2008.07.004; Fadili MJ, 2001, MED IMAGE ANAL, V5, P55, DOI 10.1016/S1361-8415(00)00035-9; Fadili MJ, 2000, HUM BRAIN MAPP, V10, P160, DOI 10.1002/1097-0193(200008)10:4<160::AID-HBM20>3.0.CO;2-U; Ferandez-Miranda JC, 2008, J NEUROSURG, V108, P764, DOI 10.3171/JNS/2008/108/4/0764; Fiset P, 1999, J NEUROSCI, V19, P5506; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Fox MD, 2006, NAT NEUROSCI, V9, P23, DOI 10.1038/nn1616; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Fransson P, 2006, NEUROPSYCHOLOGIA, V44, P2836, DOI 10.1016/j.neuropsychologia.2006.06.017; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Golay X, 1998, MAGNET RESON MED, V40, P249, DOI 10.1002/mrm.1910400211; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Habas C, 2009, J NEUROSCI, V29, P8586, DOI 10.1523/JNEUROSCI.1868-09.2009; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hampson M, 2002, HUM BRAIN MAPP, V15, P247, DOI 10.1002/hbm.10022; JOHNSON PB, 1993, EXP BRAIN RES, V97, P361; Koski L, 2000, EXP BRAIN RES, V133, P55, DOI 10.1007/s002210000400; Laufs H, 2003, P NATL ACAD SCI USA, V100, P11053, DOI 10.1073/pnas.1831638100; Laureys S, 1999, NEUROIMAGE, V9, P377, DOI 10.1006/nimg.1998.0414; Leichnetz GR, 2001, ANAT RECORD, V263, P215, DOI 10.1002/ar.1082; Maddock RJ, 1999, TRENDS NEUROSCI, V22, P310, DOI 10.1016/S0166-2236(98)01374-5; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Maquet P, 1997, J NEUROSCI, V17, P2807; Margulies DS, 2007, NEUROIMAGE, V37, P579, DOI 10.1016/j.neuroimage.2007.05.019; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; Miller KJ, 2009, P NATL ACAD SCI USA, V106, P12174, DOI 10.1073/pnas.0902071106; Moller U, 2002, NEUROIMAGE, V17, P431, DOI 10.1006/nimg.2002.1166; Napadow V, 2008, NEUROIMAGE, V42, P169, DOI 10.1016/j.neuroimage.2008.04.238; Nioche C, 2009, AM J NEURORADIOL, V30, P396, DOI 10.3174/ajnr.A1375; Parvizi J, 2006, P NATL ACAD SCI USA, V103, P1563, DOI 10.1073/pnas.0507729103; Petrella JR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001104; Postuma RB, 2006, CEREB CORTEX, V16, P1508, DOI 10.1093/cercor/bhj088; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Rombouts SARB, 2005, HUM BRAIN MAPP, V26, P231, DOI 10.1002/hbm.20160; Roy AK, 2009, NEUROIMAGE, V45, P614, DOI 10.1016/j.neuroimage.2008.11.030; Sacco K, 2006, NEUROIMAGE, V32, P1441, DOI 10.1016/j.neuroimage.2006.05.018; Smolders A, 2007, MAGN RESON IMAGING, V25, P860, DOI 10.1016/j.mri.2007.02.018; Sorensen T., 1948, K DAN VIDENSK SELSK, V5, P1; Spearman C, 1910, BRIT J PSYCHOL, V3, P271, DOI 10.1111/j.2044-8295.1910.tb00206.x; Taylor KS, 2009, HUM BRAIN MAPP, V30, P2731, DOI 10.1002/hbm.20705; Thier P, 1998, J NEUROPHYSIOL, V80, P1713, DOI 10.1152/jn.1998.80.4.1713; Vogt BA, 2005, PROG BRAIN RES, V150, P205, DOI 10.1016/S0079-6123(05)50015-3; Vogt BA, 2006, NEUROIMAGE, V29, P452, DOI 10.1016/j.neuroimage.2005.07.048; von Economo C, 1925, CYTOARCHITEKTONIK HI; WEISSENBACHER A, 2009, NEUROIMAGE; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; ZADEH LA, 1977, CLASSFICATION CLUSTE, P355; Zhang DY, 2008, J NEUROPHYSIOL, V100, P1740, DOI 10.1152/jn.90463.2008; ZHANG N, IN PRESS J NEUROSCI; Zilles Karl, 2003, Adv Neurol, V93, P1	80	97	97	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e13107	10.1371/journal.pone.0013107	http://dx.doi.org/10.1371/journal.pone.0013107			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20927345	Green Published, Green Submitted, gold			2022-12-27	WOS:000282312600029
J	Creel, S; Rotella, JJ				Creel, Scott; Rotella, Jay J.			Meta-Analysis of Relationships between Human Offtake, Total Mortality and Population Dynamics of Gray Wolves (Canis lupus)	PLOS ONE			English	Article							CONSERVATION; PREDATION; ELK	Following the growth and geographic expansion of wolf (Canis lupus) populations reintroduced to Yellowstone National Park and central Idaho in 1995-1996, Rocky Mountain wolves were removed from the endangered species list in May 2009. Idaho and Montana immediately established hunting seasons with quotas equaling 20% of the regional wolf population. Combining hunting with predator control, 37.1% of Montana and Idaho wolves were killed in the year of delisting. Hunting and predator control are well-established methods to broaden societal acceptance of large carnivores, but it is unprecedented for a species to move so rapidly from protection under the Endangered Species Act to heavy direct harvest, and it is important to use all available data to assess the likely consequences of these changes in policy. For wolves, it is widely argued that human offtake has little effect on total mortality rates, so that a harvest of 28-50% per year can be sustained. Using previously published data from 21 North American wolf populations, we related total annual mortality and population growth to annual human offtake. Contrary to current conventional wisdom, there was a strong association between human offtake and total mortality rates across North American wolf populations. Human offtake was associated with a strongly additive or super-additive increase in total mortality. Population growth declined as human offtake increased, even at low rates of offtake. Finally, wolf populations declined with harvests substantially lower than the thresholds identified in current state and federal policies. These results should help to inform management of Rocky Mountain wolves.	[Creel, Scott; Rotella, Jay J.] Montana State Univ, Dept Ecol, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman	Creel, S (corresponding author), Montana State Univ, Dept Ecol, Bozeman, MT 59717 USA.	screel@montana.edu			National Science Foundation	National Science Foundation(National Science Foundation (NSF))	This work was funded by the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LG, 2008, WILDLIFE MONOGR, P1, DOI 10.2193/2008-012; [Anonymous], 2009, FED REGISTER, V74, p[15, 123]; Brainerd SM, 2008, J WILDLIFE MANAGE, V72, P89, DOI 10.2193/2006-305; Creel S., 2002, AFRICAN WILD DOG BEH; Creel S, 2007, SCIENCE, V315, P960, DOI 10.1126/science.1135918; Fuller T.K, 2003, WOLVES BEHAV ECOLOGY; Haight RG, 2002, WILDLIFE SOC B, V30, P844; HAMLIN K, 2005, MONTANA FINAL ELK MA; Hebblewhite M, 2002, CAN J ZOOL, V80, P789, DOI 10.1139/Z02-058; *ID DEP FISH GAM, 2009, WOLF HUNT SEAS RUL; Idaho Legislative Wolf Oversight Committee, 2002, ID WOLF CONS MAN PLA; Lebreton JD, 2005, AUST NZ J STAT, V47, P49, DOI 10.1111/j.1467-842X.2005.00371.x; Martin J, 2009, ECOL APPL, V19, P1079, DOI 10.1890/08-0255.1; Mech LD, 2001, WILDLIFE SOC B, V29, P70; Morris W. F., 2002, QUANTITATIVE CONSERV; *MT DEP FISH WILDL, 2003, MONT GRAY WOLF CONS; *MT DEP FISH WILDL, 2009, MONT HUNT REG WOLF; PACKER C, 2010, CONS BIOL, DOI DOI 10.1111/J.1525-1739.2010.01576.X; Packer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005941; Smith DW, 2010, J WILDLIFE MANAGE, V74, P620, DOI 10.2193/2008-584; *US FISH WILDL SER, 2009, ROCK MOUNT WOLF REC, P1; Williams B. K., 2002, ANAL MANAGEMENT ANIM	22	85	86	1	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e12918	10.1371/journal.pone.0012918	http://dx.doi.org/10.1371/journal.pone.0012918			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20927363	Green Published, gold, Green Submitted			2022-12-27	WOS:000282269400006
J	Dinov, I; Lozev, K; Petrosyan, P; Liu, ZZ; Eggert, P; Pierce, J; Zamanyan, A; Chakrapani, S; Van Horn, J; Parker, DS; Magsipoc, R; Leung, K; Gutman, B; Woods, R; Toga, A				Dinov, Ivo; Lozev, Kamen; Petrosyan, Petros; Liu, Zhizhong; Eggert, Paul; Pierce, Jonathan; Zamanyan, Alen; Chakrapani, Shruthi; Van Horn, John; Parker, D. Stott; Magsipoc, Rico; Leung, Kelvin; Gutman, Boris; Woods, Roger; Toga, Arthur			Neuroimaging Study Designs, Computational Analyses and Data Provenance Using the LONI Pipeline	PLOS ONE			English	Article							GRAY-MATTER LOSS; CEREBRAL-CORTEX; WORKFLOW MANAGEMENT; SCIENTIFIC WORKFLOW; CORTICAL THICKNESS; BRAIN; MRI; REGISTRATION; PATTERN; FMRI	Modern computational neuroscience employs diverse software tools and multidisciplinary expertise to analyze heterogeneous brain data. The classical problems of gathering meaningful data, fitting specific models, and discovering appropriate analysis and visualization tools give way to a new class of computational challenges-management of large and incongruous data, integration and interoperability of computational resources, and data provenance. We designed, implemented and validated a new paradigm for addressing these challenges in the neuroimaging field. Our solution is based on the LONI Pipeline environment [3,4], a graphical workflow environment for constructing and executing complex data processing protocols. We developed study-design, database and visual language programming functionalities within the LONI Pipeline that enable the construction of complete, elaborate and robust graphical workflows for analyzing neuroimaging and other data. These workflows facilitate open sharing and communication of data and metadata, concrete processing protocols, result validation, and study replication among different investigators and research groups. The LONI Pipeline features include distributed grid-enabled infrastructure, virtualized execution environment, efficient integration, data provenance, validation and distribution of new computational tools, automated data format conversion, and an intuitive graphical user interface. We demonstrate the new LONI Pipeline features using large scale neuroimaging studies based on data from the International Consortium for Brain Mapping [5] and the Alzheimer's Disease Neuroimaging Initiative [6]. User guides, forums, instructions and downloads of the LONI Pipeline environment are available at http://pipeline.loni.ucla.edu.	[Dinov, Ivo; Lozev, Kamen; Petrosyan, Petros; Liu, Zhizhong; Pierce, Jonathan; Zamanyan, Alen; Chakrapani, Shruthi; Van Horn, John; Parker, D. Stott; Magsipoc, Rico; Leung, Kelvin; Gutman, Boris; Woods, Roger; Toga, Arthur] Univ Calif Los Angeles, Lab Neuro Imaging, Los Angeles, CA 90024 USA; [Eggert, Paul; Parker, D. Stott; Leung, Kelvin] Univ Calif Los Angeles, Dept Comp Sci, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Dinov, I (corresponding author), Univ Calif Los Angeles, Lab Neuro Imaging, Los Angeles, CA 90024 USA.	toga@loni.ucla.edu		Dinov, Ivo/0000-0003-3825-4375; Van Horn, John Darrell/0000-0003-1537-0816	National Institutes of Health through the NIH Roadmap for Medical Research [U54 RR021813]; NIH/NCRR [5 P41 RR013642]; NIH/NIMH [5 R01 MH71940]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR021813, P41RR013642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071940] Funding Source: NIH RePORTER	National Institutes of Health through the NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by the National Institutes of Health through the NIH Roadmap for Medical Research, Grants U54 RR021813, NIH/NCRR 5 P41 RR013642 and NIH/NIMH 5 R01 MH71940. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amunts K, 2007, NEUROIMAGE, V37, P1061, DOI 10.1016/j.neuroimage.2007.02.037; Ballmaier M, 2004, NEUROIMAGE, V23, P325, DOI 10.1016/j.neuroimage.2004.04.026; BARGA R, 2008, TRIDENT E SCI 08; Barker A, 2008, LECT NOTES COMPUT SC, V4967, P746; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Bitter I, 2007, IEEE T VIS COMPUT GR, V13, P483, DOI 10.1109/TVCG.2007.1001; BUZUG TM, 1997, IMAGE REGISTRATION C, P203; Chen ACH, 2007, ALCOHOL CLIN EXP RES, V31, P156, DOI 10.1111/j.1530-0277.2006.00277.x; Chiang MC, 2007, NEUROIMAGE, V34, P44, DOI 10.1016/j.neuroimage.2006.08.030; Churches D, 2006, CONCURR COMP-PRACT E, V18, P1021, DOI 10.1002/cpe.992; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Collins DL, 1997, INT J PATTERN RECOGN, V11, P1271, DOI 10.1142/S0218001497000597; COXRW, 1996, COMPUT BIOMED RES, V29, P162; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; CUNHA J, 2006, GRID COMPUTING; DEELMAN E, GRID COMPUTING, V3165, P131; Dinov ID, 2002, IEEE T INF TECHNOL B, V6, P73, DOI 10.1109/4233.992165; DINOV IVAN, 2009, LONI PIPELINE FRONTI, V3, P1; Dinov ID, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002265; Drevets WC, 2001, CURR OPIN NEUROBIOL, V11, P240, DOI 10.1016/S0959-4388(00)00203-8; Eickhoff SB, 2006, CEREB CORTEX, V16, P268, DOI 10.1093/cercor/bhi106; Fleisher A, 2005, ARCH NEUROL-CHICAGO, V62, P953, DOI 10.1001/archneur.62.6.953; GENTZSCH W, 2002, GRID COMPUTING NEW T, P203; Gogtay N, 2006, HIPPOCAMPUS, V16, P664, DOI 10.1002/hipo.20193; Harris NG, 2000, J CEREBR BLOOD F MET, V20, P28, DOI 10.1097/00004647-200001000-00006; Haynes JD, 2007, CURR BIOL, V17, P323, DOI 10.1016/j.cub.2006.11.072; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Just MA, 2007, CEREB CORTEX, V17, P951, DOI 10.1093/cercor/bhl006; Kawas E, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-523; KOTTHA S, 2007, P GERMAN SCI C BADEN; Kubica S, 1998, LECT NOTES COMPUT SC, V1388, P963; Langen M, 2007, BIOL PSYCHIAT, V62, P262, DOI 10.1016/j.biopsych.2006.09.040; Leow AD, 2006, NEUROIMAGE, V31, P627, DOI 10.1016/j.neuroimage.2005.12.013; Lepore N, 2008, IEEE T MED IMAGING, V27, P129, DOI 10.1109/TMI.2007.906091; LEUNG K, 2008, LNCS, V13, P1; Liao W, 2008, PROC SPIE, V6919, DOI 10.1117/12.770431; LIU L, 2005, J NEUROIMAGING, V103, P117; LIU L, 2005, NEUROIMAGING, V103, P117; Liu YX, 2004, LECT NOTES COMPUT SC, V3216, P393; LUCAS B, 2008, 14 ANN M ORG HUM BRA, P15; Ludascher B, 2006, CONCURR COMP-PRACT E, V18, P1039, DOI 10.1002/cpe.994; Luders E, 2006, HUM BRAIN MAPP, V27, P314, DOI 10.1002/hbm.20187; MacDonald D, 2000, NEUROIMAGE, V12, P340, DOI 10.1006/nimg.1999.0534; MacFall JR, 2006, NEUROPSYCHOPHARMACOL, V31, P1500, DOI 10.1038/sj.npp.1300986; MacKenzie-Graham A, 2006, NEUROIMAGE, V32, P1016, DOI 10.1016/j.neuroimage.2006.05.006; MacKenzie-Graham AJ, 2008, NEUROIMAGE, V42, P178, DOI 10.1016/j.neuroimage.2008.04.186; MacKenzie-Graham AJ, 2008, LECT NOTES COMPUT SC, V5272, P208, DOI 10.1007/978-3-540-89965-5_22; MACLEOD RS, NANO MACRO, V1, P640; Marcus DS, 2007, NEUROINFORMATICS, V5, P11, DOI 10.1385/NI:5:1:11; MAZZIOTTA JC, 1995, NEUROIMAGE, V2, P89, DOI 10.1006/nimg.1995.1012; MILES S, 2006, EXPT J GRID COMPUTIN, V5, P1; Mueller Susanne G, 2005, Alzheimers Dement, V1, P55, DOI 10.1016/j.jalz.2005.06.003; Myers JD, 2005, CLUSTER COMPUT, V8, P243, DOI 10.1007/s10586-005-4092-4; Narr KL, 2007, NEUROIMAGE, V34, P939, DOI 10.1016/j.neuroimage.2006.08.052; Neu SC, 2005, NEUROIMAGE, V24, P1170, DOI 10.1016/j.neuroimage.2004.10.035; OINN T, 2005, PRACTICE EXPERIENCE, V18, P1067; PIEPER S, 2004, FROM NANO MACRO, V1, P632; Pras A, 2007, IEEE COMMUN MAG, V45, P104, DOI 10.1109/MCOM.2007.4342832; Rasser PE, 2005, NEUROIMAGE, V26, P941, DOI 10.1016/j.neuroimage.2004.11.054; Rex DE, 2004, NEUROIMAGE, V23, P625, DOI 10.1016/j.neuroimage.2004.06.019; Rex DE, 2003, NEUROIMAGE, V19, P1033, DOI 10.1016/S1053-8119(03)00185-X; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Shafi M, 2007, NEUROSCIENCE, V146, P1082, DOI 10.1016/j.neuroscience.2006.12.072; Simmhan YL, 2005, SIGMOD REC, V34, P31, DOI 10.1145/1084805.1084812; Simmhan YL, 2008, INT J WEB SERV RES, V5, P1, DOI 10.4018/jwsr.2008040101; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sowell ER, 2007, CEREB CORTEX, V17, P1550, DOI 10.1093/cercor/bhl066; Strother S, 2004, NEUROIMAGE, V23, pS196, DOI 10.1016/j.neuroimage.2004.07.022; Strother SC, 2006, IEEE ENG MED BIOL, V25, P27, DOI 10.1109/MEMB.2006.1607667; Tasdizen T, 2005, LECT NOTES COMPUT SC, V3750, P517, DOI 10.1007/11566489_64; Taylor I., 2005, J GRID COMPUT, V3, P153, DOI [10.1007/s10723-005-9007-3, DOI 10.1007/S10723-005-9007-3]; Thompson PM, 2003, J NEUROSCI, V23, P994; Thompson PM, 2005, P NATL ACAD SCI USA, V102, P15647, DOI 10.1073/pnas.0502548102; Thompson PM, 1999, NEUROLOGY, V52, pA368; Toga AW, 2007, NEUROIMAGE, V37, P1045, DOI 10.1016/j.neuroimage.2007.02.018; Toga AW, 2006, TRENDS NEUROSCI, V29, P148, DOI 10.1016/j.tins.2006.01.007; Tu Z, 2008, IEEE T MED IMAGING, V27, P495, DOI 10.1109/TMI.2007.908121; Yang YL, 2007, BRIT J PSYCHIAT, V190, P174, DOI 10.1192/bjp.bp.106.025056; ZHAO J, 2007, PRACTICE EXPERIENCE, V20, P463; [No title captured]	80	100	100	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2010	5	9							e13070	10.1371/journal.pone.0013070	http://dx.doi.org/10.1371/journal.pone.0013070			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654ZQ	20927408	Green Published, gold, Green Submitted			2022-12-27	WOS:000282210700027
J	Cenik, C; Wakeley, J				Cenik, Can; Wakeley, John			Pacific Salmon and the Coalescent Effective Population Size	PLOS ONE			English	Article							GEOGRAPHICALLY STRUCTURED POPULATIONS; STRONG-MIGRATION LIMIT; OVERLAPPING GENERATIONS; CONSERVATION GENETICS; GENEALOGICAL PROCESS; MULTIPLE COLLISIONS; ALLELE FREQUENCY; TEMPORAL CHANGES; DNA-SEQUENCES; VARYING SIZE	Pacific salmon include several species that are both commercially important and endangered. Understanding the causes of loss in genetic variation is essential for designing better conservation strategies. Here we use a coalescent approach to analyze a model of the complex life history of salmon, and derive the coalescent effective population (CES). With the aid of Kronecker products and a convergence theorem for Markov chains with two time scales, we derive a simple formula for the CES and thereby establish its existence. Our results may be used to address important questions regarding salmon biology, in particular about the loss of genetic variation. To illustrate the utility of our approach, we consider the effects of fluctuations in population size over time. Our analysis enables the application of several tools of coalescent theory to the case of salmon.	[Cenik, Can; Wakeley, John] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Harvard University	Cenik, C (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Cambridge, MA 02138 USA.	wakeley@fas.harvard.edu		Cenik, Can/0000-0001-6370-0889				[Anonymous], 2002, MODERN DEV THEORETIC; Ardren WR, 2003, MOL ECOL, V12, P35, DOI 10.1046/j.1365-294X.2003.01705.x; BEAMSDERFER RC, 1998, SPAWNER RECRUIT DATA, P1; Birkner M, 2008, J MATH BIOL, V57, P435, DOI 10.1007/s00285-008-0170-6; Cederholm C. J., 2000, PACIFIC SALMON WILDL; Crow J.F., 1954, STAT MATH BIOL, P543; Donnelly P, 1995, ANNU REV GENET, V29, P401, DOI 10.1146/annurev.ge.29.120195.002153; Efremov V.V., 2005, Genetika, V41, P680; Efremov V. V., 2004, Genetika, V40, P538; Eldon B, 2006, GENETICS, V172, P2621, DOI 10.1534/genetics.105.052175; EMIGH TH, 1979, GENETICS, V92, P323; Ewens W. J., 1979, MATH POPULATION GENE; EWENS WJ, 1982, THEOR POPUL BIOL, V21, P373, DOI 10.1016/0040-5809(82)90024-7; FELSENSTEIN J, 1971, GENETICS, V68, P581; Fernandez J, 2001, CONSERV GENET, V2, P121, DOI 10.1023/A:1011830703723; Fisher RA, 1930, GENETICAL THEORY NAT; Fu YX, 1999, THEOR POPUL BIOL, V56, P1, DOI 10.1006/tpbi.1999.1421; GRIFFITHS RC, 1994, PHILOS T ROY SOC B, V344, P403, DOI 10.1098/rstb.1994.0079; Griffiths RC, 1996, J COMPUT BIOL, V3, P479, DOI 10.1089/cmb.1996.3.479; HEIN J, 2004, SEQUENCE VARIATION G; Hey J, 1997, GENETICS, V145, P833; HILL WG, 1979, GENETICS, V92, P317; HILL WG, 1972, THEOR POPUL BIOL, V3, P27, DOI 10.1016/0040-5809(72)90032-9; HUDSON RR, 1983, EVOLUTION, V37, P203, DOI 10.1111/j.1558-5646.1983.tb05528.x; Jagers P, 2004, J APPL PROBAB, V41, P368, DOI 10.1239/jap/1082999072; Jones J. W., 1959, THE SALMON; Kaj I, 2003, J APPL PROBAB, V40, P33, DOI 10.1017/S0021900200022257; Kaj I, 2001, J APPL PROBAB, V38, P285, DOI 10.1017/S0021900200019860; Kareiva P, 2000, SCIENCE, V290, P977, DOI 10.1126/science.290.5493.977; Karlin S., 1975, 1 COURSE STOCHASTIC, V2; Kingman J., 1982, J APPL PROB A, V19, P27, DOI DOI 10.2307/3213548; Kingman J., 1982, STOCH PROC APPL, V13, P235, DOI [DOI 10.1016/0304-4149(82)90011-4, 10.1016/0304-4149(82)90011-4]; Kingman JFC, 2000, GENETICS, V156, P1461; Kobayashi Y, 2007, THEOR POPUL BIOL, V71, P174, DOI 10.1016/j.tpb.2006.12.001; Krone SM, 1997, THEOR POPUL BIOL, V51, P210, DOI 10.1006/tpbi.1997.1299; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; Matsen FA, 2006, GENETICS, V172, P701, DOI 10.1534/genetics.105.047597; Mohle M, 1998, ADV APPL PROBAB, V30, P493, DOI 10.1239/aap/1035228080; Mohle M, 2001, ANN PROBAB, V29, P1547; Mohle M, 1998, ADV APPL PROBAB, V30, P513, DOI 10.1239/aap/1035228081; Moran P., 1962, STAT PROCESSES EVOLU; Moran P. A. P., 1958, P CAMB PHILOS SOC, V54, P60, DOI DOI 10.1017/S0305004100033193); Murray J., 1910, REPORTS SCI EXPEDITI, P17; Myers RA, 2004, SCIENCE, V303, P1980, DOI 10.1126/science.1095410; NAGYLAKI T, 1980, J MATH BIOL, V9, P101, DOI 10.1007/BF00275916; Neuhauser C, 1997, GENETICS, V145, P519; Nomura T, 2005, CONSERV GENET, V6, P655, DOI 10.1007/s10592-005-9025-5; Nordborg M, 1997, GENETICS, V146, P1185; NORDBORG M, 2001, COALESCENT THEORY, P179; NOTOHARA M, 1993, J MATH BIOL, V31, P115; NOTOHARA M, 1990, J MATH BIOL, V29, P59, DOI 10.1007/BF00173909; Pitman J, 1999, ANN PROBAB, V27, P1870, DOI 10.1214/aop/1022677552; RYMAN N, 1991, CONSERV BIOL, V5, P325, DOI 10.1111/j.1523-1739.1991.tb00144.x; Sagitov S, 2005, ANN APPL PROBAB, V15, P1778, DOI 10.1214/105051605000000223; Sagitov S, 1999, J APPL PROBAB, V36, P1116, DOI 10.1239/jap/1032374759; Sano A, 2004, THEOR POPUL BIOL, V65, P39, DOI 10.1016/j.tpb.2003.09.001; Sjodin P, 2005, GENETICS, V169, P1061, DOI 10.1534/genetics.104.026799; TAJIMA F, 1992, J HERED, V83, P309, DOI 10.1093/oxfordjournals.jhered.a111219; TAJIMA F, 1983, GENETICS, V105, P437; Wakeley J, 1998, THEOR POPUL BIOL, V53, P166, DOI 10.1006/tpbi.1997.1355; Wakeley J, 2004, THEOR POPUL BIOL, V66, P83, DOI 10.1016/j.tpb.2004.04.005; Wakeley J., 2008, COALESCENT THEORY IN; WAPLES RS, 1990, CONSERV BIOL, V4, P144, DOI 10.1111/j.1523-1739.1990.tb00103.x; Waples RS, 2006, AM NAT, V167, P118, DOI 10.1086/498584; WAPLES RS, 1990, J HERED, V81, P277, DOI 10.1093/oxfordjournals.jhered.a110990; Waples RS, 2005, MOL ECOL, V14, P3335, DOI 10.1111/j.1365-294X.2005.02673.x; WAPLES RS, 1989, GENETICS, V121, P379; Waples RS, 2002, GENETICS, V161, P783; WAPLES RS, 1990, J HERED, V81, P267, DOI 10.1093/oxfordjournals.jhered.a110989; Wilkins JF, 2002, GENETICS, V161, P873; Wilkinson-Herbots HM, 1998, J MATH BIOL, V37, P535, DOI 10.1007/s002850050140; Wright S, 1937, P NATL ACAD SCI USA, V23, P307, DOI 10.1073/pnas.23.6.307; Wright S, 1931, GENETICS, V16, P0097	73	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e13019	10.1371/journal.pone.0013019	http://dx.doi.org/10.1371/journal.pone.0013019			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20885947	Green Submitted, gold, Green Published			2022-12-27	WOS:000282167100020
J	Rayavarapu, S; Van der Meulen, JH; Gordish-Dressman, H; Hoffman, EP; Nagaraju, K; Knoblach, SM				Rayavarapu, Sree; Van der Meulen, Jack H.; Gordish-Dressman, Heather; Hoffman, Eric P.; Nagaraju, Kanneboyina; Knoblach, Susan M.			Characterization of Dysferlin Deficient SJL/J Mice to Assess Preclinical Drug Efficacy: Fasudil Exacerbates Muscle Disease Phenotype	PLOS ONE			English	Article							RHO-KINASE INHIBITOR; MUSCULAR-DYSTROPHY; SKELETAL-MUSCLES; T-CELLS; KAPPA-B; MODEL; EXPRESSION; MYOPATHY; INFLAMMATION; ACTIVATION	The dysferlin deficient SJL/J mouse strain is commonly used to study dysferlin deficient myopathies. Therefore, we systematically evaluated behavior in relatively young (9-25 weeks) SJL/J mice and compared them to C57BL6 mice to determine which functional end points may be the most effective to use for preclinical studies in the SJL/J strain. SJL/J mice had reduced body weight, lower open field scores, higher creatine kinase levels, and less muscle force than did C57BL6 mice. Power calculations for expected effect sizes indicated that grip strength normalized to body weight and open field activity were the most sensitive indicators of functional status in SJL/J mice. Weight and open field scores of SJL/J mice deteriorated over the course of the study, indicating that progressive myopathy was ongoing even in relatively young (<6 months old) SJL/J mice. To further characterize SJL/J mice within the context of treatment, we assessed the effect of fasudil, a rho-kinase inhibitor, on disease phenotype. Fasudil was evaluated based on previous observations that Rho signaling may be overly activated as part of the inflammatory cascade in SJL/J mice. Fasudil treated SJL/J mice showed increased body weight, but decreased grip strength, horizontal activity, and soleus muscle force, compared to untreated SJL/J controls. Fasudil either improved or had no effect on these outcomes in C57BL6 mice. Fasudil also reduced the number of infiltrating macrophages/monocytes in SJL/J muscle tissue, but had no effect on muscle fiber degeneration/regeneration. These studies provide a basis for standardization of preclinical drug testing trials in the dysferlin deficient SJL/J mice, and identify measures of functional status that are potentially translatable to clinical trial outcomes. In addition, the data provide pharmacological evidence suggesting that activation of rho-kinase, at least in part, may represent a beneficial compensatory response in dysferlin deficient myopathies.	[Rayavarapu, Sree; Van der Meulen, Jack H.; Gordish-Dressman, Heather; Hoffman, Eric P.; Nagaraju, Kanneboyina; Knoblach, Susan M.] Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA; [Rayavarapu, Sree] George Washington Univ, Inst Biomed Sci, Washington, DC USA; [Hoffman, Eric P.; Nagaraju, Kanneboyina; Knoblach, Susan M.] George Washington Univ, Sch Med & Hlth Sci, Dept Integrat Syst Biol, Washington, DC 20052 USA	Children's National Health System; George Washington University; George Washington University	Rayavarapu, S (corresponding author), Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA.	KNagaraju@cnmcresearch.org; sknoblach@cnmcresearch.org	Nagaraju, Kanneboyina/AAV-7684-2021; Nagaraju, Kanneboyina/ABA-6525-2021	Rayavarapu, Sree/0000-0002-5833-4711; Hoffman, Eric/0000-0001-6470-5139; Gordish-Dressman, Heather/0000-0002-2330-5427	Cecil B. Day Foundation (UMASS Medical School); Department of Defense (Mouse Drug Screening Core) [W81XWH-05-1-0616]; Foundation to Eradicate Duchenne Inc; NIH [R01-AR050478, 1U54HD053177-01A1]; Wellstone Muscular Dystrophy Center; NIH IDDRC (Intellectual and Developmental Disabilities Research Center) [P30HD40677]; NIH NCMRR/NINDS (Integrated Molecular Core for Rehabilitation Medicine) [5R24 HD050846]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD040677, R24HD050846] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD053177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050478] Funding Source: NIH RePORTER	Cecil B. Day Foundation (UMASS Medical School); Department of Defense (Mouse Drug Screening Core)(United States Department of Defense); Foundation to Eradicate Duchenne Inc; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellstone Muscular Dystrophy Center; NIH IDDRC (Intellectual and Developmental Disabilities Research Center)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NCMRR/NINDS (Integrated Molecular Core for Rehabilitation Medicine)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was funded in part by Cecil B. Day Foundation to Dr. Robert H. Brown JR (UMASS Medical School) and by the Department of Defense USAMRAA grant W81XWH-05-1-0616 (Mouse Drug Screening Core), Foundation to Eradicate Duchenne Inc, and NIH grant R01-AR050478 (K. Nagaraju), NIH grant 1U54HD053177-01A1, Wellstone Muscular Dystrophy Center (EP Hoffman) and Wellstone Muscular Dystrophy Center pilot project funding (SM Knoblach). The work was also partially supported by the NIH IDDRC P30HD40677 (Intellectual and Developmental Disabilities Research Center) and the NIH NCMRR/NINDS 5R24 HD050846 (Integrated Molecular Core for Rehabilitation Medicine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alley J, 2003, EXP NEUROL, V180, P14, DOI 10.1016/S0014-4886(02)00054-7; Aznar S, 2001, CANCER LETT, V165, P1, DOI 10.1016/S0304-3835(01)00412-8; Bauer PO, 2009, AUTOPHAGY, V5, P747, DOI 10.4161/auto.5.5.8704; Bittner RE, 1999, NAT GENET, V23, P141, DOI 10.1038/13770; BROOKS SV, 1988, J PHYSIOL-LONDON, V404, P71, DOI 10.1113/jphysiol.1988.sp017279; Cernuda-Morollon E, 2006, CIRC RES, V98, P757, DOI 10.1161/01.RES.0000210579.35304.d3; Chase TH, 2009, AM J PATHOL, V175, P2299, DOI 10.2353/ajpath.2009.080930; Chiu YH, 2009, HUM MOL GENET, V18, P1976, DOI 10.1093/hmg/ddp121; Confalonieri P, 2003, J NEUROIMMUNOL, V142, P130, DOI 10.1016/S0165-5728(03)00255-8; De Luca A, 2005, AM J PATHOL, V166, P477, DOI 10.1016/S0002-9440(10)62270-5; De Luna N, 2007, NEUROMUSCULAR DISORD, V17, P69, DOI 10.1016/j.nmd.2006.09.006; Del Re DP, 2007, J BIOL CHEM, V282, P8069, DOI 10.1074/jbc.M604298200; Erwig LP, 2006, P NATL ACAD SCI USA, V103, P12825, DOI 10.1073/pnas.0605331103; Gallardo E, 2001, NEUROLOGY, V57, P2136, DOI 10.1212/WNL.57.11.2136; Gerhauser I, 2007, J NEUROPATH EXP NEUR, V66, P809, DOI 10.1097/nen.0b013e3181461f31; Glover L, 2007, TRAFFIC, V8, P785, DOI 10.1111/j.1600-0854.2007.00573.x; Hahmann C, 2010, CELL MOL LIFE SCI, V67, P171, DOI 10.1007/s00018-009-0189-x; Han GM, 2009, CELL IMMUNOL, V258, P188, DOI 10.1016/j.cellimm.2009.05.003; He Y, 2008, ARTHRITIS RHEUM-US, V58, P3366, DOI 10.1002/art.23986; Heiman-Patterson TD, 2005, J NEUROL SCI, V236, P1, DOI 10.1016/j.jns.2005.02.006; Hidaka T, 2008, AM J PATHOL, V172, P603, DOI 10.2353/ajpath.2008.070196; Higashi M, 2003, CIRC RES, V93, P767, DOI 10.1161/01.RES.0000096650.91688.28; Knippenberg S, 2010, BEHAV BRAIN RES, V213, P82, DOI 10.1016/j.bbr.2010.04.042; LI Y, MED SCI MONIT, V16, pBR112; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; LoGrasso PV, 2009, CURR TOP MED CHEM, V9, P704, DOI 10.2174/156802609789044452; Nagaraju K, 2002, RHEUM DIS CLIN N AM, V28, P917, DOI 10.1016/S0889-857X(02)00026-1; Nagaraju K, 2008, AM J PATHOL, V172, P774, DOI 10.2353/ajpath.2008.070327; Nemoto H, 2007, EUR NEUROL, V57, P19, DOI 10.1159/000097005; Noma K, 2006, AM J PHYSIOL-CELL PH, V290, pC661, DOI 10.1152/ajpcell.00459.2005; Pelosi M, 2007, MOL CELL BIOL, V27, P6163, DOI 10.1128/MCB.01735-06; Pollinger B, 2009, J EXP MED, V206, P1303, DOI 10.1084/jem.20090299; Scheiffele Frank, 2002, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1519s49; Shi JJ, 2007, ARCH IMMUNOL THER EX, V55, P61, DOI 10.1007/s00005-007-0009-7; Shimokawa H, 1999, CARDIOVASC RES, V43, P1029, DOI 10.1016/S0008-6363(99)00144-3; Spurney CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008976; Spurney CF, 2009, MUSCLE NERVE, V39, P591, DOI 10.1002/mus.21211; Sun XJ, 2006, J NEUROIMMUNOL, V180, P126, DOI 10.1016/j.jneuroim.2006.06.027; SUZUKI K, 2005, NIPPON RINSHO S, V10, P608; Suzuki N, 2005, NEUROSCI RES, V52, P47, DOI 10.1016/j.neures.2005.01.006; Tawara S, 2007, J CARDIOVASC PHARM, V50, P195, DOI 10.1097/FJC.0b013e31806befe6; Tharaux PL, 2003, J IMMUNOL, V171, P96, DOI 10.4049/jimmunol.171.1.96; TIETZ NW, 1982, FUNDAMENTALS CLIN CH; Vafiadaki E, 2001, NEUROREPORT, V12, P625, DOI 10.1097/00001756-200103050-00039; Weller AH, 1997, MUSCLE NERVE, V20, P72, DOI 10.1002/(SICI)1097-4598(199701)20:1<72::AID-MUS10>3.0.CO;2-3; Yeh BJ, 2007, NATURE, V447, P596, DOI 10.1038/nature05851; Yu JZ, 2010, J NEUROSCI RES, V88, P1664, DOI 10.1002/jnr.22339; Zhang J, 2009, CLIN CHIM ACTA, V401, P76, DOI 10.1016/j.cca.2008.11.016	48	27	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2010	5	9							e12981	10.1371/journal.pone.0012981	http://dx.doi.org/10.1371/journal.pone.0012981			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653UN	20886045	Green Published, Green Submitted, gold			2022-12-27	WOS:000282122600016
J	Jin, L; Gan, QO; Zieba, BJ; Goicoechea, SM; Owens, GK; Otey, CA; Somlyo, AV				Jin, Li; Gan, Qiong; Zieba, Bartosz J.; Goicoechea, Silvia M.; Owens, Gary K.; Otey, Carol A.; Somlyo, Avril V.			The Actin Associated Protein Palladin Is Important for the Early Smooth Muscle Cell Differentiation	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; GENE-EXPRESSION; BINDING PARTNER; HISTONE DEACETYLASES; ANGIOTENSIN-II; MARKER GENES; STEM-CELLS; MYOCARDIN; FAMILY; CYTOSKELETON	Palladin, an actin associated protein, plays a significant role in regulating cell adhesion and cell motility. Palladin is important for development, as knockdown in mice is embryonic lethal, yet its role in the development of the vasculature is unknown. We have shown that palladin is essential for the expression of smooth muscle cells (SMC) marker genes and force development in response to agonist stimulation in palladin deficient SMCs. The goal of the study was to determine the molecular mechanisms underlying palladin's ability to regulate the expression of SMC marker genes. Results showed that palladin expression was rapidly induced in an A404 cell line upon retinoic acid (RA) induced differentiation. Suppression of palladin expression with siRNAs inhibited the expression of RA induced SMC differentiation genes, SM alpha-actin (SMA) and SM22, whereas over-expression of palladin induced SMC gene expression. Chromatin immunoprecipitation assays provided evidence that palladin bound to SMC genes, whereas co-immunoprecipitation assays also showed binding of palladin to myocardin related transcription factors (MRTFs). Endogenous palladin was imaged in the nucleus, increased with leptomycin treatment and the carboxyl-termini of palladin co-localized with MRTFs in the nucleus. Results support a model wherein palladin contributes to SMC differentiation through regulation of CArG-SRF-MRTF dependent transcription of SMC marker genes and as previously published, also through actin dynamics. Finally, in E11.5 palladin null mouse embryos, the expression of SMA and SM22 mRNA and protein is decreased in the vessel wall. Taken together, our findings suggest that palladin plays a key role in the differentiation of SMCs in the developing vasculature.	[Jin, Li; Gan, Qiong; Zieba, Bartosz J.; Owens, Gary K.; Somlyo, Avril V.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22903 USA; [Goicoechea, Silvia M.; Otey, Carol A.] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC USA	University of Virginia; University of North Carolina; University of North Carolina Chapel Hill	Jin, L (corresponding author), Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22903 USA.	avs5u@virginia.edu		Goicoechea, Silvia/0000-0003-1107-389X	National Institutes of Health [PO1 HL48807, PO1 HL 19242, AHA 0635025N, GM081505]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048807, P01HL019242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081505] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported, in whole or in part, by National Institutes of Health Grants PO1 HL48807 (to A.V.S.), PO1 HL 19242 (to A.V.S. and G.K.O.), AHA 0635025N (to S.G.), and GM081505 (to C.O.).	Boukhelifa M, 2006, FEBS J, V273, P26, DOI 10.1111/j.1742-4658.2005.05036.x; Boukhelifa M, 2004, CELL MOTIL CYTOSKEL, V58, P17, DOI 10.1002/cm.10173; Boukhelifa M, 2003, MOL CELL NEUROSCI, V23, P661, DOI 10.1016/S1044-7431(03)00127-1; Boukhelifa M, 2001, MOL BIOL CELL, V12, P2721, DOI 10.1091/mbc.12.9.2721; Dixon RDS, 2008, J BIOL CHEM, V283, P6222, DOI 10.1074/jbc.M707694200; Du KL, 2003, MOL CELL BIOL, V23, P2425, DOI 10.1128/MCB.23.7.2425-2437.2003; Endlich N, 2009, KIDNEY INT, V75, P214, DOI 10.1038/ki.2008.486; GAMEZ J, 2008, J NEUROL SCI; Goicoechea S, 2006, J CELL SCI, V119, P3316, DOI 10.1242/jcs.03076; Gorenne I, 2006, CIRC RES, V98, P378, DOI 10.1161/01.RES.0000202802.34727.fd; Gorenne I, 2003, AM J PHYSIOL-CELL PH, V285, pC674, DOI 10.1152/ajpcell.00608.2002; Hwang SJ, 2001, J COMP NEUROL, V436, P211, DOI 10.1002/cne.1062.abs; Jin L, 2007, CIRC RES, V100, P817, DOI 10.1161/01.RES.0000261351.54147.de; Jin L, 2009, J MUSCLE RES CELL M, V30, P41, DOI 10.1007/s10974-009-9173-1; Jin L, 2009, J BIOL CHEM, V284, P2121, DOI 10.1074/jbc.M806095200; Liu XS, 2007, BLOOD, V110, P870, DOI 10.1182/blood-2007-01-068528; Liu XS, 2007, J CELL BIOCHEM, V100, P1288, DOI 10.1002/jcb.21126; Liu ZP, 2005, DEV CELL, V9, P261, DOI 10.1016/j.devcel.2005.05.017; Luo HJ, 2005, MOL CELL NEUROSCI, V29, P507, DOI 10.1016/j.mcn.2004.12.002; Mack CP, 2001, J BIOL CHEM, V276, P341, DOI 10.1074/jbc.M005505200; Manabe I, 2001, CIRC RES, V88, P1127, DOI 10.1161/hh1101.091339; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Mouilleron S, 2008, EMBO J, V27, P3198, DOI 10.1038/emboj.2008.235; Otey CA, 2005, INT REV CYTOL, V246, P31, DOI 10.1016/S0074-7696(05)46002-7; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Parast MM, 2000, J CELL BIOL, V150, P643, DOI 10.1083/jcb.150.3.643; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Pipes GCT, 2005, DEV BIOL, V288, P502, DOI 10.1016/j.ydbio.2005.10.014; Rachlin AS, 2006, J CELL SCI, V119, P995, DOI 10.1242/jcs.02825; Ronty M, 2004, FEBS LETT, V566, P30, DOI 10.1061/j.febslet.2004.04.006; Ronty MJ, 2006, J INVEST DERMATOL, V126, P2387, DOI 10.1038/sj.jid.5700427; Selvaraj A, 2003, J BIOL CHEM, V278, P41977, DOI 10.1074/jbc.M305679200; Shang YT, 2008, J CELL BIOL, V181, P461, DOI 10.1083/jcb.200711145; Sinha S, 2006, STEM CELLS, V24, P1678, DOI 10.1634/stemcells.2006-0002; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang HV, 2008, DEV DYNAM, V237, P3342, DOI 10.1002/dvdy.21755; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Yoshida T, 2004, CIRC RES, V94, P1075, DOI 10.1161/01.RES.0000125622.46280.95; Yoshida T, 2003, CIRC RES, V92, P856, DOI 10.1161/01.RES.0000068405.49081.09; Yoshida T, 2007, AM J PHYSIOL-CELL PH, V292, pC886, DOI 10.1152/ajpcell.00449.2006; Yoshida T, 2008, AM J PHYSIOL-CELL PH, V295, pC1175, DOI 10.1152/ajpcell.00288.2008	45	22	22	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12823	10.1371/journal.pone.0012823	http://dx.doi.org/10.1371/journal.pone.0012823			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877641	gold, Green Published, Green Submitted			2022-12-27	WOS:000282053100013
J	Johnson, PJ; Kansky, R; Loveridge, AJ; Macdonald, DW				Johnson, Paul J.; Kansky, Ruth; Loveridge, Andrew J.; Macdonald, David W.			Size, Rarity and Charisma: Valuing African Wildlife Trophies	PLOS ONE			English	Article							CONSERVATION; EXTINCTION	We explore variation in the prices paid by recreational hunters of trophy animals in Africa and its possible causes, including perceived rarity. Previous work has raised the possibility that extinction can result if demand rises fast enough as a species becomes rarer. We attempt to disentangle this from other inter-correlated influences affecting price. Species with larger body sizes and larger trophies were more valuable. Value increased less steeply as a function of size for bovids than for felids and the effect was consistent across countries. Power laws, ubiquitous in physical and social systems, described the trends. The exponent was approximately 0.4 for bovids, compared with approximately 1.0 for felids. Rarity (as indexed by IUCN score) influenced the value of bovid trophies - price was higher for species in categories denoting higher global threat. There was substantial variation in price among and within families not explained by either size or rarity. This may be attributable to a 'charisma' effect, which seems likely to be a general attribute of human perceptions of wildlife. Species where prices were higher than predicted by size or rarity are ranked high in published accounts of desirability by hunters. We conclude that the valuation of these species is explicable to a large extent by body size and perceived rarity, and that differences in valuation between taxonomic groups are related to less easily quantified 'charisma' effects. These findings are relevant for conservationists considering the threat status of species exploited in open access markets, and where license quotas are adjusted in response to changes in perceived rarity.	[Johnson, Paul J.; Kansky, Ruth; Loveridge, Andrew J.; Macdonald, David W.] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Recanati Kaplan Ctr, Oxford OX1 3PS, England	University of Oxford	Johnson, PJ (corresponding author), Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Recanati Kaplan Ctr, S Parks Rd, Oxford OX1 3PS, England.	paul.johnson@zoo.ox.ac.uk			Panthera Foundation; Whitley Trust	Panthera Foundation; Whitley Trust	The work was partly funded by the Panthera Foundation and the Whitley Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D., 2008, MODEL BASED INFERENC, pxxiv; Angulo E, 2009, P ROY SOC B-BIOL SCI, V276, P1331, DOI 10.1098/rspb.2008.1475; Batt S., 2009, BIOSCIENCE HORIZONS, V2, P180, DOI [https://doi.org/10.1093/biohorizons/hzp021, DOI 10.1093/BIOHORIZONS/HZP021]; BURNHAM KP, 2002, MODEL SELECTION MULT, pR26; Courchamp F, 2006, PLOS BIOL, V4, P2405, DOI 10.1371/journal.pbio.0040415; Gault A, 2008, CONSERV LETT, V1, P199, DOI 10.1111/j.1755-263X.2008.00038.x; Grafen A., 2002, MODERN STAT LIFE SCI, p[XV, 351]; KELLERT SR, 1985, BIOL CONSERV, V31, P167, DOI 10.1016/0006-3207(85)90047-3; KINGDON J, 2003, KINGDON FIELD GUIDE, pR18; KRUUK H, 2002, HUNTER HUNTED RELATI, pR12; Lindsey PA, 2007, BIOL CONSERV, V134, P455, DOI 10.1016/j.biocon.2006.09.005; Lindsey PA, 2006, ANIM CONSERV, V9, P283, DOI 10.1111/j.1469-1795.2006.00034.x; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Loveridge AJ, 2007, BIOL CONSERV, V134, P548, DOI 10.1016/j.biocon.2006.09.010; Loveridge A.J., 2006, KEY TOPICS CONSERVAT, P224; Macdonald DW, 2010, BIOL CONSERVATION WI; MACDONALD DW, 2006, ENCY MAMMALS, pR41; Milner-Gulland E. J., 2009, RECREATIONAL HUNTING; PACKER C, 2009, PLOS ONE, P4; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Stokes DL, 2007, HUM ECOL, V35, P361, DOI 10.1007/s10745-006-9056-7; 2005, SAFARI CLUB INT RECO	22	43	43	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12866	10.1371/journal.pone.0012866	http://dx.doi.org/10.1371/journal.pone.0012866			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877564	Green Published, Green Submitted, gold			2022-12-27	WOS:000282053100021
J	O'Rourke, CT; Hall, MI; Pitlik, T; Fernandez-Juricic, E				O'Rourke, Colleen T.; Hall, Margaret I.; Pitlik, Todd; Fernandez-Juricic, Esteban			Hawk Eyes I: Diurnal Raptors Differ in Visual Fields and Degree of Eye Movement	PLOS ONE			English	Article							OWL TYTO-ALBA; STRIX-ALUCO L; HEAD MOVEMENTS; EVOLUTIONARY HISTORY; ORBIT ORIENTATION; PANORAMIC VISION; HUNTING BEHAVIOR; BINOCULAR VISION; SCHEMATIC OPTICS; BIRDS	Background: Different strategies to search and detect prey may place specific demands on sensory modalities. We studied visual field configuration, degree of eye movement, and orbit orientation in three diurnal raptors belonging to the Accipitridae and Falconidae families. Methodology/Principal Findings: We used an ophthalmoscopic reflex technique and an integrated 3D digitizer system. We found inter-specific variation in visual field configuration and degree of eye movement, but not in orbit orientation. Red-tailed Hawks have relatively small binocular areas (similar to 33 degrees) and wide blind areas (similar to 82 degrees), but intermediate degree of eye movement (similar to 5 degrees), which underscores the importance of lateral vision rather than binocular vision to scan for distant prey in open areas. Cooper's Hawks' have relatively wide binocular fields (similar to 36 degrees), small blind areas (similar to 60 degrees), and high degree of eye movement (similar to 8 degrees), which may increase visual coverage and enhance prey detection in closed habitats. Additionally, we found that Cooper's Hawks can visually inspect the items held in the tip of the bill, which may facilitate food handling. American Kestrels have intermediate-sized binocular and lateral areas that may be used in prey detection at different distances through stereopsis and motion parallax; whereas the low degree eye movement (similar to 1 degrees) may help stabilize the image when hovering above prey before an attack. Conclusions: We conclude that: (a) there are between-species differences in visual field configuration in these diurnal raptors; (b) these differences are consistent with prey searching strategies and degree of visual obstruction in the environment (e. g., open and closed habitats); (c) variations in the degree of eye movement between species appear associated with foraging strategies; and (d) the size of the binocular and blind areas in hawks can vary substantially due to eye movements. Inter-specific variation in visual fields and eye movements can influence behavioral strategies to visually search for and track prey while perching.	[O'Rourke, Colleen T.] Calif State Univ Long Beach, Dept Biol Sci, Long Beach, CA 90840 USA; [Hall, Margaret I.] Midwestern Univ, Dept Physiol, Glendale, AZ USA; [Pitlik, Todd] Wildlife Serv, Dept Agr, Anim & Plant Hlth Inspect Serv, Los Angeles, CA USA; [Fernandez-Juricic, Esteban] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	California State University System; California State University Long Beach; Midwestern University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	O'Rourke, CT (corresponding author), Calif State Univ Long Beach, Dept Biol Sci, Long Beach, CA 90840 USA.	efernan@purdue.edu			National Science Foundation [DBI-0641550]; California State University, Long Beach	National Science Foundation(National Science Foundation (NSF)); California State University, Long Beach	This study was funded by National Science Foundation DBI-0641550 (www.nsf.org). CTO received funding from the 2008 California State University, Long Beach, Provost's Graduate Student Summer Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson M, 2009, FUNCT ECOL, V23, P373, DOI 10.1111/j.1365-2435.2008.01512.x; [Anonymous], 1977, VISUAL SYSTEM VERTEB, DOI [DOI 10.1007/978-3-642-66468-7, 10.1007/978-3-642-66468-7_11, DOI 10.1007/978-3-642-66468-7_11]; BEYER WH, 1979, STANDARD MATH TABLES; Blackwell BF, 2009, ANIM BEHAV, V77, P673, DOI 10.1016/j.anbehav.2008.11.017; Brown L.H., 1982, BIRDS AFRICA, V1; Changizi MA, 2008, J THEOR BIOL, V254, P756, DOI 10.1016/j.jtbi.2008.07.011; CLARK W. S., 2001, HAWKS N AM; CLAY WILLIAM M., 1953, WILSON BULL, V65, P129; Curtis O. E., 2006, BIRDS N AM ONLINE; Duijni M., 1959, Archives Neerlandaises de Zoologie, V13, P128; Dunning J., 2008, CRC HDB AVIAN BODY M, V2nd; Fernandez-Juricic E, 2004, TRENDS ECOL EVOL, V19, P25, DOI 10.1016/j.tree.2003.10.003; Fernandez-Juricic E, 2008, IBIS, V150, P779, DOI 10.1111/j.1474-919X.2008.00860.x; Ferry-Graham LA, 2002, INTEGR COMP BIOL, V42, P265, DOI 10.1093/icb/42.2.265; FOX R, 1977, SCIENCE, V197, P79, DOI 10.1126/science.867054; FROST BJ, 1990, VISUAL NEUROSCI, V5, P231, DOI 10.1017/S0952523800000304; GALL MD, 2009, J COMP PHYS IN PRESS; Garamszegi LZ, 2002, P ROY SOC B-BIOL SCI, V269, P961, DOI 10.1098/rspb.2002.1967; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Hall MI, 2007, J ZOOL, V271, P437, DOI 10.1111/j.1469-7998.2006.00227.x; Heesy C.P., 2003, THESIS STONY BROOK U; Heesy CP, 2009, EVOL ANTHROPOL, V18, P21, DOI 10.1002/evan.20195; Heesy CP, 2004, ANAT REC PART A, V281A, P1104, DOI 10.1002/ar.a.20116; Iwaniuk AN, 2008, J COMP PHYSIOL A, V194, P267, DOI 10.1007/s00359-007-0304-0; Jones MP, 2007, J EXOT PET MED, V16, P69, DOI 10.1053/j.jepm.2007.03.012; KATZIR G, 1994, NATURWISSENSCHAFTEN, V81, P182, DOI 10.1007/BF01134539; Kiltie RA, 2000, FUNCT ECOL, V14, P226, DOI 10.1046/j.1365-2435.2000.00404.x; Kral K, 2003, BEHAV PROCESS, V64, P21, DOI 10.1016/S0376-6357(03)00057-3; Land MF, 1999, J COMP PHYSIOL A, V184, P265, DOI 10.1007/s003590050324; Leyhe JE, 2004, J RAPTOR RES, V38, P19; Lima SL, 2002, TRENDS ECOL EVOL, V17, P70, DOI 10.1016/S0169-5347(01)02393-X; MARTIN GR, 1986, J COMP PHYSIOL A, V159, P545, DOI 10.1007/BF00604174; MARTIN GR, 1986, VISION RES, V26, P1303, DOI 10.1016/0042-6989(86)90112-4; Martin GR, 2004, IBIS, V146, P18, DOI 10.1111/j.1474-919X.2004.00211.x; Martin GR, 2000, BRAIN BEHAV EVOLUT, V56, P340, DOI 10.1159/000047218; MARTIN GR, 1982, J COMP PHYSIOL, V145, P341, DOI 10.1007/BF00619338; Martin GR, 1999, BRAIN BEHAV EVOLUT, V53, P55, DOI 10.1159/000006582; MARTIN GR, 1984, VISION RES, V24, P1739, DOI 10.1016/0042-6989(84)90005-1; Martin GR, 2008, VISION I, P25; Martin GR, 2008, IBIS, V150, P485, DOI 10.1111/j.1474-919X.2008.00808.x; Martin GR, 2007, J ORNITHOL, V148, pS547, DOI 10.1007/s10336-007-0213-6; Martin GR, 2009, J VISION, V9, DOI 10.1167/9.11.14; Martin GR, 2009, P ROY SOC B-BIOL SCI, V276, P437, DOI 10.1098/rspb.2008.1110; MARTIN TE, 1990, STUDIES AVIAN BIOL, V0013, P00353; Meyer D.B., 1977, HDB SENSORY PHYSL, V7/5, P549; O'Rourke CT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012169; Ohayon S, 2006, J COMP PHYSIOL A, V192, P927, DOI 10.1007/s00359-006-0130-9; Peeters H, 2005, RAPTORS CALIFORNIA; Pettigrew J. D., 1978, Frontiers in Visual Science, P328; Preston C. R., 2009, BIRDS N AM; Remsen J.V. Jr, 1990, Studies in Avian Biology, P144; ROBINSON SK, 1982, ECOLOGY, V63, P1918, DOI 10.2307/1940130; Roth TC, 2003, CONDOR, V105, P474, DOI 10.1650/7219; SHERROD SK, 1978, RAPTOR RES, V12, P49; Shifferman E, 2004, J AVIAN BIOL, V35, P111, DOI 10.1111/j.0908-8857.2004.03257.x; Smallwood JA, 2002, BIRDS N AM ONLINE; STEINBACH MJ, 1974, VISION RES, V14, P745, DOI 10.1016/0042-6989(74)90075-3; Tucker VA, 2000, J EXP BIOL, V203, P3745; Tucker VA, 2000, J EXP BIOL, V203, P3733; van der Willigen RF, 1998, NEUROREPORT, V9, P1233, DOI 10.1097/00001756-199804200-00050; Verwaijen D, 2002, FUNCT ECOL, V16, P842, DOI 10.1046/j.1365-2435.2002.00696.x; WALLMAN J, 1985, J NEUROSCI, V5, P1418; WALLS GL, 1962, VISION RES, V2, P69, DOI 10.1016/0042-6989(62)90064-0; WATHEY JC, 1989, BRAIN BEHAV EVOLUT, V33, P279, DOI 10.1159/000115936	64	41	45	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12802	10.1371/journal.pone.0012802	http://dx.doi.org/10.1371/journal.pone.0012802			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877645	Green Published, Green Submitted, gold			2022-12-27	WOS:000282053100009
J	Reitzel, AM; Behrendt, L; Tarrant, AM				Reitzel, Adam M.; Behrendt, Lars; Tarrant, Ann M.			Light Entrained Rhythmic Gene Expression in the Sea Anemone Nematostella vectensis: The Evolution of the Animal Circadian Clock	PLOS ONE			English	Article							CORAL ACROPORA-MILLEPORA; PHYLOGENETIC ANALYSES; MOLECULAR-COMPONENTS; MAMMALIAN TIMELESS; PERIOD GENE; DROSOPHILA; TIM; CRYPTOCHROMES; DUPLICATION; PROMOTER	Background: Circadian rhythms in behavior and physiology are the observable phenotypes from cycles in expression of, interactions between, and degradation of the underlying molecular components. In bilaterian animals, the core molecular components include Timeless-Timeout, photoreceptive cryptochromes, and several members of the basic-loop-helix-Per-ARNT-Sim (bHLH-PAS) family. While many of core circadian genes are conserved throughout the Bilateria, their specific roles vary among species. Here, we identify and experimentally study the rhythmic gene expression of conserved circadian clock members in a sea anemone in order to characterize this gene network in a member of the phylum Cnidaria and to infer critical components of the clockwork used in the last common ancestor of cnidarians and bilaterians. Methodology/Principal Findings: We identified homologs of circadian regulatory genes in the sea anemone Nematostella vectensis, including a gene most similar to Timeout, three cryptochromes, and several key bHLH-PAS transcription factors. We then maintained N. vectensis either in complete darkness or in a 12 hour light: 12 hour dark cycle in three different light treatments (blue only, full spectrum, blue-depleted). Gene expression varied in response to light cycle and light treatment, with a particularly strong pattern observed for NvClock. The cryptochromes more closely related to the light-sensitive clade of cryptochromes were upregulated in light treatments that included blue wavelengths. With co-immunoprecipitation, we determined that heterodimerization between CLOCK and CYCLE is conserved within N. vectensis. Additionally, we identified E-box motifs, DNA sequences recognized by the CLOCK: CYCLE heterodimer, upstream of genes showing rhythmic expression. Conclusions/Significance: This study reveals conserved molecular and functional components of the circadian clock that were in place at the divergence of the Cnidaria and Bilateria, suggesting the animal circadian clockwork is more ancient than previous data suggest. Characterizing circadian regulation in a cnidarian provides insight into the early origins of animal circadian rhythms and molecular regulation of environmentally cued behaviors.	[Reitzel, Adam M.; Behrendt, Lars; Tarrant, Ann M.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	Reitzel, AM (corresponding author), Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA.	atarrant@whoi.edu	Tarrant, Ann/AAU-8263-2021; Behrendt, Lars/M-5218-2014; Reitzel, Adam M/A-9129-2017	Tarrant, Ann/0000-0002-1909-7899; Behrendt, Lars/0000-0002-8988-2032; Reitzel, Adam M/0000-0001-5734-7118	Eunice Kennedy Shriver National Institute of Child Health and Human Development [F32HD062178]; Tropical Research Initiative of the Woods Hole Oceanographic Institution; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD062178] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Tropical Research Initiative of the Woods Hole Oceanographic Institution; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The project described was supported by Award Number F32HD062178 to AMR from the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the Tropical Research Initiative of the Woods Hole Oceanographic Institution. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health and Human Development or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; AMANO S, 1988, BIOL BULL, V175, P181, DOI 10.2307/1541557; Bae K, 1998, MOL CELL BIOL, V18, P6142, DOI 10.1128/MCB.18.10.6142; Barnes JW, 2003, SCIENCE, V302, P439, DOI 10.1126/science.1086593; Benna C, 2000, CURR BIOL, V10, pR512, DOI 10.1016/S0960-9822(00)00594-7; Benna C, 2010, CURR BIOL, V20, P346, DOI 10.1016/j.cub.2009.12.048; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Evans BR, 2008, MOL PHARMACOL, V73, P387, DOI 10.1124/mol.107.040204; Fan TY, 2006, MAR ECOL PROG SER, V321, P133, DOI 10.3354/meps321133; Fritzenwanker JH, 2002, DEV GENES EVOL, V212, P99, DOI 10.1007/s00427-002-0214-7; Gehring W, 2003, J MOL EVOL, V57, pS286, DOI 10.1007/s00239-003-0038-8; Glaser FT, 2005, CURR BIOL, V15, P1352, DOI 10.1016/j.cub.2005.06.056; Gorbunov MY, 2002, LIMNOL OCEANOGR, V47, P309, DOI 10.4319/lo.2002.47.1.0309; Gotter AL, 2007, J MOL BIOL, V366, P36, DOI 10.1016/j.jmb.2006.10.097; Gotter AL, 2006, NEUROREPORT, V17, P1229, DOI 10.1097/01.wnr.0000233092.90160.92; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; HAND C, 1992, BIOL BULL, V182, P169, DOI 10.2307/1542110; Hardin PE, 2004, J BIOL RHYTHM, V19, P348, DOI 10.1177/0748730404268052; Harmer SL, 2001, ANNU REV CELL DEV BI, V17, P215, DOI 10.1146/annurev.cellbio.17.1.215; ILER WEG, 2010, FEBS J, V277, P1182; Iwai S, 2006, J INSECT PHYSIOL, V52, P625, DOI 10.1016/j.jinsphys.2006.03.001; Kaniewska P, 2009, J EXP BIOL, V212, P662, DOI 10.1242/jeb.022624; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lee CG, 1998, NEURON, V21, P857, DOI 10.1016/S0896-6273(00)80601-7; Levy O, 2007, SCIENCE, V318, P467, DOI 10.1126/science.1145432; Levy O, 2003, J EXP BIOL, V206, P4041, DOI 10.1242/jeb.00622; Looby P, 2005, TRENDS GENET, V21, P46, DOI 10.1016/j.tig.2004.11.012; McClung CR, 2001, ANNU REV PLANT PHYS, V52, P139, DOI 10.1146/annurev.arplant.52.1.139; McDonald MJ, 2001, MOL CELL BIOL, V21, P1207, DOI 10.1128/MCB.21.4.1207-1217.2001; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Reitzel AM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-230; Rosbash M, 2009, PLOS BIOL, V7, P421, DOI 10.1371/journal.pbio.1000062; Rubin EB, 2006, GENOME RES, V16, P1352, DOI 10.1101/gr.5094806; SALICHOS L, 2009, MYCOLOGIA, P9; SEHGAL A, 1995, SCIENCE, V270, P808, DOI 10.1126/science.270.5237.808; Simionato E, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-33; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sullivan JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007311; Technau U, 2005, TRENDS GENET, V21, P633, DOI 10.1016/j.tig.2005.09.007; Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086; Vize PD, 2009, BIOL BULL-US, V216, P131; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Williams JA, 2001, ANNU REV PHYSIOL, V63, P729, DOI 10.1146/annurev.physiol.63.1.729; Xu Y, 2003, EMBO J, V22, P2117, DOI 10.1093/emboj/cdg168; Yuan Q, 2007, MOL BIOL EVOL, V24, P948, DOI 10.1093/molbev/msm011; Zhu HS, 2008, PLOS BIOL, V6, P138, DOI 10.1371/journal.pbio.0060004; Zhu HS, 2005, CURR BIOL, V15, pR953, DOI 10.1016/j.cub.2005.11.030	51	54	56	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2010	5	9							e12805	10.1371/journal.pone.0012805	http://dx.doi.org/10.1371/journal.pone.0012805			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652JO	20877728	Green Published, gold			2022-12-27	WOS:000282002900005
J	Vagenas, P; Aravantinou, M; Williams, VG; Jasny, E; Piatak, M; Lifson, JD; Salazar, AM; Blanchard, JL; Gettie, A; Robbiani, M				Vagenas, Panagiotis; Aravantinou, Meropi; Williams, Vennansha G.; Jasny, Edith; Piatak, Michael, Jr.; Lifson, Jeffrey D.; Salazar, Andres M.; Blanchard, James L.; Gettie, Agegnehu; Robbiani, Melissa			A Tonsillar PolyICLC/AT-2 SIV Therapeutic Vaccine Maintains Low Viremia Following Antiretroviral Therapy Cessation	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTE RESPONSES; DENDRITIC-CELL VACCINE; RHESUS MACAQUES; DISEASE PROGRESSION; INFECTED MACAQUES; SIVMAC251 INFECTION; ANTIBODY-RESPONSES; PARTIAL PROTECTION; IMMUNE-RESPONSES	Background: HIV-infected individuals rely on antiretroviral therapy (ART) to control viral replication. Despite abundant demonstrable benefits, the multiple limitations of ART point to the potential advantages of therapeutic vaccination approaches that could provide sustained host control of viral replication after discontinuation of ART. We provide evidence from a non-human primate model that a therapeutic vaccine applied to the tonsils can maintain low viral loads after cessation of ART. Methodology/Principal Findings: Animals received 40 weeks of ART initiated 9 weeks after rectal SIVmac239 infection. During ART, animals were vaccinated (or not) with AT-2 inactivated SIVmac239 using CpG-C ISS-ODN (C274) or polyICLC as adjuvants. PolyICLC/AT-2 SIV vaccinated animals maintained viral loads <3x10(3) copies/ml for up to 16 weeks post-ART, whereas the C274/AT-2 SIV vaccinated and non-vaccinated animals' viremia ranged between 1x10(4)-4x10(5) copies/ml (p<0.03). Neutralizing Ab activity in plasma was increased by polyICLC/AT-2 tonsillar vaccination under ART, compared to controls (p<0.03). Subsequent vaccination of all animals with polyICLC/AT-2 SIV in the absence of ART did not alter viral loads. Other immune parameters measured in blood and tissues were comparable between groups. Conclusions/Significance: These results provide support for the potential benefit of mucosally delivered vaccines in therapeutic immunization strategies for control of AIDS virus infection.	[Vagenas, Panagiotis; Aravantinou, Meropi; Williams, Vennansha G.; Jasny, Edith; Robbiani, Melissa] Populat Council, Ctr Biomed Res, HIV AIDS Program, New York, NY 10021 USA; [Piatak, Michael, Jr.; Lifson, Jeffrey D.] NCI, AIDS & Canc Virus Program, SAIC Frederick Inc, Frederick, MD 21701 USA; [Salazar, Andres M.] Oncovir Inc, Washington, DC USA; [Blanchard, James L.] Tulane Univ, Tulane Natl Primate Res Ctr, Covington, LA USA; [Gettie, Agegnehu] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10021 USA	Population Council; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Tulane University; Rockefeller University	Vagenas, P (corresponding author), Populat Council, Ctr Biomed Res, HIV AIDS Program, 1230 York Ave, New York, NY 10021 USA.	mrobbiani@popcouncil.org	Vagenas, Panagiotis/H-7850-2013	Vagenas, Panagiotis/0000-0003-2107-0377	National Institutes of Health [R01 DE016256, RR00164]; National Cancer Institute, National Institutes of Health [HHSN261200800001E]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016256] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This project was funded by the National Institutes of Health grant R01 DE016256, the base grant RR00164, and in part with Federal Funds from the National Cancer Institute, National Institutes of Health, under contract HHSN261200800001E. MR was a 2002 Elizabeth Glaser Scientist. Oncovir Inc. provided the PolyICLC (Hiltonol). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABA TW, 1994, AIDS RES HUM RETROV, V10, P351, DOI 10.1089/aid.1994.10.351; Brenchley JM, 2008, MUCOSAL IMMUNOL, V1, P49, DOI 10.1038/mi.2007.5; Butowski N, 2009, J NEURO-ONCOL, V91, P175, DOI 10.1007/s11060-008-9693-3; Carpenter CCJ, 2000, JAMA-J AM MED ASSOC, V283, P381, DOI 10.1001/jama.283.3.381; Carr A, 2000, LANCET, V356, P1423, DOI 10.1016/S0140-6736(00)02854-3; Chertova E, 2003, CURR MOL MED, V3, P265, DOI 10.2174/1566524033479889; Cline AN, 2005, J MED PRIMATOL, V34, P303; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Deeks SG, 2006, BMJ-BRIT MED J, V332, P1489, DOI 10.1136/bmj.332.7556.1489; Earl PL, 2007, VIROLOGY, V366, P84, DOI 10.1016/j.virol.2007.02.041; Eggena MP, 2005, J IMMUNOL, V174, P4407, DOI 10.4049/jimmunol.174.7.4407; Este JA, 2010, ANTIVIR RES, V85, P25, DOI 10.1016/j.antiviral.2009.10.007; Evans DT, 1999, NAT MED, V5, P1270, DOI 10.1038/15224; Finnefrock AC, 2009, J IMMUNOL, V182, P980, DOI 10.4049/jimmunol.182.2.980; Frank I, 2003, JAIDS-J ACQ IMM DEF, V34, P7, DOI 10.1097/00126334-200309010-00002; Frank I, 2002, J VIROL, V76, P2936, DOI 10.1128/JVI.76.6.2936-2951.2002; Gauduin MC, 2006, METHODS, V38, P263, DOI 10.1016/j.ymeth.2005.12.004; Hardy Gareth Ad, 2007, J Immune Based Ther Vaccines, V5, P6, DOI 10.1186/1476-8518-5-6; Hidajat R, 2009, J VIROL, V83, P791, DOI 10.1128/JVI.01672-08; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; Kader M, 2008, J VIROL, V82, P11467, DOI 10.1128/JVI.01143-08; Keir ME, 2007, CURR OPIN IMMUNOL, V19, P309, DOI 10.1016/j.coi.2007.04.012; Kinloch-de Loes S, 2005, J INFECT DIS, V192, P607, DOI 10.1086/432002; Kinter AL, 2007, AIDS RES HUM RETROV, V23, P438, DOI 10.1089/aid.2006.0162; Lifson JD, 2002, J MED PRIMATOL, V31, P205, DOI 10.1034/j.1600-0684.2002.02007.x; Loffredo JT, 2009, J IMMUNOL, V182, P7763, DOI 10.4049/jimmunol.0900111; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Lu W, 2004, NAT MED, V10, P1359, DOI 10.1038/nm1147; Lu W, 2003, NAT MED, V9, P27, DOI 10.1038/nm806; Macatangay BJC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009852; Markowitz M, 2002, J INFECT DIS, V186, P634, DOI 10.1086/342559; Marshall JD, 2003, J LEUKOCYTE BIOL, V73, P781, DOI 10.1189/jlb.1202630; MILLER CJ, 1989, J VIROL, V63, P4277, DOI 10.1128/JVI.63.10.4277-4284.1989; Mothe BR, 2003, J VIROL, V77, P2736, DOI 10.1128/JVI.77.4.2736-2740.2003; Nigam P, 2010, J IMMUNOL, V184, P1690, DOI 10.4049/jimmunol.0902955; Nowak MA, 1997, J VIROL, V71, P7518, DOI 10.1128/JVI.71.10.7518-7525.1997; Ortiz GM, 2001, P NATL ACAD SCI USA, V98, P13288, DOI 10.1073/pnas.221452198; Petrovas C, 2007, BLOOD, V110, P928, DOI 10.1182/blood-2007-01-069112; Rossio JL, 1998, J VIROL, V72, P7992, DOI 10.1128/JVI.72.10.7992-8001.1998; Salisch NC, 2010, J IMMUNOL, V184, P476, DOI 10.4049/jimmunol.0902781; Sauermann U, 2000, J INFECT DIS, V182, P716, DOI 10.1086/315800; Schacker TW, 1998, ANN INTERN MED, V128, P613, DOI 10.7326/0003-4819-128-8-199804150-00001; Schmitz JE, 2003, J VIROL, V77, P2165, DOI 10.1128/JVI.77.3.2165-2173.2003; Shedlock DJ, 2009, NAT REV IMMUNOL, V9, P717, DOI 10.1038/nri2636; Shimada M, 2009, GENE THER, V16, P218, DOI 10.1038/gt.2008.152; Smith SM, 1999, AIDS RES HUM RETROV, V15, P1691, DOI 10.1089/088922299309739; Stahl-Hennig C, 2007, FRONT BIOSCI, V12, P2107, DOI 10.2741/2215; Stahl-Hennig C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000373; Teleshova N, 2006, J LEUKOCYTE BIOL, V79, P257, DOI 10.1189/jlb.0205084; Teleshova N, 2004, J IMMUNOL, V173, P1647, DOI 10.4049/jimmunol.173.3.1647; Teleshova N, 2006, J IMMUNOL, V177, P8531, DOI 10.4049/jimmunol.177.12.8531; Trapp S, 2009, J VIROL, V83, P884, DOI 10.1128/JVI.00023-08; Trumpfheller C, 2008, P NATL ACAD SCI USA, V105, P2574, DOI 10.1073/pnas.0711976105; Tryniszewska E, 2002, J IMMUNOL, V169, P5347, DOI 10.4049/jimmunol.169.9.5347; *UDOHAHS, 1985, GUID CAR US LAB AN, P1; Vagenas P, 2009, JAIDS-J ACQ IMM DEF, V52, P433, DOI 10.1097/QAI.0b013e3181b880f3; Valentin A, 2010, VACCINE, V28, P1962, DOI 10.1016/j.vaccine.2009.10.099; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Vollmer J, 2004, EUR J IMMUNOL, V34, P251, DOI 10.1002/eji.200324032; Wang Y, 2009, CLIN VACCINE IMMUNOL, V16, P499, DOI 10.1128/CVI.00471-08; Wensing AMJ, 2005, J INFECT DIS, V192, P958, DOI 10.1086/432916; Wong JP, 2009, CURR PHARM DESIGN, V15, P1269, DOI 10.2174/138161209787846775; Wong JP, 2009, VACCINE, V27, P3481, DOI 10.1016/j.vaccine.2009.01.048; Yant LJ, 2006, J VIROL, V80, P5074, DOI 10.1128/JVI.80.10.5074-5077.2006; Zhu Q, 2010, J CLIN INVEST, V120, P607, DOI 10.1172/JCI39293; zur Megede J, 2008, AIDS RES HUM RETROV, V24, P1103, DOI 10.1089/aid.2008.0055	66	17	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2010	5	9							e12891	10.1371/journal.pone.0012891	http://dx.doi.org/10.1371/journal.pone.0012891			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652JO	20877632	Green Published, Green Submitted, gold			2022-12-27	WOS:000282002900020
J	Brichacek, B; Vanpouille, C; Kiselyeva, Y; Biancotto, A; Merbah, M; Hirsch, I; Lisco, A; Grivel, JC; Margolis, L				Brichacek, Beda; Vanpouille, Christophe; Kiselyeva, Yana; Biancotto, Angelique; Merbah, Melanie; Hirsch, Ivan; Lisco, Andrea; Grivel, Jean Charles; Margolis, Leonid			Contrasting Roles for TLR Ligands in HIV-1 Pathogenesis	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; IMMUNODEFICIENCY-VIRUS TYPE-1; T-CELL-ACTIVATION; HUMAN LYMPHOID-TISSUE; TROPICAL INFECTIOUS-DISEASES; MEROZOITE SURFACE PROTEIN-1; X-C-CHEMOKINE; INNATE IMMUNITY; CXCR4-TROPIC HIV-1; EX-VIVO	The first line of a host's response to various pathogens is triggered by their engagement of cellular pattern recognition receptors (PRRs). Binding of microbial ligands to these receptors leads to the induction of a variety of cellular factors that alter intracellular and extracellular environment and interfere directly or indirectly with the life cycle of the triggering pathogen. Such changes may also affect any coinfecting microbe. Using ligands to Toll-like receptors (TLRs) 5 and 9, we examined their effect on human immunodeficiency virus (HIV)-1 replication in lymphoid tissue ex vivo. We found marked differences in the outcomes of such treatment. While flagellin (TLR5 agonist) treatment enhanced replication of CC chemokine receptor 5 (CCR 5)-tropic and CXC chemokine receptor 4 (CXCR4)-tropic HIV-1, treatment with oligodeoxynucleotide (ODN) M362 (TLR9 agonist) suppressed both viral variants. The differential effects of these TLR ligands on HIV-1 replication correlated with changes in production of CC chemokines CCL3, CCL4, CCL5, and of CXC chemokines CXCL10, and CXCL12 in the ligand-treated HIV-1-infected tissues. The nature and/or magnitude of these changes were dependent on the ligand as well as on the HIV-1 viral strain. Moreover, the tested ligands differed in their ability to induce cellular activation as evaluated by the expression of the cluster of differentiation markers (CD) 25, CD38, CD39, CD69, CD154, and human leukocyte antigen D related (HLA)-DR as well as of a cell proliferation marker, Ki67, and of CCR5. No significant effect of the ligand treatment was observed on apoptosis and cell death/loss in the treated lymphoid tissue ex vivo. Our results suggest that binding of microbial ligands to TLRs is one of the mechanisms that mediate interactions between coinfected microbes and HIV-1 in human tissues. Thus, the engagement of appropriate TLRs by microbial molecules or their mimetic might become a new strategy for HIV therapy or prevention.	[Brichacek, Beda; Vanpouille, Christophe; Kiselyeva, Yana; Biancotto, Angelique; Merbah, Melanie; Lisco, Andrea; Grivel, Jean Charles; Margolis, Leonid] NICHHD, Sect Intercellular Interact, Program Phys Biol, NIH, Bethesda, MD 20892 USA; [Hirsch, Ivan] Univ Mediterrane, Inst Paoli Calmettes, INSERM, Ctr Rech Cancerol Marseille,UMR 891, Marseille, France	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC)	Brichacek, B (corresponding author), NICHHD, Sect Intercellular Interact, Program Phys Biol, NIH, Bethesda, MD 20892 USA.	bricbeda@mail.nih.gov	biancotto, angelique/C-4632-2011; Kiseleva, Yana/AAB-5083-2020; Hirsch, Ivan/J-7726-2015; Lisco, Andrea/L-2105-2019	biancotto, angelique/0000-0003-2271-009X; Kiseleva, Yana/0000-0002-8352-4787; Hirsch, Ivan/0000-0003-1701-1438; Lisco, Andrea/0000-0002-1475-356X; Grivel, Jean-Charles/0000-0003-0365-3181; Merbah, Melanie/0000-0002-5641-8612	National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH), Bethesda, Maryland; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001416] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH), Bethesda, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by the Intramural Research Program of the National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH), Bethesda, Maryland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alfano M, 2005, AIDS, V19, P1007, DOI 10.1097/01.aids.0000174446.40379.3b; Ashkar AA, 2003, J VIROL, V77, P8948, DOI 10.1128/JVI.77.16.8948-8956.2003; Bafica A, 2004, J LEUKOCYTE BIOL, V75, P460, DOI 10.1189/jlb.0803388; Bargieri DY, 2010, VACCINE, V28, P2818, DOI 10.1016/j.vaccine.2010.02.004; Bargieri DY, 2008, VACCINE, V26, P6132, DOI 10.1016/j.vaccine.2008.08.070; Bauer S, 2008, IMMUNOBIOLOGY, V213, P315, DOI 10.1016/j.imbio.2007.10.010; Beilke MA, 2004, CLIN INFECT DIS, V39, P256, DOI 10.1086/422146; BENTWICH Z, 1995, IMMUNOL TODAY, V16, P187, DOI 10.1016/0167-5699(95)80119-7; Bergler W, 1999, CLIN EXP IMMUNOL, V116, P9; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Biancotto A, 2007, BLOOD, V109, P4272, DOI 10.1182/blood-2006-11-055764; Blanchard A, 1997, TRENDS MICROBIOL, V5, P326, DOI 10.1016/S0966-842X(97)01089-5; Blohmke CJ, 2008, J IMMUNOL, V180, P7764, DOI 10.4049/jimmunol.180.11.7764; Boo KH, 2010, YONSEI MED J, V51, P9, DOI 10.3349/ymj.2010.51.1.9; Borkow G, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000160; BUKRINSKY MI, 1991, SCIENCE, V254, P423, DOI 10.1126/science.1925601; Casartelli N, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000955; Casoli C, 2007, AIDS REV, V9, P140; Chang Q, 2007, J GEN VIROL, V88, P3341, DOI 10.1099/vir.0.83198-0; Chen F, 2010, J HUAZHONG U SCI-MED, V30, P278, DOI 10.1007/s11596-010-0343-6; Chen KY, 2006, J VIROL, V80, P7645, DOI 10.1128/JVI.00206-06; Claeys S, 2003, ALLERGY, V58, P748, DOI 10.1034/j.1398-9995.2003.00180.x; Cohen OJ, 1997, SPRINGER SEMIN IMMUN, V18, P305, DOI 10.1007/BF00813500; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Deayton JR, 2004, LANCET, V363, P2116, DOI 10.1016/S0140-6736(04)16500-8; Decker T, 2002, J CLIN INVEST, V109, P1271, DOI 10.1172/JCI200215770; Fletcher PS, 2006, AIDS, V20, P1237, DOI 10.1097/01.aids.0000232230.96134.80; Funderburg N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001915; Gaeta GB, 2006, J HEPATOL, V44, pS108, DOI 10.1016/j.jhep.2005.11.023; Ghassemi M, 2003, J MED MICROBIOL, V52, P877, DOI 10.1099/jmm.0.05231-0; Giacaman RA, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-29; Giger B, 2004, J IMMUNOL METHODS, V289, P179, DOI 10.1016/j.jim.2004.04.015; GLUSHAKOVA S, 1995, NAT MED, V1, P1320, DOI 10.1038/nm1295-1320; Goodbourn S, 2000, J GEN VIROL, V81, P2341, DOI 10.1099/0022-1317-81-10-2341; Grivel JC, 2005, J INFECT DIS, V192, P71, DOI 10.1086/430743; Grivel JC, 2003, AIDS RES HUM RETROV, V19, P211, DOI 10.1089/088922203763315713; Grivel JC, 1999, NAT MED, V5, P344, DOI 10.1038/6565; Grivel JC, 2001, NAT MED, V7, P1232, DOI 10.1038/nm1101-1232; Grivel JC, 2007, AIDS, V21, P1263, DOI 10.1097/QAD.0b013e3281864667; Hartmann G, 2003, EUR J IMMUNOL, V33, P1633, DOI 10.1002/eji.200323813; Herbeuval JP, 2006, P NATL ACAD SCI USA, V103, P7000, DOI 10.1073/pnas.0600363103; Honko AN, 2006, INFECT IMMUN, V74, P1113, DOI 10.1128/IAI.74.2.1113-1120.2006; HOOD JD, 2010, HUM VACCIN, V6; Huang LM, 2001, J BIOL CHEM, V276, P13427, DOI 10.1074/jbc.M011314200; Ito Y, 2004, J INFECT DIS, V189, P506, DOI 10.1086/381153; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jekle A, 2003, J VIROL, V77, P5846, DOI 10.1128/JVI.77.10.5846-5854.2003; Kannangara S, 2005, J INFECT DIS, V192, P1003, DOI 10.1086/432767; Kanzler H, 2007, NAT MED, V13, P552, DOI 10.1038/nm1589; Karp CL, 2007, CLIN INFECT DIS, V45, P1214, DOI 10.1086/522180; Karp CL, 2007, CLIN INFECT DIS, V45, P1208, DOI 10.1086/522181; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kawai T, 2007, J BIOCHEM, V141, P137, DOI 10.1093/jb/mvm032; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; KOELLE DM, 1994, J VIROL, V68, P2803, DOI 10.1128/JVI.68.5.2803-2810.1994; Krishnamachari Y, 2009, ADV DRUG DELIVER REV, V61, P205, DOI 10.1016/j.addr.2008.12.013; Lane BR, 2003, VIROLOGY, V307, P122, DOI 10.1016/S0042-6822(02)00045-4; Lawn SD, 2001, CLIN MICROBIOL REV, V14, P753, DOI 10.1128/CMR.14.4.753-777.2001; Le Moigne V, 2008, MOL IMMUNOL, V45, P2499, DOI 10.1016/j.molimm.2008.01.005; Lisco A, 2007, J VIROL, V81, P708, DOI 10.1128/JVI.01367-06; Lisco A, 2009, CELL HOST MICROBE, V6, P403, DOI 10.1016/j.chom.2009.10.010; LUSTER AD, 1993, J EXP MED, V178, P1057, DOI 10.1084/jem.178.3.1057; Mansson A, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-36; Mansson A, 2006, IMMUNOLOGY, V118, P539, DOI 10.1111/j.1365-2567.2006.02392.x; Margolis L, 2003, NAT BIOTECHNOL, V21, P15, DOI 10.1038/nbt0103-15; Marshall JD, 2003, J LEUKOCYTE BIOL, V73, P781, DOI 10.1189/jlb.1202630; Moss WJ, 2002, J INFECT DIS, V185, P1035, DOI 10.1086/340027; Murad YM, 2009, BIODRUGS, V23, P361, DOI 10.2165/11316930-000000000-00000; PANTALEO G, 1991, P NATL ACAD SCI USA, V88, P9838, DOI 10.1073/pnas.88.21.9838; Pantaleo G, 1998, NAT MED, V4, P341, DOI 10.1038/nm0398-341; PANTALEO G, 1993, NATURE, V362, P355, DOI 10.1038/362355a0; Peng SL, 2005, CURR OPIN IMMUNOL, V17, P230, DOI 10.1016/j.coi.2005.03.003; Polgreen PM, 2003, MICROBES INFECT, V5, P1255, DOI 10.1016/j.micinf.2003.08.006; Ramaswamy M, 2007, EXPERT REV ANTI-INFE, V5, P231, DOI 10.1586/14787210.5.2.231; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; RICHARDTPARGMAN.D, 2010, IMMUNOBIOLOGY; Rottembourg D, 2010, J IMMUNOL, V184, P7100, DOI 10.4049/jimmunol.0803935; Schlaepfer E, 2006, J IMMUNOL, V176, P2888, DOI 10.4049/jimmunol.176.5.2888; Schlaepfer E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001999; Song LZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002257; STEVENSON M, 1990, EMBO J, V9, P1551, DOI 10.1002/j.1460-2075.1990.tb08274.x; TAUB DD, 1993, J EXP MED, V177, P1809, DOI 10.1084/jem.177.6.1809; Thibault S, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-42; Thibault S, 2009, VIROLOGY, V389, P20, DOI 10.1016/j.virol.2009.04.019; TONGSTARKSEN SE, 1987, P NATL ACAD SCI USA, V84, P6845, DOI 10.1073/pnas.84.19.6845; Vanpouille C, 2007, J VIROL, V81, P12458, DOI 10.1128/JVI.00326-07; Vollmer J, 2004, EUR J IMMUNOL, V34, P251, DOI 10.1002/eji.200324032; Watt G, 2000, LANCET, V356, P475, DOI 10.1016/S0140-6736(00)02557-5; Watt G, 2003, CLIN INFECT DIS, V36, P1067, DOI 10.1086/374600; Weng YM, 1998, J BIOL CHEM, V273, P18288, DOI 10.1074/jbc.273.29.18288; Xiang JH, 2004, LANCET, V363, P2040, DOI 10.1016/S0140-6736(04)16453-2; Xiang JH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002580; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351; Zhu J, 2009, NAT MED, V15, P886, DOI 10.1038/nm.2006	96	32	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2010	5	9							e12831	10.1371/journal.pone.0012831	http://dx.doi.org/10.1371/journal.pone.0012831			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651YH	20862220	Green Published, Green Submitted, gold			2022-12-27	WOS:000281963200013
J	Sun, CM; Pager, CT; Luo, GX; Sarnow, P; Cate, JHD				Sun, Chaomin; Pager, Cara T.; Luo, Guangxiang; Sarnow, Peter; Cate, Jamie H. D.			Hepatitis C Virus Core-Derived Peptides Inhibit Genotype 1b Viral Genome Replication via Interaction with DDX3X	PLOS ONE			English	Article							BOX RNA HELICASE; PROTEIN INTERACTS; TRANSLATION; REQUIREMENT	The protein DDX3X is a DEAD-box RNA helicase that is essential for the hepatitis C virus (HCV) life cycle. The HCV core protein has been shown to bind to DDX3X both in vitro and in vivo. However, the specific interactions between these two proteins and the functional importance of these interactions for the HCV viral life cycle remain unclear. We show that amino acids 16-36 near the N-terminus of the HCV core protein interact specifically with DDX3X both in vitro and in vivo. Replication of HCV replicon NNeo/C-5B RNA (genotype 1b) is significantly suppressed in HuH-7-derived cells expressing green fluorescent protein (GFP) fusions to HCV core protein residues 16-36, but not by GFP fusions to core protein residues 16-35 or 16-34. Notably, the inhibition of HCV replication due to expression of the GFP fusion to HCV core protein residues 16-36 can be reversed by overexpression of DDX3X. These results suggest that the protein interface on DDX3X that binds the HCV core protein is important for replicon maintenance. However, infection of HuH-7 cells by HCV viruses of genotype 2a (JFH1) was not affected by expression of the GFP fusion protein. These results suggest that the role of DDX3X in HCV infection involves aspects of the viral life cycle that vary in importance between HCV genotypes.	[Sun, Chaomin] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Pager, Cara T.; Sarnow, Peter] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Luo, Guangxiang] Univ Kentucky, Dept Microbiol Immunol & Mol Genet, Lexington, KY USA; [Cate, Jamie H. D.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Cate, Jamie H. D.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Cate, Jamie H. D.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Stanford University; University of Kentucky; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Sun, CM (corresponding author), Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA.			Sun, Chaomin/0000-0003-4802-184X; Sarnow, Peter/0000-0002-2043-2770	National Institutes of Health (NIH) [GM073732]; Damon Runyon Cancer Research Foundation [DRG1954-07]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI070769] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK079293] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM073732] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grant GM073732 to J.H.D.C. and P. S. (www.nih.gov). C.T.P. is supported by the Damon Runyon Cancer Research Foundation (DRG1954-07, http://www.damonrunyon.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus AGN, 2010, J GEN VIROL, V91, P122, DOI 10.1099/vir.0.015909-0; Ariumi Y, 2007, J VIROL, V81, P13922, DOI 10.1128/JVI.01517-07; Asselah T, 2009, LIVER INT, V29, P57, DOI 10.1111/j.1478-3231.2008.01928.x; Beckham C, 2008, MOL BIOL CELL, V19, P984, DOI 10.1091/mbc.E07-09-0954; Chang PC, 2006, ONCOGENE, V25, P1991, DOI 10.1038/sj.onc.1209239; Chao CH, 2006, CANCER RES, V66, P6579, DOI 10.1158/0008-5472.CAN-05-2415; Deckert J, 2006, MOL CELL BIOL, V26, P5528, DOI 10.1128/MCB.00582-06; Dreux M, 2009, P NATL ACAD SCI USA, V106, P14046, DOI 10.1073/pnas.0907344106; Gao M, 2010, NATURE, V465, P96, DOI 10.1038/nature08960; He YP, 2007, DRUG DISCOV TODAY, V12, P209, DOI 10.1016/j.drudis.2007.01.009; Huang JS, 2004, BIOCHEM BIOPH RES CO, V315, P950, DOI 10.1016/j.bbrc.2004.01.151; Ikeda M, 2002, J VIROL, V76, P2997, DOI 10.1128/JVI.76.6.2997-3006.2002; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kim YS, 2001, MOL CELLS, V12, P209; Kwong AD, 2005, NAT REV DRUG DISCOV, V4, P845, DOI 10.1038/nrd1853; Lee CS, 2008, NUCLEIC ACIDS RES, V36, P4708, DOI 10.1093/nar/gkn454; Mamiya N, 1999, J BIOL CHEM, V274, P15751, DOI 10.1074/jbc.274.22.15751; Masek T, 2005, ANAL BIOCHEM, V336, P46, DOI 10.1016/j.ab.2004.09.010; McLauchlan J, 2000, J VIRAL HEPATITIS, V7, P2; Miyamoto M, 2005, INTERVIROLOGY, V49, P37, DOI 10.1159/000087261; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Owsianka AM, 1999, VIROLOGY, V257, P330, DOI 10.1006/viro.1999.9659; Perard J, 2009, FEBS LETT, V583, P70, DOI 10.1016/j.febslet.2008.11.025; Purcell R, 1997, HEPATOLOGY, V26, pS11, DOI 10.1002/hep.510260702; Pyronnet S, 1999, EMBO J, V18, P270, DOI 10.1093/emboj/18.1.270; Randall G, 2007, P NATL ACAD SCI USA, V104, P12884, DOI 10.1073/pnas.0704894104; Schroder M, 2008, EMBO J, V27, P2147, DOI 10.1038/emboj.2008.143; Schroder M, 2010, BIOCHEM PHARMACOL, V79, P297, DOI 10.1016/j.bcp.2009.08.032; Sekiguchi T, 2007, BIOCHEM BIOPH RES CO, V356, P668, DOI 10.1016/j.bbrc.2007.03.038; Shih JW, 2008, ONCOGENE, V27, P700, DOI 10.1038/sj.onc.1210687; Soulat D, 2008, EMBO J, V27, P2135, DOI 10.1038/emboj.2008.126; Sun M, 2008, CELL DEATH DIFFER, V15, P1887, DOI 10.1038/cdd.2008.124; Trahtenherts A, 2008, ANTIVIR RES, V77, P195, DOI 10.1016/j.antiviral.2007.12.013; Yedavalli VSRK, 2004, CELL, V119, P381, DOI 10.1016/j.cell.2004.09.029; You LR, 1999, J VIROL, V73, P2841, DOI 10.1128/JVI.73.4.2841-2853.1999; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031	37	17	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2010	5	9							e12826	10.1371/journal.pone.0012826	http://dx.doi.org/10.1371/journal.pone.0012826			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651XL	20862261	gold, Green Published, Green Submitted			2022-12-27	WOS:000281960800021
J	Hilimire, MR; Mounts, JRW; Parks, NA; Corballis, PM				Hilimire, Matthew R.; Mounts, Jeffrey R. W.; Parks, Nathan A.; Corballis, Paul M.			Event-Related Potentials Dissociate Effects of Salience and Space in Biased Competition for Visual Representation	PLOS ONE			English	Article							ELECTROPHYSIOLOGICAL EVIDENCE; ATTENTION; MECHANISMS; CAPTURE; SUPPRESSION; CORTEX; TARGET	Background: Selective visual attention is the process by which the visual system enhances behaviorally relevant stimuli and filters out others. Visual attention is thought to operate through a cortical mechanism known as biased competition. Representations of stimuli within cortical visual areas compete such that they mutually suppress each others' neural response. Competition increases with stimulus proximity and can be biased in favor of one stimulus (over another) as a function of stimulus significance, salience, or expectancy. Though there is considerable evidence of biased competition within the human visual system, the dynamics of the process remain unknown. Methodology/Principal Findings: Here, we used scalp-recorded electroencephalography (EEG) to examine neural correlates of biased competition in the human visual system. In two experiments, subjects performed a task requiring them to either simultaneously identify two targets (Experiment 1) or discriminate one target while ignoring a decoy (Experiment 2). Competition was manipulated by altering the spatial separation between target(s) and/or decoy. Both experimental tasks should induce competition between stimuli. However, only the task of Experiment 2 should invoke a strong bias in favor of the target (over the decoy). The amplitude of two lateralized components of the event-related potential, the N2pc and Ptc, mirrored these predictions. N2pc amplitude increased with increasing stimulus separation in Experiments 1 and 2. However, Ptc amplitude varied only in Experiment 2, becoming more positive with decreased spatial separation. Conclusions/Significance: These results suggest that N2pc and Ptc components may index distinct processes of biased competition-N2pc reflecting visual competitive interactions and Ptc reflecting a bias in processing necessary to individuate task-relevant stimuli.	[Hilimire, Matthew R.; Corballis, Paul M.] Georgia Inst Technol, Sch Psychol, Atlanta, GA 30332 USA; [Mounts, Jeffrey R. W.] SUNY Coll Geneseo, Dept Psychol, Geneseo, NY 14454 USA; [Parks, Nathan A.] Univ Illinois, Beckman Inst, Urbana, IL 61801 USA	University System of Georgia; Georgia Institute of Technology; State University of New York (SUNY) System; SUNY Geneseo; University of Illinois System; University of Illinois Urbana-Champaign	Hilimire, MR (corresponding author), Georgia Inst Technol, Sch Psychol, Atlanta, GA 30332 USA.	gth828b@mail.gatech.edu	Corballis, Paul M/G-3995-2011	Corballis, Paul/0000-0001-9699-3999				Bahcall DO, 1999, VISION RES, V39, P71, DOI 10.1016/S0042-6989(98)00090-X; Beck DM, 2009, VISION RES, V49, P1154, DOI 10.1016/j.visres.2008.07.012; Bles M, 2006, NEUROIMAGE, V30, P506, DOI 10.1016/j.neuroimage.2005.09.042; Cutzu F, 2003, VISION RES, V43, P205, DOI 10.1016/S0042-6989(02)00491-1; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Duncan J, 2006, Q J EXP PSYCHOL, V59, P2, DOI 10.1080/17470210500260674; Eimer M, 1996, ELECTROEN CLIN NEURO, V99, P225, DOI 10.1016/0013-4694(96)95711-9; Hickey C, 2006, J COGNITIVE NEUROSCI, V18, P604, DOI 10.1162/jocn.2006.18.4.604; Hickey C, 2009, J COGNITIVE NEUROSCI, V21, P760, DOI 10.1162/jocn.2009.21039; Hilimire MR, 2009, PSYCHOPHYSIOLOGY, V46, P1080, DOI 10.1111/j.1469-8986.2009.00846.x; Hopf JM, 2000, CEREB CORTEX, V10, P1233, DOI 10.1093/cercor/10.12.1233; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Kastner S, 2001, J NEUROPHYSIOL, V86, P1398, DOI 10.1152/jn.2001.86.3.1398; Luck SJ, 1997, COGNITIVE PSYCHOL, V33, P64, DOI 10.1006/cogp.1997.0660; Mazza V, 2009, CORTEX, V45, P879, DOI 10.1016/j.cortex.2008.10.009; McCarley JS, 2007, ACTA PSYCHOL, V126, P98, DOI 10.1016/j.actpsy.2006.11.004; Mounts JRW, 2007, PERCEPT PSYCHOPHYS, V69, P209, DOI 10.3758/BF03193743; Reddy L, 2007, J VISION, V7, DOI 10.1167/7.2.3; Sawaki R, 2010, ATTEN PERCEPT PSYCHO, V72, P1455, DOI 10.3758/APP.72.6.1455; Scalf PE, 2010, J NEUROSCI, V30, P161, DOI 10.1523/JNEUROSCI.4207-09.2010; Schubo A, 2009, PSYCHOL RES-PSYCH FO, V73, P233, DOI 10.1007/s00426-008-0215-x; THEEUWES J, 1991, PERCEPT PSYCHOPHYS, V50, P184, DOI 10.3758/BF03212219; THEEUWES J, 2010, ACTA PSYCHO IN PRESS; Turatto M, 2000, VISION RES, V40, P1639, DOI 10.1016/S0042-6989(00)00061-4	24	34	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2010	5	9							e12677	10.1371/journal.pone.0012677	http://dx.doi.org/10.1371/journal.pone.0012677			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	650QH	20862327	Green Published, gold, Green Submitted			2022-12-27	WOS:000281864100004
J	Lakhdari, O; Cultrone, A; Tap, J; Gloux, K; Bernard, F; Ehrlich, SD; Lefevre, F; Dore, J; Blottiere, HM				Lakhdari, Omar; Cultrone, Antonietta; Tap, Julien; Gloux, Karine; Bernard, Francoise; Ehrlich, S. Dusko; Lefevre, Fabrice; Dore, Joel; Blottiere, Herve M.			Functional Metagenomics: A High Throughput Screening Method to Decipher Microbiota-Driven NF-kappa B Modulation in the Human Gut	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; TOLL-LIKE RECEPTORS; CROHNS-DISEASE; BACTERIAL LIPOPROTEINS; GASTROINTESTINAL-TRACT; IMMUNE HOMEOSTASIS; IKK-BETA; EXPRESSION; ACTIVATION; INFLAMMATION	Background/Aim: The human intestinal microbiota plays an important role in modulation of mucosal immune responses. To study interactions between intestinal epithelial cells (IECs) and commensal bacteria, a functional metagenomic approach was developed. One interest of metagenomics is to provide access to genomes of uncultured microbes. We aimed at identifying bacterial genes involved in regulation of NF-kappa B signaling in IECs. A high throughput cell-based screening assay allowing rapid detection of NF-kappa B modulation in IECs was established using the reporter-gene strategy to screen metagenomic libraries issued from the human intestinal microbiota. Methods: A plasmid containing the secreted alkaline phosphatase (SEAP) gene under the control of NF-kappa B binding elements was stably transfected in HT-29 cells. The reporter clone HT-29/kb-seap-25 was selected and characterized. Then, a first screening of a metagenomic library from Crohn's disease patients was performed to identify NF-kappa B modulating clones. Furthermore, genes potentially involved in the effect of one stimulatory metagenomic clone were determined by sequence analysis associated to mutagenesis by transposition. Results: The two proinflammatory cytokines, TNF-alpha and IL-1 beta, were able to activate the reporter system, translating the activation of the NF-kappa B signaling pathway and NF-kappa B inhibitors, BAY 11-7082, caffeic acid phenethyl ester and MG132 were efficient. A screening of 2640 metagenomic clones led to the identification of 171 modulating clones. Among them, one stimulatory metagenomic clone, 52B7, was further characterized. Sequence analysis revealed that its metagenomic DNA insert might belong to a new Bacteroides strain and we identified 2 loci encoding an ABC transport system and a putative lipoprotein potentially involved in 52B7 effect on NF-kappa B. Conclusions: We have established a robust high throughput screening assay for metagenomic libraries derived from the human intestinal microbiota to study bacteria-driven NF-kappa B regulation. This opens a strategic path toward the identification of bacterial strains and molecular patterns presenting a potential therapeutic interest.	[Lakhdari, Omar; Cultrone, Antonietta; Tap, Julien; Gloux, Karine; Bernard, Francoise; Ehrlich, S. Dusko; Dore, Joel; Blottiere, Herve M.] INRA, UMR Micalis 1319, Jouy En Josas, France; [Lakhdari, Omar; Lefevre, Fabrice] LibraGen SA, Toulouse, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Lakhdari, O (corresponding author), INRA, UMR Micalis 1319, Jouy En Josas, France.	herve.blottiere@jouy.inra.fr	Gloux, karine/AAC-4451-2019; BLOTTIERE, Hervé M/C-6120-2011; Tap, Julien/E-5760-2010; Ehrlich, S./Y-2423-2019; Dore, Joel/ABA-8921-2020	BLOTTIERE, Hervé M/0000-0002-8390-0607; Tap, Julien/0000-0001-8998-5413; Ehrlich, S./0000-0002-7563-4046; gloux, karine/0000-0002-8880-6628	L'Institut National de la Recherche Agronomique; European Community [FP7/2007-2013]; Metagenomics of the Human Intestinal Tract (MetaHIT) [HEALTH-F4-2007-201052]; Ministere de l'Enseignement Superieur et de la Recherche and LibraGen	L'Institut National de la Recherche Agronomique; European Community(European Commission); Metagenomics of the Human Intestinal Tract (MetaHIT); Ministere de l'Enseignement Superieur et de la Recherche and LibraGen	This work was supported by L'Institut National de la Recherche Agronomique and in part by the European Community's Seventh Framework Programme (FP7/2007-2013): Metagenomics of the Human Intestinal Tract (MetaHIT), grant agreement HEALTH-F4-2007-201052. OL is supported by a Conventions Industrielles de Formation par la Recherche (CIFRE) grant from the Ministere de l'Enseignement Superieur et de la Recherche and LibraGen. AC is supported by the European Community-funded project MetaHIT. LibraGen participated in study design, data analysis and decision to publish. Other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RJ, 2008, AM J GASTROENTEROL, V103, P386, DOI 10.1111/j.1572-0241.2007.01577.x; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bambou JC, 2004, J BIOL CHEM, V279, P42984, DOI 10.1074/jbc.M405410200; Bocker U, 2003, INT J COLORECTAL DIS, V18, P25, DOI 10.1007/s00384-002-0415-6; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Burns K, 2000, NAT CELL BIOL, V2, P346, DOI 10.1038/35014038; Cario E, 2000, J IMMUNOL, V164, P966, DOI 10.4049/jimmunol.164.2.966; Daniel R, 2005, NAT REV MICROBIOL, V3, P470, DOI 10.1038/nrmicro1160; Diaz-Torres ML, 2006, FEMS MICROBIOL LETT, V258, P257, DOI 10.1111/j.1574-6968.2006.00221.x; Dicksved J, 2008, ISME J, V2, P716, DOI 10.1038/ismej.2008.37; Eckmann L, 1997, J CLIN INVEST, V100, P296, DOI 10.1172/JCI119535; Eckmann L, 2008, P NATL ACAD SCI USA, V105, P15058, DOI 10.1073/pnas.0808216105; Furrie E, 2005, IMMUNOLOGY, V115, P565, DOI 10.1111/j.1365-2567.2005.02200.x; Gabor EM, 2004, ENVIRON MICROBIOL, V6, P879, DOI 10.1111/j.1462-2920.2004.00640.x; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gloux K, 2007, APPL ENVIRON MICROB, V73, P3734, DOI 10.1128/AEM.02204-06; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Jones BV, 2008, P NATL ACAD SCI USA, V105, P13580, DOI 10.1073/pnas.0804437105; Kalliomaki M, 2003, CURR OPIN ALLERGY CL, V3, P15, DOI [10.1097/00130832-200302000-00003, 10.1097/01.all.0000053262.39029.a1]; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; MacDonald TT, 2005, SCIENCE, V307, P1920, DOI 10.1126/science.1106442; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; McGarr SE, 2005, J CLIN GASTROENTEROL, V39, P98; Melmed G, 2003, J IMMUNOL, V170, P1406, DOI 10.4049/jimmunol.170.3.1406; Narita S, 2006, FEBS LETT, V580, P1164, DOI 10.1016/j.febslet.2005.10.038; Natarajan K, 1996, P NATL ACAD SCI USA, V93, P9090, DOI 10.1073/pnas.93.17.9090; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Olefsky JM, 2009, CELL, V138, P834, DOI 10.1016/j.cell.2009.08.018; Omagari D, 2009, CLIN EXP IMMUNOL, V156, P294, DOI 10.1111/j.1365-2249.2009.03892.x; Otte JM, 2004, GASTROENTEROLOGY, V126, P1054, DOI 10.1053/j.gastro.2004.01.007; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Schneeman TA, 2005, J IMMUNOL, V175, P376, DOI 10.4049/jimmunol.175.1.376; Schreiber S, 1998, GUT, V42, P477, DOI 10.1136/gut.42.4.477; SCHUERERMALY CC, 1994, IMMUNOLOGY, V81, P85; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Zaph C, 2007, NATURE, V446, P552, DOI 10.1038/nature05590; Zoetendal EG, 2008, GUT, V57, P1605, DOI 10.1136/gut.2007.133603	48	69	69	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e13092	10.1371/journal.pone.0013092	http://dx.doi.org/10.1371/journal.pone.0013092			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20927194	Green Published, gold, Green Submitted			2022-12-27	WOS:000282312600023
J	Maahs, DM; Siwy, J; Argiles, A; Cerna, M; Delles, C; Dominiczak, AF; Gayrard, N; Iphofer, A; Jansch, L; Jerums, G; Medek, K; Mischak, H; Navis, GJ; Roob, JM; Rossing, K; Rossing, P; Rychlik, I; Schiffer, E; Schmieder, RE; Wascher, TC; Winklhofer-Roob, BM; Zimmerli, LU; Zurbig, P; Snell-Bergeon, JK				Maahs, David M.; Siwy, Justyna; Argiles, Angel; Cerna, Marie; Delles, Christian; Dominiczak, Anna F.; Gayrard, Nathalie; Iphoefer, Alexander; Jaensch, Lothar; Jerums, George; Medek, Karel; Mischak, Harald; Navis, Gerjan J.; Roob, Johannes M.; Rossing, Kasper; Rossing, Peter; Rychlik, Ivan; Schiffer, Eric; Schmieder, Roland E.; Wascher, Thomas C.; Winklhofer-Roob, Brigitte M.; Zimmerli, Lukas U.; Zuerbig, Petra; Snell-Bergeon, Janet K.			Urinary Collagen Fragments Are Significantly Altered in Diabetes: A Link to Pathophysiology	PLOS ONE			English	Article							ELECTRON-TRANSFER DISSOCIATION; CORONARY-ARTERY-DISEASE; CHRONIC KIDNEY-DISEASE; LEVEL PROTEIN DIGESTS; TAMM-HORSFALL PROTEIN; MASS-SPECTROMETRY; BIOMARKER DISCOVERY; SEQUENCE-ANALYSIS; IMPAIRED ACTIVITY; SYSTEMS BIOLOGY	Background: The pathogenesis of diabetes mellitus (DM) is variable, comprising different inflammatory and immune responses. Proteome analysis holds the promise of delivering insight into the pathophysiological changes associated with diabetes. Recently, we identified and validated urinary proteomics biomarkers for diabetes. Based on these initial findings, we aimed to further validate urinary proteomics biomarkers specific for diabetes in general, and particularity associated with either type 1 (T1D) or type 2 diabetes (T2D). Methodology/Principal Findings: Therefore, the low-molecular-weight urinary proteome of 902 subjects from 10 different centers, 315 controls and 587 patients with T1D (n = 299) or T2D (n = 288), was analyzed using capillary-electrophoresis mass-spectrometry. The 261 urinary biomarkers (100 were sequenced) previously discovered in 205 subjects were validated in an additional 697 subjects to distinguish DM subjects (n = 382) from control subjects (n = 315) with 94% (95% CI: 92-95) accuracy in this study. To identify biomarkers that differentiate T1D from T2D, a subset of normoalbuminuric patients with T1D (n = 68) and T2D (n = 42) was employed, enabling identification of 131 biomarker candidates (40 were sequenced) differentially regulated between T1D and T2D. These biomarkers distinguished T1D from T2D in an independent validation set of normoalbuminuric patients (n = 108) with 88% (95% CI: 81-94%) accuracy, and in patients with impaired renal function (n = 369) with 85% (95% CI: 81-88%) accuracy. Specific collagen fragments were associated with diabetes and type of diabetes indicating changes in collagen turnover and extracellular matrix as one hallmark of the molecular pathophysiology of diabetes. Additional biomarkers including inflammatory processes and pro-thrombotic alterations were observed. Conclusions/Significance: These findings, based on the largest proteomic study performed to date on subjects with DM, validate the previously described biomarkers for DM, and pinpoint differences in the urinary proteome of T1D and T2D, indicating significant differences in extracellular matrix remodeling.	[Maahs, David M.; Snell-Bergeon, Janet K.] Univ Colorado Denver, Barbara Davis Ctr Childhood Diabet, Aurora, CO USA; [Siwy, Justyna; Mischak, Harald; Schiffer, Eric; Zuerbig, Petra] Mosa Diagnost GmbH, Hannover, Germany; [Argiles, Angel; Gayrard, Nathalie] RD Nephrol, Montpellier, France; [Cerna, Marie; Medek, Karel] Charles Univ Prague, Dept Gen Biol & Genet, Fac Med 3, Prague, Czech Republic; [Delles, Christian; Dominiczak, Anna F.; Mischak, Harald; Zimmerli, Lukas U.] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Iphoefer, Alexander; Jaensch, Lothar] Helmholtz Ctr Infect Res, Dept Cell Biol, Braunschweig, Germany; [Jerums, George] Univ Melbourne, Dept Med, Heidelberg, Vic, Australia; [Navis, Gerjan J.] Univ Groningen, Univ Med Ctr Groningen, Div Nephrol, Dept Internal Med, Groningen, Netherlands; [Roob, Johannes M.] Med Univ, Div Clin Nephrol, Dept Internal Med, Graz, Austria; [Rossing, Kasper; Rossing, Peter] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Rychlik, Ivan] Charles Univ Prague, Dept Internal Med, Fac Med 3, Prague, Czech Republic; [Schmieder, Roland E.] Univ Erlangen Nurnberg, Dept Hypertens & Nephrol, Erlangen, Germany; [Wascher, Thomas C.] Med Univ Graz, Dept Internal Med, Metab & Vasc Biol Res Grp, Graz, Austria; [Winklhofer-Roob, Brigitte M.] Karl Franzens Univ Graz, Inst Mol Biosci, Human Nutr & Metab Res Ctr HNMRC, Graz, Austria	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Modular Open Systems Approach (MOSA) Solutions; Charles University Prague; University of Glasgow; Helmholtz Association; Helmholtz-Center for Infection Research; University of Melbourne; University of Groningen; Medical University of Graz; Steno Diabetes Center; Charles University Prague; University of Erlangen Nuremberg; Medical University of Graz; University of Graz	Maahs, DM (corresponding author), Univ Colorado Denver, Barbara Davis Ctr Childhood Diabet, Aurora, CO USA.	David.Maahs@ucdenver.edu	rossing, peter/AAH-7879-2021; gayrard, nathalie/AAO-2888-2020; rossing, peter/AAZ-3415-2021; Winklhofer-Roob, Brigitte M/L-7899-2015; Dominiczak, Anna/P-9390-2017	gayrard, nathalie/0000-0001-8283-8429; rossing, peter/0000-0002-1531-4294; Winklhofer-Roob, Brigitte M/0000-0002-2021-2137; Argiles, Angel/0000-0001-7029-4532; Maahs, David/0000-0002-4602-7909; Rychlik, Ivan/0000-0002-4245-5949; Snell-Bergeon, Janet/0000-0002-9337-3740; Mischak, Harald/0000-0003-0323-0306; Medek, Karel/0000-0003-4350-8659; Dominiczak, Anna/0000-0003-4913-3608; Zurbig, Petra/0000-0003-3465-2173; Siwy, Justyna/0000-0003-1407-2534	EU [LSHM-CT-2005-018733]; InGenious HyperCare [LSHM-CT-2006-037093]; National Institutes of Health National Heart, Lung and Blood Institute [R01 HL61753, R01 HL079611]; Diabetes Endocrinology Research Center Clinical Investigation Core [P30 DK57516]; American Diabetes Association [7-09-CVD-06]; NIDDK [K23 DK075360]; European Community [HEALTH-F2-2009-241544]; Novartis; Boehringer Ingelheim; Sanofi-Aventis;  [VZ MSM 0021620814]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113029, R01HL061753, R01HL079611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK075360] Funding Source: NIH RePORTER	EU(European Commission); InGenious HyperCare(European Commission); National Institutes of Health National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Diabetes Endocrinology Research Center Clinical Investigation Core; American Diabetes Association(American Diabetes Association); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); European Community(European Commission); Novartis(Novartis); Boehringer Ingelheim(Boehringer Ingelheim); Sanofi-Aventis(Sanofi-Aventis); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by grant [#LSHM-CT-2005-018733] from the EU to the PREDICTIONS (PREvention of DIabetic ComplicaTIONS) network to MC, KM, HM, GN, JMR, IR, and BW-R and by InGenious HyperCare [LSHM-CT-2006-037093] to HM and AFD. Support for this study was also provided by the National Institutes of Health National Heart, Lung and Blood Institute grants [R01 HL61753] and [R01 HL079611], Diabetes Endocrinology Research Center Clinical Investigation Core [P30 DK57516], and American Diabetes Association Post-Doctoral Fellowship [#7-09-CVD-06] to JSB and the NIDDK [K23 DK075360] to DMM. European Community's 7th Framework Programme, grant agreement HEALTH-F2-2009-241544 (SysKID). Furthermore, the Czech participants were supported in part by a Czech grant VZ MSM 0021620814. HM and PZ were partially supported by mosaiques diagnostics (MoD) (www.mosaiques-diagnostics.com). Investigators from the co-sponsoring institution (MoD) were involved in study design, data production and analysis, and interpretation of the results. Other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; H. Mischak is co-founder and a shareholder of Mosaiques Diagnostics GmbH (Hannover, Germany). P. Zurbig, J. Siwy, and E. Schiffer are employees of Mosaiques Diagnostics GmbH. P. Rossing has served as a consultant to Merck, Bristol-Myers Squibb and AstraZeneca, has received research grants from Novartis and has been a member of speakers bureaus sponsored by Novartis, Boehringer Ingelheim, and Sanofi-Aventis. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Ahmed N, 2005, DIABETES RES CLIN PR, V67, P3, DOI 10.1016/j.diabres.2004.09.004; Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS55, DOI 10.2337/dc08-S055; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cahill MA, 2007, J STEROID BIOCHEM, V105, P16, DOI 10.1016/j.jsbmb.2007.02.002; Catania JM, 2007, AM J PHYSIOL-RENAL, V292, pF905, DOI 10.1152/ajprenal.00421.2006; Coon JJ, 2005, J AM SOC MASS SPECTR, V16, P880, DOI 10.1016/j.jasms.2005.01.015; Costacou T, 2008, DIABETES, V57, P1702, DOI 10.2337/db08-0095; Costacou T, 2009, DIABETES, V58, P2904, DOI 10.2337/db09-0874; Decramer S, 2006, NAT MED, V12, P398, DOI 10.1038/nm1384; DeLeo J. M., 1993, RECEIVER OPERATING C, P318; Dominiczak AF, 2010, NEPHROL DIAL TRANSPL, V25, P1019, DOI 10.1093/ndt/gfq025; Finley JW, 2007, J NUTR, V137, P2391, DOI 10.1093/jn/137.11.2391; Gebauer P, 2002, ELECTROPHORESIS, V23, P1779, DOI 10.1002/1522-2683(200206)23:12<1779::AID-ELPS1779>3.0.CO;2-G; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Good DM, 2007, MOL CELL PROTEOMICS, V6, P1942, DOI 10.1074/mcp.M700073-MCP200; Good DM, 2006, BIOTECHNIQUES, V40, P783, DOI 10.2144/000112194; Good DM, 2010, MOL CELL PROTEOMICS; Grant PJ, 2007, J INTERN MED, V262, P157, DOI 10.1111/j.1365-2796.2007.01824.x; Gras F, 2007, DIABETOLOGIA, V50, P2544, DOI 10.1007/s00125-007-0836-4; Hashemi M, 2007, DIABETES RES CLIN PR, V75, P246, DOI 10.1016/j.diabres.2006.06.020; Holmquist P, 2001, PEDIATR NEPHROL, V16, P488, DOI 10.1007/s004670100587; Holmquist P, 2008, PEDIATR NEPHROL, V23, P1079, DOI 10.1007/s00467-008-0770-9; Hull RL, 2004, J CLIN ENDOCR METAB, V89, P3629, DOI 10.1210/jc.2004-0405; Jantos-Siwy J, 2009, J PROTEOME RES, V8, P268, DOI 10.1021/pr800401m; Kitsiou PV, 2003, AM J PHYSIOL-RENAL, V284, pF671, DOI 10.1152/ajprenal.00266.2002; Kolch W, 2005, MASS SPECTROM REV, V24, P959, DOI 10.1002/mas.20051; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Lapolla A, 2009, J MASS SPECTROM, V44, P419, DOI 10.1002/jms.1520; Li JJ, 2002, MOL CELL PROTEOMICS, V1, P157, DOI 10.1074/mcp.M100022-MCP200; Li JJ, 2000, ELECTROPHORESIS, V21, P198, DOI 10.1002/(SICI)1522-2683(20000101)21:1<198::AID-ELPS198>3.3.CO;2-M; Marzban L, 2003, EXP GERONTOL, V38, P347, DOI 10.1016/S0531-5565(03)00004-4; Meier M, 2005, J DIABETES COMPLICAT, V19, P223, DOI 10.1016/j.jdiacomp.2004.10.002; Mischak H, 2004, CLIN SCI, V107, P485, DOI 10.1042/CS20040103; Mischak H, 2009, MASS SPECTROM REV, V28, P703, DOI 10.1002/mas.20205; Molina F, 2010, NEPHROL DIAL TRANSPL, V25, P1015, DOI 10.1093/ndt/gfq033; Neuhoff NV, 2004, RAPID COMMUN MASS SP, V18, P149, DOI 10.1002/rcm.1294; Rossing K, 2008, PROTEOM CLIN APPL, V2, P997, DOI 10.1002/prca.200780166; Rossing K, 2008, J AM SOC NEPHROL, V19, P1283, DOI 10.1681/ASN.2007091025; SANDLER M, 1988, DIABETES RES CLIN PR, V5, P249, DOI 10.1016/S0168-8227(88)80059-7; Sandstrom CS, 2008, DIABETIC MED, V25, P1370, DOI 10.1111/j.1464-5491.2008.02584.x; Sharma K, 2005, PROTEOMICS, V5, P2648, DOI 10.1002/pmic.200401288; Snell-Bergeon JK, 2009, DIABETES TECHNOL THE, V11, P1, DOI 10.1089/dia.2008.0040; Syka JEP, 2004, P NATL ACAD SCI USA, V101, P9528, DOI 10.1073/pnas.0402700101; Theodorescu D, 2006, LANCET ONCOL, V7, P230, DOI 10.1016/S1470-2045(06)70584-8; Theodorescu D, 2008, PROTEOM CLIN APPL, V2, P556, DOI 10.1002/prca.200780082; Thongboonkerd V, 2007, J PROTEOME RES, V6, P3881, DOI 10.1021/pr070328s; Tsilibary EC, 2003, J PATHOL, V200, P537, DOI 10.1002/path.1439; Verzijl N, 2000, J BIOL CHEM, V275, P39027, DOI 10.1074/jbc.M006700200; von zur Muhlen C, 2009, J PROTEOME RES, V8, P335, DOI 10.1021/pr800615t; Weissinger EM, 2007, BLOOD, V109, P5511, DOI 10.1182/blood-2007-01-069757; Zhang RL, 2004, PROTEOMICS, V4, P244, DOI 10.1002/pmic.200300495; Zimmerli LU, 2008, MOL CELL PROTEOMICS, V7, P290, DOI 10.1074/mcp.M700394-MCP200; Zurbig P, 2006, ELECTROPHORESIS, V27, P2111, DOI 10.1002/elps.200500827; Zurbig P, 2009, PROTEOMICS, V9, P2108, DOI 10.1002/pmic.200800560	54	42	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2010	5	9							e13051	10.1371/journal.pone.0013051	http://dx.doi.org/10.1371/journal.pone.0013051			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654ZQ	20927192	Green Accepted, Green Published, gold			2022-12-27	WOS:000282210700021
J	Liu, J; Sandoval, J; Doh, ST; Cai, L; Lopez-Rodas, G; Casaccia, P				Liu, Jia; Sandoval, Juan; Doh, Sung Tae; Cai, Li; Lopez-Rodas, Gerardo; Casaccia, Patrizia			Epigenetic Modifiers Are Necessary but Not Sufficient for Reprogramming Non-Myelinating Cells into Myelin Gene-Expressing Cells	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; OLIGODENDROCYTE PROGENITOR DIFFERENTIATION; SMALL-MOLECULE COMPOUNDS; DNA METHYLATION; BASIC-PROTEIN; TRANSCRIPTION FACTOR; HISTONE METHYLATION; DEFINED FACTORS; FIBROBLASTS; INDUCTION	Background: Modifications on specific histone residues and DNA methylation play an essential role in lineage choice and cellular reprogramming. We have previously shown that histone modifications or combinatorial codes of transcription factors (TFs) are critical for the differentiation of multipotential progenitors into myelinating oligodendrocytes. In this study we asked whether combining global manipulation of DNA methylation and histone acetylation together with the expression of oligodendrocyte-specific TFs, was sufficient to switch the identity of fibroblasts into myelin gene-expressing cells. Methodology/Principal Findings: Transfection of six oligodendrocyte-specific TFs (Olig1, Olig2, Sox10, Mash1, E47 and Nkx2.2) into NIH3T3 fibroblasts was capable of inducing expression of myelin gene promoter-driven reporters, but did not activate endogenous myelin gene expression. These results suggested the existence of a transcriptionally incompetent chromatin conformation in NIH3T3 fibroblasts. Using chromatin immunoprecipitation (ChIP) analysis, we compared the histone code on the conserved regions of myelin genes (i.e. Mbp and Mag) in differentiating oligodendrocyte progenitors and NIH3T3 fibroblasts. Chromatin at myelin gene loci was characterized by the presence of repressive histone modifications (me3K9H3 and me3K27H3) in NIH3T3 fibroblasts and active histone marks (me3K4H3 and AcH3) in oligodendrocyte lineage cells. To induce a transcriptionally competent chromatin signature, NIH3T3 fibroblasts were treated with 5-azadeoxy-citidine (5-AzaC) to decrease DNA methylation, and trichostatin A (TSA) or sirtinol, to favor histone acetylation. Treatment with 5-AzaC/TSA but not sirtinol, resulted in the detection of endogenous myelin gene transcripts in fibroblasts, although not to the levels detected in myelinating cells. Transfection of oligodendrocyte-specific TFs after 5AzaC/TSA treatment did not further increase myelin gene expression, nor did it reprogram the transcriptional network of NIH3T3 fibroblasts into that of oligodendrocytes. Conclusions/Significance: These results suggest that reprogramming of fibroblasts into myelin gene-expressing cells not only requires transcriptional activation, but also chromatin manipulations that go beyond histone acetylation and DNA methylation.	[Liu, Jia; Casaccia, Patrizia] Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA; [Sandoval, Juan; Lopez-Rodas, Gerardo] Univ Valencia, Dept Biochem & Mol Biol, Valencia, Spain; [Doh, Sung Tae; Cai, Li] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ USA	Icahn School of Medicine at Mount Sinai; University of Valencia; Rutgers State University New Brunswick	Liu, J (corresponding author), Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA.	patrizia.casaccia@mssm.edu	Liu, Jia/AAN-2112-2020; sandoval, juan/M-4593-2015; LOPEZ-RODAS, GERARDO/I-1349-2015	Liu, Jia/0000-0001-6274-2710; sandoval, juan/0000-0002-5100-973X; Cai, Li/0000-0003-3344-337X; LOPEZ-RODAS, GERARDO/0000-0001-8367-653X	Winston Foundation [NMSS FG1874-A1]; Ministerio de Ciencia y Tecnologia [CSD2006-00049, PR2008-0243]; National Institutes of Health (NIH) [R21-EY018738]; New Jersey Commission on Spinal Cord Research [08-3074-SCR-E-0];  [NS-R01-42925-08];  [NS-R01-42925-08-S1];  [NMSS-RG3957]; NATIONAL EYE INSTITUTE [R21EY018738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042925] Funding Source: NIH RePORTER	Winston Foundation; Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Jersey Commission on Spinal Cord Research; ; ; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a fellowship to Dr. Liu (NMSS FG1874-A1, sponsored by the Winston Foundation) and by grants to: Dr. Casaccia (NS-R01-42925-08; NS-R01-42925-08-S1 ARRA supplement; NMSS-RG3957), Dr. Lopez-Rodas (Ministerio de Ciencia y Tecnologia CSD2006-00049 and PR2008-0243) and to Dr. Cai (National Institutes of Health (NIH) R21-EY018738 and New Jersey Commission on Spinal Cord Research 08-3074-SCR-E-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernatavichute YV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003156; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Copray S, 2009, GLIA, V57, P1579, DOI 10.1002/glia.20881; Cunliffe VT, 2006, MECH DEVELOP, V123, P24, DOI 10.1016/j.mod.2005.10.005; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Doh ST, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-94; Dugas JC, 2010, NEURON, V65, P597, DOI 10.1016/j.neuron.2010.01.027; Emery B, 2009, CELL, V138, P172, DOI 10.1016/j.cell.2009.04.031; Farhadi HF, 2003, J NEUROSCI, V23, P10214; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; Gokhan S, 2005, J NEUROSCI, V25, P8311, DOI 10.1523/JNEUROSCI.1850-05.2005; He Y, 2007, NEURON, V55, P217, DOI 10.1016/j.neuron.2007.06.029; Holliday R, 2006, EPIGENETICS-US, V1, P76, DOI 10.4161/epi.1.2.2762; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; JUNG M, 1995, EUR J NEUROSCI, V7, P1245, DOI 10.1111/j.1460-9568.1995.tb01115.x; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Li HL, 2009, CURR OPIN NEUROBIOL, V19, P479, DOI 10.1016/j.conb.2009.08.004; Liu AX, 2007, J NEUROSCI, V27, P7339, DOI 10.1523/JNEUROSCI.1226-07.2007; Liu H, 2009, GLIA, V57, P1, DOI 10.1002/glia.20729; Liu J, 2010, TRENDS NEUROSCI, V33, P193, DOI 10.1016/j.tins.2010.01.007; MacDonald JL, 2009, PROG NEUROBIOL, V88, P170, DOI 10.1016/j.pneurobio.2009.04.002; MIKOSHIBA K, 1991, ANNU REV NEUROSCI, V14, P201, DOI 10.1146/annurev.ne.14.030191.001221; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ruau D, 2008, STEM CELLS, V26, P920, DOI 10.1634/stemcells.2007-0649; Shen SM, 2008, NAT NEUROSCI, V11, P1024, DOI 10.1038/nn.2172; Shen SM, 2005, J CELL BIOL, V169, P577, DOI 10.1083/jcb.200412101; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Shin D, 2009, ANN NEUROL, V66, P843, DOI 10.1002/ana.21927; Smallwood A, 2007, GENE DEV, V21, P1169, DOI 10.1101/gad.1536807; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vastenhouw NL, 2010, NATURE, V464, P922, DOI 10.1038/nature08866; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wei Q, 2005, J BIOL CHEM, V280, P16284, DOI 10.1074/jbc.M500491200; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Ye F, 2009, NAT NEUROSCI, V12, P829, DOI 10.1038/nn.2333; Yu Y, 2010, EPIGENETICS-US, V5, P124, DOI 10.4161/epi.5.2.11160; Zhang CL, 2002, MOL CELL BIOL, V22, P7302, DOI 10.1128/MCB.22.20.7302-7312.2002; ZHANG XM, 2009, MOL BIOL REP; Zhao XH, 2010, NEURON, V65, P612, DOI 10.1016/j.neuron.2010.02.018	39	19	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e13023	10.1371/journal.pone.0013023	http://dx.doi.org/10.1371/journal.pone.0013023			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20885955	gold, Green Submitted, Green Published			2022-12-27	WOS:000282167100022
J	Sarkari, F; Sheng, Y; Frappier, L				Sarkari, Feroz; Sheng, Yi; Frappier, Lori			USP7/HAUSP Promotes the Sequence-Specific DNA Binding Activity of p53	PLOS ONE			English	Article							UBIQUITIN-SPECIFIC PROTEASE; TUMOR-SUPPRESSOR P53; C-TERMINAL DOMAIN; HUMAN CANCER; CONFORMATION; ACETYLATION; ACTIVATION; HAUSP/USP7; PHOSPHORYLATION; IDENTIFICATION	The p53 tumor suppressor invokes cellular responses to stressful stimuli by coordinating distinct gene expression programs. This function relies heavily on the ability of p53 to function as a transcription factor by binding promoters of target genes in a sequence specific manner. The DNA binding activity of the core domain of p53 is subject to regulation via post-translational modifications of the C-terminal region. Here we show that the ubiquitin specific protease, USP7 or HAUSP, known to stabilize p53, also regulates the sequence-specific DNA binding mediated by the core domain of p53 in vitro. This regulation is contingent upon interaction between USP7 and the C-terminal regulatory region of p53. However, our data suggest that this effect is not mediated through the N-terminal domain of USP7 previously shown to bind p53, but rather involves the USP7 C-terminal domain and is independent of the deubiquitylation activity of USP7. Consistent with our in vitro observations, we found that overexpression of catalytically inactive USP7 in cells promotes p53 binding to its target sequences and p21 expression, without increasing the levels of p53 protein. We also found that the USP7 C-terminal domain was sufficient for p21 induction. Our results suggest a novel mode of regulation of p53 function by USP7, which is independent of USP7 deubiquitylating activity.	[Sarkari, Feroz; Frappier, Lori] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Sheng, Yi] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada	University of Toronto; York University - Canada	Sarkari, F (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.	lori.frappier@utoronto.ca			Canadian Cancer Society Research; National Cancer Institute of Canada	Canadian Cancer Society Research(Canadian Cancer Society (CCS)); National Cancer Institute of Canada(Canadian Cancer Society (CCS))	This work was supported by a Canadian Cancer Society Research Grant to L. F. and a National Cancer Institute of Canada studentship to F.S.L.F. is a tier 1 Canada Research Chair in Molecular Virology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AB RICKINSON, 2001, FIELDS VIROLOGY, P2575; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Ayed A, 2001, NAT STRUCT BIOL, V8, P756, DOI 10.1038/nsb0901-756; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Espinosa JM, 2001, MOL CELL, V8, P57, DOI 10.1016/S1097-2765(01)00283-0; Gohler T, 2002, J BIOL CHEM, V277, P41192, DOI 10.1074/jbc.M202344200; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hainaut P, 2000, ADV CANCER RES, V77, P81; HALAZONETIS TD, 1993, EMBO J, V12, P1021, DOI 10.1002/j.1460-2075.1993.tb05743.x; Ho J, 2003, CELL DEATH DIFFER, V10, P404, DOI 10.1038/sj.cdd.4401191; Holowaty MN, 2003, J BIOL CHEM, V278, P47753, DOI 10.1074/jbc.M307200200; Holowaty MN, 2003, J BIOL CHEM, V278, P29987, DOI 10.1074/jbc.M303977200; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Hu M, 2006, PLOS BIOL, V4, P228, DOI 10.1371/journal.pbio.0040027; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; McKinney K, 2004, MOL CELL, V16, P413, DOI 10.1016/j.molcel.2004.09.032; McKinney K, 2002, MOL CELL BIOL, V22, P6797, DOI 10.1128/MCB.22.19.6797-6808.2002; MEREDITH M, 1994, VIROLOGY, V200, P457, DOI 10.1006/viro.1994.1209; Muller-Tiemann BF, 1998, P NATL ACAD SCI USA, V95, P6079, DOI 10.1073/pnas.95.11.6079; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; Resnick-Silverman L, 1998, GENE DEV, V12, P2102, DOI 10.1101/gad.12.14.2102; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Saridakis V, 2005, MOL CELL, V18, P25, DOI 10.1016/j.molcel.2005.02.029; SARKARI F, 2010, HERPESVIRUS AS UNPUB; Sarkari F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000624; Shan J, 2008, Ernst Schering Found Symp Proc, P127; Sheng Y, 2006, NAT STRUCT MOL BIOL, V13, P285, DOI 10.1038/nsmb1067; Sivachandran N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000170; Soussi T, 2007, CANCER CELL, V12, P303, DOI 10.1016/j.ccr.2007.10.001; Stiewe T, 2007, NAT REV CANCER, V7, P165, DOI 10.1038/nrc2072; Tafvizi A, 2008, BIOPHYS J, V95, pL1, DOI 10.1529/biophysj.108.134122; TAKENAKA I, 1995, J BIOL CHEM, V270, P5405, DOI 10.1074/jbc.270.10.5405; van der Horst A, 2006, NAT CELL BIOL, V8, P1064, DOI 10.1038/ncb1469; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wang S, 2009, J VIROL, V83, P11704, DOI 10.1128/JVI.00931-09; WANG Y, 1995, NATURE, V376, P88, DOI 10.1038/376088a0	41	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e13040	10.1371/journal.pone.0013040	http://dx.doi.org/10.1371/journal.pone.0013040			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20885946	gold, Green Published, Green Submitted			2022-12-27	WOS:000282167100028
J	Hill, JA; Szabat, M; Hoesli, CA; Gage, BK; Yang, YHC; Williams, DE; Riedel, MJ; Luciani, DS; Kalynyak, TB; Tsai, K; Ao, ZL; Andersen, RJ; Warnock, GL; Piret, JM; Kieffer, TJ; Johnson, JD				Hill, Jessica A.; Szabat, Marta; Hoesli, Corinne A.; Gage, Blair K.; Yang, Yu Hsuan C.; Williams, David E.; Riedel, Michael J.; Luciani, Dan S.; Kalynyak, Tatyana B.; Tsai, Kevin; Ao, Ziliang; Andersen, Raymond J.; Warnock, Garth L.; Piret, James M.; Kieffer, Timothy J.; Johnson, James D.			A Multi-Parameter, High-Content, High-Throughput Screening Platform to Identify Natural Compounds that Modulate Insulin and Pdx1 Expression	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; BETA-CELL APOPTOSIS; SMALL-MOLECULE; GLUCOSE; IDENTIFICATION; PALMITATE; CHANNELS; STRESS; ISLETS; ER	Diabetes is a devastating disease that is ultimately caused by the malfunction or loss of insulin-producing pancreatic beta-cells. Drugs capable of inducing the development of new beta-cells or improving the function or survival of existing beta-cells could conceivably cure this disease. We report a novel high-throughput screening platform that exploits multiparameter high-content analysis to determine the effect of compounds on beta-cell survival, as well as the promoter activity of two key beta-cell genes, insulin and pdx1. Dispersed human pancreatic islets and MIN6 beta-cells were infected with a dual reporter lentivirus containing both eGFP driven by the insulin promoter and mRFP driven by the pdx1 promoter. B-score statistical transformation was used to correct systemic row and column biases. Using this approach and 5 replicate screens, we identified 7 extracts that reproducibly changed insulin and/or pdx1 promoter activity from a library of 1319 marine invertebrate extracts. The ability of compounds purified from these extracts to significantly modulate insulin mRNA levels was confirmed with real-time PCR. Insulin secretion was analyzed by RIA. Follow-up studies focused on two lead compounds, one that stimulates insulin gene expression and one that inhibits insulin gene expression. Thus, we demonstrate that multi-parameter, high-content screening can identify novel regulators of beta-cell gene expression, such as bivittoside D. This work represents an important step towards the development of drugs to increase insulin expression in diabetes and during in vitro differentiation of beta-cell replacements.	[Hill, Jessica A.; Gage, Blair K.; Yang, Yu Hsuan C.; Riedel, Michael J.; Luciani, Dan S.; Kalynyak, Tatyana B.; Tsai, Kevin; Kieffer, Timothy J.; Johnson, James D.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada; [Ao, Ziliang; Warnock, Garth L.; Kieffer, Timothy J.; Johnson, James D.] Univ British Columbia, Dept Surg, Vancouver, BC V6T 1W5, Canada; [Szabat, Marta; Hoesli, Corinne A.; Piret, James M.] Univ British Columbia, Dept Chem & Biol Engn, Vancouver, BC V5Z 1M9, Canada; [Williams, David E.; Andersen, Raymond J.] Univ British Columbia, Dept Chem, Vancouver, BC, Canada; [Williams, David E.; Andersen, Raymond J.] Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Hill, JA (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada.	jimjohn@interchange.ubc.ca	Piret, James Michael/B-4554-2008; Hoesli, Corinne/A-6643-2019; Tsai, Kevin/GQR-1990-2022	Piret, James Michael/0000-0001-7934-9675; Hoesli, Corinne/0000-0002-5629-7128; Tsai, Kevin/0000-0001-5966-6542; Yang, Yu Hsuan Carol/0000-0001-6663-0302; Johnson, James/0000-0002-7523-9433; Luciani, Dan/0000-0002-4318-4159	Stem Cell Network; Michael Smith Foundation for Health Research (MSFHR) Centre for Human Islet Transplant and Beta-Cell Regeneration; JDRF; CIHR; MSFHR	Stem Cell Network; Michael Smith Foundation for Health Research (MSFHR) Centre for Human Islet Transplant and Beta-Cell Regeneration(Michael Smith Foundation for Health Research); JDRF(Juvenile Diabetes Research Foundation); CIHR(Canadian Institutes of Health Research (CIHR)); MSFHR(Michael Smith Foundation for Health Research)	Funding for this project was generously provided by the Stem Cell Network (to T.J.K., J.D.J., J.M.P., G. L. W., R.J.A.), and by the Michael Smith Foundation for Health Research (MSFHR) Centre for Human Islet Transplant and Beta-Cell Regeneration (G.L.W., T.J.K., J.D.J). J.D.J. was supported by JDRF, CIHR and MSFHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Ahn KS, 2007, BLOOD, V110, P2286, DOI 10.1182/blood-2007-04-084996; Alejandro EU, 2008, J BIOL CHEM, V283, P2407, DOI 10.1074/jbc.M703612200; Alejandro EU, 2010, ENDOCRINOLOGY, V151, P502, DOI 10.1210/en.2009-0678; Beith JL, 2008, ENDOCRINOLOGY, V149, P2251, DOI 10.1210/en.2007-1557; Boutros M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r66; Brideau C, 2003, J BIOMOL SCREEN, V8, P634, DOI 10.1177/1087057103258285; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chen S, 2009, NAT CHEM BIOL, V5, P258, DOI 10.1038/nchembio.154; Chou DHC, 2010, ACS CHEM BIOL, V5, P729, DOI 10.1021/cb100129d; Davalli AM, 1999, TRANSPLANTATION, V67, P174, DOI 10.1097/00007890-199901150-00028; Dror V, 2008, J BIOL CHEM, V283, P9909, DOI 10.1074/jbc.M710601200; Fomina-Yadlin D, 2010, P NATL ACAD SCI USA, V107, P15099, DOI 10.1073/pnas.1010018107; Fujimoto K, 2009, J BIOL CHEM, V284, P27664, DOI 10.1074/jbc.M109.041616; Gwiazda KS, 2009, AM J PHYSIOL-ENDOC M, V296, pE690, DOI 10.1152/ajpendo.90525.2008; Hay CW, 2006, DIABETES, V55, P3201, DOI 10.2337/db06-0788; HOAGLIN DC, 1983, UNDERSTANDING ROBUST, pR16; ISHIHARA H, 1993, DIABETOLOGIA, V36, P1139, DOI 10.1007/BF00401058; Iwamaru A, 2007, MOL CANCER THER, V6, P184, DOI 10.1158/1535-7163.MCT-06-0422; Jeffrey KD, 2008, P NATL ACAD SCI USA, V105, P8452, DOI 10.1073/pnas.0711232105; Johnson JD, 2006, P NATL ACAD SCI USA, V103, P19575, DOI 10.1073/pnas.0604208103; Johnson JD, 2010, ADV EXP MED BIOL, V654, P447, DOI 10.1007/978-90-481-3271-3_19; Johnson JD, 2009, CELL TRANSPLANT, V18, P833, DOI 10.3727/096368909X471198; Johnson JD, 2004, J BIOL CHEM, V279, P24794, DOI 10.1074/jbc.M401216200; Johnson JD, 2003, J CLIN INVEST, V111, P1147, DOI 10.1172/JCI200316537; JOHNSON JD, 2007, CANADIAN J DIABETES, V31, P8; Kajimoto Y, 1997, J CLIN INVEST, V100, P1840, DOI 10.1172/JCI119712; Kaneto H, 2007, DIABETES RES CLIN PR, V77, pS127, DOI 10.1016/j.diabres.2007.01.046; Knudsen LB, 2007, P NATL ACAD SCI USA, V104, P937, DOI 10.1073/pnas.0605701104; Lakshmi V, 2008, ARCH MED RES, V39, P631, DOI 10.1016/j.arcmed.2008.06.007; Luciani DS, 2009, DIABETES, V58, P422, DOI 10.2337/db07-1762; Luciani DS, 2005, MOL CELL ENDOCRINOL, V241, P88, DOI 10.1016/j.mce.2005.06.006; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Mitsiades CS, 2008, CANCER RES, V68, P5216, DOI 10.1158/0008-5472.CAN-07-5725; Nakamura T, 2001, J CLIN ENDOCR METAB, V86, P1795, DOI 10.1210/jc.86.4.1795; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; Roberge M, 2000, CANCER RES, V60, P5052; Szabat M, 2010, DIABETOLOGIA, V53, P1680, DOI 10.1007/s00125-010-1758-0; Szabat M, 2009, ENDOCRINOLOGY, V150, P1627, DOI 10.1210/en.2008-1224; Takayama I, 2008, Diabetes Res Clin Pract, V79, pe8, DOI 10.1016/j.diabres.2007.08.013; Tarling CA, 2008, CHEMBIOCHEM, V9, P433, DOI 10.1002/cbic.200700470; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011; Trudeau JD, 2000, DIABETES, V49, P1, DOI 10.2337/diabetes.49.1.1; Tukey JW, 1977, EXPLORATORY DATA ANA; Warnock GL, 2007, WORLD J SURG, V31, P1569, DOI 10.1007/s00268-007-9125-0; Warnock GL, 2008, TRANSPLANTATION, V86, P1762, DOI 10.1097/TP.0b013e318190b052; Wideman RD, 2006, P NATL ACAD SCI USA, V103, P13468, DOI 10.1073/pnas.0600655103; Wu WZ, 2008, J BIOMOL SCREEN, V13, P128, DOI 10.1177/1087057107313763; Wu ZJ, 2008, J BIOMOL SCREEN, V13, P159, DOI 10.1177/1087057107312628	50	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12958	10.1371/journal.pone.0012958	http://dx.doi.org/10.1371/journal.pone.0012958			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886041	gold, Green Published, Green Submitted			2022-12-27	WOS:000282091100053
J	Kim, S; Selote, DS; Vatamaniuk, OK				Kim, Sungjin; Selote, Devarshi S.; Vatamaniuk, Olena K.			The N-Terminal Extension Domain of the C. elegans Half-Molecule ABC Transporter, HMT-1, Is Required for Protein-Protein Interactions and Function	PLOS ONE			English	Article							MEMBRANE-SPANNING DOMAIN; CAENORHABDITIS-ELEGANS; HEAVY-METALS; BINDING; TRANSFORMATION; TRAFFICKING; TOLERANCE; SYSTEM; LOCALIZATION; SUPERFAMILY	Background: Members of the HMT-1 (heavy metal tolerance factor 1) subfamily of the ATP-binding cassette (ABC) transporter superfamily detoxify heavy metals and have unique topology: they are half-molecule ABC transporters that, in addition to a single transmembrane domain (TMD1) and a single nucleotide-binding domain (NBD1), possess a hydrophobic NH2-terminal extension (NTE). These structural features distinguish HMTs from other ABC transporters in different species including Drosophila and humans. Functional ABC transporters, however, are comprised of at least four-domains (two TMDs and two NDBs) formed from either a single polypeptide or by the association of two or four separate subunits. Whether HMTs act as oligomers and what role the NTE domain plays in their function have not been determined. Methodology/Principal Findings: In this study, we examined the oligomeric status of Caenorhabditis elegans HMT-1 and the functional significance of its NTE using gel-filtration chromatography in combination with the mating-based split-ubiquitin yeast two-hybrid system (mbSUS) and functional in vivo assays. We found that HMT-1 exists in a protein complex in C. elegans. Studies in S. cerevisiae showed that HMT-1 at a minimum homodimerizes and that oligomerization is essential for HMT-1 to confer cadmium tolerance. We also established that the NTE domain plays an important structural and functional role: it is essential for HMT-1 oligomerization and Cd-detoxification function. However, the NTE itself was not sufficient for oligomerization suggesting that multiple structural features of HMT-1 must associate to form a functional transporter. Conclusions: The prominence of heavy metals as environmental toxins and the remarkable conservation of HMT-1 structural architecture and function in different species reinforce the value of continued studies of HMT-1 in model systems for identifying functional domains in HMT1 of humans.	[Kim, Sungjin; Selote, Devarshi S.; Vatamaniuk, Olena K.] Cornell Univ, Dept Crop & Soil Sci, Ithaca, NY 14853 USA	Cornell University	Kim, S (corresponding author), Cornell Univ, Dept Crop & Soil Sci, Ithaca, NY 14853 USA.	okv2@cornell.edu	Selote, Devarshi/F-1560-2015		National Science Foundation (NSF) [MCB-0923731]	National Science Foundation (NSF)(National Science Foundation (NSF))	This work was funded by the National Science Foundation (NSF) MCB-0923731 grant awarded to O.K.V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele R, 2004, PHYSIOLOGY, V19, P216, DOI 10.1152/physiol.00002.2004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNER S, 1974, GENETICS, V77, P71; Chloupkova M, 2004, FEBS LETT, V569, P65, DOI 10.1016/j.febslet.2004.05.051; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; FIRE A, 1990, NUCLEIC ACIDS RES, V18, P4269, DOI 10.1093/nar/18.14.4269; GIETZ RD, 1991, YEAST, V7, P253, DOI 10.1002/yea.320070307; Graf GA, 2003, J BIOL CHEM, V278, P48275, DOI 10.1074/jbc.M310223200; Hanikenne M, 2001, FEMS MICROBIOL LETT, V196, P107; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Jalil YA, 2008, AM J PHYSIOL-CELL PH, V294, pC579, DOI 10.1152/ajpcell.00612.2006; Jones PM, 1999, FEMS MICROBIOL LETT, V179, P187, DOI 10.1111/j.1574-6968.1999.tb08727.x; Kittanakom S, 2009, METHODS MOL BIOL, V548, P247, DOI 10.1007/978-1-59745-540-4_14; Liu LX, 1999, J BIOL CHEM, V274, P32738, DOI 10.1074/jbc.274.46.32738; MADURO M, 1995, GENETICS, V141, P977; Mason DL, 2002, MOL BIOL CELL, V13, P4443, DOI 10.1091/mbc.E02-07-0405; Mello C, 1995, METHOD CELL BIOL, V48, P451; Obrdlik P, 2004, P NATL ACAD SCI USA, V101, P12242, DOI 10.1073/pnas.0404467101; ORTIZ DF, 1992, EMBO J, V11, P3491, DOI 10.1002/j.1460-2075.1992.tb05431.x; ORTIZ DF, 1995, J BIOL CHEM, V270, P4721, DOI 10.1074/jbc.270.9.4721; PARRY RV, 1989, J BIOL CHEM, V264, P20025; Paterson JK, 2007, BIOCHEMISTRY-US, V46, P9443, DOI 10.1021/bi700015m; Preveral S, 2009, J BIOL CHEM, V284, P4936, DOI 10.1074/jbc.M808130200; Ramjeesingh M, 1999, BIOCHEM J, V342, P119, DOI 10.1042/0264-6021:3420119; Rea PA, 2007, ANNU REV PLANT BIOL, V58, P347, DOI 10.1146/annurev.arplant.57.032905.105406; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Rieder S E, 2001, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0307s07; RUSS G, 1995, J BIOL CHEM, V270, P21312, DOI 10.1074/jbc.270.36.21312; Sanchez-Fernandez R, 2001, J BIOL CHEM, V276, P30231, DOI 10.1074/jbc.M103104200; Schwartz MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009564; Seddon AM, 2004, BBA-BIOMEMBRANES, V1666, P105, DOI 10.1016/j.bbamem.2004.04.011; Sooksa-Nguan T, 2009, J BIOL CHEM, V284, P354, DOI 10.1074/jbc.M806501200; Taylor JC, 2001, J BIOL CHEM, V276, P36075, DOI 10.1074/jbc.C100345200; Tian CX, 2010, DEVELOPMENT, V137, P2375, DOI 10.1242/dev.051615; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vatamaniuk OK, 2005, J BIOL CHEM, V280, P23684, DOI 10.1074/jbc.M503362200; Vatamaniuk OK, 1999, P NATL ACAD SCI USA, V96, P7110, DOI 10.1073/pnas.96.12.7110; Westlake CJ, 2005, MOL BIOL CELL, V16, P2483, DOI 10.1091/mbc.E04-12-1113; Xu JK, 2004, J BIOL CHEM, V279, P19781, DOI 10.1074/jbc.M310785200; Yang YY, 2007, J BIOL CHEM, V282, P8821, DOI 10.1074/jbc.M700152200	40	9	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12938	10.1371/journal.pone.0012938	http://dx.doi.org/10.1371/journal.pone.0012938			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886084	Green Submitted, Green Published, gold			2022-12-27	WOS:000282091100037
J	Varian, A; Nichols, KM				Varian, Anna; Nichols, Krista M.			Heritability of Morphology in Brook Trout with Variable Life Histories	PLOS ONE			English	Article							CHARR SALVELINUS-FONTINALIS; SALMON ONCORHYNCHUS-KISUTCH; JUVENILE COHO SALMON; LAKE-SUPERIOR; PHENOTYPIC PLASTICITY; ATLANTIC SALMON; CHINOOK SALMON; GENETIC ARCHITECTURE; ADAPTIVE RADIATION; SPECIES COMPLEX	Distinct morphological variation is often associated with variation in life histories within and among populations of both plants and animals. In this study, we examined the heritability of morphology in three hatchery strains of brook trout (Salvelinus fontinalis), which were historically or are currently used for stocking and supplementation of both migratory and resident ecotypes in the upper Great Lakes region. In a common garden experiment, significant variation in body morphology was observed within and across populations sampled at three time periods. The most notable differences among strains were differences in dorso-ventral body depth and the shape of the caudal peduncle, with some differences in the anterior-posterior placement of the dorsal and ventral fins. Variation with and among 70 half-sib families indicates that heritabilities of morphology and body size were significant at most developmental time points both within and across strains. Heritabilities for morphological characters within strains ranged from 0 to 0.95 across time points. Significant within-strain heritabilities for length ranged from 0 to 0.93 across time points and for weight ranged from 0 to 0.88. Significant additive genetic variation exists within and across hatchery brook trout strains for morphology and size, indicating that these traits are capable of responding to natural or artificial selection.	[Varian, Anna; Nichols, Krista M.] Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA; [Nichols, Krista M.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Varian, A (corresponding author), Minnesota Dept Nat Resources, Aitkan, MN USA.	kmnichol@purdue.edu			Purdue University Agriculture; United States Department of Agriculture-National Research Initiative (USDA-NRI) [2006-04796]	Purdue University Agriculture; United States Department of Agriculture-National Research Initiative (USDA-NRI)(United States Department of Agriculture (USDA))	This work was supported in part by a Purdue University Agriculture Research Program Fellowship and a grant from the United States Department of Agriculture-National Research Initiative (USDA-NRI) [grant number 2006-04796]. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson RC, 2008, COPEIA, P689, DOI 10.1643/CG-07-217; Alfonso NR, 2004, ENVIRON BIOL FISH, V71, P21, DOI 10.1023/B:EBFI.0000043176.61258.3d; Anderson Richard O., 1996, P447; BEEMAN JW, 1994, CAN J FISH AQUAT SCI, V51, P836, DOI 10.1139/f94-082; Bhagat Y, 2006, J FISH BIOL, V69, P79, DOI 10.1111/j.1095-8649.2006.01267.x; Birch JM, 1997, J MAMMAL, V78, P1187, DOI 10.2307/1383062; Boily P, 2002, J EXP BIOL, V205, P1031; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Carlson SM, 2008, EVOL APPL, V1, P222, DOI 10.1111/j.1752-4571.2008.00025.x; Chernoff E, 2007, J FISH BIOL, V70, P334, DOI 10.1111/j.1095-8649.2007.01328.x; CHEVERUD JM, 1983, GENET RES, V42, P65, DOI 10.1017/S0016672300021492; COOPER AM, 2009, CONSERVATION GENETIC; D'Amelio S, 2008, T AM FISH SOC, V137, P1213, DOI 10.1577/T05-275.1; Dahl J, 2006, ECOL FRESHW FISH, V15, P388, DOI 10.1111/j.1600-0633.2006.00150.x; Dickerson BR, 2005, T AM FISH SOC, V134, P1323, DOI 10.1577/T04-006.1; DuBois R.B., 1996, STATUS BROOK TROUT L; Dynes J, 1999, J FISH BIOL, V54, P955, DOI 10.1111/j.1095-8649.1999.tb00850.x; FLEMING IA, 1989, EVOLUTION, V43, P141, DOI 10.1111/j.1558-5646.1989.tb04213.x; FLICK WA, 1977, NAT CAN, V104, P353; Funk WC, 2005, J HERED, V96, P24, DOI 10.1093/jhered/esi009; Gilmour A. R., 2002, ASREML USER GUIDE RE; Hard JJ, 1999, J HERED, V90, P597, DOI 10.1093/jhered/90.6.597; Hawkins DK, 1996, CAN J FISH AQUAT SCI, V53, P1487, DOI 10.1139/cjfas-53-7-1487; Huckins CJ, 2008, T AM FISH SOC, V137, P1229, DOI 10.1577/T05-274.1; Hulsey CD, 2005, FUNCT ECOL, V19, P487, DOI 10.1111/j.1365-2435.2005.00987.x; Imre I, 2002, J FISH BIOL, V61, P1171, DOI 10.1006/jfbi.2002.2131; Keeley ER, 2005, CAN J FISH AQUAT SCI, V62, P1523, DOI 10.1139/F05-062; Kruuk LEB, 2004, PHILOS T R SOC B, V359, P873, DOI 10.1098/rstb.2003.1437; Langerhans RB, 2004, EVOLUTION, V58, P2305, DOI 10.1111/j.0014-3820.2004.tb01605.x; Letcher BH, 2003, OECOLOGIA, V137, P533, DOI 10.1007/s00442-003-1387-0; Lynch M., 1998, GENETICS ANAL QUANTI; MACCRIMM.HR, 1969, J FISH RES BOARD CAN, V26, P1699, DOI 10.1139/f69-159; Marcil J, 2006, BIOL J LINN SOC, V88, P351, DOI 10.1111/j.1095-8312.2006.00656.x; Moore SA, 2001, T AM FISH SOC, V130, P1233, DOI 10.1577/1548-8659(2001)130<1233:DOSMOL>2.0.CO;2; Morinville GR, 2008, ENVIRON BIOL FISH, V81, P171, DOI 10.1007/s10641-007-9186-9; Morinville GR, 2006, J ANIM ECOL, V75, P693, DOI 10.1111/j.1365-2656.2006.01090.x; Morinville GR, 2003, CAN J FISH AQUAT SCI, V60, P401, DOI [10.1139/f03-036, 10.1139/F03-036]; NEWMAN LE, 2003, GREAT LAKES FISHERIE; Nichols KM, 2008, GENETICS, V179, P1559, DOI 10.1534/genetics.107.084251; Nichols KM, 2007, GENETICS, V175, P335, DOI 10.1534/genetics.106.064311; NICIEZA AG, 1995, FUNCT ECOL, V9, P448, DOI 10.2307/2390008; Ohlberger J, 2006, J COMP PHYSIOL B, V176, P17, DOI 10.1007/s00360-005-0024-0; Ostbye K, 2006, MOL ECOL, V15, P3983, DOI 10.1111/j.1365-294X.2006.03062.x; Pakkasmaa S, 2001, BIOL J LINN SOC, V72, P231, DOI 10.1111/j.1095-8312.2001.tb01313.x; Parsons KJ, 2003, ENVIRON BIOL FISH, V67, P417, DOI 10.1023/A:1025895317253; Peres-Neto PR, 2004, OECOLOGIA, V140, P36, DOI 10.1007/s00442-004-1562-y; Perry GML, 2005, J EVOLUTION BIOL, V18, P1348, DOI 10.1111/j.1420-9101.2005.00954.x; Perry GML, 2004, EVOLUTION, V58, P2002, DOI 10.1111/j.0014-3820.2004.tb00485.x; Proulx R, 2004, EVOL ECOL RES, V6, P503; REIST JD, 1985, CAN J ZOOL, V63, P1429, DOI 10.1139/z85-213; RIDDELL BE, 1981, CAN J FISH AQUAT SCI, V38, P308, DOI 10.1139/f81-042; Rincon PA, 2007, OECOLOGIA, V152, P345, DOI 10.1007/s00442-006-0651-5; Robison BD, 1999, AQUACULTURE, V173, P131, DOI 10.1016/S0044-8486(98)00481-5; Rohlf F.J., 1993, CONTRIBUTIONS MORPHO; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; Rohlf FJ, 1999, J CLASSIF, V16, P197, DOI 10.1007/s003579900054; Rohlf FJ., 2006, TPSDIG DIGITIZE LAND; Rohlf FJ, 2007, TPSRELW RELATIVE WAR; SANDLUND OT, 1992, OIKOS, V64, P305, DOI 10.2307/3545056; SCHLUTER D, 1993, ECOLOGY, V74, P699, DOI 10.2307/1940797; SCHLUTER D, 1995, ECOLOGY, V76, P82, DOI 10.2307/1940633; Schreiner DR, 2008, N AM J FISH MANAGE, V28, P1350, DOI 10.1577/M05-173.1; Seiler SM, 2007, CAN J FISH AQUAT SCI, V64, P127, DOI 10.1139/F06-175; SO M, 2009, FISH STOCKING DATABA; Sutton TM, 2002, N AM J AQUACULT, V64, P188, DOI 10.1577/1548-8454(2002)064&lt;0188:HPAONA&gt;2.0.CO;2; Svanback R, 2002, OECOLOGIA, V131, P61, DOI 10.1007/s00442-001-0861-9; SWAIN DP, 1991, CAN J FISH AQUAT SCI, V48, P1783, DOI 10.1139/f91-210; SWAIN DP, 1989, CAN J FISH AQUAT SCI, V46, P1406, DOI 10.1139/f89-180; TAYLOR EB, 1986, PROG FISH CULT, V48, P171, DOI 10.1577/1548-8640(1986)48<171:DIMBWA>2.0.CO;2; Theriault V, 2007, J EVOLUTION BIOL, V20, P2266, DOI 10.1111/j.1420-9101.2007.01417.x; Theriault V, 2003, J FISH BIOL, V63, P1144, DOI 10.1046/j.1095-8649.2003.00233.x; Thrower FP, 2004, J FISH BIOL, V65, P286, DOI 10.1111/j.0022-1112.2004.00551.x; Vamosi SM, 2004, EVOLUTION, V58, P376, DOI 10.1111/j.0014-3820.2004.tb01653.x; Van Buskirk J, 2006, EVOLUTION, V60, P2428, DOI 10.1111/j.0014-3820.2006.tb01879.x; Van Offelen Henry K., 1993, North American Journal of Fisheries Management, V13, P86, DOI 10.1577/1548-8675(1993)013<0086:SGMADO>2.3.CO;2; WEBB PW, 1984, AM ZOOL, V24, P107; Wessel ML, 2006, T AM FISH SOC, V135, P333, DOI 10.1577/T04-078.1; WILAND L., 2006, COASTER CHALLENGE RE; WILLIS JH, 1993, EVOLUTION, V47, P949, DOI 10.1111/j.1558-5646.1993.tb01249.x; Wilson AJ, 2006, AM NAT, V167, pE23, DOI 10.1086/498138; WINANS GA, 1984, CAN J FISH AQUAT SCI, V41, P1150, DOI 10.1139/f84-136; Zimmerman MS, 2006, T AM FISH SOC, V135, P1056, DOI 10.1577/T05-237.1; [No title captured]	83	22	22	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12950	10.1371/journal.pone.0012950	http://dx.doi.org/10.1371/journal.pone.0012950			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886080	Green Published, Green Submitted, gold			2022-12-27	WOS:000282091100045
J	Garcia-Gonzalez, MA; Outeda, P; Zhou, Q; Zhou, F; Menezes, LF; Qian, F; Huso, DL; Germino, GG; Piontek, KB; Watnick, T				Garcia-Gonzalez, Miguel A.; Outeda, Patricia; Zhou, Qin; Zhou, Fang; Menezes, Luis F.; Qian, Feng; Huso, David L.; Germino, Gregory G.; Piontek, Klaus B.; Watnick, Terry			Pkd1 and Pkd2 Are Required for Normal Placental Development	PLOS ONE			English	Article							POLYCYSTIC KIDNEY-DISEASE; ENDOTHELIAL-CELLS; CYST FORMATION; IN-VIVO; MICE; MOUSE; EXPRESSION; DEFECTS; GENE; MUTATIONS	Background: Autosomal dominant polycystic kidney disease (ADPKD) is a common cause of inherited renal failure that results from mutations in PKD1 and PKD2. The disorder is characterized by focal cyst formation that involves somatic mutation of the wild type allele in a large fraction of cysts. Consistent with a two-hit mechanism, mice that are homozygous for inactivating mutations of either Pkd1 or Pkd2 develop cystic kidneys, edema and hemorrhage and typically die in midgestation. Cystic kidney disease is unlikely to be the cause of fetal loss since renal function is not required to complete gestation. One hypothesis is that embryonic demise is due to leaky vessels or cardiac pathology. Methodology/Principal Findings: In these studies we used a series of genetically modified Pkd1 and Pkd2 murine models to investigate the cause of embryonic lethality in mutant embryos. Since placental defects are a frequent cause of fetal loss, we conducted histopathologic analyses of placentas from Pkd1 null mice and detected abnormalities of the labyrinth layer beginning at E12.5. We performed placental rescue experiments using tetraploid aggregation and conditional inactivation of Pkd1 with the Meox2 Cre recombinase. We found that both strategies improved the viability of Pkd1 null embryos. Selective inactivation of Pkd1 and Pkd2 in endothelial cells resulted in polyhydramnios and abnormalities similar to those observed in Pkd1(-/-) placentas. However, endothelial cell specific deletion of Pkd1 or Pkd2 did not yield the dramatic vascular phenotypes observed in null animals. Conclusions/Significance: Placental abnormalities contribute to the fetal demise of Pkd(-/-) embryos. Endothelial cell specific deletion of Pkd1 or Pkd2 recapitulates a subset of findings seen in Pkd null animals. Our studies reveal a complex role for polycystins in maintaining vascular integrity.	[Garcia-Gonzalez, Miguel A.; Outeda, Patricia; Zhou, Qin; Zhou, Fang; Menezes, Luis F.; Qian, Feng; Germino, Gregory G.; Piontek, Klaus B.; Watnick, Terry] Johns Hopkins Univ, Sch Med, Dept Med, Div Nephrol, Baltimore, MD 21205 USA; [Huso, David L.] Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Garcia-Gonzalez, MA (corresponding author), Hosp Clin Univ Santiago, Inst Invest Sanitaria, Lab Nephrol 11, Genet & Dev Biol Renal Dis Lab, Santiago De Compostela, Galicia, Spain.	kpiontek@jhmi.edu; twatnick@jhmi.edu	Garcia-Gonzalez, Miguel A/G-6920-2011; Menezes, Luis Fernando/C-7286-2015; Gonzalez, Miguel Garcia/ABF-9880-2020	Gonzalez, Miguel Garcia/0000-0002-4330-7200; Germino, Gregory/0000-0002-3609-5588	NIH [DK48006, P50 DK57325, RR00171, DK076017]; Satellite Foundation; National Kidney Foundation of Maryland; European Molecular Biology Organization (EMBO) [ALTF99-2008]; Parga Pondal Xunta de Galicia; National Kidney Foundation fellowship award; NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR000171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076017, P50DK057325, ZIADK075042, R01DK048006, P30DK090868, R37DK048006] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Satellite Foundation; National Kidney Foundation of Maryland; European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Parga Pondal Xunta de Galicia(Xunta de Galicia); National Kidney Foundation fellowship award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the NIH: DK48006 and P50 DK57325 (GGG), RR00171 (DLH), DK076017 (TW), Satellite Foundation Research Award (TW), National Kidney Foundation of Maryland Professional Development Award (TW), European Molecular Biology Organization (EMBO) Fellowship, ALTF99-2008 (MAGG) and Parga Pondal Xunta de Galicia (MAGG). PO was supported by a National Kidney Foundation fellowship award. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	AbouAlaiwi WA, 2009, CIRC RES, V104, P860, DOI 10.1161/CIRCRESAHA.108.192765; AHRABI AK, NEPHROL DIAL TRANSPL, V25, P1067; Allen E, 2006, HUM MOL GENET, V15, P11, DOI 10.1093/hmg/ddi421; Allende ML, 2003, BLOOD, V102, P3665, DOI 10.1182/blood-2003-02-0460; BAERT L, 1978, KIDNEY INT, V13, P519, DOI 10.1038/ki.1978.75; Beall MH, 2007, PLACENTA, V28, P824, DOI 10.1016/j.placenta.2006.12.004; Bhunia AK, 2002, CELL, V109, P157, DOI 10.1016/S0092-8674(02)00716-X; Boletta A, 2000, MOL CELL, V6, P1267, DOI 10.1016/S1097-2765(00)00123-4; Boulter C, 2001, P NATL ACAD SCI USA, V98, P12174, DOI 10.1073/pnas.211191098; Cattelino A, 2003, J CELL BIOL, V162, P1111, DOI 10.1083/jcb.200212157; Fu JX, 2008, J CLIN INVEST, V118, P3725, DOI 10.1172/JCI36077; GABOW PA, 1993, NEW ENGL J MED, V329, P332, DOI 10.1056/NEJM199307293290508; GALLAGHER AR, ADV CHRONIC KIDNEY D, V17, P118; Gonzalez-Perrett S, 2001, P NATL ACAD SCI USA, V98, P1182, DOI 10.1073/pnas.021456598; Guay-Woodford LM, 2003, AM J PHYSIOL-RENAL, V285, pF1034, DOI 10.1152/ajprenal.00195.2003; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; JAMES RM, 1995, DEV BIOL, V167, P213, DOI 10.1006/dbio.1995.1018; Kim K, 2000, P NATL ACAD SCI USA, V97, P1731, DOI 10.1073/pnas.040550097; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Lu WN, 1997, NAT GENET, V17, P179, DOI 10.1038/ng1097-179; Lu WN, 1999, NAT GENET, V21, P160, DOI 10.1038/5944; Muto S, 2002, HUM MOL GENET, V11, P1731, DOI 10.1093/hmg/11.15.1731; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nauli SM, 2008, CIRCULATION, V117, P1161, DOI 10.1161/CIRCULATIONAHA.107.710111; Ohlsson R, 1999, DEV BIOL, V212, P124, DOI 10.1006/dbio.1999.9306; Ong ACM, 1999, AM J PATHOL, V154, P1721, DOI 10.1016/S0002-9440(10)65428-4; PARFREY PS, 1990, NEW ENGL J MED, V323, P1085, DOI 10.1056/NEJM199010183231601; Paterson AD, 2002, AM J KIDNEY DIS, V40, P16, DOI 10.1053/ajkd.2002.33908; Pei Y, 1999, J AM SOC NEPHROL, V10, P1524; Pennekamp P, 2002, CURR BIOL, V12, P938, DOI 10.1016/S0960-9822(02)00869-2; PETERS DJM, 1992, CONTRIB NEPHROL, V97, P128; Piontek KB, 2004, J AM SOC NEPHROL, V15, P3035, DOI 10.1097/01.ASN.0000144204.01352.86; Piontek K, 2007, NAT MED, V13, P1490, DOI 10.1038/nm1675; PIRSON Y, ADV CHRONIC KIDNEY D, V17, P173; Qian F, 1996, CELL, V87, P979, DOI 10.1016/S0092-8674(00)81793-6; Qian Q, 2003, J AM SOC NEPHROL, V14, P2280, DOI 10.1097/01.ASN.0000080185.38113.A3; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivasan RS, 2007, GENE DEV, V21, P2422, DOI 10.1101/gad.1588407; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Watnick T, 2000, NAT GENET, V25, P143, DOI 10.1038/75981; Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005; Wu GQ, 2000, NAT GENET, V24, P75, DOI 10.1038/71724; Wu GQ, 1998, CELL, V93, P177, DOI 10.1016/S0092-8674(00)81570-6; Yu SQ, 2007, P NATL ACAD SCI USA, V104, P18688, DOI 10.1073/pnas.0708217104; ZAMBONI L, 1981, ANAT REC, V201, P641, DOI 10.1002/ar.1092010408	47	51	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2010	5	9							e12821	10.1371/journal.pone.0012821	http://dx.doi.org/10.1371/journal.pone.0012821			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650QH	20862291	Green Published, gold			2022-12-27	WOS:000281864100028
J	Saragosti, E; Tchernov, D; Katsir, A; Shaked, Y				Saragosti, Eldad; Tchernov, Dan; Katsir, Adi; Shaked, Yeala			Extracellular Production and Degradation of Superoxide in the Coral Stylophora pistillata and Cultured Symbiodinium	PLOS ONE			English	Article							SYMBIOTIC SEA-ANEMONE; OXIDATIVE STRESS; THERMAL-STRESS; MOLECULAR CHARACTERIZATION; ANTHOPLEURA-ELEGANTISSIMA; ENDOSYMBIOTIC ALGAE; RADICAL PRODUCTION; AQUEOUS-SOLUTION; HEAT-STRESS; TEMPERATURE	Background: Reactive oxygen species (ROS) are thought to play a major role in cell death pathways and bleaching in scleractinian corals. Direct measurements of ROS in corals are conspicuously in short supply, partly due to inherent problems with ROS quantification in cellular systems. Methodology/Principal Findings: In this study we characterized the dynamics of the reactive oxygen species superoxide anion radical (O(2)(-)) in the external milieu of the coral Stylophora pistillata. Using a sensitive, rapid and selective chemiluminesence-based technique, we measured extracellular superoxide production and detoxification activity of symbiont (non-bleached) and aposymbiont (bleached) corals, and of cultured Symbiodinium (from clades A and C). Bleached and non-bleached Stylophora fragments were found to produce superoxide at comparable rates of 10(-11) -10(-9) mol O(2)(-) mg protein(-1) min(-1) in the dark. In the light, a two-fold enhancement in O(2)(-) production rates was observed in non-bleached corals, but not in bleached corals. Cultured Symbiodinium produced superoxide in the dark at a rate of 10(-18)-10(-16) mol O(2)(-) cell(-1) min(-1). Light was found to markedly enhance O(2)(-) production. The NADPH Oxidase inhibitor Diphenyleneiodonium chloride (DPI) strongly inhibited O(2)(-) production by corals (and more moderately by algae), possibly suggesting an involvement of NADPH Oxidase in the process. An extracellular O(2)(-) detoxifying activity was found for bleached and non-bleached Stylophora but not for Symbiodinium. The O(2)(-)detoxifying activity was partially characterized and found to resemble that of the enzyme superoxide dismutase (SOD). Conclusions/Significance: The findings of substantial extracellular O(2)(-) production as well as extracellular O(2)(-) detoxifying activity may shed light on the chemical interactions between the symbiont and its host and between the coral and its environment. Superoxide production by Symbiodinium possibly implies that algal bearing corals are more susceptible to an internal build-up of O(2)(-), which may in turn be linked to oxidative stress mediated bleaching.	[Saragosti, Eldad; Tchernov, Dan; Shaked, Yeala] Interuniv Inst Marine Sci, Elat, Israel; [Saragosti, Eldad; Tchernov, Dan] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Evolut Systemat & Ecol, Elat, Israel; [Katsir, Adi] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Shaked, Yeala] Hebrew Univ Jerusalem, Fredy & Nadine Herrmann Inst Earth Sci, Elat, Israel	Hebrew University of Jerusalem; Ben Gurion University; Hebrew University of Jerusalem	Saragosti, E (corresponding author), Interuniv Inst Marine Sci, Elat, Israel.	yshaked@vms.huji.ac.il	Shaked, Yeala/AAH-7956-2021; Tchernov, Dan/AAE-2545-2021	Tchernov, Dan/0000-0003-1135-8270; Shaked, Yeala/0000-0002-7831-8313	Israel Science Foundation [933/07, 981/05]; Moshe Shilo Minerva Center for Marine Biogeochemistry	Israel Science Foundation(Israel Science Foundation); Moshe Shilo Minerva Center for Marine Biogeochemistry	This work was supported in part by the Israel Science Foundation grant 933/07 and 981/05 (www.isf.org.il), and the Moshe Shilo Minerva Center for Marine Biogeochemistry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banin E, 2003, CURR MICROBIOL, V46, P418, DOI 10.1007/s00284-002-3912-5; Bartosz G, 2006, CLIN CHIM ACTA, V368, P53, DOI 10.1016/j.cca.2005.12.039; BIELSKI BHJ, 1985, J PHYS CHEM REF DATA, V14, P1041, DOI 10.1063/1.555739; BIELSKI BHJ, 1978, PHOTOCHEM PHOTOBIOL, V28, P645, DOI 10.1111/j.1751-1097.1978.tb06986.x; Bonini MG, 2006, FREE RADICAL BIO MED, V40, P968, DOI 10.1016/j.freeradbiomed.2005.10.042; Bou-Abdallah F, 2006, BBA-GEN SUBJECTS, V1760, P1690, DOI 10.1016/j.bbagen.2006.08.014; Brown BE, 2002, MAR ECOL PROG SER, V242, P119, DOI 10.3354/meps242119; BYCZKOWSKI JZ, 1988, INT J BIOCHEM, V20, P569, DOI 10.1016/0020-711X(88)90095-X; Chignell CF, 2003, FREE RADICAL BIO MED, V34, P1029, DOI 10.1016/S0891-5849(03)00022-4; Dash B, 2007, GENE, V387, P93, DOI 10.1016/j.gene.2006.08.020; Downs CA, 2000, MAR BIOTECHNOL, V2, P533, DOI 10.1007/s101260000038; DUNLAP WC, 1995, COMP BIOCHEM PHYS B, V112, P105, DOI 10.1016/0305-0491(95)00086-N; Dunn SR, 2004, CELL DEATH DIFFER, V11, P1213, DOI 10.1038/sj.cdd.4401484; DYKENS JA, 1992, J EXP BIOL, V168, P219; Fattman CL, 2003, FREE RADICAL BIO MED, V35, P236, DOI 10.1016/S0891-5849(03)00275-2; Fitt WK, 2009, J EXP MAR BIOL ECOL, V373, P102, DOI 10.1016/j.jembe.2009.03.011; Flores-Ramirez LA, 2007, COMP BIOCHEM PHYS C, V146, P194, DOI 10.1016/j.cbpc.2006.09.008; FRIDOVICH I, 1983, ANNU REV PHARMACOL, V23, P239, DOI 10.1146/annurev.pa.23.040183.001323; Glynn PW, 1996, GLOBAL CHANGE BIOL, V2, P495, DOI 10.1111/j.1365-2486.1996.tb00063.x; Goldstone JV, 2000, ENVIRON SCI TECHNOL, V34, P1043, DOI 10.1021/es9905445; Heyno E, 2008, NEW PHYTOL, V179, P687, DOI 10.1111/j.1469-8137.2008.02512.x; HOEGHGULDBERG O, 1989, J EXP MAR BIOL ECOL, V129, P279, DOI 10.1016/0022-0981(89)90109-3; JAMIESON D, 1986, ANNU REV PHYSIOL, V48, P703, DOI 10.1146/annurev.ph.48.030186.003415; Kustka AB, 2005, LIMNOL OCEANOGR, V50, P1172, DOI 10.4319/lo.2005.50.4.1172; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; Lesser MP, 2004, CORAL REEFS, V23, P367, DOI 10.1007/s00338-004-0392-z; Lesser MP, 1996, LIMNOL OCEANOGR, V41, P271, DOI 10.4319/lo.1996.41.2.0271; Marshall JA, 2005, MAR BIOL, V147, P533, DOI 10.1007/s00227-005-1596-7; MCDOWELL MS, 1983, INORG CHEM, V22, P847, DOI 10.1021/ic00147a033; Milne A, 2009, LIMNOL OCEANOGR-METH, V7, P706, DOI 10.4319/lom.2009.7.706; Munn CB, 2008, FEMS MICROBIOL LETT, V281, P58, DOI 10.1111/j.1574-6968.2008.01073.x; Murata N, 2007, BBA-BIOENERGETICS, V1767, P414, DOI 10.1016/j.bbabio.2006.11.019; Nii CM, 1997, BIOL BULL, V192, P444, DOI 10.2307/1542753; Plantivaux A, 2004, FREE RADICAL BIO MED, V37, P1170, DOI 10.1016/j.freeradbiomed.2004.06.043; PORTER JW, 1984, PROC R SOC SER B-BIO, V222, P161, DOI 10.1098/rspb.1984.0057; Raina JB, 2010, TRENDS MICROBIOL, V18, P101, DOI 10.1016/j.tim.2009.12.002; Richier S, 2006, FEBS J, V273, P4186, DOI 10.1111/j.1742-4658.2006.05414.x; Richier S, 2008, COMP BIOCHEM PHYS D, V3, P283, DOI 10.1016/j.cbd.2008.08.001; Rose AL, 2008, ENVIRON SCI TECHNOL, V42, P2387, DOI 10.1021/es7024609; Rose AL, 2008, ANAL CHEM, V80, P1215, DOI 10.1021/ac7018975; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; RUSH JD, 1985, J PHYS CHEM-US, V89, P5062, DOI 10.1021/j100269a035; Sandeman I. M, 2006, Rev. biol. trop, V54, P79; Shaked Y, 2010, ENVIRON SCI TECHNOL, V44, P3238, DOI 10.1021/es902343y; Smith DJ, 2005, GLOBAL CHANGE BIOL, V11, P1, DOI 10.1111/j.1529-8817.2003.00895.x; Suggett DJ, 2008, J PHYCOL, V44, P948, DOI 10.1111/j.1529-8817.2008.00537.x; Sumimoto H, 2008, FEBS J, V275, P3984; Sunda W, 2002, NATURE, V418, P317, DOI 10.1038/nature00851; Tchernov D, 2004, P NATL ACAD SCI USA, V101, P13531, DOI 10.1073/pnas.0402907101; Wegley L, 2007, ENVIRON MICROBIOL, V9, P2707, DOI 10.1111/j.1462-2920.2007.01383.x; Weis VM, 2008, J EXP BIOL, V211, P3059, DOI 10.1242/jeb.009597; Whitehead K, 2005, J PHOTOCH PHOTOBIO B, V80, P115, DOI 10.1016/j.jphotobiol.2005.03.008; Winters G, 2009, MAR ECOL PROG SER, V384, P107, DOI 10.3354/meps08036	53	80	80	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2010	5	9							e12508	10.1371/journal.pone.0012508	http://dx.doi.org/10.1371/journal.pone.0012508			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZO	20856857	Green Submitted, Green Published, gold			2022-12-27	WOS:000281815700004
J	Milano, F; Guarriera, M; Rygiel, AM; Krishnadath, KK				Milano, Francesca; Guarriera, Mirta; Rygiel, Agnieszka M.; Krishnadath, Kausilia K.			Trastuzumab Mediated T-Cell Response against HER-2/Neu Overexpressing Esophageal Adenocarcinoma Depends on Intact Antigen Processing Machinery	PLOS ONE			English	Article							METASTATIC BREAST-CANCER; IN-VITRO; MONOCLONAL-ANTIBODY; CERVICAL-CARCINOMA; DENDRITIC CELLS; GASTRIC-CANCER; TUMOR-CELLS; CYTOTOXICITY; COMPONENTS; EXPRESSION	Background: Esophageal adenocarcinoma (EAC) is a highly aggressive disease with poor prognosis, which frequently exhibits HER-2 gene amplification. Trastuzumab, the humanized antibody against HER-2, has potent growth inhibitory effects on HER-2 overexpressing cancers. One effect of trastuzumab is that it causes HER-2 receptor internalization and degradation, enhancing presentation of HER-2 epitopes on MHC-Class I molecules. This enhances the ability of HER-2 specific cytotoxic T lymphocytes (CTLs) to recognize and kill cancer cells. Novel strategies targeting the HER-2 receptor either directly by trastuzumab and/or indirectly by inducing a CTL response against HER-2 epitopes with, for instance, DC immunotherapy and consequently combining these strategies might prove to be very effective. Methodology/Principal Findings: In this study we report that trastuzumab has potent growth inhibitory effects on two HER-2 overexpressing EAC cell lines OE33 and OE19. However, we found that trastuzumab and HER-2 specific CTLs act synergistically in inducing tumor lysis in OE33 but not in OE19. We discovered that in OE19 this deficient response is due to a down-regulation of the Transporter Associated with Antigen Processing-2 (TAP-2). TAP-2 is an important member of the Antigen Processing Machinery (APM), and is one of the essential elements for loading antigens on MHC class I molecules. Importantly, we demonstrated that by inducing re-expression of TAP-2 in OE19 with INF-gamma treatment or by incubating the cells with INF-gamma producing CTLs, the specific anti HER-2 CTL tumor lysis response and synergistic effect with trastuzumab can be restored. Conclusion: An inefficient response of HER-2 overexpressing EAC to trastuzumab and/or DC immunotherapy can be due to a down-regulated TAP-2 expression and thus a deficient APM. Future studies combining trastuzumab with IFN-gamma and/or immune-therapies inducing potent anti HER-2 CTL responses could lead to an effective combinatorial strategy for successful treatment of HER-2 overexpressing but APM defective cancers.	[Milano, Francesca; Guarriera, Mirta; Rygiel, Agnieszka M.; Krishnadath, Kausilia K.] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands; [Milano, Francesca; Rygiel, Agnieszka M.; Krishnadath, Kausilia K.] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Milano, F (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	F.Milano@amc.uva.nl; K.K.Krishnadath@amc.uva.nl	Milano, Francesca/AAJ-7120-2021	Milano, Francesca/0000-0001-7579-6769; Rygiel, Agnieszka/0000-0002-3838-2900	Academic Medical Center, Amsterdam, The Netherlands	Academic Medical Center, Amsterdam, The Netherlands(Netherlands Government)	Academic Medical Center, Amsterdam, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxevanis CN, 2006, CANCER IMMUNOL IMMUN, V55, P85, DOI 10.1007/s00262-005-0692-3; BOONSTRA JJ, J NATL CANC I, V102, P271; Bosset JF, 1997, NEW ENGL J MED, V337, P161, DOI 10.1056/NEJM199707173370304; Bubenik J, 2004, INT J ONCOL, V25, P487; Clemenceau B, 2006, J IMMUNOTHER, V29, P53; Dahlberg PS, 2004, ANN THORAC SURG, V78, P1790, DOI 10.1016/j.athoracsur.2004.05.037; Donington JS, 2004, ANN THORAC SURG, V77, P1193, DOI 10.1016/j.athoracsur.2003.09.029; Gamliel Z, 2000, Chest Surg Clin N Am, V10, P441; Geddert H, 2002, AM J CLIN PATHOL, V118, P60; Gritzapis AD, 2006, CANCER RES, V66, P5452, DOI 10.1158/0008-5472.CAN-05-4018; Hung MC, 1999, SEMIN ONCOL, V26, P51; HURWITZ E, 1995, P NATL ACAD SCI USA, V92, P3353, DOI 10.1073/pnas.92.8.3353; Kimura K, 2006, CLIN CANCER RES, V12, P4925, DOI 10.1158/1078-0432.CCR-06-0544; Kono K, 2002, CANCER RES, V62, P5813; Kono K, 2004, CLIN CANCER RES, V10, P2538, DOI 10.1158/1078-0432.CCR-03-0424; Kono K, 2002, CLIN CANCER RES, V8, P3394; Leyland-Jones B, 2002, LANCET ONCOL, V3, P137, DOI 10.1016/S1470-2045(02)00676-9; Lopez-Albaitero A, 2006, J IMMUNOL, V176, P3402, DOI 10.4049/jimmunol.176.6.3402; Mehta AM, 2008, CANCER IMMUNOL IMMUN, V57, P197, DOI 10.1007/s00262-007-0362-8; Meissner M, 2005, CLIN CANCER RES, V11, P2552, DOI 10.1158/1078-0432.CCR-04-2146; Milano F, 2007, J IMMUNOL METHODS, V321, P94, DOI 10.1016/j.jim.2007.01.004; Milano F, 2007, CANCER IMMUNOL IMMUN, V56, P1967, DOI 10.1007/s00262-007-0341-0; Mimura K, 2005, CLIN CANCER RES, V11, P4898, DOI 10.1158/1078-0432.CCR-04-2476; Muller MR, 2003, CLIN CANCER RES, V9, P3448; Murray JL, 2002, CLIN CANCER RES, V8, P3407; Pera M, 2003, WORLD J SURG, V27, P999, DOI 10.1007/s00268-003-7052-2; Perez SA, 2002, CANCER IMMUNOL IMMUN, V50, P615, DOI 10.1007/s002620100225; Reichelt U, 2007, MODERN PATHOL, V20, P120, DOI 10.1038/modpathol.3800712; Ritz U, 2001, INT J ONCOL, V19, P1211; Rygiel AM, 2007, CANCER-AM CANCER SOC, V109, P1980, DOI 10.1002/cncr.22643; Safran H, 2007, INT J RADIAT ONCOL, V67, P405, DOI 10.1016/j.ijrobp.2006.08.076; Seliger B, 2001, CANCER RES, V61, P8647; Seliger B, 2008, CANCER IMMUNOL IMMUN, V57, P1719, DOI 10.1007/s00262-008-0515-4; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Tripathy D, 2004, J CLIN ONCOL, V22, P1063, DOI 10.1200/JCO.2004.06.557; Walch A, 2000, ANAL CELL PATHOL, V20, P25, DOI 10.1155/2000/947249; Wu AH, 2004, J NEURO-ONCOL, V66, P1, DOI 10.1023/B:NEON.0000013460.53527.28; YAMANAKA Y, 1993, HUM PATHOL, V24, P1127, DOI 10.1016/0046-8177(93)90194-L; zum Buschenfelde CM, 2002, CANCER RES, V62, P2244	39	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12424	10.1371/journal.pone.0012424	http://dx.doi.org/10.1371/journal.pone.0012424			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865050	gold, Green Published, Green Submitted			2022-12-27	WOS:000281292100019
J	Suzuki, K; Takigawa, W; Tanigawa, K; Nakamura, K; Ishido, Y; Kawashima, A; Wu, H; Akama, T; Sue, M; Yoshihara, A; Mori, S; Ishii, N				Suzuki, Koichi; Takigawa, Wataru; Tanigawa, Kazunari; Nakamura, Kazuaki; Ishido, Yuko; Kawashima, Akira; Wu, Huhehasi; Akama, Takeshi; Sue, Mariko; Yoshihara, Aya; Mori, Shuichi; Ishii, Norihisa			Detection of Mycobacterium leprae DNA from Archaeological Skeletal Remains in Japan Using Whole Genome Amplification and Polymerase Chain Reaction	PLOS ONE			English	Article							LEPROSY; EXPRESSION; PSEUDOGENES	Background: Identification of pathogen DNA from archaeological human remains is a powerful tool in demonstrating that the infectious disease existed in the past. However, it is very difficult to detect trace amounts of DNA remnants attached to the human skeleton, especially from those buried in a humid atmosphere with a relatively high environmental temperature such as in Asia. Methodology/Principal Findings: Here we demonstrate Mycobacterium leprae DNA from archaeological skeletal remains in Japan by polymerase chain reaction, DNA sequencing and single nucleotide polymorphism (SNP) analysis. In addition, we have established a highly sensitive method of detecting DNA using a combination of whole genome amplification and polymerase chain reaction, or WGA-PCR, which provides superior sensitivity and specificity in detecting DNA from trace amounts of skeletal materials. Conclusion/Significance: We have detected M. leprae DNA in archaeological skeletal remains for the first time in the Far East. Its SNP genotype corresponded to type 1; the first detected case worldwide of ancient M. leprae DNA. We also developed a highly sensitive method to detect ancient DNA by utilizing whole genome amplification.	[Suzuki, Koichi; Tanigawa, Kazunari; Ishido, Yuko; Kawashima, Akira; Wu, Huhehasi; Akama, Takeshi; Sue, Mariko; Yoshihara, Aya] Natl Inst Infect Dis, Leprosy Res Ctr, Dept Mycobacteriol, Lab Mol Diagnost, Tokyo, Japan; [Takigawa, Wataru] Int Univ Hlth & Welf, Sch Rehabil Sci Fukuoka, Fukuoka, Japan; [Nakamura, Kazuaki] Natl Res Inst Child Hlth & Dev, Dept Pharmacol, Tokyo, Japan; [Mori, Shuichi] Natl Inst Infect Dis, Leprosy Res Ctr, Lab Mol Epidemiol & Social Sci, Tokyo, Japan	National Institute of Infectious Diseases (NIID); International University of Health & Welfare; National Center for Child Health & Development - Japan; National Institute of Infectious Diseases (NIID)	Suzuki, K (corresponding author), Natl Inst Infect Dis, Leprosy Res Ctr, Dept Mycobacteriol, Lab Mol Diagnost, Tokyo, Japan.	koichis@nih.go.jp	Akama, Takeshi/C-9392-2011; Suzuki, Koichi/C-4177-2013	Akama, Takeshi/0000-0002-6470-7174; Suzuki, Koichi/0000-0001-8659-4660	Ministry of Health, Labour, and Welfare of Japan	Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Grant-in-Aid for Research on Emerging and Re-emerging Infectious Diseases from the Ministry of Health, Labour, and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akama T, 2009, J BACTERIOL, V191, P3321, DOI 10.1128/JB.00120-09; Aufderheide A. C., 1998, HUMAN PALEOPATHOLOGY; Barker DL, 2004, GENOME RES, V14, P901, DOI 10.1101/gr.1949704; Blau S, 2005, AM J PHYS ANTHROPOL, V126, P150, DOI 10.1002/ajpa.20121; Boldsen JL, 2008, AM J PHYS ANTHROPOL, V135, P301, DOI 10.1002/ajpa.20744; Boldsen JL, 2006, AM J PHYS ANTHROPOL, V130, P344, DOI 10.1002/ajpa.20363; Carpintero P, 1998, Acta Leprol, V11, P21; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; COUTELIER L, 1971, J LEPR OTHER MYCOBAC, V39, P231; Donoghue H. D., 2002, PRESENT LEPROSY ARCH, V1054, P271; Donoghue HD, 2005, P ROY SOC B-BIOL SCI, V272, P389, DOI 10.1098/rspb.2004.2966; Drancourt M, 2005, NAT REV MICROBIOL, V3, P23, DOI 10.1038/nrmicro1063; Haas CJ, 2000, AM J CLIN PATHOL, V114, P428, DOI 10.1093/ajcp/114.3.428; Likovsky J, 2006, J ARCHAEOL SCI, V33, P1276, DOI 10.1016/j.jas.2006.01.001; Monot M, 2005, SCIENCE, V308, P1040, DOI 10.1126/science/1109759; Monot M, 2009, NAT GENET, V41, P1282, DOI 10.1038/ng.477; Montiel R, 2003, FEMS MICROBIOL LETT, V226, P413, DOI 10.1016/S0378-1097(03)00617-7; Nakamura K, 2009, MICROB PATHOGENESIS, V47, P183, DOI 10.1016/j.micpath.2009.06.006; Ortner D. J., 2003, IDENTIFICATION PATHO, DOI DOI 10.1016/B978-012528628-2/50057-0; RAFI A, 1994, LANCET, V343, P1360, DOI 10.1016/S0140-6736(94)92494-5; ROBBINS G, 2009, AM J PHYS ANTHROPOL, V125, P239; Roberts C., 2007, ARCHAEOLOGY DIS; Soysal A, 2004, CAN J NEUROL SCI, V31, P357, DOI 10.1017/S0317167100003449; SPIGELMAN M, 1993, INT J OSTEOARCHAEOL, V3, P143; SUZUKI K, 2010, J CLIN MICROBIO 0714; Suzuki K, 2006, FEMS MICROBIOL LETT, V259, P208, DOI 10.1111/j.1574-6968.2006.00276.x; TAKIGAWA W, 2002, ED BOARD AOMORI PREF, P254; Tanigawa K, 2008, FEMS MICROBIOL LETT, V289, P72, DOI 10.1111/j.1574-6968.2008.01369.x; Taylor GM, 2006, J ARCHAEOL SCI, V33, P1569, DOI 10.1016/j.jas.2006.02.008; Taylor GM, 2000, J ARCHAEOL SCI, V27, P1133, DOI 10.1006/jasc.1999.0532; Watson CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007547	31	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12422	10.1371/journal.pone.0012422	http://dx.doi.org/10.1371/journal.pone.0012422			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865042	Green Published, Green Submitted, gold			2022-12-27	WOS:000281292100018
J	Yeoman, CJ; Yildirim, S; Thomas, SM; Durkin, AS; Torralba, M; Sutton, G; Buhay, CJ; Ding, Y; Dugan-Rocha, SP; Muzny, DM; Qin, XA; Gibbs, RA; Leigh, SR; Stumpf, R; White, BA; Highlander, SK; Nelson, KE; Wilson, BA				Yeoman, Carl J.; Yildirim, Suleyman; Thomas, Susan M.; Durkin, A. Scott; Torralba, Manolito; Sutton, Granger; Buhay, Christian J.; Ding, Yan; Dugan-Rocha, Shannon P.; Muzny, Donna M.; Qin, Xiang; Gibbs, Richard A.; Leigh, Steven R.; Stumpf, Rebecca; White, Bryan A.; Highlander, Sarah K.; Nelson, Karen E.; Wilson, Brenda A.			Comparative Genomics of Gardnerella vaginalis Strains Reveals Substantial Differences in Metabolic and Virulence Potential	PLOS ONE			English	Article							BACTERIAL-VAGINOSIS; SIALIDASE ACTIVITY; RESISTANCE; GENE; IDENTIFICATION; ANNOTATION; PROTEIN; VAGINOLYSIN; INFECTION; PROGRAM	Background: Gardnerella vaginalis is described as a common vaginal bacterial species whose presence correlates strongly with bacterial vaginosis (BV). Here we report the genome sequencing and comparative analyses of three strains of G. vaginalis. Strains 317 (ATCC 14019) and 594 (ATCC 14018) were isolated from the vaginal tracts of women with symptomatic BV, while Strain 409-05 was isolated from a healthy, asymptomatic individual with a Nugent score of 9. Principal Findings: Substantial genomic rearrangement and heterogeneity were observed that appeared to have resulted from both mobile elements and substantial lateral gene transfer. These genomic differences translated to differences in metabolic potential. All strains are equipped with significant virulence potential, including genes encoding the previously described vaginolysin, pili for cytoadhesion, EPS biosynthetic genes for biofilm formation, and antimicrobial resistance systems, We also observed systems promoting multi-drug and lantibiotic extrusion. All G. vaginalis strains possess a large number of genes that may enhance their ability to compete with and exclude other vaginal colonists. These include up to six toxin-antitoxin systems and up to nine additional antitoxins lacking cognate toxins, several of which are clustered within each genome. All strains encode bacteriocidal toxins, including two lysozyme-like toxins produced uniquely by strain 409-05. Interestingly, the BV isolates encode numerous proteins not found in strain 409-05 that likely increase their pathogenic potential. These include enzymes enabling mucin degradation, a trait previously described to strongly correlate with BV, although commonly attributed to non-G. vaginalis species. Conclusions: Collectively, our results indicate that all three strains are able to thrive in vaginal environments, and therein the BV isolates are capable of occupying a niche that is unique from 409-05. Each strain has significant virulence potential, although genomic and metabolic differences, such as the ability to degrade mucin, indicate that the detection of G. vaginalis in the vaginal tract provides only partial information on the physiological potential of the organism.	[Yeoman, Carl J.; Yildirim, Suleyman; Thomas, Susan M.; White, Bryan A.; Wilson, Brenda A.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Durkin, A. Scott; Torralba, Manolito; Sutton, Granger; Nelson, Karen E.] J Craig Venter Inst, Rockville, MD USA; [Buhay, Christian J.; Ding, Yan; Dugan-Rocha, Shannon P.; Muzny, Donna M.; Qin, Xiang; Gibbs, Richard A.; Highlander, Sarah K.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Leigh, Steven R.; Stumpf, Rebecca] Univ Illinois, Dept Anthropol, Urbana, IL 61801 USA; [White, Bryan A.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Highlander, Sarah K.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Wilson, Brenda A.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; J. Craig Venter Institute; Baylor College of Medicine; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Baylor College of Medicine; University of Illinois System; University of Illinois Urbana-Champaign	Yeoman, CJ (corresponding author), Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.	bawilson@life.illinois.edu	Yeoman, Carl/ABA-1906-2021	Yeoman, Carl/0000-0002-8775-7879; Yildirim, Suleyman/0000-0002-2752-1223; Highlander, Sarah/0000-0002-3800-4950; LEIGH, STEVEN/0000-0001-6844-7122	National Institutes of Health [N01 AI 30071, U54-AI084844]; Baylor College of Medicine [U54-HG003273, U54-HG004973]; Institute for Genomic Biology; Research Board of the University of Illinois at Urbana-Champaign; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273, U54HG004973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI084844] Funding Source: NIH RePORTER; Division Of Behavioral and Cognitive Sci [0820709] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baylor College of Medicine; Institute for Genomic Biology; Research Board of the University of Illinois at Urbana-Champaign; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	We would like to acknowledge and thank the National Institutes of Health for funding this project to The J. Craig Venter Institute (N01 AI 30071; U54-AI084844) and Baylor College of Medicine (U54-HG003273; U54-HG004973). The authors also wish to acknowledge the support of the Institute for Genomic Biology and the Research Board of the University of Illinois at Urbana-Champaign. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aoki-Kinoshita Kiyoko F., 2007, V396, P71; Benson DA, 1997, NUCLEIC ACIDS RES, V25, P1, DOI 10.1093/nar/25.1.1; BERGERBACHI B, 1989, MOL GEN GENET, V219, P263; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Cauci S, 1998, AM J OBSTET GYNECOL, V178, P511, DOI 10.1016/S0002-9378(98)70430-2; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; Davis JJ, 2010, MOL BIOL EVOL, V27, P800, DOI 10.1093/molbev/msp281; DAVIS JJ, MOL BIOL EV IN PRESS; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; FOSTER TJ, 1983, MICROBIOL REV, V47, P361, DOI 10.1128/MMBR.47.3.361-409.1983; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Friedrich A, 2001, APPL ENVIRON MICROB, V67, P3140, DOI 10.1128/AEM.67.7.3140-3148.2001; Gao BL, 2005, INT J SYST EVOL MICR, V55, P2401, DOI 10.1099/ijs.0.63785-0; GARDNER HL, 1955, AM J OBSTET GYNECOL, V69, P962, DOI 10.1016/0002-9378(55)90095-8; Gelber SE, 2008, J BACTERIOL, V190, P3896, DOI 10.1128/JB.01965-07; Graham S, 2009, J MED MICROBIOL, V58, P1382, DOI 10.1099/jmm.0.007781-0; Hallin PF, 2009, STAND GENOMIC SCI, V1, P204, DOI 10.4056/sigs.28177; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; HARPER JJ, 1982, INT J SYST BACTERIOL, V32, P48, DOI 10.1099/00207713-32-1-48; HESS J, 1995, INFECT IMMUN, V63, P2047, DOI 10.1128/IAI.63.5.2047-2053.1995; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Horgan M, 2009, APPL ENVIRON MICROB, V75, P872, DOI 10.1128/AEM.01831-08; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Hyman RW, 2005, P NATL ACAD SCI USA, V102, P7952, DOI 10.1073/pnas.0503236102; Jarosik GP, 1998, INFECT IMMUN, V66, P5041, DOI 10.1128/IAI.66.10.5041-5047.1998; Johansson MU, 1997, J MOL BIOL, V266, P859, DOI 10.1006/jmbi.1996.0856; Kim TK, 2009, J CLIN MICROBIOL, V47, P1181, DOI 10.1128/JCM.00854-08; KJOS M, 2010, J BACTERIOL IN PRESS; Kramer N, 2007, MOL MICROBIOL, V65, P454, DOI 10.1111/j.1365-2958.2007.05799.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Letunic I, 2008, TRENDS BIOCHEM SCI, V33, P101, DOI 10.1016/j.tibs.2008.01.001; Lim D, 1994, DNA Res, V1, P115, DOI 10.1093/dnares/1.3.115; Lindahl G, 2005, CLIN MICROBIOL REV, V18, P102, DOI 10.1128/CMR.18.1.102-127.2005; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mania-Pramanik J, 2009, INT J STD AIDS, V20, P778, DOI 10.1258/ijsa.2009.009193; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Menard JP, 2010, OBSTET GYNECOL, V115, P134, DOI 10.1097/AOG.0b013e3181c391d7; Miller JR, 2008, BIOINFORMATICS, V24, P2818, DOI 10.1093/bioinformatics/btn548; Neri P, 2009, OCUL IMMUNOL INFLAMM, V17, P36, DOI 10.1080/09273940802491876; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Okazaki A, 2007, ANTIMICROB AGENTS CH, V51, P359, DOI 10.1128/AAC.00795-06; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Patterson JL, 2010, MICROBIOL-SGM, V156, P392, DOI 10.1099/mic.0.034280-0; Peterson S, 2000, J BACTERIOL, V182, P6192, DOI 10.1128/JB.182.21.6192-6202.2000; PIACENZA L, 2008, BIOCHEM J, V1, P359; PUNSALANG AP, 1973, INFECT IMMUN, V8, P255, DOI 10.1128/IAI.8.2.255-263.1973; Rajan N, 1999, INFECT IMMUN, V67, P5027, DOI 10.1128/IAI.67.10.5027-5032.1999; Roberton AM, 2005, J CLIN MICROBIOL, V43, P5504, DOI 10.1128/JCM.43.11.5504-5508.2005; Roe VA, 2008, J MIDWIFERY WOM HEAL, V53, P216, DOI 10.1016/j.jmwh.2008.01.003; ROTTINI G, 1990, INFECT IMMUN, V58, P3751, DOI 10.1128/IAI.58.11.3751-3758.1990; SASHINAMI H, 2010, FEMS IMMUN IN PRESS; Schmid G, 2000, SEX TRANSM INFECT, V76, P3, DOI 10.1136/sti.76.1.3; SCHMIDT M, 1994, FEBS LETT, V356, P238, DOI 10.1016/0014-5793(94)01277-6; SHAW AJ, APPL ENV MI IN PRESS; Shen HB, 2007, PROTEIN ENG DES SEL, V20, P39, DOI 10.1093/protein/gzl053; SHIMADA K, 1994, J BIOL CHEM, V269, P18275; Sivadon-Tardy V, 2009, J CLIN MICROBIOL, V47, P264, DOI 10.1128/JCM.01854-08; Snyder LAS, 2007, MOL BIOL EVOL, V24, P2802, DOI 10.1093/molbev/msm215; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stranden AM, 1997, J BACTERIOL, V179, P9, DOI 10.1128/jb.179.1.9-16.1997; TEIXEIRA GS, J MED MICRO IN PRESS; Tomich M, 2006, J BACTERIOL, V188, P6899, DOI 10.1128/JB.00690-06; Van Melderen L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000437; WEINBERG W, 1955, S Afr Med J, V29, P14; Wiggins R, 2000, J CLIN MICROBIOL, V38, P3096, DOI 10.1128/JCM.38.8.3096-3097.2000; Wilcox MH, 2009, J INFECTION, V59, pS75, DOI 10.1016/S0163-4453(09)60010-4; Zhang JR, 1999, MOL MICROBIOL, V31, P1477, DOI 10.1046/j.1365-2958.1999.01291.x; Zvirbliene A, 2010, TOXICON, V56, P19, DOI 10.1016/j.toxicon.2010.03.007	70	92	95	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12411	10.1371/journal.pone.0012411	http://dx.doi.org/10.1371/journal.pone.0012411			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865041	Green Published, Green Submitted, gold			2022-12-27	WOS:000281292100012
J	Freedman, BS; Miller, KE; Heald, R				Freedman, Benjamin S.; Miller, Kelly E.; Heald, Rebecca			Xenopus Egg Extracts Increase Dynamics of Histone H1 on Sperm Chromatin	PLOS ONE			English	Article							LINKER HISTONES; NUCLEAR IMPORT; IN-VIVO; DOMAINS; BINDING; DNA; NUCLEOSOME; LOCATION; CELLS; PHOSPHORYLATION	Background: Linker histone H1 has been studied in vivo and using reconstituted chromatin, but there have been few systematic studies of the effects of the cellular environment on its function. Due to the presence of many other chromatin factors and specific chaperones such as RanBP7/importin beta that regulate histone H1, linker histones likely function differently in vivo than in purified systems. Methodology/Principal Findings: We have directly compared H1 binding to sperm nuclei in buffer versus Xenopus egg extract cytoplasm, and monitored the effects of adding nuclear import chaperones. In buffer, RanBP7 decondenses sperm nuclei, while H1 binds tightly to the chromatin and rescues RanBP7-mediated decondensation. H1 binding is reduced in cytoplasm, and H1 exhibits rapid FRAP dynamics in cytoplasm but not in buffer. RanBP7 decreases H1 binding to chromatin in both buffer and extract but does not significantly affect H1 dynamics in either condition. Importin beta has a lesser effect than RanBP7 on sperm chromatin decondensation and H1 binding, while a combination of RanBP7/importin beta is no more effective than RanBP7 alone. In extracts supplemented with RanBP7, H1 localizes to chromosomal foci, which increase after DNA damage. Unlike somatic H1, the embryonic linker histone H1M binds equally well to chromatin in cytoplasm compared to buffer. Amino-globular and carboxyl terminal domains of H1M bind chromatin comparably to the full-length protein in buffer, but are inhibited similar to 10-fold in cytoplasm. High levels of H1 or its truncations distort mitotic chromosomes and block their segregation during anaphase. Conclusion/Significance: RanBP7 can decondense sperm nuclei and decrease H1 binding, but the rapid dynamics of H1 on chromatin depend on other cytoplasmic factors. Cytoplasm greatly impairs the activity of individual H1 domains, and only the full-length protein can condense chromatin properly. Our findings begin to bridge the gap between purified and in vivo chromatin systems.	[Freedman, Benjamin S.; Miller, Kelly E.; Heald, Rebecca] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Freedman, BS (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	bheald@berkeley.edu		Heald, Rebecca/0000-0001-6671-6528; Miller, Kelly/0000-0002-2273-2064	National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057839] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN J, 1986, J MOL BIOL, V187, P591, DOI 10.1016/0022-2836(86)90337-2; ALLAN J, 1980, NATURE, V288, P675, DOI 10.1038/288675a0; Baatout S, 2006, CELL BIOCHEM FUNCT, V24, P93, DOI 10.1002/cbf.1293; Becker M, 2005, MOL BIOL CELL, V16, P3887, DOI 10.1091/mbc.E05-04-0350; Bustin M, 2005, MOL CELL, V17, P617, DOI 10.1016/j.molcel.2005.02.019; Chen DY, 2005, J CELL BIOL, V168, P41, DOI 10.1083/jcb.200407182; Chi NC, 1996, J CELL BIOL, V135, P559, DOI 10.1083/jcb.135.3.559; Dou YL, 2002, J CELL BIOL, V158, P1161, DOI 10.1083/jcb.200202131; Facchino S, 2010, J NEUROSCI, V30, P10096, DOI 10.1523/JNEUROSCI.1634-10.2010; FINCH JT, 1976, P NATL ACAD SCI USA, V73, P1897, DOI 10.1073/pnas.73.6.1897; Freedman BS, 2010, CURR BIOL, V20, P1048, DOI 10.1016/j.cub.2010.04.025; Grandi P, 2001, J CELL SCI, V114, P3345; Happel N, 2009, GENE, V431, P1, DOI 10.1016/j.gene.2008.11.003; Jakel S, 2002, EMBO J, V21, P377, DOI 10.1093/emboj/21.3.377; Kasinsky HE, 2001, FASEB J, V15, P34, DOI 10.1096/fj.00-0237rev; Lever MA, 2000, NATURE, V408, P873, DOI 10.1038/35048603; Maresca Thomas J., 2006, V322, P459; Maresca TJ, 2005, J CELL BIOL, V169, P859, DOI 10.1083/jcb.200503031; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; Muhlhausser P, 2001, EMBO REP, V2, P690, DOI 10.1093/embo-reports/kve168; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; OLIVA R, 1991, PROG NUCLEIC ACID RE, V40, P25; RAGHURAM N, BIOCHEMISTRY, V49, P4420; RAMAKRISHNAN V, 1993, NATURE, V362, P219, DOI 10.1038/362219a0; Rosidi B, 2008, NUCLEIC ACIDS RES, V36, P1610, DOI 10.1093/nar/gkn013; SHEN XT, 1995, CELL, V82, P47, DOI 10.1016/0092-8674(95)90051-9; Stasevich TJ, 2010, EMBO J, V29, P1225, DOI 10.1038/emboj.2010.24; STAYNOV DZ, 1988, EMBO J, V7, P3685, DOI 10.1002/j.1460-2075.1988.tb03250.x; Tamada H, 2006, MOL CELL BIOL, V26, P1259, DOI 10.1128/MCB.26.4.1259-1271.2006; Tashker JS, 2002, MOL BIOL CELL, V13, P393, DOI 10.1091/mbc.01-06-0291; THOMA F, 1977, CELL, V12, P101, DOI 10.1016/0092-8674(77)90188-X; THOMA F, 1979, J CELL BIOL, V83, P403, DOI 10.1083/jcb.83.2.403; THOMA F, 1983, J MOL BIOL, V167, P619, DOI 10.1016/S0022-2836(83)80102-8; THOMAS JO, 1992, NUCLEIC ACIDS RES, V20, P187, DOI 10.1093/nar/20.2.187; Ura K, 1996, EMBO J, V15, P4959, DOI 10.1002/j.1460-2075.1996.tb00876.x; VARSHAVSKY AJ, 1976, NUCLEIC ACIDS RES, V3, P477, DOI 10.1093/nar/3.2.477; WHITLOCK JP, 1976, BIOCHEMISTRY-US, V15, P3307, DOI 10.1021/bi00660a022	38	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e13111	10.1371/journal.pone.0013111	http://dx.doi.org/10.1371/journal.pone.0013111			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20927327	Green Published, Green Submitted, gold			2022-12-27	WOS:000282269400033
J	Gerretsen, SC; Kooi, ME; Kessels, AG; Schalla, S; Katoh, M; van der Geest, RJ; Manning, WJ; Waltenberger, J; van Engelshoven, JMA; Botnar, RM; Leiner, T				Gerretsen, Suzanne C.; Kooi, M. Eline; Kessels, Alfons G.; Schalla, Simon; Katoh, Marcus; van der Geest, Rob J.; Manning, Warren J.; Waltenberger, Johannes; van Engelshoven, Jos M. A.; Botnar, Rene M.; Leiner, Tim			Visualization of Coronary Wall Atherosclerosis in Asymptomatic Subjects and Patients with Coronary Artery Disease Using Magnetic Resonance Imaging	PLOS ONE			English	Article							MULTISLICE COMPUTED-TOMOGRAPHY; MULTIPLE END-POINTS; VESSEL WALL; INTRAVASCULAR ULTRASOUND; HEART-DISEASE; PLAQUE CHARACTERIZATION; VULNERABLE PLAQUE; CAROTID-ARTERY; RISK; ANGIOGRAPHY	Background: Magnetic resonance imaging (MRI) is sensitive to early atherosclerotic changes such as positive remodeling in patients with coronary artery disease (CAD). We assessed prevalence, quality, and extent of coronary atherosclerosis in a group of healthy subjects compared to patients with confirmed CAD. Methodology: Twenty-two patients with confirmed CAD (15M, 7F, mean age 60.4 +/- 10.4 years) and 26 healthy subjects without history of CAD (11M, 15F, mean age 56.1 +/- 4.4 years) underwent MRI of the right coronary artery (RCA) and vessel wall (MR-CVW) on a clinical 1.5T MR-scanner. Wall thickness measurements of both groups were compared. Principal Findings: Stenoses of the RCA (both < and >= 50% on CAG) were present in all patients. In 21/22 patients, stenoses detected at MRI corresponded to stenoses detected with conventional angiography. In 19/26 asymptomatic subjects, there was visible luminal narrowing in the MR luminography images. Fourteen of these subjects demonstrated corresponding increase in vessel wall thickness. In 4/26 asymptomatic subjects, vessel wall thickening without luminal narrowing was present. Maximum and mean wall thicknesses in patients were significantly higher (2.16 vs 1.92 mm, and 1.38 vs 1.22 mm, both p < 0.05). Conclusions: In this cohort of middle-aged individuals, both patients with stable angina and angiographically proven coronary artery disease, as well as age-matched asymptomatic subjects. exhibited coronary vessel wall thickening detectable with MR coronary vessel wall imaging. Maximum and mean wall thicknesses were significantly higher in patients. The vast majority of asymptomatic subjects had either positive remodeling without luminal narrowing, or non-significant stenosis.	[Gerretsen, Suzanne C.; Kooi, M. Eline; van Engelshoven, Jos M. A.; Leiner, Tim] Maastricht Univ, Dept Radiol, Med Ctr, Maastricht, Netherlands; [Gerretsen, Suzanne C.; Kooi, M. Eline; Schalla, Simon; Waltenberger, Johannes; van Engelshoven, Jos M. A.; Leiner, Tim] Maastricht Univ, Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands; [Kessels, Alfons G.] Maastricht Univ, Dept Clin Epidemiol & Med Tech Assessment, Med Ctr, Maastricht, Netherlands; [Schalla, Simon; Waltenberger, Johannes] Maastricht Univ, Dept Cardiol, Med Ctr, Maastricht, Netherlands; [Katoh, Marcus] Saarland Univ Hosp, Dept Diagnost & Intervent Radiol, Homburg, Germany; [van der Geest, Rob J.] Leiden Univ, Med Ctr, Dept Radiol, Div Image Proc LKEB, Leiden, Netherlands; [Manning, Warren J.] Beth Israel Deaconess Med Ctr, Dept Med, Div Cardiovasc, Boston, MA 02215 USA; [Manning, Warren J.] Beth Israel Deaconess Med Ctr, Dept Radiol, Boston, MA 02215 USA; [Manning, Warren J.] Harvard Univ, Sch Med, Boston, MA USA; [Botnar, Rene M.] Kings Coll London, Div Imaging Sci, London WC2R 2LS, England	Maastricht University; Maastricht University; Maastricht University; Maastricht University; Universitatsklinikum des Saarlandes; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of London; King's College London	Gerretsen, SC (corresponding author), Maastricht Univ, Dept Radiol, Med Ctr, Maastricht, Netherlands.	timleiner@gmail.com	Kooi, M. Eline/D-3848-2016; van der Geest, Rob J/J-8193-2015; Botnar, Rene M/E-6875-2012; Botnar, Rene Michael/AAZ-2112-2020; Waltenberger, Johannes/I-1813-2013	Kooi, M. Eline/0000-0001-7562-5724; van der Geest, Rob J/0000-0002-9084-5597; Botnar, Rene M/0000-0003-2811-2509; Botnar, Rene/0000-0002-9447-4367; Waltenberger, Johannes/0000-0002-2417-9880	Netherlands Organization for Scientific Research [916.46.034]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Netherlands Organization for Scientific Research (http://www.nwo.nl/nwohome.nsf/pages/SPPD_5R2QE7_Eng; NWO VENI scheme, Grant number 916.46.034). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adame IM, 2004, MAGN RESON MATER PHY, V16, P227, DOI 10.1007/s10334-003-0030-8; Akhter N, 2009, AM HEART J, V157, P141, DOI 10.1016/j.ahj.2008.08.012; Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; Austen W G, 1975, Circulation, V51, P5; Botnar RM, 2000, CIRCULATION, V102, P2582; Botnar RM, 2001, MAGNET RESON MED, V46, P848, DOI 10.1002/mrm.1268; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Burke AP, 1997, NEW ENGL J MED, V336, P1276, DOI 10.1056/NEJM199705013361802; Cai JM, 2002, CIRCULATION, V106, P1368, DOI 10.1161/01.CIR.0000028591.44554.F9; Cappendijk VC, 2005, RADIOLOGY, V234, P487, DOI 10.1148/radiol.2342032101; Clevert DA, 2006, EUR J RADIOL, V60, P379, DOI 10.1016/j.ejrad.2006.07.012; Davies MJ, 1997, NEW ENGL J MED, V336, P1312, DOI 10.1056/NEJM199705013361809; de Roos A, 2007, J MAGN RESON IMAGING, V26, P14, DOI 10.1002/jmri.20971; Desai MY, 2005, EUR HEART J, V26, P2320, DOI 10.1093/eurheartj/ehi357; Fayad ZA, 2000, CIRCULATION, V101, P2503, DOI 10.1161/01.CIR.101.21.2503; Fayad ZA, 2000, CIRCULATION, V102, P506; Fujii K, 2005, AM J CARDIOL, V96, P1476, DOI 10.1016/j.amjcard.2005.07.054; FUSTER V, 1994, CIRCULATION, V90, P2126, DOI 10.1161/01.CIR.90.4.2126; Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210; Grundy SM, 1998, CIRCULATION, V97, P1876, DOI 10.1161/01.CIR.97.18.1876; Kim WY, 2007, CIRCULATION, V115, P228, DOI 10.1161/CIRCULATIONAHA.106.633339; Kim WY, 2002, CIRCULATION, V106, P296, DOI 10.1161/01.CIR.0000025629.85631.1E; Lauter J, 1996, BIOMETRICS, V52, P964, DOI 10.2307/2533057; Leber AW, 2006, J AM COLL CARDIOL, V47, P672, DOI 10.1016/j.jacc.2005.10.058; Lee RT, 1997, ARTERIOSCL THROM VAS, V17, P1859, DOI 10.1161/01.ATV.17.10.1859; Leiner Tim, 2005, Top Magn Reson Imaging, V16, P21, DOI 10.1097/01.rmr.0000185431.50535.d7; Lokhandwala JO, 2009, J CARDIOVASC TRANSL, V2, P300, DOI 10.1007/s12265-009-9119-4; Mackay J, 2004, ATLAS HEART DIS STRO; Maintz D, 2006, EUR HEART J, V27, P1732, DOI 10.1093/eurheartj/ehl102; Miao CL, 2009, J AM COLL CARDIOL, V53, P1708, DOI 10.1016/j.jacc.2008.12.063; Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97; OBRIEN PC, 1984, BIOMETRICS, V40, P1079, DOI 10.2307/2531158; Patel ST, 2005, J VASC SURG, V41, P462, DOI 10.1016/j.jvs.2004.12.045; Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; RUMBERGER JA, 1995, CIRCULATION, V92, P2157, DOI 10.1161/01.CIR.92.8.2157; Schoenhagen P, 2000, CIRCULATION, V101, P598, DOI 10.1161/01.CIR.101.6.598; Spuentrup E, 2004, RADIOLOGY, V231, P581, DOI 10.1148/radiol.2312030451; STRONG JP, 1962, AM J PATHOL, V40, P37; Tuzcu EM, 2001, CIRCULATION, V103, P2705; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wood D, 1998, EUR HEART J, V19, P1434; Yeon SB, 2007, J AM COLL CARDIOL, V50, P441, DOI 10.1016/j.jacc.2007.03.052; Zhang SX, 2001, MAGN RESON IMAGING, V19, P795, DOI 10.1016/S0730-725X(01)00408-8	45	15	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e12998	10.1371/journal.pone.0012998	http://dx.doi.org/10.1371/journal.pone.0012998			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20927368	gold, Green Published, Green Submitted			2022-12-27	WOS:000282269400009
J	Seebacher, F; Glanville, EJ				Seebacher, Frank; Glanville, Elsa J.			Low Levels of Physical Activity Increase Metabolic Responsiveness to Cold in a Rat (Rattus fuscipes)	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; DIET-INDUCED THERMOGENESIS; FATTY-ACID OXIDATION; SKELETAL-MUSCLE; TRANSCRIPTIONAL COACTIVATOR; MITOCHONDRIAL BIOGENESIS; ENERGY-EXPENDITURE; BODY-TEMPERATURE; CHRONIC DISEASE; EXERCISE	Background: Physical activity modulates expression of metabolic genes and may therefore be a prerequisite for metabolic responses to environmental stimuli. However, the extent to which exercise interacts with environmental conditions to modulate metabolism is unresolved. Hence, we tested the hypothesis that even low levels of physical activity are beneficial by improving metabolic responsiveness to temperatures below the thermal neutral zone, thereby increasing the capacity for substrate oxidation and energy expenditure. Methodology/Principal Findings: We used wild rats (Rattus fuscipes) to avoid potential effects of breeding on physiological phenotypes. Exercise acclimation (for 30 min/day on 5 days/week for 30 days at 60% of maximal performance) at 22 degrees C increased mRNA concentrations of PGC1 alpha, PPAR delta, and NRF-1 in skeletal muscle and brown adipose tissue compared to sedentary animals. Lowering ambient temperature to 12 degrees C caused further increases in relative expression of NRF-1 in skeletal muscle, and of PPARd of brown adipose tissue. Surprisingly, relative expression of UCP1 increased only when both exercise and cold stimuli were present. Importantly, in sedentary animals cold acclimation (12 degrees C) alone did not change any of the above variables. Similarly, cold alone did not increase maximum capacity for substrate oxidation in mitochondria (cytochrome c oxidase and citrate synthase activities) of either muscle or brown adipose tissue. Animals that exercised regularly had higher exercise induced metabolic rates in colder environments than sedentary rats, and temperature induced metabolic scope was greater in exercised rats. Conclusions/Significance: Physical activity is a necessary prerequisite for the expression of transcriptional regulators that influence a broad range of physiological functions from energy metabolism to cardiovascular function and nutrient uptake. A sedentary lifestyle leads to decreased daily energy expenditure because of a lack of direct use of energy and a muted metabolic response to ambient temperature, which can be reversed even by low levels of physical activity.	[Seebacher, Frank; Glanville, Elsa J.] Univ Sydney, Sch Biol Sci, Integrat Physiol Res Grp, Sydney, NSW 2006, Australia	University of Sydney	Seebacher, F (corresponding author), Univ Sydney, Sch Biol Sci, Integrat Physiol Res Grp, Sydney, NSW 2006, Australia.	frank.seebacher@sydney.edu.au		Seebacher, Frank/0000-0002-2281-9311	Australian Research Council [DP0772438]	Australian Research Council(Australian Research Council)	This work was partly funded by the Australian Research Council (grant DP0772438; www.arc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arany Z, 2006, P NATL ACAD SCI USA, V103, P10086, DOI 10.1073/pnas.0603615103; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; BENNETT AF, 1979, SCIENCE, V206, P649, DOI 10.1126/science.493968; Booth FW, 2009, J PHYSIOL-LONDON, V587, P5527, DOI 10.1113/jphysiol.2009.179507; Booth FW, 2008, BRIT J SPORT MED, V42, P950, DOI 10.1136/bjsm.2008.052589; Booth FW, 2008, EUR J APPL PHYSIOL, V102, P381, DOI 10.1007/s00421-007-0606-5; Booth FW, 2002, J PHYSIOL-LONDON, V543, P399, DOI 10.1113/jphysiol.2002.019265; BRETT JR, 1964, J FISH RES BOARD CAN, V21, P1183, DOI 10.1139/f64-103; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon B, 2009, P NUTR SOC, V68, P401, DOI 10.1017/S0029665109990255; Chappell MA, 2004, J EXP BIOL, V207, P3839, DOI 10.1242/jeb.01213; Cheng LH, 2004, NAT MED, V10, P1245, DOI 10.1038/nm1116; Chinsomboon J, 2009, P NATL ACAD SCI USA, V106, P21401, DOI 10.1073/pnas.0909131106; Das J, 2006, BIOESSAYS, V28, P890, DOI 10.1002/bies.20463; DAUNCEY MJ, 1981, BRIT J NUTR, V45, P257, DOI 10.1079/BJN19810102; Enerback S, 2010, CELL METAB, V11, P248, DOI 10.1016/j.cmet.2010.03.008; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Fruhbeck G, 2009, TRENDS PHARMACOL SCI, V30, P387, DOI 10.1016/j.tips.2009.05.003; Gillis LJ, 2002, INT J OBESITY, V26, P458, DOI 10.1038/sj.ijo.0801967; GLANVILLE EJ, 2010, J MAMMAL IN PRESS; Glanville EJ, 2010, COMP BIOCHEM PHYS A, V155, P383, DOI 10.1016/j.cbpa.2009.12.008; Grundy SM, 2008, EUR HEART J SUPPL, V10, pB16, DOI 10.1093/eurheartj/sum044; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Hoehn KL, 2010, CELL METAB, V11, P70, DOI 10.1016/j.cmet.2009.11.008; Holloszy JO, 2008, J PHYSIOL PHARMACOL, V59, P5; Holloway GP, 2009, AM J CLIN NUTR, V89, p455S, DOI 10.3945/ajcn.2008.26717B; Huang PL, 2009, TRENDS ENDOCRIN MET, V20, P295, DOI 10.1016/j.tem.2009.03.005; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Klingenspor M, 2003, EXP PHYSIOL, V88, P141, DOI 10.1113/eph8802508; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; Kozak LP, 2008, INT J OBESITY, V32, pS32, DOI 10.1038/ijo.2008.236; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; Mekjavic IB, 2006, J APPL PHYSIOL, V100, P2065, DOI 10.1152/japplphysiol.01118.2005; Moyes CD, 2003, J EXP BIOL, V206, P4385, DOI 10.1242/jeb.00699; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Nedergaard J, 2001, BBA-BIOENERGETICS, V1504, P82, DOI 10.1016/S0005-2728(00)00247-4; Nunn AVW, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-16; O'Gorman DJ, 2008, ENDOCRIN METAB CLIN, V37, P887, DOI 10.1016/j.ecl.2008.07.006; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Redinger RN, 2009, TRANSL RES, V154, P52, DOI 10.1016/j.trsl.2009.05.003; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Seebacher F, 2003, J EXP BIOL, V206, P1193, DOI 10.1242/jeb.00223; Seebacher F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000281; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Withers PC, 2001, AUST J ZOOL, V49, P445, DOI 10.1071/ZO00057; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Zaykin DV, 2002, GENET EPIDEMIOL, V22, P170, DOI 10.1002/gepi.0042	55	34	37	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e13022	10.1371/journal.pone.0013022	http://dx.doi.org/10.1371/journal.pone.0013022			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20885954	Green Published, gold, Green Submitted			2022-12-27	WOS:000282167100021
J	Xavier, S; Gilbert, V; Rastaldi, MP; Krick, S; Kollins, D; Reddy, A; Bottinger, E; Cohen, CD; Schlondorff, D				Xavier, Sandhya; Gilbert, Victoria; Rastaldi, Maria Pia; Krick, Stefanie; Kollins, Dmitrij; Reddy, Anand; Bottinger, Erwin; Cohen, Clemens D.; Schlondorff, Detlef			BAMBI Is Expressed in Endothelial Cells and Is Regulated by Lysosomal/Autolysosomal Degradation	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; MEMBRANE-BOUND INHIBITOR; ISOLATED RAT HEPATOCYTES; TGF-BETA; GENE-EXPRESSION; PSEUDORECEPTOR BAMBI; PROTEIN-DEGRADATION; COLORECTAL-CANCER; MESANGIAL CELLS; AUTOPHAGY	Background: BAMBI (BMP and Activin Membrane Bound Inhibitor) is considered to influence TGF beta and Wnt signaling, and thereby fibrosis. Surprisingly data on cell type-specific expression of BAMBI are not available. We therefore examined the localization, gene regulation, and protein turnover of BAMBI in kidneys. Methodology/Principal Findings: By immunofluorescence microscopy and by mRNA expression, BAMBI is restricted to endothelial cells of the glomerular and some peritubular capillaries and of arteries and veins in both murine and human kidneys. TGF beta upregulated mRNA of BAMBI in murine glomerular endothelial cells (mGEC). LPS did not downregulate mRNA for BAMBI in mGEC or in HUVECs. BAMBI mRNA had a half-life of only 60 minutes and was stabilized by cycloheximide, indicating post-transcriptional regulation due to AU-rich elements, which we identified in the 3' untranslated sequence of both the human and murine BAMBI gene. BAMBI protein turnover was studied in HUVECs with BAMBI overexpression using a lentiviral system. Serum starvation as an inducer of autophagy caused marked BAMBI degradation, which could be totally prevented by inhibition of lysosomal and autolysosomal degradation with bafilomycin, and partially by inhibition of autophagy with 3-methyladenine, but not by proteasomal inhibitors. Rapamycin activates autophagy by inhibiting TOR, and resulted in BAMBI protein degradation. Both serum starvation and rapamycin increased the conversion of the autophagy marker LC3 from LC3-I to LC3-II and also enhanced co-staining for BAMBI and LC3 in autolysosomal vesicles. Conclusions/Significance: 1. BAMBI localizes to endothelial cells in the kidney and to HUVECs. 2. BAMBI mRNA is regulated by post-transcriptional mechanisms. 3. BAMBI protein is regulated by lysosomal and autolysosomal degradation. The endothelial localization and the quick turnover of BAMBI may indicate novel, yet to be defined functions of this modulator for TGF beta and Wnt protein actions in the renal vascular endothelium in health and disease.	[Xavier, Sandhya; Gilbert, Victoria; Krick, Stefanie; Kollins, Dmitrij; Reddy, Anand; Bottinger, Erwin; Schlondorff, Detlef] Mt Sinai Sch Med, Dept Med, New York, NY USA; [Cohen, Clemens D.] Univ Hosp, Div Nephrol, Zurich, Switzerland; [Cohen, Clemens D.] Univ Hosp, Inst Physiol, Ctr Integrat Human Physiol, Zurich, Switzerland; [Cohen, Clemens D.] Univ Zurich, Zurich, Switzerland; [Rastaldi, Maria Pia] Fdn DAmico Ric Malattie Renali, Renal Immunopathol Lab, Milan, Italy	Icahn School of Medicine at Mount Sinai; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich	Xavier, S (corresponding author), Mt Sinai Sch Med, Dept Med, New York, NY USA.	detlef.schlondorff@mssm.edu			National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases) [R01-DK081420-01]; Else Kroener-Fresenius Foundation [A62/04]; Swiss National Science Foundation [32-122439/1]; Fondazione IRCCS Policlinico; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081420, R01DK056077, R01DK060043] Funding Source: NIH RePORTER	National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Else Kroener-Fresenius Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fondazione IRCCS Policlinico; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health ( National Institute of Diabetes and Digestive and Kidney Diseases R01-DK081420-01 to D. S.) and in part by the Else Kroener-Fresenius Foundation (A62/04 to C. D. C.) and the Swiss National Science Foundation (32-122439/1 to C. D. C.), and Progetto a concorso 2009/2010 Fondazione IRCCS Policlinico to M. P. R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akis N, 2004, KIDNEY INT, V65, P2223, DOI 10.1111/j.1523-1755.2004.00634.x; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Bedford JJ, 2003, J AM SOC NEPHROL, V14, P2581, DOI 10.1097/01.ASN.0000089566.28106.F6; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Bottinger EP, 2007, SEMIN NEPHROL, V27, P309, DOI 10.1016/j.semnephrol.2007.02.009; Chen JQ, 2007, GENESIS, V45, P482, DOI 10.1002/dvg.20320; Cohen CD, 2002, KIDNEY INT, V61, P133, DOI 10.1046/j.1523-1755.2002.00113.x; Demaison C, 2002, HUM GENE THER, V13, P803, DOI 10.1089/10430340252898984; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; El-Achkar TM, 2006, AM J PHYSIOL-RENAL, V290, pF1034, DOI 10.1152/ajprenal.00414.2005; Finn PE, 2005, AUTOPHAGY, V1, P141, DOI 10.4161/auto.1.3.2000; Fritzmann J, 2009, GASTROENTEROLOGY, V137, P165, DOI 10.1053/j.gastro.2009.03.041; GAZIT D, 1993, MOL ENDOCRINOL, V7, P189, DOI 10.1210/me.7.2.189; Grotewold L, 2001, MECH DEVELOP, V100, P327, DOI 10.1016/S0925-4773(00)00524-4; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; HAVERTY TP, 1988, J CELL BIOL, V107, P1359, DOI 10.1083/jcb.107.4.1359; Hayes S, 2002, J CELL BIOL, V158, P1239, DOI 10.1083/jcb.200204088; Higashihori N, 2008, DEV DYNAM, V237, P1500, DOI 10.1002/dvdy.21529; Hwang I, 2009, ARCH PHARM RES, V32, P1653, DOI 10.1007/s12272-009-2200-3; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Knight C, 2001, J DENT RES, V80, P1895, DOI 10.1177/00220345010800100701; Lin CL, 2006, J AM SOC NEPHROL, V17, P2812, DOI 10.1681/ASN.2005121355; Lin ZH, 2008, J BIOL CHEM, V283, P33053, DOI 10.1074/jbc.M804039200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loveland KL, 2003, ENDOCRINOLOGY, V144, P4180, DOI 10.1210/en.2002-0124; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Merkel CE, 2007, PEDIATR NEPHROL, V22, P1825, DOI 10.1007/s00467-007-0504-4; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Neusser MA, 2010, AM J PATHOL, V176, P594, DOI 10.2353/ajpath.2010.090268; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; O'Connor MN, 2009, BLOOD, V113, P4754, DOI 10.1182/blood-2008-06-162693; Onichtchouk D, 1999, NATURE, V401, P480, DOI 10.1038/46794; Raught B, 2001, P NATL ACAD SCI USA, V98, P7037, DOI 10.1073/pnas.121145898; ROTE KV, 1983, J CELL PHYSIOL, V116, P103, DOI 10.1002/jcp.1041160116; Satriano JA, 1997, J AM SOC NEPHROL, V8, P596; Schlondorff D, 2009, J AM SOC NEPHROL, V20, P1179, DOI 10.1681/ASN.2008050549; Schmid H, 2003, J AM SOC NEPHROL, V14, P2958, DOI 10.1097/01.ASN.0000090745.85482.06; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Sekiya T, 2004, BIOCHEM BIOPH RES CO, V320, P680, DOI 10.1016/j.bbrc.2004.06.017; Sekiya T, 2004, J BIOL CHEM, V279, P6840, DOI 10.1074/jbc.M310876200; Shi SL, 2008, J AM SOC NEPHROL, V19, P2159, DOI 10.1681/ASN.2008030312; Togo N, 2008, WORLD J GASTROENTERO, V14, P4880, DOI 10.3748/wjg.14.4880; Tsang M, 2000, GENESIS, V28, P47, DOI 10.1002/1526-968X(200010)28:2<47::AID-GENE20>3.0.CO;2-S; WOLF G, 1993, J CLIN INVEST, V92, P1366, DOI 10.1172/JCI116710; WOODWARD TL, 1995, J CELL PHYSIOL, V165, P339, DOI 10.1002/jcp.1041650215; Xavier S, 2009, J AM SOC NEPHROL, V20, P2127, DOI 10.1681/ASN.2008070806; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; YAMAWAKI M, 1993, J HISTOCHEM CYTOCHEM, V41, P105, DOI 10.1177/41.1.8417105; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Zerlin M, 2008, ANGIOGENESIS, V11, P63, DOI 10.1007/s10456-008-9095-3	55	36	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2010	5	9							e12995	10.1371/journal.pone.0012995	http://dx.doi.org/10.1371/journal.pone.0012995			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653UN	20886049	Green Published, Green Submitted, gold			2022-12-27	WOS:000282122600020
J	Chang, JW; Hsu, HS; Ni, HJ; Chuang, CT; Hsiung, CH; Huang, TH; Wang, YC				Chang, Jer-Wei; Hsu, Han-Shui; Ni, Huey-Juin; Chuang, Ching-Ting; Hsiung, Chi-Hui; Huang, Tim H.; Wang, Yi-Ching			Distinct Epigenetic Domains Separated by a CTCF Bound Insulator between the Tandem Genes, BLU and RASSF1A	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; CELL LUNG-CANCER; DNA METHYLATION; NASOPHARYNGEAL CARCINOMA; MOLECULAR PATHOGENESIS; REGULATORY ELEMENTS; BREAST-CANCER; PROTEIN CTCF; ALLELE LOSS; INACTIVATION	Background: Tumor suppressor gene (TSG) RASSF1A and candidate TSG BLU are two tandem head-to-tail genes located at 3p21.3. We hypothesized that there may be a concordance on their gene expression and promoter methylation status. If not, then there may be an insulator located between RASSF1A and BLU genes that provides a barrier activity. Methodology/Principal Findings: We first identified potential transcriptionally important CpG sites using the methylation-specific oligonucleotide array in relation to mRNA expression of RASSF1A and BLU genes in primary lung tumors. We demonstrated that E2F1 bound to the potential transcriptionally important CpG sites in RASSF1A gene of a normal lung cell line expressing RASSF1A transcripts, whereas loss of E2F1 binding to RASSF1A in A549 cancer cell line was the result of DNA methylation. Both RASSF1A and BLU genes had their own potential transcriptionally important CpG regions. However, there was no correlation of methylation status between RASSF1A and BLU. Using gel shift assay and chromatin immunoprecipitation-PCR (ChIP-PCR), we found that CCCTC-binding factor (CTCF) bound to insulator sequences located between these two genes. Bisulfite sequencing and ChIP-PCR revealed distinct methylation and chromatin boundaries separated by the CTCF binding domains in normal cells, whereas such distinct epigenetic domains were not observed in cancer cells. Note that demethylation reagent and histone deacetylase inhibitor treatments led to CTCF binding and recovery of barrier effect for RASSF1A and BLU genes in cancer cells. Conclusions/Significance: Our study dissects the potential transcriptionally important CpG sites for RASSF1A and BLU genes at the sequence level and demonstrates that CTCF binding to the insulator of BLU gene provides a barrier activity within separate epigenetic domains of the juxtaposed BLU and RASSF1A loci in the 3p21.3 gene cluster region.	[Chang, Jer-Wei; Hsiung, Chi-Hui; Wang, Yi-Ching] Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 70101, Taiwan; [Hsu, Han-Shui] Natl Yang Ming Univ, Inst Emergency & Crit Care Med, Taipei Vet Gen Hosp, Div Thorac Surg, Taipei 112, Taiwan; [Ni, Huey-Juin; Chuang, Ching-Ting] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Huang, Tim H.] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA	National Cheng Kung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Taiwan Normal University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Chang, JW (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 70101, Taiwan.	ycw5798@mail.ncku.edu.tw	Wang, Yi-Ching/J-8702-2019	Wang, Yi-Ching/0000-0002-7694-2067	National Science Council [NSC96-2628-B-006-048-MY3]; Department of Health (The Executive Yuan, Republic of China) [DOH98-TD-G-111-024]	National Science Council(Ministry of Science and Technology, Taiwan); Department of Health (The Executive Yuan, Republic of China)	This work was supported in part by grant NSC96-2628-B-006-048-MY3 from the National Science Council and grant DOH98-TD-G-111-024 from the Department of Health (The Executive Yuan, Republic of China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agathanggelou A, 2003, ONCOGENE, V22, P1580, DOI 10.1038/sj.onc.1206243; Agathanggelou A, 2005, CANCER RES, V65, P3497, DOI 10.1158/0008-5472.CAN-04-4088; Antes TJ, 2001, BIOCHEMISTRY-US, V40, P6731, DOI 10.1021/bi0100743; Bell AC, 2001, SCIENCE, V291, P447, DOI 10.1126/science.291.5503.447; Burbee DG, 2001, JNCI-J NATL CANCER I, V93, P691, DOI 10.1093/jnci/93.9.691; Campanero MR, 2000, P NATL ACAD SCI USA, V97, P6481, DOI 10.1073/pnas.100340697; Dallol A, 2005, CANCER RES, V65, P7653, DOI 10.1158/0008-5472.CAN-05-0247; Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389; Filippova GN, 2008, CURR TOP DEV BIOL, V80, P337, DOI 10.1016/S0070-2153(07)80009-3; Fong KM, 1999, J THORAC CARDIOV SUR, V118, P1136, DOI 10.1016/S0022-5223(99)70121-2; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Gitan RS, 2002, GENOME RES, V12, P158, DOI 10.1101/gr.202801; Hesson L, 2004, ONCOGENE, V23, P2408, DOI 10.1038/sj.onc.1207407; Hesson LB, 2007, ONCOGENE, V26, P7283, DOI 10.1038/sj.onc.1210547; Kim DH, 2003, CANCER RES, V63, P3743; Liu L, 2007, CELL CYCLE, V6, P1663, DOI 10.4161/cc.6.13.4435; Marsit CJ, 2005, INT J CANCER, V114, P219, DOI 10.1002/ijc.20714; Martinez A, 2001, J CLIN PATHOL-MOL PA, V54, P300, DOI 10.1136/mp.54.5.300; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Mukhopadhyay R, 2004, GENOME RES, V14, P1594, DOI 10.1101/gr.2408304; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Mund C, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni072; Ortiz-Vega S, 2002, ONCOGENE, V21, P1381, DOI 10.1038/sj.onc.1205192; Palakurthy RK, 2009, MOL CELL, V36, P219, DOI 10.1016/j.molcel.2009.10.009; Qiu GH, 2004, ONCOGENE, V23, P4793, DOI 10.1038/sj.onc.1207632; Rabizadeh S, 2004, J BIOL CHEM, V279, P29247, DOI 10.1074/jbc.M401699200; Riquelme E, 2007, CANCER LETT, V250, P100, DOI 10.1016/j.canlet.2006.09.019; Sekido Y, 1998, BBA-REV CANCER, V1378, pF21, DOI 10.1016/S0304-419X(98)00010-9; Song MS, 2004, NAT CELL BIOL, V6, P129, DOI 10.1038/ncb1091; Strunnikova M, 2005, MOL CELL BIOL, V25, P3923, DOI 10.1128/MCB.25.10.3923-3933.2005; Thiagalingam S, 2002, CURR OPIN ONCOL, V14, P65, DOI 10.1097/00001622-200201000-00012; Tischoff I, 2005, INT J CANCER, V115, P684, DOI 10.1002/ijc.20944; Tseng RC, 2005, INT J CANCER, V117, P241, DOI 10.1002/ijc.21178; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Vos MD, 2006, J BIOL CHEM, V281, P4557, DOI 10.1074/jbc.M512128200; Vos MD, 2004, CANCER RES, V64, P4244, DOI 10.1158/0008-5472.CAN-04-0339; Wang YC, 1998, CANCER RES, V58, P328; Witcher M, 2009, MOL CELL, V34, P271, DOI 10.1016/j.molcel.2009.04.001; Yan Pearlly S, 2004, Methods Mol Biol, V287, P251; Yan PS, 2003, CANCER RES, V63, P6178; Yau WL, 2006, INT J CANCER, V119, P2821, DOI 10.1002/ijc.22232; Zhang B, 2009, ONCOGENE, V28, P651, DOI 10.1038/onc.2008.419; Zhang DD, 2006, ANAL BIOCHEM, V355, P117, DOI 10.1016/j.ab.2006.04.048	43	11	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2010	5	9							e12847	10.1371/journal.pone.0012847	http://dx.doi.org/10.1371/journal.pone.0012847			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651YH	20877461	Green Published, gold, Green Submitted			2022-12-27	WOS:000281963200016
J	Johnson, EC; Kazgan, N; Bretz, CA; Forsberg, LJ; Hector, CE; Worthen, RJ; Onyenwoke, R; Brenman, JE				Johnson, Erik C.; Kazgan, Nevzat; Bretz, Colin A.; Forsberg, Lawrence J.; Hector, Clare E.; Worthen, Ryan J.; Onyenwoke, Rob; Brenman, Jay E.			Altered Metabolism and Persistent Starvation Behaviors Caused by Reduced AMPK Function in Drosophila	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; DIETARY RESTRICTION; LIFE-SPAN; ABLATION; STRESS; DOMAIN; CELLS; INHIBITION; RESISTANCE; EXERCISE	Organisms must utilize multiple mechanisms to maintain energetic homeostasis in the face of limited nutrient availability. One mechanism involves activation of the heterotrimeric AMP-activated protein kinase (AMPK), a cell-autonomous sensor to energetic changes regulated by ATP to AMP ratios. We examined the phenotypic consequences of reduced AMPK function, both through RNAi knockdown of the gamma subunit (AMPK gamma) and through expression of a dominant negative alpha (AMPK alpha) variant in Drosophila melanogaster. Reduced AMPK signaling leads to hypersensitivity to starvation conditions as measured by lifespan and locomotor activity. Locomotor levels in flies with reduced AMPK function were lower during unstressed conditions, but starvation-induced hyperactivity, an adaptive response to encourage foraging, was significantly higher than in wild type. Unexpectedly, total dietary intake was greater in animals with reduced AMPK function yet total triglyceride levels were lower. AMPK mutant animals displayed starvation-like lipid accumulation patterns in metabolically key liver-like cells, oenocytes, even under fed conditions, consistent with a persistent starved state. Measurements of O-2 consumption reveal that metabolic rates are greater in animals with reduced AMPK function. Lastly, rapamycin treatment tempers the starvation sensitivity and lethality associated with reduced AMPK function. Collectively, these results are consistent with models that AMPK shifts energy usage away from expenditures into a conservation mode during nutrient-limited conditions at a cellular level. The highly conserved AMPK subunits throughout the Metazoa, suggest such findings may provide significant insight for pharmaceutical strategies to manipulate AMPK function in humans.	[Johnson, Erik C.; Bretz, Colin A.; Hector, Clare E.] Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA; [Johnson, Erik C.] Wake Forest Univ, Translat Sci Ctr, Winston Salem, NC 27109 USA; [Kazgan, Nevzat; Forsberg, Lawrence J.; Worthen, Ryan J.; Onyenwoke, Rob; Brenman, Jay E.] Univ N Carolina, Neurosci Ctr, Chapel Hill, NC USA; [Brenman, Jay E.] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC USA	Wake Forest University; Wake Forest University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Johnson, EC (corresponding author), Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA.	johnsoec@wfu.edu; brenman@med.unc.edu		Worthen, Ryan Joseph/0000-0002-2010-5876	Wake Forest University; National Science Foundation (NSF) Integrative Organismal Systems (IOS) [092931]; National Institutes of Health (NIH) [MH073155]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS080108] Funding Source: NIH RePORTER	Wake Forest University; National Science Foundation (NSF) Integrative Organismal Systems (IOS)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by the Science Research Fund of Wake Forest University and National Science Foundation (NSF) Integrative Organismal Systems (IOS) grant 092931 to ECJ and National Institutes of Health (NIH) grant MH073155 to JEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Anzi B, 2006, CURR BIOL, V16, P1034, DOI 10.1016/j.cub.2006.04.002; Alarcon CM, 1999, MOL BIOL CELL, V10, P2531, DOI 10.1091/mbc.10.8.2531; Birk JB, 2006, J PHYSIOL-LONDON, V577, P1021, DOI 10.1113/jphysiol.2006.120972; BLAND ML, 2010, DEV BIOL IN PRESS; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; CARRERA AC, 1993, P NATL ACAD SCI USA, V90, P442, DOI 10.1073/pnas.90.2.442; Claret M, 2007, J CLIN INVEST, V117, P2325, DOI 10.1172/JCI31516; Deshmukh AS, 2008, MOL ENDOCRINOL, V22, P1105, DOI 10.1210/me.2007-0448; Dowling RJO, 2010, BBA-PROTEINS PROTEOM, V1804, P433, DOI 10.1016/j.bbapap.2009.12.001; Dzamko N, 2010, J BIOL CHEM, V285, P115, DOI 10.1074/jbc.M109.056762; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Greer EL, 2009, AGING CELL, V8, P113, DOI 10.1111/j.1474-9726.2009.00459.x; Gronke S, 2003, CURR BIOL, V13, P603, DOI 10.1016/S0960-9822(03)00175-1; Gutierrez E, 2007, NATURE, V445, P275, DOI 10.1038/nature05382; Hector CE, 2009, J EXP BIOL, V212, P3142, DOI 10.1242/jeb.033175; Hennig KM, 2002, GENESIS, V34, P107, DOI 10.1002/gene.10139; Isabel G, 2005, AM J PHYSIOL-REG I, V288, pR531, DOI 10.1152/ajpregu.00158.2004; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; Johnson EC, 2009, HORMONES, BRAIN AND BEHAVIOR, VOLS 1-5, 2ND EDITION, P1069; KAMPS MP, 1986, MOL CELL BIOL, V6, P751, DOI 10.1128/MCB.6.3.751; Lee GH, 2004, GENETICS, V167, P311, DOI 10.1534/genetics.167.1.311; Lee HJ, 2008, J BIOL CHEM, V283, P14988, DOI 10.1074/jbc.M709115200; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Melcher C, 2005, PLOS BIOL, V3, P1618, DOI 10.1371/journal.pbio.0030305; Mirouse V, 2007, J CELL BIOL, V177, P387, DOI 10.1083/jcb.200702053; Nagata D, 2003, J BIOL CHEM, V278, P31000, DOI 10.1074/jbc.M300643200; Nagata D, 2009, HYPERTENS RES, V32, P133, DOI 10.1038/hr.2008.25; Narbonne P, 2009, NATURE, V457, P210, DOI 10.1038/nature07536; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Pan DA, 2002, BIOCHEM J, V367, P179, DOI 10.1042/BJ20020703; Poels J, 2009, BIOESSAYS, V31, P944, DOI 10.1002/bies.200900003; Riek U, 2008, J BIOL CHEM, V283, P18331, DOI 10.1074/jbc.M708379200; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Schulz C, 2001, DEV GENES EVOL, V211, P581, DOI 10.1007/s00427-001-0194-z; Spasic MR, 2008, J NEUROSCI, V28, P6419, DOI 10.1523/JNEUROSCI.1646-08.2008; SULLIVAN JE, 1994, FEBS LETT, V353, P33, DOI 10.1016/0014-5793(94)01006-4; Tohyama D, 2010, BIOCHEM BIOPH RES CO, V394, P112, DOI 10.1016/j.bbrc.2010.02.126; Viollet B, 2009, FRONT BIOSCI-LANDMRK, V14, P3380, DOI 10.2741/3460; Williams T, 2009, AUTOPHAGY, V5, P1155, DOI 10.4161/auto.5.8.10090; Winder WW, 2007, CELL BIOCHEM BIOPHYS, V47, P332, DOI 10.1007/s12013-007-0008-7; Woods A, 2000, MOL CELL BIOL, V20, P6704, DOI 10.1128/MCB.20.18.6704-6711.2000; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9; Zang MW, 2004, J BIOL CHEM, V279, P47898, DOI 10.1074/jbc.M408149200; Zhao Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009141	44	64	67	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2010	5	9							e12799	10.1371/journal.pone.0012799	http://dx.doi.org/10.1371/journal.pone.0012799			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651YH	20862213	gold, Green Published, Green Submitted			2022-12-27	WOS:000281963200005
J	Moore, ME; Goetz, FA; Van Doornik, DM; Tezak, EP; Quinn, TP; Reyes-Tomassini, JJ; Berejikian, BA				Moore, Megan E.; Goetz, Fred A.; Van Doornik, Donald M.; Tezak, Eugene P.; Quinn, Thomas P.; Reyes-Tomassini, Jose J.; Berejikian, Barry A.			Early Marine Migration Patterns of Wild Coastal Cutthroat Trout (Oncorhynchus clarki clarki), Steelhead Trout (Oncorhynchus mykiss), and Their Hybrids	PLOS ONE			English	Article							NATURAL HYBRIDIZATION; JUVENILE STEELHEAD; RAINBOW-TROUT; COHO SALMON; INTROGRESSION; RIVER; SURVIVAL; BEHAVIOR; IRIDEUS; SMOLTS	Background: Hybridization between coastal cutthroat trout (Oncorhynchus clarki clarki) and steelhead or rainbow trout (Oncorhynchus mykiss) has been documented in several streams along the North American west coast. The two species occupy similar freshwater habitats but the anadromous forms differ greatly in the duration of marine residence and migration patterns at sea. Intermediate morphological, physiological, and performance traits have been reported for hybrids but little information has been published comparing the behavior of hybrids to the pure species. Methodology/Principal Findings: This study used acoustic telemetry to record the movements of 52 cutthroat, 42 steelhead x cutthroat hybrids, and 89 steelhead smolts, all wild, that migrated from Big Beef Creek into Hood Canal (Puget Sound, Washington). Various spatial and temporal metrics were used to compare the behavior of the pure species to their hybrids. Median hybrid residence time, estuary time, and tortuosity values were intermediate compared to the pure species. The median total track distance was greater for hybrids than for either cutthroat or steelhead. At the end of each track, most steelhead (80%) were located near or north of the Hood Canal, as expected for this seaward migrating species, whereas most cutthroat (89%) were within 8 kilometers of the estuary. Most hybrids (70%) were detected leaving Hood Canal, though a substantial percentage (20%) remained near the Big Beef Creek estuary. More hybrids (7.5%) than pure cutthroat (4.5%) or steelhead (0.0%) were last detected in the southern reaches of Hood Canal. Conclusions/Significance: Given the similarity in freshwater ecology between the species, differences in marine ecology may play an important role in maintaining species integrity in areas of sympatry.	[Moore, Megan E.; Tezak, Eugene P.; Reyes-Tomassini, Jose J.; Berejikian, Barry A.] NW Fisheries Sci Ctr, Resource Enhancement & Utilizat Technol Div, Natl Ocean & Atmospher Adm Fisheries, Manchester Res Stn, Manchester, WA USA; [Goetz, Fred A.; Quinn, Thomas P.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Van Doornik, Donald M.] NW Fisheries Sci Ctr, Conservat Biol Div, Natl Ocean & Atmospher Adm Fisheries, Manchester Res Stn, Manchester, WA USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Washington; University of Washington Seattle; National Oceanic Atmospheric Admin (NOAA) - USA	Moore, ME (corresponding author), NW Fisheries Sci Ctr, Resource Enhancement & Utilizat Technol Div, Natl Ocean & Atmospher Adm Fisheries, Manchester Res Stn, Manchester, WA USA.	megan.moore@noaa.gov		Berejikian, Barry/0000-0003-2933-7806	National Oceanic and Atmospheric Administration (NOAA)	National Oceanic and Atmospheric Administration (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA)	This study was primarily funded by the National Oceanic and Atmospheric Administration (NOAA), with some acoustic tags provided by the Army Corps of Engineers. Those who determine fund allocation within NOAA had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLENDORF F W, 1988, Conservation Biology, V2, P170, DOI 10.1111/j.1523-1739.1988.tb00168.x; Allendorf FW, 2001, TRENDS ECOL EVOL, V16, P613, DOI 10.1016/S0169-5347(01)02290-X; ANDERSON BW, 1971, CONDOR, V73, P342, DOI 10.2307/1365761; [Anonymous], 1963, ANIMAL SPECIES EVOLU; Arnold M.L., 2006, EVOLUTION GENETIC EX, P271; ARNOLD ML, 1995, TRENDS ECOL EVOL, V10, P67, DOI 10.1016/S0169-5347(00)88979-X; Baker J, 2002, T AM FISH SOC, V131, P404, DOI 10.1577/1548-8659(2002)131&lt;0404:MMDCCT&gt;2.0.CO;2; Banks MA, 1999, J HERED, V90, P281, DOI 10.1093/jhered/90.2.281; Baumsteiger J, 2005, T AM FISH SOC, V134, P829, DOI 10.1577/T04-114.1; Behnke R.J., 1992, AM FISHERIES SOC AM, V6, P275; Bettles CM, 2005, J EVOLUTION BIOL, V18, P1220, DOI 10.1111/j.1420-9101.2005.00935.x; BETTLES CM, 2004, THESIS U WINDSOR WIN; BISSON PA, 1988, T AM FISH SOC, V117, P262, DOI 10.1577/1548-8659(1988)117<0262:CHHUAB>2.3.CO;2; BUCHHOLZ WS, 1999, SUMMARY PCR PRIMERS, P99; Burgner R. L., 1992, INT N PACIFIC FISHER, V51; BUSACK CA, 1981, CAN J FISH AQUAT SCI, V38, P939, DOI 10.1139/f81-127; Busby P. J. T. C., 1996, NMFSNWFSC27 NOAA US; CAMPTON DE, 1985, CAN J FISH AQUAT SCI, V42, P110, DOI 10.1139/f85-014; CANDOLIN U, 2006, EVOL BIOL, V20, P233; Chittenden CM, 2008, J FISH BIOL, V72, P614, DOI 10.1111/j.1095-8649.2007.01729.x; DEMARAIS BD, 1992, P NATL ACAD SCI USA, V89, P2747, DOI 10.1073/pnas.89.7.2747; Dowling TE, 1997, ANNU REV ECOL SYST, V28, P593, DOI 10.1146/annurev.ecolsys.28.1.593; Gargett AE, 1997, FISH OCEANOGR, V6, P109, DOI 10.1046/j.1365-2419.1997.00033.x; GIGER RD, 1972, 6 OR STAT GAM COMM; GOETZ FA, HOOD CANAL UNPUB; Gompert Z, 2006, SCIENCE, V314, P1923, DOI 10.1126/science.1135875; Goodman SJ, 1999, GENETICS, V152, P355; GRANT PR, 1992, SCIENCE, V256, P193, DOI 10.1126/science.256.5054.193; Hawkins DK, 1998, CAN J FISH AQUAT SCI, V55, P2097, DOI 10.1139/cjfas-55-9-2097; Hawkins DK, 1996, CAN J FISH AQUAT SCI, V53, P1487, DOI 10.1139/cjfas-53-7-1487; HAWKINS DK, 1997, THESIS U WASHINGTON; HUBBS CL, 1955, SYST ZOOL, V4, P1, DOI 10.2307/2411933; Johnson O.W., 1999, NOAA TECHNICAL MEMOR; Kennedy BM, 2009, MAR COAST FISH, V1, P45, DOI 10.1577/C08-006.1; KOKKO H, 2008, PHILOS T R SOC B, V361, P319; LEARY RF, 1995, AM FISH S S, V15, P91; LEWONTIN RC, 1966, EVOLUTION, V20, P315, DOI 10.1111/j.1558-5646.1966.tb03369.x; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; MCCONNELL RJ, 1972, KEY FIELD IDENTIFICA; Melnychuk MC, 2007, HYDROBIOLOGIA, V582, P55, DOI 10.1007/s10750-006-0541-1; Moore ME, 2010, T AM FISH SOC, V139, P49, DOI 10.1577/T09-012.1; Muhlfeld CC, 2009, BIOL LETTERS, V5, P328, DOI 10.1098/rsbl.2009.0033; Nelson RJ, 1999, ANIM GENET, V30, P228, DOI 10.1046/j.1365-2052.1999.00404-4.x; Ostberg CO, 2004, MOL ECOL, V13, P2773, DOI 10.1111/j.1365-294X.2004.02268.x; Ostberg CO, 2004, MOL ECOL NOTES, V4, P26, DOI 10.1046/j.1471-8286.2003.00554.x; QUINN TP, 2005, FISCH OCEANOGR, V6, P109; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; Seehausen O, 2008, MOL ECOL, V17, P30, DOI 10.1111/j.1365-294X.2007.03529.x; TROTTER PC, 1989, T AM FISH SOC, V118, P463, DOI 10.1577/1548-8659(1989)118<0463:CCTALH>2.3.CO;2; Welch DW, 2002, OCEANOL ACTA, V25, P243, DOI 10.1016/S0399-1784(02)01206-9; Wenburg JK, 1998, MOL ECOL, V7, P733, DOI 10.1046/j.1365-294x.1998.00386.x; Williams I, 2007, T AM FISH SOC, V136, P926, DOI 10.1577/T06-214.1; Young WP, 2001, MOL ECOL, V10, P921, DOI 10.1046/j.1365-294X.2001.01247.x	54	29	30	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2010	5	9							e12881	10.1371/journal.pone.0012881	http://dx.doi.org/10.1371/journal.pone.0012881			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651YH	20862225	gold, Green Published, Green Submitted			2022-12-27	WOS:000281963200024
J	Fuller, K; Ross, JL; Szewczyk, KA; Moss, R; Chambers, TJ				Fuller, Karen; Ross, Jade L.; Szewczyk, Kinga A.; Moss, Raymond; Chambers, Tim J.			Bone Is Not Essential for Osteoclast Activation	PLOS ONE			English	Article							ISOLATED RABBIT OSTEOCLASTS; VITRONECTIN RECEPTOR; SEALING ZONE; IN-VITRO; CYTOSKELETAL ORGANIZATION; ALPHA(V)BETA(3) INTEGRIN; RESORBING OSTEOCLASTS; CULTURED OSTEOCLASTS; EXTRACELLULAR-MATRIX; PARATHYROID-HORMONE	Background: The mechanism whereby bone activates resorptive behavior in osteoclasts, the cells that resorb bone, is unknown. It is known that alpha(v)beta(3) ligands are important, because blockade of alpha(v)beta(3) receptor signaling inhibits bone resorption, but this might be through inhibition of adhesion or migration rather than resorption itself. Nor is it known whether alpha(v)beta(3) ligands are sufficient for resorption the consensus is that bone mineral is essential for the recognition of bone as the substrate appropriate for resorption. Methodology/Principal Findings: Vitronectin-but not fibronectin-coated coverslips induced murine osteoclasts to secrete tartrate-resistant acid phosphatase, as they do on bone. Osteoclasts incubated on vitronectin, unlike fibronectin, formed podosome belts on glass coverslips, and these were modulated by resorption-regulating cytokines. Podosome belts formed on vitronectin-coated surfaces whether the substrates were rough or smooth, rigid or flexible. We developed a novel approach whereby the substrate-apposed surface of cells can be visualized in the scanning electron microscope. With this approach, supported by transmission electron microscopy, we found that osteoclasts on vitronectin-coated surfaces show ruffled borders and clear zones characteristic of resorbing osteoclasts. Ruffles were obscured by a film if cells were incubated in the cathepsin inhibitor E64, suggesting that removal of the film represents substrate-degrading behavior. Analogously, osteoclasts formed resorption-like trails on vitronectin-coated substrates. Like bone resorption, these trails were dependent upon resorbogenic cytokines and were inhibited by E64. Bone mineral induced actin rings and surface excavation only if first coated with vitronectin. Fibronectin could not substitute in any of these activities, despite enabling adhesion and cell spreading. Conclusions/Significance: Our results show that ligands alpha(v)beta(3) are not only necessary but sufficient for the induction of resorptive behavior in osteoclasts; and suggest that bone is recognized through its affinity for these ligands, rather than by its mechanical or topographical attributes, or through a putative 'mineral receptor'.	[Fuller, Karen; Ross, Jade L.; Szewczyk, Kinga A.; Moss, Raymond; Chambers, Tim J.] St Georges Univ London, Div Basic Med Sci, London, England	St Georges University London	Fuller, K (corresponding author), St Georges Univ London, Div Basic Med Sci, London, England.	tchamber@sgul.ac.uk			St George's, University of London	St George's, University of London	This work was supported by St George's, University of London (www.sgul.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAI N, 1995, J BONE MINER RES, V10, P1209; Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Baharloo B, 2005, J BIOMED MATER RES A, V74A, P12, DOI 10.1002/jbm.a.30321; BIANCO P, 1991, CALCIFIED TISSUE INT, V49, P421, DOI 10.1007/BF02555854; BOSKEY AL, 1993, BONE MINER, V22, P147, DOI 10.1016/S0169-6009(08)80225-5; BOYCE BF, 1992, J CLIN INVEST, V90, P1622, DOI 10.1172/JCI116032; BOYD NAM, 1993, J CLIN PATHOL, V46, P1042, DOI 10.1136/jcp.46.11.1042; Burgess TL, 1999, J CELL BIOL, V145, P527, DOI 10.1083/jcb.145.3.527; CHAMBERS TJ, 1991, VITAM HORM, V46, P41; CHAMBERS TJ, 1984, J CELL SCI, V66, P383; CHAMBERS TJ, 1984, J CELL SCI, V70, P61; CHAMBERS TJ, 1985, J CELL SCI, V76, P155; Chambers TJ, 2000, J PATHOL, V192, P4; CHAMBERS TJ, 1986, BONE MINER, V1, P127; CHARO IF, 1990, J CELL BIOL, V111, P2795, DOI 10.1083/jcb.111.6.2795; DODDS RA, 1995, J BONE MINER RES, V10, P1666; Duong L, 2000, MATRIX BIOL, V19, P97, DOI 10.1016/S0945-053X(00)00051-2; Engelman VW, 1997, J CLIN INVEST, V99, P2284, DOI 10.1172/JCI119404; Felsenfeld DP, 1999, NAT CELL BIOL, V1, P200, DOI 10.1038/12021; FISHER JE, 1993, ENDOCRINOLOGY, V132, P1411, DOI 10.1210/en.132.3.1411; Fuller K, 2006, ENDOCRINOLOGY, V147, P1979, DOI 10.1210/en.2005-1340; FULLER K, 1993, J EXP MED, V178, P1733, DOI 10.1084/jem.178.5.1733; GEBLINGER D, 2010, J CELL SCI; Geblinger D, 2009, CHEMBIOCHEM, V10, P158, DOI 10.1002/cbic.200800549; Grossner-Schreiber B, 2006, CLIN ORAL IMPLAN RES, V17, P736, DOI 10.1111/j.1600-0501.2006.01277.x; Holliday LS, 1997, J BIOL CHEM, V272, P22053, DOI 10.1074/jbc.272.35.22053; HOLTROP ME, 1974, J CELL BIOL, V60, P346, DOI 10.1083/jcb.60.2.346; HORNE WC, 1992, J CELL BIOL, V119, P1003, DOI 10.1083/jcb.119.4.1003; HORTON MA, 1991, EXP CELL RES, V195, P368, DOI 10.1016/0014-4827(91)90386-9; Huang HH, 2004, BIOMOL ENG, V21, P93, DOI 10.1016/j.bioeng.2004.05.001; HUGHES DE, 1993, J BONE MINER RES, V8, P527; Huq NL, 2000, J MOL MODEL, V6, P35; Jurdic P, 2006, EUR J CELL BIOL, V85, P195, DOI 10.1016/j.ejcb.2005.09.008; Kirstein B, 2006, J CELL BIOCHEM, V98, P1085, DOI 10.1002/jcb.20835; Lakkakorpi PT, 1996, MICROSC RES TECHNIQ, V33, P171, DOI 10.1002/(SICI)1097-0029(19960201)33:2<171::AID-JEMT7>3.0.CO;2-W; LAKKAKORPI PT, 1991, J CELL BIOL, V115, P1179, DOI 10.1083/jcb.115.4.1179; LAKKAKORPI PT, 1990, J HISTOCHEM CYTOCHEM, V38, P1487, DOI 10.1177/38.10.2169493; LAKKAKORPI PT, 1993, J CELL SCI, V104, P663; LOWE C, 1993, P NATL ACAD SCI USA, V90, P4485, DOI 10.1073/pnas.90.10.4485; Luxenburg C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000179; MCSHEEHY PMJ, 1986, ENDOCRINOLOGY, V118, P824, DOI 10.1210/endo-118-2-824; Nakamura I, 1999, J CELL SCI, V112, P3985; Nakamura I, 2002, J IMMUNOL, V168, P5103, DOI 10.4049/jimmunol.168.10.5103; Nakamura I, 1996, J BONE MINER RES, V11, P1873; OLDBERG A, 1986, P NATL ACAD SCI USA, V83, P8819, DOI 10.1073/pnas.83.23.8819; Orr AW, 2006, MOL BIOL CELL, V17, P4686, DOI 10.1091/mbc.E06-04-0289; ROBEY PG, 1989, J CELL BIOL, V108, P719, DOI 10.1083/jcb.108.2.719; Saltel F, 2004, MOL BIOL CELL, V15, P5231, DOI 10.1091/mbc.E04-06-0522; Saltel F, 2008, EUR J CELL BIOL, V87, P459, DOI 10.1016/j.ejcb.2008.01.001; SHAFFER MC, 1984, J LAB CLIN MED, V103, P783; Shyu JF, 2007, BONE, V40, P1329, DOI 10.1016/j.bone.2007.01.014; Stenbeck G, 2002, SEMIN CELL DEV BIOL, V13, P285, DOI 10.1016/S1084952102000587; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; TETI A, 1991, AM J PHYSIOL, V261, pC1, DOI 10.1152/ajpcell.1991.261.1.C1; TEZUKA K, 1992, J BONE MINER RES, V7, pS130; TURKSEN K, 1988, J BONE MINER RES, V3, P389; Vaananen HK, 2000, J CELL SCI, V113, P377	57	35	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2010	5	9							e12837	10.1371/journal.pone.0012837	http://dx.doi.org/10.1371/journal.pone.0012837			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651XL	20862258	Green Published, gold, Green Submitted			2022-12-27	WOS:000281960800025
J	Halton, KA; Cook, D; Paterson, DL; Safdar, N; Graves, N				Halton, Kate A.; Cook, David; Paterson, David L.; Safdar, Nasia; Graves, Nicholas			Cost-Effectiveness of a Central Venous Catheter Care Bundle	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; QUALITY-OF-LIFE; AUSTRALIA; ECONOMICS	Background: A bundled approach to central venous catheter care is currently being promoted as an effective way of preventing catheter-related bloodstream infection (CR-BSI). Consumables used in the bundled approach are relatively inexpensive which may lead to the conclusion that the bundle is cost-effective. However, this fails to consider the nontrivial costs of the monitoring and education activities required to implement the bundle, or that alternative strategies are available to prevent CR-BSI. We evaluated the cost-effectiveness of a bundle to prevent CR-BSI in Australian intensive care patients. Methods and Findings: A Markov decision model was used to evaluate the cost-effectiveness of the bundle relative to remaining with current practice (a non-bundled approach to catheter care and uncoated catheters), or use of antimicrobial catheters. We assumed the bundle reduced relative risk of CR-BSI to 0.34. Given uncertainty about the cost of the bundle, threshold analyses were used to determine the maximum cost at which the bundle remained cost-effective relative to the other approaches to infection control. Sensitivity analyses explored how this threshold alters under different assumptions about the economic value placed on bed-days and health benefits gained by preventing infection. If clinicians are prepared to use antimicrobial catheters, the bundle is cost-effective if national 18-month implementation costs are below $1.1 million. If antimicrobial catheters are not an option the bundle must cost less than $4.3 million. If decision makers are only interested in obtaining cash-savings for the unit, and place no economic value on either the bed-days or the health benefits gained through preventing infection, these cost thresholds are reduced by two-thirds. Conclusions: A catheter care bundle has the potential to be cost-effective in the Australian intensive care setting. Rather than anticipating cash-savings from this intervention, decision makers must be prepared to invest resources in infection control to see efficiency improvements.	[Halton, Kate A.; Paterson, David L.; Graves, Nicholas] Ctr Healthcare Related Infect Surveillance & Prev, Brisbane, Qld, Australia; [Halton, Kate A.; Graves, Nicholas] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Cook, David] Princess Alexandra Hosp, Intens Care Unit, Brisbane, Qld 4102, Australia; [Paterson, David L.] Univ Queensland, Clin Res Ctr, Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia; [Safdar, Nasia] Univ Wisconsin, Dept Med, Infect Dis Sect, Sch Med & Publ Hlth, Madison, WI USA	Queensland University of Technology (QUT); Royal Brisbane & Women's Hospital; University of Queensland; University of Wisconsin System; University of Wisconsin Madison	Halton, KA (corresponding author), Ctr Healthcare Related Infect Surveillance & Prev, Brisbane, Qld, Australia.	k.halton@qut.edu.au	Cook, David/D-7318-2013; Graves, Nicholas/A-3052-2011; Paterson, David L/A-9258-2010; Halton, Kate/I-9964-2012	Graves, Nicholas/0000-0002-5559-3267; Paterson, David/0000-0003-2079-4437; Halton, Kate/0000-0001-9785-1458	Queensland Health Quality and Safety Programme; National Health and Medical Research Council	Queensland Health Quality and Safety Programme; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The Queensland Health Quality and Safety Programme and a National Health and Medical Research Council project grant provided support for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboelela SW, 2007, J HOSP INFECT, V66, P101, DOI 10.1016/j.jhin.2006.10.019; *AUST I HLTH WELF, 2006, AUST HLTH 2006; Berenholtz SM, 2004, CRIT CARE MED, V32, P2014, DOI 10.1097/01.CCM.0000142399.70913.2F; Berwick DM, 2006, JAMA-J AM MED ASSOC, V295, P324, DOI 10.1001/jama.295.3.324; Blot SI, 2005, CLIN INFECT DIS, V41, P1591, DOI 10.1086/497833; *BUR LAB STAT, BUR LAB STAT CONS PR; Cooper Nicola, 2005, J Health Serv Res Policy, V10, P245, DOI 10.1258/135581905774414187; Cuthbertson BH, 2005, ANAESTHESIA, V60, P332, DOI 10.1111/j.1365-2044.2004.04109.x; Devlin N, 2004, HEALTH ECON, V13, P437, DOI 10.1002/hec.864; Dowdy DW, 2005, INTENS CARE MED, V31, P611, DOI 10.1007/s00134-005-2592-6; Drummond MF, 2005, METHODS EC EVALUATIO, P27; Gastmeier P, 2006, J HOSP INFECT, V64, P326, DOI 10.1016/j.jhin.2006.07.005; George B, 2001, PHARMACOECONOMICS, V19, P1103, DOI 10.2165/00019053-200119110-00004; Gold MR, 1996, COST EFFECTIVENESS H; Graves N, 2005, WOUND REPAIR REGEN, V13, P462, DOI 10.1111/j.1067-1927.2005.00066.x; Graves N, 2004, EMERG INFECT DIS, V10, P561, DOI 10.3201/eid1004.020754; Graves N., 2008, HEALTHCARE INFECT, V13, P48; GRAVES N, 2008, REDUCING HARM PATIEN; Graves N, 2008, JAMA-J AM MED ASSOC, V300, P1577, DOI 10.1001/jama.300.13.1577; Graves N, 2007, INFECT CONT HOSP EP, V28, P178, DOI 10.1086/510787; Halton K, 2007, EMERG INFECT DIS, V13, P815, DOI 10.3201/eid1306.070048; Halton KA, 2009, CRIT CARE, V13, DOI 10.1186/cc7744; Harbarth S, 2003, J HOSP INFECT, V54, P258, DOI 10.1016/S0195-6701(03)00150-6; Hawthorne G, 2005, AUST NZ J PUBL HEAL, V29, P136, DOI 10.1111/j.1467-842X.2005.tb00063.x; Kahn JM, 2008, MED CARE, V46, P1226, DOI 10.1097/MLR.0b013e31817d9342; MARTIN J, 2006, INTENSIVE CARE RESOU; McConnell SA, 2003, CLIN INFECT DIS, V37, P65, DOI 10.1086/375227; McLaws ML, 2005, INFECT CONT HOSP EP, V26, P715, DOI 10.1086/502608; Morton AP, 2008, INFECT CONT HOSP EP, V29, P695, DOI 10.1086/589904; Oda T, 1997, ANESTHESIOLOGY, V87, P1242, DOI 10.1097/00000542-199711000-00031; Pronovost P, 2003, J CRIT CARE, V18, P71, DOI 10.1053/jcrc.2003.50008; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Pronovost Peter J, 2004, Jt Comm J Qual Saf, V30, P59; PRONOVOST PJ, 2005, HLTH EXEC, V20, P15; PRONOVOST PJ, 2005, J PATIENT SAF, V1, P33; Ramritu P, 2008, AM J INFECT CONTROL, V36, P104, DOI 10.1016/j.ajic.2007.02.012; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; Rechner IJ, 2005, ANAESTH INTENS CARE, V33, P477, DOI 10.1177/0310057X0503300409; Roberts RR, 1999, JAMA-J AM MED ASSOC, V281, P644, DOI 10.1001/jama.281.7.644; SHIROIWA T, 2009, HLTH EC; Ward William J Jr, 2006, Healthc Financ Manage, V60, P92; Warren DK, 2006, CRIT CARE MED, V34, P2084, DOI 10.1097/01.CCM.0000227648.15804.2D; Williams TA, 2006, ANAESTH INTENS CARE, V34, P307, DOI 10.1177/0310057X0603400316; 2008, FED REG, V73, P48434; 2005, MMWR MORBIDITY MORTA, V54, P1013	45	40	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2010	5	9							e12815	10.1371/journal.pone.0012815	http://dx.doi.org/10.1371/journal.pone.0012815			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	651XL	20862246	gold, Green Submitted, Green Published			2022-12-27	WOS:000281960800016
J	Yang, FK; Ke, YH; Tan, YF; Bi, YJ; Shi, QH; Yang, HY; Qiu, JF; Wang, XY; Guo, ZB; Ling, H; Yang, RF; Du, ZM				Yang, Fengkun; Ke, Yuehua; Tan, Yafang; Bi, Yujing; Shi, Qinghai; Yang, Huiying; Qiu, Jinfu; Wang, Xiaoyi; Guo, Zhaobiao; Ling, Hong; Yang, Ruifu; Du, Zongmin			Cell Membrane Is Impaired, Accompanied by Enhanced Type III Secretion System Expression in Yersinia pestis Deficient in RovA Regulator	PLOS ONE			English	Article							ESCHERICHIA-COLI; H-NS; TRANSCRIPTIONAL REGULATOR; GENOME SEQUENCE; VIRULENCE; ENTEROCOLITICA; PROTEIN; PSEUDOTUBERCULOSIS; TRANSLOCATION; ACTIVATOR	Background: In the enteropathogenic Yersinia species, RovA regulates the expression of invasin, which is important for enteropathogenic pathogenesis but is inactivated in Yersinia pestis. Investigation of the RovA regulon in Y. pestis at 26 degrees C has revealed that RovA is a global regulator that contributes to virulence in part by the direct regulation of psaEFABC. However, the regulatory roles of RovA in Y. pestis at 37 degrees C, which allows most virulence factors in mammalian hosts to be expressed, are still poorly understood. Methodology/Principal Findings: The transcriptional profile of an in-frame rovA mutant of Y. pestis biovar Microtus strain 201 was analyzed under type III secretion system (T3SS) induction conditions using microarray techniques, and it was revealed that many cell-envelope and transport/binding proteins were differentially expressed in the Delta rovA mutant. Most noticeably, many of the T3SS genes, including operons encoding the translocon, needle and Yop (Yersinia outer protein) effectors, were significantly up-regulated. Analysis of Yop proteins confirmed that YopE and YopJ were also expressed in greater amounts in the mutant. However, electrophoresis mobility shift assay results demonstrated that the His-RovA protein could not bind to the promoter sequences of the T3SS genes, suggesting that an indirect regulatory mechanism is involved. Transmission electron microscopy analysis indicated that there are small loose electron dense particle-like structures that surround the outer membrane of the mutant cells. The bacterial membrane permeability to CFSE (carboxyfluorescein diacetate succinimidyl ester) was significantly decreased in the Delta rovA mutant compared to the wild-type strain. Taken together, these results revealed the improper construction and dysfunction of the membrane in the Delta rovA mutant. Conclusions/Significance: We demonstrated that the RovA regulator plays critical roles in the construction and functioning of the bacterial membrane, which sheds considerable light on the regulatory functions of RovA in antibiotic resistance and environmental adaptation. The expression of T3SS was upregulated in the Delta rovA mutant through an indirect regulatory mechanism, which is possibly related to the altered membrane construction in the mutant.	[Yang, Fengkun; Ling, Hong] Harbin Med Univ, Dept Parasitol, Harbin, Heilongjiang, Peoples R China; [Yang, Fengkun; Ke, Yuehua; Tan, Yafang; Bi, Yujing; Shi, Qinghai; Yang, Huiying; Qiu, Jinfu; Wang, Xiaoyi; Guo, Zhaobiao; Yang, Ruifu; Du, Zongmin] Acad Mil Med Sci, Inst Microbiol & Epidemiol, Lab Analyt Microbiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China	Harbin Medical University; Academy of Military Medical Sciences - China	Ling, H (corresponding author), Harbin Med Univ, Dept Parasitol, Harbin, Heilongjiang, Peoples R China.	Profling2003@yahoo.com; ruifuyang@gmail.com; zongmindu@gmail.com		ling, hong/0000-0002-1886-1242	National Natural Science Foundation of China [30970121, 30430620]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Financial support for this work came from the National Natural Science Foundation of China (No. 30970121, No. 30430620). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWN WF, 1964, AM J HYG, V79, P37, DOI 10.1093/oxfordjournals.aje.a120362; Brzostek K, 2007, FOLIA MICROBIOL, V52, P73, DOI 10.1007/BF02932142; Butler T, 2009, CLIN INFECT DIS, V49, P736, DOI 10.1086/604718; Cathelyn JS, 2007, MOL MICROBIOL, V66, P189, DOI 10.1111/j.1365-2958.2007.05907.x; Cathelyn JS, 2006, P NATL ACAD SCI USA, V103, P13514, DOI 10.1073/pnas.0603456103; CORNELIS G, 1989, J BACTERIOL, V171, P254, DOI 10.1128/jb.171.1.254-262.1989; Cornelis GR, 2000, PHILOS T R SOC B, V355, P681, DOI 10.1098/rstb.2000.0608; Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Day JB, 2003, MOL MICROBIOL, V47, P807, DOI 10.1046/j.1365-2958.2003.03343.x; Du YD, 2002, INFECT IMMUN, V70, P1453, DOI 10.1128/IAI.70.3.1453-1460.2002; Ellison DW, 2006, J BACTERIOL, V188, P5101, DOI 10.1128/JB.00862-05; Ellison DW, 2004, TRENDS MICROBIOL, V12, P296, DOI 10.1016/j.tim.2004.04.006; Francis MS, 2002, CURR OPIN MICROBIOL, V5, P166, DOI 10.1016/S1369-5274(02)00301-6; Gao H, 2008, J BACTERIOL, V190, P3063, DOI 10.1128/JB.01910-07; Han YP, 2004, MICROBIOL IMMUNOL, V48, P791, DOI 10.1111/j.1348-0421.2004.tb03605.x; Herbst K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000435; Heroven AK, 2004, MOL MICROBIOL, V53, P871, DOI 10.1111/j.1365-2958.2004.04162.x; Heroven AK, 2008, MOL MICROBIOL, V68, P1179, DOI 10.1111/j.1365-2958.2008.06218.x; HOE NP, 1993, J BACTERIOL, V175, P7901, DOI 10.1128/JB.175.24.7901-7909.1993; Hoefel D, 2003, J MICROBIOL METH, V52, P379, DOI 10.1016/S0167-7012(02)00207-5; Huang XX, 2004, FEMS MICROBIOL LETT, V234, P239, DOI 10.1016/j.femsle.2004.03.030; Iriarte M, 1998, EMBO J, V17, P1907, DOI 10.1093/emboj/17.7.1907; Li YL, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-128; Motin VL, 2004, J BACTERIOL, V186, P6298, DOI 10.1128/JB.186.18.6298-6305.2004; Nagel G, 2001, MOL MICROBIOL, V41, P1249, DOI 10.1046/j.1365-2958.2001.02522.x; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Revell PA, 2000, MOL MICROBIOL, V35, P677, DOI 10.1046/j.1365-2958.2000.01740.x; SKRZYPEK E, 1993, J BACTERIOL, V175, P3520, DOI 10.1128/jb.175.11.3520-3528.1993; SODEINDE OA, 1992, SCIENCE, V258, P1004, DOI 10.1126/science.1439793; Song YJ, 2004, DNA RES, V11, P179, DOI 10.1093/dnares/11.3.179; Spory A, 2002, J BACTERIOL, V184, P3549, DOI 10.1128/JB.184.13.3549-3559.2002; Stapleton MR, 2002, J BIOL CHEM, V277, P17630, DOI 10.1074/jbc.M110178200; Stenseth NC, 2008, PLOS MED, V5, P9, DOI 10.1371/journal.pmed.0050003; Tampakaki AP, 2004, CELL MICROBIOL, V6, P805, DOI 10.1111/j.1462-5822.2004.00432.x; Tran HJ, 2005, J BIOL CHEM, V280, P42423, DOI 10.1074/jbc.M504464200; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; WESTON SA, 1990, J IMMUNOL METHODS, V133, P87, DOI 10.1016/0022-1759(90)90322-M; Williams AW, 1998, J BACTERIOL, V180, P350, DOI 10.1128/JB.180.2.350-358.1998; Wulff-Strobel CR, 2002, MOL MICROBIOL, V43, P411, DOI 10.1046/j.1365-2958.2002.02752.x; Wyborn NR, 2004, J BACTERIOL, V186, P1620, DOI 10.1128/JB.186.6.1620-1628.2004; Zavyalov VP, 1996, FEMS IMMUNOL MED MIC, V14, P53, DOI 10.1111/j.1574-695X.1996.tb00267.x; Zhou DS, 2004, J BACTERIOL, V186, P5147, DOI 10.1128/jb.186.15.5147-5152.2004	45	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2010	5	9							e12840	10.1371/journal.pone.0012840	http://dx.doi.org/10.1371/journal.pone.0012840			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651XL	20862262	Green Published, gold, Green Submitted			2022-12-27	WOS:000281960800026
J	Gowen, BB; Wong, MH; Larson, D; Ye, W; Jung, KH; Sefing, EJ; Skirpstunas, R; Smee, DF; Morrey, JD; Schneller, SW				Gowen, Brian B.; Wong, Min-Hui; Larson, Deanna; Ye, Wei; Jung, Kie-Hoon; Sefing, Eric J.; Skirpstunas, Ramona; Smee, Donald F.; Morrey, John D.; Schneller, Stewart W.			Development of a New Tacaribe Arenavirus Infection Model and Its Use to Explore Antiviral Activity of a Novel Aristeromycin Analog	PLOS ONE			English	Article							ARGENTINE HEMORRHAGIC-FEVER; S-ADENOSYLHOMOCYSTEINE HYDROLASE; CARBOCYCLIC ADENOSINE-ANALOGS; GAMMA-INTERFERONS; VIRUS-INFECTION; LASSA FEVER; GUINEA-PIGS; RIBAVIRIN; DISEASE; INHIBITION	Background: A growing number of arenaviruses can cause a devastating viral hemorrhagic fever (VHF) syndrome. They pose a public health threat as emerging viruses and because of their potential use as bioterror agents. All of the highly pathogenic New World arenaviruses (NWA) phylogenetically segregate into clade B and require maximum biosafety containment facilities for their study. Tacaribe virus (TCRV) is a nonpathogenic member of clade B that is closely related to the VHF arenaviruses at the amino acid level. Despite this relatedness, TCRV lacks the ability to antagonize the host interferon (IFN) response, which likely contributes to its inability to cause disease in animals other than newborn mice. Methodology/Principal Findings: Here we describe a new mouse model based on TCRV challenge of AG129 IFN-a/b and -gamma receptor-deficient mice. Titration of the virus by intraperitoneal (i.p.) challenge of AG129 mice resulted in an LD(50) of similar to 100 fifty percent cell culture infectious doses. Virus replication was evident in the serum, liver, lung, spleen, and brain 4-8 days after inoculation. MY-24, an aristeromycin derivative active against TCRV in cell culture at 0.9 mu M, administered i.p. once daily for 7 days, offered highly significant (P<0.001) protection against mortality in the AG129 mouse TCRV infection model, without appreciably reducing viral burden. In contrast, in a hamster model of arenaviral hemorrhagic fever based on challenge with clade A Pichinde arenavirus, MY-24 did not offer significant protection against mortality. Conclusions/Significance: MY-24 is believed to act as an inhibitor of S-adenosyl-L-homocysteine hydrolase, but our findings suggest that it may ameliorate disease by blunting the effects of the host response that play a role in disease pathogenesis. The new AG129 mouse TCRV infection model provides a safe and cost-effective means to conduct early-stage pre-clinical evaluations of candidate antiviral therapies that target clade B arenaviruses.	[Gowen, Brian B.; Wong, Min-Hui; Larson, Deanna; Jung, Kie-Hoon; Sefing, Eric J.; Skirpstunas, Ramona; Smee, Donald F.; Morrey, John D.] Utah State Univ, Dept Anim Dairy & Vet Sci, Inst Antiviral Res, Logan, UT 84322 USA; [Ye, Wei; Schneller, Stewart W.] Auburn Univ, Molette Lab Drug Discovery Res, Dept Chem & Biochem, Auburn, AL 36849 USA; [Skirpstunas, Ramona] Dept Agr & Food, Logan, UT USA	Utah System of Higher Education; Utah State University; Auburn University System; Auburn University	Gowen, BB (corresponding author), Utah State Univ, Dept Anim Dairy & Vet Sci, Inst Antiviral Res, Logan, UT 84322 USA.	brian.gowen@usu.edu			Virology Branch, NIAID, NIH [N01-AI-30048, N01-AI-15435, N01-AI-30063, U19-AI-56540]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030048, R37AI030048, U19AI056540, N01AI015435, R29AI030063] Funding Source: NIH RePORTER	Virology Branch, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by contract/grant N01-AI-30048, N01-AI-15435, N01-AI-30063 (awarded to Southern Research Institute), and U19-AI-56540, Virology Branch, NIAID, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asper M, 2004, J VIROL, V78, P3162, DOI 10.1128/JVI.78.6.3162-3169.2004; BENNETT LL, 1985, MOL PHARMACOL, V27, P666; BENNETT LL, 1986, MOL PHARMACOL, V29, P383; BENNETT LL, 1986, BIOCHEM PHARMACOL, V35, P4106, DOI 10.1016/0006-2952(86)90036-5; Bolken TC, 2006, ANTIVIR RES, V69, P86, DOI 10.1016/j.antiviral.2005.10.008; Borio L, 2002, JAMA-J AM MED ASSOC, V287, P2391, DOI 10.1001/jama.287.18.2391; Bray M, 2005, CURR OPIN IMMUNOL, V17, P399, DOI 10.1016/j.coi.2005.05.001; COOLS M, 1990, BIOCHEM PHARMACOL, V40, P2259, DOI 10.1016/0006-2952(90)90720-6; De Clercq E, 2005, NUCLEOS NUCLEOT NUCL, V24, P1395, DOI 10.1080/15257770500265638; Delgado S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000047; ENRIA DA, 1987, ANTIVIR RES, V7, P353, DOI 10.1016/0166-3542(87)90017-9; Enria DA, 2008, ANTIVIR RES, V78, P132, DOI 10.1016/j.antiviral.2007.10.010; Furuta Y, 2005, ANTIMICROB AGENTS CH, V49, P981, DOI 10.1128/AAC.49.3.981-986.2005; Gowen BB, 2005, ANTIMICROB AGENTS CH, V49, P2378, DOI 10.1128/AAC.49.6.2378-2386.2005; Gowen BB, 2008, ANTIVIR RES, V78, P79, DOI 10.1016/j.antiviral.2007.10.002; Gowen Brian B., 2006, Antiviral Chemistry & Chemotherapy, V17, P175; Gowen BB, 2007, ANTIMICROB AGENTS CH, V51, P3168, DOI 10.1128/AAC.00356-07; Gowen BB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003725; Grajkowski A, 2005, NUCLEIC ACIDS RES, V33, P3550, DOI 10.1093/nar/gki657; Hall WC, 1996, AM J TROP MED HYG, V55, P81, DOI 10.4269/ajtmh.1996.55.81; HILL DL, 1971, MOL PHARMACOL, V7, P375; JAHRLING PB, 1982, INFECT IMMUN, V37, P771, DOI 10.1128/IAI.37.2.771-778.1982; Kilgore PE, 1997, CLIN INFECT DIS, V24, P718, DOI 10.1093/clind/24.4.718; KISHI T, 1972, CHEM PHARM BULL, V20, P940; Leyssen P, 2008, ANTIVIR RES, V78, P9, DOI 10.1016/j.antiviral.2008.01.004; MAIZTEGUI JI, 1979, LANCET, V2, P1216; Martinez-Sobrido L, 2007, J VIROL, V81, P12696, DOI 10.1128/JVI.00882-07; MCCORMICK JB, 1986, NEW ENGL J MED, V314, P20, DOI 10.1056/NEJM198601023140104; MONTGOMERY JA, 1982, J MED CHEM, V25, P626, DOI 10.1021/jm00348a004; OUBINA JR, 1984, AM J TROP MED HYG, V33, P1251, DOI 10.4269/ajtmh.1984.33.1251; PETERS CJ, 1989, REV INFECT DIS, V11, pS743; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rodriguez JB, 2003, MINI-REV MED CHEM, V3, P95, DOI 10.2174/1389557033405331; Ryman KD, 2007, VIROLOGY, V368, P273, DOI 10.1016/j.virol.2007.06.039; Schneller Stewart W., 2002, Current Topics in Medicinal Chemistry, V2, P1087, DOI 10.2174/1568026023393228; Schnittler HJ, 2003, THROMB HAEMOSTASIS, V89, P967; Shresta S, 2006, J VIROL, V80, P10208, DOI 10.1128/JVI.00062-06; Snell N J, 2001, Expert Opin Pharmacother, V2, P1317, DOI 10.1517/14656566.2.8.1317; Soares MM, 2008, NAT MED, V14, P1357, DOI 10.1038/nm.1885; VANDENBROEK MF, 1995, J VIROL, V69, P4792, DOI 10.1128/JVI.69.8.4792-4796.1995; Xiao SY, 2001, AM J TROP MED HYG, V64, P111, DOI 10.4269/ajtmh.2001.64.111; Yang MM, 2005, BIOORG MED CHEM LETT, V15, P149, DOI 10.1016/j.bmcl.2004.10.019	42	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2010	5	9							e12760	10.1371/journal.pone.0012760	http://dx.doi.org/10.1371/journal.pone.0012760			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650QH	20862280	gold, Green Published			2022-12-27	WOS:000281864100012
J	Murdoch, BM; Clawson, ML; Yue, S; Basu, U; McKay, S; Settles, M; Capoferri, R; Laegreid, WW; Williams, JL; Moore, SS				Murdoch, Brenda M.; Clawson, Michael L.; Yue, Samuel; Basu, Urmila; McKay, Stephanie; Settles, Matthew; Capoferri, Rossana; Laegreid, William W.; Williams, John L.; Moore, Stephen S.			PRNP Haplotype Associated with Classical BSE Incidence in European Holstein Cattle	PLOS ONE			English	Article							NF-KAPPA-B; PRION PROTEIN; VARIANT; MICE; CJD	Background: Classical bovine spongiform encephalopathy (BSE) is an acquired prion disease of cattle. The bovine prion gene (PRNP) contains regions of both high and low linkage disequilibrium (LD) that appear to be conserved across Bos taurus populations. The region of high LD, which spans the promoter and part of intron 2, contains polymorphic loci that have been associated with classical BSE status. However, the complex genetic architecture of PRNP has not been systematically tested for an association with classical BSE. Methodology/Principal Findings: In this study, haplotype tagging single nucleotide polymorphisms (htSNPs) within PRNP were used to test for association between PRNP haplotypes and BSE disease. A combination of Illumina goldengate assay, sequencing and PCR amplification was used to genotype 18 htSNPs and 2 indels in 95 BSE case and 134 control animals. A haplotype within the region of high LD was found to be associated with BSE unaffected animals (p-value = 0.000114). Conclusion/Significance: A PRNP haplotype association with classical BSE incidence has been identified. This result suggests that a genetic determinant in or near PRNP may influence classical BSE incidence in cattle.	[Murdoch, Brenda M.; Yue, Samuel; Basu, Urmila; McKay, Stephanie; Moore, Stephen S.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Clawson, Michael L.] ARS, Meat Anim Res Ctr, USDA, Clay Ctr, NE USA; [Laegreid, William W.] Univ Illinois, Dept Vet Pathobiol, Urbana, IL 61801 USA; [McKay, Stephanie] Univ Missouri, Div Anim Sci, Columbia, MO USA; [Settles, Matthew] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [Capoferri, Rossana] Ist Sperimentale Italiano, IDRA Lab, Lodi, Italy; [Williams, John L.] Polo Univ, Lodi, Italy	University of Alberta; United States Department of Agriculture (USDA); University of Illinois System; University of Illinois Urbana-Champaign; University of Missouri System; University of Missouri Columbia; Idaho; University of Idaho	Murdoch, BM (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.	bmurdoch@ualberta.ca	Settles, Matthew L/F-2031-2011; Moore, Stephen S/F-5285-2013	Settles, Matthew L/0000-0002-3424-1086; Moore, Stephen/0000-0002-9758-166X; Clawson, Michael/0000-0002-3355-5390; Laegreid, William/0000-0002-8694-5229; Williams, John/0000-0001-5188-7957; Murdoch, Brenda M/0000-0001-8675-3473; McKay, Stephanie/0000-0003-1434-3111	PrioNet Canada; Alberta Prion Research Institute [200500696]; USDA; Cariplo Foundation	PrioNet Canada; Alberta Prion Research Institute; USDA(United States Department of Agriculture (USDA)); Cariplo Foundation(Fondazione Cariplo)	The authors would like to thank the PrioNet Canada and Alberta Prion Research Institute (200500696) for their funding and support of this work. JLW would like to thank the USDA and the Cariplo Foundation for research support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez L, 2006, J ANIM SCI, V84, P259, DOI 10.2527/2006.842259x; Blanchong JA, 2009, INFECT GENET EVOL, V9, P1329, DOI 10.1016/j.meegid.2009.08.010; Bourteele S, 2007, CELL MICROBIOL, V9, P2202, DOI 10.1111/j.1462-5822.2007.00950.x; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Brunelle BW, 2007, J ANIM SCI, V85, P3142, DOI 10.2527/jas.2007-0208; Clawson ML, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-51; Clawson Michael L, 2008, BMC Res Notes, V1, P32, DOI 10.1186/1756-0500-1-32; Clawson ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001830; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Gambetti P, 2003, BRIT MED BULL, V66, P213, DOI 10.1093/bmb/66.1.213; Haase B, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-15; Heaton MP, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-25; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Hills D, 2001, ANIM GENET, V32, P231, DOI 10.1046/j.1365-2052.2001.0769a.x; Inoue S, 1997, J VET MED SCI, V59, P175, DOI 10.1292/jvms.59.175; Juling K, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-33; Julius C, 2008, J GEN VIROL, V89, P1545, DOI 10.1099/vir.0.83622-0; Kim JI, 1999, MOL BRAIN RES, V73, P17, DOI 10.1016/S0169-328X(99)00229-6; Laegreid WW, 2008, J VIROL, V82, P10318, DOI 10.1128/JVI.00710-08; Mabbott NA, 2006, NAT REV MICROBIOL, V4, P201, DOI 10.1038/nrmicro1346; Majewski J, 2002, GENOME RES, V12, P1827, DOI 10.1101/gr.606402; Mattson MP, 2005, NEUROCHEM RES, V30, P883, DOI 10.1007/s11064-005-6961-x; McKay SD, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-74; Murdoch BM, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-20; OLIPHANT A, 2002, BIOTECHNIQUES S, V56, P60; PRUSINER SB, 1994, ANN NEUROL, V35, P385, DOI 10.1002/ana.410350404; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Richt JA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000156; Sander P, 2005, J BIOL CHEM, V280, P37408, DOI 10.1074/jbc.M506361200; Sanderson K, 2004, CHEM WORLD-UK, V1, P19; Sherman EL, 2008, ANIM GENET, V39, P225, DOI 10.1111/j.1365-2052.2008.01704.x; Stack MJ, 2009, VET REC, V165, P605, DOI 10.1136/vr.165.20.605-c; Strom A, 2006, PROTEOMICS, V6, P26, DOI 10.1002/pmic.200500066; Tester S, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-64; Weissmann C, 2003, BRIT MED BULL, V66, P43, DOI 10.1093/bmb/66.1.43; Wilson GA, 2009, J TOXICOL ENV HEAL A, V72, P1025, DOI 10.1080/15287390903084264; XUE G, 2008, BIOCHEM BIOPH RES CO, V4, P530; Yuan ZM, 2009, MOL CELL BIOL, V29, P2431, DOI 10.1128/MCB.01344-08	39	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2010	5	9							e12786	10.1371/journal.pone.0012786	http://dx.doi.org/10.1371/journal.pone.0012786			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650QH	20862290	Green Published, gold			2022-12-27	WOS:000281864100021
J	Benardais, K; Kasem, B; Couegnas, A; Samama, B; Fernandez, S; Schaeffer, C; Antal, MC; Job, D; Schweitzer, A; Andrieux, A; Giersch, A; Nehlig, A; Boehm, N				Benardais, Karelle; Kasem, Basem; Couegnas, Alice; Samama, Brigitte; Fernandez, Sebastien; Schaeffer, Christiane; Antal, Maria-Cristina; Job, Didier; Schweitzer, Annie; Andrieux, Annie; Giersch, Anne; Nehlig, Astrid; Boehm, Nelly			Loss of STOP Protein Impairs Peripheral Olfactory Neurogenesis	PLOS ONE			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; COLD-STABLE MICROTUBULES; CELL-DEATH; VOMERONASAL EPITHELIUM; SENSORY NEURONS; ADULT MICE; NULL MICE; SCHIZOPHRENIA; MOUSE; EXPRESSION	Background: STOP (Stable Tubulin-Only Polypeptide) null mice show behavioral deficits, impaired synaptic plasticity, decrease in synaptic vesicular pools and disturbances in dopaminergic transmission, and are considered a neurodevelopmental model of schizophrenia. Olfactory neurons highly express STOP protein and are continually generated throughout life. Experimentally-induced loss of olfactory neurons leads to epithelial regeneration within two months, providing a useful model to evaluate the role played by STOP protein in adult olfactory neurogenesis. Methodology/Principal Findings: Immunocytochemistry and electron microscopy were used to study the structure of the glomerulus in the main olfactory bulb and neurogenesis in the neurosensorial epithelia. In STOP null mice, olfactory neurons showed presynaptic swellings with tubulovesicular profiles and autophagic-like structures. In olfactory and vomeronasal epithelia, there was an increase in neurons turnover, as shown by the increase in number of proliferating, apoptotic and immature cells with no changes in the number of mature neurons. Similar alterations in peripheral olfactory neurogenesis have been previously described in schizophrenia patients. In STOP null mice, regeneration of the olfactory epithelium did not modify these anomalies; moreover, regeneration resulted in abnormal organisation of olfactory terminals within the olfactory glomeruli in STOP null mice. Conclusions/Significance: In conclusion, STOP protein seems to be involved in the establishment of synapses in the olfactory glomerulus. Our results indicate that the olfactory system of STOP null mice is a well-suited experimental model (1) for the study of the mechanism of action of STOP protein in synaptic function/plasticity and (2) for pathophysiological studies of the mechanisms of altered neuronal connections in schizophrenia.	[Benardais, Karelle; Kasem, Basem; Couegnas, Alice; Samama, Brigitte; Schaeffer, Christiane; Antal, Maria-Cristina; Giersch, Anne; Nehlig, Astrid; Boehm, Nelly] INSERM, U666, Strasbourg, France; [Benardais, Karelle; Kasem, Basem; Couegnas, Alice; Samama, Brigitte; Fernandez, Sebastien; Schaeffer, Christiane; Antal, Maria-Cristina; Boehm, Nelly] Univ Strasbourg, Fac Med, Hist Inst, Strasbourg, France; [Samama, Brigitte; Schaeffer, Christiane; Antal, Maria-Cristina; Boehm, Nelly] Hop Univ Strasbourg, Strasbourg, France; [Job, Didier; Schweitzer, Annie; Andrieux, Annie] Grenoble Inst Neurosci, INSERM, U836, Grenoble, France; [Job, Didier; Schweitzer, Annie; Andrieux, Annie] CEA Grenoble, IRTSV GPC, Grenoble, France; [Job, Didier; Schweitzer, Annie; Andrieux, Annie] Univ Grenoble 1, Grenoble, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Benardais, K (corresponding author), INSERM, U666, Strasbourg, France.	Brigitte.Samama@medecine.u-strasbg.fr	Giersch, Anne/H-6444-2016; ANDRIEUX, ANNIE/B-2134-2017	Giersch, Anne/0000-0002-8577-6021; ANDRIEUX, ANNIE/0000-0002-4022-6405	INSERM (Institut National de la Sante et de la Recherche Medicale)	INSERM (Institut National de la Sante et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm))	Source of funding: INSERM (Institut National de la Sante et de la Recherche Medicale). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrieux A, 2002, GENE DEV, V16, P2350, DOI 10.1101/gad.223302; Arnold SE, 2001, ARCH GEN PSYCHIAT, V58, P829, DOI 10.1001/archpsyc.58.9.829; Baratier J, 2006, J BIOL CHEM, V281, P19561, DOI 10.1074/jbc.M509602200; BARBER PC, 1978, BRAIN RES, V141, P57, DOI 10.1016/0006-8993(78)90616-9; Begou M, 2007, SYNAPSE, V61, P689, DOI 10.1002/syn.20409; Beites CL, 2005, EXP CELL RES, V306, P309, DOI 10.1016/j.yexcr.2005.03.027; BOEHM N, 1991, PHYSIOL BEHAV, V50, P1001, DOI 10.1016/0031-9384(91)90428-Q; Bosc C, 2003, BIOCHEMISTRY-US, V42, P12125, DOI 10.1021/bi0352163; Bouvrais-Veret C, 2008, J NEUROCHEM, V104, P745, DOI 10.1111/j.1471-4159.2007.05025.x; Bouvrais-Veret C, 2007, NEUROPHARMACOLOGY, V52, P1691, DOI 10.1016/j.neuropharm.2007.03.015; Brenner E, 2007, J NEUROSCI RES, V85, P3487, DOI 10.1002/jnr.21200; Brun P, 2005, J NEUROCHEM, V94, P63, DOI 10.1111/j.1471-4159.2005.03166.x; Calof AL, 1996, J NEUROBIOL, V30, P67; CARR VM, 1992, EXP NEUROL, V115, P55, DOI 10.1016/0014-4886(92)90221-B; Cascella NG, 2007, J NEUROCHEM, V102, P587, DOI 10.1111/j.1471-4159.2007.04628.x; Couegnas A, 2007, J NEUROSCI RES, V85, P1515, DOI 10.1002/jnr.21278; Cowan CM, 2002, MICROSC RES TECHNIQ, V58, P204, DOI 10.1002/jemt.10150; Cowan CM, 2001, J NEUROSCI, V21, P7099, DOI 10.1523/JNEUROSCI.21-18-07099.2001; DELA ROSAPRIETO, 2009, J COMP NEUROL, V517, P723; Delotterie D, 2010, PSYCHOPHARMACOLOGY, V208, P131, DOI 10.1007/s00213-009-1712-3; Dillon C, 2005, ANNU REV NEUROSCI, V28, P25, DOI 10.1146/annurev.neuro.28.061604.135757; Ducray A, 2002, EUR J NEUROSCI, V15, P1907, DOI 10.1046/j.1460-9568.2002.02044.x; Eastwood SL, 2007, J PSYCHOPHARMACOL, V21, P635, DOI 10.1177/0269881106068825; FARBMAN AI, 1988, J NEUROSCI, V8, P3290; Feron F, 1999, SCHIZOPHR RES, V40, P211, DOI 10.1016/S0920-9964(99)00055-9; Fradley RL, 2005, BEHAV BRAIN RES, V163, P257, DOI 10.1016/j.bbr.2005.05.012; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Friocourt G, 2003, CEREB CORTEX, V13, P620, DOI 10.1093/cercor/13.6.620; Fung KM, 1997, BRAIN RES, V761, P347, DOI 10.1016/S0006-8993(97)00467-8; Garden GA, 2002, J NEUROSCI, V22, P4015, DOI 10.1523/JNEUROSCI.22-10-04015.2002; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; GRAZIADEI PPC, 1979, J NEUROCYTOL, V8, P1, DOI 10.1007/BF01206454; Guillaud L, 1998, J CELL BIOL, V142, P167, DOI 10.1083/jcb.142.1.167; Hanaya R, 2008, NEUROBIOL DIS, V31, P451, DOI 10.1016/j.nbd.2008.06.006; JOB D, 1981, P NATL ACAD SCI-BIOL, V78, P4679, DOI 10.1073/pnas.78.8.4679; Margolis F L, 1982, Scand J Immunol Suppl, V9, P181; Martinez-Marcos A, 2005, J NEUROBIOL, V63, P173, DOI 10.1002/neu.20128; Martinez-Marcos A, 2000, J NEUROBIOL, V44, P423, DOI 10.1002/1097-4695(20000915)44:4<423::AID-NEU5>3.0.CO;2-H; Mattson MP, 1998, EXP NEUROL, V153, P35, DOI 10.1006/exnr.1998.6863; McCurdy RD, 2006, SCHIZOPHR RES, V82, P163, DOI 10.1016/j.schres.2005.10.012; Murdoch B, 2007, J MOL HISTOL, V38, P581, DOI 10.1007/s10735-007-9141-2; Powell KJ, 2007, BEHAV NEUROSCI, V121, P826, DOI 10.1037/0735-7044.121.5.826; Rheuben MB, 2004, TOXICOL APPL PHARM, V196, P266, DOI 10.1016/j.taap.2004.01.004; Richard M, 2009, MOL CELL NEUROSCI, V41, P120, DOI 10.1016/j.mcn.2009.02.004; Robertson GS, 2006, J PSYCHIATR NEUROSCI, V31, P157; Rossler W, 2002, CHEM SENSES, V27, P803, DOI 10.1093/chemse/27.9.803; Schwob James E., 2002, Anatomical Record, V269, P33, DOI 10.1002/ar.10047; Sultan-Styne K, 2009, J COMP NEUROL, V515, P696, DOI 10.1002/cne.22084; Turetsky BI, 2009, SCHIZOPHRENIA BULL, V35, P1117, DOI 10.1093/schbul/sbp111; VERHAAGEN J, 1989, J NEUROSCI, V9, P683; Weiler E, 2005, J NEUROCYTOL, V34, P217, DOI 10.1007/s11068-005-8355-z	51	6	7	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12753	10.1371/journal.pone.0012753	http://dx.doi.org/10.1371/journal.pone.0012753			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856814	gold, Green Published, Green Submitted			2022-12-27	WOS:000281815800019
J	Liu, Y; Wu, N; Dong, J; Gao, YP; Zhang, X; Mu, CH; Shao, NS; Yang, GA				Liu, Yu; Wu, Na; Dong, Jie; Gao, Yaping; Zhang, Xin; Mu, Chunhua; Shao, Ningsheng; Yang, Guang			Hfq Is a Global Regulator That Controls the Pathogenicity of Staphylococcus aureus	PLOS ONE			English	Article							SM-LIKE PROTEIN; MESSENGER-RNA TARGETS; VIRULENCE FACTORS; AGR; BINDING; GENE; SARA; MUTANTS; CLONING; GROWTH	The Hfq protein is reported to be an RNA chaperone, which is involved in the stress response and the virulence of several pathogens. In E. coli, Hfq can mediate the interaction between some sRNAs and their target mRNAs. But it is controversial whether Hfq plays an important role in S. aureus. In this study, we found that the deletion of hfq gene in S. aureus 8325-4 can increase the surface carotenoid pigments. The hfq mutant was more resistant to oxidative stress but the pathogenicity of the mutant was reduced. We reveal that the Hfq protein can be detected only in some S. aureus strains. Using microarray and qRT-PCR, we identified 116 genes in the hfq mutant which had differential expression from the wild type, most of which are related to the phenotype and virulence of S. aureus. Among the 116 genes, 49 mRNAs can specifically bind Hfq protein, which indicates that Hfq also acts as an RNA binding protein in S. aureus. Our data suggest that Hfq protein of S. aureus is a multifunctional regulator involved in stress and virulence.	[Liu, Yu; Wu, Na; Dong, Jie; Gao, Yaping; Zhang, Xin; Mu, Chunhua; Shao, Ningsheng; Yang, Guang] Beijing Inst Basic Med Sci, Beijing, Peoples R China	Academy of Military Medical Sciences - China	Liu, Y (corresponding author), Beijing Inst Basic Med Sci, Beijing, Peoples R China.	shaonsh@hotmail.com; yanggg@hotmail.com			China National Key Program on Basic Research [2005CB724600]; National Natural Science Foundation of China [30700007, 30870093]; National High-Tech Research and Development Program [2006AA02Z132, 2006AA02Z323]	China National Key Program on Basic Research; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech Research and Development Program(National High Technology Research and Development Program of China)	This work was supported by grants from China National Key Program on Basic Research (2005CB724600, http://www.973.gov.cn/English/), National Natural Science Foundation of China (30700007, 30870093, http://www.nsfc.gov.cn/Portal0/default106.htm) and National High-Tech Research and Development Program (2006AA02Z132, 2006AA02Z323, http://www.most.gov.cn/eng/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansong C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004809; Arluison V, 2007, PROTEIN SCI, V16, P1830, DOI 10.1110/ps.072883707; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Becher D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008176; Blevins JS, 2002, INFECT IMMUN, V70, P470, DOI 10.1128/IAI.70.2.470-480.2002; Bohn C, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-10; Boisset S, 2007, GENE DEV, V21, P1353, DOI 10.1101/gad.423507; Brennan RG, 2007, CURR OPIN MICROBIOL, V10, P125, DOI 10.1016/j.mib.2007.03.015; Cassat J, 2006, MICROBIOL-SGM, V152, P3075, DOI 10.1099/mic.0.29033-0; CHAKRABORTY T, 1992, J BACTERIOL, V174, P568, DOI 10.1128/jb.174.2.568-574.1992; Coulter SN, 1998, MOL MICROBIOL, V30, P393, DOI 10.1046/j.1365-2958.1998.01075.x; Ding YP, 2004, MOL MICROBIOL, V53, P345, DOI 10.1111/j.1365-2958.2004.04142.x; Dunman PM, 2001, J BACTERIOL, V183, P7341, DOI 10.1128/JB.183.24.7341-7353.2001; Fantappie L, 2009, INFECT IMMUN, V77, P1842, DOI 10.1128/IAI.01216-08; Figueroa-Bossi N, 2006, MOL MICROBIOL, V62, P838, DOI 10.1111/j.1365-2958.2006.05413.x; Franze de Fernandez M T, 1972, J Biol Chem, V247, P824; Geisinger E, 2006, MOL MICROBIOL, V61, P1038, DOI 10.1111/j.1365-2958.2006.05292.x; Huntzinger E, 2005, EMBO J, V24, P824, DOI 10.1038/sj.emboj.7600572; ISENBERG HD, 1976, INFECT IMMUN, V14, P483, DOI 10.1128/IAI.14.2.483-489.1976; Jarraud S, 2000, J BACTERIOL, V182, P6517, DOI 10.1128/JB.182.22.6517-6522.2000; Korem M, 2005, INFECT IMMUN, V73, P6220, DOI 10.1128/IAI.73.10.6220-6228.2005; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Liu GY, 2005, J EXP MED, V202, P209, DOI 10.1084/jem.20050846; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Masse E, 2003, GENE DEV, V17, P2374, DOI 10.1101/gad.1127103; Mohanty BK, 2004, MOL MICROBIOL, V54, P905, DOI 10.1111/j.1365-2958.2004.04337.x; Moll I, 2003, RNA, V9, P1308, DOI 10.1261/rna.5850703; Moller T, 2002, MOL CELL, V9, P23, DOI 10.1016/S1097-2765(01)00436-1; NOVICK R, 1967, VIROLOGY, V33, P155, DOI 10.1016/0042-6822(67)90105-5; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; PENG HL, 1988, J BACTERIOL, V170, P4365, DOI 10.1128/jb.170.9.4365-4372.1988; Rothfork JM, 2004, P NATL ACAD SCI USA, V101, P13867, DOI 10.1073/pnas.0402996101; Schumacher MA, 2002, EMBO J, V21, P3546, DOI 10.1093/emboj/cdf322; SCHWESINGER MD, 1975, J BACTERIOL, V123, P724, DOI 10.1128/JB.123.2.724-738.1975; Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163; Sittka A, 2007, MOL MICROBIOL, V63, P193, DOI 10.1111/j.1365-2958.2006.05489.x; Sonnleitner E, 2003, MICROB PATHOGENESIS, V35, P217, DOI 10.1016/S0882-4010(03)00149-9; Speziali CD, 2006, J BACTERIOL, V188, P2048, DOI 10.1128/JB.188.6.2048-2055.2006; Sukhodolets MV, 2003, BIOCHEMISTRY-US, V42, P8022, DOI 10.1021/bi020638i; TSUI HCT, 1994, MOL MICROBIOL, V13, P35, DOI 10.1111/j.1365-2958.1994.tb00400.x; Valentin-Hansen P, 2004, MOL MICROBIOL, V51, P1525, DOI 10.1111/j.1365-2958.2003.03935.x; Vassilieva IM, 2002, BIOCHEMISTRY-MOSCOW+, V67, P1293, DOI 10.1023/A:1021365808520; WIELAND B, 1994, J BACTERIOL, V176, P7719, DOI 10.1128/JB.176.24.7719-7726.1994; Zhang AX, 2003, MOL MICROBIOL, V50, P1111, DOI 10.1046/j.1365-2958.2003.03734.x	44	44	48	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e13069	10.1371/journal.pone.0013069	http://dx.doi.org/10.1371/journal.pone.0013069			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20927372	gold, Green Submitted, Green Published			2022-12-27	WOS:000282269400020
J	Borst, JP; Taatgen, NA; Stocco, A; van Rijn, H				Borst, Jelmer P.; Taatgen, Niels A.; Stocco, Andrea; van Rijn, Hedderik			The Neural Correlates of Problem States: Testing fMRI Predictions of a Computational Model of Multitasking	PLOS ONE			English	Article							INFORMATION-PROCESSING MODEL; 3 CORTICAL REGIONS; WORKING-MEMORY; SENTENCE COMPREHENSION; SYMBOL MANIPULATION; INTEGRATED THEORY; BRAIN ACTIVATION; FRONTAL-CORTEX; FUNCTIONAL MRI; BOLD RESPONSE	Background: It has been shown that people can only maintain one problem state, or intermediate mental representation, at a time. When more than one problem state is required, for example in multitasking, performance decreases considerably. This effect has been explained in terms of a problem state bottleneck. Methodology: In the current study we use the complimentary methodologies of computational cognitive modeling and neuroimaging to investigate the neural correlates of this problem state bottleneck. In particular, an existing computational cognitive model was used to generate a priori fMRI predictions for a multitasking experiment in which the problem state bottleneck plays a major role. Hemodynamic responses were predicted for five brain regions, corresponding to five cognitive resources in the model. Most importantly, we predicted the intraparietal sulcus to show a strong effect of the problem state manipulations. Conclusions: Some of the predictions were confirmed by a subsequent fMRI experiment, while others were not matched by the data. The experiment supported the hypothesis that the problem state bottleneck is a plausible cause of the interference in the experiment and that it could be located in the intraparietal sulcus.	[Borst, Jelmer P.; Taatgen, Niels A.] Univ Groningen, Dept Artificial Intelligence, Groningen, Netherlands; [Stocco, Andrea] Univ Washington, Inst Learning & Brain Sci, Seattle, WA 98195 USA; [van Rijn, Hedderik] Univ Groningen, Dept Psychol, NL-9712 TS Groningen, Netherlands	University of Groningen; University of Washington; University of Washington Seattle; University of Groningen	Borst, JP (corresponding author), Univ Groningen, Dept Artificial Intelligence, Groningen, Netherlands.	jpborst@ai.rug.nl	Taatgen, Niels/A-3216-2008; van Rijn, Hedderik/L-3685-2014; Stocco, Andrea/A-2159-2013; Borst, Jelmer/C-4666-2008	van Rijn, Hedderik/0000-0002-0461-9850; Stocco, Andrea/0000-0001-8919-3934; Borst, Jelmer/0000-0002-4493-8223; Taatgen, Niels/0000-0001-7286-3460	Office of Naval Research [N00014-08-10541]	Office of Naval Research(Office of Naval Research)	This study was supported by the Office of Naval Research (http://www.onr.navy.mil/) grant N00014-08-10541 awarded to Niels A. Taatgen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J.R., 2007, CAN HUMAN MIND OCCUR; Anderson J.R., 1998, ATOMIC COMPONENTS TH; Anderson JR, 2008, TRENDS COGN SCI, V12, P136, DOI 10.1016/j.tics.2008.01.006; Anderson JR, 2007, COGNITIVE PSYCHOL, V54, P185, DOI 10.1016/j.cogpsych.2006.06.003; Anderson JR, 2005, J COGNITIVE NEUROSCI, V17, P1261, DOI 10.1162/0898929055002427; Anderson JR, 2005, COGNITIVE SCI, V29, P313, DOI 10.1207/s15516709cog0000_22; Anderson JR, 2004, J COGNITIVE NEUROSCI, V16, P637, DOI 10.1162/089892904323057353; Anderson JR, 2003, PSYCHON B REV, V10, P241, DOI 10.3758/BF03196490; Bandettini PA, 2001, NAT NEUROSCI, V4, P864, DOI 10.1038/nn0901-864; Borst J., 2007, P 8 INT C COGNITIVE, P133; Borst JP, 2010, J EXP PSYCHOL LEARN, V36, P363, DOI 10.1037/a0018106; Brett M, 2002, NEUROIMAGE, V16; Buckner RL, 1999, NAT NEUROSCI, V2, P311, DOI 10.1038/7221; Byrne MD, 2001, PSYCHOL REV, V108, P847, DOI 10.1037/0033-295X.108.4.847; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Culham JC, 2001, CURR OPIN NEUROBIOL, V11, P157, DOI 10.1016/S0959-4388(00)00191-4; Dale AM, 1997, HUM BRAIN MAPP, V5, P329, DOI 10.1002/(SICI)1097-0193(1997)5:5<329::AID-HBM1>3.0.CO;2-5; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Dux PE, 2006, NEURON, V52, P1109, DOI 10.1016/j.neuron.2006.11.009; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; Friston K. J., 2003, HUMAN BRAIN FUNCTION, P599; Glover GH, 1999, NEUROIMAGE, V9, P416, DOI 10.1006/nimg.1998.0419; Handwerker DA, 2004, NEUROIMAGE, V21, P1639, DOI 10.1016/j.neuroimage.2003.11.029; Hendriks P, 2007, LINGUA, V117, P1879, DOI 10.1016/j.lingua.2006.11.008; Just MA, 2008, BRAIN RES, V1205, P70, DOI 10.1016/j.brainres.2007.12.075; LaBar KS, 1999, NEUROIMAGE, V10, P695, DOI 10.1006/nimg.1999.0503; Lacadie CM, 2008, NEUROIMAGE, V42, P717, DOI 10.1016/j.neuroimage.2008.04.240; Lewis RL, 2006, TRENDS COGN SCI, V10, P447, DOI 10.1016/j.tics.2006.08.007; Lewis RL, 2005, COGNITIVE SCI, V29, P375, DOI 10.1207/s15516709cog0000_25; McElree B, 2001, J EXP PSYCHOL LEARN, V27, P817, DOI 10.1037/0278-7393.27.3.817; Meyer DE, 1997, PSYCHOL REV, V104, P3, DOI 10.1037/0033-295X.104.1.3; Myung IJ, 2000, J MATH PSYCHOL, V44, P190, DOI 10.1006/jmps.1999.1283; NAVON D, 1979, PSYCHOL REV, V86, P214, DOI 10.1037/0033-295X.86.3.214; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Roberts S, 2000, PSYCHOL REV, V107, P358, DOI 10.1037/0033-295X.107.2.358; Salvucci D.D., 2002, COGN SYST RES, V3, P95, DOI [10.1016/S1389-0417(01)00048-1, DOI 10.1016/S1389-0417(01)00048-1, DOI 10.1016/]; Salvucci D. D, 2010, MULTITASKING MIND; Salvucci DD, 2008, PSYCHOL REV, V115, P101, DOI 10.1037/0033-295X.115.1.101; SALVUCCI DD, 2009, HUM FACT COMP SYST C, P1819; Smith EE, 1998, P NATL ACAD SCI USA, V95, P876, DOI 10.1073/pnas.95.3.876; Sohn MH, 2005, NEUROIMAGE, V25, P21, DOI 10.1016/j.neuroimage.2004.11.001; SPELKE E, 1976, COGNITION, V4, P215, DOI 10.1016/0010-0277(76)90018-4; Stocco A, 2008, J COGNITIVE NEUROSCI, V20, P1300, DOI 10.1162/jocn.2008.20089; TAATGEN NA, 2008, HDB COGNITIVE MODELI, P170; TAATGEN NA, 2009, COGNITIVE PSYCHOL; Taatgen NA, 2007, PSYCHOL REV, V114, P577, DOI 10.1037/0033-295X.114.3.577; van Rij J, 2010, J CHILD LANG, V37, P731, DOI 10.1017/S0305000909990560; Vazquez AL, 1998, NEUROIMAGE, V7, P108, DOI 10.1006/nimg.1997.0316; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Wickens C. D., 2002, THEORETICAL ISSUES E, V3, P159, DOI [10.1080/14639220210123806, DOI 10.1080/14639220210123806]	51	37	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12966	10.1371/journal.pone.0012966	http://dx.doi.org/10.1371/journal.pone.0012966			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886034	Green Published, gold, Green Submitted			2022-12-27	WOS:000282091100056
J	Rando, JC; Alcover, JA; Illera, JC				Carlos Rando, Juan; Antoni Alcover, Josep; Carlos Illera, Juan			Disentangling Ancient Interactions: A New Extinct Passerine Provides Insights on Character Displacement among Extinct and Extant Island Finches	PLOS ONE			English	Article							FRINGILLA-COELEBS; K-AR; CHAFFINCHES; EVOLUTION; COLONIZATION; VARIABILITY; POPULATIONS; INFERENCE; AVIFAUNA; MRBAYES	Background: Evolutionary studies of insular biotas are based mainly on extant taxa, although such biotas represent artificial subsets of original faunas because of human-caused extinctions of indigenous species augmented by introduced exotic taxa. This makes it difficult to obtain a full understanding of the history of ecological interactions between extant sympatric species. Morphological bill variation of Fringilla coelebs and F. teydea (common and blue chaffinches) has been previously studied in the North Atlantic Macaronesian archipelagos. Character displacement between both species has been argued to explain bill sizes in sympatry. However, this explanation is incomplete, as similar patterns of bill size have been recorded in F. coelebs populations from islands with and without F. teydea. Methodology/Principal Findings: The discovery of a new extinct species in Tenerife (Canary Islands), here named Carduelis aurelioi n. sp. (slender-billed greenfinch), provides the opportunity to study ancient ecological interactions among Macaronesian finches. To help understand the evolutionary histories of forest granivores in space and time, we have performed a multidisciplinary study combining: (1) morphological analyses and radiocarbon dating (11,460 +/- 60 yr BP) of the new taxon and, (2) molecular divergence among the extant finch species and populations in order to infer colonization times (1.99 and 1.09 My for F. teydea and F. coelebs respectively). Conclusion/Significance: C. aurelioi, F. coelebs and F. teydea co-habited in Tenerife for at least one million years. The unique anatomical trends of the new species, namely chaffinch-like beak and modified hind and forelimbs, reveal that there was a process of divergence of resource competition traits among the three sympatric finches. The results of our study, combined with the presence of more extinct greenfinches in other Macaronesian islands with significant variation in their beak sizes, suggests that the character displacement has influenced patterns of divergence in bill size and shape on other Macaronesian islands as well.	[Carlos Rando, Juan] Univ La Laguna, Dept Biol Anim, Tenerife, Spain; [Antoni Alcover, Josep] CSIC UIB, Inst Mediterrani Estudis Avancats, Esporles, Mallorca, Spain; [Carlos Illera, Juan] IPNA CSIC, Isl Ecol & Evolut Res Grp, Tenerife, Spain; [Carlos Illera, Juan] CSIC UO PA, Inst Cantabr Biodiversidad, Oviedo, Spain	Universidad de la Laguna; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Productos Naturales y Agrobiologia (IPNA); Consejo Superior de Investigaciones Cientificas (CSIC)	Rando, JC (corresponding author), Univ La Laguna, Dept Biol Anim, Tenerife, Spain.	canariomys@yahoo.es	Illera, Juan Carlos/C-6583-2014; Alcover, Josep Antoni/Y-3796-2018	Illera, Juan Carlos/0000-0002-4389-0264; Rando, Juan Carlos/0000-0001-7397-869X; Alcover, Josep Antoni/0000-0001-9905-2588	Spanish Direccion General de Investigacion Cientifica y Tecnica Research [CGL2007-62047/BTE]; Spanish Ministry of Education	Spanish Direccion General de Investigacion Cientifica y Tecnica Research; Spanish Ministry of Education(Spanish Government)	JAA and JCR were partially supported by Spanish Direccion General de Investigacion Cientifica y Tecnica Research Project CGL2007-62047/BTE. JCI was supported by a postdoctoral contract (Juan de La Cierva) from the Spanish Ministry of Education. The funding institutions had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcover J.A., 1987, Vieraea, V17, P75; Alcover JA, 2001, ENDINS, V24, P5; Alonso MR, 2006, J CONCHOL, V39, P41; ANCOCHEA E, 1990, J VOLCANOL GEOTH RES, V44, P231, DOI 10.1016/0377-0273(90)90019-C; BAKER AJ, 1990, EVOLUTION, V44, P981, DOI 10.1111/j.1558-5646.1990.tb03819.x; BOCK WJ, 1966, AUK, V83, P10, DOI 10.2307/4082976; Bover P, 2003, J BIOGEOGR, V30, P771, DOI 10.1046/j.1365-2699.2003.00872.x; Boyer AG, 2008, DIVERS DISTRIB, V14, P509, DOI 10.1111/j.1472-4642.2007.00459.x; Bramwell D, 2001, WILD FLOWERS CANARY, V2nd; BROWN WL, 1956, SYST ZOOL, V5, P49, DOI 10.2307/2411924; Illera JC, 2008, MOL PHYLOGENET EVOL, V48, P1145, DOI 10.1016/j.ympev.2008.05.016; Cramp S.E., 1994, HDB BIRDS EUROPE MID; DENNISON MD, 1991, EVOLUTION, V45, P29, DOI 10.1111/j.1558-5646.1991.tb05263.x; DIAZ M, 1994, OECOLOGIA, V99, P1, DOI 10.1007/BF00317076; Diaz M, 1996, COMP BIOCHEM PHYS A, V113, P239, DOI 10.1016/0300-9629(95)02093-4; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Garcia-Alonso MD, 2005, SCOT J POLIT ECON, V52, P305; GRANT P R, 1980, Bonner Zoologische Beitraege, V31, P311; Grant P.R., 2007, WHY SPECIES MULTIPLY; Grant PR, 2006, SCIENCE, V313, P224, DOI 10.1126/science.1128374; GRANT PR, 1979, BIOL J LINN SOC, V11, P301, DOI 10.1111/j.1095-8312.1979.tb00042.x; Guillou H, 2001, J VOLCANOL GEOTH RES, V106, P175, DOI 10.1016/S0377-0273(00)00294-8; Guillou H, 1996, J VOLCANOL GEOTH RES, V73, P141, DOI 10.1016/0377-0273(96)00021-2; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HERNANDEZ JJ, 1995, CATALOGO ESPELEOLOGI; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; James HF, 2004, ZOOL J LINN SOC-LOND, V141, P207, DOI 10.1111/j.1096-3642.2004.00117.x; JauMe d., 1993, BOL MUS MUNIC FUNCHA, P147; Marshall HD, 1999, MOL PHYLOGENET EVOL, V11, P201, DOI 10.1006/mpev.1998.0552; Martin A., 2001, AVES ARCHIPIELAGO CA; Martuin A., 2000, PALOMAS ENDEMICAS CA; MILLENER P R, 1989, Notornis, V36, P280; MILLENER PR, 1991, J ROY SOC NEW ZEAL, V21, P179; Moreno E., 1985, Ardeola, V32, P295; Olmos M, 1996, ANN SCI NAT ZOOL, V17, P39; OLSON SL, 1982, SCIENCE, V217, P633, DOI 10.1126/science.217.4560.633; PENNYCUICK DJ, 1972, STUDIES BIOL, V33; Pfennig KS, 2009, Q REV BIOL, V84, P253, DOI 10.1086/605079; PIEPER H, 1985, BOCAGIANA, V88, P1; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Quinn G.P., 2002, EXPT DESIGN DATA ANA; Ramis D., 2002, J MEDITERR ARCHAEOL, V15, DOI [DOI 10.1558/jmea.v15i1.3, 10.1558/jmea.v15i1.3, DOI 10.1558/JMEA.V15I1.3]; RAMOS JA, 1995, BIOL CONSERV, V71, P237, DOI 10.1016/0006-3207(94)00033-M; RAMOS JA, 2008, EQUIPAATLAS, P492; Rando JC, 1999, CONDOR, V101, P1, DOI 10.2307/1370440; RANDO JC, 1996, 7 INT S VULC, V1, P171; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Scheiner Samuel M., 1993, P94; SCHLUTER D, 1988, AM NAT, V131, P799, DOI 10.1086/284823; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; SNOW DW, 1998, BIRDS W PALEARCTIC C, V2; Steadman David W., 2006, P1; Suarez NM, 2009, MOL PHYLOGENET EVOL, V53, P556, DOI 10.1016/j.ympev.2009.07.018; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TUGGLE HD, 2000, ASIAN PERSPECT, V39, P165; Valido Alfredo, 1994, Ardeola, V41, P29; Vanden Berge James C., 1993, Publications of the Nuttall Ornithological Club, V23, P189; Vanhooydonck B, 2009, BIOL J LINN SOC, V98, P129, DOI 10.1111/j.1095-8312.2009.01269.x; Worthy TH, 2002, PREHISTORIC LIFE NZ; Zilhao J, 2001, P NATL ACAD SCI USA, V98, P14180, DOI 10.1073/pnas.241522898	60	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12956	10.1371/journal.pone.0012956	http://dx.doi.org/10.1371/journal.pone.0012956			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886036	Green Submitted, gold, Green Published			2022-12-27	WOS:000282091100051
J	O'Rourke, CT; Pitlik, T; Hoover, M; Fernandez-Juricic, E				O'Rourke, Colleen T.; Pitlik, Todd; Hoover, Melissa; Fernandez-Juricic, Esteban			Hawk Eyes II: Diurnal Raptors Differ in Head Movement Strategies When Scanning from Perches	PLOS ONE			English	Article							SPATIAL VISUAL-ACUITY; MOTION PARALLAX; GAZE DIRECTION; DEEP FOVEA; DEPTH; VISION; PREDATOR; SEARCH; PERCEPTION; VIGILANCE	Background: Relatively little is known about the degree of inter-specific variability in visual scanning strategies in species with laterally placed eyes (e. g., birds). This is relevant because many species detect prey while perching; therefore, head movement behavior may be an indicator of prey detection rate, a central parameter in foraging models. We studied head movement strategies in three diurnal raptors belonging to the Accipitridae and Falconidae families. Methodology/Principal Findings: We used behavioral recording of individuals under field and captive conditions to calculate the rate of two types of head movements and the interval between consecutive head movements. Cooper's Hawks had the highest rate of regular head movements, which can facilitate tracking prey items in the visually cluttered environment they inhabit (e. g., forested habitats). On the other hand, Red-tailed Hawks showed long intervals between consecutive head movements, which is consistent with prey searching in less visually obstructed environments (e. g., open habitats) and with detecting prey movement from a distance with their central foveae. Finally, American Kestrels have the highest rates of translational head movements (vertical or frontal displacements of the head keeping the bill in the same direction), which have been associated with depth perception through motion parallax. Higher translational head movement rates may be a strategy to compensate for the reduced degree of eye movement of this species. Conclusions: Cooper's Hawks, Red-tailed Hawks, and American Kestrels use both regular and translational head movements, but to different extents. We conclude that these diurnal raptors have species-specific strategies to gather visual information while perching. These strategies may optimize prey search and detection with different visual systems in habitat types with different degrees of visual obstruction.	[O'Rourke, Colleen T.] Calif State Univ Long Beach, Dept Biol Sci, Long Beach, CA 90840 USA; [Pitlik, Todd] Wildlife Serv, Dept Agr, Anim & Plant Hlth Inspect Serv, Los Angeles, CA USA; [Hoover, Melissa; Fernandez-Juricic, Esteban] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	California State University System; California State University Long Beach; Purdue University System; Purdue University; Purdue University West Lafayette Campus	O'Rourke, CT (corresponding author), Calif State Univ Long Beach, Dept Biol Sci, Long Beach, CA 90840 USA.	efernan@purdue.edu			National Science Foundation [DBI-0641550]; California State University, Long Beach	National Science Foundation(National Science Foundation (NSF)); California State University, Long Beach	This study was funded by National Science Foundation DBI-0641550. CTO received funding from the 2008 California State University, Long Beach, Provost's Graduate Student Summer Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON M, 1981, THEOR POPUL BIOL, V19, P58, DOI 10.1016/0040-5809(81)90035-6; Andersson M, 2009, FUNCT ECOL, V23, P373, DOI 10.1111/j.1365-2435.2008.01512.x; Blumstein D. T., 2007, QUANTIFYING BEHAV JW; Bradbury Jack W., 1998, pi; Casperson Lee W., 1999, Bird Behavior, V13, P31; Curtis O. E., 2006, BIRDS N AM ONLINE; Dawkins MS, 2002, ANIM BEHAV, V63, P991, DOI [10.1006/anbe.2002.1999, 10.1006/anbe.2002.999]; Dukas R, 2004, BRAIN BEHAV EVOLUT, V63, P197, DOI 10.1159/000076781; Fernandez-Juricic E, 2004, TRENDS ECOL EVOL, V19, P25, DOI 10.1016/j.tree.2003.10.003; FITE KV, 1975, BRAIN BEHAV EVOLUT, V12, P97, DOI 10.1159/000124142; FOX R, 1977, SCIENCE, V197, P79, DOI 10.1126/science.867054; FROST BJ, 1990, VISUAL NEUROSCI, V5, P231, DOI 10.1017/S0952523800000304; Fujita M, 2004, COMP BIOCHEM PHYS A, V139, P117, DOI 10.1016/j.cbpb.2004.07.005; Fux M, 2009, PHYSIOL BEHAV, V98, P359, DOI 10.1016/j.physbeh.2009.06.016; Gall MD, 2010, J COMP PHYSIOL A, V196, P15, DOI 10.1007/s00359-009-0488-6; Gall MD, 2009, CONDOR, V111, P150, DOI 10.1525/cond.2009.080016; Gibson JJ, 1950, PERCEPTION VISUAL WO; Griesser M, 2003, BEHAV ECOL, V14, P246, DOI 10.1093/beheco/14.2.246; HARKNESS L, 1978, NATURE, V272, P814, DOI 10.1038/272814a0; Ilany A, 2008, BEHAV ECOL SOCIOBIOL, V62, P923, DOI 10.1007/s00265-007-0516-x; Jones KA, 2007, ANIM BEHAV, V74, P1181, DOI 10.1016/j.anbehav.2006.09.029; Jones MP, 2007, J EXOT PET MED, V16, P69, DOI 10.1053/j.jepm.2007.03.012; Kaminski J, 2005, ANIM BEHAV, V69, P11, DOI 10.1016/j.anbehav.2004.05.008; KELLY DH, 1979, J OPT SOC AM, V69, P1340, DOI 10.1364/JOSA.69.001340; Kjaersgaard A, 2008, J AVIAN BIOL, V39, P466, DOI 10.1111/j.2008.0908-8857.04288.x; Kral K, 2003, BEHAV PROCESS, V64, P21, DOI 10.1016/S0376-6357(03)00057-3; Kral K, 1998, BEHAV PROCESS, V43, P71, DOI 10.1016/S0376-6357(98)00007-2; Land MF, 1999, J COMP PHYSIOL A, V185, P341, DOI 10.1007/s003590050393; Land MF, 1999, J COMP PHYSIOL A, V184, P265, DOI 10.1007/s003590050324; Leyhe JE, 2004, J RAPTOR RES, V38, P19; MARTIN GR, 1986, NATURE, V319, P357, DOI 10.1038/319357a0; MARTIN GR, 1986, IBIS, V128, P266, DOI 10.1111/j.1474-919X.1986.tb02674.x; Meyer D.B., 1977, HDB SENSORY PHYSL, V7/5, P549; Mouritsen H, 2004, CURR BIOL, V14, P1946, DOI 10.1016/j.cub.2004.10.025; Nadler JW, 2008, NATURE, V452, P642, DOI 10.1038/nature06814; Nadler JW, 2009, NEURON, V63, P523, DOI 10.1016/j.neuron.2009.07.029; Nawrot M, 2003, J VISION, V3, P841, DOI 10.1167/3.11.17; Nawrot M, 2003, VISION RES, V43, P1553, DOI 10.1016/S0042-6989(03)00144-5; O'Rourke CT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012802; Ohayon S, 2008, BIOL CYBERN, V98, P115, DOI 10.1007/s00422-007-0199-4; Ohayon S, 2006, J COMP PHYSIOL A, V192, P927, DOI 10.1007/s00359-006-0130-9; Pettigrew J. D., 1978, Frontiers in Visual Science, P328; POGGIO GF, 1984, ANNU REV NEUROSCI, V7, P379, DOI 10.1146/annurev.ne.07.030184.002115; Preston C. R., 2009, BIRDS N AM; PUMPHREY RJ, 1948, J EXP BIOL, V25, P299; REYMOND L, 1987, VISION RES, V27, P1859, DOI 10.1016/0042-6989(87)90114-3; REYMOND L, 1985, VISION RES, V25, P1477, DOI 10.1016/0042-6989(85)90226-3; Shifferman E, 2004, J AVIAN BIOL, V35, P111, DOI 10.1111/j.0908-8857.2004.03257.x; Smallwood JA, 2002, BIRDS N AM ONLINE; STEINBACH MJ, 1973, VISION RES, V13, P889, DOI 10.1016/0042-6989(73)90055-2; Stevens D., 1986, FORAGING THEORY; Tomonaga M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009131; Treves A, 2000, ANIM BEHAV, V60, P711, DOI 10.1006/anbe.2000.1528; Tucker VA, 2000, J EXP BIOL, V203, P3745; Tucker VA, 2000, J EXP BIOL, V203, P3733; van der Willigen RF, 2002, J COMP PHYSIOL A, V187, P997, DOI 10.1007/s00359-001-0271-9; van der Willigen RF, 1998, NEUROREPORT, V9, P1233, DOI 10.1097/00001756-199804200-00050; Wallman Josh, 1993, P245; Walls G. L., 1942, B CRANBROOK I SCI, V19; WATHEY JC, 1989, BRAIN BEHAV EVOLUT, V33, P279, DOI 10.1159/000115936; Wolfe JM, 2000, SEEING, P335, DOI DOI 10.1016/B978-012443760-9/50010-6	61	20	22	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12169	10.1371/journal.pone.0012169	http://dx.doi.org/10.1371/journal.pone.0012169			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877650	Green Published, Green Submitted, gold			2022-12-27	WOS:000282053100001
J	Prieto-Godino, LL; de Polavieja, GG				Prieto-Godino, Lucia L.; de Polavieja, Gonzalo G.			Brain Activity at 70-80 Hz Changes during Olfactory Stimulation Protocols in Drosophila	PLOS ONE			English	Article							ODOR REPRESENTATIONS; OSCILLATIONS; SYNCHRONIZATION; MEMORY; DISCRIMINATION; DISHABITUATION; SENSITIZATION; LOCALIZATION	Oscillatory and synchronized activities in the mammalian brain have been correlated with the execution of complex cognitive tasks. Similar oscillations have been observed in local field potentials (LFPs) in flies, in this case correlated with different attentional states. To further test the significance of these oscillations we recorded LFPs from the brain of Drosophila melanogaster as it responded to the presentation of olfactory stimuli. We find that responses in the 70-80 Hz range increase during olfactory stimulation. Recurrent stimulation specifically decreased the power of LFPs in this frequency range. Delivery of electric shocks before olfactory stimulation modulated LFPs in the 70-80 Hz range by evoking a transient increase. These results suggest that these signals are a simple neuronal correlate of higher-order olfactory processing in flies.	[Prieto-Godino, Lucia L.; de Polavieja, Gonzalo G.] Univ Autonoma Madrid, Dept Theoret Phys, Madrid, Spain; [Prieto-Godino, Lucia L.; de Polavieja, Gonzalo G.] Univ Autonoma Madrid, Inst Nicolas Cabrera Fis Mat, Madrid, Spain	Autonomous University of Madrid; Autonomous University of Madrid	Prieto-Godino, LL (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.	llp23@cam.ac.uk; gonzalo.polavieja@cajal.csic.es		Prieto-Godino, Lucia L/0000-0002-2980-362X; de Polavieja, Gonzalo/0000-0001-5359-3426	Ministerio de Ciencia e Innovacion (MICINN); CAM	Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CAM	GGP acknowledges grants from Ministerio de Ciencia e Innovacion (MICINN) and the CAM Biociencia program. LPG acknowledges fellowship 'de aprovechamiento academico excelente' from CAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asztalos Z, 2007, J NEUROGENET, V21, P59, DOI 10.1080/01677060701249488; Asztalos Z, 2007, J NEUROGENET, V21, P1, DOI 10.1080/01677060701247508; Beshel J, 2007, J NEUROSCI, V27, P8358, DOI 10.1523/JNEUROSCI.1199-07.2007; Bhandawat V, 2007, NAT NEUROSCI, V10, P1474, DOI 10.1038/nn1976; BRAGIN A, 1995, J NEUROSCI, V15, P47; Christensen TA, 2003, P NATL ACAD SCI USA, V100, P11076, DOI 10.1073/pnas.1934001100; Engel AK, 2001, TRENDS COGN SCI, V5, P16, DOI 10.1016/S1364-6613(00)01568-0; Fries P, 1997, P NATL ACAD SCI USA, V94, P12699, DOI 10.1073/pnas.94.23.12699; GELPERIN A, 1990, NATURE, V345, P437, DOI 10.1038/345437a0; Giurfa M, 2001, NATURE, V410, P930, DOI 10.1038/35073582; Kay Leslie M, 2003, J Integr Neurosci, V2, P31, DOI 10.1142/S0219635203000196; LAURENT G, 1994, J NEUROSCI, V14, P2993; Lee TS, 2002, NAT NEUROSCI, V5, P589, DOI 10.1038/nn860; Liu L, 1999, NATURE, V400, P753, DOI 10.1038/23456; MacLeod K, 1998, NATURE, V395, P693, DOI 10.1038/27201; MAUELSHAGEN J, 1993, J NEUROPHYSIOL, V69, P609, DOI 10.1152/jn.1993.69.2.609; NICOLELIS MAL, 1995, SCIENCE, V268, P1353, DOI 10.1126/science.7761855; Nitz DA, 2002, CURR BIOL, V12, P1934, DOI 10.1016/S0960-9822(02)01300-3; Olsen SR, 2008, NATURE, V452, P956, DOI 10.1038/nature06864; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; QUINN WG, 1974, P NATL ACAD SCI USA, V71, P708, DOI 10.1073/pnas.71.3.708; Schaefer AT, 2006, PLOS BIOL, V4, P1010, DOI 10.1371/journal.pbio.0040163; Schwaerzel M, 2002, NEURON, V35, P951, DOI 10.1016/S0896-6273(02)00832-2; SINGER W, 1993, ANNU REV PHYSIOL, V55, P349, DOI 10.1146/annurev.physiol.55.1.349; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Tanaka NK, 2009, J NEUROSCI, V29, P8595, DOI 10.1523/JNEUROSCI.1455-09.2009; van Swinderen B, 2003, NAT NEUROSCI, V6, P579, DOI 10.1038/nn1054; van Swinderen B, 2007, SCIENCE, V315, P1590, DOI 10.1126/science.1137931; Vergoz V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000288; Yarali A, 2009, P R SOC B, V276, P3413, DOI 10.1098/rspb.2009.0705; Yu DH, 2004, NEURON, V42, P437, DOI 10.1016/S0896-6273(04)00217-X; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672; ZILBERGA.NF, 1974, COMP BIOCHEM PHYSIOL, V49, P441, DOI 10.1016/0300-9629(74)90560-X	34	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12867	10.1371/journal.pone.0012867	http://dx.doi.org/10.1371/journal.pone.0012867			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877566	Green Submitted, gold, Green Published			2022-12-27	WOS:000282053100022
J	Sampson, SD; Loewen, MA; Farke, AA; Roberts, EM; Forster, CA; Smith, JA; Titus, AL				Sampson, Scott D.; Loewen, Mark A.; Farke, Andrew A.; Roberts, Eric M.; Forster, Catherine A.; Smith, Joshua A.; Titus, Alan L.			New Horned Dinosaurs from Utah Provide Evidence for Intracontinental Dinosaur Endemism	PLOS ONE			English	Article							1ST CERATOPSID DINOSAUR; KAIPAROWITS FORMATION; WESTERN INTERIOR; 40AR/39AR AGE; SOUTHERN UTAH; BODY-SIZE; EVOLUTION; FACIES	Background: During much of the Late Cretaceous, a shallow, epeiric sea divided North America into eastern and western landmasses. The western landmass, known as Laramidia, although diminutive in size, witnessed a major evolutionary radiation of dinosaurs. Other than hadrosaurs (duck-billed dinosaurs), the most common dinosaurs were ceratopsids (large-bodied horned dinosaurs), currently known only from Laramidia and Asia. Remarkably, previous studies have postulated the occurrence of latitudinally arrayed dinosaur "provinces,'' or "biomes,'' on Laramidia. Yet this hypothesis has been challenged on multiple fronts and has remained poorly tested. Methodology/Principal Findings: Here we describe two new, co-occurring ceratopsids from the Upper Cretaceous Kaiparowits Formation of Utah that provide the strongest support to date for the dinosaur provincialism hypothesis. Both pertain to the clade of ceratopsids known as Chasmosaurinae, dramatically increasing representation of this group from the southern portion of the Western Interior Basin of North America. Utahceratops gettyi gen. et sp. nov.-characterized by short, rounded, laterally projecting supraorbital horncores and an elongate frill with a deep median embayment-is recovered as the sister taxon to Pentaceratops sternbergii from the late Campanian of New Mexico. Kosmoceratops richardsoni gen. et sp. nov.-characterized by elongate, laterally projecting supraorbital horncores and a short, broad frill adorned with ten well developed hooks-has the most ornate skull of any known dinosaur and is closely allied to Chasmosaurus irvinensis from the late Campanian of Alberta. Conclusions/Significance: Considered in unison, the phylogenetic, stratigraphic, and biogeographic evidence documents distinct, co-occurring chasmosaurine taxa north and south on the diminutive landmass of Laramidia. The famous Triceratops and all other, more nested chasmosaurines are postulated as descendants of forms previously restricted to the southern portion of Laramidia. Results further suggest the presence of latitudinally arrayed evolutionary centers of endemism within chasmosaurine ceratopsids during the late Campanian, the first documented occurrence of intracontinental endemism within dinosaurs.	[Sampson, Scott D.; Loewen, Mark A.; Smith, Joshua A.] Univ Utah, Utah Museum Nat Hist, Salt Lake City, UT 84112 USA; [Sampson, Scott D.; Loewen, Mark A.; Smith, Joshua A.] Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA; [Farke, Andrew A.] Raymond M Alf Museum Paleontol, Claremont, CA USA; [Roberts, Eric M.] James Cook Univ, Sch Earth & Environm Sci, Townsville, Qld, Australia; [Forster, Catherine A.] George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA; [Titus, Alan L.] Bur Land Management, Grand Staircase Escalante Natl Monument, Kanab, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; James Cook University; George Washington University	Sampson, SD (corresponding author), Univ Utah, Utah Museum Nat Hist, Salt Lake City, UT 84112 USA.	ssampson@umnh.utah.edu	Roberts, Eric/J-1836-2014	Roberts, Eric/0000-0002-8583-7437; Farke, Andrew/0000-0002-6930-2002	National Science Foundation [0745454, 0819953]; Division Of Earth Sciences [0819953, 0745454] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by grants from the National Science Foundation (EAR 0745454, 0819953; http://www.nsf.gov/funding/), Bureau of Land Management ( GSENM; http://www.blm.gov), Discovery Quest (http://www.discovery.com), and the University of Utah (http://www.utah.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Befus KS, 2008, J VOLCANOL GEOTH RES, V173, P245, DOI 10.1016/j.jvolgeores.2008.01.021; Blakey R. C., 2009, REGIONAL PALEOGEOGRA; BROWN JH, 1993, AM NAT, V142, P573, DOI 10.1086/285558; BROWN JH, 1989, SCIENCE, V243, P1145, DOI 10.1126/science.243.4895.1145; Burness GP, 2001, P NATL ACAD SCI USA, V98, P14518, DOI 10.1073/pnas.251548698; Dodson P, 1997, ENCY DINOSAURS, P473; Dodson P, 2004, DINOSAURIA, 2ND EDITION, P494; EBERTH DA, 1993, CAN J EARTH SCI, V30, P174, DOI 10.1139/e93-016; FASSETT JE, 1997, NEW MEXICO GEOLOGICA, V48, P29; Forster Catherine A., 1993, Journal of Vertebrate Paleontology, V13, P161; Gates TA, 2010, PALAEOGEOGR PALAEOCL, V291, P371, DOI 10.1016/j.palaeo.2010.03.008; Gates TA, 2007, ZOOL J LINN SOC-LOND, V151, P351, DOI 10.1111/j.1096-3642.2007.00349.x; Godfrey SJ, 1995, J VERTEBR PALEONTOL, V15, P726, DOI 10.1080/02724634.1995.10011258; Goloboff PA, 2004, CLADISTICS, V20, P84; Goloboff P, 2008, CLADISTICS, V24, P91; GOODWIN MB, 1989, CAN J EARTH SCI, V26, P1384, DOI 10.1139/e89-118; Holmes RB, 2001, CAN J EARTH SCI, V38, P1423, DOI 10.1139/e01-036; HORNER JR, 1992, NATURE, V358, P59, DOI 10.1038/358059a0; Horner JR, 1984, FIELD C GUIDEBOOK, P299; Kirkland James I., 2010, P117; Lambe LM., 1915, CANADA GEOLOGICAL SU, V12, P1; Lehman T. M., 1997, DINOFEST INT, P223; Lehman Thomas M., 2001, P310; LEHMAN TM, 1993, J PALEONTOL, V67, P279, DOI 10.1017/S0022336000032200; LEHMAN TM, 1987, PALAEOGEOGR PALAEOCL, V60, P189, DOI 10.1016/0031-0182(87)90032-0; Longrich NR, 2010, J PALEONTOL, V84, P681, DOI 10.1666/09-114.1; LUCAS SG, 2006, NEW MEXICO MUSEUM NA, V35, P367; Maddison W.P., MESQUITE MODULAR SYS; Marquet PA, 1998, EVOL ECOL, V12, P127, DOI 10.1023/A:1006567227154; Marsh O.C., 1890, AM J SCI, V39, P418, DOI DOI 10.2475/AJS.S3-39.233.418; Marsh OC., 1888, AM J SCI, V36, P477, DOI [10.2475/ajs.s3-36.216.477, DOI 10.2475/AJS.S3-36.216.477.]; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; PADIAN K, 1993, NEW MEXICO MUSEUM NA, V3, P379; Roberts EM, 2005, CRETACEOUS RES, V26, P307, DOI 10.1016/j.cretres.2005.01.002; Roberts EM, 2007, SEDIMENT GEOL, V197, P207, DOI 10.1016/j.sedgeo.2006.10.001; ROGERS RR, 1993, CAN J EARTH SCI, V30, P1066, DOI 10.1139/e93-090; RUSSELL D., 1967, NAT MUS CAN NATUR HIST PAP, V36, P1; Ryan MJ, 2005, LIFE O PAST, P312; Sampson Scott D., 2010, P405; SAMPSON SD, LEARN LAND IN PRESS; SEELEY HG, 1887, P ROY SOC LONDON, V43, P165, DOI DOI 10.1098/RSPL.1887.0117; Sereno Paul C., 1998, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V210, P41; Sues HD, 2009, NATURWISSENSCHAFTEN, V96, P645, DOI 10.1007/s00114-009-0518-9; SULLIVAN RM, 2006, NEW MEXICO MUSEUM NA, V35, P7; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; VANDEGRAFF FR, 1972, J SEDIMENT PETROL, V42, P558; Vavrek MJ, 2010, P NATL ACAD SCI USA, V107, P8265, DOI 10.1073/pnas.0913645107; Xu X, 2010, CHINESE SCI BULL, V55, P1631, DOI 10.1007/s11434-009-3614-5; Zanno LE, 2005, J VERTEBR PALEONTOL, V25, P897, DOI 10.1671/0272-4634(2005)025[0897:ANOTMF]2.0.CO;2	49	124	127	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12292	10.1371/journal.pone.0012292	http://dx.doi.org/10.1371/journal.pone.0012292			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877459	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000282053100002
J	Jaoko, W; Karita, E; Kayitenkore, K; Omosa-Manyonyi, G; Allen, S; Than, S; Adams, EM; Graham, BS; Koup, RA; Bailer, RT; Smith, C; Dally, L; Farah, B; Anzala, O; Muvunyi, CM; Bizimana, J; Tarragona-Fiol, T; Bergin, PJ; Hayes, P; Ho, M; Loughran, K; Komaroff, W; Stevens, G; Thomson, H; Boaz, MJ; Cox, JH; Schmidt, C; Gilmour, J; Nabel, GJ; Fast, P; Bwayo, J				Jaoko, Walter; Karita, Etienne; Kayitenkore, Kayitesi; Omosa-Manyonyi, Gloria; Allen, Susan; Than, Soe; Adams, Elizabeth M.; Graham, Barney S.; Koup, Richard A.; Bailer, Robert T.; Smith, Carol; Dally, Len; Farah, Bashir; Anzala, Omu; Muvunyi, Claude M.; Bizimana, Jean; Tarragona-Fiol, Tony; Bergin, Philip J.; Hayes, Peter; Ho, Martin; Loughran, Kelley; Komaroff, Wendy; Stevens, Gwynneth; Thomson, Helen; Boaz, Mark J.; Cox, Josephine H.; Schmidt, Claudia; Gilmour, Jill; Nabel, Gary J.; Fast, Patricia; Bwayo, Job			Safety and Immunogenicity Study of Multiclade HIV-1 Adenoviral Vector Vaccine Alone or as Boost following a Multiclade HIV-1 DNA Vaccine in Africa	PLOS ONE			English	Article							T-CELLS; NEUTRALIZING ANTIBODIES; CLINICAL-TRIALS; PHASE-1 SAFETY; CANDIDATE; IMMUNITY; ASSAY; REPLICATION; INFECTION; GAG	Background: We conducted a double-blind, randomized, placebo-controlled Phase I study of a recombinant replication-defective adenovirus type 5 (rAd5) vector expressing HIV-1 Gag and Pol from subtype B and Env from subtypes A, B and C, given alone or as boost following a DNA plasmid vaccine expressing the same HIV-1 proteins plus Nef, in 114 healthy HIV-uninfected African adults. Methodology/Principal Findings: Volunteers were randomized to 4 groups receiving the rAd5 vaccine intramuscularly at dosage levels of 1x10(10) or 1x10(11) particle units (PU) either alone or as boost following 3 injections of the DNA vaccine given at 4 mg/dose intramuscularly by needle-free injection using Biojector (R) 2000. Safety and immunogenicity were evaluated for 12 months. Both vaccines were well-tolerated. Overall, 62% and 86% of vaccine recipients in the rAd5 alone and DNA prime - rAd5 boost groups, respectively, responded to the HIV-1 proteins by an interferon-gamma (IFN-gamma) ELISPOT. The frequency of immune responses was independent of rAd5 dosage levels. The highest frequency of responses after rAd5 alone was detected at 6 weeks; after DNA prime - rAd5 boost, at 6 months (end of study). At baseline, neutralizing antibodies against Ad5 were present in 81% of volunteers; the distribution was similar across the 4 groups. Pre-existing immunity to Ad5 did not appear to have a significant impact on reactogenicity or immune response rates to HIV antigens by IFN-gamma ELISPOT. Binding antibodies against Env were detected in up to 100% recipients of DNA prime - rAd5 boost. One volunteer acquired HIV infection after the study ended, two years after receipt of rAd5 alone. Conclusions/Significance: The HIV-1 rAd5 vaccine, either alone or as a boost following HIV-1 DNA vaccine, was well-tolerated and immunogenic in African adults. DNA priming increased the frequency and magnitude of cellular and humoral immune responses, but there was no effect of rAd5 dosage on immunogenicity endpoints. Trial Registration: ClinicalTrials.gov NCT00124007	[Jaoko, Walter; Omosa-Manyonyi, Gloria; Farah, Bashir; Anzala, Omu; Bwayo, Job] Kenya AIDS Vaccine Initiat KAVI, Nairobi, Kenya; [Karita, Etienne; Kayitenkore, Kayitesi; Muvunyi, Claude M.; Bizimana, Jean] Rwanda Zambia HIV Res Project, PSF, Kigali, Rwanda; [Allen, Susan] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Than, Soe; Komaroff, Wendy; Stevens, Gwynneth; Thomson, Helen; Boaz, Mark J.; Cox, Josephine H.; Schmidt, Claudia; Fast, Patricia] Int AIDS Vaccine Initiat IAVI, New York, NY USA; [Adams, Elizabeth M.] NIAID, VCRB, VRP, DAIDS,NIH, Bethesda, MD 20892 USA; [Graham, Barney S.; Koup, Richard A.; Bailer, Robert T.; Nabel, Gary J.] NIAID, VRC, NIH, Bethesda, MD 20892 USA; [Smith, Carol; Dally, Len; Ho, Martin; Loughran, Kelley] EMMES Corp, Rockville, MD USA; [Tarragona-Fiol, Tony; Bergin, Philip J.; Hayes, Peter; Gilmour, Jill] Univ London Imperial Coll Sci Technol & Med, IAVI Human Immunol, London, England	Emory University; Rollins School Public Health; International AIDS Vaccine Initiative; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Emmes Corporation; Imperial College London; International AIDS Vaccine Initiative	Jaoko, W (corresponding author), Kenya AIDS Vaccine Initiat KAVI, Nairobi, Kenya.	pfast@iavi.org	Graham, Barney S./AAC-5898-2019; Jaoko, Walter/AAN-5048-2020	Graham, Barney S./0000-0001-8112-0853; Ho, Martin/0000-0002-8970-5095; Cox, Josephine/0000-0003-1301-7373; Bergin, Philip/0000-0001-5522-8350; Jaoko, Walter/0000-0002-7134-6581	International AIDS Vaccine Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005035, ZIAAI005073] Funding Source: NIH RePORTER	International AIDS Vaccine Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the International AIDS Vaccine Initiative and its donors, including the generous support of the American people through the United States Agency for International Development (USAID; USAID Cooperative Agreement Number GPO-A-00-06-00006-00). The contents of this manuscript are the responsibility of IAVI and do not necessarily reflect the views of USAID or the US government. The following organizations/institutions played a direct role in study design, data collection and analysis, decision to publish, and preparation of this manuscript: i) the International AIDS Vaccine Initiative, ii) the Vaccine Clinical Research Branch/DAIDS/NIAID/NIH, iii) the Vaccine Research Center/NIAID/NIH. The EMMES Corporation is a Contract Research Organization (CRO). IAVI subcontracted data coordination, management and analysis for the V001 study to the EMMES Corporation.	Abbink P, 2007, J VIROL, V81, P4654, DOI 10.1128/JVI.02696-06; Boaz MJ, 2009, CLIN VACCINE IMMUNOL, V16, P147, DOI 10.1128/CVI.00326-08; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Catanzaro AT, 2007, VACCINE, V25, P4085, DOI 10.1016/j.vaccine.2007.02.050; Catanzaro AT, 2006, J INFECT DIS, V194, P1638, DOI 10.1086/509258; Chen H, 2009, J VIROL, V83, P3138, DOI 10.1128/JVI.02073-08; Cox KS, 2008, J VIROL, V82, P8161, DOI 10.1128/JVI.00620-08; Currier JR, 2002, J IMMUNOL METHODS, V260, P157, DOI 10.1016/S0022-1759(01)00535-X; D'Souza MP, 2010, AIDS, V24, P803, DOI 10.1097/QAD.0b013e3283379712; Eller MA, 2007, VACCINE, V25, P7737, DOI 10.1016/j.vaccine.2007.08.056; Fauce SR, 2007, J IMMUNOL METHODS, V327, P75, DOI 10.1016/j.jim.2007.07.017; Goonetilleke N, 2006, J VIROL, V80, P4717, DOI 10.1128/JVI.80.10.4717-4728.2006; Graham BS, 2006, J INFECT DIS, V194, P1650, DOI 10.1086/509259; JULG B, 2010, ENHANCED ANTIHIV FUN; Karita E, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-S3-P197; Khurana S, 2006, J VIROL, V80, P2092, DOI 10.1128/JVI.80.5.2092-2099.2006; Kibuuka H, 2010, J INFECT DIS, V201, P600, DOI 10.1086/650299; Koup RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009015; Letvin NL, 2009, SCIENCE, V326, P1196, DOI 10.1126/science.1183278; Mast TC, 2010, VACCINE, V28, P950, DOI 10.1016/j.vaccine.2009.10.145; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; Mwau M, 2002, AIDS RES HUM RETROV, V18, P611, DOI 10.1089/088922202760019301; Peters BS, 2007, VACCINE, V25, P2120, DOI 10.1016/j.vaccine.2006.11.016; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Spentzou A, 2010, J INFECT DIS, V201, P720, DOI 10.1086/650492; Sprangers MC, 2003, J CLIN MICROBIOL, V41, P5046, DOI 10.1128/JCM.41.11.5046-5052.2003; STILES T, 2003, GOOD CLIN LAB PRACTI, P1; Sumida SM, 2005, J IMMUNOL, V174, P7179, DOI 10.4049/jimmunol.174.11.7179; Tavel JA, 2007, JAIDS-J ACQ IMM DEF, V44, P601, DOI 10.1097/QAI.0b013e3180417cb6; Vogels R, 2003, J VIROL, V77, P8263, DOI 10.1128/JVI.77.15.8263-8271.2003	31	77	78	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2010	5	9							e12873	10.1371/journal.pone.0012873	http://dx.doi.org/10.1371/journal.pone.0012873			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652JO	20877623	Green Submitted, gold, Green Published			2022-12-27	WOS:000282002900014
J	van der Poorten, D; Shahidi, M; Tay, E; Sesha, J; Tran, K; McLeod, D; Milliken, JS; Ho, V; Hebbard, LW; Douglas, MW; George, J				van der Poorten, David; Shahidi, Mahsa; Tay, Enoch; Sesha, Jayshree; Tran, Kayla; McLeod, Duncan; Milliken, Jane S.; Ho, Vikki; Hebbard, Lionel W.; Douglas, Mark W.; George, Jacob			Hepatitis C Virus Induces the Cannabinoid Receptor 1	PLOS ONE			English	Article							CORE PROTEIN; RISK-FACTOR; CB1 RECEPTORS; STEATOSIS; FIBROSIS; ENDOCANNABINOIDS; ACTIVATION; MECHANISMS; LOCALIZATION; HEPATOCYTES	Background: Activation of hepatic CB1 receptors (CB1) is associated with steatosis and fibrosis in experimental forms of liver disease. However, CB1 expression has not been assessed in patients with chronic hepatitis C (CHC), a disease associated with insulin resistance, steatosis and metabolic disturbance. We aimed to determine the importance and explore the associations of CB1 expression in CHC. Methods: CB1 receptor mRNA was measured by real time quantitative PCR on extracted liver tissue from 88 patients with CHC (genotypes 1 and 3), 12 controls and 10 patients with chronic hepatitis B (CHB). The Huh7/JFH1 Hepatitis C virus (HCV) cell culture model was used to validate results. Principal Findings: CB1 was expressed in all patients with CHC and levels were 6-fold higher than in controls (P<0.001). CB1 expression increased with fibrosis stage, with cirrhotics having up to a 2 fold up-regulation compared to those with low fibrosis stage (p<0.05). Even in mild CHC with no steatosis (F0-1), CB1 levels remained substantially greater than in controls (p<0.001) and in those with mild CHB (F0-1; p<0.001). Huh7 cells infected with JFH-1 HCV showed an 8-fold up-regulation of CB1, and CB1 expression directly correlated with the percentage of cells infected over time, suggesting that CB1 is an HCV inducible gene. While HCV structural proteins appear essential for CB1 induction, there was no core genotype specific difference in CB1 expression. CB1 significantly increased with steatosis grade, primarily driven by patients with genotype 3 CHC. In genotype 3 patients, CB1 correlated with SREBP-1c and its downstream target FASN (SREBP-1c; R = 0.37, FASN; R = 0.39, p<0.05 for both). Conclusions/Significance: CB1 is up-regulated in CHC and is associated with increased steatosis in genotype 3. It is induced by the hepatitis C virus.	[van der Poorten, David; Shahidi, Mahsa; Tay, Enoch; Sesha, Jayshree; Ho, Vikki; Hebbard, Lionel W.; Douglas, Mark W.; George, Jacob] Univ Sydney, Westmead Hosp, Storr Liver Unit, Westmead Millennium Inst, Sydney, NSW 2006, Australia; [Tran, Kayla; McLeod, Duncan; Milliken, Jane S.] Westmead Hosp, Dept Anat Pathol, Inst Clin Pathol & Med Res ICPMR, Sydney, NSW, Australia; [Douglas, Mark W.] Westmead Hosp, Ctr Infect Dis & Microbiol, Sydney, NSW, Australia	University of Sydney; Westmead Institute for Medical Research; University of Sydney; University of Sydney	van der Poorten, D (corresponding author), Univ Sydney, Westmead Hosp, Storr Liver Unit, Westmead Millennium Inst, Sydney, NSW 2006, Australia.	jacob.george@sydney.edu.au	George, jacob/P-1496-2014; Hebbard, Lionel w/F-7272-2014; Douglas, Mark/D-5513-2011; Hebbard, Lionel/W-4057-2019; Hebbard, Lionel/O-1489-2017	Douglas, Mark/0000-0003-4621-3485; Hebbard, Lionel/0000-0002-7094-9065	Gastroenterological Society of Australia (GESA); Australian National Health and Medical Research Council [402577, 219282]; CJ Martin Fellowship; Robert W. Storr Bequest	Gastroenterological Society of Australia (GESA); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); CJ Martin Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Robert W. Storr Bequest	This work was funded by the Gastroenterological Society of Australia (GESA) Postgraduate Medical Scholarship (DVDP), Australian National Health and Medical Research Council #402577, #219282 (JG), CJ Martin Fellowship (MD) and the Robert W. Storr Bequest to the University of Sydney (JG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselah T, 2006, GUT, V55, P123, DOI 10.1136/gut.2005.069757; Barba G, 1997, P NATL ACAD SCI USA, V94, P1200, DOI 10.1073/pnas.94.4.1200; Bataller R, 2004, GASTROENTEROLOGY, V126, P529, DOI 10.1053/j.gastro.2003.11.018; Boivin B, 2008, J RECEPT SIG TRANSD, V28, P15, DOI [10.1080/10799890801941889, 10.1080/10799890801941889 ]; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Ellis J, 2006, J BIOL CHEM, V281, P38812, DOI 10.1074/jbc.M602494200; *EUR MED AG, 2008, EMEACHMP537777532008; Gary-Bobo M, 2007, HEPATOLOGY, V46, P122, DOI 10.1002/hep.21641; Hezode C, 2005, HEPATOLOGY, V42, P63, DOI 10.1002/hep.20733; Hezode C, 2008, GASTROENTEROLOGY, V134, P432, DOI 10.1053/j.gastro.2007.11.039; Hui JM, 2003, GASTROENTEROLOGY, V125, P1695, DOI 10.1053/j.gastro.2003.08.032; Hui JM, 2002, J GASTROEN HEPATOL, V17, P873, DOI 10.1046/j.1440-1746.2002.02813.x; Jeong WI, 2008, CELL METAB, V7, P227, DOI 10.1016/j.cmet.2007.12.007; Julien B, 2005, GASTROENTEROLOGY, V128, P742, DOI 10.1053/j.gastro.2004.12.050; Kato T, 2003, GASTROENTEROLOGY, V125, P1808, DOI 10.1053/j.gastro.2003.09.023; Kim KH, 2007, BIOCHEM BIOPH RES CO, V355, P883, DOI 10.1016/j.bbrc.2007.02.044; Kumar D, 2002, HEPATOLOGY, V36, P1266, DOI 10.1053/jhep.2002.36370; Kunos G, 2008, J BIOL CHEM, V283, P33021, DOI 10.1074/jbc.R800012200; McCaughan GW, 2004, GUT, V53, P318, DOI 10.1136/gut.2003.026393; Munoz-Luque J, 2008, J PHARMACOL EXP THER, V324, P475, DOI 10.1124/jpet.107.131896; Negro F, 2006, WORLD J GASTROENTERO, V12, P6756, DOI 10.3748/wjg.v12.i42.6756; Ohata K, 2003, CANCER-AM CANCER SOC, V97, P3036, DOI 10.1002/cncr.11427; Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057; Osei-Hyiaman D, 2008, J CLIN INVEST, V118, P3160, DOI 10.1172/JCI34827; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Parfieniuk A, 2008, WORLD J GASTROENTERO, V14, P6109, DOI 10.3748/wjg.14.6109; Perlemuter G, 2002, FASEB J, V16, P185, DOI 10.1096/fj.01-0396com; Rasband W.S., 1997, IMAGEJ; SCHEUER PJ, 1991, J HEPATOL, V13, P372, DOI 10.1016/0168-8278(91)90084-O; Schulze-Krebs A, 2005, GASTROENTEROLOGY, V129, P246, DOI 10.1053/j.gastro.2005.03.089; Shaw ML, 2003, J MED VIROL, V70, P361, DOI 10.1002/jmv.10404; Shi ST, 2002, VIROLOGY, V292, P198, DOI 10.1006/viro.2001.1225; Smart RG, 2000, ADDICT BEHAV, V25, P455, DOI 10.1016/S0306-4603(99)00013-1; Su AI, 2002, P NATL ACAD SCI USA, V99, P15669, DOI 10.1073/pnas.202608199; Teixeira-Clerc F, 2006, NAT MED, V12, P671, DOI 10.1038/nm1421; Trillou CR, 2004, INT J OBESITY, V28, P640, DOI 10.1038/sj.ijo.0802583; van der Poorten D, 2008, CLIN LIVER DIS, V12, P805, DOI 10.1016/j.cld.2008.07.003; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; *WHO, WHO IN VACC RES IVR; Yang W, 2008, HEPATOLOGY, V48, P1396, DOI 10.1002/hep.22508	42	37	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2010	5	9							e12841	10.1371/journal.pone.0012841	http://dx.doi.org/10.1371/journal.pone.0012841			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651XL	20862263	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000281960800027
J	Reece, JC; Loh, L; Alcantara, S; Fernandez, CS; Stambas, J; Sexton, A; De Rose, R; Petravic, J; Davenport, MP; Kent, SJ				Reece, Jeanette C.; Loh, Liyen; Alcantara, Sheilajen; Fernandez, Caroline S.; Stambas, John; Sexton, Amy; De Rose, Robert; Petravic, Janka; Davenport, Miles P.; Kent, Stephen J.			Timing of Immune Escape Linked to Success or Failure of Vaccination	PLOS ONE			English	Article							CYTOTOXIC T-LYMPHOCYTE; CLASS-I ALLELE; ACUTE SIV INFECTION; IMMUNODEFICIENCY-VIRUS; SIMIAN-HUMAN; PIGTAIL MACAQUES; KILLING KINETICS; HIV-1 VACCINE; VIRAL LOAD; REVERSION	Successful vaccination against HIV should limit viral replication sufficiently to prevent the emergence of viral immune escape mutations. Broadly directed immunity is likely to be required to limit opportunities for immune escape variants to flourish. We studied the emergence of an SIV Gag cytotoxic T cell immune escape variant in pigtail macaques expressing the Mane-A* 10 MHC I allele using a quantitative RT-PCR to measure viral loads of escape and wild type variants. Animals receiving whole Gag expressing vaccines completely controlled an SIVmac251 challenge, had broader CTL responses and exhibited minimal CTL escape. In contrast, animals vaccinated with only a single CTL epitope and challenged with the same SIVmac251 stock had high levels of viral replication and rapid CTL escape. Unvaccinated naive animals exhibited a slower emergence of immune escape variants. Thus narrowly directed vaccination against a single epitope resulted in rapid immune escape and viral levels equivalent to that of naive unvaccinated animals. These results emphasize the importance of inducing broadly directed HIV-specific immunity that effectively quashes early viral replication and limits the generation of immune escape variants. This has important implications for the selection of HIV vaccines for expanded human trials.	[Reece, Jeanette C.; Loh, Liyen; Alcantara, Sheilajen; Fernandez, Caroline S.; Stambas, John; Sexton, Amy; De Rose, Robert; Kent, Stephen J.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Petravic, Janka; Davenport, Miles P.] Univ New S Wales, Ctr Vasc Res, Sydney, NSW, Australia	University of Melbourne; University of New South Wales Sydney	Reece, JC (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia.	skent@unimelb.edu.au	Kent, Stephen/AAL-5101-2020; Petravic, Janka/AAD-9192-2020	Kent, Stephen/0000-0002-8539-4891; Petravic, Janka/0000-0002-2263-2776; Davenport, Miles/0000-0002-4751-1831; Reece, Jeanette/0000-0003-2897-0271; Stambas, John/0000-0002-5690-2551; De Rose, Robert/0000-0003-4316-3910; Loh, Liyen/0000-0002-1676-0579	NHMRC [508902, 454553]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	Supported by NHMRC awards 508902 and 454553 (http://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2002, J VIROL, V76, P4108, DOI 10.1128/JVI.76.8.4108-4112.2002; Allen TM, 2002, J VIROL, V76, P10507, DOI 10.1128/JVI.76.20.10507-10511.2002; Batten CJ, 2006, AIDS RES HUM RETROV, V22, P580, DOI 10.1089/aid.2006.22.580; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Chopera DR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000033; Corey L, 2009, AIDS, V23, P3, DOI 10.1097/QAD.0b013e32830e6d6d; Dale CJ, 2004, J VIROL, V78, P13819, DOI 10.1128/JVI.78.24.13819-13828.2004; Davenport MP, 2008, TRENDS MICROBIOL, V16, P561, DOI 10.1016/j.tim.2008.09.001; De Rose R, 2008, VIROLOGY, V378, P201, DOI 10.1016/j.virol.2008.06.006; De Rose R, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000055; De Rose R, 2007, J VIROL, V81, P292, DOI 10.1128/JVI.01727-06; Fernandez CS, 2005, J VIROL, V79, P5721, DOI 10.1128/JVI.79.9.5721-5731.2005; Frahm N, 2006, NAT IMMUNOL, V7, P173, DOI 10.1038/ni1281; Friedrich TC, 2004, NAT MED, V10, P275, DOI 10.1038/nm998; Goepfert PA, 2008, J EXP MED, V205, P1009, DOI 10.1084/jem.20072457; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Kalams SA, 1999, J VIROL, V73, P6715, DOI 10.1128/JVI.73.8.6715-6720.1999; KENT SJ, 2008, VIROLOGY, V347, P538; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Loh L, 2007, J VIROL, V81, P5418, DOI 10.1128/JVI.02763-06; Loh L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000378; Loh L, 2008, AIDS RES HUM RETROV, V24, P1067, DOI 10.1089/aid.2007.0309; Loh L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040012; Mankowski JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003603; Mason RD, 2009, VIROLOGY, V388, P315, DOI 10.1016/j.virol.2009.03.020; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; OLEARY CE, 2009, IMMUNOGENETICS; Petravic J, 2008, J VIROL, V82, P4091, DOI 10.1128/JVI.02552-07; Pratt BF, 2006, IMMUNOGENETICS, V58, P995, DOI 10.1007/s00251-006-0164-8; Price DA, 2004, IMMUNITY, V21, P793, DOI 10.1016/j.immuni.2004.10.010; Rollman E, 2007, J IMMUNOL, V179, P4571, DOI 10.4049/jimmunol.179.7.4571; Rollman E, 2008, J MED PRIMATOL, V37, P24, DOI 10.1111/j.1600-0684.2008.00326.x; Sexton A, 2009, J VIROL, V83, P7619, DOI 10.1128/JVI.00470-09; Smith MZ, 2005, J VIROL, V79, P684, DOI 10.1128/JVI.79.2.684-695.2005; Smith MZ, 2005, J MED PRIMATOL, V34, P282, DOI 10.1111/j.1600-0684.2005.00126.x	40	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2010	5	9							e12774	10.1371/journal.pone.0012774	http://dx.doi.org/10.1371/journal.pone.0012774			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650QH	20862289	Green Published, gold			2022-12-27	WOS:000281864100017
J	Cai, YD; Huang, T; Feng, KY; Hu, LL; Xie, L				Cai, Yu-Dong; Huang, Tao; Feng, Kai-Yan; Hu, Lele; Xie, Lu			A Unified 35-Gene Signature for both Subtype Classification and Survival Prediction in Diffuse Large B-Cell Lymphomas	PLOS ONE			English	Article							GRADE FIBROMYXOID SARCOMA; GENE-EXPRESSION PROFILES; PROSTATE-CANCER; HISTONE DEACETYLASE-1; KINASE; IMMUNOPHENOTYPE; TRANSCRIPTION; INDUCTION; CARCINOMA; MOTILITY	Cancer subtype classification and survival prediction both relate directly to patients' specific treatment plans, making them fundamental medical issues. Although the two factors are interrelated learning problems, most studies tackle each separately. In this paper, expression levels of genes are used for both cancer subtype classification and survival prediction. We considered 350 diffuse large B-cell lymphoma (DLBCL) subjects, taken from four groups of patients (activated B-cell-like subtype dead, activated B-cell-like subtype alive, germinal center B-cell-like subtype dead, and germinal center B-cell-like subtype alive). As classification features, we used 11,271 gene expression levels of each subject. The features were first ranked by mRMR (Maximum Relevance Minimum Redundancy) principle and further selected by IFS (Incremental Feature Selection) procedure. Thirty-five gene signatures were selected after the IFS procedure, and the patients were divided into the above mentioned four groups. These four groups were combined in different ways for subtype prediction and survival prediction, specifically, the activated versus the germinal center and the alive versus the dead. Subtype prediction accuracy of the 35-gene signature was 98.6%. We calculated cumulative survival time of high-risk group and low-risk groups by the Kaplan-Meier method. The log-rank test p-value was 5.98e-08. Our methodology provides a way to study subtype classification and survival prediction simultaneously. Our results suggest that for some diseases, especially cancer, subtype classification may be used to predict survival, and, conversely, survival prediction features may shed light on subtype features.	[Cai, Yu-Dong; Hu, Lele] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Huang, Tao] Chinese Acad Sci, Key Lab Syst Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Huang, Tao; Feng, Kai-Yan; Xie, Lu] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Cai, Yu-Dong] Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China	Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Fudan University	Cai, YD (corresponding author), Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China.	cai_yud@yahoo.com.cn; xielu@scbit.org		cai, yudong/0000-0001-5664-7979	National High-Tech RD Program [2006AA02Z334, 2007DFA31040]; China National Key Projects for Infectious Disease [2008ZX10002-021]; National Basic Research Program of China [2006CB910700]; National Natural Science Foundation of China [31070752]; CAS [KSCX2-YW-R-112]	National High-Tech RD Program(National High Technology Research and Development Program of China); China National Key Projects for Infectious Disease; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS(Chinese Academy of Sciences)	This work was supported by grants from National High-Tech R&D Program (863) (2006AA02Z334, 2007DFA31040), China National Key Projects for Infectious Disease (2008ZX10002-021), National Basic Research Program of China (2006CB910700), National Natural Science Foundation of China (Grant No. 31070752) and Key Research Program (CAS) (KSCX2-YW-R-112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Ammanamanchi S, 2003, J BIOL CHEM, V278, P35775, DOI 10.1074/jbc.M305961200; ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Baytel D, 1998, BBA-GENE STRUCT EXPR, V1442, P274, DOI 10.1016/S0167-4781(98)00185-7; Berglund M, 2005, MODERN PATHOL, V18, P1113, DOI 10.1038/modpathol.3800396; Chan WC, 1997, BLOOD, V89, P3909; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Choi JH, 2001, JPN J CANCER RES, V92, P1300, DOI 10.1111/j.1349-7006.2001.tb02153.x; Dai H, 2005, PROSTATE, V65, P276, DOI 10.1002/pros.20294; FRIEDMAN JH, 1975, IEEE T COMPUT, V24, P1000, DOI 10.1109/T-C.1975.224110; Gong JP, 2009, J SURG RES, V153, P17, DOI 10.1016/j.jss.2008.03.033; Goytain A, 2008, AM J PHYSIOL-CELL PH, V295, pC944, DOI 10.1152/ajpcell.00091.2008; HARRINGTON DP, 1982, BIOMETRIKA, V69, P553, DOI 10.2307/2335991; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011900; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010972; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008126; Huang T, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-44; Hung JJ, 2006, MOL CELL BIOL, V26, P1770, DOI 10.1128/MCB.26.5.1770-1785.2006; Kallergi G, 2007, CELL PHYSIOL BIOCHEM, V20, P977, DOI 10.1159/000110458; Koch JG, 2007, MAMM GENOME, V18, P300, DOI 10.1007/s00335-007-9028-2; Lacoste J, 2005, MOL CELL ENDOCRINOL, V235, P51, DOI 10.1016/j.mce.2004.06.014; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Lenz G, 2008, P NATL ACAD SCI USA, V105, P13520, DOI 10.1073/pnas.0804295105; Lossos IS, 2003, INT J HEMATOL, V77, P321, DOI 10.1007/BF02982638; Lossos IS, 2001, BLOOD, V98, P945, DOI 10.1182/blood.V98.4.945; Lossos IS, 2004, NEW ENGL J MED, V350, P1828, DOI 10.1056/NEJMoa032520; Marinkovic D, 2004, NUCLEIC ACIDS RES, V32, P5368, DOI 10.1093/nar/gkh877; Monti S, 2005, BLOOD, V105, P1851, DOI 10.1182/blood-2004-07-2947; Nicolas E, 2000, J BIOL CHEM, V275, P9797, DOI 10.1074/jbc.275.13.9797; Noonan EJ, 2009, ONCOGENE, V28, P1714, DOI 10.1038/onc.2009.19; Panagopoulos L, 2004, GENE CHROMOSOME CANC, V40, P218, DOI 10.1002/gcc.20037; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Qian ZL, 2006, BIOCHEM BIOPH RES CO, V348, P1034, DOI 10.1016/j.bbrc.2006.07.149; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Rosenwald A, 2003, J EXP MED, V198, P851, DOI 10.1084/jem.20031074; Senga T, 2002, ONCOGENE, V21, P8186, DOI 10.1038/sj.onc.1205918; Shaffer AL, 2006, IMMUNOL REV, V210, P67, DOI 10.1111/j.0105-2896.2006.00373.x; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shim H, 2006, BIOTECHNOL LETT, V28, P2057, DOI 10.1007/s10529-006-9190-8; Storlazzi CT, 2003, HUM MOL GENET, V12, P2349, DOI 10.1093/hmg/ddg237; Toh Y, 2003, ONCOL REP, V10, P333; Turgeon M.L., 2005, CLIN HEMATOLOGY THEO; Veelken H, 2007, ANN ONCOL, V18, P931, DOI 10.1093/annonc/mdm012; Wright G, 2003, P NATL ACAD SCI USA, V100, P9991, DOI 10.1073/pnas.1732008100; Yan B, 2003, J BIOL CHEM, V278, P45358, DOI 10.1074/jbc.M307933200; Zhang ZH, 2005, BREAST CANCER RES TR, V94, P11, DOI 10.1007/s10549-005-6001-1	46	19	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2010	5	9							e12726	10.1371/journal.pone.0012726	http://dx.doi.org/10.1371/journal.pone.0012726			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648ZZ	20856936	gold, Green Published, Green Submitted			2022-12-27	WOS:000281735700024
J	Rolli, J; Rosenblatt-Velin, N; Li, JH; Loukili, N; Levrand, S; Pacher, P; Waeber, B; Feihl, F; Ruchat, P; Liaudet, L				Rolli, Joelle; Rosenblatt-Velin, Nathalie; Li, Jianhui; Loukili, Noureddine; Levrand, Sandra; Pacher, Pal; Waeber, Bernard; Feihl, Francois; Ruchat, Patrick; Liaudet, Lucas			Bacterial Flagellin Triggers Cardiac Innate Immune Responses and Acute Contractile Dysfunction	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-5; MYOCARDIAL INFLAMMATION; SIGNALING PATHWAY; SEPTIC SHOCK; CUTTING EDGE; SEPSIS; PEROXYNITRITE; EXPRESSION; HEART; LIPOPOLYSACCHARIDE	Background: Myocardial contractile failure in septic shock may develop following direct interactions, within the heart itself, between molecular motifs released by pathogens and their specific receptors, notably those belonging to the toll-like receptor (TLR) family. Here, we determined the ability of bacterial flagellin, the ligand of mammalian TLR5, to trigger myocardial inflammation and contractile dysfunction. Methodology/Principal Findings: TLR5 expression was determined in H9c2 cardiac myoblasts, in primary rat cardiomyocytes, and in whole heart extracts from rodents and humans. The ability of flagellin to activate pro-inflammatory signaling pathways (NF-kappaB and MAP kinases) and the expression of inflammatory cytokines was investigated in H9c2 cells, and, in part, in primary cardiomyocytes, as well as in the mouse myocardium in vivo. The influence of flagellin on left ventricular function was evaluated in mice by a conductance pressure-volume catheter. Cardiomyoyctes and intact myocardium disclosed significant TLR5 expression. In vitro, flagellin activated NF-kappaB, MAP kinases, and the transcription of inflammatory genes. In vivo, flagellin induced cardiac activation of NF-kappaB, expression of inflammatory cytokines (TNF alpha, IL-1 beta, IL-6, MIP-2 and MCP-1), and provoked a state of reversible myocardial dysfunction, characterized by cardiac dilation, reduced ejection fraction, and decreased end-systolic elastance. Conclusion/Significance: These results are the first to indicate that flagellin has the ability to trigger cardiac innate immune responses and to acutely depress myocardial contractility.	[Rolli, Joelle; Li, Jianhui; Loukili, Noureddine; Levrand, Sandra; Liaudet, Lucas] Univ Lausanne Hosp, Med Ctr, Dept Intens Care Med, Lausanne, Switzerland; [Rolli, Joelle; Rosenblatt-Velin, Nathalie; Li, Jianhui; Loukili, Noureddine; Levrand, Sandra; Waeber, Bernard; Feihl, Francois; Ruchat, Patrick; Liaudet, Lucas] Fac Biol & Med, Lausanne, Switzerland; [Rosenblatt-Velin, Nathalie; Levrand, Sandra; Waeber, Bernard; Feihl, Francois; Liaudet, Lucas] Univ Lausanne Hosp, Med Ctr, Div Pathophysiol, Lausanne, Switzerland; [Ruchat, Patrick] Univ Lausanne Hosp, Med Ctr, Dept Cardiovasc Surg, Lausanne, Switzerland; [Pacher, Pal] NIAAA, Lab Physiol Studies, NIH, Bethesda, MD USA; [Li, Jianhui] Zhejiang Univ, Dept Hepatobiliary Surg, Affiliated Hosp 1, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Zhejiang University	Rolli, J (corresponding author), Univ Lausanne Hosp, Med Ctr, Dept Intens Care Med, Lausanne, Switzerland.	lucas.liaudet@chuv.ch	Pacher, Pal/B-6378-2008; Liaudet, Lucas/E-1322-2017	Pacher, Pal/0000-0001-7036-8108; Liaudet, Lucas/0000-0003-2670-4930; Rosenblatt, Nathalie/0000-0003-2011-2862	Swiss National Fund for Scientific Research [PP00B-68882/1, 320000-118174/1]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000375] Funding Source: NIH RePORTER	Swiss National Fund for Scientific Research(Swiss National Science Foundation (SNSF)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by grants from the Swiss National Fund for Scientific Research (PP00B-68882/1 and 320000-118174/1) to Lucas Liaudet. URL: www.snf.ch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen-Nissen E, 2007, J IMMUNOL, V178, P4717, DOI 10.4049/jimmunol.178.8.4717; Boyd JH, 2006, CARDIOVASC RES, V72, P384, DOI 10.1016/j.cardiores.2006.09.011; Constable PD, 1999, SHOCK, V12, P391, DOI 10.1097/00024382-199911000-00008; Dowling D, 2008, CYTOKINE, V41, P254, DOI 10.1016/j.cyto.2007.11.020; Eaves-Pyles T, 2001, J IMMUNOL, V166, P1248, DOI 10.4049/jimmunol.166.2.1248; Feuillet V, 2006, P NATL ACAD SCI USA, V103, P12487, DOI 10.1073/pnas.0605200103; Flierl MA, 2008, MOL MED, V14, P327, DOI 10.2119/2007-00130.Flierl; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; HESCHELER J, 1991, CIRC RES, V69, P1476, DOI 10.1161/01.RES.69.6.1476; Knuefermann P, 2004, CIRCULATION, V110, P3693, DOI 10.1161/01.CIR.0000143081.13042.04; Knuefermann P, 2002, CIRCULATION, V106, P2608, DOI 10.1161/01.CIR.0000038110.69369.4C; Knuefermann P, 2008, CARDIOVASC RES, V78, P26, DOI 10.1093/cvr/cvn011; Levrand S, 2005, J BIOL CHEM, V280, P34878, DOI 10.1074/jbc.M501977200; Levrand S, 2007, BIOCHEM BIOPH RES CO, V359, P445, DOI 10.1016/j.bbrc.2007.05.147; Levrand S, 2006, FREE RADICAL BIO MED, V41, P886, DOI 10.1016/j.freeradbiomed.2006.04.034; Liaudet L, 2003, SHOCK, V19, P131, DOI 10.1097/00024382-200302000-00008; Liaudet L, 2002, INFECT IMMUN, V70, P192, DOI 10.1128/IAI.70.1.192-198.2002; Loukili N, 2010, J BIOL CHEM, V285, P15746, DOI 10.1074/jbc.M110.103259; Merx MW, 2007, CIRCULATION, V116, P793, DOI 10.1161/CIRCULATIONAHA.106.678359; Murakami Y, 2007, J IMMUNOL, V178, P1144, DOI 10.4049/jimmunol.178.2.1144; NATANSON C, 1986, J CLIN INVEST, V78, P259, DOI 10.1172/JCI112559; Nemoto S, 2002, AM J PHYSIOL-HEART C, V282, pH2316, DOI 10.1152/ajpheart.00763.2001; Neviere RR, 1999, AM J PHYSIOL-HEART C, V277, pH885, DOI 10.1152/ajpheart.1999.277.3.H885; Pacher P, 2003, CIRCULATION, V107, P896, DOI 10.1161/01.CIR.0000048192.52098.DD; PARKER MM, 1984, ANN INTERN MED, V100, P483, DOI 10.7326/0003-4819-100-4-483; Peng TQ, 2003, CARDIOVASC RES, V59, P893, DOI 10.1016/S0008-6363(03)00509-1; Pinsky MR, 2000, AM J RESP CRIT CARE, V161, P1087, DOI 10.1164/ajrccm.161.4.9904033; Rosenblatt-Velin N, 2005, J CLIN INVEST, V115, P1724, DOI 10.1172/JCI23418; Rudiger A, 2007, CRIT CARE MED, V35, P1599, DOI 10.1097/01.CCM.0000266683.64081.02; Russell JA, 2006, NEW ENGL J MED, V355, P1699, DOI 10.1056/NEJMra043632; SUGA H, 1974, CIRC RES, V35, P117, DOI 10.1161/01.RES.35.1.117; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; Waeckel L, 2006, ARTERIOSCL THROM VAS, V26, P773, DOI 10.1161/01.ATV.0000203510.96492.14; Yang M, 2008, AM J PHYSIOL-HEART C, V294, pH994, DOI 10.1152/ajpheart.01044.2007; Zhang HC, 2007, AM J PHYSIOL-HEART C, V292, pH2408, DOI 10.1152/ajpheart.01150.2006; Zhang Z, 2007, INFECT IMMUN, V75, P5985, DOI 10.1128/IAI.00678-07	38	33	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2010	5	9							e12687	10.1371/journal.pone.0012687	http://dx.doi.org/10.1371/journal.pone.0012687			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648ZZ	20856884	Green Submitted, Green Published, gold			2022-12-27	WOS:000281735700012
J	Behnke, MS; Wootton, JC; Lehmann, MM; Radke, JB; Lucas, O; Nawas, J; Sibley, LD; White, MW				Behnke, Michael S.; Wootton, John C.; Lehmann, Margaret M.; Radke, Josh B.; Lucas, Olivier; Nawas, Julie; Sibley, L. David; White, Michael W.			Coordinated Progression through Two Subtranscriptomes Underlies the Tachyzoite Cycle of Toxoplasma gondii	PLOS ONE			English	Article							CELL-NUCLEAR-ANTIGENS; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; BRADYZOITE DIFFERENTIATION; TRANSCRIPTIONAL CONTROL; COMPARATIVE GENOMICS; REGULATED GENES; DNA-BINDING; IDENTIFICATION; PROTEIN	Background: Apicomplexan parasites replicate by varied and unusual processes where the typically eukaryotic expansion of cellular components and chromosome cycle are coordinated with the biosynthesis of parasite-specific structures essential for transmission. Methodology/Principal Findings: Here we describe the global cell cycle transcriptome of the tachyzoite stage of Toxoplasma gondii. In dividing tachyzoites, more than a third of the mRNAs exhibit significant cyclical profiles whose timing correlates with biosynthetic events that unfold during daughter parasite formation. These 2,833 mRNAs have a bimodal organization with peak expression occurring in one of two transcriptional waves that are bounded by the transition into S phase and cell cycle exit following cytokinesis. The G1-subtranscriptome is enriched for genes required for basal biosynthetic and metabolic functions, similar to most eukaryotes, while the S/M-subtranscriptome is characterized by the uniquely apicomplexan requirements of parasite maturation, development of specialized organelles, and egress of infectious daughter cells. Two dozen AP2 transcription factors form a series through the tachyzoite cycle with successive sharp peaks of protein expression in the same timeframes as their mRNA patterns, indicating that the mechanisms responsible for the timing of protein delivery might be mediated by AP2 domains with different promoter recognition specificities. Conclusion/Significance: Underlying each of the major events in apicomplexan cell cycles, and many more subordinate actions, are dynamic changes in parasite gene expression. The mechanisms responsible for cyclical gene expression timing are likely crucial to the efficiency of parasite replication and may provide new avenues for interfering with parasite growth.	[Behnke, Michael S.; Lehmann, Margaret M.; Radke, Josh B.; White, Michael W.] Montana State Univ, Dept Vet Mol Biol, Bozeman, MT 59717 USA; [Radke, Josh B.; Lucas, Olivier; White, Michael W.] Univ S Florida, Dept Mol Med, Tampa, FL USA; [Radke, Josh B.; Lucas, Olivier; White, Michael W.] Univ S Florida, Dept Global Hlth, Tampa, FL USA; [Wootton, John C.] Natl Lib Med, Computat Biol Branch, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD USA; [Behnke, Michael S.; Nawas, Julie; Sibley, L. David] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	Montana State University System; Montana State University Bozeman; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Washington University (WUSTL)	Behnke, MS (corresponding author), Montana State Univ, Dept Vet Mol Biol, Bozeman, MT 59717 USA.	mwhite.usf@gmail.com	White, Michael/A-4978-2012; Behnke, Michael S/R-8839-2016	Behnke, Michael S/0000-0002-4668-8109	National Institutes of Health [AI 48390, AI077662, AI072739, AI034036]; NCBI, National Library of Medicine, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077662, R01AI048390, R01AI059176, R01AI034036, R01AI036629, R21AI072739] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCBI, National Library of Medicine, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by grants from the National Institutes of Health to MWW (AI 48390, AI077662, and AI072739) and LDS (AI034036). JCW is supported by the Intramural program of NCBI, National Library of Medicine, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; Altschul SF, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000852; Arnot DE, 1998, ANN TROP MED PARASIT, V92, P361, DOI 10.1080/00034989859357; Bahler J, 2005, ANNU REV GENET, V39, P69, DOI 10.1146/annurev.genet.39.110304.095808; Balaji S, 2005, NUCLEIC ACIDS RES, V33, P3994, DOI 10.1093/nar/gki709; Bar-Joseph Z, 2003, J COMPUT BIOL, V10, P341, DOI 10.1089/10665270360688057; Behnke MS, 2008, MOL MICROBIOL, V68, P1502, DOI 10.1111/j.1365-2958.2008.06249.x; Bernstein KA, 2007, MOL BIOL CELL, V18, P953, DOI 10.1091/mbc.E06-06-0512; Billups SC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-96; Binder EM, 2008, TRAFFIC, V9, P1485, DOI 10.1111/j.1600-0854.2008.00774.x; Bougdour A, 2009, J EXP MED, V206, P953, DOI 10.1084/jem.20082826; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Breeden LL, 2003, CURR BIOL, V13, pR31, DOI 10.1016/S0960-9822(02)01386-6; Chotivanich K, 2000, J INFECT DIS, V181, P1206, DOI 10.1086/315353; Cleary MD, 2002, EUKARYOT CELL, V1, P329, DOI 10.1128/EC.1.3.329-340.2002; Coleman BI, 2008, CELL MICROBIOL, V10, P1935, DOI 10.1111/j.1462-5822.2008.01203.x; Cooper Stephen, 2003, Cell Chromosome, V2, P1, DOI 10.1186/1475-9268-2-1; Cote P, 2009, MOL BIOL CELL, V20, P3363, DOI 10.1091/mbc.E09-03-0210; Coulson RMR, 2004, GENOME RES, V14, P1548, DOI 10.1101/gr.2218604; Coulson RMR, 2003, NUCLEIC ACIDS RES, V31, P653, DOI 10.1093/nar/gkg156; DARZYNKIEWICZ Z, 1980, P NATL ACAD SCI-BIOL, V77, P6696, DOI 10.1073/pnas.77.11.6696; Das MK, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S21; de Felipe MMC, 2008, MOL BIOCHEM PARASIT, V157, P22, DOI 10.1016/j.molbiopara.2007.09.003; De Silva EK, 2008, P NATL ACAD SCI USA, V105, P8393, DOI 10.1073/pnas.0801993105; DEROJAS MO, 1985, T ROY SOC TROP MED H, V79, P792, DOI 10.1016/0035-9203(85)90119-1; DIXON SE, MOL BIOCH PARASITOL; Dondorp AM, 2005, PLOS MED, V2, P788, DOI 10.1371/journal.pmed.0020204; Elemento O, 2007, MOL CELL, V28, P337, DOI 10.1016/j.molcel.2007.09.027; Flueck C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000784; Fox BA, 2009, EUKARYOT CELL, V8, P520, DOI 10.1128/EC.00357-08; Futschik ME, 2008, BIOINFORMATICS, V24, P1063, DOI 10.1093/bioinformatics/btn072; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; GRITZMACHER CA, 1984, J BACTERIOL, V160, P1165, DOI 10.1128/JB.160.3.1165-1167.1984; Gubbels MJ, 2008, INT J PARASITOL, V38, P1343, DOI 10.1016/j.ijpara.2008.06.004; Gubbels MJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040036; Guerini MN, 2000, MOL BIOCHEM PARASIT, V109, P121, DOI 10.1016/S0166-6851(00)00240-1; Guerini MN, 2005, MOL BIOCHEM PARASIT, V142, P56, DOI 10.1016/j.molbiopara.2005.03.020; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Hammoudeh DI, 2009, J AM CHEM SOC, V131, P7390, DOI 10.1021/ja900616b; Hannah MA, 2008, NAT BIOTECHNOL, V26, P741, DOI 10.1038/nbt0708-741; HARTWELL LH, 1977, J CELL BIOL, V75, P422, DOI 10.1083/jcb.75.2.422; Hu K, 2002, MOL BIOL CELL, V13, P593, DOI 10.1091/mbc.01-06-0309; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Iuchi S, 2001, CELL MOL LIFE SCI, V58, P625, DOI 10.1007/PL00000885; Iyer LM, 2008, INT J PARASITOL, V38, P1, DOI 10.1016/j.ijpara.2007.07.018; Jensen LJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-403; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; KHAN A, 2009, EUKARYOT CELL; Kibe MK, 2005, NUCLEIC ACIDS RES, V33, P1722, DOI 10.1093/nar/gki314; Kocken CHM, 1998, J BIOL CHEM, V273, P15119, DOI 10.1074/jbc.273.24.15119; Kovacs LAS, 2008, CELL CYCLE, V7, P2626, DOI 10.4161/cc.7.17.6515; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Ma P, 2006, NUCLEIC ACIDS RES, V34, P1261, DOI 10.1093/nar/gkl013; Ma YF, 2004, INT J PARASITOL, V34, P333, DOI 10.1016/j.ijpara.2003.11.020; Matrajt M, 2004, MOL BIOCHEM PARASIT, V137, P229, DOI 10.1016/j.molbiopara.2003.12.015; MCDONALD V, 1986, EXP PARASITOL, V61, P192, DOI 10.1016/0014-4894(86)90152-9; MCDONALD V, 1987, J PARASITOL, V73, P993, DOI 10.2307/3282523; MEISSNER M, 2005, MICROBES INFECT; Mercier C, 1996, MOL MICROBIOL, V21, P421, DOI 10.1046/j.1365-2958.1996.6501361.x; MOORE SA, 1988, J BIOL CHEM, V263, P9674; Mullapudi N, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r34; MURRAY A, 1993, CELL CYCLE; Nishi M, 2008, J CELL SCI, V121, P1559, DOI 10.1242/jcs.021089; Omberg L, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.70; Qu ZL, 2003, AM J PHYSIOL-CELL PH, V284, pC349, DOI 10.1152/ajpcell.00066.2002; Radke JR, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-26; Radke JR, 2003, MOL BIOCHEM PARASIT, V131, P119, DOI 10.1016/S0166-6851(03)00198-1; Radke JR, 2001, MOL BIOCHEM PARASIT, V115, P165, DOI 10.1016/S0166-6851(01)00284-5; Radke JR, 1998, MOL BIOCHEM PARASIT, V94, P237, DOI 10.1016/S0166-6851(98)00074-7; Reilly HB, 2007, INT J PARASITOL, V37, P1599, DOI 10.1016/j.ijpara.2007.05.003; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Saksouk N, 2005, MOL CELL BIOL, V25, P10301, DOI 10.1128/MCB.25.23.10301-10314.2005; SENAUD J, 1966, CR ACAD SCI D NAT, V262, P119; SHEFFIELD HG, 1968, J PARASITOL, V54, P209, DOI 10.2307/3276925; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Singh U, 2002, MOL MICROBIOL, V44, P721, DOI 10.1046/j.1365-2958.2002.02903.x; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Striepen B, 2000, J CELL BIOL, V151, P1423, DOI 10.1083/jcb.151.7.1423; Striepen B, 2007, PLOS PATHOG, V3, P691, DOI 10.1371/journal.ppat.0030078; Taylor S, 2006, SCIENCE, V314, P1776, DOI 10.1126/science.1133643; Van Poppel NFJ, 2006, PARASITOLOGY, V133, P19, DOI 10.1017/S0031182006009954; Wastling JM, 2009, INT J PARASITOL, V39, P135, DOI 10.1016/j.ijpara.2008.10.003; White MW, 2007, CELL CYCLE CONTROL P; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; YUDA M, 2009, MOL MICROBIOL; Yuda M, 2009, MOL MICROBIOL, V71, P1402, DOI 10.1111/j.1365-2958.2009.06609.x	87	182	183	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12354	10.1371/journal.pone.0012354	http://dx.doi.org/10.1371/journal.pone.0012354			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865045	Green Submitted, Green Published, gold			2022-12-27	WOS:000281292100008
J	Kapun, M; Nolte, V; Flatt, T; Schlotterer, C				Kapun, Martin; Nolte, Viola; Flatt, Thomas; Schloetterer, Christian			Host Range and Specificity of the Drosophila C Virus	PLOS ONE			English	Article							MUTATION-RATES; MELANOGASTER; RECOMBINATION; POPULATION; EVOLUTION	Background: The Drosophila C virus (DCV) is a common and well-studied Drosophila pathogen. Although natural infections are known from Drosophila melanogaster and D. simulans, and artificial infections have been reported from several Drosophila species and other insects, it remains unclear to date whether DCV infections also occur naturally in other Drosophila species. Methods/Principal Findings: Using reverse transcription PCR, we detected natural infections in six Drosophila species, which have not been previously known as natural hosts. By subsequent Sanger sequencing we compared DCV haplotypes among eight Drosophila host species. Our data suggest that cross-infections might be frequent both within and among species within the laboratory environment. Moreover, we find that some lines exhibit multiple infections with distinct DCV haplotypes. Conclusions: Our results suggest that the natural host range of DCV is much broader than previously assumed and that cross-infections might be a common phenomenon in the laboratory, even among different Drosophila hosts.	[Kapun, Martin; Nolte, Viola; Flatt, Thomas; Schloetterer, Christian] Vetmeduni Vienna, Inst Populat Genet, Vienna, Austria	University of Veterinary Medicine Vienna	Kapun, M (corresponding author), Vetmeduni Vienna, Inst Populat Genet, Vienna, Austria.	christian.schloetterer@vetmeduni.ac.at	Schlötterer, Christian/G-6326-2010; Flatt, Thomas/AAE-7329-2019; Flatt, Thomas/A-7384-2009; Schlötterer, Christian/Q-5264-2019; Kapun, Martin/GVT-4278-2022; Kapun, Martin/GLU-9265-2022; Kapun, Martin/I-3536-2019	Schlötterer, Christian/0000-0003-4710-6526; Flatt, Thomas/0000-0002-5990-1503; Schlötterer, Christian/0000-0003-4710-6526; Kapun, Martin/0000-0002-3810-0504; Kapun, Martin/0000-0002-3810-0504; Kapun, Martin/0000-0002-3810-0504	Austrian Academy of Sciences; Austrian Science Fund (FWF) [P19467-B11]; Austrian Science Fund (FWF) [P 19467] Funding Source: researchfish	Austrian Academy of Sciences; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was funded through a DOC fellowship of the Austrian Academy of Sciences (http://stipendien.oeaw.ac.at/doc-doktorandinnenprogrammder-oesterreichischen-akademie-der-wissenschaften) to MK. CS is supported through the Austrian Science Fund (FWF) by grant P19467-B11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHBURNER M, 2007, MAINTENANCE DROSOPHI; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; BRUN G, 1980, BIOL GENETICS DROSOP, P625; Carpenter JA, 2007, MOL ECOL, V16, P3947, DOI 10.1111/j.1365-294X.2007.03460.x; Christian PD, 1998, VIRUSES, P301; CLEWLEY JP, 1983, J GEN VIROL, V64, P503, DOI 10.1099/0022-1317-64-2-503; COMENDADOR MA, 1986, GENET SEL EVOL, V18, P131, DOI 10.1186/1297-9686-18-2-131; Drake JW, 1999, P NATL ACAD SCI USA, V96, P13910, DOI 10.1073/pnas.96.24.13910; Filipe D, 1998, ENDOCYTOBIOSIS CELL, V12, P163; GOMARIZZILBER E, 1995, J INVERTEBR PATHOL, V65, P243, DOI 10.1006/jipa.1995.1037; Gravot E, 2000, J INVERTEBR PATHOL, V75, P144, DOI 10.1006/jipa.1999.4913; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Huszart T, 2008, ADV VIRUS RES, V72, P227, DOI 10.1016/S0065-3527(08)00406-5; Jenkins GM, 2002, J MOL EVOL, V54, P156, DOI 10.1007/s00239-001-0064-3; Johnson KN, 1998, J GEN VIROL, V79, P191, DOI 10.1099/0022-1317-79-1-191; Johnson KN, 1999, J INVERTEBR PATHOL, V73, P248, DOI 10.1006/jipa.1998.4830; JOUSSET FX, 1976, ANN INST PASTEUR MIC, VA127, P529; JOUSSET FX, 1972, CR ACAD SCI D NAT, P3043; KING LA, 1994, ADV INSECT PHYSL, V25; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; LAUTIEHARIVEL N, 1990, BIOL CELL, V69, P35, DOI 10.1016/0248-4900(90)90326-X; Maddison D. R., 2003, MACCLADE 4 ANAL PHYL; MOORE NF, 1991, VIRUSES INVERTEBRATE; Nobusawa E, 2006, J VIROL, V80, P3675, DOI 10.1128/JVI.80.7.3675-3678.2006; PLUS N, 1978, J INVERTEBR PATHOL, V31, P296, DOI 10.1016/0022-2011(78)90219-7; PLUS N, 1975, ANN INST PASTEUR MIC, VA126, P107; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Tamura K, 2004, MOL BIOL EVOL, V21, P36, DOI 10.1093/molbev/msg236; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; THOMASORILLARD M, 1984, GENETICS, V107, P635; TULLY T, 2008, DCV PROTOCOLS; Worobey M, 1999, J GEN VIROL, V80, P2535, DOI 10.1099/0022-1317-80-10-2535; Yang ZH, 1996, TRENDS ECOL EVOL, V11, P367, DOI 10.1016/0169-5347(96)10041-0	33	26	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12421	10.1371/journal.pone.0012421	http://dx.doi.org/10.1371/journal.pone.0012421			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865043	Green Published, Green Submitted, gold			2022-12-27	WOS:000281292100017
J	Wang, D; Qiu, CX; Zhang, HJ; Wang, JA; Cui, QH; Yin, YX				Wang, Dong; Qiu, Chengxiang; Zhang, Haijun; Wang, Juan; Cui, Qinghua; Yin, Yuxin			Human MicroRNA Oncogenes and Tumor Suppressors Show Significantly Different Biological Patterns: From Functions to Targets	PLOS ONE			English	Article							CELL-DEATH; C-ELEGANS; EVOLUTION; CANCER; DATABASE; SITES; APOPTOSIS; MIRNAS; LIN-14; GENES	MicroRNAs (miRNAs) are small noncoding RNAs which play essential roles in many important biological processes. Therefore, their dysfunction is associated with a variety of human diseases, including cancer. Increasing evidence shows that miRNAs can act as oncogenes or tumor suppressors, and although there is great interest in research into these cancer-associated miRNAs, little is known about them. In this study, we performed a comprehensive analysis of putative human miRNA oncogenes and tumor suppressors. We found that miRNA oncogenes and tumor suppressors clearly show different patterns in function, evolutionary rate, expression, chromosome distribution, molecule size, free energy, transcription factors, and targets. For example, miRNA oncogenes are located mainly in the amplified regions in human cancers, whereas miRNA tumor suppressors are located mainly in the deleted regions. miRNA oncogenes tend to cleave target mRNAs more frequently than miRNA tumor suppressors. These results indicate that these two types of cancer-associated miRNAs play different roles in cancer formation and development. Moreover, the patterns identified here can discriminate novel miRNA oncogenes and tumor suppressors with a high degree of accuracy. This study represents the first large-scale bioinformatic analysis of human miRNA oncogenes and tumor suppressors. Our findings provide help for not only understanding of miRNAs in cancer but also for the specific identification of novel miRNAs as miRNA oncogenes and tumor suppressors. In addition, the data presented in this study will be valuable for the study of both miRNAs and cancer.	[Wang, Dong; Qiu, Chengxiang; Zhang, Haijun; Wang, Juan; Cui, Qinghua] Peking Univ, Hlth Sci Ctr, Dept Biomed Informat, Beijing 100871, Peoples R China; [Wang, Dong; Qiu, Chengxiang; Zhang, Haijun; Wang, Juan; Cui, Qinghua; Yin, Yuxin] Peking Univ, Hlth Sci Ctr, Inst Syst Biomed, Beijing 100871, Peoples R China; [Yin, Yuxin] Peking Univ, Hlth Sci Ctr, Dept Pathol, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Wang, D (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Biomed Informat, Beijing 100871, Peoples R China.	cuiqinghua@hsc.pku.edu.cn; yinyuxin@hsc.pku.edu.cn	Qiu, Chengxiang/X-5040-2019	Qiu, Chengxiang/0000-0002-6346-8669	Natural Science Foundation of China [30900829]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China (Grant No. 30900829). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguda BD, 2008, P NATL ACAD SCI USA, V105, P19678, DOI 10.1073/pnas.0811166106; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Babbitt CC, 2007, CELL, V131, P225, DOI 10.1016/j.cell.2007.10.001; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berezikov E, 2006, NAT GENET, V38, pS2, DOI 10.1038/ng1794; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen K, 2006, NAT GENET, V38, P1452, DOI 10.1038/ng1910; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Cloonan N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r127; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Cui QH, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100200; Cui QH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100089; Davis JC, 2004, PLOS BIOL, V2, P318, DOI 10.1371/journal.pbio.0020055; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Hirsh AE, 2001, NATURE, V411, P1046, DOI 10.1038/35082561; Hobert O, 2007, CELL, V131, P22, DOI 10.1016/j.cell.2007.09.031; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; Latronico MVG, 2007, CIRC RES, V101, P1225, DOI 10.1161/CIRCRESAHA.107.163147; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Pal C, 2006, NAT REV GENET, V7, P337, DOI 10.1038/nrg1838; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Reich DE, 2003, NAT GENET, V33, P457, DOI 10.1038/ng1133; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Spizzo R, 2009, CELL, V137, P586, DOI 10.1016/j.cell.2009.04.040; Taccioli C, 2009, NUCLEIC ACIDS RES, V37, pD41, DOI 10.1093/nar/gkn702; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Wang J, 2010, NUCLEIC ACIDS RES, V38, pD119, DOI 10.1093/nar/gkp803; Wang XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002557; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Xu CQ, 2007, J CELL SCI, V120, P3045, DOI 10.1242/jcs.010728; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Xu PZ, 2004, TRENDS GENET, V20, P617, DOI 10.1016/j.tig.2004.09.010; Yantiss RK, 2009, AM J SURG PATHOL, V33, P572, DOI 10.1097/PAS.0b013e31818afd6b; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; ZHANG Q, 2008, NATURE P, P1; Zhang R, 2007, GENOME RES, V17, P612, DOI 10.1101/gr.6146507; Zhou T, 2008, J MOL EVOL, V66, P395, DOI 10.1007/s00239-008-9094-4	49	119	126	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e13067	10.1371/journal.pone.0013067	http://dx.doi.org/10.1371/journal.pone.0013067			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20927335	Green Published, Green Submitted, gold			2022-12-27	WOS:000282312600016
J	Bottley, A; Phillips, NM; Webb, TE; Willis, AE; Spriggs, KA				Bottley, Andrew; Phillips, Nicola M.; Webb, Thomas E.; Willis, Anne E.; Spriggs, Keith A.			eIF4A Inhibition Allows Translational Regulation of mRNAs Encoding Proteins Involved in Alzheimer's Disease	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; MILD COGNITIVE IMPAIRMENT; RIBOSOMAL ENTRY SITE; OXIDATIVE STRESS; A-BETA; DIFFERENTIAL-DISPLAY; GENE-EXPRESSION; TRANSGENIC MICE; CELL-CYCLE; INITIATION	Alzheimer's disease (AD) is the main cause of dementia in our increasingly aging population. The debilitating cognitive and behavioral symptoms characteristic of AD make it an extremely distressing illness for patients and carers. Although drugs have been developed to treat AD symptoms and to slow disease progression, there is currently no cure. The incidence of AD is predicted to increase to over one hundred million by 2050, placing a heavy burden on communities and economies, and making the development of effective therapies an urgent priority. Two proteins are thought to have major contributory roles in AD: the microtubule associated protein tau, also known as MAPT; and the amyloid-beta peptide (A-beta), a cleavage product of amyloid precursor protein (APP). Oxidative stress is also implicated in AD pathology from an early stage. By targeting eIF4A, an RNA helicase involved in translation initiation, the synthesis of APP and tau, but not neuroprotective proteins, can be simultaneously and specifically reduced, representing a novel avenue for AD intervention. We also show that protection from oxidative stress is increased upon eIF4A inhibition. We demonstrate that the reduction of these proteins is not due to changes in mRNA levels or increased protein degradation, but is a consequence of translational repression conferred by inhibition of the helicase activity of eIF4A. Inhibition of eIF4A selectively and simultaneously modulates the synthesis of proteins involved in Alzheimer's disease: reducing A-beta and tau synthesis, while increasing proteins predicted to be neuroprotective.	[Bottley, Andrew; Phillips, Nicola M.; Webb, Thomas E.; Willis, Anne E.; Spriggs, Keith A.] Univ Nottingham, Sch Pharm, Nottingham NG7 2RD, England	University of Nottingham	Bottley, A (corresponding author), Univ Nottingham, Sch Pharm, Nottingham NG7 2RD, England.	keith.spriggs@nottingham.ac.uk		Willis, Anne/0000-0002-1470-8531; Webb, Thomas/0000-0003-4660-2341	Biotechnology and Biological Sciences Research Council, UK [BB/F006926/1]; School of Pharmacy, University of Nottingham, UK; BBSRC [BB/F006926/1, BB/F02326X/2] Funding Source: UKRI; MRC [MC_UP_A600_1023] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F006926/1, BB/F02326X/2] Funding Source: researchfish; Medical Research Council [MC_UP_A600_1023] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); School of Pharmacy, University of Nottingham, UK; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Biotechnology and Biological Sciences Research Council, UK (BB/F006926/1) and the School of Pharmacy, University of Nottingham, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Akterin S, 2006, CELL DEATH DIFFER, V13, P1454, DOI 10.1038/sj.cdd.4401818; An J, 2005, PROTEOMICS, V5, P1656, DOI 10.1002/pmic.200401049; Beaudoin ME, 2008, NUCLEIC ACIDS RES, V36, P6835, DOI 10.1093/nar/gkn792; Biran Y, 2009, J CELL MOL MED, V13, P61, DOI 10.1111/j.1582-4934.2008.00595.x; Bordeleau ME, 2006, NAT CHEM BIOL, V2, P213, DOI 10.1038/nchembio776; Brink TC, 2009, BIOGERONTOLOGY, V10, P549, DOI 10.1007/s10522-008-9197-8; Butterfield DA, 2007, FREE RADICAL BIO MED, V43, P658, DOI 10.1016/j.freeradbiomed.2007.05.037; Butterfield DA, 2002, J ALZHEIMERS DIS, V4, P193, DOI 10.3233/JAD-2002-4309; Butterfield DA, 2001, TRENDS MOL MED, V7, P548, DOI 10.1016/S1471-4914(01)02173-6; Celsi F, 2004, NEUROCHEM INT, V44, P25, DOI 10.1016/S0197-0186(03)00101-3; Daga RR, 1999, J CELL SCI, V112, P3137; Davuluri RV, 2000, GENOME RES, V10, P1807, DOI 10.1101/gr.GR-1460R; Fukao A, 2009, MOL CELL, V36, P1007, DOI 10.1016/j.molcel.2009.11.013; Giorgi C, 2007, CELL, V130, P179, DOI 10.1016/j.cell.2007.05.028; Harris SE, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-43; Haugabook SJ, 2001, FASEB J, V15, P16; Iadecola C, 1999, NAT NEUROSCI, V2, P157, DOI 10.1038/5715; Jansen AP, 2005, CANCER RES, V65, P6034, DOI 10.1158/0008-5472.CAN-04-2119; Jin H, 2006, MOL CANCER THER, V5, P1041, DOI 10.1158/1535-7163.MCT-05-0433; Lahiri DK, 2005, FASEB J, V19, P653, DOI 10.1096/fj.04-2900fje; Le Corre S, 2006, P NATL ACAD SCI USA, V103, P9673, DOI 10.1073/pnas.0602913103; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li QY, 1999, MOL CELL BIOL, V19, P7336; Lin JC, 2007, P NATL ACAD SCI USA, V104, P2235, DOI 10.1073/pnas.0611015104; Lovell MA, 2007, J NEUROSCI RES, V85, P3036, DOI 10.1002/jnr.21346; Masutani H, 2004, MOL NEUROBIOL, V29, P229, DOI 10.1385/MN:29:3:229; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Morel M, 2009, J CELL MOL MED, V13, P1476, DOI 10.1111/j.1582-4934.2009.00849.x; Morgan R, 1997, DEVELOPMENT, V124, P2751; Morse LJ, 2004, J MOL NEUROSCI, V24, P129, DOI 10.1385/JMN:24:1:129; Mus E, 2007, P NATL ACAD SCI USA, V104, P10679, DOI 10.1073/pnas.0701532104; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047; Payton S, 2003, J MOL NEUROSCI, V20, P267, DOI 10.1385/JMN:20:3:267; Ponten F, 2008, J PATHOL, V216, P387, DOI 10.1002/path.2440; Pratico D, 2008, TRENDS PHARMACOL SCI, V29, P609, DOI 10.1016/j.tips.2008.09.001; Resende R, 2008, J NEUROSCI RES, V86, P2091, DOI 10.1002/jnr.21648; Rhein V, 2009, P NATL ACAD SCI USA, V106, P20057, DOI 10.1073/pnas.0905529106; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Rogers JT, 2002, J MOL NEUROSCI, V19, P77, DOI 10.1007/s12031-002-0014-6; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; Small SA, 2008, NEURON, V60, P534, DOI 10.1016/j.neuron.2008.11.007; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spriggs KA, 2009, MOL CELL BIOL, V29, P1565, DOI 10.1128/MCB.01283-08; Stoneley M, 2000, MOL CELL BIOL, V20, P1162, DOI 10.1128/MCB.20.4.1162-1169.2000; Svitkin YV, 2001, RNA, V7, P1743; Turner BJ, 2004, NEUROCHEM RES, V29, P2281, DOI 10.1007/s11064-004-7037-z; van Marum RJ, 2008, FUND CLIN PHARMACOL, V22, P265, DOI 10.1111/j.1472-8206.2008.00578.x; Veo BL, 2009, J ALZHEIMERS DIS, V16, P271, DOI 10.3233/JAD-2009-0978; Wang HD, 2002, J NEUROSCI, V22, P10232; Yan P, 2009, J NEUROSCI, V29, P10706, DOI 10.1523/JNEUROSCI.2637-09.2009; Yeh CH, 2004, CHEST, V125, P228, DOI 10.1378/chest.125.1.228	53	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2010	5	9							e13030	10.1371/journal.pone.0013030	http://dx.doi.org/10.1371/journal.pone.0013030			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654ZQ	20927385	Green Submitted, Green Published, gold			2022-12-27	WOS:000282210700011
J	Schubert, S; Knoch, KP; Ouwendijk, J; Mohammed, S; Bodrov, Y; Jager, M; Altkruger, A; Wegbrod, C; Adams, ME; Kim, Y; Froehner, SC; Jensen, ON; Kalaidzidis, Y; Solimena, M				Schubert, Sandra; Knoch, Klaus-Peter; Ouwendijk, Joke; Mohammed, Shabaz; Bodrov, Yury; Jaeger, Melanie; Altkrueger, Anke; Wegbrod, Carolin; Adams, Marvin E.; Kim, Yong; Froehner, Stanley C.; Jensen, Ole N.; Kalaidzidis, Yannis; Solimena, Michele			beta 2-Syntrophin Is a Cdk5 Substrate That Restrains the Motility of Insulin Secretory Granules	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASE-5; SITE-SPECIFIC PHOSPHORYLATION; PROTEIN-TYROSINE-PHOSPHATASE; SYNAPTIC VESICLE ENDOCYTOSIS; PANCREATIC BETA-CELLS; NITRIC-OXIDE SYNTHASE; MYOSIN-VA; PLASMA-MEMBRANE; F-ACTIN; SODIUM-CHANNELS	The molecular basis for the interaction of insulin granules with the cortical cytoskeleton of pancreatic beta-cells remains unknown. We have proposed that binding of the granule protein ICA512 to the PDZ domain of beta 2-syntrophin anchors granules to actin filaments and that the phosphorylation/dephosphorylation of beta 2-syntrophin regulates this association. Here we tested this hypothesis by analyzing INS-1 cells expressing GFP-beta 2-syntrophin through the combined use of biochemical approaches, imaging studies by confocal and total internal reflection fluorescence microscopy as well as electron microscopy. Our results support the notion that beta 2-syntrophin restrains the mobility of cortical granules in insulinoma INS-1 cells, thereby reducing insulin secretion and increasing insulin stores in resting cells, while increasing insulin release upon stimulation. Using mass spectrometry, in vitro phosphorylation assays and beta 2-syntrophin phosphomutants we found that phosphorylation of beta 2-syntrophin on S75 near the PDZ domain decreases its binding to ICA512 and correlates with increased granule motility, while phosphorylation of S90 has opposite effects. We further show that Cdk5, which regulates insulin secretion, phosphorylates S75. These findings provide mechanistic insight into how stimulation displaces insulin granules from cortical actin, thus promoting their motility and exocytosis.	[Schubert, Sandra; Knoch, Klaus-Peter; Ouwendijk, Joke; Jaeger, Melanie; Altkrueger, Anke; Wegbrod, Carolin; Solimena, Michele] Tech Univ Dresden, Uniklinikum Carl Gustav Carus, Paul Langerhans Inst Dresden, D-8027 Dresden, Germany; [Schubert, Sandra; Bodrov, Yury; Wegbrod, Carolin; Kalaidzidis, Yannis; Solimena, Michele] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Mohammed, Shabaz; Jensen, Ole N.] Univ So Denmark, Dept Biochem & Mol Biol, Odense, Denmark; [Adams, Marvin E.; Froehner, Stanley C.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Kim, Yong] Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA; [Kalaidzidis, Yannis] Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia	Technische Universitat Dresden; Max Planck Society; University of Southern Denmark; University of Washington; University of Washington Seattle; Rockefeller University; Lomonosov Moscow State University	Schubert, S (corresponding author), Tech Univ Dresden, Uniklinikum Carl Gustav Carus, Paul Langerhans Inst Dresden, D-8027 Dresden, Germany.	michele.solimena@tu-dresden.de	Jensen, Ole N/J-1763-2012; Solimena, Michele/E-1275-2011; Solimena, Michele/GVS-5990-2022; Mohammed, Shabaz/D-1042-2010; Mohammed, Shabaz/AAY-6313-2020; Kalaidzidis, Yannis/H-3094-2016	Jensen, Ole N/0000-0003-1862-8528; Mohammed, Shabaz/0000-0003-2640-9560; Mohammed, Shabaz/0000-0003-2640-9560; Kalaidzidis, Yannis/0000-0002-6137-1193; Kim, Yong/0000-0002-1387-2962	Humboldt Foundation; Bundesministerium fur Bildung und Forschung (Klinisches Kompetenznetzwerk Diabetes mellitus and Deutsches Zentrum fur Diabetesforschung e.V.); Deutsche Forschungsgemeinschaft [SFB 655, SO 818/1-1]; Medical School of Dresden University of Technology; National Institutes of Health [NS33145]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033145] Funding Source: NIH RePORTER	Humboldt Foundation(Alexander von Humboldt Foundation); Bundesministerium fur Bildung und Forschung (Klinisches Kompetenznetzwerk Diabetes mellitus and Deutsches Zentrum fur Diabetesforschung e.V.)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Medical School of Dresden University of Technology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by funds from the Paul Award from the Humboldt Foundation, the Bundesministerium fur Bildung und Forschung (Klinisches Kompetenznetzwerk Diabetes mellitus and Deutsches Zentrum fur Diabetesforschung e.V.) the Deutsche Forschungsgemeinschaft (SFB 655 and SO 818/1-1) to M. S., a MedDrive Grant from the Medical School of Dresden University of Technology to S. S., and by National Institutes of Health grant NS33145 to S. C. F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS ME, 1995, J BIOL CHEM, V270, P25859, DOI 10.1074/jbc.270.43.25859; Ahn AH, 1996, J BIOL CHEM, V271, P2724, DOI 10.1074/jbc.271.5.2724; AHN AH, 1995, J CELL BIOL, V128, P363, DOI 10.1083/jcb.128.3.363; Albrecht DE, 2002, NEUROSIGNALS, V11, P123, DOI 10.1159/000065053; Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P2106, DOI 10.1073/pnas.0437946100; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Axelrod D, 2001, TRAFFIC, V2, P764, DOI 10.1034/j.1600-0854.2001.21104.x; Bergert H, 2005, CELL TRANSPLANT, V14, P441, DOI 10.3727/000000005783982873; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Desnos C, 2003, J CELL BIOL, V163, P559, DOI 10.1083/jcb.200302157; Desnos C, 2007, J NEUROSCI, V27, P10636, DOI 10.1523/JNEUROSCI.1228-07.2007; Eichler TW, 2006, BIOCHEM SOC T, V34, P671, DOI 10.1042/BST0340671; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Fierro-Monti I, 2006, J PROTEOME RES, V5, P1367, DOI 10.1021/pr0504539; Fletcher AI, 1999, J BIOL CHEM, V274, P4027, DOI 10.1074/jbc.274.7.4027; FROEHNER SC, 1987, J CELL BIOL, V104, P1633, DOI 10.1083/jcb.104.6.1633; Fukuda M, 2004, J BIOL CHEM, V279, P22314, DOI 10.1074/jbc.401791200; Fukuda M, 2002, J BIOL CHEM, V277, P43096, DOI 10.1074/jbc.M203862200; Gee SH, 1998, J NEUROSCI, V18, P128; Goodson HV, 1997, CURR OPIN CELL BIOL, V9, P18, DOI 10.1016/S0955-0674(97)80147-0; Grant P, 2001, EUR J BIOCHEM, V268, P1534, DOI 10.1046/j.1432-1033.2001.02025.x; Hashida-Okumura A, 1999, J BIOL CHEM, V274, P11736, DOI 10.1074/jbc.274.17.11736; Huet S, 2006, BIOPHYS J, V91, P3542, DOI 10.1529/biophysj.105.080622; Ivarsson R, 2005, TRAFFIC, V6, P1027, DOI 10.1111/j.1600-0854.2005.00342.x; Kachinsky AM, 1999, J CELL BIOL, V145, P391, DOI 10.1083/jcb.145.2.391; Kaksonen M, 2000, J CELL SCI, V113, P4421; Knoch KP, 2006, CELL METAB, V3, P123, DOI 10.1016/j.cmet.2005.12.008; KRAMARCY NR, 1994, J BIOL CHEM, V269, P2870; Kuroda TS, 2005, METHOD ENZYMOL, V403, P419, DOI 10.1016/S0076-6879(05)03037-5; Kuroda TS, 2005, METHOD ENZYMOL, V403, P431, DOI 10.1016/S0076-6879(05)03038-7; Kuroda TS, 2003, MOL CELL BIOL, V23, P5245, DOI 10.1128/MCB.23.15.5245-5255.2003; Lahtinen U, 2003, FEBS LETT, V538, P85, DOI 10.1016/S0014-5793(03)00135-2; LAN MS, 1994, DNA CELL BIOL, V13, P505, DOI 10.1089/dna.1994.13.505; Lang T, 2000, BIOPHYS J, V78, P2863, DOI 10.1016/S0006-3495(00)76828-7; Lee SY, 2004, P NATL ACAD SCI USA, V101, P546, DOI 10.1073/pnas.0307813100; Lilja L, 2004, J BIOL CHEM, V279, P29534, DOI 10.1074/jbc.M312711200; LU J, 1994, BIOCHEM BIOPH RES CO, V204, P930, DOI 10.1006/bbrc.1994.2549; Lumeng C, 1999, NAT NEUROSCI, V2, P611, DOI 10.1038/10165; Matsubara M, 1996, J BIOL CHEM, V271, P21108, DOI 10.1074/jbc.271.35.21108; Merrifield CJ, 1999, NAT CELL BIOL, V1, P72, DOI 10.1038/9048; Moores CA, 2000, CELL MOTIL CYTOSKEL, V46, P116, DOI 10.1002/1097-0169(200006)46:2<116::AID-CM4>3.0.CO;2-L; Neely JD, 2001, P NATL ACAD SCI USA, V98, P14108, DOI 10.1073/pnas.241508198; Nguyen C, 2003, J CELL BIOL, V163, P697, DOI 10.1083/jcb.200310038; Oheim M, 2000, EUR BIOPHYS J BIOPHY, V29, P67, DOI 10.1007/s002490050253; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ort T, 2001, EMBO J, V20, P4013, DOI 10.1093/emboj/20.15.4013; Ort T, 2000, EUR J CELL BIOL, V79, P621, DOI 10.1078/0171-9335-00095; Piluso G, 2000, J BIOL CHEM, V275, P15851, DOI 10.1074/jbc.M000439200; Pollard TD, 2003, NATURE, V422, P741, DOI 10.1038/nature01598; RABIN DU, 1992, DIABETES, V41, P183, DOI 10.2337/diabetes.41.2.183; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rogers SL, 2000, CURR OPIN CELL BIOL, V12, P57, DOI 10.1016/S0955-0674(99)00057-5; Rudolf R, 2003, J CELL SCI, V116, P1339, DOI 10.1242/jcs.00317; Rutter GA, 2004, CELL BIOCHEM BIOPHYS, P179; Saito T, 2003, J NEUROSCI, V23, P1189, DOI 10.1523/JNEUROSCI.23-04-01189.2003; Scheiffele P, 1998, J CELL BIOL, V140, P795, DOI 10.1083/jcb.140.4.795; Schultz J, 1998, NAT STRUCT BIOL, V5, P19, DOI 10.1038/nsb0198-19; Sekine N, 1997, DIABETES, V46, P1424, DOI 10.2337/diabetes.46.9.1424; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Solimena M, 1996, EMBO J, V15, P2102, DOI 10.1002/j.1460-2075.1996.tb00564.x; Solimena M, 2003, TRENDS CELL BIOL, V13, P399, DOI 10.1016/S0962-8924(03)00150-8; SONTAG JM, 1988, EUR J CELL BIOL, V46, P316; Steyer JA, 2001, NAT REV MOL CELL BIO, V2, P268, DOI 10.1038/35067069; Tan TC, 2003, NAT CELL BIOL, V5, P701, DOI 10.1038/ncb1020; Taunton J, 2000, J CELL BIOL, V148, P519, DOI 10.1083/jcb.148.3.519; Tomizawa K, 2003, J CELL BIOL, V163, P813, DOI 10.1083/jcb.200308110; Tomizawa K, 2002, J NEUROSCI, V22, P2590, DOI 10.1523/JNEUROSCI.22-07-02590.2002; Trajkovski M, 2004, J CELL BIOL, V167, P1063, DOI 10.1083/jcb.200408172; Trajkovski M, 2008, J BIOL CHEM, V283, P33719, DOI 10.1074/jbc.M804928200; Traub LM, 2005, BBA-MOL CELL RES, V1744, P415, DOI 10.1016/j.bbamcr.2005.04.005; Trifaro JM, 2000, BIOCHIMIE, V82, P339, DOI 10.1016/S0300-9084(00)00193-0; Varadi A, 2005, MOL BIOL CELL, V16, P2670, DOI 10.1091/mbc.e04-11-1001; Verkade P, 2008, J MICROSC-OXFORD, V230, P317, DOI 10.1111/j.1365-2818.2008.01989.x; VITALE ML, 1991, J CELL BIOL, V113, P1057, DOI 10.1083/jcb.113.5.1057; Waselle L, 2003, MOL BIOL CELL, V14, P4103, DOI 10.1091/mbc.E03-01-0022; Wei FY, 2005, NAT MED, V11, P1104, DOI 10.1038/nm1299; Yokota T, 2000, P JPN ACAD B-PHYS, V76, P22, DOI 10.2183/pjab.76.22	78	32	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12929	10.1371/journal.pone.0012929	http://dx.doi.org/10.1371/journal.pone.0012929			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886068	gold, Green Submitted, Green Published			2022-12-27	WOS:000282091100032
J	Bai, M; Jarvis, K; Wang, SY; Song, KQ; Wang, YP; Wang, ZL; Li, WZ; Wang, W; Yang, XK				Bai, Ming; Jarvis, Karl; Wang, Shu-Yong; Song, Ke-Qing; Wang, Yan-Ping; Wang, Zhi-Liang; Li, Wen-Zhu; Wang, Wei; Yang, Xing-Ke			A Second New Species of Ice Crawlers from China (Insecta: Grylloblattodea), with Thorax Evolution and the Prediction of Potential Distribution	PLOS ONE			English	Article							PHYLOGENY; ORDER; FLIGHTLESSNESS; PERSISTENCE; TAXONOMY	Modern grylloblattids are one of the least diverse of the modern insect orders. The thorax changes in morphology might be associated with the changes of the function of the forelegs, wing loss, changes in behavior and adaptation to habitat. As temperature is the main barrier for migration of modern grylloblattids, the range of each species is extremely limited. The potential distribution areas of grylloblattids remain unclear. A second new species of ice crawlers (Insecta: Grylloblattodea), Grylloblattella cheni Bai, Wang et Yang sp. nov., is described from China. The distribution map and key to species of Grylloblattella are given. A comparison of the thorax of extant and extinct Grylloblattodea is presented, with an emphasis on the pronotum using geometric morphometric analysis, which may reflect thorax adaptation and the evolution of Grylloblattodea. Potential global distribution of grylloblattids is inferred. Highly diversified pronota of extinct Grylloblattodea may reflect diverse habitats and niches. The relatively homogeneous pronota of modern grylloblattids might be explained by two hypotheses: synapomorphy or convergent evolution. Most fossils of Grylloblattodea contain an obviously longer meso-and metathorax than prothorax. The length of the meso- and metathorax of modern grylloblattids is normally shorter than the prothorax. This may be associated with the wing loss, which is accompanied by muscle reduction and changes to the thoracic skeleton system. Threats to grylloblattids and several conservation comments are also provided.	[Bai, Ming; Wang, Shu-Yong; Song, Ke-Qing; Wang, Yan-Ping; Wang, Zhi-Liang; Li, Wen-Zhu; Yang, Xing-Ke] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China; [Jarvis, Karl] No Arizona Univ, Flagstaff, AZ 86011 USA; [Wang, Wei] Minist Environm Protect, Foreign Econ Cooperat Off, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Northern Arizona University	Bai, M (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China.	yangxk@ioz.ac.cn	Yuan, Ningyi/HDO-3272-2022; Jarvis, Karl J./M-6537-2015	Jarvis, Karl J./0000-0002-9658-6872	Key Laboratory of Zoological Systematics and Evolution of the Chinese Academy of Sciences [O529YX5105]; National Science Fund for Fostering Talents in Basic Research [NSFC-J0630964/J0109, J0930004]	Key Laboratory of Zoological Systematics and Evolution of the Chinese Academy of Sciences; National Science Fund for Fostering Talents in Basic Research	This research was partly supported by grants from the Key Laboratory of Zoological Systematics and Evolution of the Chinese Academy of Sciences (No. O529YX5105), and the National Science Fund for Fostering Talents in Basic Research (Special Subjects in Animal Taxonomy, NSFC-J0630964/J0109, J0930004). Discovery of the unique specimen resulted from the North Xinjiang Environment Exploration Program presided by Dr. Run-Zhi Zhang, Professor of the Institute of Zoology, Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aristov DS, 2006, PALEONTOL J+, V40, P79, DOI 10.1134/S0031030106010096; Aristov Danil, 2009, Virgo, V12, P30; Aristov DS, 2004, PALEONTOL J+, V38, pS80; Asahina S., 1961, Kontyu Tokyo, V29, P85; Asahina S., 1959, Kontyu Tokyo, V27, P249; Bei-Bienko G. Ya., 1951, Entomologicheskoe Obozrenie, V31, P506; Beutel RG, 2001, J ZOOL SYST EVOL RES, V39, P177, DOI 10.1046/j.1439-0469.2001.00155.x; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; BYERS GW, 1969, EVOLUTION, V23, P346, DOI 10.1111/j.1558-5646.1969.tb03517.x; Cameron SL, 2006, MOL PHYLOGENET EVOL, V38, P274, DOI 10.1016/j.ympev.2005.09.020; Caudell A. N., 1924, Proceedings of the Entomological Society of Washington, V26, P53; Caudell A. N., 1924, Journal of the Washington Academy of Sciences, V14, P369; Chapman R.E., 1990, P MICHIGAN MORPHOMET, P251; Denno RF, 2001, ECOL ENTOMOL, V26, P25, DOI 10.1046/j.1365-2311.2001.00293.x; Goodall C., 1987, Computer Science and Statistics: Proceedings of the 19th Symposium on the Interface, P86; GOODALL C, 1991, J ROY STAT SOC B MET, V53, P285, DOI 10.1111/j.2517-6161.1991.tb01825.x; Grimaldi D, 2001, J PALEONTOL, V75, P1152, DOI 10.1666/0022-3360(2001)075<1152:IEHFHT>2.0.CO;2; Grimaldi David, 2005, pi; Gurney A. B., 1937, Pan-Pacific Entomologist, V13, P159; GURNEY ASHLEY B., 1961, PROC BIOL SOC WASHINGTON, V74, P67; Haeberli W, 1999, GEOGR ANN A, V81A, P585, DOI 10.1111/1468-0459.00086; Houghton J. T., 2001, CLIMATE CHANGE 2001; Huang DY, 2008, ZOOL J LINN SOC-LOND, V152, P17, DOI 10.1111/j.1096-3642.2007.00351.x; Jarvis KJ, 2006, MOL PHYLOGENET EVOL, V41, P222, DOI 10.1016/j.ympev.2006.04.013; KAMP J. W., 1963, ANN ENTOMOL SOC AMER, V56, P53; KAMP JW, 1979, CAN ENTOMOL, V111, P27, DOI 10.4039/Ent11127-1; Kim BW, 2007, ZOOL SCI, V24, P733, DOI 10.2108/zsj.24.733; Levine RS, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-7; MARCUS LF, 1993, CONTRIHUTIONS MORPHO; NAMKUNG J, 1974, Korean Journal of Entomology, V4, P1; Namkung J., 1974, Korean J Ent, V4, P91; Novokshonov VG, 1999, NEUES JAHRB GEOL P M, P193; Oberhauser K, 2003, P NATL ACAD SCI USA, V100, P14063, DOI 10.1073/pnas.2331584100; PRAVDIN F N, 1977, Entomologicheskoe Obozrenie, V56, P352; Pretorius E, 2001, BIOL J LINN SOC, V74, P35, DOI 10.1111/j.1095-8312.2001.tb01375.x; PRITCHARD G, 1978, CAN ENTOMOL, V110, P205, DOI 10.4039/Ent110205-2; Rasnitsyn A.P., 1980, Trudy Paleontologicheskogo Instituta, V175, P150; RASNITSYN AP, 1976, DOKL AKAD NAUK SSSR+, V228, P502; ROFF DA, 1994, AM NAT, V144, P772, DOI 10.1086/285706; ROFF DA, 1990, ECOL MONOGR, V60, P389, DOI 10.2307/1943013; Rohlf, 2007, NTSYS PC NUMERICAL T; Rohlf F.J., 1993, CONTRIBUTIONS MORPHO, P131; Rohlf F.J., 2003, TPS SMALL VERSION 1; Rohlf F. J., 2018, TPSUTIL VERSION 1 76; Rohlf F. J., 2006, TPS DIG DIGITIZE LAN; Rohlf F.J., 2006, TPS UTIL FILE UTILIT; Rohlf FJ, 2006, TPS RELW RELATIVE WA; ROHLF FJ, 1990, ORDINATIONS STUDY MO; Rohlf FJ, 2004, TPS SPLIN THIN PLATE; Sneath P.H.A., 1973, NUMERICAL TAXONOMY P; Snodgrass RE, 1935, PRINCIPLES INSECT MO; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Storozhenko S., 1988, Articulata, V3, P167; Storozhenko S. Y., 1996, ZOOSYSTEMATICA ROSSI, V4, P320; Storozhenko S.Yu., 1996, Chteniya Pamyati Alekseya Ivanovicha Kurentsova, V6, P13; Storozhenko S.Yu., 1984, Entomologicheskoe Obozrenie, V63, P729; Storozhenko S.Yu., 2002, Far Eastern Entomologist, V114, P18; Storozhenko S. Yu., 1997, Far Eastern Entomologist, V42, P1; Storozhenko S.Yu., 1992, Sovmestnaya Sovetsko-Mongol'skaya Paleontologicheskaya Ekspeditsiya Trudy, V41, P122; STOROZHENKO SY, 1988, PALEONTOL ZH, P48; SYu Storozhenko, 1996, RUSSIAN ENTOMOLOGICA, V19, P115; Terry MD, 2005, CLADISTICS, V21, P240, DOI 10.1111/j.1096-0031.2005.00062.x; *U CFIESINCC, 2005, GRIDD POP WORLD FUT; *U CFIESINCC CIAT, 2005, GRIDD POP WORLD VERS; Vrsansky P, 2001, ANN ENTOMOL SOC AM, V94, P179, DOI 10.1603/0013-8746(2001)094[0179:GOSNGG]2.0.CO;2; WAGNER DL, 1992, TRENDS ECOL EVOL, V7, P216, DOI 10.1016/0169-5347(92)90047-F; Walker E. M., 1914, Canadian Entomologist, V46; WANG SY, 1987, ACTA ENTOMOL SINICA, V30, P423; Wheeler WC, 2001, CLADISTICS, V17, P113, DOI [10.1111/j.1096-0031.2001.tb00115.x, 10.1006/clad.2000.0147]; Winkler S, 2010, GEOMORPHOLOGY, V116, P87, DOI 10.1016/j.geomorph.2009.10.011; Zalessky G., 1938, Annales de la Societe Geologique du Nord, V63, P62; Zemp M., 2008, GLOBAL GLACIER CHANG; Zera AJ, 1997, ANNU REV ENTOMOL, V42, P207, DOI 10.1146/annurev.ento.42.1.207	73	23	34	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12850	10.1371/journal.pone.0012850	http://dx.doi.org/10.1371/journal.pone.0012850			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877572	Green Published, Green Submitted, gold			2022-12-27	WOS:000282053100017
J	Doherty, HE; Kim, HS; Hiller, S; Sulik, KK; Maeda, N				Doherty, Heather E.; Kim, Hyung-Suk; Hiller, Sylvia; Sulik, Kathleen K.; Maeda, Nobuyo			A Mouse Strain Where Basal Connective Tissue Growth Factor Gene Expression Can Be Switched from Low to High	PLOS ONE			English	Article							DIABETIC-NEPHROPATHY; EMBRYOS LACKING; LIVER FIBROSIS; BLOOD-PRESSURE; TGF-BETA; MICE; CELLS; OVEREXPRESSION; REPAIR; CTGF	Connective tissue growth factor (CTGF) is a signaling molecule that primarily functions in extracellular matrix maintenance and repair. Increased Ctgf expression is associated with fibrosis in chronic organ injury. Studying the role of CTGF in fibrotic disease in vivo, however, has been hampered by perinatal lethality of the Ctgf null mice as well as the limited scope of previous mouse models of Ctgf overproduction. Here, we devised a new approach and engineered a single mutant mouse strain where the endogenous Ctgf-3' untranslated region (3'UTR) was replaced with a cassette containing two 3'UTR sequences arranged in tandem. The modified Ctgf allele uses a 3'UTR from the mouse FBJ osteosarcoma oncogene (c-Fos) and produces an unstable mRNA, resulting in 60% of normal Ctgf expression (Lo allele). Upon Cre-expression, excision of the c-Fos-3'UTR creates a transcript utilizing the more stable bovine growth hormone (bGH) 3'UTR, resulting in increased Ctgf expression (Hi allele). Using the Ctgf Lo and Hi mutants, and crosses to a Ctgf knockout or Cre-expressing mice, we have generated a series of strains with a 30-fold range of Ctgf expression. Mice with the lowest Ctgf expression, 30% of normal, appear healthy, while a global nine-fold overexpression of Ctgf causes abnormalities, including developmental delay and craniofacial defects, and embryonic death at E10-12. Overexpression of Ctgf by tamoxifen-inducible Cre in the postnatal life, on the other hand, is compatible with life. The Ctgf Lo-Hi mutant mice should prove useful in further understanding the function of CTGF in fibrotic diseases. Additionally, this method can be used for the production of mouse lines with quantitative variations in other genes, particularly with genes that are broadly expressed, have distinct functions in different tissues, or where altered gene expression is not compatible with normal development.	[Doherty, Heather E.; Maeda, Nobuyo] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27515 USA; [Doherty, Heather E.; Kim, Hyung-Suk; Hiller, Sylvia; Maeda, Nobuyo] Univ N Carolina, Sch Med, Dept Pathol & Lab Med, Chapel Hill, NC USA; [Sulik, Kathleen K.] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC USA; [Sulik, Kathleen K.] Univ N Carolina, Bowles Ctr Alcohol Studies, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Doherty, HE (corresponding author), Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27515 USA.	nobuyo@med.unc.edu	Ariel, Pablo/AGJ-4118-2022; Doherty, Heather/D-8199-2011		National Institutes of Health [HL042630, HL077145]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL042630, R01HL042630, R01HL077145] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors gratefully acknowledge funding from the National Institutes of Health (www.nih.gov), grant numbers HL042630 and HL077145. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blom IE, 2002, MATRIX BIOL, V21, P473, DOI 10.1016/S0945-053X(02)00055-0; Brocard J, 1997, P NATL ACAD SCI USA, V94, P14559, DOI 10.1073/pnas.94.26.14559; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chai Y, 2006, DEV DYNAM, V235, P2353, DOI 10.1002/dvdy.20833; Cheng O, 2006, AM J TRANSPLANT, V6, P2292, DOI 10.1111/j.1600-6143.2006.01493.x; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Gonzalez A, 2002, EUR HEART J SUPPL, V4, pD18, DOI 10.1016/S1520-765X(02)90156-2; Gordois A, 2004, J DIABETES COMPLICAT, V18, P18, DOI 10.1016/S1056-8727(03)00035-7; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; Gupta AK, 2008, ENT-EAR NOSE THROAT, V87, P291, DOI 10.1177/014556130808700514; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; HEFFNER C, 2010, STRAIN NAME FVB N TG; Holzenberger M, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.21.e92; IGARASHI A, 1993, MOL BIOL CELL, V4, P637, DOI 10.1091/mbc.4.6.637; Inoki I, 2001, FASEB J, V15, P219, DOI 10.1096/fj.01-0332fje; Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505; Jacobsson C, 1997, SCAND J PLAST RECONS, V31, P125, DOI 10.3109/02844319709085479; Kakoki M, 2004, DEV CELL, V6, P597, DOI 10.1016/S1534-5807(04)00094-2; Kovalenko E, 2009, J VIRAL HEPATITIS, V16, P612, DOI 10.1111/j.1365-2893.2009.01110.x; Kwon S, 2007, INT J ONCOL, V31, P693; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Leamy LJ, 2005, GENET SEL EVOL, V37, P151, DOI 10.1051/gse:2004042; Leask A, 2003, BIOCHEM CELL BIOL, V81, P355, DOI 10.1139/O03-069; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Makhanova N, 2008, HYPERTENSION, V51, P134, DOI 10.1161/HYPERTENSIONAHA.107.098897; METZGER D, 1995, P NATL ACAD SCI USA, V92, P6991, DOI 10.1073/pnas.92.15.6991; Mori T, 1999, J CELL PHYSIOL, V181, P153, DOI 10.1002/(SICI)1097-4652(199910)181:1<153::AID-JCP16>3.0.CO;2-K; Nakanishi T, 2001, BIOCHEM BIOPH RES CO, V281, P678, DOI 10.1006/bbrc.2001.4379; Panek AN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006743; PIEDRAHITA JA, 1992, P NATL ACAD SCI USA, V89, P4471, DOI 10.1073/pnas.89.10.4471; Ren SY, 2009, KIDNEY INT, V76, P857, DOI 10.1038/ki.2009.297; Riser BL, 2003, KIDNEY INT, V64, P451, DOI 10.1046/j.1523-1755.2003.00130.x; RYSECK RP, 1991, CELL GROWTH DIFFER, V2, P225; Sanford LP, 1997, DEVELOPMENT, V124, P2659; Shi-Wen X, 2008, CYTOKINE GROWTH F R, V19, P133, DOI 10.1016/j.cytogfr.2008.01.002; Smerdel-Ramoya' A, 2008, ENDOCRINOLOGY, V149, P4374, DOI 10.1210/en.2008-0254; SONNYLAL S, ARTHRITIS RHEUM, V62, P1523; SULIK KK, 1982, SCAN ELECTRON MICROS, P309; Sun Y, 2000, CARDIOVASC RES, V46, P250, DOI 10.1016/S0008-6363(00)00032-8; Sun Y, 2000, J LAB CLIN MED, V135, P316, DOI 10.1067/mlc.2000.105971; Sun YO, 1998, J MOL CELL CARDIOL, V30, P1559, DOI 10.1006/jmcc.1998.0721; Surveyor GA, 1999, GROWTH FACTORS, V17, P115, DOI 10.3109/08977199909103520; Suzuma K, 2000, J BIOL CHEM, V275, P40725, DOI 10.1074/jbc.M006509200; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; Tikellis C, 2004, ENDOCRINOLOGY, V145, P860, DOI 10.1210/en.2003-0967; Tong ZY, 2009, HEPATOLOGY, V50, P939, DOI 10.1002/hep.23102; Tsai YS, 2009, P NATL ACAD SCI USA, V106, P19084, DOI 10.1073/pnas.0909657106; Tsai YS, 2009, MOL ENDOCRINOL, V23, P1787, DOI 10.1210/me.2009-0073; Tucker RP, 2004, INT J BIOCHEM CELL B, V36, P173, DOI 10.1016/S1357-2725(03)00243-7; Wakimoto K, 2000, J BIOL CHEM, V275, P36991, DOI 10.1074/jbc.M004035200; Walls JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002853; Williams EJ, 1998, POSTGRAD MED J, V74, P193, DOI 10.1136/pgmj.74.870.193; WU S, AM J RESP CELL MOL B, V42, P552; Yang DH, 1998, J CLIN ENDOCR METAB, V83, P2593, DOI 10.1210/jc.83.7.2593; Yokoi H, 2008, KIDNEY INT, V73, P446, DOI 10.1038/sj.ki.5002722	55	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12909	10.1371/journal.pone.0012909	http://dx.doi.org/10.1371/journal.pone.0012909			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877562	Green Published, gold, Green Submitted			2022-12-27	WOS:000282053100033
J	Radulescu, AR				Radulescu, Anca R.			Mechanisms Explaining Transitions between Tonic and Phasic Firing in Neuronal Populations as Predicted by a Low Dimensional Firing Rate Model	PLOS ONE			English	Article							NIGRAL DOPAMINERGIC-NEURONS; PEDUNCULOPONTINE TEGMENTAL NUCLEUS; EXTRACELLULAR ELECTROPHYSIOLOGY; BIOPHYSICAL MODEL; SPIKING NEURONS; NEURAL-NETWORKS; ANTENNAL LOBES; SINGLE NEURON; ANIMAL-MODEL; AREA NEURONS	Several firing patterns experimentally observed in neural populations have been successfully correlated to animal behavior. Population bursting, hereby regarded as a period of high firing rate followed by a period of quiescence, is typically observed in groups of neurons during behavior. Biophysical membrane-potential models of single cell bursting involve at least three equations. Extending such models to study the collective behavior of neural populations involves thousands of equations and can be very expensive computationally. For this reason, low dimensional population models that capture biophysical aspects of networks are needed. The present paper uses a firing-rate model to study mechanisms that trigger and stop transitions between tonic and phasic population firing. These mechanisms are captured through a two-dimensional system, which can potentially be extended to include interactions between different areas of the nervous system with a small number of equations. The typical behavior of midbrain dopaminergic neurons in the rodent is used as an example to illustrate and interpret our results. The model presented here can be used as a building block to study interactions between networks of neurons. This theoretical approach may help contextualize and understand the factors involved in regulating burst firing in populations and how it may modulate distinct aspects of behavior.	[Radulescu, Anca R.] Univ Colorado, Dept Psychol, Boulder, CO 80309 USA; [Radulescu, Anca R.] SUNY Stony Brook, Sch Med, Dept Biomed Engn, Stony Brook, NY 11794 USA	University of Colorado System; University of Colorado Boulder; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Radulescu, AR (corresponding author), Univ Colorado, Dept Psychol, Campus Box 345, Boulder, CO 80309 USA.	radulesc@colorado.edu	Radulescu, Anca/GYR-1316-2022	Radulescu, Anca/0000-0002-2681-7233				AVRON E, 1993, BIOL CYBERN, V69, P87, DOI 10.1007/BF00201411; AVRON E, 1991, BIOL CYBERN, V65, P487, DOI 10.1007/BF00204662; Bailey EF, 2001, J PHYSIOL-LONDON, V532, P525, DOI 10.1111/j.1469-7793.2001.0525f.x; Bazhenov M, 2005, NEURON, V46, P483, DOI 10.1016/j.neuron.2005.03.022; Brown E, 2005, INT J BIFURCAT CHAOS, V15, P803, DOI 10.1142/S0218127405012478; Brozovic M, 2008, J COMPUT NEUROSCI, V25, P158, DOI 10.1007/s10827-007-0070-6; BUCHANAN JT, 1992, BIOL CYBERN, V66, P367, DOI 10.1007/BF00203673; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Cateau H, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.058101; CHRISTENSEN TA, 1987, J COMP PHYSIOL A, V160, P553, DOI 10.1007/BF00611929; Dhooge A, 2003, ACM T MATH SOFTWARE, V29, P141, DOI 10.1145/779359.779362; Fergestad T, 2008, GENETICS, V178, P947, DOI 10.1534/genetics.107.082115; FITZHUGH R, 1961, BIOPHYS J, V1, P445, DOI 10.1016/S0006-3495(61)86902-6; Floresco SB, 2003, NAT NEUROSCI, V6, P968, DOI 10.1038/nn1103; Floresco SB, 2001, J NEUROSCI, V21, P4915, DOI 10.1523/JNEUROSCI.21-13-04915.2001; Friedman A, 2008, J MOL NEUROSCI, V34, P201, DOI 10.1007/s12031-007-9016-8; Gonon F, 1997, J NEUROSCI, V17, P5972; GRACE AA, 1983, NEUROSCIENCE, V10, P317, DOI 10.1016/0306-4522(83)90136-7; GRACE AA, 1984, J NEUROSCI, V4, P2877; GRACE AA, 1983, NEUROSCIENCE, V10, P301, DOI 10.1016/0306-4522(83)90135-5; GRACE AA, 1983, NEUROSCIENCE, V10, P333, DOI 10.1016/0306-4522(83)90137-9; Guckenheimer J., 1990, NONLINEAR OSCILLATIO; He JF, 2002, J NEUROPHYSIOL, V88, P2152, DOI 10.1152/jn.2002.88.4.2152; Heinbockel T, 1998, J COMP PHYSIOL A, V182, P703, DOI 10.1007/s003590050215; Heinz A, 2009, BIOL PSYCHIAT, V65, P101, DOI 10.1016/j.biopsych.2008.11.003; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Hyland BI, 2002, NEUROSCIENCE, V114, P475, DOI 10.1016/S0306-4522(02)00267-1; IZHIKEVICH E, 2006, DYNAMICAL SYSTEMS NE, P267; Joerges J, 1997, NATURE, V387, P285, DOI 10.1038/387285a0; JOHNSON SW, 1992, SCIENCE, V258, P665, DOI 10.1126/science.1329209; Kauffman S.A., 1993, ORIGINS ORDER; Kitzbichler MG, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000314; Kiyatkin EA, 1998, NEUROSCIENCE, V85, P1285, DOI 10.1016/S0306-4522(98)00054-2; Knight BW, 2000, NEURAL COMPUT, V12, P1045, DOI 10.1162/089976600300015493; KNIGHT BW, 1972, J GEN PHYSIOL, V59, P767, DOI 10.1085/jgp.59.6.767; KNIGHT BW, 1972, J GEN PHYSIOL, V59, P734, DOI 10.1085/jgp.59.6.734; Komendantov AO, 2002, J NEUROPHYSIOL, V87, P1526, DOI 10.1152/jn.00255.2001; Krofczik S, 2009, FRONT COMPUT NEUROSC, V2, DOI 10.3389/neuro.10.009.2008; KUZNETSOV Y, 1995, APPL MATH SCI, V112, P295; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Lodge DJ, 2007, J NEUROSCI, V27, P11424, DOI 10.1523/JNEUROSCI.2847-07.2007; Lodge DJ, 2006, NEUROPSYCHOPHARMACOL, V31, P1356, DOI 10.1038/sj.npp.1300963; Lodge DJ, 2006, P NATL ACAD SCI USA, V103, P5167, DOI 10.1073/pnas.0510715103; Lokwan SJA, 1999, NEUROSCIENCE, V92, P245, DOI 10.1016/S0306-4522(98)00748-9; Marreiros AC, 2008, NEUROIMAGE, V42, P147, DOI 10.1016/j.neuroimage.2008.04.239; McCrimmon DR, 1997, RESP PHYSIOL, V110, P161, DOI 10.1016/S0034-5687(97)00081-9; MEADORWOODRUFF JH, 1994, P NATL ACAD SCI USA, V91, P8297, DOI 10.1073/pnas.91.17.8297; Medvedev GS, 2001, SIAM J APPL MATH, V61, P1762, DOI 10.1137/S0036139900368807; Meller R, 2003, CELL DEATH DIFFER, V10, P539, DOI 10.1038/sj.cdd.4401206; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Nykamp DQ, 2000, J COMPUT NEUROSCI, V8, P19, DOI 10.1023/A:1008912914816; Omelchenko N, 2007, NEUROSCIENCE, V146, P1259, DOI 10.1016/j.neuroscience.2007.02.016; Omelchenko N, 2005, J COMP NEUROL, V483, P217, DOI 10.1002/cne.20417; Pan WX, 2005, J NEUROSCI, V25, P4725, DOI 10.1523/JNEUROSCI.0277-05.2005; PEINADO A, 1993, NEURON, V10, P103, DOI 10.1016/0896-6273(93)90246-N; PEREZVELAZQUEZ JL, 1994, J NEUROSCI, V14, P4308; Plenz D., 2009, ARXIV09125369; PULVER SR, 2009, NAT NEUROSCI, V13, P53; Rinzel J., 1998, METHODS NEURONAL MOD, V2, P251; Roxin A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000046; Rozental R, 1998, J NEUROSCI, V18, P1753; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; SCHULTZ W, 1993, J NEUROSCI, V13, P900; Schumann D, 1998, RADIOCHIM ACTA, V80, P1; Sil'kis I G, 2008, Neurosci Behav Physiol, V38, P399, DOI 10.1007/s11055-008-0057-4; Skinner FK, 1999, J NEUROPHYSIOL, V81, P1274, DOI 10.1152/jn.1999.81.3.1274; SQALLIHOUSSAINI Y, 1993, J NEUROPHYSIOL, V70, P803, DOI 10.1152/jn.1993.70.2.803; Steffensen SC, 1998, J NEUROSCI, V18, P8003; Terada K, 2000, ELECTRON COMM JPN 3, V83, P86, DOI 10.1002/(SICI)1520-6440(200006)83:6<86::AID-ECJC10>3.0.CO;2-C; TIERNEY AJ, 1992, J NEUROPHYSIOL, V67, P599, DOI 10.1152/jn.1992.67.3.599; Toyoizumi T, 2009, NEURAL COMPUT, V21, P1203, DOI 10.1162/neco.2008.04-08-757; TRAUB RD, 1989, SCIENCE, V243, P1319, DOI 10.1126/science.2646715; Tremblay LK, 2005, ARCH GEN PSYCHIAT, V62, P1228, DOI 10.1001/archpsyc.62.11.1228; van Welie I, 2006, J PHYSIOL-LONDON, V576, P203, DOI 10.1113/jphysiol.2006.113944; Vandecasteele M, 2005, J NEUROSCI, V25, P291, DOI 10.1523/JNEUROSCI.4167-04.2005; Varkonyi PL, 2008, J COMPUT NEUROSCI, V25, P245, DOI 10.1007/s10827-008-0076-8; Velazquez JLP, 2000, TRENDS NEUROSCI, V23, P68; WILLIAMS TL, 1992, SCIENCE, V258, P662, DOI 10.1126/science.1411575; Wilson CJ, 2004, J NEUROPHYSIOL, V91, P1963, DOI 10.1152/jn.00924.2003; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Wong KF, 2006, J NEUROSCI, V26, P1314, DOI 10.1523/JNEUROSCI.3733-05.2006; Zald DH, 2008, J NEUROSCI, V28, P14372, DOI 10.1523/JNEUROSCI.2423-08.2008; Zhang X, 2002, J NEUROSCI, V22, P6052; Zweifel LS, 2009, P NATL ACAD SCI USA, V106, P7281, DOI 10.1073/pnas.0813415106; [No title captured]	87	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12695	10.1371/journal.pone.0012695	http://dx.doi.org/10.1371/journal.pone.0012695			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877649	Green Submitted, Green Published, gold			2022-12-27	WOS:000282053100004
J	Hendrickson, SL; Lautenberger, JA; Chinn, LW; Malasky, M; Sezgin, E; Kingsley, LA; Goedert, JJ; Kirk, GD; Gomperts, ED; Buchbinder, SP; Troyer, JL; O'Brien, SJ				Hendrickson, Sher L.; Lautenberger, James A.; Chinn, Leslie Wei; Malasky, Michael; Sezgin, Efe; Kingsley, Lawrence A.; Goedert, James J.; Kirk, Gregory D.; Gomperts, Edward D.; Buchbinder, Susan P.; Troyer, Jennifer L.; O'Brien, Stephen J.			Genetic Variants in Nuclear-Encoded Mitochondrial Genes Influence AIDS Progression	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CD4(+) T-CELLS; HIV-1 INFECTION; EXPRESSION; DNA; IDENTIFICATION; ASSOCIATION; HEMOPHILIA; CARCINOMA; ISOMERASE	Background: The human mitochondrial genome includes only 13 coding genes while nuclear-encoded genes account for 99% of proteins responsible for mitochondrial morphology, redox regulation, and energetics. Mitochondrial pathogenesis occurs in HIV patients and genetically, mitochondrial DNA haplogroups with presumed functional differences have been associated with differential AIDS progression. Methodology/Principal Findings: Here we explore whether single nucleotide polymorphisms (SNPs) within 904 of the estimated 1,500 genes that specify nuclear-encoded mitochondrial proteins (NEMPs) influence AIDS progression among HIV-1 infected patients. We examined NEMPs for association with the rate of AIDS progression using genotypes generated by an Affymetrix 6.0 genotyping array of 1,455 European American patients from five US AIDS cohorts. Successfully genotyped SNPs gave 50% or better haplotype coverage for 679 of known NEMP genes. With a Bonferroni adjustment for the number of genes and tests examined, multiple SNPs within two NEMP genes showed significant association with AIDS progression: acyl-CoA synthetase medium-chain family member 4 (ACSM4) on chromosome 12 and peroxisomal D3, D2-enoyl-CoA isomerase (PECI) on chromosome 6. Conclusions: Our previous studies on mitochondrial DNA showed that European haplogroups with presumed functional differences were associated with AIDS progression and HAART mediated adverse events. The modest influences of nuclear-encoded mitochondrial genes found in the current study add support to the idea that mitochondrial function plays a role in AIDS pathogenesis.	[Hendrickson, Sher L.; Lautenberger, James A.; Chinn, Leslie Wei; Sezgin, Efe; O'Brien, Stephen J.] NCI, Lab Genom Divers, Frederick, MD 21701 USA; [Malasky, Michael; Troyer, Jennifer L.] SAIC Frederick Inc, Lab Genom Divers, Frederick, MD USA; [Kingsley, Lawrence A.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Kingsley, Lawrence A.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA USA; [Goedert, James J.] NCI, Infect & Immunoepidemiol Branch, Bethesda, MD 20892 USA; [Kirk, Gregory D.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Gomperts, Edward D.] Childrens Hosp Los Angeles, Div Hematol Oncol, Los Angeles, CA 90027 USA; [Buchbinder, Susan P.] San Francisco City Clin, Dept Publ Hlth, San Francisco, CA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Children's Hospital Los Angeles	Hendrickson, SL (corresponding author), NCI, Lab Genom Divers, Frederick, MD 21701 USA.	hendricksons@mail.nih.gov	Sezgin, Efe/B-8418-2012; Troyer, Jennifer/B-8415-2012; OBRIEN, STEPHEN/ABD-1346-2020	Sezgin, Efe/0000-0002-8000-7485; Chinn, Leslie/0000-0003-3127-6758; OBRIEN, STEPHEN/0000-0001-7857-0757; Kingsley, Lawrence/0000-0002-7000-8556	National Cancer Institute [N02-CP-55504, UO1-AI-35042, 5-MO1-RR-00722, UO1-AI-35043, UO1-AI-37984, UO1-AI-35039, UO1-AI-35040, UO1-AI-37613, UO1-AI-35041]; National Institutes of Health [UO1-AI-35042, 5-MO1-RR-00722, UO1-AI-35043, UO1-AI-37984, UO1-AI-35039, UO1-AI-35040, UO1-AI-37613, UO1-AI-35041, HHSN261200800001E, N01-CO-12400, R01-DA-04334, R01-DA-12568, M01 RR00425]; National Center for Research Resources at Harbor-UCLA Research and Education Institute; National Institute of Child Health; Human Development [1 R01 HD41224]; NATIONAL CANCER INSTITUTE [ZIABC010317] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources at Harbor-UCLA Research and Education Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Child Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Human Development; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health (contract HHSN261200800001E). ALIVE was supported by NIH grants R01-DA-04334 and R01-DA-12568. MACS work was supported by NIH grants UO1-AI-35042, 5-MO1-RR-00722 (GCRC), UO1-AI-35043, UO1-AI-37984, UO1-AI-35039, UO1-AI-35040, UO1-AI-37613, UO1-AI-35041 and M01 RR00425 (National Center for Research Resources grant awarded to the GCRC at Harbor-UCLA Research and Education Institute). The MHCS is supported by National Cancer Institute contract N02-CP-55504 with RTI International. The HGDS is funded by the National Institutes of Health, National Institute of Child Health and Human Development, 1 R01 HD41224. National Cancer Institute contracts include: UO1-AI-35042, 5-MO1-RR-00722 (GCRC), UO1-AI-35043, UO1-AI-37984, UO1-AI-35039, UO1-AI-35040, UO1-AI-37613, UO1-AI-35041. This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract N01-CO-12400. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; BUCHBINDER SP, 1994, AIDS, V8, P1123, DOI 10.1097/00002030-199408000-00014; Centers for Disease Control, 1987, MMWR-MORBID MORTAL W, V21, p1S; Chan EY, 2007, J VIROL, V81, P7571, DOI 10.1128/JVI.00288-07; CHAN EY, DYNAMIC HOST ENERGET; Chun TW, 2003, P NATL ACAD SCI USA, V100, P1908, DOI 10.1073/pnas.0437640100; Corbeil A, 2001, GENOME RES, V11, P1198, DOI 10.1101/gr.GR-1802R; COX DR, 1972, J R STAT SOC B, V34, P187; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Geisbrecht BV, 1999, J BIOL CHEM, V274, P21797, DOI 10.1074/jbc.274.31.21797; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; GOEDERT JJ, 1989, NEW ENGL J MED, V321, P1141, DOI 10.1056/NEJM198910263211701; Goto M, 2003, J MED VIROL, V70, P497, DOI 10.1002/jmv.10423; Hendrickson SL, 2009, JAIDS-J ACQ IMM DEF, V51, P111, DOI 10.1097/QAI.0b013e3181a324d6; Hendrickson SL, 2008, AIDS, V22, P2429, DOI 10.1097/QAD.0b013e32831940bb; HILGARTNER MW, 1993, AM J PEDIAT HEMATOL, V15, P208; Imbeault M, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-5; Janssen U, 2002, J BIOL CHEM, V277, P19579, DOI 10.1074/jbc.M110993200; Jaruga P, 2002, FREE RADICAL BIO MED, V32, P414, DOI 10.1016/S0891-5849(01)00821-8; KAMEOKA M, 1993, FEBS LETT, V331, P182, DOI 10.1016/0014-5793(93)80322-L; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Olinski R, 2002, FREE RADICAL BIO MED, V33, P192, DOI 10.1016/S0891-5849(02)00878-X; Oosthuizen W, 2006, AM J CLIN NUTR, V83, P1193, DOI 10.1093/ajcn/83.5.1193; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; PHAIR J, 1992, J ACQ IMMUN DEF SYND, V5, P490; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Qi Y, 2006, PLOS PATHOG, V2, P741, DOI 10.1371/journal.ppat.0020079; Ringrose J, 2008, J VIROL, V82, P4320, DOI 10.1128/JVI.01819-07; Ryo A, 2000, AIDS RES HUM RETROV, V16, P995, DOI 10.1089/08892220050058416; Scanlan M J, 2001, Cancer Immun, V1, P4; Scanlan MJ, 1999, INT J CANCER, V83, P456, DOI 10.1002/(SICI)1097-0215(19991112)83:4<456::AID-IJC4>3.0.CO;2-5; Shedlock DJ, 2008, APOPTOSIS, V13, P1088, DOI 10.1007/s10495-008-0239-0; Suk K, 1999, BBA-MOL BASIS DIS, V1454, P126, DOI 10.1016/S0925-4439(99)00033-2; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; TROYER JL, LANCET UNPUB; van't Wout AB, 2003, J VIROL, V77, P1392, DOI 10.1128/JVI.77.2.1392-1402.2003; Vlahov D, 1991, NIDA Res Monogr, V109, P75; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang Y, 2002, J IMMUNOL, V169, P1102, DOI 10.4049/jimmunol.169.2.1102; Watkins PA, 2007, J LIPID RES, V48, P2736, DOI 10.1194/jlr.M700378-JLR200; Wen WR, 2005, VIRUS RES, V113, P26, DOI 10.1016/j.virusres.2005.04.002; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	42	34	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2010	5	9							e12862	10.1371/journal.pone.0012862	http://dx.doi.org/10.1371/journal.pone.0012862			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652JO	20877624	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000282002900012
J	Mulrennan, S; Tempone, SS; Ling, ITW; Williams, SH; Gan, GC; Murray, RJ; Speers, DJ				Mulrennan, Siobhain; Tempone, Simone Sara; Ling, Ivan Thian Wai; Williams, Simon Hedley; Gan, Gek-Choo; Murray, Ronan John; Speers, David John			Pandemic Influenza (H1N1) 2009 Pneumonia: CURB-65 Score for Predicting Severity and Nasopharyngeal Sampling for Diagnosis Are Unreliable	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; RAPID-TEST SENSITIVITY; A H1N1; UNITED-STATES; VIRUS; HUMANS	Background: From the first case reports of pandemic influenza (H1N1) 2009 it was clear that a significant proportion of infected individuals suffered a primary viral pneumonia. The objective of this study was twofold; to assess the utility of the CURB-65 community acquired pneumonia (CAP) severity index in predicting pneumonia severity and ICU admission, and to assess the relative sensitivity of nasopharyngeal versus lower respiratory tract sampling for the detection of pandemic influenza (H1N1) CAP. Methods: A retrospective cohort study of 70 patients hospitalised for pandemic influenza (H1N1) 2009 in an adult tertiary referral hospital. Characteristics evaluated included age, pregnancy status, sex, respiratory signs and symptoms, smoking and alcohol history, CURB-65 score, co-morbidities, disabling sequelae, length of stay and in-hospital mortality outcomes. Laboratory features evaluated included lymphocyte count, C-reactive protein (CRP), nasopharyngeal and lower respiratory tract pandemic influenza (H1N1) 2009 PCR results. Results: Patients with pandemic (H1N1) 2009 influenza CAP differed significantly from those without pneumonia regarding length of stay, need for ICU admission, CRP and the likelihood of disabling sequelae. The CURB-65 score did not predict CAP severity or the need for ICU admission (only 2/11 patients admitted to ICU had CURB-65 scores of 2 or 3). Nasopharyngeal specimens for PCR were only 62.9% sensitive in CAP patients compared to 97.8% sensitivity for lower respiratory tract specimens. Conclusions: The CURB-65 score does not predict severe pandemic influenza (H1N1) 2009 CAP or need for ICU admission. Lower respiratory tract specimens should be collected when pandemic (H1N1) 2009 influenza CAP is suspected.	[Mulrennan, Siobhain; Ling, Ivan Thian Wai] Sir Charles Gairdner Hosp, Dept Resp Med, Nedlands, WA 6009, Australia; [Tempone, Simone Sara; Williams, Simon Hedley; Murray, Ronan John; Speers, David John] PathWest Lab Med Western Australia, Dept Microbiol, Nedlands, WA, Australia; [Gan, Gek-Choo] Sir Charles Gairdner Hosp, Dept Radiol, Nedlands, WA 6009, Australia; [Murray, Ronan John] Sir Charles Gairdner Hosp, Dept Infect Dis, Nedlands, WA 6009, Australia; [Speers, David John] Univ Western Australia, Dept Med & Pharmacol, Crawley, WA, Australia	University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia	Mulrennan, S (corresponding author), Sir Charles Gairdner Hosp, Dept Resp Med, Nedlands, WA 6009, Australia.	Siobhain.Mulrennan@health.wa.gov.au		Ling, Ivan/0000-0003-1429-3476; Williams, Simon/0000-0002-6276-4685				*AUSTR GOV DEP HLT, 2009, 24 AUSTR GOV DEP HLT; Blyth CC, 2009, NEW ENGL J MED, V361, P2493, DOI 10.1056/NEJMc0909049; Buising KL, 2006, THORAX, V61, P419, DOI 10.1136/thx.2005.051326; Cao B, 2009, NEW ENGL J MED, V361, P2507, DOI 10.1056/NEJMoa0906612; Chidlow G, 2010, J CLIN MICROBIOL, V48, P862, DOI 10.1128/JCM.01435-09; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Faix DJ, 2009, NEW ENGL J MED, V361, P728, DOI 10.1056/NEJMc0904264; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; *NAT HLTH MED RES, 2003, DOES QUAL ASS HEALTH; NHMRC, 2018, NAT STAT ETH COND HU; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; Whiley DM, 2005, DIAGN MICR INFEC DIS, V53, P335, DOI 10.1016/j.diagmicrobio.2005.08.002; 2009, MMWR MORB MORTAL WKL, V58, P497	15	44	47	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2010	5	9							e12849	10.1371/journal.pone.0012849	http://dx.doi.org/10.1371/journal.pone.0012849			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652JO	20877727	Green Published, gold, Green Submitted			2022-12-27	WOS:000282002900008
J	Duarte, CAB; Foti, L; Nakatani, SM; Riediger, IN; Poersch, CO; Pavoni, DP; Krieger, MA				Duarte, Cesar A. B.; Foti, Leonardo; Nakatani, Sueli M.; Riediger, Irina N.; Poersch, Celina O.; Pavoni, Daniela P.; Krieger, Marco A.			A Novel Hepatitis C Virus Genotyping Method Based on Liquid Microarray	PLOS ONE			English	Article							ASSAY; IDENTIFICATION; VALIDATION; CORE	The strategy used to treat HCV infection depends on the genotype involved. An accurate and reliable genotyping method is therefore of paramount importance. We describe here, for the first time, the use of a liquid microarray for HCV genotyping. This liquid microarray is based on the 5'UTR - the most highly conserved region of HCV - and the variable region NS5B sequence. The simultaneous genotyping of two regions can be used to confirm findings and should detect inter-genotypic recombination. Plasma samples from 78 patients infected with viruses with genotypes and subtypes determined in the Versant (TM) HCV Genotype Assay LiPA (version I; Siemens Medical Solutions, Diagnostics Division, Fernwald, Germany) were tested with our new liquid microarray method. This method successfully determined the genotypes of 74 of the 78 samples previously genotyped in the Versant (TM) HCV Genotype Assay LiPA (74/78, 95%). The concordance between the two methods was 100% for genotype determination (74/74). At the subtype level, all 3a and 2b samples gave identical results with both methods (17/17 and 7/7, respectively). Two 2c samples were correctly identified by microarray, but could only be determined to the genotype level with the Versant (TM) HCV assay. Genotype "1'' subtypes (1a and 1b) were correctly identified by the Versant (TM) HCV assay and the microarray in 68% and 40% of cases, respectively. No genotype discordance was found for any sample. HCV was successfully genotyped with both methods, and this is of prime importance for treatment planning. Liquid microarray assays may therefore be added to the list of methods suitable for HCV genotyping. It provides comparable results and may readily be adapted for the detection of other viruses frequently co-infecting HCV patients. Liquid array technology is thus a reliable and promising platform for HCV genotyping.	[Duarte, Cesar A. B.; Foti, Leonardo; Poersch, Celina O.; Pavoni, Daniela P.; Krieger, Marco A.] Inst Carlos Chagas Fundacao Oswaldo Cruz FIOCRUZ, Curitiba, Parana, Brazil; [Duarte, Cesar A. B.; Foti, Leonardo; Poersch, Celina O.; Pavoni, Daniela P.; Krieger, Marco A.] Inst Biol Mol Parana IBMP, Curitiba, Parana, Brazil; [Nakatani, Sueli M.; Riediger, Irina N.] Lab Cent Estado LACEN PR, Sao Jose Dos Pinhais, Brazil; [Nakatani, Sueli M.] Univ Sao Paulo, Sch Med, Dept Gastroenterol, Sao Paulo, Brazil	Fundacao Oswaldo Cruz; Universidade de Sao Paulo	Duarte, CAB (corresponding author), Inst Carlos Chagas Fundacao Oswaldo Cruz FIOCRUZ, Curitiba, Parana, Brazil.	mkrieger@fiocruz.br	Publica, Inct Saude/J-9544-2013; Foti, Leonardo/F-1763-2014; Pavoni, Daniela P/L-3302-2014; Krieger, Marco/AAE-8611-2020; P, CM/B-1358-2013	Foti, Leonardo/0000-0003-2948-9914; Pavoni, Daniela P/0000-0001-6776-4345; Krieger, Marco Aurelio/0000-0003-0030-3952	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Instituto Nacional de Ciencia e Tecnologia em Diagnosticos para a Saude Publica, FIOCRUZ	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia em Diagnosticos para a Saude Publica, FIOCRUZ	This investigation received financial support from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Instituto Nacional de Ciencia e Tecnologia em Diagnosticos para a Saude Publica, FIOCRUZ. MAK holds CNPq research fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTER MJ, 1992, NEW ENGL J MED, V327, P1899, DOI 10.1056/NEJM199212313272702; Banoo S, 2008, NAT REV MICROBIOL, V6, pS16, DOI 10.1038/nrmicro1523y; Campbell K, 2006, ABA BANK MARKET, V38, P41; Chen ZY, 2002, J CLIN MICROBIOL, V40, P3127, DOI 10.1128/JCM.40.9.3127-3134.2002; Colina R, 2004, J GEN VIROL, V85, P31, DOI 10.1099/vir.0.19472-0; Drexler JF, 2009, PLOS MED, V6, P210, DOI 10.1371/journal.pmed.1000031; Dumonceaux Tim J, 2009, J Clin Microbiol, V47, P4067, DOI 10.1128/JCM.00112-09; Dunbar SA, 2006, CLIN CHIM ACTA, V363, P71, DOI 10.1016/j.cccn.2005.06.023; ENOMOTO N, 1995, J CLIN INVEST, V96, P224, DOI 10.1172/JCI118025; Etienne KA, 2009, J CLIN MICROBIOL, V47, P1096, DOI 10.1128/JCM.01899-08; Germer JJ, 1999, J CLIN MICROBIOL, V37, P2625, DOI 10.1128/JCM.37.8.2625-2630.1999; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Kalinina O, 2002, J VIROL, V76, P4034, DOI 10.1128/JVI.76.8.4034-4043.2002; KELLY S, 2005, JALA, V10, P301; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lavanchy D, 1999, J VIRAL HEPATITIS, V6, P35; Noppornpanth S, 2006, J CLIN MICROBIOL, V44, P3969, DOI 10.1128/JCM.01122-06; SIMMONDS P, 1994, J GEN VIROL, V75, P1053, DOI 10.1099/0022-1317-75-5-1053; Strom CM, 2006, J MOL DIAGN, V8, P371, DOI 10.2353/jmoldx.2006.050115; Verbeeck J, 2008, J CLIN MICROBIOL, V46, P1901, DOI 10.1128/JCM.02390-07; WANG W, 2009, VIROL METHODS, V40, P1621; Wilson WJ, 2005, MOL CELL PROBE, V19, P137, DOI 10.1016/j.mcp.2004.10.005; WOOD WI, 1985, P NATL ACAD SCI USA, V82, P1585, DOI 10.1073/pnas.82.6.1585; Zheng XT, 2003, J CLIN VIROL, V28, P214, DOI 10.1016/S1386-6532(03)00076-3	25	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2010	5	9							e12822	10.1371/journal.pone.0012822	http://dx.doi.org/10.1371/journal.pone.0012822			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651YH	20862224	Green Submitted, Green Published, gold			2022-12-27	WOS:000281963200009
J	Hanson, EK; Ballantyne, J				Hanson, Erin K.; Ballantyne, Jack			A Blue Spectral Shift of the Hemoglobin Soret Band Correlates with the Age (Time Since Deposition) of Dried Bloodstains	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; IDENTIFICATION; PIGMENTATION; COLOR; HAIR; OXYHEMOGLOBIN; POLYMORPHISM; INDICATOR; GENETICS; STATURE	The ability to determine the time since deposition of a bloodstain found at a crime scene could prove invaluable to law enforcement investigators, defining the time frame in which the individual depositing the evidence was present. Although various methods of accomplishing this have been proposed, none has gained widespread use due to poor time resolution and weak age correlation. We have developed a method for the estimation of the time since deposition (TSD) of dried bloodstains using UV-VIS spectrophotometric analysis of hemoglobin (Hb) that is based upon its characteristic oxidation chemistry. A detailed study of the Hb Soret band (lambda max = 412 nm) in aged bloodstains revealed a blue shift (shift to shorter wavelength) as the age of the stain increases. The extent of this shift permits, for the first time, a distinction to be made between bloodstains that were deposited minutes, hours, days and weeks prior to recovery and analysis. The extent of the blue shift was found to be a function of ambient relative humidity and temperature. The method is extremely sensitive, requiring as little as a 1 mu l dried bloodstain for analysis. We demonstrate that it might be possible to perform TSD measurements at the crime scene using a portable low-sample-volume spectrophotometer.	[Hanson, Erin K.; Ballantyne, Jack] Natl Ctr Forens Sci, Orlando, FL USA; [Ballantyne, Jack] Univ Cent Florida, Dept Chem, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida	Hanson, EK (corresponding author), Natl Ctr Forens Sci, Orlando, FL USA.	jballant@mail.ucf.edu			Office of Justice Program, National Institute of Justice, Department of Justice [2005-MU-BX-K071, 2008-MU-MU-K003]	Office of Justice Program, National Institute of Justice, Department of Justice	This work was supported under award number 2005-MU-BX-K071 and 2008-MU-MU-K003 from the Office of Justice Program, National Institute of Justice, Department of Justice. Points of view in this document are those of the authors and do not necessarily represent the official positions of the U. S. Department of Justice. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez M, 2006, ANAL BIOCHEM, V357, P21, DOI 10.1016/j.ab.2006.06.024; Anderson S, 2005, FORENSIC SCI INT, V148, P37, DOI 10.1016/j.forsciint.2004.04.071; Andrasko J, 1997, J FORENSIC SCI, V42, P601; Bauer M, 2003, FORENSIC SCI INT, V138, P94, DOI 10.1016/j.forsciint.2003.09.008; Butler JM, 2006, J FORENSIC SCI, V51, P253, DOI 10.1111/j.1556-4029.2006.00046.x; Castanet J, 1997, EXS, V78, P209; *CTR NOAA SAT INF, 2005, CLIM MAPS US 1961 19; Duffy DL, 2007, AM J HUM GENET, V80, P241, DOI 10.1086/510885; Eiberg H, 1996, EUR J HUM GENET, V4, P237; FRDUAKIS T, 2008, MOL PHOTOFITTING PRE; Frudakis T, 2003, GENETICS, V165, P2071; FUNAO T, 1959, JPN J LEGAL MED, V13, P735; Grimes EA, 2001, FORENSIC SCI INT, V122, P124, DOI 10.1016/S0379-0738(01)00480-7; Hochmeister MN, 1999, J FORENSIC SCI, V44, P597; Horecker BL, 1943, J BIOL CHEM, V148, P173; INOUE H, 1992, FORENSIC SCI INT, V57, P17, DOI 10.1016/0379-0738(92)90041-T; INOUE H, 1991, INT J LEGAL MED, V104, P127, DOI 10.1007/BF01369715; Juusola J, 2003, FORENSIC SCI INT, V135, P85, DOI 10.1016/S0379-0738(03)00197-X; KIND S S, 1973, Forensic Science, V2, P325, DOI 10.1016/0300-9432(73)90047-2; KIND S S, 1972, Forensic Science, V1, P27, DOI 10.1016/0300-9432(72)90146-X; Kumagai R, 1993, Nihon Hoigaku Zasshi, V47, P213; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Liu YZ, 2006, HUM GENET, V119, P295, DOI 10.1007/s00439-006-0136-y; Liu YZ, 2004, ANN HUM GENET, V68, P472, DOI 10.1046/j.1529-8817.2003.00117.x; Marrone A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005110; MATSUOKA T, 1995, BIOL PHARM BULL, V18, P1031; MIGROM RL, 1997, COLORS LIFE INTRO CH; Palmert MR, 2003, MOL GENET METAB, V80, P1, DOI 10.1016/S1096-7192(03)00107-0; RACHMILEWITZ EA, 1971, J BIOL CHEM, V246, P3356; RACHMILEWITZ EA, 1969, ANN NY ACAD SCI, V165, P171, DOI 10.1111/j.1749-6632.1969.tb27787.x; Rajamannar K, 1977, J Forensic Sci, V22, P159; Rees JL, 2003, ANNU REV GENET, V37, P67, DOI 10.1146/annurev.genet.37.110801.143233; RIGAS DA, 1961, BLOOD, V18, P1; Sturm RA, 2001, GENE, V277, P49, DOI 10.1016/S0378-1119(01)00694-1	34	55	58	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2010	5	9							e12830	10.1371/journal.pone.0012830	http://dx.doi.org/10.1371/journal.pone.0012830			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651YH	20877468	Green Published, Green Submitted, gold			2022-12-27	WOS:000281963200012
J	Agnarsson, I; Kuntner, M; Blackledge, TA				Agnarsson, Ingi; Kuntner, Matjaz; Blackledge, Todd A.			Bioprospecting Finds the Toughest Biological Material: Extraordinary Silk from a Giant Riverine Orb Spider	PLOS ONE			English	Article							WEAVING SPIDERS; MECHANICAL-PROPERTIES; DRAGLINE SILK; CAPTURE THREADS; FORCED SILKING; EVOLUTION; WEB; PERFORMANCE; BIOMATERIAL; PREY	Background: Combining high strength and elasticity, spider silks are exceptionally tough, i.e., able to absorb massive kinetic energy before breaking. Spider silk is therefore a model polymer for development of high performance biomimetic fibers. There are over 41.000 described species of spiders, most spinning multiple types of silk. Thus we have available some 200.000+ unique silks that may cover an amazing breadth of material properties. To date, however, silks from only a few tens of species have been characterized, most chosen haphazardly as model organisms (Nephila) or simply from researchers' backyards. Are we limited to 'blindly fishing' in efforts to discover extraordinary silks? Or, could scientists use ecology to predict which species are likely to spin silks exhibiting exceptional performance properties? Methodology: We examined the biomechanical properties of silk produced by the remarkable Malagasy 'Darwin's bark spider' (Caerostris darwini), which we predicted would produce exceptional silk based upon its amazing web. The spider constructs its giant orb web (up to 2.8 m(2)) suspended above streams, rivers, and lakes. It attaches the web to substrates on each riverbank by anchor threads as long as 25 meters. Dragline silk from both Caerostris webs and forcibly pulled silk, exhibits an extraordinary combination of high tensile strength and elasticity previously unknown for spider silk. The toughness of forcibly silked fibers averages 350 MJ/m(3), with some samples reaching 520 MJ/m3. Thus, C. darwini silk is more than twice tougher than any previously described silk, and over 10 times better than Kevlar (R). Caerostris capture spiral silk is similarly exceptionally tough. Conclusions: Caerostris darwini produces the toughest known biomaterial. We hypothesize that this extraordinary toughness coevolved with the unusual ecology and web architecture of these spiders, decreasing the likelihood of bridgelines breaking and collapsing the web into the river. This hypothesis predicts that rapid change in material properties of silk co-occurred with ecological shifts within the genus, and can thus be tested by combining material science, behavioral observations, and phylogenetics. Our findings highlight the potential benefits of natural history-informed bioprospecting to discover silks, as well as other materials, with novel and exceptional properties to serve as models in biomimicry.	[Agnarsson, Ingi] Univ Puerto Rico, Dept Biol, Fac Nat Sci, San Juan, PR 00936 USA; [Agnarsson, Ingi; Kuntner, Matjaz] Slovenian Acad Sci & Arts, Inst Biol, Ctr Sci Res, Ljubljana, Slovenia; [Agnarsson, Ingi; Blackledge, Todd A.] Univ Akron, Dept Biol, Akron, OH 44325 USA; [Agnarsson, Ingi; Blackledge, Todd A.] Univ Akron, Integrated Biosci Program, Akron, OH 44325 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico Rio Piedras; National Institute of Biology - Slovenia; Slovenian Academy of Sciences & Arts (SASA); University System of Ohio; University of Akron; University System of Ohio; University of Akron	Agnarsson, I (corresponding author), Univ Puerto Rico, Dept Biol, Fac Nat Sci, San Juan, PR 00936 USA.	iagnarsson@gmail.com	Kuntner, Matjaz/AAE-2195-2020		Slovenian Research Agency [Z1-9799-0618-07]; National Geographic Society [8655-09]; National Science Foundation [DBI-0521261, DEB-0516038, IOS-0745379]; European Community [MIRG-CT-2005 036536]; Sallee Charitable Trust; United States National Science Foundation [DEB-9712353]	Slovenian Research Agency(Slovenian Research Agency - Slovenia); National Geographic Society(National Geographic Society); National Science Foundation(National Science Foundation (NSF)); European Community(European Commission); Sallee Charitable Trust; United States National Science Foundation(National Science Foundation (NSF))	Primary funding for this work came from the Slovenian Research Agency (grant Z1-9799-0618-07 to I. Agnarsson), the National Geographic Society (grant 8655-09 to the authors), and the National Science Foundation (grants DBI-0521261, DEB-0516038 and IOS-0745379 to T. Blackledge). Additional funding came from the European Community 6th Framework Programme (a Marie Curie International Reintegration Grant MIRG-CT-2005 036536 to M. Kuntner). The 2001 field work was supported by the Sallee Charitable Trust grant to I. Agnarsson and M. Kuntner and by a United States National Science Foundation grant (DEB-9712353) to G. Hormiga and J. A. Coddington. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarsson I, 2009, J ZOOL, V278, P134, DOI 10.1111/j.1469-7998.2009.00558.x; Agnarsson I, 2008, J EXP ZOOL PART A, V309A, P494, DOI 10.1002/jez.480; Agnarsson I, 2009, J EXP BIOL, V212, P1989, DOI 10.1242/jeb.028282; Blackledge TA, 2006, J EXP BIOL, V209, P2452, DOI 10.1242/jeb.02275; Blackledge TA, 2005, J EXP BIOL, V208, P1937, DOI 10.1242/jeb.01597; Blackledge TA, 2005, INVERTEBR BIOL, V124, P165, DOI 10.1111/j.1744-7410.2005.00016.x; Blackledge TA, 2009, J EXP BIOL, V212, P1980, DOI 10.1242/jeb.028944; Blackledge TA, 2009, P NATL ACAD SCI USA, V106, P5229, DOI 10.1073/pnas.0901377106; BOOTH C, 1989, COMPREHENSIVE POLYM; Boutry C, 2008, J EXP ZOOL PART A, V309A, P542, DOI 10.1002/jez.487; Boutry C, 2009, ZOOLOGY, V112, P451, DOI 10.1016/j.zool.2009.03.003; EBERHARD WG, 1990, ANNU REV ECOL SYST, V21, P341, DOI 10.1146/annurev.es.21.110190.002013; Elices M, 2009, BIOMACROMOLECULES, V10, P1904, DOI 10.1021/bm900312c; Garrido MA, 2002, POLYMER, V43, P1537, DOI 10.1016/S0032-3861(01)00713-3; GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9; Gosline JM, 1999, J EXP BIOL, V202, P3295; Guan ZB, 2007, POLYM INT, V56, P467, DOI 10.1002/pi.2245; Guinea GV, 2006, BIOMACROMOLECULES, V7, P2173, DOI 10.1021/bm060138v; Hayashi CY, 2004, MOL BIOL EVOL, V21, P1950, DOI 10.1093/molbev/msh204; Kuntner M, 2008, CLADISTICS, V24, P147, DOI 10.1111/j.1096-0031.2007.00176.x; Kuntner M, 2007, SYST ENTOMOL, V32, P95, DOI 10.1111/j.1365-3113.2006.00348.x; Kuntner M, 2010, J ARACHNOL, V38, P346, DOI 10.1636/B09-113.1; Lee SM, 2009, SCIENCE, V324, P488, DOI 10.1126/science.1168162; Opell BD, 2000, BIOL J LINN SOC, V70, P107, DOI 10.1111/j.1095-8312.2000.tb00203.x; OPELL BD, 1994, FUNCT ECOL, V8, P85, DOI 10.2307/2390115; Opell BD, 2001, EVOL ECOL RES, V3, P567; Opell BD, 2006, ZOOLOGY, V109, P339, DOI 10.1016/j.zool.2006.04.002; Ortlepp CS, 2004, BIOMACROMOLECULES, V5, P727, DOI 10.1021/bm034269x; Perez-Rigueiro J, 2003, POLYMER, V44, P3733, DOI 10.1016/S0032-3861(03)00245-3; Perez-Rigueiro J, 2001, J APPL POLYM SCI, V82, P1928, DOI 10.1002/app.2038; SENSENIG A, 2010, J EVOLUTION IN PRESS, V23; Swanson BO, 2006, APPL PHYS A-MATER, V82, P213, DOI 10.1007/s00339-005-3427-6; Swanson BO, 2007, J EXP ZOOL PART A, V307A, P654, DOI 10.1002/jez.420; Swanson BO, 2006, EVOLUTION, V60, P2539; Swanson BO, 2009, INTEGR COMP BIOL, V49, P21, DOI 10.1093/icb/icp013; Vollrath F, 2006, APPL PHYS A-MATER, V82, P205, DOI 10.1007/s00339-005-3437-4; Vollrath F, 1999, INT J BIOL MACROMOL, V24, P243, DOI 10.1016/S0141-8130(98)00095-6; Vollrath F, 2001, P ROY SOC B-BIOL SCI, V268, P2339, DOI 10.1098/rspb.2001.1590; Vollrath F, 2009, POLYMER, V50, P5623, DOI 10.1016/j.polymer.2009.09.068	39	175	181	6	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2010	5	9							e11234	10.1371/journal.pone.0011234	http://dx.doi.org/10.1371/journal.pone.0011234			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650QH	20856804	Green Submitted, gold, Green Published			2022-12-27	WOS:000281864100001
J	Delaney, KS; Riley, SPD; Fisher, RN				Delaney, Kathleen Semple; Riley, Seth P. D.; Fisher, Robert N.			A Rapid, Strong, and Convergent Genetic Response to Urban Habitat Fragmentation in Four Divergent and Widespread Vertebrates	PLOS ONE			English	Article							JERUSALEM CRICKET ORTHOPTERA; SKINKS EGERNIA-CUNNINGHAMI; MICROSATELLITE LOCI; POPULATION-STRUCTURE; DISPERSAL; EXTINCTION; ROADS; DIVERSITY; DIFFERENTIATION; PATTERNS	Background: Urbanization is a major cause of habitat fragmentation worldwide. Ecological and conservation theory predicts many potential impacts of habitat fragmentation on natural populations, including genetic impacts. Habitat fragmentation by urbanization causes populations of animals and plants to be isolated in patches of suitable habitat that are surrounded by non-native vegetation or severely altered vegetation, asphalt, concrete, and human structures. This can lead to genetic divergence between patches and in turn to decreased genetic diversity within patches through genetic drift and inbreeding. Methodology/Principal Findings: We examined population genetic patterns using microsatellites in four common vertebrate species, three lizards and one bird, in highly fragmented urban southern California. Despite significant phylogenetic, ecological, and mobility differences between these species, all four showed similar and significant reductions in gene flow over relatively short geographic and temporal scales. For all four species, the greatest genetic divergence was found where development was oldest and most intensive. All four animals also showed significant reduction in gene flow associated with intervening roads and freeways, the degree of patch isolation, and the time since isolation. Conclusions/Significance: Despite wide acceptance of the idea in principle, evidence of significant population genetic changes associated with fragmentation at small spatial and temporal scales has been rare, even in smaller terrestrial vertebrates, and especially for birds. Given the striking pattern of similar and rapid effects across four common and widespread species, including a volant bird, intense urbanization may represent the most severe form of fragmentation, with minimal effective movement through the urban matrix.	[Delaney, Kathleen Semple] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Delaney, Kathleen Semple; Riley, Seth P. D.] Natl Pk Serv, Santa Monica Mt Natl Recreat Area, Thousand Oaks, CA USA; [Fisher, Robert N.] US Geol Survey, San Diego Field Stn, San Diego, CA USA	University of California System; University of California Los Angeles; United States Department of the Interior; United States Department of the Interior; United States Geological Survey	Delaney, KS (corresponding author), Natl Pk Serv, Santa Monica Mt Natl Recreat Area, Thousand Oaks, CA USA.	Katy_Delaney@nps.gov	Fisher, Robert/AAA-7301-2022	Fisher, Robert/0000-0002-2956-3240	Western office of the National Resources	Western office of the National Resources	The source of funding was a USGS grant from the Western office of the National Resources Preservation Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER M, 1995, CONDOR, V97, P663, DOI 10.2307/1369175; Barnett JR, 2008, CONSERV GENET, V9, P1403, DOI 10.1007/s10592-007-9463-3; Bjorklund M, 2010, BIOL J LINN SOC, V99, P9, DOI 10.1111/j.1095-8312.2009.01335.x; BOLGER DT, 1991, AM NAT, V137, P155, DOI 10.1086/285151; Boutin-Ganache I, 2001, BIOTECHNIQUES, V31, P24, DOI 10.2144/01311bm02; BROWN JH, 1977, ECOLOGY, V58, P445, DOI 10.2307/1935620; Busteed GT, 2003, EFFECTS HABITAT FRAG; CAMPBELL HW, 1982, 13 US DEP INT FISH W, P193; Case TJ, 2001, SPATIAL UNCERTAINTY IN ECOLOGY, P47; Chace JF, 2006, LANDSCAPE URBAN PLAN, V74, P46, DOI 10.1016/j.landurbplan.2004.08.007; Cincotta RP, 2000, NATURE, V404, P990, DOI 10.1038/35010105; Coughlan JP, 2004, MOL ECOL NOTES, V4, P678, DOI 10.1111/j.1471-8286.2004.00782.x; Crooks KR, 2004, BIOL CONSERV, V115, P451, DOI 10.1016/S0006-3207(03)00162-9; Crooks KR, 2001, CONSERV BIOL, V15, P159, DOI 10.1046/j.1523-1739.2001.99379.x; Donnelly M. A., 1994, MEASURING MONITORING, P277; DOUGHTY P, 1994, J HERPETOL, V28, P485, DOI 10.2307/1564962; DOUGHTY P, 1994, ANIM BEHAV, V47, P227, DOI 10.1006/anbe.1994.1029; Fisher RN, 2002, CONSERV BIOL, V16, P205, DOI 10.1046/j.1523-1739.2002.00326.x; FITCH HS, 1977, HERPETOLOGICA, V33, P303; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; Frankham R., 2006, CONNECTIVITY CONSERV, P72; GEUPEL GR, WRENTIT CHAMAEA FASC; Glaubitz JC, 2004, MOL ECOL NOTES, V4, P309, DOI 10.1111/j.1471-8286.2004.00597.x; GOUDET J, 2002, FSTAT SOFTWARE ESTIM; *GOV EX LAND US DA, 2005, LAND US DAT COUNT IM; HANSKI I, 1991, BIOL J LINN SOC, V42, P17, DOI 10.1111/j.1095-8312.1991.tb00549.x; Hanski I, 1999, OIKOS, V87, P209, DOI 10.2307/3546736; Hoehn M, 2007, MOL ECOL, V16, P3299, DOI 10.1111/j.1365-294X.2007.03352.x; Howes BJ, 2004, MOL ECOL NOTES, V4, P237, DOI 10.1111/j.1471-8286.2004.00628.x; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Keller I, 2004, MOL ECOL, V13, P2983, DOI 10.1111/j.1365-294X.2004.02310.x; Keller I, 2003, P ROY SOC B-BIOL SCI, V270, P417, DOI 10.1098/rspb.2002.2247; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Keyghobadi N, 2007, CAN J ZOOL, V85, P1049, DOI 10.1139/Z07-095; Koenig J, 2001, WILDLIFE RES, V28, P215, DOI 10.1071/WR00068; LANDE R, 1993, AM NAT, V142, P911, DOI 10.1086/285580; Langkilde T, 2006, J EXP BIOL, V209, P1035, DOI 10.1242/jeb.02112; Legendre P., 2012, NUMERICAL ECOLOGY; Lynch M, 1999, GENETICS, V152, P1753; Magle SB, 2010, J MAMMAL, V91, P326, DOI 10.1644/09-MAMM-A-019.1; Marsh DM, 2008, CONSERV GENET, V9, P603, DOI 10.1007/s10592-007-9377-0; Massot M, 2003, BEHAV ECOL, V14, P650, DOI 10.1093/beheco/arg056; McGarigal K., 2002, FRAGSTATS SPATIAL PA, DOI DOI 10.1016/S0022-3913(12)00047-9; Miller JR, 2002, CONSERV BIOL, V16, P330, DOI 10.1046/j.1523-1739.2002.00420.x; Miller MP, 2005, J HERED, V96, P722, DOI 10.1093/jhered/esi119; Moore JA, 2008, MOL ECOL, V17, P4630, DOI 10.1111/j.1365-294X.2008.03951.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Mylecraine KA, 2008, CONSERV GENET, V9, P1633, DOI 10.1007/s10592-008-9518-0; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Noel S, 2007, CONSERV GENET, V8, P599, DOI 10.1007/s10592-006-9202-1; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; Redeker S, 2006, MAMM BIOL, V71, P144, DOI 10.1016/j.mambio.2005.12.003; Reed DH, 2004, ANIM CONSERV, V7, P181, DOI 10.1017/S1367943004001313; Reed DH, 2003, CONSERV GENET, V4, P405, DOI 10.1023/A:1024081416729; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Reed DH, 2002, CONSERV GENET, V3, P301, DOI 10.1023/A:1019948130263; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Richardson DS, 2000, MOL ECOL, V9, P2226; RICHMOND JQ, 2008, CONSERV GENET, V10, P1291; Riley SPD, 2006, MOL ECOL, V15, P1733, DOI 10.1111/j.1365-294X.2006.02907.x; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; Schneider S., 2000, ARLEQUIN VER 2 000 S; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Schwacke L, 2005, RERAT RELATEDNESS ES; Segelbacher G, 2008, MOL ECOL, V17, P2356, DOI 10.1111/j.1365-294X.2008.03767.x; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; Shepard DB, 2008, ANIM CONSERV, V11, P288, DOI 10.1111/j.1469-1795.2008.00183.x; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Sinervo B, 2006, AM NAT, V168, P88, DOI 10.1086/505765; SOULE M E, 1988, Conservation Biology, V2, P75, DOI 10.1111/j.1523-1739.1988.tb00337.x; Stebbins R.C., 1954, AMPHIBIANS REPTILES; Stow AJ, 2004, MOL ECOL, V13, P419, DOI 10.1046/j.1365-294X.2003.02061.x; Stow AJ, 2004, MOL ECOL, V13, P443, DOI 10.1046/j.1365-294X.2003.02060.x; Sumner J, 2005, CONSERV GENET, V6, P333, DOI 10.1007/s10592-005-4959-1; Sumner J, 2004, MOL ECOL, V13, P259, DOI 10.1046/j.1365-294X.2003.02056.x; Syphard AD, 2005, ECOL COMPLEX, V2, P185, DOI 10.1016/j.ecocom.2004.11.003; Thomas SC, 2005, PHILOS T R SOC B, V360, P1457, DOI 10.1098/rstb.2005.1675; Vandergast AG, 2007, MOL ECOL, V16, P977, DOI 10.1111/j.1365-294X.2006.03216.x; Vandergast AG, 2009, J INSECT CONSERV, V13, P329, DOI 10.1007/s10841-008-9176-z; Veit ML, 2005, CONSERV GENET, V6, P159, DOI 10.1007/s10592-004-7831-9; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Zamudio KR, 2000, P NATL ACAD SCI USA, V97, P14427, DOI 10.1073/pnas.011544998; Zink RM, 2000, CONSERV BIOL, V14, P1394, DOI 10.1046/j.1523-1739.2000.99082.x	85	147	149	3	153	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2010	5	9							e12767	10.1371/journal.pone.0012767	http://dx.doi.org/10.1371/journal.pone.0012767			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650QH	20862274	Green Submitted, Green Published, gold			2022-12-27	WOS:000281864100013
J	Shin, YJ; Bleris, L				Shin, Yong-Jun; Bleris, Leonidas			Linear Control Theory for Gene Network Modeling	PLOS ONE			English	Article							REGULATORY NETWORKS; SYNTHETIC BIOLOGY; EXPRESSION; CIRCUIT; NOISE; SYSTEMS; ROBUST; MOTIFS	Systems biology is an interdisciplinary field that aims at understanding complex interactions in cells. Here we demonstrate that linear control theory can provide valuable insight and practical tools for the characterization of complex biological networks. We provide the foundation for such analyses through the study of several case studies including cascade and parallel forms, feedback and feedforward loops. We reproduce experimental results and provide rational analysis of the observed behavior. We demonstrate that methods such as the transfer function (frequency domain) and linear state-space (time domain) can be used to predict reliably the properties and transient behavior of complex network topologies and point to specific design strategies for synthetic networks.	[Shin, Yong-Jun; Bleris, Leonidas] Univ Texas Dallas, Dept Elect Engn, Richardson, TX 75083 USA; [Bleris, Leonidas] Univ Texas Dallas, Dept Bioengn, Richardson, TX 75083 USA	University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Dallas	Shin, YJ (corresponding author), Cornell Univ, Sch Elect & Comp Engn, Ithaca, NY 14853 USA.	yshin@cornell.edu; bleris@utdallas.edu						Alon U, 2007, INTRO SYSTEMS BIOL D; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Anderson BDO., 1990, OPTIMAL CONTROL LINE; Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Austin DW, 2006, NATURE, V439, P608, DOI 10.1038/nature04194; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; BLERIS LG, 2009, SYSTEMS BIOL HUMAN D; Bolouri H, 2008, COMPUTATIONAL MODELI; Brogan W. L., 1991, MODERN CONTROL THEOR; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Casey R, 2006, J MATH BIOL, V52, P27, DOI 10.1007/s00285-005-0338-2; Cox CD, 2006, CHAOS, V16, DOI 10.1063/1.2204354; Cuccato G, 2009, HEREDITY, V102, P527, DOI 10.1038/hdy.2009.18; DASGUPTA B, 2010, ALGORITHMS COMPUTATI; De Jong H, 2004, B MATH BIOL, V66, P301, DOI 10.1016/j.bulm.2003.08.010; Dunlop MJ, 2008, NAT GENET, V40, P1493, DOI 10.1038/ng.281; Eichenberger P, 2004, PLOS BIOL, V2, P1664, DOI 10.1371/journal.pbio.0020328; Garg A, 2008, BIOINFORMATICS, V24, P1917, DOI 10.1093/bioinformatics/btn336; Goutsias J, 2007, CURR PHARM DESIGN, V13, P1415, DOI 10.2174/138161207780765945; Guido NJ, 2006, NATURE, V439, P856, DOI 10.1038/nature04473; Hasty J, 2001, NAT REV GENET, V2, P268, DOI 10.1038/35066056; Iglesias PA, 2009, CONTROL THEORY SYSTE; Iglesias PA., 2010, CONTROL THEORY SYSTE; Karlebach G, 2008, NAT REV MOL CELL BIO, V9, P770, DOI 10.1038/nrm2503; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; KOHANE IS, 2005, MICROARRAYS INTEGRAT; Lathi B.P., 2002, LINEAR SYSTEMS SIGNA; Locke JCW, 2009, NAT REV MICROBIOL, V7, P383, DOI 10.1038/nrmicro2056; Lu TK, 2009, NAT BIOTECHNOL, V27, P1139, DOI 10.1038/nbt.1591; Luenberger D. G., 1979, INTRO DYNAMIC SYSTEM; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Marucci L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008083; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Nelson D.L., 2017, LEHNINGER PRINCIPLES, V7th; Nise NS, 2000, CONTROL SYSTEMS ENG; Polynikis A, 2009, J THEOR BIOL, V261, P511, DOI 10.1016/j.jtbi.2009.07.040; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schilstra MJ, 2008, ARTIF LIFE, V14, P121, DOI 10.1162/artl.2008.14.1.121; SCHWEICKHARDT T, 2004, QUANTITATIVE NONLINE; Shin YJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009376; Shmulevich I, 2002, BIOINFORMATICS, V18, P1319, DOI 10.1093/bioinformatics/18.10.1319; Simon D., 2006, OPTIMAL STATE ESTIMA; Simpson ML, 2003, P NATL ACAD SCI USA, V100, P4551, DOI 10.1073/pnas.0736140100; Skogestad S, 1996, MULTIVARIABLE FEEDBA; Smolen P, 2000, B MATH BIOL, V62, P247, DOI 10.1006/bulm.1999.0155; Sprinzak D, 2005, NATURE, V438, P443, DOI 10.1038/nature04335; Steggles LJ, 2007, BIOINFORMATICS, V23, P336, DOI 10.1093/bioinformatics/btl596; Stengel R. F., 1994, OPTIMAL CONTROL ESTI; Strang G., 2007, COMPUTATIONAL SCI EN; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; THOMAS R, 1973, J THEOR BIOL, V42, P563, DOI 10.1016/0022-5193(73)90247-6; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Yuh Chiou-Hwa, 2001, P73	58	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2010	5	9							e12785	10.1371/journal.pone.0012785	http://dx.doi.org/10.1371/journal.pone.0012785			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650QH	20862288	Green Published, Green Submitted, gold			2022-12-27	WOS:000281864100020
J	Bentley, JP; Asselbergs, FW; Coffey, CS; Hebert, PR; Moore, JH; Hillege, HL; van Gilst, WH				Bentley, John P.; Asselbergs, Folkert W.; Coffey, Christopher S.; Hebert, Patricia R.; Moore, Jason H.; Hillege, Hans L.; van Gilst, Wiek H.			Cardiovascular Risk Associated with Interactions among Polymorphisms in Genes from the Renin-Angiotensin, Bradykinin, and Fibrinolytic Systems	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; CONVERTING-ENZYME GENE; MULTIFACTOR-DIMENSIONALITY REDUCTION; PLASMA T-PA; URINARY ALBUMIN EXCRETION; CORONARY-ARTERY-DISEASE; MYOCARDIAL-INFARCTION; INSERTION/DELETION POLYMORPHISM; VENOUS THROMBOEMBOLISM; DELETION POLYMORPHISM	Background: Vascular fibrinolytic balance is maintained primarily by interplay of tissue plasminogen activator (t-PA) and plasminogen activator inhibitor type 1 (PAI-1). Previous research has shown that polymorphisms in genes from the reninangiotensin (RA), bradykinin, and fibrinolytic systems affect plasma concentrations of both t-PA and PAI-1 through a set of gene-gene interactions. In the present study, we extend this finding by exploring the effects of polymorphisms in genes from these systems on incident cardiovascular disease, explicitly examining two-way interactions in a large population-based study. Methodology/Principal Findings: Data from the population-based PREVEND study in Groningen, The Netherlands (n = 8,138) were analyzed. The effects of the polymorphisms and their interactions on cardiovascular events were analyzed via Cox proportional hazards models. There was no association between five of the six polymorphisms singly and risk of cardiovascular disease. There was a significant main effect for the ACE I/D polymorphism for both dominant and additive coding schemes. There were significant interactions between the following polymorphism pairs even after adjustment for known risk factors: ACE I/D & PAI-1 4G/5G (p = 0.012), BDKRB2 C181T & ACE I/D (p = 0.016), BDKRB2 C58T & ACE I/D (p = 0.025), BDKRB2 exon 1 I/D & AT1R A1166C (p = 0.017), and BDKRB2 C58T & AT1R A1166C (p = 0.015). Conclusions/Significance: This study suggests possible interactions between genes from the RA, bradykinin, and fibrinolytic systems on the risk of cardiovascular disease, extending previous research that has demonstrated that interactions among genes from these systems influence plasma concentrations of both t-PA and PAI-1. Further explorations of these interactions are needed.	[Bentley, John P.] Univ Mississippi, Sch Pharm, Dept Pharm Adm, University, MS 38677 USA; [Asselbergs, Folkert W.] Univ Med Ctr Utrecht, Div Heart & Lungs, Dept Cardiol, Utrecht, Netherlands; [Coffey, Christopher S.] Univ Iowa, Coll Publ Hlth, Dept Biostat, Iowa City, IA USA; [Hebert, Patricia R.] Florida Atlantic Univ, Charles E Schmidt Coll Biomed Sci, Boca Raton, FL 33431 USA; [Moore, Jason H.] Dartmouth Med Sch, Dept Genet, Lebanon, NH USA; [Moore, Jason H.] Dartmouth Med Sch, Dept Community & Family Med, Lebanon, NH USA; [Asselbergs, Folkert W.; Hillege, Hans L.] Univ Groningen, Dept Cardiol, Univ Med Ctr Groningen, Groningen, Netherlands; [van Gilst, Wiek H.] Univ Groningen, Dept Expt Cardiol, Univ Med Ctr Groningen, Groningen, Netherlands	University of Mississippi; Utrecht University; Utrecht University Medical Center; University of Iowa; State University System of Florida; Florida Atlantic University; Dartmouth College; Dartmouth College; University of Groningen; University of Groningen	Bentley, JP (corresponding author), Univ Mississippi, Sch Pharm, Dept Pharm Adm, University, MS 38677 USA.	f.w.asselbergs@umcutrecht.nl	van Gilst, Wiek H/C-3828-2008; Moore, Jason H./AAV-9645-2021; van Gilst, Wiek/R-1806-2019; Asselbergs, Folkert W./ABD-6752-2021	Moore, Jason H./0000-0002-5015-1099; van Gilst, Wiek/0000-0003-2968-8585; Asselbergs, Folkert W./0000-0002-1692-8669	National Institutes of Health (NIH) [HL65234, HL67466, RR018787, LM010098]; Netherlands Kidney Foundation [E. 013]; ZonMW Clinical Fellowship [90700342]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018787] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065234, R01HL067466] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010098] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Kidney Foundation; ZonMW Clinical Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by National Institutes of Health (NIH) grant HL65234, HL67466, RR018787, LM010098, and by grant E. 013 of Netherlands Kidney Foundation. Dr. F.W. Asselbergs is supported by a ZonMW Clinical Fellowship (grant 90700342). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselbergs FW, 2007, J THROMB HAEMOST, V5, P313, DOI 10.1111/j.1538-7836.2007.02311.x; Asselbergs FW, 2007, GENOMICS, V89, P362, DOI 10.1016/j.ygeno.2006.11.004; Asselbergs FW, 2006, THROMB HAEMOSTASIS, V96, P471, DOI 10.1160/TH06-06-0335; Borggreve SE, 2006, J CLIN ENDOCR METAB, V91, P3382, DOI 10.1210/jc.2005-2322; Brown NJ, 2000, CIRCULATION, V102, P2190; Brown NJ, 1999, HYPERTENSION, V34, P285, DOI 10.1161/01.HYP.34.2.285; Brown NJ, 2002, CIRCULATION, V105, P304, DOI 10.1161/hc0302.102570; CAMBIEN F, 1992, NATURE, V359, P641, DOI 10.1038/359641a0; Coffey CS, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-49; DAWSON S, 1991, ARTERIOSCLER THROMB, V11, P183, DOI 10.1161/01.ATV.11.1.183; DAWSON SJ, 1993, J BIOL CHEM, V268, P10739; ERIKSSON P, 1995, P NATL ACAD SCI USA, V92, P1851, DOI 10.1073/pnas.92.6.1851; Geluk CA, 2008, ATHEROSCLEROSIS, V196, P372, DOI 10.1016/j.atherosclerosis.2006.11.013; Gerds TA, 2007, BIOMETRICS, V63, P1283, DOI 10.1111/j.1541-0420.2007.00832.x; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Kim DK, 1997, ARTERIOSCL THROM VAS, V17, P3242, DOI 10.1161/01.ATV.17.11.3242; Labinjoh C, 2001, J AM COLL CARDIOL, V38, P1402, DOI 10.1016/S0735-1097(01)01562-5; Mahmoodi BK, 2009, JAMA-J AM MED ASSOC, V301, P1790, DOI 10.1001/jama.2009.565; Margaglione M, 1998, ARTERIOSCL THROM VAS, V18, P152, DOI 10.1161/01.ATV.18.2.152; Minai K, 2001, J AM COLL CARDIOL, V37, P1565, DOI 10.1016/S0735-1097(01)01202-5; Moore JH, 2002, CLIN GENET, V62, P53, DOI 10.1034/j.1399-0004.2002.620107.x; Ordonez AJG, 2000, BLOOD COAGUL FIBRIN, V11, P485; Pankow JS, 2000, BLOOD COAGUL FIBRIN, V11, P551, DOI 10.1097/00001721-200009000-00007; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pinto-Sietsma SJ, 2000, J AM SOC NEPHROL, V11, P1882, DOI 10.1681/ASN.V11101882; RIDKER PM, 1993, CIRCULATION, V87, P1969, DOI 10.1161/01.CIR.87.6.1969; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; RUIZ J, 1994, P NATL ACAD SCI USA, V91, P3662, DOI 10.1073/pnas.91.9.3662; SAKSELA O, 1988, ANNU REV CELL BIOL, V4, P93, DOI 10.1146/annurev.cb.04.110188.000521; Skinner C.J., 1989, ANAL COMPLEX SURVEYS; Thogersen AM, 1998, CIRCULATION, V98, P2241, DOI 10.1161/01.CIR.98.21.2241; Vaughan DE, 1997, CIRCULATION, V96, P442; Verhave JC, 2004, J INTERN MED, V256, P324, DOI 10.1111/j.1365-2796.2004.01390.x; Wells PS, 2003, THROMB HAEMOSTASIS, V90, P829, DOI 10.1160/TH03-03-0170; Wiman B, 2000, ARTERIOSCL THROM VAS, V20, P2019, DOI 10.1161/01.ATV.20.8.2019	36	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12757	10.1371/journal.pone.0012757	http://dx.doi.org/10.1371/journal.pone.0012757			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856803	gold, Green Published, Green Submitted			2022-12-27	WOS:000281815800022
J	Guo, F; Tao, HA; Buss, J; Coltharp, C; Hensel, Z; Jie, XA				Guo Fu; Tao Huang; Buss, Jackson; Coltharp, Carla; Hensel, Zach; Jie Xiao			In Vivo Structure of the E. coli FtsZ-ring Revealed by Photoactivated Localization Microscopy (PALM)	PLOS ONE			English	Article							BACTERIAL-CELL-DIVISION; SPIRAL-LIKE INTERMEDIATE; ESCHERICHIA-COLI; ASSEMBLY DYNAMICS; BACILLUS-SUBTILIS; PROTEIN FTSZ; CRYSTAL-STRUCTURE; COMPLETE SET; TUBULIN; BINDING	The FtsZ protein, a tubulin-like GTPase, plays a pivotal role in prokaryotic cell division. In vivo it localizes to the midcell and assembles into a ring-like structure-the Z-ring. The Z-ring serves as an essential scaffold to recruit all other division proteins and generates contractile force for cytokinesis, but its supramolecular structure remains unknown. Electron microscopy (EM) has been unsuccessful in detecting the Z-ring due to the dense cytoplasm of bacterial cells, and conventional fluorescence light microscopy (FLM) has only provided images with limited spatial resolution (200-300 nm) due to the diffraction of light. Hence, given the small sizes of bacteria cells, identifying the in vivo structure of the Z-ring presents a substantial challenge. Here, we used photoactivated localization microscopy (PALM), a single molecule-based super-resolution imaging technique, to characterize the in vivo structure of the Z-ring in E. coli. We achieved a spatial resolution of similar to 35 nm and discovered that in addition to the expected ring-like conformation, the Z-ring of E. coli adopts a novel compressed helical conformation with variable helical length and pitch. We measured the thickness of the Z-ring to be similar to 110 nm and the packing density of FtsZ molecules inside the Z-ring to be greater than what is expected for a single-layered flat ribbon configuration. Our results strongly suggest that the Z-ring is composed of a loose bundle of FtsZ protofilaments that randomly overlap with each other in both longitudinal and radial directions of the cell. Our results provide significant insight into the spatial organization of the Z-ring and open the door for further investigations of structure-function relationships and cell cycle-dependent regulation of the Z-ring.	[Guo Fu; Tao Huang; Buss, Jackson; Coltharp, Carla; Hensel, Zach; Jie Xiao] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Guo, F (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA.	xiao@jhmi.edu	Hensel, Zach/G-2941-2015; huang, tao/D-1769-2013	Hensel, Zach/0000-0002-4348-6229; huang, tao/0000-0002-5373-1187; Xiao, Jie/0000-0003-1433-5437	Johns Hopkins University School of Medicine; March of Dimes [5-FY20]; National Science Foundation [MCB-1019000]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086447] Funding Source: NIH RePORTER	Johns Hopkins University School of Medicine(Johns Hopkins University); March of Dimes(March of Dimes); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a start-up grant from the Johns Hopkins University School of Medicine, March of Dimes Starter Scholar Research Award 5-FY20, and National Science Foundation EAGER Grant MCB-1019000. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsman MEG, 2005, MOL MICROBIOL, V55, P1631, DOI 10.1111/j.1365-2958.2005.04502.x; Abbe E., 1873, ARCH F MIKROSK ANAT, V9, P413, DOI [10.1007/ BF02956173, DOI 10.1007/BF02956173]; Addinall SG, 1997, J BACTERIOL, V179, P4277, DOI 10.1128/jb.179.13.4277-4284.1997; Anderson DE, 2004, J BACTERIOL, V186, P5775, DOI 10.1128/JB.186.17.5775-5781.2004; ANDREWS SS, 2007, BIOPHYS J; Barak I, 2008, MOL MICROBIOL, V68, P1315, DOI 10.1111/j.1365-2958.2008.06236.x; Ben-Yehuda S, 2002, CELL, V109, P257, DOI 10.1016/S0092-8674(02)00698-0; Bernhardt TG, 2005, MOL CELL, V18, P555, DOI 10.1016/j.molcel.2005.04.012; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; Biteen JS, 2008, NAT METHODS, V5, P947, DOI 10.1038/nmeth.1258; Bozzola J. J, 1999, ELECT MICROSCOPY PRI; Chen YD, 2005, J BIOL CHEM, V280, P22549, DOI 10.1074/jbc.M500895200; Chen YD, 2005, BIOPHYS J, V88, P505, DOI 10.1529/biophysj.104.044149; DAI K, 1991, J BACTERIOL, V173, P3500, DOI 10.1128/jb.173.11.3500-3506.1991; Dajkovic A, 2008, CURR BIOL, V18, P235, DOI 10.1016/j.cub.2008.01.042; DEBOER P, 1992, NATURE, V359, P254, DOI 10.1038/359254a0; Ebersbach G, 2008, MOL MICROBIOL, V68, P720, DOI 10.1111/j.1365-2958.2008.06190.x; EGNER A, 2007, BIOPHYS J; Erickson HP, 2009, P NATL ACAD SCI USA, V106, P9238, DOI 10.1073/pnas.0902258106; Erickson HP, 1996, P NATL ACAD SCI USA, V93, P519, DOI 10.1073/pnas.93.1.519; Geisbrecht BV, 2006, PROTEIN EXPRES PURIF, V46, P23, DOI 10.1016/j.pep.2005.09.003; Geissler B, 2007, MICROBIOL-SGM, V153, P814, DOI 10.1099/mic.0.2006/001834-0; Gonzalez JM, 2005, P NATL ACAD SCI USA, V102, P1895, DOI 10.1073/pnas.0409517102; Gueiros FJ, 2002, GENE DEV, V16, P2544, DOI 10.1101/gad.1014102; Hale CA, 1997, CELL, V88, P175, DOI 10.1016/S0092-8674(00)81838-3; Harry E., 2006, INT REV CYTOL, V253, P27; Hell SW, 2009, NAT METHODS, V6, P24, DOI [10.1038/NMETH.1291, 10.1038/nmeth.1291]; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Lan GH, 2008, BIOPHYS J, V95, P4045, DOI 10.1529/biophysj.108.132837; Li Z, 2007, EMBO J, V26, P4694, DOI 10.1038/sj.emboj.7601895; Low HH, 2004, J MOL BIOL, V341, P839, DOI 10.1016/j.jmb.2004.05.031; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Lu CL, 1998, CELL MOTIL CYTOSKEL, V40, P71, DOI 10.1002/(SICI)1097-0169(1998)40:1<71::AID-CM7>3.3.CO;2-Z; Ma XL, 1996, P NATL ACAD SCI USA, V93, P12998, DOI 10.1073/pnas.93.23.12998; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; Margolin W, 2000, FEMS MICROBIOL REV, V24, P531, DOI 10.1016/S0168-6445(00)00038-3; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; Michie KA, 2006, J BACTERIOL, V188, P1680, DOI 10.1128/JB.188.5.1680-1690.2006; Michie KA, 2006, ANNU REV BIOCHEM, V75, P467, DOI 10.1146/annurev.biochem.75.103004.142452; Mingorance J, 2005, J BIOL CHEM, V280, P20909, DOI 10.1074/jbc.M503059200; Mohammadi T, 2009, BIOCHEMISTRY-US, V48, P11056, DOI 10.1021/bi901461p; Monahan LG, 2009, MOL MICROBIOL, V74, P1004, DOI 10.1111/j.1365-2958.2009.06914.x; Nogales E, 1998, NAT STRUCT BIOL, V5, P451, DOI 10.1038/nsb0698-451; Oliva MA, 2007, J MOL BIOL, V373, P1229, DOI 10.1016/j.jmb.2007.08.056; OSAWA M, 2009, EMBO J; Osawa M, 2008, SCIENCE, V320, P792, DOI 10.1126/science.1154520; Peters PC, 2007, MOL MICROBIOL, V64, P487, DOI 10.1111/j.1365-2958.2007.05673.x; Pichoff S, 2005, MOL MICROBIOL, V55, P1722, DOI 10.1111/j.1365-2958.2005.04522.x; PLA J, 1991, MOL MICROBIOL, V5, P1681, DOI 10.1111/j.1365-2958.1991.tb01915.x; Pogliano J, 1997, P NATL ACAD SCI USA, V94, P559, DOI 10.1073/pnas.94.2.559; POPP D, 2009, BIOPOLYMERS; Quardokus EM, 2001, MOL MICROBIOL, V39, P949, DOI 10.1046/j.1365-2958.2001.02287.x; RAYCHAUDHURI D, 1992, NATURE, V359, P251, DOI 10.1038/359251a0; Romberg L, 2001, J BIOL CHEM, V276, P11743, DOI 10.1074/jbc.M009033200; Rueda S, 2003, J BACTERIOL, V185, P3344, DOI 10.1128/JB.185.11.3344-3351.2003; Saka K, 2005, DNA RES, V12, P63, DOI 10.1093/dnares/12.1.63; Shih YL, 2003, P NATL ACAD SCI USA, V100, P7865, DOI 10.1073/pnas.1232225100; Shroff H, 2008, NAT METHODS, V5, P417, DOI [10.1038/nmeth.1202, 10.1038/NMETH.1202]; Small E, 2007, J MOL BIOL, V369, P210, DOI 10.1016/j.jmb.2007.03.025; Stricker J, 2002, P NATL ACAD SCI USA, V99, P3171, DOI 10.1073/pnas.052595099; Stricker J, 2003, J BACTERIOL, V185, P4796, DOI 10.1128/JB.185.16.4796-4805.2003; Sun Q, 1998, J BACTERIOL, V180, P2050, DOI 10.1128/JB.180.8.2050-2056.1998; Thanedar S, 2004, CURR BIOL, V14, P1167, DOI 10.1016/j.cub.2004.06.048; Vats P, 2007, P NATL ACAD SCI USA, V104, P17795, DOI 10.1073/pnas.0708739104; Wang XD, 2005, GENE DEV, V19, P2367, DOI 10.1101/gad.345305; WARD JE, 1985, CELL, V42, P941, DOI 10.1016/0092-8674(85)90290-9; Weiss DS, 2004, MOL MICROBIOL, V54, P588, DOI 10.1111/j.1365-2958.2004.04283.x; Wiedenmann J, 2004, P NATL ACAD SCI USA, V101, P15905, DOI 10.1073/pnas.0403668101; XIAO J, 2007, SINGLE MOL IN PRESS	70	135	137	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2010	5	9							e12680	10.1371/journal.pone.0012680	http://dx.doi.org/10.1371/journal.pone.0012680			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648ZZ	20856929	gold, Green Published, Green Submitted			2022-12-27	WOS:000281735700008
J	Negro, SS; Caudron, AK; Dubois, M; Delahaut, P; Gemmell, NJ				Negro, Sandra S.; Caudron, Abigail K.; Dubois, Michel; Delahaut, Philippe; Gemmell, Neil J.			Correlation between Male Social Status, Testosterone Levels, and Parasitism in a Dimorphic Polygynous Mammal	PLOS ONE			English	Article							ZEALAND FUR-SEAL; MALE MATING SUCCESS; HISTORY TRADE-OFFS; ARCTOCEPHALUS-FORSTERI; SPECIES RICHNESS; SEASONAL-CHANGES; BEHAVIOR; MODULATION; SIZE; EVOLUTION	Life history trade-offs have often been assumed to be the consequence of restrictions in the availability of critical resources such as energy and nutrients, which necessitate the differential allocation of resources to costly traits. Here, we examined endocrine (testosterone) and health (parasite burdens) parameters in territorial and non-territorial New Zealand fur seal males. We documented intra-sexual differences in sexual behaviours, testosterone levels, and parasitism that suggest a trade-off exists between reproductive success and physical health, particularly susceptibility to helminths and acanthocephalans, in males displaying different mating tactics (i.e., territorial and non-territorial tactics). Levels of testosterone were higher in territorial males and correlated positively with reproductive effort (i.e., intra-and inter-sexual interactions). However, these territorial males also exhibited high levels of parasitic infection, which may impair survival in the long-term. Our study, while limited in sample size, provides preliminary evidence for a link between male mating tactics, testosterone levels and parasite loads, and potential effects on reproductive success and life history that should be explored further.	[Negro, Sandra S.; Caudron, Abigail K.; Gemmell, Neil J.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand; [Negro, Sandra S.] Univ Liege, BiopTis S A, Sart Tilman Par Liege, Belgium; [Caudron, Abigail K.] Univ Liege, Inst Zool, Liege, Belgium; [Dubois, Michel; Delahaut, Philippe] Ctr Economie Rurale, Marloie, Belgium; [Gemmell, Neil J.] Univ Otago, Dept Anat & Struct Biol, Dunedin, New Zealand	University of Canterbury; University of Liege; University of Liege; University of Otago	Negro, SS (corresponding author), Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand.	sandras.negro@gmail.com	Delahaut, Philippe/ABC-8350-2021; Gemmell, Neil J/C-6774-2009	Gemmell, Neil J/0000-0003-0671-3637; Delahaut, Philippe/0000-0003-2328-3042	University of Canterbury; New Zealand International Doctoral Research (NZIDR); University of California Santa Cruz (UCSC) National Institutes of Health	University of Canterbury; New Zealand International Doctoral Research (NZIDR); University of California Santa Cruz (UCSC) National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	SSN was funded by University of Canterbury and New Zealand International Doctoral Research (NZIDR). Research support for this project was obtained from the University of California Santa Cruz (UCSC) National Institutes of Health Minority International Research Training scheme and University of Canterbury. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alatalo RV, 1996, P ROY SOC B-BIOL SCI, V263, P1697, DOI 10.1098/rspb.1996.0248; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; AMOS W, 1993, P ROY SOC B-BIOL SCI, V252, P199, DOI 10.1098/rspb.1993.0066; Atkinson S, 1997, Rev Reprod, V2, P175, DOI 10.1530/revreprod/2.3.175; ATKINSON S, 1992, J REPROD FERTIL, V96, P35; BARTHOLOMEW GA, 1970, EVOLUTION, V24, P546, DOI 10.1111/j.1558-5646.1970.tb01790.x; BARTSH SS, 1992, CAN J ZOOL, V70, P680, DOI 10.1139/z92-102; Boren LJ, 2006, WILDLIFE RES, V33, P497, DOI 10.1071/WR05092; Bradshaw CJA, 2000, J ZOOL, V252, P41, DOI 10.1111/j.1469-7998.2000.tb00818.x; CAREY PW, 1989, THESIS U CANTERBURY; Caudron AK, 2009, AUST J ZOOL, V57, P409, DOI 10.1071/ZO09024; Clutton-Brock T.H., 1988, P325; Coltman DW, 2001, EVOLUTION, V55, P2116, DOI 10.1111/j.0014-3820.2001.tb01326.x; Dailey MD, 2001, CRC HANDBOOK OF MARINE MAMMAL MEDICINE, SECOND EDITION, P357; DEMAS GE, 2006, HDB NEUROCHEMISTRY M; Ezenwa VO, 2006, OIKOS, V115, P526, DOI 10.1111/j.2006.0030-1299.15186.x; Fauquier D, 2004, J WILDLIFE DIS, V40, P816, DOI 10.7589/0090-3558-40.4.816; FLETCHER D, 1998, INT ASS AQ AN MED 29; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; GALES NJ, 1994, J ZOOL, V234, P353, DOI 10.1111/j.1469-7998.1994.tb04853.x; Gemmell NJ, 2001, MOL ECOL, V10, P451, DOI 10.1046/j.1365-294x.2001.01186.x; GOLDSWORTHY SD, 1994, WILDLIFE RES, V21, P365, DOI 10.1071/WR9940365; Goymann W, 2001, P ROY SOC B-BIOL SCI, V268, P2453, DOI 10.1098/rspb.2001.1828; GROSSMAN CJ, 1985, SCIENCE, V227, P257, DOI 10.1126/science.3871252; Gulland FMD, 1997, MAR MAMMAL SCI, V13, P446, DOI 10.1111/j.1748-7692.1997.tb00651.x; HARDING CF, 1981, AM ZOOL, V21, P223; Hughes J, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-227; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Ionita M, 2008, PARASITOL RES, V103, P1025, DOI 10.1007/s00436-008-1087-0; Jacobs JD, 2000, CONDOR, V102, P35, DOI 10.1650/0010-5422(2000)102[0035:ECOLCS]2.0.CO;2; JOHNSON SC, 1967, PSYCHOMETRIKA, V32, P241, DOI 10.1007/BF02289588; KETTERSON ED, 1992, AM NAT, V140, P980, DOI 10.1086/285451; Knapp R, 2003, INTEGR COMP BIOL, V43, P658, DOI 10.1093/icb/43.5.658; KREBS JR, 1983, INTRO BEHAV ECOLOGY; Kunc HP, 2008, ETHOLOGY, V114, P381, DOI 10.1111/j.1439-0310.2008.01484.x; LAUCKNER G, 1985, DIS MARINE ANIMALS 2, V4, P683; le Boeuf B.J., 1988, P344; Lidgard DC, 2008, HORM BEHAV, V53, P241, DOI 10.1016/j.yhbeh.2007.10.003; Martin LB, 2008, PHILOS T R SOC B, V363, P321, DOI 10.1098/rstb.2007.2142; Mattlin RH, 1978, THESIS U CANTERBURY; Mcglothlin JW, 2008, J EVOLUTION BIOL, V21, P39, DOI 10.1111/j.1420-9101.2007.01471.x; Mills SC, 2009, AM NAT, V173, P475, DOI 10.1086/597222; Mostl E, 2005, ANN NY ACAD SCI, V1046, P17, DOI 10.1196/annals.1343.004; Muehlenbein MP, 2005, AM J HUM BIOL, V17, P527, DOI 10.1002/ajhb.20419; NEGRO SS, 2008, THESIS U CANTERBURY; Oliveira RF, 1996, HORM BEHAV, V30, P2, DOI 10.1006/hbeh.1996.0002; Palme R, 2005, ANN NY ACAD SCI, V1046, P75, DOI 10.1196/annals.1343.007; Preston BT, 2003, P ROY SOC B-BIOL SCI, V270, P633, DOI 10.1098/rspb.2002.2268; RIDGWAY S H, 1975, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V169, P327; SAPOLSKY RM, 1986, ENDOCRINOLOGY, V118, P1630, DOI 10.1210/endo-118-4-1630; Shargal D, 2008, THERIOGENOLOGY, V69, P673, DOI 10.1016/j.theriogenology.2007.11.017; Simkova A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-29; Sinervo B, 1998, OIKOS, V83, P432, DOI 10.2307/3546671; Statsoft Inc., 2007, STAT DAT AN SOFTW SY; Stevenson IR, 1995, P ROY SOC B-BIOL SCI, V262, P267, DOI 10.1098/rspb.1995.0205; STIRLING I, 1970, J MAMMAL, V51, P766, DOI 10.2307/1378300; Thienpont D., 1979, DIAGNOSTIC VERMINOSE; TRILLMICH F, 1984, BIOL J LINN SOC, V21, P209; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134; Wingfield JC, 2001, BRAIN BEHAV EVOLUT, V57, P239, DOI 10.1159/000047243; YOUNG PC, 1969, J COMP PATHOL, V79, P301, DOI 10.1016/0021-9975(69)90043-7; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006; Zuk M, 1996, INT J PARASITOL, V26, P1009, DOI [10.1016/S0020-7519(96)00086-0, 10.1016/S0020-7519(96)80001-4]; [No title captured]	64	28	28	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2010	5	9							e12507	10.1371/journal.pone.0012507	http://dx.doi.org/10.1371/journal.pone.0012507			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648ZZ	20856933	Green Published, Green Submitted, gold			2022-12-27	WOS:000281735700004
J	Nowak, I; Majorczyk, E; Wisniewski, A; Pawlik, A; Magott-Procelewska, M; Passowicz-Muszynska, E; Malejczyk, J; Ploski, R; Giebel, S; Barcz, E; Zon-Giebel, A; Malinowski, A; Tchorzewski, H; Chlebicki, A; Luszczek, W; Kurpisz, M; Grybos, M; Wilczynski, J; Wiland, P; Senitzer, D; Sun, JY; Jankowska, R; Klinger, M; Kusnierczyk, P				Nowak, Izabela; Majorczyk, Edyta; Wisniewski, Andrzej; Pawlik, Andrzej; Magott-Procelewska, Maria; Passowicz-Muszynska, Ewa; Malejczyk, Jacek; Ploski, Rafal; Giebel, Sebastian; Barcz, Ewa; Zon-Giebel, Aleksandra; Malinowski, Andrzej; Tchorzewski, Henryk; Chlebicki, Arkadiusz; Luszczek, Wioleta; Kurpisz, Maciej; Grybos, Marian; Wilczynski, Jacek; Wiland, Piotr; Senitzer, David; Sun, Ji-Yao; Jankowska, Renata; Klinger, Marian; Kusnierczyk, Piotr			Does the KIR2DS5 Gene Protect from Some Human Diseases?	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; ANKYLOSING-SPONDYLITIS; SUSCEPTIBILITY; RECEPTOR; KIR; TRANSPLANTATION; CLASSIFICATION; ENDOMETRIOSIS; ASSOCIATION; DIVERSITY	Background: KIR2DS5 gene encodes an activating natural killer cell receptor whose ligand is not known. It was recently reported to affect the outcome of hematopoietic stem cell transplantation. Methodology/Principal Findings: In our studies on KIR2DS5 gene associations with human diseases, we compared the frequencies of this gene in patients and relevant controls. Typing for KIR2DS5 gene was performed by either individual or multiplex polymerase chain reactions which, when compared in the same samples, gave concordant results. We noted an apparently protective effect of KIR2DS5 gene presence in several clinical conditions, but not in others. Namely, this effect was observed in ankylosing spondylitis (p = 0.003, odds ratio [OR] = 0.47, confidence interval [CI] = 0.28-0.79), endometriosis (p = 0.03, OR = 0.25, CI = 0.07-0.82) and acute rejection of kidney graft (p = 0.0056, OR = 0.44, CI = 0.24-0.80), but not in non-small-cell lung carcinoma, rheumatoid arthritis, spontaneous abortion, or leukemia (all p>0.05). In addition, the simultaneous presence of KIR2DS5 gene and HLA-C C1 allotype exhibited an even stronger protective effect on ankylosing spondylitis (p = 0.0003, OR = 0.35, CI = 0.19-0.65), whereas a lack of KIR2DS5 and the presence of the HLA-C C2 allotype was associated with ankylosing spondylitis (p = 0.0017, OR = 1.92, CI = 1.28-2.89), whereas a lack of KIR2DS5 and presence of C1 allotype was associated with rheumatoid arthritis (p = 0.005, OR = 1.47, CI = 1.13-1.92). The presence of both KIR2DS5 and C1 seemed to protect from acute kidney graft rejection (p = 0.017, OR = 0.47, CI = 0.25-0.89), whereas lack of KIR2DS5 and presence of C2 seemed to favor rejection (p = 0.0015, OR = 2.13, CI = 1.34-3.37). Conclusions/Significance: Our results suggest that KIR2DS5 may protect from endometriosis, ankylosing spondylitis, and acute rejection of kidney graft.	[Nowak, Izabela; Majorczyk, Edyta; Wisniewski, Andrzej; Luszczek, Wioleta; Kusnierczyk, Piotr] Polish Acad Sci, Inst Immunol & Expt Therapy, Dept Clin Immunol, PL-53114 Wroclaw, Poland; [Pawlik, Andrzej] Pomeranian Med Univ, Dept Pharmacokinet & Therapeut Drug Monitoring, Szczecin, Poland; [Magott-Procelewska, Maria; Klinger, Marian] Wroclaw Med Univ, Fac Med, Dept Nephrol & Transplantat Med, Wroclaw, Poland; [Magott-Procelewska, Maria; Klinger, Marian] Wroclaw Med Univ, Fac Med, Clin Nephrol & Transplantat Med, Wroclaw, Poland; [Passowicz-Muszynska, Ewa; Jankowska, Renata] Wroclaw Med Univ, Dept Pulmonol & Lung Canc, Wroclaw, Poland; [Malejczyk, Jacek] Med Univ Warsaw, Dept Histol & Embryol, Ctr Biostruct Res, Warsaw, Poland; [Ploski, Rafal] Warsaw Med Univ, Dept Med Genet, Ctr Biostruct Res, Warsaw, Poland; [Giebel, Sebastian] Maria Sklodowska Curie Mem Inst Oncol, Dept Clin & Expt Oncol, Ctr Comprehens Canc, Branch Gliwice, Gliwice, Poland; [Giebel, Sebastian] Silesian Med Univ, Dept Hematol & Bone Marrow Transplantat, Katowice, Poland; [Barcz, Ewa] Med Univ Warsaw, Chair Obstet & Gynecol 1, Warsaw, Poland; [Barcz, Ewa] Med Univ Warsaw, Clin Obstet & Gynecol, Warsaw, Poland; [Zon-Giebel, Aleksandra] Silesian Hosp Rheumatol & Rehabil, Ustron, Poland; [Malinowski, Andrzej] Polish Mothers Mem Hosp, Res Inst, Dept Surg & Endoscop Gynecol, Lodz, Poland; [Tchorzewski, Henryk] Polish Mothers Mem Hosp, Res Inst, Dept Clin Immunol, Lodz, Poland; [Chlebicki, Arkadiusz; Wiland, Piotr] Wroclaw Med Univ, Chair Rheumatol & Internal Dis, Wroclaw, Poland; [Chlebicki, Arkadiusz; Wiland, Piotr] Wroclaw Med Univ, Clin Rheumatol & Internal Dis, Wroclaw, Poland; [Kurpisz, Maciej] Polish Acad Sci, Dept Reprod Biol & Stem Cells, Inst Human Genet, PL-53114 Wroclaw, Poland; [Grybos, Marian] Med Univ Wroclaw, Dept Obstet & Gynecol 1, Wroclaw, Poland; [Wilczynski, Jacek] Polish Mothers Mem Hosp, Res Inst, Dept Gynecol Surg, Lodz, Poland; [Senitzer, David; Sun, Ji-Yao] City Hope Comprehens Canc Ctr, Duarte, CA USA; [Kusnierczyk, Piotr] Jan Dlugosz Pedag Univ, Czestochowa, Poland	Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Pomeranian Medical University; Wroclaw Medical University; Wroclaw Medical University; Wroclaw Medical University; Medical University of Warsaw; Medical University of Warsaw; Maria Sklodowska-Curie National Research Institute of Oncology; Medical University Silesia; Medical University of Warsaw; Medical University of Warsaw; Polish Mother's Memorial Hospital - Research Institute; Polish Mother's Memorial Hospital - Research Institute; Wroclaw Medical University; Wroclaw Medical University; Polish Academy of Sciences; Institute of Human Genetics of the Polish Academy of Sciences; Wroclaw Medical University; Polish Mother's Memorial Hospital - Research Institute; City of Hope; Jan Dlugosz University	Nowak, I (corresponding author), Polish Acad Sci, Inst Immunol & Expt Therapy, Dept Clin Immunol, PL-53114 Wroclaw, Poland.	pkusnier@iitd.pan.wroc.pl	Kusnierczyk, Piotr/ABB-6734-2020; Pawlik, Andrzej/A-9052-2015; Majorczyk, Edyta/P-3066-2019; Wilczyński, Jacek R/M-7134-2014; Barcz, Ewa/AAS-7533-2020; Malinowski, Andrzej/O-8796-2014	Majorczyk, Edyta/0000-0001-7248-9544; Pawlik, Andrzej/0000-0001-6557-1208; Nowak, Izabela/0000-0002-9127-1089; Malejczyk, Jacek/0000-0002-5371-8476; Wisniewski, Andrzej/0000-0002-1919-2298; Kurpisz, Maciej/0000-0003-3275-3245; Giebel, Sebastian/0000-0002-4827-4401; Ploski, Rafal/0000-0001-6286-5526; Wiland, Piotr/0000-0001-9999-0267	Polish Ministry of Science and Higher Education [N402 078 31/2416, N401 077 31/1819, 2P05A 069 28, 2 PO5B 155 28]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by grants N402 078 31/2416, N401 077 31/1819, 2P05A 069 28, and 2 PO5B 155 28 from the Polish Ministry of Science and Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad T, 2003, HUM MOL GENET, V12, P647, DOI 10.1093/hmg/ddg066; Allen RL, 2001, J IMMUNOL, V167, P5543, DOI 10.4049/jimmunol.167.10.5543; Beilke JN, 2007, J AM SOC NEPHROL, V18, P2262, DOI 10.1681/ASN.2007040423; Berkkanoglu M, 2003, AM J REPROD IMMUNOL, V50, P48, DOI 10.1034/j.1600-0897.2003.00042.x; Canis M, 1997, FERTIL STERIL, V67, P817; Cheent K, 2009, IMMUNOLOGY, V126, P449, DOI 10.1111/j.1365-2567.2009.03045.x; Diaz-Pena R, 2008, HUM IMMUNOL, V69, P437, DOI 10.1016/j.humimm.2008.04.012; Diaz-Pena R, 2010, ARTHRITIS RHEUM-US, V62, P1000, DOI 10.1002/art.27332; Frohn C, 1998, J IMMUNOL METHODS, V218, P155, DOI 10.1016/S0022-1759(98)00126-4; Giebel S, 2009, EUR J HAEMATOL, V83, P343, DOI 10.1111/j.1600-0609.2009.01280.x; Jiao YL, 2008, J CLIN IMMUNOL, V28, P343, DOI 10.1007/s10875-008-9183-6; Kollnberger S, 2007, EUR J IMMUNOL, V37, P1313, DOI 10.1002/eji.200635997; de Castro JAL, 2010, TISSUE ANTIGENS, V75, P9, DOI 10.1111/j.1399-0039.2009.01405.x; Lopez-Larrea C, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1988; Luszczek W, 2004, HUM IMMUNOL, V65, P758, DOI 10.1016/j.humimm.2004.05.008; Majorczyk E, 2007, GENES IMMUN, V8, P678, DOI 10.1038/sj.gene.6364433; McCappin J, 2010, TISSUE ANTIGENS, V75, P68, DOI 10.1111/j.1399-0039.2009.01392.x; Middleton D, 2003, TISSUE ANTIGENS, V61, P403, DOI 10.1034/j.1399-0039.2003.00062.x; Middleton D, 2010, IMMUNOLOGY, V129, P8, DOI 10.1111/j.1365-2567.2009.03208.x; Nowak I, 2009, J APPL GENET, V50, P391, DOI 10.1007/BF03195699; Ploski R, 2006, HUM IMMUNOL, V67, P521, DOI 10.1016/j.humimm.2006.04.001; Ploski R, 2009, J REPROD IMMUNOL, V79, P196, DOI 10.1016/j.jri.2008.11.004; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; Reveille John D, 2009, Curr Rheumatol Rep, V11, P340, DOI 10.1007/s11926-009-0049-6; Single RM, 2008, IMMUNOGENETICS, V60, P711, DOI 10.1007/s00251-008-0331-1; Sun JY, 2004, TISSUE ANTIGENS, V64, P462, DOI 10.1111/j.1399-0039.2004.00303.x; Ulukus M, 2005, Minerva Ginecol, V57, P237; van der Meer A, 2008, MOL IMMUNOL, V45, P3631, DOI 10.1016/j.molimm.2008.04.016; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; *WHO, 1981, HIST TYP LUNG CANC T; Zenhaeusern G, 2009, AM J TRANSPLANT, V9, P2624, DOI 10.1111/j.1600-6143.2009.02808.x	31	43	44	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12381	10.1371/journal.pone.0012381	http://dx.doi.org/10.1371/journal.pone.0012381			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865034	Green Published, Green Submitted, gold			2022-12-27	WOS:000281292100009
J	Wippel, K; Wittek, A; Hedrich, R; Sauer, N				Wippel, Kathrin; Wittek, Anke; Hedrich, Rainer; Sauer, Norbert			Inverse pH Regulation of Plant and Fungal Sucrose Transporters: A Mechanism to Regulate Competition for Sucrose at the Host/Pathogen Interface?	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; PLASMA-MEMBRANE; APOPLASTIC PH; YEAST-CELLS; GUARD-CELL; COMPARTMENTATION; TRANSFORMATION; EXPRESSION; PROTEINS; SIGNAL	Background: Plant sucrose transporter activities were shown to respond to changes in the extracellular pH and redox status, and oxidizing compounds like glutathione (GSSG) or H(2)O(2) were reported to effect the subcellular targeting of these proteins. We hypothesized that changes in both parameters might be used to modulate the activities of competing sucrose transporters at a plant/pathogen interface. We, therefore, compared the effects of redox-active compounds and of extracellular pH on the sucrose transporters UmSRT1 and ZmSUT1 known to compete for extracellular sucrose in the Ustilago maydis (corn smut)/Zea mays (maize) pathosystem. Methodology/Principal Findings: We present functional analyses of the U. maydis sucrose transporter UmSRT1 and of the plant sucrose transporters ZmSUT1 and StSUT1 in Saccharomyces cerevisiae or in Xenopus laevis oocytes in the presence of different extracellular pH-values and redox systems, and study the possible effects of these treatments on the subcellular targeting. We observed an inverse regulation of host and pathogen sucrose transporters by changes in the apoplastic pH. Under none of the conditions analyzed, we could confirm the reported effects of redox-active compounds. Conclusions/Significance: Our data suggest that changes in the extracellular pH but not of the extracellular redox status might be used to oppositely adjust the transport activities of plant and fungal sucrose transporters at the host/pathogen interface.	[Wippel, Kathrin; Sauer, Norbert] Univ Erlangen Nurnberg, Erlangen, Germany; [Wittek, Anke; Hedrich, Rainer] Univ Wurzburg, Julius von Sachs Inst, Biozentrum, Wurzburg, Germany	University of Erlangen Nuremberg; University of Wurzburg	Wippel, K (corresponding author), Univ Erlangen Nurnberg, Erlangen, Germany.	nsauer@biologie.uni-erlangen.de	Hedrich, Rainer/G-8771-2011	Hedrich, Rainer/0000-0003-3224-1362	Deutsche Forschungsgemeinschaft [SA382/16-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft (http://www.DFG.de) SA382/16-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki N, 1999, PLANT CELL PHYSIOL, V40, P1072, DOI 10.1093/oxfordjournals.pcp.a029489; Becker D, 1996, P NATL ACAD SCI USA, V93, P8123, DOI 10.1073/pnas.93.15.8123; BLATT MR, 1992, J GEN PHYSIOL, V99, P615, DOI 10.1085/jgp.99.4.615; Bourbouloux A, 2000, J BIOL CHEM, V275, P13259, DOI 10.1074/jbc.275.18.13259; Carpaneto A, 2005, J BIOL CHEM, V280, P21437, DOI 10.1074/jbc.M501785200; ELLMAN GL, 1958, ARCH BIOCHEM BIOPHYS, V74, P443, DOI 10.1016/0003-9861(58)90014-6; Felle HH, 1998, J EXP BOT, V49, P987, DOI 10.1093/jexbot/49.323.987; Felle HH, 2002, J EXP BOT, V53, P73, DOI 10.1093/jexbot/53.366.73; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Grossmann G, 2006, EUKARYOT CELL, V5, P945, DOI 10.1128/EC.00206-05; Grossmann G, 2008, J CELL BIOL, V183, P1075, DOI 10.1083/jcb.200806035; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hartung W, 1998, J EXP BOT, V49, P361, DOI 10.1093/jexbot/49.suppl_1.361; Krugel U, 2008, PLANT CELL, V20, P2497, DOI 10.1105/tpc.108.058271; Krugel U, 2009, PLANT CELL, V21, P4059, DOI 10.1105/tpc.109.211260; Malinska K, 2003, MOL BIOL CELL, V14, P4427, DOI 10.1091/mbc.E03-04-0221; Martinez-Espinoza AD, 2002, FUNGAL GENET BIOL, V35, P1, DOI 10.1006/fgbi.2001.1301; Mendgen K, 2002, TRENDS PLANT SCI, V7, P352, DOI 10.1016/S1360-1385(02)02297-5; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; RIESMEIER JW, 1993, PLANT CELL, V5, P1591, DOI 10.1105/tpc.5.11.1591; Sauer N, 2007, FEBS LETT, V581, P2309, DOI 10.1016/j.febslet.2007.03.048; Schmitt B, 2008, PLANT PHYSIOL, V148, P187, DOI 10.1104/pp.108.120410; Sun Y, 2010, PLANT CELL PHYSIOL, V51, P114, DOI 10.1093/pcp/pcp172; Wahl R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000303; Wilkinson S, 1997, PLANT PHYSIOL, V113, P559, DOI 10.1104/pp.113.2.559; Wilkinson S, 1999, PLANT GROWTH REGUL, V29, P87, DOI 10.1023/A:1006203715640; Yu Q., 2001, Plant nutrition: food security and sustainability of agro-ecosystems through basic and applied research. Fourteenth International Plant Nutrition Colloquium, Hannover, Germany, P242	27	15	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12429	10.1371/journal.pone.0012429	http://dx.doi.org/10.1371/journal.pone.0012429			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865151	Green Published, gold, Green Submitted			2022-12-27	WOS:000281292100024
J	Syngkon, A; Elluri, S; Koley, H; Rompikuntal, PK; Saha, DR; Chakrabarti, MK; Bhadra, RK; Wai, SN; Pal, A				Syngkon, Aurelia; Elluri, Sridhar; Koley, Hemanta; Rompikuntal, Pramod K.; Saha, Dhira Rani; Chakrabarti, Manoj K.; Bhadra, Rupak K.; Wai, Sun Nyunt; Pal, Amit			Studies on a Novel Serine Protease of a Delta hapA Delta prtV Vibrio cholerae O1 Strain and Its Role in Hemorrhagic Response in the Rabbit Ileal Loop Model	PLOS ONE			English	Article							HEMAGGLUTININ PROTEASE; EXTRACELLULAR PROTEASES; VACCINE STRAINS; EL-TOR; GENE; VIRULENCE; TOXIN; METALLOPROTEASE; PURIFICATION; CLONING	Background: Two well-characterized proteases secreted by Vibrio cholerae O1 strains are hemagglutinin protease (HAP) and V. cholerae protease (PrtV). The hapA and prtV knock out mutant, V. cholerae O1 strain CHA6.8 Delta prtV, still retains residual protease activity. We initiated this study to characterize the protease present in CHA6.8 Delta prtV strain and study its role in pathogenesis in rabbit ileal loop model (RIL). Methodology/Principal Findings: We partially purified the residual protease secreted by strain CHA6.8DprtV from culture supernatant by anion-exchange chromatography. The major protein band in native PAGE was identified by MS peptide mapping and sequence analysis showed homology with a 59-kDa trypsin-like serine protease encoded by VC1649. The protease activity was partially inhibited by 25 mM PMSF and 10 mM EDTA and completely inhibited by EDTA and PMSF together. RIL assay with culture supernatants of strains C6709 (FA ratio 1.1+/-0.3 n = 3), CHA6.8 (FA ratio 1.08+/-0.2 n = 3), CHA6.8 Delta prtV (FA ratio 1.02+/-0.2 n = 3) and partially purified serine protease from CHA6.8 Delta prtV (FA ratio 1.2+/-0.3 n = 3) induced fluid accumulation and histopathological studies on rabbit ileum showed destruction of the villus structure with hemorrhage in all layers of the mucosa. RIL assay with culture supernatant of CHA6.8 Delta prtV Delta VC1649 strain (FA ratio 0.11+/-0.005 n = 3) and with protease incubated with PMSF and EDTA (FA ratio 0.3+/-0.05 n = 3) induced a significantly reduced FA ratio with almost complete normal villus structure. Conclusion: Our results show the presence of a novel 59-kDa serine protease in a Delta hapA Delta prtV V. cholerae O1 strain and its role in hemorrhagic response in RIL model.	[Syngkon, Aurelia; Elluri, Sridhar; Chakrabarti, Manoj K.; Pal, Amit] Natl Inst Cholera & Enter Dis, Div Pathophysiol, Kolkata, West Bengal, India; [Koley, Hemanta] Natl Inst Cholera & Enter Dis, Div Bacteriol, Kolkata, West Bengal, India; [Saha, Dhira Rani] Natl Inst Cholera & Enter Dis, Div Histol & Electron Microscopy, Kolkata, West Bengal, India; [Elluri, Sridhar; Rompikuntal, Pramod K.; Wai, Sun Nyunt] Umea Univ, Dept Mol Biol, UCMR, Umea, Sweden; [Bhadra, Rupak K.] Indian Inst Chem Biol, Infect Dis & Immunol Div, Kolkata, West Bengal, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Umea University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Syngkon, A (corresponding author), Natl Inst Cholera & Enter Dis, Div Pathophysiol, Kolkata, West Bengal, India.	apal7364@rediffmail.com	rompikuntal, pramod/C-6917-2015	rompikuntal, pramod/0000-0002-4754-4676; Wai, Sun Nyunt/0000-0003-4793-4671	Swedish Foundation for International Cooperation in Research and Higher Education (STINT), Sweden [IG2008 2049]; Department of Biotechnology, India; Indian Council of Medical Research, New Delhi, India; STINT	Swedish Foundation for International Cooperation in Research and Higher Education (STINT), Sweden; Department of Biotechnology, India(Department of Biotechnology (DBT) India); Indian Council of Medical Research, New Delhi, India(Indian Council of Medical Research (ICMR)); STINT	This work was supported by grants from the Swedish Foundation for International Cooperation in Research and Higher Education (STINT), Sweden (Institutional Grants IG2008 2049). The awards of Senior Research Fellowship to A. S. is from the Department of Biotechnology, India and to S. E. from the Indian Council of Medical Research, New Delhi, India and also from STINT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIOSCA EG, 1991, J FISH DIS, V14, P103, DOI 10.1111/j.1365-2761.1991.tb00581.x; BLAKE PA, 1980, ANNU REV MICROBIOL, V34, P341, DOI 10.1146/annurev.mi.34.100180.002013; BOOTH BA, 1984, INFECT IMMUN, V45, P558, DOI 10.1128/IAI.45.3.558-560.1984; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P427; DE SN, 1953, J PATHOL BACTERIOL, V66, P559, DOI 10.1002/path.1700660228; FIELDS PI, 1992, J CLIN MICROBIOL, V30, P2118, DOI 10.1128/JCM.30.8.2118-2121.1992; FINKELSTEIN RA, 1992, INFECT IMMUN, V60, P472, DOI 10.1128/IAI.60.2.472-478.1992; FINKELSTEIN RA, 1982, INFECT IMMUN, V36, P1199, DOI 10.1128/IAI.36.3.1199-1208.1982; FINKELSTEINRR, 1983, P NATL ACAD SCI USA, V80, P1092; Fullner KJ, 2002, J EXP MED, V195, P1455, DOI 10.1084/jem.20020318; Ghosh A, 2006, INFECT IMMUN, V74, P2937, DOI 10.1128/IAI.74.5.2937-2946.2006; GILL DM, 1979, J INFECT DIS, V139, P674, DOI 10.1093/infdis/139.6.674; Haralalka S, 2003, J BACTERIOL, V185, P4672, DOI 10.1128/JB.185.16.4672-4682.2003; Harrington DJ, 1996, INFECT IMMUN, V64, P1885, DOI 10.1128/IAI.64.6.1885-1891.1996; HASE CC, 1991, J BACTERIOL, V173, P3311; HASE CC, 1993, MICROBIOL REV, V57, P823; HASE CC, 1990, INFECT IMMUN, V58, P4011; Ishihara M, 2002, MICROBIOL IMMUNOL, V46, P299, DOI 10.1111/j.1348-0421.2002.tb02699.x; Lee CY, 2002, FEMS MICROBIOL LETT, V209, P31, DOI 10.1111/j.1574-6968.2002.tb11105.x; MAURIZI MR, 1990, J BIOL CHEM, V265, P12546; MEKALANOS JJ, 1979, J BIOL CHEM, V254, P5855; Mel SF, 2000, INFECT IMMUN, V68, P6487, DOI 10.1128/IAI.68.11.6487-6492.2000; MILTON DL, 1992, J BACTERIOL, V174, P7235, DOI 10.1128/jb.174.22.7235-7244.1992; Miyoshi S, 2000, MICROBES INFECT, V2, P91, DOI 10.1016/S1286-4579(00)00280-X; Miyoshi S, 2006, J DERMATOL, V33, P589, DOI 10.1111/j.1346-8138.2006.00139.x; Ogierman MA, 1997, J BACTERIOL, V179, P7072, DOI 10.1128/jb.179.22.7072-7080.1997; Peterson JD, 2001, NUCLEIC ACIDS RES, V29, P123, DOI 10.1093/nar/29.1.123; Rodriguez BL, 2001, INFECT IMMUN, V69, P613, DOI 10.1128/IAI.69.1.613-616.2001; Skorupski K, 1996, GENE, V169, P47, DOI 10.1016/0378-1119(95)00793-8; SRIMINOVA NI, 2004, MICROB PATHOG, V36, P131; Toma C, 1996, INFECT IMMUN, V64, P4495, DOI 10.1128/IAI.64.11.4495-4500.1996; Toma C, 1996, FEMS MICROBIOL LETT, V135, P143, DOI 10.1016/0378-1097(95)00463-7; Vaitkevicius K, 2006, P NATL ACAD SCI USA, V103, P9280, DOI 10.1073/pnas.0601754103; Wang J, 2008, MICROB PATHOGENESIS, V44, P494, DOI 10.1016/j.micpath.2008.01.001; Wu ZY, 2000, CELL MICROBIOL, V2, P11, DOI 10.1046/j.1462-5822.2000.00025.x; YOUNG DB, 1982, INFECT IMMUN, V37, P875, DOI 10.1128/IAI.37.3.875-883.1982; Zhou X, 2004, INFECT IMMUN, V72, P389, DOI 10.1128/IAI.72.1.389-397.2004; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	38	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e13122	10.1371/journal.pone.0013122	http://dx.doi.org/10.1371/journal.pone.0013122			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20927349	gold, Green Published, Green Submitted			2022-12-27	WOS:000282312600035
J	Salim, NN; Feig, AL				Salim, Nilshad N.; Feig, Andrew L.			An Upstream Hfq Binding Site in the fhlA mRNA Leader Region Facilitates the OxyS-fhlA Interaction	PLOS ONE			English	Article							ESCHERICHIA-COLI-HFQ; SM-LIKE PROTEIN; SELECTIVE 2'-HYDROXYL ACYLATION; SINGLE NUCLEOTIDE RESOLUTION; PRIMER EXTENSION SHAPE; RIBOSOME-BINDING; REGULATORY RNA; VIRULENCE; DSRA; SALMONELLA	Background: To survive, bacteria must be able to adapt to environmental stresses. Small regulatory RNAs have been implicated as intermediates in a variety of stress-response pathways allowing dynamic gene regulation. The RNA binding protein Hfq facilitates this process in many cases, helping sRNAs base pair with their target mRNAs and initiate gene regulation. Although Hfq has been identified as a critical component in many RNPs, the manner by which Hfq controls these interactions is not known. Methodology/Principal Findings: To test the requirement of Hfq in these mRNA-sRNA complexes, the OxyS-fhlA system was used as a model. OxyS is induced in response to oxidative stress and down regulates the translation of fhlA, a gene encoding a transcriptional activator for formate metabolism. Biophysical characterization of this system previously used a minimal construct of the fhlA mRNA which inadvertently removed a critical element within the leader sequence of this mRNA that effected thermodynamics and kinetics for the interaction with Hfq. Conclusions/Significance: Herein, we report thermodynamic, kinetic and structural mapping studies during binary and ternary complex formation between Hfq, OxyS and fhlA mRNA. Hfq binds fhlA mRNA using both the proximal and distal surfaces and stimulates association kinetics between the sRNA and mRNA but remains bound to fhlA forming a ternary complex. The upstream Hfq binding element within fhlA is similar to (ARN) x elements recently identified in other mRNAs regulated by Hfq. This work leads to a kinetic model for the dynamics of these complexes and the regulation of gene expression by bacterial sRNAs.	[Salim, Nilshad N.; Feig, Andrew L.] Wayne State Univ, Dept Chem, Detroit, MI 48202 USA	Wayne State University	Salim, NN (corresponding author), Wayne State Univ, Dept Chem, Detroit, MI 48202 USA.	afeig@chem.wayne.edu	Feig, Andrew/B-7414-2011	Feig, Andrew/0000-0002-5783-1097	National Institutes of Health [R01-GM075068]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075068] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by a grant from the National Institutes of Health R01-GM075068 (to A.L.F.). Purchase of the Biacore was generously supported by Wayne State University, Office of the Vice President for Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba H, 2007, CURR OPIN MICROBIOL, V10, P134, DOI 10.1016/j.mib.2007.03.010; Altuvia S, 1998, EMBO J, V17, P6069, DOI 10.1093/emboj/17.20.6069; Ansong C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004809; Argaman L, 2000, J MOL BIOL, V300, P1101, DOI 10.1006/jmbi.2000.3942; Brantl S, 2007, CURR OPIN MICROBIOL, V10, P102, DOI 10.1016/j.mib.2007.03.012; Brennan RG, 2007, CURR OPIN MICROBIOL, V10, P125, DOI 10.1016/j.mib.2007.03.015; Brescia CC, 2003, RNA, V9, P33, DOI 10.1261/rna.2570803; Christiansen JK, 2004, J BACTERIOL, V186, P3355, DOI 10.1128/JB.186.11.3355-3362.2004; Das R, 2005, RNA, V11, P344, DOI 10.1261/rna.7214405; Ding YP, 2004, MOL MICROBIOL, V53, P345, DOI 10.1111/j.1365-2958.2004.04142.x; Franze de Fernandez M T, 1972, J Biol Chem, V247, P824; Lease RA, 2004, J MOL BIOL, V344, P1211, DOI 10.1016/j.jmb.2004.10.006; Lee T, 2008, RNA, V14, P514, DOI 10.1261/rna.531408; Link TM, 2009, P NATL ACAD SCI USA, V106, P19286, DOI 10.1073/pnas.0908744106; LUTZ S, 1991, MOL MICROBIOL, V5, P123, DOI 10.1111/j.1365-2958.1991.tb01833.x; MATHEWS DH, 2006, CURR PROTOC BIOINFOR, pCH12, DOI DOI 10.1002/0471250953.BI1206S13; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; Mikulecky PJ, 2004, NAT STRUCT MOL BIOL, V11, P1206, DOI 10.1038/nsmb858; Moller T, 2002, MOL CELL, V9, P23, DOI 10.1016/S1097-2765(01)00436-1; Papenfort K, 2009, RES MICROBIOL, V160, P278, DOI 10.1016/j.resmic.2009.03.004; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd, ed.; Schumacher MA, 2002, EMBO J, V21, P3546, DOI 10.1093/emboj/cdf322; Sharma CM, 2007, GENE DEV, V21, P2804, DOI 10.1101/gad.447207; Sittka A, 2007, MOL MICROBIOL, V63, P193, DOI 10.1111/j.1365-2958.2006.05489.x; Sonnleitner E, 2003, MICROB PATHOGENESIS, V35, P217, DOI 10.1016/S0882-4010(03)00149-9; Soper T, 2010, P NATL ACAD SCI USA, V107, P9602, DOI 10.1073/pnas.1004435107; Soper TJ, 2008, RNA, V14, P1907, DOI 10.1261/rna.1110608; Sun XG, 2006, BIOCHEMISTRY-US, V45, P4875, DOI 10.1021/bi0523613; Takada A, 1999, BIOCHEM BIOPH RES CO, V266, P579, DOI 10.1006/bbrc.1999.1863; TSUI HCT, 1994, MOL MICROBIOL, V13, P35, DOI 10.1111/j.1365-2958.1994.tb00400.x; Updegrove T, 2008, BIOCHEMISTRY-US, V47, P11184, DOI 10.1021/bi800479p; Valentin-Hansen P, 2004, MOL MICROBIOL, V51, P1525, DOI 10.1111/j.1365-2958.2003.03935.x; Vasa SM, 2008, RNA, V14, P1979, DOI 10.1261/rna.1166808; Vogel J, 2009, MOL MICROBIOL, V71, P1, DOI 10.1111/j.1365-2958.2008.06505.x; WAGNER EGH, 1994, ANNU REV MICROBIOL, V48, P713, DOI 10.1146/annurev.mi.48.100194.003433; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Wilkinson KA, 2008, PLOS BIOL, V6, P883, DOI 10.1371/journal.pbio.0060096; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Windbichler N, 2008, RNA BIOL, V5, P30, DOI 10.4161/rna.5.1.5694; Zhang AX, 2003, MOL MICROBIOL, V50, P1111, DOI 10.1046/j.1365-2958.2003.03734.x; Zhang AX, 2002, MOL CELL, V9, P11, DOI 10.1016/S1097-2765(01)00437-3; Zhang CX, 2009, CURR OPIN MOL THER, V11, P641	43	49	51	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2010	5	9							e13028	10.1371/journal.pone.0013028	http://dx.doi.org/10.1371/journal.pone.0013028			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654ZQ	20927406	Green Submitted, Green Published, gold			2022-12-27	WOS:000282210700009
J	Kubota, T; Ikeda, S; Yanagisawa, H; Yuki, M; Okamoto, A				Kubota, Takeshi; Ikeda, Shuji; Yanagisawa, Hiroyuki; Yuki, Mizue; Okamoto, Akimitsu			Sets of RNA Repeated Tags and Hybridization-Sensitive Fluorescent Probes for Distinct Images of RNA in a Living Cell	PLOS ONE			English	Article							ORANGE-LABELED DNA; MESSENGER-RNA; INTRACELLULAR RNA; FUSED PROTEIN; DYNAMICS; TRANSPORT; EMISSION; APTAMER; TRANSCRIPTION; PARASPECKLES	Background: Imaging the behavior of RNA in a living cell is a powerful means for understanding RNA functions and acquiring spatiotemporal information in a single cell. For more distinct RNA imaging in a living cell, a more effective chemical method to fluorescently label RNA is now required. In addition, development of the technology labeling with different colors for different RNA would make it easier to analyze plural RNA strands expressing in a cell. Methodology/Principal Findings: Tag technology for RNA imaging in a living cell has been developed based on the unique chemical functions of exciton-controlled hybridization-sensitive oligonucleotide (ECHO) probes. Repetitions of selected 18-nucleotide RNA tags were incorporated into the mRNA 39-UTR. Pairs with complementary ECHO probes exhibited hybridization-sensitive fluorescence emission for the mRNA expressed in a living cell. The mRNA in a nucleus was detected clearly as fluorescent puncta, and the images of the expression of two mRNAs were obtained independently and simultaneously with two orthogonal tag-probe pairs. Conclusions/Significance: A compact and repeated label has been developed for RNA imaging in a living cell, based on the photochemistry of ECHO probes. The pairs of an 18-nt RNA tag and the complementary ECHO probes are highly thermostable, sequence-specifically emissive, and orthogonal to each other. The nucleotide length necessary for one tag sequence is much shorter compared with conventional tag technologies, resulting in easy preparation of the tag sequences with a larger number of repeats for more distinct RNA imaging.	[Kubota, Takeshi; Ikeda, Shuji; Yanagisawa, Hiroyuki; Yuki, Mizue; Okamoto, Akimitsu] RIKEN Adv Sci Inst, Saitama, Japan; [Okamoto, Akimitsu] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Saitama, Japan	RIKEN; Japan Science & Technology Agency (JST)	Kubota, T (corresponding author), RIKEN Adv Sci Inst, Saitama, Japan.	aki-okamoto@riken.jp	Okamoto, Akimitsu/K-8965-2018	Okamoto, Akimitsu/0000-0002-7418-6237; Yanagisawa, Hiroyuki/0000-0002-3486-497X; Kubota, Takeshi/0000-0002-2007-0503	Japan Society for the Promotion of Science [21,750,182, 20,350,083]; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [20,014,030]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grants-in Aid for Young Scientists ( B) (#21,750,182) (TK) and a Grant-in-Aid for Scientific Research (B) (#20,350,083) (AO) from the Japan Society for the Promotion of Science, and a Grant-in-Aid for Scientific Research on Priority Areas (Cancer) (#20,014,030) (AO) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babendure JR, 2003, J AM CHEM SOC, V125, P14716, DOI 10.1021/ja037994o; Bao G, 2009, ANNU REV BIOMED ENG, V11, P25, DOI 10.1146/annurev-bioeng-061008-124920; Baugh C, 2000, J MOL BIOL, V301, P117, DOI 10.1006/jmbi.2000.3951; Becalska AN, 2009, DEVELOPMENT, V136, P2493, DOI 10.1242/dev.032391; Bratu DP, 2003, P NATL ACAD SCI USA, V100, P13308, DOI 10.1073/pnas.2233244100; Chen LL, 2009, MOL CELL, V35, P467, DOI 10.1016/j.molcel.2009.06.027; Constantin TP, 2008, ORG LETT, V10, P1561, DOI 10.1021/ol702920e; Derewenda ZS, 2004, METHODS, V34, P354, DOI 10.1016/j.ymeth.2004.03.024; Dynes JL, 2007, J COMP NEUROL, V500, P433, DOI 10.1002/cne.21189; EARNSHAW DL, 1987, BIOCHEM J, V241, P649, DOI 10.1042/bj2410649; Fox AH, 2005, MOL BIOL CELL, V16, P5304, DOI 10.1091/mbc.E05-06-0587; Fox AH, 2002, CURR BIOL, V12, P13, DOI 10.1016/S0960-9822(01)00632-7; Fusco D, 2003, CURR BIOL, V13, P161, DOI 10.1016/S0960-9822(02)01436-7; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; Gerits N, 2009, CELL MOL BIOL LETT, V14, P548, DOI 10.2478/s11658-009-0020-6; Golding I, 2004, P NATL ACAD SCI USA, V101, P11310, DOI 10.1073/pnas.0404443101; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; HOCHULI E, 1987, J CHROMATOGR, V411, P177, DOI 10.1016/S0021-9673(00)93969-4; Honda K, 2007, CHEMBIOCHEM, V8, P1370, DOI 10.1002/cbic.200700146; Honda K, 2006, CHEM COMMUN, P4024, DOI 10.1039/b608684e; Ikeda S, 2008, BIOCONJUGATE CHEM, V19, P1719, DOI 10.1021/bc800201m; Ikeda S, 2008, CHEM-ASIAN J, V3, P958, DOI 10.1002/asia.200800014; Ikeda S, 2010, ORG BIOMOL CHEM, V8, P546, DOI 10.1039/b917321h; Ikeda S, 2009, ANGEW CHEM INT EDIT, V48, P6480, DOI 10.1002/anie.200902000; Kapanidis AN, 2001, J AM CHEM SOC, V123, P12123, DOI 10.1021/ja017074a; KOOTER JM, 1984, NUCLEIC ACIDS RES, V12, P9457, DOI 10.1093/nar/12.24.9457; Kubota T, 2009, BIOCONJUGATE CHEM, V20, P1256, DOI 10.1021/bc900120a; Kubota T, 2009, B CHEM SOC JPN, V82, P110, DOI 10.1246/bcsj.82.110; Li YX, 2001, J NEUROSCI, V21, P2738, DOI 10.1523/JNEUROSCI.21-08-02738.2001; Nagase T, 2008, DNA RES, V15, P137, DOI 10.1093/dnares/dsn004; Ojida A, 2006, J AM CHEM SOC, V128, P10452, DOI 10.1021/ja0618604; Perlette J, 2001, ANAL CHEM, V73, P5544, DOI 10.1021/ac010633b; Sando S, 2008, CHEM COMMUN, P3858, DOI 10.1039/b808449a; Sando S, 2007, CHEMBIOCHEM, V8, P1795, DOI 10.1002/cbic.200700325; Sparano BA, 2007, J AM CHEM SOC, V129, P4785, DOI 10.1021/ja070111z; Suzuki K, 2009, PHYS CHEM CHEM PHYS, V11, P9850, DOI 10.1039/b912178a; Tyagi S, 2009, NAT METHODS, V6, P331, DOI [10.1038/NMETH.1321, 10.1038/nmeth.1321]; Vargas DY, 2005, P NATL ACAD SCI USA, V102, P17008, DOI 10.1073/pnas.0505580102; Yamagishi M, 2009, EXP CELL RES, V315, P1142, DOI 10.1016/j.yexcr.2009.02.009; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976; Zhao CX, 2010, ANAL BIOCHEM, V399, P237, DOI 10.1016/j.ab.2009.12.028	41	32	32	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e13003	10.1371/journal.pone.0013003	http://dx.doi.org/10.1371/journal.pone.0013003			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20885944	Green Published, Green Submitted, gold			2022-12-27	WOS:000282167100011
J	Lyons, PJ; Ma, LH; Baker, R; Fricker, LD				Lyons, Peter J.; Ma, Leung-hang; Baker, Robert; Fricker, Lloyd D.			Carboxypeptidase A6 in Zebrafish Development and Implications for VIth Cranial Nerve Pathfinding	PLOS ONE			English	Article							DUANE-SYNDROME; EMBRYONIC-DEVELOPMENT; GENE; IDENTIFICATION; DELETION; REGION; ALPHA-2-CHIMAERIN; HYBRIDIZATION; INHIBITION; MUTATIONS	Carboxypeptidase A6 (CPA6) is an extracellular protease that cleaves carboxy-terminal hydrophobic amino acids and has been implicated in the defective innervation of the lateral rectus muscle by the VIth cranial nerve in Duane syndrome. In order to investigate the role of CPA6 in development, in particular its potential role in axon guidance, the zebrafish ortholog was identified and cloned. Zebrafish CPA6 was secreted and interacted with the extracellular matrix where it had a neutral pH optimum and specificity for C-terminal hydrophobic amino acids. Transient mRNA expression was found in newly formed somites, pectoral fin buds, the stomodeum and a conspicuous condensation posterior to the eye. Markers showed this tissue was not myogenic in nature. Rather, the CPA6 localization overlapped with a chondrogenic site which subsequently forms the walls of a myodome surrounding the lateral rectus muscle. No other zebrafish CPA gene exhibited a similar expression profile. Morpholino-mediated knockdown of CPA6 combined with retrograde labeling and horizontal eye movement analyses demonstrated that deficiency of CPA6 alone did not affect either VIth nerve development or function in the zebrafish. We suggest that mutations in other genes and/or enhancer elements, together with defective CPA6 expression, may be required for altered VIth nerve pathfinding. If mutations in CPA6 contribute to Duane syndrome, our results also suggest that Duane syndrome can be a chondrogenic rather than a myogenic or neurogenic developmental disorder.	[Lyons, Peter J.; Fricker, Lloyd D.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA; [Ma, Leung-hang; Baker, Robert] NYU, Sch Med, Dept Physiol & Neurosci, New York, NY USA	Yeshiva University; Albert Einstein College of Medicine; New York University	Lyons, PJ (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA.	peter.lyons@einstein.yu.edu		Lyons, Peter/0000-0001-5214-5445; Baker, Robert/0000-0001-7920-1769	Natural Sciences and Engineering Research Council of Canada (NSERC); National Institutes of Health (NIH NRSA) [EY19433]; Grass Foundation; National Institutes of Health (NIH) [DA004494, EY002007]; NATIONAL EYE INSTITUTE [R01EY002007, F32EY019433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004494] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Institutes of Health (NIH NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grass Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by fellowships from the Natural Sciences and Engineering Research Council of Canada (NSERC), National Institutes of Health (NIH NRSA EY19433) and the Grass Foundation to P.J.L., as well as National Institutes of Health (NIH) Grants DA004494 (L. D. F.) and EY002007 (R. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Baradie R, 2002, AM J HUM GENET, V71, P1195, DOI 10.1086/343821; Allis EP, 1918, P NATL ACAD SCI USA, V4, P241, DOI 10.1073/pnas.4.8.241; Arolas JL, 2007, CURR PHARM DESIGN, V13, P349, DOI 10.2174/138161207780162980; Barry JS, 2008, OPHTHALMIC GENET, V29, P177, DOI 10.1080/13816810802354224; Beck JC, 2004, METHOD CELL BIOL, V76, P385; Beck JC, 2004, J NEUROPHYSIOL, V92, P3546, DOI 10.1152/jn.00311.2004; Bentley L, 2003, J MED GENET, V40, P249, DOI 10.1136/jmg.40.4.249; Bosley TM, 2007, NEUROLOGY, V69, P1245, DOI 10.1212/01.wnl.0000276947.59704.cf; Calabrese G, 1998, EUR J HUM GENET, V6, P187, DOI 10.1038/sj.ejhg.5200173; COULY GF, 1992, DEVELOPMENT, V114, P1; Devoto SH, 1996, DEVELOPMENT, V122, P3371; Dobson JT, 2008, BLOOD, V112, P2969, DOI 10.1182/blood-2008-03-145011; Easter SS, 1996, DEV BIOL, V180, P646; Fontenele-Neto JD, 2005, MOL BRAIN RES, V137, P132, DOI 10.1016/j.molbrainres.2005.02.026; Garcia-Saez I, 1997, EMBO J, V16, P6906, DOI 10.1093/emboj/16.23.6906; Geerinckx T, 2005, J MORPHOL, V266, P331, DOI 10.1002/jmor.10381; Germanguz I, 2007, DEV DYNAM, V236, P2615, DOI 10.1002/dvdy.21267; Gilland E, 2005, BRAIN BEHAV EVOLUT, V66, P234, DOI 10.1159/000088128; Gutowski NJ, 2000, EUR J NEUROL, V7, P145, DOI 10.1046/j.1468-1331.2000.00029.x; Huang HJ, 1999, CANCER RES, V59, P2981; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lehman AM, 2009, EUR J MED GENET, V52, P436, DOI 10.1016/j.ejmg.2009.09.006; Lin CY, 2006, DEV BIOL, V299, P594, DOI 10.1016/j.ydbio.2006.08.042; Lyons PJ, 2008, J BIOL CHEM, V283, P7054, DOI 10.1074/jbc.M707680200; Miyake N, 2008, SCIENCE, V321, P839, DOI 10.1126/science.1156121; Monfort S, 2008, J MED GENET, V45, P432, DOI 10.1136/jmg.2008.057596; Mootoosamy RC, 2002, DEVELOPMENT, V129, P573; Murillo-Correa CE, 2009, J AAPOS, V13, P245, DOI 10.1016/j.jaapos.2009.03.007; PASTOR AM, 1991, J NEUROPHYSIOL, V66, P2125, DOI 10.1152/jn.1991.66.6.2125; Pizzuti A, 2002, INVEST OPHTH VIS SCI, V43, P3609; Reijntjes S, 2007, INT J DEV BIOL, V51, P753, DOI 10.1387/ijdb.072332sr; Reznik SE, 2001, CELL MOL LIFE SCI, V58, P1790, DOI 10.1007/PL00000819; Rickard S, 2001, HUM GENET, V108, P398, DOI 10.1007/s004390100495; Row RH, 2009, DEV BIOL, V329, P55, DOI 10.1016/j.ydbio.2009.02.016; Starks EC, 1905, SCIENCE, V21, P0754, DOI 10.1126/science.21.541.754; Stickney HL, 2000, DEV DYNAM, V219, P287; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Wei SW, 2002, J BIOL CHEM, V277, P14954, DOI 10.1074/jbc.M112254200; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Yee NS, 2005, DEV BIOL, V284, P84, DOI 10.1016/j.ydbio.2005.04.035; Zannino DA, 2009, J NEUROSCI, V29, P2322, DOI 10.1523/JNEUROSCI.3755-08.2009	41	21	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2010	5	9							e12967	10.1371/journal.pone.0012967	http://dx.doi.org/10.1371/journal.pone.0012967			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653UN	20885977	Green Published, gold, Green Submitted			2022-12-27	WOS:000282122600007
J	Song, WB; Wang, YY; Meng, FS; Zhang, QH; Zeng, JY; Xiao, LP; Yu, XP; Peng, DD; Su, L; Xiao, B; Zhang, ZS				Song, Wei-Bing; Wang, Yuan-Yuan; Meng, Fan-Su; Zhang, Qing-Hua; Zeng, Jian-Ying; Xiao, Li-Ping; Yu, Xin-Pei; Peng, Dan-dan; Su, Lei; Xiao, Bing; Zhang, Zhen-Shu			Curcumin Protects Intestinal Mucosal Barrier Function of Rat Enteritis via Activation of MKP-1 and Attenuation of p38 and NF-kappa B Activation	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; TUMOR-NECROSIS-FACTOR; EPITHELIAL-CELLS; TNF-ALPHA; PROINFLAMMATORY CYTOKINES; NEUTROPHIL INFILTRATION; ALVEOLAR MACROPHAGES; EXPERIMENTAL COLITIS; ULCERATIVE-COLITIS; REPERFUSION INJURY	Background: Intestinal mucosa barrier (IMB) dysfunction results in many notorious diseases for which there are currently few effective treatments. We studied curcumin's protective effect on IMB and examined its mechanism by using methotrexate (MTX) induced rat enteritis model and lipopolysaccharide (LPS) treated cell death model. Methodology/Principal Findings: Curcumin was intragastrically administrated from the first day, models were made for 7 days. Cells were treated with curcumin for 30 min before exposure to LPS. Rat intestinal mucosa was collected for evaluation of pathological changes. We detected the activities of D-lactate and diamine oxidase (DAO) according to previous research and measured the levels of myeloperoxidase (MPO) and superoxide dismutase (SOD) by colorimetric method. Intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor alpha (TNF-alpha) and interleukin 1 beta (IL-1 beta) were determined by RT-PCR and IL-10 production was determined by ELISA. We found Curcumin decreased the levels of D-lactate, DAO, MPO, ICAM-1, IL-1 beta and TNF-alpha, but increased the levels of IL-10 and SOD in rat models. We further confirmed mitogen-activated protein kinase phosphatase-1 (MKP-1) was activated but phospho-p38 was inhibited by curcumin by western blot assay. Finally, NF-kappa B translocation was monitored by immunofluorescent staining. We showed that curcumin repressed I-kappa B and interfered with the translocation of NF-kappa B into nucleus. Conclusions/Significance: The effect of curcumin is mediated by the MKP-1-dependent inactivation of p38 and inhibition of NF-kappa B-mediated transcription. Curcumin, with anti-inflammatory and anti-oxidant activities may be used as an effective reagent for protecting intestinal mucosa barrier and other related intestinal diseases.	[Song, Wei-Bing; Zeng, Jian-Ying; Xiao, Li-Ping; Yu, Xin-Pei; Peng, Dan-dan; Su, Lei] Guangzhou Mil Command Peoples Liberat Army, Gen Hosp, Dept Gerontol, Guangzhou, Guangdong, Peoples R China; [Wang, Yuan-Yuan; Xiao, Bing; Zhang, Zhen-Shu] So Med Univ, Nanfang Hosp, Dept Gastroenterol, Guangdong Prov Key Lab Gastroenterol, Guangzhou, Guangdong, Peoples R China; [Meng, Fan-Su] Tradit Chinese Med Hosp ZhongSan City, Dept Intens Care Unit, Zhongshan, Peoples R China; [Zhang, Qing-Hua] 458 Hosp Peoples Liberat Army, Dept Gerontol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Song, WB (corresponding author), Guangzhou Mil Command Peoples Liberat Army, Gen Hosp, Dept Gerontol, Guangzhou, Guangdong, Peoples R China.	songweibing@yahoo.com			General Hospital of Guangzhou Military Command of People's Liberation Army of Medical Technology; Guangdong Provincial Key Laboratory of Gastroenterology	General Hospital of Guangzhou Military Command of People's Liberation Army of Medical Technology; Guangdong Provincial Key Laboratory of Gastroenterology	This work was supported by the research fund of General Hospital of Guangzhou Military Command of People's Liberation Army of Medical & Technology and the research fund of Guangdong Provincial Key Laboratory of Gastroenterology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Aranow JS, 1996, BRIT J ANAESTH, V77, P71, DOI 10.1093/bja/77.1.71; Bruewer M, 2003, J IMMUNOL, V171, P6164, DOI 10.4049/jimmunol.171.11.6164; Camacho-Barquero L, 2007, INT IMMUNOPHARMACOL, V7, P333, DOI 10.1016/j.intimp.2006.11.006; Campbell J, 2004, J IMMUNOL, V173, P6928, DOI 10.4049/jimmunol.173.11.6928; Chanteux H, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-71; Cheon JH, 2006, INFLAMM BOWEL DIS, V12, P1152, DOI 10.1097/01.mib.0000235830.94057.c6; Chretien A, 2008, FREE RADICAL BIO MED, V44, P1732, DOI 10.1016/j.freeradbiomed.2008.01.026; De Plaen IG, 2000, BRIT J PHARMACOL, V129, P307, DOI 10.1038/sj.bjp.0703055; Dinarello CA, 2005, CRIT CARE MED, V33, pS460, DOI 10.1097/01.CCM.0000185500.11080.91; Emre Y, 2007, BIOCHEM J, V402, P271, DOI 10.1042/BJ20061430; Farhadi A, 2003, J GASTROEN HEPATOL, V18, P479, DOI 10.1046/j.1440-1746.2003.03032.x; Gong JP, 2002, WORLD J GASTROENTERO, V8, P923, DOI 10.3748/wjg.v8.i5.923; GRISHAM MB, 1986, AM J PHYSIOL, V251, pG567, DOI 10.1152/ajpgi.1986.251.4.G567; Hale LP, 2005, INFLAMM BOWEL DIS, V11, P1060, DOI 10.1097/01.MIB.0000187582.90423.bc; Hanai H, 2009, CURR PHARM DESIGN, V15, P2087, DOI 10.2174/138161209788489177; Howarth GS, 1996, J NUTR, V126, P2519, DOI 10.1093/jn/126.10.2519; Iles KE, 2002, FREE RADICAL BIO MED, V32, P1304, DOI 10.1016/S0891-5849(02)00840-7; Jang BC, 2007, FEMS IMMUNOL MED MIC, V51, P171, DOI 10.1111/j.1574-695X.2007.00293.x; Jeong HJ, 2002, CYTOKINE, V18, P252, DOI 10.1006/cyto.2002.0894; Jobin C, 1999, J IMMUNOL, V163, P3474; Jung KK, 2006, LIFE SCI, V79, P2022, DOI 10.1016/j.lfs.2006.06.048; Kalff JC, 1999, ARCH ORTHOP TRAUM SU, V119, P89, DOI 10.1007/s004020050363; Kim BH, 2008, MOL PHARMACOL, V73, P1309, DOI 10.1124/mol.107.041251; Kimura T, 1998, EUR J GASTROEN HEPAT, V10, P659; Kondoh K, 2007, J BIOL CHEM, V282, P3058, DOI 10.1074/jbc.M607630200; Laharie D, 2007, DIGEST DIS SCI, V52, P84, DOI 10.1007/s10620-006-9183-4; Lappas M, 2002, BIOL REPROD, V67, P668, DOI 10.1095/biolreprod67.2.668; LUK GD, 1983, J CLIN INVEST, V71, P1308, DOI 10.1172/JCI110881; Neurath MF, 1996, NAT MED, V2, P998, DOI 10.1038/nm0996-998; Nieto N, 2000, DIGEST DIS SCI, V45, P1820, DOI 10.1023/A:1005565708038; Olanders K, 2002, SHOCK, V18, P86, DOI 10.1097/00024382-200207000-00016; PATEL RT, 1995, DIS COLON RECTUM, V38, P831, DOI 10.1007/BF02049839; Pladzyk A, 2006, INVEST OPHTH VIS SCI, V47, P5395, DOI 10.1167/iovs.06-0469; Qu LK, 2004, GENE DEV, V18, P261, DOI 10.1101/gad.1165804; Roozendaal C, 1998, CLIN EXP IMMUNOL, V112, P10; Ruh J, 2000, MICROVASC RES, V59, P329, DOI 10.1006/mvre.1999.2201; Sandborn WJ, 2003, BEST PRACT RES CL GA, V17, P105, DOI 10.1053/bega.2002.0345; Shishodia S, 2004, J IMMUNOL, V173, P2011, DOI 10.4049/jimmunol.173.3.2011; Son YH, 2008, J CARDIOVASC PHARM, V51, P71, DOI 10.1097/FJC.0b013e31815bd23d; Steidler L, 2000, SCIENCE, V289, P1352, DOI 10.1126/science.289.5483.1352; Sugimoto K, 2002, GASTROENTEROLOGY, V123, P1912, DOI 10.1053/gast.2002.37050; Sydora BC, 2007, INFLAMM BOWEL DIS, V13, P947, DOI 10.1002/ibd.20155; Tanaka T, 2008, NEUROSCI LETT, V431, P262, DOI 10.1016/j.neulet.2007.11.051; Thorpe CM, 1999, INFECT IMMUN, V67, P5985, DOI 10.1128/IAI.67.11.5985-5993.1999; Tibble JA, 2000, GASTROENTEROLOGY, V119, P15, DOI 10.1053/gast.2000.8523; Van't Land B, 2004, DIGEST DIS SCI, V49, P425, DOI 10.1023/B:DDAS.0000020497.35250.93; Venugopal SK, 2007, J BIOL CHEM, V282, P31900, DOI 10.1074/jbc.M703729200; Waetzig GH, 2002, J IMMUNOL, V168, P5342, DOI 10.4049/jimmunol.168.10.5342; Wang KJ, 2008, PROD PLAN CONTROL, V19, P475, DOI 10.1080/09537280802088659; Weaver SA, 2001, GASTROENTEROLOGY, V120, P1117, DOI 10.1053/gast.2001.23257; Wong ET, 2009, CLIN SCI, V116, P451, DOI 10.1042/CS20080502; Wu JJ, 2005, J BIOL CHEM, V280, P16461, DOI 10.1074/jbc.M501762200; Xian CJ, 2000, BRIT J CANCER, V82, P945, DOI 10.1054/bjoc.1999.1023; Yagci G, 2004, J GASTROENTEROL, V39, P268, DOI 10.1007/s00535-003-1287-4; Ye JP, 2000, ANN CLIN LAB SCI, V30, P65; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001; Zingarelli B, 2001, GUT, V48, P610, DOI 10.1136/gut.48.5.610	58	72	76	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2010	5	9							e12969	10.1371/journal.pone.0012969	http://dx.doi.org/10.1371/journal.pone.0012969			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653UN	20885979	gold, Green Published, Green Submitted			2022-12-27	WOS:000282122600008
J	Desikan, RS; Sabuncu, MR; Schmansky, NJ; Reuter, M; Cabral, HJ; Hess, CP; Weiner, MW; Biffi, A; Anderson, CD; Rosand, J; Salat, DH; Kemper, TL; Dale, AM; Sperling, RA; Fischl, B				Desikan, Rahul S.; Sabuncu, Mert R.; Schmansky, Nicholas J.; Reuter, Martin; Cabral, Howard J.; Hess, Christopher P.; Weiner, Michael W.; Biffi, Alessandro; Anderson, Christopher D.; Rosand, Jonathan; Salat, David H.; Kemper, Thomas L.; Dale, Anders M.; Sperling, Reisa A.; Fischl, Bruce		Alzheimer's Dis Neuroimaging Initi	Selective Disruption of the Cerebral Neocortex in Alzheimer's Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; SURFACE-BASED ANALYSIS; DEFAULT-MODE NETWORK; FUNCTIONAL CONNECTIVITY; AMYLOID DEPOSITION; CORTICAL SURFACE; COORDINATE SYSTEM; APOLIPOPROTEIN-E; ELDERLY SUBJECTS; PRODROMAL AD	Background: Alzheimer's disease (AD) and its transitional state mild cognitive impairment (MCI) are characterized by amyloid plaque and tau neurofibrillary tangle (NFT) deposition within the cerebral neocortex and neuronal loss within the hippocampal formation. However, the precise relationship between pathologic changes in neocortical regions and hippocampal atrophy is largely unknown. Methodology/Principal Findings: In this study, combining structural MRI scans and automated image analysis tools with reduced cerebrospinal fluid (CSF) A beta levels, a surrogate for intra-cranial amyloid plaques and elevated CSF phosphorylated tau (p-tau) levels, a surrogate for neocortical NFTs, we examined the relationship between the presence of Alzheimer's pathology, gray matter thickness of select neocortical regions, and hippocampal volume in cognitively normal older participants and individuals with MCI and AD (n = 724). Amongst all 3 groups, only select heteromodal cortical regions significantly correlated with hippocampal volume. Amongst MCI and AD individuals, gray matter thickness of the entorhinal cortex and inferior temporal gyrus significantly predicted longitudinal hippocampal volume loss in both amyloid positive and p-tau positive individuals. Amongst cognitively normal older adults, thinning only within the medial portion of the orbital frontal cortex significantly differentiated amyloid positive from amyloid negative individuals whereas thinning only within the entorhinal cortex significantly discriminated p-tau positive from p-tau negative individuals. Conclusions/Significance: Cortical Ab and tau pathology affects gray matter thinning within select neocortical regions and potentially contributes to downstream hippocampal degeneration. Neocortical Alzheimer's pathology is evident even amongst older asymptomatic individuals suggesting the existence of a preclinical phase of dementia.	[Desikan, Rahul S.; Sabuncu, Mert R.; Schmansky, Nicholas J.; Reuter, Martin; Salat, David H.; Sperling, Reisa A.; Fischl, Bruce] Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Desikan, Rahul S.; Dale, Anders M.] Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA; [Cabral, Howard J.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Hess, Christopher P.; Weiner, Michael W.] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA; [Weiner, Michael W.] Dept Vet Affairs, San Francisco, CA USA; [Biffi, Alessandro; Anderson, Christopher D.; Rosand, Jonathan] Massachusetts Gen Hosp, Dept Neurol, Ctr Human Genet Res, Boston, MA 02114 USA; [Biffi, Alessandro; Anderson, Christopher D.; Rosand, Jonathan] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Kemper, Thomas L.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Dale, Anders M.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Sperling, Reisa A.] Brigham & Womens Hosp, Dept Neurol, Ctr Alzheimer Res & Treatment, Boston, MA 02115 USA; [Sabuncu, Mert R.; Fischl, Bruce] Massachusetts Gen Hosp, Comp Sci & Artificial Intelligence Lab, Cambridge, MA USA; [Sabuncu, Mert R.; Fischl, Bruce] Massachusetts Gen Hosp, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; University of California System; University of California San Diego; Boston University; University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Boston University; University of California System; University of California San Diego; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Desikan, RS (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA.	rahul@nmr.mgh.harvard.edu	Sabuncu, Mert Rory/ABE-2284-2021; Reuter, Martin/B-3456-2010	Reuter, Martin/0000-0002-2665-9693; Hess, Christopher/0000-0002-5132-5302; Anderson, Christopher/0000-0002-0053-2002; Sabuncu, Mert/0000-0002-7068-719X; Cabral, Howard/0000-0002-1185-8331; Kemper, Thomas/0000-0002-4623-4094	National Center for Research Resources [P41-RR14075, R01 RR 16594-01A1, BIRN002, U24 RR021382]; National Institute for Biomedical Imaging and Bioengineering [R01 EB001550, R01EB006758]; National Institute for Neurological Disorders and Stroke [R01 NS052585-01]; Mental Illness and Neuroscience Discovery (MIND) Institute; National Institute on Aging [P50 AG05681, P01 AG03991, AG02238, AG021910]; Ellison Medical Foundation; NIH [P30 AG010129, K01 AG030514]; NATIONAL CENTER FOR RESEARCH RESOURCES [U24RR021382, P41RR014075, R01RR016594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001550, R01EB006758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052585] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005681, U01AG024904, R01AG021910, P30AG010129, K01AG030514, P01AG003991] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute for Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institute for Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Mental Illness and Neuroscience Discovery (MIND) Institute; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ellison Medical Foundation(Lawrence Ellison Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by grants from the National Center for Research Resources (P41-RR14075, R01 RR 16594-01A1 and the NCRR BIRN Morphometric Project BIRN002, U24 RR021382), the National Institute for Biomedical Imaging and Bioengineering (R01 EB001550, R01EB006758), National Institute for Neurological Disorders and Stroke (R01 NS052585-01), the Mental Illness and Neuroscience Discovery (MIND) Institute, and the National Institute on Aging (P50 AG05681, P01 AG03991, AG02238 and AG021910). Additional support was provided by The Autism & Dyslexia Project funded by the Ellison Medical Foundation. Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott, AstraZeneca AB, Bayer Schering Pharma AG, Bristol-Myers Squibb, Eisai Global Clinical Development, Elan Corporation, Genentech, GE Healthcare, GlaxoSmithKline, Innogenetics, Johnson and Johnson, Eli Lilly and Co., Medpace, Inc., Merck and Co., Inc., Novartis AG, Pfizer Inc, F. Hoffman-La Roche, Schering-Plough, Synarc, Inc., as well as non-profit partners the Alzheimer's Association and Alzheimer's Drug Discovery Foundation, with participation from the U. S. Food and Drug Administration. Private sector contributions to ADNI are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California Los Angeles. This research was also supported by NIH grants P30 AG010129, K01 AG030514, and the Dana Foundation.	Arnold SE, 1991, CEREB CORTEX, V1, P103, DOI 10.1093/cercor/1.1.103; Bakkour A, 2009, NEUROLOGY, V72, P1048, DOI 10.1212/01.wnl.0000340981.97664.2f; Bourgeat P, 2010, NEUROLOGY, V74, P121, DOI 10.1212/WNL.0b013e3181c918b5; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Buerger K, 2006, BRAIN, V129, P3035, DOI 10.1093/brain/awl269; Chetelat G, 2010, ANN NEUROL, V67, P317, DOI 10.1002/ana.21955; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DeMattos RB, 2002, J NEUROCHEM, V81, P229, DOI 10.1046/j.1471-4159.2002.00889.x; Desikan RS, 2008, NEUROLOGY, V71, P819, DOI 10.1212/01.wnl.0000320055.57329.34; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Desikan RS, 2009, BRAIN, V132, P2048, DOI 10.1093/brain/awp123; Dickerson BC, 2009, CEREB CORTEX, V19, P497, DOI 10.1093/cercor/bhn113; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frisoni GB, 2009, NEUROLOGY, V72, P1504, DOI 10.1212/WNL.0b013e3181a2e896; Gomez-Isla Teresa, 2008, Handb Clin Neurol, V89, P233, DOI 10.1016/S0072-9752(07)01222-5; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; Hedden T, 2009, J NEUROSCI, V29, P12686, DOI 10.1523/JNEUROSCI.3189-09.2009; Hof PR, 2004, TRENDS NEUROSCI, V27, P607, DOI 10.1016/j.tins.2004.07.013; HYMAN BT, 1984, SCIENCE, V225, P1168, DOI 10.1126/science.6474172; Jack CR, 2008, BRAIN, V131, P665, DOI 10.1093/brain/awm336; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jones E. G., 1985, CEREB CORTEX, V4, P3; Kemper T. L., 1994, CLIN NEUROLOGY AGING, V2nd, P3; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Mesulam NM, 1999, NEURON, V24, P521, DOI 10.1016/S0896-6273(00)81109-5; Mormino EC, 2009, BRAIN, V132, P1310, DOI 10.1093/brain/awn320; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Morris JC, 2010, ANN NEUROL, V67, P122, DOI 10.1002/ana.21843; Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412; Narr KL, 2005, BIOL PSYCHIAT, V58, P32, DOI 10.1016/j.biopsych.2005.03.043; Pandya D.N., 1990, NEUROBIOLOGY HIGHER, P53; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; REUTER M, 2010, NEUROIMAGE      0713; SANIDES F, 1969, ANN NY ACAD SCI, V167, P404, DOI 10.1111/j.1749-6632.1969.tb20459.x; Scahill RI, 2002, P NATL ACAD SCI USA, V99, P4703, DOI 10.1073/pnas.052587399; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Small GW, 2006, NEW ENGL J MED, V355, P2652, DOI 10.1056/NEJMoa054625; Sperling RA, 2009, NEURON, V63, P178, DOI 10.1016/j.neuron.2009.07.003; Thompson PM, 2003, J NEUROSCI, V23, P994; Thompson PM, 2001, CEREB CORTEX, V11, P1, DOI 10.1093/cercor/11.1.1; Vemuri P, 2008, NEUROIMAGE, V42, P559, DOI 10.1016/j.neuroimage.2008.05.012; Vemuri P, 2010, ANN NEUROL, V67, P308, DOI 10.1002/ana.21953; Whitwell JL, 2008, NEUROLOGY, V71, P743, DOI 10.1212/01.wnl.0000324924.91351.7d; Whitwell JL, 2007, BRAIN, V130, P1777, DOI 10.1093/brain/awm112; Wolk DA, 2010, P NATL ACAD SCI USA, V107, P10256, DOI 10.1073/pnas.1001412107; YAKOVLEV PI, 1948, J NERV MENT DIS, V107, P313, DOI 10.1097/00005053-194810740-00001	60	63	66	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12853	10.1371/journal.pone.0012853	http://dx.doi.org/10.1371/journal.pone.0012853			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886094	gold, Green Published			2022-12-27	WOS:000282091100002
J	Mo, KG; Razak, Z; Rao, PC; Yu, ZG; Adachi, H; Katsuno, M; Sobue, G; Lieberman, AP; Westwood, JT; Monks, DA				Mo, Kaiguo; Razak, Zak; Rao, Pengcheng; Yu, Zhigang; Adachi, Hiroaki; Katsuno, Masahisa; Sobue, Gen; Lieberman, Andrew P.; Westwood, J. Timothy; Monks, D. Ashley			Microarray Analysis of Gene Expression by Skeletal Muscle of Three Mouse Models of Kennedy Disease/Spinal Bulbar Muscular Atrophy	PLOS ONE			English	Article							ANDROGEN RECEPTOR PROTEIN; HEAT-SHOCK PROTEINS; AMELIORATES PHENOTYPES; BODY-COMPOSITION; AGGREGATION; TOXICITY; BINDING; OVEREXPRESSION; ABNORMALITIES; MITOCHONDRIAL	Background: Emerging evidence implicates altered gene expression within skeletal muscle in the pathogenesis of Kennedy disease/spinal bulbar muscular atrophy (KD/SBMA). We therefore broadly characterized gene expression in skeletal muscle of three independently generated mouse models of this disease. The mouse models included a polyglutamine expanded (polyQ) AR knock-in model (AR113Q), a polyQ AR transgenic model (AR97Q), and a transgenic mouse that overexpresses wild type AR solely in skeletal muscle (HSA-AR). HSA-AR mice were included because they substantially reproduce the KD/SBMA phenotype despite the absence of polyQ AR. Methodology/Principal Findings: We performed microarray analysis of lower hindlimb muscles taken from these three models relative to wild type controls using high density oligonucleotide arrays. All microarray comparisons were made with at least 3 animals in each condition, and only those genes having at least 2-fold difference and whose coefficient of variance was less than 100% were considered to be differentially expressed. When considered globally, there was a similar overlap in gene changes between the 3 models: 19% between HSA-AR and AR97Q, 21% between AR97Q and AR113Q, and 17% between HSA-AR and AR113Q, with 8% shared by all models. Several patterns of gene expression relevant to the disease process were observed. Notably, patterns of gene expression typical of loss of AR function were observed in all three models, as were alterations in genes involved in cell adhesion, energy balance, muscle atrophy and myogenesis. We additionally measured changes similar to those observed in skeletal muscle of a mouse model of Huntington's Disease, and to those common to muscle atrophy from diverse causes. Conclusions/Significance: By comparing patterns of gene expression in three independent models of KD/SBMA, we have been able to identify candidate genes that might mediate the core myogenic features of KD/SBMA.	[Mo, Kaiguo; Rao, Pengcheng; Monks, D. Ashley] Univ Toronto, Dept Psychol, Mississauga, ON L5L 1C6, Canada; [Mo, Kaiguo; Razak, Zak; Westwood, J. Timothy] Univ Toronto, Dept Cell & Syst Biol, Mississauga, ON L5L 1C6, Canada; [Yu, Zhigang; Lieberman, Andrew P.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA; [Adachi, Hiroaki; Katsuno, Masahisa; Sobue, Gen] Nagoya Univ, Grad Sch Med, Dept Neurol, Nagoya, Aichi 4648601, Japan; [Katsuno, Masahisa] Nagoya Univ, Inst Adv Res, Nagoya, Aichi 4648601, Japan; [Monks, D. Ashley] Univ Toronto, Inst Med Sci, Mississauga, ON L5L 1C6, Canada	University of Toronto; University Toronto Mississauga; University of Toronto; University Toronto Mississauga; University of Michigan System; University of Michigan; Nagoya University; Nagoya University; University of Toronto; University Toronto Mississauga	Mo, KG (corresponding author), Univ Toronto, Dept Psychol, Mississauga, ON L5L 1C6, Canada.	ashley.monks@utoronto.ca	Adachi, Hiroaki/AAM-7812-2020; KATSUNO, MASAHISA/I-7502-2014; Yu, Zhigang/A-6893-2009	Adachi, Hiroaki/0000-0002-9302-4663; KATSUNO, MASAHISA/0000-0001-9453-9311; 	National Institutes of Health [R01-NS51257, R01-NS055746]; Natural Sciences and Research Council of Canada [138234-06, 326916-06]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055746, R01NS051257] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work reported in this manuscript received financial support from the National Institutes of Health [(http://www.nih.gov/) R01-NS51257 to DAM, R01-NS055746 to APL]; Natural Sciences and Research Council of Canada [(http://www.nserc-crsng.gc.ca/) 138234-06, 326916-06 to JTW]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi H, 2007, NEUROPATH APPL NEURO, V33, P135, DOI 10.1111/j.1365-2990.2007.00830.x; Adachi H, 2003, J NEUROSCI, V23, P2203; Adachi H, 2007, J NEUROSCI, V27, P5115, DOI 10.1523/JNEUROSCI.1242-07.2007; Atsuta N, 2006, BRAIN, V129, P1446, DOI 10.1093/brain/awl096; Bailey CK, 2002, HUM MOL GENET, V11, P515, DOI 10.1093/hmg/11.5.515; Boirie Y, 2001, DIABETES, V50, P2652, DOI 10.2337/diabetes.50.12.2652; Chuang JZ, 2002, J BIOL CHEM, V277, P19831, DOI 10.1074/jbc.M109613200; Eigenthaler M, 2003, AM J PHYSIOL-HEART C, V285, pH2471, DOI 10.1152/ajpheart.00362.2003; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fayazi Z, 2006, NEUROBIOL DIS, V24, P226, DOI 10.1016/j.nbd.2006.06.015; Fernando SM, 2010, ENDOCRINOLOGY, V151, P3125, DOI 10.1210/en.2010-0018; Ishihara K, 2003, J BIOL CHEM, V278, P25143, DOI 10.1074/jbc.M302975200; JOHANSEN JA, 2008, NEUROBIOL DIS; Katsuno M, 2005, P NATL ACAD SCI USA, V102, P16801, DOI 10.1073/pnas.0506249102; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; KATSUNO M, 2003, ACNR, V3, P8; Katsuno M, 2006, EXP NEUROL, V200, P8, DOI 10.1016/j.expneurol.2006.01.021; Katsuno M, 2010, J NEUROSCI, V30, P5702, DOI 10.1523/JNEUROSCI.0388-10.2010; KENNEDY WR, 1968, NEUROLOGY, V18, P671, DOI 10.1212/WNL.18.7.671; Kobayashi Y, 2000, J BIOL CHEM, V275, P8772, DOI 10.1074/jbc.275.12.8772; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Li J, 2003, DEV BIOL, V261, P209, DOI 10.1016/S0012-1606(03)00304-X; Li J, 1999, J CELL BIOL, V147, P1391, DOI 10.1083/jcb.147.7.1391; Li M, 2007, J BIOL CHEM, V282, P3157, DOI 10.1074/jbc.M609972200; Lieberman AP, 2002, HUM MOL GENET, V11, P1967, DOI 10.1093/hmg/11.17.1967; MacLean HE, 2008, FASEB J, V22, P2676, DOI 10.1096/fj.08-105726; Mandrusiak LM, 2003, HUM MOL GENET, V12, P1497, DOI 10.1093/hmg/ddg161; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; Merry DE, 1998, HUM MOL GENET, V7, P693, DOI 10.1093/hmg/7.4.693; MINAMIYAMA M, 2004, HUM MOL GENET; Miyazaki M, 2009, AM J PHYSIOL-CELL PH, V296, pC583, DOI 10.1152/ajpcell.00464.2008; Monks DA, 2008, HORM BEHAV, V53, P729, DOI 10.1016/j.yhbeh.2007.12.009; Monks DA, 2007, P NATL ACAD SCI USA, V104, P18259, DOI 10.1073/pnas.0705501104; Orngreen MC, 2008, NEUROLOGY, V70, P1876, DOI 10.1212/01.wnl.0000289190.66955.67; Palazzolo I, 2007, HUM MOL GENET, V16, P1593, DOI 10.1093/hmg/ddm109; Pires-Oliveira M, 2010, J APPL PHYSIOL, V108, P266, DOI 10.1152/japplphysiol.00490.2009; Pisani DF, 2005, BIOCHEM BIOPH RES CO, V326, P788, DOI 10.1016/j.bbrc.2004.11.111; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ranganathan S, 2009, HUM MOL GENET, V18, P27, DOI 10.1093/hmg/ddn310; Ribchester RR, 2004, EUR J NEUROSCI, V20, P3092, DOI 10.1111/j.1460-9568.2004.03783.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; Sopher BL, 2004, NEURON, V41, P687, DOI 10.1016/S0896-6273(04)00082-0; Stenoien DL, 1999, HUM MOL GENET, V8, P731, DOI 10.1093/hmg/8.5.731; Strand AD, 2005, HUM MOL GENET, V14, P1863, DOI 10.1093/hmg/ddi192; Stump CS, 2003, P NATL ACAD SCI USA, V100, P7996, DOI 10.1073/pnas.1332551100; Thomas M, 2005, J BIOL CHEM, V280, P21264, DOI 10.1074/jbc.M500144200; Thomas M, 2006, HUM MOL GENET, V15, P1876, DOI 10.1093/hmg/ddl110; Thomas PS, 2006, HUM MOL GENET, V15, P2225, DOI 10.1093/hmg/ddl148; Tong JF, 2009, J CELL BIOCHEM, V108, P458, DOI 10.1002/jcb.22272; Walcott JL, 2002, J BIOL CHEM, V277, P50855, DOI 10.1074/jbc.M209466200; Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298; Wootton PTE, 2007, NUTR METAB CARDIOVAS, V17, P24, DOI 10.1016/j.numecd.2005.11.008; Wuyts W, 2005, AM J MED GENET A, V133A, P82, DOI 10.1002/ajmg.a.30517; Wyttenbach A, 2000, P NATL ACAD SCI USA, V97, P2898, DOI 10.1073/pnas.97.6.2898; Yoshioka M, 2006, J MOL ENDOCRINOL, V36, P247, DOI 10.1677/jme.1.01964; Yoshioka M, 2007, J MOL ENDOCRINOL, V39, P119, DOI 10.1677/JME-07-0027; Yu ZG, 2006, AM J PATHOL, V168, P195, DOI 10.2353/ajpath.2006.050619; Yu Z, 2006, J CLIN INVEST, V116, P2663, DOI 10.1172/JCI28773; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	61	44	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12922	10.1371/journal.pone.0012922	http://dx.doi.org/10.1371/journal.pone.0012922			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886071	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000282091100026
J	Mohamet, L; Lea, ML; Ward, CM				Mohamet, Lisa; Lea, Michelle L.; Ward, Christopher M.			Abrogation of E-Cadherin-Mediated Cellular Aggregation Allows Proliferation of Pluripotent Mouse Embryonic Stem Cells in Shake Flask Bioreactors	PLOS ONE			English	Article							5T4 ONCOFETAL ANTIGEN; SELF-RENEWAL; SUSPENSION BIOREACTORS; DIFFERENTIATION; EXPANSION; CULTURE; INDUCTION; SERUM	Background: A fundamental requirement for the exploitation of embryonic stem (ES) cells in regenerative medicine is the ability to reproducibly derive sufficient numbers of cells of a consistent quality in a cost-effective manner. However, undifferentiated ES cells are not ideally suited to suspension culture due to the formation of cellular aggregates, ultimately limiting scalability. Significant advances have been made in recent years in the culture of ES cells, including automated adherent culture and suspension microcarrier or embryoid body bioreactor culture. However, each of these methods exhibits specific disadvantages, such as high cost, additional downstream processes or reduced cell doubling times. Methodology/Principal Findings: Here we show that abrogation of the cell surface protein E-cadherin, using either gene knockout (Ecad-/-) or the neutralising antibody DECMA-1 (EcadAb), allows culture of mouse ES cells as a near-single cell suspension in scalable shake flask culture over prolonged periods without additional media supplements. Both Ecad-/- and EcadAb ES cells exhibited adaptation phases in suspension culture, with optimal doubling times of 7.3 h +/- 60.9 and 15.6 h +/- 64.7 respectively and mean-fold increase in viable cell number of 95.1 +/- 2.0 and 16 +/- 0.9-fold over 48 h. EcadAb ES cells propagated as a dispersed cell suspension for 15 d maintained expression of pluripotent markers, exhibited a normal karyotype and high viability. Subsequent differentiation of EcadAb ES cells resulted in expression of transcripts and proteins associated with the three primary germ layers. Conclusions/Significance: This is the first demonstration of the culture of pluripotent ES cells as a near-single cell suspension in a manual fed-batch shake flask bioreactor and represents a significant improvement on current ES cell culture techniques. Whilst this proof-of-principle method would be useful for the culture of human ES and iPS cells, further steps are necessary to increase cell viability of hES cells in suspension.	[Mohamet, Lisa; Ward, Christopher M.] Univ Manchester, Fac Med & Human Sci, Core Technol Facil, Manchester, Lancs, England; [Lea, Michelle L.] Eden Biodesign Ltd, Liverpool, Merseyside, England	University of Manchester	Mohamet, L (corresponding author), Univ Manchester, Fac Med & Human Sci, Core Technol Facil, Manchester, Lancs, England.	christopher.ward@manchester.ac.uk	Mohamet, Lisa/K-3081-2015	Mohamet, Lisa/0000-0001-6336-8775; Ward, Christopher/0000-0001-7389-4488	Northwest Development Agency (NWDA); Biotechnology and Biological Sciences Research Council; Engineering and Physical Sciences Research Council; Technology Strategy Board; BBSRC [BB/E527239/1] Funding Source: UKRI; EPSRC [TS/G000646/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E527239/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [TS/G000646/1] Funding Source: researchfish	Northwest Development Agency (NWDA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Technology Strategy Board; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by the Access Fund from the Northwest Development Agency (NWDA) (http://www.nwda.co.uk/). LM and CW are supported by grants from the Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/), the Engineering and Physical Sciences Research Council (http://www.epsrc.ac.uk/) and the Technology Strategy Board (http://www.innovateuk.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abranches E, 2007, BIOTECHNOL BIOENG, V96, P1211, DOI 10.1002/bit.21191; Bauwens C, 2005, BIOTECHNOL BIOENG, V90, P452, DOI 10.1002/bit.20445; Buchs J, 2001, BIOCHEM ENG J, V7, P91, DOI 10.1016/S1369-703X(00)00106-6; Cormier JT, 2006, TISSUE ENG, V12, P3233, DOI 10.1089/ten.2006.12.3233; Dang SM, 2004, STEM CELLS, V22, P275, DOI 10.1634/stemcells.22-3-275; Dang Stephen M, 2005, Methods Mol Biol, V290, P353; Eastham AM, 2007, CANCER RES, V67, P11254, DOI 10.1158/0008-5472.CAN-07-2253; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fok EYL, 2005, STEM CELLS, V23, P1333, DOI 10.1634/stemcells.2005-0112; Harb N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003001; Kehoe DE, 2008, BIOTECHNOL PROGR, V24, P1342, DOI 10.1002/btpr.57; Larue L, 1996, DEVELOPMENT, V122, P3185; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Mizuseki K, 1998, DEVELOPMENT, V125, P579; Murray P, 2001, J CELL SCI, V114, P931; Oh SKW, 2005, BIOTECHNOL BIOENG, V91, P523, DOI 10.1002/bit.20650; Sen A, 2002, BIOTECHNOL PROGR, V18, P337, DOI 10.1021/bp010150t; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Soncin F, 2009, STEM CELLS, V27, P2069, DOI 10.1002/stem.134; Spencer HL, 2007, MOL BIOL CELL, V18, P2838, DOI 10.1091/mbc.E06-09-0875; STRASBERG RM, 2007, APOPTOSIS, V12, P449; Thomson H, 2007, TRENDS BIOTECHNOL, V25, P224, DOI 10.1016/j.tibtech.2007.03.003; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tsuji Y, 2008, DEV DYNAM, V237, P2129, DOI 10.1002/dvdy.21617; VESTWEBER D, 1984, EXP CELL RES, V152, P169, DOI 10.1016/0014-4827(84)90241-6; VESTWEBER D, 1985, DEV BIOL, V112, P213, DOI 10.1016/0012-1606(85)90135-6; Ward CM, 2003, J CELL SCI, V116, P4533, DOI 10.1242/jcs.00767; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; zur Nieden NI, 2007, J BIOTECHNOL, V129, P421, DOI 10.1016/j.jbiotec.2007.01.006	32	43	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12921	10.1371/journal.pone.0012921	http://dx.doi.org/10.1371/journal.pone.0012921			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886069	Green Submitted, Green Published, gold			2022-12-27	WOS:000282091100025
J	Lyons, JA; Haring, JS; Biga, PR				Lyons, Jeri-Anne; Haring, Jodie S.; Biga, Peggy R.			Myostatin Expression, Lymphocyte Population, and Potential Cytokine Production Correlate with Predisposition to High-Fat Diet Induced Obesity in Mice	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; INNATE IMMUNE PROTECTION; BETA SUPERFAMILY MEMBER; INBRED MOUSE STRAINS; SKELETAL-MUSCLE MASS; INSULIN-RESISTANCE; ADIPOSE-TISSUE; LISTERIA-MONOCYTOGENES; TRANSGENIC MICE; GLUCOSE-UPTAKE	A strong relationship exists between increased inflammatory cytokines and muscle insulin resistance in obesity. This study focused on identifying a relationship between metabolic propensity and myostatin expression in muscle and spleen cells in response to high-fat diet intake. Using a comparative approach, we analyzed the effects of high-fat diet intake on myostatin and follistatin expression, spleen cell composition, and potential cytokine expression in high-fat diet induced obesity (HFDIO) resistant (SWR/J) and susceptible (C57BL/6) mice models. Results demonstrated overall increased myostatin expression in muscle following high-fat diet intake in HFDIO-susceptible mice, while myostatin expression levels decreased initially in muscle from high-fat diet fed resistant mice. In HFDIO-resistant mice, myostatin expression decreased in spleen, while myostatin increased in spleen tissue from HFDIO-susceptible mice. Proinflammatory cytokine (IL-17, IL-1 beta, and IFN gamma) potential increased in splenocytes from HFDIO-susceptible mice. In comparison, C57BL/6 mice fed a high-fat diet exhibited higher frequencies of CD4(+)/CD44(hi) and CD8(+)/CD44(hi) cells in the spleen compared to control fed mice. Together, these results suggest that susceptibility to high-fat diet induced obesity could be influenced by local myostatin activity in a tissue-specific manner and that splenocytes exhibit differential cytokine production in a strain-dependent manner. This study sets the stage for future investigations into the interactions between growth, inflammation, and metabolism.	[Lyons, Jeri-Anne] Univ Wisconsin, Dept Clin Hlth Sci, Milwaukee, WI 53201 USA; [Haring, Jodie S.] N Dakota State Univ, Dept Chem & Mol Biol, Fargo, ND 58105 USA; [Biga, Peggy R.] N Dakota State Univ, Dept Biol Sci, Fargo, ND 58105 USA	University of Wisconsin System; University of Wisconsin Milwaukee; North Dakota State University Fargo; North Dakota State University Fargo	Lyons, JA (corresponding author), Univ Wisconsin, Dept Clin Hlth Sci, Milwaukee, WI 53201 USA.	peggy.biga@ndsu.edu		Biga, Peggy/0000-0002-0540-291X	NIH NCRR COBRE, Center for Protease Research [2P20RR015566]; NSF [EPS-00447679]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015566] Funding Source: NIH RePORTER	NIH NCRR COBRE, Center for Protease Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NSF(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by funds to PRB by NIH NCRR COBRE, Center for Protease Research Grant # 2P20RR015566 and ND EPSCoR Grant # EPS-00447679 from NSF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khalili L, 2006, MOL ENDOCRINOL, V20, P3364, DOI 10.1210/me.2005-0490; Amthor H, 2004, DEV BIOL, V270, P19, DOI 10.1016/j.ydbio.2004.01.046; Artaza JN, 2005, ENDOCRINOLOGY, V146, P3547, DOI 10.1210/en.2005-0362; BARON AD, 1988, AM J PHYSIOL, V255, pE769, DOI 10.1152/ajpendo.1988.255.6.E769; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Bastard JP, 2002, J CLIN ENDOCR METAB, V87, P2084, DOI 10.1210/jc.87.5.2084; Berg RE, 2005, J IMMUNOL, V175, P1751, DOI 10.4049/jimmunol.175.3.1751; Berg RE, 2003, J EXP MED, V198, P1583, DOI 10.1084/jem.20031051; Biga PR, 2004, GEN COMP ENDOCR, V138, P32, DOI 10.1016/j.ygcen.2004.05.001; Bruce CR, 2004, AM J PHYSIOL-ENDOC M, V287, pE616, DOI 10.1152/ajpendo.00150.2004; Carey AL, 2004, DIABETOLOGIA, V47, P1029, DOI 10.1007/s00125-004-1403-x; Cline GW, 1999, NEW ENGL J MED, V341, P240, DOI 10.1056/NEJM199907223410404; DAGENAIS GR, 1976, J CLIN INVEST, V58, P421, DOI 10.1172/JCI108486; Feldman BJ, 2006, P NATL ACAD SCI USA, V103, P15675, DOI 10.1073/pnas.0607501103; Fried SK, 1998, J CLIN ENDOCR METAB, V83, P847, DOI 10.1210/jc.83.3.847; GOTTSCHLICH MM, 1993, J AM DIET ASSOC, V93, P1261, DOI 10.1016/0002-8223(93)91952-M; Guo TQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004937; Guzik TJ, 2006, J PHYSIOL PHARMACOL, V57, P505; Hamrick MW, 2006, INT J OBESITY, V30, P868, DOI 10.1038/sj.ijo.0803200; Hill JJ, 2002, J BIOL CHEM, V277, P40735, DOI 10.1074/jbc.M206379200; Horsley V, 2003, CELL, V113, P483, DOI 10.1016/S0092-8674(03)00319-2; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Kishioka Y, 2008, J CELL PHYSIOL, V215, P856, DOI 10.1002/jcp.21371; KRISHNAN EC, 1982, J SURG RES, V33, P89, DOI 10.1016/0022-4804(82)90012-9; Lazar MA, 2005, SCIENCE, V307, P373, DOI 10.1126/science.1104342; Lewis SR, 2007, PHYSIOL BEHAV, V90, P82, DOI 10.1016/j.physbeh.2006.08.028; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; MCINNES A, 1988, J EXP MED, V167, P598, DOI 10.1084/jem.167.2.598; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 2002, J CLIN INVEST, V109, P595, DOI 10.1172/JCI200213562; Miura T, 2006, BIOCHEM BIOPH RES CO, V340, P675, DOI 10.1016/j.bbrc.2005.12.060; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; OH IS, AM J PHYSL ENDOCRINO, V299, pE47; PAIGEN B, 1995, AM J CLIN NUTR, V62, p458S, DOI 10.1093/ajcn/62.2.458S; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reisz-Porszasz S, 2003, AM J PHYSIOL-ENDOC M, V285, pE876, DOI 10.1152/ajpendo.00107.2003; Rocha VZ, 2008, CIRC RES, V103, P467, DOI 10.1161/CIRCRESAHA.108.177105; Rodgers BD, 2003, AM J PHYSIOL-REG I, V284, pR1277, DOI 10.1152/ajpregu.00644.2002; Sharma M, 1999, J CELL PHYSIOL, V180, P1; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Smith AG, 2007, J NUTR, V137, P1236, DOI 10.1093/jn/137.5.1236; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; Thomas M, 2000, J BIOL CHEM, V275, P40235, DOI 10.1074/jbc.M004356200; Trickett A, 2003, J IMMUNOL METHODS, V275, P251, DOI 10.1016/S0022-1759(03)00010-3; Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; WEST DB, 1992, AM J PHYSIOL, V262, pR1025, DOI 10.1152/ajpregu.1992.262.6.R1025; White LJ, 2006, METABOLISM, V55, P128, DOI 10.1016/j.metabol.2005.08.026; Willoughby DS, 2004, MED SCI SPORT EXER, V36, P574, DOI 10.1249/01.MSS.0000121952.71533.EA; Yang JZ, 2001, MOL REPROD DEV, V60, P351, DOI 10.1002/mrd.1097; Zhao BQ, 2005, BIOCHEM BIOPH RES CO, V337, P248, DOI 10.1016/j.bbrc.2005.09.044; Zhu J, 2007, J BIOL CHEM, V282, P25852, DOI 10.1074/jbc.M704146200	54	26	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12928	10.1371/journal.pone.0012928	http://dx.doi.org/10.1371/journal.pone.0012928			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877574	Green Submitted, Green Published, gold			2022-12-27	WOS:000282053100034
J	Rujoi, M; Pipalia, NH; Maxfield, FR				Rujoi, Madalina; Pipalia, Nina H.; Maxfield, Frederick R.			Cholesterol Pathways Affected by Small Molecules That Decrease Sterol Levels in Niemann-Pick Type C Mutant Cells	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; HAMSTER OVARY CELLS; COENZYME-A REDUCTASE; INTRACELLULAR TRAFFICKING; PLASMA-MEMBRANE; CULTURED FIBROBLASTS; ACYL-COENZYME; PROTEIN; DISEASE; RECEPTOR	Background: Niemann-Pick type C (NPC) disease is a genetically inherited multi-lipid storage disorder with impaired efflux of cholesterol from lysosomal storage organelles. Methodology/Principal Findings: The effect of screen-selected cholesterol lowering compounds on the major sterol pathways was studied in CT60 mutant CHO cells lacking NPC1 protein. Each of the selected chemicals decreases cholesterol in the lysosomal storage organelles of NPC1 mutant cells through one or more of the following mechanisms: increased cholesterol efflux from the cell, decreased uptake of low-density lipoproteins, and/or increased levels of cholesteryl esters. Several chemicals promote efflux of cholesterol to extracellular acceptors in both non-NPC and NPC1 mutant cells. The uptake of low-density lipoprotein-derived cholesterol is inhibited by some of the studied compounds. Conclusions/Significance: Results herein provide the information for prioritized further studies in identifying molecular targets of the chemicals. This approach proved successful in the identification of seven chemicals as novel inhibitors of lysosomal acid lipase (Rosenbaum et al, Biochim. Biophys. Acta. 2009, 1791:1155-1165).	[Rujoi, Madalina; Pipalia, Nina H.; Maxfield, Frederick R.] Weill Cornell Med Coll, Dept Biochem, New York, NY USA	Cornell University	Rujoi, M (corresponding author), Depaul Univ, Dept Chem, Chicago, IL 60604 USA.	frmaxfie@med.cornell.edu	Maxfield, Fred/A-1718-2011; Maxfield, Fred/M-6747-2019	Maxfield, Fred/0000-0003-4396-8866	NIH [R37-DK27083]; Ara Parseghian Medical Research Foundation; W.M. Keck Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK027083] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ara Parseghian Medical Research Foundation; W.M. Keck Foundation(W.M. Keck Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grant R37-DK27083 (http://www.nih.gov/) and a grant from the Ara Parseghian Medical Research Foundation (http:// www.parseghian.org/). MR was supported in part by a grant from the W.M. Keck Foundation (http://www.wmkeck.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaven SW, 2006, ANNU REV MED, V57, P313, DOI 10.1146/annurev.med.57.121304.131428; Blanchette-Mackie EJ, 2000, BBA-MOL CELL BIOL L, V1486, P171, DOI 10.1016/S1388-1981(00)00055-X; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; BROWN MS, 1978, J BIOL CHEM, V253, P1121; CADIGAN KM, 1990, J CELL BIOL, V110, P295, DOI 10.1083/jcb.110.2.295; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; CASTANHO MARB, 1992, J BIOL CHEM, V267, P204; Chang TY, 2005, J BIOL CHEM, V280, P20917, DOI 10.1074/jbc.R400040200; Chang TY, 1997, ANNU REV BIOCHEM, V66, P613, DOI 10.1146/annurev.biochem.66.1.613; CHANG TY, 1980, J BIOL CHEM, V255, P7787; Choi HY, 2003, J BIOL CHEM, V278, P32569, DOI 10.1074/jbc.M304553200; Cosner CC, 2009, J MED CHEM, V52, P6494, DOI 10.1021/jm900707n; Cruz JC, 2000, J BIOL CHEM, V275, P4013, DOI 10.1074/jbc.275.6.4013; DAHL NK, 1992, J BIOL CHEM, V267, P4889; DUNN KW, 1992, J CELL BIOL, V117, P301, DOI 10.1083/jcb.117.2.301; Frolov A, 2003, J BIOL CHEM, V278, P25517, DOI 10.1074/jbc.M302588200; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; GOLDSTEIN JL, 1975, J BIOL CHEM, V250, P8487; Higgins ME, 1999, MOL GENET METAB, V68, P1, DOI 10.1006/mgme.1999.2882; Ikonen E, 2004, SEMIN CELL DEV BIOL, V15, P445, DOI 10.1016/j.semcdb.2004.03.001; Ioannou YA, 2005, TRENDS BIOCHEM SCI, V30, P498, DOI 10.1016/j.tibs.2005.07.007; Jones C, 2003, J BIOL CHEM, V278, P29024, DOI 10.1074/jbc.M304855200; KRISTENSEN T, 1990, FEBS LETT, V276, P151, DOI 10.1016/0014-5793(90)80530-V; LEFEVRE M, 1988, J LIPID RES, V29, P815; Lin S, 2003, MOL BIOL CELL, V14, P2447, DOI 10.1091/mbc.E02-11-0725; LISCUM L, 1989, J CELL BIOL, V108, P1625, DOI 10.1083/jcb.108.5.1625; Liscum L, 2004, BBA-MOL CELL BIOL L, V1685, P22, DOI 10.1016/j.bbalip.2004.08.008; LISCUM L, 1987, J BIOL CHEM, V262, P17002; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Morris JA, 1998, MOL MED TODAY, V4, P525, DOI 10.1016/S1357-4310(98)01374-4; Mukhejee S, 2004, BBA-MOL CELL BIOL L, V1685, P28, DOI 10.1016/j.bbalip.2004.08.009; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; Neufeld EB, 1996, J BIOL CHEM, V271, P21604, DOI 10.1074/jbc.271.35.21604; Neufeld EB, 1999, J BIOL CHEM, V274, P9627, DOI 10.1074/jbc.274.14.9627; Ohgami N, 2004, P NATL ACAD SCI USA, V101, P12473, DOI 10.1073/pnas.0405255101; Okamura N, 1999, BBA-MOL CELL BIOL L, V1438, P377, DOI 10.1016/S1388-1981(99)00070-0; Pagano RE, 2003, PHILOS T R SOC B, V358, P885, DOI 10.1098/rstb.2003.1275; Patel SC, 1999, P NATL ACAD SCI USA, V96, P1657, DOI 10.1073/pnas.96.4.1657; Patterson MC, 2004, BBA-MOL CELL BIOL L, V1685, P77, DOI 10.1016/j.bbalip.2004.08.013; PENTCHEV PG, 1985, P NATL ACAD SCI USA, V82, P8247, DOI 10.1073/pnas.82.23.8247; PENTCHEV PG, 1987, FASEB J, V1, P40, DOI 10.1096/fasebj.1.1.3609608; Pipalia NH, 2006, J LIPID RES, V47, P284, DOI 10.1194/jlr.M500388-JLR200; Pipalia NH, 2007, TRAFFIC, V8, P130, DOI 10.1111/j.1600-0854.2006.00513.x; PITAS RE, 1981, ARTERIOSCLEROSIS, V1, P177, DOI 10.1161/01.ATV.1.3.177; Reid PC, 2008, J NEUROSCI METH, V168, P15, DOI 10.1016/j.jneumeth.2007.09.002; Repa JJ, 2007, J NEUROSCI, V27, P14470, DOI 10.1523/JNEUROSCI.4823-07.2007; Rosenbaum AI, 2009, BBA-MOL CELL BIOL L, V1791, P1155, DOI 10.1016/j.bbalip.2009.08.005; Scott C, 2004, BBA-MOL CELL BIOL L, V1685, P8, DOI 10.1016/j.bbalip.2004.08.006; SOKOL J, 1988, J BIOL CHEM, V263, P3411; SPILLANE DM, 1995, BBA-LIPID LIPID MET, V1254, P283, DOI 10.1016/0005-2760(94)00190-A; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; Sturley SL, 2004, BBA-MOL CELL BIOL L, V1685, P83, DOI 10.1016/j.bbalip.2004.08.014; Tall AR, 2003, ARTERIOSCL THROM VAS, V23, P710, DOI 10.1161/01.ATV.0000068683.51375.59; Vanier MT, 2003, CLIN GENET, V64, P269, DOI 10.1034/j.1399-0004.2003.00147.x; WILLINGHAM MC, 1979, J CELL BIOL, V82, P614, DOI 10.1083/jcb.82.3.614; Wojtanik KM, 2003, J BIOL CHEM, V278, P14850, DOI 10.1074/jbc.M300488200; Yvan-Charvet L, 2010, ARTERIOSCL THROM VAS, V30, P139, DOI 10.1161/ATVBAHA.108.179283; Zhang M, 2003, ACTA PAEDIATR, V92, P63, DOI 10.1080/08035320310021958	60	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2010	5	9							e12788	10.1371/journal.pone.0012788	http://dx.doi.org/10.1371/journal.pone.0012788			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652JO	20877719	Green Submitted, Green Published, gold			2022-12-27	WOS:000282002900002
J	Edwards, TE; Phan, I; Abendroth, J; Dieterich, SH; Masoudi, A; Guo, W; Hewitt, SN; Kelley, A; Leibly, D; Brittnacher, MJ; Staker, BL; Miller, SI; Van Voorhis, WC; Myler, PJ; Stewart, LJ				Edwards, Thomas E.; Phan, Isabelle; Abendroth, Jan; Dieterich, Shellie H.; Masoudi, Amir; Guo, Wenjin; Hewitt, Stephen N.; Kelley, Angela; Leibly, David; Brittnacher, Mitch J.; Staker, Bart L.; Miller, Samuel I.; Van Voorhis, Wesley C.; Myler, Peter J.; Stewart, Lance J.			Structure of a Burkholderia pseudomallei Trimeric Autotransporter Adhesin Head	PLOS ONE			English	Article							PROTEIN; DOMAIN; MODEL; YADA; PREDICTION; ALIGNMENT; TOOLS; BINDS; DNA	Background: Pathogenic bacteria adhere to the host cell surface using a family of outer membrane proteins called Trimeric Autotransporter Adhesins (TAAs). Although TAAs are highly divergent in sequence and domain structure, they are all conceptually comprised of a C-terminal membrane anchoring domain and an N-terminal passenger domain. Passenger domains consist of a secretion sequence, a head region that facilitates binding to the host cell surface, and a stalk region. Methodology/Principal Findings: Pathogenic species of Burkholderia contain an overabundance of TAAs, some of which have been shown to elicit an immune response in the host. To understand the structural basis for host cell adhesion, we solved a 1.35 angstrom resolution crystal structure of a BpaA TAA head domain from Burkholderia pseudomallei, the pathogen that causes melioidosis. The structure reveals a novel fold of an intricately intertwined trimer. The BpaA head is composed of structural elements that have been observed in other TAA head structures as well as several elements of previously unknown structure predicted from low sequence homology between TAAs. These elements are typically up to 40 amino acids long and are not domains, but rather modular structural elements that may be duplicated or omitted through evolution, creating molecular diversity among TAAs. Conclusions/Significance: The modular nature of BpaA, as demonstrated by its head domain crystal structure, and of TAAs in general provides insights into evolution of pathogen-host adhesion and may provide an avenue for diagnostics.	[Edwards, Thomas E.; Phan, Isabelle; Abendroth, Jan; Dieterich, Shellie H.; Masoudi, Amir; Guo, Wenjin; Hewitt, Stephen N.; Kelley, Angela; Leibly, David; Staker, Bart L.; Van Voorhis, Wesley C.; Myler, Peter J.; Stewart, Lance J.] Seattle Struct Genom Ctr Infect Dis SSGCID, Seattle, WA USA; [Edwards, Thomas E.; Abendroth, Jan; Dieterich, Shellie H.; Staker, Bart L.; Stewart, Lance J.] Emerald BioStruct, Bainbridge Isl, WA USA; [Phan, Isabelle; Masoudi, Amir; Guo, Wenjin; Myler, Peter J.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Hewitt, Stephen N.; Kelley, Angela; Leibly, David; Van Voorhis, Wesley C.] Univ Washington, Sch Med, Seattle, WA USA; [Brittnacher, Mitch J.; Miller, Samuel I.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Brittnacher, Mitch J.; Miller, Samuel I.] Univ Washington, Dept Med, Seattle, WA USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Brittnacher, Mitch J.; Miller, Samuel I.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA	Center for Infectious Disease Research; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Edwards, TE (corresponding author), Seattle Struct Genom Ctr Infect Dis SSGCID, Seattle, WA USA.	tedwards@embios.com	Myler, Peter John/AAR-9535-2021	Staker, Bart/0000-0001-9570-5086; Myler, Peter/0000-0002-0056-0513; Edwards, Thomas/0000-0002-0474-8003	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272200700057C]	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded under federal contract number HHSN272200700057C from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alvarez BH, 2010, J STRUCT BIOL, V170, P236, DOI 10.1016/j.jsb.2010.02.009; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Clifton MC, 2009, BIOMETALS, V22, P557, DOI 10.1007/s10534-009-9207-6; Conners R, 2008, EMBO J, V27, P1779, DOI 10.1038/emboj.2008.101; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dauter Miroslawa, 2007, Methods Mol Biol, V364, P149; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Eisen JA, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000224; El Tahir Y, 2000, MOL MICROBIOL, V37, P192, DOI 10.1046/j.1365-2958.2000.01992.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Hartmann MD, 2009, P NATL ACAD SCI USA, V106, P16950, DOI 10.1073/pnas.0907256106; Hoiczyk E, 2000, EMBO J, V19, P5989, DOI 10.1093/emboj/19.22.5989; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kantardjieff KA, 2003, PROTEIN SCI, V12, P1865, DOI 10.1110/ps.0350503; Kim DE, 2005, PROTEINS, V61, P193, DOI 10.1002/prot.20737; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Leo JC, 2008, PROTEIN ENG DES SEL, V21, P475, DOI 10.1093/protein/gzn025; Linke D, 2006, TRENDS MICROBIOL, V14, P264, DOI 10.1016/j.tim.2006.04.005; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Meng GY, 2006, EMBO J, V25, P2297, DOI 10.1038/sj.emboj.7601132; Meng G, 2008, J MOL BIOL, V384, P824, DOI 10.1016/j.jmb.2008.09.085; Mil-Homens D, 2010, MICROBIOL-SGM, V156, P1084, DOI 10.1099/mic.0.032623-0; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Myler P. J., 2009, Infectious Disorders - Drug Targets, V9, P493; Newman J, 2005, ACTA CRYSTALLOGR D, V61, P1426, DOI [10.1107/S0907444905024984, 10.1107/S090744905024984]; Nummelin H, 2004, EMBO J, V23, P701, DOI 10.1038/sj.emboj.7600100; Ray SK, 2002, MOL MICROBIOL, V46, P637, DOI 10.1046/j.1365-2958.2002.03188.x; Remmert M, 2010, MOL BIOL EVOL, V27, P1348, DOI 10.1093/molbev/msq017; Seib KL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000612; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Szczesny P, 2008, BIOINFORMATICS, V24, P1251, DOI 10.1093/bioinformatics/btn118; Szczesny P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000119; Tiyawisutsri R, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-19; van den Berg B, 2010, J MOL BIOL, V396, P627, DOI 10.1016/j.jmb.2009.12.061; Van Voorhis WC, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000530; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Wernimont A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005094; Yeo HJ, 2004, EMBO J, V23, P1245, DOI 10.1038/sj.emboj.7600142; Yogavel M, 2007, ACTA CRYSTALLOGR D, V63, P931, DOI 10.1107/S0907444907029174; Zhang Z, 2010, J MOL BIOL, V400, P335, DOI 10.1016/j.jmb.2010.04.049	49	27	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2010	5	9							e12803	10.1371/journal.pone.0012803	http://dx.doi.org/10.1371/journal.pone.0012803			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651YH	20862217	gold, Green Published, Green Submitted			2022-12-27	WOS:000281963200006
J	Factor, VM; Seo, D; Ishikawa, T; Kaposi-Novak, P; Marquardt, JU; Andersen, JB; Conner, EA; Thorgeirsson, SS				Factor, Valentina M.; Seo, Daekwan; Ishikawa, Tsuyoshi; Kaposi-Novak, Pal; Marquardt, Jens U.; Andersen, Jesper B.; Conner, Elizabeth A.; Thorgeirsson, Snorri S.			Loss of c-Met Disrupts Gene Expression Program Required for G2/M Progression during Liver Regeneration in Mice	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; MITOTIC CHROMOSOME CONDENSATION; SIGNAL-REGULATED KINASE; CELL-CYCLE PROGRESSION; EGF RECEPTOR; HISTONE H3; PATHWAY; PHOSPHORYLATION; MITOSIS; ACTIVATION	Background: Previous work has established that HGF/c-Met signaling plays a pivotal role in regulating the onset of S phase following partial hepatectomy (PH). In this study, we used Met(fl/fl); Alb-Cre(+/-) conditional knockout mice to determine the effects of c-Met dysfunction in hepatocytes on kinetics of liver regeneration. Methodology/Principal Finding: The priming events appeared to be intact in Met(fl/fl); Alb-Cre(+/-) livers. Up-regulation of stress response (MAFK, IKBZ, SOCS3) and early growth response (c-Myc, c-Jun, c-Fos, DUSP1 and 6) genes as assessed by RT-qPCR and/or microarray profiling was unchanged. This was consistent with an early induction of MAPK/Erk and STAT3. However, after a successful completion of the first round of DNA replication, c-Met deficient hepatocytes were blocked in early/mid G2 phase as shown by staining with phosphorylated form of histone H3. Furthermore, loss of c-Met in hepatocytes diminished the subsequent G1/S progression and delayed liver recovery after partial hepatectomy. Upstream signaling pathways involved in the blockage of G2/M transition included lack of persistent Erk1/2 activation and inability to up-regulate the levels of Cdk1, Plk1, Aurora A and B, and Mad2 along with a defective histone 3 phosphorylation and lack of chromatin condensation. Continuous supplementation with EGF in vitro increased proliferation of Met(fl/fl); Alb-Cre(+/-) primary hepatocytes and partially restored expression levels of mitotic cell cycle regulators albeit to a lesser degree as compared to control cultures. Conclusion/Significance: In conclusion, our results assign a novel non-redundant function for HGF/c-Met signaling in regulation of G2/M gene expression program via maintaining a persistent Erk1/2 activation throughout liver regeneration.	[Factor, Valentina M.; Seo, Daekwan; Ishikawa, Tsuyoshi; Kaposi-Novak, Pal; Marquardt, Jens U.; Andersen, Jesper B.; Conner, Elizabeth A.; Thorgeirsson, Snorri S.] NCI, Expt Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Factor, VM (corresponding author), NCI, Expt Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	snorri_thorgeirsson@nih.gov		Marquardt, Jens/0000-0002-8314-2682; Andersen, Jesper B/0000-0003-1760-5244	NIH; National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010638] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish or preparation of manuscript.	Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Boccaccio C, 1998, NATURE, V391, P285, DOI 10.1038/34657; Bollen M, 2009, TRENDS CELL BIOL, V19, P531, DOI 10.1016/j.tcb.2009.06.005; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borowiak M, 2004, P NATL ACAD SCI USA, V101, P10608, DOI 10.1073/pnas.0403412101; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; Dumesic PA, 2009, J CELL BIOL, V185, P409, DOI 10.1083/jcb.200804038; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Fremin C, 2009, HEPATOLOGY, V49, P930, DOI 10.1002/hep.22730; Fu Z, 2008, NAT CELL BIOL, V10, P1076, DOI 10.1038/ncb1767; Goto H, 2002, GENES CELLS, V7, P11, DOI 10.1046/j.1356-9597.2001.00498.x; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Ito T, 2007, J BIOCHEM, V141, P609, DOI 10.1093/jb/mvm091; Laoukili J, 2008, MOL CELL BIOL, V28, P3076, DOI 10.1128/MCB.01710-07; LARSSON N, 1995, J BIOL CHEM, V270, P14175, DOI 10.1074/jbc.270.23.14175; Lee JS, 2004, HEPATOLOGY, V40, P667, DOI 10.1002/hep.20375; Li JN, 2009, AM J PATHOL, V175, P947, DOI 10.2353/ajpath.2009.090043; Liao YJ, 2004, J BIOL CHEM, V279, P43107, DOI 10.1074/jbc.M407969200; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; Liu X, 2004, ONCOGENE, V23, P763, DOI 10.1038/sj.onc.1207188; MATSUMOTO K, 1991, J GASTROEN HEPATOL, V6, P509, DOI 10.1111/j.1440-1746.1991.tb00897.x; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Michalopoulos GK, 2010, AM J PATHOL, V176, P2, DOI 10.2353/ajpath.2010.090675; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Murphy LO, 2004, MOL CELL BIOL, V24, P144, DOI 10.1128/MCB.24.1.144-153.2004; Natarajan A, 2007, P NATL ACAD SCI USA, V104, P17081, DOI 10.1073/pnas.0704126104; Neuhauser Markus, 2006, Appl Bioinformatics, V5, P173, DOI 10.2165/00822942-200605030-00005; Paranjpe S, 2007, HEPATOLOGY, V45, P1471, DOI 10.1002/hep.21570; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Roberts EC, 2002, MOL CELL BIOL, V22, P7226, DOI 10.1128/MCB.22.20.7226-7241.2002; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Scheving LA, 2002, BIOCHEM BIOPH RES CO, V290, P197, DOI 10.1006/bbrc.2001.6157; Shiota G, 1998, INT J EXP PATHOL, V79, P267, DOI 10.1046/j.1365-2613.1998.730403.x; Strimmer K, 2008, BIOINFORMATICS, V24, P1461, DOI 10.1093/bioinformatics/btn209; Suryadinata R, 2010, BIOSCIENCE REP, V30, P243, DOI 10.1042/BSR20090171; Talarmin H, 1999, MOL CELL BIOL, V19, P6003; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; THROWER DA, 1995, EMBO J, V14, P918, DOI 10.1002/j.1460-2075.1995.tb07073.x; Vande Woude GF, 1997, CIBA F SYMP, V212, P119; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wright JH, 1999, P NATL ACAD SCI USA, V96, P11335, DOI 10.1073/pnas.96.20.11335; Yamamoto T, 2006, CURR BIOL, V16, P1171, DOI 10.1016/j.cub.2006.04.044	46	51	53	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2010	5	9							e12739	10.1371/journal.pone.0012739	http://dx.doi.org/10.1371/journal.pone.0012739			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650QH	20862286	Green Published, Green Submitted, gold			2022-12-27	WOS:000281864100007
J	Rassoul, RA; Alves, S; Pantesco, V; De Vos, J; Michel, B; Perret, M; Mestre-Frances, N; Verdier, JM; Devau, G				Rassoul, Ronza Abdel; Alves, Sabine; Pantesco, Veronique; De Vos, John; Michel, Bernard; Perret, Martine; Mestre-Frances, Nadine; Verdier, Jean-Michel; Devau, Gina			Distinct Transcriptome Expression of the Temporal Cortex of the Primate Microcebus murinus during Brain Aging versus Alzheimer's Disease-Like Pathology	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENE-EXPRESSION; NONHUMAN PRIMATE; PROSIMIAN PRIMATE; WHITE-MATTER; DISCRIMINATION; NEUROSCIENCE; PLASTICITY; PATTERNS; MEMORY	Aging is the primary risk factor of neurodegenerative disorders such as Alzheimer's disease (AD). However, the molecular events occurring during brain aging are extremely complex and still largely unknown. For a better understanding of these age-associated modifications, animal models as close as possible to humans are needed. We thus analyzed the transcriptome of the temporal cortex of the primate Microcebus murinus using human oligonucleotide microarrays (Affymetrix). Gene expression profiles were assessed in the temporal cortex of 6 young adults, 10 healthy old animals and 2 old, "AD-like" animals that presented beta-amyloid plaques and cortical atrophy, which are pathognomonic signs of AD in humans. Gene expression data of the 14,911 genes that were detected in at least 3 samples were analyzed. By SAM (significance analysis of microarrays), we identified 47 genes that discriminated young from healthy old and "AD-like" animals. These findings were confirmed by principal component analysis (PCA). ANOVA of the expression data from the three groups identified 695 genes (including the 47 genes previously identified by SAM and PCA) with significant changes of expression in old and "AD-like" in comparison to young animals. About one third of these genes showed similar changes of expression in healthy aging and in "AD-like" animals, whereas more than two thirds showed opposite changes in these two groups in comparison to young animals. Hierarchical clustering analysis of the 695 markers indicated that each group had distinct expression profiles which characterized each group, especially the "AD-like" group. Functional categorization showed that most of the genes that were up-regulated in healthy old animals and down-regulated in "AD-like" animals belonged to metabolic pathways, particularly protein synthesis. These data suggest the existence of compensatory mechanisms during physiological brain aging that disappear in "AD-like" animals. These results open the way to new exploration of physiological and "AD-like" aging in primates.	[Rassoul, Ronza Abdel; Alves, Sabine; Michel, Bernard; Mestre-Frances, Nadine; Verdier, Jean-Michel; Devau, Gina] Univ Montpellier 2, Montpellier, France; [Rassoul, Ronza Abdel; Alves, Sabine; Michel, Bernard; Mestre-Frances, Nadine; Verdier, Jean-Michel; Devau, Gina] INSERM, U710, Montpellier, France; [Rassoul, Ronza Abdel; Alves, Sabine; Michel, Bernard; Mestre-Frances, Nadine; Verdier, Jean-Michel; Devau, Gina] EPHE, F-75006 Paris, France; [Pantesco, Veronique; De Vos, John] Hop St Eloi, CHU Montpellier, Inst Res Biotherapy, Montpellier, France; [Michel, Bernard] Hop St Marguerite, Serv Neurol, Marseille, France; [Perret, Martine] UMR 7179 CNRS MNHN, Brunoy, France	Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite de Montpellier; CHU de Montpellier; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN)	Rassoul, RA (corresponding author), Univ Montpellier 2, Montpellier, France.	gina.devau@univ-montp2.fr	Mestre-Francés, Nadine/V-6289-2019; DE VOS, John/A-5703-2010	Mestre-Francés, Nadine/0000-0002-6856-3067; VERDIER, Jean-Michel/0000-0002-7252-1556; DE VOS, John/0000-0003-1880-4130	Projet Exploratoire Pluridisciplinaires-Sciences et Tecnologies de l'Information et de Ingenierie (PEPS-ST2I) du Centre National de la Recherche Scientifique (CNRS), France; Fondation Jerome Lejeune, France; Fond de Cooperation Scientifique Alzheimer, France; Fond Unique Interministeriel et Region Languedoc-Roussillon, France	Projet Exploratoire Pluridisciplinaires-Sciences et Tecnologies de l'Information et de Ingenierie (PEPS-ST2I) du Centre National de la Recherche Scientifique (CNRS), France(Centre National de la Recherche Scientifique (CNRS)); Fondation Jerome Lejeune, France; Fond de Cooperation Scientifique Alzheimer, France; Fond Unique Interministeriel et Region Languedoc-Roussillon, France(Region Occitanie)	This work was funded by Projet Exploratoire Pluridisciplinaires-Sciences et Tecnologies de l'Information et de Ingenierie (PEPS-ST2I) du Centre National de la Recherche Scientifique (CNRS), France; Fondation Jerome Lejeune, France; Fond de Cooperation Scientifique Alzheimer, France; Fond Unique Interministeriel et Region Languedoc-Roussillon, France. The funders had no role in the study design, collection and analyses of the data, decision to publish or preparation of the manuscript.	Berchtold NC, 2008, P NATL ACAD SCI USA, V105, P15605, DOI 10.1073/pnas.0806883105; Bertram L, 2009, HUM MOL GENET, V18, pR137, DOI 10.1093/hmg/ddp406; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Bons N, 1998, BRAIN RES BULL, V46, P1; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Burke SN, 2010, TRENDS NEUROSCI, V33, P153, DOI 10.1016/j.tins.2009.12.003; Burke SN, 2006, NAT REV NEUROSCI, V7, P30, DOI 10.1038/nrn1809; Caceres M, 2003, P NATL ACAD SCI USA, V100, P13030, DOI 10.1073/pnas.2135499100; Cayetanot F, 2009, CHRONOBIOL INT, V26, P1587, DOI 10.3109/07420520903398518; DELACOURTE A, 1995, CR ACAD SCI III-VIE, V318, P85; Duce JA, 2008, GLIA, V56, P106, DOI 10.1002/glia.20593; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fraser HB, 2005, PLOS BIOL, V3, P1653, DOI 10.1371/journal.pbio.0030274; Geschwind DH, 2009, NATURE, V461, P908, DOI 10.1038/nature08537; Hof PR, 2004, TRENDS NEUROSCI, V27, P607, DOI 10.1016/j.tins.2004.07.013; Joly M, 2004, PHYSIOL BEHAV, V82, P325, DOI 10.1016/j.physbeh.2004.03.019; Joly M, 2006, NEUROBIOL AGING, V27, P1045, DOI 10.1016/j.neurobiolaging.2005.05.001; Kelly KM, 2006, EPILEPSY RES, V68, pS5, DOI 10.1016/j.eplepsyres.2005.07.015; Khaitovich P, 2004, GENOME RES, V14, P1462, DOI 10.1101/gr.2538704; KRASKA A, 2009, NEUROBIOL A IN PRESS; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Liang WS, 2008, PHYSIOL GENOMICS, V33, P240, DOI 10.1152/physiolgenomics.00242.2007; Loerch PM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003329; Lu A, 2009, J MOL NEUROSCI, V38, P19, DOI 10.1007/s12031-008-9155-6; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Marvanova M, 2003, FASEB J, V17, P929, DOI 10.1096/fj.02-0681fje; Mestre-Frances N, 2000, NEUROBIOL DIS, V7, P1, DOI 10.1006/nbdi.1999.0270; Miller JA, 2008, J NEUROSCI, V28, P1410, DOI 10.1523/JNEUROSCI.4098-07.2008; Mucke L, 2009, NATURE, V461, P895, DOI 10.1038/461895a; Ondrejcak T, 2010, NEUROMOL MED, V12, P13, DOI 10.1007/s12017-009-8091-0; Papassotiropoulos A, 2006, J CLIN PSYCHIAT, V67, P652, DOI 10.4088/JCP.v67n0418; Parameshwaran K, 2008, EXP NEUROL, V210, P7, DOI 10.1016/j.expneurol.2007.10.008; Partridge L, 2002, NAT REV GENET, V3, P165, DOI 10.1038/nrg753; Perret M, 1997, J BIOL RHYTHM, V12, P136, DOI 10.1177/074873049701200205; Picq JL, 2007, EXP GERONTOL, V42, P223, DOI 10.1016/j.exger.2006.09.013; Reinius B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000100; ROTH TL, 2009, CURR OPINION NEUROBI, V19, P1; Salat DH, 2009, NEUROIMAGE, V48, P21, DOI 10.1016/j.neuroimage.2009.06.074; Sullivan EV, 2002, CEREB CORTEX, V12, P438, DOI 10.1093/cercor/12.4.438; Trouche SG, 2010, NEUROBIOL LEARN MEM, V94, P100, DOI 10.1016/j.nlm.2010.04.006; Trouche SG, 2009, VACCINE, V27, P957, DOI 10.1016/j.vaccine.2008.12.012; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Venkitaramani DV, 2007, J NEUROSCI, V27, P11832, DOI 10.1523/JNEUROSCI.3478-07.2007; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044	45	24	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2010	5	9							e12770	10.1371/journal.pone.0012770	http://dx.doi.org/10.1371/journal.pone.0012770			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650QH	20862281	gold, Green Published			2022-12-27	WOS:000281864100015
J	Sun, ZH; Errami, M; Long, T; Renard, C; Choradia, N; Garner, H				Sun, Zhaohui; Errami, Mounir; Long, Tara; Renard, Chris; Choradia, Nishant; Garner, Harold			Systematic Characterizations of Text Similarity in Full Text Biomedical Publications	PLOS ONE			English	Article							DEJA-VU; PLAGIARISM; CITATIONS; MEDLINE	Background: Computational methods have been used to find duplicate biomedical publications in MEDLINE. Full text articles are becoming increasingly available, yet the similarities among them have not been systematically studied. Here, we quantitatively investigated the full text similarity of biomedical publications in PubMed Central. Methodology/Principal Findings: 72,011 full text articles from PubMed Central (PMC) were parsed to generate three different datasets: full texts, sections, and paragraphs. Text similarity comparisons were performed on these datasets using the text similarity algorithm eTBLAST. We measured the frequency of similar text pairs and compared it among different datasets. We found that high abstract similarity can be used to predict high full text similarity with a specificity of 20.1% (95% CI [17.3%, 23.1%]) and sensitivity of 99.999%. Abstract similarity and full text similarity have a moderate correlation (Pearson correlation coefficient: -0.423) when the similarity ratio is above 0.4. Among pairs of articles in PMC, method sections are found to be the most repetitive (frequency of similar pairs, methods: 0.029, introduction: 0.0076, results: 0.0043). In contrast, among a set of manually verified duplicate articles, results are the most repetitive sections (frequency of similar pairs, results: 0.94, methods: 0.89, introduction: 0.82). Repetition of introduction and methods sections is more likely to be committed by the same authors (odds of a highly similar pair having at least one shared author, introduction: 2.31, methods: 1.83, results: 1.03). There is also significantly more similarity in pairs of review articles than in pairs containing one review and one nonreview paper (frequency of similar pairs: 0.0167 and 0.0023, respectively). Conclusion/Significance: While quantifying abstract similarity is an effective approach for finding duplicate citations, a comprehensive full text analysis is necessary to uncover all potential duplicate citations in the scientific literature and is helpful when establishing ethical guidelines for scientific publications.	[Sun, Zhaohui; Long, Tara; Garner, Harold] Virginia Bioinformat Inst, Blacksburg, VA USA; [Errami, Mounir; Renard, Chris; Choradia, Nishant] Collin Coll, Dept Math & Nat Sci, Plano, TX USA		Sun, ZH (corresponding author), Virginia Bioinformat Inst, Blacksburg, VA USA.	garner@vbi.vt.edu			Hudson Foundation; National Institutes of Health/National Library of Medicine [LM009758-01]; NATIONAL LIBRARY OF MEDICINE [R01LM009758] Funding Source: NIH RePORTER	Hudson Foundation; National Institutes of Health/National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The work was supported by the Hudson Foundation and the National Institutes of Health/National Library of Medicine (R01 grant number LM009758-01). The funders had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation, review, and approval of the manuscript.	Arriola-Quiroz I, 2010, HEALTH INFO LIBR J, V27, P148, DOI 10.1111/j.1471-1842.2010.00878.x; Bland JM, 2000, BRIT MED J, V320, P1468, DOI 10.1136/bmj.320.7247.1468; Couzin-Frankel J, 2009, SCIENCE, V324, P1004, DOI 10.1126/science.324_1004; Dove A, 2009, NAT MED, V15, P469, DOI 10.1038/nm0509-469a; ELM EV, 2004, JAMA-J AM MED ASSOC, V291, P974; Errami M, 2008, BIOINFORMATICS, V24, P243, DOI 10.1093/bioinformatics/btm574; Errami M, 2008, NATURE, V451, P397, DOI 10.1038/451397a; Errami M, 2009, NUCLEIC ACIDS RES, V37, pD921, DOI 10.1093/nar/gkn546; Lewis J, 2006, BIOINFORMATICS, V22, P2298, DOI 10.1093/bioinformatics/btl388; Long TC, 2009, SCIENCE, V323, P1293, DOI 10.1126/science.1167408; Mayta-Tristán Percy, 2009, Rev. perú. med. exp. salud publica, V26, P5; Reyes H, 2007, REV MED CHILE, V135, P529, DOI 10.4067/S0034-98872007000400017; Rojas-Revoredo V, 2007, REV MED CHILE, V135, P1087; Salinas Jorge Luis, 2008, Rev. gastroenterol. Perú, V28, P390	14	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12704	10.1371/journal.pone.0012704	http://dx.doi.org/10.1371/journal.pone.0012704			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856807	gold, Green Submitted, Green Published			2022-12-27	WOS:000281815800006
J	Stiebler, R; Hoang, AN; Egan, TJ; Wright, DW; Oliveira, MF				Stiebler, Renata; Hoang, Anh N.; Egan, Timothy J.; Wright, David W.; Oliveira, Marcus F.			Increase on the Initial Soluble Heme Levels in Acidic Conditions Is an Important Mechanism for Spontaneous Heme Crystallization In Vitro	PLOS ONE			English	Article							BETA-HEMATIN FORMATION; PLASMODIUM-FALCIPARUM; MALARIA PIGMENT; SCHISTOSOMA-MANSONI; HEMOZOIN FORMATION; POLYMERIZATION; DEGRADATION; MEMBRANE; PROLIXUS; MIDGUT	Background: Hemozoin (Hz) is a heme crystal that represents a vital pathway for heme disposal in several blood-feeding organisms. Recent evidence demonstrated that beta-hematin (beta H) (the synthetic counterpart of Hz) formation occurs under physiological conditions near synthetic or biological hydrophilic-hydrophobic interfaces. This seems to require a heme dimer acting as a precursor of Hz crystals that would be formed spontaneously in the absence of the competing water molecules bound to the heme iron. Here, we aimed to investigate the role of medium polarity on spontaneous beta H formation in vitro. Methodology/Principal Findings: We assessed the effect of water content on spontaneous beta H formation by using the aprotic solvent dimethylsulfoxide (DMSO) and a series of polyethyleneglycols (PEGs). We observed that both DMSO and PEGs (3.350, 6.000, 8.000, and 22.000) increased the levels of soluble heme under acidic conditions. These compounds were able to stimulate the production of beta H crystals in the absence of any biological sample. Interestingly, the effects of DMSO and PEGs on beta H formation were positively correlated with their capacity to promote previous heme solubilization in acidic conditions. Curiously, a short chain polyethyleneglycol (PEG 300) caused a significant reduction in both soluble heme levels and beta H formation. Finally, both heme solubilization and beta H rmation strongly correlated with reduced medium water activity provided by increased DMSO concentrations. Conclusions: The data presented here support the notion that reduction of the water activity is an important mechanism to support spontaneous heme crystallization, which depends on the previous increase of soluble heme levels.	[Stiebler, Renata; Oliveira, Marcus F.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Lab Bioquim Redox, Programa Biol Mol & Biotecnol, Rio De Janeiro, Brazil; [Hoang, Anh N.; Wright, David W.] Vanderbilt Univ, Dept Chem, Nashville, TN USA; [Egan, Timothy J.] Univ Cape Town, Dept Chem, ZA-7700 Rondebosch, South Africa	Universidade Federal do Rio de Janeiro; Vanderbilt University; University of Cape Town	Stiebler, R (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Lab Bioquim Redox, Programa Biol Mol & Biotecnol, Rio De Janeiro, Brazil.	timothy.egan@uct.ac.za; david.w.wright@vanderbilt.edu; maroli@bioqmed.ufrj.br	Oliveira, Marcus/G-3158-2011	Oliveira, Marcus/0000-0002-9890-8425	International Centre for Genetic Engineering and Biotechnology (ICGEB); CNPq; FAPERJ (Jovens Cientistas do Nosso Estado); CAPES; NIH [1R01AI083145-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083145] Funding Source: NIH RePORTER	International Centre for Genetic Engineering and Biotechnology (ICGEB); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ (Jovens Cientistas do Nosso Estado)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This investigation received financial support from the International Centre for Genetic Engineering and Biotechnology (ICGEB), CNPq, FAPERJ (Jovens Cientistas do Nosso Estado) and CAPES. MFO is a research scholar from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. TJE and DWW acknowledge support from the NIH (1R01AI083145-01) for their contributions to this study.	AFT RL, 1983, J BIOL CHEM, V258, P2069; AFT RL, 1984, J BIOL CHEM, V259, P301; BERGER BJ, 1995, ANAL BIOCHEM, V231, P151, DOI 10.1006/abio.1995.1514; Blauer G, 2002, ARCH BIOCHEM BIOPHYS, V398, P7, DOI 10.1006/abbi.2001.2638; BOGITSH BJ, 1991, J PARASITOL, V77, P187, DOI 10.2307/3283078; Bohle DS, 1997, J BIOL CHEM, V272, P713, DOI 10.1074/jbc.272.2.713; Bohle DS, 2002, ACTA CRYSTALLOGR D, V58, P1752, DOI 10.1107/S0907444902014294; BROWN WH, 1911, J EXP MED, V15, P579; Carter MD, 2007, BIOCHEM BIOPH RES CO, V363, P867, DOI 10.1016/j.bbrc.2007.09.051; Chen MM, 2001, MOL BIOCHEM PARASIT, V113, P1, DOI 10.1016/S0166-6851(00)00365-0; Soares JBR, 2007, FEBS LETT, V581, P1742, DOI 10.1016/j.febslet.2007.03.054; DE VILLIERS KA, 2007, J BIOL INORG CHEM, V12, P101; DORN A, 1995, NATURE, V374, P269, DOI 10.1038/374269a0; Dorn A, 1998, BIOCHEM PHARMACOL, V55, P737, DOI 10.1016/S0006-2952(97)00509-1; DUPONT Y, 1983, FEBS LETT, V156, P93, DOI 10.1016/0014-5793(83)80255-5; Egan TJ, 2006, DALTON T, P5024, DOI 10.1039/b610866k; Egan TJ, 2006, FEBS LETT, V580, P5105, DOI 10.1016/j.febslet.2006.08.043; Egan TJ, 2002, BIOCHEM J, V365, P343, DOI 10.1042/BJ20020793; Egan TJ, 2001, BIOCHEMISTRY-US, V40, P204, DOI 10.1021/bi0013501; Falk J.E, 1964, PORPHYRINS METALLOPO, P181, DOI [10.1002/jobm.19640040512, DOI 10.1002/JOBM.19640040512]; FITCH CD, 1987, J BIOL CHEM, V262, P15552; Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009; GUTTERIDGE JMC, 1988, BIOCHEM J, V256, P861, DOI 10.1042/bj2560861; Hempelmann E, 2003, TRENDS PARASITOL, V19, P23, DOI 10.1016/S1471-4922(02)00011-9; Hoang AN, 2010, DALTON T, V39, P1235, DOI 10.1039/b914359a; Huy NT, 2007, ACTA TROP, V101, P130, DOI 10.1016/j.actatropica.2007.01.001; IGNARRO LJ, 1984, J BIOL CHEM, V259, P6201; Jani D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000053; Kiss G., 2004, ATMOS CHEM PHYS DISC, V4, P7667, DOI DOI 10.5194/ACPD-4-7667-2004; Klonis N, 2007, BIOCHEM J, V407, P343, DOI 10.1042/BJ20070934; Mury FB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006966; Oliveira MF, 2007, COMP BIOCHEM PHYS C, V146, P168, DOI 10.1016/j.cbpc.2006.12.007; Oliveira MF, 2000, FEBS LETT, V477, P95, DOI 10.1016/S0014-5793(00)01786-5; Oliveira MF, 2005, FEBS LETT, V579, P6010, DOI 10.1016/j.febslet.2005.09.035; Pagola S, 2000, NATURE, V404, P307, DOI 10.1038/35005132; Pisciotta JM, 2007, BIOCHEM J, V402, P197, DOI 10.1042/BJ20060986; Ponka P, 1999, AM J MED SCI, V318, P241, DOI 10.1097/00000441-199910000-00004; Ryter SW, 2000, FREE RADICAL BIO MED, V28, P289, DOI 10.1016/S0891-5849(99)00223-3; SCHMITT TH, 1993, ARCH BIOCHEM BIOPHYS, V307, P96, DOI 10.1006/abbi.1993.1566; SLATER AFG, 1991, P NATL ACAD SCI USA, V88, P325, DOI 10.1073/pnas.88.2.325; Stiebler R, 2010, INSECT BIOCHEM MOLEC, V40, P284, DOI 10.1016/j.ibmb.2009.12.013; Sullivan DJ, 1996, P NATL ACAD SCI USA, V93, P11865, DOI 10.1073/pnas.93.21.11865; TAPPEL AL, 1955, J BIOL CHEM, V217, P721; Terra W. R., 1996, P206; TERRA WR, 1988, BRAZ J MED BIOL RES, V21, P675; WHITE KA, 1992, BIOCHEMISTRY-US, V31, P6627, DOI 10.1021/bi00144a001	46	19	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2010	5	9							e12694	10.1371/journal.pone.0012694	http://dx.doi.org/10.1371/journal.pone.0012694			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648ZZ	20856937	gold, Green Published, Green Submitted			2022-12-27	WOS:000281735700014
J	Lugada, E; Millar, D; Haskew, J; Grabowsky, M; Garg, N; Vestergaard, M; Kahn, J; Muraguri, N; Mermin, J				Lugada, Eric; Millar, Debra; Haskew, John; Grabowsky, Mark; Garg, Navneet; Vestergaard, Mikkel; Kahn, James; Muraguri, Nicholas; Mermin, Jonathan			Rapid Implementation of an Integrated Large-Scale HIV Counseling and Testing, Malaria, and Diarrhea Prevention Campaign in Rural Kenya	PLOS ONE			English	Article							MILLENNIUM DEVELOPMENT GOALS; INSECTICIDE-TREATED BEDNETS; RISK-FACTORS; COTRIMOXAZOLE PROPHYLAXIS; UGANDAN COMMUNITY; WESTERN KENYA; BED NETS; INFECTION; MORTALITY; ADULTS	Background: Integrated disease prevention in low resource settings can increase coverage, equity and efficiency in controlling high burden infectious diseases. A public-private partnership with the Ministry of Health, CDC, Vestergaard Frandsen and CHF International implemented a one-week integrated multi-disease prevention campaign. Method: Residents of Lurambi, Western Kenya were eligible for participation. The aim was to offer services to at least 80% of those aged 15-49. 31 temporary sites in strategically dispersed locations offered: HIV counseling and testing, 60 male condoms, an insecticide-treated bednet, a household water filter for women or an individual filter for men, and for those testing positive, a 3-month supply of cotrimoxazole and referral for follow-up care and treatment. Findings: Over 7 days, 47,311 people attended the campaign with a 96% uptake of the multi-disease preventive package. Of these, 99.7% were tested for HIV (87% in the target 15-49 age group); 80% had previously never tested. 4% of those tested were positive, 61% were women (5% of women and 3% of men), 6% had median CD4 counts of 541 cell/mL (IQR; 356, 754). 386 certified counselors attended to an average 17 participants per day, consistent with recommended national figures for mass campaigns. Among women, HIV infection varied by age, and was more likely with an ended marriage (e. g. widowed vs. never married, OR. 3.91; 95% CI. 2.87-5.34), and lack of occupation. In men, quantitatively stronger relationships were found (e. g. widowed vs. never married, OR. 7.0; 95% CI. 3.5-13.9). Always using condoms with a non-steady partner was more common among HIV-infected women participants who knew their status compared to those who did not (OR. 5.4 95% CI. 2.3-12.8). Conclusion: Through integrated campaigns it is feasible to efficiently cover large proportions of eligible adults in rural underserved communities with multiple disease preventive services simultaneously achieving various national and international health development goals.	[Lugada, Eric] CHF Int, Nairobi, Kenya; [Millar, Debra] CHF Int, Silver Spring, MD USA; [Haskew, John] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Grabowsky, Mark] ESP UN Fdn, Washington, DC USA; [Garg, Navneet; Vestergaard, Mikkel] Vestergaard Frandsen Inc, Lausanne, Switzerland; [Kahn, James] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Muraguri, Nicholas] Natl AIDS STI Control Program NASCOP, Minist Publ Hlth & Sanitat, Nairobi, Kenya; [Mermin, Jonathan] Ctr Dis Control & Prevent, Coordinating Off Global Hlth, Nairobi, Kenya	Liverpool School of Tropical Medicine; University of Liverpool; University of California System; University of California San Francisco	Lugada, E (corresponding author), CHF Int, Nairobi, Kenya.	ericlugada@yahoo.com	Mermin, Jonathan/J-9847-2012		Vestergaard Frandsen company	Vestergaard Frandsen company	Vestergaard Frandsen company provided a grant to CHF International Kenya to implement this integrated disease prevention program in Lurambi Division Western Kenya in conjunction with the Ministry of Public Health and Sanitation Kenya. In addition, the company manufactured and donated the long lasting insecticide treated bed nets (LLIN) and water filters used in this campaign. The funders had no role in study design, data collection and analysis, decision to publish, but two of their employees contributed as co-authors in the preparation of the manuscript.	Adazu K, 2005, AM J TROP MED HYG, V73, P1151, DOI 10.4269/ajtmh.2005.73.1151; [Anonymous], KENYA DEMOGRAPHIC HL; *CDCP, CDC ACT KEN; CLASEN T, 2008, INTERVENTIONS IMPROV; Curtis C, 2003, LANCET INFECT DIS, V3, P304, DOI 10.1016/S1473-3099(03)00612-1; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Holveck JC, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-6; Howard SC, 2000, T ROY SOC TROP MED H, V94, P357, DOI 10.1016/S0035-9203(00)90103-2; KIMAIYO SWK, 2008, 17 INT AIDS C AUG 20; Kitua AY, 2008, SCIENCE, V319, P900, DOI 10.1126/science.319.5865.900c; LAWN SD, LANCET INFECT DIS, V10, P489; MALAMBA SS, 1994, AIDS, V8, P253, DOI 10.1097/00002030-199402000-00014; Matovu JKB, 2002, TROP MED INT HEALTH, V7, P1064, DOI 10.1046/j.1365-3156.2002.00964.x; Mermin J, 2006, LANCET, V367, P1256, DOI 10.1016/S0140-6736(06)68541-3; Mermin J, 2005, AIDS, V19, P1035, DOI 10.1097/01.aids.0000174449.32756.c7; Mermin J, 2008, JAMA-J AM MED ASSOC, V300, P540, DOI 10.1001/jama.300.5.540; *NAT GUID HIV TEST, 2008, NAT AIDS STD CONTR P; NUNN AJ, 1994, AIDS, V8, P81, DOI 10.1097/00002030-199401000-00012; Parashar UD, 2003, B WORLD HEALTH ORGAN, V81, P236; Phillips-Howard PA, 2003, AM J TROP MED HYG, V68, P23, DOI 10.4269/ajtmh.2003.68.23; Quick R, 2003, INT J ENVIRON HEAL R, V13, pS115, DOI 10.1080/0960312031000102877; Sachs JD, 2005, LANCET, V365, P347, DOI 10.1016/S0140-6736(05)70201-4; Sachs JD, 2005, NEW ENGL J MED, V352, P115, DOI 10.1056/NEJMp048319; Wanyenze R, 2006, AIDS BEHAV, V10, P361, DOI 10.1007/s10461-005-9035-9; Weinhardt LS, 1999, AM J PUBLIC HEALTH, V89, P1397, DOI 10.2105/AJPH.89.9.1397; Were W, 2003, LANCET, V361, P1569, DOI 10.1016/S0140-6736(03)13212-6; *WHO, EPIDEMIOLOGICAL PROF; Wolff B, 2005, HEALTH POLICY PLANN, V20, P109, DOI 10.1093/heapol/czi013; World Health Organization, COUNTR PROF ENV BURD; World Health Organization, 2008, GLOB BURD DIS 2004 U; 2004, MMWR WEEKLY      DEC; 2007, KENYA AIDS INDICTOR; TOWARDS UNIVERSAL AC	33	58	58	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12435	10.1371/journal.pone.0012435	http://dx.doi.org/10.1371/journal.pone.0012435			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	643JL	20865049	Green Submitted, Green Published, gold			2022-12-27	WOS:000281292100028
J	Santos, HF; Cury, JC; Carmo, FL; Rosado, AS; Peixoto, RS				Santos, Henrique F.; Cury, Juliano C.; Carmo, Flavia L.; Rosado, Alexandre S.; Peixoto, Raquel S.			18S rDNA Sequences from Microeukaryotes Reveal Oil Indicators in Mangrove Sediment	PLOS ONE			English	Article							GENETIC DIVERSITY; PICOPLANKTON; WATERS; EUKARYOTES; ECOSYSTEMS; UNIVERSAL; POLLUTION; SOUTH	Background: Microeukaryotes are an effective indicator of the presence of environmental contaminants. However, the characterisation of these organisms by conventional tools is often inefficient, and recent molecular studies have revealed a great diversity of microeukaryotes. The full extent of this diversity is unknown, and therefore, the distribution, ecological role and responses to anthropogenic effects of microeukaryotes are rather obscure. The majority of oil from oceanic oil spills (e. g., the May 2010 accident in the Gulf of Mexico) converges on coastal ecosystems such as mangroves, which are threatened with worldwide disappearance, highlighting the need for efficient tools to indicate the presence of oil in these environments. However, no studies have used molecular methods to assess the effects of oil contamination in mangrove sediment on microeukaryotes as a group. Methodology/Principal Findings: We evaluated the population dynamics and the prevailing 18S rDNA phylotypes of microeukaryotes in mangrove sediment microcosms with and without oil contamination, using PCR/DGGE and clone libraries. We found that microeukaryotes are useful for monitoring oil contamination in mangroves. Our clone library analysis revealed a decrease in both diversity and species richness after contamination. The phylogenetic group that showed the greatest sensitivity to oil was the Nematoda. After contamination, a large increase in the abundance of the groups Bacillariophyta (diatoms) and Biosoecida was detected. The oil-contaminated samples were almost entirely dominated by organisms related to Bacillariophyta sp. and Cafeteria minima, which indicates that these groups are possible targets for biomonitoring oil in mangroves. The DGGE fingerprints also indicated shifts in microeukaryote profiles; specific band sequencing indicated the appearance of Bacillariophyta sp. only in contaminated samples and Nematoda only in non-contaminated sediment. Conclusions/Significance: We believe that the microeukaryotic targets indicated by our work will be of great applicability in biomonitoring hydrocarbons in mangroves under oil contamination risk or during recovery strategies.	[Santos, Henrique F.; Cury, Juliano C.; Carmo, Flavia L.; Rosado, Alexandre S.; Peixoto, Raquel S.] Univ Fed Rio de Janeiro, Lab Mol Microbial Ecol, Dept Gen Microbiol, Inst Microbiol Prof Paulo de Goes, Rio de Janeiro, Brazil	Universidade Federal do Rio de Janeiro	Santos, HF (corresponding author), Univ Fed Rio de Janeiro, Lab Mol Microbial Ecol, Dept Gen Microbiol, Inst Microbiol Prof Paulo de Goes, Rio de Janeiro, Brazil.	raquelpeixoto@micro.ufrj.br	Santos, Henrique/AAI-9410-2020; Rosado, Alexandre Soares/G-1955-2012; Santos, Henrique Fragoso dos/G-3697-2014; Peixoto, Raquel/V-2554-2019	Santos, Henrique/0000-0001-8850-7399; Rosado, Alexandre Soares/0000-0001-5135-1394; Santos, Henrique Fragoso dos/0000-0001-8850-7399; Cury, Juliano/0000-0002-1450-5726; Peixoto, Raquel/0000-0002-9536-3132	Petrobras; Brazilian National Research Council (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)	Petrobras(Fundacao de Amparo a Pesquisa do Amapa (FAPEAP)Petrobras); Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	H. F. S. was awarded with a Petrobras fellowship. A. S. R. also greatly appreciates the support of Brazilian National Research Council (CNPq) and the Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Araujo F. V. De, 1995, Antonie van Leeuwenhoek, V68, P91, DOI 10.1007/BF00873096; Beyrem H, 2010, MAR ENVIRON RES, V69, P248, DOI 10.1016/j.marenvres.2009.10.018; BRANDINI FP, 1997, PLANCTONOLOGIA PLATA; Burns K. A., 1998, MANGROVES SALT MARSH, V2, P63, DOI DOI 10.1023/A:1009959529039; Buss Daniel Forsin, 2003, Cad. Saúde Pública, V19, P465, DOI 10.1590/S0102-311X2003000200013; Caron DA, 1999, LIMNOL OCEANOGR, V44, P259, DOI 10.4319/lo.1999.44.2.0259; Cesar A, 2007, ENVIRON INT, V33, P429, DOI 10.1016/j.envint.2006.11.007; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; Chen QH, 2009, MAR POLLUT BULL, V58, P711, DOI 10.1016/j.marpolbul.2008.12.020; Cheung MK, 2010, ISME J, V4, P1053, DOI 10.1038/ismej.2010.26; COULL BC, 1992, OCEANOGR MAR BIOL, V30, P191; Diez B, 2001, APPL ENVIRON MICROB, V67, P2932, DOI 10.1128/AEM.67.7.2932-2941.2001; Duke NC, 2007, SCIENCE, V317, P41, DOI 10.1126/science.317.5834.41b; El-Sheekh MM, 2000, WATER AIR SOIL POLL, V124, P187, DOI 10.1023/A:1005268615405; El-Tarabily KA, 2002, CAN J MICROBIOL, V48, P176, DOI 10.1139/W01-140; Epstein S, 2008, BIODIVERS CONSERV, V17, P261, DOI 10.1007/s10531-007-9250-y; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; FELSESTEIN J, 1993, PHYLOGENETIC INFEREN; Gadanho M, 2006, FEMS MICROBIOL ECOL, V57, P139, DOI 10.1111/j.1574-6941.2006.00098.x; GIOVANNONI SJ, 1990, NATURE, V345, P60, DOI 10.1038/345060a0; Hagler AN, 2006, BIODIVERSITY AND ECOPHYSIOLOGY OF YEASTS, P515, DOI 10.1007/3-540-30985-3_21; HAGLER AN, 1993, CAN J MICROBIOL, V39, P973, DOI 10.1139/m93-146; HYNE RV, 2000, MACROINVERTEBRATE BI; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; Lee SY, 2006, AUSTRAL ECOL, V31, P149, DOI 10.1111/j.1442-9993.2006.01581.x; Li HL, 2007, MAR POLLUT BULL, V54, P1146, DOI 10.1016/j.marpolbul.2007.04.015; LI WKW, 1983, SCIENCE, V219, P292, DOI 10.1126/science.219.4582.292; Lopez-Garcia P, 2001, NATURE, V409, P603, DOI 10.1038/35054537; Massana R, 2008, CURR OPIN MICROBIOL, V11, P213, DOI 10.1016/j.mib.2008.04.004; MENDONC A, 2001, OECOL BRASILIENSIS, V9, P197; Middelhoven WJ, 2000, INT J SYST EVOL MICR, V50, P381, DOI 10.1099/00207713-50-1-381; Moon-van der Staay SY, 2001, NATURE, V409, P607, DOI 10.1038/35054541; Moreno M, 2009, MAR POLLUT BULL, V58, P1192, DOI 10.1016/j.marpolbul.2009.03.016; NOT F, 2009, MAR PROT DIVERS, V4, P1; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rajkumar M, 2009, J ENVIRON BIOL, V30, P489; Rappe MS, 1998, APPL ENVIRON MICROB, V64, P294; SANTOS HF, 2010, WATER AIR S IN PRESS; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Shannon C. E., 1949, MATH THEORY COMMUNIC; STOECK T, 2010, MOL ECOL, V31, P19; Sunil Kumar R., 2000, Zoos' Print Journal, V15, P221; Takishita K, 2008, MAR BIOTECHNOL, V10, P13, DOI 10.1007/s10126-007-9032-2; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Valiela I, 1995, MARINE ECOLOGICAL PR; Wilms R, 2006, APPL ENVIRON MICROB, V72, P2756, DOI 10.1128/AEM.72.4.2756-2764.2006; Zuendorf A, 2006, FEMS MICROBIOL ECOL, V58, P476, DOI 10.1111/j.1574-6941.2006.00171.x	50	38	39	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12437	10.1371/journal.pone.0012437	http://dx.doi.org/10.1371/journal.pone.0012437			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865054	Green Published, gold, Green Submitted			2022-12-27	WOS:000281292100030
J	Toussaint, J; Durbecq, V; Altintas, S; Doriath, V; Rouas, G; Paesmans, M; Bedard, P; Haibe-Kains, B; Tjalma, WA; Larsimont, D; Piccart, M; Sotiriou, C				Toussaint, Jerome; Durbecq, Virginie; Altintas, Sevilay; Doriath, Valerie; Rouas, Ghizlane; Paesmans, Marianne; Bedard, Philippe; Haibe-Kains, Benjamin; Tjalma, Wiebren A.; Larsimont, Denis; Piccart, Martine; Sotiriou, Christos			Low CD10 mRNA Expression Identifies High-Risk Ductal Carcinoma In Situ (DCIS)	PLOS ONE			English	Article							BREAST-CONSERVING TREATMENT; MYOEPITHELIAL CELLS; RADIATION-THERAPY; PROGNOSTIC INDEX; YOUNG AGE; CANCER; INVASION	Purpose: Optimal management of breast ductal carcinoma in situ (DCIS) is controversial, and many patients are still overtreated. The local death of myoepithelial cells (MECs) is believed to be a pre-requisite to tumor invasion. We thus hypothesized that loss of CD10 expression, a MEC surface peptidase, would signify basement membrane disruption and confer increased risk of relapse in DCIS. The aim of our study was to retrospectively evaluate the prognostic value of CD10 in DCIS. Experimental Design: CD10 expression was evaluated by quantitative RT-PCR and immunohistochemistry using paraffin-embedded samples of normal breast tissue (n = 11); of morphologically normal ducts associated with DCIS (n = 10); and of DCIS without an invasive component (n = 154). Results: CD10 immunostaining was only observed in MECs in normal tissue and in DCIS. Normal tissue showed high mRNA expression levels of CD10, whereas DCIS showed a variable range. After a median follow-up of 6 years, DCIS with CD10 expression below the levels observed in normal tissue (71%) demonstrated a higher risk of local relapse (HR = 1.88; [95CI: 1.30-2.70], p = 0.001) in univariate analysis. No relapse was observed in patients expressing high CD10 mRNA levels (29%) similar to the ones observed in normal tissue. In multivariate analysis including known prognostic factors, low CD10 mRNA expression remained significant (HR = 2.25; [95% CI: 1.24-4.09], p = 0.008), as did the recently revised Van Nuys Prognostic Index (VNPI) score (HR = 2.03; [95% CI: 1.23-3.35], p = 0.006). Conclusion: The decrease of CD10 expression in MECs is associated with a higher risk of relapse in DCIS; this knowledge has the potential to improve DCIS management.	[Toussaint, Jerome; Durbecq, Virginie; Rouas, Ghizlane; Paesmans, Marianne; Bedard, Philippe; Haibe-Kains, Benjamin; Larsimont, Denis; Piccart, Martine; Sotiriou, Christos] Inst Jules Bordet, Breast Canc Translat Res Lab JC Heuson, B-1000 Brussels, Belgium; [Doriath, Valerie; Piccart, Martine; Sotiriou, Christos] Inst Jules Bordet, Dept Med Oncol, B-1000 Brussels, Belgium; [Altintas, Sevilay; Tjalma, Wiebren A.] Univ Antwerp Hosp, Dept Med Oncol, Edegem, Belgium	Institut Jules Bordet; Institut Jules Bordet; University of Antwerp	Toussaint, J (corresponding author), Inst Jules Bordet, Breast Canc Translat Res Lab JC Heuson, B-1000 Brussels, Belgium.	christos.sotiriou@bordet.be	Haibe-Kains, Benjamin/D-3702-2011; Altintas, Sevilay/D-2129-2014	Haibe-Kains, Benjamin/0000-0002-7684-0079; Bedard, Philippe/0000-0002-6771-2999	Breast Cancer Research Foundation (BCRF); Swiss MEDIC Foundation; Fonds National de la Recherche Scientifique (FNRS); FNRS (FRIA)	Breast Cancer Research Foundation (BCRF); Swiss MEDIC Foundation; Fonds National de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); FNRS (FRIA)(Fonds de la Recherche Scientifique - FNRS)	The Breast Cancer Research Foundation (BCRF - http://www.cancer.be/), the Swiss MEDIC Foundation, the Fonds National de la Recherche Scientifique (FNRS - http://www2.frs-fnrs.be/) have supported the work. Jerome Toussaint was supported by a grant from the FNRS (FRIA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Bijker N, 2001, EUR J SURG ONCOL, V27, P135, DOI 10.1053/ejso.2000.1062; Boughey JC, 2007, ONCOLOGIST, V12, P1276, DOI 10.1634/theoncologist.12-11-1276; Fisher B, 1998, J CLIN ONCOL, V16, P2672, DOI 10.1200/JCO.1998.16.8.2672; Goldstein NS, 2000, CANCER, V88, P2553, DOI 10.1002/1097-0142(20000601)88:11<2553::AID-CNCR18>3.0.CO;2-V; Hilson JB, 2009, AM J SURG PATHOL, V33, P227, DOI 10.1097/PAS.0b013e318180431d; Jones JL, 2003, J PATHOL, V201, P562, DOI 10.1002/path.1483; Julien JP, 2000, LANCET, V355, P528, DOI 10.1016/S0140-6736(99)06341-2; Kalof AN, 2004, J CLIN PATHOL, V57, P625, DOI 10.1136/jcp.2003.013227; Li CI, 2005, CANCER EPIDEM BIOMAR, V14, P1008, DOI 10.1158/1055-9965.EPI-04-0849; Man YG, 2004, EXP CELL RES, V301, P103, DOI 10.1016/j.yexcr.2004.08.037; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Polyak K, 2005, J MAMMARY GLAND BIOL, V10, P231, DOI 10.1007/s10911-005-9584-6; Silverstein MJ, 2003, AM J SURG, V186, P337, DOI 10.1016/S0002-9610(03)00265-4; Silverstein MJ, 1996, CANCER-AM CANCER SOC, V77, P2267, DOI 10.1002/(SICI)1097-0142(19960601)77:11<2267::AID-CNCR13>3.0.CO;2-V; Sternlicht MD, 1997, CLIN CANCER RES, V3, P1949; Szelei-Stevens KA, 2000, INT J RADIAT ONCOL, V48, P943, DOI 10.1016/S0360-3016(00)00715-X; Vicini FA, 2000, J CLIN ONCOL, V18, P296, DOI 10.1200/JCO.2000.18.2.296	18	14	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2010	5	8							e12100	10.1371/journal.pone.0012100	http://dx.doi.org/10.1371/journal.pone.0012100			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637IW	20856894	Green Published, Green Submitted, gold			2022-12-27	WOS:000280811900036
J	Bare, LA; Ruiz-Narvaez, EA; Tong, CH; Arellano, AR; Rowland, CM; Catanese, JJ; Sacks, FM; Devlin, JJ; Campos, H				Bare, Lance A.; Ruiz-Narvaez, Edward A.; Tong, Carmen H.; Arellano, Andre R.; Rowland, Charles M.; Catanese, Joseph J.; Sacks, Frank M.; Devlin, James J.; Campos, Hannia			Investigation of KIF6 Trp719Arg in a Case-Control Study of Myocardial Infarction: A Costa Rican Population	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; GENE VARIANTS; ADMIXTURE; RISK; ASSOCIATION; VALLEY	Background and Methodology: The 719Arg allele of KIF6 (rs20455) was associated with coronary events in Caucasian participants of five prospective studies. We investigated whether this KIF6 variant was associated with non-fatal myocardial infarction (MI) in a case-control study of an admixed population from the Central Valley of Costa Rica. Genotypes of the KIF6 variant were determined for 4,134 men and women. Cases (1,987) had survived a first MI; controls (2,147) had no history of MI and were matched to cases by age, sex, and area of residence. We tested the association between the KIF6 719Arg allele and non-fatal MI by conditional logistic regression and adjusted for admixture of founder populations. Principal Findings: Compared with the reference Trp/Trp homozygotes, KIF6 719Arg carriers were not at significantly higher risk for non-fatal MI in this study after adjustment for traditional risk factors or admixture (OR = 1.12; 95% CI, 0.98-1.28). Heterozygotes of the KIF6 Trp719Arg variant were at increased risk of non-fatal MI: the adjusted odds ratio was 1.16 (95% confidence interval, 1.01-1.34), but this association would not be significant after a multiple testing correction. Conclusions/Significance: We found that carriers of the KIF6 719Arg allele were not at increased risk of non-fatal MI in a case-control study of Costa Ricans living in the Central Valley of Costa Rica.	[Bare, Lance A.; Tong, Carmen H.; Arellano, Andre R.; Rowland, Charles M.; Catanese, Joseph J.; Devlin, James J.] Celera, Alameda, CA USA; [Ruiz-Narvaez, Edward A.] Boston Univ, Slone Epidemiol Ctr, Boston, MA 02215 USA; [Sacks, Frank M.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Campos, Hannia] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	Boston University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Bare, LA (corresponding author), Celera, Alameda, CA USA.	lance.bare@celera.com		Ruiz-Narvaez, Edward/0000-0002-0339-5824	National Institutes of Health [HL49086, HL60692]; American Heart Association [0625819T]; Celera; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060692, R01HL049086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Celera; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Recruitment and sample collection for the case-control study was supported by grants HL49086 and HL60692 from the National Institutes of Health. Edward A. Ruiz-Narvaez was supported by post-doctoral fellowship 0625819T from the American Heart Association. National Institutes of Health and the American Heart Association had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Statistical analysis was funded by Celera. Celera conducted the genotyping and had a role in study design, analysis, decision to publish and preparation of the manuscript.	Arnal I, 1998, STRUCTURE, V6, P33, DOI 10.1016/S0969-2126(98)00005-7; Bare LA, 2007, GENET MED, V9, P682, DOI 10.1097/GIM.0b013e318156fb62; Bonilla C, 2004, ANN HUM GENET, V68, P139, DOI 10.1046/j.1529-8817.2003.00084.x; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Campos H, 2000, INT J EPIDEMIOL, V29, P429, DOI 10.1093/ije/29.3.429; Campos-Sanchez R, 2006, HUM BIOL, V78, P551, DOI 10.1353/hub.2007.0002; Germer S, 2000, GENOME RES, V10, P258, DOI 10.1101/gr.10.2.258; Iakoubova OA, 2008, J AM COLL CARDIOL, V51, P435, DOI 10.1016/j.jacc.2007.05.057; Kabagambe EK, 2007, CIRCULATION, V115, P1075, DOI 10.1161/CIRCULATIONAHA.106.643544; Morera B, 2004, REV BIOL TROP, V52, P629; Morera B, 2004, REV BIOL TROP, V52, P713; Morera B, 2003, ANN HUM GENET, V67, P71, DOI 10.1046/j.1469-1809.2003.00010.x; RUIZNARVAEZ EA, 2010, HUM GENET; Shiffman D, 2008, J AM COLL CARDIOL, V51, P444, DOI 10.1016/j.jacc.2007.09.044; Shiffman D, 2008, ARTERIOSCL THROM VAS, V28, P173, DOI 10.1161/ATVBAHA.107.153981; Shriver MD, 2003, HUM GENET, V112, P387, DOI 10.1007/s00439-002-0896-y; Stewart AFR, 2009, J AM COLL CARDIOL, V53, P1471, DOI 10.1016/j.jacc.2008.12.051	17	12	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e13081	10.1371/journal.pone.0013081	http://dx.doi.org/10.1371/journal.pone.0013081			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20927332	Green Published, gold			2022-12-27	WOS:000282269400027
J	Loewen, CA; Feany, MB				Loewen, Carin A.; Feany, Mel B.			The Unfolded Protein Response Protects from Tau Neurotoxicity In Vivo	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; CELL-CYCLE REENTRY; ALZHEIMERS-DISEASE; RETINAL DEGENERATION; NEUROFIBRILLARY TANGLES; DROSOPHILA; NEURODEGENERATION; PHOSPHORYLATION; TAUOPATHY; TOXICITY	The unfolded protein response is a critical system by which the cell handles excess misfolded protein in the secretory pathway. The role of the system in modulating the effects of aggregation prone cytosolic proteins has received less attention. We use genetic reporters to demonstrate activation of the unfolded protein response in a transgenic Drosophila model of Alzheimer's disease and related tauopathies. We then use loss of function genetic reagents to support a role for the unfolded protein response in protecting from tau neurotoxicity. Our findings suggest that the unfolded protein response can ameliorate the toxicity of tau in vivo.	[Loewen, Carin A.; Feany, Mel B.] Harvard Univ, Brigham & Womens Hosp, Dept Pathol, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Loewen, CA (corresponding author), Harvard Univ, Brigham & Womens Hosp, Dept Pathol, Sch Med, Boston, MA 02115 USA.	mel_feany@hms.harvard.edu		Feany, Mel/0000-0003-0315-7970	National Institutes of Health (NIH) [R01 AG019790]; Ellison Medical Foundation; NATIONAL INSTITUTE ON AGING [R01AG019790] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Institutes of Health (NIH) R01 AG019790 and The Ellison Medical Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andorfer C, 2005, J NEUROSCI, V25, P5446, DOI 10.1523/JNEUROSCI.4637-04.2005; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; BRAND AH, 1993, DEVELOPMENT, V118, P401; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Busser J, 1998, J NEUROSCI, V18, P2801; Chafekar SM, 2008, CURR ALZHEIMER RES, V5, P469, DOI 10.2174/156720508785908883; Chafekar SM, 2007, ANTIOXID REDOX SIGN, V9, P2245, DOI 10.1089/ars.2007.1797; Dias-Santagata D, 2007, J CLIN INVEST, V117, P236, DOI 10.1172/JCI28769; Fulga TA, 2007, NAT CELL BIOL, V9, P139, DOI 10.1038/ncb1528; Ghosh S, 2004, HUM MOL GENET, V13, P2011, DOI 10.1093/hmg/ddh214; Hetz C, 2009, GENE DEV, V23, P2294, DOI 10.1101/gad.1830709; Hoozemans JJM, 2009, AM J PATHOL, V174, P1241, DOI 10.2353/ajpath.2009.080814; Hoozemans JJM, 2005, ACTA NEUROPATHOL, V110, P165, DOI 10.1007/s00401-005-1038-0; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Jackson GR, 2002, NEURON, V34, P509, DOI 10.1016/S0896-6273(02)00706-7; Jaworski T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007280; Kang MJ, 2009, P NATL ACAD SCI USA, V106, P17043, DOI 10.1073/pnas.0905566106; Khurana V, 2006, CURR BIOL, V16, P230, DOI 10.1016/j.cub.2005.12.042; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Mendes CS, 2009, EMBO J, V28, P1296, DOI 10.1038/emboj.2009.76; Naidoo N, 2009, REV NEUROSCIENCE, V20, P23; Nishimura I, 2004, CELL, V116, P671, DOI 10.1016/S0092-8674(04)00170-9; Oakes SA, 2006, CURR MOL MED, V6, P99, DOI 10.2174/156652406775574587; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Ryoo HD, 2007, EMBO J, V26, P242, DOI 10.1038/sj.emboj.7601477; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shulman JM, 2003, GENETICS, V165, P1233; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Steinhilb ML, 2007, MOL BIOL CELL, V18, P5060, DOI 10.1091/mbc.E07-04-0327; Steinhilb ML, 2007, J NEUROSCI RES, V85, P1271, DOI 10.1002/jnr.21232; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Unterberger U, 2006, J NEUROPATH EXP NEUR, V65, P348, DOI 10.1097/01.jnen.0000218445.30535.6f; Williams DW, 2006, NAT NEUROSCI, V9, P1234, DOI 10.1038/nn1774; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077	35	68	69	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e13084	10.1371/journal.pone.0013084	http://dx.doi.org/10.1371/journal.pone.0013084			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20927324	Green Published, Green Submitted, gold			2022-12-27	WOS:000282269400029
J	Torres-Arancivia, C; Ross, CM; Chavez, J; Assur, Z; Dolios, G; Mancia, F; Ubarretxena-Belandia, I				Torres-Arancivia, Celia; Ross, Carolyn M.; Chavez, Jose; Assur, Zahra; Dolios, Georgia; Mancia, Filippo; Ubarretxena-Belandia, Iban			Identification of an Archaeal Presenilin-Like Intramembrane Protease	PLOS ONE			English	Article							SIGNAL PEPTIDE PEPTIDASE; GAMMA-SECRETASE ACTIVITY; AMYLOID PRECURSOR PROTEIN; ASPARTIC PROTEASE; ALZHEIMERS-DISEASE; CRYSTAL-STRUCTURE; CLEAVAGE; PROTEOLYSIS; FAMILY; SUBSTRATE	Background: The GXGD-type diaspartyl intramembrane protease, presenilin, constitutes the catalytic core of the gamma-secretase multi-protein complex responsible for activating critical signaling cascades during development and for the production of beta-amyloid peptides (A beta) implicated in Alzheimer's disease. The only other known GXGD-type diaspartyl intramembrane proteases are the eukaryotic signal peptide peptidases (SPPs). The presence of presenilin-like enzymes outside eukaryots has not been demonstrated. Here we report the existence of presenilin-like GXGD-type diaspartyl intramembrane proteases in archaea. Methodology and Principal Findings: We have employed in vitro activity assays to show that MCMJR1, a polytopic membrane protein from the archaeon Methanoculleus marisnigri JR1, is an intramembrane protease bearing the signature YD and GXGD catalytic motifs of presenilin-like enzymes. Mass spectrometry analysis showed MCMJR1 could cleave model intramembrane protease substrates at several sites within their transmembrane region. Remarkably, MCMJR1 could also cleave substrates derived from the beta-amyloid precursor protein (APP) without the need of protein co-factors, as required by presenilin. Two distinct cleavage sites within the transmembrane domain of APP could be identified, one of which coincided with A beta 40, the predominant site processed by gamma-secretase. Finally, an established presenilin and SPP transition-state analog inhibitor could inhibit MCMJR1. Conclusions and Significance: Our findings suggest that a primitive GXGD-type diaspartyl intramembrane protease from archaea can recapitulate key biochemical properties of eukaryotic presenilins and SPPs. MCMJR1 promises to be a more tractable, simpler system for in depth structural and mechanistic studies of GXGD-type diaspartyl intramembrane proteases.	[Torres-Arancivia, Celia; Chavez, Jose; Ubarretxena-Belandia, Iban] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA; [Torres-Arancivia, Celia; Chavez, Jose] CUNY, Grad Ctr, New York, NY USA; [Ross, Carolyn M.; Assur, Zahra] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY USA; [Dolios, Georgia] Mt Sinai Sch Med, Dept Human Genet, New York, NY USA; [Mancia, Filippo] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY USA	Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Columbia University; Icahn School of Medicine at Mount Sinai; Columbia University	Torres-Arancivia, C (corresponding author), Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA.	fm123@columbia.edu; iban.ubarretxena@mssm.edu	Ubarretxena-Belandia, Iban/AAA-8939-2019	Chavez, Jose/0000-0003-4351-1516; Mancia, Filippo/0000-0003-3293-2200	National Science Foundation [MCB-0546087]	National Science Foundation(National Science Foundation (NSF))	Funding for this work was provided by grant MCB-0546087 (to I.U.-B.) from the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov A, 2001, BIOTECHNIQUES, V30, P1194, DOI 10.2144/01306bm01; Beel AJ, 2008, CELL MOL LIFE SCI, V65, P1311, DOI 10.1007/s00018-008-7462-2; Ben-Shem A, 2007, P NATL ACAD SCI USA, V104, P462, DOI 10.1073/pnas.0609773104; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Feng L, 2007, SCIENCE, V318, P1608, DOI 10.1126/science.1150755; Fluhrer R, 2008, J BIOL CHEM, V283, P30121, DOI 10.1074/jbc.M806092200; Fluhrer R, 2006, NAT CELL BIOL, V8, P894, DOI 10.1038/ncb1450; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; Golde TE, 2009, SEMIN CELL DEV BIOL, V20, P225, DOI 10.1016/j.semcdb.2009.02.003; Iben LG, 2007, J BIOL CHEM, V282, P36829, DOI 10.1074/jbc.M707002200; Knappenberger KS, 2004, BIOCHEMISTRY-US, V43, P6208, DOI 10.1021/bi036072v; Kornilova AY, 2003, J BIOL CHEM, V278, P16470, DOI 10.1074/jbc.C300019200; LaPointe CF, 2000, J BIOL CHEM, V275, P1502, DOI 10.1074/jbc.275.2.1502; Laudon H, 2005, J BIOL CHEM, V280, P35352, DOI 10.1074/jbc.M507217200; Lee JR, 2001, CELL, V107, P161, DOI 10.1016/S0092-8674(01)00526-8; Lemberg MK, 2002, MOL CELL, V10, P735, DOI 10.1016/S1097-2765(02)00655-X; Lemieux MJ, 2007, P NATL ACAD SCI USA, V104, P750, DOI 10.1073/pnas.0609981104; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Marambaud P, 2005, GENES BRAIN BEHAV, V4, P134, DOI 10.1111/j.1601-183X.2005.00086.x; Martin L, 2009, J BIOL CHEM, V284, P5662, DOI 10.1074/jbc.M807485200; Mirza SP, 2007, PHYSIOL GENOMICS, V30, P89, DOI 10.1152/physiolgenomics.00279.2006; Narayanan S, 2007, J BIOL CHEM, V282, P20172, DOI 10.1074/jbc.M701536200; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Panavas Tadas, 2009, V497, P303, DOI 10.1007/978-1-59745-566-4_20; Ponting CP, 2002, HUM MOL GENET, V11, P1037, DOI 10.1093/hmg/11.9.1037; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Sato C, 2008, J NEUROSCI, V28, P6264, DOI 10.1523/JNEUROSCI.1163-08.2008; Sato T, 2006, BIOCHEMISTRY-US, V45, P8649, DOI 10.1021/bi060597g; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Szabo Z, 2006, J BACTERIOL, V188, P1437, DOI 10.1128/JB.188.4.1437-1443.2006; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Tolia A, 2009, SEMIN CELL DEV BIOL, V20, P211, DOI 10.1016/j.semcdb.2008.10.007; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wang J, 2004, NEUROBIOL DIS, V15, P654, DOI 10.1016/j.nbd.2003.12.008; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Weihofen A, 2003, J BIOL CHEM, V278, P16528, DOI 10.1074/jbc.M301372200; Weihofen A, 2003, TRENDS CELL BIOL, V13, P71, DOI 10.1016/S0962-8924(02)00041-7; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wolfe MS, 2009, SEMIN CELL DEV BIOL, V20, P219, DOI 10.1016/j.semcdb.2008.12.011; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wu ZR, 2006, NAT STRUCT MOL BIOL, V13, P1084, DOI 10.1038/nsmb1179	49	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e13072	10.1371/journal.pone.0013072	http://dx.doi.org/10.1371/journal.pone.0013072			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20927381	Green Published, gold			2022-12-27	WOS:000282269400022
J	Champlot, S; Berthelot, C; Pruvost, M; Bennett, EA; Grange, T; Geigl, EM				Champlot, Sophie; Berthelot, Camille; Pruvost, Melanie; Bennett, E. Andrew; Grange, Thierry; Geigl, Eva-Maria			An Efficient Multistrategy DNA Decontamination Procedure of PCR Reagents for Hypersensitive PCR Applications	PLOS ONE			English	Article							REAL-TIME PCR; CHAIN-REACTION REAGENTS; CONTAMINATING DNA; FALSE-POSITIVES; SINGLE-STRAND; RIBOSOMAL DNA; POLYMERASE; AMPLIFICATION; IRRADIATION; SEQUENCE	Background: PCR amplification of minute quantities of degraded DNA for ancient DNA research, forensic analyses, wildlife studies and ultrasensitive diagnostics is often hampered by contamination problems. The extent of these problems is inversely related to DNA concentration and target fragment size and concern (i) sample contamination, (ii) laboratory surface contamination, (iii) carry-over contamination, and (iv) contamination of reagents. Methodology/Principal Findings: Here we performed a quantitative evaluation of current decontamination methods for these last three sources of contamination, and developed a new procedure to eliminate contaminating DNA contained in PCR reagents. We observed that most current decontamination methods are either not efficient enough to degrade short contaminating DNA molecules, rendered inefficient by the reagents themselves, or interfere with the PCR when used at doses high enough to eliminate these molecules. We also show that efficient reagent decontamination can be achieved by using a combination of treatments adapted to different reagent categories. Our procedure involves c-and UV-irradiation and treatment with a mutant recombinant heat-labile double-strand specific DNase from the Antarctic shrimp Pandalus borealis. Optimal performance of these treatments is achieved in narrow experimental conditions that have been precisely analyzed and defined herein. Conclusions/Significance: There is not a single decontamination method valid for all possible contamination sources occurring in PCR reagents and in the molecular biology laboratory and most common decontamination methods are not efficient enough to decontaminate short DNA fragments of low concentration. We developed a versatile multistrategy decontamination procedure for PCR reagents. We demonstrate that this procedure allows efficient reagent decontamination while preserving the efficiency of PCR amplification of minute quantities of DNA.	[Champlot, Sophie; Berthelot, Camille; Pruvost, Melanie; Bennett, E. Andrew; Grange, Thierry; Geigl, Eva-Maria] Univ Paris 07, Inst Jacques Monod, UMR7592, CNRS, F-75251 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Champlot, S (corresponding author), Univ Paris 07, Inst Jacques Monod, UMR7592, CNRS, F-75251 Paris, France.	geigl.eva-maria@ijm.univ-paris-diderot.fr	Berthelot, Camille/K-5570-2017	Berthelot, Camille/0000-0001-5054-2690; Geigl, Eva-Maria/0000-0001-6376-2094; Grange, Thierry/0000-0001-8700-3092; Pruvost, Melanie/0000-0001-7824-2155	Centre National de Recherche Scientifique (CNRS) France; French National Research Agency (ANR) [ANR-GAN1-004]	Centre National de Recherche Scientifique (CNRS) France(Centre National de la Recherche Scientifique (CNRS)); French National Research Agency (ANR)(French National Research Agency (ANR))	This work was funded by the Centre National de Recherche Scientifique (CNRS) France and the French National Research Agency (ANR), Project ANR-GAN1-004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASLANZADEH J, 1993, MOL CELL PROBE, V7, P145, DOI 10.1006/mcpr.1993.1020; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beja-Pereira A, 2009, MOL ECOL RESOUR, V9, P1279, DOI 10.1111/j.1755-0998.2009.02699.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bollongino R, 2006, BIOL LETTERS, V2, P155, DOI 10.1098/rsbl.2005.0404; BOTTGER EC, 1990, CLIN CHEM, V36, P1258; Brettell TA, 2007, ANAL CHEM, V79, P4365, DOI 10.1021/ac070871s; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; Burgess LC, 1999, BIOTECHNIQUES, V27, P252, DOI 10.2144/99272bm07; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Butler JM, 1998, TRENDS BIOTECHNOL, V16, P158, DOI 10.1016/S0167-7799(98)01173-1; CADET J, 1986, BIOCHIMIE, V68, P813, DOI 10.1016/S0300-9084(86)80097-9; Carroll NM, 1999, J CLIN MICROBIOL, V37, P3402, DOI 10.1128/JCM.37.10.3402-3404.1999; CHEN K, 1989, FEMS MICROBIOL LETT, V57, P19, DOI 10.1016/S0378-1097(97)00476-X; CHOU Q, 1992, NUCLEIC ACIDS RES, V20, P1717, DOI 10.1093/nar/20.7.1717; CIMINO GD, 1991, NUCLEIC ACIDS RES, V19, P99, DOI 10.1093/nar/19.1.99; Corless CE, 2000, J CLIN MICROBIOL, V38, P1747, DOI 10.1128/JCM.38.5.1747-1752.2000; DEFILIPPES FM, 1991, BIOTECHNIQUES, V10, P26; DERAGON JM, 1990, NUCLEIC ACIDS RES, V18, P6149, DOI 10.1093/nar/18.20.6149; DOUGHERTY RM, 1993, J VIROL METHODS, V41, P235, DOI 10.1016/0166-0934(93)90130-J; Endicott P, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-29; Eshleman J, 2001, ELECTROPHORESIS, V22, P4316, DOI 10.1002/1522-2683(200112)22:20<4316::AID-ELPS4316>3.0.CO;2-V; ESPY MJ, 1993, J CLIN MICROBIOL, V31, P2361, DOI 10.1128/JCM.31.9.2361-2365.1993; Fahle GA, 1999, J CLIN MICROBIOL, V37, P261, DOI 10.1128/JCM.37.1.261-262.1999; Fang MY, 2006, P R SOC B, V273, P1803, DOI 10.1098/rspb.2006.3514; FERRACCIPORRI M, 2009, AFFAIRE FANTOME HEIL; Fortea J, 2008, J HUM EVOL, V55, P353, DOI 10.1016/j.jhevol.2008.03.005; FROTHINGHAM R, 1992, BIOTECHNIQUES, V13, P208; FURRER B, 1990, NATURE, V346, P324, DOI 10.1038/346324b0; Gefrides LA, 2010, FORENSIC SCI INT-GEN, V4, P89, DOI 10.1016/j.fsigen.2009.06.008; Gilbert N, 2010, NATURE, V464, P347, DOI 10.1038/464347a; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Green RE, 2009, EMBO J, V28, P2494, DOI 10.1038/emboj.2009.222; Hall A, 2004, ANAL BIOANAL CHEM, V380, P72, DOI 10.1007/s00216-004-2681-3; Heddi B, 2010, J MOL BIOL, V395, P123, DOI 10.1016/j.jmb.2009.10.023; Hilali F, 1997, MOL BIOTECHNOL, V7, P207, DOI 10.1007/BF02740812; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; ITO T, 1993, INT J RADIAT BIOL, V63, P289, DOI 10.1080/09553009314550391; JINNO Y, 1990, NUCLEIC ACIDS RES, V18, P6739, DOI 10.1093/nar/18.22.6739; Klaschik S, 2002, MOL BIOTECHNOL, V22, P231, DOI 10.1385/MB:22:3:231; Klausegger A, 1999, J CLIN MICROBIOL, V37, P464, DOI 10.1128/JCM.37.2.464-466.1999; Krause J, 2007, CURR BIOL, V17, P1908, DOI 10.1016/j.cub.2007.10.008; KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0; Leonard JA, 2007, J ARCHAEOL SCI, V34, P1361, DOI 10.1016/j.jas.2006.10.023; Linderholm A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002316; LONGO MC, 1990, GENE, V93, P125, DOI 10.1016/0378-1119(90)90145-H; Lutfalla G, 2006, METHOD ENZYMOL, V410, P386, DOI 10.1016/S0076-6879(06)10019-1; Malmstrom H, 2005, MOL BIOL EVOL, V22, P2040, DOI 10.1093/molbev/msi195; Malmstrom H, 2007, MOL BIOL EVOL, V24, P998, DOI 10.1093/molbev/msm015; McDonald J.H., 2009, HDB BIOL STAT; MEIER A, 1993, J CLIN MICROBIOL, V31, P646, DOI 10.1128/JCM.31.3.646-652.1993; Millar BC, 2002, J CLIN MICROBIOL, V40, P1575, DOI 10.1128/JCM.40.5.1575-1580.2002; Mohammadi T, 2003, J CLIN MICROBIOL, V41, P4796, DOI 10.1128/JCM.41.10.4796-4798.2003; Mona S, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-83; Newsome T, 2004, J CLIN MICROBIOL, V42, P2264, DOI 10.1128/JCM.42.5.2264-2267.2004; Niederhauser C, 1994, PCR Methods Appl, V4, P117; Nilsen IW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010295; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; OU CY, 1991, BIOTECHNIQUES, V10, P442; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Padua RA, 1999, LEUKEMIA, V13, P1898, DOI 10.1038/sj.leu.2401579; PAO CC, 1993, MOL CELL PROBE, V7, P217, DOI 10.1006/mcpr.1993.1031; PRINCE AM, 1992, BIOTECHNIQUES, V12, P358; Pruvost M, 2005, BIOTECHNIQUES, V38, P569, DOI 10.2144/05384ST03; Pruvost M, 2004, J ARCHAEOL SCI, V31, P1191, DOI 10.1016/j.jas.2002.05.002; Pruvost M, 2008, PALAEOGEOGR PALAEOCL, V266, P211, DOI 10.1016/j.palaeo.2008.03.041; Pruvost M, 2007, P NATL ACAD SCI USA, V104, P739, DOI 10.1073/pnas.0610257104; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; ROCHELLE PA, 1992, BIOTECHNIQUES, V13, P520; Rueckert A, 2007, J MICROBIOL METH, V68, P596, DOI 10.1016/j.mimet.2006.11.006; SAKAR G, 1991, BIOTECHNIQUES, V11, P176; SAKAR G, 1993, METHOD ENZYMOL, V218, P381; SCHMIDT TM, 1991, BIOTECHNIQUES, V11, P176; SHENG ZY, 1991, NUCLEIC ACIDS RES, V19, P2511; SIDDIQI MA, 1987, RADIAT RES, V112, P449, DOI 10.2307/3577098; Silkie SS, 2008, J MICROBIOL METH, V72, P275, DOI 10.1016/j.mimet.2007.12.011; Stahlberg A, 2003, CLIN CHEM, V49, P51, DOI 10.1373/49.1.51; Tamariz J, 2006, J FORENSIC SCI, V51, P790, DOI 10.1111/j.1556-4029.2006.00172.x; Teletchea F, 2005, TRENDS BIOTECHNOL, V23, P359, DOI 10.1016/j.tibtech.2005.05.006; Troy CS, 2001, NATURE, V410, P1088, DOI 10.1038/35074088; von Sonntag C., 2006, FREE RADICAL INDUCED; WIDJOJOATMODJO MN, 1994, J CLIN MICROBIOL, V32, P3002, DOI 10.1128/JCM.32.12.3002-3007.1994; Williams R, 2006, NAT METHODS, V3, P545, DOI 10.1038/NMETH896	84	184	192	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2010	5	9							e13042	10.1371/journal.pone.0013042	http://dx.doi.org/10.1371/journal.pone.0013042			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654ZQ	20927390	Green Published, Green Submitted, gold			2022-12-27	WOS:000282210700018
J	Harth, S; Kotzsch, A; Hu, JL; Sebald, W; Mueller, TD				Harth, Stefan; Kotzsch, Alexander; Hu, Junli; Sebald, Walter; Mueller, Thomas D.			A Selection Fit Mechanism in BMP Receptor IA as a Possible Source for BMP Ligand-Receptor Promiscuity	PLOS ONE			English	Article							STRUCTURE ANALYSIS REVEALS; FACTOR-BETA SUPERFAMILY; PROTEIN COMPLEXES; CRYSTAL-STRUCTURE; HIGH-AFFINITY; MORPHOGENETIC PROTEINS; MOLECULAR RECOGNITION; SIGNAL-TRANSDUCTION; STRUCTURAL BASIS; SPECIFICITY	Background: Members of the TGF-beta superfamily are characterized by a highly promiscuous ligand-receptor interaction as is readily apparent from the numeral discrepancy of only seven type I and five type II receptors available for more than 40 ligands. Structural and functional studies have been used to address the question of how specific signals can be deduced from a limited number of receptor combinations and to unravel the molecular mechanisms underlying the protein-protein recognition that allow such limited specificity. Principal Findings: In this study we have investigated how an antigen binding antibody fragment (Fab) raised against the extracellular domain of the BMP receptor type IA (BMPR-IA) recognizes the receptor's BMP-2 binding epitope and thereby neutralizes BMP-2 receptor activation. The crystal structure of the complex of the BMPR-IA ectodomain bound to the Fab AbD1556 revealed that the contact surface of BMPR-IA overlaps extensively with the contact surface for BMP-2 interaction. Although the structural epitopes of BMPR-IA to both binding partners coincides, the structures of BMPR-IA in the two complexes differ significantly. In contrast to the structural differences, alanine-scanning mutagenesis of BMPR-IA showed that the functional determinants for binding to the antibody and BMP-2 are almost identical. Conclusions: Comparing the structures of BMPR-IA bound to BMP-2 or bound to the Fab AbD1556 with the structure of unbound BMPR-IA shows that binding of BMPR-IA to its interaction partners follows a selection fit mechanism, possibly indicating that the ligand promiscuity of BMPR-IA is inherently encoded by structural adaptability. The functional and structural analysis of the BMPR-IA binding antibody AbD1556 mimicking the BMP-2 binding epitope may thus pave the way for the design of low-molecular weight synthetic receptor binders/inhibitors.	[Harth, Stefan; Hu, Junli; Sebald, Walter] Univ Wurzburg, Lehrstuhl Physiol Chem 2, Theodor Boveri Inst Biowissensch, Wurzburg, Germany; [Kotzsch, Alexander; Mueller, Thomas D.] Univ Wurzburg, Lehrstuhl Mol Pflanzenphysiol & Biophys, Julius von Sachs Inst, Wurzburg, Germany	University of Wurzburg; University of Wurzburg	Harth, S (corresponding author), Univ Wurzburg, Lehrstuhl Physiol Chem 2, Theodor Boveri Inst Biowissensch, Wurzburg, Germany.	mueller@biozentrum.uni-wuerzburg.de		Mueller, Thomas/0000-0003-1862-7357	Deutsche Forschungsgemeinschaft (DFG) [SFB 487 TP B1 and B2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This project was supported by the Deutsche Forschungsgemeinschaft (DFG), SFB 487 TP B1 and B2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; Allendorph GP, 2006, P NATL ACAD SCI USA, V103, P7643, DOI 10.1073/pnas.0602558103; Babitt JL, 2005, J BIOL CHEM, V280, P29820, DOI 10.1074/jbc.M503511200; Barker PA, 2004, NEURON, V42, P529, DOI 10.1016/j.neuron.2004.04.001; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; CHOTHIA C, 1989, NATURE, V342, P877, DOI 10.1038/342877a0; de Caestecker M, 2004, CYTOKINE GROWTH F R, V15, P1, DOI 10.1016/j.cytogfr.2003.10.004; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Eagle RA, 2007, NAT REV IMMUNOL, V7, P737, DOI 10.1038/nri2144; Faber C, 1998, IMMUNOTECHNOLOGY, V3, P253, DOI 10.1016/S1380-2933(97)10003-3; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gavin AC, 2003, CURR OPIN CHEM BIOL, V7, P21, DOI 10.1016/S1367-5931(02)00007-8; Gordon KJ, 2008, BBA-MOL BASIS DIS, V1782, P197, DOI 10.1016/j.bbadis.2008.01.006; Greenwald J, 2003, MOL CELL, V11, P605, DOI 10.1016/S1097-2765(03)00094-7; Harth S, 2010, ACTA CRYSTALLOGR F, V66, P964, DOI 10.1107/S1744309110024681; Hein G, 2009, CENT EUR J MATH, V7, P59, DOI 10.2478/s11533-008-0058-0; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hodivala-Dilke KM, 2003, CELL TISSUE RES, V314, P131, DOI 10.1007/s00441-003-0774-5; Hogan BLM, 1996, CURR OPIN GENET DEV, V6, P432, DOI 10.1016/S0959-437X(96)80064-5; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Keller S, 2004, NAT STRUCT MOL BIOL, V11, P481, DOI 10.1038/nsmb756; Kirsch T, 2000, NAT STRUCT BIOL, V7, P492; Kirsch T, 2000, FEBS LETT, V468, P215, DOI 10.1016/S0014-5793(00)01214-X; Klages J, 2008, BIOCHEMISTRY-US, V47, P11930, DOI 10.1021/bi801059j; Knappik A, 2000, J MOL BIOL, V296, P57, DOI 10.1006/jmbi.1999.3444; Kotzsch A, 2008, J BIOL CHEM, V283, P5876, DOI 10.1074/jbc.M706029200; Kotzsch A, 2009, EMBO J, V28, P937, DOI 10.1038/emboj.2009.37; Kraich M, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-13; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Muller-Newen Gerhard, 2003, Sci STKE, V2003, pPE40, DOI 10.1126/stke.2003.201.pe40; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nickel J, 2009, CYTOKINE GROWTH F R, V20, P367, DOI 10.1016/j.cytogfr.2009.10.022; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Reddi AH, 1998, NAT BIOTECHNOL, V16, P247, DOI 10.1038/nbt0398-247; Rothe C, 2008, J MOL BIOL, V376, P1182, DOI 10.1016/j.jmb.2007.12.018; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Steidl S, 2008, MOL IMMUNOL, V46, P135, DOI 10.1016/j.molimm.2008.07.013; Sundberg EJ, 2003, ADV PROTEIN CHEM, V61, P119; Sundberg EJ, 2009, METHODS MOL BIOL, V524, P23, DOI 10.1007/978-1-59745-450-6_2; Tsai CJ, 2009, TRENDS BIOCHEM SCI, V34, P594, DOI 10.1016/j.tibs.2009.07.007; Weber D, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-6; Weikl TR, 2009, PROTEINS, V75, P104, DOI 10.1002/prot.22223; Xu D, 1997, PROTEIN ENG, V10, P999, DOI 10.1093/protein/10.9.999; Zhang JL, 2008, DEV CELL, V14, P739, DOI 10.1016/j.devcel.2008.02.017	48	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2010	5	9							e13049	10.1371/journal.pone.0013049	http://dx.doi.org/10.1371/journal.pone.0013049			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654ZQ	20927405	gold, Green Published, Green Submitted			2022-12-27	WOS:000282210700020
J	Somda, ZC; Perry, HN; Messonnier, NR; Djingarey, MH; Ki, SO; Meltzer, MI				Somda, Zana C.; Perry, Helen N.; Messonnier, Nancy R.; Djingarey, Mamadou H.; Ki, Salimata Ouedraogo; Meltzer, Martin I.			Modeling the Cost-Effectiveness of the Integrated Disease Surveillance and Response (IDSR) System: Meningitis in Burkina Faso	PLOS ONE			English	Article							MENINGOCOCCAL MENINGITIS; IMMUNIZATION CAMPAIGNS; DEVELOPING-COUNTRIES; EPIDEMICS; MALARIA; BURDEN; AFRICA; INTERVENTIONS; VACCINATION; LEVEL	Background: Effective surveillance for infectious diseases is an essential component of public health. There are few studies estimating the cost-effectiveness of starting or improving disease surveillance. We present a cost-effectiveness analysis the Integrated Disease Surveillance and Response (IDSR) strategy in Africa. Methodology/Principal Findings: To assess the impact of the IDSR in Africa, we used pre- and post-IDSR meningococcal meningitis surveillance data from Burkina Faso (1996-2002 and 2003-2007). IDSR implementation was correlated with a median reduction of 2 weeks to peak of outbreaks (25(th) percentile 1 week; 75(th) percentile 4 weeks). IDSR was also correlated with a reduction of 43 meningitis cases per 100,000 (25(th)-40: 75(th)-129). Assuming the correlations between reductions in time to peak of outbreaks and cases are related, the cost-effectiveness of IDSR was $23 per case averted (25(th)-$30; 75(th)-cost saving), and $98 per meningitis-related death averted (25(th)-$140: 75(th)-cost saving). Conclusions/Significance: We cannot absolutely claim that the measured differences were due to IDSR. We believe, however, that it is reasonable to claim that IDSR can improve the cost-effectiveness of public health surveillance.	[Somda, Zana C.; Perry, Helen N.; Messonnier, Nancy R.; Meltzer, Martin I.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Djingarey, Mamadou H.] WHO IST W Africa, Ouagadougou, Burkina Faso; [Ki, Salimata Ouedraogo] Minist Sante, Ouagadougou, Burkina Faso	Centers for Disease Control & Prevention - USA	Somda, ZC (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.	qzm4@cdc.gov	Meltzer, Martin/AAT-3235-2021	Meltzer, Martin/0000-0002-7250-0472	U.S. Centers for Disease Control and Prevention (CDC); USAID Global Surveillance and Africa Bureaus	U.S. Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); USAID Global Surveillance and Africa Bureaus(United States Agency for International Development (USAID))	This research was supported by the U.S. Centers for Disease Control and Prevention (CDC) with funding from USAID Global Surveillance and Africa Bureaus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bovier PA, 1999, SOC SCI MED, V48, P1205, DOI 10.1016/S0277-9536(98)00419-5; Campagne G, 1999, B WORLD HEALTH ORGAN, V77, P499; Chima RI, 2003, HEALTH POLICY, V63, P17, DOI 10.1016/S0168-8510(02)00036-2; du Chatelet IP, 2001, VACCINE, V19, P3420, DOI 10.1016/S0264-410X(01)00066-4; Elbasha EH, 2000, EMERG INFECT DIS, V6, P293, DOI 10.3201/eid0603.000310; Fauci AS, 2001, CLIN INFECT DIS, V32, P675, DOI 10.1086/319235; Hutubessy RCW, 2001, ACTA TROP, V78, P191, DOI 10.1016/S0001-706X(00)00176-5; International Monetary Fund, WORLD EC FIN SURV WO; John TJ, 1998, LANCET, V352, P58, DOI 10.1016/S0140-6736(97)10494-9; Kaninda AV, 2000, INT J EPIDEMIOL, V29, P933, DOI 10.1093/ije/29.5.933; Khan MM, 2004, J HEALTH POPUL NUTR, V22, P404; Lapeyssonnie L., 1963, B WHO              S, V28, P3; Lewis R, 2001, LANCET, V358, P287, DOI 10.1016/S0140-6736(01)05484-8; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Miller MA, 2005, PHARMACOECONOMICS, V23, P333, DOI 10.2165/00019053-200523040-00004; Mohammed I, 2000, T ROY SOC TROP MED H, V94, P265, DOI 10.1016/S0035-9203(00)90316-X; MONATH TP, 1993, AM J TROP MED HYG, V48, P274, DOI 10.4269/ajtmh.1993.48.274; Morel CM, 2005, BMJ-BRIT MED J, V331, P1299, DOI 10.1136/bmj.38639.702384.AE; Nicolas P, 2005, J CLIN MICROBIOL, V43, P5129, DOI 10.1128/JCM.43.10.5129-5135.2005; Nicolas P, 2001, EMERG INFECT DIS, V7, P849; Perry HN, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-24; Robbins JB, 1997, LANCET, V350, P880, DOI 10.1016/S0140-6736(97)03227-3; ROBERTSON RL, 1985, J TROP MED HYG, V88, P343; Russell S, 2004, AM J TROP MED HYG, V71, P147, DOI 10.4269/ajtmh.2004.71.147; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; SMITH AW, 1988, T ROY SOC TROP MED H, V82, P312, DOI 10.1016/0035-9203(88)90459-2; Somda Zana C, 2009, Cost Eff Resour Alloc, V7, P1, DOI 10.1186/1478-7547-7-1; Taha MK, 2002, J CLIN MICROBIOL, V40, P1083, DOI 10.1128/JCM.40.3.1083-1084.2002; Uzicanin A, 2004, VACCINE, V22, P3419, DOI 10.1016/j.vaccine.2004.02.042; Walker D, 2000, HEALTH ECON, V9, P681, DOI 10.1002/1099-1050(200012)9:8<681::AID-HEC545>3.0.CO;2-X; *WHO, 2002, TECHN GUID INT DIS S; *WHO, 1999, INT DIS SURV RESP RE; Wilkins JJ, 2002, T ROY SOC TROP MED H, V96, P85, DOI 10.1016/S0035-9203(02)90251-8; World Health Organisation, 2000, WKLY EPIDEMIOL REC, V75, P306; Worrall E, 2004, AM J TROP MED HYG, V71, P136, DOI 10.4269/ajtmh.2004.71.136	35	14	14	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2010	5	9							e13044	10.1371/journal.pone.0013044	http://dx.doi.org/10.1371/journal.pone.0013044			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	654ZQ	20927386	Green Published, Green Submitted, gold			2022-12-27	WOS:000282210700019
J	Qidwai, W; Ishaque, S; Shah, S; Rahim, M				Qidwai, Waris; Ishaque, Sidra; Shah, Sabeen; Rahim, Maheen			Adolescent Lifestyle and Behaviour: A Survey from a Developing Country	PLOS ONE			English	Article							UNIVERSITY-STUDENTS; RISK BEHAVIORS; DIET QUALITY; HEALTH; ASSOCIATION; SMOKING; CHILDHOOD; INSOMNIA; PATTERNS	Introduction: Adolescents form two-thirds of our population. This is a unique group of people with special needs. Our survey aims to identify the lifestyle and behavioral patterns in this group of people and subsequently come up with issues that warrant special attention. Methods: A survey was performed in various schools of Karachi. Data collection was done via a face-to-face interview based on a structured, pre-tested questionnaire. Participants included all willing persons between 12-19 years of age. Results: Most adolescents with lifestyle issues fell in the age group of 16-18 years. Females were more depressed than males and had more sleep problems. Substance abuse and other addictions were documented more in males. Watching television or listening to music was stated as the most common late night activity (61.8%) and therefore was also referred to as the contributory factor for less than eight hours of sleep each day. (58.9%) of the respondents are getting less than eight hours of sleep daily. (41.5%) of the respondents who felt depressed sought treatment for it. Quite a few of them were also indulged in substance abuse and other addictions. Only (16.8%) of the respondents opined that physical activity is essential for health. Thirty-five adolescents out of all the respondents were smoking cigarettes currently, whereas 7% of the respondents chewed paan (areca nut). Peer pressure was the most common reason (37.1%) to start smoking. Conclusion: Adolescents need to be treated as a distinct segment of our population and it is important to realize and address their health and lifestyle problems. Inadequate sleep, depression and smoking were the leading unhealthy behaviours among the respondents. Families can play an important role to help these adolescents live a healthier life. Further research studies should be carried out to highlight issues of concern and their possible solutions in this population.	[Qidwai, Waris; Shah, Sabeen; Rahim, Maheen] Aga Khan Univ, Dept Family Med, Karachi, Pakistan; [Ishaque, Sidra] Aga Khan Univ, Coll Med, Karachi, Pakistan	Aga Khan University; Aga Khan University	Qidwai, W (corresponding author), Aga Khan Univ, Dept Family Med, Karachi, Pakistan.	sidraishaque@gmail.com						Acebo C, 2005, SLEEP DEPRIVATION, P151; Achenbach TM, 1983, MANUAL CHILD BEHAV C; *AD FRIENDL HLTH S, AD FRIEND HLTH SERV; Ali DB, 2009, MIND BODY INTERACTIO; [Anonymous], NATL LONGITUDINAL ST; [Anonymous], DIAGNOSTIC STAT MANU; Bootzin RR, 2005, CLIN PSYCHOL REV, V25, P629, DOI 10.1016/j.cpr.2005.04.007; Brener Nancy D., 2004, Morbidity and Mortality Weekly Report, V53, P1; Caspersen CJ, 2000, MED SCI SPORT EXER, V32, P1601; Currie C., 2001, HBSC WHO CROSS NATL; Dierker LC, 2007, COMPR PSYCHIAT, V48, P237, DOI 10.1016/j.comppsych.2007.01.002; Eccles JS, 2003, J SOC ISSUES, V59, P865, DOI 10.1046/j.0022-4537.2003.00095.x; Francis K, 2007, SUBST USE MISUSE, V42, P1323, DOI 10.1080/10826080701212410; Gillman MW, 2000, ARCH FAM MED, V9, P235, DOI 10.1001/archfami.9.3.235; Hancox RJ, 2005, ARCH PEDIAT ADOL MED, V159, P614, DOI 10.1001/archpedi.159.7.614; Hancox RJ, 2004, LANCET, V364, P257, DOI 10.1016/S0140-6736(04)16675-0; Hawton K, 1999, BRIT J PSYCHIAT, V175, P271, DOI 10.1192/bjp.175.3.271; Hughes-Hassell S, 2007, J ADOLESC ADULT LIT, V51, P22, DOI 10.1598/JAAL.51.1.3; JOHNSON JG, 2004, ARCH PEDIAT ADOLESC, P597; Khan A., 2000, ADOLESCENTS REPROD H; Kunitsuka Koko, 2002, Nihon Koshu Eisei Zasshi, V49, P525; Larson NI, 2007, J AM DIET ASSOC, V107, P1502, DOI 10.1016/j.jada.2007.06.012; Livaudais JC, 2007, ETHNIC DIS, V17, P298; Manni R, 1997, J SLEEP RES, V6, P44, DOI 10.1046/j.1365-2869.1997.00025.x; Miles DR, 2001, DRUG ALCOHOL DEPEN, V62, P57, DOI 10.1016/S0376-8716(00)00165-4; Millman RP, 2005, PEDIATRICS, V115, P1774, DOI 10.1542/peds.2005-0772; Muller MJ, 2005, P NUTR SOC, V64, P249, DOI 10.1079/PNS2005424; O'Connor R., 2000, UNDERSTANDING SUICID; *POP ASS PAK, AD STAT; RAHKONEN O, 1992, BRIT J ADDICT, V87, P103; Rajput V, 1999, AM FAM PHYSICIAN, V60, P1431; Robinson TN, 2001, PEDIATR CLIN N AM, V48, P1017, DOI 10.1016/S0031-3955(05)70354-0; Rudatsikira E., 2007, ANN GEN PSYCHIAT, V6; Simons-Morton B, 2007, AM J HEALTH BEHAV, V31, P672, DOI 10.5993/AJHB.31.6.13; Steptoe A, 2002, PREV MED, V35, P97, DOI 10.1006/pmed.2002.1048; Stock C, 2001, HEALTH PROMOT INT, V16, P145, DOI 10.1093/heapro/16.2.145; Thomas RE, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004493.pub2; *WHO, WHO 10 FACTS AD HLTH; World Medical Association, DECL HELS; Wu WC, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-323; 2002, DIS MANAG ADVIS, V8, P81; DATABASE MANAGEMENT	42	32	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e12914	10.1371/journal.pone.0012914	http://dx.doi.org/10.1371/journal.pone.0012914			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	654KL	20886001	Green Published, gold			2022-12-27	WOS:000282167100001
J	Ribeiro, CMS; Pontes, MJSL; Bird, S; Chadzinska, M; Scheer, M; Verburg-van Kemenade, BML; Savelkoul, HFJ; Wiegertjes, GF				Ribeiro, Carla M. S.; Pontes, Maria J. S. L.; Bird, Steve; Chadzinska, Magdalena; Scheer, Marleen; Verburg-van Kemenade, B. M. Lidy; Savelkoul, Huub F. J.; Wiegertjes, Geert F.			Trypanosomiasis-Induced Th17-Like Immune Responses in Carp	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-2; TOXOPLASMA-GONDII INFECTION; IL-12 P40 HOMODIMER; FRESH-WATER FISH; CYPRINUS-CARPIO; TH17 CELLS; PLASMODIUM-FALCIPARUM; DENDRITIC CELLS; NK CELLS; SIGNALING PATHWAY	Background: In mammalian vertebrates, the cytokine interleukin (IL)-12 consists of a heterodimer between p35 and p40 subunits whereas interleukin-23 is formed by a heterodimer between p19 and p40 subunits. During an immune response, the balance between IL-12 and IL-23 can depend on the nature of the pathogen associated molecular pattern (PAMP) recognized by, for example TLR2, leading to a preferential production of IL-23. IL-23 production promotes a Th17-mediated immune response characterized by the production of IL-17A/F and several chemokines, important for neutrophil recruitment and activation. For the cold blooded vertebrate common carp, only the IL-12 subunits have been described so far. Methodology/Principal Findings: Common carp is the natural host of two protozoan parasites: Trypanoplasma borreli and Trypanosoma carassii. We found that these parasites negatively affect p35 and p40a gene expression in carp. Transfection studies of HEK293 and carp macrophages show that T. carassii-derived PAMPs are agonists of carp TLR2, promoting p19 and p40c gene expression. The two protozoan parasites induce different immune responses as assessed by gene expression and histological studies. During T. carassii infections, in particular, we observed a propensity to induce p19 and p40c gene expression, suggestive of the formation of IL-23. Infections with T. borreli and T. carassii lead to an increase of IFN-gamma 2 gene expression whereas IL-17A/F2 gene expression was only observed during T. carasssii infections. The moderate increase in the number of splenic macrophages during T. borreli infection contrasts the marked increase in the number of splenic neutrophilic granulocytes during T. carassii infection, along with an increased gene expression of metalloproteinase-9 and chemokines. Conclusion/Significance: This is the first study that provides evidence for a Th17-like immune response in fish in response to infection with a protozoan parasite.	[Ribeiro, Carla M. S.; Pontes, Maria J. S. L.; Scheer, Marleen; Verburg-van Kemenade, B. M. Lidy; Savelkoul, Huub F. J.; Wiegertjes, Geert F.] Wageningen Univ, Dept Anim Sci, Cell Biol & Immunol Grp, Wageningen, Netherlands; [Bird, Steve] Univ Aberdeen, Scottish Fish Immunol Res Ctr, Sch Biol Sci, Aberdeen, Scotland; [Chadzinska, Magdalena] Jagiellonian Univ, Inst Zool, Dept Evolutionary Immunobiol, PL-30060 Krakow, Poland	Wageningen University & Research; University of Aberdeen; Jagiellonian University	Ribeiro, CMS (corresponding author), Wageningen Univ, Dept Anim Sci, Cell Biol & Immunol Grp, Wageningen, Netherlands.	geert.wiegertjes@wur.nl	Bird, Steve/K-4822-2014; Savelkoul, Huub FJ/F-6026-2012; Wiegertjes, Geert F/E-3330-2012	Bird, Steve/0000-0003-2937-8579; wiegertjes, geert/0000-0001-9265-3436; van Kemenade, Lidy/0000-0002-5031-7335; Ribeiro, Carla/0000-0002-5682-4143	Portuguese foundation Fundacao para a Ciencia e Tecnologia [SFR/BD/21522/2005]; European Commission [FP6007103]	Portuguese foundation Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and Technology); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Portuguese foundation Fundacao para a Ciencia e Tecnologia under grant agreement number SFR/BD/21522/2005 and the European Commission through contract FP6007103 (Improved Immunity of Aquacultured Animals, IMAQUANIM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No author has any financial, personal, or professional interest that could be construed to have influenced the paper.	Abdelkhalek NK, 2009, FISH SHELLFISH IMMUN, V27, P763, DOI 10.1016/j.fsi.2009.08.004; Artavanis-Tsakonas K, 2002, J IMMUNOL, V169, P2956, DOI 10.4049/jimmunol.169.6.2956; Becker I, 2003, MOL BIOCHEM PARASIT, V130, P65, DOI 10.1016/S0166-6851(03)00160-9; Cameron P, 2004, J IMMUNOL, V173, P3297, DOI 10.4049/jimmunol.173.5.3297; Campos MA, 2001, J IMMUNOL, V167, P416, DOI 10.4049/jimmunol.167.1.416; Carmody RJ, 2007, J IMMUNOL, V178, P186, DOI 10.4049/jimmunol.178.1.186; Chin AC, 2009, J IMMUNOL, V183, P5957, DOI 10.4049/jimmunol.0900789; D'Ombrain MC, 2007, EUR J IMMUNOL, V37, P1864, DOI 10.1002/eji.200636889; Damsker JM, 2010, ANN NY ACAD SCI, V1183, P211, DOI 10.1111/j.1749-6632.2009.05133.x; Dardalhon V, 2008, J AUTOIMMUN, V31, P252, DOI 10.1016/j.jaut.2008.04.017; Debierre-Grockiego F, 2003, J BIOL CHEM, V278, P32987, DOI 10.1074/jbc.M304791200; FEDELE G, PLOS ONE, V5, pE8734; Forlenza M, 2008, MOL IMMUNOL, V45, P1531, DOI 10.1016/j.molimm.2007.10.010; Forlenza M, 2009, J IMMUNOL, V183, P5319, DOI 10.4049/jimmunol.0901780; Gaffen SL, 2006, VITAM HORM, V74, P255, DOI 10.1016/S0083-6729(06)74010-9; Gazzinelli RT, 2004, IMMUNOL REV, V201, P9, DOI 10.1111/j.0105-2896.2004.00174.x; GILLESSEN S, 1995, EUR J IMMUNOL, V25, P200, DOI 10.1002/eji.1830250133; Goriely S, 2008, NAT REV IMMUNOL, V8, P81, DOI 10.1038/nri2225; Gunimaladevi I, 2006, FISH SHELLFISH IMMUN, V21, P393, DOI 10.1016/j.fsi.2006.01.004; Holscher C, 2004, MED MICROBIOL IMMUN, V193, P1, DOI 10.1007/s00430-003-0186-x; HOLT A, 2010, DISCOVERY ZEBR UNPUB; Huising MO, 2006, MOL IMMUNOL, V43, P1519, DOI 10.1016/j.molimm.2005.10.010; Huising MO, 2006, J ENDOCRINOL, V189, P1, DOI 10.1677/joe.1.06591; Hunter CA, 2005, NAT REV IMMUNOL, V5, P521, DOI 10.1038/nri1648; IRNAZAROW I, 1995, AQUACULTURE, V129, P215, DOI 10.1016/0044-8486(95)91961-T; Jayakumar A, 2008, J PARASITOL, V94, P84, DOI 10.1645/GE-1153.1; Joerink M, 2006, J IMMUNOL, V177, P61, DOI 10.4049/jimmunol.177.1.61; Joerink M, 2006, FISH SHELLFISH IMMUN, V21, P561, DOI 10.1016/j.fsi.2006.03.006; Kelly MN, 2005, INFECT IMMUN, V73, P617, DOI 10.1128/IAI.73.1.617-621.2005; Kemenade B, 1994, J EXP BIOL, V187, P143; KOBAYASHI M, 1989, J EXP MED, V170, P827, DOI 10.1084/jem.170.3.827; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Krishnegowda G, 2005, J BIOL CHEM, V280, P8606, DOI 10.1074/jbc.M413541200; Langrish CL, 2004, IMMUNOL REV, V202, P96, DOI 10.1111/j.0105-2896.2004.00214.x; LING P, 1995, J IMMUNOL, V154, P116; Mun HS, 2003, INT IMMUNOL, V15, P1081, DOI 10.1093/intimm/dxg108; Nakae S, 2007, J LEUKOCYTE BIOL, V81, P1258, DOI 10.1189/jlb.1006610; Nakayasu C, 1998, FISH SHELLFISH IMMUN, V8, P91, DOI 10.1006/fsim.1997.0125; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Nishimura K, 2008, J PARASITOL, V94, P99, DOI 10.1645/GE-1322.1; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Overath P, 1998, PARASITOL RES, V84, P343, DOI 10.1007/s004360050408; Overath P, 1999, PARASITOLOGY, V119, P591, DOI 10.1017/S0031182099005089; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Peck A, 2010, INFECT IMMUN, V78, P32, DOI 10.1128/IAI.00929-09; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Presky DH, 1996, P NATL ACAD SCI USA, V93, P14002, DOI 10.1073/pnas.93.24.14002; Re F, 2001, J BIOL CHEM, V276, P37692, DOI 10.1074/jbc.M105927200; Ribeiro CMS, 2010, J IMMUNOL, V184, P2355, DOI 10.4049/jimmunol.0900990; Romano N, 1998, ANAT EMBRYOL, V198, P31, DOI 10.1007/s004290050162; Saeij JPJ, 2002, PARASITOLOGY, V124, P77, DOI 10.1017/S0031182001008915; Schwarzenberger P, 1998, J IMMUNOL, V161, P6383; Shi GP, 2008, J IMMUNOL, V181, P7205, DOI 10.4049/jimmunol.181.10.7205; Stafford JL, 2001, DEV COMP IMMUNOL, V25, P447, DOI 10.1016/S0145-305X(01)00015-5; STEINHAGEN D, 1989, J PARASITOL, V75, P685, DOI 10.2307/3283050; Steinhagen D, 2000, DIS AQUAT ORGAN, V41, P195, DOI 10.3354/dao041195; Stolte EH, 2008, DEV COMP IMMUNOL, V32, P1467, DOI 10.1016/j.dci.2008.06.012; Tichopad A, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng122; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; van de Veerdonk FL, 2009, BMB REP, V42, P776, DOI 10.5483/BMBRep.2009.42.12.776; Wenink MH, 2009, J IMMUNOL, V183, P6960, DOI 10.4049/jimmunol.0900713; Weyts FAA, 1997, FISH SHELLFISH IMMUN, V7, P123, DOI 10.1006/fsim.1996.0069; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Yoshida H, 2008, IMMUNOL REV, V226, P234, DOI 10.1111/j.1600-065X.2008.00710.x	66	40	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2010	5	9							e13012	10.1371/journal.pone.0013012	http://dx.doi.org/10.1371/journal.pone.0013012			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654KL	20885956	gold, Green Submitted, Green Published			2022-12-27	WOS:000282167100015
J	Felisberti, FM; Pavey, L				Felisberti, Fatima Maria; Pavey, Louisa			Contextual Modulation of Biases in Face Recognition	PLOS ONE			English	Article							SOCIAL-EXCHANGE; ENHANCED RECOGNITION; ALTRUIST-DETECTION; BRAIN RESPONSES; SOURCE MEMORY; COOPERATION; EVOLUTION; TRUSTWORTHINESS; EXPOSURE; JUDGMENT	Background: The ability to recognize the faces of potential cooperators and cheaters is fundamental to social exchanges, given that cooperation for mutual benefit is expected. Studies addressing biases in face recognition have so far proved inconclusive, with reports of biases towards faces of cheaters, biases towards faces of cooperators, or no biases at all. This study attempts to uncover possible causes underlying such discrepancies. Methodology and Findings: Four experiments were designed to investigate biases in face recognition during social exchanges when behavioral descriptors (prosocial, antisocial or neutral) embedded in different scenarios were tagged to faces during memorization. Face recognition, measured as accuracy and response latency, was tested with modified yes-no, forced-choice and recall tasks (N = 174). An enhanced recognition of faces tagged with prosocial descriptors was observed when the encoding scenario involved financial transactions and the rules of the social contract were not explicit (experiments 1 and 2). Such bias was eliminated or attenuated by making participants explicitly aware of "cooperative'', "cheating'' and "neutral/indifferent'' behaviors via a pre-test questionnaire and then adding such tags to behavioral descriptors (experiment 3). Further, in a social judgment scenario with descriptors of salient moral behaviors, recognition of antisocial and prosocial faces was similar, but significantly better than neutral faces (experiment 4). Conclusion: The results highlight the relevance of descriptors and scenarios of social exchange in face recognition, when the frequency of prosocial and antisocial individuals in a group is similar. Recognition biases towards prosocial faces emerged when descriptors did not state the rules of a social contract or the moral status of a behavior, and they point to the existence of broad and flexible cognitive abilities finely tuned to minor changes in social context.	[Felisberti, Fatima Maria; Pavey, Louisa] Kingston Univ London, Fac Arts & Social Sci, London, England	Kingston University	Felisberti, FM (corresponding author), Kingston Univ London, Fac Arts & Social Sci, London, England.	f.felisberti@kingston.ac.uk	Pavey, Louisa/AAM-4375-2021; Felisberti, Fatima M/F-3166-2010	Felisberti, Fatima M/0000-0002-8703-4400; Pavey, Louisa/0000-0002-7646-099X; Lauwereyns, Jan/0000-0003-0551-2550				Adolphs R, 1998, NATURE, V393, P470, DOI 10.1038/30982; Aggleton JP, 1996, NEUROPSYCHOLOGIA, V34, P51, DOI 10.1016/0028-3932(95)00150-6; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Barclay P, 2008, COGNITION, V107, P817, DOI 10.1016/j.cognition.2007.11.013; Barclay P, 2006, HUM NATURE-INT BIOS, V17, P98, DOI 10.1007/s12110-006-1022-y; Bastin C, 2003, NEUROPSYCHOLOGY, V17, P14, DOI 10.1037/0894-4105.17.1.14; Bayley PJ, 2008, J COGNITIVE NEUROSCI, V20, P505, DOI 10.1162/jocn.2008.20038; Blais C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003022; BONNER L, 2003, VIS COGN, V10, P507; Brown W.M., 2003, EVOL PSYCHOL-US, V1, P42, DOI DOI 10.1177/147470490300100104; Brown WM, 2000, EVOL HUM BEHAV, V21, P25, DOI 10.1016/S1090-5138(99)00018-5; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Buchner A, 2009, EVOL HUM BEHAV, V30, P212, DOI 10.1016/j.evolhumbehav.2009.01.004; CARLSTON DE, 1986, J PERS SOC PSYCHOL, V50, P5, DOI 10.1037/0022-3514.50.1.5; Chiappe D., 2004, EVOLUTIONARY PSYCHOL, V2, P108, DOI DOI 10.1177/147470490400200117; Cohen TR, 2010, J EXP SOC PSYCHOL, V46, P39, DOI 10.1016/j.jesp.2009.09.009; COSMIDES L, 1989, COGNITION, V31, P187, DOI 10.1016/0010-0277(89)90023-1; Cosmides L., 1992, ADAPTED MIND EVOLUTI, P163; Cosmides L, 2010, P NATL ACAD SCI USA, V107, P9007, DOI 10.1073/pnas.0914623107; Engell AD, 2007, J COGNITIVE NEUROSCI, V19, P1508, DOI 10.1162/jocn.2007.19.9.1508; FARELLI D, 2008, EVOLUTIONARY PSYCHOL, V6, P523; FELISBERTI FM, 2009, ANN M EUR HUM BEH AS; Flynn FJ, 2006, J PERS SOC PSYCHOL, V91, P1123, DOI 10.1037/0022-3514.91.6.1123; GIGERENZER G, 1992, COGNITION, V43, P127, DOI 10.1016/0010-0277(92)90060-U; Gino F, 2009, PSYCHOL SCI, V20, P393, DOI 10.1111/j.1467-9280.2009.02306.x; Gold JJ, 2006, P NATL ACAD SCI USA, V103, P9351, DOI 10.1073/pnas.0602716103; Hardy CL, 2006, PERS SOC PSYCHOL B, V32, P1402, DOI 10.1177/0146167206291006; Jiang F, 2009, PSYCHOL SCI, V20, P318, DOI 10.1111/j.1467-9280.2009.02285.x; Kerr NL, 2009, J EXP SOC PSYCHOL, V45, P603, DOI 10.1016/j.jesp.2009.02.017; Kiyonari T, 2008, J PERS SOC PSYCHOL, V95, P826, DOI 10.1037/a0011381; KOMORITA SS, 1992, J PERS SOC PSYCHOL, V62, P607, DOI 10.1037/0022-3514.62.4.607; LAUGHERY KR, 1971, J APPL PSYCHOL, V55, P477, DOI 10.1037/h0031646; MANDLER G, 1980, PSYCHOL REV, V87, P252, DOI 10.1037/0033-295X.87.3.252; Mealey L, 1996, ETHOL SOCIOBIOL, V17, P119, DOI 10.1016/0162-3095(95)00131-X; Mehl B, 2008, EVOL HUM BEHAV, V29, P35, DOI 10.1016/j.evolhumbehav.2007.08.001; Oda R, 2006, EVOL HUM BEHAV, V27, P366, DOI 10.1016/j.evolhumbehav.2006.03.002; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Price ME, 2006, ORGAN BEHAV HUM DEC, V101, P20, DOI 10.1016/j.obhdp.2006.06.001; REEDER GD, 1979, PSYCHOL REV, V86, P61, DOI 10.1037/0033-295X.86.1.61; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; Shinada M, 2007, EVOL HUM BEHAV, V28, P330, DOI 10.1016/j.evolhumbehav.2007.04.001; Singer T, 2004, NEURON, V41, P653, DOI 10.1016/S0896-6273(04)00014-5; SKOWRONSKI JJ, 1989, PSYCHOL BULL, V105, P131, DOI 10.1037/0033-2909.105.1.131; Stevens JR, 2005, ANNU REV ECOL EVOL S, V36, P499, DOI 10.1146/annurev.ecolsys.36.113004.083814; Todorov A, 2003, J EXP SOC PSYCHOL, V39, P549, DOI 10.1016/S0022-1031(03)00059-3; Todorov A, 2007, NEUROPSYCHOLOGIA, V45, P163, DOI 10.1016/j.neuropsychologia.2006.04.018; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Van Vugt M, 2004, J PERS SOC PSYCHOL, V86, P585, DOI 10.1037/0022-3514.86.4.585; Van Vugt M, 1999, J PERS SOC PSYCHOL, V76, P587, DOI 10.1037/0022-3514.76.4.587; Willis J, 2006, PSYCHOL SCI, V17, P592, DOI 10.1111/j.1467-9280.2006.01750.x; Winston JS, 2002, NAT NEUROSCI, V5, P277, DOI 10.1038/nn816; Wixted JT, 2007, PSYCHOL REV, V114, P152, DOI 10.1037/0033-295X.114.1.152; Zhang Y, 2009, J PERS SOC PSYCHOL, V97, P796, DOI 10.1037/a0016233	53	8	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12939	10.1371/journal.pone.0012939	http://dx.doi.org/10.1371/journal.pone.0012939			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	653KV	20886086	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000282091100038
J	Tilghman, RW; Cowan, CR; Mih, JD; Koryakina, Y; Gioeli, D; Slack-Davis, JK; Blackman, BR; Tschumperlin, DJ; Parsons, JT				Tilghman, Robert W.; Cowan, Catharine R.; Mih, Justin D.; Koryakina, Yulia; Gioeli, Daniel; Slack-Davis, Jill K.; Blackman, Brett R.; Tschumperlin, Daniel J.; Parsons, J. Thomas			Matrix Rigidity Regulates Cancer Cell Growth and Cellular Phenotype	PLOS ONE			English	Article							E-CADHERIN; MYOCARDIAL-INFARCTION; GENE-EXPRESSION; ADHESION KINASE; TISSUE; PROLIFERATION; TRANSITIONS; TENSION; DIRECTS; DIFFERENTIATION	Background: The mechanical properties of the extracellular matrix have an important role in cell growth and differentiation. However, it is unclear as to what extent cancer cells respond to changes in the mechanical properties (rigidity/stiffness) of the microenvironment and how this response varies among cancer cell lines. Methodology/Principal Findings: In this study we used a recently developed 96-well plate system that arrays extracellular matrix-conjugated polyacrylamide gels that increase in stiffness by at least 50-fold across the plate. This plate was used to determine how changes in the rigidity of the extracellular matrix modulate the biological properties of tumor cells. The cell lines tested fall into one of two categories based on their proliferation on substrates of differing stiffness: "rigidity dependent" (those which show an increase in cell growth as extracellular rigidity is increased), and "rigidity independent" (those which grow equally on both soft and stiff substrates). Cells which grew poorly on soft gels also showed decreased spreading and migration under these conditions. More importantly, seeding the cell lines into the lungs of nude mice revealed that the ability of cells to grow on soft gels in vitro correlated with their ability to grow in a soft tissue environment in vivo. The lung carcinoma line A549 responded to culture on soft gels by expressing the differentiated epithelial marker E-cadherin and decreasing the expression of the mesenchymal transcription factor Slug. Conclusions/Significance: These observations suggest that the mechanical properties of the matrix environment play a significant role in regulating the proliferation and the morphological properties of cancer cells. Further, the multiwell format of the soft-plate assay is a useful and effective adjunct to established 3-dimensional cell culture models.	[Tilghman, Robert W.; Cowan, Catharine R.; Koryakina, Yulia; Gioeli, Daniel; Slack-Davis, Jill K.; Parsons, J. Thomas] Univ Virginia, Sch Med, Dept Microbiol, Charlottesville, VA 22908 USA; [Tilghman, Robert W.; Cowan, Catharine R.; Koryakina, Yulia; Gioeli, Daniel; Slack-Davis, Jill K.; Parsons, J. Thomas] Univ Virginia, Ctr Canc, Sch Med, Charlottesville, VA 22908 USA; [Mih, Justin D.; Tschumperlin, Daniel J.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Blackman, Brett R.] Univ Virginia, Sch Med, Dept Biomed Engn, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; Harvard University; Harvard T.H. Chan School of Public Health; University of Virginia	Tilghman, RW (corresponding author), Univ Virginia, Sch Med, Dept Microbiol, Charlottesville, VA 22908 USA.	jtp@virginia.edu			NIH-NCI (National Institutes of Health-National Cancer Institute) [CA40042]; Coulter Foundation [NIH HL092961, NIH CA124706]; NATIONAL CANCER INSTITUTE [R01CA124706] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092961] Funding Source: NIH RePORTER	NIH-NCI (National Institutes of Health-National Cancer Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Coulter Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grants NIH-NCI CA40042 (National Institutes of Health-National Cancer Institute) (www.nih.gov) and funding from the Coulter Foundation Translational Partners Award (www.whcf.org) (JTP), NIH HL092961 (DJT), and NIH CA124706 (DG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assoian RK, 2008, TRENDS CELL BIOL, V18, P347, DOI 10.1016/j.tcb.2008.05.002; Barr S, 2008, CLIN EXP METASTAS, V25, P685, DOI 10.1007/s10585-007-9121-7; Baum B, 2008, SEMIN CELL DEV BIOL, V19, P294, DOI 10.1016/j.semcdb.2008.02.001; Berry MF, 2006, AM J PHYSIOL-HEART C, V290, pH2196, DOI 10.1152/ajpheart.01017.2005; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Buck E, 2007, MOL CANCER THER, V6, P532, DOI 10.1158/1535-7163.MCT-06-0462; Christofori G, 1999, TRENDS BIOCHEM SCI, V24, P73, DOI 10.1016/S0968-0004(98)01343-7; Dean RG, 2005, J HISTOCHEM CYTOCHEM, V53, P1245, DOI 10.1369/jhc.4A6560.2005; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Engler A. J., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P335; Engler AJ, 2008, J CELL SCI, V121, P3794, DOI 10.1242/jcs.029678; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004; Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/00001756-200212200-00007; Fre S, 2008, ADV CANCER RES, V100, P85, DOI 10.1016/S0065-230X(08)00003-1; Gagne D, 2010, J CELL PHYSIOL, V222, P387, DOI 10.1002/jcp.21963; Hayashida Y, 2006, J BIOL CHEM, V281, P32469, DOI 10.1074/jbc.M607240200; Huang S, 2005, CANCER CELL, V8, P175, DOI 10.1016/j.ccr.2005.08.009; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Klein EA, 2009, CURR BIOL, V19, P1511, DOI 10.1016/j.cub.2009.07.069; Kostic A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006361; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Provenzano PP, 2009, ONCOGENE, V28, P4326, DOI 10.1038/onc.2009.299; Rehfeldt F, 2007, ADV DRUG DELIVER REV, V59, P1329, DOI 10.1016/j.addr.2007.08.007; Shibue T, 2009, P NATL ACAD SCI USA, V106, P10290, DOI 10.1073/pnas.0904227106; Stockinger A, 2001, J CELL BIOL, V154, P1185, DOI 10.1083/jcb.200104036; Tilghman RW, 2008, SEMIN CANCER BIOL, V18, P45, DOI 10.1016/j.semcancer.2007.08.002; Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859; Wang HB, 2000, AM J PHYSIOL-CELL PH, V279, pC1345, DOI 10.1152/ajpcell.2000.279.5.C1345; Wang YL, 1998, METHOD ENZYMOL, V298, P489, DOI 10.1016/S0076-6879(98)98041-7; Wozniak MA, 2003, J CELL BIOL, V163, P583, DOI 10.1083/jcb.200305010	33	238	246	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12905	10.1371/journal.pone.0012905	http://dx.doi.org/10.1371/journal.pone.0012905			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886123	Green Published, gold, Green Submitted			2022-12-27	WOS:000282091100014
J	Chen, SJ; Chen, GH; Chen, YH; Liu, CY; Chang, KP; Chang, YS; Chen, HC				Chen, Shu-Jen; Chen, Gian-Hung; Chen, Yi-Hsuan; Liu, Cheng-Yuan; Chang, Kai-Ping; Chang, Yu-Sun; Chen, Hua-Chien			Characterization of Epstein-Barr Virus miRNAome in Nasopharyngeal Carcinoma by Deep Sequencing	PLOS ONE			English	Article							MICRORNA EXPRESSION PROFILES; MIR-200 FAMILY; PROTEIN EXPRESSION; LUNG-CANCER; IDENTIFICATION; ZEB1; MODULATION; LEUKEMIA; TARGETS; GENES	Virus-encoded microRNAs (miRNAs) have been shown to regulate a variety of biological processes involved in viral infection and viral-associated pathogenesis. Epstein-Barr virus (EBV) is a herpesvirus implicated in nasopharyngeal carcinoma (NPC) and other human malignancies. EBV-encoded miRNAs were among the first group of viral miRNAs identified. To understand the roles of EBV miRNAs in the pathogenesis of NPC, we utilized deep sequencing technology to characterize the EBV miRNA transcriptome in clinical NPC tissues. We obtained more than 110,000 sequence reads in NPC samples and identified 44 EBV BART miRNAs, including four new mature miRNAs derived from previously identified BART miRNA precursor hairpins. Further analysis revealed extensive sequence variations (isomiRs) of EBV miRNAs, including terminal isomiRs at both the 59 and 39 ends and nucleotide variants. Analysis of EBV genomic sequences indicated that the majority of EBV miRNA nucleotide variants resulted from post-transcriptional modifications. Read counts of individual EBV miRNA in NPC tissue spanned from a few reads to approximately 18,000 reads, confirming the wide expression range of EBV miRNAs. Several EBV miRNAs were expressed at levels similar to highly abundant human miRNAs. Sequence analysis revealed that most of the highly abundant EBV miRNAs share their seed sequences (nucleotides 2-7) with human miRNAs, suggesting that seed sequence content may be an important factor underlying the differential accumulation of BART miRNAs. Interestingly, many of these human miRNAs have been found to be dysregulated in human malignancies, including NPC. These observations not only provide a potential linkage between EBV miRNAs and human malignancy but also suggest a highly coordinated mechanism through which EBV miRNAs may mimic or compete with human miRNAs to affect cellular functions.	[Chen, Shu-Jen; Chen, Gian-Hung; Chen, Yi-Hsuan; Chen, Hua-Chien] Chang Gung Univ, Dept Life Sci, Tao Yuan, Taiwan; [Chen, Shu-Jen; Liu, Cheng-Yuan; Chang, Yu-Sun; Chen, Hua-Chien] Chang Gung Univ, Mol Med Res Ctr, Tao Yuan, Taiwan; [Chang, Kai-Ping] Chang Gung Mem Hosp Lin Kou, Dept Otolaryngol, Tao Yuan, Taiwan	Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital	Chen, SJ (corresponding author), Chang Gung Univ, Dept Life Sci, Tao Yuan, Taiwan.	hcchen@mail.cgu.edu.tw	Chang, Kai-Ping/B-5135-2011	Chang, Yu-Sun/0000-0002-6457-3890	Ministry of Education	Ministry of Education	This work was supported by grants from the Ministry of Education to Chang Gung University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bankier A T, 1983, Mol Biol Med, V1, P21; Barth S, 2008, NUCLEIC ACIDS RES, V36, P666, DOI 10.1093/nar/gkm1080; Burgos JS, 2005, MED ONCOL, V22, P113, DOI 10.1385/MO:22:2:113; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Cai Xuezhong, 2006, PLoS Pathogens, V2, P236, DOI 10.1371/journal.ppat.0020023; Chatterjee S, 2009, NATURE, V461, P546, DOI 10.1038/nature08349; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen HC, 2009, BRIT J CANCER, V100, P1002, DOI 10.1038/sj.bjc.6604948; Choy EYW, 2008, J EXP MED, V205, P2551, DOI 10.1084/jem.20072581; Cosmopoulos K, 2009, J VIROL, V83, P2357, DOI 10.1128/JVI.02104-08; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de Hoon MJL, 2010, GENOME RES, V20, P257, DOI 10.1101/gr.095273.109; Edwards RH, 2008, J VIROL, V82, P9094, DOI 10.1128/JVI.00785-08; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Ghosh Z, 2009, NUCLEIC ACIDS RES, V37, P1035, DOI 10.1093/nar/gkn1004; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grundhoff A, 2006, RNA, V12, P733, DOI 10.1261/rna.2326106; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Iwakiri D, 2010, ADV CANCER RES, V107, P119, DOI 10.1016/S0065-230X(10)07004-1; Karube Y, 2005, CANCER SCI, V96, P111, DOI 10.1111/j.1349-7006.2005.00015.x; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Kawahara Y, 2008, NUCLEIC ACIDS RES, V36, P5270, DOI 10.1093/nar/gkn479; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kuchenbauer F, 2008, GENOME RES, V18, P1787, DOI 10.1101/gr.077578.108; Ladeiro Y, 2008, HEPATOLOGY, V47, P1955, DOI 10.1002/hep.22256; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Liang H, 2009, MOL BIOL EVOL, V26, P1195, DOI 10.1093/molbev/msp053; Lo AKF, 2007, P NATL ACAD SCI USA, V104, P16164, DOI 10.1073/pnas.0702896104; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lung RWM, 2009, NEOPLASIA, V11, P1174, DOI 10.1593/neo.09888; Marti E, 2010, NUCLEIC ACIDS RES, V38, P7219, DOI 10.1093/nar/gkq575; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Middeldorp JM, 2008, SEMIN CANCER BIOL, V18, P388, DOI 10.1016/j.semcancer.2008.10.004; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Nachmani D, 2009, CELL HOST MICROBE, V5, P376, DOI 10.1016/j.chom.2009.03.003; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pekarsky Y, 2006, CANCER RES, V66, P11590, DOI 10.1158/0008-5472.CAN-06-3613; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Pratt ZL, 2009, VIROLOGY, V386, P387, DOI 10.1016/j.virol.2009.01.006; Reid JG, 2008, GENOME RES, V18, P1571, DOI 10.1101/gr.078246.108; Riley KJL, 2010, J VIROL, V84, P5148, DOI 10.1128/JVI.00110-10; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Schulte JH, 2010, NUCLEIC ACIDS RES, V38, P5919, DOI 10.1093/nar/gkq342; Seitz H, 2008, CURR BIOL, V18, P147, DOI 10.1016/j.cub.2007.12.049; Sengupta S, 2008, P NATL ACAD SCI USA, V105, P5874, DOI 10.1073/pnas.0801130105; Skalsky RL, 2007, J VIROL, V81, P12836, DOI 10.1128/JVI.01804-07; Swaminathan S, 2008, J CELL PHYSIOL, V216, P321, DOI 10.1002/jcp.21480; Umbach JL, 2010, J VIROL, V84, P695, DOI 10.1128/JVI.02013-09; Walz N, 2010, J VIROL, V84, P716, DOI 10.1128/JVI.01302-09; Xia T, 2008, CANCER RES, V68, P1436, DOI 10.1158/0008-5472.CAN-07-5126; Yoshizaki T, 2002, HISTOL HISTOPATHOL, V17, P845, DOI 10.14670/HH-17.845; Zhu JY, 2009, J VIROL, V83, P3333, DOI 10.1128/JVI.01689-08	56	106	110	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2010	5	9							e12745	10.1371/journal.pone.0012745	http://dx.doi.org/10.1371/journal.pone.0012745			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651YH	20862214	Green Published, Green Submitted, gold			2022-12-27	WOS:000281963200002
J	Stelzer, CP; Schmidt, J; Wiedlroither, A; Riss, S				Stelzer, Claus-Peter; Schmidt, Johanna; Wiedlroither, Anneliese; Riss, Simone			Loss of Sexual Reproduction and Dwarfing in a Small Metazoan	PLOS ONE			English	Article							BRACHIONUS-CALYCIFLORUS; DAPHNIA-PULEX; ROTIFER; PARTHENOGENESIS; CULTURE; INDUCTION; EVOLUTION; DYNAMICS; STRAIN	Background: Asexuality has major theoretical advantages over sexual reproduction, yet newly formed asexual lineages rarely endure. The success, or failure, of such lineages is affected by their mechanism of origin, because it determines their initial genetic makeup and variability. Most previously described mechanisms imply that asexual lineages are randomly frozen subsamples of a sexual population. Methodology/Principal Findings: We found that transitions to obligate parthenogenesis (OP) in the rotifer Brachionus calyciflorus, a small freshwater invertebrate which normally reproduces by cyclical parthenogenesis, were controlled by a simple Mendelian inheritance. Pedigree analysis suggested that obligate parthenogens were homozygous for a recessive allele, which caused inability to respond to the chemical signals that normally induce sexual reproduction in this species. Alternative mechanisms, such as ploidy changes, could be ruled out on the basis of flow cytometric measurements and genetic marker analysis. Interestingly, obligate parthenogens were also dwarfs (approximately 50% smaller than cyclical parthenogens), indicating pleiotropy or linkage with genes that strongly affect body size. We found no adverse effects of OP on survival or fecundity. Conclusions/Significance: This mechanism of inheritance implies that genes causing OP may evolve within sexual populations and remain undetected in the heterozygous state long before they get frequent enough to actually cause a transition to asexual reproduction. In this process, genetic variation at other loci might become linked to OP genes, leading to non-random associations between asexuality and other phenotypic traits.	[Stelzer, Claus-Peter; Schmidt, Johanna; Wiedlroither, Anneliese; Riss, Simone] Austrian Acad Sci, Inst Limnol, A-5310 Mondsee, Austria	Austrian Academy of Sciences	Stelzer, CP (corresponding author), Austrian Acad Sci, Inst Limnol, A-5310 Mondsee, Austria.	claus-peter.stelzer@oeaw.ac.at	Stelzer, Claus-Peter/F-3789-2018	Stelzer, Claus-Peter/0000-0002-6682-0904	FWF (Fonds zur Foerderung der wissenschaftlichen Forschung) [P20735-B17]; Austrian Science Fund (FWF) [P 20735] Funding Source: researchfish	FWF (Fonds zur Foerderung der wissenschaftlichen Forschung)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Funding was provided by a FWF (Fonds zur Foerderung der wissenschaftlichen Forschung) Grant P20735-B17 to CPS (http://www.fwf.ac.at/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton NH, 1998, SCIENCE, V281, P1986, DOI 10.1126/science.281.5385.1986; Bell G., 1982, MASTERPIECE NATURE; BENNETT WN, 1988, AQUACULTURE, V73, P27, DOI 10.1016/0044-8486(88)90038-5; BENNETT WN, 1989, OIKOS, V55, P365, DOI 10.2307/3565596; Beukeboom LW, 2007, SCIENCE, V315, P206, DOI 10.1126/science.1133388; BORAAS ME, 1983, LIMNOL OCEANOGR, V28, P546, DOI 10.4319/lo.1983.28.3.0546; BUCHNER H, 1987, ARCH HYDROBIOL, V109, P333; Carmona MJ, 2009, J EVOLUTION BIOL, V22, P1975, DOI 10.1111/j.1420-9101.2009.01811.x; Fussmann GF, 2003, P ROY SOC B-BIOL SCI, V270, P1015, DOI 10.1098/rspb.2003.2335; Gilbert JJ, 2005, HYDROBIOLOGIA, V546, P257, DOI 10.1007/s10750-005-4205-3; Gilbert John J., 2004, Journal of Limnology, V63, P32; Hurst Laurence D., 1996, Trends in Ecology and Evolution, V11, P46, DOI 10.1016/0169-5347(96)81041-X; INNES DJ, 1988, EVOLUTION, V42, P1024, DOI 10.1111/j.1558-5646.1988.tb02521.x; Jokela J, 1997, ECOLOGY, V78, P452; Kilham SS, 1998, HYDROBIOLOGIA, V377, P147, DOI 10.1023/A:1003231628456; KONDRASHOV AS, 1993, J HERED, V84, P372, DOI 10.1093/oxfordjournals.jhered.a111358; Kubanek J, 2008, CHEMICAL COMMUNICATION AMONG BACTERIA, P453; Lattorff HMG, 2005, HEREDITY, V94, P533, DOI 10.1038/sj.hdy.6800654; Lynch M, 2008, GENETICS, V180, P317, DOI 10.1534/genetics.107.084657; Nogrady T., 1993, ROTIFERA BIOL ECOLOG, P137; Otto SP, 2009, AM NAT, V174, pS1, DOI 10.1086/599084; Ruttner-Kolisko A., 1977, ARCH HYDROBIOL, V8, P71; Serra M, 1999, J EVOLUTION BIOL, V12, P263; Serra Manuel, 2004, P135; Simon JC, 2003, BIOL J LINN SOC, V79, P151, DOI 10.1046/j.1095-8312.2003.00175.x; SMITH JM, 1978, EVOLUTION SEX; Snell TW, 2006, MAR BIOL, V149, P763, DOI 10.1007/s00227-006-0251-2; Stelzer CP, 2008, J EVOLUTION BIOL, V21, P287, DOI 10.1111/j.1420-9101.2007.01437.x; Stelzer CP, 2005, HYDROBIOLOGIA, V546, P335, DOI 10.1007/s10750-005-4243-x; Stelzer CP, 2003, LIMNOL OCEANOGR, V48, P939, DOI 10.4319/lo.2003.48.2.0939; SUOMALAINEN E, 1950, ADV GENET, V3, P193, DOI 10.1016/S0065-2660(08)60086-3; Timmermeyer N, 2006, J PLANKTON RES, V28, P1233, DOI 10.1093/plankt/fbl052; VRIJENHOEK RC, 2009, GEOGRAPHICAL PARTHEN, P99	33	34	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2010	5	9							e12854	10.1371/journal.pone.0012854	http://dx.doi.org/10.1371/journal.pone.0012854			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651YH	20862222	Green Submitted, gold, Green Published			2022-12-27	WOS:000281963200018
J	Osterblom, H; Sumaila, UR; Bodin, O; Sundberg, JH; Press, AJ				Osterblom, Henrik; Sumaila, U. Rashid; Bodin, Orjan; Sundberg, Jonas Hentati; Press, Anthony J.			Adapting to Regional Enforcement: Fishing Down the Governance Index	PLOS ONE			English	Article							ILLEGAL	Background: Illegal, Unreported and Unregulated (IUU) fishing is a problem for marine resource managers, leading to depletion of fish stocks and negative impacts on marine ecosystems. These problems are particularly evident in regions with weak governance. Countries responsible for sustainable natural resource management in the Southern Ocean have actively worked to reduce IUU fishing in the region over a period of 15 years, leading to a sequence of three distinct peaks of IUU fishing. Methodology/Principal Findings: We reviewed existing public records relating to IUU fishing in the Southern Ocean between 1995-2009 and related this information to the governance capacity of flag states responsible for IUU vessels. IUU operators used a number of methods to adapt to enforcement actions, resulting in reduced risks of detection, apprehension and sanctioning. They changed fishing locations, vessel names and flag states, and ports for offloading IUU catches. There was a significant decrease in the proportion of IUU vessels flagged to CCAMLR countries, and a significant decrease in the average governance index of flag states. Despite a decreasing trend of IUU fishing, further actions are hampered by the regional scope of CCAMLR and the governance capacity of responsible states. Conclusions/Significance: This is the first study of long-term change in the modus operandi of IUU fishing fishing operators, illustrating that IUU operators can adapt to enforcement actions and that such dynamics may lead to new problems elsewhere, where countries have a limited capacity. This outsourcing of problems may have similarities to natural resource extraction in other sectors and in other regions. IUU fishing is the result of a number of factors, and effectively addressing this major challenge to sustainable marine resource extraction will likely require a stronger focus on governance. Highly mobile resource extractors with substantial funds are able to adapt to changing regulations by exploiting countries and regions with limited capacity.	[Osterblom, Henrik] Univ British Columbia, Fisheries Ctr, Vancouver, BC V5Z 1M9, Canada; [Osterblom, Henrik; Sumaila, U. Rashid] Stockholm Univ, Stockholm Resilience Ctr, Baltic Nest Inst, S-10691 Stockholm, Sweden; [Bodin, Orjan] Stockholm Univ, Dept Syst Ecol, S-10691 Stockholm, Sweden; [Press, Anthony J.] Antarctic Climate & Ecosyst Cooperat Res Ctr, Hobart, Tas, Australia	University of British Columbia; Stockholm University; Stockholm University; Antarctic Climate & Ecosystems Cooperative Research Centre (ACE CRC)	Osterblom, H (corresponding author), Univ British Columbia, Fisheries Ctr, Vancouver, BC V5Z 1M9, Canada.	henrik.osterblom@stockholmresilience.su.se	Hentati-Sundberg, Jonas/N-6535-2017; Sumaila, U. Rashid/ABE-6475-2020; Osterblom, Henrik/D-4249-2012; Bodin, Örjan/A-5098-2010	Hentati-Sundberg, Jonas/0000-0002-3201-9262; Bodin, Örjan/0000-0002-8218-1153; Osterblom, Henrik/0000-0002-1913-5197	FORMAS [2008-504]; MISTRA; Pew Charitable Trust	FORMAS(Swedish Research Council Formas); MISTRA; Pew Charitable Trust	This work was funded by a post doc scholarship by FORMAS (http://formas.se/) awarded to HO, grant number 2008-504. HO and OB received additional support by MISTRA (http://www.mistra.org/). The Sea Around Us and Global Ocean Economics Projects, both funded by the Pew Charitable Trust (http://www.pewtrusts.org/), supported RS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AAPA, 2010, WORLD PORT RANK 2008; Agnew DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004570; Agnew DJ, 2000, MAR POLICY, V24, P361, DOI 10.1016/S0308-597X(00)00012-9; [Anonymous], 2009, GOVERNANCE MATTERS 8; Australian National Audit Office (ANAO), 2008, ILL UNR UNR FISH SO; BAIRD R, 2005, INT FISHERIES LAW PO, V1, P170; Baird R.J., 2006, ASPECTS ILLEGAL UNRE; Berkes F, 2006, SCIENCE, V311, P1557, DOI 10.1126/science.1122804; Brack D, 2002, GLOBAL ENVIRON CHANG, V12, P143, DOI 10.1016/S0959-3780(01)00019-X; CCAMLR, 2002, 21 M COMM HOB CCAMLR; *CCAMLR, 2004, 23 M COMM HOB CCAMLR; *CCAMLR, 2009, 28 M COMM HOB CCAMLR; *CCAMLR, 2009, STAT B CCAMLR, V21; *CCAMLR, 2010, COMB IUU VESS LIST A; *CCAMLR, 1997, 16 M COMM HOB CCAMLR; *CCAMLR, 2003, 22 M COMM HOB CCAMLR; *CCAMLR, 2005, 24 M COMM HOB CCAMLR; *CCAMLR, 2006, 25 M COMM HOB CCAMLR; *CCAMLR, 2007, 26 M COMM HOB CCAMLR; *CCAMLR, 2000, 19 M COMM HOB CCAMLR; *CCAMLR, 2008, 27 M COMM HOB CCAMLR; *COLTO, 2003, ROG GALLERY NEW FAC; COLTO, 2003, TOOTHF PIR DRAM SO O; Dietz T, 2003, SCIENCE, V302, P1907, DOI 10.1126/science.1091015; Erceg D, 2006, MAR POLICY, V30, P173, DOI 10.1016/j.marpol.2004.11.004; Fallon LD, 2004, OCEAN DEV INT LAW, V35, P221, DOI 10.1080/00908320490467323; FAO, 2009, AGR PORT STAT MEAS P; FAO (Food and Agriculture Organization), 2001, INT PLAN ACT PREV DE; FLOTHMANN S, SCIENCE; Folke C, 2005, ANNU REV ENV RESOUR, V30, P441, DOI 10.1146/annurev.energy.30.050504.144511; Fukumi Sayaka, 2008, COCAINE TRAFFICKING; Gallic B.L., 2006, MAR POLICY, V30, P689, DOI DOI 10.1016/J.MARP0L.2005.09.008; Griggs L, 2007, MAR POLICY, V31, P159, DOI 10.1016/j.marpol.2006.05.015; *MARM, 2009, ACT MARM REL DET BUQ; MASTERS C, 2002, TOOTFISH PIRATES; MILLER D, 2004, INT J MARINE COASTAL, V317, P317; Miller D. G. M., 2010, LAW TECHNOLOGY SCI O; Mitchell Ronald B, 1993, REV EUR COMP INT ENV, V2, P327; MRAG (Marine Resources and Fisheries Consultants), 2008, STUD AN STAT IUU FIS; National Environmental Trust (NET), 2004, BLACK MARK WHIT GOLD; *NOAA, 2004, 3 SEAFOOD IND EX SEN; OLSEN M, 1965, LOGICA COLLECTIVE AC; Ostrom E, 1999, ANNU REV POLIT SCI, V2, P493, DOI 10.1146/annurev.polisci.2.1.493; Ostrom E, 1998, AM POLIT SCI REV, V92, P1, DOI 10.2307/2585925; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; RITTEL HWJ, 1973, POLICY SCI, V4, P155, DOI 10.1007/BF01405730; *SC CCAMLR, 2008, 27 M SCI COMM HOB SC; Sumaila UR, 2006, MAR POLICY, V30, P696, DOI 10.1016/j.marpol.2005.11.001	48	67	67	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2010	5	9							e12832	10.1371/journal.pone.0012832	http://dx.doi.org/10.1371/journal.pone.0012832			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	651XL	20877460	Green Published, Green Submitted, gold			2022-12-27	WOS:000281960800022
J	Schuchmann, M; Siemers, BM				Schuchmann, Maike; Siemers, Bjoern M.			Variability in Echolocation Call Intensity in a Community of Horseshoe Bats: A Role for Resource Partitioning or Communication?	PLOS ONE			English	Article							BIG BROWN BATS; RHINOLOPHUS-FERRUMEQUINUM; MEHELYI CHIROPTERA; INSECTIVOROUS BATS; FORAGING BEHAVIOR; EPTESICUS-FUSCUS; DAUBENTONS BATS; PREY SELECTION; BODY-SIZE; SEX	Background: Only recently data on bat echolocation call intensities is starting to accumulate. Yet, intensity is an ecologically crucial parameter, as it determines the extent of the bats' perceptual space and, specifically, prey detection distance. Interspecifically, we thus asked whether sympatric, congeneric bat species differ in call intensities and whether differences play a role for niche differentiation. Specifically, we investigated whether R. mehelyi that calls at a frequency clearly above what is predicted by allometry, compensates for frequency-dependent loss in detection distance by using elevated call intensity. Maximum echolocation call intensities might depend on body size or condition and thus be used as an honest signal of quality for intraspecific communication. We for the first time investigated whether a size-intensity relation is present in echolocating bats. Methodology/Principal Findings: We measured maximum call intensities and frequencies for all five European horseshoe bat species. Maximum intensity differed among species largely due to R. euryale. Furthermore, we found no compensation for frequency-dependent loss in detection distance in R. mehelyi. Intraspecifically, there is a negative correlation between forearm lengths and intensity in R. euryale and a trend for a negative correlation between body condition index and intensity in R. ferrumequinum. In R. hipposideros, females had 8 dB higher intensities than males. There were no correlations with body size or sex differences and intensity for the other species. Conclusions/Significance: Based on call intensity and frequency measurements, we estimated echolocation ranges for our study community. These suggest that intensity differences result in different prey detection distances and thus likely play some role for resource access. It is interesting and at first glance counter-intuitive that, where a correlation was found, smaller bats called louder than large individuals. Such negative relationship between size or condition and vocal amplitude may indicate an as yet unknown physiological or sexual selection pressure.	[Schuchmann, Maike; Siemers, Bjoern M.] Max Planck Inst Ornithol, Sensory Ecol Grp, Seewiesen, Germany	Max Planck Society	Schuchmann, M (corresponding author), Max Planck Inst Ornithol, Sensory Ecol Grp, Seewiesen, Germany.	schuchmann@orn.mpg.de			Max Planck Society	Max Planck Society(Max Planck Society)	This work was funded by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Ivailo Borissov, Stefan Greif, Markus Schuller and Daniela Schmieder for invaluable help during fieldwork; as well as the Directorate of the Rusenski Lom Nature Park (director Milko Belberov), the Bulgarian Bat Research and Conservation Group, and Christiana Popova for cooperation and support. Henrik Brumm and Matthais Ritchard provided discussion on call intensities and body size. Capture, husbandry and behavioral studies were carried out under license of the responsible Bulgarian authorities (MOEW-Sofia and RIOSV-Ruse, 57/18.04.2006 and 100/04.07.2007). Brock Fenton and two anonymous referees provided insightful comments that helped to improve the manuscript.	ARAK A, 1988, BEHAV ECOL SOCIOBIOL, V22, P317; BARCLAY RMR, 1982, BEHAV ECOL SOCIOBIOL, V10, P271, DOI 10.1007/BF00302816; BARCLAY RMR, 1991, AM NAT, V137, P693, DOI 10.1086/285188; BERNAYS EA, 1994, Q REV BIOL, V69, P187, DOI 10.1086/418539; Bogdanowicz W, 1999, J ZOOL, V247, P381, DOI 10.1111/j.1469-7998.1999.tb01001.x; Bontadina F, 2002, J ZOOL, V258, P281, DOI 10.1017/S0952836902001401; Boonman A, 2002, J EXP BIOL, V205, P2865; BRACKENBURY JH, 1979, J EXP BIOL, V78, P163; Brumm H, 2004, J ANIM ECOL, V73, P434, DOI 10.1111/j.0021-8790.2004.00814.x; Brumm H, 2006, CURR BIOL, V16, pR1003, DOI 10.1016/j.cub.2006.10.043; Brumm H, 2006, ANIM BEHAV, V72, P699, DOI 10.1016/j.anbehav.2006.01.020; Brumm H, 2009, ADV STUD BEHAV, V40, P1, DOI 10.1016/S0065-3454(09)40001-9; Brumm H, 2009, BEHAV ECOL SOCIOBIOL, V63, P1157, DOI 10.1007/s00265-009-0743-4; COLES RB, 1989, J COMP PHYSIOL A, V165, P269, DOI 10.1007/BF00619201; Cooper SJB, 2001, J MAMMAL, V82, P328, DOI 10.1644/1545-1542(2001)082<0328:AOSBIA>2.0.CO;2; Cynx J, 2004, ANIM BEHAV, V67, P451, DOI 10.1016/j.anbehav.2003.04.008; Dechmann DKN, 2009, P ROY SOC B-BIOL SCI, V276, P2721, DOI 10.1098/rspb.2009.0473; Dietz C., 2007, ASPECTS ECOMORPHOLOG; Dietz C., 2007, HDB FLEDERMAUSE EURO; Dietz C, 2006, ACTA CHIROPTEROL, V8, P523, DOI 10.3161/1733-5329(2006)8[523:EOFBOH]2.0.CO;2; Estok P, 2010, BIOL LETTERS, V6, P59, DOI 10.1098/rsbl.2009.0611; Fenton MB, 2003, MAMMAL REV, V33, P193, DOI 10.1046/j.1365-2907.2003.00019.x; FITCH WT, 1995, AM J PRIMATOL, V37, P191, DOI 10.1002/ajp.1350370303; GERHARDT HC, 1975, J COMP PHYSIOL, V102, P1, DOI 10.1007/BF00657481; Gillam EH, 2007, CAN J ZOOL, V85, P795, DOI 10.1139/Z07-060; Gray DA, 1997, ANIM BEHAV, V54, P1553, DOI 10.1006/anbe.1997.0584; Griffin DR, 1958, LISTENING DARK; Guillen A, 2000, J EVOLUTION BIOL, V13, P70; Heffner RS, 1996, HEARING RES, V99, P13, DOI 10.1016/S0378-5955(96)00074-3; HELLER KG, 1989, OECOLOGIA, V80, P178, DOI 10.1007/BF00380148; Holderied MW, 2005, J EXP BIOL, V208, P1321, DOI 10.1242/jeb.01528; Holderied MW, 2003, P ROY SOC B-BIOL SCI, V270, P2293, DOI 10.1098/rspb.2003.2487; Houston Robert D., 2003, P339; Jacobs DS, 2008, BEHAV ECOL, V19, P1333, DOI 10.1093/beheco/arn071; Jacobs DS, 2007, OECOLOGIA, V152, P583, DOI 10.1007/s00442-007-0679-1; Jensen ME, 1999, BEHAV ECOL SOCIOBIOL, V47, P60, DOI 10.1007/s002650050650; JONES G, 1990, J ANIM ECOL, V59, P587, DOI 10.2307/4882; JONES G, 1994, MAMMALIA, V58, P41, DOI 10.1515/mamm.1994.58.1.41; JONES G, 1994, FOLIA ZOOL, V43, P347; JONES G, 1992, MAMMALIA, V56, P189; JONES G, 1989, BEHAV ECOL SOCIOBIOL, V25, P183, DOI 10.1007/BF00302917; Jones Gareth, 1995, Rhinolophe, V11, P53; Jung K, 2007, J ZOOL, V272, P125, DOI 10.1111/j.1469-7998.2006.00250.x; Kazial KA, 2004, ANIM BEHAV, V67, P855, DOI 10.1016/j.anbehav.2003.04.016; Kazial KA, 2008, ETHOLOGY, V114, P469, DOI 10.1111/j.1439-0310.2008.01483.x; Kerth G, 2008, BIOSCIENCE, V58, P737, DOI 10.1641/B580810; KICK SA, 1982, J COMP PHYSIOL, V145, P431, DOI 10.1007/BF00612808; Kingston T, 2000, OECOLOGIA, V124, P332, DOI 10.1007/PL00008866; Mehl B., 1988, ANIMAL SONAR PROCESS, P435, DOI DOI 10.1007/978-1-4684-7493-0_43; NEUWEILER G, 1984, J COMP PHYSIOL, V154, P133, DOI 10.1007/BF00605398; NEUWEILER G, 1987, BEHAV ECOL SOCIOBIOL, V20, P53, DOI 10.1007/BF00292166; Pfefferle D, 2007, J ACOUST SOC AM, V121, P3947, DOI 10.1121/1.2722507; RITSCHARD M, 2010, ANIMAL BEHAV; Russo D, 2005, J ZOOL, V266, P327, DOI 10.1017/S0952836905006990; Russo D, 2002, J ZOOL, V258, P91, DOI 10.1017/S0952836902001231; Russo D, 2001, MAMMALIA, V65, P429, DOI 10.1515/mamm.2001.65.4.429; Russo D, 2007, J BIOGEOGR, V34, P2129, DOI 10.1111/j.1365-2699.2007.01762.x; SAFI K, 2010, EVOLUTIONARY ECOLOGY; Salsamendi E, 2008, ACTA CHIROPTEROL, V10, P279, DOI 10.3161/150811008X414854; Sanvito S, 2003, BIOACOUSTICS, V14, P47, DOI 10.1080/09524622.2003.9753512; Schuchmann M, 2010, AM NAT, V176, P72, DOI 10.1086/652993; Shi LM, 2009, ACTA THERIOL, V54, P371, DOI 10.4098/j.at.0001-7051.099.2008; Siemers BM, 2004, NATURE, V429, P657, DOI 10.1038/nature02547; Siemers BM, 2006, BEHAV ECOL SOCIOBIOL, V59, P373, DOI 10.1007/s00265-005-0060-5; Siemers BM, 2005, ACTA CHIROPTEROL, V7, P259, DOI 10.3161/1733-5329(2005)7[259:ISISAO]2.0.CO;2; SIMMONS LW, 1988, ANIM BEHAV, V36, P380, DOI 10.1016/S0003-3472(88)80009-5; Skowronski MD, 2008, J ACOUST SOC AM, V124, P328, DOI 10.1121/1.2924122; STAPELLS DR, 1982, J ACOUST SOC AM, V72, P74, DOI 10.1121/1.388026; STILZ P, 2004, THESIS U TUBINGEN TU; SUGA N, 1987, J NEUROPHYSIOL, V58, P643, DOI 10.1152/jn.1987.58.4.643; SURLYKKE A, 1993, BEHAV ECOL SOCIOBIOL, V33, P1, DOI 10.1007/BF00164341; Surlykke A, 2000, J ACOUST SOC AM, V108, P2419, DOI 10.1121/1.1315295; Surlykke A, 1999, NATURWISSENSCHAFTEN, V86, P238, DOI 10.1007/s001140050607; Surlykke A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002036; TUTTLE MD, 1985, ANIM BEHAV, V33, P1369, DOI 10.1016/S0003-3472(85)80204-9; VOIGT CC, 2010, J COMP PHYSIOL B, V79, P877; WATERS DA, 1995, BEHAV ECOL SOCIOBIOL, V37, P321, DOI 10.1007/BF00174136; WATERS DA, 1995, J EXP BIOL, V198, P475; WILKINSON GS, 1992, ANIM BEHAV, V44, P501, DOI 10.1016/0003-3472(92)90059-I; Wyman MT, 2008, ANIM BEHAV, V76, P1625, DOI 10.1016/j.anbehav.2008.05.032; Yovel Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000400	81	24	25	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2010	5	9							e12842	10.1371/journal.pone.0012842	http://dx.doi.org/10.1371/journal.pone.0012842			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651XL	20862252	Green Published, gold, Green Submitted			2022-12-27	WOS:000281960800028
J	Pirisinu, L; Di Bari, M; Marcon, S; Vaccari, G; D'Agostino, C; Fazzi, P; Esposito, E; Galeno, R; Langeveld, J; Agrimi, U; Nonno, R				Pirisinu, Laura; Di Bari, Michele; Marcon, Stefano; Vaccari, Gabriele; D'Agostino, Claudia; Fazzi, Paola; Esposito, Elena; Galeno, Roberta; Langeveld, Jan; Agrimi, Umberto; Nonno, Romolo			A New Method for the Characterization of Strain-Specific Conformational Stability of Protease-Sensitive and Protease-Resistant PrPSc	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; CREUTZFELDT-JAKOB-DISEASE; SCRAPIE PRION PROTEIN; TRANSGENIC MICE; MOLECULAR-BASIS; SHEEP SCRAPIE; IN-VITRO; CONVERSION; OVINE; SUSCEPTIBILITY	Although proteinacious in nature, prions exist as strains with specific self-perpetuating biological properties. Prion strains are thought to be associated with different conformers of PrPSc, a disease-associated isoform of the host-encoded cellular protein (PrPC). Molecular strain typing approaches have been developed which rely on the characterization of protease-resistant Prp(Sc). However, Prp(Sc) is composed not only of protease-resistant but also of protease-sensitive isoforms. The aim of this work was to develop a protocol for the molecular characterization of both, protease-resistant and protease-sensitive Prp(Sc) aggregates. We first set up experimental conditions which allowed the most advantageous separation of PrPC and Prp(Sc) by means of differential centrifugation. The conformational solubility and stability assay (CSSA) was then developed by measuring Prp(Sc) solubility as a function of increased exposure to GdnHCl. Brain homogenates from voles infected with human and sheep prion isolates were analysed by CSSA and showed strain-specific conformational stabilities, with mean [GdnHCl](1/2) values ranging from 1.6 M for MM2 sCJD to 2.1 for scrapie and to 2.8 M for MM1/MV1 sCJD and E200K gCJD. Interestingly, the rank order of [GdnHCl](1/2) values observed in the human and sheep isolates used as inocula closely matched those found following transmission in voles, being MM1 sCJD the most resistant (3.3 M), followed by sheep scrapie (2.2 M) and by MM2 sCJD (1.6 M). In order to test the ability of CSSA to characterise protease-sensitive Prp(Sc), we analysed sheep isolates of Nor98 and compared them to classical scrapie isolates. In Nor98, insoluble Prp(Sc) aggregates were mainly protease-sensitive and showed a conformational stability much lower than in classical scrapie. Our results show that CSSA is able to reveal strain-specified Prp(Sc) conformational stabilities of protease-resistant and protease-sensitive PrpSc and that it is a valuable tool for strain typing in natural hosts, such as humans and sheep.	[Pirisinu, Laura; Di Bari, Michele; Marcon, Stefano; Vaccari, Gabriele; D'Agostino, Claudia; Fazzi, Paola; Esposito, Elena; Agrimi, Umberto; Nonno, Romolo] Ist Super Sanita, Dept Vet Publ Hlth & Food Safety, I-00161 Rome, Italy; [Galeno, Roberta] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy; [Langeveld, Jan] Cent Vet Inst, Lelystad, Netherlands	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Wageningen University & Research	Pirisinu, L (corresponding author), Ist Super Sanita, Dept Vet Publ Hlth & Food Safety, Viale Regina Elena 299, I-00161 Rome, Italy.	romolo.nonno@iss.it	D'AGOSTINO, CLAUDIA/C-8326-2015; Vaccari, Gabriele/A-9597-2010; Di Bari, Michele Angelo/Q-5028-2019; NONNO, ROMOLO/C-8323-2015; Agrimi, Umberto/C-9956-2015; PIRISINU, LAURA/C-8993-2015; Di Bari, Michele Angelo/C-8327-2015	D'AGOSTINO, CLAUDIA/0000-0002-0696-1641; Vaccari, Gabriele/0000-0003-0215-3521; Di Bari, Michele Angelo/0000-0003-0943-6823; NONNO, ROMOLO/0000-0001-7556-1564; Agrimi, Umberto/0000-0001-7828-0186; PIRISINU, LAURA/0000-0002-6548-8225; Di Bari, Michele Angelo/0000-0003-0943-6823	European Union (Neuroprion Network of Excellence) [CT-2004-506579]; Italian Ministry of Health	European Union (Neuroprion Network of Excellence)(European Commission); Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by grants from the European Union (Neuroprion Network of Excellence CT-2004-506579) and the Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrimi U, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000113; Benestad SL, 2003, VET REC, V153, P202, DOI 10.1136/vr.153.7.202; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; Biacabe AG, 2004, EMBO REP, V5, P110, DOI 10.1038/sj.embor.7400054; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; Bruce ME, 2007, VET REC, V160, P665, DOI 10.1136/vr.160.19.665; Bruce M E, 1991, Curr Top Microbiol Immunol, V172, P125; BRUCE ME, 1993, BRIT MED BULL, V49, P822, DOI 10.1093/oxfordjournals.bmb.a072649; BRUCE ME, 1991, J GEN VIROL, V72, P595, DOI 10.1099/0022-1317-72-3-595; Buschmann A, 2004, J GEN VIROL, V85, P2727, DOI 10.1099/vir.0.79997-0; Cali I, 2009, BRAIN, V132, P2643, DOI 10.1093/brain/awp196; Casalone C, 2004, P NATL ACAD SCI USA, V101, P3065, DOI 10.1073/pnas.0305777101; CAUGHEY B, 1991, J VIROL, V65, P6597, DOI 10.1128/JVI.65.12.6597-6603.1991; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Cronier S, 2008, BIOCHEM J, V416, P297, DOI 10.1042/BJ20081235; DI BARI MA, 2008, J GEN VIROL 12, V89, P2975; FRASER H, 1973, J COMP PATHOL, V83, P29, DOI 10.1016/0021-9975(73)90024-8; Gambetti P, 2008, ANN NEUROL, V63, P697, DOI 10.1002/ana.21420; Green KM, 2008, J GEN VIROL, V89, P598, DOI 10.1099/vir.0.83168-0; Jacobs JG, 2007, J CLIN MICROBIOL, V45, P1821, DOI 10.1128/JCM.00160-07; Jeffrey M, 2001, J COMP PATHOL, V125, P271, DOI 10.1053/jcpa.2001.0499; KASCSAK RJ, 1985, J GEN VIROL, V66, P1715, DOI 10.1099/0022-1317-66-8-1715; Kocisko DA, 1996, BIOCHEMISTRY-US, V35, P13434, DOI 10.1021/bi9610562; Kuczius T, 1999, MOL MED, V5, P406, DOI 10.1007/BF03402129; Legname G, 2006, P NATL ACAD SCI USA, V103, P19105, DOI 10.1073/pnas.0608970103; Mange A, 2004, BIOL CELL, V96, P125, DOI 10.1016/j.biolcel.2003.11.007; Mazza M, 2010, RES VET SCI, V88, P478, DOI 10.1016/j.rvsc.2009.11.015; MCKINLEY MP, 1991, J VIROL, V65, P1340, DOI 10.1128/JVI.65.3.1340-1351.1991; MEYER RK, 1986, P NATL ACAD SCI USA, V83, P2310, DOI 10.1073/pnas.83.8.2310; Nazor KE, 2005, EMBO J, V24, P2472, DOI 10.1038/sj.emboj.7600717; Nonno R, 2006, PLOS PATHOG, V2, P112, DOI 10.1371/journal.ppat.0020012; Owen JP, 2007, J VIROL, V81, P10532, DOI 10.1128/JVI.00640-07; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Parchi P, 1996, ANN NEUROL, V39, P767, DOI 10.1002/ana.410390613; Pastrana MA, 2006, BIOCHEMISTRY-US, V45, P15710, DOI 10.1021/bi0615442; Peretz D, 2002, NEURON, V34, P921, DOI 10.1016/S0896-6273(02)00726-2; Peretz D, 2001, PROTEIN SCI, V10, P854, DOI 10.1110/ps.39201; Piening N, 2006, J BIOL CHEM, V281, P9373, DOI 10.1074/jbc.M512239200; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Safar JG, 2005, P NATL ACAD SCI USA, V102, P3501, DOI 10.1073/pnas.0409651102; Scott MR, 2005, J VIROL, V79, P5259, DOI 10.1128/JVI.79.9.5259-5271.2005; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Thackray AM, 2007, BIOCHEM J, V401, P475, DOI 10.1042/BJ20061264; Tremblay P, 2004, J VIROL, V78, P2088, DOI 10.1128/JVI.78.4.2088-2099.2004; Tzaban S, 2002, BIOCHEMISTRY-US, V41, P12868, DOI 10.1021/bi025958g; Vaccari G, 2007, J VIROL, V81, P7306, DOI 10.1128/JVI.02880-06; Zou WQ, 2004, P NATL ACAD SCI USA, V101, P1380, DOI 10.1073/pnas.0307825100	50	37	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2010	5	9							e12723	10.1371/journal.pone.0012723	http://dx.doi.org/10.1371/journal.pone.0012723			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZO	20856860	Green Published, Green Submitted, gold			2022-12-27	WOS:000281815700012
J	Shin, YK; Martin, B; Kim, W; White, CM; Ji, SG; Sun, YX; Smith, RG; Sevigny, J; Tschop, MH; Maudsley, S; Egan, JM				Shin, Yu-Kyong; Martin, Bronwen; Kim, Wook; White, Caitlin M.; Ji, Sunggoan; Sun, Yuxiang; Smith, Roy G.; Sevigny, Jean; Tschoep, Matthias H.; Maudsley, Stuart; Egan, Josephine M.			Ghrelin Is Produced in Taste Cells and Ghrelin Receptor Null Mice Show Reduced Taste Responsivity to Salty (NaCl) and Sour (Citric Acid) Tastants	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; COEXPRESSION PATTERNS; SODIUM TASTE; RAT; HORMONE; EXPRESSION; AMILORIDE; BUDS; LOCALIZATION; CHANNELS	Background: The gustatory system plays a critical role in determining food preferences, food intake and energy balance. The exact mechanisms that fine tune taste sensitivity are currently poorly defined, but it is clear that numerous factors such as efferent input and specific signal transduction cascades are involved. Methodology/Principal Findings: Using immunohistochemical analyses, we show that ghrelin, a hormone classically considered to be an appetite-regulating hormone, is present within the taste buds of the tongue. Prepro-ghrelin, prohormone convertase 1/3 (PC 1/3), ghrelin, its cognate receptor (GHSR), and ghrelin-O-acyltransferase (GOAT, the enzyme that activates ghrelin) are expressed in Type I, II, III and IV taste cells of mouse taste buds. In addition, ghrelin and GHSR co-localize in the same taste cells, suggesting that ghrelin works in an autocrine manner in taste cells. To determine a role for ghrelin in modifying taste perception, we performed taste behavioral tests using GHSR null mice. GHSR null mice exhibited significantly reduced taste responsivity to sour (citric acid) and salty (sodium chloride) tastants. Conclusions/Significance: These findings suggest that ghrelin plays a local modulatory role in determining taste bud signaling and function and could be a novel mechanism for the modulation of salty and sour taste responsivity.	[Shin, Yu-Kyong; Martin, Bronwen; Kim, Wook; White, Caitlin M.; Ji, Sunggoan; Maudsley, Stuart; Egan, Josephine M.] NIA, NIH, Baltimore, MD 21224 USA; [Sun, Yuxiang] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; [Smith, Roy G.] Scripps Res Inst, Dept Metab & Aging, Jupiter, FL USA; [Sevigny, Jean] Univ Laval, Ctr Hosp Univ Quebec, Ctr Rech Rhumatol & Immunol, Quebec City, PQ, Canada; [Tschoep, Matthias H.] Univ Cincinnati, Div Endocrinol, Coll Med, Dept Med,Metab Dis Inst, Cincinnati, OH USA; [Tschoep, Matthias H.] Univ Cincinnati, Div Endocrinol, Coll Med, Dept Psychiat,Metab Dis Inst, Cincinnati, OH USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Baylor College of Medicine; Scripps Research Institute; Laval University; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Shin, YK (corresponding author), NIA, NIH, Baltimore, MD 21224 USA.	eganj@mail.nih.gov	Sévigny, Jean/AGH-9323-2022; Tschoep, Matthias H/I-5443-2014; Maudsley, Stuart/Q-4782-2019; Sevigny, Jean/E-8039-2012; Maudsley, Stuart/AAV-9929-2021	Sévigny, Jean/0000-0003-2922-1600; Sevigny, Jean/0000-0003-2922-1600; Maudsley, Stuart/0000-0002-1868-184X; Tschoep, Matthias/0000-0002-4744-371X; Martin, Bronwen/0000-0002-9185-6925; Ji, Sung Goan/0000-0003-1308-2474	NIH, National Institute on Aging; NATIONAL INSTITUTE ON AGING [ZIAAG000917, ZIAAG000325, ZIAAG000319, ZIAAG000915, ZIAAG000318, R01AG019230] Funding Source: NIH RePORTER	NIH, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the Intramural Research Program of the NIH, National Institute on Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DL, 2006, J COMP NEUROL, V497, P1, DOI 10.1002/cne.20954; BEHE P, 1990, J GEN PHYSIOL, V96, P1061, DOI 10.1085/jgp.96.5.1061; Bigiani A, 2007, J NEUROPHYSIOL, V98, P2483, DOI 10.1152/jn.00716.2007; Boughter JD, 2002, CHEM SENSES, V27, P133, DOI 10.1093/chemse/27.2.133; BRAND JG, 1985, BRAIN RES, V334, P207, DOI 10.1016/0006-8993(85)90212-4; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Chandrashekar J, 2010, NATURE, V464, P297, DOI 10.1038/nature08783; CONG WN, 2010, CNS NEUROL DISORD DR; DESIMONE JA, 1984, J GEN PHYSIOL, V83, P633, DOI 10.1085/jgp.83.5.633; Dixit VD, 2004, J CLIN INVEST, V114, P57, DOI 10.1172/JCI200421134; Dotson CD, 2004, CHEM SENSES, V29, P489, DOI 10.1093/chemse/bjh051; Ghelardoni S, 2006, J ENDOCRINOL INVEST, V29, P115, DOI 10.1007/BF03344083; Glendinning JI, 2002, CHEM SENSES, V27, P461, DOI 10.1093/chemse/27.5.461; Glendinning JI, 2008, PHYSIOL BEHAV, V93, P757, DOI 10.1016/j.physbeh.2007.11.029; Groschl M, 2005, CLIN CHEM, V51, P997, DOI 10.1373/clinchem.2004.040667; Gutierrez JA, 2008, P NATL ACAD SCI USA, V105, P6320, DOI 10.1073/pnas.0800708105; Harrison JL, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-25; HECK GL, 1984, SCIENCE, V223, P403, DOI 10.1126/science.6691151; Herness S, 2002, J NEUROSCI, V22, P10018; HIROHITO M, 2005, CHEM SENSES, V30, P367; Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Huang YA, 2009, J NEUROSCI, V29, P13909, DOI 10.1523/JNEUROSCI.2351-09.2009; Huang YJ, 2005, ARCH ITAL BIOL, V143, P87; Iglesias MJ, 2004, CARDIOVASC RES, V62, P481, DOI 10.1016/j.cardiores.2004.01.024; Ishimaru Y, 2006, P NATL ACAD SCI USA, V103, P12569, DOI 10.1073/pnas.0602702103; Kataoka S, 2008, CHEM SENSES, V33, P243, DOI 10.1093/chemse/bjm083; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kojima M, 2008, REGUL PEPTIDES, V145, P2, DOI 10.1016/j.regpep.2007.09.023; Korbonits M, 2004, FRONT NEUROENDOCRIN, V25, P27, DOI 10.1016/j.yfrne.2004.03.002; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Lin WH, 1999, J COMP NEUROL, V405, P406, DOI 10.1002/(SICI)1096-9861(19990315)405:3<406::AID-CNE10>3.0.CO;2-F; LopezJimenez ND, 2006, J NEUROCHEM, V98, P68, DOI 10.1111/j.1471-4159.2006.03842.x; Ma HZ, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-5; Martin B, 2010, DIABETES, V59, P1143, DOI 10.2337/db09-0807; Martin B, 2009, ANN NY ACAD SCI, V1170, P98, DOI 10.1111/j.1749-6632.2009.03920.x; Martin B, 2009, TRENDS ENDOCRIN MET, V20, P163, DOI 10.1016/j.tem.2009.01.006; McKee KK, 1997, MOL ENDOCRINOL, V11, P415, DOI 10.1210/me.11.4.415; Miura H, 2006, ARCH HISTOL CYTOL, V69, P209, DOI 10.1679/aohc.69.209; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Nelson TM, 2003, CHEM SENSES, V28, P695, DOI 10.1093/chemse/bjg062; O'Brien M, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-55; Ohgusu H, 2009, BIOCHEM BIOPH RES CO, V386, P153, DOI 10.1016/j.bbrc.2009.06.001; Pumplin DW, 1997, J COMP NEUROL, V378, P389, DOI 10.1002/(SICI)1096-9861(19970217)378:3<389::AID-CNE7>3.0.CO;2-#; Quarta D, 2009, NEUROCHEM INT, V54, P89, DOI 10.1016/j.neuint.2008.12.006; Roper SD, 2006, CELL MOL LIFE SCI, V63, P1494, DOI 10.1007/s00018-006-6112-9; Ruiz C, 2006, CHEM SENSES, V31, P813, DOI 10.1093/chemse/bjl024; Schuppe H, 2007, DEV NEUROBIOL, V67, P219, DOI 10.1002/dneu.20343; Scott K, 2005, NEURON, V48, P455, DOI 10.1016/j.neuron.2005.10.015; Shen T, 2005, NEUROSCIENCE, V130, P229, DOI 10.1016/j.neuroscience.2004.09.017; Shigemura N, 2005, CHEM SENSES, V30, P531, DOI 10.1093/chemse/bji046; Shin YK, 2008, J NEUROCHEM, V106, P455, DOI 10.1111/j.1471-4159.2008.05397.x; Stahler F, 2008, CHEMOSENS PERCEPT, V1, P78, DOI 10.1007/s12078-008-9006-4; Sun YX, 2003, MOL CELL BIOL, V23, P7973, DOI 10.1128/MCB.23.22.7973-7981.2003; Sun YX, 2004, P NATL ACAD SCI USA, V101, P4679, DOI 10.1073/pnas.0305930101; Theodorakis MJ, 2006, AM J PHYSIOL-ENDOC M, V290, pE550, DOI 10.1152/ajpendo.00326.2004; Tomchik SM, 2007, J NEUROSCI, V27, P10840, DOI 10.1523/JNEUROSCI.1863-07.2007; VAN DER LELY AJ, 2004, ENDOCR REV, V25, P426; Vandenbeuch A, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-1; Wortley KE, 2005, J CLIN INVEST, V115, P3573, DOI 10.1172/JCI26003; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Yang RB, 2004, J COMP NEUROL, V471, P59, DOI 10.1002/cne.20021; Yee CL, 2001, J COMP NEUROL, V440, P97, DOI 10.1002/cne.1372; Yoshida R, 2009, NEUROSCIENCE, V159, P795, DOI 10.1016/j.neuroscience.2008.12.052; Yoshida R, 2009, J PHYSIOL-LONDON, V587, P4425, DOI 10.1113/jphysiol.2009.175075; YOSHIO Y, 2006, NEUROSCI LETT, V402, P227; Zhao FL, 2005, P NATL ACAD SCI USA, V102, P11100, DOI 10.1073/pnas.0501988102; Zhu XR, 2006, J BIOL CHEM, V281, P38867, DOI 10.1074/jbc.M607955200	68	78	86	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2010	5	9							e12729	10.1371/journal.pone.0012729	http://dx.doi.org/10.1371/journal.pone.0012729			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZO	20856820	gold, Green Submitted, Green Published			2022-12-27	WOS:000281815700016
J	Soanes, DM; Talbot, NJ				Soanes, Darren M.; Talbot, Nicholas J.			Comparative Genome Analysis Reveals an Absence of Leucine-Rich Repeat Pattern-Recognition Receptor Proteins in the Kingdom Fungi	PLOS ONE			English	Article							PLANT INNATE IMMUNITY; ADENYLATE-CYCLASE; EVOLUTION; IDENTIFICATION; PATHOGENICITY; PHYLOGENIES; VIRULENCE; ALIGNMENT; ANIMALS; ORIGINS	Background: In plants and animals innate immunity is the first line of defence against attack by microbial pathogens. Specific molecular features of bacteria and fungi are recognised by pattern recognition receptors that have extracellular domains containing leucine rich repeats. Recognition of microbes by these receptors induces defence responses that protect hosts against potential microbial attack. Methodology/Principal Findings: A survey of genome sequences from 101 species, representing a broad cross-section of the eukaryotic phylogenetic tree, reveals an absence of leucine rich repeat-domain containing receptors in the fungal kingdom. Uniquely, however, fungi possess adenylate cyclases that contain distinct leucine rich repeat-domains, which have been demonstrated to act as an alternative means of perceiving the presence of bacteria by at least one fungal species. Interestingly, the morphologically similar osmotrophic oomycetes, which are taxonomically distant members of the stramenopiles, possess pattern recognition receptors with similar domain structures to those found in plants. Conclusions: The absence of pattern recognition receptors suggests that fungi may possess novel classes of pattern-recognition receptor, such as the modified adenylate cyclase, or instead rely on secretion of anti-microbial secondary metabolites for protection from microbial attack. The absence of pattern recognition receptors in fungi, coupled with their abundance in oomycetes, suggests this may be a unique characteristic of the fungal kingdom rather than a consequence of the osmotrophic growth form.	[Soanes, Darren M.; Talbot, Nicholas J.] Univ Exeter, Sch Biosci, Exeter, Devon, England	University of Exeter	Soanes, DM (corresponding author), Univ Exeter, Sch Biosci, Exeter, Devon, England.	n.j.talbot@exeter.ac.uk	Talbot, Nicholas J/I-9584-2014; Talbot, Nicholas J/I-5618-2019	Talbot, Nicholas J/0000-0001-6434-7757; Talbot, Nicholas J/0000-0001-6434-7757	Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council [BB/E022677/1, BB/E002803/1] Funding Source: researchfish; BBSRC [BB/E022677/1, BB/E002803/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal AJ, 2008, MOL PLANT MICROBE IN, V21, P507, DOI 10.1094/MPMI-21-5-0507; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arnold DL, 2007, TRENDS GENET, V23, P293, DOI 10.1016/j.tig.2007.03.017; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Burki F, 2008, BIOL LETTERS, V4, P366, DOI 10.1098/rsbl.2008.0224; D'Souza CA, 2001, FEMS MICROBIOL REV, V25, P349, DOI 10.1111/j.1574-6976.2001.tb00582.x; Demain AL, 2000, ADV BIOCHEM ENG BIOT, V69, P1; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Federici L, 2006, TRENDS PLANT SCI, V11, P65, DOI 10.1016/j.tplants.2005.12.005; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Folman LB, 2003, MICROBIOL RES, V158, P107, DOI 10.1078/0944-5013-00185; Fox EM, 2008, CURR OPIN MICROBIOL, V11, P481, DOI 10.1016/j.mib.2008.10.007; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hirt RP, 2002, MOL BIOCHEM PARASIT, V125, P195, DOI 10.1016/S0166-6851(02)00211-6; Ivey FD, 2005, P NATL ACAD SCI USA, V102, P6108, DOI 10.1073/pnas.0502270102; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kido M, 2002, J BIOL CHEM, V277, P3117, DOI 10.1074/jbc.M109526200; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kulkarni RD, 2004, MOL GENET GENOMICS, V270, P497, DOI 10.1007/s00438-003-0935-y; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Milgroom MG, 2004, ANNU REV PHYTOPATHOL, V42, P311, DOI 10.1146/annurev.phyto.42.040803.140325; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Palsson-McDermott EM, 2007, BIOCHEM SOC T, V35, P1437, DOI 10.1042/BST0351437; Paoletti M, 2009, BIOESSAYS, V31, P1201, DOI 10.1002/bies.200900085; Richards TA, 2006, CURR BIOL, V16, P1857, DOI 10.1016/j.cub.2006.07.052; Shiu SH, 2003, PLANT PHYSIOL, V132, P530, DOI 10.1104/pp.103.021964; Soanes DM, 2007, PLANT CELL, V19, P3318, DOI 10.1105/tpc.107.056663; Staal J, 2007, TRENDS PLANT SCI, V12, P334, DOI 10.1016/j.tplants.2007.06.014; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Xu XL, 2008, CELL HOST MICROBE, V4, P28, DOI 10.1016/j.chom.2008.05.014; Yoder OC, 2001, CURR OPIN PLANT BIOL, V4, P315, DOI 10.1016/S1369-5266(00)00179-5; Zipfel C, 2005, CURR OPIN PLANT BIOL, V8, P353, DOI 10.1016/j.pbi.2005.05.004	35	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2010	5	9							e12725	10.1371/journal.pone.0012725	http://dx.doi.org/10.1371/journal.pone.0012725			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZO	20856863	Green Submitted, Green Published, gold			2022-12-27	WOS:000281815700013
J	Gustavsson, C; Agardh, CD; Zetterqvist, AV; Nilsson, J; Agardh, E; Gomez, MF				Gustavsson, Carin; Agardh, Carl-David; Zetterqvist, Anna V.; Nilsson, Jan; Agardh, Elisabet; Gomez, Maria F.			Vascular Cellular Adhesion Molecule-1 (VCAM-1) Expression in Mice Retinal Vessels Is Affected by Both Hyperglycemia and Hyperlipidemia	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; DIABETIC-RETINOPATHY; ENDOTHELIAL DYSFUNCTION; TNF-ALPHA; INFLAMMATION; MARKERS; IMMUNE; MECHANISMS; COMPLICATIONS; PATHOGENESIS	Background: Inflammation has been proposed to be important in the pathogenesis of diabetic retinopathy. An early feature of inflammation is the release of cytokines leading to increased expression of endothelial activation markers such as vascular cellular adhesion molecule-1 (VCAM-1). Here we investigated the impact of diabetes and dyslipidemia on VCAM-1 expression in mouse retinal vessels, as well as the potential role of tumor necrosis factor-alpha (TNF alpha). Methodology/Principal Findings: Expression of VCAM-1 was examined by confocal immunofluorescence microscopy in vessels of wild type (wt), hyperlipidemic (ApoE(-/-)) and TNF alpha deficient (TNF alpha(-/-), ApoE(-/-)/TNF alpha(-/-)) mice. Eight weeks of streptozotocin-induced diabetes resulted in increased VCAM-1 in wt mice, predominantly in small vessels (<10 mu m). Diabetic wt mice had higher total retinal TNF alpha, IL-6 and IL-1 beta mRNA than controls; as well as higher soluble VCAM-1 (sVCAM-1) in plasma. Lack of TNF alpha increased higher basal VCAM-1 protein and sVCAM-1, but failed to up-regulate IL-6 and IL-1 beta mRNA and VCAM-1 protein in response to diabetes. Basal VCAM-1 expression was higher in ApoE(-/-) than in wt mice and both VCAM-1 mRNA and protein levels were further increased by high fat diet. These changes correlated to plasma cholesterol, LDL- and HDL-cholesterol, but not to triglycerides levels. Diabetes, despite further increasing plasma cholesterol in ApoE(-/-) mice, had no effects on VCAM-1 protein expression or on sVCAM-1. However, it increased ICAM-1 mRNA expression in retinal vessels, which correlated to plasma triglycerides. Conclusions/Significance: Hyperglycemia triggers an inflammatory response in the retina of normolipidemic mice and up-regulation of VCAM-1 in retinal vessels. Hypercholesterolemia effectively promotes VCAM-1 expression without evident stimulation of inflammation. Diabetes-induced endothelial activation in ApoE(-/-) mice seems driven by elevated plasma triglycerides but not by cholesterol. Results also suggest a complex role for TNF alpha in the regulation of VCAM-1 expression, being protective under basal conditions but pro-inflammatory in response to diabetes.	[Gustavsson, Carin; Agardh, Carl-David; Zetterqvist, Anna V.; Nilsson, Jan; Agardh, Elisabet; Gomez, Maria F.] Lund Univ, Dept Clin Sci, Malmo, Sweden	Lund University	Gustavsson, C (corresponding author), Lund Univ, Dept Clin Sci, Malmo, Sweden.	maria.gomez@med.lu.se	Gomez, Maria F/D-3696-2014	Gomez, Maria F/0000-0001-6210-3142	Lund University; Skane County Council for Research and Development; Swedish Research Council; Foundation for Visually Impaired in Former Malmohus Lan; Malmo University Hospital Foundation at Lund University; Foundation of the National Board of Health and Welfare; Lund University Diabetes Centre (LUDC); Carmen and Bertil Regner; Crown Princess Margareta; Jarnhardt; Lars Hierta Memorial; Pahlsson; Knut and Alice Wallenberg Foundation; Swedish Diabetes Association; Swedish Heart & Lung Foundations	Lund University; Skane County Council for Research and Development; Swedish Research Council(Swedish Research CouncilEuropean Commission); Foundation for Visually Impaired in Former Malmohus Lan; Malmo University Hospital Foundation at Lund University; Foundation of the National Board of Health and Welfare; Lund University Diabetes Centre (LUDC); Carmen and Bertil Regner; Crown Princess Margareta; Jarnhardt; Lars Hierta Memorial; Pahlsson; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Diabetes Association; Swedish Heart & Lung Foundations(Swedish Heart-Lung Foundation)	The study was supported by grants from Lund University, the Skane County Council for Research and Development, the Swedish Research Council, the Foundation for Visually Impaired in Former Malmohus Lan, Malmo University Hospital Foundation at Lund University, the Foundation of the National Board of Health and Welfare, Lund University Diabetes Centre (LUDC), the Carmen and Bertil Regner, the Crown Princess Margareta, the Jarnhardt, the Lars Hierta Memorial, the Pahlsson, the Knut and Alice Wallenberg Foundation, the Swedish Diabetes Association and the Swedish Heart & Lung Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamiec-Mroczek J, 2008, GRAEF ARCH CLIN EXP, V246, P1665, DOI 10.1007/s00417-008-0868-6; Adamis AP, 2008, SEMIN IMMUNOPATHOL, V30, P65, DOI 10.1007/s00281-008-0111-x; Agardh CD, 2006, METABOLISM, V55, P892, DOI 10.1016/j.metabol.2006.02.016; Agardh E, 2006, METABOLISM, V55, P168, DOI 10.1016/j.metabol.2005.08.009; AMELI S, 1994, CIRCULATION, V90, P1935, DOI 10.1161/01.CIR.90.4.1935; Antonetti DA, 2006, DIABETES, V55, P2401, DOI 10.2337/db05-1635; Azcutia V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010091; Barile GR, 2005, INVEST OPHTH VIS SCI, V46, P2916, DOI 10.1167/iovs.04-1409; Barile GR, 1999, CURR EYE RES, V19, P219, DOI 10.1076/ceyr.19.3.219.5314; Bertazza L, 2008, FRONT BIOSCI-LANDMRK, V13, P2736, DOI 10.2741/2881; BOYLES JK, 1985, J CLIN INVEST, V76, P1501, DOI 10.1172/JCI112130; Chadwick W, 2008, TRENDS NEUROSCI, V31, P504, DOI 10.1016/j.tins.2008.07.005; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Collins T, 2001, J CLIN INVEST, V107, P255, DOI 10.1172/JCI10373; DE GOOYER TE, 2006, INVEST OPHTH VIS SCI, V47, P5561; Diabet Control Complications Trial Res Grp, 1997, DIABETES, V46, P1829; Dodson PM, 2009, EYE, V23, P997, DOI 10.1038/eye.2008.428; Engelhardt B, 2006, J NEURAL TRANSM, V113, P477, DOI 10.1007/s00702-005-0409-y; Eugster HP, 1996, INT IMMUNOL, V8, P23, DOI 10.1093/intimm/8.1.23; Ferrante AW, 2007, J INTERN MED, V262, P408, DOI 10.1111/j.1365-2796.2007.01852.x; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Goldberg RB, 2009, J CLIN ENDOCR METAB, V94, P3171, DOI 10.1210/jc.2008-2534; Gustavsson C, 2008, J DIABETES COMPLICAT, V22, P309, DOI 10.1016/j.jdiacomp.2007.03.001; Gustavsson C, 2008, RETINA-J RET VIT DIS, V28, P645, DOI 10.1097/IAE.0b013e31815ec32d; Hartge Martin M, 2007, Diab Vasc Dis Res, V4, P84; HATCHELL DL, 1994, MICROVASC RES, V47, P344, DOI 10.1006/mvre.1994.1027; Hsueh W, 2007, CIRC RES, V100, P1415, DOI 10.1161/01.RES.0000266449.37396.1f; JOHNSENSORIANO S, GRAEFES ARCH CLIN EX, V248, P985; Joussen AM, 2009, MOL VIS, V15, P1418; Keech AC, 2007, LANCET, V370, P1687, DOI 10.1016/S0140-6736(07)61607-9; Kern TS, 2007, EXP DIABETES RES, DOI 10.1155/2007/95103; Khalfaoui T, 2008, J MOL HISTOL, V39, P243, DOI 10.1007/s10735-007-9159-5; Khan ZA, 2007, EXP DIABETES RES, DOI 10.1155/2007/31867; Klein BEK, 2009, ARCH OPHTHALMOL-CHIC, V127, P1175, DOI 10.1001/archophthalmol.2009.172; Kruglov AA, 2008, CYTOKINE GROWTH F R, V19, P231, DOI 10.1016/j.cytogfr.2008.04.010; Leiter LA, 2005, DIABETES RES CLIN PR, V68, pS3, DOI 10.1016/j.diabres.2005.03.015; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Limb GA, 1999, INVEST OPHTH VIS SCI, V40, P2453; Lyons TJ, 2004, INVEST OPHTH VIS SCI, V45, P910, DOI 10.1167/iovs.02-0648; Matsumoto K, 2002, DIABETIC MED, V19, P822, DOI 10.1046/j.1464-5491.2002.00799.x; Mohr S, 2002, DIABETES, V51, P1172, DOI 10.2337/diabetes.51.4.1172; Murugeswari P, 2008, RETINA-J RET VIT DIS, V28, P817, DOI 10.1097/IAE.0b013e31816576d5; Navaratna D, 2007, DIABETES, V56, P2380, DOI 10.2337/db06-1694; Nguyen TT, 2009, DIABETES CARE, V32, P1704, DOI 10.2337/dc09-0102; NILSSONOHMAN J, 2009, ARTERIOSCLER THROMB; Nowak M, 2008, CLIN EXP MED, V8, P159, DOI 10.1007/s10238-008-0173-z; Patel JI, 2008, EYE, V22, P223, DOI 10.1038/sj.eye.6702584; Soedamah-Muthu SS, 2006, J DIABETES COMPLICAT, V20, P188, DOI 10.1016/j.jdiacomp.2005.06.005; Spijkerman AMW, 2007, DIABETIC MED, V24, P969, DOI 10.1111/j.1464-5491.2007.02217.x; VAN BUUL JD, 2007, ARTERIOSCL THROM VAS, V27, P1870; Videm V, 2008, SCAND J IMMUNOL, V67, P523, DOI 10.1111/j.1365-3083.2008.02029.x; Wu KK, 2007, ATHEROSCLEROSIS, V191, P241, DOI 10.1016/j.atherosclerosis.2006.08.030; Yoshimura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008158; Zhang HR, 2009, CLIN SCI, V116, P219, DOI 10.1042/CS20080196; N ENGL J MED	57	79	81	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2010	5	9							e12699	10.1371/journal.pone.0012699	http://dx.doi.org/10.1371/journal.pone.0012699			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648ZZ	20856927	Green Published, gold, Green Submitted			2022-12-27	WOS:000281735700017
J	Jenkins, RH; Bennagi, R; Martin, J; Phillips, AO; Redman, JE; Fraser, DJ				Jenkins, Robert H.; Bennagi, Rasha; Martin, John; Phillips, Aled O.; Redman, James E.; Fraser, Donald J.			A Conserved Stem Loop Motif in the 5 ' Untranslated Region Regulates Transforming Growth Factor-beta(1) Translation	PLOS ONE			English	Article							MESSENGER-RIBONUCLEOPROTEIN PARTICLES; PROXIMAL TUBULAR CELLS; SECONDARY STRUCTURE; FACTOR-BETA; POSTTRANSCRIPTIONAL REGULATION; TGF-BETA-1 SYNTHESIS; NONCODING SEQUENCES; SIGNALING PATHWAYS; CYTOPLASMIC MRNP; BINDING-PROTEINS	Transforming growth factor-beta(1) (TGF-beta(1)) regulates cellular proliferation, differentiation, migration, and survival. The human TGF-beta(1) transcript is inherently poorly translated, and translational activation has been documented in relation to several stimuli. In this paper, we have sought to identify in cis regulatory elements within the TGF-beta(1) 5'Untranslated Region (5'UTR). In silico analysis predicted formation of stable secondary structure in a G/C-rich element between nucleotides + 77 to + 106, and demonstrated that this element is highly conserved across species. Circular dichroism spectroscopy confirmed the presence of secondary structure in this region. The proximal 5'UTR was inhibitory to translation in reporter gene experiments, and mutation of the secondary structure motif increased translational efficiency. Translational regulation of TGF-beta(1) mRNA is linked to altered binding of YB-1 protein to its 5'UTR. Immunoprecipitation-RT-qPCR demonstrated a high basal association of YB-1 with TGF-beta(1) mRNA. However, mutation of the secondary structure motif did not prevent interaction of YB-1 with the 5'UTR, suggesting that YB-1 binds to this region due to its G/C-rich composition, rather than a specific, sequence-dependent, binding site. These data identify a highly conserved element within the TGF-beta(1) 5'UTR that forms stable secondary structure, and is responsible for the inherent low translation efficiency of this cytokine.	[Jenkins, Robert H.; Bennagi, Rasha; Martin, John; Phillips, Aled O.; Fraser, Donald J.] Cardiff Univ, Sch Med, Inst Nephrol, Cardiff, S Glam, Wales; [Redman, James E.] Cardiff Univ, Sch Chem, Cardiff, S Glam, Wales	Cardiff University; Cardiff University	Jenkins, RH (corresponding author), Cardiff Univ, Sch Med, Inst Nephrol, Heath Pk, Cardiff, S Glam, Wales.	fraserdj@cf.ac.uk	Redman, James/B-7175-2008	Redman, James/0000-0001-5492-2869; Fraser, Donald/0000-0003-0102-9342; Jenkins, Robert/0000-0001-8500-9044	Kidney Research UK [RP32/2/2006]	Kidney Research UK(Kidney Research UK (KRUK))	This study was funded by Kidney Research UK, grant number RP32/2/2006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison RSH, 1998, GROWTH FACTORS, V16, P89, DOI 10.3109/08977199809002120; Capowski EE, 2001, J IMMUNOL, V167, P5970, DOI 10.4049/jimmunol.167.10.5970; Chen CY, 2000, GENE DEV, V14, P1236; Dong JJ, 2009, RNA BIOL, V6, P59, DOI 10.4161/rna.6.1.7458; DURET L, 1993, NUCLEIC ACIDS RES, V21, P2315, DOI 10.1093/nar/21.10.2315; EDDY S, 2002, SQUID UTILITIES; Evdokimova V, 2001, EMBO J, V20, P5491, DOI 10.1093/emboj/20.19.5491; Evdokimova V, 2006, CELL CYCLE, V5, P1143, DOI 10.4161/cc.5.11.2784; Evdokimova VM, 1998, J BIOL CHEM, V273, P3574, DOI 10.1074/jbc.273.6.3574; EVDOKIMOVA VM, 1995, J BIOL CHEM, V270, P3186, DOI 10.1074/jbc.270.7.3186; FOWLIS DJ, 1992, CELL GROWTH DIFFER, V3, P81; Fraser D, 2003, AM J PATHOL, V163, P2565, DOI 10.1016/S0002-9440(10)63611-5; Fraser D, 2002, AM J PATHOL, V161, P1039, DOI 10.1016/S0002-9440(10)64265-4; Fraser D, 2008, KIDNEY INT, V73, P724, DOI 10.1038/sj.ki.5002719; Frazer KA, 2003, GENOME RES, V13, P1, DOI 10.1101/gr.222003; Fukuda T, 2004, NUCLEIC ACIDS RES, V32, P611, DOI 10.1093/nar/gkh223; Gordon KJ, 2008, BBA-MOL BASIS DIS, V1782, P197, DOI 10.1016/j.bbadis.2008.01.006; Gray NK, 1998, ANNU REV CELL DEV BI, V14, P399, DOI 10.1146/annurev.cellbio.14.1.399; Hardison RC, 2000, TRENDS GENET, V16, P369, DOI 10.1016/S0168-9525(00)02081-3; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Izumi H, 2001, NUCLEIC ACIDS RES, V29, P1200, DOI 10.1093/nar/29.5.1200; Karlin S, 1997, P NATL ACAD SCI USA, V94, P10227, DOI 10.1073/pnas.94.19.10227; KEHRL JH, 1986, J EXP MED, V163, P1037, DOI 10.1084/jem.163.5.1037; KIM SJ, 1992, J BIOL CHEM, V267, P13702; KOZAK M, 1986, P NATL ACAD SCI USA, V83, P2850, DOI 10.1073/pnas.83.9.2850; KOZAK M, 1989, MOL CELL BIOL, V9, P5134, DOI 10.1128/MCB.9.11.5134; LADOMERY M, 1994, NUCLEIC ACIDS RES, V22, P5582, DOI 10.1093/nar/22.25.5582; Lai MC, 2008, MOL BIOL CELL, V19, P3847, DOI 10.1091/mbc.E07-12-1264; LAWSON TG, 1986, J BIOL CHEM, V261, P13979; LE SY, 1989, J THEOR BIOL, V138, P495, DOI 10.1016/S0022-5193(89)80047-5; LEHNERT SA, 1988, DEVELOPMENT, V104, P263; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; MCCASKILL JS, 1990, BIOPOLYMERS, V29, P1105, DOI 10.1002/bip.360290621; Mergny JL, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni134; Mergny JL, 1998, FEBS LETT, V435, P74, DOI 10.1016/S0014-5793(98)01043-6; MINICH WB, 1993, EUR J BIOCHEM, V212, P633, DOI 10.1111/j.1432-1033.1993.tb17701.x; MINICH WB, 1992, BIOCHIMIE, V74, P477, DOI 10.1016/0300-9084(92)90088-V; Morrisey K, 2001, AM J PATHOL, V159, P1905, DOI 10.1016/S0002-9440(10)63037-4; Nekrasov MP, 2003, J BIOL CHEM, V278, P13936, DOI 10.1074/jbc.M209145200; PELLETIER J, 1985, MOL CELL BIOL, V5, P3222, DOI 10.1128/MCB.5.11.3222; Pennacchio LA, 2001, NAT REV GENET, V2, P100, DOI 10.1038/35052548; Peritz T, 2006, NAT PROTOC, V1, P577, DOI 10.1038/nprot.2006.82; PHILLIPS AO, 1995, AM J PATHOL, V147, P362; Phillips AO, 1997, AM J PATHOL, V150, P1101; Phillips AO, 1996, KIDNEY INT, V50, P1546, DOI 10.1038/ki.1996.470; ROMEO DS, 1993, MOL ENDOCRINOL, V7, P759, DOI 10.1210/me.7.6.759; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; Skabkin MA, 2001, J BIOL CHEM, V276, P44841, DOI 10.1074/jbc.M107581200; Skabkin MA, 2004, NUCLEIC ACIDS RES, V32, P5621, DOI 10.1093/nar/gkh889; Skabkina OV, 2005, MOL CELL BIOL, V25, P3317, DOI 10.1128/MCB.25.8.3317-3323.2005; SONENBERG N, 1994, CURR OPIN GENET DEV, V4, P310, DOI 10.1016/S0959-437X(05)80059-0; Svitkin YV, 2009, EMBO J, V28, P58, DOI 10.1038/emboj.2008.259; Workman C, 1999, NUCLEIC ACIDS RES, V27, P4816, DOI 10.1093/nar/27.24.4816; Zasedateleva OA, 2002, J MOL BIOL, V324, P73, DOI 10.1016/S0022-2836(02)00937-3; Zhang M, 2006, AM J PATHOL, V169, P1282, DOI 10.2353/ajpath.2006.050921; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	58	30	30	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2010	5	8							e12283	10.1371/journal.pone.0012283	http://dx.doi.org/10.1371/journal.pone.0012283			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643JL	20865036	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000281292100004
J	Holliday, CM; Ridgely, RC; Sedlmayr, JC; Witmer, LM				Holliday, Casey M.; Ridgely, Ryan C.; Sedlmayr, Jayc C.; Witmer, Lawrence M.			Cartilaginous Epiphyses in Extant Archosaurs and Their Implications for Reconstructing Limb Function in Dinosaurs	PLOS ONE			English	Article							ARTICULAR-CARTILAGE; GROWTH-PATTERNS; PRIMITIVE FORM; LONG BONES; EVOLUTION; FORELIMB; THEROPODA; THICKNESS; MAMMALS; POSTURE	Extinct archosaurs, including many non-avian dinosaurs, exhibit relatively simply shaped condylar regions in their appendicular bones, suggesting potentially large amounts of unpreserved epiphyseal ( articular) cartilage. This "lost anatomy'' is often underappreciated such that the ends of bones are typically considered to be the joint surfaces, potentially having a major impact on functional interpretation. Extant alligators and birds were used to establish an objective basis for inferences about cartilaginous articular structures in such extinct archosaur clades as non-avian dinosaurs. Limb elements of alligators, ostriches, and other birds were dissected, disarticulated, and defleshed. Lengths and condylar shapes of elements with intact epiphyses were measured. Limbs were subsequently completely skeletonized and the measurements repeated. Removal of cartilaginous condylar regions resulted in statistically significant changes in element length and condylar breadth. Moreover, there was marked loss of those cartilaginous structures responsible for joint architecture and congruence. Compared to alligators, birds showed less dramatic, but still significant changes. Condylar morphologies of dinosaur limb bones suggest that most non-coelurosaurian clades possessed large cartilaginous epiphyses that relied on the maintenance of vascular channels that are otherwise eliminated early in ontogeny in smaller-bodied tetrapods. A sensitivity analysis using cartilage correction factors (CCFs) obtained from extant taxa indicates that whereas the presence of cartilaginous epiphyses only moderately increases estimates of dinosaur height and speed, it has important implications for our ability to infer joint morphology, posture, and the complicated functional movements in the limbs of many extinct archosaurs. Evidence suggests that the sizes of sauropod epiphyseal cartilages surpassed those of alligators, which account for at least 10% of hindlimb length. These data suggest that large cartilaginous epiphyses were widely distributed among non-avian archosaurs and must be considered when making inferences about locomotor functional morphology in fossil taxa.	[Holliday, Casey M.] Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO 65211 USA; [Ridgely, Ryan C.; Witmer, Lawrence M.] Ohio Univ, Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA; [Sedlmayr, Jayc C.] Louisiana State Univ New Orleans, Sch Med, Dept Cell Biol & Anat, New Orleans, LA 70112 USA	University of Missouri System; University of Missouri Columbia; University System of Ohio; Ohio University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Holliday, CM (corresponding author), Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO 65211 USA.	hollidayca@missouri.edu		Holliday, Casey/0000-0001-8210-8434; Witmer, Lawrence/0000-0002-7610-0118	National Science Foundation (NSF) [DDIG 0407735, IBN-9601174, IBN-0343744, IOB-0517257]; Ohio University Department of Biological; Ohio University Department of Biomedical Sciences; Ohio University College of Osteopathic Medicine; University of Missouri Department of Pathology and Anatomical Sciences	National Science Foundation (NSF)(National Science Foundation (NSF)); Ohio University Department of Biological; Ohio University Department of Biomedical Sciences; Ohio University College of Osteopathic Medicine; University of Missouri Department of Pathology and Anatomical Sciences	Funding was provided by National Science Foundation (NSF) DDIG 0407735 (to L. M. W and C. M. H.) and NSF IBN-9601174, IBN-0343744, IOB-0517257 (to L.M.W.) as well as Ohio University Departments of Biological and Biomedical Sciences, Ohio University College of Osteopathic Medicine, and University of Missouri Department of Pathology and Anatomical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RM, 1985, ZOOL J LINN SOC-LOND, V83, P1, DOI 10.1111/j.1096-3642.1985.tb00871.x; ALEXANDER RM, 1991, SCI AM, V264, P130, DOI 10.1038/scientificamerican0491-130; ALEXANDER RM, 1983, J ZOOL, V201, P135, DOI 10.1111/j.1469-7998.1983.tb04266.x; BAKKER RT, 1971, NATURE, V229, P172, DOI 10.1038/229172a0; Bakker RT., 1986, DINOSAUR HERESIES; BARRETO C, 1993, SCIENCE, V262, P2020, DOI 10.1126/science.262.5142.2020; BAUMEL JJ, 1993, HDB AVIAN ANATOMY NO, P00133; Baumel Julian J., 1993, Publications of the Nuttall Ornithological Club, V23, P45; BIKNEVICIUS AR, 1992, ANAT RECORD, V232, P157, DOI 10.1002/ar.1092320118; Biknevicius AR, 1999, J ZOOL, V248, P179, DOI 10.1111/j.1469-7998.1999.tb01194.x; Blob RW, 2000, J ZOOL, V250, P507, DOI 10.1111/j.1469-7998.2000.tb00793.x; BONNAN M, IN PRESS ANAT REC; Bonnan MF, 2007, SPEC PAP PALAEONTOL, P139; Bonnan MF, 2004, PALEOBIOLOGY, V30, P444, DOI 10.1666/0094-8373(2004)030<0444:MAOHAF>2.0.CO;2; Brochu CA, 2001, J PALEONTOL, V75, P1185, DOI 10.1666/0022-3360(2001)075<1185:PAFDIA>2.0.CO;2; Brochu CA, 1999, J VERTEBR PALEONTOL, V19, P9, DOI 10.1080/02724634.1999.10011201; Brown B., 1940, Annals of the New York Academy of Sciences, V40, P133; CARPENTER K, 1999, EGGS NESTS BABY DINO, P352; Carpenter Kenneth, 1997, P150; Carrano MT, 1998, PALEOBIOLOGY, V24, P450, DOI 10.1017/S0094837300020108; Carrano MT, 2001, J ZOOL, V254, P41, DOI 10.1017/S0952836901000541; Carrano MT, 1999, J ZOOL, V247, P29, DOI 10.1111/j.1469-7998.1999.tb00190.x; Carter DR, 2003, PHILOS T ROY SOC B, V358, P1461, DOI 10.1098/rstb.2003.1346; Carter DR, 1998, ZOOL J LINN SOC-LOND, V123, P163, DOI 10.1006/zjls.1997.0108; Carter DR, 2001, SKELETAL FUNCTION FO; Charig A.J., 1972, P121; CHATTERJEE S, 1985, PHILOS T ROY SOC B, V309, P395, DOI 10.1098/rstb.1985.0092; Chrtstiansen P, 1999, J VERTEBR PALEONTOL, V19, P666, DOI 10.1080/02724634.1999.10011180; Colbert E. H, 1989, MUSEUM NO ARIZONA B, V57, P1; Colbert Edwin H., 1947, BULL AMER MUS NAT HIST, V88, P53; COOMBS WP, 1975, PALAEOGEOGR PALAEOCL, V17, P1, DOI 10.1016/0031-0182(75)90027-9; COPE E, 1884, AM NAT, V18, P526; Cope ED, 1878, AM NAT, V12, P71, DOI [10.1086/272033., DOI 10.1086/272033]; CURREY JD, 1985, J ZOOL, V206, P453; Dodson P., 1996, HORNED DINOSAURS NAT; Eckstein F, 1997, J BIOMECH, V30, P285, DOI 10.1016/S0021-9290(97)81146-3; Egger GF, 2008, J MORPHOL, V269, P118, DOI 10.1002/jmor.10600; Enlow D. H., 1969, pUnpaginated; Enlow DH, 1980, SCI F ORTHOPAEDICS T, P185; Erickson GM, 2005, TRENDS ECOL EVOL, V20, P677, DOI 10.1016/j.tree.2005.08.012; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; Farlow JO, 2004, LETHAIA, V37, P401, DOI 10.1080/00241160410002117; Farlow JO, 2000, AM ZOOL, V40, P640, DOI 10.1668/0003-1569(2000)040[0640:TL]2.0.CO;2; Faux CM, 2007, PALEOBIOLOGY, V33, P201, DOI 10.1666/06015.1; FREY E, 1988, STUTTGARTER BEITRAGE, V426, P1; Fujiwara S, 2010, J MORPHOL, V271, P883, DOI 10.1002/jmor.10846; GALTON P M, 1970, Journal of Paleontology, V44, P464; Galton PM, 2004, DINOSAURIA, 2ND EDITION, P232; Gatesy SM, 1997, J VERTEBR PALEONTOL, V17, P308, DOI 10.1080/02724634.1997.10010977; Gatesy SM, 2009, J VERTEBR PALEONTOL, V29, P535, DOI 10.1671/039.029.0213; Geist NR, 1996, SCIENCE, V272, P712, DOI 10.1126/science.272.5262.712; Gishlick AD, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P301; Haine RW, 1942, BIOL REV, V17, P262; Haines R. W, 1969, EPIPHYSES SESAMOIDS, P81; Haines RW, 1941, J ANAT, V75, P282; Haines RW, 1938, J ANAT, V72, P323; Haines RW, 1939, J ANAT, V74, P80; Hall B.K., 2015, BONES CARTILAGE DEV; HALLETT M, 1987, DINOSAURS PAST PRESE, V1, P96; Hatcher JB., 1901, MEM CARNEGIE MUS, V1, P1, DOI [10.5962/p.234818, DOI 10.5962/P.234818]; Hay OP, 1908, AM NAT, V42, P672, DOI 10.1086/278992; HEINRICH RE, 1993, ZOOL J LINN SOC-LOND, V108, P179, DOI 10.1111/j.1096-3642.1993.tb00294.x; Heinrich RE, 1998, J MORPHOL, V235, P121, DOI 10.1002/(SICI)1097-4687(199802)235:2<121::AID-JMOR3>3.0.CO;2-C; Holliday Casey M., 2001, Journal of Vertebrate Paleontology, V21, p62A; HOLTZ TR, 1994, J VERTEBR PALEONTOL, V14, P480, DOI 10.1080/02724634.1995.10011574; Hutchinson JR, 2006, NATURE, V440, P292, DOI 10.1038/440292a; Hutchinson JR, 2005, PALEOBIOLOGY, V31, P676; Hutchinson JR, 2004, J MORPHOL, V262, P441, DOI 10.1002/jmor.10240; Hutchinson JR, 2002, NATURE, V415, P1018, DOI 10.1038/4151018a; Hutchinson JR, 2000, PALEOBIOLOGY, V26, P734, DOI 10.1666/0094-8373(2000)026<0734:AAATEO>2.0.CO;2; Jaramillo D, 2004, AM J ROENTGENOL, V182, P353, DOI 10.2214/ajr.182.2.1820353; JOHNSON RE, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P205; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Long R.A., 1995, NEW MEXICO MUSEUM NA, V4, P1; LUBOSCH W, 1924, MORPH JB, V53, P49; Lull R. S., 1942, Geological Society of America Special Paper, V40, P1; Madsen JH., 1976, UTAH GEOLOGICAL SURV, V109, P163; Marsh O., 1883, AM J SCI, V26, P81; MARSH OC, 1896, 16 US GEOL SURV, P133; MARSH OC, 1883, AM J SCI, V3, P81; MAZZETTA G, 2004, BODY SIZE SOME SO S, P1; MCCUTCHEN CW, 1983, CARTILAGE BIOMEDICAL, P87; Moodie RL, 1908, AM J ANAT, V7, P443, DOI 10.1002/aja.1000070403; NICHOLLS EL, 1985, PALAEONTOLOGY, V28, P643; NORMAN DB, 1980, I ROYAL SCI NATURELL, V178, P1; Osborn H. F., 1898, Bulletin of the American Museum of Natural History, Vx, P219; Ostrom J. A., 1966, MARSHS DINOSAURS COL; Ostrom J.H., 1976, BREVIORA, V439, P1; OWEN R, 1875, MONOGRAPHS BRIT FO 2, P875; Padian K, 2001, NATURE, V412, P405, DOI 10.1038/35086500; Parrish J.M., 1986, P35; Parrish J.M., 1986, Hunteria, V1, P1; Parsons T.S., 1969, BIOL REPTILIA, VI, P81, DOI DOI 10.1093/ICB/ICP063; PAUL G, 1998, SIMON SCHUSTER, P464; PAUL G, 2002, JOHNS HOPKINS U PRES; Paul GS, 2000, PALEOBIOLOGY, V26, P450, DOI 10.1666/0094-8373(2000)026<0450:FPINDI>2.0.CO;2; Reid R.E.H., 1996, Brigham Young University Geology Studies, V41, P25; REID REH, 1984, S ZOOLOGICAL SOC LON, V52, P629; Ricqles A., 1991, BONE BONE MATRIX BON, V3, P1, DOI DOI 10.1111/J.0021-8782.2004.00275.X; Rogers KC, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P303; Royo-Torres R, 2006, SCIENCE, V314, P1925, DOI 10.1126/science.1132885; Ruff C., 1990, P119; Schmidt-Nielson K., 1984, SCALING WHY IS ANIMA; Schwarz D, 2007, J GEOL SOC LONDON, V164, P61, DOI 10.1144/0016-76492006-019; Senter P, 2005, PALEOBIOLOGY, V31, P373, DOI 10.1666/0094-8373(2005)031[0373:FITSFO]2.0.CO;2; Senter P, 2005, J ZOOL, V266, P307, DOI 10.1017/S0952836905006989; Senter P, 2007, J ZOOL, V273, P305, DOI 10.1111/j.1469-7998.2007.00329.x; Sereno P.C., 1991, Journal of Vertebrate Paleontology, V11, P1; Sereno Paul C., 1993, Journal of Vertebrate Paleontology, V13, P385; SIMON WH, 1970, ARTHRITIS RHEUM, V13, P244, DOI 10.1002/art.1780130305; Starck JM, 2002, J MORPHOL, V254, P232, DOI 10.1002/jmor.10029; Thulborn R.A., 1989, DINOSAUR TRACKS TRAC, P39; THULBORN RA, 1982, PALAEOGEOGR PALAEOCL, V38, P227, DOI 10.1016/0031-0182(82)90005-0; Upchurch P, 2004, DINOSAURIA, 2ND EDITION, P259; Wilson JA, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011115; Wilson JA, 1999, PALEOBIOLOGY, V25, P252, DOI 10.1017/S0094837300026543; Wilson JA, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P15; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; [No title captured]	119	85	85	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e13120	10.1371/journal.pone.0013120	http://dx.doi.org/10.1371/journal.pone.0013120			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20927347	Green Submitted, gold, Green Published			2022-12-27	WOS:000282312600033
J	Fenstad, MH; Johnson, MP; Roten, LT; Aas, PA; Forsmo, S; Klepper, K; East, CE; Abraham, LJ; Blangero, J; Brennecke, SP; Austgulen, R; Moses, EK				Fenstad, Mona H.; Johnson, Matthew P.; Roten, Linda T.; Aas, Per A.; Forsmo, Siri; Klepper, Kjetil; East, Christine E.; Abraham, Lawrence J.; Blangero, John; Brennecke, Shaun P.; Austgulen, Rigmor; Moses, Eric K.			Genetic and Molecular Functional Characterization of Variants within TNFSF13B, a Positional Candidate Preeclampsia Susceptibility Gene on 13q	PLOS ONE			English	Article							B-LYMPHOCYTE STIMULATOR; NECROSIS-FACTOR FAMILY; TRAIT LINKAGE ANALYSIS; NK CELLS; TRANSMISSION DISEQUILIBRIUM; SUPERFAMILY LIGANDS; RISK; LOCUS; FETAL; BLYS	Background: Preeclampsia is a serious pregnancy complication, demonstrating a complex pattern of inheritance. The elucidation of genetic liability to preeclampsia remains a major challenge in obstetric medicine. We have adopted a positional cloning approach to identify maternal genetic components, with linkages previously demonstrated to chromosomes 2q, 5q and 13q in an Australian/New Zealand familial cohort. The current study aimed to identify potential functional and structural variants in the positional candidate gene TNFSF13B under the 13q linkage peak and assess their association status with maternal preeclampsia genetic susceptibility. Methodology/Principal Findings: The proximal promoter and coding regions of the positional candidate gene TNFSF13B residing within the 13q linkage region was sequenced using 48 proband or founder individuals from Australian/New Zealand families. Ten sequence variants (nine SNPs and one single base insertion) were identified and seven SNPs were successfully genotyped in the total Australian/New Zealand family cohort (74 families/480 individuals). Borderline association to preeclampsia (p = 0.0153) was observed for three rare SNPs (rs16972194, rs16972197 and rs56124946) in strong linkage disequilibrium with each other. Functional evaluation by electrophoretic mobility shift assays showed differential nuclear factor binding to the minor allele of the rs16972194 SNP, residing upstream of the translation start site, making this a putative functional variant. The observed genetic associations were not replicated in a Norwegian case/control cohort (The Nord-Trondelag Health Study (HUNT2), 851 preeclamptic and 1,440 non-preeclamptic women). Conclusion/Significance: TNFSF13B has previously been suggested to contribute to the normal immunological adaption crucial for a successful pregnancy. Our observations support TNFSF13B as a potential novel preeclampsia susceptibility gene. We discuss a possible role for TNFSF13B in preeclampsia pathogenesis, and propose the rs16972194 variant as a candidate for further functional evaluation.	[Fenstad, Mona H.; Roten, Linda T.; Aas, Per A.; Klepper, Kjetil; Austgulen, Rigmor] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Johnson, Matthew P.; Blangero, John; Moses, Eric K.] SW Fdn Biomed Res, Dept Genet, San Antonio, TX USA; [Forsmo, Siri] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway; [East, Christine E.; Brennecke, Shaun P.] Univ Melbourne, Parkville, Vic 3052, Australia; [East, Christine E.; Brennecke, Shaun P.] Royal Womens Hosp, Dept Obstet & Gynaecol, Dept Perinatal Med, Parkville, Vic, Australia; [Abraham, Lawrence J.] Univ Western Australia Crawley, Sch Biomed Biomol & Chem Sci, Perth, WA, Australia	Norwegian University of Science & Technology (NTNU); Texas Biomedical Research Institute; Norwegian University of Science & Technology (NTNU); University of Melbourne; University of Western Australia	Fenstad, MH (corresponding author), Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway.	mona.n.fenstad@ntnu.no	East, Christine/H-4938-2013; Blangero, John/ABA-7175-2021; Brennecke, Shaun/AFV-3919-2022	East, Christine/0000-0002-1196-8426; Brennecke, Shaun/0000-0003-3070-6971; Moses, Eric/0000-0001-7781-4465; Fenstad, Mona Hoysaeter/0000-0002-9102-8409	National Institutes of Health [HD049847, MH059490]; Norwegian University of Science and Technology (NTNU); Liaison Committee of NTNU; Central Norway Regional Health Authority; Research Council of Norway; Fulbright Foundation for Educational Exchange; National Center for Research Resources, National Institutes of Health [RR13556, RR017515]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD049847] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR013556, C06RR017515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH059490, R01MH059490] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Norwegian University of Science and Technology (NTNU); Liaison Committee of NTNU; Central Norway Regional Health Authority; Research Council of Norway(Research Council of Norway); Fulbright Foundation for Educational Exchange; National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health grants HD049847 (to E. K. M, S. P. B. and J.B.) and MH059490 (to J.B.); The Norwegian University of Science and Technology (NTNU) (M. H. F, L. T. R., R. A.); the Liaison Committee of NTNU and Central Norway Regional Health Authority (M. H. F. and L. T. R.); the Research Council of Norway (M. H. F., travel grant) and the Fulbright Foundation for Educational Exchange (M. H. F., travel grant). This investigation was conducted in facilities constructed with support from Research Facilities Improvement Program grants RR13556 and RR017515 from the National Center for Research Resources, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas PA, 2009, DNA REPAIR, V8, P822, DOI 10.1016/j.dnarep.2009.03.008; Abecasis GR, 2000, EUR J HUM GENET, V8, P545, DOI 10.1038/sj.ejhg.5200494; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Arngrimsson R, 1999, HUM MOL GENET, V8, P1799, DOI 10.1093/hmg/8.9.1799; Babu MM, 2004, CURR OPIN STRUC BIOL, V14, P283, DOI 10.1016/j.sbi.2004.05.004; Blangero J, 2005, HUM BIOL, V77, P541, DOI 10.1353/hub.2006.0003; BOERWINKLE E, 1986, ANN HUM GENET, V50, P181, DOI 10.1111/j.1469-1809.1986.tb01037.x; Brosens I A, 1972, Obstet Gynecol Annu, V1, P177; Brown MA, 2000, AUST NZ J OBSTET GYN, V40, P133, DOI 10.1111/j.1479-828X.2000.tb01136.x; BROWN MA, 1993, MED J AUSTRALIA, V158, P700; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Challis JR, 2009, REPROD SCI, V16, P206, DOI 10.1177/1933719108329095; Chang SK, 2006, BLOOD, V108, P2687, DOI 10.1182/blood-2005-12-017319; Chappell S, 2006, CLIN SCI, V110, P443, DOI 10.1042/CS20050323; Cnattingius S, 2004, AM J MED GENET A, V130A, P365, DOI 10.1002/ajmg.a.30257; Conde-Agudelo A, 2008, AM J OBSTET GYNECOL, V198, P7, DOI 10.1016/j.ajog.2007.07.040; COSTARODRIGUEZ EV, 2007, EUR J IMMUNOL, V37, P990; Dekker G, 2007, J REPROD IMMUNOL, V76, P8, DOI 10.1016/j.jri.2007.03.015; Duggirala R, 1997, GENET EPIDEMIOL, V14, P987, DOI 10.1002/(SICI)1098-2272(1997)14:6<987::AID-GEPI71>3.0.CO;2-G; Easton DF, 2007, AM J HUM GENET, V81, P873, DOI 10.1086/521032; Erridge C, 2010, J LEUKOCYTE BIOL, V87, P989, DOI 10.1189/jlb.1209775; Esplin MS, 2001, NEW ENGL J MED, V344, P867, DOI 10.1056/NEJM200103223441201; Fenstad MH, 2010, MOL HUM REPROD, V16, P960, DOI 10.1093/molehr/gaq064; Fitzpatrick E, 2004, HUM BIOL, V76, P849, DOI 10.1353/hub.2005.0017; Fitzpatrick E, 2009, MOL HUM REPROD, V15, P195, DOI 10.1093/molehr/gap001; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Guo WJ, 2008, CHINESE MED J-PEKING, V121, P309, DOI 10.1097/00029330-200802020-00006; Harrison GA, 1997, AM J HUM GENET, V60, P1158; Hatada EN, 2003, J IMMUNOL, V171, P761, DOI 10.4049/jimmunol.171.2.761; Havill LM, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S91; Hiby SE, 2004, J EXP MED, V200, P957, DOI 10.1084/jem.20041214; Holmen J, 2003, NORSK EPIDEMIOLOGI, V13, P19, DOI DOI 10.1093/eurheartj/eht019; Huppertz B, 2008, HYPERTENSION, V51, P970, DOI 10.1161/HYPERTENSIONAHA.107.107607; Jauniaux E, 2000, AM J PATHOL, V157, P2111, DOI 10.1016/S0002-9440(10)64849-3; Johnson MP, 2007, MOL HUM REPROD, V13, P61, DOI 10.1093/molehr/gal095; Johnson MP, 2009, HUM GENET, V126, P655, DOI 10.1007/s00439-009-0714-x; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; KLEMM JD, 1994, CELL, V77, P21, DOI 10.1016/0092-8674(94)90231-3; Lachmeijer AMA, 2001, EUR J HUM GENET, V9, P758, DOI 10.1038/sj.ejhg.5200706; Laivuori H, 2003, AM J HUM GENET, V72, P168, DOI 10.1086/345311; Laivuori H, 2007, FRONT BIOSCI-LANDMRK, V12, P2372, DOI 10.2741/2239; Li DK, 2000, AM J EPIDEMIOL, V151, P57, DOI 10.1093/oxfordjournals.aje.a010122; Lie RT, 1998, BRIT MED J, V316, P1343, DOI 10.1136/bmj.316.7141.1343; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Mackay Fabienne, 2005, V8, P243; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Masters JR, 2002, NAT REV CANCER, V2, P315, DOI 10.1038/nrc775; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Moses EK, 2006, MOL HUM REPROD, V12, P505, DOI 10.1093/molehr/gal056; Moses EK, 2000, AM J HUM GENET, V67, P1581, DOI 10.1086/316888; Moses EK, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.09.024; Moskvina V, 2008, GENET EPIDEMIOL, V32, P567, DOI 10.1002/gepi.20331; Muetze S, 2008, J PERINAT MED, V36, P38, DOI 10.1515/JPM.2008.004; Nardelli B, 2001, BLOOD, V97, P198, DOI 10.1182/blood.V97.1.198; Ness RB, 1996, AM J OBSTET GYNECOL, V175, P1365, DOI 10.1016/S0002-9378(96)70056-X; Novak AJ, 2006, J CLIN ONCOL, V24, P983, DOI 10.1200/JCO.2005.02.7938; Novak AJ, 2009, CANCER RES, V69, P4217, DOI 10.1158/0008-5472.CAN-08-4915; Oudejans CBM, 2007, HUM GENET, V120, P607, DOI 10.1007/s00439-006-0259-1; Phillips TA, 2003, J LEUKOCYTE BIOL, V74, P81, DOI 10.1189/jlb.0103033; Phillips TA, 2001, PLACENTA, V22, P663, DOI 10.1053/plac.2001.0703; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Pu J, 2009, EUR J HAEMATOL, V82, P267, DOI 10.1111/j.1600-0609.2008.01203.x; Redman CWG, 2010, AM J REPROD IMMUNOL, V63, P534, DOI 10.1111/j.1600-0897.2010.00831.x; Riley JK, 2010, CLIN REV ALLERG IMMU, V39, P185, DOI 10.1007/s12016-009-8178-2; Roberts JM, 2005, HYPERTENSION, V46, P1243, DOI 10.1161/01.HYP.0000188408.49896.c5; Roten LT, 2009, EUR J HUM GENET, V17, P250, DOI 10.1038/ejhg.2008.158; ROTEN LT, 2009, THESIS NORWEGIAN U S; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; Saito S, 2010, AM J REPROD IMMUNOL, V63, P601, DOI 10.1111/j.1600-0897.2010.00852.x; Santoni A, 2007, AM J REPROD IMMUNOL, V58, P280, DOI 10.1111/j.1600-0897.2007.00513.x; Sargent IL, 2006, REPROD BIOMED ONLINE, V13, P680, DOI 10.1016/S1472-6483(10)60659-1; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Shan X, 2006, PHYSIOL RES, V55, P301, DOI 10.33549/physiolres.930816; Skjaerven R, 2005, BRIT MED J, V331, P877, DOI 10.1136/bmj.38555.462685.8F; Sobel E, 1996, AM J HUM GENET, V58, P1323; Tai MH, 2005, CARCINOGENESIS, V26, P495, DOI 10.1093/carcin/bgh321; Wallis AB, 2008, AM J HYPERTENS, V21, P521, DOI 10.1038/ajh.2008.20; Wingender E, 2008, BRIEF BIOINFORM, V9, P326, DOI 10.1093/bib/bbn016; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Xu W, 2008, J IMMUNOL, V181, P276, DOI 10.4049/jimmunol.181.1.276; Zhang W, 2008, IMMUNOL LETT, V120, P96, DOI 10.1016/j.imlet.2008.07.005	85	16	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e12993	10.1371/journal.pone.0012993	http://dx.doi.org/10.1371/journal.pone.0012993			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20927378	Green Submitted, Green Published, gold			2022-12-27	WOS:000282269400007
J	Kullo, IJ; Ding, KY; Jouni, H; Smith, CY; Chute, CG				Kullo, Iftikhar J.; Ding, Keyue; Jouni, Hayan; Smith, Carin Y.; Chute, Christopher G.			A Genome-Wide Association Study of Red Blood Cell Traits Using the Electronic Medical Record	PLOS ONE			English	Article							HEMOGLOBIN LEVELS; DISEASE; TMPRSS6; CONSORTIUM; VISCOSITY; VARIANTS; PRESSURE; LINKAGE; ANEMIA; VOLUME	Background: The Electronic Medical Record (EMR) is a potential source for high throughput phenotyping to conduct genome-wide association studies (GWAS), including those of medically relevant quantitative traits. We describe use of the Mayo Clinic EMR to conduct a GWAS of red blood cell (RBC) traits in a cohort of patients with peripheral arterial disease (PAD) and controls without PAD. Methodology and Principal Findings: Results for hemoglobin level, hematocrit, RBC count, mean corpuscular volume, mean corpuscular hemoglobin, and mean corpuscular hemoglobin concentration were extracted from the EMR from January 1994 to September 2009. Out of 35,159 RBC trait values in 3,411 patients, we excluded 12,864 values in 1,165 patients that had been measured during hospitalization or in the setting of hematological disease, malignancy, or use of drugs that affect RBC traits, leaving a final genotyped sample of 3,012, 80% of whom had >= 2 measurements. The median of each RBC trait was used in the genetic analyses, which were conducted using an additive model that adjusted for age, sex, and PAD status. We identified four genomic loci that were associated (P<5 x 10(-8)) with one or more of the RBC traits (HBLS1/MYB on 6q23.3, TMPRSS6 on 22q12.3, HFE on 6p22.1, and SLC17A1 on 6p22.2). Three of these loci (HBLS1/MYB, TMPRSS6, and HFE) had been identified in recent GWAS and the allele frequencies, effect sizes, and the directions of effects of the replicated SNPs were similar to the prior studies. Conclusions: Our results demonstrate feasibility of using the EMR to conduct high throughput genomic studies of medically relevant quantitative traits.	[Kullo, Iftikhar J.; Ding, Keyue; Jouni, Hayan] Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA	Mayo Clinic	Kullo, IJ (corresponding author), Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA.	kullo.iftikhar@mayo.edu	Chute, Christopher/AAT-8540-2021	Smith, Carin/0000-0002-3610-6945; Ding, Keyue/0000-0002-3496-6415	National Human Genome Research Institute [HG05499]	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This study was funded as part of the National Human Genome Research Institute-supported eMERGE (Electronic Records and Genomics) Network (HG05499). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews NC, 2009, NAT GENET, V41, P1161, DOI 10.1038/ng1109-1161; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Benyamin B, 2009, NAT GENET, V41, P1173, DOI 10.1038/ng.456; Benyamin B, 2009, AM J HUM GENET, V84, P60, DOI 10.1016/j.ajhg.2008.11.011; CARPENTER PC, 1994, INT J BIOMED COMPUT, V34, P159, DOI 10.1016/0020-7101(94)90019-1; Chambers JC, 2009, NAT GENET, V41, P1170, DOI 10.1038/ng.462; Chernecky C.C., 2001, LAB TESTS DIAGNOSTIC, V3rd; Chute CG, 2010, J AM MED INFORM ASSN, V17, P131, DOI 10.1136/jamia.2009.002691; de Lusignan Simon, 2006, Inform Prim Care, V14, P203; de Simone G, 2005, HYPERTENSION, V45, P625, DOI 10.1161/01.HYP.0000157526.07977.ec; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; Ganesh SK, 2009, NAT GENET, V41, P1191, DOI 10.1038/ng.466; Giannetti AM, 2004, J BIOL CHEM, V279, P25866, DOI 10.1074/jbc.M401467200; Kullo IJ, 2010, J AM MED INFORM ASSN, V17, P568, DOI 10.1136/jamia.2010.004366; LETCHER RL, 1983, HYPERTENSION, V5, P757, DOI 10.1161/01.HYP.5.5.757; Lettre G, 2008, P NATL ACAD SCI USA, V105, P11869, DOI 10.1073/pnas.0804799105; Lin JP, 2007, AM J HEMATOL, V82, P605, DOI 10.1002/ajh.20868; Louie B, 2007, J BIOMED INFORM, V40, P5, DOI 10.1016/j.jbi.2006.02.007; Manolio TA, 2009, PHARMACOGENOMICS, V10, P235, DOI 10.2217/14622416.10.2.235; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sarnak MJ, 2002, J AM COLL CARDIOL, V40, P27, DOI 10.1016/S0735-1097(02)01938-1; Sharp DS, 1996, CIRCULATION, V93, P1677, DOI 10.1161/01.CIR.93.9.1677; Silva-Brandao KL, 2008, MOL ECOL RESOUR, V8, P502, DOI 10.1111/j.1471-8286.2007.02022.x; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Timmer RT, 2000, J GEN PHYSIOL, V116, P363, DOI 10.1085/jgp.116.3.363; Velasco G, 2002, J BIOL CHEM, V277, P37637, DOI 10.1074/jbc.M203007200	27	86	87	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2010	5	9							e13011	10.1371/journal.pone.0013011	http://dx.doi.org/10.1371/journal.pone.0013011			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	654ZQ	20927387	gold, Green Published, Green Submitted			2022-12-27	WOS:000282210700008
J	Lu, B; Mahmud, H; Maass, AH; Yu, B; van Gilst, WH; de Boer, RA; Sillje, HHW				Lu, Bo; Mahmud, Hasan; Maass, Alexander H.; Yu, Bo; van Gilst, Wiek H.; de Boer, Rudolf A.; Sillje, Herman H. W.			The Plk1 Inhibitor BI 2536 Temporarily Arrests Primary Cardiac Fibroblasts in Mitosis and Generates Aneuploidy In Vitro	PLOS ONE			English	Article							POLO-LIKE KINASE-1; BOX DOMAIN; CANCER-CELLS; SUBSTRATE; REVEALS; POLO-LIKE-KINASE-1; ACTIVATION; DIVISION; THERAPY; BI-2536	BI 2536 is a new anti-mitotic drug that targets polo-like kinase 1 (Plk1) and is currently under clinical development for cancer therapy. The effect of this drug on cancer cells has been extensively investigated, but information about the effects on primary dividing cells and differentiated non-dividing cells is scarce. We have investigated the effects of this drug on primary neonatal rat cardiac fibroblasts and on differentiated cardiomyocytes and explored the possibility to use this drug to enrich differentiated cell populations in vitro. BI 2536 had a profound effect on cardiac fibroblast proliferation in vitro and arrested these cells in mitosis with an IC50 of about 43 nM. Similar results were observed with primary human cells (HUVEC, IC50 = 30 nM), whereas the cancer cell line HeLa was more sensitive (IC50 of 9 nM). Further analysis revealed that prolonged mitotic arrest resulted in cell death for about 40% of cardiac fibroblasts. The remaining cells showed an interphase morphology with mostly multi-and micro-nucleated nuclei. This indicates that a significant number of primary fibroblasts are able to escape BI 2536 induced mitotic arrest and apparently become aneuploid. No effects were observed on cardiomyocytes and hypertrophic response (growth) upon endothelin-1 and phenylephrine stimulation was normal in the presence of BI 2536. This indicates that BI 2536 has no adverse effects on terminally differentiated cells and still allows proliferation independent growth induction in these cells. In conclusion, cardiomyocytes could be enriched using BI 2536, but the formation of aneuploidy in proliferating cells most likely limits this in vitro application and does not allow its use in putative cell based therapies.	[Lu, Bo; Mahmud, Hasan; Maass, Alexander H.; van Gilst, Wiek H.; de Boer, Rudolf A.; Sillje, Herman H. W.] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [Yu, Bo] Harbin Med Coll, Affiliated Hosp 2, Dept Cardiol, Key Labs,Educ Minist Myocardial Ischemia Mech & T, Harbin, Peoples R China	University of Groningen; Harbin Medical University	Sillje, HHW (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands.	h.h.w.sillje@thorax.umcg.nl	de Boer, Rudolf/ABE-9879-2020; Maass, Alexander/B-8534-2008; van Gilst, Wiek H/C-3828-2008; van Gilst, Wiek/R-1806-2019	Maass, Alexander/0000-0002-7936-360X; van Gilst, Wiek/0000-0003-2968-8585	Graduate School for Drug Exploration (GUIDE) of the University of Groningen	Graduate School for Drug Exploration (GUIDE) of the University of Groningen	B. Lu is a recipient of a fellowship by the Graduate School for Drug Exploration (GUIDE) of the University of Groningen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANVUGT MA, 2004, J BIOL CHEM, V279, P36841; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Brito DA, 2009, CELL MOTIL CYTOSKEL, V66, P437, DOI 10.1002/cm.20316; Elez R, 2003, ONCOGENE, V22, P69, DOI 10.1038/sj.onc.1206038; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB; Hanisch A, 2006, MOL BIOL CELL, V17, P448, DOI 10.1091/mbc.E05-08-0801; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Kumagai A, 1996, SCIENCE, V273, P1377, DOI 10.1126/science.273.5280.1377; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Liu XQ, 2006, MOL CELL BIOL, V26, P2093, DOI 10.1128/MCB.26.6.2093-2108.2006; Lowery DM, 2007, EMBO J, V26, P2262, DOI 10.1038/sj.emboj.7601683; Maass A, 2003, J MOL CELL CARDIOL, V35, P823, DOI 10.1016/S0022-2828(03)00140-8; MAASS AH, 1995, EUR HEART J, V16, P12, DOI 10.1093/eurheartj/16.suppl_C.12; Maass Alexander H, 2007, Methods Mol Biol, V366, P321; Mross K, 2008, J CLIN ONCOL, V26, P5511, DOI 10.1200/JCO.2008.16.1547; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Oeseburg H, 2010, ARTERIOSCL THROM VAS, V30, P1407, DOI 10.1161/ATVBAHA.110.206425; Okano-Uchida T, 2003, EMBO J, V22, P5633, DOI 10.1093/emboj/cdg535; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; Ren D, 2003, BRAIN RES BULL, V61, P547, DOI 10.1016/S0361-9230(03)00193-X; Santamaria A, 2007, MOL BIOL CELL, V18, P4024, DOI 10.1091/mbc.E07-05-0517; SCHOFFSKI P, 2010, EUR J CANC; Schoffski P, 2009, ONCOLOGIST, V14, P559, DOI 10.1634/theoncologist.2009-0010; Schraaa AJ, 2002, J CONTROL RELEASE, V83, P241, DOI 10.1016/S0168-3659(02)00206-7; Spankuch-Schmitt B, 2002, JNCI-J NATL CANCER I, V94, P1863, DOI 10.1093/jnci/94.24.1863; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; van de Weerdt BCM, 2006, CELL CYCLE, V5, P853, DOI 10.4161/cc.5.8.2692; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015	33	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2010	5	9							e12963	10.1371/journal.pone.0012963	http://dx.doi.org/10.1371/journal.pone.0012963			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653UN	20886032	Green Published, gold, Green Submitted			2022-12-27	WOS:000282122600005
J	Beissner, F; Brandau, A; Henke, C; Felden, L; Baumgartner, U; Treede, RD; Oertel, BG; Lotsch, J				Beissner, Florian; Brandau, Amadeus; Henke, Christian; Felden, Lisa; Baumgaertner, Ulf; Treede, Rolf-Detlef; Oertel, Bruno G.; Loetsch, Joern			Quick Discrimination of A(delta) and C Fiber Mediated Pain Based on Three Verbal Descriptors	PLOS ONE			English	Article							A-FIBER; SECONDARY HYPERALGESIA; NEUROPATHIC PAIN; STIMULATION; PERCEPTION; HUMANS; QUESTIONNAIRE; SKIN; PREVALENCE; ACTIVATION	Background: Ad and C fibers are the major pain-conducting nerve fibers, activate only partly the same brain areas, and are differently involved in pain syndromes. Whether a stimulus excites predominantly Ad or C fibers is a commonly asked question in basic pain research but a quick test was lacking so far. Methodology/Principal Findings: Of 77 verbal descriptors of pain sensations, "pricking'', "dull'' and "pressing'' distinguished best (95% cases correctly) between Ad fiber mediated (punctate pressure produced by means of von Frey hairs) and C fiber mediated (blunt pressure) pain, applied to healthy volunteers in experiment 1. The sensation was assigned to Ad fibers when "pricking'' but neither "dull'' nor "pressing'' were chosen, and to C fibers when the sum of the selections of "dull'' or "pressing'' was greater than that of the selection of "pricking''. In experiment 2, with an independent cohort, the three-descriptor questionnaire achieved sensitivity and specificity above 0.95 for distinguishing fiber preferential non-mechanical induced pain (laser heat, exciting Ad fibers, and 5-Hz electric stimulation, exciting C fibers). Conclusion: A three-item verbal rating test using the words "pricking'', "dull'', and "pressing'' may provide sufficient information to characterize a pain sensation evoked by a physical stimulus as transmitted via Ad or via C fibers. It meets the criteria of a screening test by being easy to administer, taking little time, being comfortable in handling, and inexpensive while providing high specificity for relevant information.	[Beissner, Florian; Henke, Christian] Goethe Univ Frankfurt, Neurol Clin, Frankfurt, Germany; [Brandau, Amadeus; Felden, Lisa; Oertel, Bruno G.; Loetsch, Joern] Goethe Univ Frankfurt, Inst Clin Pharmacol, Ctr Drug Res Dev & Safety ZAFES, Pharmazentrum Frankfurt, Frankfurt, Germany; [Baumgaertner, Ulf; Treede, Rolf-Detlef] Heidelberg Univ, Med Fac Mannheim, Ctr Biomed & Med Technol Mannheim CBTM, Div Neurophysiol, D-6800 Mannheim, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Ruprecht Karls University Heidelberg	Beissner, F (corresponding author), Goethe Univ Frankfurt, Neurol Clin, Frankfurt, Germany.	j.loetsch@em.uni-frankfurt.de	Beissner, Florian/I-3474-2019; Baumgärtner, Ulf/L-4149-2019; Treede, Rolf-Detlef/I-3632-2014	Beissner, Florian/0000-0003-0513-7551; Baumgärtner, Ulf/0000-0001-6371-3073; Lotsch, Jorn/0000-0002-5818-6958; Treede, Rolf-Detlef/0000-0001-8065-1708	Horst Goertz Foundation	Horst Goertz Foundation	FB was financially supported by the Horst Goertz Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; ALTMAN DG, 1994, BRIT MED J, V309, P102, DOI 10.1136/bmj.309.6947.102; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Bennett MI, 2007, PAIN, V127, P199, DOI 10.1016/j.pain.2006.10.034; BLUMBERG H, 1991, REFLEX SYMPATHETIC D, P29; BOWSHER D, 1991, ACUPUNCT MED, V9, P58; BROMM B, 1984, HUM NEUROBIOL, V3, P33; Chen A, 1998, J PAIN, V7, P159; CHEN ACN, 1985, PAIN, V22, P67, DOI 10.1016/0304-3959(85)90149-6; COOPER BY, 1986, PAIN, V24, P93, DOI 10.1016/0304-3959(86)90030-8; Cordell WH, 2002, AM J EMERG MED, V20, P165, DOI 10.1053/ajem.2002.32643; HANCOCK GR, 1993, EDUC PSYCHOL MEAS, V53, P651, DOI 10.1177/0013164493053003006; Hasselstrom J, 2002, EUR J PAIN, V6, P375, DOI 10.1016/S1090-3801(02)00025-3; HOBSON AR, 2010, AM J PHYSIOL-GASTR L, V298, P631; Hui Kathleen K S, 2007, BMC Complement Altern Med, V7, P33, DOI 10.1186/1472-6882-7-33; HUIJER HA, 2010, LEBAN MED J, V58, P21; KOLTZENBURG M, 1992, PAIN, V51, P207, DOI 10.1016/0304-3959(92)90262-A; KOLTZENBURG M, 1993, PAIN, V53, P363, DOI 10.1016/0304-3959(93)90238-K; Kong J, 2007, J ALTERN COMPLEM MED, V13, P1059, DOI 10.1089/acm.2007.0524; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Laursen RJ, 1999, MUSCLE NERVE, V22, P1564, DOI 10.1002/(SICI)1097-4598(199911)22:11<1564::AID-MUS12>3.3.CO;2-V; LEBARS D, 1976, BRAIN RES, V115, P518, DOI 10.1016/0006-8993(76)90370-X; LEEM JW, 1993, J NEUROPHYSIOL, V70, P2411, DOI 10.1152/jn.1993.70.6.2411; Liu SS, 1996, ANESTH ANALG, V82, P98, DOI 10.1097/00000539-199601000-00017; Lotsch J, 2003, PAIN, V102, P151, DOI 10.1016/S0304-3959(02)00349-4; MASSON EA, 1989, DIABETOLOGIA, V32, P724, DOI 10.1007/BF00274531; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; Nahra H, 2003, EUR J PAIN, V7, P189, DOI 10.1016/S1090-3801(02)00099-X; PITEI DL, 1994, DIABETIC MED, V11, P872, DOI 10.1111/j.1464-5491.1994.tb00371.x; Plaghki L, 2003, NEUROPHYSIOL CLIN, V33, P269, DOI 10.1016/j.neucli.2003.10.003; STEIN C, 1988, PAIN, V32, P251, DOI 10.1016/0304-3959(88)90074-7; Sumitani M, 2008, RHEUMATOLOGY, V47, P1038, DOI 10.1093/rheumatology/ken170; TOREBJORK HE, 1973, EXP BRAIN RES, V16, P321; TOREBJORK HE, 1992, J PHYSIOL-LONDON, V448, P765, DOI 10.1113/jphysiol.1992.sp019069; Truini A, 2008, PAIN, V140, P405, DOI 10.1016/j.pain.2008.08.018; VEVES A, 1994, DIABETES CARE, V17, P1200, DOI 10.2337/diacare.17.10.1200; Weiss T, 2008, NEUROIMAGE, V41, P1372, DOI 10.1016/j.neuroimage.2008.03.047; Wilkie DJ, 2001, J PAIN SYMPTOM MANAG, V22, P899, DOI 10.1016/S0885-3924(01)00351-7; Ziegler EA, 1999, BRAIN, V122, P2245, DOI 10.1093/brain/122.12.2245	39	74	75	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12944	10.1371/journal.pone.0012944	http://dx.doi.org/10.1371/journal.pone.0012944			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886070	Green Submitted, gold, Green Published			2022-12-27	WOS:000282091100042
J	Chamilos, G; Ganguly, D; Lande, R; Gregorio, J; Meller, S; Goldman, WE; Gilliet, M; Kontoyiannis, DP				Chamilos, Georgios; Ganguly, Dipyaman; Lande, Roberto; Gregorio, Josh; Meller, Stephan; Goldman, William E.; Gilliet, Michel; Kontoyiannis, Dimitrios P.			Generation of IL-23 Producing Dendritic Cells (DCs) by Airborne Fungi Regulates Fungal Pathogenicity via the Induction of T-H-17 Responses	PLOS ONE			English	Article							BETA-GLUCAN RECEPTOR; GROWTH-FACTOR-BETA; T-HELPER-CELLS; ASPERGILLUS-FUMIGATUS; CANDIDA-ALBICANS; IMMUNE RECOGNITION; HOST-DEFENSE; DECTIN-1; INFECTION; INTERLEUKIN-23	Interleukin-17 (IL-17) producing T helper cells (T-H-17) comprise a newly recognized T cell subset with an emerging role in adaptive immunity to a variety of fungi. Whether different airborne fungi trigger a common signaling pathway for T-H-17 induction, and whether this ability is related to the inherent pathogenic behavior of each fungus is currently unknown. Here we show that, as opposed to primary pathogenic fungi (Histoplasma capsulatum), opportunistic fungal pathogens (Aspergillus and Rhizopus) trigger a common innate sensing pathway in human dendritic cells (DCs) that results in robust production of IL-23 and drives T-H-17 responses. This response requires activation of dectin-1 by the fungal cell wall polysaccharide b-glucan that is selectively exposed during the invasive growth of opportunistic fungi. Notably, unmasking of b-glucan in the cell wall of a mutant of Histoplasma not only abrogates the pathogenicity of this fungus, but also triggers the induction of IL-23 producing DCs. Thus, b-glucan exposure in the fungal cell wall is essential for the induction of IL-23/T-H-17 axis and may represent a key factor that regulates protective immunity to opportunistic but not pathogenic fungi.	[Chamilos, Georgios; Ganguly, Dipyaman; Lande, Roberto; Gregorio, Josh; Meller, Stephan; Gilliet, Michel] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Chamilos, Georgios; Kontoyiannis, Dimitrios P.] Univ Texas MD Anderson Canc Ctr, Dept Infect Dis Infect Control & Employee Hlth, Houston, TX 77030 USA; [Gilliet, Michel] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA; [Goldman, William E.] Univ N Carolina Chapel Hill, Dept Microbiol & Immunol, Chapel Hill, NC USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of North Carolina; University of North Carolina Chapel Hill	Chamilos, G (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	mgilliet@mdanderson.org; dkontoyi@mdanderson.org	Meller, Stephan/GYA-5568-2022; Lande, Roberto/L-5803-2019; Lande, Roberto/B-9987-2016; Ganguly, Dipyaman/GON-3988-2022	Lande, Roberto/0000-0001-8398-4567; Lande, Roberto/0000-0001-8398-4567; Ganguly, Dipyaman/0000-0002-7786-1795; Goldman, William/0000-0002-1551-6718; Chamilos, Georgios/0000-0002-7987-4055	DANA Foundation; University of Texas [CA16672]; N.I.H. [AI25584]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI025584] Funding Source: NIH RePORTER	DANA Foundation; University of Texas; N.I.H.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant of the DANA Foundation (to M. G.), the M.D. Anderson Cancer Center Core Grant (CA16672) from the University of Texas (to D. P. K.), and the N.I.H. research grant AI25584 (to W. E. G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Aimanianda V, 2009, NATURE, V460, P1117, DOI 10.1038/nature08264; Bozza S, 2002, J IMMUNOL, V168, P1362, DOI 10.4049/jimmunol.168.3.1362; Bozza S, 2009, J IMMUNOL, V183, P2407, DOI 10.4049/jimmunol.0900961; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; d'Ostiani CF, 2000, J EXP MED, V191, P1661, DOI 10.1084/jem.191.10.1661; Da Silva CA, 2008, J IMMUNOL, V181, P4279, DOI 10.4049/jimmunol.181.6.4279; Dagenais TRT, 2009, CLIN MICROBIOL REV, V22, P447, DOI 10.1128/CMR.00055-08; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Eyerich K, 2008, J INVEST DERMATOL, V128, P2640, DOI 10.1038/jid.2008.139; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; Fridkin SK, 2005, CLIN INFECT DIS, V41, P1455, DOI 10.1086/497138; Gerosa F, 2008, J EXP MED, V205, P1447, DOI 10.1084/jem.20071450; Gersuk GM, 2006, J IMMUNOL, V176, P3717, DOI 10.4049/jimmunol.176.6.3717; Glocker EO, 2009, NEW ENGL J MED, V361, P1727, DOI 10.1056/NEJMoa0810719; Gringhuis SI, 2009, NAT IMMUNOL, V10, P203, DOI 10.1038/ni.1692; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Hohl TM, 2006, CURR OPIN IMMUNOL, V18, P465, DOI 10.1016/j.coi.2006.05.003; Hohl TM, 2005, PLOS PATHOG, V1, P232, DOI 10.1371/journal.ppat.0010030; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Ibrahim AS, 2005, ANTIMICROB AGENTS CH, V49, P721, DOI 10.1128/AAC.49.2.721-727.2005; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; Kleinschek MA, 2006, J IMMUNOL, V176, P1098, DOI 10.4049/jimmunol.176.2.1098; Kontoyiannis DP, 2006, INFECT DIS CLIN N AM, V20, P581, DOI 10.1016/j.idc.2006.06.003; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Latge JP, 2007, MOL MICROBIOL, V66, P279, DOI 10.1111/j.1365-2958.2007.05872.x; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Nucci M, 2005, CLIN INFECT DIS, V41, P521, DOI 10.1086/432060; Rappleye CA, 2007, P NATL ACAD SCI USA, V104, P1366, DOI 10.1073/pnas.0609848104; Rappleyel CA, 2008, TRENDS IMMUNOL, V29, P18, DOI 10.1016/j.it.2007.10.001; Reid DM, 2009, CURR OPIN IMMUNOL, V21, P30, DOI 10.1016/j.coi.2009.01.003; Ribes JA, 2000, CLIN MICROBIOL REV, V13, P236, DOI 10.1128/CMR.13.2.236-301.2000; Robinson MJ, 2009, J EXP MED, V206, P2037, DOI 10.1084/jem.20082818; Romani L, 2004, NAT REV IMMUNOL, V4, P11, DOI 10.1038/nri1255; Rothfuchs AG, 2007, J IMMUNOL, V179, P3463, DOI 10.4049/jimmunol.179.6.3463; Rudner XL, 2007, INFECT IMMUN, V75, P3055, DOI 10.1128/IAI.01329-06; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; TOMINAGA Y, 1981, AGR BIOL CHEM TOKYO, V45, P1569, DOI 10.1080/00021369.1981.10864749; van de Veerdonk FL, 2009, CELL HOST MICROBE, V5, P329, DOI 10.1016/j.chom.2009.02.006; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Werner JL, 2009, J IMMUNOL, V182, P4938, DOI 10.4049/jimmunol.0804250; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Yamasaki S, 2009, P NATL ACAD SCI USA, V106, P1897, DOI 10.1073/pnas.0805177106	47	87	90	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12955	10.1371/journal.pone.0012955	http://dx.doi.org/10.1371/journal.pone.0012955			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886035	Green Published, gold, Green Submitted			2022-12-27	WOS:000282091100050
J	Huang, XL; Fan, Z; Borowski, L; Mailliard, RB; Rolland, M; Mullins, JI; Day, RD; Rinaldo, CR				Huang, Xiao-Li; Fan, Zheng; Borowski, LuAnn; Mailliard, Robbie B.; Rolland, Morgane; Mullins, James I.; Day, Richard D.; Rinaldo, Charles R.			Dendritic Cells Reveal a Broad Range of MHC Class I Epitopes for HIV-1 in Persons with Suppressed Viral Load on Antiretroviral Therapy	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CD8(+) T-CELLS; MEMORY RESPONSES; PEPTIDE BINDING; AVIDITY; IMMUNIZATION; VACCINIA; HLA-A-ASTERISK-0201; POLYFUNCTIONALITY; PROLIFERATION	Background: HIV-1 remains sequestered during antiretroviral therapy (ART) and can resume high-level replication upon cessation of ART or development of drug resistance. Reactivity of memory CD8(+) T lymphocytes to HIV-1 could potentially inhibit this residual viral replication, but is largely muted by ART in relation to suppression of viral antigen burden. Dendritic cells (DC) are important for MHC class I processing and presentation of peptide epitopes to memory CD8(+) T cells, and could potentially be targeted to activate memory CD8(+) T cells to a broad array of HIV-1 epitopes during ART. Principal Findings: We show for the first time that HIV-1 peptide-loaded, CD40L-matured DC from HIV-1 infected persons on ART induce IFN gamma production by CD8(+) T cells specific for a much broader range and magnitude of Gag and Nef epitopes than do peptides without DC. The DC also reveal novel, MHC class I restricted, Gag and Nef epitopes that are able to induce polyfunctional T cells producing various combinations of IFN gamma, interleukin 2, tumor necrosis factor alpha, macrophage inhibitory protein 1 beta and the cytotoxic de-granulation molecule CD107a. Significance: There is an underlying, broad antigenic spectrum of anti-HIV-1, memory CD8(+) T cell reactivity in persons on ART that is revealed by DC. This supports the use of DC-based immunotherapy for HIV-1 infection.	[Huang, Xiao-Li; Fan, Zheng; Borowski, LuAnn; Mailliard, Robbie B.; Day, Richard D.; Rinaldo, Charles R.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA; [Huang, Xiao-Li; Fan, Zheng; Borowski, LuAnn; Mailliard, Robbie B.; Day, Richard D.; Rinaldo, Charles R.] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15261 USA; [Rolland, Morgane; Mullins, James I.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Day, Richard D.; Rinaldo, Charles R.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Rinaldo, Charles R.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Pathol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Huang, XL (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA.	rinaldo@pitt.edu	Mailiiard, Robbie/M-9723-2015	Mailliard, Robbie/0000-0001-5501-503X	National Institutes of Allergy and Infectious Diseases [P01 AI-055794, U01 AI-35041, R37 AI-41870]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI035041, P01AI055794, R37AI041870, P01AI057005] Funding Source: NIH RePORTER	National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Allergy and Infectious Diseases grants P01 AI-055794, U01 AI-35041 and R37 AI-41870. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Almeida JR, 2009, BLOOD, V113, P6351, DOI 10.1182/blood-2009-02-206557; Baker BM, 2009, EXPERT OPIN BIOL TH, V9, P55, DOI [10.1517/14712590802571928, 10.1517/14712590802571928 ]; Belz GT, 2006, EUR J IMMUNOL, V36, P327, DOI 10.1002/eji.200535432; Betts MR, 2008, CURR OPIN HIV AIDS, V3, P349, DOI 10.1097/COH.0b013e3282fbaa81; Currier JR, 2002, J IMMUNOL METHODS, V260, P157, DOI 10.1016/S0022-1759(01)00535-X; Dorrell L, 2006, J VIROL, V80, P4705, DOI 10.1128/JVI.80.10.4705-4716.2006; Draenert R, 2004, J EXP MED, V199, P905, DOI 10.1084/jem.20031982; Dubey S, 2007, JAIDS-J ACQ IMM DEF, V45, P20, DOI 10.1097/QAI.0b013e3180377b5b; Dzutsev AH, 2007, INT IMMUNOL, V19, P497, DOI 10.1093/intimm/dxm016; Frahm N, 2007, EUR J IMMUNOL, V37, P2419, DOI 10.1002/eji.200737365; GEPPERT TD, 1990, IMMUNOL REV, V117, P5, DOI 10.1111/j.1600-065X.1990.tb00566.x; Gnjatic S, 2003, J IMMUNOL, V170, P1191, DOI 10.4049/jimmunol.170.3.1191; Goonetilleke N, 2006, J VIROL, V80, P4717, DOI 10.1128/JVI.80.10.4717-4728.2006; HALVORSEN R, 1988, SCAND J IMMUNOL, V27, P555, DOI 10.1111/j.1365-3083.1988.tb02383.x; Harari A, 2007, P NATL ACAD SCI USA, V104, P16233, DOI 10.1073/pnas.0707570104; Huang SH, 2008, J IMMUNOL, V181, P8103, DOI 10.4049/jimmunol.181.11.8103; Huang XL, 2009, CLIN VACCINE IMMUNOL, V16, P1504, DOI 10.1128/CVI.00104-09; Kalams SA, 1999, J VIROL, V73, P6721, DOI 10.1128/JVI.73.8.6721-6728.1999; Kedzierska K, 2005, P NATL ACAD SCI USA, V102, P11432, DOI 10.1073/pnas.0504851102; Kerry SE, 2005, IMMUNOLOGY, V114, P44, DOI 10.1111/j.1365-2567.2004.02070.x; Kiecker F, 2004, HUM IMMUNOL, V65, P523, DOI 10.1016/j.humimm.2004.02.017; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kloverpris HN, 2009, APMIS, V117, P849, DOI 10.1111/j.1600-0463.2009.02544.x; KORBER BTM, 2006, HIV MOL IMMUNOLOGY; Kroger CJ, 2008, J IMMUNOL, V180, P5784, DOI 10.4049/jimmunol.180.9.5784; Kroger CJ, 2007, IMMUNOLOGY, V122, P167, DOI 10.1111/j.1365-2567.2007.02622.x; Lafuente EM, 2009, CURR PHARM DESIGN, V15, P3209, DOI 10.2174/138161209789105162; LEPONE L, CLIN VACCIN IN PRESS; Lopez-Abaitero A, 2009, J IMMUNOTHER, V32, P465, DOI 10.1097/CJI.0b013e3181a1c24e; MACATANGAY BJ, 2010, CLIN VACCIN IN PRESS; Mailliard RB, 2004, CANCER RES, V64, P5934, DOI 10.1158/0008-5472.CAN-04-1261; Marsh S. G. E., 2000, HLA FACTSBOOK; Masson F, 2008, IMMUNOL CELL BIOL, V86, P333, DOI 10.1038/icb.2008.15; Migueles SA, 2009, J VIROL, V83, P11876, DOI 10.1128/JVI.01153-09; Moser B, 2006, TRENDS IMMUNOL, V27, P112, DOI 10.1016/j.it.2006.01.002; Oseroff C, 2005, P NATL ACAD SCI USA, V102, P13980, DOI 10.1073/pnas.0506768102; Pasquetto V, 2005, J IMMUNOL, V175, P5504, DOI 10.4049/jimmunol.175.8.5504; Precopio ML, 2008, CYTOM PART A, V73A, P1071, DOI 10.1002/cyto.a.20646; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Rinaldo CR, 2009, J INTERN MED, V265, P138, DOI 10.1111/j.1365-2796.2008.02047.x; Rinaldo CR, 2000, J VIROL, V74, P4127, DOI 10.1128/JVI.74.9.4127-4138.2000; Riquelme E, 2009, EUR J IMMUNOL, V39, P2259, DOI 10.1002/eji.200939341; Rolland M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001424; Seth A, 2001, J INFECT DIS, V183, P722, DOI 10.1086/318816; SIA DY, 1988, IMMUNOL INVEST, V17, P77, DOI 10.3109/08820138809055720; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; Thobakgale CF, 2007, J VIROL, V81, P12775, DOI 10.1128/JVI.00624-07; Turk G, 2008, J VIROL, V82, P2853, DOI 10.1128/JVI.02260-07; van Montfoort N, 2009, P NATL ACAD SCI USA, V106, P6730, DOI 10.1073/pnas.0900969106; Wang MJ, 2007, VACCINE, V25, P2823, DOI 10.1016/j.vaccine.2006.12.038; Wauben Marca H M, 2003, Novartis Found Symp, V252, P211; WAUBEN MH, 2003, NOVART FDN SYMP, V252, P257; WAUBEN MH, 2003, NOVART FDN SYMP, V252, P220; Yewdell JW, 2006, IMMUNITY, V25, P533, DOI 10.1016/j.immuni.2006.09.005; Yewdell JW, 2005, IMMUNOL REV, V207, P8; Yu K, 2002, MOL MED, V8, P137, DOI 10.1007/BF03402006; Yu QG, 2003, J IMMUNOL, V170, P1797, DOI 10.4049/jimmunol.170.4.1797; Zammit DJ, 2006, MICROBES INFECT, V8, P1108, DOI 10.1016/j.micinf.2005.12.002; Zammit DJ, 2005, IMMUNITY, V22, P561, DOI 10.1016/j.immuni.2005.03.005	61	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12936	10.1371/journal.pone.0012936	http://dx.doi.org/10.1371/journal.pone.0012936			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20886040	Green Published, gold			2022-12-27	WOS:000282091100035
J	Guz, NV; Dokukin, ME; Sokolov, I				Guz, Natalia V.; Dokukin, Maxim E.; Sokolov, Igor			Atomic Force Microscopy Study of Nano-Physiological Response of Ladybird Beetles to Photostimuli	PLOS ONE			English	Article							HEARTBEAT REVERSAL; MANDUCA-SEXTA; PUPAE; RESPIRATION; CELLS	Background: Insects are of interest not only as the most numerous and diverse group of animals but also as highly efficient bio-machines varying greatly in size. They are the main human competitors for crop, can transmit various diseases, etc. However, little study of insects with modern nanotechnology tools has been done. Methodology/Principal Findings: Here we applied an atomic force microscopy (AFM) method to study stimulation of ladybird beetles with light. This method allows for measuring of the internal physiological responses of insects by recording surface oscillations in different parts of the insect at sub-nanometer amplitude level and sub-millisecond time. Specifically, we studied the sensitivity of ladybird beetles to light of different wavelengths. We demonstrated previously unknown blindness of ladybird beetles to emerald color (similar to 500nm) light, while being able to see UV-blue and green light. Furthermore, we showed how one could study the speed of the beetle adaptation to repetitive flashing light and its relaxation back to the initial stage. Conclusions: The results show the potential of the method in studying insects. We see this research as a part of what might be a new emerging area of "nanophysiology'' of insects.	[Guz, Natalia V.; Dokukin, Maxim E.; Sokolov, Igor] Clarkson Univ, Dept Phys, Potsdam, NY 13699 USA; [Sokolov, Igor] Clarkson Univ, Nanoengn & Biotechnol Labs Ctr NABLAB, Potsdam, NY USA	Clarkson University; Clarkson University	Guz, NV (corresponding author), Clarkson Univ, Dept Phys, Potsdam, NY 13699 USA.	isokolov@clarkson.edu	Sokolov, Igor/A-6858-2009	Sokolov, Igor/0000-0001-6260-4326	Clarkson University	Clarkson University	The research was supported by Dr. Sokolov's startup funds provided by Clarkson University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cator LJ, 2009, SCIENCE, V323, P1077, DOI 10.1126/science.1166541; Dokukin ME, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3273371; Domke J, 1999, EUR BIOPHYS J BIOPHY, V28, P179, DOI 10.1007/s002490050198; Hetz SK, 2005, NATURE, V433, P516, DOI 10.1038/nature03106; Iyer S, 2009, NAT NANOTECHNOL, V4, P389, DOI [10.1038/nnano.2009.77, 10.1038/NNANO.2009.77]; Maksym GN, 2000, J APPL PHYSIOL, V89, P1619, DOI 10.1152/jappl.2000.89.4.1619; Mishra M, 2006, INVERTEBR BIOL, V125, P265, DOI 10.1111/j.1744-7410.2006.00059.x; Pelling AE, 2004, SCIENCE, V305, P1147, DOI 10.1126/science.1097640; Pelling AE, 2009, J R SOC INTERFACE, V6, P29, DOI 10.1098/rsif.2008.0224; RADMACHER M, 1994, SCIENCE, V265, P1577, DOI 10.1126/science.8079171; Slama K, 1999, ANN ENTOMOL SOC AM, V92, P916, DOI 10.1093/aesa/92.6.916; Slama K, 2000, J INSECT PHYSIOL, V46, P977, DOI 10.1016/S0022-1910(99)00208-5; Slama K, 2001, EUR J ENTOMOL, V98, P415, DOI 10.14411/eje.2001.061; Slama K, 2003, J INSECT PHYSIOL, V49, P645, DOI 10.1016/S0022-1910(03)00065-9; Slama L, 2005, J INSECT PHYSIOL, V51, P489, DOI 10.1016/j.jinsphys.2004.11.016; Stephen WP, 2005, J KANSAS ENTOMOL SOC, V78, P373, DOI 10.2317/0410.03.1; Szabo B, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041910; Tartes U, 2000, PHYSIOL ENTOMOL, V25, P151, DOI 10.1046/j.1365-3032.2000.00180.x; Westneat MW, 2003, SCIENCE, V299, P558, DOI 10.1126/science.1078008	19	8	8	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12834	10.1371/journal.pone.0012834	http://dx.doi.org/10.1371/journal.pone.0012834			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877638	gold, Green Submitted, Green Published			2022-12-27	WOS:000282053100014
J	Meijaard, E; Albar, G; Nardiyono; Rayadin, Y; Ancrenaz, M; Spehar, S				Meijaard, Erik; Albar, Guillaume; Nardiyono; Rayadin, Yaya; Ancrenaz, Marc; Spehar, Stephanie			Unexpected Ecological Resilience in Bornean Orangutans and Implications for Pulp and Paper Plantation Management	PLOS ONE			English	Article							PONGO-PYGMAEUS-MORIO; POPULATION-DENSITY; WEST KALIMANTAN; EAST KALIMANTAN; AERIAL SURVEYS; FORESTS; BIODIVERSITY; DEFORESTATION; CONSERVATION; SABAH	Ecological studies of orangutans have almost exclusively focused on populations living in primary or selectively logged rainforest. The response of orangutans to severe habitat degradation remains therefore poorly understood. Most experts assume that viable populations cannot survive outside undisturbed or slightly disturbed forests. This is a concern because nearly 75% of all orangutans live outside protected areas, where degradation of natural forests is likely to occur, or where these are replaced by planted forests. To improve our understanding of orangutan survival in highly altered forest habitats, we conducted population density surveys in two pulp and paper plantation concessions in East Kalimantan, Indonesia. These plantations consist of areas planted with fast-growing exotics intermixed with stands of highly degraded forests and scrublands. Our rapid surveys indicate unexpectedly high orangutan densities in plantation landscapes dominated by Acacia spp., although it remains unclear whether such landscapes can maintain long-term viable populations. These findings indicate the need to better understand how plantation-dominated landscapes can potentially be incorporated into orangutan conservation planning. Although we emphasize that plantations have less value for overall biodiversity conservation than natural forests, they could potentially boost the chances of orangutan survival. Our findings are based on a relatively short study and various methodological issues need to be addressed, but they suggest that orangutans may be more ecologically flexible than previously thought.	[Meijaard, Erik] People & Nat Consulting Int, Jakarta, Indonesia; [Meijaard, Erik] Australian Natl Univ, Sch Archaeol & Anthropol, Canberra, ACT, Australia; [Albar, Guillaume] Soc Ornithol Polynesie, Taravao, Tahiti, France; [Nardiyono] Nat Conservancy Indonesia Program, Balikpapan, E Kalimantan, Indonesia; [Rayadin, Yaya] Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido, Japan; [Rayadin, Yaya] Mulawarman Univ, Fac Forestry, Samarinda, E Kalimantan, Indonesia; [Spehar, Stephanie] Univ Wisconsin, Dept Religious Studies & Anthropol, Oshkosh, WI 54901 USA	People & Nature Consulting International; Australian National University; Hokkaido University; Universitas Mulawarman; University of Wisconsin System	Meijaard, E (corresponding author), People & Nat Consulting Int, Jakarta, Indonesia.	emeijaard@pnc-int.com	Meijaard, Erik/A-2687-2016	Meijaard, Erik/0000-0001-8685-3685	United States Agency for International Development (USAID); Sall Family Foundation	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); Sall Family Foundation(European Commission)	The studies were financially supported by United States Agency for International Development (USAID) (www.usaid.gov/) and the Sall Family Foundation, who paid the salaries of Erik Meijaard and Nardiyono, and covered the field costs of the study. USAID agreed to the study being conducted. USAID, the Sall Family Foundation, and PNCI had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancrenaz M, 2005, PLOS BIOL, V3, P30, DOI 10.1371/journal.pbio.0030003; Ancrenaz M, 2004, ANIM CONSERV, V7, P375, DOI 10.1017/S136794300400157X; Ancrenaz M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011510; Andau Patrick Mahedi, 1994, Oryx, V28, P263; BARR C, 2008, ROUNDT IND PULP PAP; Brockerhoff EG, 2008, BIODIVERS CONSERV, V17, P925, DOI 10.1007/s10531-008-9380-x; Brook BW, 2003, NATURE, V424, P420, DOI 10.1038/nature01795; Buckland S.T., 2001, pi; Buckland S. T., 1993, Distance sampling: estimating abundance of biological populations.; Chazdon RL, 2008, SCIENCE, V320, P1458, DOI 10.1126/science.1155365; Chazdon RL, 2009, CONSERV BIOL, V23, P1406, DOI 10.1111/j.1523-1739.2009.01338.x; Dennis RA, 2006, SINGAPORE J TROP GEO, V27, P30, DOI 10.1111/j.1467-9493.2006.00238.x; DOI T, 1986, PRESENT STATUS LARGE; *FAO, 2006, 147 FAO UN; Felton AM, 2003, BIOL CONSERV, V114, P91, DOI 10.1016/S0006-3207(03)00013-2; Franklin JF, 2009, P NATL ACAD SCI USA, V106, P349, DOI 10.1073/pnas.0812016105; FULTON M, 1996, B ECOL SOC AM, V77, P217; HARTMAN P, 2010, ORANGUTAN CONSERVATI; Henle K, 2004, BIODIVERS CONSERV, V13, P207, DOI 10.1023/B:BIOC.0000004319.91643.9e; Johnson AE, 2005, BIOL CONSERV, V121, P495, DOI 10.1016/j.biocon.2004.06.002; Knop E, 2004, BIOL CONSERV, V120, P183, DOI 10.1016/j.biocon.2004.02.010; Koh LP, 2007, BIODIVERS CONSERV, V16, P3935, DOI 10.1007/s10531-007-9177-3; Koh LP, 2010, BIOTROPICA, V42, P67, DOI 10.1111/j.1744-7429.2009.00588.x; Lawton JH, 1998, NATURE, V391, P72, DOI 10.1038/34166; MacKinnon Kathy, 1994, Oryx, V28, P191, DOI 10.1017/S0030605300028556; MALINGREAU JP, 1985, AMBIO, V14, P314; Marshall AJ, 2007, INT J PRIMATOL, V28, P1218, DOI 10.1007/s10764-007-9218-5; Marshall AJ, 2007, AM J PRIMATOL, V69, P212, DOI 10.1002/ajp.20341; Marshall AJ, 2006, BIOL CONSERV, V129, P566, DOI 10.1016/j.biocon.2005.11.025; Marshall AJ, 2009, ORYX, V43, P416, DOI 10.1017/S0030605309001513; Mathewson PD, 2008, ECOL APPL, V18, P208, DOI 10.1890/07-0385.1; McShea WJ, 2009, BIOL CONSERV, V142, P3108, DOI 10.1016/j.biocon.2009.08.009; Meijaard E, 2007, CURR BIOL, V17, pR540, DOI 10.1016/j.cub.2007.05.016; Meijaard Erik, 2005, pi; Morrogh-Bernard H, 2003, BIOL CONSERV, V110, P141, DOI 10.1016/S0006-3207(02)00186-6; Morrogh-Bernard Helen C., 2009, P119; Myers N, 1996, ENVIRON CONSERV, V23, P156, DOI 10.1017/S0376892900038546; Prasetyo Didik, 2009, P269; RAYADIN Y, 2007, LAPORAN HASIL UNPUB; Rayadin Y, 2009, AM J PRIMATOL, V71, P393, DOI 10.1002/ajp.20666; Rijksen HD, 1999, OUR VANISHING RELATI; Russon Anne E., 2009, P135; Sheil D, 2010, BIOTROPICA, V42, P566, DOI 10.1111/j.1744-7429.2010.00687.x; Siegert F, 2001, NATURE, V414, P437, DOI 10.1038/35106547; Singleton I., 2004, ORANGUTAN POPULATION; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; Stibig H.-J., 2007, JRC SCI TECHNICAL RE; THOMAS L., 2006, DISTANCE 5 0 RELEASE; vanSchaik CP, 1995, NEGLECTED APE, P109; Wich SA, 2008, ORYX, V42, P329, DOI 10.1017/S003060530800197X; Wilson KA, 2010, ECOL APPL, V20, P1721, DOI 10.1890/09-1051.1; WITKAMP H, 1932, TROPISCHE NATUUR, V21, P169; Wright SJ, 2006, BIOTROPICA, V38, P443, DOI 10.1111/j.1744-7429.2006.00177.x	53	64	65	3	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2010	5	9							e12813	10.1371/journal.pone.0012813	http://dx.doi.org/10.1371/journal.pone.0012813			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653AC	20877646	gold, Green Published, Green Submitted			2022-12-27	WOS:000282053100011
J	Agam, A; Yalcin, B; Bhomra, A; Cubin, M; Webber, C; Holmes, C; Flint, J; Mott, R				Agam, Avigail; Yalcin, Binnaz; Bhomra, Amarjit; Cubin, Matthew; Webber, Caleb; Holmes, Christopher; Flint, Jonathan; Mott, Richard			Elusive Copy Number Variation in the Mouse Genome	PLOS ONE			English	Article							GENE-EXPRESSION; ARRAY; POLYMORPHISMS; IMPACT; MAP	Background: Array comparative genomic hybridization (aCGH) to detect copy number variants (CNVs) in mammalian genomes has led to a growing awareness of the potential importance of this category of sequence variation as a cause of phenotypic variation. Yet there are large discrepancies between studies, so that the extent of the genome affected by CNVs is unknown. We combined molecular and aCGH analyses of CNVs in inbred mouse strains to investigate this question. Principal Findings: Using a 2.1 million probe array we identified 1,477 deletions and 499 gains in 7 inbred mouse strains. Molecular characterization indicated that approximately one third of the CNVs detected by the array were false positives and we estimate the false negative rate to be more than 50%. We show that low concordance between studies is largely due to the molecular nature of CNVs, many of which consist of a series of smaller deletions and gains interspersed by regions where the DNA copy number is normal. Conclusions: Our results indicate that CNVs detected by arrays may be the coincidental co-localization of smaller CNVs, whose presence is more likely to perturb an aCGH hybridization profile than the effect of an isolated, small, copy number alteration. Our findings help explain the hitherto unexplored discrepancies between array-based studies of copy number variation in the mouse genome.	[Agam, Avigail; Yalcin, Binnaz; Bhomra, Amarjit; Cubin, Matthew; Flint, Jonathan; Mott, Richard] Wellcome Trust Ctr Human Genet, Oxford, England; [Webber, Caleb] Henry Wellcome Bldg Gene Funct, Dept Physiol Anat & Genet, Oxford, England; [Holmes, Christopher] Henry Wellcome Bldg Gene Funct, Dept Stat, Oxford, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Oxford	Agam, A (corresponding author), Wellcome Trust Ctr Human Genet, Oxford, England.	agam@well.ox.ac.uk	Yalcin, Binnaz/ABB-7735-2020; Yalcin, Binnaz/P-5482-2016	Yalcin, Binnaz/0000-0002-1924-6807; Yalcin, Binnaz/0000-0002-1924-6807; BHOMRA, AMARJIT/0000-0002-0439-0128; Flint, Jonathan/0000-0002-9427-4429; Mott, Richard/0000-0002-1022-9330; Webber, Caleb/0000-0001-8063-7674	Engineering and Physical Sciences Research Council; Wellcome Trust; MRC [G0500115, MC_U137761446, MC_UP_A390_1107] Funding Source: UKRI; Medical Research Council [MC_U137761446, MC_UP_A390_1107, G0500115] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was funded by the Engineering and Physical Sciences Research Council (http://www.epsrc.ac.uk) and by the Wellcome Trust (http://www. wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyden LM, 2008, NAT GENET, V40, P656, DOI 10.1038/ng.108; Breunis WB, 2008, BLOOD, V111, P1029, DOI 10.1182/blood-2007-03-079913; Cahan P, 2009, NAT GENET, V41, P430, DOI 10.1038/ng.350; Cahan P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn110; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Conrad S, 2009, NATURE, V460, DOI 10.1038/nature08353; Curtis C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-588; Cutler G, 2007, GENOME RES, V17, P1743, DOI 10.1101/gr.6754607; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Graubert TA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030003; Henrichsen CN, 2009, NAT GENET, V41, P424, DOI 10.1038/ng.345; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Huang GJ, 2009, GENOME RES, V19, P1133, DOI 10.1101/gr.088120.108; Hupe P, 2004, BIOINFORMATICS, V20, P3413, DOI 10.1093/bioinformatics/bth418; Kubista Mikael, 2006, Molecular Aspects of Medicine, V27, P95, DOI 10.1016/j.mam.2005.12.007; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Maas NMC, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.049510; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Nguyen DQ, 2006, PLOS GENET, V2, P198, DOI 10.1371/journal.pgen.0020020; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Orozco LD, 2009, HUM MOL GENET, V18, P4118, DOI 10.1093/hmg/ddp360; Perry GH, 2008, AM J HUM GENET, V82, P685, DOI 10.1016/j.ajhg.2007.12.010; Price TS, 2005, NUCLEIC ACIDS RES, V33, P3455, DOI 10.1093/nar/gki643; QUINLAN AR, 2010, GENOME RES IN PRESS; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rozen S, 2000, Methods Mol Biol, V132, P365; Scherer SW, 2007, NAT GENET, V39, pS7, DOI 10.1038/ng2093; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; She XW, 2008, NAT GENET, V40, P909, DOI 10.1038/ng.172; Smit A, 1996, REPEATMASKER OPEN 30; St Clair D, 2009, SCHIZOPHRENIA BULL, V35, P9, DOI 10.1093/schbul/sbn147; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Watkins-Chow DE, 2008, GENOME RES, V18, P60, DOI 10.1101/gr.6927808; Yalcin B, 2004, NAT GENET, V36, P1197, DOI 10.1038/ng1450	37	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2010	5	9							e12839	10.1371/journal.pone.0012839	http://dx.doi.org/10.1371/journal.pone.0012839			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	652JO	20877625	gold, Green Published, Green Accepted			2022-12-27	WOS:000282002900007
J	Fridley, BL; Jenkins, GD; Biernacka, JM				Fridley, Brooke L.; Jenkins, Gregory D.; Biernacka, Joanna M.			Self-Contained Gene-Set Analysis of Expression Data: An Evaluation of Existing and Novel Methods	PLOS ONE			English	Article							COMBINING P-VALUES; MICROARRAY DATA; INDEPENDENT TESTS; GLOBAL TEST; ASSOCIATION; VARIANCE; MODEL	Gene set methods aim to assess the overall evidence of association of a set of genes with a phenotype, such as disease or a quantitative trait. Multiple approaches for gene set analysis of expression data have been proposed. They can be divided into two types: competitive and self-contained. Benefits of self-contained methods include that they can be used for genome-wide, candidate gene, or pathway studies, and have been reported to be more powerful than competitive methods. We therefore investigated ten self-contained methods that can be used for continuous, discrete and time-to-event phenotypes. To assess the power and type I error rate for the various previously proposed and novel approaches, an extensive simulation study was completed in which the scenarios varied according to: number of genes in a gene set, number of genes associated with the phenotype, effect sizes, correlation between expression of genes within a gene set, and the sample size. In addition to the simulated data, the various methods were applied to a pharmacogenomic study of the drug gemcitabine. Simulation results demonstrated that overall Fisher's method and the global model with random effects have the highest power for a wide range of scenarios, while the analysis based on the first principal component and Kolmogorov-Smirnov test tended to have lowest power. The methods investigated here are likely to play an important role in identifying pathways that contribute to complex traits.	[Fridley, Brooke L.; Jenkins, Gregory D.; Biernacka, Joanna M.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA	Mayo Clinic	Fridley, BL (corresponding author), Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA.	fridley.brooke@mayo.edu	Fridley, Brooke L/D-8315-2015	Fridley, Brooke L/0000-0001-7739-7956	NIH [U01 GM61388, NIH RO3 AA019570]; Minnesota Partnership for Biotechnology and Medical Genomics [H9046000431]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R03AA019570] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Minnesota Partnership for Biotechnology and Medical Genomics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The research was supported by the NIH U01 GM61388, NIH RO3 AA019570 and Minnesota Partnership for Biotechnology and Medical Genomics grant H9046000431. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewale AJ, 2008, J COMPUT BIOL, V15, P269, DOI 10.1089/cmb.2008.0002; Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; [Anonymous], 1932, STAT METHODS RES WOR; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chai HS, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-102; Chen YH, 2008, BIOSTATISTICS, V9, P81, DOI 10.1093/biostatistics/kxm011; Cox D. R., 1984, ANAL SURVIVAL DATA; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dinu I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-242; Dinu I, 2008, CANCER INFORM, V6, P357; Goeman JJ, 2007, BIOINFORMATICS, V23, P980, DOI 10.1093/bioinformatics/btm051; Goeman JJ, 2006, J ROY STAT SOC B, V68, P477, DOI 10.1111/j.1467-9868.2006.00551.x; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Li L, 2008, CANCER RES, V68, P7050, DOI 10.1158/0008-5472.CAN-08-0405; LITTELL RC, 1973, J AM STAT ASSOC, V68, P193, DOI 10.2307/2284167; Liu Q, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-431; Ma S, 2009, BIOINFORMATICS, V25, P882, DOI 10.1093/bioinformatics/btp085; Mansmann U, 2005, METHOD INFORM MED, V44, P449; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; MOYER AM, 2010, ACETAMINOPHEN NAPQI; Moyer AM, 2010, CANCER EPIDEM BIOMAR, V19, P811, DOI 10.1158/1055-9965.EPI-09-0871; Neter J., 1996, APPL LINEAR STAT MOD; PATEL M, 1992, PHARMACOGENETICS, V2, P38, DOI 10.1097/00008571-199202000-00007; Stouffer S. A., 1949, AM SOLDIER, V1; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taylor J, 2006, BIOSTATISTICS, V7, P167, DOI 10.1093/biostatistics/kxj009; Tomfohr J, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-225; Tsai CA, 2009, BIOINFORMATICS, V25, P897, DOI 10.1093/bioinformatics/btp098; Whitlock MC, 2005, J EVOLUTION BIOL, V18, P1368, DOI 10.1111/j.1420-9101.2005.00917.x; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Zaykin DV, 2007, PHARM STAT, V6, P217, DOI 10.1002/pst.304; Zaykin DV, 2002, GENET EPIDEMIOL, V22, P170, DOI 10.1002/gepi.0042	34	47	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2010	5	9							e12693	10.1371/journal.pone.0012693	http://dx.doi.org/10.1371/journal.pone.0012693			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651XL	20862301	Green Submitted, gold, Green Published			2022-12-27	WOS:000281960800006
J	Borlado, MCG; Lastres, DM; Hoyuela, MG; Moran, M; Blazquez, A; Pello, R; Buera, LM; Gabaldon, T; Penas, JJG; Martin, MA; Arenas, J; Ugalde, C				Gil Borlado, Mari Carmen; Moreno Lastres, David; Gonzalez Hoyuela, Maritza; Moran, Maria; Blazquez, Alberto; Pello, Rosa; Marin Buera, Lorena; Gabaldon, Toni; Garcia Penas, Juan Jose; Martin, Miguel A.; Arenas, Joaquin; Ugalde, Cristina			Impact of the Mitochondrial Genetic Background in Complex III Deficiency	PLOS ONE			English	Article							CYTOCHROME-B GENE; MISSENSE MUTATION; SEQUENCE; MODEL; MTDNA	Background: In recent years clinical evidence has emphasized the importance of the mtDNA genetic background that hosts a primary pathogenic mutation in the clinical expression of mitochondrial disorders, but little experimental confirmation has been provided. We have analyzed the pathogenic role of a novel homoplasmic mutation (m. 15533 A>G) in the cytochrome b (MT-CYB) gene in a patient presenting with lactic acidosis, seizures, mild mental delay, and behaviour abnormalities. Methodology: Spectrophotometric analyses of the respiratory chain enzyme activities were performed in different tissues, the whole muscle mitochondrial DNA of the patient was sequenced, and the novel mutation was confirmed by PCR-RFLP. Transmitochondrial cybrids were constructed to confirm the pathogenicity of the mutation, and assembly/stability studies were carried out in fibroblasts and cybrids by means of mitochondrial translation inhibition in combination with blue native gel electrophoresis. Principal Findings: Biochemical analyses revealed a decrease in respiratory chain complex III activity in patient's skeletal muscle, and a combined enzyme defect of complexes III and IV in fibroblasts. Mutant transmitochondrial cybrids restored normal enzyme activities and steady-state protein levels, the mutation was mildly conserved along evolution, and the proband's mother and maternal aunt, both clinically unaffected, also harboured the homoplasmic mutation. These data suggested a nuclear genetic origin of the disease. However, by forcing the de novo functioning of the OXPHOS system, a severe delay in the biogenesis of the respiratory chain complexes was observed in the mutants, which demonstrated a direct functional effect of the mitochondrial genetic background. Conclusions: Our results point to possible pitfalls in the detection of pathogenic mitochondrial mutations, and highlight the role of the genetic mtDNA background in the development of mitochondrial disorders.	[Gil Borlado, Mari Carmen; Moreno Lastres, David; Gonzalez Hoyuela, Maritza; Moran, Maria; Blazquez, Alberto; Pello, Rosa; Marin Buera, Lorena; Martin, Miguel A.; Arenas, Joaquin; Ugalde, Cristina] Hosp Univ 12 Octubre, Ctr Invest, Madrid, Spain; [Moreno Lastres, David; Moran, Maria; Blazquez, Alberto; Marin Buera, Lorena; Martin, Miguel A.; Arenas, Joaquin; Ugalde, Cristina] CIBERER, U723, Madrid, Spain; [Gabaldon, Toni] CRG, Barcelona, Spain; [Garcia Penas, Juan Jose] Hosp Univ Nino Jesus, Serv Neurol, Madrid, Spain	Hospital Universitario 12 de Octubre; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Borlado, MCG (corresponding author), Hosp Univ 12 Octubre, Ctr Invest, Madrid, Spain.	cugalde@h12o.es	Ugalde, Cristina/P-7533-2016; Martin, Miguel A/S-2758-2018; Moran, Maria/HHS-1798-2022; Gabaldón, Toni/A-7336-2008; Blázquez Encinar, Alberto/S-4425-2018	Ugalde, Cristina/0000-0002-9742-1877; Martin, Miguel A/0000-0003-4741-772X; Gabaldón, Toni/0000-0003-0019-1735; Blázquez Encinar, Alberto/0000-0002-6479-3615; Arenas, Joaquin/0000-0002-2877-5049	Fundacion de Investigacion Biomedica del Hospital Universitario 12 de Octubre/Agencia Pedro Lain Entralgo; Instituto de Salud Carlos III (ISCIII) [PI05-0379, PI08-0021, PI09-01359, PI060213]; Spanish Ministry of Science (MICINN) [BFU2009-09168]	Fundacion de Investigacion Biomedica del Hospital Universitario 12 de Octubre/Agencia Pedro Lain Entralgo; Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Spanish Ministry of Science (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This study was partially supported by Fundacion de Investigacion Biomedica del Hospital Universitario 12 de Octubre/Agencia Pedro Lain Entralgo, and Instituto de Salud Carlos III (ISCIII) to C. U. (grant numbers PI05-0379 and PI08-0021), and to M. A. M. (PI09-01359). T. G. was supported by grants from the ISCIII (PI060213) and the Spanish Ministry of Science (MICINN) (BFU2009-09168). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Andreu AL, 2000, PEDIATR RES, V48, P311, DOI 10.1203/00006450-200009000-00008; Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; BAUM H, 1967, P NATL ACAD SCI USA, V57, P798, DOI 10.1073/pnas.57.3.798; Benit P, 2009, BBA-MOL CELL RES, V1793, P181, DOI 10.1016/j.bbamcr.2008.06.004; BROWN MD, 1992, GENETICS, V130, P163; Carelli V, 2009, BBA-BIOENERGETICS, V1787, P518, DOI 10.1016/j.bbabio.2009.02.024; D'Aurelio M, 2010, HUM MOL GENET, V19, P374, DOI 10.1093/hmg/ddp503; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fuku N, 2002, BIOCHEM BIOPH RES CO, V290, P1199, DOI 10.1006/bbrc.2002.6330; Gomez-Duran A, 2010, HUM MOL GENET, V19, P3343, DOI 10.1093/hmg/ddq246; Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Keightley JA, 2000, AM J HUM GENET, V67, P1400, DOI 10.1086/316900; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Martinez B, 2001, J NEUROCHEM, V78, P1054, DOI 10.1046/j.1471-4159.2001.00487.x; McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819; Montoya J, 2009, BBA-BIOENERGETICS, V1787, P476, DOI 10.1016/j.bbabio.2008.09.003; Pello R, 2008, HUM MOL GENET, V17, P4001, DOI 10.1093/hmg/ddn303; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Schuelke M, 2002, ANN NEUROL, V51, P388, DOI 10.1002/ana.10151; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011; Suissa S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000474; Ugalde C, 2004, HUM MOL GENET, V13, P2461, DOI 10.1093/hmg/ddh262; Valnot I, 1999, HUM GENET, V104, P460, DOI 10.1007/s004390050988; Wang LM, 2001, J MATER SCI TECHNOL, V17, P263; Wibrand F, 2001, ANN NEUROL, V50, P540, DOI 10.1002/ana.1224; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60	31	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2010	5	9							e2801	10.1371/journal.pone.0012801	http://dx.doi.org/10.1371/journal.pone.0012801			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651XL	20862300	Green Submitted, gold, Green Published			2022-12-27	WOS:000281960800014
J	Wei, SJ; Shi, M; Chen, XX; Sharkey, MJ; van Achterberg, C; Ye, GY; He, JH				Wei, Shu-Jun; Shi, Min; Chen, Xue-Xin; Sharkey, Michael J.; van Achterberg, Cornelis; Ye, Gong-Yin; He, Jun-Hua			New Views on Strand Asymmetry in Insect Mitochondrial Genomes	PLOS ONE			English	Article							DIRECTIONAL MUTATION PRESSURE; GENE REARRANGEMENTS; DROSOPHILA-MELANOGASTER; PHYLOGENETIC UTILITY; TERMINATION FACTOR; ESCHERICHIA-COLI; DNA EVOLUTION; T MUTATIONS; TRANSCRIPTION; REPLICATION	Strand asymmetry in nucleotide composition is a remarkable feature of animal mitochondrial genomes. Understanding the mutation processes that shape strand asymmetry is essential for comprehensive knowledge of genome evolution, demographical population history and accurate phylogenetic inference. Previous studies found that the relative contributions of different substitution types to strand asymmetry are associated with replication alone or both replication and transcription. However, the relative contributions of replication and transcription to strand asymmetry remain unclear. Here we conducted a broad survey of strand asymmetry across 120 insect mitochondrial genomes, with special reference to the correlation between the signs of skew values and replication orientation/gene direction. The results show that the sign of GC skew on entire mitochondrial genomes is reversed in all species of three distantly related families of insects, Philopteridae (Phthiraptera), Aleyrodidae (Hemiptera) and Braconidae (Hymenoptera); the replication-related elements in the A+T-rich regions of these species are inverted, confirming that reversal of strand asymmetry (GC skew) was caused by inversion of replication origin; and finally, the sign of GC skew value is associated with replication orientation but not with gene direction, while that of AT skew value varies with gene direction, replication and codon positions used in analyses. These findings show that deaminations during replication and other mutations contribute more than selection on amino acid sequences to strand compositions of G and C, and that the replication process has a stronger affect on A and T content than does transcription. Our results may contribute to genome-wide studies of replication and transcription mechanisms.	[Wei, Shu-Jun; Shi, Min; Chen, Xue-Xin; Ye, Gong-Yin; He, Jun-Hua] Zhejiang Univ, State Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Wei, Shu-Jun; Shi, Min; Chen, Xue-Xin; Ye, Gong-Yin; He, Jun-Hua] Zhejiang Univ, Minist Agr, Key Lab Mol Biol Crop Pathogens & Insects, Inst Insect Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Wei, Shu-Jun] Beijing Acad Agr & Forestry Sci, Inst Plant & Environm Protect, Beijing, Peoples R China; [Sharkey, Michael J.] Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA; [van Achterberg, Cornelis] Natl Museum Nat Hist, Dept Entomol, Leiden, Netherlands	Zhejiang University; Ministry of Agriculture & Rural Affairs; Zhejiang University; Beijing Academy of Agriculture & Forestry; University of Kentucky	Wei, SJ (corresponding author), Zhejiang Univ, State Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China.	xxchen@zju.edu.cn	van Achterberg, Kees/AFV-5150-2022; Chen, Xue-xin/D-1592-2010; Wei, Shu-Jun/C-1109-2011	Chen, Xue-xin/0000-0002-9109-8853; Wei, Shu-Jun/0000-0001-7398-0968; Zhang, Ming/0000-0001-6574-3006	National Science Fund for Distinguished Young Scholars [30625006]; 973 Program [2006CB102005]; National Science Foundation of China [30970384, 30700063, 30499341]; National Special Basic Research Funds [2006FY110500-3, 2006FY120100]; Special Fund for Agro-Scientific Research of the Public Interest [200803005-04]; Zhejiang Key Program of Agriculture [2009C12048]; NSF [EF-0337220]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); 973 Program(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Special Basic Research Funds; Special Fund for Agro-Scientific Research of the Public Interest; Zhejiang Key Program of Agriculture; NSF(National Science Foundation (NSF))	Funding for this study was provided jointly by the National Science Fund for Distinguished Young Scholars (30625006), the 973 Program (2006CB102005), the National Science Foundation of China (30970384, 30700063 and 30499341), the National Special Basic Research Funds (2006FY110500-3, 2006FY120100), Special Fund for Agro-Scientific Research of the Public Interest (200803005-04) and Zhejiang Key Program of Agriculture (2009C12048) to XXC, and the NSF (EF-0337220) to MJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht-Buehler G, 2006, P NATL ACAD SCI USA, V103, P17828, DOI 10.1073/pnas.0605553103; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Beletskii A, 1998, BIOL CHEM, V379, P549; Beletskii A, 1996, P NATL ACAD SCI USA, V93, P13919, DOI 10.1073/pnas.93.24.13919; Bogenhagen DF, 2003, TRENDS BIOCHEM SCI, V28, P357, DOI 10.1016/S0968-0004(03)00132-4; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105; Cameron SL, 2007, J MOL EVOL, V65, P589, DOI 10.1007/s00239-007-9042-8; Cha SY, 2007, GENE, V392, P206, DOI 10.1016/j.gene.2006.12.031; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; Covacin C, 2006, INSECT MOL BIOL, V15, P63, DOI 10.1111/j.1365-2583.2005.00608.x; Denver DR, 2000, SCIENCE, V289, P2342, DOI 10.1126/science.289.5488.2342; Dowton M, 2003, J MOL EVOL, V56, P517, DOI 10.1007/s00239-002-2420-3; Dowton M, 2002, INVERTEBR SYST, V16, P345, DOI 10.1071/IS02003; Faith JJ, 2003, GENETICS, V165, P735; Fonseca MM, 2008, MOL BIOL EVOL, V25, P805, DOI 10.1093/molbev/msn050; Francino MP, 2001, MOL BIOL EVOL, V18, P1147, DOI 10.1093/oxfordjournals.molbev.a003888; Francino MP, 1996, SCIENCE, V272, P107, DOI 10.1126/science.272.5258.107; Francino MP, 1997, TRENDS GENET, V13, P240, DOI 10.1016/S0168-9525(97)01118-9; FREDERICO LA, 1990, BIOCHEMISTRY-US, V29, P2532, DOI 10.1021/bi00462a015; Gaspari M, 2004, BBA-BIOENERGETICS, V1659, P148, DOI 10.1016/j.bbabio.2004.10.003; Green P, 2003, NAT GENET, V33, P514, DOI 10.1038/ng1103; Haag-Liautard C, 2008, PLOS BIOL, V6, P1706, DOI 10.1371/journal.pbio.0060204; Hassanin A, 2005, SYST BIOL, V54, P277, DOI 10.1080/10635150590947843; Hassanin A, 2006, MOL PHYLOGENET EVOL, V38, P100, DOI 10.1016/j.ympev.2005.09.012; Helfenbein KG, 2001, MOL BIOL EVOL, V18, P1734, DOI 10.1093/oxfordjournals.molbev.a003961; JERMIIN LS, 1995, MOL BIOL EVOL, V12, P558; KILPERT F, 2006, BMC GENOMICS, V7, DOI DOI 10.1186/1471-2164-1187-1241; Lee YS, 2008, NUCLEIC ACIDS RES, V36, pD938, DOI 10.1093/nar/gkm763; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LOBRY JR, 1995, J MOL EVOL, V40, P326, DOI 10.1007/BF00163237; Masta SE, 2009, MOL PHYLOGENET EVOL, V50, P117, DOI 10.1016/j.ympev.2008.10.010; Min XJ, 2007, DNA RES, V14, P201, DOI 10.1093/dnares/dsm019; Miyako K, 1999, EUR J BIOCHEM, V259, P412, DOI 10.1046/j.1432-1327.1999.00056.x; Montooth KL, 2008, PLOS BIOL, V6, P1634, DOI 10.1371/journal.pbio.0060213; Morton RA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-369; Nikolaou C, 2005, NUCLEIC ACIDS RES, V33, P6816, DOI 10.1093/nar/gki988; Nikolaou C, 2006, GENE, V381, P34, DOI 10.1016/j.gene.2006.06.010; Oliveira DCSG, 2008, MOL BIOL EVOL, V25, P2167, DOI 10.1093/molbev/msn159; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Raina SZ, 2005, GENOME RES, V15, P665, DOI 10.1101/gr.3128605; Reyes A, 1998, MOL BIOL EVOL, V15, P957, DOI 10.1093/oxfordjournals.molbev.a026011; Roberti M, 2003, NUCLEIC ACIDS RES, V31, P1597, DOI 10.1093/nar/gkg272; Roberti M, 2006, NUCLEIC ACIDS RES, V34, P2109, DOI 10.1093/nar/gkl181; Rocha EPC, 2006, GENOME RES, V16, P1537, DOI 10.1101/gr.5525106; SANCAR A, 1988, ANNU REV BIOCHEM, V57, P29, DOI 10.1146/annurev.bi.57.070188.000333; Scouras A, 2006, MOL PHYLOGENET EVOL, V39, P323, DOI 10.1016/j.ympev.2005.11.004; Shao RF, 2003, MOL BIOL EVOL, V20, P362, DOI 10.1093/molbev/msg045; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; TANAKA M, 1994, GENOMICS, V22, P327, DOI 10.1006/geno.1994.1391; Tang Q.Y., 2006, DPS DATA PROCESSING, P635; THAO M, 2004, BMC EVOLUTIONARY BIO, V4, DOI DOI 10.1186/1471-2148-1184-1125; Touchon M, 2004, NUCLEIC ACIDS RES, V32, P4969, DOI 10.1093/nar/gkh823; Wang XZ, 2007, GENE, V399, P11, DOI 10.1016/j.gene.2007.04.019; Wei SJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-371; Wei SJ, 2009, GENOME, V52, P308, DOI [10.1139/G09-008, 10.1139/g09-008]; Zhang DX, 1997, BIOCHEM SYST ECOL, V25, P99, DOI 10.1016/S0305-1978(96)00042-7	59	202	213	5	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2010	5	9							e12708	10.1371/journal.pone.0012708	http://dx.doi.org/10.1371/journal.pone.0012708			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZP	20856815	Green Published, Green Submitted, gold			2022-12-27	WOS:000281815800008
J	Sievers, C; Billig, G; Gottschalk, K; Rudel, T				Sievers, Claudia; Billig, Gwendolyn; Gottschalk, Kathleen; Rudel, Thomas			Prohibitins Are Required for Cancer Cell Proliferation and Adhesion	PLOS ONE			English	Article							REPLICATIVE LIFE-SPAN; M-AAA PROTEASE; 3'-UNTRANSLATED REGION; MITOCHONDRIAL PROTEINS; RNA INTERFERENCE; HELA-CELLS; MEMBRANE; POLYMORPHISM; APOPTOSIS; OPA1	Prohibitin 1 (PHB1) is a highly conserved protein that together with its homologue prohibitin 2 (PHB2) mainly localizes to the inner mitochondrial membrane. Although it was originally identified by its ability to inhibit G1/S progression in human fibroblasts, its role as tumor suppressor is debated. To determine the function of prohibitins in maintaining cell homeostasis, we generated cancer cell lines expressing prohibitin-directed shRNAs. We show that prohibitin proteins are necessary for the proliferation of cancer cells. Down-regulation of prohibitin expression drastically reduced the rate of cell division. Furthermore, mitochondrial morphology was not affected, but loss of prohibitins did lead to the degradation of the fusion protein OPA1 and, in certain cancer cell lines, to a reduced capability to exhibit anchorage-independent growth. These cancer cells also exhibited reduced adhesion to the extracellular matrix. Taken together, these observations suggest prohibitins play a crucial role in adhesion processes in the cell and thereby sustaining cancer cell propagation and survival.	[Sievers, Claudia; Billig, Gwendolyn; Gottschalk, Kathleen; Rudel, Thomas] Max Planck Inst Infect Biol, Dept Mol Biol, Res Grp Mol Infect & Canc Biol, Berlin, Germany; [Sievers, Claudia; Billig, Gwendolyn] Free Univ Berlin, Dept Biochem, D-1000 Berlin, Germany; [Rudel, Thomas] Univ Wurzburg, Bioctr, Wurzburg, Germany	Max Planck Society; Free University of Berlin; University of Wurzburg	Sievers, C (corresponding author), Max Planck Inst Infect Biol, Dept Mol Biol, Res Grp Mol Infect & Canc Biol, Berlin, Germany.	thomas.rudel@biozentrum.uni-wuerzburg.de	Billig, Gwendolyn M/A-1297-2012; Schuck, Kathleen/AAQ-4664-2021		European Union [LSHB-CT-2004-005276]	European Union(European Commission)	This work was supported by the by funding under the Sixth Research Framework Programme of the European Union, Project RIGHT (LSHB-CT-2004-005276) to TR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASAMOTO M, 1994, CANCER LETT, V83, P201, DOI 10.1016/0304-3835(94)90320-4; Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; Campbell IG, 2003, CANCER EPIDEM BIOMAR, V12, P1273; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021; Coates PJ, 1997, CURR BIOL, V7, P607, DOI 10.1016/S0960-9822(06)00261-2; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Fusaro G, 2002, ONCOGENE, V21, P4539, DOI 10.1038/sj.onc.1205551; Fusaro G, 2003, J BIOL CHEM, V278, P47853, DOI 10.1074/jbc.M305171200; Glenn HL, 2003, CELL MOTIL CYTOSKEL, V55, P265, DOI 10.1002/cm.10128; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184; Jupe ER, 2001, LANCET, V357, P1588, DOI 10.1016/S0140-6736(00)04747-4; Jupe ER, 1996, CELL GROWTH DIFFER, V7, P871; Kasashima K, 2006, J BIOL CHEM, V281, P36401, DOI 10.1074/jbc.M605260200; MCCLUNG JK, 1995, EXP GERONTOL, V30, P99, DOI 10.1016/0531-5565(94)00069-7; Merkwirth C, 2008, GENE DEV, V22, P476, DOI 10.1101/gad.460708; Mielenz D, 2005, J IMMUNOL, V174, P3508, DOI 10.4049/jimmunol.174.6.3508; Mishra S, 2006, J CELL MOL MED, V10, P353, DOI 10.1111/j.1582-4934.2006.tb00404.x; Nijtmans LGJ, 2002, CELL MOL LIFE SCI, V59, P143, DOI 10.1007/s00018-002-8411-0; Nijtmans LGJ, 2000, EMBO J, V19, P2444, DOI 10.1093/emboj/19.11.2444; NUELL MJ, 1991, MOL CELL BIOL, V11, P1372, DOI 10.1128/MCB.11.3.1372; Peng XJ, 2006, CANCER RES, V66, P7361, DOI 10.1158/0008-5472.CAN-06-1004; Piper PW, 2002, AGING CELL, V1, P149, DOI 10.1046/j.1474-9728.2002.00018.x; Rajalingam K, 2005, CELL CYCLE, V4, P1503, DOI 10.4161/cc.4.11.2142; Rajalingam K, 2005, NAT CELL BIOL, V7, P837, DOI 10.1038/ncb1283; Ross JA, 2008, J BIOL CHEM, V283, P4699, DOI 10.1074/jbc.M708232200; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Schleicher M, 2008, J CELL BIOL, V180, P101, DOI 10.1083/jcb.200706072; Spurdle AB, 2002, LANCET, V360, P925, DOI 10.1016/S0140-6736(02)11043-9; Steglich G, 1999, MOL CELL BIOL, V19, P3435; Tatsuta T, 2005, MOL BIOL CELL, V16, P248, DOI 10.1091/mbc.e04-09-0807; Tatsuta T, 2007, EMBO J, V26, P325, DOI 10.1038/sj.emboj.7601514; TERASHIMA M, 1994, EMBO J, V13, P3782, DOI 10.1002/j.1460-2075.1994.tb06689.x; Theiss AL, 2007, FASEB J, V21, P197, DOI 10.1096/fj.06-6801com; Vogel F, 2006, J CELL BIOL, V175, P237, DOI 10.1083/jcb.200605138; Wang S, 1999, ONCOGENE, V18, P3501, DOI 10.1038/sj.onc.1202684; Wang S, 2002, ONCOGENE, V21, P8388, DOI 10.1038/sj.onc.1205944; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003	39	59	62	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2010	5	9							e12735	10.1371/journal.pone.0012735	http://dx.doi.org/10.1371/journal.pone.0012735			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZO	20856874	Green Published, Green Submitted, gold			2022-12-27	WOS:000281815700019
J	Benameur, T; Soleti, R; Porro, C; Andriantsitohaina, R; Martinez, MC				Benameur, Tarek; Soleti, Raffaella; Porro, Chiara; Andriantsitohaina, Ramaroson; Martinez, Maria Carmen			Microparticles Carrying Sonic Hedgehog Favor Neovascularization through the Activation of Nitric Oxide Pathway in Mice	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; ENDOTHELIAL-CELLS; MATRIX METALLOPROTEINASES; CAPILLARY MORPHOGENESIS; VASCULAR FUNCTION; OXIDATIVE STRESS; SKELETAL-MUSCLE; MOUSE MODEL; ANGIOGENESIS; RATS	Background: Microparticles (MPs) are vesicles released from plasma membrane upon cell activation and during apoptosis. Human T lymphocytes undergoing activation and apoptosis generate MPs bearing morphogen Shh (MPs(Shh+)) that are able to regulate in vitro angiogenesis. Methodology/Principal Findings: Here, we investigated the ability of MPs(Shh+) to modulate neovascularization in a model of mouse hind limb ischemia. Mice were treated in vivo for 21 days with vehicle, MPs(Shh+), MPs(Shh+) plus cyclopamine or cyclopamine alone, an inhibitor of Shh signalling. Laser doppler analysis revealed that the recovery of the blood flow was 1.4 fold higher in MPs(Shh+)-treated mice than in controls, and this was associated with an activation of Shh pathway in muscles and an increase in NO production in both aorta and muscles. MPs(Shh+)-mediated effects on flow recovery and NO production were completely prevented when Shh signalling was inhibited by cyclopamine. In aorta, MPs increased activation of eNOS/Akt pathway, and VEGF expression, being inhibited by cyclopamine. By contrast, in muscles, MPs(Shh+) enhanced eNOS expression and phosphorylation and decreased caveolin-1 expression, but cyclopamine prevented only the effects of MPs(Shh+) on eNOS pathway. Quantitative RT-PCR revealed that MPs(Shh+) treatment increased FGF5, FGF2, VEGF A and C mRNA levels and decreased those of alpha 5-integrin, FLT-4, HGF, IGF-1, KDR, MCP-1, MT1-MMP, MMP-2, TGF beta 1, TGF beta 2, TSP-1 and VCAM-1, in ischemic muscles. Conclusions/Significance: These findings suggest that MPs(Shh+) may contribute to reparative neovascularization after ischemic injury by regulating NO pathway and genes involved in angiogenesis.	[Benameur, Tarek; Soleti, Raffaella; Andriantsitohaina, Ramaroson; Martinez, Maria Carmen] Univ Angers, Fac Med, CNRS, INSERM,UMR 6214,U771, Angers, France; [Porro, Chiara] Univ Foggia, Dept Biomed Sci, Sch Med, Foggia, Italy	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; University of Foggia	Benameur, T (corresponding author), Univ Angers, Fac Med, CNRS, INSERM,UMR 6214,U771, Angers, France.	carmen.martinez@univ-angers.fr	soleti, raffaella/AAC-1678-2021; ANDRIANTSITOHAINA, Ramaroson/H-5286-2018; BENAMEUR, TAREK/P-9053-2019; B, T/ABD-6713-2020; SOLETI, RAFFAELLA/ABB-5455-2020; Porro, Chiara/G-7849-2018	SOLETI, RAFFAELLA/0000-0002-0271-0490; Porro, Chiara/0000-0002-7526-6968; Martinez, M Carmen/0000-0003-3897-7397; andriantsitohaina, ramaroson/0000-0002-4770-3585	Agence Nationale pour la Recherche [ANR-07-PHYSIO-010-01]; Fonds Europen pour le Developpement Regional; CNRS; INSERM; Universite Angers; French Education Ministry (MENRT)	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Fonds Europen pour le Developpement Regional; CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Angers; French Education Ministry (MENRT)	This work was supported in part by grants from Agence Nationale pour la Recherche [M.C.M. ANR-07-PHYSIO-010-01]; Fonds Europen pour le Developpement Regional [R.A.]; CNRS; INSERM; and Universite Angers. T.B. is the recipient of a doctoral fellowship from French Education Ministry (MENRT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agouni A, 2007, FUND CLIN PHARMACOL, V21, P21; Anisimov A, 2009, CIRC RES, V104, P1302, DOI 10.1161/CIRCRESAHA.109.197830; Baron-Menguy C, 2007, FASEB J, V21, P3511, DOI 10.1096/fj.06-7782com; Bijlsma MF, 2010, EXP BIOL MED, V235, P447, DOI 10.1258/ebm.2009.009303; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Martinez MC, 2006, BLOOD, V108, P3012, DOI 10.1182/blood-2006-04-019109; Couffinhal T, 1998, AM J PATHOL, V152, P1667; Dokucu AI, 2009, INT UROL NEPHROL, V41, P101, DOI 10.1007/s11255-008-9460-6; Ghajar CM, 2008, CRIT REV EUKAR GENE, V18, P251, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.30; Giordano FJ, 1996, NAT MED, V2, P534, DOI 10.1038/nm0596-534; Gratton JP, 2004, CIRC RES, V94, P1408, DOI 10.1161/01.RES.0000129178.56294.17; Hoff J, 2000, LAB ANIMAL, V29, P47; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Kanda S, 2003, J BIOL CHEM, V278, P8244, DOI 10.1074/jbc.M210635200; Krum JM, 1998, EXP NEUROL, V154, P57, DOI 10.1006/exnr.1998.6930; Kusano KF, 2005, NAT MED, V11, P1197, DOI 10.1038/nm1313; Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185; Luo JD, 2009, AM J PHYSIOL-ENDOC M, V297, pE525, DOI 10.1152/ajpendo.00308.2009; Martinez MC, 2005, AM J PHYSIOL-HEART C, V288, pH1004, DOI 10.1152/ajpheart.00842.2004; Mezentsev A, 2005, AM J PHYSIOL-HEART C, V289, pH1106, DOI 10.1152/ajpheart.00265.2005; Mostefai HA, 2008, J IMMUNOL, V180, P5028, DOI 10.4049/jimmunol.180.7.5028; Motley ED, 2007, HYPERTENSION, V49, P577, DOI 10.1161/01.HYP.0000255954.80025.34; Ozturk H, 2007, RENAL FAILURE, V29, P249, DOI 10.1080/08860220601166289; Podlasek CA, 2005, CURR PHARM DESIGN, V11, P4011, DOI 10.2174/138161205774913408; Pola R, 2001, NAT MED, V7, P706, DOI 10.1038/89083; Pola R, 2003, CIRCULATION, V108, P479, DOI 10.1161/01.CIR.0000080338.60981.FA; Porro C, 2009, CURR SIGNAL TRANSD T, V4, P31, DOI 10.2174/157436209787048694; Ridnour LA, 2005, P NATL ACAD SCI USA, V102, P13147, DOI 10.1073/pnas.0502979102; Seiki M, 2003, CANCER LETT, V194, P1, DOI 10.1016/S0304-3835(02)00699-7; Soleti R, 2009, CARCINOGENESIS, V30, P580, DOI 10.1093/carcin/bgp030; Taraboletti G, 2002, AM J PATHOL, V160, P673, DOI 10.1016/S0002-9440(10)64887-0; Tuncer MC, 2007, WORLD J GASTROENTERO, V13, P3841; VAN HINSBERGH VWM, 2008, CARDIOVASC RES, V78, P203; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Watts VL, 2009, EXP BIOL MED, V234, P132, DOI 10.3181/0807-RM-233; Yang C, 2008, AM J PHYSIOL-REG I, V294, pR467, DOI 10.1152/ajpregu.00432.2007; Zhang JH, 2009, FASEB J, V23, P153, DOI 10.1096/fj.08-113860	38	81	82	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2010	5	9							e12688	10.1371/journal.pone.0012688	http://dx.doi.org/10.1371/journal.pone.0012688			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	648ZZ	20856928	gold, Green Published			2022-12-27	WOS:000281735700013
J	Jensen, MA; Fukushima, M; Davis, RW				Jensen, Michael A.; Fukushima, Marilyn; Davis, Ronald W.			DMSO and Betaine Greatly Improve Amplification of GC-Rich Constructs in De Novo Synthesis	PLOS ONE			English	Article							FACTOR-II RECEPTOR; ESCHERICHIA-COLI; PCR-AMPLIFICATION; DNA AMPLIFICATION; REPEAT SEQUENCES; GENE SYNTHESIS; GENOME; CANCER; EXPRESSION; GROWTH	In Synthetic Biology, de novo synthesis of GC-rich constructs poses a major challenge because of secondary structure formation and mispriming. While there are many web-based tools for codon optimizing difficult regions, no method currently exists that allows for potentially phenotypically important sequence conservation. Therefore, to overcome these limitations in researching GC-rich genes and their non-coding elements, we explored the use of DMSO and betaine in two conventional methods of assembly and amplification. For this study, we compared the polymerase (PCA) and ligase-based (LCR) methods for construction of two GC-rich gene fragments implicated in tumorigenesis, IGF2R and BRAF. Though we found no benefit in employing either DMSO or betaine during the assembly steps, both additives greatly improved target product specificity and yield during PCR amplification. Of the methods tested, LCR assembly proved far superior to PCA, generating a much more stable template to amplify from. We further report that DMSO and betaine are highly compatible with all other reaction components of gene synthesis and do not require any additional protocol modifications. Furthermore, we believe either additive will allow for the production of a wide variety of GC-rich gene constructs without the need for expensive and time-consuming sample extraction and purification prior to downstream application.	[Jensen, Michael A.; Fukushima, Marilyn; Davis, Ronald W.] Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA	Stanford University	Jensen, MA (corresponding author), Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA.	m.a.jensen@stanford.edu	; Kjaer, Andreas/E-8932-2015	Bjorkling, Fredrik/0000-0001-7018-8334; Kjaer, Andreas/0000-0002-2706-5547; Erichsen, Kamille Dumong/0000-0002-8814-7220	National Institutes of Health [P01-HG000205]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000205] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the National Institutes of Health [P01-HG000205]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au LC, 1998, BIOCHEM BIOPH RES CO, V248, P200, DOI 10.1006/bbrc.1998.8929; BACHMANN B, 1990, NUCLEIC ACIDS RES, V18, P1309, DOI 10.1093/nar/18.5.1309; BARANY F, 1991, P NATL ACAD SCI USA, V88, P189, DOI 10.1073/pnas.88.1.189; Benner SA, 2005, NAT REV GENET, V6, P533, DOI 10.1038/nrg1637; BRODY RS, 1986, J BIOL CHEM, V261, P7136; CHOU Q, 1992, NUCLEIC ACIDS RES, V20, P4371, DOI 10.1093/nar/20.16.4371; Cohen J, 2003, J NATL CANCER I, V95, P625, DOI 10.1093/jnci/95.8.625; D'Souza GGM, 2007, PHARM RES-DORDR, V24, P228, DOI 10.1007/s11095-006-9150-y; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; Drouin R, 2005, BIOCHEM CELL BIOL, V83, P147, DOI 10.1139/O04-134; FRACKMAN S, 1998, BETAINE DMSO ENHANCI; Frey UH, 2008, NAT PROTOC, V3, P1312, DOI 10.1038/nprot.2008.112; GELLERT M, 1962, P NATL ACAD SCI USA, V48, P2013, DOI 10.1073/pnas.48.12.2013; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Hakkaart GAJ, 2006, EMBO REP, V7, P341, DOI 10.1038/sj.embor.7400601; Hapgood JP, 2001, CELL BIOL INT, V25, P17, DOI 10.1006/cbir.2000.0674; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; Jayaraj S, 2005, NUCLEIC ACIDS RES, V33, P3011, DOI 10.1093/nar/gki614; KHORANA HG, 1979, SCIENCE, V203, P614, DOI 10.1126/science.366749; Kotsinas A, 2008, CANCER LETT, V259, P177, DOI 10.1016/j.canlet.2007.10.013; Marcuello E, 2004, INT J CANCER, V112, P733, DOI 10.1002/ijc.20487; MCCONLOGUE L, 1988, NUCLEIC ACIDS RES, V16, P9869, DOI 10.1093/nar/16.20.9869; McDowell DG, 1998, NUCLEIC ACIDS RES, V26, P3340, DOI 10.1093/nar/26.14.3340; Meyer Peter, 2003, J Carcinog, V2, P7, DOI 10.1186/1477-3163-2-7; MORGAN DO, 1987, NATURE, V329, P301, DOI 10.1038/329301a0; PANZER S, 1995, STEM CELLS, V13, P146, DOI 10.1002/stem.5530130206; REES WA, 1993, BIOCHEMISTRY-US, V32, P137, DOI 10.1021/bi00052a019; Richardson SM, 2006, GENOME RES, V16, P550, DOI 10.1101/gr.4431306; Rouillard JM, 2004, NUCLEIC ACIDS RES, V32, pW176, DOI 10.1093/nar/gkh401; Sahdev S, 2007, MOL CELL PROBE, V21, P303, DOI 10.1016/j.mcp.2007.03.004; Sanli G, 2001, J MOL MICROB BIOTECH, V3, P123; SARKAR G, 1990, NUCLEIC ACIDS RES, V18, P7465, DOI 10.1093/nar/18.24.7465; Simonsson T, 2001, BIOL CHEM, V382, P621, DOI 10.1515/BC.2001.073; Smith HO, 2003, P NATL ACAD SCI USA, V100, P15440, DOI 10.1073/pnas.2237126100; Spiess AN, 2004, CLIN CHEM, V50, P1256, DOI 10.1373/clinchem.2004.031336; Stahler P, 2006, J BIOTECHNOL, V124, P206, DOI 10.1016/j.jbiotec.2005.12.011; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; USDIN K, 1995, NUCLEIC ACIDS RES, V23, P4202, DOI 10.1093/nar/23.20.4202; VARADARAJ K, 1994, GENE, V140, P1, DOI 10.1016/0378-1119(94)90723-4; WEISSMAN SM, 2000, Patent No. 6114150; WINSHIP PR, 1989, NUCLEIC ACIDS RES, V17, P1266, DOI 10.1093/nar/17.3.1266; Zavras AI, 2003, CANCER RES, V63, P296; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	44	107	120	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2010	5	6							e11024	10.1371/journal.pone.0011024	http://dx.doi.org/10.1371/journal.pone.0011024			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	609NG	20885974	Green Published, Green Submitted, gold			2022-12-27	WOS:000278662900007
J	Tan, W; Dean, M; Law, AJ				Tan, Wei; Dean, Michael; Law, Amanda J.			Molecular Cloning and Characterization of the Human ErbB4 Gene: Identification of Novel Splice Isoforms in the Developing and Adult Brain	PLOS ONE			English	Article							SCHIZOPHRENIA; EXPRESSION; NEUREGULIN-1; TRANSLATION; VARIANTS; DISEASE; CODE	ErbB4 is a growth factor receptor tyrosine kinase essential for neurodevelopment. Genetic variation in ErbB4 is associated with schizophrenia and risk-associated polymorphisms predict overexpression of ErbB4 CYT-1 isoforms in the brain in the disorder. The molecular mechanism of association is unclear because the polymorphisms flank exon 3 of the gene and reside 700 kb distal to the CYT-1 defining exon. We hypothesized that the polymorphisms are indirectly associated with ErbB4 CYT-1 via splicing of exon 3 on the CYT-1 background. We report via cloning and sequencing of adult and fetal human brain cDNA libraries the identification of novel splice isoforms of ErbB4, whereby exon 3 is skipped (del. 3). ErbB4 del. 3 transcripts exist as CYT-2 isoforms and are predicted to produce truncated proteins. Furthermore, our data refine the structure of the human ErbB4 gene, clarify that juxtamembrane (JM) splice variants of ErbB4, JM-a and JM-b respectively, are characterized by the replacement of a 75 nucleotide (nt) sequence with a 45-nt insertion, and demonstrate that there are four alternative exons in the gene. Our analyses reveal that novel splice variants of ErbB4 exist in the developing and adult human brain and, given the failure to identify ErbB4 del. 3 CYT-1 transcripts, suggest that the association of risk polymorphisms in the ErbB4 gene with CYT-1 transcript levels is not mediated via an exon 3 splicing event.	[Tan, Wei] Natl Canc Inst Frederick, Basic Sci Program, Sci Applicat Int Corp Frederick, Frederick, MD USA; [Dean, Michael] Natl Canc Inst Frederick, Expt Immunol Lab, Canc & Inflammat Program, Ctr Canc Res, Frederick, MD USA; [Law, Amanda J.] NIMH, Clin Brain Disorders Branch, Intramural Res Program, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Tan, W (corresponding author), Natl Canc Inst Frederick, Basic Sci Program, Sci Applicat Int Corp Frederick, Frederick, MD USA.	lawa@mail.nih.gov	Law, Amanda J/G-6372-2012; Dean, Michael/R-7501-2019; Dean, Michael C/G-8172-2012; Pethe, Kevin/L-1199-2013	Law, Amanda J/0000-0002-2574-1564; Dean, Michael C/0000-0003-2234-0631; Pethe, Kevin/0000-0003-0297-0150; Dick, Thomas/0000-0002-9604-9452; Cliff, Penelope/0000-0001-6558-6039; Pethe, Kevin/0000-0003-0916-8873	National Institute of Mental Health, National Institutes of Health (NIH), Bethesda, MD; National Cancer Institute, National Institutes of Health [HHSN26120080001E]; NIH, National Cancer Institute, Center for Cancer Research; MRC [G120/997] Funding Source: UKRI; Medical Research Council [G120/997] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [ZIABC011301] Funding Source: NIH RePORTER	National Institute of Mental Health, National Institutes of Health (NIH), Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institute of Mental Health, National Institutes of Health (NIH), Bethesda, MD 20892, USA and federal funds from the National Cancer Institute, National Institutes of Health, under contract HHSN26120080001E. This research was also supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Elenius K, 1997, J BIOL CHEM, V272, P26761, DOI 10.1074/jbc.272.42.26761; Elenius K, 1999, ONCOGENE, V18, P2607, DOI 10.1038/sj.onc.1202612; Harrison PJ, 2006, BIOL PSYCHIAT, V60, P132, DOI 10.1016/j.biopsych.2005.11.002; Junttila TT, 2003, CLIN CANCER RES, V9, P5346; Konrad A, 2009, NEUROPSYCHOPHARMACOL, V34, P641, DOI 10.1038/npp.2008.112; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; Law AJ, 2007, HUM MOL GENET, V16, P129, DOI 10.1093/hmg/ddl449; LUUKKONEN BGM, 1995, J VIROL, V69, P4086, DOI 10.1128/JVI.69.7.4086-4094.1995; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Nicholson P, 2010, CELL MOL LIFE SCI, V67, P677, DOI 10.1007/s00018-009-0177-1; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Rudloff U, 2010, CELL CYCLE, V9, P1487, DOI 10.4161/cc.9.8.11239; Silberberg G, 2006, AM J MED GENET B, V141B, P142, DOI 10.1002/ajmg.b.30275; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164	17	94	95	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12924	10.1371/journal.pone.0012924	http://dx.doi.org/10.1371/journal.pone.0012924			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	21048946	gold, Green Published, Green Submitted			2022-12-27	WOS:000282091100028
J	Liang, YL; Gao, H; Lin, SY; Goss, JA; Brunicardi, FC; Li, KY				Liang, Yulong; Gao, Hong; Lin, Shiaw-Yih; Goss, John A.; Brunicardi, Francis C.; Li, Kaiyi			siRNA-Based Targeting of Cyclin E Overexpression Inhibits Breast Cancer Cell Growth and Suppresses Tumor Development in Breast Cancer Mouse Model	PLOS ONE			English	Article							RNA INTERFERENCE; IN-VIVO; HEPATOCELLULAR-CARCINOMA; LINES; GENE; PHOSPHORYLATION; ACTIVATION; EXPRESSION; STRATEGIES; APOPTOSIS	Cyclin E is aberrantly expressed in many types of cancer including breast cancer. High levels of the full length as well as the low molecular weight isoforms of cyclin E are associated with poor prognosis of breast cancer patients. Notably, cyclin E overexpression is also correlated with triple-negative basal-like breast cancers, which lack specific therapeutic targets. In this study, we used siRNA to target cyclin E overexpression and assessed its ability to suppress breast cancer growth in nude mice. Our results revealed that cyclin E siRNA could effectively inhibit overexpression of both full length and low molecular weight isoforms of cyclin E. We found that depletion of cyclin E promoted apoptosis of cyclin E-overexpressing cells and blocked their proliferation and transformation phenotypes. Significantly, we further demonstrated that administration of cyclin E siRNA could inhibit breast tumor growth in nude mice. In addition, we found that cyclin E siRNA synergistically enhanced the cell killing effects of doxorubicin in cell culture and this combination greatly suppressed the tumor growth in mice. In conclusion, our results indicate that cyclin E, which is overexpressed in 30% of breast cancer, may serve as a novel and effective therapeutic target. More importantly, our study clearly demonstrates a very promising therapeutic potential of cyclin E siRNA for treating the cyclin E-overexpressing breast cancers, including the very malignant triple-negative breast cancers.	[Liang, Yulong; Gao, Hong; Goss, John A.; Brunicardi, Francis C.; Li, Kaiyi] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [Lin, Shiaw-Yih] Univ Texas Houston, MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Liang, YL (corresponding author), Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA.	kli@bcm.tmc.edu	Liang, Yulong/A-2171-2013; Gao, Haichun/A-2160-2014	Liang, Yulong/0000-0001-8219-9575; Gao, Haichun/0000-0002-2647-6563	Susan Komen Breast Cancer Foundation; National Institutes of Health [NIH R01]	Susan Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is supported by grants from the Susan Komen Breast Cancer Foundation (to K. Li) and National Institutes of Health (NIH R01, to K. Li). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bales E, 2005, CANCER RES, V65, P692; Bedrosian I, 2004, ONCOGENE, V23, P2648, DOI 10.1038/sj.onc.1207408; Bertrand JR, 2002, BIOCHEM BIOPH RES CO, V296, P1000, DOI 10.1016/S0006-291X(02)02013-2; Bortner DM, 1997, MOL CELL BIOL, V17, P453, DOI 10.1128/MCB.17.1.453; Braasch DA, 2002, BIOCHEMISTRY-US, V41, P4503, DOI 10.1021/bi0122112; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Buchholz TA, 2003, CANCER J, V9, P33, DOI 10.1097/00130404-200301000-00007; Chiao PJ, 2002, CANCER, V95, P1696, DOI 10.1002/cncr.10829; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Clurman BE, 1996, GENE DEV, V10, P1979, DOI 10.1101/gad.10.16.1979; Foulkes WD, 2004, CANCER RES, V64, P830, DOI 10.1158/0008-5472.CAN-03-2970; Goyal BR, 2009, FUND CLIN PHARMACOL, V23, P367, DOI 10.1111/j.1472-8206.2009.00694.x; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Harwell RM, 2000, CANCER RES, V60, P481; Hough SR, 2003, NAT BIOTECHNOL, V21, P731, DOI 10.1038/nbt0703-731b; Jang SJ, 1999, EUR J SURG ONCOL, V25, P157, DOI 10.1053/ejso.1998.0619; Jin W, 2003, BRIT J CANCER, V89, P185, DOI 10.1038/sj.bjc.6601048; KEYOMARSI K, 1994, CANCER RES, V54, P380; Keyomarsi K, 2002, NEW ENGL J MED, V347, P1566, DOI 10.1056/NEJMoa021153; Kim DH, 2007, NAT REV GENET, V8, P173, DOI 10.1038/nrg2006; Knuefermann C, 2003, ONCOGENE, V22, P3205, DOI 10.1038/sj.onc.1206394; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; Li KY, 2003, CANCER RES, V63, P3593; Li KY, 1999, ONCOGENE, V18, P2617, DOI 10.1038/sj.onc.1202605; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nielsen NH, 1996, BRIT J CANCER, V74, P874, DOI 10.1038/bjc.1996.451; OVERMOYER BA, 1995, SEMIN ONCOL, V22, P2; Porter DC, 2001, MOL CELL BIOL, V21, P6254, DOI 10.1128/MCB.21.18.6254-6269.2001; Sauer K, 1995, Prog Cell Cycle Res, V1, P125; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Takahashi N, 2002, CANCER RES, V62, P6909; van Hille B, 1999, ANTI-CANCER DRUG, V10, P551, DOI 10.1097/00001813-199907000-00007; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Wilda M, 2002, ONCOGENE, V21, P5716, DOI 10.1038/sj.onc.1205653; Wingate H, 2005, J BIOL CHEM, V280, P15148, DOI 10.1074/jbc.M409789200; Wingate H, 2009, CELL CYCLE, V8, P1062, DOI 10.4161/cc.8.7.8119	42	68	70	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2010	5	9							e12860	10.1371/journal.pone.0012860	http://dx.doi.org/10.1371/journal.pone.0012860			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651YH	21203399	Green Published, Green Submitted, gold			2022-12-27	WOS:000281963200020
J	Chen, HL; Yuh, CH; Wu, KK				Chen, Hua-Ling; Yuh, Chiou-Hwa; Wu, Kenneth K.			Nestin Is Essential for Zebrafish Brain and Eye Development through Control of Progenitor Cell Apoptosis	PLOS ONE			English	Article							EXPRESSION; PROTEIN; DEATH; CYTOSKELETON	Background: Nestin is expressed in neural progenitor cells (NPC) of developing brain. Despite its wide use as an NPC marker, the function of nestin in embryo development is unclear. Methodology/Principal Findings: As nestin is conserved in zebrafish and its predicted sequence is clustered with the mammalian nestin orthologue, we used zebrafish as a model to investigate its role in embryogenesis. Injection of nestin morpholino (MO) into fertilized eggs induced time-and dose-dependent brain and eye developmental defects. Nestin morphants exhibited characteristic morphological changes including small head, small eyes and hydrocephalus. Histological examinations show reduced hind-and mid-brain size, dilated ventricle, poorly organized retina and underdeveloped lens. Injection of control nestin MO did not induce brain or eye changes. Nestin MO injection reduced expression of ascl1b (achaete-scute complex-like 1b), a marker of NPCs, without affecting its distribution. Nestin MO did not influence Elavl3/4 (Embryonic lethal, abnormal vision, Drosophila-like 3/4) (a neuronal marker), or otx2 (a midbrain neuronal marker), but severely perturbed cranial motor nerve development and axon distribution. To determine whether the developmental defects are due to excessive NPC apoptosis and/or reduced NPC proliferation, we analyzed apoptosis by TUNEL assay and acridine orange staining and proliferation by BrdU incorporation, pcna and mcm5 expressions. Excessive apoptosis was noted in hindbrain and midbrain cells. Apoptotic signals were colocalized with ascl1b. Proliferation markers were not significantly altered by nestin MO. Conclusion/Significance: These results suggest that nestin is essential for zebrafish brain and eye development probably through control of progenitor cell apoptosis.	[Chen, Hua-Ling; Wu, Kenneth K.] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan; [Yuh, Chiou-Hwa] Natl Hlth Res Inst, Div Mol & Genom Med, Zhunan, Taiwan	National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan	Chen, HL (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan.	kkgo@nhri.org.tw	Yuh, Chiou-Hwa/AAL-2938-2020; Yuh, Chiou-Hwa/E-3972-2010; Wu, Kenneth Kun-Yu/B-1070-2010; Yuh, Chiou-Hwa/AAL-3531-2020; Chernyshev, Alexei/A-7195-2014	Kajihara, Hiroshi/0000-0001-6510-9355; Chernyshev, Alexei/0000-0002-2203-3001; Yuh, Chiou-Hwa/0000-0002-2356-1551	National Health Research Institutes, Taiwan; National Science Council, Taiwan	National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by National Health Research Institutes, Taiwan and National Science Council (Stem Cell Flagship Center Program), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bieberich E, 2003, J CELL BIOL, V162, P469, DOI 10.1083/jcb.200212067; Cairns NJ, 2004, J PATHOL, V204, P438, DOI 10.1002/path.1650; Chan TM, 2009, DEV BIOL, V326, P456, DOI 10.1016/j.ydbio.2008.11.010; Duggal N, 1997, BRAIN RES, V768, P1, DOI 10.1016/S0006-8993(97)00588-X; Ekker SC, 2001, GENESIS, V30, P89, DOI 10.1002/gene.1038; Gilbert S, 2008, APOPTOSIS, V13, P1479, DOI 10.1007/s10495-008-0274-x; Gourlay CW, 2005, NAT REV MOL CELL BIO, V6, P583, DOI 10.1038/nrm1682; Gulati-Leekha A, 2006, DEV BIOL, V296, P29, DOI 10.1016/j.ydbio.2006.03.024; Hanington PC, 2008, DEV BIOL, V314, P250, DOI 10.1016/j.ydbio.2007.10.012; Higashijima S, 2000, J NEUROSCI, V20, P206, DOI 10.1523/JNEUROSCI.20-01-00206.2000; Kageyama R, 1997, INT J BIOCHEM CELL B, V29, P1389, DOI 10.1016/S1357-2725(97)89968-2; Lam CS, 2009, DEV DYNAM, V238, P475, DOI 10.1002/dvdy.21853; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Mahler J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-89; Marvin NJ, 1998, J CELL SCI, V111, P1951; Mokry J, 1998, Acta Medica (Hradec Kralove), V41, P73; Mueller T, 2003, DEV BRAIN RES, V140, P137, DOI 10.1016/S0165-3806(02)00583-7; Qiu GT, 2007, EXP EYE RES, V84, P1047, DOI 10.1016/j.exer.2007.01.014; Rieske P, 2007, EUR J NEUROSCI, V25, P31, DOI 10.1111/j.1460-9568.2006.05254.x; Sabaliauskas NA, 2006, METHODS, V39, P246, DOI 10.1016/j.ymeth.2006.03.001; Sahlgren CM, 2006, EMBO J, V25, P4808, DOI 10.1038/sj.emboj.7601366; Sahlgren CM, 2003, MOL CELL BIOL, V23, P5090, DOI 10.1128/MCB.23.14.5090-5106.2003; Shen Q, 2002, DEVELOPMENT, V129, P4843; SJOBERG G, 1994, EXP CELL RES, V214, P447, DOI 10.1006/excr.1994.1281; Toivola DM, 2005, TRENDS CELL BIOL, V15, P608, DOI 10.1016/j.tcb.2005.09.004; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6	26	104	111	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9318	10.1371/journal.pone.0009318	http://dx.doi.org/10.1371/journal.pone.0009318			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SS	20174467	Green Published, gold, Green Submitted			2022-12-27	WOS:000274923700020
J	Sato, Y; Poynter, G; Huss, D; Filla, MB; Czirok, A; Rongish, BJ; Little, CD; Fraser, SE; Lansford, R				Sato, Yuki; Poynter, Greg; Huss, David; Filla, Michael B.; Czirok, Andras; Rongish, Brenda J.; Little, Charles D.; Fraser, Scott E.; Lansford, Rusty			Dynamic Analysis of Vascular Morphogenesis Using Transgenic Quail Embryos	PLOS ONE			English	Article							BLOOD-VESSEL FORMATION; LENTIVIRAL VECTORS; CHICK EMBRYO; CELL-MIGRATION; VASCULOGENESIS; MECHANISMS; EXPRESSION; EFFICIENT; EMBRYOGENESIS; ANGIOGENESIS	Background: One of the least understood and most central questions confronting biologists is how initially simple clusters or sheet-like cell collectives can assemble into highly complex three-dimensional functional tissues and organs. Due to the limits of oxygen diffusion, blood vessels are an essential and ubiquitous presence in all amniote tissues and organs. Vasculogenesis, the de novo self-assembly of endothelial cell (EC) precursors into endothelial tubes, is the first step in blood vessel formation [1]. Static imaging and in vitro models are wholly inadequate to capture many aspects of vascular pattern formation in vivo, because vasculogenesis involves dynamic changes of the endothelial cells and of the forming blood vessels, in an embryo that is changing size and shape. Methodology/Principal Findings: We have generated Tie1 transgenic quail lines Tg(tie1:H2B-eYFP) that express H2B-eYFP in all of their endothelial cells which permit investigations into early embryonic vascular morphogenesis with unprecedented clarity and insight. By combining the power of molecular genetics with the elegance of dynamic imaging, we follow the precise patterning of endothelial cells in space and time. We show that during vasculogenesis within the vascular plexus, ECs move independently to form the rudiments of blood vessels, all while collectively moving with gastrulating tissues that flow toward the embryo midline. The aortae are a composite of somatic derived ECs forming its dorsal regions and the splanchnic derived ECs forming its ventral region. The ECs in the dorsal regions of the forming aortae exhibit variable mediolateral motions as they move rostrally; those in more ventral regions show significant lateral-to-medial movement as they course rostrally. Conclusions/Significance: The present results offer a powerful approach to the major challenge of studying the relative role(s) of the mechanical, molecular, and cellular mechanisms of vascular development. In past studies, the advantages of the molecular genetic tools available in mouse were counterbalanced by the limited experimental accessibility needed for imaging and perturbation studies. Avian embryos provide the needed accessibility, but few genetic resources. The creation of transgenic quail with labeled endothelia builds upon the important roles that avian embryos have played in previous studies of vascular development.	[Sato, Yuki; Poynter, Greg; Huss, David; Fraser, Scott E.; Lansford, Rusty] CALTECH, Beckman Inst, Biol Imaging Ctr, Div Biol, Pasadena, CA 91125 USA; [Filla, Michael B.; Czirok, Andras; Rongish, Brenda J.; Little, Charles D.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA	California Institute of Technology; University of Kansas; University of Kansas Medical Center	Sato, Y (corresponding author), CALTECH, Beckman Inst, Biol Imaging Ctr, Div Biol, Pasadena, CA 91125 USA.	rusty@caltech.edu	Fraser, Scott/Y-3406-2019; Czirok, Andras/E-4253-2014; Rongish, Brenda/G-7637-2016; Lansford, Rusty/C-6956-2014; Rochel, Natacha/A-5718-2016; Sato, Yoshinori/J-2497-2015	Fraser, Scott/0000-0002-5377-0223; Czirok, Andras/0000-0002-2694-5163; Rongish, Brenda/0000-0002-1559-2876; Lansford, Rusty/0000-0002-2159-3699; Ueno, Takamasa/0000-0003-4852-4236; Poussin-Courmontagne, Pierre/0000-0003-4813-6882; POTIER, Noelle/0000-0002-6381-4365; Rochel, Natacha/0000-0002-3573-5889; Takata, Hiroshi/0000-0003-1457-6919; Nakagata, Naomi/0000-0002-5737-9993; Sato, Yoshinori/0000-0001-8250-6598	National Institutes of Health (NIH) National Center for Research Resources [R21HD047347-01]; NIH National Heart, Lung, and Blood Institute [(R01) HL085694, HL068855, HL87136]; NIH Center of Excellence in Genomic Science [P50 HG004071]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD047347] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085694, R01HL087136, R01HL068855] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG004071] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH Center of Excellence in Genomic Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Grants by the National Institutes of Health (NIH) National Center for Research Resources (R21HD047347-01), NIH National Heart, Lung, and Blood Institute (R01) HL085694 (BJR), HL068855 (CDL), HL87136 (AC), and NIH Center of Excellence in Genomic Science (P50 HG004071) supported the work. Y.S. was a postdoctoral fellow for research abroad of the Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Blomer U, 1997, J VIROL, V71, P6641; Cleaver O, 1998, DEVELOPMENT, V125, P3905; COFFIN JD, 1991, ANAT REC, V231, P383; Czirok A, 2002, J MICROSC-OXFORD, V206, P209, DOI 10.1046/j.1365-2818.2002.01032.x; DE PALMA M, 2003, HUM GENE THER, V14, P1193; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DERUITER MC, 1993, ANAT RECORD, V235, P261, DOI 10.1002/ar.1092350210; DRAKE CJ, 1992, DEV DYNAM, V193, P83, DOI 10.1002/aja.1001930111; Drake CJ, 1997, DEV BIOL, V192, P17, DOI 10.1006/dbio.1997.8751; DRAKE CJ, 1995, P NATL ACAD SCI USA, V92, P7657, DOI 10.1073/pnas.92.17.7657; Eichmann A, 2005, INT J DEV BIOL, V49, P259, DOI 10.1387/ijdb.041941ae; EYALGILADI H, 1976, DEV BIOL, V49, P321, DOI 10.1016/0012-1606(76)90178-0; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; GONZALEZCRUSSI F, 1971, AM J ANAT, V130, P441, DOI 10.1002/aja.1001300406; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Harvey AJ, 2002, NAT BIOTECHNOL, V20, P396, DOI 10.1038/nbt0402-396; Huss D, 2008, LAB ANIMAL, V37, P513, DOI 10.1038/laban1108-513; Iljin K, 2002, FASEB J, V16, P1764, DOI 10.1096/fj.01-1043com; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Keller R, 2006, DEVELOPMENT, V133, P2291, DOI 10.1242/dev.02406; Kootstra NA, 2003, ANNU REV PHARMACOL, V43, P413, DOI 10.1146/annurev.pharmtox.43.100901.140257; Kulesa PM, 2000, DEVELOPMENT, V127, P1161; Le Douarin N, 1973, Dev Biol, V30, P217, DOI 10.1016/0012-1606(73)90061-4; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; McGrew MJ, 2004, EMBO REP, V5, P728, DOI 10.1038/sj.embor.7400171; NEW DAT, 1955, J EMBRYOL EXP MORPH, V3, P320; PARDANAUD L, 1987, CELL DIFFER DEV, V22, P47, DOI 10.1016/0045-6039(87)90412-X; Pardanaud L, 1996, DEVELOPMENT, V122, P1363; PARTANEN J, 1992, MOL CELL BIOL, V12, P1698, DOI 10.1128/MCB.12.4.1698; Perryn ED, 2008, DEV BIOL, V313, P545, DOI 10.1016/j.ydbio.2007.10.036; Pinter E, 1997, AM J PATHOL, V150, P1523; POOLE TJ, 1989, J EXP ZOOL, V251, P224, DOI 10.1002/jez.1402510210; POYNTER G, 2009, COLD SPRING HARBOR P; Pudliszewski M, 2005, INT J DEV BIOL, V49, P355, DOI 10.1387/ijdb.041956mp; Risau W, 1995, ANNU REV CELL DEV BI, V11, P73, DOI 10.1146/annurev.cb.11.110195.000445; ROMANOFF A, 1960, HEMATOPOIETIC VASCUL, P571; Rupp PA, 2004, DEVELOPMENT, V131, P2887, DOI 10.1242/dev.01160; Sabin FR, 1920, CONTRIB EMBRYOL, V9, P215; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Schmidt A, 2007, CIRC RES, V101, P125, DOI 10.1161/CIRCRESAHA.107.148932; Scott BB, 2005, P NATL ACAD SCI USA, V102, P16443, DOI 10.1073/pnas.0508437102; Sedmera D, 2006, ANAT REC PART A, V288A, P933, DOI 10.1002/ar.a.20383; STALSBERG H, 1969, DEV BIOL, V19, P128, DOI 10.1016/0012-1606(69)90052-9; Trinkaus J.P., 1969, CELLS ORGANS FORCES, Vfirst; Zamir EA, 2005, ANN BIOMED ENG, V33, P854, DOI 10.1007/s10439-005-3037-7; Zamir EA, 2006, P NATL ACAD SCI USA, V103, P19806, DOI 10.1073/pnas.0606100103; Zamir EA, 2008, PLOS BIOL, V6, P2163, DOI 10.1371/journal.pbio.0060247; Zeng GF, 2007, BLOOD, V109, P1345, DOI 10.1182/blood-2006-07-037952	50	104	105	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2010	5	9							e12674	10.1371/journal.pone.0012674	http://dx.doi.org/10.1371/journal.pone.0012674			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZO	21152046	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000281815700006
